<SEC-DOCUMENT>0001142750-21-000046.txt : 20211105
<SEC-HEADER>0001142750-21-000046.hdr.sgml : 20211105
<ACCEPTANCE-DATETIME>20211105161759
ACCESSION NUMBER:		0001142750-21-000046
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		64
CONFORMED PERIOD OF REPORT:	20210930
FILED AS OF DATE:		20211105
DATE AS OF CHANGE:		20211105

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			AMN HEALTHCARE SERVICES INC
		CENTRAL INDEX KEY:			0001142750
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-HELP SUPPLY SERVICES [7363]
		IRS NUMBER:				061500476
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-16753
		FILM NUMBER:		211384771

	BUSINESS ADDRESS:	
		STREET 1:		8840 CYPRESS WATERS BOULEVARD
		STREET 2:		SUITE 300
		CITY:			DALLAS
		STATE:			TX
		ZIP:			75019
		BUSINESS PHONE:		8668718519

	MAIL ADDRESS:	
		STREET 1:		8840 CYPRESS WATERS BOULEVARD
		STREET 2:		SUITE 300
		CITY:			DALLAS
		STATE:			TX
		ZIP:			75019
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>amn-20210930.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2021 Workiva--><!--r:8a0f5122-b6dd-433b-8020-1a2d882303bb,g:c8a2db26-f545-4776-aff0-0a05f8878828,d:a383c8c7878a498d91f9e8901f0cfd9c--><html xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns="http://www.w3.org/1999/xhtml" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:amn="http://www.amnhealthcare.com/20210930" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>amn-20210930</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180L2ZyYWc6MTQ1NjJkMDY4ZWM5NDA2ZWI2OTU1MjZmZjUyZDRjYzYvdGFibGU6YWQ3N2I3ZWU1ODM1NDE3MDhkMDVjZDhlOTQ1ODE3YjgvdGFibGVyYW5nZTphZDc3YjdlZTU4MzU0MTcwOGQwNWNkOGU5NDU4MTdiOF8zLTEtMS0xLTEwNzcw_c38269af-3fcd-49e8-885d-99c27a5a46a4">0001142750</ix:nonNumeric><ix:nonNumeric contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" format="ixt:date-month-day" name="dei:CurrentFiscalYearEndDate" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180L2ZyYWc6MTQ1NjJkMDY4ZWM5NDA2ZWI2OTU1MjZmZjUyZDRjYzYvdGFibGU6YWQ3N2I3ZWU1ODM1NDE3MDhkMDVjZDhlOTQ1ODE3YjgvdGFibGVyYW5nZTphZDc3YjdlZTU4MzU0MTcwOGQwNWNkOGU5NDU4MTdiOF80LTEtMS0xLTEwNzcw_03787563-38fb-4611-8325-40e81e598322">12/31</ix:nonNumeric><ix:nonNumeric contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180L2ZyYWc6MTQ1NjJkMDY4ZWM5NDA2ZWI2OTU1MjZmZjUyZDRjYzYvdGFibGU6YWQ3N2I3ZWU1ODM1NDE3MDhkMDVjZDhlOTQ1ODE3YjgvdGFibGVyYW5nZTphZDc3YjdlZTU4MzU0MTcwOGQwNWNkOGU5NDU4MTdiOF81LTEtMS0xLTEwNzcw_34650222-16db-41a4-8f88-06455f61b355">2021</ix:nonNumeric><ix:nonNumeric contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180L2ZyYWc6MTQ1NjJkMDY4ZWM5NDA2ZWI2OTU1MjZmZjUyZDRjYzYvdGFibGU6YWQ3N2I3ZWU1ODM1NDE3MDhkMDVjZDhlOTQ1ODE3YjgvdGFibGVyYW5nZTphZDc3YjdlZTU4MzU0MTcwOGQwNWNkOGU5NDU4MTdiOF82LTEtMS0xLTEwNzcw_55b778f5-88c5-4170-9c2c-8982ee0ea5f4">Q3</ix:nonNumeric><ix:nonNumeric contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180L2ZyYWc6MTQ1NjJkMDY4ZWM5NDA2ZWI2OTU1MjZmZjUyZDRjYzYvdGFibGU6YWQ3N2I3ZWU1ODM1NDE3MDhkMDVjZDhlOTQ1ODE3YjgvdGFibGVyYW5nZTphZDc3YjdlZTU4MzU0MTcwOGQwNWNkOGU5NDU4MTdiOF83LTEtMS0xLTEwNzcw_2f8874e9-f026-4c18-b23d-56c4411be7ea">false</ix:nonNumeric><ix:nonNumeric contextRef="i7dde690144bc4ace94b25dc75e54f674_D20190101-20191231" name="us-gaap:AccountingStandardsUpdateExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjA4YjkwYmJkYmMzNDRhY2Q4MjczNzY0OGJhM2FmNzY2L3RhYmxlcmFuZ2U6MDhiOTBiYmRiYzM0NGFjZDgyNzM3NjQ4YmEzYWY3NjZfNS0wLTEtMS0xMDc3MA_9cc5eab4-fa7b-478b-ad5a-e122472c78ab">http://fasb.org/us-gaap/2021-01-31#AccountingStandardsUpdate201613Member</ix:nonNumeric><ix:nonNumeric contextRef="iae23414cbc0f4638aab5dbaabe6e5cc4_D20200101-20201231" name="us-gaap:AccountingStandardsUpdateExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zMS9mcmFnOmNlNDgxOGVmYTM1YjQ2NDI4NGUxN2Q2NWEwYThiNjc3L3RhYmxlOmU5MmY2N2EzMmZkYjRlZmY5MmRhZThhMjE3M2M0NzBmL3RhYmxlcmFuZ2U6ZTkyZjY3YTMyZmRiNGVmZjkyZGFlOGEyMTczYzQ3MGZfMi0wLTEtMS0xMDc3MA_2e5b46ce-627c-4ad2-9f91-f5ecc232b823">http://fasb.org/us-gaap/2021-01-31#AccountingStandardsUpdate201613Member</ix:nonNumeric><ix:nonNumeric contextRef="i7dde690144bc4ace94b25dc75e54f674_D20190101-20191231" name="us-gaap:AccountingStandardsUpdateExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zMS9mcmFnOmNlNDgxOGVmYTM1YjQ2NDI4NGUxN2Q2NWEwYThiNjc3L3RhYmxlOmU5MmY2N2EzMmZkYjRlZmY5MmRhZThhMjE3M2M0NzBmL3RhYmxlcmFuZ2U6ZTkyZjY3YTMyZmRiNGVmZjkyZGFlOGEyMTczYzQ3MGZfMi0wLTEtMS0xMDc3MA_5c495df8-c4dc-4a11-8dcb-5b212c885604">http://fasb.org/us-gaap/2021-01-31#AccountingStandardsUpdate201613Member</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="amn-20210930.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="i59e42fb4c1064ece98100d592cf3657c_I20211103"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-11-03</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i68ecd84e8da440808154baac134e839e_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i61f65cd0793e47078410af8ea7c03faa_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i150492f298fa47a78ef2c10a285a64f8_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6cb0c51ba8fa45fda70ec7e5df8b4ef1_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2f727815e2874946b60bd2e1bb5e93be_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaa1c76ff437b4f6ab9cb7b6cfe222bf4_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if7393c775ca64e5aad76fe5c6f242546_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i42390657f50c458e90b81cff65ca34a5_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i60d729ea22d44fd2a79b8bf55e800ca9_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i73ad7702c4f241548c42eab7eb506186_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib229d5f30fdf41e28a8c14b58ac7f71a_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i58a3e48055114d67b6bc5e307451f03b_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifb81bab0961842fb8ad3378a3b9343b6_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7dde690144bc4ace94b25dc75e54f674_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1289950aefbc4d06a62bac0d92b90879_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i55f9e8f7bfb74ed0a97dc5b843a44941_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i718b700dbfbb43239149794d4ebae58b_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4f7d797c1d4844499f22b04b3704142b_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib9bfddb010034bb38eded0804243bd37_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i97238f9b66054193b28698bcbd56bffd_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8374f5c37e3c42bcb5d46ed38d202316_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3fdc200320734b32ba399fb32a98810b_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i21ae371fccca46019f452281282a8e2e_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie4c03c1bf0694cdb83793beff3d0c14d_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ice0ddb5cd06441b9bbeccf3e4c82794d_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i22cbe5469ffd4ae29750942feb990e4a_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6d7b8b207f474903b3f67df5d7afc0b7_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic9ff33a69ee247cca762b7fc9c84ab44_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iba98b023b51845efaf19bbdbfccdd906_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i31b9aece0de343d4938455d196c5db4d_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2b53f2fafe1d4e4db0704085cd21df06_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7d335e9ab53a4968a587f6a232b63ae6_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i171378b7da944f48bc6e24f7e01f7ba2_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7a73aec65e1645e497b0db29a7acbd13_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i864c53255b1c4eecafc3c0eac9341add_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i61d471d96d2b497e850b061f9eed0d11_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i226e8207b95f41d1ad9ee9df88356228_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1318bf5c6a9f40ae8b4706d6aadc9c71_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if2cb1f3c6ed840009dec907fba58a43d_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6e14eb9c93e74f3296e6b86f12a28f94_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i912fae7382c74520a36b966d54d94e55_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1204f31b85134c68b260fb9d3a28ba82_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaa7b25fceae44920a18c86a32eb37837_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if2981eb3d48d4b619016fcb5f4dcabdc_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i041c1c8fe78444f88611087c404a5e99_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3656a73d18b94b609e6f1990823c9b89_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8479ccefea534b2dad7f94b83fe989f0_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaee22aaa9ae44b1391c0b85a98440ff2_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i04614019537444e7b0521086b438b3b9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7af796f0576e42eca232001f8709a3b5_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i02f81d784dce4b24a61070fc9496df23_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie5a0923496204e499de51398c3adbec5_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib2a70c6698bc4fb2a2ee6a77c38e17e7_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i88adf94124da4574a028c28b388799d6_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iac59e5529bc54834bcd03309405d87e9_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9dafaa37d5364e1ba2bb35e85967fa2c_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1ce2b693b671480e806a25a643c7f12d_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i403d2a055ccd43bb8b88f5d7cab63117_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idbce5210eba9474d85e1137c4859a231_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic160cb42fea14c7584293e11e1aa33d3_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i705012913b884ada9d0c3c4d270ed4d2_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3ef4f52f779e4faf95d4601d80832007_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i32dfbd39eb3d43cb911abb42fa8a42ef_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i77c68cc8659943eea02704a6a078bf18_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib57f7397b0a0419fb8f2b4cb5a7b0ff7_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibfb3f98525f24d859c4abcde0f73f237_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5577c5bda907400ea634496c766b83e8_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id73c4bc3bbf84e21b5f04cbfc8a138a4_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id04a12fb0c1a4d8cb8704c13c181f0c8_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i57a944b08046487db5fbee0222d76c46_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i054622b9ff6b45d094e6d62e718bb40a_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i65cb728c1968429faa88cef83eef8a65_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifce17ccf7b614cb3aeb8d263bb97ccf5_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id10a5dbf399445d3b8969edabe30751a_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i14e64987a4644969a8cf482d758cef56_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic432083dde80448887610e8035a6b032_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ide77a3fd11044dd3926be5b05e61a140_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib42c30aaa2d7465e8f21c1e6a8e2a52f_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iee8941b97b824762bb44d764f5549f5f_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1754ebd74a03401da95dc00b4abde2a7_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i02fea62d4d29457fb6f838bf4cba33b5_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iae23414cbc0f4638aab5dbaabe6e5cc4_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3540c67ef3ad4b86931989fd054e0b50_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="acquisition"><xbrli:measure>amn:acquisition</xbrli:measure></xbrli:unit><xbrli:context id="ifa30b8cb72094c7ca771fc176115f67e_D20210407-20210407"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">amn:SynziMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-07</xbrli:startDate><xbrli:endDate>2021-04-07</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i202e46c5ac0646f8b3354ce9a1eb5b00_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">amn:SynziMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieff88e899cdb408197ed1ff99234a795_D20210930-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">amn:SynziMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-30</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icbbe0cb0e30e4fc195db16971b04921b_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">amn:SynziMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id8a8066df2cd49fb99c9a296eb4b267d_I20210407"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">amn:SynziMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-07</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2ddc12eab3644117aaadf0ffbc24c476_I20210407"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">amn:SynziMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-07</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i750e5ac42b744b7999aafb93dd8e3926_D20200214-20200214"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">amn:StratusVideoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-02-14</xbrli:startDate><xbrli:endDate>2020-02-14</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1809609cdf714d66916ae3141253f6cd_I20180209"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-02-09</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie9d4571d2fdf44c6ba87db28c14cb175_I20200214"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">amn:TermDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-02-14</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib98f074e5878463f913e950ba5784162_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">amn:StratusVideoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i87dc697cd0464e2c938ed8477a3a3237_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">amn:StratusVideoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id09df577cd134e6994ece5aa31598ed7_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">amn:StratusVideoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2a27a4a6c0964a5194ffc4f8f4176fbf_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">amn:StratusVideoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3d55955405794cb789f5432f8c06331e_I20200214"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">amn:StratusVideoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-02-14</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia69287e7ab6c43f095adc3cb43556c44_D20200214-20200214"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">amn:StratusVideoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-02-14</xbrli:startDate><xbrli:endDate>2020-02-14</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3dad049f61fe4171831aea7245fff5c6_I20200214"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">amn:StratusVideoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-02-14</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idd4f7d02ac0c4fbcab236ee010c28075_D20200214-20200214"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">amn:StratusVideoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-02-14</xbrli:startDate><xbrli:endDate>2020-02-14</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i450e36d3b7b24a9a930abcbcebb33f8b_D20200214-20200214"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">amn:StratusVideoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-02-14</xbrli:startDate><xbrli:endDate>2020-02-14</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id060857eed0b4cc5a5f2798ea3dcc0c1_I20200214"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">amn:StratusVideoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-02-14</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4c6a14bbd81143a7b0ccd248e1c2ea39_D20200214-20200214"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">amn:StratusVideoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-02-14</xbrli:startDate><xbrli:endDate>2020-02-14</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic43cd4c81a97471aa9a13d84fb4031e2_I20200214"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">amn:InterpreterDatabaseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">amn:StratusVideoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-02-14</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5699c9a4945c4f429b834511a0a22cbc_D20200214-20200214"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">amn:InterpreterDatabaseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">amn:StratusVideoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-02-14</xbrli:startDate><xbrli:endDate>2020-02-14</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i67759f1dfa1b4429aabe1215e03414dc_I20200214"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">amn:StratusVideoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-02-14</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic87fd517c51345a2a17d4c391a7c46c3_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">amn:StratusVideoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic430d291a7804180aa0b06c38d0c7c55_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">amn:StratusVideoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id449bccf189e469e8b6a234845cba859_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">amn:StratusVideoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:NonrecurringAdjustmentAxis">us-gaap:AcquisitionRelatedCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2450926f8adf4dedb94c370247e5310b_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">amn:StratusVideoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:NonrecurringAdjustmentAxis">us-gaap:AcquisitionRelatedCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="segment"><xbrli:measure>amn:segment</xbrli:measure></xbrli:unit><xbrli:context id="i72bc6814293d41ce8300f2c38fcdd1bc_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:NurseAndAlliedHealthcareStaffingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3473b76faf004446b11d60f76e27591c_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:NurseAndAlliedHealthcareStaffingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5021bcb8a5144f2e92e4d17294f25756_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:NurseAndAlliedHealthcareStaffingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib58839822ae8478c8d8ef1cb827d2ebe_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:NurseAndAlliedHealthcareStaffingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5bb9c1ce74924d3fb6c80bf5bc7070ca_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:PhysicianAndLeadershipSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3bdfcb612866449f8fc82428772bc4e0_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:PhysicianAndLeadershipSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifd4b5ea0c6464abaafa771245dd4872b_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:PhysicianAndLeadershipSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8096536e07244cbc88570b4cd0b1df3b_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:PhysicianAndLeadershipSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i286479f51b3847f180927296005817b3_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:TechnologyAndWorkforceSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iebe1c6905368491eb38b8213c9304590_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:TechnologyAndWorkforceSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9f81f9d1a6314e098bdd58b74619a28f_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:TechnologyAndWorkforceSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib31de07b75904e5cb9fd99c168d04547_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:TechnologyAndWorkforceSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1a24f793f440442085a27968a5583766_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icdd1cb3977024d5d959ea51ad54b783d_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5479404ee04b498ab6fd8545f90d86b9_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i703fc84123784c69b090877fb4125906_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie946fae8ec0046439446bb138d525757_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i674c8f2758bf45ae8bb93948b5860e97_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib14ea5527ced44f5979f01683cbc7fc4_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieeebf848246c441ba6ab2c571e599296_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6841006ed66046048b923a10d1f02618_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amn:TemporaryStaffingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:NurseAndAlliedHealthcareStaffingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8aaeb4e7d78e45c4afa1ea8345243c26_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amn:TemporaryStaffingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:PhysicianAndLeadershipSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie7ed1c91706145b489b11684ae9f8f91_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amn:TemporaryStaffingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:TechnologyAndWorkforceSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6aff1598e94c41a9a49290be61afbb6c_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amn:TemporaryStaffingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i830444b4b4eb4bc49ed555e461733a60_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:NurseAndAlliedHealthcareStaffingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amn:PermanentPlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1dcde31709c646a282f435f6c32eace5_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:PhysicianAndLeadershipSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amn:PermanentPlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8a01cf9bd5e742be9ad5969b5dd25b9f_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:TechnologyAndWorkforceSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amn:PermanentPlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i469189243c1643a29f2acd332c552f64_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amn:PermanentPlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i97bcb414c2014844b1112de85e955858_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amn:OutsourcedWorkforceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:NurseAndAlliedHealthcareStaffingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0f2791f2f77d4b30b30f4f41b86a32be_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amn:OutsourcedWorkforceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:PhysicianAndLeadershipSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8d6328bac8bb4c5c9bc2c8b9292f8422_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amn:OutsourcedWorkforceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:TechnologyAndWorkforceSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ica26aea190054f37883620f719402399_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amn:OutsourcedWorkforceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iebe807a1030c4daab052b4d1c1386537_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amn:SaaSBasedTechnologiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:NurseAndAlliedHealthcareStaffingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3d75e1df27914f09a7b8252950f87b6b_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amn:SaaSBasedTechnologiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:PhysicianAndLeadershipSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i71d6cb2f38004881a4b6bd6017255a7a_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amn:SaaSBasedTechnologiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:TechnologyAndWorkforceSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibc6ef11462fa4624a5db4ae2d23f8e83_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amn:SaaSBasedTechnologiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i01269464f14e481692beaf81a76fb87d_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:NurseAndAlliedHealthcareStaffingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icc871800a2a54344bc972988728aa887_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:PhysicianAndLeadershipSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id0250f51d2d145cfa3b9c421cb969cfb_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:TechnologyAndWorkforceSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia6d8015a18974a7b896656aecc3ec4b4_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amn:TemporaryStaffingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:NurseAndAlliedHealthcareStaffingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifc8564de3068430abe113d5c5abeabe1_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amn:TemporaryStaffingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:PhysicianAndLeadershipSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i386e01817e9d4c42b6cd2228fb3796c2_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amn:TemporaryStaffingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:TechnologyAndWorkforceSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8d235eb71df14e8b9908f2e396c873cb_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amn:TemporaryStaffingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i44c7ce7db7f54f14969af01502dd38a0_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:NurseAndAlliedHealthcareStaffingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amn:PermanentPlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie04ed0997a484867b8fe5f9956a3292d_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:PhysicianAndLeadershipSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amn:PermanentPlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if26529ce715f495dafc6d4b52493ea02_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:TechnologyAndWorkforceSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amn:PermanentPlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if818b67b623c45a8aff218e40a7005c3_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amn:PermanentPlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9aba0cbe92634056880604c35ba04d52_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amn:OutsourcedWorkforceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:NurseAndAlliedHealthcareStaffingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieee345988a9b4cc4937342242689e98e_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amn:OutsourcedWorkforceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:PhysicianAndLeadershipSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i76440e2d28744cc98ead1974809c865f_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amn:OutsourcedWorkforceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:TechnologyAndWorkforceSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3d7b5abbd0ee4fca9a5b3efb81d07d5d_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amn:OutsourcedWorkforceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5893522597a942f38cbfe46a853546eb_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amn:SaaSBasedTechnologiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:NurseAndAlliedHealthcareStaffingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id296025a7e114f8b9f9b44d6b14233f1_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amn:SaaSBasedTechnologiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:PhysicianAndLeadershipSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9568bc87c368403cbb9e4180b3a0d538_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amn:SaaSBasedTechnologiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:TechnologyAndWorkforceSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0e447016b010458c883c1ef90a609651_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amn:SaaSBasedTechnologiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic8d64c3d8e5a47489226ba7a492dae32_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:NurseAndAlliedHealthcareStaffingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i44b9c9fa813d4c3688eab2f7ea808291_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:PhysicianAndLeadershipSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6460c9bf442443d3abf247bad9d30336_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:TechnologyAndWorkforceSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ida0f30c7727943e798527294cdf4394a_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amn:TemporaryStaffingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:NurseAndAlliedHealthcareStaffingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idcab03e09bc1437399cc7a03d8fc8b57_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amn:TemporaryStaffingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:PhysicianAndLeadershipSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i89958f0ec7cf446b98d11c657f7ee603_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amn:TemporaryStaffingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:TechnologyAndWorkforceSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i90eb3e7675a044e992b317175d9afcd9_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amn:TemporaryStaffingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8750be21113a4757ac053b8f62cd2ad2_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:NurseAndAlliedHealthcareStaffingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amn:PermanentPlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i30aa16b5b25048ca8dfeff42d533a177_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:PhysicianAndLeadershipSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amn:PermanentPlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3cfc2a42fe0e4807b29bf91ce0a45f43_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:TechnologyAndWorkforceSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amn:PermanentPlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibbdabae4c4224976a6088e48ddb040ba_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amn:PermanentPlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i536910b4999c4e32a95c6a8ac9c30f1d_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amn:OutsourcedWorkforceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:NurseAndAlliedHealthcareStaffingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4c17ffb386c649368efa203669f28351_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amn:OutsourcedWorkforceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:PhysicianAndLeadershipSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idf8b667f2cd34632a587e2d17a82e3fd_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amn:OutsourcedWorkforceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:TechnologyAndWorkforceSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iedbce8552e1b455082a65e938d6dec5b_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amn:OutsourcedWorkforceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9bb701054c8d4b2ca7bb36f5445e6a6a_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amn:SaaSBasedTechnologiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:NurseAndAlliedHealthcareStaffingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i80d03ebd1c054ee9977c5f826afd98f7_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amn:SaaSBasedTechnologiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:PhysicianAndLeadershipSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i85f859e6dc0a4f40aef7f8f521affd1c_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amn:SaaSBasedTechnologiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:TechnologyAndWorkforceSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icf4e0ac3bff74d3c81967d52a934245e_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amn:SaaSBasedTechnologiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i70417b2a548f4dc8aa5f1b5e01ea94f6_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:NurseAndAlliedHealthcareStaffingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic7cb32a8e20f4e59b29cb208784742f9_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:PhysicianAndLeadershipSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i19bf0b91fc2e4d4088d260a4a7291a68_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:TechnologyAndWorkforceSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if95e75fc39f542e0937abe52bd16b043_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amn:TemporaryStaffingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:NurseAndAlliedHealthcareStaffingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i41fa2315f758457689e492a76a31c2bc_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amn:TemporaryStaffingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:PhysicianAndLeadershipSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id149b105ef884b0d9c47f05bec237702_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amn:TemporaryStaffingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:TechnologyAndWorkforceSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8ee31b74c9154f7b815c08300a1950e0_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amn:TemporaryStaffingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i38ab08218c234821bc589e3cc2c80f3c_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:NurseAndAlliedHealthcareStaffingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amn:PermanentPlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4c3268cc1706415686fd7683f6ed1d51_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:PhysicianAndLeadershipSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amn:PermanentPlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4167819349934cd59d501e7c4c7ddcfc_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:TechnologyAndWorkforceSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amn:PermanentPlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i43362dd8fe0949449a39af825a732e7a_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amn:PermanentPlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i88f59cdb95f040e2b571b678226a7fec_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amn:OutsourcedWorkforceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:NurseAndAlliedHealthcareStaffingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iee45b2697e73423393102240edfca12a_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amn:OutsourcedWorkforceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:PhysicianAndLeadershipSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if3d5b12a279d423b9852c9ec50634277_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amn:OutsourcedWorkforceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:TechnologyAndWorkforceSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i93145b50299a45b0b7e234415765c760_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amn:OutsourcedWorkforceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia3589685d5bf494da6ce3464e2194081_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amn:SaaSBasedTechnologiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:NurseAndAlliedHealthcareStaffingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i683c901af8234ee8b34a8de537a4faed_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amn:SaaSBasedTechnologiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:PhysicianAndLeadershipSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9c392d9ab824476a96a3f41148cbe7fe_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amn:SaaSBasedTechnologiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:TechnologyAndWorkforceSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i598b74681e034171b491236964be10f1_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amn:SaaSBasedTechnologiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2a46e165877d46f7b437d72073d883c6_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:NurseAndAlliedHealthcareStaffingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if3be0a64ed0349d3ae2297e6a8a914d7_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:PhysicianAndLeadershipSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i11efb6327d494ef79b4c1a4e768e70bf_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:TechnologyAndWorkforceSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia707a5ecf30d4576a74a17b34e193c15_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:NurseAndAlliedHealthcareStaffingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifb5e6237d7d54806a979a6a53e302a7a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:PhysicianAndLeadershipSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibd0be51207114cd1b17f02ebecffc197_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:TechnologyAndWorkforceSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iff2345b9439d4c93833b660edbe6ce7f_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:NurseAndAlliedHealthcareStaffingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4161c5f102584f0fbecf9454461d6028_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:PhysicianAndLeadershipSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i33f34f84f7e146998551e4e55f51111a_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:TechnologyAndWorkforceSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8962b4b53b6140de975c8a15752edd5d_I20190614"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">amn:TermDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-14</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i75b241ded9e04282a87e07b5ca93bb10_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibdfd9e1e6a6a4aea800ca23a42cc6d9c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic8ecfcf890884810930a3db121a37947_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i46feda5d0d364eabb7ec42a6d33247c6_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i98888a04caa94c449d58020688cc10b7_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9aeb16c096e94fd18a6a4407369f7baf_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7406af186f1f431ba3a5cae4e80d7461_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">amn:DeferredCompensationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i148698ba11334fa7962b91a16b3e7880_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">amn:DeferredCompensationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i975bc3f2b0594c2996194a6fa3fd0687_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">amn:DeferredCompensationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia0adbc48e0574d688983232e62d3bdfa_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">amn:DeferredCompensationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9f2f077331ea49d9a65ccd6f803814da_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i12f5a5f263ab4ab69a41578d13ee6032_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1643e3ce569e435e90215e4c1f80cc45_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i04416ccdf99b4368b4ae3bb3d5c50522_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2779feaa7ca44c64a5d0144e462d669e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie85028cf6e7e4291811ded1080e9ccef_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i12292bac56af415ebe14864b760b6aee_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaad52f29996b478daad64bf29bf17dbe_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">amn:DeferredCompensationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i90ee55464c34456ab9205a90173c745d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">amn:DeferredCompensationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2dae041f1c2049bc8a78d41d20bd5c01_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">amn:DeferredCompensationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i01af2c6807964bd3a70f87bed11d7f18_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">amn:DeferredCompensationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i52afbebb62d24268b4227e4d0ecbfbd0_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i33219b4f757444d0acfe2defee9c77a2_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icabd932ac65d40a9ad263428cb023998_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia2321e23f81c49fca30df6d0483acd39_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">amn:ContingentConsiderationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie87be00cfa4e4645b636d077357bfaaa_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">amn:ContingentConsiderationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibe1edb1c0b7d484da43d71c0fcdd0d28_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">amn:ContingentConsiderationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6181153aab9d4bf1a9ac5e86d83189ec_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">amn:ContingentConsiderationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id213a9f9047d4508aeef40c71a6fe7f3_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">amn:ContingentConsiderationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i26375226748e457a83389380abbeabb8_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">amn:ContingentConsiderationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia06522632d4f4b51b495d744af0113af_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">amn:B4healthLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">amn:ContingentConsiderationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3225a1c038234fd6ad8decf2eea09642_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">amn:B4healthLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">amn:ContingentConsiderationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia1c38f520570446e977fefc12947c6df_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">amn:ContingentConsiderationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if25b9265f3954756bd8d09991a579c63_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">amn:ContingentConsiderationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i27f0dfb23ddc496989d2606c383df2c5_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">amn:ContingentConsiderationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia74ee65117cd4be980399efaba0fd27f_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">amn:AdvancedMedicalPersonnelServicesInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">amn:ContingentConsiderationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3dced23531a14782bb18a2d74864eba6_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">amn:AdvancedMedicalPersonnelServicesInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">amn:ContingentConsiderationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia8887638bb5c4199a5d785b2a07d5378_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">amn:B4healthLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">amn:ContingentConsiderationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8797e43b32204823b6a3ad14b6669a69_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">amn:B4healthLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">amn:ContingentConsiderationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i77b494fe460f4789ba120f413470a8d9_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic05278c1e0a647149ea04d2fc5ffc568_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="ic9968f7f2c454182aab2b88a2b279e04_I20200813"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">amn:A4.625SeniorNotesDue2027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-08-13</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2f6d79fdc037408d9dc6b393a68f3b3f_I20201020"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">amn:A4000SeniorNotesDue2029Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i74b3184e58994da0b7590f17370f09da_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">amn:A4.625SeniorNotesDue2027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia140cdbfeac94d9dbe04b0a64460ff19_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">amn:A4.625SeniorNotesDue2027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia9ea250e0d094ba5b694f077af429acd_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">amn:A4000SeniorNotesDue2029Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i17ce2ad3d6e849fc9dea40319a4961e3_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">amn:A4000SeniorNotesDue2029Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="phase"><xbrli:measure>amn:phase</xbrli:measure></xbrli:unit><xbrli:context id="ibdd33d48b3ef404689d6e95d9989f154_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">amn:WageAndHourClaimsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic4d0f83036ab4e5a816bee3070f588e7_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001142750</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">amn:WageAndHourClaimsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="ia383c8c7878a498d91f9e8901f0cfd9c_1"></div><div style="min-height:22.5pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">UNITED STATES </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">____________________</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xL2ZyYWc6NzNkMzI5ZjYwZjM0NDA1M2E5YzhlMGIzYzI4MjZhNzMvdGV4dHJlZ2lvbjo3M2QzMjlmNjBmMzQ0MDUzYTljOGUwYjNjMjgyNmE3M18xOTk0_e22facaf-c616-4aed-94e5-3312b9176b2f">10-Q</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">____________________</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:6.677%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:91.123%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" format="ixt-sec:boolballotbox" name="dei:DocumentQuarterlyReport" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xL2ZyYWc6NzNkMzI5ZjYwZjM0NDA1M2E5YzhlMGIzYzI4MjZhNzMvdGFibGU6YTllMzI2OTZhZWE1NDlmM2I3MjlkMzgxMTk1MDFjMDEvdGFibGVyYW5nZTphOWUzMjY5NmFlYTU0OWYzYjcyOWQzODExOTUwMWMwMV8wLTAtMS0xLTEwNzcw_5d4d57d1-eedc-495c-aa08-468e27c022e0">&#9746;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the quarterly period ended <ix:nonNumeric contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" format="ixt:date-monthname-day-year-en" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xL2ZyYWc6NzNkMzI5ZjYwZjM0NDA1M2E5YzhlMGIzYzI4MjZhNzMvdGV4dHJlZ2lvbjo3M2QzMjlmNjBmMzQ0MDUzYTljOGUwYjNjMjgyNmE3M18xNjU_4d45d63f-f04f-402c-ae06-7613fc412d4f">September&#160;30, 2021</ix:nonNumeric> </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:6.122%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:91.678%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OR</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" format="ixt-sec:boolballotbox" name="dei:DocumentTransitionReport" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xL2ZyYWc6NzNkMzI5ZjYwZjM0NDA1M2E5YzhlMGIzYzI4MjZhNzMvdGFibGU6ZWMzYjIzMjgxOTYwNDVhMmFlYWVmZTMzYjhlM2VjZTYvdGFibGVyYW5nZTplYzNiMjMyODE5NjA0NWEyYWVhZWZlMzNiOGUzZWNlNl8xLTAtMS0xLTEwNzcw_b01c5964-dc91-4280-abb1-72d8492f8c66">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the transition period from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commission File No.: <ix:nonNumeric contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xL2ZyYWc6NzNkMzI5ZjYwZjM0NDA1M2E5YzhlMGIzYzI4MjZhNzMvdGV4dHJlZ2lvbjo3M2QzMjlmNjBmMzQ0MDUzYTljOGUwYjNjMjgyNmE3M18xOTg5_e5d762cf-0bdc-48a7-b080-acf27cc25f3a">001-16753</ix:nonNumeric> </span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><img src="amn-20210930_g1.jpg" alt="amn-20210930_g1.jpg" style="height:62px;margin-bottom:5pt;vertical-align:text-bottom;width:192px"/></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:24pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xL2ZyYWc6NzNkMzI5ZjYwZjM0NDA1M2E5YzhlMGIzYzI4MjZhNzMvdGV4dHJlZ2lvbjo3M2QzMjlmNjBmMzQ0MDUzYTljOGUwYjNjMjgyNmE3M18xOTkw_470193bd-222e-44e7-acae-4b2896d782b8">AMN HEALTHCARE SERVICES, INC.</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(Exact Name of Registrant as Specified in Its Charter)</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.205%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xL2ZyYWc6NzNkMzI5ZjYwZjM0NDA1M2E5YzhlMGIzYzI4MjZhNzMvdGFibGU6NTIyNDM3NTViM2YzNDE3YmE5NGU3OTcyMDU1ZjVjOTQvdGFibGVyYW5nZTo1MjI0Mzc1NWIzZjM0MTdiYTk0ZTc5NzIwNTVmNWM5NF8wLTAtMS0xLTEwNzcw_159634ef-78ac-4c33-90c1-45b6d23bc108">Delaware</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xL2ZyYWc6NzNkMzI5ZjYwZjM0NDA1M2E5YzhlMGIzYzI4MjZhNzMvdGFibGU6NTIyNDM3NTViM2YzNDE3YmE5NGU3OTcyMDU1ZjVjOTQvdGFibGVyYW5nZTo1MjI0Mzc1NWIzZjM0MTdiYTk0ZTc5NzIwNTVmNWM5NF8wLTItMS0xLTEwNzcw_83fd3c3c-0b20-4006-aa4c-45db5ef02fc6">06-1500476</ix:nonNumeric></span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(State or Other Jurisdiction of<br/>Incorporation or Organization)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(I.R.S. Employer<br/>Identification No.)</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xL2ZyYWc6NzNkMzI5ZjYwZjM0NDA1M2E5YzhlMGIzYzI4MjZhNzMvdGFibGU6NTIyNDM3NTViM2YzNDE3YmE5NGU3OTcyMDU1ZjVjOTQvdGFibGVyYW5nZTo1MjI0Mzc1NWIzZjM0MTdiYTk0ZTc5NzIwNTVmNWM5NF8zLTAtMS0xLTEwNzcw_0f9505bd-6830-4b2f-95de-3e24ae1ec9ae">8840 Cypress Waters Boulevard</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" name="dei:EntityAddressAddressLine2" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xL2ZyYWc6NzNkMzI5ZjYwZjM0NDA1M2E5YzhlMGIzYzI4MjZhNzMvdGFibGU6NTIyNDM3NTViM2YzNDE3YmE5NGU3OTcyMDU1ZjVjOTQvdGFibGVyYW5nZTo1MjI0Mzc1NWIzZjM0MTdiYTk0ZTc5NzIwNTVmNWM5NF8zLTEtMS0xLTEwNzcw_c27fbfdb-01c0-4087-93dc-ec5f004b4412">Suite 300</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xL2ZyYWc6NzNkMzI5ZjYwZjM0NDA1M2E5YzhlMGIzYzI4MjZhNzMvdGFibGU6NTIyNDM3NTViM2YzNDE3YmE5NGU3OTcyMDU1ZjVjOTQvdGFibGVyYW5nZTo1MjI0Mzc1NWIzZjM0MTdiYTk0ZTc5NzIwNTVmNWM5NF80LTAtMS0xLTEwNzcw_d463a581-fe3d-4766-95b1-39de9b006fb1">Dallas</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xL2ZyYWc6NzNkMzI5ZjYwZjM0NDA1M2E5YzhlMGIzYzI4MjZhNzMvdGFibGU6NTIyNDM3NTViM2YzNDE3YmE5NGU3OTcyMDU1ZjVjOTQvdGFibGVyYW5nZTo1MjI0Mzc1NWIzZjM0MTdiYTk0ZTc5NzIwNTVmNWM5NF80LTEtMS0xLTEwNzcw_e165d90f-375f-4785-b9df-a423484c0857">Texas</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xL2ZyYWc6NzNkMzI5ZjYwZjM0NDA1M2E5YzhlMGIzYzI4MjZhNzMvdGFibGU6NTIyNDM3NTViM2YzNDE3YmE5NGU3OTcyMDU1ZjVjOTQvdGFibGVyYW5nZTo1MjI0Mzc1NWIzZjM0MTdiYTk0ZTc5NzIwNTVmNWM5NF80LTItMS0xLTEwNzcw_ef34af38-bd1d-4760-97b9-9cfa14ae411f">75019</ix:nonNumeric></span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(Address of Principal Executive Offices)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(Zip Code)</span></td></tr></table></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Registrant&#8217;s Telephone Number, Including Area Code: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xL2ZyYWc6NzNkMzI5ZjYwZjM0NDA1M2E5YzhlMGIzYzI4MjZhNzMvdGV4dHJlZ2lvbjo3M2QzMjlmNjBmMzQ0MDUzYTljOGUwYjNjMjgyNmE3M18xOTkx_6f3b3bdf-5e32-4c69-88c1-83619fd0e5a6">866</ix:nonNumeric>)&#160;<ix:nonNumeric contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xL2ZyYWc6NzNkMzI5ZjYwZjM0NDA1M2E5YzhlMGIzYzI4MjZhNzMvdGV4dHJlZ2lvbjo3M2QzMjlmNjBmMzQ0MDUzYTljOGUwYjNjMjgyNmE3M18xOTk1_bdd4b6bc-b929-438b-b5e1-1fd177bcb613">871-8519</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">____________________</span></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:3pt;text-align:center;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-bottom:3pt;margin-top:5pt;text-align:center;text-indent:24.75pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.555%"><tr><td style="width:1.0%"></td><td style="width:30.731%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.022%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:34.947%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Title of Each Class</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Trading Symbol</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xL2ZyYWc6NzNkMzI5ZjYwZjM0NDA1M2E5YzhlMGIzYzI4MjZhNzMvdGFibGU6ZjI1ZWUzODJmZWY0NDFmNzg0YTEzNjc3OGRiMTRhZDcvdGFibGVyYW5nZTpmMjVlZTM4MmZlZjQ0MWY3ODRhMTM2Nzc4ZGIxNGFkN18xLTAtMS0xLTEwNzcw_fada2aad-1ae9-482e-8ec7-ce2dcda4d0b5">Common Stock, $0.01 par value</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xL2ZyYWc6NzNkMzI5ZjYwZjM0NDA1M2E5YzhlMGIzYzI4MjZhNzMvdGFibGU6ZjI1ZWUzODJmZWY0NDFmNzg0YTEzNjc3OGRiMTRhZDcvdGFibGVyYW5nZTpmMjVlZTM4MmZlZjQ0MWY3ODRhMTM2Nzc4ZGIxNGFkN18xLTEtMS0xLTEwNzcw_467bfd66-d429-4cda-a6ab-4963a1c55c0e">AMN</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xL2ZyYWc6NzNkMzI5ZjYwZjM0NDA1M2E5YzhlMGIzYzI4MjZhNzMvdGFibGU6ZjI1ZWUzODJmZWY0NDFmNzg0YTEzNjc3OGRiMTRhZDcvdGFibGVyYW5nZTpmMjVlZTM4MmZlZjQ0MWY3ODRhMTM2Nzc4ZGIxNGFkN18xLTItMS0xLTEwNzcw_99ddceb1-7ab4-474e-892e-732be70aaaa4">New York Stock Exchange</ix:nonNumeric></span></td></tr></table></div><div style="margin-bottom:3pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant: (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90 days.&#160;&#160;<ix:nonNumeric contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xL2ZyYWc6NzNkMzI5ZjYwZjM0NDA1M2E5YzhlMGIzYzI4MjZhNzMvdGV4dHJlZ2lvbjo3M2QzMjlmNjBmMzQ0MDUzYTljOGUwYjNjMjgyNmE3M18xOTky_a1893182-5d33-4dbd-b970-9ff8624bbdb1">Yes</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">x</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o</span></div><div style="margin-bottom:3pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule&#160;405 of Regulation&#160;S-T during the preceding 12&#160;months (or for such shorter period that the registrant was required to submit such files).&#160;&#160;<ix:nonNumeric contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xL2ZyYWc6NzNkMzI5ZjYwZjM0NDA1M2E5YzhlMGIzYzI4MjZhNzMvdGV4dHJlZ2lvbjo3M2QzMjlmNjBmMzQ0MDUzYTljOGUwYjNjMjgyNmE3M18xOTk2_887c75e3-55af-4367-9255-d66b00f80f71">Yes</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">x</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o</span></div><div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span></div><div style="margin-top:5pt;text-indent:24.75pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.694%"><tr><td style="width:1.0%"></td><td style="width:21.396%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.267%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.188%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.396%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.267%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.204%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.751%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.702%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.629%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xL2ZyYWc6NzNkMzI5ZjYwZjM0NDA1M2E5YzhlMGIzYzI4MjZhNzMvdGFibGU6YmRjMWU1YWRiZmU5NGNlNWJhNjE3NmFiZTQ1ZDliOTkvdGFibGVyYW5nZTpiZGMxZTVhZGJmZTk0Y2U1YmE2MTc2YWJlNDVkOWI5OV8wLTAtMS0xLTEwNzcw_d628f575-cb71-42b2-b1a1-998bb5d6176c">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9746;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accelerated&#160;filer&#160;&#160;                </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-accelerated&#160;filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smaller&#160;reporting&#160;company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" format="ixt-sec:boolballotbox" name="dei:EntitySmallBusiness" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xL2ZyYWc6NzNkMzI5ZjYwZjM0NDA1M2E5YzhlMGIzYzI4MjZhNzMvdGFibGU6YmRjMWU1YWRiZmU5NGNlNWJhNjE3NmFiZTQ1ZDliOTkvdGFibGVyYW5nZTpiZGMxZTVhZGJmZTk0Y2U1YmE2MTc2YWJlNDVkOWI5OV8xLTEtMS0xLTEwNzcw_998f96e5-f0a7-4cc5-a37a-9728d59934b2">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging growth&#160;company  </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xL2ZyYWc6NzNkMzI5ZjYwZjM0NDA1M2E5YzhlMGIzYzI4MjZhNzMvdGFibGU6YmRjMWU1YWRiZmU5NGNlNWJhNjE3NmFiZTQ1ZDliOTkvdGFibGVyYW5nZTpiZGMxZTVhZGJmZTk0Y2U1YmE2MTc2YWJlNDVkOWI5OV8xLTQtMS0xLTEwNzcw_2484858c-b30f-4548-a081-9f3bb0ebba6a">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o</span></div><div style="margin-bottom:3pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange </span></div><div style="margin-bottom:3pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Act).&#160;&#160;Yes&#160;&#160;<ix:nonNumeric contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" format="ixt-sec:boolballotbox" name="dei:EntityShellCompany" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xL2ZyYWc6NzNkMzI5ZjYwZjM0NDA1M2E5YzhlMGIzYzI4MjZhNzMvdGV4dHJlZ2lvbjo3M2QzMjlmNjBmMzQ0MDUzYTljOGUwYjNjMjgyNmE3M18xOTkz_37783520-944e-4003-8009-5d6c3def741b">&#9744;</ix:nonNumeric>&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">x</span></div><div style="margin-bottom:3pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of November&#160;3, 2021, there were <ix:nonFraction unitRef="shares" contextRef="i59e42fb4c1064ece98100d592cf3657c_I20211103" decimals="INF" format="ixt:num-dot-decimal" name="dei:EntityCommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xL2ZyYWc6NzNkMzI5ZjYwZjM0NDA1M2E5YzhlMGIzYzI4MjZhNzMvdGV4dHJlZ2lvbjo3M2QzMjlmNjBmMzQ0MDUzYTljOGUwYjNjMjgyNmE3M18xOTM1_102991ea-bd9c-4289-9939-4bb03420ccb4">47,275,009</ix:nonFraction> shares of common stock, $0.01 par value, outstanding.</span></div><div style="margin-top:13pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.583%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:18pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="ia383c8c7878a498d91f9e8901f0cfd9c_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:5.195%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:83.087%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.418%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Item</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Page</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PART I - FINANCIAL INFORMATION</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia383c8c7878a498d91f9e8901f0cfd9c_13">Condensed Consolidated Financial Statements (unaudited):</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia383c8c7878a498d91f9e8901f0cfd9c_13">1</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia383c8c7878a498d91f9e8901f0cfd9c_16">Condensed Consolidated Balance Sheets, As of September 30, 2021 and December 31, 2020</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia383c8c7878a498d91f9e8901f0cfd9c_16">1</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia383c8c7878a498d91f9e8901f0cfd9c_19">Condensed Consolidated Statements of Comprehensive Income, For the Three and Nine Months Ended September 30, 2021 and 2020</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia383c8c7878a498d91f9e8901f0cfd9c_19">2</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia383c8c7878a498d91f9e8901f0cfd9c_22">Condensed Consolidated Statements of Stockholders&#8217; Equity, For the Nine Months Ended September 30, 2021 and 2020</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia383c8c7878a498d91f9e8901f0cfd9c_22">3</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia383c8c7878a498d91f9e8901f0cfd9c_25">Condensed Consolidated Statements of Cash Flows, For the Nine Months Ended September 30, 2021 and 2020</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia383c8c7878a498d91f9e8901f0cfd9c_25">4</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia383c8c7878a498d91f9e8901f0cfd9c_28">Notes to Unaudited Condensed Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia383c8c7878a498d91f9e8901f0cfd9c_28">6</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia383c8c7878a498d91f9e8901f0cfd9c_67">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia383c8c7878a498d91f9e8901f0cfd9c_67">16</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia383c8c7878a498d91f9e8901f0cfd9c_100">Quantitative and Qualitative Disclosures about Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia383c8c7878a498d91f9e8901f0cfd9c_100">26</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia383c8c7878a498d91f9e8901f0cfd9c_103">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia383c8c7878a498d91f9e8901f0cfd9c_103">26</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PART II - OTHER INFORMATION</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia383c8c7878a498d91f9e8901f0cfd9c_109">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia383c8c7878a498d91f9e8901f0cfd9c_109">27</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia383c8c7878a498d91f9e8901f0cfd9c_112">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia383c8c7878a498d91f9e8901f0cfd9c_112">27</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia383c8c7878a498d91f9e8901f0cfd9c_115">Unregistered Sales of Equity Securities and Use of Proceeds</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia383c8c7878a498d91f9e8901f0cfd9c_115">27</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia383c8c7878a498d91f9e8901f0cfd9c_118">Defaults Upon Senior Securities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia383c8c7878a498d91f9e8901f0cfd9c_118">27</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia383c8c7878a498d91f9e8901f0cfd9c_121">Mine Safety Disclosures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia383c8c7878a498d91f9e8901f0cfd9c_121">27</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia383c8c7878a498d91f9e8901f0cfd9c_124">Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia383c8c7878a498d91f9e8901f0cfd9c_124">27</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia383c8c7878a498d91f9e8901f0cfd9c_127">Exhibits</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia383c8c7878a498d91f9e8901f0cfd9c_127">28</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia383c8c7878a498d91f9e8901f0cfd9c_130">Signatures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia383c8c7878a498d91f9e8901f0cfd9c_130">29</a></span></div></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="ia383c8c7878a498d91f9e8901f0cfd9c_10"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">PART I - FINANCIAL INFORMATION </span></div><div><span><br/></span></div><div id="ia383c8c7878a498d91f9e8901f0cfd9c_13"></div><div style="padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Item&#160;1.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-style:italic;font-weight:700;line-height:120%">Condensed Consolidated Financial Statements</span></div><div><span><br/></span></div><div id="ia383c8c7878a498d91f9e8901f0cfd9c_16"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">AMN HEALTHCARE SERVICES, INC.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED BALANCE SHEETS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited and in thousands, except par value)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.662%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.883%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.071%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.884%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68ecd84e8da440808154baac134e839e_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMy0xLTEtMS0xMDc3MA_2dddca1c-8b75-486b-81f3-142f93be4e11">137,041</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMy0zLTEtMS0xMDc3MA_96b805d4-e705-4858-b08f-4f7da814ae15">29,213</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Accounts receivable, net of allowances of $<ix:nonFraction unitRef="usd" contextRef="i68ecd84e8da440808154baac134e839e_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfNC0wLTEtMS0xMDc3MC90ZXh0cmVnaW9uOjkzZDI2MjBjYzI3YjRkZmRhNDNiZmFkZjdjNTE2NmJmXzQ2_9e88f6c6-4e59-4bb6-bde3-7879fdf9656f">6,148</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfNC0wLTEtMS0xMDc3MC90ZXh0cmVnaW9uOjkzZDI2MjBjYzI3YjRkZmRhNDNiZmFkZjdjNTE2NmJmXzUz_f90e3cad-fb7f-46bf-9c31-8fd5733909f6">7,043</ix:nonFraction> at September&#160;30, 2021 and December&#160;31, 2020, respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68ecd84e8da440808154baac134e839e_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccountsReceivableNetCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfNC0xLTEtMS0xMDc3MA_18286281-b9ec-4067-93ed-309308997739">570,101</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccountsReceivableNetCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfNC0zLTEtMS0xMDc3MA_8c522d90-0b18-4e4a-bc61-1be169a8ee99">376,099</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Accounts receivable, subcontractor</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68ecd84e8da440808154baac134e839e_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="amn:Accountsreceivablesubcontractor" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfNS0xLTEtMS0xMDc3MA_49a275bb-edff-4e1f-8095-241ad4eb7a45">141,626</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="amn:Accountsreceivablesubcontractor" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfNS0zLTEtMS0xMDc3MA_336cdaf6-4db0-4361-ad94-1e8e0f49de82">73,985</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Prepaid expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68ecd84e8da440808154baac134e839e_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PrepaidExpenseCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfNi0xLTEtMS0xMDc3MA_6ca4e8cc-5810-45ed-9a28-651bfe4913e3">19,367</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PrepaidExpenseCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfNi0zLTEtMS0xMDc3MA_8adcfbfc-ea6f-4461-b9fe-56ce6e2374a8">13,629</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68ecd84e8da440808154baac134e839e_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherAssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfNy0xLTEtMS0xMDc3MA_f8298dee-67a6-45c9-a7b9-f275758055d8">31,396</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherAssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfNy0zLTEtMS0xMDc3MA_8102482b-ad0f-45a9-98ed-473f2bf9306a">40,809</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68ecd84e8da440808154baac134e839e_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfOC0xLTEtMS0xMDc3MA_d2033efd-6eaf-4a01-903c-41e12b4a81d0">899,531</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfOC0zLTEtMS0xMDc3MA_4e770a1b-b29a-4417-a744-3793e5871ab1">533,735</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Restricted cash, cash equivalents and investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68ecd84e8da440808154baac134e839e_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RestrictedCashAndInvestmentsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfOS0xLTEtMS0xMDc3MA_a1bfc46b-1315-415d-8bab-b11a111cc1d6">63,603</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RestrictedCashAndInvestmentsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfOS0zLTEtMS0xMDc3MA_787effc6-f2ed-4ab4-b7e9-2b30cbd56147">61,347</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Fixed assets, net of accumulated depreciation of $<ix:nonFraction unitRef="usd" contextRef="i68ecd84e8da440808154baac134e839e_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMTAtMC0xLTEtMTA3NzAvdGV4dHJlZ2lvbjo4MDJlMjIzYzhmZTc0NjM3OTUxNjU5NDk0N2RhMWI4Ml81Mw_aacac55a-bcd4-4b47-b9c7-747a7cbaad2a">190,578</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMTAtMC0xLTEtMTA3NzAvdGV4dHJlZ2lvbjo4MDJlMjIzYzhmZTc0NjM3OTUxNjU5NDk0N2RhMWI4Ml82MA_22ccd6fb-e531-4528-8677-a86176073586">161,752</ix:nonFraction> at September&#160;30, 2021 and December&#160;31, 2020, respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68ecd84e8da440808154baac134e839e_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMTAtMS0xLTEtMTA3NzA_d952ecc0-afc5-415f-bcd0-7b8dcbc2643c">127,762</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMTAtMy0xLTEtMTA3NzA_b041c62c-5605-4f50-819b-9887cd8de8ab">116,174</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68ecd84e8da440808154baac134e839e_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMTEtMS0xLTEtMTA3NzA_767277e6-19b2-49cb-9399-742b4021b89d">36,487</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMTEtMy0xLTEtMTA3NzA_bffbbd54-724e-40c6-b231-c6a25a93cec1">77,735</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68ecd84e8da440808154baac134e839e_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherAssetsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMTItMS0xLTEtMTA3NzA_1a356eef-2005-4308-b27d-06cc591d1b63">157,909</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherAssetsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMTItMy0xLTEtMTA3NzA_9327f8ee-4f1d-4610-9a37-834abcc9a3c8">135,120</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68ecd84e8da440808154baac134e839e_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMTMtMS0xLTEtMTA3NzA_58517117-5a65-480a-b8ed-c965db6664cf">893,283</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMTMtMy0xLTEtMTA3NzA_02cece42-1d68-4439-92d7-cf20704925c4">864,485</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Intangible assets, net of accumulated amortization of $<ix:nonFraction unitRef="usd" contextRef="i68ecd84e8da440808154baac134e839e_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMTQtMC0xLTEtMTA3NzAvdGV4dHJlZ2lvbjoxYzRkNWYzZTQ5MDQ0NTdkYTFjMTMxZjMwMGUwMjgxM181OA_db80bf26-ed49-429c-b323-f7636a895cec">262,253</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMTQtMC0xLTEtMTA3NzAvdGV4dHJlZ2lvbjoxYzRkNWYzZTQ5MDQ0NTdkYTFjMTMxZjMwMGUwMjgxM182NQ_59e296bb-010b-4d1d-8071-4e9e68af68b4">215,234</ix:nonFraction> at September&#160;30, 2021 and December&#160;31, 2020, respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68ecd84e8da440808154baac134e839e_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMTQtMS0xLTEtMTA3NzA_0b30d31c-d85a-4f56-a8f1-ecfa9315e97d">530,422</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMTQtMy0xLTEtMTA3NzA_8fe02f86-8872-4602-a3ae-5eb7012f1b1a">564,911</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68ecd84e8da440808154baac134e839e_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMTUtMS0xLTEtMTA3NzA_f1086c3d-f0e2-4089-81cd-55fdc03f7c6c">2,708,997</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMTUtMy0xLTEtMTA3NzA_05b7aa01-21f0-44a8-8285-d2f2cb4c1903">2,353,507</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Accounts payable and accrued expenses</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68ecd84e8da440808154baac134e839e_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccountsPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMTgtMS0xLTEtMTA3NzA_3d3d69aa-1ef8-4800-9e99-81e135ebc998">284,094</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccountsPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMTgtMy0xLTEtMTA3NzA_faf532d6-2bed-4a6e-bb25-e78d1b49d0bd">167,881</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Accrued compensation and benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68ecd84e8da440808154baac134e839e_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMTktMS0xLTEtMTA3NzA_f6011f53-5218-4d5e-807a-338b76b627cc">321,938</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMTktMy0xLTEtMTA3NzA_d6f0031a-04e7-4b5c-a0f9-d6c763ebb294">213,414</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Current portion of notes payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68ecd84e8da440808154baac134e839e_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:NotesPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMjEtMS0xLTEtMTA3NzA_81506363-96cd-4e43-9632-01f7d3943226">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NotesPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMjEtMy0xLTEtMTA3NzA_186bbe32-ab86-492f-a899-e01e056bd5b8">4,688</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Current portion of operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68ecd84e8da440808154baac134e839e_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMjItMS0xLTEtMTA3NzA_0b88b286-518c-4290-be36-f86aef93cb8f">14,396</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMjItMy0xLTEtMTA3NzA_68caba2c-c28b-4f08-9c6c-37d41692a6cc">15,032</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68ecd84e8da440808154baac134e839e_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMjMtMS0xLTEtMTA3NzA_a2f0c72a-3950-4bc0-a1bd-75497d14dc4a">17,904</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMjMtMy0xLTEtMTA3NzA_cff6d15c-4015-41c4-bc91-da8109bc6c9c">11,004</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68ecd84e8da440808154baac134e839e_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMjQtMS0xLTEtMTA3NzA_44abd235-a7fc-475d-b36e-499062e21c26">2,854</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMjQtMy0xLTEtMTA3NzA_505ea3f4-8a8c-40c5-927e-b102666f4b83">10,938</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68ecd84e8da440808154baac134e839e_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMjUtMS0xLTEtMTA3NzA_9ef65c41-72b7-4701-92b4-da8a3e72e646">641,186</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMjUtMy0xLTEtMTA3NzA_fe273ea2-4caf-4381-a93f-ead513bc84dc">422,957</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Notes payable, net of unamortized fees and premium</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68ecd84e8da440808154baac134e839e_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LongTermNotesPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMjctMS0xLTEtMTA3NzA_5edbbacc-0c2d-4b70-9686-35c656232967">842,027</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LongTermNotesPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMjctMy0xLTEtMTA3NzA_f449607c-484d-46e3-9516-2b33f7ccb051">857,961</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Deferred income taxes, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68ecd84e8da440808154baac134e839e_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMjgtMS0xLTEtMTA3NzA_a8a1bbd0-06d7-47d1-8506-7cca8b06fb63">61,187</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMjgtMy0xLTEtMTA3NzA_37ac2f76-948e-4555-b342-6e7c5ad998aa">67,205</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68ecd84e8da440808154baac134e839e_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMjktMS0xLTEtMTA3NzA_6a6057aa-6135-4280-99d2-0a3f372e62c6">15,004</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMjktMy0xLTEtMTA3NzA_e50e32bd-d434-4a25-9d89-4c977da0bed9">77,800</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68ecd84e8da440808154baac134e839e_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMzAtMS0xLTEtMTA3NzA_abb32972-6fbc-4034-9a89-5fd6fd20b4ff">107,115</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMzAtMy0xLTEtMTA3NzA_232b5a17-1d6a-4ec1-b5fe-5e796e4f537b">107,907</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68ecd84e8da440808154baac134e839e_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Liabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMzEtMS0xLTEtMTA3NzA_fb3a6902-887f-45a5-b05d-e18c3ea36545">1,666,519</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Liabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMzEtMy0xLTEtMTA3NzA_e0adff35-5255-4c08-b4c7-dd0f24eadc15">1,533,830</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Commitments and contingencies</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i68ecd84e8da440808154baac134e839e_I20210930" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMzItMS0xLTEtMTA3NzA_25bcb95b-c675-4d0c-b2d7-ec206c9e7bbd"></ix:nonFraction></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMzItMy0xLTEtMTA3NzA_9d564697-ede8-44f2-a54f-a200a773701e"></ix:nonFraction></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Stockholders&#8217; equity:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Preferred stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="i68ecd84e8da440808154baac134e839e_I20210930" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMzQtMC0xLTEtMTA3NzAvdGV4dHJlZ2lvbjo5ZDc5NWRkZTcwZWI0YTQ4YTRhM2NjZjBmNTc0MTVkMl8yMQ_373cc3e0-1a5e-452a-b8b3-bd425568749d"><ix:nonFraction unitRef="usdPerShare" contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMzQtMC0xLTEtMTA3NzAvdGV4dHJlZ2lvbjo5ZDc5NWRkZTcwZWI0YTQ4YTRhM2NjZjBmNTc0MTVkMl8yMQ_b2c79572-d9cc-4c88-a0f8-cf52e51badd8">0.01</ix:nonFraction></ix:nonFraction> par value; <ix:nonFraction unitRef="shares" contextRef="i68ecd84e8da440808154baac134e839e_I20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockSharesAuthorized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMzQtMC0xLTEtMTA3NzAvdGV4dHJlZ2lvbjo5ZDc5NWRkZTcwZWI0YTQ4YTRhM2NjZjBmNTc0MTVkMl8zNQ_4b7b1b7e-2c79-47ff-b7ec-96f33928d6fb"><ix:nonFraction unitRef="shares" contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockSharesAuthorized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMzQtMC0xLTEtMTA3NzAvdGV4dHJlZ2lvbjo5ZDc5NWRkZTcwZWI0YTQ4YTRhM2NjZjBmNTc0MTVkMl8zNQ_b520c63b-c9d3-463a-a293-7385dd77b3aa">10,000</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="i68ecd84e8da440808154baac134e839e_I20210930" decimals="INF" format="ixt:fixed-zero" name="us-gaap:PreferredStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMzQtMC0xLTEtMTA3NzAvdGV4dHJlZ2lvbjo5ZDc5NWRkZTcwZWI0YTQ4YTRhM2NjZjBmNTc0MTVkMl81Nw_4b532aac-a6bd-4209-8e75-8b6f9ee2a779"><ix:nonFraction unitRef="shares" contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231" decimals="INF" format="ixt:fixed-zero" name="us-gaap:PreferredStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMzQtMC0xLTEtMTA3NzAvdGV4dHJlZ2lvbjo5ZDc5NWRkZTcwZWI0YTQ4YTRhM2NjZjBmNTc0MTVkMl81Nw_d9b522f0-2112-4b3c-8735-1ec233257281"><ix:nonFraction unitRef="shares" contextRef="i68ecd84e8da440808154baac134e839e_I20210930" decimals="INF" format="ixt:fixed-zero" name="us-gaap:PreferredStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMzQtMC0xLTEtMTA3NzAvdGV4dHJlZ2lvbjo5ZDc5NWRkZTcwZWI0YTQ4YTRhM2NjZjBmNTc0MTVkMl81Nw_e8aeec39-1f0e-4b8b-a654-a901c7e9f346"><ix:nonFraction unitRef="shares" contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231" decimals="INF" format="ixt:fixed-zero" name="us-gaap:PreferredStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMzQtMC0xLTEtMTA3NzAvdGV4dHJlZ2lvbjo5ZDc5NWRkZTcwZWI0YTQ4YTRhM2NjZjBmNTc0MTVkMl81Nw_fb5218b0-410f-4cf0-b2b7-188cadd96e46">none</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> issued and outstanding at September&#160;30, 2021 and December&#160;31, 2020</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68ecd84e8da440808154baac134e839e_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:PreferredStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMzQtMS0xLTEtMTA3NzA_ec520393-14a7-48dd-9315-ff9b5ad384d4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:PreferredStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMzQtMy0xLTEtMTA3NzA_ffa0279b-6f6b-49b8-b68d-02e8e0275a32">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMzUtMC0xLTEtMTA3NzAvdGV4dHJlZ2lvbjowZTk2OWY3NThhM2E0MGMzODM4NGM2NTY3MWJkZTJkZF8xOA_3d03b700-fc06-41a9-94d4-5adc22554c20"><ix:nonFraction unitRef="usdPerShare" contextRef="i68ecd84e8da440808154baac134e839e_I20210930" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMzUtMC0xLTEtMTA3NzAvdGV4dHJlZ2lvbjowZTk2OWY3NThhM2E0MGMzODM4NGM2NTY3MWJkZTJkZF8xOA_d090eb86-3868-4c7a-936d-7ce1c49e670a">0.01</ix:nonFraction></ix:nonFraction> par value; <ix:nonFraction unitRef="shares" contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesAuthorized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMzUtMC0xLTEtMTA3NzAvdGV4dHJlZ2lvbjowZTk2OWY3NThhM2E0MGMzODM4NGM2NTY3MWJkZTJkZF8zMg_94be7f00-0d5b-448c-9b2b-9582bf2cc972"><ix:nonFraction unitRef="shares" contextRef="i68ecd84e8da440808154baac134e839e_I20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesAuthorized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMzUtMC0xLTEtMTA3NzAvdGV4dHJlZ2lvbjowZTk2OWY3NThhM2E0MGMzODM4NGM2NTY3MWJkZTJkZF8zMg_ccbde74e-efff-4b43-a6cd-05a1e56777cc">200,000</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="i68ecd84e8da440808154baac134e839e_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMzUtMC0xLTEtMTA3NzAvdGV4dHJlZ2lvbjowZTk2OWY3NThhM2E0MGMzODM4NGM2NTY3MWJkZTJkZF81NA_91702a2b-fb55-4810-ba00-1e45c859d5d9">49,836</ix:nonFraction> issued and <ix:nonFraction unitRef="shares" contextRef="i68ecd84e8da440808154baac134e839e_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMzUtMC0xLTEtMTA3NzAvdGV4dHJlZ2lvbjowZTk2OWY3NThhM2E0MGMzODM4NGM2NTY3MWJkZTJkZF82OA_8e611149-d5e3-4339-ab03-d51bab7f3883">47,275</ix:nonFraction> outstanding at September&#160;30, 2021 and <ix:nonFraction unitRef="shares" contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMzUtMC0xLTEtMTA3NzAvdGV4dHJlZ2lvbjowZTk2OWY3NThhM2E0MGMzODM4NGM2NTY3MWJkZTJkZF85Mw_e65001c6-01c7-4e6d-baba-e7c502bf05c5">49,614</ix:nonFraction> issued and <ix:nonFraction unitRef="shares" contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMzUtMC0xLTEtMTA3NzAvdGV4dHJlZ2lvbjowZTk2OWY3NThhM2E0MGMzODM4NGM2NTY3MWJkZTJkZF8xMDc_683b2fc8-3439-485c-a7a2-3a22cd7d6cf0">47,053</ix:nonFraction> outstanding at December&#160;31, 2020</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68ecd84e8da440808154baac134e839e_I20210930" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMzUtMS0xLTEtMTA3NzA_07e282b8-2236-47bd-8d67-f141278de5e8">498</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMzUtMy0xLTEtMTA3NzA_b7ee6a4b-7b76-47bf-b9ab-09c962b349f6">496</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68ecd84e8da440808154baac134e839e_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdditionalPaidInCapital" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMzYtMS0xLTEtMTA3NzA_a304a8f2-238a-4b18-8d15-cf6acbb666f2">480,364</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdditionalPaidInCapital" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMzYtMy0xLTEtMTA3NzA_0a6686b8-9e44-41c0-9a78-8cbd5765f4fb">468,726</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Treasury stock, at cost; <ix:nonFraction unitRef="shares" contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:TreasuryStockShares" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMzctMC0xLTEtMTA3NzAvdGV4dHJlZ2lvbjpkODU2MTFkNjAyYjY0MWE2OWQzNzlmMzMwN2ZmZTE4NV8yOQ_3d4976b5-e54e-46c5-9ad6-78c3a90fbb4a"><ix:nonFraction unitRef="shares" contextRef="i68ecd84e8da440808154baac134e839e_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:TreasuryStockShares" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMzctMC0xLTEtMTA3NzAvdGV4dHJlZ2lvbjpkODU2MTFkNjAyYjY0MWE2OWQzNzlmMzMwN2ZmZTE4NV8yOQ_96faad55-187f-4704-935a-ff973e1a268e">2,561</ix:nonFraction></ix:nonFraction> shares at September&#160;30, 2021 and December&#160;31, 2020</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i68ecd84e8da440808154baac134e839e_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:TreasuryStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMzctMS0xLTEtMTA3NzA_93ba46a2-9ab2-45d2-9913-c85867461bdd">119,143</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:TreasuryStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMzctMy0xLTEtMTA3NzA_ad86767a-1001-4280-96e9-e0dfe6a44761">119,143</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68ecd84e8da440808154baac134e839e_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMzgtMS0xLTEtMTA3NzA_1c235a21-47b6-4b3d-9394-c23f8fcd7924">680,729</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMzgtMy0xLTEtMTA3NzA_1d4bc51c-109f-4c04-bce4-c9b0335ee34c">469,558</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Accumulated other comprehensive income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68ecd84e8da440808154baac134e839e_I20210930" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMzktMS0xLTEtMTA3NzA_2c277a10-4a69-44a5-8e2a-9541c3ed1934">30</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMzktMy0xLTEtMTA3NzA_90093d5b-c55e-4492-bf14-395f5cc56aef">40</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Total stockholders&#8217; equity</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68ecd84e8da440808154baac134e839e_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfNDAtMS0xLTEtMTA3NzA_d8584ff6-e66a-4bb7-87e7-fdbfa98f9f7a">1,042,478</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfNDAtMy0xLTEtMTA3NzA_1d399107-5894-453d-be86-51ad6724fafb">819,677</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Total liabilities and stockholders&#8217; equity</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68ecd84e8da440808154baac134e839e_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfNDEtMS0xLTEtMTA3NzA_a2491eca-eb9e-42a5-8fc9-ecee619fbd9c">2,708,997</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfNDEtMy0xLTEtMTA3NzA_35ad0f03-9ac0-48e7-a309-f02856ede75c">2,353,507</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to unaudited condensed consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</span></div></div></div><div id="ia383c8c7878a498d91f9e8901f0cfd9c_19"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:18pt;padding-right:18pt;text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">AMN HEALTHCARE SERVICES, INC.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited and in thousands, except per share amounts)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.016%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.283%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i150492f298fa47a78ef2c10a285a64f8_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfMi0xLTEtMS0xMDc3MA_6f63bef5-0ce3-4459-8744-42069eeca06a">877,800</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6cb0c51ba8fa45fda70ec7e5df8b4ef1_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfMi0zLTEtMS0xMDc3MA_2a73aa5a-6ab0-45fd-becc-5e088c3e57b2">551,631</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfMi01LTEtMS0xMDc3MA_ad3f08b8-ccb8-4a8c-bbea-18f6ceafb9aa">2,621,190</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfMi03LTEtMS0xMDc3MA_86ecc28f-0f27-4705-8024-96230f0821da">1,762,443</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i150492f298fa47a78ef2c10a285a64f8_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfMy0xLTEtMS0xMDc3MA_cab17c80-ae00-48d9-b4b1-da594cd7bf42">571,935</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6cb0c51ba8fa45fda70ec7e5df8b4ef1_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfMy0zLTEtMS0xMDc3MA_d698df13-69f8-4d67-8ac7-240bb1ddde78">366,998</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfMy01LTEtMS0xMDc3MA_672b0b16-37ed-42fe-b2bc-eb17a9fc0031">1,745,914</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfMy03LTEtMS0xMDc3MA_1a60e29b-9861-4bdc-9d7c-7a4ad471e27e">1,178,204</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i150492f298fa47a78ef2c10a285a64f8_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GrossProfit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfNC0xLTEtMS0xMDc3MA_504edfd3-aea3-4bac-8216-c17f79461681">305,865</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6cb0c51ba8fa45fda70ec7e5df8b4ef1_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GrossProfit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfNC0zLTEtMS0xMDc3MA_bd26b512-46db-4fdd-a212-894fc847fd2a">184,633</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GrossProfit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfNC01LTEtMS0xMDc3MA_24fdd701-1754-4bda-a223-4309246c402d">875,276</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GrossProfit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfNC03LTEtMS0xMDc3MA_e041e902-76e0-4375-b9ac-1193fce19420">584,239</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i150492f298fa47a78ef2c10a285a64f8_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfNi0xLTEtMS0xMDc3MA_b0e5d288-7c1a-456d-b295-50bfdd5cda6b">173,932</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6cb0c51ba8fa45fda70ec7e5df8b4ef1_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfNi0zLTEtMS0xMDc3MA_f2ccd686-0481-4cfc-ab45-6e1c8769b85a">111,235</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfNi01LTEtMS0xMDc3MA_91c94ded-59bd-4cea-ac0f-5ba28008bdfd">491,773</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfNi03LTEtMS0xMDc3MA_91fa4bc6-4065-419d-9f8e-36df4acd0458">394,537</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization (exclusive of depreciation included in cost of revenue)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i150492f298fa47a78ef2c10a285a64f8_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfNy0xLTEtMS0xMDc3MA_23f7d0fb-d7cd-4cbc-bb28-0345496c6031">26,104</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6cb0c51ba8fa45fda70ec7e5df8b4ef1_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfNy0zLTEtMS0xMDc3MA_779fb29c-ae66-4901-abb1-272d503ab59e">26,936</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfNy01LTEtMS0xMDc3MA_451822a7-bf2c-473d-93e9-ebd8996d7120">74,098</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfNy03LTEtMS0xMDc3MA_877a6af8-e8a0-42af-8175-42008e79ce7b">69,096</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i150492f298fa47a78ef2c10a285a64f8_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfOC0xLTEtMS0xMDc3MA_dc19e92c-98e4-41b4-8fd8-6aa2fda749d9">200,036</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6cb0c51ba8fa45fda70ec7e5df8b4ef1_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfOC0zLTEtMS0xMDc3MA_baff416d-d55c-4eea-b3af-aeb7be95eacb">138,171</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfOC01LTEtMS0xMDc3MA_f86118b6-5a59-4d64-b620-a73fd2f0d739">565,871</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfOC03LTEtMS0xMDc3MA_fd39b9e5-98ab-446a-b903-b4e76d68b647">463,633</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from operations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i150492f298fa47a78ef2c10a285a64f8_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfOS0xLTEtMS0xMDc3MA_8b6f2bcd-d2b3-4232-ab7a-fc192a21a6ca">105,829</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6cb0c51ba8fa45fda70ec7e5df8b4ef1_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfOS0zLTEtMS0xMDc3MA_8f42725c-f8e4-4ab0-af2d-43462836acc2">46,462</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfOS01LTEtMS0xMDc3MA_3a99b741-dde2-4ad1-98b2-75820ddf9d98">309,405</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfOS03LTEtMS0xMDc3MA_3383adfb-cb3d-499e-92d2-e800df90551a">120,606</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net, and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i150492f298fa47a78ef2c10a285a64f8_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfMTAtMS0xLTEtMTA3NzA_f6feada2-51ac-47dd-9a25-b95779e0ccef">5,223</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6cb0c51ba8fa45fda70ec7e5df8b4ef1_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfMTAtMy0xLTEtMTA3NzA_2bec96e8-7e8c-43ec-a1f3-aa9bfff5926d">12,564</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfMTAtNS0xLTEtMTA3NzA_9fec3880-99dd-4aeb-9b39-d4226c7010d2">24,278</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfMTAtNy0xLTEtMTA3NzA_38c5ca37-3fac-4093-a5b0-8c5a4ddc68b5">35,061</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i150492f298fa47a78ef2c10a285a64f8_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfMTEtMS0xLTEtMTA3NzA_e0e03aac-7005-4abf-acce-4cf58e7fdf71">100,606</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6cb0c51ba8fa45fda70ec7e5df8b4ef1_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfMTEtMy0xLTEtMTA3NzA_73ea7389-837b-41ed-98fe-0fbc4160fe44">33,898</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfMTEtNS0xLTEtMTA3NzA_646dbc86-fb59-42ac-8bcf-dac906f55097">285,127</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfMTEtNy0xLTEtMTA3NzA_a86055ca-66e1-45d6-ae3f-954d973c466b">85,545</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i150492f298fa47a78ef2c10a285a64f8_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfMTItMS0xLTEtMTA3NzA_5efb859a-9040-4c01-9b05-a17f5d71691e">26,583</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6cb0c51ba8fa45fda70ec7e5df8b4ef1_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfMTItMy0xLTEtMTA3NzA_5f86cf77-36e3-4ce4-b913-224412d9185d">7,831</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfMTItNS0xLTEtMTA3NzA_c9c0fad8-13d2-4273-b32e-70c31159139d">73,956</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfMTItNy0xLTEtMTA3NzA_470364e9-23cd-43f2-baa9-72337e3aae0f">24,188</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i150492f298fa47a78ef2c10a285a64f8_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfMTMtMS0xLTEtMTA3NzA_e2d3a336-8dad-4f3e-8786-77b7cea81a01"><ix:nonFraction unitRef="usd" contextRef="i150492f298fa47a78ef2c10a285a64f8_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfMTMtMS0xLTEtMTA3NzA_efff5a03-8551-4e93-a0e5-a22a1e915046">74,023</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6cb0c51ba8fa45fda70ec7e5df8b4ef1_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfMTMtMy0xLTEtMTA3NzA_55f14d18-0e78-4532-8438-964eb731efe6"><ix:nonFraction unitRef="usd" contextRef="i6cb0c51ba8fa45fda70ec7e5df8b4ef1_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfMTMtMy0xLTEtMTA3NzA_f0ff9ce4-8dd3-48a3-bf23-a7dd3a16d444">26,067</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfMTMtNS0xLTEtMTA3NzA_eb0c20d2-b18d-490a-bbce-9f275d8a448b"><ix:nonFraction unitRef="usd" contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfMTMtNS0xLTEtMTA3NzA_f14545f9-8870-499b-943c-0688cc9fb12b">211,171</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfMTMtNy0xLTEtMTA3NzA_172b8971-f392-48a3-afb9-66a3fda40494"><ix:nonFraction unitRef="usd" contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfMTMtNy0xLTEtMTA3NzA_97d2cddd-93ac-40ee-9644-9af6f298d471">61,357</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss):</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i150492f298fa47a78ef2c10a285a64f8_D20210701-20210930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfMTYtMS0xLTEtMTA3NzA_cf43af2f-ddb9-415d-b99e-d01131953c0b">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6cb0c51ba8fa45fda70ec7e5df8b4ef1_D20200701-20200930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfMTYtMy0xLTEtMTA3NzA_1f687ea9-f363-48ef-bcaa-5563bc97943e">14</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfMTYtNS0xLTEtMTA3NzA_41da66b2-4330-49da-a4fa-88b9c598ad34">10</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfMTYtNy0xLTEtMTA3NzA_67a363e1-14a6-40c2-8c84-158aa0f88f2b">119</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i150492f298fa47a78ef2c10a285a64f8_D20210701-20210930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfMTctMS0xLTEtMTA3NzA_6f338eec-a366-4426-8ebf-f7d98f507c0b">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6cb0c51ba8fa45fda70ec7e5df8b4ef1_D20200701-20200930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfMTctMy0xLTEtMTA3NzA_d84fcb1d-4962-464d-b1fa-90504f4ee12c">14</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfMTctNS0xLTEtMTA3NzA_cf48e684-e1b1-463d-8478-404edc358b23">10</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfMTctNy0xLTEtMTA3NzA_27f3eff7-23db-440b-8e01-b98e7b44a932">119</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i150492f298fa47a78ef2c10a285a64f8_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfMTktMS0xLTEtMTA3NzA_cf0d65b8-93d4-4c55-bc6b-af34320d0e0d">74,034</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6cb0c51ba8fa45fda70ec7e5df8b4ef1_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfMTktMy0xLTEtMTA3NzA_01541bd0-4542-4f6e-9ce0-9c3be7164eb7">26,053</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfMTktNS0xLTEtMTA3NzA_dcd03498-fe8e-44a6-92c5-0af15b0bffbe">211,161</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfMTktNy0xLTEtMTA3NzA_340c5680-caea-4117-abba-745040d96eec">61,238</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income per common share:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i150492f298fa47a78ef2c10a285a64f8_D20210701-20210930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfMjItMS0xLTEtMTA3NzA_8314d84c-6e2c-4558-bffb-6c297070d87a">1.55</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i6cb0c51ba8fa45fda70ec7e5df8b4ef1_D20200701-20200930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfMjItMy0xLTEtMTA3NzA_b64cf2a6-69cc-4df5-9345-474db05102e4">0.55</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfMjItNS0xLTEtMTA3NzA_bbc95430-281c-4460-be37-bd802729d7c4">4.43</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfMjItNy0xLTEtMTA3NzA_2507c2f5-a080-4b59-a213-4679efd005f0">1.29</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i150492f298fa47a78ef2c10a285a64f8_D20210701-20210930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfMjMtMS0xLTEtMTA3NzA_68108a81-89cf-472e-a675-f3ea82c9b24c">1.54</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i6cb0c51ba8fa45fda70ec7e5df8b4ef1_D20200701-20200930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfMjMtMy0xLTEtMTA3NzA_21bf28e6-d12f-4ae8-9a88-16867419609e">0.55</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfMjMtNS0xLTEtMTA3NzA_caeeeba4-0685-4ded-aca7-0571d2670794">4.40</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfMjMtNy0xLTEtMTA3NzA_5daa6dc6-a987-4860-9a90-55b3874308be">1.29</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i150492f298fa47a78ef2c10a285a64f8_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfMjUtMS0xLTEtMTA3NzA_94f3875a-ca98-4798-b091-550316b6d3a6">47,737</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6cb0c51ba8fa45fda70ec7e5df8b4ef1_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfMjUtMy0xLTEtMTA3NzA_76f2b2c3-8dc5-4cfc-acbb-14d20b33e78a">47,476</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfMjUtNS0xLTEtMTA3NzA_6f7eb06b-b539-47cd-b69d-40eec1446325">47,666</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfMjUtNy0xLTEtMTA3NzA_3dd0e067-e76a-4bd6-ae5b-dc552906c44c">47,406</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i150492f298fa47a78ef2c10a285a64f8_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfMjYtMS0xLTEtMTA3NzA_afbada0d-3f26-4dc1-9e2d-85c01ffe3ef2">48,080</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6cb0c51ba8fa45fda70ec7e5df8b4ef1_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfMjYtMy0xLTEtMTA3NzA_f72ee4fa-516e-46ee-b9e5-1fad92bc2645">47,676</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfMjYtNS0xLTEtMTA3NzA_af6b7a84-e486-42b4-97b7-ee1400537b6c">48,022</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfMjYtNy0xLTEtMTA3NzA_e3f9bb21-fb60-4b9f-95bb-6e038f36c2cd">47,647</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to unaudited condensed consolidated financial statements.</span></div><div style="margin-bottom:17pt;margin-top:17pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="ia383c8c7878a498d91f9e8901f0cfd9c_22"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">AMN HEALTHCARE SERVICES, INC.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS&#8217; EQUITY</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited and in thousands)</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:20.976%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.186%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.267%"></td><td style="width:0.1%"></td></tr><tr style="height:23pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional<br/>Paid-in<br/>Capital</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained Earnings</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Income</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance, December 31, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2f727815e2874946b60bd2e1bb5e93be_I20191231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjA4YjkwYmJkYmMzNDRhY2Q4MjczNzY0OGJhM2FmNzY2L3RhYmxlcmFuZ2U6MDhiOTBiYmRiYzM0NGFjZDgyNzM3NjQ4YmEzYWY3NjZfMi0xLTEtMS0xMDc3MA_acd1daf7-e0b9-4db2-8c71-55f2b3939efa">49,283</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f727815e2874946b60bd2e1bb5e93be_I20191231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjA4YjkwYmJkYmMzNDRhY2Q4MjczNzY0OGJhM2FmNzY2L3RhYmxlcmFuZ2U6MDhiOTBiYmRiYzM0NGFjZDgyNzM3NjQ4YmEzYWY3NjZfMi0zLTEtMS0xMDc3MA_f34d1ce6-0c8f-48f2-ab0e-8945c51d7c1f">493</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa1c76ff437b4f6ab9cb7b6cfe222bf4_I20191231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjA4YjkwYmJkYmMzNDRhY2Q4MjczNzY0OGJhM2FmNzY2L3RhYmxlcmFuZ2U6MDhiOTBiYmRiYzM0NGFjZDgyNzM3NjQ4YmEzYWY3NjZfMi01LTEtMS0xMDc3MA_176d3294-f6c4-416c-9c46-4b0d652eb0cf">455,193</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="if7393c775ca64e5aad76fe5c6f242546_I20191231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjA4YjkwYmJkYmMzNDRhY2Q4MjczNzY0OGJhM2FmNzY2L3RhYmxlcmFuZ2U6MDhiOTBiYmRiYzM0NGFjZDgyNzM3NjQ4YmEzYWY3NjZfMi03LTEtMS0xMDc3MA_7a8bca33-3f4b-48b3-8a00-01f1f50c574a">2,561</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if7393c775ca64e5aad76fe5c6f242546_I20191231" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjA4YjkwYmJkYmMzNDRhY2Q4MjczNzY0OGJhM2FmNzY2L3RhYmxlcmFuZ2U6MDhiOTBiYmRiYzM0NGFjZDgyNzM3NjQ4YmEzYWY3NjZfMi05LTEtMS0xMDc3MA_602be9db-2820-4e86-a5cf-05f81371092b">119,143</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42390657f50c458e90b81cff65ca34a5_I20191231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjA4YjkwYmJkYmMzNDRhY2Q4MjczNzY0OGJhM2FmNzY2L3RhYmxlcmFuZ2U6MDhiOTBiYmRiYzM0NGFjZDgyNzM3NjQ4YmEzYWY3NjZfMi0xMS0xLTEtMTA3NzA_cdfbb519-ecbb-4485-b30c-c684d11fae5f">400,047</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60d729ea22d44fd2a79b8bf55e800ca9_I20191231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjA4YjkwYmJkYmMzNDRhY2Q4MjczNzY0OGJhM2FmNzY2L3RhYmxlcmFuZ2U6MDhiOTBiYmRiYzM0NGFjZDgyNzM3NjQ4YmEzYWY3NjZfMi0xMy0xLTEtMTA3NzA_b098d0d9-e9ae-40d5-ac35-e7da618481fa">152</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73ad7702c4f241548c42eab7eb506186_I20191231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjA4YjkwYmJkYmMzNDRhY2Q4MjczNzY0OGJhM2FmNzY2L3RhYmxlcmFuZ2U6MDhiOTBiYmRiYzM0NGFjZDgyNzM3NjQ4YmEzYWY3NjZfMi0xNS0xLTEtMTA3NzA_4bb74887-864a-476d-b37f-15126c207f93">736,742</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity awards vested and exercised, net of shares withheld for payroll taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib229d5f30fdf41e28a8c14b58ac7f71a_D20200101-20200331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjA4YjkwYmJkYmMzNDRhY2Q4MjczNzY0OGJhM2FmNzY2L3RhYmxlcmFuZ2U6MDhiOTBiYmRiYzM0NGFjZDgyNzM3NjQ4YmEzYWY3NjZfNC0xLTEtMS0xMDc3MA_673a2f77-ac8f-4ded-9742-0bc30c625e27">140</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib229d5f30fdf41e28a8c14b58ac7f71a_D20200101-20200331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjA4YjkwYmJkYmMzNDRhY2Q4MjczNzY0OGJhM2FmNzY2L3RhYmxlcmFuZ2U6MDhiOTBiYmRiYzM0NGFjZDgyNzM3NjQ4YmEzYWY3NjZfNC0zLTEtMS0xMDc3MA_136dd7d1-a2b3-46ec-a5c4-6a2c2b395fc3">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i58a3e48055114d67b6bc5e307451f03b_D20200101-20200331" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjA4YjkwYmJkYmMzNDRhY2Q4MjczNzY0OGJhM2FmNzY2L3RhYmxlcmFuZ2U6MDhiOTBiYmRiYzM0NGFjZDgyNzM3NjQ4YmEzYWY3NjZfNC01LTEtMS0xMDc3MA_59a6183c-584e-4043-82ed-78453f8658d0">4,354</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifb81bab0961842fb8ad3378a3b9343b6_D20200101-20200331" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjA4YjkwYmJkYmMzNDRhY2Q4MjczNzY0OGJhM2FmNzY2L3RhYmxlcmFuZ2U6MDhiOTBiYmRiYzM0NGFjZDgyNzM3NjQ4YmEzYWY3NjZfNC0xNS0xLTEtMTA3NzA_e13cb1b6-fe1c-496e-b11c-8fcfd38e4389">4,353</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjA4YjkwYmJkYmMzNDRhY2Q4MjczNzY0OGJhM2FmNzY2L3RhYmxlcmFuZ2U6MDhiOTBiYmRiYzM0NGFjZDgyNzM3NjQ4YmEzYWY3NjZfNS0wLTEtMS0xMDc3MA_9cc5eab4-fa7b-478b-ad5a-e122472c78ab">Cumulative-effect adjustment from adoption of the credit loss standard, net of tax</span></span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1289950aefbc4d06a62bac0d92b90879_I20191231" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjA4YjkwYmJkYmMzNDRhY2Q4MjczNzY0OGJhM2FmNzY2L3RhYmxlcmFuZ2U6MDhiOTBiYmRiYzM0NGFjZDgyNzM3NjQ4YmEzYWY3NjZfNS0xMS0xLTEtMTA3NzA_d86fc26b-56bd-45b0-9697-fbc67ad807fc">1,154</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i55f9e8f7bfb74ed0a97dc5b843a44941_I20191231" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjA4YjkwYmJkYmMzNDRhY2Q4MjczNzY0OGJhM2FmNzY2L3RhYmxlcmFuZ2U6MDhiOTBiYmRiYzM0NGFjZDgyNzM3NjQ4YmEzYWY3NjZfNS0xNS0xLTEtMTA3NzA_4a191b28-9656-429a-bf5d-f2dc3a9be778">1,154</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58a3e48055114d67b6bc5e307451f03b_D20200101-20200331" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjA4YjkwYmJkYmMzNDRhY2Q4MjczNzY0OGJhM2FmNzY2L3RhYmxlcmFuZ2U6MDhiOTBiYmRiYzM0NGFjZDgyNzM3NjQ4YmEzYWY3NjZfNi01LTEtMS0xMDc3MA_47e3d408-323f-4070-8c31-a42cde42ca53">4,927</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb81bab0961842fb8ad3378a3b9343b6_D20200101-20200331" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjA4YjkwYmJkYmMzNDRhY2Q4MjczNzY0OGJhM2FmNzY2L3RhYmxlcmFuZ2U6MDhiOTBiYmRiYzM0NGFjZDgyNzM3NjQ4YmEzYWY3NjZfNi0xNS0xLTEtMTA3NzA_19833fd0-15d2-4574-8d0a-e04520bf9d25">4,927</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i718b700dbfbb43239149794d4ebae58b_D20200101-20200331" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjA4YjkwYmJkYmMzNDRhY2Q4MjczNzY0OGJhM2FmNzY2L3RhYmxlcmFuZ2U6MDhiOTBiYmRiYzM0NGFjZDgyNzM3NjQ4YmEzYWY3NjZfNy0xMS0xLTEtMTA3NzA_0f23133e-f2eb-4943-b889-090a3010c8c6">12,965</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4f7d797c1d4844499f22b04b3704142b_D20200101-20200331" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjA4YjkwYmJkYmMzNDRhY2Q4MjczNzY0OGJhM2FmNzY2L3RhYmxlcmFuZ2U6MDhiOTBiYmRiYzM0NGFjZDgyNzM3NjQ4YmEzYWY3NjZfNy0xMy0xLTEtMTA3NzA_81ad605b-7f98-4768-85a4-d704e039a9a3">47</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb81bab0961842fb8ad3378a3b9343b6_D20200101-20200331" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjA4YjkwYmJkYmMzNDRhY2Q4MjczNzY0OGJhM2FmNzY2L3RhYmxlcmFuZ2U6MDhiOTBiYmRiYzM0NGFjZDgyNzM3NjQ4YmEzYWY3NjZfNy0xNS0xLTEtMTA3NzA_3698d0da-20f6-4266-85a3-fe750ff4f53e">12,918</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance, March 31, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib9bfddb010034bb38eded0804243bd37_I20200331" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjA4YjkwYmJkYmMzNDRhY2Q4MjczNzY0OGJhM2FmNzY2L3RhYmxlcmFuZ2U6MDhiOTBiYmRiYzM0NGFjZDgyNzM3NjQ4YmEzYWY3NjZfOC0xLTEtMS0xMDc3MA_2168e6c9-07e7-4a19-8edd-64a0a3dbf00f">49,423</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9bfddb010034bb38eded0804243bd37_I20200331" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjA4YjkwYmJkYmMzNDRhY2Q4MjczNzY0OGJhM2FmNzY2L3RhYmxlcmFuZ2U6MDhiOTBiYmRiYzM0NGFjZDgyNzM3NjQ4YmEzYWY3NjZfOC0zLTEtMS0xMDc3MA_d5bde639-ff42-47e0-95d8-fb188cf87a2f">494</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97238f9b66054193b28698bcbd56bffd_I20200331" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjA4YjkwYmJkYmMzNDRhY2Q4MjczNzY0OGJhM2FmNzY2L3RhYmxlcmFuZ2U6MDhiOTBiYmRiYzM0NGFjZDgyNzM3NjQ4YmEzYWY3NjZfOC01LTEtMS0xMDc3MA_8db1f845-6c5b-442a-b1cf-e7318e751421">455,766</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i8374f5c37e3c42bcb5d46ed38d202316_I20200331" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjA4YjkwYmJkYmMzNDRhY2Q4MjczNzY0OGJhM2FmNzY2L3RhYmxlcmFuZ2U6MDhiOTBiYmRiYzM0NGFjZDgyNzM3NjQ4YmEzYWY3NjZfOC03LTEtMS0xMDc3MA_7fa22ebc-249d-49c0-9c1d-796028cf65c4">2,561</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8374f5c37e3c42bcb5d46ed38d202316_I20200331" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjA4YjkwYmJkYmMzNDRhY2Q4MjczNzY0OGJhM2FmNzY2L3RhYmxlcmFuZ2U6MDhiOTBiYmRiYzM0NGFjZDgyNzM3NjQ4YmEzYWY3NjZfOC05LTEtMS0xMDc3MA_763254c1-5771-4e34-874d-c805043bed93">119,143</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fdc200320734b32ba399fb32a98810b_I20200331" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjA4YjkwYmJkYmMzNDRhY2Q4MjczNzY0OGJhM2FmNzY2L3RhYmxlcmFuZ2U6MDhiOTBiYmRiYzM0NGFjZDgyNzM3NjQ4YmEzYWY3NjZfOC0xMS0xLTEtMTA3NzA_4db7e1ef-da2e-4d6b-8366-b9f00a471c28">411,858</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21ae371fccca46019f452281282a8e2e_I20200331" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjA4YjkwYmJkYmMzNDRhY2Q4MjczNzY0OGJhM2FmNzY2L3RhYmxlcmFuZ2U6MDhiOTBiYmRiYzM0NGFjZDgyNzM3NjQ4YmEzYWY3NjZfOC0xMy0xLTEtMTA3NzA_2435364d-97f9-4741-b636-77d77b22e3db">105</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4c03c1bf0694cdb83793beff3d0c14d_I20200331" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjA4YjkwYmJkYmMzNDRhY2Q4MjczNzY0OGJhM2FmNzY2L3RhYmxlcmFuZ2U6MDhiOTBiYmRiYzM0NGFjZDgyNzM3NjQ4YmEzYWY3NjZfOC0xNS0xLTEtMTA3NzA_eaf5e12e-6056-40ef-a6a9-2c91812721ab">749,080</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity awards vested and exercised, net of shares withheld for payroll taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ice0ddb5cd06441b9bbeccf3e4c82794d_D20200401-20200630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjA4YjkwYmJkYmMzNDRhY2Q4MjczNzY0OGJhM2FmNzY2L3RhYmxlcmFuZ2U6MDhiOTBiYmRiYzM0NGFjZDgyNzM3NjQ4YmEzYWY3NjZfMTAtMS0xLTEtMTA3NzA_25266298-b336-4b71-9ec8-68ac24f0378c">119</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice0ddb5cd06441b9bbeccf3e4c82794d_D20200401-20200630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjA4YjkwYmJkYmMzNDRhY2Q4MjczNzY0OGJhM2FmNzY2L3RhYmxlcmFuZ2U6MDhiOTBiYmRiYzM0NGFjZDgyNzM3NjQ4YmEzYWY3NjZfMTAtMy0xLTEtMTA3NzA_e10cce3f-5bb3-4ea2-bee6-d5d40c1ff46c">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i22cbe5469ffd4ae29750942feb990e4a_D20200401-20200630" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjA4YjkwYmJkYmMzNDRhY2Q4MjczNzY0OGJhM2FmNzY2L3RhYmxlcmFuZ2U6MDhiOTBiYmRiYzM0NGFjZDgyNzM3NjQ4YmEzYWY3NjZfMTAtNS0xLTEtMTA3NzA_d75a3e5a-75d9-46f1-aa7c-3bce9f7564fc">289</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6d7b8b207f474903b3f67df5d7afc0b7_D20200401-20200630" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjA4YjkwYmJkYmMzNDRhY2Q4MjczNzY0OGJhM2FmNzY2L3RhYmxlcmFuZ2U6MDhiOTBiYmRiYzM0NGFjZDgyNzM3NjQ4YmEzYWY3NjZfMTAtMTUtMS0xLTEwNzcw_b2b9fbce-0486-490d-b3ab-96730591df03">288</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22cbe5469ffd4ae29750942feb990e4a_D20200401-20200630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjA4YjkwYmJkYmMzNDRhY2Q4MjczNzY0OGJhM2FmNzY2L3RhYmxlcmFuZ2U6MDhiOTBiYmRiYzM0NGFjZDgyNzM3NjQ4YmEzYWY3NjZfMTEtNS0xLTEtMTA3NzA_88d12bff-abda-4a19-99e5-86c9bc9d1614">6,347</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7b8b207f474903b3f67df5d7afc0b7_D20200401-20200630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjA4YjkwYmJkYmMzNDRhY2Q4MjczNzY0OGJhM2FmNzY2L3RhYmxlcmFuZ2U6MDhiOTBiYmRiYzM0NGFjZDgyNzM3NjQ4YmEzYWY3NjZfMTEtMTUtMS0xLTEwNzcw_68d22ed6-0c6e-47cf-a2a5-3c11814bf230">6,347</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9ff33a69ee247cca762b7fc9c84ab44_D20200401-20200630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjA4YjkwYmJkYmMzNDRhY2Q4MjczNzY0OGJhM2FmNzY2L3RhYmxlcmFuZ2U6MDhiOTBiYmRiYzM0NGFjZDgyNzM3NjQ4YmEzYWY3NjZfMTItMTEtMS0xLTEwNzcw_64605a96-2a5d-4e42-b1a5-6d4829bc1bcf">22,325</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iba98b023b51845efaf19bbdbfccdd906_D20200401-20200630" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjA4YjkwYmJkYmMzNDRhY2Q4MjczNzY0OGJhM2FmNzY2L3RhYmxlcmFuZ2U6MDhiOTBiYmRiYzM0NGFjZDgyNzM3NjQ4YmEzYWY3NjZfMTItMTMtMS0xLTEwNzcw_9d615b98-6bdd-4252-a97a-1c02d4765fe6">58</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7b8b207f474903b3f67df5d7afc0b7_D20200401-20200630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjA4YjkwYmJkYmMzNDRhY2Q4MjczNzY0OGJhM2FmNzY2L3RhYmxlcmFuZ2U6MDhiOTBiYmRiYzM0NGFjZDgyNzM3NjQ4YmEzYWY3NjZfMTItMTUtMS0xLTEwNzcw_9c92cefe-24c7-4198-9579-8698200804ba">22,267</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance, June 30, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i31b9aece0de343d4938455d196c5db4d_I20200630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjA4YjkwYmJkYmMzNDRhY2Q4MjczNzY0OGJhM2FmNzY2L3RhYmxlcmFuZ2U6MDhiOTBiYmRiYzM0NGFjZDgyNzM3NjQ4YmEzYWY3NjZfMTMtMS0xLTEtMTA3NzA_eaa8da70-181d-4737-a432-69aeaa787d58">49,542</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31b9aece0de343d4938455d196c5db4d_I20200630" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjA4YjkwYmJkYmMzNDRhY2Q4MjczNzY0OGJhM2FmNzY2L3RhYmxlcmFuZ2U6MDhiOTBiYmRiYzM0NGFjZDgyNzM3NjQ4YmEzYWY3NjZfMTMtMy0xLTEtMTA3NzA_7c0d2ad6-163f-4f46-b162-f1d0e24c1077">495</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b53f2fafe1d4e4db0704085cd21df06_I20200630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjA4YjkwYmJkYmMzNDRhY2Q4MjczNzY0OGJhM2FmNzY2L3RhYmxlcmFuZ2U6MDhiOTBiYmRiYzM0NGFjZDgyNzM3NjQ4YmEzYWY3NjZfMTMtNS0xLTEtMTA3NzA_3167fed0-3559-4b13-b02b-053f031b9954">461,824</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i7d335e9ab53a4968a587f6a232b63ae6_I20200630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjA4YjkwYmJkYmMzNDRhY2Q4MjczNzY0OGJhM2FmNzY2L3RhYmxlcmFuZ2U6MDhiOTBiYmRiYzM0NGFjZDgyNzM3NjQ4YmEzYWY3NjZfMTMtNy0xLTEtMTA3NzA_b5b82d93-a770-458a-873d-9576df7cd310">2,561</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7d335e9ab53a4968a587f6a232b63ae6_I20200630" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjA4YjkwYmJkYmMzNDRhY2Q4MjczNzY0OGJhM2FmNzY2L3RhYmxlcmFuZ2U6MDhiOTBiYmRiYzM0NGFjZDgyNzM3NjQ4YmEzYWY3NjZfMTMtOS0xLTEtMTA3NzA_b6de3008-5844-4c61-833b-94f99a5fc364">119,143</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i171378b7da944f48bc6e24f7e01f7ba2_I20200630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjA4YjkwYmJkYmMzNDRhY2Q4MjczNzY0OGJhM2FmNzY2L3RhYmxlcmFuZ2U6MDhiOTBiYmRiYzM0NGFjZDgyNzM3NjQ4YmEzYWY3NjZfMTMtMTEtMS0xLTEwNzcw_861dee3e-5f9e-4eaa-aba4-1d7b2b5a7700">434,183</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a73aec65e1645e497b0db29a7acbd13_I20200630" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjA4YjkwYmJkYmMzNDRhY2Q4MjczNzY0OGJhM2FmNzY2L3RhYmxlcmFuZ2U6MDhiOTBiYmRiYzM0NGFjZDgyNzM3NjQ4YmEzYWY3NjZfMTMtMTMtMS0xLTEwNzcw_6c513b8b-233b-4235-bd0f-1f76fa12cd0a">47</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i864c53255b1c4eecafc3c0eac9341add_I20200630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjA4YjkwYmJkYmMzNDRhY2Q4MjczNzY0OGJhM2FmNzY2L3RhYmxlcmFuZ2U6MDhiOTBiYmRiYzM0NGFjZDgyNzM3NjQ4YmEzYWY3NjZfMTMtMTUtMS0xLTEwNzcw_8e50ea91-27a7-42a5-adcb-bc427a2edf72">777,406</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity awards vested and exercised, net of shares withheld for payroll taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i61d471d96d2b497e850b061f9eed0d11_D20200701-20200930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjA4YjkwYmJkYmMzNDRhY2Q4MjczNzY0OGJhM2FmNzY2L3RhYmxlcmFuZ2U6MDhiOTBiYmRiYzM0NGFjZDgyNzM3NjQ4YmEzYWY3NjZfMTUtMS0xLTEtMTA3NzA_9377718c-7c15-4859-8b11-6694f33af039">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i226e8207b95f41d1ad9ee9df88356228_D20200701-20200930" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjA4YjkwYmJkYmMzNDRhY2Q4MjczNzY0OGJhM2FmNzY2L3RhYmxlcmFuZ2U6MDhiOTBiYmRiYzM0NGFjZDgyNzM3NjQ4YmEzYWY3NjZfMTUtNS0xLTEtMTA3NzA_f2f96fd8-e393-4092-8870-b33151bc3052">158</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6cb0c51ba8fa45fda70ec7e5df8b4ef1_D20200701-20200930" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjA4YjkwYmJkYmMzNDRhY2Q4MjczNzY0OGJhM2FmNzY2L3RhYmxlcmFuZ2U6MDhiOTBiYmRiYzM0NGFjZDgyNzM3NjQ4YmEzYWY3NjZfMTUtMTUtMS0xLTEwNzcw_ae8e4603-60f7-45e5-92e0-eb8a8c3f1792">158</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i226e8207b95f41d1ad9ee9df88356228_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjA4YjkwYmJkYmMzNDRhY2Q4MjczNzY0OGJhM2FmNzY2L3RhYmxlcmFuZ2U6MDhiOTBiYmRiYzM0NGFjZDgyNzM3NjQ4YmEzYWY3NjZfMTYtNS0xLTEtMTA3NzA_6a5b0438-ef26-4acf-b883-c73af7197acc">3,772</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6cb0c51ba8fa45fda70ec7e5df8b4ef1_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjA4YjkwYmJkYmMzNDRhY2Q4MjczNzY0OGJhM2FmNzY2L3RhYmxlcmFuZ2U6MDhiOTBiYmRiYzM0NGFjZDgyNzM3NjQ4YmEzYWY3NjZfMTYtMTUtMS0xLTEwNzcw_be3cdeea-bbba-48b3-a34d-39fbe88982ab">3,772</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1318bf5c6a9f40ae8b4706d6aadc9c71_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjA4YjkwYmJkYmMzNDRhY2Q4MjczNzY0OGJhM2FmNzY2L3RhYmxlcmFuZ2U6MDhiOTBiYmRiYzM0NGFjZDgyNzM3NjQ4YmEzYWY3NjZfMTctMTEtMS0xLTEwNzcw_1ed17b3c-d3a3-4d48-8147-7d6f2b15d18a">26,067</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if2cb1f3c6ed840009dec907fba58a43d_D20200701-20200930" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjA4YjkwYmJkYmMzNDRhY2Q4MjczNzY0OGJhM2FmNzY2L3RhYmxlcmFuZ2U6MDhiOTBiYmRiYzM0NGFjZDgyNzM3NjQ4YmEzYWY3NjZfMTctMTMtMS0xLTEwNzcw_a82e7c1e-b6a2-4569-b27c-baf45011864c">14</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6cb0c51ba8fa45fda70ec7e5df8b4ef1_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjA4YjkwYmJkYmMzNDRhY2Q4MjczNzY0OGJhM2FmNzY2L3RhYmxlcmFuZ2U6MDhiOTBiYmRiYzM0NGFjZDgyNzM3NjQ4YmEzYWY3NjZfMTctMTUtMS0xLTEwNzcw_598dfff4-036f-49b7-9359-2b19b3a00c74">26,053</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance, September 30, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6e14eb9c93e74f3296e6b86f12a28f94_I20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjA4YjkwYmJkYmMzNDRhY2Q4MjczNzY0OGJhM2FmNzY2L3RhYmxlcmFuZ2U6MDhiOTBiYmRiYzM0NGFjZDgyNzM3NjQ4YmEzYWY3NjZfMTgtMS0xLTEtMTA3NzA_03af8653-7475-4f12-81c0-01393f986cf7">49,550</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e14eb9c93e74f3296e6b86f12a28f94_I20200930" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjA4YjkwYmJkYmMzNDRhY2Q4MjczNzY0OGJhM2FmNzY2L3RhYmxlcmFuZ2U6MDhiOTBiYmRiYzM0NGFjZDgyNzM3NjQ4YmEzYWY3NjZfMTgtMy0xLTEtMTA3NzA_8e0270c3-3b09-482a-be83-bff54549f72a">495</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i912fae7382c74520a36b966d54d94e55_I20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjA4YjkwYmJkYmMzNDRhY2Q4MjczNzY0OGJhM2FmNzY2L3RhYmxlcmFuZ2U6MDhiOTBiYmRiYzM0NGFjZDgyNzM3NjQ4YmEzYWY3NjZfMTgtNS0xLTEtMTA3NzA_585952b1-e322-4520-932e-e2f6f3082636">465,438</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i1204f31b85134c68b260fb9d3a28ba82_I20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjA4YjkwYmJkYmMzNDRhY2Q4MjczNzY0OGJhM2FmNzY2L3RhYmxlcmFuZ2U6MDhiOTBiYmRiYzM0NGFjZDgyNzM3NjQ4YmEzYWY3NjZfMTgtNy0xLTEtMTA3NzA_24d11879-439e-40d8-80f5-8c61d69b3a22">2,561</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1204f31b85134c68b260fb9d3a28ba82_I20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjA4YjkwYmJkYmMzNDRhY2Q4MjczNzY0OGJhM2FmNzY2L3RhYmxlcmFuZ2U6MDhiOTBiYmRiYzM0NGFjZDgyNzM3NjQ4YmEzYWY3NjZfMTgtOS0xLTEtMTA3NzA_fb4e57f9-63cd-416f-aa02-9eca922f9393">119,143</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa7b25fceae44920a18c86a32eb37837_I20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjA4YjkwYmJkYmMzNDRhY2Q4MjczNzY0OGJhM2FmNzY2L3RhYmxlcmFuZ2U6MDhiOTBiYmRiYzM0NGFjZDgyNzM3NjQ4YmEzYWY3NjZfMTgtMTEtMS0xLTEwNzcw_a89ef210-91a4-48aa-ad46-ae46fa7c61bb">460,250</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2981eb3d48d4b619016fcb5f4dcabdc_I20200930" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjA4YjkwYmJkYmMzNDRhY2Q4MjczNzY0OGJhM2FmNzY2L3RhYmxlcmFuZ2U6MDhiOTBiYmRiYzM0NGFjZDgyNzM3NjQ4YmEzYWY3NjZfMTgtMTMtMS0xLTEwNzcw_f3274afe-08e3-489d-81c6-108844655db2">33</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i041c1c8fe78444f88611087c404a5e99_I20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjA4YjkwYmJkYmMzNDRhY2Q4MjczNzY0OGJhM2FmNzY2L3RhYmxlcmFuZ2U6MDhiOTBiYmRiYzM0NGFjZDgyNzM3NjQ4YmEzYWY3NjZfMTgtMTUtMS0xLTEwNzcw_dae28612-14d1-4365-ad5b-db77c5ae9742">807,073</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:20.976%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.186%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.267%"></td><td style="width:0.1%"></td></tr><tr style="height:23pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional<br/>Paid-in<br/>Capital</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained Earnings</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Income</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr style="height:11pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance, December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3656a73d18b94b609e6f1990823c9b89_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjMwOGUyY2ZiZWRlNDQ5Njk5YjAyNmU5MGNmNjUwYzVlL3RhYmxlcmFuZ2U6MzA4ZTJjZmJlZGU0NDk2OTliMDI2ZTkwY2Y2NTBjNWVfMi0xLTEtMS0xMDc3MA_0a894a0d-d384-43fd-826d-82e761a61d55">49,614</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3656a73d18b94b609e6f1990823c9b89_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjMwOGUyY2ZiZWRlNDQ5Njk5YjAyNmU5MGNmNjUwYzVlL3RhYmxlcmFuZ2U6MzA4ZTJjZmJlZGU0NDk2OTliMDI2ZTkwY2Y2NTBjNWVfMi0zLTEtMS0xMDc3MA_64248850-f201-4abe-a41b-c1adf62bbaa6">496</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8479ccefea534b2dad7f94b83fe989f0_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjMwOGUyY2ZiZWRlNDQ5Njk5YjAyNmU5MGNmNjUwYzVlL3RhYmxlcmFuZ2U6MzA4ZTJjZmJlZGU0NDk2OTliMDI2ZTkwY2Y2NTBjNWVfMi01LTEtMS0xMDc3MA_10355639-5e4b-43bd-b82e-5d01d3e46a1e">468,726</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="iaee22aaa9ae44b1391c0b85a98440ff2_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjMwOGUyY2ZiZWRlNDQ5Njk5YjAyNmU5MGNmNjUwYzVlL3RhYmxlcmFuZ2U6MzA4ZTJjZmJlZGU0NDk2OTliMDI2ZTkwY2Y2NTBjNWVfMi03LTEtMS0xMDc3MA_bf564c7c-9a78-4a02-baeb-bc0cb0b20678">2,561</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaee22aaa9ae44b1391c0b85a98440ff2_I20201231" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjMwOGUyY2ZiZWRlNDQ5Njk5YjAyNmU5MGNmNjUwYzVlL3RhYmxlcmFuZ2U6MzA4ZTJjZmJlZGU0NDk2OTliMDI2ZTkwY2Y2NTBjNWVfMi05LTEtMS0xMDc3MA_96d62dac-7b4d-4529-97dc-66c71c59b46d">119,143</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04614019537444e7b0521086b438b3b9_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjMwOGUyY2ZiZWRlNDQ5Njk5YjAyNmU5MGNmNjUwYzVlL3RhYmxlcmFuZ2U6MzA4ZTJjZmJlZGU0NDk2OTliMDI2ZTkwY2Y2NTBjNWVfMi0xMS0xLTEtMTA3NzA_51b02432-94d9-4934-80a2-23b23019fdd3">469,558</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7af796f0576e42eca232001f8709a3b5_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjMwOGUyY2ZiZWRlNDQ5Njk5YjAyNmU5MGNmNjUwYzVlL3RhYmxlcmFuZ2U6MzA4ZTJjZmJlZGU0NDk2OTliMDI2ZTkwY2Y2NTBjNWVfMi0xMy0xLTEtMTA3NzA_586ee00f-f0eb-4dc8-ab57-2ed0f1b38b79">40</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjMwOGUyY2ZiZWRlNDQ5Njk5YjAyNmU5MGNmNjUwYzVlL3RhYmxlcmFuZ2U6MzA4ZTJjZmJlZGU0NDk2OTliMDI2ZTkwY2Y2NTBjNWVfMi0xNS0xLTEtMTA3NzA_c1eca1a6-9ec4-4083-996f-17173a88aca4">819,677</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity awards vested and exercised, net of shares withheld for payroll taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i02f81d784dce4b24a61070fc9496df23_D20210101-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjMwOGUyY2ZiZWRlNDQ5Njk5YjAyNmU5MGNmNjUwYzVlL3RhYmxlcmFuZ2U6MzA4ZTJjZmJlZGU0NDk2OTliMDI2ZTkwY2Y2NTBjNWVfNC0xLTEtMS0xMDc3MA_8cc3c158-66d8-46d5-a4bd-196d1a6233c9">132</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02f81d784dce4b24a61070fc9496df23_D20210101-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjMwOGUyY2ZiZWRlNDQ5Njk5YjAyNmU5MGNmNjUwYzVlL3RhYmxlcmFuZ2U6MzA4ZTJjZmJlZGU0NDk2OTliMDI2ZTkwY2Y2NTBjNWVfNC0zLTEtMS0xMDc3MA_e2819f8b-be65-4b62-82c2-31a02ed52f09">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie5a0923496204e499de51398c3adbec5_D20210101-20210331" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjMwOGUyY2ZiZWRlNDQ5Njk5YjAyNmU5MGNmNjUwYzVlL3RhYmxlcmFuZ2U6MzA4ZTJjZmJlZGU0NDk2OTliMDI2ZTkwY2Y2NTBjNWVfNC01LTEtMS0xMDc3MA_9f1e13b4-d659-4a72-b38b-570fea45c0fc">5,259</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib2a70c6698bc4fb2a2ee6a77c38e17e7_D20210101-20210331" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjMwOGUyY2ZiZWRlNDQ5Njk5YjAyNmU5MGNmNjUwYzVlL3RhYmxlcmFuZ2U6MzA4ZTJjZmJlZGU0NDk2OTliMDI2ZTkwY2Y2NTBjNWVfNC0xNS0xLTEtMTA3NzA_57266f2e-db16-4f68-9f70-be94d08d3a9e">5,258</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5a0923496204e499de51398c3adbec5_D20210101-20210331" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjMwOGUyY2ZiZWRlNDQ5Njk5YjAyNmU5MGNmNjUwYzVlL3RhYmxlcmFuZ2U6MzA4ZTJjZmJlZGU0NDk2OTliMDI2ZTkwY2Y2NTBjNWVfNi01LTEtMS0xMDc3MA_05f70803-cd63-4364-a281-c32699b0e745">9,287</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2a70c6698bc4fb2a2ee6a77c38e17e7_D20210101-20210331" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjMwOGUyY2ZiZWRlNDQ5Njk5YjAyNmU5MGNmNjUwYzVlL3RhYmxlcmFuZ2U6MzA4ZTJjZmJlZGU0NDk2OTliMDI2ZTkwY2Y2NTBjNWVfNi0xNS0xLTEtMTA3NzA_f3e503f2-eaa7-446b-8322-bfeb6deaeae3">9,287</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88adf94124da4574a028c28b388799d6_D20210101-20210331" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjMwOGUyY2ZiZWRlNDQ5Njk5YjAyNmU5MGNmNjUwYzVlL3RhYmxlcmFuZ2U6MzA4ZTJjZmJlZGU0NDk2OTliMDI2ZTkwY2Y2NTBjNWVfNy0xMS0xLTEtMTA3NzA_ff4787b2-1ec7-4344-a482-94b2804bb78d">70,378</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iac59e5529bc54834bcd03309405d87e9_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjMwOGUyY2ZiZWRlNDQ5Njk5YjAyNmU5MGNmNjUwYzVlL3RhYmxlcmFuZ2U6MzA4ZTJjZmJlZGU0NDk2OTliMDI2ZTkwY2Y2NTBjNWVfNy0xMy0xLTEtMTA3NzA_4688f349-bc71-4704-a70c-5bf19ae14b2e">24</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2a70c6698bc4fb2a2ee6a77c38e17e7_D20210101-20210331" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjMwOGUyY2ZiZWRlNDQ5Njk5YjAyNmU5MGNmNjUwYzVlL3RhYmxlcmFuZ2U6MzA4ZTJjZmJlZGU0NDk2OTliMDI2ZTkwY2Y2NTBjNWVfNy0xNS0xLTEtMTA3NzA_ee8ae11b-2ab3-4172-a8eb-12ef1c3472b5">70,354</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance, March 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9dafaa37d5364e1ba2bb35e85967fa2c_I20210331" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjMwOGUyY2ZiZWRlNDQ5Njk5YjAyNmU5MGNmNjUwYzVlL3RhYmxlcmFuZ2U6MzA4ZTJjZmJlZGU0NDk2OTliMDI2ZTkwY2Y2NTBjNWVfOC0xLTEtMS0xMDc3MA_e0b32bdb-da48-48c4-8b8f-2579b2391972">49,746</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dafaa37d5364e1ba2bb35e85967fa2c_I20210331" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjMwOGUyY2ZiZWRlNDQ5Njk5YjAyNmU5MGNmNjUwYzVlL3RhYmxlcmFuZ2U6MzA4ZTJjZmJlZGU0NDk2OTliMDI2ZTkwY2Y2NTBjNWVfOC0zLTEtMS0xMDc3MA_e704f4d2-59d1-4dfd-a9cf-d6817fcbd260">497</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ce2b693b671480e806a25a643c7f12d_I20210331" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjMwOGUyY2ZiZWRlNDQ5Njk5YjAyNmU5MGNmNjUwYzVlL3RhYmxlcmFuZ2U6MzA4ZTJjZmJlZGU0NDk2OTliMDI2ZTkwY2Y2NTBjNWVfOC01LTEtMS0xMDc3MA_9ffe0b11-e825-4300-817f-0167a46ac26e">472,754</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i403d2a055ccd43bb8b88f5d7cab63117_I20210331" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjMwOGUyY2ZiZWRlNDQ5Njk5YjAyNmU5MGNmNjUwYzVlL3RhYmxlcmFuZ2U6MzA4ZTJjZmJlZGU0NDk2OTliMDI2ZTkwY2Y2NTBjNWVfOC03LTEtMS0xMDc3MA_ce192a89-8f7b-491a-8fe1-85640ebaeb7e">2,561</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i403d2a055ccd43bb8b88f5d7cab63117_I20210331" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjMwOGUyY2ZiZWRlNDQ5Njk5YjAyNmU5MGNmNjUwYzVlL3RhYmxlcmFuZ2U6MzA4ZTJjZmJlZGU0NDk2OTliMDI2ZTkwY2Y2NTBjNWVfOC05LTEtMS0xMDc3MA_e0200161-ba1c-4da9-a9bd-bd929ea4b502">119,143</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idbce5210eba9474d85e1137c4859a231_I20210331" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjMwOGUyY2ZiZWRlNDQ5Njk5YjAyNmU5MGNmNjUwYzVlL3RhYmxlcmFuZ2U6MzA4ZTJjZmJlZGU0NDk2OTliMDI2ZTkwY2Y2NTBjNWVfOC0xMS0xLTEtMTA3NzA_6459c648-0943-4827-a70e-8bae422cbbaf">539,936</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic160cb42fea14c7584293e11e1aa33d3_I20210331" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjMwOGUyY2ZiZWRlNDQ5Njk5YjAyNmU5MGNmNjUwYzVlL3RhYmxlcmFuZ2U6MzA4ZTJjZmJlZGU0NDk2OTliMDI2ZTkwY2Y2NTBjNWVfOC0xMy0xLTEtMTA3NzA_9f21abb0-8ec8-4e06-a38c-e33c2b6873d3">16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i705012913b884ada9d0c3c4d270ed4d2_I20210331" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjMwOGUyY2ZiZWRlNDQ5Njk5YjAyNmU5MGNmNjUwYzVlL3RhYmxlcmFuZ2U6MzA4ZTJjZmJlZGU0NDk2OTliMDI2ZTkwY2Y2NTBjNWVfOC0xNS0xLTEtMTA3NzA_90395ff7-4808-4ed1-91ee-e57ae17d0d6d">894,060</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity awards vested and exercised, net of shares withheld for payroll taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3ef4f52f779e4faf95d4601d80832007_D20210401-20210630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjMwOGUyY2ZiZWRlNDQ5Njk5YjAyNmU5MGNmNjUwYzVlL3RhYmxlcmFuZ2U6MzA4ZTJjZmJlZGU0NDk2OTliMDI2ZTkwY2Y2NTBjNWVfMTAtMS0xLTEtMTA3NzA_90bcba39-4f30-4c88-9600-37ee744b7cb8">78</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ef4f52f779e4faf95d4601d80832007_D20210401-20210630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjMwOGUyY2ZiZWRlNDQ5Njk5YjAyNmU5MGNmNjUwYzVlL3RhYmxlcmFuZ2U6MzA4ZTJjZmJlZGU0NDk2OTliMDI2ZTkwY2Y2NTBjNWVfMTAtMy0xLTEtMTA3NzA_96920b25-9ba8-4646-ac2a-3117fc6861bc">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i32dfbd39eb3d43cb911abb42fa8a42ef_D20210401-20210630" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjMwOGUyY2ZiZWRlNDQ5Njk5YjAyNmU5MGNmNjUwYzVlL3RhYmxlcmFuZ2U6MzA4ZTJjZmJlZGU0NDk2OTliMDI2ZTkwY2Y2NTBjNWVfMTAtNS0xLTEtMTA3NzA_9b51a1be-2279-43bf-949c-e7506670e372">471</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i77c68cc8659943eea02704a6a078bf18_D20210401-20210630" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjMwOGUyY2ZiZWRlNDQ5Njk5YjAyNmU5MGNmNjUwYzVlL3RhYmxlcmFuZ2U6MzA4ZTJjZmJlZGU0NDk2OTliMDI2ZTkwY2Y2NTBjNWVfMTAtMTUtMS0xLTEwNzcw_1749a2bd-2c3d-45dc-b65a-428e341bcba6">470</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32dfbd39eb3d43cb911abb42fa8a42ef_D20210401-20210630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjMwOGUyY2ZiZWRlNDQ5Njk5YjAyNmU5MGNmNjUwYzVlL3RhYmxlcmFuZ2U6MzA4ZTJjZmJlZGU0NDk2OTliMDI2ZTkwY2Y2NTBjNWVfMTEtNS0xLTEtMTA3NzA_9faaa1d0-ffbf-4e54-81fd-b4b93127f6d4">6,019</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77c68cc8659943eea02704a6a078bf18_D20210401-20210630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjMwOGUyY2ZiZWRlNDQ5Njk5YjAyNmU5MGNmNjUwYzVlL3RhYmxlcmFuZ2U6MzA4ZTJjZmJlZGU0NDk2OTliMDI2ZTkwY2Y2NTBjNWVfMTEtMTUtMS0xLTEwNzcw_b5bdea00-85eb-4d74-acab-9d685ee6e980">6,019</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Comprehensive income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib57f7397b0a0419fb8f2b4cb5a7b0ff7_D20210401-20210630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjMwOGUyY2ZiZWRlNDQ5Njk5YjAyNmU5MGNmNjUwYzVlL3RhYmxlcmFuZ2U6MzA4ZTJjZmJlZGU0NDk2OTliMDI2ZTkwY2Y2NTBjNWVfMTItMTEtMS0xLTEwNzcw_2ff6854b-843b-4dc3-8620-efcebd7d1bdb">66,770</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfb3f98525f24d859c4abcde0f73f237_D20210401-20210630" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjMwOGUyY2ZiZWRlNDQ5Njk5YjAyNmU5MGNmNjUwYzVlL3RhYmxlcmFuZ2U6MzA4ZTJjZmJlZGU0NDk2OTliMDI2ZTkwY2Y2NTBjNWVfMTItMTMtMS0xLTEwNzcw_ee995681-b8e8-4b54-82c2-f3deb9734e61">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77c68cc8659943eea02704a6a078bf18_D20210401-20210630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjMwOGUyY2ZiZWRlNDQ5Njk5YjAyNmU5MGNmNjUwYzVlL3RhYmxlcmFuZ2U6MzA4ZTJjZmJlZGU0NDk2OTliMDI2ZTkwY2Y2NTBjNWVfMTItMTUtMS0xLTEwNzcw_599d3e8d-7a0d-4380-980d-8538b812fe75">66,773</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance, June 30, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5577c5bda907400ea634496c766b83e8_I20210630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjMwOGUyY2ZiZWRlNDQ5Njk5YjAyNmU5MGNmNjUwYzVlL3RhYmxlcmFuZ2U6MzA4ZTJjZmJlZGU0NDk2OTliMDI2ZTkwY2Y2NTBjNWVfMTMtMS0xLTEtMTA3NzA_32b4e843-928d-4190-b62d-bbc74cd694bd">49,824</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5577c5bda907400ea634496c766b83e8_I20210630" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjMwOGUyY2ZiZWRlNDQ5Njk5YjAyNmU5MGNmNjUwYzVlL3RhYmxlcmFuZ2U6MzA4ZTJjZmJlZGU0NDk2OTliMDI2ZTkwY2Y2NTBjNWVfMTMtMy0xLTEtMTA3NzA_00d18ed2-8668-4aea-a743-0fbd72198287">498</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id73c4bc3bbf84e21b5f04cbfc8a138a4_I20210630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjMwOGUyY2ZiZWRlNDQ5Njk5YjAyNmU5MGNmNjUwYzVlL3RhYmxlcmFuZ2U6MzA4ZTJjZmJlZGU0NDk2OTliMDI2ZTkwY2Y2NTBjNWVfMTMtNS0xLTEtMTA3NzA_f8cb0b3c-23cb-4d21-8e72-2962b2f19d79">478,302</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="id04a12fb0c1a4d8cb8704c13c181f0c8_I20210630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjMwOGUyY2ZiZWRlNDQ5Njk5YjAyNmU5MGNmNjUwYzVlL3RhYmxlcmFuZ2U6MzA4ZTJjZmJlZGU0NDk2OTliMDI2ZTkwY2Y2NTBjNWVfMTMtNy0xLTEtMTA3NzA_a58dd925-eddb-4281-a0af-e5f51012ac1a">2,561</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id04a12fb0c1a4d8cb8704c13c181f0c8_I20210630" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjMwOGUyY2ZiZWRlNDQ5Njk5YjAyNmU5MGNmNjUwYzVlL3RhYmxlcmFuZ2U6MzA4ZTJjZmJlZGU0NDk2OTliMDI2ZTkwY2Y2NTBjNWVfMTMtOS0xLTEtMTA3NzA_365724e3-bf13-46bb-8043-b9eb7225f0bd">119,143</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i57a944b08046487db5fbee0222d76c46_I20210630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjMwOGUyY2ZiZWRlNDQ5Njk5YjAyNmU5MGNmNjUwYzVlL3RhYmxlcmFuZ2U6MzA4ZTJjZmJlZGU0NDk2OTliMDI2ZTkwY2Y2NTBjNWVfMTMtMTEtMS0xLTEwNzcw_05cb8de0-460a-424c-abb5-32db1757bd4d">606,706</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i054622b9ff6b45d094e6d62e718bb40a_I20210630" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjMwOGUyY2ZiZWRlNDQ5Njk5YjAyNmU5MGNmNjUwYzVlL3RhYmxlcmFuZ2U6MzA4ZTJjZmJlZGU0NDk2OTliMDI2ZTkwY2Y2NTBjNWVfMTMtMTMtMS0xLTEwNzcw_082dc435-8ac1-4326-9ab9-848bb032ccef">19</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65cb728c1968429faa88cef83eef8a65_I20210630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjMwOGUyY2ZiZWRlNDQ5Njk5YjAyNmU5MGNmNjUwYzVlL3RhYmxlcmFuZ2U6MzA4ZTJjZmJlZGU0NDk2OTliMDI2ZTkwY2Y2NTBjNWVfMTMtMTUtMS0xLTEwNzcw_64912312-7e31-4526-8a46-efcbf1975167">966,382</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity awards vested and exercised, net of shares withheld for payroll taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifce17ccf7b614cb3aeb8d263bb97ccf5_D20210701-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjMwOGUyY2ZiZWRlNDQ5Njk5YjAyNmU5MGNmNjUwYzVlL3RhYmxlcmFuZ2U6MzA4ZTJjZmJlZGU0NDk2OTliMDI2ZTkwY2Y2NTBjNWVfMTUtMS0xLTEtMTA3NzA_3abf744f-79f4-4a68-9ef8-68fdd4a2e126">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id10a5dbf399445d3b8969edabe30751a_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjMwOGUyY2ZiZWRlNDQ5Njk5YjAyNmU5MGNmNjUwYzVlL3RhYmxlcmFuZ2U6MzA4ZTJjZmJlZGU0NDk2OTliMDI2ZTkwY2Y2NTBjNWVfMTUtNS0xLTEtMTA3NzA_7216db91-39f5-4702-ba97-dc3710494b80">527</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i150492f298fa47a78ef2c10a285a64f8_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjMwOGUyY2ZiZWRlNDQ5Njk5YjAyNmU5MGNmNjUwYzVlL3RhYmxlcmFuZ2U6MzA4ZTJjZmJlZGU0NDk2OTliMDI2ZTkwY2Y2NTBjNWVfMTUtMTUtMS0xLTEwNzcw_2dbeff58-9db9-4087-af8a-b14379495743">527</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id10a5dbf399445d3b8969edabe30751a_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjMwOGUyY2ZiZWRlNDQ5Njk5YjAyNmU5MGNmNjUwYzVlL3RhYmxlcmFuZ2U6MzA4ZTJjZmJlZGU0NDk2OTliMDI2ZTkwY2Y2NTBjNWVfMTYtNS0xLTEtMTA3NzA_79e154bc-7679-448f-a4e9-40ea0193db46">2,589</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i150492f298fa47a78ef2c10a285a64f8_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjMwOGUyY2ZiZWRlNDQ5Njk5YjAyNmU5MGNmNjUwYzVlL3RhYmxlcmFuZ2U6MzA4ZTJjZmJlZGU0NDk2OTliMDI2ZTkwY2Y2NTBjNWVfMTYtMTUtMS0xLTEwNzcw_fa0e262d-606a-4cc4-90df-3d0d06055217">2,589</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Comprehensive income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14e64987a4644969a8cf482d758cef56_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjMwOGUyY2ZiZWRlNDQ5Njk5YjAyNmU5MGNmNjUwYzVlL3RhYmxlcmFuZ2U6MzA4ZTJjZmJlZGU0NDk2OTliMDI2ZTkwY2Y2NTBjNWVfMTctMTEtMS0xLTEwNzcw_901c61f4-f8b4-4e03-8661-05756d98ab55">74,023</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic432083dde80448887610e8035a6b032_D20210701-20210930" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjMwOGUyY2ZiZWRlNDQ5Njk5YjAyNmU5MGNmNjUwYzVlL3RhYmxlcmFuZ2U6MzA4ZTJjZmJlZGU0NDk2OTliMDI2ZTkwY2Y2NTBjNWVfMTctMTMtMS0xLTEwNzcw_61206cd3-63ac-4e5a-b944-f5c8a82eea51">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i150492f298fa47a78ef2c10a285a64f8_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjMwOGUyY2ZiZWRlNDQ5Njk5YjAyNmU5MGNmNjUwYzVlL3RhYmxlcmFuZ2U6MzA4ZTJjZmJlZGU0NDk2OTliMDI2ZTkwY2Y2NTBjNWVfMTctMTUtMS0xLTEwNzcw_fc02047d-9b87-4017-ab23-53980207a3d6">74,034</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance, September 30, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ide77a3fd11044dd3926be5b05e61a140_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjMwOGUyY2ZiZWRlNDQ5Njk5YjAyNmU5MGNmNjUwYzVlL3RhYmxlcmFuZ2U6MzA4ZTJjZmJlZGU0NDk2OTliMDI2ZTkwY2Y2NTBjNWVfMTgtMS0xLTEtMTA3NzA_de6b1ac5-e0d8-4428-bdc4-555d8c1c80a5">49,836</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide77a3fd11044dd3926be5b05e61a140_I20210930" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjMwOGUyY2ZiZWRlNDQ5Njk5YjAyNmU5MGNmNjUwYzVlL3RhYmxlcmFuZ2U6MzA4ZTJjZmJlZGU0NDk2OTliMDI2ZTkwY2Y2NTBjNWVfMTgtMy0xLTEtMTA3NzA_a10ecb95-f0a4-4a5d-bf59-60a331f82e99">498</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib42c30aaa2d7465e8f21c1e6a8e2a52f_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjMwOGUyY2ZiZWRlNDQ5Njk5YjAyNmU5MGNmNjUwYzVlL3RhYmxlcmFuZ2U6MzA4ZTJjZmJlZGU0NDk2OTliMDI2ZTkwY2Y2NTBjNWVfMTgtNS0xLTEtMTA3NzA_113d2009-3f63-4428-9c9c-60dc53962b45">480,364</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="iee8941b97b824762bb44d764f5549f5f_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjMwOGUyY2ZiZWRlNDQ5Njk5YjAyNmU5MGNmNjUwYzVlL3RhYmxlcmFuZ2U6MzA4ZTJjZmJlZGU0NDk2OTliMDI2ZTkwY2Y2NTBjNWVfMTgtNy0xLTEtMTA3NzA_4aa15d5a-00c1-408b-bf21-8f599af17e3f">2,561</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iee8941b97b824762bb44d764f5549f5f_I20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjMwOGUyY2ZiZWRlNDQ5Njk5YjAyNmU5MGNmNjUwYzVlL3RhYmxlcmFuZ2U6MzA4ZTJjZmJlZGU0NDk2OTliMDI2ZTkwY2Y2NTBjNWVfMTgtOS0xLTEtMTA3NzA_e82131a4-8b20-41f3-8c11-c620963a8464">119,143</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1754ebd74a03401da95dc00b4abde2a7_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjMwOGUyY2ZiZWRlNDQ5Njk5YjAyNmU5MGNmNjUwYzVlL3RhYmxlcmFuZ2U6MzA4ZTJjZmJlZGU0NDk2OTliMDI2ZTkwY2Y2NTBjNWVfMTgtMTEtMS0xLTEwNzcw_4aceeae0-77af-422a-9741-746b6ce29de8">680,729</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02fea62d4d29457fb6f838bf4cba33b5_I20210930" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjMwOGUyY2ZiZWRlNDQ5Njk5YjAyNmU5MGNmNjUwYzVlL3RhYmxlcmFuZ2U6MzA4ZTJjZmJlZGU0NDk2OTliMDI2ZTkwY2Y2NTBjNWVfMTgtMTMtMS0xLTEwNzcw_59d3bb54-2f8e-4bd8-ac0b-bcf939b9e7e2">30</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68ecd84e8da440808154baac134e839e_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjMwOGUyY2ZiZWRlNDQ5Njk5YjAyNmU5MGNmNjUwYzVlL3RhYmxlcmFuZ2U6MzA4ZTJjZmJlZGU0NDk2OTliMDI2ZTkwY2Y2NTBjNWVfMTgtMTUtMS0xLTEwNzcw_ffbb117f-9e80-4fff-bf95-5a329b2bdcc6">1,042,478</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to unaudited condensed consolidated financial statements.</span></div><div style="text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="ia383c8c7878a498d91f9e8901f0cfd9c_25"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">AMN HEALTHCARE SERVICES, INC.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited and in thousands)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:59.163%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.401%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.403%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></div></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash flows from operating activities:</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfMy0xLTEtMS0xMDc3MA_939e552b-7180-4cbc-aafa-4cea112fcc7d">211,171</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfMy0zLTEtMS0xMDc3MA_1d057cf5-6214-4e1a-84af-27e3371a9f2b">61,357</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to reconcile net income to net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization (inclusive of depreciation included in cost of revenue)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfNS0xLTEtMS0xMDc3MA_de437844-56f4-42a0-969d-72e09674024d">75,871</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfNS0zLTEtMS0xMDc3MA_9355c0b6-eb4d-417a-b208-60bbb55a8027">70,077</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash interest expense and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherNoncashIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfNi0xLTEtMS0xMDc3MA_6954acfd-6f1a-4be3-8b53-d0df332b68a3">4,541</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:OtherNoncashIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfNi0zLTEtMS0xMDc3MA_3cb68350-2093-419c-98a7-c26cc6ef0b97">3,727</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Write-off of fees on credit facilities and senior notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" decimals="-3" name="us-gaap:WriteOffOfDeferredDebtIssuanceCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfNy0xLTEtMS0xMDc3MA_08f63641-c507-4e33-858b-1cded9c16267">158</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WriteOffOfDeferredDebtIssuanceCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfNy0zLTEtMS0xMDc3MA_ab8fe1e4-2d14-4039-b4cf-a7f48b27d287">1,773</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfOC0xLTEtMS0xMDc3MA_0df3d00d-41ac-462d-8047-e5df746c88c3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfOC0zLTEtMS0xMDc3MA_832c1570-1fb7-4f40-ba11-4183e856ef1a">1,700</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase in allowance for credit losses and sales credits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="amn:AccountsReceivableAndSalesCreditsCreditLossExpenseReversal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfOS0xLTEtMS0xMDc3MA_bfee5c86-e196-470a-8f45-cc23ea76bcb4">2,103</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="amn:AccountsReceivableAndSalesCreditsCreditLossExpenseReversal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfOS0zLTEtMS0xMDc3MA_3b891c74-829b-4689-b88d-469774eb0b1e">7,580</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for deferred income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfMTAtMS0xLTEtMTA3NzA_e54ac168-28df-4e0f-8068-ef9a4f703b35">4,328</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfMTAtMy0xLTEtMTA3NzA_315037f3-a8d5-4673-a70f-97df5484579c">17,923</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfMTEtMS0xLTEtMTA3NzA_47f74999-7b4e-4b2b-9731-2ae3fa3a00b3">17,895</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfMTEtMy0xLTEtMTA3NzA_81356293-d230-4705-9099-1c503f3e7bf9">15,046</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on disposal or sale of fixed assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:GainLossOnDispositionOfAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfMTItMS0xLTEtMTA3NzA_8d1c08e3-9cc6-4411-b38a-8b9666d68fd0">386</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:GainLossOnDispositionOfAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfMTItMy0xLTEtMTA3NzA_56658b4c-11d8-4955-82be-950c38e81f17">3,664</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of discount on investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" decimals="-3" name="us-gaap:InvestmentIncomeAmortizationOfDiscount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfMTMtMS0xLTEtMTA3NzA_ff95a47a-d45a-4e9c-b0f6-1b189881f8d4">41</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930" decimals="-3" name="us-gaap:InvestmentIncomeAmortizationOfDiscount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfMTMtMy0xLTEtMTA3NzA_b2b3ac23-771f-4755-972a-33e169386a33">96</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss on deferred compensation balances</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" decimals="-3" sign="-" name="amn:GainLossOnDeferredCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfMTQtMS0xLTEtMTA3NzA_1330d729-c538-448a-8ee9-aaace1d4b217">96</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930" decimals="-3" sign="-" name="amn:GainLossOnDeferredCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfMTQtMy0xLTEtMTA3NzA_35a41411-3cdc-4e6c-84cf-caf210b8b349">798</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash lease expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" decimals="-3" sign="-" name="amn:LesseeOperatingLeaseNoncashExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfMTUtMS0xLTEtMTA3NzA_b95279d2-b940-4603-ab00-3d1207138ee1">257</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930" decimals="-3" name="amn:LesseeOperatingLeaseNoncashExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfMTUtMy0xLTEtMTA3NzA_f4bff9af-5282-4cc8-82ed-0e782b8f5912">244</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in assets and liabilities, net of effects from acquisitions:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfMTctMS0xLTEtMTA3NzA_bf94c866-57a4-4456-b8c6-9869740e0b4f">196,342</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfMTctMy0xLTEtMTA3NzA_9b497ba6-5dc4-413d-b05b-5cdc472ac982">15,151</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, subcontractor</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="amn:IncreaseDecreaseinAccountsReceivablessubcontractor" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfMTgtMS0xLTEtMTA3NzA_90ed8979-b9a0-499c-9fed-ac46df34e45e">67,641</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="amn:IncreaseDecreaseinAccountsReceivablessubcontractor" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfMTgtMy0xLTEtMTA3NzA_0c1284ac-47a2-4908-b504-e0d2d3947c47">16,414</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInIncomeTaxesReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfMTktMS0xLTEtMTA3NzA_b129665d-4d6e-46d3-97a4-f41a467afe3a">5,472</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInIncomeTaxesReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfMTktMy0xLTEtMTA3NzA_c5057641-399c-4dff-b842-b0d6b94798f9">6,157</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInPrepaidExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfMjAtMS0xLTEtMTA3NzA_2aee3c39-e4e9-4f03-852a-f677dde51775">5,695</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInPrepaidExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfMjAtMy0xLTEtMTA3NzA_fbbc9156-ac17-4463-915c-8e4392eed91c">3,361</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInOtherCurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfMjEtMS0xLTEtMTA3NzA_25e035a0-1713-4efb-be6e-ac03097ebf21">3,411</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInOtherCurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfMjEtMy0xLTEtMTA3NzA_7815e0a9-2787-4ee4-8e54-73ae1386a4fd">2,977</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfMjItMS0xLTEtMTA3NzA_07d37b86-e084-4f02-9114-c138ef0d1f9c">780</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfMjItMy0xLTEtMTA3NzA_9857a0c8-3678-4140-9bbc-46841262e7cc">3,378</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfMjQtMS0xLTEtMTA3NzA_081ef706-182c-4d0f-8e0e-2693052c0027">112,183</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfMjQtMy0xLTEtMTA3NzA_a7fc5b8c-94c8-4720-9f82-36ad9fb2019f">5,484</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued compensation and benefits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfMjUtMS0xLTEtMTA3NzA_0f2c3747-f6fd-4c86-ba26-317c92345ea1">96,666</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfMjUtMy0xLTEtMTA3NzA_95d3d5d4-d645-4435-ab0f-4bc20bdfea79">7,630</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInOtherOperatingLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfMjYtMS0xLTEtMTA3NzA_aecf59eb-ee6b-40ec-af9d-fe98727f5a44">26,268</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInOtherOperatingLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfMjYtMy0xLTEtMTA3NzA_769e785f-da38-42c1-97c3-2f2a881fefb4">29,592</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfMjgtMS0xLTEtMTA3NzA_d3c920dd-51f5-4c13-9366-e892a0e45f00">6,276</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfMjgtMy0xLTEtMTA3NzA_0bcaaf66-c00a-4d77-b7e4-6ef6f70a4394">32</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted investments balance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInRestrictedCashAndInvestmentsForOperatingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfMjktMS0xLTEtMTA3NzA_5b557914-6de5-4072-96b1-3ba747863398">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInRestrictedCashAndInvestmentsForOperatingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfMjktMy0xLTEtMTA3NzA_01997fee-a590-4c7d-9045-799cbe0a1936">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 79.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfMzAtMS0xLTEtMTA3NzA_f22fec8f-8fb1-4a1f-bfad-0e68827cd3a0">227,371</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfMzAtMy0xLTEtMTA3NzA_18d2c40b-421e-458d-94af-9a5d0b8332e2">216,981</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash flows from investing activities:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase and development of fixed assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfMzMtMS0xLTEtMTA3NzA_c8b09f1d-00a6-4b60-bcba-6d6a71181544">38,710</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfMzMtMy0xLTEtMTA3NzA_7afeacdf-3ce8-411a-b056-48f1113c8453">27,357</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase of investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquireShortTermInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfMzQtMS0xLTEtMTA3NzA_88da5c43-4286-4631-a601-a0354337f335">32,437</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquireShortTermInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfMzQtMy0xLTEtMTA3NzA_058ee66d-90ef-4f6c-b427-e428b2c40f83">37,418</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from maturity of investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfMzUtMS0xLTEtMTA3NzA_e78ef4d8-7500-4c20-ae1d-e28a6adf8816">40,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfMzUtMy0xLTEtMTA3NzA_715b0d2f-d74f-44e2-a73b-2084b259c052">21,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase of equity investment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" decimals="-3" name="us-gaap:PaymentsToAcquireEquitySecuritiesFvNi" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfMzYtMS0xLTEtMTA3NzA_fb1cdede-ae22-461a-8944-598c384b05dd">500</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:PaymentsToAcquireEquitySecuritiesFvNi" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfMzYtMy0xLTEtMTA3NzA_266bf573-bede-452b-af8b-1d44388a10cf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments to fund deferred compensation plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquireLifeInsurancePolicies" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfMzctMS0xLTEtMTA3NzA_60078bf3-8c60-44a4-a8b5-df85b444879a">6,094</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquireLifeInsurancePolicies" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfMzctMy0xLTEtMTA3NzA_ed075981-3de3-4a5b-9512-b3174b16a5e8">7,171</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from sale of equity investment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" decimals="-3" name="us-gaap:ProceedsFromSaleOfTradingSecuritiesHeldforinvestment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfMzgtMS0xLTEtMTA3NzA_8c992a36-7ff2-4258-9b99-1c4f57f773c6">78</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930" decimals="-3" name="us-gaap:ProceedsFromSaleOfTradingSecuritiesHeldforinvestment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfMzgtMy0xLTEtMTA3NzA_d4e6eab5-d73a-46d0-8b70-8e778330dcee">303</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase of convertible promissory notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:PaymentsToAcquireNotesReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfMzktMS0xLTEtMTA3NzA_389edb30-3c72-4643-a12c-496c788a5ed6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930" decimals="-3" name="us-gaap:PaymentsToAcquireNotesReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfMzktMy0xLTEtMTA3NzA_ec785a9a-ff6b-40fa-a8c6-efa478950091">490</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for acquisitions, net of cash and restricted cash received</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfNDAtMS0xLTEtMTA3NzA_99f89f19-24e2-4300-af09-4620f8d9cfb6">41,264</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfNDAtMy0xLTEtMTA3NzA_74a5e5c9-5dce-4c8f-856a-0e3486106a00">476,491</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for other intangibles</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" decimals="-3" name="us-gaap:PaymentsToAcquireIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfNDEtMS0xLTEtMTA3NzA_1decb077-062d-4bb6-aab7-f93e860208c9">90</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquireIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfNDEtMy0xLTEtMTA3NzA_eb4cc02c-0324-4443-9d8c-c136f2b5965c">1,400</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash received for working capital adjustments for prior year acquisitions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:ProceedsFromPreviousAcquisition" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfNDItMS0xLTEtMTA3NzA_8d7a08e9-caa5-40c3-8ce7-c7a6ddf6dc2f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930" decimals="-3" name="us-gaap:ProceedsFromPreviousAcquisition" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfNDItMy0xLTEtMTA3NzA_c5e780e0-ade9-44b5-92cb-887cfb46aac4">66</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 79.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in investing activities</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfNDMtMS0xLTEtMTA3NzA_c64fcc89-253f-46be-a246-5ba43315b9e4">79,017</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfNDMtMy0xLTEtMTA3NzA_7437b4b9-646d-41d9-aa65-3d9149035053">528,458</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:59.163%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.401%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.403%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></div></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash flows from financing activities:</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments on term loans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RepaymentsOfSecuredDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfNDYtMS0xLTEtMTA3NzA_38af2000-0fb8-476e-ada2-011ce5e6e778">21,875</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RepaymentsOfSecuredDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfNDYtMy0xLTEtMTA3NzA_528f6ecf-d969-453a-922a-b2ddbe3dbb2c">203,125</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from term loans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:ProceedsFromIssuanceOfSecuredDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfNDctMS0xLTEtMTA3NzA_c90eec2e-db44-4f8a-a26d-99f887d52bd0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOfSecuredDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfNDctMy0xLTEtMTA3NzA_31ac7540-4c83-44a5-9a3c-a958e26e78a2">250,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments on revolving credit facility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RepaymentsOfLinesOfCredit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfNDgtMS0xLTEtMTA3NzA_e345093f-3f9c-4407-ac01-2ea0a8e543cf">70,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RepaymentsOfLinesOfCredit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfNDgtMy0xLTEtMTA3NzA_4169bf38-3689-4de9-9a3d-4e9519b39598">205,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from revolving credit facility</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromLinesOfCredit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfNDktMS0xLTEtMTA3NzA_e622df79-1a5e-4fa7-bf9e-96f680abcfa6">70,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromLinesOfCredit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfNDktMy0xLTEtMTA3NzA_5a7eb5e0-1094-4843-a2c8-dd8aeef4187d">245,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from senior notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfNTAtMS0xLTEtMTA3NzA_6fc8c491-5d62-4bdc-9c83-a63041f91ea5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfNTAtMy0xLTEtMTA3NzA_81aba7a9-40c5-4c40-869f-b09e7c966ee1">202,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payment of financing costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:PaymentsOfFinancingCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfNTMtMS0xLTEtMTA3NzA_1a2f3545-d59f-444d-b2ad-c5ada00c8c94">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsOfFinancingCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfNTMtMy0xLTEtMTA3NzA_6221beb0-f3cc-4870-9fa1-5d486debfe45">6,898</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earn-out payments to settle contingent consideration liabilities for prior acquisitions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="amn:PaymentsForPreviousAcquisitionEarnOutPayment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfNTQtMS0xLTEtMTA3NzA_297f0a64-f624-4908-9b8a-4a05f72a6222">3,100</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="amn:PaymentsForPreviousAcquisitionEarnOutPayment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfNTQtMy0xLTEtMTA3NzA_ea904880-2a53-420f-ab7d-1bf80e76f65c">10,622</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for shares withheld for taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfNTUtMS0xLTEtMTA3NzA_807a25a1-b9de-4dda-83c0-850117aea8d3">6,255</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfNTUtMy0xLTEtMTA3NzA_6fce0fec-65c1-4d03-95b3-387775c83be6">4,798</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 79.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by (used in) financing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfNTYtMS0xLTEtMTA3NzA_ab5d4c10-bf30-4946-b2ce-5ca572c67235">31,230</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfNTYtMy0xLTEtMTA3NzA_3b09c97e-ddac-4360-9c33-c727e3f61d54">266,557</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of exchange rate changes on cash</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfNTctMS0xLTEtMTA3NzA_c4cbd814-107a-45ba-9cf0-9872ab349aac">10</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930" decimals="-3" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfNTctMy0xLTEtMTA3NzA_1172e0da-b2ab-4fe2-acc7-81b8652cffe1">119</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net increase (decrease) in cash, cash equivalents and restricted cash</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfNTgtMS0xLTEtMTA3NzA_723f2b55-862d-427f-8232-75761eccda9c">117,114</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfNTgtMy0xLTEtMTA3NzA_56b90937-03e3-4f5f-a9a5-9f8ad41ba3b6">45,039</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash at beginning of period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfNTktMS0xLTEtMTA3NzA_0458445b-bf67-4e9a-8380-4998e4ca7d6b">83,990</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73ad7702c4f241548c42eab7eb506186_I20191231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfNTktMy0xLTEtMTA3NzA_c44942f4-c7a7-4e8d-9e13-8b8141097742">153,962</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash at end of period</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68ecd84e8da440808154baac134e839e_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfNjAtMS0xLTEtMTA3NzA_40fd6bf2-ba5b-40b9-acb0-13baf2ce9465">201,104</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i041c1c8fe78444f88611087c404a5e99_I20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfNjAtMy0xLTEtMTA3NzA_92b46ba1-216f-407f-b885-0143d507938f">108,923</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental disclosures of cash flow information:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of operating lease liabilities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeasePayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfNjMtMS0xLTEtMTA3NzA_dc310d8f-7842-4bc3-a1a6-56ea1de3a67e">35,066</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeasePayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfNjMtMy0xLTEtMTA3NzA_e47d9ef5-cf3d-40e5-bdae-401b9339760c">15,079</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for interest (net of $<ix:nonFraction unitRef="usd" contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" decimals="-3" name="us-gaap:InterestPaidCapitalized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfNjQtMC0xLTEtMTA3NzAvdGV4dHJlZ2lvbjoyZjQ1MWNhZDdlNTY0ZTQ5OTIxMzcwZmJiODQxMDViYV8zNQ_a116f33c-1f35-471c-ac96-1737b7b113b0">248</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930" decimals="-3" name="us-gaap:InterestPaidCapitalized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfNjQtMC0xLTEtMTA3NzAvdGV4dHJlZ2lvbjoyZjQ1MWNhZDdlNTY0ZTQ5OTIxMzcwZmJiODQxMDViYV80Mg_c7ddcf84-e504-4807-9256-21946e6dd1bf">300</ix:nonFraction> capitalized for the nine months ended September 30, 2021 and 2020, respectively)</span></div></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InterestPaidNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfNjQtMS0xLTEtMTA3NzA_ff188d57-62f8-4f7f-bc45-03560a61f8b7">19,301</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InterestPaidNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfNjQtMy0xLTEtMTA3NzA_cbdea969-97e7-49ec-9c1b-d2c302bfdb83">13,848</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for income taxes</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxesPaidNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfNjUtMS0xLTEtMTA3NzA_4915f8f7-abc1-4a3a-8d7f-2fbd8ddd74b4">72,863</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxesPaidNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfNjUtMy0xLTEtMTA3NzA_7bac97ad-4ccb-4c17-8d23-fa0c401bdc87">30,727</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of tangible assets acquired in acquisitions, net of cash and restricted cash received</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FairValueOfAssetsAcquired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfNjctMS0xLTEtMTA3NzA_7be587c9-0911-419d-ac7d-960827d802b9">1,906</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FairValueOfAssetsAcquired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfNjctMy0xLTEtMTA3NzA_19ccf923-64dd-4dd9-a460-063a4f2aa520">35,704</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="amn:SupplementalDisclosuresOfNonCashInvestingAndFinancingActivitiesGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfNjgtMS0xLTEtMTA3NzA_73746a15-32ef-46dd-92e3-6b96df182a9e">28,135</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="amn:SupplementalDisclosuresOfNonCashInvestingAndFinancingActivitiesGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfNjgtMy0xLTEtMTA3NzA_a68f504b-39a6-48ee-8729-029d703fe202">274,427</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="amn:SupplementalDisclosuresOfNonCashInvestingAndFinancingActivitiesIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfNjktMS0xLTEtMTA3NzA_76385c42-2932-4af5-8893-bcd83a89f812">12,440</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="amn:SupplementalDisclosuresOfNonCashInvestingAndFinancingActivitiesIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfNjktMy0xLTEtMTA3NzA_79c995fe-4cfa-4733-996c-ea77eb7bf42f">228,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities assumed</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesAssumed1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfNzAtMS0xLTEtMTA3NzA_3f367c6b-541d-4006-b380-ccb7fe902bcc">1,217</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesAssumed1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfNzAtMy0xLTEtMTA3NzA_28a3a97f-c5af-41e6-923e-4964813b418a">61,640</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 79.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash paid for acquisitions</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfNzQtMS0xLTEtMTA3NzA_321a691d-4512-4841-acd5-bd33ee743716">41,264</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfNzQtMy0xLTEtMTA3NzA_223f19f5-b619-4901-80ac-04b1f76dcfd6">476,491</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Supplemental disclosures of non-cash investing and financing activities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase of fixed assets recorded in accounts payable and accrued expenses</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="amn:Purchaseoffixedassetsrecordedinaccountspayableandaccruedexpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfNzYtMS0xLTEtMTA3NzA_9666f2a2-1f59-4bf7-9cee-b15d0a6c0f1a">5,080</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="amn:Purchaseoffixedassetsrecordedinaccountspayableandaccruedexpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfNzYtMy0xLTEtMTA3NzA_5c57144e-b124-4aef-9dac-3e351e9d6f97">1,007</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:1pt;text-align:center"><span><br/></span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to unaudited condensed consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><div id="ia383c8c7878a498d91f9e8901f0cfd9c_28"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">AMN HEALTHCARE SERVICES, INC.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands, except per share amounts)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></div><div id="ia383c8c7878a498d91f9e8901f0cfd9c_31"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1. <ix:nonNumeric contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" name="us-gaap:BasisOfAccounting" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zMS9mcmFnOmNlNDgxOGVmYTM1YjQ2NDI4NGUxN2Q2NWEwYThiNjc3L3RleHRyZWdpb246Y2U0ODE4ZWZhMzViNDY0Mjg0ZTE3ZDY1YTBhOGI2NzdfNTI0Mw_84eecb3d-8132-48b6-9bcd-740428a915f2" continuedAt="i357cef71183b482fa5effd79f1df143e" escape="true">BASIS OF PRESENTATION</ix:nonNumeric></span></div><ix:continuation id="i357cef71183b482fa5effd79f1df143e" continuedAt="i6369d56e0d9241d19fdc78b90ae87af8"><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The condensed consolidated balance sheets and related condensed consolidated statements of comprehensive income and cash flows contained in this Quarterly Report on Form&#160;10-Q (this &#8220;Quarterly Report&#8221;), which are unaudited, include the accounts of AMN&#160;Healthcare Services, Inc. and its wholly-owned subsidiaries (collectively, the &#8220;Company&#8221;). All significant intercompany balances and transactions have been eliminated in consolidation. In the opinion of management, all entries necessary for a fair presentation of such unaudited condensed consolidated financial statements have been included. These entries consisted of all normal recurring items. The results of operations for the interim period are not necessarily indicative of the results to be expected for any other interim period or for the entire fiscal year or for any future period.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited condensed consolidated financial statements do not include all information and notes necessary for a complete presentation of financial position, results of operations and cash flows in conformity with accounting principles generally accepted in the United States (&#8220;U.S. GAAP&#8221;). Please refer to the Company&#8217;s audited consolidated financial statements and the related notes for the fiscal year ended December&#160;31, 2020, contained in the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2020, filed with the Securities and Exchange Commission on February 26, 2021 (&#8220;2020 Annual Report&#8221;). </span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zMS9mcmFnOmNlNDgxOGVmYTM1YjQ2NDI4NGUxN2Q2NWEwYThiNjc3L3RleHRyZWdpb246Y2U0ODE4ZWZhMzViNDY0Mjg0ZTE3ZDY1YTBhOGI2NzdfNTI1Mg_83ba779b-24f9-453f-a2fb-51a886fe7d71" escape="true">The preparation of financial statements in conformity with U.S. GAAP requires management to make a number of estimates and assumptions relating to the reporting of assets and liabilities and the disclosure of contingent assets and liabilities at the dates of the financial statements and the reported amounts of revenue and expenses during the reporting periods. On an ongoing basis, the Company evaluates its estimates, including those related to intangible assets purchased in a business combination, asset impairments, accruals for self-insurance, compensation and related benefits, accounts receivable, contingencies and litigation, contingent consideration liabilities associated with acquisitions, and income taxes. Actual results could differ from those estimates under different assumptions or conditions. The impact of the novel coronavirus (COVID-19) pandemic did not have a material effect on the Company&#8217;s estimates as of September&#160;30, 2021.</ix:nonNumeric></span></div><ix:nonNumeric contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zMS9mcmFnOmNlNDgxOGVmYTM1YjQ2NDI4NGUxN2Q2NWEwYThiNjc3L3RleHRyZWdpb246Y2U0ODE4ZWZhMzViNDY0Mjg0ZTE3ZDY1YTBhOGI2NzdfNTI1OQ_c628c7fd-4d69-4aa3-b8aa-3401b2450959" escape="true"><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Adopted Accounting Pronouncements</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standard Update (&#8220;ASU&#8221;) 2019-12, &#8220;Simplifying the Accounting for Income Taxes.&#8221; The standard is expected to reduce cost and complexity related to accounting for income taxes. The new guidance eliminates certain exceptions and clarifies and amends existing guidance to promote consistent application among reporting entities. Depending on the amended guidance within this standard, adoption is to be applied on a retrospective, modified retrospective or prospective basis. The Company adopted this standard effective January 1, 2021, and the adoption did not have a material effect on the Company&#8217;s consolidated financial statements.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2020, the FASB issued ASU 2020-01, &#8220;Clarifying the Interactions between Topic 321, Topic 323, and Topic 815.&#8221; The new guidance clarifies the interactions between accounting standards that apply to equity investments without readily determinable fair values. Specifically, it addresses the accounting for the transition into and out of the equity method. The Company adopted this standard effective January 1, 2021 on a prospective basis, and the adoption did not have a material effect on the Company&#8217;s consolidated financial statements.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" name="us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zMS9mcmFnOmNlNDgxOGVmYTM1YjQ2NDI4NGUxN2Q2NWEwYThiNjc3L3RleHRyZWdpb246Y2U0ODE4ZWZhMzViNDY0Mjg0ZTE3ZDY1YTBhOGI2NzdfNTIzOQ_8ec10dbf-37b8-4890-97d1-6377a9acc4ee" escape="true"><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash, Cash Equivalents and Restricted Cash</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents. Cash and cash equivalents include currency on hand, deposits with financial institutions, money market funds, commercial paper and other highly liquid investments. Restricted cash and cash equivalents primarily includes cash and commercial paper that serve as collateral for the Company&#8217;s captive insurance subsidiary claim payments. See Note (7), &#8220;Fair Value Measurement&#8221; for additional information.</span></div></ix:nonNumeric><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" name="us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zMS9mcmFnOmNlNDgxOGVmYTM1YjQ2NDI4NGUxN2Q2NWEwYThiNjc3L3RleHRyZWdpb246Y2U0ODE4ZWZhMzViNDY0Mjg0ZTE3ZDY1YTBhOGI2NzdfNTI0MQ_ac208b29-d8ab-46a4-a559-0f0df6906f25" continuedAt="i0211f39e316c4c57a371658645fd3096" escape="true">The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the accompanying condensed consolidated balance sheets and related notes to the amounts presented in the accompanying condensed consolidated statements of cash flows.</ix:nonNumeric></span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i6369d56e0d9241d19fdc78b90ae87af8"><div style="margin-top:14pt"><ix:continuation id="i0211f39e316c4c57a371658645fd3096"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.590%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.544%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68ecd84e8da440808154baac134e839e_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zMS9mcmFnOmNlNDgxOGVmYTM1YjQ2NDI4NGUxN2Q2NWEwYThiNjc3L3RhYmxlOjQzOWJjNmFhNmQyNDRiNDM4MGYxNjI3ZmY3MTAwNTg4L3RhYmxlcmFuZ2U6NDM5YmM2YWE2ZDI0NGI0MzgwZjE2MjdmZjcxMDA1ODhfMS0xLTEtMS0xMDc3MA_2dddca1c-8b75-486b-81f3-142f93be4e11">137,041</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zMS9mcmFnOmNlNDgxOGVmYTM1YjQ2NDI4NGUxN2Q2NWEwYThiNjc3L3RhYmxlOjQzOWJjNmFhNmQyNDRiNDM4MGYxNjI3ZmY3MTAwNTg4L3RhYmxlcmFuZ2U6NDM5YmM2YWE2ZDI0NGI0MzgwZjE2MjdmZjcxMDA1ODhfMS0zLTEtMS0xMDc3MA_96b805d4-e705-4858-b08f-4f7da814ae15">29,213</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash and cash equivalents (included in other current assets)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68ecd84e8da440808154baac134e839e_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RestrictedCashAndCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zMS9mcmFnOmNlNDgxOGVmYTM1YjQ2NDI4NGUxN2Q2NWEwYThiNjc3L3RhYmxlOjQzOWJjNmFhNmQyNDRiNDM4MGYxNjI3ZmY3MTAwNTg4L3RhYmxlcmFuZ2U6NDM5YmM2YWE2ZDI0NGI0MzgwZjE2MjdmZjcxMDA1ODhfMi0xLTEtMS0xMDc3MA_8a79ba97-a211-4859-bdfd-afc80ef17b7d">18,118</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RestrictedCashAndCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zMS9mcmFnOmNlNDgxOGVmYTM1YjQ2NDI4NGUxN2Q2NWEwYThiNjc3L3RhYmxlOjQzOWJjNmFhNmQyNDRiNDM4MGYxNjI3ZmY3MTAwNTg4L3RhYmxlcmFuZ2U6NDM5YmM2YWE2ZDI0NGI0MzgwZjE2MjdmZjcxMDA1ODhfMi0zLTEtMS0xMDc3MA_f9f4de69-3538-43af-a115-d1d1fa4cb178">18,626</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash, cash equivalents and investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68ecd84e8da440808154baac134e839e_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RestrictedCashAndInvestmentsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zMS9mcmFnOmNlNDgxOGVmYTM1YjQ2NDI4NGUxN2Q2NWEwYThiNjc3L3RhYmxlOjQzOWJjNmFhNmQyNDRiNDM4MGYxNjI3ZmY3MTAwNTg4L3RhYmxlcmFuZ2U6NDM5YmM2YWE2ZDI0NGI0MzgwZjE2MjdmZjcxMDA1ODhfMy0xLTEtMS0xMDc3MA_a1bfc46b-1315-415d-8bab-b11a111cc1d6">63,603</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RestrictedCashAndInvestmentsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zMS9mcmFnOmNlNDgxOGVmYTM1YjQ2NDI4NGUxN2Q2NWEwYThiNjc3L3RhYmxlOjQzOWJjNmFhNmQyNDRiNDM4MGYxNjI3ZmY3MTAwNTg4L3RhYmxlcmFuZ2U6NDM5YmM2YWE2ZDI0NGI0MzgwZjE2MjdmZjcxMDA1ODhfMy0zLTEtMS0xMDc3MA_787effc6-f2ed-4ab4-b7e9-2b30cbd56147">61,347</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents and restricted cash and investments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68ecd84e8da440808154baac134e839e_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="amn:TotalCashCashEquivalentsAndRestrictedCashCashEquivalentsandInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zMS9mcmFnOmNlNDgxOGVmYTM1YjQ2NDI4NGUxN2Q2NWEwYThiNjc3L3RhYmxlOjQzOWJjNmFhNmQyNDRiNDM4MGYxNjI3ZmY3MTAwNTg4L3RhYmxlcmFuZ2U6NDM5YmM2YWE2ZDI0NGI0MzgwZjE2MjdmZjcxMDA1ODhfNC0xLTEtMS0xMDc3MA_bd2326c3-2da6-4a20-b542-66de445743e9">218,762</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="amn:TotalCashCashEquivalentsAndRestrictedCashCashEquivalentsandInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zMS9mcmFnOmNlNDgxOGVmYTM1YjQ2NDI4NGUxN2Q2NWEwYThiNjc3L3RhYmxlOjQzOWJjNmFhNmQyNDRiNDM4MGYxNjI3ZmY3MTAwNTg4L3RhYmxlcmFuZ2U6NDM5YmM2YWE2ZDI0NGI0MzgwZjE2MjdmZjcxMDA1ODhfNC0zLTEtMS0xMDc3MA_167c74cf-eecf-45ca-b172-ccf91dc73e7e">109,186</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less restricted investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i68ecd84e8da440808154baac134e839e_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RestrictedInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zMS9mcmFnOmNlNDgxOGVmYTM1YjQ2NDI4NGUxN2Q2NWEwYThiNjc3L3RhYmxlOjQzOWJjNmFhNmQyNDRiNDM4MGYxNjI3ZmY3MTAwNTg4L3RhYmxlcmFuZ2U6NDM5YmM2YWE2ZDI0NGI0MzgwZjE2MjdmZjcxMDA1ODhfNS0xLTEtMS0xMDc3MA_07ed54fc-df2b-44af-a4fe-d15b034fed6c">17,658</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RestrictedInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zMS9mcmFnOmNlNDgxOGVmYTM1YjQ2NDI4NGUxN2Q2NWEwYThiNjc3L3RhYmxlOjQzOWJjNmFhNmQyNDRiNDM4MGYxNjI3ZmY3MTAwNTg4L3RhYmxlcmFuZ2U6NDM5YmM2YWE2ZDI0NGI0MzgwZjE2MjdmZjcxMDA1ODhfNS0zLTEtMS0xMDc3MA_e55afd58-b2d5-4ab3-999b-69c3f4596905">25,196</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents and restricted cash</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68ecd84e8da440808154baac134e839e_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zMS9mcmFnOmNlNDgxOGVmYTM1YjQ2NDI4NGUxN2Q2NWEwYThiNjc3L3RhYmxlOjQzOWJjNmFhNmQyNDRiNDM4MGYxNjI3ZmY3MTAwNTg4L3RhYmxlcmFuZ2U6NDM5YmM2YWE2ZDI0NGI0MzgwZjE2MjdmZjcxMDA1ODhfNi0xLTEtMS0xMDc3MA_ddd3c432-3c13-4f56-b0e1-936a189eb39b">201,104</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zMS9mcmFnOmNlNDgxOGVmYTM1YjQ2NDI4NGUxN2Q2NWEwYThiNjc3L3RhYmxlOjQzOWJjNmFhNmQyNDRiNDM4MGYxNjI3ZmY3MTAwNTg4L3RhYmxlcmFuZ2U6NDM5YmM2YWE2ZDI0NGI0MzgwZjE2MjdmZjcxMDA1ODhfNi0zLTEtMS0xMDc3MA_ff5cb12d-e68b-4eaa-9f1f-33b337c22e92">83,990</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><ix:nonNumeric contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" name="us-gaap:TradeAndOtherAccountsReceivablePolicy" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zMS9mcmFnOmNlNDgxOGVmYTM1YjQ2NDI4NGUxN2Q2NWEwYThiNjc3L3RleHRyZWdpb246Y2U0ODE4ZWZhMzViNDY0Mjg0ZTE3ZDY1YTBhOGI2NzdfNTI2OQ_3e486ccb-ca84-4233-867f-21fbc840b2b3" escape="true"><div style="margin-top:4pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounts Receivable</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records accounts receivable at the invoiced amount. Accounts receivable are non-interest bearing. The Company maintains an allowance for expected credit losses based on the Company&#8217;s historical write-off experience, an assessment of its customers&#8217; financial conditions and available information that is relevant to assessing the collectability of cash flows, which includes current conditions and forecasts about future economic conditions.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" name="us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zMS9mcmFnOmNlNDgxOGVmYTM1YjQ2NDI4NGUxN2Q2NWEwYThiNjc3L3RleHRyZWdpb246Y2U0ODE4ZWZhMzViNDY0Mjg0ZTE3ZDY1YTBhOGI2NzdfNTI0Mg_aa25166b-388e-4395-ab92-b4c66f69975d" escape="true"><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a reconciliation of activity in the allowance for credit losses for accounts receivable:</span></div><div style="margin-top:14pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.590%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.544%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1,</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zMS9mcmFnOmNlNDgxOGVmYTM1YjQ2NDI4NGUxN2Q2NWEwYThiNjc3L3RhYmxlOmU5MmY2N2EzMmZkYjRlZmY5MmRhZThhMjE3M2M0NzBmL3RhYmxlcmFuZ2U6ZTkyZjY3YTMyZmRiNGVmZjkyZGFlOGEyMTczYzQ3MGZfMS0xLTEtMS0xMDc3MA_d937108a-24a5-42bd-8adb-d84460a7bde2">7,043</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73ad7702c4f241548c42eab7eb506186_I20191231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zMS9mcmFnOmNlNDgxOGVmYTM1YjQ2NDI4NGUxN2Q2NWEwYThiNjc3L3RhYmxlOmU5MmY2N2EzMmZkYjRlZmY5MmRhZThhMjE3M2M0NzBmL3RhYmxlcmFuZ2U6ZTkyZjY3YTMyZmRiNGVmZjkyZGFlOGEyMTczYzQ3MGZfMS0zLTEtMS0xMDc3MA_f1fc732e-51f3-48c5-98a5-2ac894f56a96">3,332</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zMS9mcmFnOmNlNDgxOGVmYTM1YjQ2NDI4NGUxN2Q2NWEwYThiNjc3L3RhYmxlOmU5MmY2N2EzMmZkYjRlZmY5MmRhZThhMjE3M2M0NzBmL3RhYmxlcmFuZ2U6ZTkyZjY3YTMyZmRiNGVmZjkyZGFlOGEyMTczYzQ3MGZfMi0wLTEtMS0xMDc3MA_2e5b46ce-627c-4ad2-9f91-f5ecc232b823"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zMS9mcmFnOmNlNDgxOGVmYTM1YjQ2NDI4NGUxN2Q2NWEwYThiNjc3L3RhYmxlOmU5MmY2N2EzMmZkYjRlZmY5MmRhZThhMjE3M2M0NzBmL3RhYmxlcmFuZ2U6ZTkyZjY3YTMyZmRiNGVmZjkyZGFlOGEyMTczYzQ3MGZfMi0wLTEtMS0xMDc3MA_5c495df8-c4dc-4a11-8dcb-5b212c885604">Adoption of the credit loss standard, cumulative-effect adjustment to retained earnings</span></span></span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3540c67ef3ad4b86931989fd054e0b50_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zMS9mcmFnOmNlNDgxOGVmYTM1YjQ2NDI4NGUxN2Q2NWEwYThiNjc3L3RhYmxlOmU5MmY2N2EzMmZkYjRlZmY5MmRhZThhMjE3M2M0NzBmL3RhYmxlcmFuZ2U6ZTkyZjY3YTMyZmRiNGVmZjkyZGFlOGEyMTczYzQ3MGZfMi0xLTEtMS0xMDc3MA_7a1621e3-584c-4d38-a7cb-3b88c67b588f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55f9e8f7bfb74ed0a97dc5b843a44941_I20191231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zMS9mcmFnOmNlNDgxOGVmYTM1YjQ2NDI4NGUxN2Q2NWEwYThiNjc3L3RhYmxlOmU5MmY2N2EzMmZkYjRlZmY5MmRhZThhMjE3M2M0NzBmL3RhYmxlcmFuZ2U6ZTkyZjY3YTMyZmRiNGVmZjkyZGFlOGEyMTczYzQ3MGZfMi0zLTEtMS0xMDc3MA_2204efc1-3d98-4bd3-824b-f164dd57ceaa">1,334</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for expected credit losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" decimals="-3" name="us-gaap:ProvisionForDoubtfulAccounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zMS9mcmFnOmNlNDgxOGVmYTM1YjQ2NDI4NGUxN2Q2NWEwYThiNjc3L3RhYmxlOmU5MmY2N2EzMmZkYjRlZmY5MmRhZThhMjE3M2M0NzBmL3RhYmxlcmFuZ2U6ZTkyZjY3YTMyZmRiNGVmZjkyZGFlOGEyMTczYzQ3MGZfMy0xLTEtMS0xMDc3MA_227777b1-171c-4fe8-9c25-4a5882264760">325</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProvisionForDoubtfulAccounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zMS9mcmFnOmNlNDgxOGVmYTM1YjQ2NDI4NGUxN2Q2NWEwYThiNjc3L3RhYmxlOmU5MmY2N2EzMmZkYjRlZmY5MmRhZThhMjE3M2M0NzBmL3RhYmxlcmFuZ2U6ZTkyZjY3YTMyZmRiNGVmZjkyZGFlOGEyMTczYzQ3MGZfMy0zLTEtMS0xMDc3MA_8657b526-c9e4-4818-9a8b-c2e3a011b3a0">5,178</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts written off charged against the allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zMS9mcmFnOmNlNDgxOGVmYTM1YjQ2NDI4NGUxN2Q2NWEwYThiNjc3L3RhYmxlOmU5MmY2N2EzMmZkYjRlZmY5MmRhZThhMjE3M2M0NzBmL3RhYmxlcmFuZ2U6ZTkyZjY3YTMyZmRiNGVmZjkyZGFlOGEyMTczYzQ3MGZfNC0xLTEtMS0xMDc3MA_a7e14b4d-6309-4e0a-ad82-564a4aa081bb">1,220</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zMS9mcmFnOmNlNDgxOGVmYTM1YjQ2NDI4NGUxN2Q2NWEwYThiNjc3L3RhYmxlOmU5MmY2N2EzMmZkYjRlZmY5MmRhZThhMjE3M2M0NzBmL3RhYmxlcmFuZ2U6ZTkyZjY3YTMyZmRiNGVmZjkyZGFlOGEyMTczYzQ3MGZfNC0zLTEtMS0xMDc3MA_c5563743-6fcd-4a80-8f08-2bf18d28f901">1,333</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of September 30,</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68ecd84e8da440808154baac134e839e_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zMS9mcmFnOmNlNDgxOGVmYTM1YjQ2NDI4NGUxN2Q2NWEwYThiNjc3L3RhYmxlOmU5MmY2N2EzMmZkYjRlZmY5MmRhZThhMjE3M2M0NzBmL3RhYmxlcmFuZ2U6ZTkyZjY3YTMyZmRiNGVmZjkyZGFlOGEyMTczYzQ3MGZfNi0xLTEtMS0xMDc3MA_60f1d2f6-5466-47a0-bb7b-82aa9868e3b9">6,148</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i041c1c8fe78444f88611087c404a5e99_I20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zMS9mcmFnOmNlNDgxOGVmYTM1YjQ2NDI4NGUxN2Q2NWEwYThiNjc3L3RhYmxlOmU5MmY2N2EzMmZkYjRlZmY5MmRhZThhMjE3M2M0NzBmL3RhYmxlcmFuZ2U6ZTkyZjY3YTMyZmRiNGVmZjkyZGFlOGEyMTczYzQ3MGZfNi0zLTEtMS0xMDc3MA_1fece7ef-d57a-44c9-8f84-596898485eb5">8,511</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div id="ia383c8c7878a498d91f9e8901f0cfd9c_34"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2. <ix:nonNumeric contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" name="us-gaap:BusinessCombinationDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zNC9mcmFnOjM2YTE4ODM3NmY3ZTQ1NDliNzA0ZjYxNGI1M2Q0NDA3L3RleHRyZWdpb246MzZhMTg4Mzc2ZjdlNDU0OWI3MDRmNjE0YjUzZDQ0MDdfNjAyOA_9ceba31f-4b71-426c-91fd-2baeac3b1b52" continuedAt="i8990fa43f9df4560909b53e46c824ef0" escape="true">ACQUISITIONS </ix:nonNumeric></span></div><ix:continuation id="i8990fa43f9df4560909b53e46c824ef0" continuedAt="i5614bb243b2b421da1d8e89c71a4fd38"><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As set forth below, the Company completed <ix:nonFraction unitRef="acquisition" contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:NumberOfBusinessesAcquired" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zNC9mcmFnOjM2YTE4ODM3NmY3ZTQ1NDliNzA0ZjYxNGI1M2Q0NDA3L3RleHRyZWdpb246MzZhMTg4Mzc2ZjdlNDU0OWI3MDRmNjE0YjUzZDQ0MDdfNjQ_c8a548bf-7811-4d51-a341-f42079d44458">two</ix:nonFraction> acquisitions from January&#160;1, 2020 through September&#160;30, 2021, which were accounted for using the acquisition method of accounting. Accordingly, the Company recorded the tangible and intangible assets acquired and liabilities assumed at their estimated fair values as of the applicable date of acquisition. Since the applicable date of acquisition, the Company has revised the allocation of the purchase price to the tangible and intangible assets acquired and liabilities assumed based on analysis of information that has been made available through September&#160;30, 2021. The allocations will continue to be updated through the measurement period, if necessary. The Company recognizes acquisition-related costs in selling, general and administrative expenses in the consolidated statements of comprehensive income.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Synzi and SnapMD Acquisition</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 7, 2021, the Company completed its acquisition of Synzi Holdings, Inc. (&#8220;Synzi&#8221;) and its wholly-owned subsidiary, SnapMD, LLC (&#8220;SnapMD&#8221;). Synzi is a virtual care communication platform that enables organizations to conduct virtual visits and use secure messaging, text, and email for clinician-to-patient and clinician-to-clinician communications. SnapMD is a full-service virtual care management company, specializing in providing software to enable healthcare providers to better engage with their patients. The initial purchase price of $<ix:nonFraction unitRef="usd" contextRef="ifa30b8cb72094c7ca771fc176115f67e_D20210407-20210407" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquireBusinessesGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zNC9mcmFnOjM2YTE4ODM3NmY3ZTQ1NDliNzA0ZjYxNGI1M2Q0NDA3L3RleHRyZWdpb246MzZhMTg4Mzc2ZjdlNDU0OWI3MDRmNjE0YjUzZDQ0MDdfMTQxMw_90751307-96df-4bc5-aa73-313b182f3d2c">42,240</ix:nonFraction> consisted entirely of cash consideration paid upon acquisition. The acquisition was funded primarily through borrowings under the Senior Credit Facility (as defined below). The results of Synzi and SnapMD have been included in the Company&#8217;s technology and workforce solutions segment since the date of acquisition. During the second quarter of 2021, $<ix:nonFraction unitRef="usd" contextRef="i202e46c5ac0646f8b3354ce9a1eb5b00_D20210401-20210630" decimals="-3" name="us-gaap:CashAcquiredFromAcquisition" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zNC9mcmFnOjM2YTE4ODM3NmY3ZTQ1NDliNzA0ZjYxNGI1M2Q0NDA3L3RleHRyZWdpb246MzZhMTg4Mzc2ZjdlNDU0OWI3MDRmNjE0YjUzZDQ0MDdfMTc2Ng_eb5cb6e0-dea4-493d-a505-ba7ac018d7fa">92</ix:nonFraction> was returned to the Company in respect of the final working capital settlement.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preliminary allocation of the $<ix:nonFraction unitRef="usd" contextRef="ieff88e899cdb408197ed1ff99234a795_D20210930-20210930" decimals="-3" format="ixt:num-dot-decimal" name="amn:BusinessCombinationConsiderationTransferredNetOfWorkingCapitalAdjustment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zNC9mcmFnOjM2YTE4ODM3NmY3ZTQ1NDliNzA0ZjYxNGI1M2Q0NDA3L3RleHRyZWdpb246MzZhMTg4Mzc2ZjdlNDU0OWI3MDRmNjE0YjUzZDQ0MDdfMTg4Mw_aab77bea-7be6-4eb9-8e4b-29d1ef112281">42,148</ix:nonFraction> purchase price, which was reduced by the final working capital settlement, consisted of (1) $<ix:nonFraction unitRef="usd" contextRef="icbbe0cb0e30e4fc195db16971b04921b_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="amn:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalentsAndPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zNC9mcmFnOjM2YTE4ODM3NmY3ZTQ1NDliNzA0ZjYxNGI1M2Q0NDA3L3RleHRyZWdpb246MzZhMTg4Mzc2ZjdlNDU0OWI3MDRmNjE0YjUzZDQ0MDdfMTk3OA_b51e6d17-cacc-4e77-b898-3ea0f0381fc6">2,790</ix:nonFraction> of fair value of tangible assets acquired, which included $<ix:nonFraction unitRef="usd" contextRef="icbbe0cb0e30e4fc195db16971b04921b_I20210930" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zNC9mcmFnOjM2YTE4ODM3NmY3ZTQ1NDliNzA0ZjYxNGI1M2Q0NDA3L3RleHRyZWdpb246MzZhMTg4Mzc2ZjdlNDU0OWI3MDRmNjE0YjUzZDQ0MDdfMjAzOQ_38d98faa-6801-40a0-b0eb-380e66ec2850">884</ix:nonFraction> cash received, (2) $<ix:nonFraction unitRef="usd" contextRef="icbbe0cb0e30e4fc195db16971b04921b_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zNC9mcmFnOjM2YTE4ODM3NmY3ZTQ1NDliNzA0ZjYxNGI1M2Q0NDA3L3RleHRyZWdpb246MzZhMTg4Mzc2ZjdlNDU0OWI3MDRmNjE0YjUzZDQ0MDdfMjA2MQ_ee3d069f-8fb9-435a-ba37-e77c920a0fda">1,217</ix:nonFraction> of liabilities assumed, (3) $<ix:nonFraction unitRef="usd" contextRef="icbbe0cb0e30e4fc195db16971b04921b_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zNC9mcmFnOjM2YTE4ODM3NmY3ZTQ1NDliNzA0ZjYxNGI1M2Q0NDA3L3RleHRyZWdpb246MzZhMTg4Mzc2ZjdlNDU0OWI3MDRmNjE0YjUzZDQ0MDdfMjA5Mg_a05f4c32-5cb0-46b2-b1c1-b3fe6fb30d83">12,440</ix:nonFraction> of identified intangible assets, and (4) $<ix:nonFraction unitRef="usd" contextRef="icbbe0cb0e30e4fc195db16971b04921b_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zNC9mcmFnOjM2YTE4ODM3NmY3ZTQ1NDliNzA0ZjYxNGI1M2Q0NDA3L3RleHRyZWdpb246MzZhMTg4Mzc2ZjdlNDU0OWI3MDRmNjE0YjUzZDQ0MDdfMjEzNg_4a7449e8-6a98-42f7-a5cd-104be676d68f">28,135</ix:nonFraction> of goodwill, of which $<ix:nonFraction unitRef="usd" contextRef="icbbe0cb0e30e4fc195db16971b04921b_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zNC9mcmFnOjM2YTE4ODM3NmY3ZTQ1NDliNzA0ZjYxNGI1M2Q0NDA3L3RleHRyZWdpb246MzZhMTg4Mzc2ZjdlNDU0OWI3MDRmNjE0YjUzZDQ0MDdfMjE2MQ_e7e15a88-751e-498f-9aa7-0631575c7a9d">6,085</ix:nonFraction> is deductible for tax purposes. The provisional items pending finalization are income tax related matters and the assessment of additional information related to determining the fair value of certain assets acquired and liabilities assumed. The fair value of intangible assets primarily includes $<ix:nonFraction unitRef="usd" contextRef="id8a8066df2cd49fb99c9a296eb4b267d_I20210407" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zNC9mcmFnOjM2YTE4ODM3NmY3ZTQ1NDliNzA0ZjYxNGI1M2Q0NDA3L3RleHRyZWdpb246MzZhMTg4Mzc2ZjdlNDU0OWI3MDRmNjE0YjUzZDQ0MDdfMjM2OA_7b408d69-5e95-41d0-80eb-bf96cfab23c1">10,890</ix:nonFraction> of developed technology and $<ix:nonFraction unitRef="usd" contextRef="i2ddc12eab3644117aaadf0ffbc24c476_I20210407" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zNC9mcmFnOjM2YTE4ODM3NmY3ZTQ1NDliNzA0ZjYxNGI1M2Q0NDA3L3RleHRyZWdpb246MzZhMTg4Mzc2ZjdlNDU0OWI3MDRmNjE0YjUzZDQ0MDdfMjM5OQ_155e0a96-f1a5-4406-9945-287019f7bb87">1,220</ix:nonFraction> of trademarks with a weighted average useful life of approximately <ix:nonNumeric contextRef="ifa30b8cb72094c7ca771fc176115f67e_D20210407-20210407" format="ixt-sec:durwordsen" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zNC9mcmFnOjM2YTE4ODM3NmY3ZTQ1NDliNzA0ZjYxNGI1M2Q0NDA3L3RleHRyZWdpb246MzZhMTg4Mzc2ZjdlNDU0OWI3MDRmNjE0YjUzZDQ0MDdfMjQ2OQ_fe625a21-d82b-4692-b1b3-ffc6686bcc72">seven years</ix:nonNumeric>. </span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stratus Video Acquisition</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i5614bb243b2b421da1d8e89c71a4fd38"><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 14, 2020, the Company completed its acquisition of Stratus Video, a remote video interpreting company that provides healthcare interpretation via remote video, over the phone, and onsite in-person, all supported by proprietary technology platforms. The initial purchase price of $<ix:nonFraction unitRef="usd" contextRef="i750e5ac42b744b7999aafb93dd8e3926_D20200214-20200214" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquireBusinessesGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zNC9mcmFnOjM2YTE4ODM3NmY3ZTQ1NDliNzA0ZjYxNGI1M2Q0NDA3L3RleHRyZWdpb246MzZhMTg4Mzc2ZjdlNDU0OWI3MDRmNjE0YjUzZDQ0MDdfMjc5MQ_0b44c698-cddc-4954-8ee1-6d8df3165465">485,568</ix:nonFraction> consisted entirely of cash consideration paid upon acquisition. The acquisition was funded primarily through (1) borrowings under the Company&#8217;s $<ix:nonFraction unitRef="usd" contextRef="i1809609cdf714d66916ae3141253f6cd_I20180209" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zNC9mcmFnOjM2YTE4ODM3NmY3ZTQ1NDliNzA0ZjYxNGI1M2Q0NDA3L3RleHRyZWdpb246MzZhMTg4Mzc2ZjdlNDU0OWI3MDRmNjE0YjUzZDQ0MDdfMjkzOA_49c6bee4-b5cb-47e2-b2a9-ea00df86de98">400,000</ix:nonFraction> secured revolving credit facility (the &#8220;Senior Credit Facility&#8221;), provided for under a credit agreement (the &#8220;New Credit Agreement&#8221;), and (2) the Second Amendment (as defined in Note (6) below) to the New Credit Agreement, which provided $<ix:nonFraction unitRef="usd" contextRef="ie9d4571d2fdf44c6ba87db28c14cb175_I20200214" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LongTermDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zNC9mcmFnOjM2YTE4ODM3NmY3ZTQ1NDliNzA0ZjYxNGI1M2Q0NDA3L3RleHRyZWdpb246MzZhMTg4Mzc2ZjdlNDU0OWI3MDRmNjE0YjUzZDQ0MDdfMzE3OQ_3aeacd78-d4ed-47b5-8fc4-6c23c4691acc">250,000</ix:nonFraction> of additional available borrowings to the Company. The Senior Credit Facility, New Credit Agreement and Second Amendment are more fully described in Note (6), &#8220;Notes Payable and Credit Agreement.&#8221; The results of Stratus Video have been included in the Company&#8217;s technology and workforce solutions segment since the date of acquisition. During the second quarter of 2020, an additional $<ix:nonFraction unitRef="usd" contextRef="ib98f074e5878463f913e950ba5784162_D20200401-20200630" decimals="-3" name="us-gaap:PaymentsToAcquireBusinessesGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zNC9mcmFnOjM2YTE4ODM3NmY3ZTQ1NDliNzA0ZjYxNGI1M2Q0NDA3L3RleHRyZWdpb246MzZhMTg4Mzc2ZjdlNDU0OWI3MDRmNjE0YjUzZDQ0MDdfMzU2Nw_df2bd5e6-eb3c-493c-8e45-0e5cc116e5ec">99</ix:nonFraction> of cash consideration was paid to the selling shareholders in respect of the final working capital settlement. The Company incurred $<ix:nonFraction unitRef="usd" contextRef="i87dc697cd0464e2c938ed8477a3a3237_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zNC9mcmFnOjM2YTE4ODM3NmY3ZTQ1NDliNzA0ZjYxNGI1M2Q0NDA3L3RleHRyZWdpb246MzZhMTg4Mzc2ZjdlNDU0OWI3MDRmNjE0YjUzZDQ0MDdfMzcwMg_2e9d0fcb-f9ba-4e8d-beb9-ab06e7830a36">10,548</ix:nonFraction> of acquisition-related costs during the nine months ended September 30, 2020 as a result of its acquisition of Stratus Video.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The allocation of the $<ix:nonFraction unitRef="usd" contextRef="id09df577cd134e6994ece5aa31598ed7_D20210101-20210331" decimals="-3" format="ixt:num-dot-decimal" name="amn:BusinessCombinationConsiderationTransferredNetOfWorkingCapitalAdjustment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zNC9mcmFnOjM2YTE4ODM3NmY3ZTQ1NDliNzA0ZjYxNGI1M2Q0NDA3L3RleHRyZWdpb246MzZhMTg4Mzc2ZjdlNDU0OWI3MDRmNjE0YjUzZDQ0MDdfMzgxOQ_62044b04-2a44-4a40-87a7-c8689506c773">485,667</ix:nonFraction> purchase price, which included the additional cash consideration paid for the final working capital settlement and was finalized during the first quarter of 2021, consisted of (1) $<ix:nonFraction unitRef="usd" contextRef="i2a27a4a6c0964a5194ffc4f8f4176fbf_I20210331" decimals="-3" format="ixt:num-dot-decimal" name="amn:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zNC9mcmFnOjM2YTE4ODM3NmY3ZTQ1NDliNzA0ZjYxNGI1M2Q0NDA3L3RleHRyZWdpb246MzZhMTg4Mzc2ZjdlNDU0OWI3MDRmNjE0YjUzZDQ0MDdfNDAwMg_5185ad9c-19dd-4d57-a8d9-63ee21c29104">44,092</ix:nonFraction></span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of fair value of tangible assets acquired, which included $<ix:nonFraction unitRef="usd" contextRef="i2a27a4a6c0964a5194ffc4f8f4176fbf_I20210331" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zNC9mcmFnOjM2YTE4ODM3NmY3ZTQ1NDliNzA0ZjYxNGI1M2Q0NDA3L3RleHRyZWdpb246MzZhMTg4Mzc2ZjdlNDU0OWI3MDRmNjE0YjUzZDQ0MDdfNDA2Mw_cbe242ab-de81-428e-a22b-5d9431794429">9,176</ix:nonFraction> cash received, (2) $<ix:nonFraction unitRef="usd" contextRef="i2a27a4a6c0964a5194ffc4f8f4176fbf_I20210331" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zNC9mcmFnOjM2YTE4ODM3NmY3ZTQ1NDliNzA0ZjYxNGI1M2Q0NDA3L3RleHRyZWdpb246MzZhMTg4Mzc2ZjdlNDU0OWI3MDRmNjE0YjUzZDQ0MDdfNDA4NQ_17614277-ca1b-423e-a90f-04548021bc13">56,059</ix:nonFraction> of liabilities assumed, (3) $<ix:nonFraction unitRef="usd" contextRef="i2a27a4a6c0964a5194ffc4f8f4176fbf_I20210331" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zNC9mcmFnOjM2YTE4ODM3NmY3ZTQ1NDliNzA0ZjYxNGI1M2Q0NDA3L3RleHRyZWdpb246MzZhMTg4Mzc2ZjdlNDU0OWI3MDRmNjE0YjUzZDQ0MDdfNDExNg_8e430880-74c1-4b79-8662-696e309446f8">228,000</ix:nonFraction> of identified intangible assets, and (4) $<ix:nonFraction unitRef="usd" contextRef="i2a27a4a6c0964a5194ffc4f8f4176fbf_I20210331" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zNC9mcmFnOjM2YTE4ODM3NmY3ZTQ1NDliNzA0ZjYxNGI1M2Q0NDA3L3RleHRyZWdpb246MzZhMTg4Mzc2ZjdlNDU0OWI3MDRmNjE0YjUzZDQ0MDdfNDE2MA_83813aff-be15-4edd-aa30-e05951e86606">269,634</ix:nonFraction> of goodwill, of which $<ix:nonFraction unitRef="usd" contextRef="i2a27a4a6c0964a5194ffc4f8f4176fbf_I20210331" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zNC9mcmFnOjM2YTE4ODM3NmY3ZTQ1NDliNzA0ZjYxNGI1M2Q0NDA3L3RleHRyZWdpb246MzZhMTg4Mzc2ZjdlNDU0OWI3MDRmNjE0YjUzZDQ0MDdfNDE4NQ_93198d5f-7d7b-4630-a6ec-88215d091dbe">10,182</ix:nonFraction> is deductible for tax purposes. The intangible assets acquired have a weighted average useful life of approximately <ix:nonNumeric contextRef="i750e5ac42b744b7999aafb93dd8e3926_D20200214-20200214" format="ixt-sec:durwordsen" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zNC9mcmFnOjM2YTE4ODM3NmY3ZTQ1NDliNzA0ZjYxNGI1M2Q0NDA3L3RleHRyZWdpb246MzZhMTg4Mzc2ZjdlNDU0OWI3MDRmNjE0YjUzZDQ0MDdfNDMwNA_cad41909-bb28-4cb5-a8c5-eeba39e0bf0f">seventeen years</ix:nonNumeric>. <ix:nonNumeric contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zNC9mcmFnOjM2YTE4ODM3NmY3ZTQ1NDliNzA0ZjYxNGI1M2Q0NDA3L3RleHRyZWdpb246MzZhMTg4Mzc2ZjdlNDU0OWI3MDRmNjE0YjUzZDQ0MDdfNjAzMA_fdb730bc-e23b-45f1-8e93-838e6bdac188" continuedAt="iabd8769713714cc99e355472110e20f2" escape="true">The following table summarizes the fair value and useful life of each intangible asset acquired as of the acquisition date:</ix:nonNumeric></span></div><div style="margin-top:14pt;text-align:center;text-indent:13.5pt"><ix:continuation id="iabd8769713714cc99e355472110e20f2"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:68.128%"><tr><td style="width:1.0%"></td><td style="width:4.693%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.170%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.423%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.423%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.835%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.856%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Useful Life</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in years)</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Identifiable intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer Relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d55955405794cb789f5432f8c06331e_I20200214" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zNC9mcmFnOjM2YTE4ODM3NmY3ZTQ1NDliNzA0ZjYxNGI1M2Q0NDA3L3RhYmxlOmIxNTAxNDQ1ODkxYjRjYTY4YmVjYmU2NzdhOGU5NjkwL3RhYmxlcmFuZ2U6YjE1MDE0NDU4OTFiNGNhNjhiZWNiZTY3N2E4ZTk2OTBfMy0zLTEtMS0xMDc3MA_aa1347fb-e8ce-447c-84a3-558bf7dd94c3">171,000</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia69287e7ab6c43f095adc3cb43556c44_D20200214-20200214" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zNC9mcmFnOjM2YTE4ODM3NmY3ZTQ1NDliNzA0ZjYxNGI1M2Q0NDA3L3RhYmxlOmIxNTAxNDQ1ODkxYjRjYTY4YmVjYmU2NzdhOGU5NjkwL3RhYmxlcmFuZ2U6YjE1MDE0NDU4OTFiNGNhNjhiZWNiZTY3N2E4ZTk2OTBfMy01LTEtMS0xMDc3MA_197fb07e-9d5a-477c-9d4a-499ebc71f76e">20</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tradenames and Trademarks</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3dad049f61fe4171831aea7245fff5c6_I20200214" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zNC9mcmFnOjM2YTE4ODM3NmY3ZTQ1NDliNzA0ZjYxNGI1M2Q0NDA3L3RhYmxlOmIxNTAxNDQ1ODkxYjRjYTY4YmVjYmU2NzdhOGU5NjkwL3RhYmxlcmFuZ2U6YjE1MDE0NDU4OTFiNGNhNjhiZWNiZTY3N2E4ZTk2OTBfNC0zLTEtMS0xMDc3MA_31dfb657-cd7e-4097-a302-b502538c6244">40,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="idd4f7d02ac0c4fbcab236ee010c28075_D20200214-20200214" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zNC9mcmFnOjM2YTE4ODM3NmY3ZTQ1NDliNzA0ZjYxNGI1M2Q0NDA3L3RhYmxlOmIxNTAxNDQ1ODkxYjRjYTY4YmVjYmU2NzdhOGU5NjkwL3RhYmxlcmFuZ2U6YjE1MDE0NDU4OTFiNGNhNjhiZWNiZTY3N2E4ZTk2OTBfNC01LTEtMS0xMDc3MC90ZXh0cmVnaW9uOmU2NTc1ZjkzODY0MDQzZDg4MWMzZDk2NTFlZTJkODY4XzQ_3c46e051-6ab8-4076-b1dd-4d452b5d9eed">5</ix:nonNumeric> - <ix:nonNumeric contextRef="i450e36d3b7b24a9a930abcbcebb33f8b_D20200214-20200214" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zNC9mcmFnOjM2YTE4ODM3NmY3ZTQ1NDliNzA0ZjYxNGI1M2Q0NDA3L3RhYmxlOmIxNTAxNDQ1ODkxYjRjYTY4YmVjYmU2NzdhOGU5NjkwL3RhYmxlcmFuZ2U6YjE1MDE0NDU4OTFiNGNhNjhiZWNiZTY3N2E4ZTk2OTBfNC01LTEtMS0xMDc3MC90ZXh0cmVnaW9uOmU2NTc1ZjkzODY0MDQzZDg4MWMzZDk2NTFlZTJkODY4Xzk_db7eeaa2-1894-4c56-910a-f88741c7a7f8">10</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed Technology</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id060857eed0b4cc5a5f2798ea3dcc0c1_I20200214" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zNC9mcmFnOjM2YTE4ODM3NmY3ZTQ1NDliNzA0ZjYxNGI1M2Q0NDA3L3RhYmxlOmIxNTAxNDQ1ODkxYjRjYTY4YmVjYmU2NzdhOGU5NjkwL3RhYmxlcmFuZ2U6YjE1MDE0NDU4OTFiNGNhNjhiZWNiZTY3N2E4ZTk2OTBfNS0zLTEtMS0xMDc3MA_6ee828d8-2f4a-41c6-89b1-4c2aeb1660ed">16,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i4c6a14bbd81143a7b0ccd248e1c2ea39_D20200214-20200214" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zNC9mcmFnOjM2YTE4ODM3NmY3ZTQ1NDliNzA0ZjYxNGI1M2Q0NDA3L3RhYmxlOmIxNTAxNDQ1ODkxYjRjYTY4YmVjYmU2NzdhOGU5NjkwL3RhYmxlcmFuZ2U6YjE1MDE0NDU4OTFiNGNhNjhiZWNiZTY3N2E4ZTk2OTBfNS01LTEtMS0xMDc3MA_cb990ab5-1d4f-4f22-930c-dde4b8de224c">5</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interpreter Database</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic43cd4c81a97471aa9a13d84fb4031e2_I20200214" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zNC9mcmFnOjM2YTE4ODM3NmY3ZTQ1NDliNzA0ZjYxNGI1M2Q0NDA3L3RhYmxlOmIxNTAxNDQ1ODkxYjRjYTY4YmVjYmU2NzdhOGU5NjkwL3RhYmxlcmFuZ2U6YjE1MDE0NDU4OTFiNGNhNjhiZWNiZTY3N2E4ZTk2OTBfNi0zLTEtMS0xMDc3MA_d67f59e0-8fff-4203-936f-d56d0d90a40e">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5699c9a4945c4f429b834511a0a22cbc_D20200214-20200214" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zNC9mcmFnOjM2YTE4ODM3NmY3ZTQ1NDliNzA0ZjYxNGI1M2Q0NDA3L3RhYmxlOmIxNTAxNDQ1ODkxYjRjYTY4YmVjYmU2NzdhOGU5NjkwL3RhYmxlcmFuZ2U6YjE1MDE0NDU4OTFiNGNhNjhiZWNiZTY3N2E4ZTk2OTBfNi01LTEtMS0xMDc3MA_75298366-c280-43a5-8691-30d6c4f4edcf">4</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67759f1dfa1b4429aabe1215e03414dc_I20200214" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zNC9mcmFnOjM2YTE4ODM3NmY3ZTQ1NDliNzA0ZjYxNGI1M2Q0NDA3L3RhYmxlOmIxNTAxNDQ1ODkxYjRjYTY4YmVjYmU2NzdhOGU5NjkwL3RhYmxlcmFuZ2U6YjE1MDE0NDU4OTFiNGNhNjhiZWNiZTY3N2E4ZTk2OTBfNy0zLTEtMS0xMDc3MA_ddc3c500-9c33-4406-abaa-959b1247705e">228,000</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></ix:continuation></div><div style="margin-top:4pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the third quarter of 2020, the Company revised the estimated useful lives for the tradenames and trademarks intangible assets as a result of its plan to rebrand the language services business. Based on this change in circumstances since the date of acquisition, the Company determined that the remaining useful lives of the assets are <ix:nonNumeric contextRef="ic87fd517c51345a2a17d4c391a7c46c3_D20200701-20200930" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zNC9mcmFnOjM2YTE4ODM3NmY3ZTQ1NDliNzA0ZjYxNGI1M2Q0NDA3L3RleHRyZWdpb246MzZhMTg4Mzc2ZjdlNDU0OWI3MDRmNjE0YjUzZDQ0MDdfNDc3Ng_39101564-1b59-4421-b712-4631ca9f37c9">5</ix:nonNumeric> years and is amortizing the remaining value on a straight-line basis over the remaining useful life. The Company will continue to evaluate the remaining useful lives of other intangible assets impacted by its brand consolidation efforts.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Approximately $<ix:nonFraction unitRef="usd" contextRef="ic430d291a7804180aa0b06c38d0c7c55_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zNC9mcmFnOjM2YTE4ODM3NmY3ZTQ1NDliNzA0ZjYxNGI1M2Q0NDA3L3RleHRyZWdpb246MzZhMTg4Mzc2ZjdlNDU0OWI3MDRmNjE0YjUzZDQ0MDdfNTAyNQ_725f6daa-6b36-427b-9e35-1a0dd23e275d">35,329</ix:nonFraction> of revenue and $<ix:nonFraction unitRef="usd" contextRef="ic430d291a7804180aa0b06c38d0c7c55_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zNC9mcmFnOjM2YTE4ODM3NmY3ZTQ1NDliNzA0ZjYxNGI1M2Q0NDA3L3RleHRyZWdpb246MzZhMTg4Mzc2ZjdlNDU0OWI3MDRmNjE0YjUzZDQ0MDdfNTA0Mw_9eb738d1-1777-4d3a-94b2-5be08e544df5">8,322</ix:nonFraction> of income before income taxes of Stratus Video were included in the unaudited condensed consolidated statement of comprehensive income for the three months ended September 30, 2020. Approximately $<ix:nonFraction unitRef="usd" contextRef="i87dc697cd0464e2c938ed8477a3a3237_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zNC9mcmFnOjM2YTE4ODM3NmY3ZTQ1NDliNzA0ZjYxNGI1M2Q0NDA3L3RleHRyZWdpb246MzZhMTg4Mzc2ZjdlNDU0OWI3MDRmNjE0YjUzZDQ0MDdfNTIwNw_a69ced45-7636-4cbb-9b6c-fb3ba75088b2">78,080</ix:nonFraction> of revenue and $<ix:nonFraction unitRef="usd" contextRef="i87dc697cd0464e2c938ed8477a3a3237_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zNC9mcmFnOjM2YTE4ODM3NmY3ZTQ1NDliNzA0ZjYxNGI1M2Q0NDA3L3RleHRyZWdpb246MzZhMTg4Mzc2ZjdlNDU0OWI3MDRmNjE0YjUzZDQ0MDdfNTIyNQ_7e588265-6a33-47c5-9c9a-5d42b6c98122">13,787</ix:nonFraction> of income before income taxes of Stratus Video were included in the unaudited condensed consolidated statement of comprehensive income for the nine months ended September 30, 2020.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Pro Forma Financial Information (Unaudited)</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summary presents unaudited pro forma consolidated results of operations of the Company as if the acquisition of Stratus Video had occurred on January 1, 2019, which gives effect to certain adjustments, including acquisition-related costs of $<ix:nonFraction unitRef="usd" contextRef="id449bccf189e469e8b6a234845cba859_D20200701-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zNC9mcmFnOjM2YTE4ODM3NmY3ZTQ1NDliNzA0ZjYxNGI1M2Q0NDA3L3RleHRyZWdpb246MzZhMTg4Mzc2ZjdlNDU0OWI3MDRmNjE0YjUzZDQ0MDdfNTY3NA_1e9e644d-5ac0-41b5-8ae6-cbde6815d935">1,023</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i2450926f8adf4dedb94c370247e5310b_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zNC9mcmFnOjM2YTE4ODM3NmY3ZTQ1NDliNzA0ZjYxNGI1M2Q0NDA3L3RleHRyZWdpb246MzZhMTg4Mzc2ZjdlNDU0OWI3MDRmNjE0YjUzZDQ0MDdfNTY4MQ_877effb9-bc54-4474-af84-a7754160065f">11,662</ix:nonFraction>, that were reclassified from the three and nine months ended September 30, 2020, respectively, to the three and nine months ended September 30, 2019, respectively. <ix:nonNumeric contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" name="us-gaap:BusinessAcquisitionProFormaInformationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zNC9mcmFnOjM2YTE4ODM3NmY3ZTQ1NDliNzA0ZjYxNGI1M2Q0NDA3L3RleHRyZWdpb246MzZhMTg4Mzc2ZjdlNDU0OWI3MDRmNjE0YjUzZDQ0MDdfNjAzMQ_d7fe18a1-3f54-4556-af11-93f148f82313" continuedAt="ie3a334bedfbf42898f4282497a281f0d" escape="true">The unaudited pro forma financial information is not necessarily indicative of the operating results that would have occurred had the acquisition been consummated as of the date indicated, nor is it necessarily indicative of the Company&#8217;s future operating results. </ix:nonNumeric></span></div><div style="margin-top:6pt;text-align:center"><ix:continuation id="ie3a334bedfbf42898f4282497a281f0d"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.584%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.215%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.317%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic430d291a7804180aa0b06c38d0c7c55_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessAcquisitionsProFormaRevenue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zNC9mcmFnOjM2YTE4ODM3NmY3ZTQ1NDliNzA0ZjYxNGI1M2Q0NDA3L3RhYmxlOjE5MmRiMzFlMjRkNTRjNTQ4OTlkOGRjZTcwMmFlNjNkL3RhYmxlcmFuZ2U6MTkyZGIzMWUyNGQ1NGM1NDg5OWQ4ZGNlNzAyYWU2M2RfMi0xLTEtMS0xMDc3MA_63e81e56-3dcb-48ea-88fb-d35a5fa428f7">551,631</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87dc697cd0464e2c938ed8477a3a3237_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessAcquisitionsProFormaRevenue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zNC9mcmFnOjM2YTE4ODM3NmY3ZTQ1NDliNzA0ZjYxNGI1M2Q0NDA3L3RhYmxlOjE5MmRiMzFlMjRkNTRjNTQ4OTlkOGRjZTcwMmFlNjNkL3RhYmxlcmFuZ2U6MTkyZGIzMWUyNGQ1NGM1NDg5OWQ4ZGNlNzAyYWU2M2RfMi01LTEtMS0xMDc3MA_11260824-9887-40b1-bcf4-4e593618266f">1,776,315</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from operations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic430d291a7804180aa0b06c38d0c7c55_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zNC9mcmFnOjM2YTE4ODM3NmY3ZTQ1NDliNzA0ZjYxNGI1M2Q0NDA3L3RhYmxlOjE5MmRiMzFlMjRkNTRjNTQ4OTlkOGRjZTcwMmFlNjNkL3RhYmxlcmFuZ2U6MTkyZGIzMWUyNGQ1NGM1NDg5OWQ4ZGNlNzAyYWU2M2RfMy0xLTEtMS0xMDc3MA_baad55c0-e892-4296-b850-69008af49e1e">50,465</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87dc697cd0464e2c938ed8477a3a3237_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zNC9mcmFnOjM2YTE4ODM3NmY3ZTQ1NDliNzA0ZjYxNGI1M2Q0NDA3L3RhYmxlOjE5MmRiMzFlMjRkNTRjNTQ4OTlkOGRjZTcwMmFlNjNkL3RhYmxlcmFuZ2U6MTkyZGIzMWUyNGQ1NGM1NDg5OWQ4ZGNlNzAyYWU2M2RfMy01LTEtMS0xMDc3MA_d482efdd-564a-4a9d-a95b-99f15bda71fb">135,618</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic430d291a7804180aa0b06c38d0c7c55_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zNC9mcmFnOjM2YTE4ODM3NmY3ZTQ1NDliNzA0ZjYxNGI1M2Q0NDA3L3RhYmxlOjE5MmRiMzFlMjRkNTRjNTQ4OTlkOGRjZTcwMmFlNjNkL3RhYmxlcmFuZ2U6MTkyZGIzMWUyNGQ1NGM1NDg5OWQ4ZGNlNzAyYWU2M2RfNC0xLTEtMS0xMDc3MA_4f6749df-56e7-497c-9372-501cd44ef297">29,030</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87dc697cd0464e2c938ed8477a3a3237_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zNC9mcmFnOjM2YTE4ODM3NmY3ZTQ1NDliNzA0ZjYxNGI1M2Q0NDA3L3RhYmxlOjE5MmRiMzFlMjRkNTRjNTQ4OTlkOGRjZTcwMmFlNjNkL3RhYmxlcmFuZ2U6MTkyZGIzMWUyNGQ1NGM1NDg5OWQ4ZGNlNzAyYWU2M2RfNC01LTEtMS0xMDc3MA_531a22a4-ef1b-40be-9d6f-942fe61f5b73">71,434</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation></div></ix:continuation><div style="text-indent:13.5pt"><span><br/></span></div><div id="ia383c8c7878a498d91f9e8901f0cfd9c_37"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3. <ix:nonNumeric contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zNy9mcmFnOjIwYjczNDZiODJiZDQxYzc4NGZhMWViNWQ3YTdiNGYxL3RleHRyZWdpb246MjBiNzM0NmI4MmJkNDFjNzg0ZmExZWI1ZDdhN2I0ZjFfMzI3Ng_41f7519f-ca88-49d4-9f14-c4b31086645a" continuedAt="idc2d328f0f014cc2859277f1a0b5e169" escape="true">REVENUE RECOGNITION</ix:nonNumeric></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="idc2d328f0f014cc2859277f1a0b5e169"><ix:nonNumeric contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zNy9mcmFnOjIwYjczNDZiODJiZDQxYzc4NGZhMWViNWQ3YTdiNGYxL3RleHRyZWdpb246MjBiNzM0NmI4MmJkNDFjNzg0ZmExZWI1ZDdhN2I0ZjFfMzI3Mw_a896d88d-6e4e-4946-8b76-977e484291fa" escape="true"><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue primarily consists of fees earned from the temporary staffing and permanent placement of healthcare professionals, executives, and leaders (clinical and operational). The Company also generates revenue from its software as a service (&#8220;SaaS&#8221;)-based technologies, including vendor management systems and scheduling software, and outsourced workforce services, including language interpretation and recruitment process outsourcing. The Company recognizes revenue when control of its services is transferred to its customers, in an amount that reflects the consideration the Company expects to be entitled to receive in exchange for those services. Revenue from temporary staffing services is recognized as the services are rendered by clinical and non-clinical healthcare professionals. Under the Company&#8217;s managed services program (&#8220;MSP&#8221;) arrangements, the Company manages all or a part of a customer&#8217;s supplemental workforce needs utilizing its own network of healthcare professionals along with those of third-party subcontractors. Revenue and the related direct costs under MSP arrangements are recorded in accordance with the accounting guidance on reporting revenue gross as a principal versus net as an agent. When the Company uses subcontractors and acts as an agent, revenue is recorded net of the related subcontractor&#8217;s expense. Revenue from permanent placement and outsourced workforce services is recognized as the services are rendered. Depending on the arrangement, the Company&#8217;s SaaS-based revenue is recognized either as the services are rendered or ratably over the applicable arrangement&#8217;s service period.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s customers are primarily billed as services are rendered. Any fees billed in advance of being earned are recorded as deferred revenue. While payment terms vary by the type of customer and the services rendered, the term between invoicing and when payment is due is not significant. During the nine months ended September 30, 2021 and 2020, previously deferred revenue recognized as revenue was $<ix:nonFraction unitRef="usd" contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zNy9mcmFnOjIwYjczNDZiODJiZDQxYzc4NGZhMWViNWQ3YTdiNGYxL3RleHRyZWdpb246MjBiNzM0NmI4MmJkNDFjNzg0ZmExZWI1ZDdhN2I0ZjFfMjAyOQ_e959c5ca-0462-4555-bd8c-f97435256f4e">10,515</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zNy9mcmFnOjIwYjczNDZiODJiZDQxYzc4NGZhMWViNWQ3YTdiNGYxL3RleHRyZWdpb246MjBiNzM0NmI4MmJkNDFjNzg0ZmExZWI1ZDdhN2I0ZjFfMjAzNg_9c6f5766-d12a-48d1-9390-a62488b9748b">11,408</ix:nonFraction>, respectively.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has elected to apply the following practical expedients and optional exemptions related to contract costs and revenue recognition:</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Recognize incremental costs of obtaining a contract with amortization periods of one year or less as expense when incurred. These costs are recorded within selling, general and administrative expenses.</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Recognize revenue in the amount of consideration that the Company has a right to invoice the customer if that amount corresponds directly with the value to the customer of the Company&#8217;s services completed to date.</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Exemptions from disclosing the value of unsatisfied performance obligations for (i) contracts with an original expected length of one year or less, (ii) contracts for which revenue is recognized in the amount of consideration that the Company has a right to invoice for services performed and (iii) contracts for which variable consideration is allocated entirely to a wholly unsatisfied performance obligation or to a wholly unsatisfied promise to transfer a distinct service that forms part of a single performance obligation.</span></div></ix:nonNumeric><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note (5), &#8220;Segment Information,&#8221; for additional information regarding the Company&#8217;s revenue disaggregated by service type.</span></div></ix:continuation><div><span><br/></span></div><div id="ia383c8c7878a498d91f9e8901f0cfd9c_40"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4. <ix:nonNumeric contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180MC9mcmFnOjJmMGFiN2EwZjhkNjQyZGViODZhNzAyNzUzZWNkZTBmL3RleHRyZWdpb246MmYwYWI3YTBmOGQ2NDJkZWI4NmE3MDI3NTNlY2RlMGZfNzY2_3369b548-16a1-4230-849f-0a5781a5f8e2" continuedAt="i620c34b74b314f2a955f6e95fe92776a" escape="true">NET INCOME PER COMMON SHARE</ix:nonNumeric></span></div><ix:continuation id="i620c34b74b314f2a955f6e95fe92776a"><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" name="us-gaap:EarningsPerSharePolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180MC9mcmFnOjJmMGFiN2EwZjhkNjQyZGViODZhNzAyNzUzZWNkZTBmL3RleHRyZWdpb246MmYwYWI3YTBmOGQ2NDJkZWI4NmE3MDI3NTNlY2RlMGZfNzcw_9883a0eb-f847-4ca4-8c3b-959a7b7bd4af" escape="true">Basic net income per common share is calculated by dividing net income by the weighted average number of common shares outstanding during the reporting period.</ix:nonNumeric> <ix:nonNumeric contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180MC9mcmFnOjJmMGFiN2EwZjhkNjQyZGViODZhNzAyNzUzZWNkZTBmL3RleHRyZWdpb246MmYwYWI3YTBmOGQ2NDJkZWI4NmE3MDI3NTNlY2RlMGZfNzgw_98125249-6f3e-4c70-8af3-27a82852ea34" continuedAt="i9909f91bd5254be6a28695bfb6dc5220" escape="true">The following table sets forth the computation of basic and diluted net income per common share:</ix:nonNumeric></span></div><div style="margin-top:5pt"><ix:continuation id="i9909f91bd5254be6a28695bfb6dc5220"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:53.724%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.429%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i150492f298fa47a78ef2c10a285a64f8_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180MC9mcmFnOjJmMGFiN2EwZjhkNjQyZGViODZhNzAyNzUzZWNkZTBmL3RhYmxlOjBiNTU0ZDg1MWE1ODQwOThhZjkwZWI4ZTdmZTVjNWNiL3RhYmxlcmFuZ2U6MGI1NTRkODUxYTU4NDA5OGFmOTBlYjhlN2ZlNWM1Y2JfMi0xLTEtMS0xMDc3MA_e2d3a336-8dad-4f3e-8786-77b7cea81a01"><ix:nonFraction unitRef="usd" contextRef="i150492f298fa47a78ef2c10a285a64f8_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180MC9mcmFnOjJmMGFiN2EwZjhkNjQyZGViODZhNzAyNzUzZWNkZTBmL3RhYmxlOjBiNTU0ZDg1MWE1ODQwOThhZjkwZWI4ZTdmZTVjNWNiL3RhYmxlcmFuZ2U6MGI1NTRkODUxYTU4NDA5OGFmOTBlYjhlN2ZlNWM1Y2JfMi0xLTEtMS0xMDc3MA_efff5a03-8551-4e93-a0e5-a22a1e915046">74,023</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6cb0c51ba8fa45fda70ec7e5df8b4ef1_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180MC9mcmFnOjJmMGFiN2EwZjhkNjQyZGViODZhNzAyNzUzZWNkZTBmL3RhYmxlOjBiNTU0ZDg1MWE1ODQwOThhZjkwZWI4ZTdmZTVjNWNiL3RhYmxlcmFuZ2U6MGI1NTRkODUxYTU4NDA5OGFmOTBlYjhlN2ZlNWM1Y2JfMi0zLTEtMS0xMDc3MA_55f14d18-0e78-4532-8438-964eb731efe6"><ix:nonFraction unitRef="usd" contextRef="i6cb0c51ba8fa45fda70ec7e5df8b4ef1_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180MC9mcmFnOjJmMGFiN2EwZjhkNjQyZGViODZhNzAyNzUzZWNkZTBmL3RhYmxlOjBiNTU0ZDg1MWE1ODQwOThhZjkwZWI4ZTdmZTVjNWNiL3RhYmxlcmFuZ2U6MGI1NTRkODUxYTU4NDA5OGFmOTBlYjhlN2ZlNWM1Y2JfMi0zLTEtMS0xMDc3MA_f0ff9ce4-8dd3-48a3-bf23-a7dd3a16d444">26,067</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180MC9mcmFnOjJmMGFiN2EwZjhkNjQyZGViODZhNzAyNzUzZWNkZTBmL3RhYmxlOjBiNTU0ZDg1MWE1ODQwOThhZjkwZWI4ZTdmZTVjNWNiL3RhYmxlcmFuZ2U6MGI1NTRkODUxYTU4NDA5OGFmOTBlYjhlN2ZlNWM1Y2JfMi01LTEtMS0xMDc3MA_eb0c20d2-b18d-490a-bbce-9f275d8a448b"><ix:nonFraction unitRef="usd" contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180MC9mcmFnOjJmMGFiN2EwZjhkNjQyZGViODZhNzAyNzUzZWNkZTBmL3RhYmxlOjBiNTU0ZDg1MWE1ODQwOThhZjkwZWI4ZTdmZTVjNWNiL3RhYmxlcmFuZ2U6MGI1NTRkODUxYTU4NDA5OGFmOTBlYjhlN2ZlNWM1Y2JfMi01LTEtMS0xMDc3MA_f14545f9-8870-499b-943c-0688cc9fb12b">211,171</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180MC9mcmFnOjJmMGFiN2EwZjhkNjQyZGViODZhNzAyNzUzZWNkZTBmL3RhYmxlOjBiNTU0ZDg1MWE1ODQwOThhZjkwZWI4ZTdmZTVjNWNiL3RhYmxlcmFuZ2U6MGI1NTRkODUxYTU4NDA5OGFmOTBlYjhlN2ZlNWM1Y2JfMi03LTEtMS0xMDc3MA_172b8971-f392-48a3-afb9-66a3fda40494"><ix:nonFraction unitRef="usd" contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180MC9mcmFnOjJmMGFiN2EwZjhkNjQyZGViODZhNzAyNzUzZWNkZTBmL3RhYmxlOjBiNTU0ZDg1MWE1ODQwOThhZjkwZWI4ZTdmZTVjNWNiL3RhYmxlcmFuZ2U6MGI1NTRkODUxYTU4NDA5OGFmOTBlYjhlN2ZlNWM1Y2JfMi03LTEtMS0xMDc3MA_97d2cddd-93ac-40ee-9644-9af6f298d471">61,357</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income per common share - basic </span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i150492f298fa47a78ef2c10a285a64f8_D20210701-20210930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180MC9mcmFnOjJmMGFiN2EwZjhkNjQyZGViODZhNzAyNzUzZWNkZTBmL3RhYmxlOjBiNTU0ZDg1MWE1ODQwOThhZjkwZWI4ZTdmZTVjNWNiL3RhYmxlcmFuZ2U6MGI1NTRkODUxYTU4NDA5OGFmOTBlYjhlN2ZlNWM1Y2JfNC0xLTEtMS0xMDc3MA_8314d84c-6e2c-4558-bffb-6c297070d87a">1.55</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i6cb0c51ba8fa45fda70ec7e5df8b4ef1_D20200701-20200930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180MC9mcmFnOjJmMGFiN2EwZjhkNjQyZGViODZhNzAyNzUzZWNkZTBmL3RhYmxlOjBiNTU0ZDg1MWE1ODQwOThhZjkwZWI4ZTdmZTVjNWNiL3RhYmxlcmFuZ2U6MGI1NTRkODUxYTU4NDA5OGFmOTBlYjhlN2ZlNWM1Y2JfNC0zLTEtMS0xMDc3MA_b64cf2a6-69cc-4df5-9345-474db05102e4">0.55</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180MC9mcmFnOjJmMGFiN2EwZjhkNjQyZGViODZhNzAyNzUzZWNkZTBmL3RhYmxlOjBiNTU0ZDg1MWE1ODQwOThhZjkwZWI4ZTdmZTVjNWNiL3RhYmxlcmFuZ2U6MGI1NTRkODUxYTU4NDA5OGFmOTBlYjhlN2ZlNWM1Y2JfNC01LTEtMS0xMDc3MA_bbc95430-281c-4460-be37-bd802729d7c4">4.43</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180MC9mcmFnOjJmMGFiN2EwZjhkNjQyZGViODZhNzAyNzUzZWNkZTBmL3RhYmxlOjBiNTU0ZDg1MWE1ODQwOThhZjkwZWI4ZTdmZTVjNWNiL3RhYmxlcmFuZ2U6MGI1NTRkODUxYTU4NDA5OGFmOTBlYjhlN2ZlNWM1Y2JfNC03LTEtMS0xMDc3MA_2507c2f5-a080-4b59-a213-4679efd005f0">1.29</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income per common share - diluted </span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i150492f298fa47a78ef2c10a285a64f8_D20210701-20210930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180MC9mcmFnOjJmMGFiN2EwZjhkNjQyZGViODZhNzAyNzUzZWNkZTBmL3RhYmxlOjBiNTU0ZDg1MWE1ODQwOThhZjkwZWI4ZTdmZTVjNWNiL3RhYmxlcmFuZ2U6MGI1NTRkODUxYTU4NDA5OGFmOTBlYjhlN2ZlNWM1Y2JfNS0xLTEtMS0xMDc3MA_68108a81-89cf-472e-a675-f3ea82c9b24c">1.54</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i6cb0c51ba8fa45fda70ec7e5df8b4ef1_D20200701-20200930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180MC9mcmFnOjJmMGFiN2EwZjhkNjQyZGViODZhNzAyNzUzZWNkZTBmL3RhYmxlOjBiNTU0ZDg1MWE1ODQwOThhZjkwZWI4ZTdmZTVjNWNiL3RhYmxlcmFuZ2U6MGI1NTRkODUxYTU4NDA5OGFmOTBlYjhlN2ZlNWM1Y2JfNS0zLTEtMS0xMDc3MA_21bf28e6-d12f-4ae8-9a88-16867419609e">0.55</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180MC9mcmFnOjJmMGFiN2EwZjhkNjQyZGViODZhNzAyNzUzZWNkZTBmL3RhYmxlOjBiNTU0ZDg1MWE1ODQwOThhZjkwZWI4ZTdmZTVjNWNiL3RhYmxlcmFuZ2U6MGI1NTRkODUxYTU4NDA5OGFmOTBlYjhlN2ZlNWM1Y2JfNS01LTEtMS0xMDc3MA_caeeeba4-0685-4ded-aca7-0571d2670794">4.40</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180MC9mcmFnOjJmMGFiN2EwZjhkNjQyZGViODZhNzAyNzUzZWNkZTBmL3RhYmxlOjBiNTU0ZDg1MWE1ODQwOThhZjkwZWI4ZTdmZTVjNWNiL3RhYmxlcmFuZ2U6MGI1NTRkODUxYTU4NDA5OGFmOTBlYjhlN2ZlNWM1Y2JfNS03LTEtMS0xMDc3MA_5daa6dc6-a987-4860-9a90-55b3874308be">1.29</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding - basic</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i150492f298fa47a78ef2c10a285a64f8_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180MC9mcmFnOjJmMGFiN2EwZjhkNjQyZGViODZhNzAyNzUzZWNkZTBmL3RhYmxlOjBiNTU0ZDg1MWE1ODQwOThhZjkwZWI4ZTdmZTVjNWNiL3RhYmxlcmFuZ2U6MGI1NTRkODUxYTU4NDA5OGFmOTBlYjhlN2ZlNWM1Y2JfNy0xLTEtMS0xMDc3MA_94f3875a-ca98-4798-b091-550316b6d3a6">47,737</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6cb0c51ba8fa45fda70ec7e5df8b4ef1_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180MC9mcmFnOjJmMGFiN2EwZjhkNjQyZGViODZhNzAyNzUzZWNkZTBmL3RhYmxlOjBiNTU0ZDg1MWE1ODQwOThhZjkwZWI4ZTdmZTVjNWNiL3RhYmxlcmFuZ2U6MGI1NTRkODUxYTU4NDA5OGFmOTBlYjhlN2ZlNWM1Y2JfNy0zLTEtMS0xMDc3MA_76f2b2c3-8dc5-4cfc-acbb-14d20b33e78a">47,476</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180MC9mcmFnOjJmMGFiN2EwZjhkNjQyZGViODZhNzAyNzUzZWNkZTBmL3RhYmxlOjBiNTU0ZDg1MWE1ODQwOThhZjkwZWI4ZTdmZTVjNWNiL3RhYmxlcmFuZ2U6MGI1NTRkODUxYTU4NDA5OGFmOTBlYjhlN2ZlNWM1Y2JfNy01LTEtMS0xMDc3MA_6f7eb06b-b539-47cd-b69d-40eec1446325">47,666</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180MC9mcmFnOjJmMGFiN2EwZjhkNjQyZGViODZhNzAyNzUzZWNkZTBmL3RhYmxlOjBiNTU0ZDg1MWE1ODQwOThhZjkwZWI4ZTdmZTVjNWNiL3RhYmxlcmFuZ2U6MGI1NTRkODUxYTU4NDA5OGFmOTBlYjhlN2ZlNWM1Y2JfNy03LTEtMS0xMDc3MA_3dd0e067-e76a-4bd6-ae5b-dc552906c44c">47,406</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plus dilutive effect of potential common shares</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i150492f298fa47a78ef2c10a285a64f8_D20210701-20210930" decimals="-3" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180MC9mcmFnOjJmMGFiN2EwZjhkNjQyZGViODZhNzAyNzUzZWNkZTBmL3RhYmxlOjBiNTU0ZDg1MWE1ODQwOThhZjkwZWI4ZTdmZTVjNWNiL3RhYmxlcmFuZ2U6MGI1NTRkODUxYTU4NDA5OGFmOTBlYjhlN2ZlNWM1Y2JfOC0xLTEtMS0xMDc3MA_59cd98ee-2eb7-4d08-bee9-064e9eb3a00c">343</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6cb0c51ba8fa45fda70ec7e5df8b4ef1_D20200701-20200930" decimals="-3" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180MC9mcmFnOjJmMGFiN2EwZjhkNjQyZGViODZhNzAyNzUzZWNkZTBmL3RhYmxlOjBiNTU0ZDg1MWE1ODQwOThhZjkwZWI4ZTdmZTVjNWNiL3RhYmxlcmFuZ2U6MGI1NTRkODUxYTU4NDA5OGFmOTBlYjhlN2ZlNWM1Y2JfOC0zLTEtMS0xMDc3MA_819b8f50-cf6f-4507-badf-6a3565d48282">200</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" decimals="-3" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180MC9mcmFnOjJmMGFiN2EwZjhkNjQyZGViODZhNzAyNzUzZWNkZTBmL3RhYmxlOjBiNTU0ZDg1MWE1ODQwOThhZjkwZWI4ZTdmZTVjNWNiL3RhYmxlcmFuZ2U6MGI1NTRkODUxYTU4NDA5OGFmOTBlYjhlN2ZlNWM1Y2JfOC01LTEtMS0xMDc3MA_b4a3d9fa-19eb-4267-8440-7832873e8d02">356</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930" decimals="-3" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180MC9mcmFnOjJmMGFiN2EwZjhkNjQyZGViODZhNzAyNzUzZWNkZTBmL3RhYmxlOjBiNTU0ZDg1MWE1ODQwOThhZjkwZWI4ZTdmZTVjNWNiL3RhYmxlcmFuZ2U6MGI1NTRkODUxYTU4NDA5OGFmOTBlYjhlN2ZlNWM1Y2JfOC03LTEtMS0xMDc3MA_2dd210be-806e-4bc9-9360-09b9f43ef7fb">241</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding - diluted</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i150492f298fa47a78ef2c10a285a64f8_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180MC9mcmFnOjJmMGFiN2EwZjhkNjQyZGViODZhNzAyNzUzZWNkZTBmL3RhYmxlOjBiNTU0ZDg1MWE1ODQwOThhZjkwZWI4ZTdmZTVjNWNiL3RhYmxlcmFuZ2U6MGI1NTRkODUxYTU4NDA5OGFmOTBlYjhlN2ZlNWM1Y2JfOS0xLTEtMS0xMDc3MA_afbada0d-3f26-4dc1-9e2d-85c01ffe3ef2">48,080</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6cb0c51ba8fa45fda70ec7e5df8b4ef1_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180MC9mcmFnOjJmMGFiN2EwZjhkNjQyZGViODZhNzAyNzUzZWNkZTBmL3RhYmxlOjBiNTU0ZDg1MWE1ODQwOThhZjkwZWI4ZTdmZTVjNWNiL3RhYmxlcmFuZ2U6MGI1NTRkODUxYTU4NDA5OGFmOTBlYjhlN2ZlNWM1Y2JfOS0zLTEtMS0xMDc3MA_f72ee4fa-516e-46ee-b9e5-1fad92bc2645">47,676</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180MC9mcmFnOjJmMGFiN2EwZjhkNjQyZGViODZhNzAyNzUzZWNkZTBmL3RhYmxlOjBiNTU0ZDg1MWE1ODQwOThhZjkwZWI4ZTdmZTVjNWNiL3RhYmxlcmFuZ2U6MGI1NTRkODUxYTU4NDA5OGFmOTBlYjhlN2ZlNWM1Y2JfOS01LTEtMS0xMDc3MA_af6b7a84-e486-42b4-97b7-ee1400537b6c">48,022</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180MC9mcmFnOjJmMGFiN2EwZjhkNjQyZGViODZhNzAyNzUzZWNkZTBmL3RhYmxlOjBiNTU0ZDg1MWE1ODQwOThhZjkwZWI4ZTdmZTVjNWNiL3RhYmxlcmFuZ2U6MGI1NTRkODUxYTU4NDA5OGFmOTBlYjhlN2ZlNWM1Y2JfOS03LTEtMS0xMDc3MA_e3f9bb21-fb60-4b9f-95bb-6e038f36c2cd">47,647</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-top:4pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share-based awards to purchase <ix:nonFraction unitRef="shares" contextRef="i150492f298fa47a78ef2c10a285a64f8_D20210701-20210930" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180MC9mcmFnOjJmMGFiN2EwZjhkNjQyZGViODZhNzAyNzUzZWNkZTBmL3RleHRyZWdpb246MmYwYWI3YTBmOGQ2NDJkZWI4NmE3MDI3NTNlY2RlMGZfMzI2_e691661b-39d1-47a8-8dbe-cb981178071b">21</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180MC9mcmFnOjJmMGFiN2EwZjhkNjQyZGViODZhNzAyNzUzZWNkZTBmL3RleHRyZWdpb246MmYwYWI3YTBmOGQ2NDJkZWI4NmE3MDI3NTNlY2RlMGZfMzMz_6f9fa4ce-728e-453e-b70d-368801f932d8">26</ix:nonFraction> shares of common stock were not included in the above calculation of diluted net income per common share for the three and nine months ended September 30, 2021, respectively, because the effect of these instruments was anti-dilutive. Share-based awards to purchase <ix:nonFraction unitRef="shares" contextRef="i6cb0c51ba8fa45fda70ec7e5df8b4ef1_D20200701-20200930" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180MC9mcmFnOjJmMGFiN2EwZjhkNjQyZGViODZhNzAyNzUzZWNkZTBmL3RleHRyZWdpb246MmYwYWI3YTBmOGQ2NDJkZWI4NmE3MDI3NTNlY2RlMGZfNTU3_abf8cf21-c506-412a-a5b4-652a7ca1bb88">84</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180MC9mcmFnOjJmMGFiN2EwZjhkNjQyZGViODZhNzAyNzUzZWNkZTBmL3RleHRyZWdpb246MmYwYWI3YTBmOGQ2NDJkZWI4NmE3MDI3NTNlY2RlMGZfNTY0_44805654-aa83-4c18-8060-56ae792f411a">79</ix:nonFraction> shares of common stock were not included in the above calculation of diluted net income per common share for the three and nine months ended September 30, 2020, respectively, because the effect of these instruments was anti-dilutive.</span></div></ix:continuation><div><span><br/></span></div><div id="ia383c8c7878a498d91f9e8901f0cfd9c_43"></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5. <ix:nonNumeric contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RleHRyZWdpb246YWI0MTJlMTlmYzY0NDFmMGFiZGVhYTE2ODgxYmJmYjRfMjMzNg_a108f409-082c-4d1b-8c58-b34e099803ca" continuedAt="i4386597f41304295b2303e3e568d9e71" escape="true">SEGMENT INFORMATION</ix:nonNumeric></span></div><ix:continuation id="i4386597f41304295b2303e3e568d9e71" continuedAt="i0fc77fc021f54df3a36a428ffbb9e2f5"><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s operating segments are identified in the same manner as they are reported internally and used by the Company&#8217;s chief operating decision maker for the purpose of evaluating performance and allocating resources. The Company has <ix:nonFraction unitRef="segment" contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:NumberOfOperatingSegments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RleHRyZWdpb246YWI0MTJlMTlmYzY0NDFmMGFiZGVhYTE2ODgxYmJmYjRfMjY5_20e8f03e-3f48-4cdd-8483-0e9b08bac58d">three</ix:nonFraction> reportable segments: (1) nurse and allied solutions, (2) physician and leadership solutions, and (3) technology and workforce solutions. The nurse and allied solutions segment includes the Company&#8217;s travel nurse staffing, rapid response nurse staffing and labor disruption, allied staffing, local staffing, and revenue cycle solutions businesses. The physician and leadership solutions segment includes the Company&#8217;s locum tenens staffing, healthcare interim leadership staffing, executive search, and physician permanent placement businesses. The technology and workforce solutions segment includes the Company&#8217;s language services, vendor management systems, workforce optimization, recruitment process outsourcing, telehealth, credentialing, and flex pool management and other outsourced solutions businesses.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" name="us-gaap:SegmentReportingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RleHRyZWdpb246YWI0MTJlMTlmYzY0NDFmMGFiZGVhYTE2ODgxYmJmYjRfMjMwOQ_4db11190-038e-4e9e-ac67-07c58f510ff9" escape="true">The Company&#8217;s chief operating decision maker relies on internal management reporting processes that provide revenue and operating income by reportable segment for making financial decisions and allocating resources. Segment operating income represents income before income taxes plus depreciation, amortization of intangible assets, share-based compensation, interest expense, net, and other, and unallocated corporate overhead. The Company&#8217;s management does not evaluate, manage or measure performance of segments using asset information; accordingly, asset information by segment is not prepared or disclosed.</ix:nonNumeric></span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RleHRyZWdpb246YWI0MTJlMTlmYzY0NDFmMGFiZGVhYTE2ODgxYmJmYjRfMjMxMQ_4bf79877-2d10-48e0-82a1-2412bfbf6193" escape="true"><div style="margin-bottom:3pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a reconciliation of revenue and operating income by reportable segment to consolidated results and was derived from each segment&#8217;s internal financial information as used for corporate management purposes:</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.227%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.227%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.227%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.184%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nurse and allied solutions</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72bc6814293d41ce8300f2c38fcdd1bc_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmE5ZTY5YjA5Zjk1NzQ2Y2Y4MzU0OTEyYjQwYTE0MTI4L3RhYmxlcmFuZ2U6YTllNjliMDlmOTU3NDZjZjgzNTQ5MTJiNDBhMTQxMjhfMy0xLTEtMS0xMDc3MA_e2ca27ce-569e-48da-90e4-1bc6174425c9">627,049</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3473b76faf004446b11d60f76e27591c_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmE5ZTY5YjA5Zjk1NzQ2Y2Y4MzU0OTEyYjQwYTE0MTI4L3RhYmxlcmFuZ2U6YTllNjliMDlmOTU3NDZjZjgzNTQ5MTJiNDBhMTQxMjhfMy0zLTEtMS0xMDc3MA_68efd4b1-7952-4a4a-9f15-f5106987c800">382,699</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5021bcb8a5144f2e92e4d17294f25756_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmE5ZTY5YjA5Zjk1NzQ2Y2Y4MzU0OTEyYjQwYTE0MTI4L3RhYmxlcmFuZ2U6YTllNjliMDlmOTU3NDZjZjgzNTQ5MTJiNDBhMTQxMjhfMy01LTEtMS0xMDc3MA_be8b08a7-c17b-43ff-b8cb-5fb98c97d36e">1,908,195</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib58839822ae8478c8d8ef1cb827d2ebe_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmE5ZTY5YjA5Zjk1NzQ2Y2Y4MzU0OTEyYjQwYTE0MTI4L3RhYmxlcmFuZ2U6YTllNjliMDlmOTU3NDZjZjgzNTQ5MTJiNDBhMTQxMjhfMy03LTEtMS0xMDc3MA_6523e766-a942-4b38-928f-eb810112172e">1,251,509</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Physician and leadership solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bb9c1ce74924d3fb6c80bf5bc7070ca_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmE5ZTY5YjA5Zjk1NzQ2Y2Y4MzU0OTEyYjQwYTE0MTI4L3RhYmxlcmFuZ2U6YTllNjliMDlmOTU3NDZjZjgzNTQ5MTJiNDBhMTQxMjhfNC0xLTEtMS0xMDc3MA_53ea9bc5-16ce-4f45-9246-59d860058452">150,663</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bdfcb612866449f8fc82428772bc4e0_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmE5ZTY5YjA5Zjk1NzQ2Y2Y4MzU0OTEyYjQwYTE0MTI4L3RhYmxlcmFuZ2U6YTllNjliMDlmOTU3NDZjZjgzNTQ5MTJiNDBhMTQxMjhfNC0zLTEtMS0xMDc3MA_7ee5bd73-7628-4b7f-8a44-b6ded88b84c5">109,116</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd4b5ea0c6464abaafa771245dd4872b_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmE5ZTY5YjA5Zjk1NzQ2Y2Y4MzU0OTEyYjQwYTE0MTI4L3RhYmxlcmFuZ2U6YTllNjliMDlmOTU3NDZjZjgzNTQ5MTJiNDBhMTQxMjhfNC01LTEtMS0xMDc3MA_4544fdab-e6de-44ee-9f5b-a4ee21f6e8ed">430,523</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8096536e07244cbc88570b4cd0b1df3b_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmE5ZTY5YjA5Zjk1NzQ2Y2Y4MzU0OTEyYjQwYTE0MTI4L3RhYmxlcmFuZ2U6YTllNjliMDlmOTU3NDZjZjgzNTQ5MTJiNDBhMTQxMjhfNC03LTEtMS0xMDc3MA_51b0d525-158e-4fa0-9d02-36840a381655">355,580</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology and workforce solutions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i286479f51b3847f180927296005817b3_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmE5ZTY5YjA5Zjk1NzQ2Y2Y4MzU0OTEyYjQwYTE0MTI4L3RhYmxlcmFuZ2U6YTllNjliMDlmOTU3NDZjZjgzNTQ5MTJiNDBhMTQxMjhfNS0xLTEtMS0xMDc3MA_8af21e7d-91f2-4fa9-8352-d815ea6aa769">100,088</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebe1c6905368491eb38b8213c9304590_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmE5ZTY5YjA5Zjk1NzQ2Y2Y4MzU0OTEyYjQwYTE0MTI4L3RhYmxlcmFuZ2U6YTllNjliMDlmOTU3NDZjZjgzNTQ5MTJiNDBhMTQxMjhfNS0zLTEtMS0xMDc3MA_90ccb7d7-1914-42ae-8f8b-5f750584305a">59,816</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f81f9d1a6314e098bdd58b74619a28f_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmE5ZTY5YjA5Zjk1NzQ2Y2Y4MzU0OTEyYjQwYTE0MTI4L3RhYmxlcmFuZ2U6YTllNjliMDlmOTU3NDZjZjgzNTQ5MTJiNDBhMTQxMjhfNS01LTEtMS0xMDc3MA_6cd9680f-736a-4320-a007-1d74eee9ab19">282,472</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib31de07b75904e5cb9fd99c168d04547_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmE5ZTY5YjA5Zjk1NzQ2Y2Y4MzU0OTEyYjQwYTE0MTI4L3RhYmxlcmFuZ2U6YTllNjliMDlmOTU3NDZjZjgzNTQ5MTJiNDBhMTQxMjhfNS03LTEtMS0xMDc3MA_83d63a8e-6f61-4e18-8ac2-f69df5ac5228">155,354</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a24f793f440442085a27968a5583766_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmE5ZTY5YjA5Zjk1NzQ2Y2Y4MzU0OTEyYjQwYTE0MTI4L3RhYmxlcmFuZ2U6YTllNjliMDlmOTU3NDZjZjgzNTQ5MTJiNDBhMTQxMjhfNi0xLTEtMS0xMDc3MA_20b79833-16af-47ae-8958-261eb3d10e5b">877,800</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icdd1cb3977024d5d959ea51ad54b783d_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmE5ZTY5YjA5Zjk1NzQ2Y2Y4MzU0OTEyYjQwYTE0MTI4L3RhYmxlcmFuZ2U6YTllNjliMDlmOTU3NDZjZjgzNTQ5MTJiNDBhMTQxMjhfNi0zLTEtMS0xMDc3MA_a38f2b84-2031-4841-8659-3222ec023c1f">551,631</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5479404ee04b498ab6fd8545f90d86b9_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmE5ZTY5YjA5Zjk1NzQ2Y2Y4MzU0OTEyYjQwYTE0MTI4L3RhYmxlcmFuZ2U6YTllNjliMDlmOTU3NDZjZjgzNTQ5MTJiNDBhMTQxMjhfNi01LTEtMS0xMDc3MA_16ce8a88-4f02-416a-8c69-0f88fb3bd0b2">2,621,190</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i703fc84123784c69b090877fb4125906_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmE5ZTY5YjA5Zjk1NzQ2Y2Y4MzU0OTEyYjQwYTE0MTI4L3RhYmxlcmFuZ2U6YTllNjliMDlmOTU3NDZjZjgzNTQ5MTJiNDBhMTQxMjhfNi03LTEtMS0xMDc3MA_cfd59e8b-8019-43db-b45c-cdc5c97f2b6b">1,762,443</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment operating income</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nurse and allied solutions</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72bc6814293d41ce8300f2c38fcdd1bc_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmE5ZTY5YjA5Zjk1NzQ2Y2Y4MzU0OTEyYjQwYTE0MTI4L3RhYmxlcmFuZ2U6YTllNjliMDlmOTU3NDZjZjgzNTQ5MTJiNDBhMTQxMjhfOC0xLTEtMS0xMDc3MA_a49d5c0b-bf37-4db8-b7a9-4842a6a74a27">92,564</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3473b76faf004446b11d60f76e27591c_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmE5ZTY5YjA5Zjk1NzQ2Y2Y4MzU0OTEyYjQwYTE0MTI4L3RhYmxlcmFuZ2U6YTllNjliMDlmOTU3NDZjZjgzNTQ5MTJiNDBhMTQxMjhfOC0zLTEtMS0xMDc3MA_99b10b57-8fb1-4812-affe-254be2ad9952">52,923</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5021bcb8a5144f2e92e4d17294f25756_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmE5ZTY5YjA5Zjk1NzQ2Y2Y4MzU0OTEyYjQwYTE0MTI4L3RhYmxlcmFuZ2U6YTllNjliMDlmOTU3NDZjZjgzNTQ5MTJiNDBhMTQxMjhfOC01LTEtMS0xMDc3MA_7eb51800-4a08-486e-b3c4-d99c97a583fc">283,768</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib58839822ae8478c8d8ef1cb827d2ebe_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmE5ZTY5YjA5Zjk1NzQ2Y2Y4MzU0OTEyYjQwYTE0MTI4L3RhYmxlcmFuZ2U6YTllNjliMDlmOTU3NDZjZjgzNTQ5MTJiNDBhMTQxMjhfOC03LTEtMS0xMDc3MA_34684db9-270e-40fb-a4ed-8da1b4413a30">173,706</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Physician and leadership solutions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bb9c1ce74924d3fb6c80bf5bc7070ca_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmE5ZTY5YjA5Zjk1NzQ2Y2Y4MzU0OTEyYjQwYTE0MTI4L3RhYmxlcmFuZ2U6YTllNjliMDlmOTU3NDZjZjgzNTQ5MTJiNDBhMTQxMjhfOS0xLTEtMS0xMDc3MA_529c0182-037a-447c-b6ab-07eb722930ee">19,301</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bdfcb612866449f8fc82428772bc4e0_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmE5ZTY5YjA5Zjk1NzQ2Y2Y4MzU0OTEyYjQwYTE0MTI4L3RhYmxlcmFuZ2U6YTllNjliMDlmOTU3NDZjZjgzNTQ5MTJiNDBhMTQxMjhfOS0zLTEtMS0xMDc3MA_0b97eed8-62a2-4a0b-922d-204c791b7c7d">15,538</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd4b5ea0c6464abaafa771245dd4872b_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmE5ZTY5YjA5Zjk1NzQ2Y2Y4MzU0OTEyYjQwYTE0MTI4L3RhYmxlcmFuZ2U6YTllNjliMDlmOTU3NDZjZjgzNTQ5MTJiNDBhMTQxMjhfOS01LTEtMS0xMDc3MA_dc09d62a-5817-4552-be67-4c98294e3b43">62,366</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8096536e07244cbc88570b4cd0b1df3b_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmE5ZTY5YjA5Zjk1NzQ2Y2Y4MzU0OTEyYjQwYTE0MTI4L3RhYmxlcmFuZ2U6YTllNjliMDlmOTU3NDZjZjgzNTQ5MTJiNDBhMTQxMjhfOS03LTEtMS0xMDc3MA_de328345-8240-4b40-b7b2-d76e727a02ae">45,432</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology and workforce solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i286479f51b3847f180927296005817b3_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmE5ZTY5YjA5Zjk1NzQ2Y2Y4MzU0OTEyYjQwYTE0MTI4L3RhYmxlcmFuZ2U6YTllNjliMDlmOTU3NDZjZjgzNTQ5MTJiNDBhMTQxMjhfMTAtMS0xLTEtMTA3NzA_390ad566-f261-412a-b5a3-172946a99483">47,210</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebe1c6905368491eb38b8213c9304590_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmE5ZTY5YjA5Zjk1NzQ2Y2Y4MzU0OTEyYjQwYTE0MTI4L3RhYmxlcmFuZ2U6YTllNjliMDlmOTU3NDZjZjgzNTQ5MTJiNDBhMTQxMjhfMTAtMy0xLTEtMTA3NzA_50b7030f-0a4b-4618-b3fd-e17d5ef11b10">25,680</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f81f9d1a6314e098bdd58b74619a28f_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmE5ZTY5YjA5Zjk1NzQ2Y2Y4MzU0OTEyYjQwYTE0MTI4L3RhYmxlcmFuZ2U6YTllNjliMDlmOTU3NDZjZjgzNTQ5MTJiNDBhMTQxMjhfMTAtNS0xLTEtMTA3NzA_0e5bfdbc-19b5-42fa-94df-46a600167b24">131,952</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib31de07b75904e5cb9fd99c168d04547_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmE5ZTY5YjA5Zjk1NzQ2Y2Y4MzU0OTEyYjQwYTE0MTI4L3RhYmxlcmFuZ2U6YTllNjliMDlmOTU3NDZjZjgzNTQ5MTJiNDBhMTQxMjhfMTAtNy0xLTEtMTA3NzA_ec16ee88-de02-41c2-8581-81be42b2e38b">62,814</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a24f793f440442085a27968a5583766_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmE5ZTY5YjA5Zjk1NzQ2Y2Y4MzU0OTEyYjQwYTE0MTI4L3RhYmxlcmFuZ2U6YTllNjliMDlmOTU3NDZjZjgzNTQ5MTJiNDBhMTQxMjhfMTEtMS0xLTEtMTA3NzA_db1fa800-fb7b-482b-9bf0-2c27ee16292f">159,075</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icdd1cb3977024d5d959ea51ad54b783d_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmE5ZTY5YjA5Zjk1NzQ2Y2Y4MzU0OTEyYjQwYTE0MTI4L3RhYmxlcmFuZ2U6YTllNjliMDlmOTU3NDZjZjgzNTQ5MTJiNDBhMTQxMjhfMTEtMy0xLTEtMTA3NzA_2a2b6f38-6237-4c50-9f5e-a72c6872d805">94,141</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5479404ee04b498ab6fd8545f90d86b9_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmE5ZTY5YjA5Zjk1NzQ2Y2Y4MzU0OTEyYjQwYTE0MTI4L3RhYmxlcmFuZ2U6YTllNjliMDlmOTU3NDZjZjgzNTQ5MTJiNDBhMTQxMjhfMTEtNS0xLTEtMTA3NzA_dea4621c-e5e1-441e-a3c1-9bedfc3873df">478,086</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i703fc84123784c69b090877fb4125906_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmE5ZTY5YjA5Zjk1NzQ2Y2Y4MzU0OTEyYjQwYTE0MTI4L3RhYmxlcmFuZ2U6YTllNjliMDlmOTU3NDZjZjgzNTQ5MTJiNDBhMTQxMjhfMTEtNy0xLTEtMTA3NzA_da5c8785-3de3-411a-94fc-376a163781c9">281,952</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unallocated corporate overhead</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie946fae8ec0046439446bb138d525757_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="amn:UnallocatedCorporateOverhead" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmE5ZTY5YjA5Zjk1NzQ2Y2Y4MzU0OTEyYjQwYTE0MTI4L3RhYmxlcmFuZ2U6YTllNjliMDlmOTU3NDZjZjgzNTQ5MTJiNDBhMTQxMjhfMTItMS0xLTEtMTA3NzA_d3c6d9f0-e970-4984-a7d0-6e3f4c4c9ff2">23,867</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i674c8f2758bf45ae8bb93948b5860e97_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="amn:UnallocatedCorporateOverhead" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmE5ZTY5YjA5Zjk1NzQ2Y2Y4MzU0OTEyYjQwYTE0MTI4L3RhYmxlcmFuZ2U6YTllNjliMDlmOTU3NDZjZjgzNTQ5MTJiNDBhMTQxMjhfMTItMy0xLTEtMTA3NzA_55d9b18d-5ef4-4381-b9b0-8e5dbb89500c">16,490</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib14ea5527ced44f5979f01683cbc7fc4_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="amn:UnallocatedCorporateOverhead" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmE5ZTY5YjA5Zjk1NzQ2Y2Y4MzU0OTEyYjQwYTE0MTI4L3RhYmxlcmFuZ2U6YTllNjliMDlmOTU3NDZjZjgzNTQ5MTJiNDBhMTQxMjhfMTItNS0xLTEtMTA3NzA_271ad980-f267-4c07-a628-742c04d849fc">74,915</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieeebf848246c441ba6ab2c571e599296_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="amn:UnallocatedCorporateOverhead" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmE5ZTY5YjA5Zjk1NzQ2Y2Y4MzU0OTEyYjQwYTE0MTI4L3RhYmxlcmFuZ2U6YTllNjliMDlmOTU3NDZjZjgzNTQ5MTJiNDBhMTQxMjhfMTItNy0xLTEtMTA3NzA_8ed85987-514a-492a-a6d0-2a9dabbca339">76,223</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i150492f298fa47a78ef2c10a285a64f8_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmE5ZTY5YjA5Zjk1NzQ2Y2Y4MzU0OTEyYjQwYTE0MTI4L3RhYmxlcmFuZ2U6YTllNjliMDlmOTU3NDZjZjgzNTQ5MTJiNDBhMTQxMjhfMTMtMS0xLTEtMTA3NzA_919daf11-4d88-468e-b799-95a1395be40f">26,104</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6cb0c51ba8fa45fda70ec7e5df8b4ef1_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmE5ZTY5YjA5Zjk1NzQ2Y2Y4MzU0OTEyYjQwYTE0MTI4L3RhYmxlcmFuZ2U6YTllNjliMDlmOTU3NDZjZjgzNTQ5MTJiNDBhMTQxMjhfMTMtMy0xLTEtMTA3NzA_3c152c63-82de-43a3-bca1-86ecb8c35751">26,936</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmE5ZTY5YjA5Zjk1NzQ2Y2Y4MzU0OTEyYjQwYTE0MTI4L3RhYmxlcmFuZ2U6YTllNjliMDlmOTU3NDZjZjgzNTQ5MTJiNDBhMTQxMjhfMTMtNS0xLTEtMTA3NzA_ab1906db-d846-45c7-80b8-991a007f3a11">74,098</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmE5ZTY5YjA5Zjk1NzQ2Y2Y4MzU0OTEyYjQwYTE0MTI4L3RhYmxlcmFuZ2U6YTllNjliMDlmOTU3NDZjZjgzNTQ5MTJiNDBhMTQxMjhfMTMtNy0xLTEtMTA3NzA_b8f65d2f-9d19-4d5c-8eb9-440140bbe6e8">69,096</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation (included in cost of revenue)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i150492f298fa47a78ef2c10a285a64f8_D20210701-20210930" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSoldDepreciation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmE5ZTY5YjA5Zjk1NzQ2Y2Y4MzU0OTEyYjQwYTE0MTI4L3RhYmxlcmFuZ2U6YTllNjliMDlmOTU3NDZjZjgzNTQ5MTJiNDBhMTQxMjhfMTQtMS0xLTEtMTA3NzA_96a803a0-d445-4edf-bb64-bcedeab55753">686</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6cb0c51ba8fa45fda70ec7e5df8b4ef1_D20200701-20200930" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSoldDepreciation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmE5ZTY5YjA5Zjk1NzQ2Y2Y4MzU0OTEyYjQwYTE0MTI4L3RhYmxlcmFuZ2U6YTllNjliMDlmOTU3NDZjZjgzNTQ5MTJiNDBhMTQxMjhfMTQtMy0xLTEtMTA3NzA_ed87fcce-903e-421b-a600-05fefb48672f">481</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CostOfGoodsAndServicesSoldDepreciation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmE5ZTY5YjA5Zjk1NzQ2Y2Y4MzU0OTEyYjQwYTE0MTI4L3RhYmxlcmFuZ2U6YTllNjliMDlmOTU3NDZjZjgzNTQ5MTJiNDBhMTQxMjhfMTQtNS0xLTEtMTA3NzA_0ded31be-af68-4360-9975-fe614eecc3c1">1,773</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSoldDepreciation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmE5ZTY5YjA5Zjk1NzQ2Y2Y4MzU0OTEyYjQwYTE0MTI4L3RhYmxlcmFuZ2U6YTllNjliMDlmOTU3NDZjZjgzNTQ5MTJiNDBhMTQxMjhfMTQtNy0xLTEtMTA3NzA_ed73e99c-6c78-412c-9d16-45eceb364ba0">981</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i150492f298fa47a78ef2c10a285a64f8_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmE5ZTY5YjA5Zjk1NzQ2Y2Y4MzU0OTEyYjQwYTE0MTI4L3RhYmxlcmFuZ2U6YTllNjliMDlmOTU3NDZjZjgzNTQ5MTJiNDBhMTQxMjhfMTUtMS0xLTEtMTA3NzA_8f2e6191-c972-4d3e-bbdf-b4f05aeb2d02">2,589</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6cb0c51ba8fa45fda70ec7e5df8b4ef1_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmE5ZTY5YjA5Zjk1NzQ2Y2Y4MzU0OTEyYjQwYTE0MTI4L3RhYmxlcmFuZ2U6YTllNjliMDlmOTU3NDZjZjgzNTQ5MTJiNDBhMTQxMjhfMTUtMy0xLTEtMTA3NzA_97d27a6e-85e4-427e-b410-9276092db770">3,772</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmE5ZTY5YjA5Zjk1NzQ2Y2Y4MzU0OTEyYjQwYTE0MTI4L3RhYmxlcmFuZ2U6YTllNjliMDlmOTU3NDZjZjgzNTQ5MTJiNDBhMTQxMjhfMTUtNS0xLTEtMTA3NzA_5d058e0a-981d-4fa3-9d37-208096ebcb12">17,895</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmE5ZTY5YjA5Zjk1NzQ2Y2Y4MzU0OTEyYjQwYTE0MTI4L3RhYmxlcmFuZ2U6YTllNjliMDlmOTU3NDZjZjgzNTQ5MTJiNDBhMTQxMjhfMTUtNy0xLTEtMTA3NzA_d56baada-3cd6-48a4-afcb-0d0832d64e89">15,046</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net, and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i150492f298fa47a78ef2c10a285a64f8_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmE5ZTY5YjA5Zjk1NzQ2Y2Y4MzU0OTEyYjQwYTE0MTI4L3RhYmxlcmFuZ2U6YTllNjliMDlmOTU3NDZjZjgzNTQ5MTJiNDBhMTQxMjhfMTYtMS0xLTEtMTA3NzA_6c57492d-3192-4133-8353-5501b1fa0b2d">5,223</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6cb0c51ba8fa45fda70ec7e5df8b4ef1_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmE5ZTY5YjA5Zjk1NzQ2Y2Y4MzU0OTEyYjQwYTE0MTI4L3RhYmxlcmFuZ2U6YTllNjliMDlmOTU3NDZjZjgzNTQ5MTJiNDBhMTQxMjhfMTYtMy0xLTEtMTA3NzA_082f35a4-3fc6-4718-9606-4dfda040c201">12,564</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmE5ZTY5YjA5Zjk1NzQ2Y2Y4MzU0OTEyYjQwYTE0MTI4L3RhYmxlcmFuZ2U6YTllNjliMDlmOTU3NDZjZjgzNTQ5MTJiNDBhMTQxMjhfMTYtNS0xLTEtMTA3NzA_21aaab3c-dfb5-4a83-9f36-f04e9272fd2f">24,278</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmE5ZTY5YjA5Zjk1NzQ2Y2Y4MzU0OTEyYjQwYTE0MTI4L3RhYmxlcmFuZ2U6YTllNjliMDlmOTU3NDZjZjgzNTQ5MTJiNDBhMTQxMjhfMTYtNy0xLTEtMTA3NzA_60c90ec7-84ff-43df-a51c-340f3a7b418c">35,061</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before income taxes</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i150492f298fa47a78ef2c10a285a64f8_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmE5ZTY5YjA5Zjk1NzQ2Y2Y4MzU0OTEyYjQwYTE0MTI4L3RhYmxlcmFuZ2U6YTllNjliMDlmOTU3NDZjZjgzNTQ5MTJiNDBhMTQxMjhfMTctMS0xLTEtMTA3NzA_6fd9a117-688b-4da8-b6a6-54755dcc6eb2">100,606</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6cb0c51ba8fa45fda70ec7e5df8b4ef1_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmE5ZTY5YjA5Zjk1NzQ2Y2Y4MzU0OTEyYjQwYTE0MTI4L3RhYmxlcmFuZ2U6YTllNjliMDlmOTU3NDZjZjgzNTQ5MTJiNDBhMTQxMjhfMTctMy0xLTEtMTA3NzA_05f7df4e-04c0-4bd4-b368-39e1cdb83442">33,898</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmE5ZTY5YjA5Zjk1NzQ2Y2Y4MzU0OTEyYjQwYTE0MTI4L3RhYmxlcmFuZ2U6YTllNjliMDlmOTU3NDZjZjgzNTQ5MTJiNDBhMTQxMjhfMTctNS0xLTEtMTA3NzA_b09b4bbc-4bb2-483e-bb95-06147eef4794">285,127</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmE5ZTY5YjA5Zjk1NzQ2Y2Y4MzU0OTEyYjQwYTE0MTI4L3RhYmxlcmFuZ2U6YTllNjliMDlmOTU3NDZjZjgzNTQ5MTJiNDBhMTQxMjhfMTctNy0xLTEtMTA3NzA_ee4fbbaf-7a00-4a5f-96f2-26980a623f0e">85,545</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RleHRyZWdpb246YWI0MTJlMTlmYzY0NDFmMGFiZGVhYTE2ODgxYmJmYjRfMjMyMA_6856f52c-5ef5-42cd-96fd-2331fe928389" continuedAt="i416bc5da278441e08dd181bfbef1dade" escape="true"><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present the Company&#8217;s revenue disaggregated by service type:</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:37.350%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.524%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nurse&#160;and&#160;Allied Solutions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Physician and Leadership Solutions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Technology and Workforce Solutions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Temporary staffing</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6841006ed66046048b923a10d1f02618_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOjg2NDJlYjFjODMwNDRmZGI4NTFkZDUwNjJiYmY4NzY4L3RhYmxlcmFuZ2U6ODY0MmViMWM4MzA0NGZkYjg1MWRkNTA2MmJiZjg3NjhfMi0xLTEtMS0xMDc3MA_26f54ce5-9c86-4d94-aa4c-1dbdc430b829">627,049</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8aaeb4e7d78e45c4afa1ea8345243c26_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOjg2NDJlYjFjODMwNDRmZGI4NTFkZDUwNjJiYmY4NzY4L3RhYmxlcmFuZ2U6ODY0MmViMWM4MzA0NGZkYjg1MWRkNTA2MmJiZjg3NjhfMi0zLTEtMS0xMDc3MA_6d86e31d-a690-4942-8f40-f4d192d1ebd7">132,848</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7ed1c91706145b489b11684ae9f8f91_D20210701-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOjg2NDJlYjFjODMwNDRmZGI4NTFkZDUwNjJiYmY4NzY4L3RhYmxlcmFuZ2U6ODY0MmViMWM4MzA0NGZkYjg1MWRkNTA2MmJiZjg3NjhfMi01LTEtMS0xMDc3MA_b0a5c141-18d0-4fea-aa62-79f4da448a2d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6aff1598e94c41a9a49290be61afbb6c_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOjg2NDJlYjFjODMwNDRmZGI4NTFkZDUwNjJiYmY4NzY4L3RhYmxlcmFuZ2U6ODY0MmViMWM4MzA0NGZkYjg1MWRkNTA2MmJiZjg3NjhfMi03LTEtMS0xMDc3MA_aeb52424-677a-446b-9414-4f46e04c2786">759,897</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Permanent placement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i830444b4b4eb4bc49ed555e461733a60_D20210701-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOjg2NDJlYjFjODMwNDRmZGI4NTFkZDUwNjJiYmY4NzY4L3RhYmxlcmFuZ2U6ODY0MmViMWM4MzA0NGZkYjg1MWRkNTA2MmJiZjg3NjhfMy0xLTEtMS0xMDc3MA_20592bc0-322f-4b77-bd7b-d7ef47391b33">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1dcde31709c646a282f435f6c32eace5_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOjg2NDJlYjFjODMwNDRmZGI4NTFkZDUwNjJiYmY4NzY4L3RhYmxlcmFuZ2U6ODY0MmViMWM4MzA0NGZkYjg1MWRkNTA2MmJiZjg3NjhfMy0zLTEtMS0xMDc3MA_df377e0d-8188-4ec1-a375-e77824580c06">17,815</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a01cf9bd5e742be9ad5969b5dd25b9f_D20210701-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOjg2NDJlYjFjODMwNDRmZGI4NTFkZDUwNjJiYmY4NzY4L3RhYmxlcmFuZ2U6ODY0MmViMWM4MzA0NGZkYjg1MWRkNTA2MmJiZjg3NjhfMy01LTEtMS0xMDc3MA_1a93472a-d069-41db-86c3-60001cf3bb5a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i469189243c1643a29f2acd332c552f64_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOjg2NDJlYjFjODMwNDRmZGI4NTFkZDUwNjJiYmY4NzY4L3RhYmxlcmFuZ2U6ODY0MmViMWM4MzA0NGZkYjg1MWRkNTA2MmJiZjg3NjhfMy03LTEtMS0xMDc3MA_d0f2dc3c-126a-4a48-90c6-d4a8937fb7fb">17,815</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outsourced workforce</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97bcb414c2014844b1112de85e955858_D20210701-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOjg2NDJlYjFjODMwNDRmZGI4NTFkZDUwNjJiYmY4NzY4L3RhYmxlcmFuZ2U6ODY0MmViMWM4MzA0NGZkYjg1MWRkNTA2MmJiZjg3NjhfNC0xLTEtMS0xMDc3MA_313c0dd8-3844-4f21-9873-57ca6f4a9874">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f2791f2f77d4b30b30f4f41b86a32be_D20210701-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOjg2NDJlYjFjODMwNDRmZGI4NTFkZDUwNjJiYmY4NzY4L3RhYmxlcmFuZ2U6ODY0MmViMWM4MzA0NGZkYjg1MWRkNTA2MmJiZjg3NjhfNC0zLTEtMS0xMDc3MA_c77b1ce0-e5b9-43c6-9124-e9225113a149">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d6328bac8bb4c5c9bc2c8b9292f8422_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOjg2NDJlYjFjODMwNDRmZGI4NTFkZDUwNjJiYmY4NzY4L3RhYmxlcmFuZ2U6ODY0MmViMWM4MzA0NGZkYjg1MWRkNTA2MmJiZjg3NjhfNC01LTEtMS0xMDc3MA_f23ca4d8-60fd-4c37-b031-ed34d20c9abd">58,802</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica26aea190054f37883620f719402399_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOjg2NDJlYjFjODMwNDRmZGI4NTFkZDUwNjJiYmY4NzY4L3RhYmxlcmFuZ2U6ODY0MmViMWM4MzA0NGZkYjg1MWRkNTA2MmJiZjg3NjhfNC03LTEtMS0xMDc3MA_ff7e47aa-872c-4d24-a237-7df858d7d36a">58,802</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SaaS-based technologies</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebe807a1030c4daab052b4d1c1386537_D20210701-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOjg2NDJlYjFjODMwNDRmZGI4NTFkZDUwNjJiYmY4NzY4L3RhYmxlcmFuZ2U6ODY0MmViMWM4MzA0NGZkYjg1MWRkNTA2MmJiZjg3NjhfNS0xLTEtMS0xMDc3MA_5dcd7bb7-5774-4c55-8ed1-645b0b4493ae">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d75e1df27914f09a7b8252950f87b6b_D20210701-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOjg2NDJlYjFjODMwNDRmZGI4NTFkZDUwNjJiYmY4NzY4L3RhYmxlcmFuZ2U6ODY0MmViMWM4MzA0NGZkYjg1MWRkNTA2MmJiZjg3NjhfNS0zLTEtMS0xMDc3MA_39780147-4281-48fc-b151-8a9ec2393728">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71d6cb2f38004881a4b6bd6017255a7a_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOjg2NDJlYjFjODMwNDRmZGI4NTFkZDUwNjJiYmY4NzY4L3RhYmxlcmFuZ2U6ODY0MmViMWM4MzA0NGZkYjg1MWRkNTA2MmJiZjg3NjhfNS01LTEtMS0xMDc3MA_b8ba1e37-6dc5-4a9e-b4b5-05959f20d809">41,286</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc6ef11462fa4624a5db4ae2d23f8e83_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOjg2NDJlYjFjODMwNDRmZGI4NTFkZDUwNjJiYmY4NzY4L3RhYmxlcmFuZ2U6ODY0MmViMWM4MzA0NGZkYjg1MWRkNTA2MmJiZjg3NjhfNS03LTEtMS0xMDc3MA_057fd6dd-989d-4ea4-a84a-daee0f691c94">41,286</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01269464f14e481692beaf81a76fb87d_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOjg2NDJlYjFjODMwNDRmZGI4NTFkZDUwNjJiYmY4NzY4L3RhYmxlcmFuZ2U6ODY0MmViMWM4MzA0NGZkYjg1MWRkNTA2MmJiZjg3NjhfNi0xLTEtMS0xMDc3MA_e015b155-1fa5-44fd-b0cb-cb8d2094b61a">627,049</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc871800a2a54344bc972988728aa887_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOjg2NDJlYjFjODMwNDRmZGI4NTFkZDUwNjJiYmY4NzY4L3RhYmxlcmFuZ2U6ODY0MmViMWM4MzA0NGZkYjg1MWRkNTA2MmJiZjg3NjhfNi0zLTEtMS0xMDc3MA_1750a340-6530-4c1e-b7b9-10c092503cbf">150,663</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0250f51d2d145cfa3b9c421cb969cfb_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOjg2NDJlYjFjODMwNDRmZGI4NTFkZDUwNjJiYmY4NzY4L3RhYmxlcmFuZ2U6ODY0MmViMWM4MzA0NGZkYjg1MWRkNTA2MmJiZjg3NjhfNi01LTEtMS0xMDc3MA_8fd72fa3-ac78-4833-97b5-f4b4bb31ac5c">100,088</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i150492f298fa47a78ef2c10a285a64f8_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOjg2NDJlYjFjODMwNDRmZGI4NTFkZDUwNjJiYmY4NzY4L3RhYmxlcmFuZ2U6ODY0MmViMWM4MzA0NGZkYjg1MWRkNTA2MmJiZjg3NjhfNi03LTEtMS0xMDc3MA_1a3a33c4-7ba9-4d2b-a162-be34e7509bc8">877,800</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i0fc77fc021f54df3a36a428ffbb9e2f5"><ix:continuation id="i416bc5da278441e08dd181bfbef1dade"><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:37.350%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.524%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nurse&#160;and&#160;Allied Solutions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Physician and Leadership Solutions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Technology and Workforce Solutions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Temporary staffing</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia6d8015a18974a7b896656aecc3ec4b4_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmJkMGZhZjI0NzhlNzQ0Mzk4YTUyZDU4NmY0OWRmOTY4L3RhYmxlcmFuZ2U6YmQwZmFmMjQ3OGU3NDQzOThhNTJkNTg2ZjQ5ZGY5NjhfMi0xLTEtMS0xMDc3MA_1f6e00cd-881c-4feb-b97f-f65309d17f63">382,699</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc8564de3068430abe113d5c5abeabe1_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmJkMGZhZjI0NzhlNzQ0Mzk4YTUyZDU4NmY0OWRmOTY4L3RhYmxlcmFuZ2U6YmQwZmFmMjQ3OGU3NDQzOThhNTJkNTg2ZjQ5ZGY5NjhfMi0zLTEtMS0xMDc3MA_24966a28-8837-4fef-b95d-3e2626bafe43">95,648</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i386e01817e9d4c42b6cd2228fb3796c2_D20200701-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmJkMGZhZjI0NzhlNzQ0Mzk4YTUyZDU4NmY0OWRmOTY4L3RhYmxlcmFuZ2U6YmQwZmFmMjQ3OGU3NDQzOThhNTJkNTg2ZjQ5ZGY5NjhfMi01LTEtMS0xMDc3MA_42f5aea1-eebf-4d4f-b133-5415c4cb61db">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d235eb71df14e8b9908f2e396c873cb_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmJkMGZhZjI0NzhlNzQ0Mzk4YTUyZDU4NmY0OWRmOTY4L3RhYmxlcmFuZ2U6YmQwZmFmMjQ3OGU3NDQzOThhNTJkNTg2ZjQ5ZGY5NjhfMi03LTEtMS0xMDc3MA_9da1da44-ccc7-4d71-a343-f5eb63907978">478,347</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Permanent placement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44c7ce7db7f54f14969af01502dd38a0_D20200701-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmJkMGZhZjI0NzhlNzQ0Mzk4YTUyZDU4NmY0OWRmOTY4L3RhYmxlcmFuZ2U6YmQwZmFmMjQ3OGU3NDQzOThhNTJkNTg2ZjQ5ZGY5NjhfMy0xLTEtMS0xMDc3MA_da44ce74-c896-4ff6-860b-41166ffa7a94">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie04ed0997a484867b8fe5f9956a3292d_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmJkMGZhZjI0NzhlNzQ0Mzk4YTUyZDU4NmY0OWRmOTY4L3RhYmxlcmFuZ2U6YmQwZmFmMjQ3OGU3NDQzOThhNTJkNTg2ZjQ5ZGY5NjhfMy0zLTEtMS0xMDc3MA_1353a456-8baf-4bd4-85d2-c86c21bf53ba">13,468</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if26529ce715f495dafc6d4b52493ea02_D20200701-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmJkMGZhZjI0NzhlNzQ0Mzk4YTUyZDU4NmY0OWRmOTY4L3RhYmxlcmFuZ2U6YmQwZmFmMjQ3OGU3NDQzOThhNTJkNTg2ZjQ5ZGY5NjhfMy01LTEtMS0xMDc3MA_2a212d5e-6fe3-4445-af18-9ba62ede99fd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if818b67b623c45a8aff218e40a7005c3_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmJkMGZhZjI0NzhlNzQ0Mzk4YTUyZDU4NmY0OWRmOTY4L3RhYmxlcmFuZ2U6YmQwZmFmMjQ3OGU3NDQzOThhNTJkNTg2ZjQ5ZGY5NjhfMy03LTEtMS0xMDc3MA_6e307f4c-9e4d-47d6-9c18-97bbbe25ad49">13,468</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outsourced workforce</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9aba0cbe92634056880604c35ba04d52_D20200701-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmJkMGZhZjI0NzhlNzQ0Mzk4YTUyZDU4NmY0OWRmOTY4L3RhYmxlcmFuZ2U6YmQwZmFmMjQ3OGU3NDQzOThhNTJkNTg2ZjQ5ZGY5NjhfNC0xLTEtMS0xMDc3MA_bfcdb727-bfbf-4572-a87b-edc3b2160fc6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieee345988a9b4cc4937342242689e98e_D20200701-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmJkMGZhZjI0NzhlNzQ0Mzk4YTUyZDU4NmY0OWRmOTY4L3RhYmxlcmFuZ2U6YmQwZmFmMjQ3OGU3NDQzOThhNTJkNTg2ZjQ5ZGY5NjhfNC0zLTEtMS0xMDc3MA_e1983fec-f43b-499b-8417-a210264023d2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76440e2d28744cc98ead1974809c865f_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmJkMGZhZjI0NzhlNzQ0Mzk4YTUyZDU4NmY0OWRmOTY4L3RhYmxlcmFuZ2U6YmQwZmFmMjQ3OGU3NDQzOThhNTJkNTg2ZjQ5ZGY5NjhfNC01LTEtMS0xMDc3MA_c437531d-c339-452f-beac-ae0a0f7363d1">38,159</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d7b5abbd0ee4fca9a5b3efb81d07d5d_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmJkMGZhZjI0NzhlNzQ0Mzk4YTUyZDU4NmY0OWRmOTY4L3RhYmxlcmFuZ2U6YmQwZmFmMjQ3OGU3NDQzOThhNTJkNTg2ZjQ5ZGY5NjhfNC03LTEtMS0xMDc3MA_1e1cdaca-fa4f-47e9-8c6a-3f3c2f73bb12">38,159</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SaaS-based technologies</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5893522597a942f38cbfe46a853546eb_D20200701-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmJkMGZhZjI0NzhlNzQ0Mzk4YTUyZDU4NmY0OWRmOTY4L3RhYmxlcmFuZ2U6YmQwZmFmMjQ3OGU3NDQzOThhNTJkNTg2ZjQ5ZGY5NjhfNS0xLTEtMS0xMDc3MA_763abe8e-54ec-445a-a124-fdc487056376">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id296025a7e114f8b9f9b44d6b14233f1_D20200701-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmJkMGZhZjI0NzhlNzQ0Mzk4YTUyZDU4NmY0OWRmOTY4L3RhYmxlcmFuZ2U6YmQwZmFmMjQ3OGU3NDQzOThhNTJkNTg2ZjQ5ZGY5NjhfNS0zLTEtMS0xMDc3MA_a570bcf6-b1b2-4f9e-b114-9f1f6b0e79ce">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9568bc87c368403cbb9e4180b3a0d538_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmJkMGZhZjI0NzhlNzQ0Mzk4YTUyZDU4NmY0OWRmOTY4L3RhYmxlcmFuZ2U6YmQwZmFmMjQ3OGU3NDQzOThhNTJkNTg2ZjQ5ZGY5NjhfNS01LTEtMS0xMDc3MA_b80db23c-5974-4392-b57b-a5ec4680dbea">21,657</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e447016b010458c883c1ef90a609651_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmJkMGZhZjI0NzhlNzQ0Mzk4YTUyZDU4NmY0OWRmOTY4L3RhYmxlcmFuZ2U6YmQwZmFmMjQ3OGU3NDQzOThhNTJkNTg2ZjQ5ZGY5NjhfNS03LTEtMS0xMDc3MA_fa5e8e35-4f81-486a-930d-c4520be0806f">21,657</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8d64c3d8e5a47489226ba7a492dae32_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmJkMGZhZjI0NzhlNzQ0Mzk4YTUyZDU4NmY0OWRmOTY4L3RhYmxlcmFuZ2U6YmQwZmFmMjQ3OGU3NDQzOThhNTJkNTg2ZjQ5ZGY5NjhfNi0xLTEtMS0xMDc3MA_019b4d2a-4a64-41e7-89d0-8503e7cd8062">382,699</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44b9c9fa813d4c3688eab2f7ea808291_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmJkMGZhZjI0NzhlNzQ0Mzk4YTUyZDU4NmY0OWRmOTY4L3RhYmxlcmFuZ2U6YmQwZmFmMjQ3OGU3NDQzOThhNTJkNTg2ZjQ5ZGY5NjhfNi0zLTEtMS0xMDc3MA_b5d74d8b-27f3-4f84-b34a-fb8ad80dbd0b">109,116</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6460c9bf442443d3abf247bad9d30336_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmJkMGZhZjI0NzhlNzQ0Mzk4YTUyZDU4NmY0OWRmOTY4L3RhYmxlcmFuZ2U6YmQwZmFmMjQ3OGU3NDQzOThhNTJkNTg2ZjQ5ZGY5NjhfNi01LTEtMS0xMDc3MA_a934a262-e4df-414c-ba61-aa1dfb344e58">59,816</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6cb0c51ba8fa45fda70ec7e5df8b4ef1_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmJkMGZhZjI0NzhlNzQ0Mzk4YTUyZDU4NmY0OWRmOTY4L3RhYmxlcmFuZ2U6YmQwZmFmMjQ3OGU3NDQzOThhNTJkNTg2ZjQ5ZGY5NjhfNi03LTEtMS0xMDc3MA_793b5e9d-d9e2-414e-99ea-18e0f40b5691">551,631</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:37.350%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.524%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nurse&#160;and&#160;Allied Solutions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Physician and Leadership Solutions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Technology and Workforce Solutions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Temporary staffing</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida0f30c7727943e798527294cdf4394a_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmIyMWFkZjZkMmZlMDQzZmVhMTc5MTJhYmFhMTk1NGFjL3RhYmxlcmFuZ2U6YjIxYWRmNmQyZmUwNDNmZWExNzkxMmFiYWExOTU0YWNfMi0xLTEtMS0xMDc3MA_9475f4e5-4f92-401a-b9b8-4f671794c367">1,908,195</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idcab03e09bc1437399cc7a03d8fc8b57_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmIyMWFkZjZkMmZlMDQzZmVhMTc5MTJhYmFhMTk1NGFjL3RhYmxlcmFuZ2U6YjIxYWRmNmQyZmUwNDNmZWExNzkxMmFiYWExOTU0YWNfMi0zLTEtMS0xMDc3MA_ddc4b124-a8b7-4247-86f8-23c23e35c32e">379,814</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89958f0ec7cf446b98d11c657f7ee603_D20210101-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmIyMWFkZjZkMmZlMDQzZmVhMTc5MTJhYmFhMTk1NGFjL3RhYmxlcmFuZ2U6YjIxYWRmNmQyZmUwNDNmZWExNzkxMmFiYWExOTU0YWNfMi01LTEtMS0xMDc3MA_071453f7-c909-456f-9d99-239aeced9b1e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90eb3e7675a044e992b317175d9afcd9_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmIyMWFkZjZkMmZlMDQzZmVhMTc5MTJhYmFhMTk1NGFjL3RhYmxlcmFuZ2U6YjIxYWRmNmQyZmUwNDNmZWExNzkxMmFiYWExOTU0YWNfMi03LTEtMS0xMDc3MA_87f721fe-324f-4a12-b8c1-78f09c7a855b">2,288,009</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Permanent placement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8750be21113a4757ac053b8f62cd2ad2_D20210101-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmIyMWFkZjZkMmZlMDQzZmVhMTc5MTJhYmFhMTk1NGFjL3RhYmxlcmFuZ2U6YjIxYWRmNmQyZmUwNDNmZWExNzkxMmFiYWExOTU0YWNfMy0xLTEtMS0xMDc3MA_0233b2f8-6620-4e1b-af02-68526427e761">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30aa16b5b25048ca8dfeff42d533a177_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmIyMWFkZjZkMmZlMDQzZmVhMTc5MTJhYmFhMTk1NGFjL3RhYmxlcmFuZ2U6YjIxYWRmNmQyZmUwNDNmZWExNzkxMmFiYWExOTU0YWNfMy0zLTEtMS0xMDc3MA_dd302890-b05c-45cf-9bc4-5d21b7354b62">50,709</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3cfc2a42fe0e4807b29bf91ce0a45f43_D20210101-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmIyMWFkZjZkMmZlMDQzZmVhMTc5MTJhYmFhMTk1NGFjL3RhYmxlcmFuZ2U6YjIxYWRmNmQyZmUwNDNmZWExNzkxMmFiYWExOTU0YWNfMy01LTEtMS0xMDc3MA_bf992596-6f3e-45a1-a511-b97bab9147ce">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbdabae4c4224976a6088e48ddb040ba_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmIyMWFkZjZkMmZlMDQzZmVhMTc5MTJhYmFhMTk1NGFjL3RhYmxlcmFuZ2U6YjIxYWRmNmQyZmUwNDNmZWExNzkxMmFiYWExOTU0YWNfMy03LTEtMS0xMDc3MA_f2f12093-3c6c-448a-97a1-be48ace82e85">50,709</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outsourced workforce</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i536910b4999c4e32a95c6a8ac9c30f1d_D20210101-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmIyMWFkZjZkMmZlMDQzZmVhMTc5MTJhYmFhMTk1NGFjL3RhYmxlcmFuZ2U6YjIxYWRmNmQyZmUwNDNmZWExNzkxMmFiYWExOTU0YWNfNC0xLTEtMS0xMDc3MA_0a576fba-8137-4758-93a5-1931b622cfdc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c17ffb386c649368efa203669f28351_D20210101-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmIyMWFkZjZkMmZlMDQzZmVhMTc5MTJhYmFhMTk1NGFjL3RhYmxlcmFuZ2U6YjIxYWRmNmQyZmUwNDNmZWExNzkxMmFiYWExOTU0YWNfNC0zLTEtMS0xMDc3MA_a22cd30a-8917-41a5-8c8a-ebd5a4e681e4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf8b667f2cd34632a587e2d17a82e3fd_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmIyMWFkZjZkMmZlMDQzZmVhMTc5MTJhYmFhMTk1NGFjL3RhYmxlcmFuZ2U6YjIxYWRmNmQyZmUwNDNmZWExNzkxMmFiYWExOTU0YWNfNC01LTEtMS0xMDc3MA_a1d9323a-95fa-45e5-8944-cd6f10d7f5fd">164,595</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iedbce8552e1b455082a65e938d6dec5b_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmIyMWFkZjZkMmZlMDQzZmVhMTc5MTJhYmFhMTk1NGFjL3RhYmxlcmFuZ2U6YjIxYWRmNmQyZmUwNDNmZWExNzkxMmFiYWExOTU0YWNfNC03LTEtMS0xMDc3MA_182a64b2-7332-4d17-9d1d-91d69d5ef4f4">164,595</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SaaS-based technologies</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bb701054c8d4b2ca7bb36f5445e6a6a_D20210101-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmIyMWFkZjZkMmZlMDQzZmVhMTc5MTJhYmFhMTk1NGFjL3RhYmxlcmFuZ2U6YjIxYWRmNmQyZmUwNDNmZWExNzkxMmFiYWExOTU0YWNfNS0xLTEtMS0xMDc3MA_7c157b85-86b4-4da4-987e-1b322454e18e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80d03ebd1c054ee9977c5f826afd98f7_D20210101-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmIyMWFkZjZkMmZlMDQzZmVhMTc5MTJhYmFhMTk1NGFjL3RhYmxlcmFuZ2U6YjIxYWRmNmQyZmUwNDNmZWExNzkxMmFiYWExOTU0YWNfNS0zLTEtMS0xMDc3MA_e80634fd-e1de-4422-8684-4c04dbbebe73">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85f859e6dc0a4f40aef7f8f521affd1c_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmIyMWFkZjZkMmZlMDQzZmVhMTc5MTJhYmFhMTk1NGFjL3RhYmxlcmFuZ2U6YjIxYWRmNmQyZmUwNDNmZWExNzkxMmFiYWExOTU0YWNfNS01LTEtMS0xMDc3MA_dffa2964-2394-4146-851d-ba91a3335546">117,877</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf4e0ac3bff74d3c81967d52a934245e_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmIyMWFkZjZkMmZlMDQzZmVhMTc5MTJhYmFhMTk1NGFjL3RhYmxlcmFuZ2U6YjIxYWRmNmQyZmUwNDNmZWExNzkxMmFiYWExOTU0YWNfNS03LTEtMS0xMDc3MA_8ca8889e-1652-4848-b39d-e7aa01859ab2">117,877</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70417b2a548f4dc8aa5f1b5e01ea94f6_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmIyMWFkZjZkMmZlMDQzZmVhMTc5MTJhYmFhMTk1NGFjL3RhYmxlcmFuZ2U6YjIxYWRmNmQyZmUwNDNmZWExNzkxMmFiYWExOTU0YWNfNi0xLTEtMS0xMDc3MA_0e128e78-9d71-4ee9-be8d-aa818ba6eea5">1,908,195</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7cb32a8e20f4e59b29cb208784742f9_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmIyMWFkZjZkMmZlMDQzZmVhMTc5MTJhYmFhMTk1NGFjL3RhYmxlcmFuZ2U6YjIxYWRmNmQyZmUwNDNmZWExNzkxMmFiYWExOTU0YWNfNi0zLTEtMS0xMDc3MA_c23046d7-38ae-478e-acd6-0fe86ab0e0b1">430,523</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19bf0b91fc2e4d4088d260a4a7291a68_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmIyMWFkZjZkMmZlMDQzZmVhMTc5MTJhYmFhMTk1NGFjL3RhYmxlcmFuZ2U6YjIxYWRmNmQyZmUwNDNmZWExNzkxMmFiYWExOTU0YWNfNi01LTEtMS0xMDc3MA_0775fff7-fd21-4bd2-b039-d7bcaa79964c">282,472</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmIyMWFkZjZkMmZlMDQzZmVhMTc5MTJhYmFhMTk1NGFjL3RhYmxlcmFuZ2U6YjIxYWRmNmQyZmUwNDNmZWExNzkxMmFiYWExOTU0YWNfNi03LTEtMS0xMDc3MA_0108ca54-6df9-4cec-afc7-c05ecb91f790">2,621,190</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:37.350%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.524%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nurse&#160;and&#160;Allied Solutions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Physician and Leadership Solutions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Technology and Workforce Solutions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Temporary staffing</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if95e75fc39f542e0937abe52bd16b043_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOjY5ZWZjNzMyNmYwMDQ4MTFiY2FmMTAyOGU1ZTczN2RmL3RhYmxlcmFuZ2U6NjllZmM3MzI2ZjAwNDgxMWJjYWYxMDI4ZTVlNzM3ZGZfMi0xLTEtMS0xMDc3MA_45835ab5-5c1d-4151-9b44-c10690910190">1,251,509</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41fa2315f758457689e492a76a31c2bc_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOjY5ZWZjNzMyNmYwMDQ4MTFiY2FmMTAyOGU1ZTczN2RmL3RhYmxlcmFuZ2U6NjllZmM3MzI2ZjAwNDgxMWJjYWYxMDI4ZTVlNzM3ZGZfMi0zLTEtMS0xMDc3MA_bca5fc00-a55f-4142-8d68-e554e3d264d9">310,945</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id149b105ef884b0d9c47f05bec237702_D20200101-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOjY5ZWZjNzMyNmYwMDQ4MTFiY2FmMTAyOGU1ZTczN2RmL3RhYmxlcmFuZ2U6NjllZmM3MzI2ZjAwNDgxMWJjYWYxMDI4ZTVlNzM3ZGZfMi01LTEtMS0xMDc3MA_d7b732ca-08e0-411e-990d-e7df583110da">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ee31b74c9154f7b815c08300a1950e0_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOjY5ZWZjNzMyNmYwMDQ4MTFiY2FmMTAyOGU1ZTczN2RmL3RhYmxlcmFuZ2U6NjllZmM3MzI2ZjAwNDgxMWJjYWYxMDI4ZTVlNzM3ZGZfMi03LTEtMS0xMDc3MA_77b471f2-a3ae-48da-bfb6-7e6e378b0a01">1,562,454</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Permanent placement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i38ab08218c234821bc589e3cc2c80f3c_D20200101-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOjY5ZWZjNzMyNmYwMDQ4MTFiY2FmMTAyOGU1ZTczN2RmL3RhYmxlcmFuZ2U6NjllZmM3MzI2ZjAwNDgxMWJjYWYxMDI4ZTVlNzM3ZGZfMy0xLTEtMS0xMDc3MA_66896f3b-2028-4862-99fb-5a0e36a7718b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c3268cc1706415686fd7683f6ed1d51_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOjY5ZWZjNzMyNmYwMDQ4MTFiY2FmMTAyOGU1ZTczN2RmL3RhYmxlcmFuZ2U6NjllZmM3MzI2ZjAwNDgxMWJjYWYxMDI4ZTVlNzM3ZGZfMy0zLTEtMS0xMDc3MA_f0fdf079-7847-419e-a55d-1c787173015d">44,635</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4167819349934cd59d501e7c4c7ddcfc_D20200101-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOjY5ZWZjNzMyNmYwMDQ4MTFiY2FmMTAyOGU1ZTczN2RmL3RhYmxlcmFuZ2U6NjllZmM3MzI2ZjAwNDgxMWJjYWYxMDI4ZTVlNzM3ZGZfMy01LTEtMS0xMDc3MA_0b9231ee-d6ab-4cc6-b2ed-496c8c3480af">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43362dd8fe0949449a39af825a732e7a_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOjY5ZWZjNzMyNmYwMDQ4MTFiY2FmMTAyOGU1ZTczN2RmL3RhYmxlcmFuZ2U6NjllZmM3MzI2ZjAwNDgxMWJjYWYxMDI4ZTVlNzM3ZGZfMy03LTEtMS0xMDc3MA_2b81445f-3652-474c-9be0-7746f545870e">44,635</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outsourced workforce</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88f59cdb95f040e2b571b678226a7fec_D20200101-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOjY5ZWZjNzMyNmYwMDQ4MTFiY2FmMTAyOGU1ZTczN2RmL3RhYmxlcmFuZ2U6NjllZmM3MzI2ZjAwNDgxMWJjYWYxMDI4ZTVlNzM3ZGZfNC0xLTEtMS0xMDc3MA_0b28988e-afbb-42e5-891d-64d52dcb45ba">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee45b2697e73423393102240edfca12a_D20200101-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOjY5ZWZjNzMyNmYwMDQ4MTFiY2FmMTAyOGU1ZTczN2RmL3RhYmxlcmFuZ2U6NjllZmM3MzI2ZjAwNDgxMWJjYWYxMDI4ZTVlNzM3ZGZfNC0zLTEtMS0xMDc3MA_9f7d4bba-35b9-4edd-9e79-55311fd30703">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3d5b12a279d423b9852c9ec50634277_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOjY5ZWZjNzMyNmYwMDQ4MTFiY2FmMTAyOGU1ZTczN2RmL3RhYmxlcmFuZ2U6NjllZmM3MzI2ZjAwNDgxMWJjYWYxMDI4ZTVlNzM3ZGZfNC01LTEtMS0xMDc3MA_16a972bd-55f4-4e8c-8cc4-02f11775c576">87,705</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93145b50299a45b0b7e234415765c760_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOjY5ZWZjNzMyNmYwMDQ4MTFiY2FmMTAyOGU1ZTczN2RmL3RhYmxlcmFuZ2U6NjllZmM3MzI2ZjAwNDgxMWJjYWYxMDI4ZTVlNzM3ZGZfNC03LTEtMS0xMDc3MA_2d59c568-b4dd-4899-ab02-cab9498dafea">87,705</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SaaS-based technologies</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3589685d5bf494da6ce3464e2194081_D20200101-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOjY5ZWZjNzMyNmYwMDQ4MTFiY2FmMTAyOGU1ZTczN2RmL3RhYmxlcmFuZ2U6NjllZmM3MzI2ZjAwNDgxMWJjYWYxMDI4ZTVlNzM3ZGZfNS0xLTEtMS0xMDc3MA_d8724b17-6d96-46da-a78f-065cfdb198d9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i683c901af8234ee8b34a8de537a4faed_D20200101-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOjY5ZWZjNzMyNmYwMDQ4MTFiY2FmMTAyOGU1ZTczN2RmL3RhYmxlcmFuZ2U6NjllZmM3MzI2ZjAwNDgxMWJjYWYxMDI4ZTVlNzM3ZGZfNS0zLTEtMS0xMDc3MA_8213ce08-664b-4a28-a33f-edb06702e3b7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c392d9ab824476a96a3f41148cbe7fe_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOjY5ZWZjNzMyNmYwMDQ4MTFiY2FmMTAyOGU1ZTczN2RmL3RhYmxlcmFuZ2U6NjllZmM3MzI2ZjAwNDgxMWJjYWYxMDI4ZTVlNzM3ZGZfNS01LTEtMS0xMDc3MA_dd5a2092-dc17-4985-9966-94378bd98c0d">67,649</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i598b74681e034171b491236964be10f1_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOjY5ZWZjNzMyNmYwMDQ4MTFiY2FmMTAyOGU1ZTczN2RmL3RhYmxlcmFuZ2U6NjllZmM3MzI2ZjAwNDgxMWJjYWYxMDI4ZTVlNzM3ZGZfNS03LTEtMS0xMDc3MA_13b90327-50f6-4d6f-9547-cd0e4f71f917">67,649</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a46e165877d46f7b437d72073d883c6_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOjY5ZWZjNzMyNmYwMDQ4MTFiY2FmMTAyOGU1ZTczN2RmL3RhYmxlcmFuZ2U6NjllZmM3MzI2ZjAwNDgxMWJjYWYxMDI4ZTVlNzM3ZGZfNi0xLTEtMS0xMDc3MA_9658fd4c-ed30-4db8-8dfe-ee73ce285cdc">1,251,509</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3be0a64ed0349d3ae2297e6a8a914d7_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOjY5ZWZjNzMyNmYwMDQ4MTFiY2FmMTAyOGU1ZTczN2RmL3RhYmxlcmFuZ2U6NjllZmM3MzI2ZjAwNDgxMWJjYWYxMDI4ZTVlNzM3ZGZfNi0zLTEtMS0xMDc3MA_fd85d91b-4fd7-4a8e-b86c-cdbc65d81aad">355,580</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11efb6327d494ef79b4c1a4e768e70bf_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOjY5ZWZjNzMyNmYwMDQ4MTFiY2FmMTAyOGU1ZTczN2RmL3RhYmxlcmFuZ2U6NjllZmM3MzI2ZjAwNDgxMWJjYWYxMDI4ZTVlNzM3ZGZfNi01LTEtMS0xMDc3MA_f9e1bc91-6e7b-4326-b6a3-fbb455648ddb">155,354</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOjY5ZWZjNzMyNmYwMDQ4MTFiY2FmMTAyOGU1ZTczN2RmL3RhYmxlcmFuZ2U6NjllZmM3MzI2ZjAwNDgxMWJjYWYxMDI4ZTVlNzM3ZGZfNi03LTEtMS0xMDc3MA_c898766d-7522-41da-8a27-7ff1c6632514">1,762,443</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><ix:nonNumeric contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" name="us-gaap:ScheduleOfGoodwillTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RleHRyZWdpb246YWI0MTJlMTlmYzY0NDFmMGFiZGVhYTE2ODgxYmJmYjRfMjMzMw_018bc651-58b0-469e-814a-ca32cc301dd5" escape="true"><div style="margin-top:9pt;padding-left:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the activity related to the carrying value of goodwill by reportable segment:</span></div><div style="margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:37.788%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.111%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nurse&#160;and&#160;Allied Solutions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Physician and Leadership Solutions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Technology and Workforce Solutions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, January 1, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia707a5ecf30d4576a74a17b34e193c15_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOjMzODhiZTY0MWM3NjRjNjdiMTFiMzljODZmNTRmNWQ0L3RhYmxlcmFuZ2U6MzM4OGJlNjQxYzc2NGM2N2IxMWIzOWM4NmY1NGY1ZDRfMS0xLTEtMS0xMDc3MA_07820268-81da-4ede-8cc0-236105913cf5">339,015</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb5e6237d7d54806a979a6a53e302a7a_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOjMzODhiZTY0MWM3NjRjNjdiMTFiMzljODZmNTRmNWQ0L3RhYmxlcmFuZ2U6MzM4OGJlNjQxYzc2NGM2N2IxMWIzOWM4NmY1NGY1ZDRfMS0zLTEtMS0xMDc3MA_719e35be-9df8-461b-a9a9-64bad2022234">152,800</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd0be51207114cd1b17f02ebecffc197_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOjMzODhiZTY0MWM3NjRjNjdiMTFiMzljODZmNTRmNWQ0L3RhYmxlcmFuZ2U6MzM4OGJlNjQxYzc2NGM2N2IxMWIzOWM4NmY1NGY1ZDRfMS01LTEtMS0xMDc3MA_ae7d6f84-c2d1-4e31-95d7-2228944134ad">372,670</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOjMzODhiZTY0MWM3NjRjNjdiMTFiMzljODZmNTRmNWQ0L3RhYmxlcmFuZ2U6MzM4OGJlNjQxYzc2NGM2N2IxMWIzOWM4NmY1NGY1ZDRfMS03LTEtMS0xMDc3MA_86f3101e-dcc9-4762-abd8-e4e8637e3bcf">864,485</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill adjustment for Stratus Video acquisition</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70417b2a548f4dc8aa5f1b5e01ea94f6_D20210101-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:GoodwillPurchaseAccountingAdjustments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOjMzODhiZTY0MWM3NjRjNjdiMTFiMzljODZmNTRmNWQ0L3RhYmxlcmFuZ2U6MzM4OGJlNjQxYzc2NGM2N2IxMWIzOWM4NmY1NGY1ZDRfMi0xLTEtMS0xMDc3MA_e1bddae2-664a-4c64-9736-a6eac45fc95a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7cb32a8e20f4e59b29cb208784742f9_D20210101-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:GoodwillPurchaseAccountingAdjustments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOjMzODhiZTY0MWM3NjRjNjdiMTFiMzljODZmNTRmNWQ0L3RhYmxlcmFuZ2U6MzM4OGJlNjQxYzc2NGM2N2IxMWIzOWM4NmY1NGY1ZDRfMi0zLTEtMS0xMDc3MA_9eefd3aa-559f-4a01-bb87-f7d2d1c5c9cf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19bf0b91fc2e4d4088d260a4a7291a68_D20210101-20210930" decimals="-3" name="us-gaap:GoodwillPurchaseAccountingAdjustments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOjMzODhiZTY0MWM3NjRjNjdiMTFiMzljODZmNTRmNWQ0L3RhYmxlcmFuZ2U6MzM4OGJlNjQxYzc2NGM2N2IxMWIzOWM4NmY1NGY1ZDRfMi01LTEtMS0xMDc3MA_5dee2990-fe02-41b8-90c1-95f691d0e069">663</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" decimals="-3" name="us-gaap:GoodwillPurchaseAccountingAdjustments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOjMzODhiZTY0MWM3NjRjNjdiMTFiMzljODZmNTRmNWQ0L3RhYmxlcmFuZ2U6MzM4OGJlNjQxYzc2NGM2N2IxMWIzOWM4NmY1NGY1ZDRfMi03LTEtMS0xMDc3MA_471b3157-1c11-4be1-b7e7-86f7f7187a39">663</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill from Synzi and SnapMD acquisition</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70417b2a548f4dc8aa5f1b5e01ea94f6_D20210101-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOjMzODhiZTY0MWM3NjRjNjdiMTFiMzljODZmNTRmNWQ0L3RhYmxlcmFuZ2U6MzM4OGJlNjQxYzc2NGM2N2IxMWIzOWM4NmY1NGY1ZDRfNC0xLTEtMS0xMDc3MA_548aa83e-5fd4-4295-9cfe-5c4720801e63">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7cb32a8e20f4e59b29cb208784742f9_D20210101-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOjMzODhiZTY0MWM3NjRjNjdiMTFiMzljODZmNTRmNWQ0L3RhYmxlcmFuZ2U6MzM4OGJlNjQxYzc2NGM2N2IxMWIzOWM4NmY1NGY1ZDRfNC0zLTEtMS0xMDc3MA_b485feb2-a230-43e5-a19b-3713624a4f1d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19bf0b91fc2e4d4088d260a4a7291a68_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOjMzODhiZTY0MWM3NjRjNjdiMTFiMzljODZmNTRmNWQ0L3RhYmxlcmFuZ2U6MzM4OGJlNjQxYzc2NGM2N2IxMWIzOWM4NmY1NGY1ZDRfNC01LTEtMS0xMDc3MA_57a35d38-cfe9-4d78-9572-02ffe7f87666">28,135</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOjMzODhiZTY0MWM3NjRjNjdiMTFiMzljODZmNTRmNWQ0L3RhYmxlcmFuZ2U6MzM4OGJlNjQxYzc2NGM2N2IxMWIzOWM4NmY1NGY1ZDRfNC03LTEtMS0xMDc3MA_2c01624e-5b16-43bd-8f4b-8d6144cb91e8">28,135</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, September 30, 2021</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff2345b9439d4c93833b660edbe6ce7f_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOjMzODhiZTY0MWM3NjRjNjdiMTFiMzljODZmNTRmNWQ0L3RhYmxlcmFuZ2U6MzM4OGJlNjQxYzc2NGM2N2IxMWIzOWM4NmY1NGY1ZDRfNi0xLTEtMS0xMDc3MA_2906e5a7-ec9f-43ec-a146-856b698b34ec">339,015</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4161c5f102584f0fbecf9454461d6028_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOjMzODhiZTY0MWM3NjRjNjdiMTFiMzljODZmNTRmNWQ0L3RhYmxlcmFuZ2U6MzM4OGJlNjQxYzc2NGM2N2IxMWIzOWM4NmY1NGY1ZDRfNi0zLTEtMS0xMDc3MA_87759bcc-2fe5-4915-8990-dc89df22a8b1">152,800</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33f34f84f7e146998551e4e55f51111a_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOjMzODhiZTY0MWM3NjRjNjdiMTFiMzljODZmNTRmNWQ0L3RhYmxlcmFuZ2U6MzM4OGJlNjQxYzc2NGM2N2IxMWIzOWM4NmY1NGY1ZDRfNi01LTEtMS0xMDc3MA_ba3d6da6-73bc-4211-a490-c246bf5aa5fc">401,468</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68ecd84e8da440808154baac134e839e_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOjMzODhiZTY0MWM3NjRjNjdiMTFiMzljODZmNTRmNWQ0L3RhYmxlcmFuZ2U6MzM4OGJlNjQxYzc2NGM2N2IxMWIzOWM4NmY1NGY1ZDRfNi03LTEtMS0xMDc3MA_b9a2dc14-45cc-433d-bd0b-6a15151013c3">893,283</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated impairment loss as of December 31, 2020 and September 30, 2021</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff2345b9439d4c93833b660edbe6ce7f_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOjMzODhiZTY0MWM3NjRjNjdiMTFiMzljODZmNTRmNWQ0L3RhYmxlcmFuZ2U6MzM4OGJlNjQxYzc2NGM2N2IxMWIzOWM4NmY1NGY1ZDRfNy0xLTEtMS0xMDc3MA_17208002-cfa1-4c46-a731-efe9c869dc49"><ix:nonFraction unitRef="usd" contextRef="ia707a5ecf30d4576a74a17b34e193c15_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOjMzODhiZTY0MWM3NjRjNjdiMTFiMzljODZmNTRmNWQ0L3RhYmxlcmFuZ2U6MzM4OGJlNjQxYzc2NGM2N2IxMWIzOWM4NmY1NGY1ZDRfNy0xLTEtMS0xMDc3MA_f144216d-3322-4e6a-b1e4-674a3701cd78">154,444</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb5e6237d7d54806a979a6a53e302a7a_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOjMzODhiZTY0MWM3NjRjNjdiMTFiMzljODZmNTRmNWQ0L3RhYmxlcmFuZ2U6MzM4OGJlNjQxYzc2NGM2N2IxMWIzOWM4NmY1NGY1ZDRfNy0zLTEtMS0xMDc3MA_67f33fec-2dfa-4de3-b5d2-1eb0a2280ef1"><ix:nonFraction unitRef="usd" contextRef="i4161c5f102584f0fbecf9454461d6028_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOjMzODhiZTY0MWM3NjRjNjdiMTFiMzljODZmNTRmNWQ0L3RhYmxlcmFuZ2U6MzM4OGJlNjQxYzc2NGM2N2IxMWIzOWM4NmY1NGY1ZDRfNy0zLTEtMS0xMDc3MA_8bcb9fc1-edd6-497b-b0f7-647ecd8103b8">60,495</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33f34f84f7e146998551e4e55f51111a_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOjMzODhiZTY0MWM3NjRjNjdiMTFiMzljODZmNTRmNWQ0L3RhYmxlcmFuZ2U6MzM4OGJlNjQxYzc2NGM2N2IxMWIzOWM4NmY1NGY1ZDRfNy01LTEtMS0xMDc3MA_19fdcfb6-d1b9-4241-abe0-dca7540f9ffb"><ix:nonFraction unitRef="usd" contextRef="ibd0be51207114cd1b17f02ebecffc197_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOjMzODhiZTY0MWM3NjRjNjdiMTFiMzljODZmNTRmNWQ0L3RhYmxlcmFuZ2U6MzM4OGJlNjQxYzc2NGM2N2IxMWIzOWM4NmY1NGY1ZDRfNy01LTEtMS0xMDc3MA_1dbc6b33-9425-49c1-bea9-68abf81ca489">&#8212;</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOjMzODhiZTY0MWM3NjRjNjdiMTFiMzljODZmNTRmNWQ0L3RhYmxlcmFuZ2U6MzM4OGJlNjQxYzc2NGM2N2IxMWIzOWM4NmY1NGY1ZDRfNy03LTEtMS0xMDc3MA_2aa1ab44-3136-4c5d-8d92-24474997c8f8"><ix:nonFraction unitRef="usd" contextRef="i68ecd84e8da440808154baac134e839e_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOjMzODhiZTY0MWM3NjRjNjdiMTFiMzljODZmNTRmNWQ0L3RhYmxlcmFuZ2U6MzM4OGJlNjQxYzc2NGM2N2IxMWIzOWM4NmY1NGY1ZDRfNy03LTEtMS0xMDc3MA_c417c356-7248-4073-b4dc-e7d34dfa1162">214,939</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div id="ia383c8c7878a498d91f9e8901f0cfd9c_46"></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:46.491%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6. <ix:nonNumeric contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" name="us-gaap:DebtDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180Ni9mcmFnOjFjN2FiODMzZjc4NjQxMjFiYWYxYWM1ZmJiYzhjMTdhL3RleHRyZWdpb246MWM3YWI4MzNmNzg2NDEyMWJhZjFhYzVmYmJjOGMxN2FfMTM3Mw_598b3b3e-0ac9-492c-85b5-62371f9230cb" continuedAt="ie4abaf4a0042418c94537bbaca6af387" escape="true">NOTES PAYABLE AND CREDIT AGREEMENT</ix:nonNumeric></span></div></div><div style="display:inline-block;max-width:7.017%;min-width:6.017%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:46.492%"></div></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ie4abaf4a0042418c94537bbaca6af387" continuedAt="i0a836eecc660403584457dfc5983eac0">On February 9, 2018, the Company entered into the New Credit Agreement with several lenders to provide for the $<ix:nonFraction unitRef="usd" contextRef="i1809609cdf714d66916ae3141253f6cd_I20180209" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180Ni9mcmFnOjFjN2FiODMzZjc4NjQxMjFiYWYxYWM1ZmJiYzhjMTdhL3RleHRyZWdpb246MWM3YWI4MzNmNzg2NDEyMWJhZjFhYzVmYmJjOGMxN2FfMTU0_49c6bee4-b5cb-47e2-b2a9-ea00df86de98">400,000</ix:nonFraction> Senior Credit Facility to replace its then-existing credit facilities. On June 14, 2019, the Company entered into the first amendment to the New Credit Agreement (the &#8220;First Amendment&#8221;) to provide for, among other things, a $<ix:nonFraction unitRef="usd" contextRef="i8962b4b53b6140de975c8a15752edd5d_I20190614" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LongTermDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180Ni9mcmFnOjFjN2FiODMzZjc4NjQxMjFiYWYxYWM1ZmJiYzhjMTdhL3RleHRyZWdpb246MWM3YWI4MzNmNzg2NDEyMWJhZjFhYzVmYmJjOGMxN2FfMzgx_79a5099a-06aa-40b7-bdab-80fe408402ff">150,000</ix:nonFraction> secured term loan credit facility (the &#8220;Term Loan&#8221;). The Company fully repaid all amounts under the Term Loan in 2019. On February 14, 2020, the Company entered into the second amendment to the New Credit Agreement (the &#8220;Second Amendment&#8221;) to provide for, among other things, a $<ix:nonFraction unitRef="usd" contextRef="ie9d4571d2fdf44c6ba87db28c14cb175_I20200214" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LongTermDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180Ni9mcmFnOjFjN2FiODMzZjc4NjQxMjFiYWYxYWM1ZmJiYzhjMTdhL3RleHRyZWdpb246MWM3YWI4MzNmNzg2NDEyMWJhZjFhYzVmYmJjOGMxN2FfNjYy_3aeacd78-d4ed-47b5-8fc4-6c23c4691acc">250,000</ix:nonFraction> secured term loan credit facility (the &#8220;Additional Term Loan&#8221;). The Second Amendment (together with the New Credit Agreement and the First Amendment, collectively, the &#8220;Amended Credit Agreement&#8221;) extended the maturity date of the Senior Credit Facility to be coterminous with the Additional Term Loan. The Company used the proceeds from the Additional Term Loan, together with a drawdown of a portion of the Senior Credit Facility, to complete its acquisition of Stratus Video as more fully described in Note (2), &#8220;Acquisitions.&#8221; The Company repaid </ix:continuation></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i0a836eecc660403584457dfc5983eac0">its outstanding indebtedness under the Additional Term Loan in the first quarter of 2021. The maturity date of the Senior Credit Facility is February 14, 2025.</ix:continuation></span></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:46.491%"><div><span><br/></span></div><div id="ia383c8c7878a498d91f9e8901f0cfd9c_49"></div></div><div style="display:inline-block;max-width:7.017%;min-width:6.017%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:46.492%"></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7. <ix:nonNumeric contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" name="us-gaap:FairValueDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180OS9mcmFnOjlmMmE0ZDZjODMwODRlMDJiOTY5OWMxNjM4MWY4NzFlL3RleHRyZWdpb246OWYyYTRkNmM4MzA4NGUwMmI5Njk5YzE2MzgxZjg3MWVfNTU3Ng_5d72a708-1571-4868-8724-969619cfe201" continuedAt="i9ef0c984f4824d619023101e759ad603" escape="true">FAIR VALUE MEASUREMENT</ix:nonNumeric></span></div><ix:continuation id="i9ef0c984f4824d619023101e759ad603" continuedAt="i7e5be243232444e79342fc6ec9a223db"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s valuation techniques and inputs used to measure fair value and the definition of the three levels (Level 1, Level 2, and Level 3) of the fair value hierarchy are disclosed in Part II, Item 8, &#8220;Financial Statements and Supplementary Data&#8212;Notes to Consolidated Financial Statements&#8212;Note 3&#8212;Fair Value Measurement&#8221; of the 2020 Annual Report. The Company has not changed the valuation techniques or inputs it uses for its fair value measurement during the nine months ended September 30, 2021.</span></div><ix:nonNumeric contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" name="us-gaap:FairValueMeasurementPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180OS9mcmFnOjlmMmE0ZDZjODMwODRlMDJiOTY5OWMxNjM4MWY4NzFlL3RleHRyZWdpb246OWYyYTRkNmM4MzA4NGUwMmI5Njk5YzE2MzgxZjg3MWVfNTU3Mw_8319de36-75b9-46c9-a3d3-7f0b350dfa7c" continuedAt="i279055f38a664353a7127f5902fee3df" escape="true"><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Assets and Liabilities Measured on a Recurring Basis</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning in the third quarter of 2021, the Company invests a portion of its cash and cash equivalents in non-federally insured money market funds that are measured at fair value based on quoted prices, which are Level 1 inputs.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a deferred compensation plan for certain executives and employees, which is composed of deferred compensation and all related income and losses attributable thereto. The Company&#8217;s obligation under its deferred compensation plan is measured at fair value based on quoted market prices of the participants&#8217; elected investments, which are Level 1 inputs.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s restricted cash equivalents and investments that serve as collateral for the Company&#8217;s captive insurance company primarily consist of commercial paper that is measured at observable market prices for identical securities that are traded in less active markets, which are Level 2 inputs. The Company&#8217;s cash equivalents also include commercial paper classified as Level 2 in the fair value hierarchy. Of the $<ix:nonFraction unitRef="usd" contextRef="i75b241ded9e04282a87e07b5ca93bb10_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FairValueNetAssetLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180OS9mcmFnOjlmMmE0ZDZjODMwODRlMDJiOTY5OWMxNjM4MWY4NzFlL3RleHRyZWdpb246OWYyYTRkNmM4MzA4NGUwMmI5Njk5YzE2MzgxZjg3MWVfMTQ2Nw_c9fccd82-9872-4db5-818a-0ac32da069ba">126,584</ix:nonFraction> commercial paper issued and outstanding as of September&#160;30, 2021, $<ix:nonFraction unitRef="usd" contextRef="i75b241ded9e04282a87e07b5ca93bb10_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180OS9mcmFnOjlmMmE0ZDZjODMwODRlMDJiOTY5OWMxNjM4MWY4NzFlL3RleHRyZWdpb246OWYyYTRkNmM4MzA4NGUwMmI5Njk5YzE2MzgxZjg3MWVfMTUyMA_0432d339-2826-408e-898a-48fb68831509">17,658</ix:nonFraction> had original maturities greater than three months, which were considered available-for-sale securities. As of December&#160;31, 2020, the Company had $<ix:nonFraction unitRef="usd" contextRef="ibdfd9e1e6a6a4aea800ca23a42cc6d9c_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FairValueNetAssetLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180OS9mcmFnOjlmMmE0ZDZjODMwODRlMDJiOTY5OWMxNjM4MWY4NzFlL3RleHRyZWdpb246OWYyYTRkNmM4MzA4NGUwMmI5Njk5YzE2MzgxZjg3MWVfMTY1Mw_77ae5813-83e0-4d06-9eaa-4283df27a0ff">58,345</ix:nonFraction> commercial paper issued and outstanding, of which $<ix:nonFraction unitRef="usd" contextRef="ibdfd9e1e6a6a4aea800ca23a42cc6d9c_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180OS9mcmFnOjlmMmE0ZDZjODMwODRlMDJiOTY5OWMxNjM4MWY4NzFlL3RleHRyZWdpb246OWYyYTRkNmM4MzA4NGUwMmI5Njk5YzE2MzgxZjg3MWVfMTcwNg_1fc19c06-0619-4485-8aa7-8a8684187ba9">25,196</ix:nonFraction> had original maturities greater than three months and were considered available-for-sale securities.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s contingent consideration liabilities associated with acquisitions are measured at fair value using a probability-weighted discounted cash flow analysis or a simulation-based methodology for the acquired companies, which are Level 3 inputs. The Company recognizes changes to the fair value of its contingent consideration liabilities in selling, general and administrative expenses in the condensed consolidated statements of comprehensive income.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180OS9mcmFnOjlmMmE0ZDZjODMwODRlMDJiOTY5OWMxNjM4MWY4NzFlL3RleHRyZWdpb246OWYyYTRkNmM4MzA4NGUwMmI5Njk5YzE2MzgxZjg3MWVfNTU4Nw_d06a946c-9a02-4b01-ba18-72dc3627ffe0" escape="true"><div style="margin-bottom:3pt;margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present information about the above-referenced assets and liabilities and indicate the fair value hierarchy of the valuation techniques utilized to determine such fair value: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.929%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.765%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.208%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurements as of September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted&#160;Prices&#160;in<br/>Active&#160;Markets<br/>for Identical<br/>Assets<br/>(Level 1)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant Other Observable Inputs<br/>(Level 2)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant Unobservable Inputs<br/>(Level 3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8ecfcf890884810930a3db121a37947_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FairValueNetAssetLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180OS9mcmFnOjlmMmE0ZDZjODMwODRlMDJiOTY5OWMxNjM4MWY4NzFlL3RhYmxlOmQ3YWIxN2VkMzBiZTQyOTRhZDY5Y2ZiZmM0YzIwNzgwL3RhYmxlcmFuZ2U6ZDdhYjE3ZWQzMGJlNDI5NGFkNjljZmJmYzRjMjA3ODBfMi0xLTEtMS0xMDc3MA_dd839856-6a96-4367-b0d7-e95df6aaa68d">31,569</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46feda5d0d364eabb7ec42a6d33247c6_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FairValueNetAssetLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180OS9mcmFnOjlmMmE0ZDZjODMwODRlMDJiOTY5OWMxNjM4MWY4NzFlL3RhYmxlOmQ3YWIxN2VkMzBiZTQyOTRhZDY5Y2ZiZmM0YzIwNzgwL3RhYmxlcmFuZ2U6ZDdhYjE3ZWQzMGJlNDI5NGFkNjljZmJmYzRjMjA3ODBfMi0zLTEtMS0xMDc3MA_f3f71249-3115-49e5-9aab-73baed645845">31,569</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98888a04caa94c449d58020688cc10b7_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:FairValueNetAssetLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180OS9mcmFnOjlmMmE0ZDZjODMwODRlMDJiOTY5OWMxNjM4MWY4NzFlL3RhYmxlOmQ3YWIxN2VkMzBiZTQyOTRhZDY5Y2ZiZmM0YzIwNzgwL3RhYmxlcmFuZ2U6ZDdhYjE3ZWQzMGJlNDI5NGFkNjljZmJmYzRjMjA3ODBfMi01LTEtMS0xMDc3MA_c5950c06-a884-4cf6-acd0-a0b53a03e30b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9aeb16c096e94fd18a6a4407369f7baf_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:FairValueNetAssetLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180OS9mcmFnOjlmMmE0ZDZjODMwODRlMDJiOTY5OWMxNjM4MWY4NzFlL3RhYmxlOmQ3YWIxN2VkMzBiZTQyOTRhZDY5Y2ZiZmM0YzIwNzgwL3RhYmxlcmFuZ2U6ZDdhYjE3ZWQzMGJlNDI5NGFkNjljZmJmYzRjMjA3ODBfMi03LTEtMS0xMDc3MA_dc126938-a67b-4c68-8953-76a6fee74708">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7406af186f1f431ba3a5cae4e80d7461_I20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:FairValueNetAssetLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180OS9mcmFnOjlmMmE0ZDZjODMwODRlMDJiOTY5OWMxNjM4MWY4NzFlL3RhYmxlOmQ3YWIxN2VkMzBiZTQyOTRhZDY5Y2ZiZmM0YzIwNzgwL3RhYmxlcmFuZ2U6ZDdhYjE3ZWQzMGJlNDI5NGFkNjljZmJmYzRjMjA3ODBfMy0xLTEtMS0xMDc3MA_9dfffd18-d206-4a16-9d5c-187beaa046ca">117,020</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i148698ba11334fa7962b91a16b3e7880_I20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:FairValueNetAssetLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180OS9mcmFnOjlmMmE0ZDZjODMwODRlMDJiOTY5OWMxNjM4MWY4NzFlL3RhYmxlOmQ3YWIxN2VkMzBiZTQyOTRhZDY5Y2ZiZmM0YzIwNzgwL3RhYmxlcmFuZ2U6ZDdhYjE3ZWQzMGJlNDI5NGFkNjljZmJmYzRjMjA3ODBfMy0zLTEtMS0xMDc3MA_12bac602-4073-4e23-bfa3-9265fcea6af1">117,020</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i975bc3f2b0594c2996194a6fa3fd0687_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:FairValueNetAssetLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180OS9mcmFnOjlmMmE0ZDZjODMwODRlMDJiOTY5OWMxNjM4MWY4NzFlL3RhYmxlOmQ3YWIxN2VkMzBiZTQyOTRhZDY5Y2ZiZmM0YzIwNzgwL3RhYmxlcmFuZ2U6ZDdhYjE3ZWQzMGJlNDI5NGFkNjljZmJmYzRjMjA3ODBfMy01LTEtMS0xMDc3MA_97c58850-d43a-42e6-951a-03f001ec6071">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0adbc48e0574d688983232e62d3bdfa_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:FairValueNetAssetLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180OS9mcmFnOjlmMmE0ZDZjODMwODRlMDJiOTY5OWMxNjM4MWY4NzFlL3RhYmxlOmQ3YWIxN2VkMzBiZTQyOTRhZDY5Y2ZiZmM0YzIwNzgwL3RhYmxlcmFuZ2U6ZDdhYjE3ZWQzMGJlNDI5NGFkNjljZmJmYzRjMjA3ODBfMy03LTEtMS0xMDc3MA_5d65f87a-73e5-42ab-85d4-4901ff58769f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f2f077331ea49d9a65ccd6f803814da_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FairValueNetAssetLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180OS9mcmFnOjlmMmE0ZDZjODMwODRlMDJiOTY5OWMxNjM4MWY4NzFlL3RhYmxlOmQ3YWIxN2VkMzBiZTQyOTRhZDY5Y2ZiZmM0YzIwNzgwL3RhYmxlcmFuZ2U6ZDdhYjE3ZWQzMGJlNDI5NGFkNjljZmJmYzRjMjA3ODBfNC0xLTEtMS0xMDc3MA_4906e47c-49ea-450c-8d32-0fcd29bb4553">126,584</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12f5a5f263ab4ab69a41578d13ee6032_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:FairValueNetAssetLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180OS9mcmFnOjlmMmE0ZDZjODMwODRlMDJiOTY5OWMxNjM4MWY4NzFlL3RhYmxlOmQ3YWIxN2VkMzBiZTQyOTRhZDY5Y2ZiZmM0YzIwNzgwL3RhYmxlcmFuZ2U6ZDdhYjE3ZWQzMGJlNDI5NGFkNjljZmJmYzRjMjA3ODBfNC0zLTEtMS0xMDc3MA_3d13417d-619d-482c-be4d-e365a4448892">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75b241ded9e04282a87e07b5ca93bb10_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FairValueNetAssetLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180OS9mcmFnOjlmMmE0ZDZjODMwODRlMDJiOTY5OWMxNjM4MWY4NzFlL3RhYmxlOmQ3YWIxN2VkMzBiZTQyOTRhZDY5Y2ZiZmM0YzIwNzgwL3RhYmxlcmFuZ2U6ZDdhYjE3ZWQzMGJlNDI5NGFkNjljZmJmYzRjMjA3ODBfNC01LTEtMS0xMDc3MA_dc66bb38-2fe9-4740-8adb-b9dfc5a40af4">126,584</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1643e3ce569e435e90215e4c1f80cc45_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:FairValueNetAssetLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180OS9mcmFnOjlmMmE0ZDZjODMwODRlMDJiOTY5OWMxNjM4MWY4NzFlL3RhYmxlOmQ3YWIxN2VkMzBiZTQyOTRhZDY5Y2ZiZmM0YzIwNzgwL3RhYmxlcmFuZ2U6ZDdhYjE3ZWQzMGJlNDI5NGFkNjljZmJmYzRjMjA3ODBfNC03LTEtMS0xMDc3MA_a0ab9156-f09a-4904-b96b-2cc46db7fd77">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.929%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.765%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.208%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurements as of December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted&#160;Prices&#160;in<br/>Active&#160;Markets<br/>for Identical<br/>Assets<br/>(Level 1)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant Other Observable Inputs<br/>(Level 2)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant Unobservable Inputs<br/>(Level 3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04416ccdf99b4368b4ae3bb3d5c50522_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FairValueNetAssetLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180OS9mcmFnOjlmMmE0ZDZjODMwODRlMDJiOTY5OWMxNjM4MWY4NzFlL3RhYmxlOjI2N2I0M2YzZGMzMjQwYzA4NjI4MjU2N2M5ZDJjZmJiL3RhYmxlcmFuZ2U6MjY3YjQzZjNkYzMyNDBjMDg2MjgyNTY3YzlkMmNmYmJfMi0xLTEtMS0xMDc3MA_1b30c773-7cf4-4c70-9bd8-836c9a510042">2,198</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2779feaa7ca44c64a5d0144e462d669e_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FairValueNetAssetLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180OS9mcmFnOjlmMmE0ZDZjODMwODRlMDJiOTY5OWMxNjM4MWY4NzFlL3RhYmxlOjI2N2I0M2YzZGMzMjQwYzA4NjI4MjU2N2M5ZDJjZmJiL3RhYmxlcmFuZ2U6MjY3YjQzZjNkYzMyNDBjMDg2MjgyNTY3YzlkMmNmYmJfMi0zLTEtMS0xMDc3MA_e3f31b79-d467-4014-8477-53accdbfbb4c">2,198</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie85028cf6e7e4291811ded1080e9ccef_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:FairValueNetAssetLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180OS9mcmFnOjlmMmE0ZDZjODMwODRlMDJiOTY5OWMxNjM4MWY4NzFlL3RhYmxlOjI2N2I0M2YzZGMzMjQwYzA4NjI4MjU2N2M5ZDJjZmJiL3RhYmxlcmFuZ2U6MjY3YjQzZjNkYzMyNDBjMDg2MjgyNTY3YzlkMmNmYmJfMi01LTEtMS0xMDc3MA_f2cd669c-312f-4e48-90d8-2aeb8de8c276">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12292bac56af415ebe14864b760b6aee_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:FairValueNetAssetLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180OS9mcmFnOjlmMmE0ZDZjODMwODRlMDJiOTY5OWMxNjM4MWY4NzFlL3RhYmxlOjI2N2I0M2YzZGMzMjQwYzA4NjI4MjU2N2M5ZDJjZmJiL3RhYmxlcmFuZ2U6MjY3YjQzZjNkYzMyNDBjMDg2MjgyNTY3YzlkMmNmYmJfMi03LTEtMS0xMDc3MA_524a172a-50ed-4391-9a33-cba25c49e3fc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaad52f29996b478daad64bf29bf17dbe_I20201231" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:FairValueNetAssetLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180OS9mcmFnOjlmMmE0ZDZjODMwODRlMDJiOTY5OWMxNjM4MWY4NzFlL3RhYmxlOjI2N2I0M2YzZGMzMjQwYzA4NjI4MjU2N2M5ZDJjZmJiL3RhYmxlcmFuZ2U6MjY3YjQzZjNkYzMyNDBjMDg2MjgyNTY3YzlkMmNmYmJfMy0xLTEtMS0xMDc3MA_12e36d84-5981-4069-86ac-0b8748699963">97,184</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i90ee55464c34456ab9205a90173c745d_I20201231" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:FairValueNetAssetLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180OS9mcmFnOjlmMmE0ZDZjODMwODRlMDJiOTY5OWMxNjM4MWY4NzFlL3RhYmxlOjI2N2I0M2YzZGMzMjQwYzA4NjI4MjU2N2M5ZDJjZmJiL3RhYmxlcmFuZ2U6MjY3YjQzZjNkYzMyNDBjMDg2MjgyNTY3YzlkMmNmYmJfMy0zLTEtMS0xMDc3MA_c14f187c-61e2-495d-aff4-3c9c431c8bfb">97,184</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2dae041f1c2049bc8a78d41d20bd5c01_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:FairValueNetAssetLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180OS9mcmFnOjlmMmE0ZDZjODMwODRlMDJiOTY5OWMxNjM4MWY4NzFlL3RhYmxlOjI2N2I0M2YzZGMzMjQwYzA4NjI4MjU2N2M5ZDJjZmJiL3RhYmxlcmFuZ2U6MjY3YjQzZjNkYzMyNDBjMDg2MjgyNTY3YzlkMmNmYmJfMy01LTEtMS0xMDc3MA_0e94335a-46cb-46f5-b320-8e552c3a4b3b">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01af2c6807964bd3a70f87bed11d7f18_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:FairValueNetAssetLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180OS9mcmFnOjlmMmE0ZDZjODMwODRlMDJiOTY5OWMxNjM4MWY4NzFlL3RhYmxlOjI2N2I0M2YzZGMzMjQwYzA4NjI4MjU2N2M5ZDJjZmJiL3RhYmxlcmFuZ2U6MjY3YjQzZjNkYzMyNDBjMDg2MjgyNTY3YzlkMmNmYmJfMy03LTEtMS0xMDc3MA_099d1f7c-6505-445c-beeb-3416bb47128a">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52afbebb62d24268b4227e4d0ecbfbd0_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FairValueNetAssetLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180OS9mcmFnOjlmMmE0ZDZjODMwODRlMDJiOTY5OWMxNjM4MWY4NzFlL3RhYmxlOjI2N2I0M2YzZGMzMjQwYzA4NjI4MjU2N2M5ZDJjZmJiL3RhYmxlcmFuZ2U6MjY3YjQzZjNkYzMyNDBjMDg2MjgyNTY3YzlkMmNmYmJfNC0xLTEtMS0xMDc3MA_f39a711e-e16b-4d57-b4c9-862c354fdf57">58,345</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33219b4f757444d0acfe2defee9c77a2_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:FairValueNetAssetLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180OS9mcmFnOjlmMmE0ZDZjODMwODRlMDJiOTY5OWMxNjM4MWY4NzFlL3RhYmxlOjI2N2I0M2YzZGMzMjQwYzA4NjI4MjU2N2M5ZDJjZmJiL3RhYmxlcmFuZ2U6MjY3YjQzZjNkYzMyNDBjMDg2MjgyNTY3YzlkMmNmYmJfNC0zLTEtMS0xMDc3MA_1bb6592c-6a71-4ba0-96b6-c2aa8c9ca554">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibdfd9e1e6a6a4aea800ca23a42cc6d9c_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FairValueNetAssetLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180OS9mcmFnOjlmMmE0ZDZjODMwODRlMDJiOTY5OWMxNjM4MWY4NzFlL3RhYmxlOjI2N2I0M2YzZGMzMjQwYzA4NjI4MjU2N2M5ZDJjZmJiL3RhYmxlcmFuZ2U6MjY3YjQzZjNkYzMyNDBjMDg2MjgyNTY3YzlkMmNmYmJfNC01LTEtMS0xMDc3MA_e544910b-46cd-430c-a1c4-d71f9770670e">58,345</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icabd932ac65d40a9ad263428cb023998_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:FairValueNetAssetLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180OS9mcmFnOjlmMmE0ZDZjODMwODRlMDJiOTY5OWMxNjM4MWY4NzFlL3RhYmxlOjI2N2I0M2YzZGMzMjQwYzA4NjI4MjU2N2M5ZDJjZmJiL3RhYmxlcmFuZ2U6MjY3YjQzZjNkYzMyNDBjMDg2MjgyNTY3YzlkMmNmYmJfNC03LTEtMS0xMDc3MA_93af0c08-6677-42bb-830a-4a803504387e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition contingent consideration liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia2321e23f81c49fca30df6d0483acd39_I20201231" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:FairValueNetAssetLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180OS9mcmFnOjlmMmE0ZDZjODMwODRlMDJiOTY5OWMxNjM4MWY4NzFlL3RhYmxlOjI2N2I0M2YzZGMzMjQwYzA4NjI4MjU2N2M5ZDJjZmJiL3RhYmxlcmFuZ2U6MjY3YjQzZjNkYzMyNDBjMDg2MjgyNTY3YzlkMmNmYmJfNS0xLTEtMS0xMDc3MA_44244836-be28-4f0f-a82d-b3df6b056c49">8,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie87be00cfa4e4645b636d077357bfaaa_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:FairValueNetAssetLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180OS9mcmFnOjlmMmE0ZDZjODMwODRlMDJiOTY5OWMxNjM4MWY4NzFlL3RhYmxlOjI2N2I0M2YzZGMzMjQwYzA4NjI4MjU2N2M5ZDJjZmJiL3RhYmxlcmFuZ2U6MjY3YjQzZjNkYzMyNDBjMDg2MjgyNTY3YzlkMmNmYmJfNS0zLTEtMS0xMDc3MA_89016cc2-55de-4158-979c-4debb8db5eab">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe1edb1c0b7d484da43d71c0fcdd0d28_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:FairValueNetAssetLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180OS9mcmFnOjlmMmE0ZDZjODMwODRlMDJiOTY5OWMxNjM4MWY4NzFlL3RhYmxlOjI2N2I0M2YzZGMzMjQwYzA4NjI4MjU2N2M5ZDJjZmJiL3RhYmxlcmFuZ2U6MjY3YjQzZjNkYzMyNDBjMDg2MjgyNTY3YzlkMmNmYmJfNS01LTEtMS0xMDc3MA_8f6dd47d-7583-4964-acb4-5d8465c44db2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6181153aab9d4bf1a9ac5e86d83189ec_I20201231" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:FairValueNetAssetLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180OS9mcmFnOjlmMmE0ZDZjODMwODRlMDJiOTY5OWMxNjM4MWY4NzFlL3RhYmxlOjI2N2I0M2YzZGMzMjQwYzA4NjI4MjU2N2M5ZDJjZmJiL3RhYmxlcmFuZ2U6MjY3YjQzZjNkYzMyNDBjMDg2MjgyNTY3YzlkMmNmYmJfNS03LTEtMS0xMDc3MA_f2e3597a-4a52-4c87-a07d-647d2a1252e8">8,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i7e5be243232444e79342fc6ec9a223db" continuedAt="i1320be9d3d7e4ab694fb1698d290adf7"><div style="margin-top:4pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Level 3 Information</span></div><ix:nonNumeric contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180OS9mcmFnOjlmMmE0ZDZjODMwODRlMDJiOTY5OWMxNjM4MWY4NzFlL3RleHRyZWdpb246OWYyYTRkNmM4MzA4NGUwMmI5Njk5YzE2MzgxZjg3MWVfNTU3NA_a3eb3636-256d-461f-9133-35b9fa3ebcfe" escape="true"><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables set forth a reconciliation of changes in the fair value of contingent consideration liabilities classified as Level 3 in the fair value hierarchy:</span></div><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.291%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.192%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.194%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of July 1,</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id213a9f9047d4508aeef40c71a6fe7f3_I20210630" decimals="-3" format="ixt:fixed-zero" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180OS9mcmFnOjlmMmE0ZDZjODMwODRlMDJiOTY5OWMxNjM4MWY4NzFlL3RhYmxlOjRiYTM1NzIyNWY0MjQ3NWM4YzgxNzk5ZmVjYzljMzRiL3RhYmxlcmFuZ2U6NGJhMzU3MjI1ZjQyNDc1YzhjODE3OTlmZWNjOWMzNGJfMS0xLTEtMS0xMDc3MA_39cabb96-48bc-42a8-9ce4-78ac31f5b430">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i26375226748e457a83389380abbeabb8_I20200630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180OS9mcmFnOjlmMmE0ZDZjODMwODRlMDJiOTY5OWMxNjM4MWY4NzFlL3RhYmxlOjRiYTM1NzIyNWY0MjQ3NWM4YzgxNzk5ZmVjYzljMzRiL3RhYmxlcmFuZ2U6NGJhMzU3MjI1ZjQyNDc1YzhjODE3OTlmZWNjOWMzNGJfMS0zLTEtMS0xMDc3MA_43093abd-ba98-4518-969f-53868a26cbba">8,100</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of contingent consideration liability from b4health acquisition </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia06522632d4f4b51b495d744af0113af_D20210701-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180OS9mcmFnOjlmMmE0ZDZjODMwODRlMDJiOTY5OWMxNjM4MWY4NzFlL3RhYmxlOjRiYTM1NzIyNWY0MjQ3NWM4YzgxNzk5ZmVjYzljMzRiL3RhYmxlcmFuZ2U6NGJhMzU3MjI1ZjQyNDc1YzhjODE3OTlmZWNjOWMzNGJfNi0xLTEtMS0xMDc3MA_8ece0c65-6159-457d-92de-c81888a6e6b3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3225a1c038234fd6ad8decf2eea09642_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180OS9mcmFnOjlmMmE0ZDZjODMwODRlMDJiOTY5OWMxNjM4MWY4NzFlL3RhYmxlOjRiYTM1NzIyNWY0MjQ3NWM4YzgxNzk5ZmVjYzljMzRiL3RhYmxlcmFuZ2U6NGJhMzU3MjI1ZjQyNDc1YzhjODE3OTlmZWNjOWMzNGJfNi0zLTEtMS0xMDc3MA_139d62fe-6ce6-4386-8b70-77e121ca8387">6,700</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of September 30,</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1c38f520570446e977fefc12947c6df_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180OS9mcmFnOjlmMmE0ZDZjODMwODRlMDJiOTY5OWMxNjM4MWY4NzFlL3RhYmxlOjRiYTM1NzIyNWY0MjQ3NWM4YzgxNzk5ZmVjYzljMzRiL3RhYmxlcmFuZ2U6NGJhMzU3MjI1ZjQyNDc1YzhjODE3OTlmZWNjOWMzNGJfNy0xLTEtMS0xMDc3MA_0e73d772-671c-455d-bb70-822991ce0494">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if25b9265f3954756bd8d09991a579c63_I20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180OS9mcmFnOjlmMmE0ZDZjODMwODRlMDJiOTY5OWMxNjM4MWY4NzFlL3RhYmxlOjRiYTM1NzIyNWY0MjQ3NWM4YzgxNzk5ZmVjYzljMzRiL3RhYmxlcmFuZ2U6NGJhMzU3MjI1ZjQyNDc1YzhjODE3OTlmZWNjOWMzNGJfNy0zLTEtMS0xMDc3MA_92c9d61e-f4a9-47b8-9241-dfb534b7b015">1,400</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.291%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.192%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.194%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1,</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6181153aab9d4bf1a9ac5e86d83189ec_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180OS9mcmFnOjlmMmE0ZDZjODMwODRlMDJiOTY5OWMxNjM4MWY4NzFlL3RhYmxlOjZiMjE1MGZlM2UwZTRkMWM5NTliNGM3ZTc1MjkyY2I3L3RhYmxlcmFuZ2U6NmIyMTUwZmUzZTBlNGQxYzk1OWI0YzdlNzUyOTJjYjdfMS0xLTEtMS0xMDc3MA_e378e1d9-305b-468d-9c46-857b6d8803e3">8,000</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i27f0dfb23ddc496989d2606c383df2c5_I20191231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180OS9mcmFnOjlmMmE0ZDZjODMwODRlMDJiOTY5OWMxNjM4MWY4NzFlL3RhYmxlOjZiMjE1MGZlM2UwZTRkMWM5NTliNGM3ZTc1MjkyY2I3L3RhYmxlcmFuZ2U6NmIyMTUwZmUzZTBlNGQxYzk1OWI0YzdlNzUyOTJjYjdfMS0zLTEtMS0xMDc3MA_939ca570-d717-4959-b058-1a0874772326">23,100</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlement of Advanced contingent consideration liability for year ended December 31, 2019</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia74ee65117cd4be980399efaba0fd27f_D20210101-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180OS9mcmFnOjlmMmE0ZDZjODMwODRlMDJiOTY5OWMxNjM4MWY4NzFlL3RhYmxlOjZiMjE1MGZlM2UwZTRkMWM5NTliNGM3ZTc1MjkyY2I3L3RhYmxlcmFuZ2U6NmIyMTUwZmUzZTBlNGQxYzk1OWI0YzdlNzUyOTJjYjdfMi0xLTEtMS0xMDc3MA_f8cd506b-b672-4513-bee6-7d31e08c15e9">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3dced23531a14782bb18a2d74864eba6_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180OS9mcmFnOjlmMmE0ZDZjODMwODRlMDJiOTY5OWMxNjM4MWY4NzFlL3RhYmxlOjZiMjE1MGZlM2UwZTRkMWM5NTliNGM3ZTc1MjkyY2I3L3RhYmxlcmFuZ2U6NmIyMTUwZmUzZTBlNGQxYzk1OWI0YzdlNzUyOTJjYjdfMi0zLTEtMS0xMDc3MA_fcd1b8b3-8d42-426b-8be6-5ca1de70d138">20,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlement of b4health contingent consideration liability for year ended December 31, 2020</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8887638bb5c4199a5d785b2a07d5378_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180OS9mcmFnOjlmMmE0ZDZjODMwODRlMDJiOTY5OWMxNjM4MWY4NzFlL3RhYmxlOjZiMjE1MGZlM2UwZTRkMWM5NTliNGM3ZTc1MjkyY2I3L3RhYmxlcmFuZ2U6NmIyMTUwZmUzZTBlNGQxYzk1OWI0YzdlNzUyOTJjYjdfMy0xLTEtMS0xMDc3MA_8406a298-321e-4c06-8f1b-4a129b86f836">8,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8797e43b32204823b6a3ad14b6669a69_D20200101-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180OS9mcmFnOjlmMmE0ZDZjODMwODRlMDJiOTY5OWMxNjM4MWY4NzFlL3RhYmxlOjZiMjE1MGZlM2UwZTRkMWM5NTliNGM3ZTc1MjkyY2I3L3RhYmxlcmFuZ2U6NmIyMTUwZmUzZTBlNGQxYzk1OWI0YzdlNzUyOTJjYjdfMy0zLTEtMS0xMDc3MA_f84dfa57-c525-464e-9027-ee2eaeebd909">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of contingent consideration liability from b4health acquisition </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8887638bb5c4199a5d785b2a07d5378_D20210101-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180OS9mcmFnOjlmMmE0ZDZjODMwODRlMDJiOTY5OWMxNjM4MWY4NzFlL3RhYmxlOjZiMjE1MGZlM2UwZTRkMWM5NTliNGM3ZTc1MjkyY2I3L3RhYmxlcmFuZ2U6NmIyMTUwZmUzZTBlNGQxYzk1OWI0YzdlNzUyOTJjYjdfOS0xLTEtMS0xMDc3MA_bd59fb7e-507e-48e7-95b2-74f177b20f0e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8797e43b32204823b6a3ad14b6669a69_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180OS9mcmFnOjlmMmE0ZDZjODMwODRlMDJiOTY5OWMxNjM4MWY4NzFlL3RhYmxlOjZiMjE1MGZlM2UwZTRkMWM5NTliNGM3ZTc1MjkyY2I3L3RhYmxlcmFuZ2U6NmIyMTUwZmUzZTBlNGQxYzk1OWI0YzdlNzUyOTJjYjdfOS0zLTEtMS0xMDc3MA_22a50de5-ad25-4231-b8ae-2a717441269d">1,700</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of September 30,</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1c38f520570446e977fefc12947c6df_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180OS9mcmFnOjlmMmE0ZDZjODMwODRlMDJiOTY5OWMxNjM4MWY4NzFlL3RhYmxlOjZiMjE1MGZlM2UwZTRkMWM5NTliNGM3ZTc1MjkyY2I3L3RhYmxlcmFuZ2U6NmIyMTUwZmUzZTBlNGQxYzk1OWI0YzdlNzUyOTJjYjdfMTAtMS0xLTEtMTA3NzA_0e73d772-671c-455d-bb70-822991ce0494">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if25b9265f3954756bd8d09991a579c63_I20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180OS9mcmFnOjlmMmE0ZDZjODMwODRlMDJiOTY5OWMxNjM4MWY4NzFlL3RhYmxlOjZiMjE1MGZlM2UwZTRkMWM5NTliNGM3ZTc1MjkyY2I3L3RhYmxlcmFuZ2U6NmIyMTUwZmUzZTBlNGQxYzk1OWI0YzdlNzUyOTJjYjdfMTAtMy0xLTEtMTA3NzA_92c9d61e-f4a9-47b8-9241-dfb534b7b015">1,400</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:continuation id="i279055f38a664353a7127f5902fee3df" continuedAt="i391556c343694b2da322c58fb2a223fc"><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Assets Measured on a Non-Recurring Basis</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company applies fair value techniques on a non-recurring basis associated with valuing potential impairment losses related to its goodwill, indefinite-lived intangible assets, long-lived assets, and equity investments. </span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluates goodwill and indefinite-lived intangible assets annually for impairment and whenever events or changes in circumstances indicate that it is more likely than not that an impairment exists. The Company determines the fair value of its reporting units based on a combination of inputs, including the market capitalization of the Company, as well as Level 3 inputs such as discounted cash flows, which are not observable from the market, directly or indirectly. The Company determines the fair value of its indefinite-lived intangible assets using the income approach (relief-from-royalty method) based on Level 3 inputs.</span></div></ix:continuation><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i391556c343694b2da322c58fb2a223fc" continuedAt="i07e2654ac3734bbc9b81f5207757222b">The Company&#8217;s equity investment represents an investment in a non-controlled corporation without a readily determinable market value. The Company has elected to measure the investment at cost minus impairment, if any, plus or minus changes resulting from observable price changes. The fair value is determined by using quoted prices for identical or similar investments of the same issuer, which are Level 2 inputs, and other information available to the Company such as the rights and obligations of the securities. The Company recognizes changes to the fair value of its equity investment in interest expense, net, and other in the condensed consolidated statements of comprehensive income.</ix:continuation> The balance of the equity investment was $<ix:nonFraction unitRef="usd" contextRef="i77b494fe460f4789ba120f413470a8d9_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:EquitySecuritiesFvNi" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180OS9mcmFnOjlmMmE0ZDZjODMwODRlMDJiOTY5OWMxNjM4MWY4NzFlL3RleHRyZWdpb246OWYyYTRkNmM4MzA4NGUwMmI5Njk5YzE2MzgxZjg3MWVfNDI1NA_01ec4095-c9cf-492e-a04f-b3741537eb7e">22,633</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="ic05278c1e0a647149ea04d2fc5ffc568_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:EquitySecuritiesFvNi" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180OS9mcmFnOjlmMmE0ZDZjODMwODRlMDJiOTY5OWMxNjM4MWY4NzFlL3RleHRyZWdpb246OWYyYTRkNmM4MzA4NGUwMmI5Njk5YzE2MzgxZjg3MWVfNDI2MQ_f2eec956-29a2-421b-9687-9bd7528c67a7">15,449</ix:nonFraction> as of September&#160;30, 2021 and December&#160;31, 2020, respectively.</span></div><div style="margin-top:4pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no triggering events identified, no indication of impairment of the Company&#8217;s goodwill, indefinite-lived intangible assets, long-lived assets, or equity investments, and <ix:nonFraction unitRef="usd" contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" decimals="INF" format="ixt:fixed-zero" name="us-gaap:AssetImpairmentCharges" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180OS9mcmFnOjlmMmE0ZDZjODMwODRlMDJiOTY5OWMxNjM4MWY4NzFlL3RleHRyZWdpb246OWYyYTRkNmM4MzA4NGUwMmI5Njk5YzE2MzgxZjg3MWVfNDQ3Ng_85b9e44a-cfc9-4c0c-8ef0-39e8e30f2f52"><ix:nonFraction unitRef="usd" contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930" decimals="INF" format="ixt:fixed-zero" name="us-gaap:AssetImpairmentCharges" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180OS9mcmFnOjlmMmE0ZDZjODMwODRlMDJiOTY5OWMxNjM4MWY4NzFlL3RleHRyZWdpb246OWYyYTRkNmM4MzA4NGUwMmI5Njk5YzE2MzgxZjg3MWVfNDQ3Ng_b77ea092-bc3b-43cb-b950-d51a39c45095">no</ix:nonFraction></ix:nonFraction> impairment charges recorded during the nine months ended September 30, 2021 and 2020. </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i1320be9d3d7e4ab694fb1698d290adf7" continuedAt="ia3f8179bab59476ab4a0ec6fd0938cb5"><ix:continuation id="i07e2654ac3734bbc9b81f5207757222b" continuedAt="iffde8dc02ca54c9cba2813ac40112152"><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value of Financial Instruments</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is required to disclose the fair value of financial instruments for which it is practicable to estimate the value, even though these instruments are not recognized at fair value in the consolidated balance sheets. The fair value of the Company&#8217;s <ix:nonFraction unitRef="number" contextRef="ic9968f7f2c454182aab2b88a2b279e04_I20200813" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180OS9mcmFnOjlmMmE0ZDZjODMwODRlMDJiOTY5OWMxNjM4MWY4NzFlL3RleHRyZWdpb246OWYyYTRkNmM4MzA4NGUwMmI5Njk5YzE2MzgxZjg3MWVfNDgyNA_7db26a25-1638-4384-bcbc-c33ce99c459f">4.625</ix:nonFraction>% senior notes due 2027 (the &#8220;2027 Notes&#8221;) and <ix:nonFraction unitRef="number" contextRef="i2f6d79fdc037408d9dc6b393a68f3b3f_I20201020" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180OS9mcmFnOjlmMmE0ZDZjODMwODRlMDJiOTY5OWMxNjM4MWY4NzFlL3RleHRyZWdpb246OWYyYTRkNmM4MzA4NGUwMmI5Njk5YzE2MzgxZjg3MWVfNDg3Mg_37a7c628-59d8-4008-991b-890bfcfddfe9">4.000</ix:nonFraction>% senior notes due 2029 (the &#8220;2029 Notes&#8221;) was estimated using quoted market prices in active markets for identical liabilities, which are Level 1 inputs. The carrying amounts and estimated fair value of the 2027 Notes and the 2029 Notes are presented in the following table. <ix:nonNumeric contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" name="us-gaap:ScheduleOfFairValueOffBalanceSheetRisksTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180OS9mcmFnOjlmMmE0ZDZjODMwODRlMDJiOTY5OWMxNjM4MWY4NzFlL3RleHRyZWdpb246OWYyYTRkNmM4MzA4NGUwMmI5Njk5YzE2MzgxZjg3MWVfNTYwNg_f9da9739-41ba-40be-9d0c-1a74b5562384" continuedAt="ia8da0b8916a84cfeb0eeb01bef3fd356" escape="true">See additional information regarding the 2027 Notes and the 2029 Notes in Part II, Item 8, &#8220;Financial Statements and Supplementary Data&#8212;Notes to Consolidated Financial Statements&#8212;Note (8), Notes Payable and Credit Agreement&#8221; of the 2020 Annual Report. </ix:nonNumeric></span></div><div style="margin-top:14pt"><ix:continuation id="ia8da0b8916a84cfeb0eeb01bef3fd356"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.373%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.666%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.666%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.666%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.960%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027 Notes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74b3184e58994da0b7590f17370f09da_I20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFaceAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180OS9mcmFnOjlmMmE0ZDZjODMwODRlMDJiOTY5OWMxNjM4MWY4NzFlL3RhYmxlOjI3NWFhOTk3NjlmMDQ2OTI5MDRlZmRhNmYwOWVkYWM0L3RhYmxlcmFuZ2U6Mjc1YWE5OTc2OWYwNDY5MjkwNGVmZGE2ZjA5ZWRhYzRfMi0xLTEtMS0xMDc3MA_8ed0b227-8774-4cc3-bde6-50d9cabc5886">500,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74b3184e58994da0b7590f17370f09da_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180OS9mcmFnOjlmMmE0ZDZjODMwODRlMDJiOTY5OWMxNjM4MWY4NzFlL3RhYmxlOjI3NWFhOTk3NjlmMDQ2OTI5MDRlZmRhNmYwOWVkYWM0L3RhYmxlcmFuZ2U6Mjc1YWE5OTc2OWYwNDY5MjkwNGVmZGE2ZjA5ZWRhYzRfMi0yLTEtMS0xMDc3MA_fbe47aac-eaa2-4e00-a12e-5feae209ec32">518,750</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia140cdbfeac94d9dbe04b0a64460ff19_I20201231" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFaceAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180OS9mcmFnOjlmMmE0ZDZjODMwODRlMDJiOTY5OWMxNjM4MWY4NzFlL3RhYmxlOjI3NWFhOTk3NjlmMDQ2OTI5MDRlZmRhNmYwOWVkYWM0L3RhYmxlcmFuZ2U6Mjc1YWE5OTc2OWYwNDY5MjkwNGVmZGE2ZjA5ZWRhYzRfMi00LTEtMS0xMDc3MA_1e8efb34-9510-49ab-81f5-bad28b279945">500,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia140cdbfeac94d9dbe04b0a64460ff19_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180OS9mcmFnOjlmMmE0ZDZjODMwODRlMDJiOTY5OWMxNjM4MWY4NzFlL3RhYmxlOjI3NWFhOTk3NjlmMDQ2OTI5MDRlZmRhNmYwOWVkYWM0L3RhYmxlcmFuZ2U6Mjc1YWE5OTc2OWYwNDY5MjkwNGVmZGE2ZjA5ZWRhYzRfMi01LTEtMS0xMDc3MA_e3493e2b-9a26-4cfa-896e-b94abb1fcfab">521,250</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2029 Notes</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9ea250e0d094ba5b694f077af429acd_I20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFaceAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180OS9mcmFnOjlmMmE0ZDZjODMwODRlMDJiOTY5OWMxNjM4MWY4NzFlL3RhYmxlOjI3NWFhOTk3NjlmMDQ2OTI5MDRlZmRhNmYwOWVkYWM0L3RhYmxlcmFuZ2U6Mjc1YWE5OTc2OWYwNDY5MjkwNGVmZGE2ZjA5ZWRhYzRfMy0xLTEtMS0xMDc3MA_cc94ed98-dc4f-47fc-b8ae-fe2362bb8c1d">350,000</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9ea250e0d094ba5b694f077af429acd_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180OS9mcmFnOjlmMmE0ZDZjODMwODRlMDJiOTY5OWMxNjM4MWY4NzFlL3RhYmxlOjI3NWFhOTk3NjlmMDQ2OTI5MDRlZmRhNmYwOWVkYWM0L3RhYmxlcmFuZ2U6Mjc1YWE5OTc2OWYwNDY5MjkwNGVmZGE2ZjA5ZWRhYzRfMy0yLTEtMS0xMDc3MA_ba728a77-8685-42a4-97e3-44104bd28710">359,625</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17ce2ad3d6e849fc9dea40319a4961e3_I20201231" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFaceAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180OS9mcmFnOjlmMmE0ZDZjODMwODRlMDJiOTY5OWMxNjM4MWY4NzFlL3RhYmxlOjI3NWFhOTk3NjlmMDQ2OTI5MDRlZmRhNmYwOWVkYWM0L3RhYmxlcmFuZ2U6Mjc1YWE5OTc2OWYwNDY5MjkwNGVmZGE2ZjA5ZWRhYzRfMy00LTEtMS0xMDc3MA_94839132-e695-4002-8d4c-02bee5728910">350,000</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17ce2ad3d6e849fc9dea40319a4961e3_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180OS9mcmFnOjlmMmE0ZDZjODMwODRlMDJiOTY5OWMxNjM4MWY4NzFlL3RhYmxlOjI3NWFhOTk3NjlmMDQ2OTI5MDRlZmRhNmYwOWVkYWM0L3RhYmxlcmFuZ2U6Mjc1YWE5OTc2OWYwNDY5MjkwNGVmZGE2ZjA5ZWRhYzRfMy01LTEtMS0xMDc3MA_bd0ca8b6-3032-4786-9c42-bd6c92c6a457">357,000</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:continuation></ix:continuation><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ia3f8179bab59476ab4a0ec6fd0938cb5"><ix:continuation id="iffde8dc02ca54c9cba2813ac40112152">The fair value of the Company&#8217;s long-term self-insurance accruals cannot be estimated as the Company cannot reasonably determine the timing of future payments.</ix:continuation></ix:continuation> </span></div><div id="ia383c8c7878a498d91f9e8901f0cfd9c_52"></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8. <ix:nonNumeric contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" name="us-gaap:LesseeOperatingLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y181Mi9mcmFnOjY1YzQyZmU5ZTlmODQ2MTI4NjhlMjRlNjkxMmZmMWExL3RleHRyZWdpb246NjVjNDJmZTllOWY4NDYxMjg2OGUyNGU2OTEyZmYxYTFfMzg0ODI5MDY5ODI4Ng_fdec650e-1f3f-4030-a7de-cacd9936b939" continuedAt="i88d11127c5bf485aa4997de116b611d7" escape="true">LEASES</ix:nonNumeric></span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:continuation id="i88d11127c5bf485aa4997de116b611d7">During the three months ended September 30, 2021, the Company entered into an arrangement to terminate the lease agreement (as amended to date) for its office space in San Diego. The termination will occur in <ix:nonFraction unitRef="phase" contextRef="i150492f298fa47a78ef2c10a285a64f8_D20210701-20210930" decimals="INF" format="ixt-sec:numwordsen" name="amn:NumberOfPhasesOfLeaseTerminationAgreement" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y181Mi9mcmFnOjY1YzQyZmU5ZTlmODQ2MTI4NjhlMjRlNjkxMmZmMWExL3RleHRyZWdpb246NjVjNDJmZTllOWY4NDYxMjg2OGUyNGU2OTEyZmYxYTFfMzg0ODI5MDcwNTYzNA_eef8c47b-6ae3-40e6-a09b-36a3f360fe31">two</ix:nonFraction> phases: the first phase terminates the Company&#8217;s right to use certain floors effective February 28, 2022 and the second phase reduces the remaining lease term to December 31, 2024 from its original termination date of July 31, 2027. As a result of the arrangement, which was accounted for as a modification, the Company paid a termination fee of $<ix:nonFraction unitRef="usd" contextRef="i150492f298fa47a78ef2c10a285a64f8_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="amn:PaymentsOfLeaseTerminationFee" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y181Mi9mcmFnOjY1YzQyZmU5ZTlmODQ2MTI4NjhlMjRlNjkxMmZmMWExL3RleHRyZWdpb246NjVjNDJmZTllOWY4NDYxMjg2OGUyNGU2OTEyZmYxYTFfMTY0OTI2NzQ0NzE4OA_51a56f1d-f64b-4c7e-8907-e431285bc2c9">17,000</ix:nonFraction>, remeasured the lease liability using its incremental borrowing rate as the discount rate, and recorded decreases to its operating lease liabilities and right-of-use assets of $<ix:nonFraction unitRef="usd" contextRef="i150492f298fa47a78ef2c10a285a64f8_D20210701-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="amn:OperatingLeaseLiabilityIncreaseDecreaseFromModification" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y181Mi9mcmFnOjY1YzQyZmU5ZTlmODQ2MTI4NjhlMjRlNjkxMmZmMWExL3RleHRyZWdpb246NjVjNDJmZTllOWY4NDYxMjg2OGUyNGU2OTEyZmYxYTFfMTY0OTI2NzQ0NzE5Nw_3f5055ca-e02f-422e-9f26-60fa95891a45"><ix:nonFraction unitRef="usd" contextRef="i150492f298fa47a78ef2c10a285a64f8_D20210701-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="amn:OperatingLeaseRightOfUseAssetIncreaseDecreaseFromModification" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y181Mi9mcmFnOjY1YzQyZmU5ZTlmODQ2MTI4NjhlMjRlNjkxMmZmMWExL3RleHRyZWdpb246NjVjNDJmZTllOWY4NDYxMjg2OGUyNGU2OTEyZmYxYTFfMTY0OTI2NzQ0NzE5Nw_aaff58c3-65cf-4e03-8c76-40602d94403a">27,340</ix:nonFraction></ix:nonFraction> during the three months ended September 30, 2021. Prior to the modification, the total remaining lease payments for this office lease were $<ix:nonFraction unitRef="usd" contextRef="i68ecd84e8da440808154baac134e839e_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="amn:LesseeOperatingLeaseLiabilityToBePaidPremodification" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y181Mi9mcmFnOjY1YzQyZmU5ZTlmODQ2MTI4NjhlMjRlNjkxMmZmMWExL3RleHRyZWdpb246NjVjNDJmZTllOWY4NDYxMjg2OGUyNGU2OTEyZmYxYTFfMTY0OTI2NzQ0NzIwNg_6a085e13-c5d6-46b4-bd70-a56a01610498">62,487</ix:nonFraction>. Under the modified lease terms, the total remaining lease payments (excluding the termination fee paid during the three months ended September 30, 2021) are $<ix:nonFraction unitRef="usd" contextRef="i68ecd84e8da440808154baac134e839e_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="amn:LesseeOperatingLeaseLiabilityToBePaidPostmodification" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y181Mi9mcmFnOjY1YzQyZmU5ZTlmODQ2MTI4NjhlMjRlNjkxMmZmMWExL3RleHRyZWdpb246NjVjNDJmZTllOWY4NDYxMjg2OGUyNGU2OTEyZmYxYTFfMTY0OTI2NzQ0NzIxNQ_c1205e2e-eb9a-4aa8-8f76-cee3f4108ce9">9,564</ix:nonFraction>.</ix:continuation> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span></div><div id="ia383c8c7878a498d91f9e8901f0cfd9c_55"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9. <ix:nonNumeric contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y181NS9mcmFnOmM4Zjg1OTM3MTUzYTRkN2U5NGNmMjYxZGVhMDVhMmQ2L3RleHRyZWdpb246YzhmODU5MzcxNTNhNGQ3ZTk0Y2YyNjFkZWEwNWEyZDZfMTI5NA_467dc3e4-713a-4e7c-84d0-7f6d5232c9d4" continuedAt="if2d1e3d9bc294ecf89859036be6c6c1d" escape="true">INCOME TAXES</ix:nonNumeric></span></div><div style="text-indent:24.75pt"><span><br/></span></div><ix:continuation id="if2d1e3d9bc294ecf89859036be6c6c1d"><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company is subject to taxation in the U.S. and various states and foreign jurisdictions. With few exceptions, as of September&#160;30, 2021, the Company is no longer subject to state, local or foreign examinations by tax authorities for tax years before 2011, and the Company is no longer subject to U.S. federal income or payroll tax examinations for tax years before 2017. </span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notwithstanding the foregoing, the Company could adjust its provision for income taxes and contingent tax liability based on future developments.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">CARES Act</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 27, 2020, the Coronavirus Aid, Relief, and Economic Security Act (the &#8220;CARES Act&#8221;) was enacted and signed into law in response to the COVID-19 pandemic. Among other things, the CARES Act contains significant business tax provisions, including a deferral of payment of employer payroll taxes and an employer retention credit for employer payroll taxes.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has deferred payment of the employer&#8217;s share of payroll taxes of $<ix:nonFraction unitRef="usd" contextRef="i68ecd84e8da440808154baac134e839e_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="amn:DeferredPayrollTaxesCARESAct" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y181NS9mcmFnOmM4Zjg1OTM3MTUzYTRkN2U5NGNmMjYxZGVhMDVhMmQ2L3RleHRyZWdpb246YzhmODU5MzcxNTNhNGQ3ZTk0Y2YyNjFkZWEwNWEyZDZfOTc1_14d47c88-de54-4c7c-aaad-cb8481e8fd0b">48,452</ix:nonFraction>, which is included in accrued compensation and benefits and other long-term liabilities in the consolidated balance sheet as of September&#160;30, 2021, with half of such taxes to be paid by the end of 2021 and the other half to be paid by the end of 2022. The Company has claimed an employee retention employment tax credit of $<ix:nonFraction unitRef="usd" contextRef="i68ecd84e8da440808154baac134e839e_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="amn:EmployeeRetentionEmploymentTaxCreditCARESAct" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y181NS9mcmFnOmM4Zjg1OTM3MTUzYTRkN2U5NGNmMjYxZGVhMDVhMmQ2L3RleHRyZWdpb246YzhmODU5MzcxNTNhNGQ3ZTk0Y2YyNjFkZWEwNWEyZDZfMTI4NQ_b32cd390-d8e6-4880-b93a-335b4063b19a">1,756</ix:nonFraction>.</span></div></ix:continuation><div><span><br/></span></div><div id="ia383c8c7878a498d91f9e8901f0cfd9c_58"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10. <ix:nonNumeric contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y181OC9mcmFnOmJhMmQ1ZmU2ZTljNTRkNWFhZjFkYjlmZTk5YzhmZWQ2L3RleHRyZWdpb246YmEyZDVmZTZlOWM1NGQ1YWFmMWRiOWZlOTljOGZlZDZfNTM2MQ_aa960888-64ab-41b5-a552-7ac24f51927e" continuedAt="ib0b88af2e3bd4507aac6dd23f17de086" escape="true">COMMITMENTS AND CONTINGENCIES: LEGAL PROCEEDINGS</ix:nonNumeric></span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:continuation id="ib0b88af2e3bd4507aac6dd23f17de086" continuedAt="iceff7e6aa49b4ab9b28585b369d64bf4">From time to time, the Company is involved in various lawsuits, claims, investigations, and proceedings that arise in the ordinary course of business. These matters typically relate to professional liability, tax, compensation, contract, competitor disputes and employee-related matters and include individual and class action lawsuits, as well as inquiries and investigations by governmental agencies regarding the Company&#8217;s employment and compensation practices. Additionally, some of the Company&#8217;s clients may also become subject to claims, governmental inquiries and investigations, and legal actions relating to services provided by the Company&#8217;s healthcare professionals. Depending upon the particular facts and circumstances, the </ix:continuation></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="iceff7e6aa49b4ab9b28585b369d64bf4"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Company may also be subject to indemnification obligations under its contracts with such clients relating to these matters. The Company accrues for contingencies and records a liability when management believes an adverse outcome from a loss contingency is both probable and the amount, or a range, can be reasonably estimated. Significant judgment is required to determine both probability of loss and the estimated amount. The Company reviews its loss contingencies at least quarterly and adjusts its accruals and/or disclosures to reflect the impact of negotiations, settlements, rulings, advice of legal counsel, or other new information, as deemed necessary. The most significant matters for which the Company has established loss contingencies are class actions related to wage and hour claims under California and Federal law. Specifically, among other claims in these lawsuits, it is alleged that certain expense reimbursements should be considered wages and included in the regular rate of pay for purposes of calculating overtime rates. </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On May 26, 2016, former travel nurse Verna Maxwell Clarke filed a complaint against AMN Services, LLC, in California Superior Court in Los Angeles County. The Company removed the case to the United States District Court for the Central District of California (Case No. 2:16-cv-04132-DSF-KS) (the &#8220;Clarke Matter&#8221;). The complaint asserts that, due to the Company&#8217;s per diem adjustment practices, traveling nurses&#8217; per diem benefits should be included in their regular rate of pay for the purposes of calculating their overtime compensation. On June 26, 2018, the district court denied the plaintiffs&#8217; Motion for Summary Judgment in its entirety, and granted the Company&#8217;s Motion for Summary Judgment with respect to the Plaintiffs&#8217; per diem and overtime claims. The plaintiffs filed an appeal of the judgment relating to the per diem claims with the Ninth Circuit Court of Appeals (the &#8220;Ninth Circuit&#8221;). On February 8, 2021, a three-judge panel of the Ninth Circuit issued an opinion that reversed the district court&#8217;s granting of the Company&#8217;s Motion for Summary Judgment and remanded the matter to the district court instructing the district to enter partial summary judgment in favor of the Plaintiffs. On May 7, 2021, the Ninth Circuit issued an order denying the Company&#8217;s petition for rehearing. On August 26, 2021, the Company filed a Petition for Writ of Certiorari in the United States Supreme Court seeking review of the Ninth Circuit&#8217;s decision. At this time, it is unknown whether the Supreme Court will consider the appeal.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On May 2, 2019, former travel nurse Sara Woehrle filed a complaint against AMN Services, LLC, and Providence Health System &#8211; Southern California in California Superior Court in Los Angeles County. The Company removed the case to the United States District Court for the Central District of California (Case No. 2:19-cv-05282 DSF-KS). The complaint asserts that, due to the Company&#8217;s per diem adjustment practices, traveling nurses&#8217; per diem benefits should be included in their regular rate of pay for the purposes of calculating their overtime compensation. The Complaint also alleges that the putative class members were denied required meal periods, denied proper overtime compensation, were not compensated for all time worked, including reporting time and training time, and received non-compliant wage statements. The Company has reached a preliminary agreement to settle this matter in its entirety. Final settlement is not expected until the fourth quarter of 2022.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company believes that its wage and hour practices, including those associated with the cases described above, conform with the applicable law in all material respects. However, because of the February 2021 ruling by the Ninth Circuit in the Clarke Matter and the inherent uncertainty of litigation, the Company is not able to reasonably predict if any matter will be resolved in a manner that is materially adverse to the Company. Accordingly, the Company recorded an increase to its accruals established in connection with the matters described above amounting to $<ix:nonFraction unitRef="usd" contextRef="ibdd33d48b3ef404689d6e95d9989f154_D20201001-20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LossContingencyAccrualCarryingValuePeriodIncreaseDecrease" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y181OC9mcmFnOmJhMmQ1ZmU2ZTljNTRkNWFhZjFkYjlmZTk5YzhmZWQ2L3RleHRyZWdpb246YmEyZDVmZTZlOWM1NGQ1YWFmMWRiOWZlOTljOGZlZDZfNDc2NA_f7b7f940-9d11-4a6f-99fc-07e6fab2fbe4">20,000</ix:nonFraction> during the fourth quarter of 2020, and the ultimate resolution could result in a loss of up to $<ix:nonFraction unitRef="usd" contextRef="ic4d0f83036ab4e5a816bee3070f588e7_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LossContingencyEstimateOfPossibleLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y181OC9mcmFnOmJhMmQ1ZmU2ZTljNTRkNWFhZjFkYjlmZTk5YzhmZWQ2L3RleHRyZWdpb246YmEyZDVmZTZlOWM1NGQ1YWFmMWRiOWZlOTljOGZlZDZfNDk4Mg_7d91065a-11fa-43e1-90ad-793e551383b2">15,000</ix:nonFraction>, excluding penalties, in excess of the amounts currently accrued. For all other matters, the Company is unable to currently estimate the possible loss or range of loss beyond the amounts already accrued. Loss contingencies accrued as of September&#160;30, 2021 are included in accounts payable and accrued expenses and other long-term liabilities in the consolidated balance sheets.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><div id="ia383c8c7878a498d91f9e8901f0cfd9c_61"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11. <ix:nonNumeric contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" name="us-gaap:SupplementalBalanceSheetDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y182MS9mcmFnOmU0Njg0NTE5ODc2ZjRiN2M5ZGYzNmRjOGVjZjA4ZTJmL3RleHRyZWdpb246ZTQ2ODQ1MTk4NzZmNGI3YzlkZjM2ZGM4ZWNmMDhlMmZfOTM_4ce88c5d-d4ac-495e-b6a4-f5cd299a412e" continuedAt="i5f7280f8147c4761866f8551869494cb" escape="true">BALANCE SHEET DETAILS</ix:nonNumeric></span></div><div style="padding-left:36pt"><span><br/></span></div><ix:continuation id="i5f7280f8147c4761866f8551869494cb"><ix:nonNumeric contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930" name="amn:ScheduleofSupplementalBalanceSheetDisclosuresTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y182MS9mcmFnOmU0Njg0NTE5ODc2ZjRiN2M5ZGYzNmRjOGVjZjA4ZTJmL3RleHRyZWdpb246ZTQ2ODQ1MTk4NzZmNGI3YzlkZjM2ZGM4ZWNmMDhlMmZfOTI_c491051c-bb02-49c8-a7a5-227bdc754841" escape="true"><div style="margin-bottom:3pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated balance sheets detail is as follows:</span></div><div style="margin-bottom:3pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.946%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.771%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.344%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.931%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash and cash equivalents</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68ecd84e8da440808154baac134e839e_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RestrictedCashAndCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y182MS9mcmFnOmU0Njg0NTE5ODc2ZjRiN2M5ZGYzNmRjOGVjZjA4ZTJmL3RhYmxlOjNhZTAyZjQ4MjgzYzQxMWQ5YzcwZmUyZGIwYjU2ODYyL3RhYmxlcmFuZ2U6M2FlMDJmNDgyODNjNDExZDljNzBmZTJkYjBiNTY4NjJfMi0yLTEtMS0xMDc3MA_8a79ba97-a211-4859-bdfd-afc80ef17b7d">18,118</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RestrictedCashAndCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y182MS9mcmFnOmU0Njg0NTE5ODc2ZjRiN2M5ZGYzNmRjOGVjZjA4ZTJmL3RhYmxlOjNhZTAyZjQ4MjgzYzQxMWQ5YzcwZmUyZGIwYjU2ODYyL3RhYmxlcmFuZ2U6M2FlMDJmNDgyODNjNDExZDljNzBmZTJkYjBiNTY4NjJfMi00LTEtMS0xMDc3MA_f9f4de69-3538-43af-a115-d1d1fa4cb178">18,626</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes receivable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68ecd84e8da440808154baac134e839e_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxesReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y182MS9mcmFnOmU0Njg0NTE5ODc2ZjRiN2M5ZGYzNmRjOGVjZjA4ZTJmL3RhYmxlOjNhZTAyZjQ4MjgzYzQxMWQ5YzcwZmUyZGIwYjU2ODYyL3RhYmxlcmFuZ2U6M2FlMDJmNDgyODNjNDExZDljNzBmZTJkYjBiNTY4NjJfMy0yLTEtMS0xMDc3MA_8b8a575b-c20d-49ff-8642-b99ffff9e588">1,119</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxesReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y182MS9mcmFnOmU0Njg0NTE5ODc2ZjRiN2M5ZGYzNmRjOGVjZjA4ZTJmL3RhYmxlOjNhZTAyZjQ4MjgzYzQxMWQ5YzcwZmUyZGIwYjU2ODYyL3RhYmxlcmFuZ2U6M2FlMDJmNDgyODNjNDExZDljNzBmZTJkYjBiNTY4NjJfMy00LTEtMS0xMDc3MA_c931a6c8-46d9-41d4-8d0a-a124eb95a216">6,591</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68ecd84e8da440808154baac134e839e_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherAssetsMiscellaneousCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y182MS9mcmFnOmU0Njg0NTE5ODc2ZjRiN2M5ZGYzNmRjOGVjZjA4ZTJmL3RhYmxlOjNhZTAyZjQ4MjgzYzQxMWQ5YzcwZmUyZGIwYjU2ODYyL3RhYmxlcmFuZ2U6M2FlMDJmNDgyODNjNDExZDljNzBmZTJkYjBiNTY4NjJfNC0yLTEtMS0xMDc3MA_4ea8a3ed-6763-413e-bee5-872f99edf311">12,159</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherAssetsMiscellaneousCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y182MS9mcmFnOmU0Njg0NTE5ODc2ZjRiN2M5ZGYzNmRjOGVjZjA4ZTJmL3RhYmxlOjNhZTAyZjQ4MjgzYzQxMWQ5YzcwZmUyZGIwYjU2ODYyL3RhYmxlcmFuZ2U6M2FlMDJmNDgyODNjNDExZDljNzBmZTJkYjBiNTY4NjJfNC00LTEtMS0xMDc3MA_3f787d8b-4c98-432a-b3f0-c98e46cc2500">15,592</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68ecd84e8da440808154baac134e839e_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherAssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y182MS9mcmFnOmU0Njg0NTE5ODc2ZjRiN2M5ZGYzNmRjOGVjZjA4ZTJmL3RhYmxlOjNhZTAyZjQ4MjgzYzQxMWQ5YzcwZmUyZGIwYjU2ODYyL3RhYmxlcmFuZ2U6M2FlMDJmNDgyODNjNDExZDljNzBmZTJkYjBiNTY4NjJfNS0yLTEtMS0xMDc3MA_00eafeb6-aadb-4b73-93ee-1a719ca5a40a">31,396</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherAssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y182MS9mcmFnOmU0Njg0NTE5ODc2ZjRiN2M5ZGYzNmRjOGVjZjA4ZTJmL3RhYmxlOjNhZTAyZjQ4MjgzYzQxMWQ5YzcwZmUyZGIwYjU2ODYyL3RhYmxlcmFuZ2U6M2FlMDJmNDgyODNjNDExZDljNzBmZTJkYjBiNTY4NjJfNS00LTEtMS0xMDc3MA_585aa184-03e7-45cc-bc7c-935a75b1e20e">40,809</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68ecd84e8da440808154baac134e839e_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FurnitureAndFixturesGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y182MS9mcmFnOmU0Njg0NTE5ODc2ZjRiN2M5ZGYzNmRjOGVjZjA4ZTJmL3RhYmxlOjNhZTAyZjQ4MjgzYzQxMWQ5YzcwZmUyZGIwYjU2ODYyL3RhYmxlcmFuZ2U6M2FlMDJmNDgyODNjNDExZDljNzBmZTJkYjBiNTY4NjJfOC0yLTEtMS0xMDc3MA_17bddc7e-ac0e-4ae3-837e-a1c2f4d5ce36">54,634</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FurnitureAndFixturesGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y182MS9mcmFnOmU0Njg0NTE5ODc2ZjRiN2M5ZGYzNmRjOGVjZjA4ZTJmL3RhYmxlOjNhZTAyZjQ4MjgzYzQxMWQ5YzcwZmUyZGIwYjU2ODYyL3RhYmxlcmFuZ2U6M2FlMDJmNDgyODNjNDExZDljNzBmZTJkYjBiNTY4NjJfOC00LTEtMS0xMDc3MA_bbd5e666-9aea-4a89-bdfb-87d420e4a4b2">47,355</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68ecd84e8da440808154baac134e839e_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CapitalizedComputerSoftwareGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y182MS9mcmFnOmU0Njg0NTE5ODc2ZjRiN2M5ZGYzNmRjOGVjZjA4ZTJmL3RhYmxlOjNhZTAyZjQ4MjgzYzQxMWQ5YzcwZmUyZGIwYjU2ODYyL3RhYmxlcmFuZ2U6M2FlMDJmNDgyODNjNDExZDljNzBmZTJkYjBiNTY4NjJfOS0yLTEtMS0xMDc3MA_60a54a1f-6584-42d1-8c11-655d6bc78416">254,090</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CapitalizedComputerSoftwareGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y182MS9mcmFnOmU0Njg0NTE5ODc2ZjRiN2M5ZGYzNmRjOGVjZjA4ZTJmL3RhYmxlOjNhZTAyZjQ4MjgzYzQxMWQ5YzcwZmUyZGIwYjU2ODYyL3RhYmxlcmFuZ2U6M2FlMDJmNDgyODNjNDExZDljNzBmZTJkYjBiNTY4NjJfOS00LTEtMS0xMDc3MA_85e1dc03-6ce7-497e-bcdb-378dda1d36e2">220,971</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68ecd84e8da440808154baac134e839e_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LeaseholdImprovementsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y182MS9mcmFnOmU0Njg0NTE5ODc2ZjRiN2M5ZGYzNmRjOGVjZjA4ZTJmL3RhYmxlOjNhZTAyZjQ4MjgzYzQxMWQ5YzcwZmUyZGIwYjU2ODYyL3RhYmxlcmFuZ2U6M2FlMDJmNDgyODNjNDExZDljNzBmZTJkYjBiNTY4NjJfMTAtMi0xLTEtMTA3NzA_db1c9882-ad65-49cb-9f96-7f07cc6d1f81">9,616</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LeaseholdImprovementsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y182MS9mcmFnOmU0Njg0NTE5ODc2ZjRiN2M5ZGYzNmRjOGVjZjA4ZTJmL3RhYmxlOjNhZTAyZjQ4MjgzYzQxMWQ5YzcwZmUyZGIwYjU2ODYyL3RhYmxlcmFuZ2U6M2FlMDJmNDgyODNjNDExZDljNzBmZTJkYjBiNTY4NjJfMTAtNC0xLTEtMTA3NzA_aa86d2c2-01fb-4f91-ac75-d787ab731b95">9,600</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68ecd84e8da440808154baac134e839e_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y182MS9mcmFnOmU0Njg0NTE5ODc2ZjRiN2M5ZGYzNmRjOGVjZjA4ZTJmL3RhYmxlOjNhZTAyZjQ4MjgzYzQxMWQ5YzcwZmUyZGIwYjU2ODYyL3RhYmxlcmFuZ2U6M2FlMDJmNDgyODNjNDExZDljNzBmZTJkYjBiNTY4NjJfMTEtMi0xLTEtMTA3NzA_00511c60-0048-4352-92dc-539a0fdacce3">318,340</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y182MS9mcmFnOmU0Njg0NTE5ODc2ZjRiN2M5ZGYzNmRjOGVjZjA4ZTJmL3RhYmxlOjNhZTAyZjQ4MjgzYzQxMWQ5YzcwZmUyZGIwYjU2ODYyL3RhYmxlcmFuZ2U6M2FlMDJmNDgyODNjNDExZDljNzBmZTJkYjBiNTY4NjJfMTEtNC0xLTEtMTA3NzA_77d21b11-a47f-4784-a5af-be3876aada58">277,926</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i68ecd84e8da440808154baac134e839e_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y182MS9mcmFnOmU0Njg0NTE5ODc2ZjRiN2M5ZGYzNmRjOGVjZjA4ZTJmL3RhYmxlOjNhZTAyZjQ4MjgzYzQxMWQ5YzcwZmUyZGIwYjU2ODYyL3RhYmxlcmFuZ2U6M2FlMDJmNDgyODNjNDExZDljNzBmZTJkYjBiNTY4NjJfMTItMi0xLTEtMTA3NzA_c4b8fe4d-fd99-4c05-a335-a3b3c32bab35">190,578</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y182MS9mcmFnOmU0Njg0NTE5ODc2ZjRiN2M5ZGYzNmRjOGVjZjA4ZTJmL3RhYmxlOjNhZTAyZjQ4MjgzYzQxMWQ5YzcwZmUyZGIwYjU2ODYyL3RhYmxlcmFuZ2U6M2FlMDJmNDgyODNjNDExZDljNzBmZTJkYjBiNTY4NjJfMTItNC0xLTEtMTA3NzA_5d27f4c9-e373-43b6-8a92-3c52c42f011d">161,752</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed assets, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68ecd84e8da440808154baac134e839e_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y182MS9mcmFnOmU0Njg0NTE5ODc2ZjRiN2M5ZGYzNmRjOGVjZjA4ZTJmL3RhYmxlOjNhZTAyZjQ4MjgzYzQxMWQ5YzcwZmUyZGIwYjU2ODYyL3RhYmxlcmFuZ2U6M2FlMDJmNDgyODNjNDExZDljNzBmZTJkYjBiNTY4NjJfMTMtMi0xLTEtMTA3NzA_50500f17-1703-4941-8ff5-228fb83c7012">127,762</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y182MS9mcmFnOmU0Njg0NTE5ODc2ZjRiN2M5ZGYzNmRjOGVjZjA4ZTJmL3RhYmxlOjNhZTAyZjQ4MjgzYzQxMWQ5YzcwZmUyZGIwYjU2ODYyL3RhYmxlcmFuZ2U6M2FlMDJmNDgyODNjNDExZDljNzBmZTJkYjBiNTY4NjJfMTMtNC0xLTEtMTA3NzA_ec0b2695-6bed-44df-b76a-a1ebb1580f41">116,174</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Life insurance cash surrender value</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68ecd84e8da440808154baac134e839e_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashSurrenderValueOfLifeInsurance" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y182MS9mcmFnOmU0Njg0NTE5ODc2ZjRiN2M5ZGYzNmRjOGVjZjA4ZTJmL3RhYmxlOjNhZTAyZjQ4MjgzYzQxMWQ5YzcwZmUyZGIwYjU2ODYyL3RhYmxlcmFuZ2U6M2FlMDJmNDgyODNjNDExZDljNzBmZTJkYjBiNTY4NjJfMTYtMi0xLTEtMTA3NzA_ed5006a6-1f9a-47cb-8cc1-36bcc419221b">114,037</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashSurrenderValueOfLifeInsurance" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y182MS9mcmFnOmU0Njg0NTE5ODc2ZjRiN2M5ZGYzNmRjOGVjZjA4ZTJmL3RhYmxlOjNhZTAyZjQ4MjgzYzQxMWQ5YzcwZmUyZGIwYjU2ODYyL3RhYmxlcmFuZ2U6M2FlMDJmNDgyODNjNDExZDljNzBmZTJkYjBiNTY4NjJfMTYtNC0xLTEtMTA3NzA_67048910-a2e4-4a6b-95cb-ac41cf172833">98,161</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68ecd84e8da440808154baac134e839e_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherAssetsMiscellaneous" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y182MS9mcmFnOmU0Njg0NTE5ODc2ZjRiN2M5ZGYzNmRjOGVjZjA4ZTJmL3RhYmxlOjNhZTAyZjQ4MjgzYzQxMWQ5YzcwZmUyZGIwYjU2ODYyL3RhYmxlcmFuZ2U6M2FlMDJmNDgyODNjNDExZDljNzBmZTJkYjBiNTY4NjJfMTctMi0xLTEtMTA3NzA_7fcca5fc-a6a8-4d05-988d-6bc073cb40fe">43,872</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherAssetsMiscellaneous" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y182MS9mcmFnOmU0Njg0NTE5ODc2ZjRiN2M5ZGYzNmRjOGVjZjA4ZTJmL3RhYmxlOjNhZTAyZjQ4MjgzYzQxMWQ5YzcwZmUyZGIwYjU2ODYyL3RhYmxlcmFuZ2U6M2FlMDJmNDgyODNjNDExZDljNzBmZTJkYjBiNTY4NjJfMTctNC0xLTEtMTA3NzA_e8373a79-1b79-4c1e-8ea6-45cad253d826">36,959</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68ecd84e8da440808154baac134e839e_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherAssetsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y182MS9mcmFnOmU0Njg0NTE5ODc2ZjRiN2M5ZGYzNmRjOGVjZjA4ZTJmL3RhYmxlOjNhZTAyZjQ4MjgzYzQxMWQ5YzcwZmUyZGIwYjU2ODYyL3RhYmxlcmFuZ2U6M2FlMDJmNDgyODNjNDExZDljNzBmZTJkYjBiNTY4NjJfMTgtMi0xLTEtMTA3NzA_3e16c202-df06-447e-bc90-1ce05f614f87">157,909</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherAssetsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y182MS9mcmFnOmU0Njg0NTE5ODc2ZjRiN2M5ZGYzNmRjOGVjZjA4ZTJmL3RhYmxlOjNhZTAyZjQ4MjgzYzQxMWQ5YzcwZmUyZGIwYjU2ODYyL3RhYmxlcmFuZ2U6M2FlMDJmNDgyODNjNDExZDljNzBmZTJkYjBiNTY4NjJfMTgtNC0xLTEtMTA3NzA_19f86d3b-df1b-4316-8154-537a33436d57">135,120</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade accounts payable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68ecd84e8da440808154baac134e839e_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccountsPayableTradeCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y182MS9mcmFnOmU0Njg0NTE5ODc2ZjRiN2M5ZGYzNmRjOGVjZjA4ZTJmL3RhYmxlOjNhZTAyZjQ4MjgzYzQxMWQ5YzcwZmUyZGIwYjU2ODYyL3RhYmxlcmFuZ2U6M2FlMDJmNDgyODNjNDExZDljNzBmZTJkYjBiNTY4NjJfMjEtMi0xLTEtMTA3NzA_0569c4db-954b-4377-8b2e-bf6846c90ebb">48,468</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccountsPayableTradeCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y182MS9mcmFnOmU0Njg0NTE5ODc2ZjRiN2M5ZGYzNmRjOGVjZjA4ZTJmL3RhYmxlOjNhZTAyZjQ4MjgzYzQxMWQ5YzcwZmUyZGIwYjU2ODYyL3RhYmxlcmFuZ2U6M2FlMDJmNDgyODNjNDExZDljNzBmZTJkYjBiNTY4NjJfMjEtNC0xLTEtMTA3NzA_f643f88a-f043-45d4-8028-d9f1cf8907d1">28,089</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subcontractor payable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68ecd84e8da440808154baac134e839e_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="amn:AccountsPayableToSubcontractor" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y182MS9mcmFnOmU0Njg0NTE5ODc2ZjRiN2M5ZGYzNmRjOGVjZjA4ZTJmL3RhYmxlOjNhZTAyZjQ4MjgzYzQxMWQ5YzcwZmUyZGIwYjU2ODYyL3RhYmxlcmFuZ2U6M2FlMDJmNDgyODNjNDExZDljNzBmZTJkYjBiNTY4NjJfMjItMi0xLTEtMTA3NzA_014e52ff-49ef-4ceb-96dc-c4226a59d540">147,776</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="amn:AccountsPayableToSubcontractor" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y182MS9mcmFnOmU0Njg0NTE5ODc2ZjRiN2M5ZGYzNmRjOGVjZjA4ZTJmL3RhYmxlOjNhZTAyZjQ4MjgzYzQxMWQ5YzcwZmUyZGIwYjU2ODYyL3RhYmxlcmFuZ2U6M2FlMDJmNDgyODNjNDExZDljNzBmZTJkYjBiNTY4NjJfMjItNC0xLTEtMTA3NzA_4ebf53a7-86a0-4f52-8c69-189b7c8a2860">79,364</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68ecd84e8da440808154baac134e839e_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y182MS9mcmFnOmU0Njg0NTE5ODc2ZjRiN2M5ZGYzNmRjOGVjZjA4ZTJmL3RhYmxlOjNhZTAyZjQ4MjgzYzQxMWQ5YzcwZmUyZGIwYjU2ODYyL3RhYmxlcmFuZ2U6M2FlMDJmNDgyODNjNDExZDljNzBmZTJkYjBiNTY4NjJfMjMtMi0xLTEtMTA3NzA_aa30d075-cd62-4560-9ce6-48569f1a7a18">60,414</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y182MS9mcmFnOmU0Njg0NTE5ODc2ZjRiN2M5ZGYzNmRjOGVjZjA4ZTJmL3RhYmxlOjNhZTAyZjQ4MjgzYzQxMWQ5YzcwZmUyZGIwYjU2ODYyL3RhYmxlcmFuZ2U6M2FlMDJmNDgyODNjNDExZDljNzBmZTJkYjBiNTY4NjJfMjMtNC0xLTEtMTA3NzA_7c1a7841-048f-452e-8b94-e59ca1f14192">37,849</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss contingencies</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68ecd84e8da440808154baac134e839e_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LossContingencyAccrualCarryingValueCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y182MS9mcmFnOmU0Njg0NTE5ODc2ZjRiN2M5ZGYzNmRjOGVjZjA4ZTJmL3RhYmxlOjNhZTAyZjQ4MjgzYzQxMWQ5YzcwZmUyZGIwYjU2ODYyL3RhYmxlcmFuZ2U6M2FlMDJmNDgyODNjNDExZDljNzBmZTJkYjBiNTY4NjJfMjQtMi0xLTEtMTA3NzA_6bbda510-4e98-461b-8082-defdf4eddb97">11,627</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LossContingencyAccrualCarryingValueCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y182MS9mcmFnOmU0Njg0NTE5ODc2ZjRiN2M5ZGYzNmRjOGVjZjA4ZTJmL3RhYmxlOjNhZTAyZjQ4MjgzYzQxMWQ5YzcwZmUyZGIwYjU2ODYyL3RhYmxlcmFuZ2U6M2FlMDJmNDgyODNjNDExZDljNzBmZTJkYjBiNTY4NjJfMjQtNC0xLTEtMTA3NzA_d049fd6e-ec21-4557-a66e-5500e20ac385">7,613</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Professional liability reserve</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68ecd84e8da440808154baac134e839e_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SelfInsuranceReserveCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y182MS9mcmFnOmU0Njg0NTE5ODc2ZjRiN2M5ZGYzNmRjOGVjZjA4ZTJmL3RhYmxlOjNhZTAyZjQ4MjgzYzQxMWQ5YzcwZmUyZGIwYjU2ODYyL3RhYmxlcmFuZ2U6M2FlMDJmNDgyODNjNDExZDljNzBmZTJkYjBiNTY4NjJfMjUtMi0xLTEtMTA3NzA_7f331142-ba7d-4658-a96b-192c60cc78ce">6,773</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SelfInsuranceReserveCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y182MS9mcmFnOmU0Njg0NTE5ODc2ZjRiN2M5ZGYzNmRjOGVjZjA4ZTJmL3RhYmxlOjNhZTAyZjQ4MjgzYzQxMWQ5YzcwZmUyZGIwYjU2ODYyL3RhYmxlcmFuZ2U6M2FlMDJmNDgyODNjNDExZDljNzBmZTJkYjBiNTY4NjJfMjUtNC0xLTEtMTA3NzA_9a6bbb3b-c214-4801-a9bf-e6cd9f31c7e1">8,897</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68ecd84e8da440808154baac134e839e_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherAccountsPayableAndAccruedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y182MS9mcmFnOmU0Njg0NTE5ODc2ZjRiN2M5ZGYzNmRjOGVjZjA4ZTJmL3RhYmxlOjNhZTAyZjQ4MjgzYzQxMWQ5YzcwZmUyZGIwYjU2ODYyL3RhYmxlcmFuZ2U6M2FlMDJmNDgyODNjNDExZDljNzBmZTJkYjBiNTY4NjJfMjYtMi0xLTEtMTA3NzA_47c5d144-b638-4ba4-8668-abc0c96aeffa">9,036</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherAccountsPayableAndAccruedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y182MS9mcmFnOmU0Njg0NTE5ODc2ZjRiN2M5ZGYzNmRjOGVjZjA4ZTJmL3RhYmxlOjNhZTAyZjQ4MjgzYzQxMWQ5YzcwZmUyZGIwYjU2ODYyL3RhYmxlcmFuZ2U6M2FlMDJmNDgyODNjNDExZDljNzBmZTJkYjBiNTY4NjJfMjYtNC0xLTEtMTA3NzA_0dc91088-40dd-4515-9cac-f813c1096116">6,069</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68ecd84e8da440808154baac134e839e_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="amn:AccountsPayableAndAccruedExpensesExcludingAccruedCompensationAndBenefitsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y182MS9mcmFnOmU0Njg0NTE5ODc2ZjRiN2M5ZGYzNmRjOGVjZjA4ZTJmL3RhYmxlOjNhZTAyZjQ4MjgzYzQxMWQ5YzcwZmUyZGIwYjU2ODYyL3RhYmxlcmFuZ2U6M2FlMDJmNDgyODNjNDExZDljNzBmZTJkYjBiNTY4NjJfMjctMi0xLTEtMTA3NzA_6cd926c2-d56b-45cf-ad5e-4022baac3404">284,094</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="amn:AccountsPayableAndAccruedExpensesExcludingAccruedCompensationAndBenefitsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y182MS9mcmFnOmU0Njg0NTE5ODc2ZjRiN2M5ZGYzNmRjOGVjZjA4ZTJmL3RhYmxlOjNhZTAyZjQ4MjgzYzQxMWQ5YzcwZmUyZGIwYjU2ODYyL3RhYmxlcmFuZ2U6M2FlMDJmNDgyODNjNDExZDljNzBmZTJkYjBiNTY4NjJfMjctNC0xLTEtMTA3NzA_8b5a53c4-8e7c-4489-b21a-556c9520c154">167,881</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued compensation and benefits:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued payroll</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68ecd84e8da440808154baac134e839e_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccruedSalariesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y182MS9mcmFnOmU0Njg0NTE5ODc2ZjRiN2M5ZGYzNmRjOGVjZjA4ZTJmL3RhYmxlOjNhZTAyZjQ4MjgzYzQxMWQ5YzcwZmUyZGIwYjU2ODYyL3RhYmxlcmFuZ2U6M2FlMDJmNDgyODNjNDExZDljNzBmZTJkYjBiNTY4NjJfMzAtMi0xLTEtMTA3NzA_89c262ba-2f1b-4351-8a22-22cb75893180">114,299</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccruedSalariesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y182MS9mcmFnOmU0Njg0NTE5ODc2ZjRiN2M5ZGYzNmRjOGVjZjA4ZTJmL3RhYmxlOjNhZTAyZjQ4MjgzYzQxMWQ5YzcwZmUyZGIwYjU2ODYyL3RhYmxlcmFuZ2U6M2FlMDJmNDgyODNjNDExZDljNzBmZTJkYjBiNTY4NjJfMzAtNC0xLTEtMTA3NzA_3ee1d439-4caa-4e23-8947-077f3f850a73">59,721</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued bonuses and commissions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68ecd84e8da440808154baac134e839e_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="amn:AccruedBonusesAndCommissions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y182MS9mcmFnOmU0Njg0NTE5ODc2ZjRiN2M5ZGYzNmRjOGVjZjA4ZTJmL3RhYmxlOjNhZTAyZjQ4MjgzYzQxMWQ5YzcwZmUyZGIwYjU2ODYyL3RhYmxlcmFuZ2U6M2FlMDJmNDgyODNjNDExZDljNzBmZTJkYjBiNTY4NjJfMzEtMi0xLTEtMTA3NzA_2ace17cf-3367-4b90-b4df-ed22b85ef947">66,215</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="amn:AccruedBonusesAndCommissions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y182MS9mcmFnOmU0Njg0NTE5ODc2ZjRiN2M5ZGYzNmRjOGVjZjA4ZTJmL3RhYmxlOjNhZTAyZjQ4MjgzYzQxMWQ5YzcwZmUyZGIwYjU2ODYyL3RhYmxlcmFuZ2U6M2FlMDJmNDgyODNjNDExZDljNzBmZTJkYjBiNTY4NjJfMzEtNC0xLTEtMTA3NzA_3b1fe41e-79d0-4e50-bdba-22a4924f5db6">34,514</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued travel expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68ecd84e8da440808154baac134e839e_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="amn:AccruedTravelExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y182MS9mcmFnOmU0Njg0NTE5ODc2ZjRiN2M5ZGYzNmRjOGVjZjA4ZTJmL3RhYmxlOjNhZTAyZjQ4MjgzYzQxMWQ5YzcwZmUyZGIwYjU2ODYyL3RhYmxlcmFuZ2U6M2FlMDJmNDgyODNjNDExZDljNzBmZTJkYjBiNTY4NjJfMzItMi0xLTEtMTA3NzA_a6b144f6-d91c-4eef-a45a-b42330963a50">2,673</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="amn:AccruedTravelExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y182MS9mcmFnOmU0Njg0NTE5ODc2ZjRiN2M5ZGYzNmRjOGVjZjA4ZTJmL3RhYmxlOjNhZTAyZjQ4MjgzYzQxMWQ5YzcwZmUyZGIwYjU2ODYyL3RhYmxlcmFuZ2U6M2FlMDJmNDgyODNjNDExZDljNzBmZTJkYjBiNTY4NjJfMzItNC0xLTEtMTA3NzA_0a55824d-dd40-4345-a2f5-453806098c41">1,998</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health insurance reserve</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68ecd84e8da440808154baac134e839e_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccruedInsuranceCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y182MS9mcmFnOmU0Njg0NTE5ODc2ZjRiN2M5ZGYzNmRjOGVjZjA4ZTJmL3RhYmxlOjNhZTAyZjQ4MjgzYzQxMWQ5YzcwZmUyZGIwYjU2ODYyL3RhYmxlcmFuZ2U6M2FlMDJmNDgyODNjNDExZDljNzBmZTJkYjBiNTY4NjJfMzMtMi0xLTEtMTA3NzA_76028924-16c1-4b66-9bdc-340e4698859c">6,627</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccruedInsuranceCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y182MS9mcmFnOmU0Njg0NTE5ODc2ZjRiN2M5ZGYzNmRjOGVjZjA4ZTJmL3RhYmxlOjNhZTAyZjQ4MjgzYzQxMWQ5YzcwZmUyZGIwYjU2ODYyL3RhYmxlcmFuZ2U6M2FlMDJmNDgyODNjNDExZDljNzBmZTJkYjBiNTY4NjJfMzMtNC0xLTEtMTA3NzA_3502b434-a8f2-474d-89a9-683b877b29a3">5,590</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Workers compensation reserve</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68ecd84e8da440808154baac134e839e_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WorkersCompensationLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y182MS9mcmFnOmU0Njg0NTE5ODc2ZjRiN2M5ZGYzNmRjOGVjZjA4ZTJmL3RhYmxlOjNhZTAyZjQ4MjgzYzQxMWQ5YzcwZmUyZGIwYjU2ODYyL3RhYmxlcmFuZ2U6M2FlMDJmNDgyODNjNDExZDljNzBmZTJkYjBiNTY4NjJfMzQtMi0xLTEtMTA3NzA_49f8deb8-8186-4ee3-be87-25dff38c733e">10,297</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WorkersCompensationLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y182MS9mcmFnOmU0Njg0NTE5ODc2ZjRiN2M5ZGYzNmRjOGVjZjA4ZTJmL3RhYmxlOjNhZTAyZjQ4MjgzYzQxMWQ5YzcwZmUyZGIwYjU2ODYyL3RhYmxlcmFuZ2U6M2FlMDJmNDgyODNjNDExZDljNzBmZTJkYjBiNTY4NjJfMzQtNC0xLTEtMTA3NzA_cc244f96-7d82-4f22-a81a-69684c1e6db6">10,244</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68ecd84e8da440808154baac134e839e_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredCompensationLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y182MS9mcmFnOmU0Njg0NTE5ODc2ZjRiN2M5ZGYzNmRjOGVjZjA4ZTJmL3RhYmxlOjNhZTAyZjQ4MjgzYzQxMWQ5YzcwZmUyZGIwYjU2ODYyL3RhYmxlcmFuZ2U6M2FlMDJmNDgyODNjNDExZDljNzBmZTJkYjBiNTY4NjJfMzUtMi0xLTEtMTA3NzA_8898a53b-25ad-4755-a8bb-369ca0b2e68c">117,020</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredCompensationLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y182MS9mcmFnOmU0Njg0NTE5ODc2ZjRiN2M5ZGYzNmRjOGVjZjA4ZTJmL3RhYmxlOjNhZTAyZjQ4MjgzYzQxMWQ5YzcwZmUyZGIwYjU2ODYyL3RhYmxlcmFuZ2U6M2FlMDJmNDgyODNjNDExZDljNzBmZTJkYjBiNTY4NjJfMzUtNC0xLTEtMTA3NzA_5dceb5e0-e4b1-49e8-b2a7-9d3a2cde2207">97,184</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68ecd84e8da440808154baac134e839e_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherEmployeeRelatedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y182MS9mcmFnOmU0Njg0NTE5ODc2ZjRiN2M5ZGYzNmRjOGVjZjA4ZTJmL3RhYmxlOjNhZTAyZjQ4MjgzYzQxMWQ5YzcwZmUyZGIwYjU2ODYyL3RhYmxlcmFuZ2U6M2FlMDJmNDgyODNjNDExZDljNzBmZTJkYjBiNTY4NjJfMzYtMi0xLTEtMTA3NzA_7729182b-885c-44a8-8ec7-2ad7ff8d5e0b">4,807</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherEmployeeRelatedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y182MS9mcmFnOmU0Njg0NTE5ODc2ZjRiN2M5ZGYzNmRjOGVjZjA4ZTJmL3RhYmxlOjNhZTAyZjQ4MjgzYzQxMWQ5YzcwZmUyZGIwYjU2ODYyL3RhYmxlcmFuZ2U6M2FlMDJmNDgyODNjNDExZDljNzBmZTJkYjBiNTY4NjJfMzYtNC0xLTEtMTA3NzA_61d94abe-462f-4f83-b361-dad5833c6523">4,163</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued compensation and benefits</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68ecd84e8da440808154baac134e839e_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y182MS9mcmFnOmU0Njg0NTE5ODc2ZjRiN2M5ZGYzNmRjOGVjZjA4ZTJmL3RhYmxlOjNhZTAyZjQ4MjgzYzQxMWQ5YzcwZmUyZGIwYjU2ODYyL3RhYmxlcmFuZ2U6M2FlMDJmNDgyODNjNDExZDljNzBmZTJkYjBiNTY4NjJfMzctMi0xLTEtMTA3NzA_388863a1-c81d-43e1-a9aa-8ce05c13ab85">321,938</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y182MS9mcmFnOmU0Njg0NTE5ODc2ZjRiN2M5ZGYzNmRjOGVjZjA4ZTJmL3RhYmxlOjNhZTAyZjQ4MjgzYzQxMWQ5YzcwZmUyZGIwYjU2ODYyL3RhYmxlcmFuZ2U6M2FlMDJmNDgyODNjNDExZDljNzBmZTJkYjBiNTY4NjJfMzctNC0xLTEtMTA3NzA_389f04d9-73c0-4333-b2e9-7afedd9eb3e9">213,414</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Workers compensation reserve</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68ecd84e8da440808154baac134e839e_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WorkersCompensationLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y182MS9mcmFnOmU0Njg0NTE5ODc2ZjRiN2M5ZGYzNmRjOGVjZjA4ZTJmL3RhYmxlOjNhZTAyZjQ4MjgzYzQxMWQ5YzcwZmUyZGIwYjU2ODYyL3RhYmxlcmFuZ2U6M2FlMDJmNDgyODNjNDExZDljNzBmZTJkYjBiNTY4NjJfNDYtMi0xLTEtMTA3NzA_2466217e-d802-4efd-87a1-af90465cc537">20,716</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WorkersCompensationLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y182MS9mcmFnOmU0Njg0NTE5ODc2ZjRiN2M5ZGYzNmRjOGVjZjA4ZTJmL3RhYmxlOjNhZTAyZjQ4MjgzYzQxMWQ5YzcwZmUyZGIwYjU2ODYyL3RhYmxlcmFuZ2U6M2FlMDJmNDgyODNjNDExZDljNzBmZTJkYjBiNTY4NjJfNDYtNC0xLTEtMTA3NzA_3ae69ef5-8af0-4211-a94a-339b672ec3d4">20,930</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Professional liability reserve</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68ecd84e8da440808154baac134e839e_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SelfInsuranceReserveNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y182MS9mcmFnOmU0Njg0NTE5ODc2ZjRiN2M5ZGYzNmRjOGVjZjA4ZTJmL3RhYmxlOjNhZTAyZjQ4MjgzYzQxMWQ5YzcwZmUyZGIwYjU2ODYyL3RhYmxlcmFuZ2U6M2FlMDJmNDgyODNjNDExZDljNzBmZTJkYjBiNTY4NjJfNDctMi0xLTEtMTA3NzA_c8a5fb23-a78e-420c-8971-eaf5abab760e">31,768</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SelfInsuranceReserveNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y182MS9mcmFnOmU0Njg0NTE5ODc2ZjRiN2M5ZGYzNmRjOGVjZjA4ZTJmL3RhYmxlOjNhZTAyZjQ4MjgzYzQxMWQ5YzcwZmUyZGIwYjU2ODYyL3RhYmxlcmFuZ2U6M2FlMDJmNDgyODNjNDExZDljNzBmZTJkYjBiNTY4NjJfNDctNC0xLTEtMTA3NzA_fdb76b90-4a6b-4038-837a-ba93017a4675">31,997</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized tax benefits</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68ecd84e8da440808154baac134e839e_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilityForUncertainTaxPositionsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y182MS9mcmFnOmU0Njg0NTE5ODc2ZjRiN2M5ZGYzNmRjOGVjZjA4ZTJmL3RhYmxlOjNhZTAyZjQ4MjgzYzQxMWQ5YzcwZmUyZGIwYjU2ODYyL3RhYmxlcmFuZ2U6M2FlMDJmNDgyODNjNDExZDljNzBmZTJkYjBiNTY4NjJfNDgtMi0xLTEtMTA3NzA_3b293a2e-cb0d-4d1c-bb5f-fd0079b548b8">5,403</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilityForUncertainTaxPositionsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y182MS9mcmFnOmU0Njg0NTE5ODc2ZjRiN2M5ZGYzNmRjOGVjZjA4ZTJmL3RhYmxlOjNhZTAyZjQ4MjgzYzQxMWQ5YzcwZmUyZGIwYjU2ODYyL3RhYmxlcmFuZ2U6M2FlMDJmNDgyODNjNDExZDljNzBmZTJkYjBiNTY4NjJfNDgtNC0xLTEtMTA3NzA_846f87b3-ede2-41a4-9393-5754fea449de">5,447</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68ecd84e8da440808154baac134e839e_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherSundryLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y182MS9mcmFnOmU0Njg0NTE5ODc2ZjRiN2M5ZGYzNmRjOGVjZjA4ZTJmL3RhYmxlOjNhZTAyZjQ4MjgzYzQxMWQ5YzcwZmUyZGIwYjU2ODYyL3RhYmxlcmFuZ2U6M2FlMDJmNDgyODNjNDExZDljNzBmZTJkYjBiNTY4NjJfNTAtMi0xLTEtMTA3NzA_f8f68646-6cc9-43d8-a560-3bc2608c1efb">49,228</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherSundryLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y182MS9mcmFnOmU0Njg0NTE5ODc2ZjRiN2M5ZGYzNmRjOGVjZjA4ZTJmL3RhYmxlOjNhZTAyZjQ4MjgzYzQxMWQ5YzcwZmUyZGIwYjU2ODYyL3RhYmxlcmFuZ2U6M2FlMDJmNDgyODNjNDExZDljNzBmZTJkYjBiNTY4NjJfNTAtNC0xLTEtMTA3NzA_aca8e36c-10b9-4678-bbbb-e14720caea92">49,533</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68ecd84e8da440808154baac134e839e_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y182MS9mcmFnOmU0Njg0NTE5ODc2ZjRiN2M5ZGYzNmRjOGVjZjA4ZTJmL3RhYmxlOjNhZTAyZjQ4MjgzYzQxMWQ5YzcwZmUyZGIwYjU2ODYyL3RhYmxlcmFuZ2U6M2FlMDJmNDgyODNjNDExZDljNzBmZTJkYjBiNTY4NjJfNTEtMi0xLTEtMTA3NzA_b1566e8b-abe7-4026-bbb7-3de34e363c3a">107,115</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y182MS9mcmFnOmU0Njg0NTE5ODc2ZjRiN2M5ZGYzNmRjOGVjZjA4ZTJmL3RhYmxlOjNhZTAyZjQ4MjgzYzQxMWQ5YzcwZmUyZGIwYjU2ODYyL3RhYmxlcmFuZ2U6M2FlMDJmNDgyODNjNDExZDljNzBmZTJkYjBiNTY4NjJfNTEtNC0xLTEtMTA3NzA_8b8eb984-d471-4911-99e7-dd63ebfd8dae">107,907</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div id="ia383c8c7878a498d91f9e8901f0cfd9c_67"></div><div style="padding-left:72pt;text-indent:-72pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Item&#160;2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-style:italic;font-weight:700;line-height:120%">.  Management&#8217;s Discussion and Analysis of Financial Condition and Results </span></div><div style="padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-style:italic;font-weight:700;line-height:120%">              of Operations</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:4.5pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following discussion should be read in conjunction with our consolidated financial statements and the notes thereto and other financial information included elsewhere herein and in our Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2020, filed with the Securities and Exchange Commission (&#8220;SEC&#8221;) on February 26, 2021 (&#8220;2020 Annual Report&#8221;). Certain statements in this &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; are &#8220;forward-looking statements.&#8221; See &#8220;Special Note Regarding Forward-Looking Statements.&#8221; We undertake no obligation to update the forward-looking statements in this Quarterly Report. References in this Quarterly Report to &#8220;AMN Healthcare,&#8221; the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;us&#8221; and &#8220;our&#8221; refer to AMN Healthcare Services, Inc. and its wholly owned subsidiaries. </span></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Overview of Our Business</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We provide healthcare workforce solutions and staffing services to healthcare organizations across the nation. As an innovative total talent solutions partner, our managed services programs, or &#8220;MSP,&#8221; vendor management systems, or &#8220;VMS,&#8221; workforce consulting services, predictive modeling, staff scheduling, credentialing services, revenue cycle solutions, language  services, and the placement of physicians, nurses, allied healthcare professionals and healthcare leaders into temporary and permanent positions enable our clients to successfully reduce staffing complexity, increase efficiency and lead their organizations within the rapidly evolving healthcare environment.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conduct business through three reportable segments: (1) nurse and allied solutions, (2) physician and leadership solutions, and (3) technology and workforce solutions. For the three months ended September 30, 2021, we recorded revenue of $877.8 million, as compared to $551.6 million for the same period last year. For the nine months ended September 30, 2021, we recorded revenue of $2,621.2 million, as compared to $1,762.4 million for the same period last year.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nurse and allied solutions segment revenue comprised 73% and 71% of total consolidated revenue for the nine months ended September 30, 2021 and 2020, respectively. Through our nurse and allied solutions segment, we provide hospitals and other healthcare facilities with a comprehensive managed services solution in which we manage and staff all of the temporary nursing and allied staffing needs of a client and traditional clinical staffing solutions of variable assignment lengths. We also provide revenue cycle solutions, which include skilled labor solutions for remote medical coding, clinical documentation improvement, case management, and clinical data registry, and provide auditing and advisory services.</span></div><div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Physician and leadership solutions segment revenue comprised 16% and 20% of total consolidated revenue for the nine months ended September 30, 2021 and 2020, respectively. Through our physician and leadership solutions segment, we provide a comprehensive managed services solution in which we manage all of the locum tenens needs of a client and place physicians of all specialties, as well as dentists and advanced practice providers, with clients on a temporary basis as independent contractors. We also recruit physicians and healthcare leaders for permanent placement and place interim leaders and executives across all healthcare settings. The interim healthcare professionals we place are typically placed on contracts with assignment lengths ranging from a few days to one year, and a growing number of these placements are under our managed services solution.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Technology and workforce solutions segment revenue comprised 11% and 9% of total consolidated revenue for the nine months ended September 30, 2021 and 2020, respectively. Through our technology and workforce solutions segment, we provide hospitals and other healthcare facilities with a range of workforce solutions, including: (1) language services, (2) software-as-a-service (&#8220;SaaS&#8221;) VMS technologies through which our clients can manage their temporary staffing needs, (3) workforce optimization services that include consulting, data analytics, predictive modeling, and SaaS-based scheduling technology, (4) recruitment process outsourcing services that leverage our expertise and support systems to replace or complement a client&#8217;s existing internal recruitment function for permanent placement needs, (5) telehealth services, (6) credentialing services, and (7) flex pool management and other outsourced solutions services.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of our long-term growth strategy to add value for our clients, healthcare professionals, and shareholders, on April 7, 2021 and February 14, 2020, we acquired Synzi, including its wholly-owned subsidiary SnapMD, and Stratus Video (which we have since rebranded as AMN Language Services), respectively. Synzi and SnapMD offer virtual care technology platforms; Synzi focuses on the care management and home health markets and primarily serves as a patient communication and engagement platform, while SnapMD focuses on the outpatient market and primarily serves as a clinical communication and documentation platform. See additional information in the accompanying Note (2), &#8220;Acquisitions.&#8221;</span></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Operating Metrics</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We monitor the following key metrics to help us evaluate our financial condition and performance, identify trends affecting our businesses, and make strategic decisions:</span></div><div style="padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">average travelers on assignment represents the average number of nurse and allied healthcare professionals on assignment during the period;</span></div><div style="padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">bill rates represent the hourly straight-time rates that we bill to clients;</span></div><div style="padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">billable hours represent hours worked by our healthcare professionals that we are able to bill on client engagements;</span></div><div style="padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">days filled is calculated by dividing total locum tenens hours filled during the period by eight hours;</span></div><div style="padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">revenue per day filled is calculated by dividing revenue of our locum tenens business by days filled for the period; and</span></div><div style="padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">bill-to-pay spreads represent the differential between wages paid to healthcare professionals and amounts billed to clients.</span></div><div id="ia383c8c7878a498d91f9e8901f0cfd9c_70"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Recent Trends</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Demand for our temporary and permanent placement staffing services is driven in part by U.S. economic and labor trends, and since early 2020 through present, the COVID-19 pandemic has impacted demand. When the imposition of &#8220;shelter-in-place&#8221; orders and the suspension of elective and &#8220;non-essential&#8221; healthcare services occurred in March 2020 in response to the COVID-19 health crisis, demand for many of our businesses declined significantly. With these orders and suspensions lifted, general utilization of healthcare has continued to improve and has generally returned to pre-COVID-19 levels. Since late 2020, we have been experiencing historically high demand for nurses and certain allied healthcare professionals. Recently, demand across all segments and business lines has been above pre-COVID-19 levels.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In our nurse and allied solutions segment, prior to the COVID-19 pandemic, our ability to recruit enough nurses to meet the then-current demand levels was impacted by the tight labor market and modest bill rate increases. At the peak of the pandemic, demand for nurses was most concentrated in specialties including ICU and telemetry nurses. Now, the current historic demand levels are dispersed across many specialties. Our clients are faced with increased labor shortages resulting from nurse burnout, attrition, retirements and, to a lesser extent, the impact of mandatory vaccination requirements. Bill rates and wages for these nurses have continued to remain well above prior year levels due to the significantly higher demand and our clients&#8217; need to frequently fill positions quickly. Although the number of nurses on travel assignments has increased since July 2020, our ability to adequately meet the high client demand is constrained by the tight labor market along with nurse burnout and the other aforementioned issues related to the pandemic.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The overall demand in our allied staffing division reached all-time highs in the third quarter. We saw record quarterly demand in our respiratory, laboratory, and radiology specialties, while our rehab therapy specialty saw its largest new demand quarter since 2019. The increased demand in some of these specialties was driven by COVID-19 hospitalizations, testing, and vaccination support. Demand in other modalities were driven by the continued surge in elective procedures as more of the population has become comfortable re-entering physician offices and outpatient centers. The return to in-person schools and additional federal funding has driven our school modality to strong year-over-year increases in all healthcare specialties.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In our physician and leadership solutions segment, demand has recovered and now exceeds pre-pandemic levels. We have seen particularly higher demand for certain specialties, such as anesthesiologists, certified registered nurse anesthetists and advanced practice clinicians, in our locum tenens division. Longer term, we expect continued strong core demand resulting from an increased level of burnout and turnover of healthcare leadership roles. </span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In our technology and workforce solutions segment, our VMS technologies experienced increased utilization and revenue growth this year due to increased demand levels and elevated bill rates.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The utilization of our language services business continued to grow as healthcare utilization returned to more normal activities and with the need and importance of these services having been demonstrated during the pandemic.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The demand for our recruitment process outsourcing increased in the third quarter as clients look for solutions to help address the increased labor shortages and the need to address vacancies in their permanent roles. We expect this increased demand to continue in the current constrained labor market.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As our businesses have continued to grow, we have increased our sales and operations workforce to support our clients and healthcare professionals. We have also increased spending to support our current team members and retain talent.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div id="ia383c8c7878a498d91f9e8901f0cfd9c_73"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Critical Accounting Policies and Estimates</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of our consolidated financial statements in conformity with United States generally accepted accounting principles (&#8220;U.S. GAAP&#8221;) requires us to make estimates and judgments that affect our reported amounts of assets and liabilities, revenue and expenses, and related disclosures of contingent assets and liabilities. On an ongoing basis, we evaluate our </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">estimates, including those related to intangible assets purchased in a business combination, asset impairments, accruals for self-insurance, compensation and related benefits, accounts receivable, contingencies and litigation, contingent consideration (&#8220;earn-out&#8221;) liabilities associated with acquisitions, and income taxes. We base these estimates on the information that is currently available to us and on various other assumptions that we believe are reasonable under the circumstances. Actual results could vary from these estimates under different assumptions or conditions. If these estimates differ significantly from actual results, our consolidated financial statements and future results of operations may be materially impacted. There have been no material changes in our critical accounting policies and estimates, other than the adoption of the Accounting Standards Updates (&#8220;ASUs&#8221;) described in the accompanying Note 1, &#8220;Basis of Presentation,&#8221; as compared to the critical accounting policies and estimates described in our 2020 Annual Report. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;</span></div><div id="ia383c8c7878a498d91f9e8901f0cfd9c_76"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Results of Operations</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth, for the periods indicated, selected unaudited condensed consolidated statements of operations data as a percentage of revenue. Our results of operations include three reportable segments: (1)&#160;nurse and allied solutions, (2)&#160;physician and leadership solutions, and (3)&#160;technology and workforce solutions. The Stratus Video, Synzi and SnapMD acquisitions impact the comparability of the results between the three and nine months ended September 30, 2021 and 2020 depending on the timing of the applicable acquisition. Our historical results are not necessarily indicative of our future results of operations.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:56.063%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.262%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unaudited Condensed Consolidated Statements of Operations:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net, and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before income taxes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div id="ia383c8c7878a498d91f9e8901f0cfd9c_79"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Comparison of Results for the Three Months Ended September 30, 2021 to the Three Months Ended September 30, 2020 </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Revenue</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">.&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue increased 59% to $877.8 million&#160;for the three months ended September 30, 2021 from $551.6 million for the same period in 2020, primarily attributable to higher organic revenue across our segments.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nurse and allied solutions segment revenue increased 64% to $627.0 million&#160;for the three months ended September 30, 2021 from $382.7 million for the same period in 2020. The $244.3 million increase was primarily attributable to a 34% increase in the average number of travelers on assignment, an approximately 18% increase in the average bill rate, and an approximately $22.0&#160;million increase in labor disruption revenue during the three months ended September 30, 2021.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Physician and leadership solutions segment revenue increased 38% to $150.7 million for the three months ended September 30, 2021 from $109.1 million for the same period in 2020, with the prior year significantly impacted by a demand decline related to the pandemic. The $41.6 million increase was primarily attributable to a 23% increase in the number of days filled and a 6% increase in the revenue per day filled in our locum tenens business during the three months ended September 30, 2021, as we have seen a return of core business demand and volume. Our interim leadership business experienced an approximately 60% growth primarily due to recovery in demand, growth in core business and COVID-19 project work. Our physician permanent placement and executive search businesses grew 33% as search counts have returned to pre-COVID-19 levels.</span></div><div style="margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Technology and workforce solutions segment revenue increased 67% to $100.1 million for the three months ended September 30, 2021 from $59.8 million for the same period in 2020. The $40.3 million increase was primarily attributable to growth within our VMS, language services, and outsourced solutions businesses. Revenue growth for our language services and VMS businesses was 33% and 113%, respectively, during the three months ended September 30, 2021.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended September 30, 2021 and 2020, revenue under our MSP arrangements comprised approximately 52% and 49% of our consolidated revenue, 69% and 67% of our nurse and allied solutions segment revenue, 16% and 16% of our physician and leadership solutions segment revenue, and 3% and less than 1% of our technology and workforce solutions segment revenue, respectively.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Gross Profit</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gross profit increased 66% to $305.9 million for the three months ended September 30, 2021 from $184.6 million for the same period in 2020, representing gross margins of 34.8% and 33.5%, respectively. The increase in consolidated gross margin for the three months ended September 30, 2021, as compared to the same period in 2020, was primarily due to a higher gross margin in relation to the higher revenue in our nurse and allied solutions segment, driven primarily by higher labor disruption revenue and an additional $5.6&#160;million of favorable actuarial-based decreases in our workers compensation reserves within the segment, and a change in sales mix resulting from higher revenue in our technology and workforce solutions segment and its higher margins as compared to our staffing businesses. Gross margin by reportable segment for the three months ended September 30, 2021 and 2020 was 29.3% and 27.4% for nurse and allied solutions, 34.8% and 36.7% for physician and leadership solutions, and 69.4% and 66.1% for technology and workforce solutions, respectively.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Selling, General and Administrative Expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selling, general and administrative (&#8220;SG&amp;A&#8221;) expenses were $173.9 million, representing 19.8% of revenue, for the three months ended September 30, 2021, as compared to $111.2 million, representing 20.2% of revenue, for the same period in 2020. The increase in SG&amp;A expenses was primarily due to higher employee compensation and benefits and other expenses associated with our revenue growth and a $3.9 million increase related to acquisition, integration, changes in the fair value of contingent consideration liabilities from acquisitions, restructuring, and extraordinary legal expenses. SG&amp;A expenses broken down among the reportable segments, unallocated corporate overhead, and share-based compensation are as follows: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.859%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.274%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.837%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In Thousands)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nurse and allied solutions</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91,449&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,067&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Physician and leadership solutions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,070&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,537&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology and workforce solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,957&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,369&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unallocated corporate overhead</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,867&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,490&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,589&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,772&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173,932&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111,235&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:3pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Depreciation and Amortization Expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Amortization expense decreased 18% to $16.0 million for the three months ended September 30, 2021 from $19.6 million for the same period in 2020, primarily attributable to the reduction of useful lives of certain tradename intangible assets during the third quarter of 2020, which was partially offset by additional amortization expenses related to the intangible assets acquired in the Synzi and SnapMD acquisition. Depreciation expense (exclusive of depreciation included in cost of revenue) increased 38% to $10.1 million for the three months ended September 30, 2021 from $7.3 million for the same period in 2020, primarily attributable to an increase in purchased and developed hardware and software placed in service for our ongoing information technology investments to support our total talent solutions initiatives and to optimize our internal front and back-office systems. Additionally, $0.7&#160;million and $0.5&#160;million of depreciation expense for our language services business is included in cost of revenue for the three months ended September 30, 2021 and 2020, respectively. </span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Interest Expense, Net, and Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">.&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense, net, and other was $5.2 million during the three months ended September 30, 2021 as compared to $12.6 million for the same period in 2020. The decrease was primarily due to a $5.4&#160;million gain related to the change in fair value of an equity investment and a lower average debt outstanding balance during the three months ended September 30, 2021, which resulted from repayments of the Credit Facilities (as defined below). The overall decrease was partially offset by a higher weighted average interest rate during the three months ended September 30, 2021, which was primarily due to the issuances of higher interest bearing senior notes during the third and fourth quarters of 2020.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Income Tax Expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Income tax expense was $26.6 million for the three months ended September 30, 2021 as compared to $7.8 million for the same period in 2020, reflecting effective income tax rates of 26% and 23% for the three months ended September 30, 2021 and 2020, respectively. The increase in the effective income tax rate was primarily attributable to the recognition of a $0.6 million discrete tax benefit for fair value changes in the cash surrender value of our Company Owned Life Insurance (&#8220;COLI&#8221;) during the three months ended September 30, 2021 compared to a $1.6 million discrete tax benefit for COLI during the same period in 2020, in relation to income before income taxes of $100.6 million and $33.9 million for the three months ended September 30, 2021 and 2020, respectively. We currently estimate our annual effective tax rate to be approximately 26% for 2021. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-indent:24.75pt"><span><br/></span></div><div id="ia383c8c7878a498d91f9e8901f0cfd9c_82"></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Comparison of Results for the Nine Months Ended September 30, 2021 to the Nine Months Ended September 30, 2020 </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Revenue</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">.&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue increased 49% to $2,621.2 million for the nine months ended September 30, 2021 from $1,762.4 million for the same period in 2020, primarily attributable to higher organic revenue across our segments along with additional revenue of $22.5 million from our Stratus Video, Synzi and SnapMD acquisitions.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nurse and allied solutions segment revenue increased 52% to $1,908.2 million&#160;for the nine months ended September 30, 2021 from $1,251.5 million for the same period in 2020. The $656.7 million increase was primarily attributable to an approximately 22% increase in the average bill rate, a 21% increase in the average number of travelers on assignment, a 2% increase in billable hours, and an approximately $21.0&#160;million increase in labor disruption revenue during the nine months ended September 30, 2021.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Physician and leadership solutions segment revenue increased 21% to $430.5 million for the nine months ended September 30, 2021 from $355.6 million for the same period in 2020. The $74.9 million increase was primarily attributable to a 14% increase in the number of days filled and a 6% increase in the revenue per day filled in our locum tenens business during the nine months ended September 30, 2021, which was driven in part by COVID-19 project work as well as a return in core demand and volume. The revenue increase was also attributable to growth in our interim leadership, physician permanent placement, and executive search businesses due to an increase in overall demand as engagement counts have experienced growth and search counts have returned to pre-COVID-19 levels along with COVID-19 project work. Our interim leadership business experienced an approximately 25% growth, while our physician permanent placement and executive search businesses grew 13% during the nine months ended September 30, 2021.</span></div><div style="margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Technology and workforce solutions segment revenue increased 82% to $282.5 million for the nine months ended September 30, 2021 from $155.4 million for the same period in 2020. The $127.1 million increase was primarily attributable to organic growth within our VMS, language services, and outsourced solutions businesses along with additional revenue of $22.5 million from our Stratus Video, Synzi and SnapMD acquisitions during the nine months ended September 30, 2021. Revenue growth for our language services and VMS businesses was 71% and 92%, respectively, during the nine months ended September 30, 2021.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the nine months ended September 30, 2021 and 2020, revenue under our MSP arrangements comprised approximately 55% and 49% of our consolidated revenue, 73% and 65% of our nurse and allied solutions segment revenue, 15% and 17% of our physician and leadership solutions segment revenue, and 2% and less than 1% of our technology and workforce solutions segment revenue, respectively.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Gross Profit</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gross profit increased 50% to $875.3 million for the nine months ended September 30, 2021 from $584.2 million for the same period in 2020, representing gross margins of 33.4% and 33.1%, respectively. The increase in consolidated gross margin for the nine months ended September 30, 2021, as compared to the same period in 2020, was primarily due to a change in sales mix resulting from higher revenue in our technology and workforce solutions segment and its higher margins as compared to our staffing businesses, which was partially offset by a lower margin in our physician and leadership solutions segment driven by the interim leadership business. Gross margin by reportable segment for the nine months ended September 30, 2021 and 2020 was 27.6% and 27.6% for nurse and allied solutions, 36.1% and 36.6% for physician and leadership solutions, and 68.3% and 69.5% for technology and workforce solutions, respectively.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Selling, General and Administrative Expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SG&amp;A expenses were $491.8 million, representing 18.8% of revenue, for the nine months ended September 30, 2021, as compared to $394.5 million, representing 22.4% of revenue, for the same period in 2020. The increase in SG&amp;A expenses was primarily due to higher employee compensation and benefits and other expenses associated with our revenue growth. The overall increase was partially offset by a $16.0 million decrease related to acquisition, integration, changes in the fair value of contingent consideration liabilities from acquisitions, restructuring, and extraordinary legal expenses. SG&amp;A expenses broken down among the reportable segments, unallocated corporate overhead, and share-based compensation are as follows: </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.859%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.274%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.837%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In Thousands)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nurse and allied solutions</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">243,306&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172,256&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Physician and leadership solutions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92,899&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84,820&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology and workforce solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,758&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,192&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unallocated corporate overhead</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,915&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,223&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,895&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,046&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">491,773&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">394,537&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:3pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Depreciation and Amortization Expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Amortization expense decreased 2% to $47.0 million for the nine months ended September 30, 2021 from $48.1 million for the same period in 2020, primarily attributable to the reduction of useful lives of certain tradename intangible assets during the third quarter of 2020, which was partially offset by additional amortization expenses related to the intangible assets acquired in the Stratus Video, Synzi and SnapMD acquisitions. Depreciation expense (exclusive of depreciation included in cost of revenue) increased 29% to $27.1 million for the nine months ended September 30, 2021 from $21.0 million for the same period in 2020, primarily attributable to an increase in purchased and developed hardware and software placed in service for our ongoing information technology investments to support our total talent solutions initiatives and to optimize our internal front and back-office systems. Additionally, $1.8&#160;million and $1.0&#160;million of depreciation expense for our language services business is included in cost of revenue for the nine months ended September 30, 2021 and 2020, respectively.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Interest Expense, Net, and Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">.&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense, net, and other was $24.3 million during the nine months ended September 30, 2021 as compared to $35.1 million for the same period in 2020. The decrease was primarily due to a $6.7&#160;million gain related to the change in fair value of an equity investment and a lower average debt outstanding balance during the nine months ended September 30, 2021, which resulted from repayments of the Credit Facilities. The overall decrease was partially offset by a higher weighted average interest rate during the nine months ended September 30, 2021, which was primarily due to the issuances of higher interest bearing senior notes during the third and fourth quarters of 2020.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Income Tax Expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Income tax expense was $74.0 million for the nine months ended September 30, 2021 as compared to $24.2 million for the same period in 2020, reflecting effective income tax rates of 26% and 28% for the nine months ended September 30, 2021 and 2020, respectively. The decrease in the effective income tax rate was primarily attributable to nondeductible meals per diem and officers compensation expenses of $5.0&#160;million during the nine months ended September 30, 2021 compared to $4.2&#160;million during the same period in 2020, in relation to income before income taxes of $285.1&#160;million and $85.5&#160;million for the nine months ended September 30, 2021 and 2020, respectively.</span></div><div><span><br/></span></div><div id="ia383c8c7878a498d91f9e8901f0cfd9c_85"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In summary, our cash flows were:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.976%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In Thousands)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">227,371&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">216,981&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in investing activities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(79,017)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(528,458)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by (used in) financing activities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31,230)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">266,557&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:3pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Historically, our primary liquidity requirements have been for acquisitions, working capital requirements, and debt service under our credit facilities and senior notes. We have funded these requirements through internally generated cash flow and funds borrowed under our credit facilities. During the first quarter of 2021, we paid off the remaining balance of our $250.0&#160;million secured term loan credit facility (the &#8220;Additional Term Loan&#8221;). As of September&#160;30, 2021, (1) no amount was drawn with $379.2 million of available credit under our $400.0&#160;million secured revolving credit facility (the &#8220;Senior Credit Facility&#8221; and, together with the Additional Term Loan, the &#8220;Credit Facilities&#8221;), (2) the aggregate principal amount of our 4.625% senior notes due 2027 (the &#8220;2027 Notes&#8221;) outstanding equaled $500.0 million and (3) the aggregate principal amount of our 4.000% senior notes due 2029 (the &#8220;2029 Notes&#8221;) outstanding equaled $350.0 million. We describe in further detail our amended credit agreement, under which the Credit Facilities are governed, the 2027 Notes, and the 2029 Notes in Part II, Item 8, &#8220;Financial Statements and Supplementary Data&#8212;Notes to Consolidated Financial Statements&#8212;Note (8), Notes Payable and Credit Agreement&#8221; of our 2020 Annual Report.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that cash generated from operations and available borrowings under the Senior Credit Facility will be sufficient to fund our operations, including expected capital expenditures, for at least the next 12 months. We intend to finance potential future acquisitions with cash provided from operations, borrowings under the Senior Credit Facility or other borrowings under our amended credit agreement, bank loans, debt or equity offerings, or some combination of the foregoing. The following discussion provides further details of our liquidity and capital resources.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Activities</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash provided by operating activities for the nine months ended September 30, 2021 was $227.4 million, compared to $217.0 million for the same period in 2020. The increase in net cash provided by operating activities was primarily attributable to (1) an increase in net income excluding non-cash expenses of $154.0 million primarily due to improved operating results in our nurse and allied solutions and technology and workforce solutions segments, (2) an increase in accounts payable and accrued expenses between periods of $117.7 million primarily due to an increase in associate vendor usage and timing of payments, and (3) an increase in accrued compensation and benefits between periods of $89.0 million primarily due to increases in pay rates, billable hours, and the average number of travelers on assignment in our nurse and allied solutions segment and increased employee compensation and benefits. The overall increase in net cash provided by operating activities was partially offset by (1) an increase in accounts receivable and subcontractor receivables between periods of $295.5 million due to a higher average receivables balance in the current year, which was due to increases in revenue and associate vendor usage along with timing of collections, and (2) a decrease in other liabilities between periods of $55.9 million primarily due to our election in the prior year to defer employer payroll taxes in accordance with the Coronavirus Aid, Relief and Economic Security Act (the &#8220;CARES Act&#8221;) and the payment of a lease termination fee during the third quarter of 2021, which was partially offset by an increase in accruals established in connection with a legal matter during the fourth quarter of 2020. Our Days Sales Outstanding (&#8220;DSO&#8221;) was 60 days at September&#160;30, 2021, 55 days at December&#160;31, 2020, and 59 days at September&#160;30, 2020.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investing Activities</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in investing activities for the nine months ended September 30, 2021 was $79.0 million, compared to $528.5 million for the same period in 2020. The decrease was primarily due to (1) $41.3 million used for acquisitions during the nine months ended September 30, 2021, as compared to $476.5 million during the nine months ended September 30, 2020, and (2) net proceeds of restricted investments related to our captive insurance company of $7.6 million during the nine months ended September 30, 2021, as compared to a net purchase of $15.9 million during the nine months ended September 30, 2020. In addition, capital expenditures were $38.7 million and $27.4 million for the nine months ended September 30, 2021 and 2020, respectively. </span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financing Activities</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in financing activities during the nine months ended September 30, 2021 was $31.2 million, primarily due to (1) repayments of $70.0&#160;million under the Senior Credit Facility and $21.9&#160;million under the Additional Term Loan, (2) $6.3&#160;million in cash paid for shares withheld for payroll taxes resulting from the vesting of employee equity awards, and (3) $3.1&#160;million for acquisition earn-out payments, partially offset by borrowings of $70.0&#160;million under the Senior Credit Facility. Net cash provided by financing activities during the nine months ended September 30, 2020 was $266.6 million, primarily due to (1) borrowings of $245.0&#160;million under the Senior Credit Facility and $250.0&#160;million under the Additional Term Loan, which were primarily used to fund our Stratus Video acquisition, and (2) $202.0&#160;million of gross proceeds received in connection with the issuance of an additional $200.0 million aggregate principal amount of 4.625% senior notes due 2027 (the &#8220;New 2027 Notes&#8221;), which were issued at a price of 101.000% of the aggregate principal amount, partially offset by (1) repayments of $205.0&#160;million under the Senior Credit Facility and $203.1&#160;million under the Additional Term Loan, (2) $10.6&#160;million for acquisition earn-out payments, (3) $4.8&#160;million in cash paid for shares withheld for payroll taxes resulting from the vesting of employee equity awards, and (4) $6.9&#160;million payment of financing costs in connection with our amended credit agreement and the issuance of the New 2027 Notes.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Letters of Credit</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September&#160;30, 2021, we maintained outstanding standby letters of credit totaling $23.0 million as collateral in relation to our workers&#8217; compensation insurance agreements and a corporate office lease agreement. Of the $23.0 million of outstanding letters of credit, we have collateralized $2.2 million in cash and cash equivalents and the remaining $20.8 million is collateralized by the Senior Credit Facility. Outstanding standby letters of credit at December&#160;31, 2020 totaled $24.1 million.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><div id="ia383c8c7878a498d91f9e8901f0cfd9c_88"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Off-Balance Sheet Arrangements</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September&#160;30, 2021, we did not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures, or capital resources that is material to investors.</span></div><div id="ia383c8c7878a498d91f9e8901f0cfd9c_91"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Contractual Obligations</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no material changes during the nine months ended September 30, 2021 to the table entitled &#8220;Contractual Obligations&#8221; in Part II, Item 7, &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; set forth in our 2020 Annual Report other than the following: (i) the borrowings and repayments under our amended credit agreement, which are described in the accompanying Note (2), &#8220;Acquisitions,&#8221; and Note (6), &#8220;Notes Payable and Credit Agreement,&#8221; and (ii) the modification to the operating lease of our office space in San Diego as described in the accompanying Note (8), &#8220;Leases.&#8221;</span></div><div><span><br/></span></div><div id="ia383c8c7878a498d91f9e8901f0cfd9c_94"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2021, the FASB issued ASU 2021-08, &#8220;Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers.&#8221; The new guidance will require companies to apply the definition of a performance obligation under Accounting Standards Codification (&#8220;ASC&#8221;) Topic 606, Revenue from Contracts with Customers, to recognize and measure contract assets and contract liabilities, such as deferred revenue, relating to contracts with customers that are acquired in a business combination. Under existing guidance, an acquirer generally recognizes assets acquired and liabilities assumed in a business combination, including contract assets and contract liabilities arising from revenue contracts with customers, at their acquisition-date fair values in accordance with ASC Subtopic 820-10, Fair Value Measurements&#8212;Overall. Generally, this new guidance will result in the acquirer recognizing acquired contract assets and liabilities on the same basis that would have been recorded by the acquiree prior to the acquisition under ASC Topic 606. This standard is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2022, with early adoption permitted. We are currently evaluating the impact of adopting this standard on our consolidated financial statements.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no other new accounting pronouncements issued but not yet adopted that are expected to materially affect our consolidated financial condition or results of operations.</span></div><div id="ia383c8c7878a498d91f9e8901f0cfd9c_97"></div><div style="margin-bottom:10pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Special Note Regarding Forward-Looking Statements</span></div><div style="margin-top:4.5pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Quarterly Report contains &#8220;forward-looking statements&#8221; within the meaning of Section&#160;27A of the Securities Act of 1933, as amended, and Section&#160;21E of the Securities Exchange Act of 1934, as amended. We base these forward-looking statements on our expectations, estimates, forecasts, and projections about future events and about the industry in which we operate. Forward-looking statements are identified by words such as &#8220;believe,&#8221; &#8220;anticipate,&#8221; &#8220;expect,&#8221; &#8220;intend,&#8221; &#8220;plan,&#8221; &#8220;will,&#8221; &#8220;should,&#8221; &#8220;would,&#8221; &#8220;project,&#8221; &#8220;may,&#8221; variations of such words, and other similar expressions. In addition, any statements that refer to projections of demand or supply trends, financial items, anticipated growth, future growth and revenues, future economic conditions and performance, plans, objectives and strategies for future operations, expectations, or other characterizations of future events or circumstances are forward-looking statements. All forward-looking statements involve risks and uncertainties. Our actual results could differ materially from those discussed in, or implied by, these forward-looking statements. Factors that could cause actual results to differ materially from those implied by the forward-looking statements in this Quarterly Report are set forth in our 2020 Annual Report and include but are not limited to: </span></div><div style="margin-top:9pt;padding-left:31.5pt;text-indent:-15.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.25pt">the effects of the COVID-19 pandemic on our business, financial condition and results of operations;</span></div><div style="margin-top:9pt;padding-left:31.5pt;text-indent:-15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.25pt">the duration and extent to which hospitals and other healthcare entities adjust their utilization of temporary nurses and allied healthcare professionals, physicians, healthcare leaders and other healthcare professionals and workforce technology applications as a result of the suspension or reinstitution of restrictions placed on non-essential and elective healthcare as a result of the COVID-19 pandemic;</span></div><div style="margin-top:9pt;padding-left:31.5pt;text-indent:-15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.25pt">the duration that individuals may continue to forgo non-essential and elective healthcare as restrictions and recommendations are reinstituted in parts of the country and lifted in others;</span></div><div style="margin-top:9pt;padding-left:31.5pt;text-indent:-15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.25pt">the extent and duration that a significant spike in unemployment that has resulted from the COVID-19 pandemic will cause an increase in under- and uninsured patients and a corresponding reduction in overall healthcare utilization and demand for our services; </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;padding-left:31.5pt;text-indent:-15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.25pt">the extent to which the COVID-19 pandemic may disrupt our operations due to the unavailability of our employees or healthcare professionals because of illness, risk of illness, quarantines, travel restrictions, mandatory vaccination requirements, desire to travel and work on temporary assignments or other factors that limit our existing or potential workforce and pool of candidates; </span></div><div style="margin-top:9pt;padding-left:31.5pt;text-indent:-15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.25pt">the severity and duration of the impact the COVID-19 pandemic has on the financial condition and cash flow of many hospitals and healthcare systems such that it impairs their ability to make payments to us, timely or otherwise, for services rendered; </span></div><div style="margin-top:9pt;padding-left:31.5pt;text-indent:-15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.25pt">the effects of economic downturns or slow recoveries, which could result in less demand for our services, pricing pressures and negatively impact payments terms and collectability of accounts receivable;</span></div><div style="margin-top:9pt;padding-left:31.5pt;text-indent:-15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.25pt">any inability on our part to anticipate and quickly respond to changing marketplace conditions, such as alternative modes of healthcare delivery, reimbursement, or client needs and requirements, including mandatory vaccination requirements;</span></div><div style="margin-top:9pt;padding-left:31.5pt;text-indent:-15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.25pt">the negative effects that intermediary organizations may have on our ability to secure new and profitable contracts; </span></div><div style="margin-top:9pt;padding-left:31.5pt;text-indent:-15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.25pt">the level of consolidation and concentration of buyers of healthcare workforce, staffing and technology solutions, which could affect the pricing of our services and our ability to mitigate concentration risk; </span></div><div style="margin-top:9pt;padding-left:31.5pt;text-indent:-15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.25pt">the ability of our clients to increase the efficiency and effectiveness of their staffing management and recruiting efforts, through predictive analytics, online recruiting, telemedicine or otherwise, which may negatively affect our revenue, results of operations, and cash flows; </span></div><div style="margin-top:9pt;padding-left:31.5pt;text-indent:-15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.25pt">the repeal or significant erosion of the Patient Protection and Affordable Care Act without a corresponding replacement may negatively affect the demand for our services;</span></div><div style="margin-top:9pt;padding-left:31.5pt;text-indent:-15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.25pt">any inability on our part to recruit and retain sufficient quality healthcare professionals at reasonable costs, which could increase our operating costs and negatively affect our business and profitability; </span></div><div style="margin-top:9pt;padding-left:31.5pt;text-indent:-15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.25pt">any inability on our part to grow and operate our business profitably in compliance with federal and state regulation, including privacy laws, conduct of operations, costs and payment for services and payment for referrals as well as laws regarding employment and compensation practices and government contracting;&#160;</span></div><div style="margin-top:9pt;padding-left:31.5pt;text-indent:-15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.25pt">any challenge to the classification of certain of our healthcare professionals as independent contractors, which could adversely affect our profitability;</span></div><div style="margin-top:9pt;padding-left:31.5pt;text-indent:-15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.25pt">the effect of investigations, claims, and legal proceedings alleging medical malpractice, violations of employment, privacy and wage regulations and other legal theories of liability asserted against us, which could subject us to substantial liabilities; </span></div><div style="margin-top:9pt;padding-left:31.5pt;text-indent:-15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.25pt">any technology disruptions or our inability to implement new infrastructure and technology systems effectively may adversely affect our operating results and ability to manage our business effectively; </span></div><div style="margin-top:9pt;padding-left:31.5pt;text-indent:-15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.25pt">any failure to further develop and evolve our current workforce solutions technology offerings and capabilities, which may harm our business;</span></div><div style="margin-top:9pt;padding-left:31.5pt;text-indent:-15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.25pt">disruption to or failures of our SaaS-based technologies, or our inability to adequately protect our intellectual property rights with respect to such technologies or sufficiently protect the privacy of personal information, could reduce client satisfaction, harm our reputation and negatively affect our business; </span></div><div style="margin-top:6pt;padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">security breaches and cybersecurity incidents, including ransomware, that could compromise our information and systems, which could adversely affect our business operations and reputation and could subject us to substantial liabilities; </span></div><div style="margin-top:6pt;padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any inability on our part to quickly and properly credential and match quality healthcare professionals with suitable placements, which may adversely affect demand for our services; </span></div><div style="margin-top:6pt;padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any inability on our part to continue to attract, develop and retain our sales and operations team members, which may deteriorate our operations; </span></div><div style="margin-top:6pt;padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our increasing dependence on third parties, including offshore vendors, for the execution of certain critical functions; </span></div><div style="margin-top:6pt;padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the loss of our key officers and management personnel, which could adversely affect our business and operating results;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:6pt;padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any inability to consummate and effectively incorporate acquisitions into our business operations, which may adversely affect our long-term growth and our results of operations;</span></div><div style="margin-top:6pt;padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">businesses we acquire may have liabilities or adverse operating issues, which could harm our operating results; </span></div><div style="margin-top:6pt;padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any increase to our business and operating risks as we develop new services and clients, enter new lines of business, and focus more of our business on providing a full range of client solutions;</span></div><div style="margin-top:6pt;padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any inability on our part to maintain our positive brand awareness and identity, which may adversely affect our results of operation; </span></div><div style="margin-top:6pt;padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the expansion of social media platforms presents new risks and challenges, which could cause damage to our brand reputation;</span></div><div style="margin-top:6pt;padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any recognition of an impairment to the substantial amount of goodwill or indefinite-lived intangibles on our balance sheet; </span></div><div style="margin-top:6pt;padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our indebtedness, which could adversely affect our ability to raise additional capital to fund operations, limit our ability to react to changes in the economy or our industry, and expose us to interest rate risk to the extent of any variable rate debt;</span></div><div style="margin-top:6pt;padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the terms of our debt instruments that impose restrictions on us that may affect our ability to successfully operate our business; and</span></div><div style="margin-top:6pt;padding-left:29.25pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the effect of significant adverse adjustments to our insurance-related accruals on our balance sheet, which could decrease our earnings or increase our losses and negatively impact our cash flows.</span></div><div id="ia383c8c7878a498d91f9e8901f0cfd9c_100"></div><div style="margin-top:13.5pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Item&#160;3.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-style:italic;font-weight:700;line-height:120%">Quantitative and Qualitative Disclosures about Market Risk </span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Market risk is the risk of loss arising from adverse changes in market rates and prices, such as interest rates, foreign currency exchange rates, and commodity prices. During the three and nine months ended September 30, 2021, our primary exposure to market risk was interest rate risk associated with our variable interest debt instruments. A 100 basis point increase in interest rates on our variable rate debt would not have resulted in a material effect on our unaudited condensed consolidated financial statements for the three and nine months ended September 30, 2021. During the three and nine months ended September 30, 2021, we generated substantially all of our revenue in the United States. Accordingly, we believe that our foreign currency risk is immaterial.</span></div><div id="ia383c8c7878a498d91f9e8901f0cfd9c_103"></div><div style="margin-top:13.5pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Item&#160;4.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-style:italic;font-weight:700;line-height:120%">Controls and Procedures </span></div><div style="margin-top:4.5pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We carried out an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer and Interim Principal Financial Officer, of the effectiveness of our disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934. Based on that evaluation, our Chief Executive Officer and Interim Principal Financial Officer have concluded that our disclosure controls and procedures as of September&#160;30, 2021 were effective to ensure that information required to be disclosed by us in reports that we file or submit under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified in the SEC&#8217;s rules and forms, and that such information is accumulated and communicated to management, including our Chief Executive Officer and Interim Principal Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no changes in our internal control over financial reporting that occurred during the quarter ended September&#160;30, 2021 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div id="ia383c8c7878a498d91f9e8901f0cfd9c_106"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">PART II - OTHER INFORMATION</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></div><div id="ia383c8c7878a498d91f9e8901f0cfd9c_109"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Item 1.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-style:italic;font-weight:700;line-height:120%">Legal Proceedings</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information with respect to this item may be found in the accompanying Note (9), &#8220;Commitments and Contingencies: Legal Proceedings,&#8221;&#160;which is incorporated herein by reference.</span></div><div><span><br/></span></div><div id="ia383c8c7878a498d91f9e8901f0cfd9c_112"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Item 1A.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-style:italic;font-weight:700;line-height:120%">Risk Factors</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not believe that there have been any material changes to the risk factors disclosed in Part I, Item 1A of our 2020 Annual Report. The risk factors described in our 2020 Annual Report are not the only risks we face. Factors we currently do not know, factors that we currently consider immaterial or factors that are not specific to us, such as general economic conditions, may also materially adversely affect our business or our consolidated operating results, financial condition or cash flows.</span></div><div><span><br/></span></div><div id="ia383c8c7878a498d91f9e8901f0cfd9c_115"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Item 2.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-style:italic;font-weight:700;line-height:120%">Unregistered Sales of Equity Securities and Use of Proceeds</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, we may repurchase our common stock in the open market pursuant to programs approved by our Board. We may repurchase our common stock for a variety of reasons, such as acquiring shares to offset dilution related to equity-based incentives and optimizing our capital structure. On November 1, 2016, our Board authorized us to repurchase up to $150.0&#160;million of our outstanding common stock in the open market. Under the repurchase program announced on November 1, 2016 (the &#8220;Company Repurchase Program&#8221;), share purchases may be made from time to time beginning in the fourth quarter of 2016, depending on prevailing market conditions and other considerations. The Company Repurchase Program has no expiration date and may be discontinued or suspended at any time.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended September 30, 2021, we did not repurchase any shares of common stock. We describe in further detail our repurchase program and the shares repurchased thereunder in Part II, Item 5, &#8220;Market For Registrant&#8217;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities&#8221; set forth in our 2020 Annual Report.</span></div><div style="text-align:justify"><span><br/></span></div><div id="ia383c8c7878a498d91f9e8901f0cfd9c_118"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Item 3.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-style:italic;font-weight:700;line-height:120%">Defaults Upon Senior Securities</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div><span><br/></span></div><div id="ia383c8c7878a498d91f9e8901f0cfd9c_121"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Item 4.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-style:italic;font-weight:700;line-height:120%">Mine Safety Disclosures</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div><span><br/></span></div><div id="ia383c8c7878a498d91f9e8901f0cfd9c_124"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Item 5.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-style:italic;font-weight:700;line-height:120%">Other Information</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div id="ia383c8c7878a498d91f9e8901f0cfd9c_127"></div><div style="-sec-extract:summary"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Item&#160;6.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-style:italic;font-weight:700;line-height:120%">Exhibits </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:7.697%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.370%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Number</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Description</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="amn-ex101x20210930x10q.htm">Lease Termination Agreement, dated as of September 9, 2021, between Kilroy Realty, L.P. and AMN Healthcare, Inc.*</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="amn-ex311x20210930x10q.htm">Certification by Susan R. Salka pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934.*</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="amn-ex312x20210930x10q.htm">Certification by Christopher S. Schwartz pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934.*</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="amn-ex321x20210930x10q.htm">Certification by Susan R. Salka pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.*</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="amn-ex322x20210930x10q.htm">Certification by Christopher S. Schwartz pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.*</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.INS</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Instance Document.*</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.SCH</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Schema Document.*</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.CAL</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Calculation Linkbase Document.*</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.DEF</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Definition Linkbase Document.*</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.LAB</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Label Linkbase Document.*</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.PRE</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Presentation Linkbase Document.*</span></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:5.351%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.565%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.784%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Filed herewith.</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><div id="ia383c8c7878a498d91f9e8901f0cfd9c_130"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date: November&#160;5, 2021</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:58.333%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">AMN HEALTHCARE SERVICES, INC.</span></td></tr><tr style="height:15pt"><td colspan="9" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/&#160;&#160;&#160;&#160;S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USAN</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> R. S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ALKA</span></div></td></tr><tr><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Susan R. Salka<br/>President and Chief Executive Officer<br/>(Principal Executive Officer)<br/></span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date: November&#160;5, 2021</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:58.333%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/&#160;&#160;&#160;&#160;C</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">HRISTOPHER </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">S.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CHWARTZ </span></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Christopher S. Schwartz<br/>Controller<br/>(Interim Principal Financial Officer)</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>amn-ex101x20210930x10q.htm
<DESCRIPTION>EX-10.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i3f71dad1964e44b3a7022fd9aaa84b69_1"></div><div style="min-height:67pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:80%">EXHIBIT 10.1</font></div></div><div><font><br></font></div><div style="margin-top:4.5pt;padding-left:174.2pt;padding-right:174.2pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%;text-decoration:underline">LEASE TERMINATION AGREEMENT</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:23pt;padding-right:71.85pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">This Lease Termination Agreement (this &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#34;) is entered into as of the 9th day of September, 2021 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Effective Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8221;), by and between KILROY REALTY, L.P., a Delaware limited partnership (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Landlord</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8221;), and AMN HEALTHCARE, INC., a Nevada corporation (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Tenant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8221;).</font></div><div><font><br></font></div><div style="margin-top:9.05pt;padding-left:174.15pt;padding-right:174.15pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;text-decoration:underline">R E C I T A L S</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> &#58;</font></div><div><font><br></font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:23pt;padding-right:71.7pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">A.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;padding-left:1.39pt">Landlord and Tenant entered into that certain Office Lease, dated April 2, 2002 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Office Lease</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8221;), as amended by that certain First Amendment to Office Lease dated as of May 31, 2002 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">First Amendment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8221;), as amended by that certain Second Amendment to Office Lease dated as of June 30, 2006 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Second Amendment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8221;), and as amended by that certain Third Amendment to Office Lease dated as of June 30, 2014 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Third Amendment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8221;) (the Office Lease, First Amendment, Second Amendment and Third Amendment are, collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Lease</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8221;), whereby Landlord leases to Tenant and Tenant leases from Landlord approximately 175,672 rentable (164,128 usable) square feet of space (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Existing Premises</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8221;) consisting of all of the first (1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:115%;position:relative;top:-4.2pt;vertical-align:baseline">st</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">), second (2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:115%;position:relative;top:-4.2pt;vertical-align:baseline">nd</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">), third (3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:115%;position:relative;top:-4.2pt;vertical-align:baseline">rd</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">), fourth (4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:115%;position:relative;top:-4.2pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">) and fifth (5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:115%;position:relative;top:-4.2pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">) floors of that certain six (6) story building located at 12400 High Bluff Drive, San Diego, California 92130 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Building</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8221;), which Building contains a total of approximately 208,961 rentable (195,264 usable) square feet of space..</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:23pt;padding-right:71.7pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">B.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;padding-left:2.05pt">Tenant and Landlord desire to enter into this Agreement in order to terminate the Lease in two phases, with the first (1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:115%;position:relative;top:-4.2pt;vertical-align:baseline">st</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">) phase comprised of approximately 141,307 rentable square feet on the first (1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:115%;position:relative;top:-4.2pt;vertical-align:baseline">st</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">), second (2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:115%;position:relative;top:-4.2pt;vertical-align:baseline">nd</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">), third (3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:115%;position:relative;top:-4.2pt;vertical-align:baseline">rd</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">) and fourth (4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:115%;position:relative;top:-4.2pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">) floors of the Building (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Phase 1 Premises</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8221;), and the second (2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:115%;position:relative;top:-4.2pt;vertical-align:baseline">nd</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">) phase comprised of approximately 34,365 rentable square feet on the fifth (5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:115%;position:relative;top:-4.2pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">) floor of the Building (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Phase 2 Premises</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8221;), and to release one another from their respective obligations thereunder, except as otherwise provided herein.</font></div><div><font><br></font></div><div style="margin-top:9.1pt;padding-left:174.15pt;padding-right:174.15pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;text-decoration:underline">A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;text-decoration:underline">G</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;text-decoration:underline">R</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;text-decoration:underline">E</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;text-decoration:underline">E</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;text-decoration:underline">M</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;text-decoration:underline">E N</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;text-decoration:underline">T</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> &#58;</font></div><div><font><br></font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:23pt;padding-right:72pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">NOW, THEREFORE, in consideration of the foregoing recitals and the conditions and the covenants hereinafter contained, and for other consideration hereinafter set forth, the receipt and sufficiency of which are hereby acknowledged, Landlord and Tenant hereby agree as follows.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:23pt;padding-right:71.75pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%;padding-left:4.05pt;text-decoration:underline">Effectiveness of this Lease Termination Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">. Landlord and Tenant hereby acknowledge and agree that, notwithstanding the full execution and delivery of this Agreement by Landlord and Tenant, this Agreement is expressly conditioned (the &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Condition Precedent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#34;) upon the full execution and delivery of a new lease agreement (the &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Third-Party Lease</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#34;) between Landlord and a third party (the &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Third Party</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#34;) for the Third Party&#8217;s lease of the Premises on or before October 31, 2021 (which date may be extended until November 30, 2021 upon written notice to Tenant by Landlord) (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Condition Outside Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8221;). The terms and conditions of the Third-Party Lease shall be acceptable to Landlord in its sole and absolute discretion. In the event the Condition Precedent is not satisfied on or before the Condition </font></div><div style="height:51pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:2.397%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.5pt;padding-left:1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">-1-</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:67pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:80%">EXHIBIT 10.1</font></div></div><div style="padding-left:23pt;padding-right:71.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Outside Date (as the same may be extended) then this Agreement shall automatically terminate and be of no further force or effect, and the Lease shall continue unmodified and in full force and effect. Landlord shall have no liability whatsoever to Tenant relating to or arising from Landlord's failure to cause the Condition Precedent to be satisfied. The Lease shall remain unmodified and in full force and effect unless and until such time as the Condition Precedent is satisfied.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:23pt;padding-right:71.65pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">2. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%;text-decoration:underline">Phased Termination of the Lease</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">. Landlord and Tenant hereby agree that conditioned upon the performance by the parties of the provisions of this Agreement, the Lease will terminate and be of no further force or effect as to (i) the Phase 1 Premises as of 11&#58;59 P.M. on February 28, 2022 (the &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Phase 1 Termination Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#34;), and (ii) the Phase 2 Premises as of 11&#58;59 P.M. on December 31, 2024 (the &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Phase 2 Termination Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#34;). The Phase 1 Termination Date and Phase 2 Termination Date shall each be a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Termination Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8221; and collectively are the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Termination Dates</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">.&#8221; Effective as of the Effective Date of this Agreement, (i) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;text-decoration:underline">Section 2.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> of the Office Lease (as amended by Section 3.2 of the Third Amendment) (Option to Extend) is hereby deleted in its entirety and of no further force or effect, (ii) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;text-decoration:underline">Section 12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> of the Third Amendment (Right of First Refusal) is hereby deleted in its entirety and of no further force or effect, and (iii) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;text-decoration:underline">Section 20</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> of the Third Amendment (Permitted Holdover) is hereby deleted it its entirety and of no further force or effect. Accordingly, and notwithstanding anything to the contrary contained in the Lease, Landlord and Tenant hereby acknowledge and agree that Tenant shall not have any further right to extend the Lease Term or any right of first offer, right of first refusal, or other expansion rights.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:23pt;padding-right:71.75pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">3. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%;text-decoration:underline">Ongoing Obligations for Phase 2 Premises</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">. Effective as of the date immediately following the Phase 1 Termination Date, (i) the Phase 1 Premises shall no longer constitute a part of the Premises, and (ii) the &#34;Premises&#34; shall thereupon and thereafter consist solely of the Phase 2 Premises, and all of the terms and conditions of the Lease shall continue unmodified and in full force and effect only with respect to the Phase 2 Premises. In connection with the foregoing, (i) Tenant&#8217;s Share with respect to the Phase 2 Premises shall be 16.4457%, (ii) Tenant shall be entitled to 172 parking passes in connection with the Phase 2 Premises (35 of which may be used for a reserved parking space), and (iii) the Base Rent schedule with respect to the Phase 2 Premises shall be as set forth below&#58;</font></div><div style="padding-right:71.75pt;text-align:justify"><font><br></font></div><div style="margin-bottom:6pt;padding-left:62.15pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:75.266%"><tr><td style="width:1.0%"></td><td style="width:23.501%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.746%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.731%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.746%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.846%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.861%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.569%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:6pt;padding-right:6pt;text-align:center;text-indent:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">Period During Extended Term</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:6pt;padding-right:6pt;text-align:center;text-indent:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">Annual Base Rent</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:6pt;padding-right:6pt;text-align:center;text-indent:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">Monthly Installment of Base Rent</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:12.42pt;padding-right:12.42pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#160;Monthly Base Rent Rate per Rentable Square Foot</font></div></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:1.27pt;padding-right:1.27pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">March 1, 2022 &#8211;</font></div><div style="padding-left:1.32pt;padding-right:1.32pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">December 31, 2022</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-top:10.8pt;padding-left:9.15pt;padding-right:9.15pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">$1,875,605.15</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-top:10.8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">$156,300.43</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-top:10.8pt;padding-left:15.65pt;padding-right:15.65pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">$4.55</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-top:5.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">January 1, 2023 &#8211;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">December 31, 2023</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9.15pt;padding-right:9.15pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">$1,941,251.33</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">$161,770.94</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:15.65pt;padding-right:15.65pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">$4.71</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-top:5.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">January 1, 2024 &#8211;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:107%">December 31, 2024</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9.15pt;padding-right:9.15pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:107%">$2,009,195.13</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:107%">$167,432.93</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:15.65pt;padding-right:15.65pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:107%">$4.87</font></div></td></tr></table></div><div style="padding-left:23pt;padding-right:71.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">The amounts identified in the column entitled Monthly Base Rent Rate per Rentable Square Foot are rounded amounts and are provided for informational purposes only.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="height:51pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:2.397%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.5pt;padding-left:1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">-2-</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:67pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:80%">EXHIBIT 10.1</font></div></div><div style="margin-top:0.05pt;padding-left:23pt;padding-right:71.7pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%;padding-left:4.05pt;text-decoration:underline">Surrender of Premises</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">.   Tenant hereby agrees to vacate the Phase 1 Premises and surrender and deliver exclusive possession of the Phase 1 Premises to Landlord on or before the Phase 1 Termination Date, and to vacate the Phase 2 Premises and surrender and deliver exclusive possession of the Phase 2 Premises to Landlord on or before the Phase 2 Termination Date, each in accordance with the provisions of the Lease and this Agreement. On or before the Phase 1 Termination Date, Tenant shall, at Tenant's sole cost and expense, remove or cause to be removed from the Phase 1 Premises any and all of Tenant's personal property, and such similar articles of any other persons claiming under Tenant, and deliver the Phase 1 Premises to Landlord in a broom-clean condition. Tenant shall be obligated to remove the building-top component of &#8220;Tenant&#8217;s Signage&#8221; (as that term is defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;text-decoration:underline">Section 23.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> of the Office Lease) on or before August 31, 2022, in the manner required under the Lease. Similarly, on or before the Phase 2 Termination Date, Tenant shall, at Tenant's sole cost and expense, remove or cause to be removed from the Phase 2 Premises any and all of Tenant's personal property and such similar articles of any other person's claiming under Tenant, and deliver the Phase 2 Premises to Landlord in a broom-clean condition, and in addition Tenant shall be obligated to remove Tenant&#8217;s sign(s) on any monument sign(s) serving the Project installed as part of Tenant&#8217;s Signage on or before the Phase 2 Termination Date, in the manner required under the Lease. Tenant shall immediately repair at its own expense all damage to the Phase 1 Premises and Phase 2 Premises, and the Building, resulting from any such removal in the manner required under the Lease. If Tenant fails to timely complete such removal and&#47;or repair any damage caused by such removal, Landlord may (but shall not be obligated to) take such action as is permitted to Landlord in the Lease. In the event Tenant fails to surrender the Phase 1 Premises and&#47;or the Phase 2 Premises by the applicable Termination Dates, then the holdover provisions of the Lease, including, without, limitation, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;text-decoration:underline">Article 16</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> of the Lease, shall apply.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:23pt;padding-right:71.9pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%;padding-left:4.05pt;text-decoration:underline">Consideration to Landlord</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">. In consideration for Landlord's execution of this Agreement, Tenant shall deliver to Landlord, promptly following the receipt by Tenant of confirmation from Landlord that the Third Party Lease has been executed and accordingly the Condition Precedent has been satisfied, the sum of Seventeen Million and No&#47;100 Dollars ($17,000,000.00) (the &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Termination Fee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#34;).</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:23pt;padding-right:71.65pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%;padding-left:4.05pt;text-decoration:underline">Release of Liability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">. Except as with respect to all obligations set forth in the Lease that survive the termination of the Lease (unless and to the extent any such obligations are modified or superseded by the express terms of this Agreement), including, without limitation, each party&#8217;s indemnity obligations, and except as provided in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;text-decoration:underline">Sections 4, 6 and 7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> hereof, and conditioned on the performance by the parties of the provisions of this Agreement, effective as of the Phase 1 Termination Date&#58;</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:23pt;padding-right:71.7pt;text-align:justify;text-indent:71.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12.5pt;font-weight:400;line-height:115%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;padding-left:35.19pt">Landlord and Tenant shall, be fully and unconditionally released and discharged from their respective obligations arising from or in connection with the provisions of the Lease, specifically including, without limitation, any right Tenant may have to audit or review Landlord&#8217;s books or records or to contest any &#8220;Operating Expenses,&#8221; as that term is defined in the Lease, billed to Tenant under the Lease, arising from or relating to the Phase 1 Premises&#59; and </font></div><div style="padding-left:23pt;padding-right:71.7pt;text-align:justify;text-indent:71.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;padding-left:0.23pt">          this Agreement shall fully and finally settle all demands, charges, claims, accounts or causes of action of any nature, including, without limitation, both known and unknown claims and causes of action that may arise out of or in connection with the obligations of the parties under the Lease with regard to the Phase 1 Premises and arising or otherwise accruing after the Phase 1 Termination Date.</font></div><div style="height:51pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:2.397%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.5pt;padding-left:1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">-3-</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:67pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:80%">EXHIBIT 10.1</font></div></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:23pt;padding-right:71.85pt;text-indent:-18.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">In addition, and conditioned on the performance by the parties of the provisions of this Agreement, effective as of the Phase 2 Termination Date&#58;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:23pt;padding-right:72pt;text-align:justify;text-indent:71.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;padding-left:35.75pt">Landlord and Tenant shall, be fully and unconditionally released and discharged from their respective obligations arising from or in connection with the provisions of the Lease, specifically including, without limitation, any right Tenant may have to audit or review Landlord&#8217;s books or records or to contest any Operating Expenses billed to Tenant under the Lease, arising from or relating to the Phase 2 Premises&#59; and</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:23pt;padding-right:71.85pt;text-align:justify;text-indent:71.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;padding-left:35.07pt">this Agreement shall fully and finally settle all demands, charges, claims, accounts or causes of action of any nature, including, without limitation, both known and unknown claims and causes of action that may arise out of or in connection with the obligations of the parties under the Lease with regard to the Phase 2 Premises and arising or otherwise accruing after the Phase 2 Termination Date.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:23pt;padding-right:71.85pt;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Each of the parties expressly waives the provisions of California Civil Code Section 1542, which provides&#58;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:95pt;padding-right:143.8pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#34;A GENERAL RELEASE DOES NOT EXTEND TO CLAIMS THAT THE CREDITOR OR RELEASING PARTY DOES NOT KNOW OR SUSPECT TO EXIST IN HIS OR HER FAVOR AT THE TIME OF EXECUTING THE RELEASE AND THAT, IF KNOWN BY HIM OR HER, WOULD HAVE MATERIALLY AFFECTED HIS OR HER SETTLEMENT WITH THE DEBTOR OR RELEASED PARTY.&#34;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:23pt;padding-right:71.8pt;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Each party acknowledges that it has received the advice of legal counsel with respect to the aforementioned waiver and understands the terms thereof.</font></div><div style="padding-right:71.8pt"><font><br></font></div><div style="margin-top:0.5pt;padding-left:23pt;padding-right:71.65pt;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">7. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%;text-decoration:underline">Representations of Tenant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">.   Tenant represents and warrants to Landlord that&#58; (a) Tenant has not heretofore assigned or sublet all or any portion of its interest in the Lease&#59; (b) as of the Phase 1 Termination Date and to Tenant&#8217;s knowledge, no person, firm or entity has any right, title or interest in the Phase 1 Premises and as of the Phase 2 Termination Date, no person, firm or entity will have any right, title or interest in the Phase 2 Premises&#59; (c) Tenant has the full right, legal power and actual authority to enter into this Agreement and to terminate the Lease without the consent of any person, firm or entity&#59; and (d) Tenant has the full right, legal power and actual authority to bind Tenant to the terms and conditions hereof. Tenant further represents and warrants to Landlord that as of the date hereof there are no, and as of the Phase 1 Termination Date there shall not be any, mechanic's liens or other liens encumbering all or any portion of the Phase 1 Premises by virtue of any act or omission on the part of Tenant, its predecessors, contractors, agents, employees, successors or assigns. In addition, Tenant further represents and warrants to Landlord that as of the Phase 2 Termination Date there shall not be any, mechanic's liens or other liens encumbering all or any portion of the Phase 2 Premises by virtue of any act or omission on the part of Tenant, its predecessors, contractors, agents, employees, successors or assigns. Notwithstanding the termination of the Lease and the release of liability provided for herein, the representations and warranties set forth in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;text-decoration:underline">Section 7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> shall survive the Termination Dates and Tenant shall be liable to remove or otherwise resolve any such liens in accordance with the terms of the Lease.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="height:51pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:2.397%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.5pt;padding-left:1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">-4-</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:67pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:80%">EXHIBIT 10.1</font></div></div><div style="margin-top:0.05pt;padding-left:23pt;padding-right:71.65pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">8. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%;text-decoration:underline">Continuing Liability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">. Notwithstanding the termination of the Lease and the release of liability provided for herein, Tenant shall remain liable, as to the Phase 1 Premises, with respect to the period of its tenancy prior to the Phase 1 Termination Date, and, as to the Phase 2 Premises, with respect to the period of its tenancy prior to the Phase 2 Termination Date, for the performance of all of its obligations under the Lease (including, without limitation, Tenant's payment of Base Rent and Additional Rent, including the reconciliation of Tenant's Share of Direct Expenses) and Landlord shall have all the rights and remedies with respect to such obligations as set forth in the Lease.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:23pt;padding-right:71.65pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">9. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%;text-decoration:underline">CASp</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">. For purposes of Section 1938 of the California Civil Code, Landlord hereby discloses to Tenant, and Tenant hereby acknowledges, that the Premises have not undergone inspection by a Certified Access Specialists (CASp). As required by Section 1938(e) of the California Civil Code, Landlord hereby states as follows&#58; &#8220;A Certified Access Specialist (CASp) can inspect the subject premises and determine whether the subject premises comply with all of the applicable construction-related accessibility standards under state law. Although state law does not require a CASp inspection of the subject premises, the commercial property owner or lessor may not prohibit the lessee or tenant from obtaining a CASp inspection of the subject premises for the occupancy or potential occupancy of the lessee or tenant, if requested by the lessee or tenant. The parties shall mutually agree on the arrangements for the time and manner of the CASp inspection, the payment of the fee for the CASp inspection, and the cost of making any repairs necessary to correct violations of construction-related accessibility standards within the premises.&#8221; In furtherance of the foregoing, Landlord and Tenant hereby agree as follows&#58; (a) any CASp inspection requested by Tenant shall be conducted, at Tenant's sole cost and expense, by a CASp designated by Landlord, subject to Landlord's reasonable rules and requirements&#59; (b) Tenant, at its sole cost and expense, shall be responsible for making any improvements or repairs within the Existing Premises or the Remaining Premises to correct violations of construction-related accessibility standards&#59; and (c) if Tenant in fact requests such CASp inspection and the results of such CASp inspection shall require any improvements or repairs to the Building or Project (outside the Existing Premises or the Remaining Premises, as applicable) to correct violations of construction-related accessibility standards, then Tenant shall reimburse Landlord upon demand, as Additional Rent, for the cost to Landlord of performing such improvements or repairs.</font></div><div><font><br></font></div><div style="margin-top:0.05pt;padding-left:23pt;padding-right:71.65pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">10. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%;text-decoration:underline">Attorneys' Fees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">. Should any dispute arise between the parties hereto or their legal representatives, successors and assigns concerning any provision of this Agreement or the rights and duties of any person in relation thereto, the party prevailing in such dispute shall be entitled, in addition to such other relief that may be granted, to recover reasonable attorneys' fees and legal costs in connection with such dispute. </font></div><div style="padding-right:71.65pt;text-align:justify"><font><br></font></div><div style="padding-left:23pt;padding-right:71.65pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">11. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%;text-decoration:underline">Governing Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">.   This Agreement shall be governed and construed under the laws of the State of California.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:23pt;padding-right:71.65pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">12. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%;text-decoration:underline">Counterparts&#59; Signatures</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">. This Agreement may be executed in counterparts, each of which shall be deemed an original, but such counterparts, when taken together, shall constitute one agreement. The parties hereto consent and agree that this Agreement may be signed and&#47;or transmitted by e-mail of a .pdf document or using electronic signature technology (e.g., via DocuSign or similar electronic signature technology), and that such signed electronic record shall be valid and as effective to bind the party so signing as a paper copy bearing such party&#8217;s handwritten signature. The parties further consent and agree that (1) to the extent a party signs </font></div><div style="height:51pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:2.397%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.5pt;padding-left:1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">-5-</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:67pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:80%">EXHIBIT 10.1</font></div></div><div style="margin-top:0.05pt;padding-left:23pt;padding-right:71.65pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">this Agreement using electronic signature technology, by clicking &#8220;SIGN&#8221;, such party is signing this Agreement electronically, and (2) the electronic signatures appearing on this Agreement shall be treated, for purposes of validity, enforceability and admissibility, the same as handwritten signatures.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:23pt;padding-right:71.65pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">13. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%;text-decoration:underline">Binding Effect</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">. This Agreement shall inure to the benefit of, and shall be binding upon, the parties hereto and their respective legal representatives, successors and assigns.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:23pt;padding-right:71.65pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">14. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%;text-decoration:underline">Time of the Essence</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">. Time is of the essence of this Agreement and the provisions contained herein.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:23pt;padding-right:71.65pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">15. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%;text-decoration:underline">Further Assurances</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">. Landlord and Tenant hereby agree to execute such further documents or instruments as may be necessary or appropriate to carry out the intention of this Agreement.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:23pt;padding-right:71.65pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">16. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%;text-decoration:underline">Voluntary Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">. The parties have read this Agreement and mutual release as contained herein, and on the advice of counsel they have freely and voluntarily entered into this Agreement.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="margin-top:4.5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:115%">signatures contained on following page</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#93; </font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:51pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:2.397%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.5pt;padding-left:1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">-6-</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:67pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:80%">EXHIBIT 10.1</font></div></div><div style="padding-left:23pt;padding-right:71.85pt;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12.5pt;font-weight:400;line-height:115%">IN WITNESS WHEREOF, Landlord and Tenant have executed this Agreement as of the day and year first above written.</font></div><div style="margin-top:0.05pt;padding-left:268.45pt"><font><br></font></div><div style="margin-top:0.04pt;padding-left:268.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">&#34;LANDLORD&#34;&#58;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:268.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">KILROY REALTY, L.P.,</font></div><div style="padding-left:268.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">a Delaware limited partnership</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:304.45pt;padding-right:128.85pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">By&#58;&#160;&#160;&#160;&#160;Kilroy Realty Corporation, a Maryland corporation</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:304.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Its&#58; General Partner</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:304.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;text-decoration:underline">    &#47;s&#47; Nelson Ackerly&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div><div style="padding-left:304.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Name&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;text-decoration:underline">    Nelson Ackerly&#160;&#160;&#160;&#160;</font></div><div style="margin-top:7.6pt;padding-right:8.9pt;text-align:right"><font><br></font></div><div style="padding-left:304.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:96%">Its&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:96%;text-decoration:underline">  Senior Vice President, San Diego</font></div><div><font><br></font></div><div style="margin-top:9.05pt;padding-left:304.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;text-decoration:underline">   &#47;s&#47; Robert Paratte&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div><div style="padding-left:304.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Name&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;text-decoration:underline">    Robert Paratte&#160;&#160;&#160;&#160;</font></div><div style="margin-top:7.45pt;padding-right:0.75pt"><font><br></font></div><div style="padding-left:304.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:97%">Its&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:97%;text-decoration:underline"> EVP, Leasing and Business Development</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="margin-top:4.5pt;padding-left:268.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">&#34;TENANT&#34;&#58;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:268.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">AMN HEALTHCARE, INC.,</font></div><div style="padding-left:268.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">a Nevada corporation</font></div><div><font><br></font></div><div style="padding-left:268.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">By&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;text-decoration:underline">          &#47;s&#47; Chris Schwartz&#160;&#160;&#160;&#160;</font></div><div style="margin-top:9.05pt;padding-left:268.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Name&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;text-decoration:underline">    Chris Schwartz&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div><div style="padding-left:270pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Its&#58;  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;text-decoration:underline">                Controller &#160;&#160;&#160;&#160;</font></div><div><font><br></font></div><div style="padding-left:268.45pt"><font><br></font></div><div style="margin-top:9.05pt;padding-left:268.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">By&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;text-decoration:underline">           &#47;s&#47; Denise Jackson                         </font></div><div style="margin-top:9.05pt;padding-left:268.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Name&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;text-decoration:underline">    Denise Jackson&#160;&#160;&#160;&#160;</font></div><div style="margin-top:6.45pt"><font><br></font></div><div style="padding-left:268.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Its&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">                Chief Legal Officer &#160;&#160;&#160;&#160;</font></div><div style="height:51pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:2.397%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.5pt;padding-left:1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">-7-</font></div></td></tr></table></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>3
<FILENAME>amn-ex311x20210930x10q.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="ic31dfc25fbc947d0b6d48e3f18a421b9_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Exhibit 31.1</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certification Pursuant To</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Rule 13a-14(a) of the Securities Exchange Act of 1934</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Susan R. Salka, certify that&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:40.5pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1. I have reviewed this report on Form 10-Q of AMN Healthcare Services, Inc.&#59;</font></div><div style="padding-left:40.5pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:40.5pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="padding-left:40.5pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:40.5pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="padding-left:40.5pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:40.5pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4. The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:76.5pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="padding-left:76.5pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:76.5pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="padding-left:76.5pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:76.5pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c) Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="padding-left:76.5pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:76.5pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d) Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:40.5pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5. The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:76.5pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="padding-left:76.5pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:76.5pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="padding-left:76.5pt;text-indent:-9pt"><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:55.116%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">S</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;&#160;&#160;&#160;&#160;S</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USAN</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> R. S</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ALKA</font></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Susan R. Salka<br>Director, President and Chief Executive Officer<br>(Principal Executive Officer)</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; November&#160;5, 2021 </font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>4
<FILENAME>amn-ex312x20210930x10q.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="ied606025536a4574960a90e091dcdd57_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Exhibit 31.2</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certification Pursuant To</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Rule 13a-14(a) of the Securities Exchange Act of 1934</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Christopher S. Schwartz, certify that&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:40.5pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1. I have reviewed this report on Form 10-Q of AMN Healthcare Services, Inc.&#59;</font></div><div style="padding-left:40.5pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:40.5pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="padding-left:40.5pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:40.5pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="padding-left:40.5pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:40.5pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4. The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:76.5pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="padding-left:76.5pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:76.5pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="padding-left:76.5pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:76.5pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c) Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="padding-left:76.5pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:76.5pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d) Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:40.5pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5. The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:76.5pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="padding-left:76.5pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:76.5pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="padding-left:76.5pt;text-indent:-9pt"><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:55.116%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">S</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;&#160;&#160;&#160;&#160;C</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">HRISTOPHER</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> S. S</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CHWARTZ</font></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Christopher S. Schwartz<br>Controller<br>(Interim Principal Financial Officer)</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; November&#160;5, 2021 </font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>5
<FILENAME>amn-ex321x20210930x10q.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="ic1b77f2f4a4245dc96a929013117e960_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Exhibit 32.1</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AMN Healthcare Services, Inc.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO SECTION 906</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OF THE SARBANES-OXLEY ACT OF 2002</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Quarterly Report of AMN Healthcare Services, Inc. (the &#8220;Company&#8221;) on Form 10-Q for the period ended September&#160;30, 2021 as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), I, Susan R. Salka, President and Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section&#160;1350, as adopted pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002, that&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:81pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="padding-left:81pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:81pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:55.116%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">S</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;&#160;&#160;&#160;&#160;S</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USAN</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> R. S</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ALKA</font></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Susan R. Salka<br>Director, President and Chief Executive Officer<br>(Principal Executive Officer)</font></td></tr></table></div><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; November&#160;5, 2021</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>6
<FILENAME>amn-ex322x20210930x10q.htm
<DESCRIPTION>EX-32.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i39da580807b94646a5bf670ede55f46d_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Exhibit 32.2</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AMN Healthcare Services, Inc.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO SECTION 906</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OF THE SARBANES-OXLEY ACT OF 2002</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Quarterly Report of AMN Healthcare Services, Inc. (the &#8220;Company&#8221;) on Form 10-Q for the period ended September&#160;30, 2021 as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), I, Christopher S. Schwartz, Interim Principal Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section&#160;1350, as adopted pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002, that&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:81pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="padding-left:81pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:81pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="padding-left:81pt;text-indent:-13.5pt"><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:55.116%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">S</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;&#160;&#160;&#160;&#160;C</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">HRISTOPHER</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> S. S</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CHWARTZ</font></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Christopher S. Schwartz<br>Controller<br>(Interim Principal Financial Officer)</font></td></tr></table></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; November&#160;5, 2021 </font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>7
<FILENAME>amn-20210930.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:8a0f5122-b6dd-433b-8020-1a2d882303bb,g:c8a2db26-f545-4776-aff0-0a05f8878828-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:amn="http://www.amnhealthcare.com/20210930" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.amnhealthcare.com/20210930">
  <xs:import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2021" schemaLocation="https://xbrl.sec.gov/dei/2021/dei-2021.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="amn-20210930_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="amn-20210930_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="amn-20210930_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="amn-20210930_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://www.amnhealthcare.com/role/CoverPage">
        <link:definition>0001001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheets" roleURI="http://www.amnhealthcare.com/role/CondensedConsolidatedBalanceSheets">
        <link:definition>1001002 - Statement - Condensed Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheetsParenthetical" roleURI="http://www.amnhealthcare.com/role/CondensedConsolidatedBalanceSheetsParenthetical">
        <link:definition>1002003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofComprehensiveIncome" roleURI="http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofComprehensiveIncome">
        <link:definition>1003004 - Statement - Condensed Consolidated Statements of Comprehensive Income</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofStockholdersEquity" roleURI="http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofStockholdersEquity">
        <link:definition>1004005 - Statement - Condensed Consolidated Statements of Stockholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofCashFlows" roleURI="http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofCashFlows">
        <link:definition>1005006 - Statement - Condensed Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofCashFlowsParenthetical" roleURI="http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofCashFlowsParenthetical">
        <link:definition>1006007 - Statement - Condensed Consolidated Statements of Cash Flows (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentation" roleURI="http://www.amnhealthcare.com/role/BasisofPresentation">
        <link:definition>2101101 - Disclosure - Basis of Presentation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationPolicies" roleURI="http://www.amnhealthcare.com/role/BasisofPresentationPolicies">
        <link:definition>2202201 - Disclosure - Basis of Presentation (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationTables" roleURI="http://www.amnhealthcare.com/role/BasisofPresentationTables">
        <link:definition>2303301 - Disclosure - Basis of Presentation (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationReconciliationofCashCashEquivalentsandRestrictedCashDetails" roleURI="http://www.amnhealthcare.com/role/BasisofPresentationReconciliationofCashCashEquivalentsandRestrictedCashDetails">
        <link:definition>2404401 - Disclosure - Basis of Presentation - Reconciliation of Cash, Cash Equivalents and Restricted Cash (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationReconciliationofCashCashEquivalentsandRestrictedCashDetails_1" roleURI="http://www.amnhealthcare.com/role/BasisofPresentationReconciliationofCashCashEquivalentsandRestrictedCashDetails_1">
        <link:definition>2404401 - Disclosure - Basis of Presentation - Reconciliation of Cash, Cash Equivalents and Restricted Cash (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationReconciliationofActivityinAllowanceforCreditLossesforAccountsReceivableDetails" roleURI="http://www.amnhealthcare.com/role/BasisofPresentationReconciliationofActivityinAllowanceforCreditLossesforAccountsReceivableDetails">
        <link:definition>2405402 - Disclosure - Basis of Presentation - Reconciliation of Activity in Allowance for Credit Losses for Accounts Receivable (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Acquisitions" roleURI="http://www.amnhealthcare.com/role/Acquisitions">
        <link:definition>2106102 - Disclosure - Acquisitions</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsTables" roleURI="http://www.amnhealthcare.com/role/AcquisitionsTables">
        <link:definition>2307302 - Disclosure - Acquisitions (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsNarrativeDetails" roleURI="http://www.amnhealthcare.com/role/AcquisitionsNarrativeDetails">
        <link:definition>2408403 - Disclosure - Acquisitions - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsScheduleofIntangibleAssetsAcquiredDetails" roleURI="http://www.amnhealthcare.com/role/AcquisitionsScheduleofIntangibleAssetsAcquiredDetails">
        <link:definition>2409404 - Disclosure - Acquisitions - Schedule of Intangible Assets Acquired (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsScheduleofProFormaFinancialInformationDetails" roleURI="http://www.amnhealthcare.com/role/AcquisitionsScheduleofProFormaFinancialInformationDetails">
        <link:definition>2410405 - Disclosure - Acquisitions - Schedule of Pro Forma Financial Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognition" roleURI="http://www.amnhealthcare.com/role/RevenueRecognition">
        <link:definition>2111103 - Disclosure - Revenue Recognition</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognitionDetails" roleURI="http://www.amnhealthcare.com/role/RevenueRecognitionDetails">
        <link:definition>2412406 - Disclosure - Revenue Recognition (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetIncomePerCommonShare" roleURI="http://www.amnhealthcare.com/role/NetIncomePerCommonShare">
        <link:definition>2113104 - Disclosure - Net Income Per Common Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetIncomePerCommonShareTables" roleURI="http://www.amnhealthcare.com/role/NetIncomePerCommonShareTables">
        <link:definition>2314303 - Disclosure - Net Income Per Common Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetIncomePerCommonShareDetails" roleURI="http://www.amnhealthcare.com/role/NetIncomePerCommonShareDetails">
        <link:definition>2415407 - Disclosure - Net Income Per Common Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformation" roleURI="http://www.amnhealthcare.com/role/SegmentInformation">
        <link:definition>2116105 - Disclosure - Segment Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationTables" roleURI="http://www.amnhealthcare.com/role/SegmentInformationTables">
        <link:definition>2317304 - Disclosure - Segment Information (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationNarrativeDetails" roleURI="http://www.amnhealthcare.com/role/SegmentInformationNarrativeDetails">
        <link:definition>2418408 - Disclosure - Segment Information - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationReconciliationofRevenueandSegmentOperatingIncomebyReportableSegmentDetails" roleURI="http://www.amnhealthcare.com/role/SegmentInformationReconciliationofRevenueandSegmentOperatingIncomebyReportableSegmentDetails">
        <link:definition>2419409 - Disclosure - Segment Information - Reconciliation of Revenue and Segment Operating Income by Reportable Segment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationDisaggregationofRevenueDetails" roleURI="http://www.amnhealthcare.com/role/SegmentInformationDisaggregationofRevenueDetails">
        <link:definition>2420410 - Disclosure - Segment Information - Disaggregation of Revenue (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationSummaryofGoodwillbyReportableSegmentDetails" roleURI="http://www.amnhealthcare.com/role/SegmentInformationSummaryofGoodwillbyReportableSegmentDetails">
        <link:definition>2421411 - Disclosure - Segment Information - Summary of Goodwill by Reportable Segment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NotesPayableandCreditAgreement" roleURI="http://www.amnhealthcare.com/role/NotesPayableandCreditAgreement">
        <link:definition>2122106 - Disclosure - Notes Payable and Credit Agreement</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NotesPayableandCreditAgreementDetails" roleURI="http://www.amnhealthcare.com/role/NotesPayableandCreditAgreementDetails">
        <link:definition>2423412 - Disclosure - Notes Payable and Credit Agreement (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurement" roleURI="http://www.amnhealthcare.com/role/FairValueMeasurement">
        <link:definition>2124107 - Disclosure - Fair Value Measurement</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementTables" roleURI="http://www.amnhealthcare.com/role/FairValueMeasurementTables">
        <link:definition>2325305 - Disclosure - Fair Value Measurement (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementNarrativeDetails" roleURI="http://www.amnhealthcare.com/role/FairValueMeasurementNarrativeDetails">
        <link:definition>2426413 - Disclosure - Fair Value Measurement - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementFinancialAssetsandLiabilitiesDetails" roleURI="http://www.amnhealthcare.com/role/FairValueMeasurementFinancialAssetsandLiabilitiesDetails">
        <link:definition>2427414 - Disclosure - Fair Value Measurement - Financial Assets and Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementReconciliationofChangesinContingentConsiderationLiabilitiesDetails" roleURI="http://www.amnhealthcare.com/role/FairValueMeasurementReconciliationofChangesinContingentConsiderationLiabilitiesDetails">
        <link:definition>2428415 - Disclosure - Fair Value Measurement - Reconciliation of Changes in Contingent Consideration Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementFairValueofFinancialInstrumentsDetails" roleURI="http://www.amnhealthcare.com/role/FairValueMeasurementFairValueofFinancialInstrumentsDetails">
        <link:definition>2429416 - Disclosure - Fair Value Measurement - Fair Value of Financial Instruments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Leases" roleURI="http://www.amnhealthcare.com/role/Leases">
        <link:definition>2130108 - Disclosure - Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesDetails" roleURI="http://www.amnhealthcare.com/role/LeasesDetails">
        <link:definition>2431417 - Disclosure - Leases (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://www.amnhealthcare.com/role/IncomeTaxes">
        <link:definition>2132109 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesDetails" roleURI="http://www.amnhealthcare.com/role/IncomeTaxesDetails">
        <link:definition>2433418 - Disclosure - Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesLegalProceedings" roleURI="http://www.amnhealthcare.com/role/CommitmentsandContingenciesLegalProceedings">
        <link:definition>2134110 - Disclosure - Commitments and Contingencies: Legal Proceedings</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesLegalProceedingsDetails" roleURI="http://www.amnhealthcare.com/role/CommitmentsandContingenciesLegalProceedingsDetails">
        <link:definition>2435419 - Disclosure - Commitments and Contingencies: Legal Proceedings (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetDetails" roleURI="http://www.amnhealthcare.com/role/BalanceSheetDetails">
        <link:definition>2136111 - Disclosure - Balance Sheet Details</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetDetailsTables" roleURI="http://www.amnhealthcare.com/role/BalanceSheetDetailsTables">
        <link:definition>2337306 - Disclosure - Balance Sheet Details (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetDetailsDetails" roleURI="http://www.amnhealthcare.com/role/BalanceSheetDetailsDetails">
        <link:definition>2438420 - Disclosure - Balance Sheet Details (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="amn_SupplementalDisclosuresOfNonCashInvestingAndFinancingActivitiesGoodwill" abstract="false" name="SupplementalDisclosuresOfNonCashInvestingAndFinancingActivitiesGoodwill" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="amn_DeferredCompensationMember" abstract="true" name="DeferredCompensationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="amn_TermDebtMember" abstract="true" name="TermDebtMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="amn_AccountsPayableToSubcontractor" abstract="false" name="AccountsPayableToSubcontractor" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="amn_WageAndHourClaimsMember" abstract="true" name="WageAndHourClaimsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="amn_BusinessCombinationConsiderationTransferredNetOfWorkingCapitalAdjustment" abstract="false" name="BusinessCombinationConsiderationTransferredNetOfWorkingCapitalAdjustment" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="amn_StratusVideoMember" abstract="true" name="StratusVideoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="amn_SaaSBasedTechnologiesMember" abstract="true" name="SaaSBasedTechnologiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="amn_PaymentsForPreviousAcquisitionEarnOutPayment" abstract="false" name="PaymentsForPreviousAcquisitionEarnOutPayment" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="amn_AccountsReceivableAndSalesCreditsCreditLossExpenseReversal" abstract="false" name="AccountsReceivableAndSalesCreditsCreditLossExpenseReversal" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="amn_LesseeOperatingLeaseLiabilityToBePaidPostmodification" abstract="false" name="LesseeOperatingLeaseLiabilityToBePaidPostmodification" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="amn_PhysicianAndLeadershipSolutionsMember" abstract="true" name="PhysicianAndLeadershipSolutionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="amn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="amn_NurseAndAlliedHealthcareStaffingMember" abstract="true" name="NurseAndAlliedHealthcareStaffingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="amn_AccountsPayableAndAccruedExpensesExcludingAccruedCompensationAndBenefitsCurrent" abstract="false" name="AccountsPayableAndAccruedExpensesExcludingAccruedCompensationAndBenefitsCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="amn_TemporaryStaffingMember" abstract="true" name="TemporaryStaffingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="amn_AdvancedMedicalPersonnelServicesInc.Member" abstract="true" name="AdvancedMedicalPersonnelServicesInc.Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="amn_ScheduleofSupplementalBalanceSheetDisclosuresTableTextBlock" abstract="false" name="ScheduleofSupplementalBalanceSheetDisclosuresTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="amn_ContingentConsiderationMember" abstract="true" name="ContingentConsiderationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="amn_A4000SeniorNotesDue2029Member" abstract="true" name="A4000SeniorNotesDue2029Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="amn_LesseeOperatingLeaseLiabilityToBePaidPremodification" abstract="false" name="LesseeOperatingLeaseLiabilityToBePaidPremodification" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="amn_EmployeeRetentionEmploymentTaxCreditCARESAct" abstract="false" name="EmployeeRetentionEmploymentTaxCreditCARESAct" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="amn_DeferredPayrollTaxesCARESAct" abstract="false" name="DeferredPayrollTaxesCARESAct" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="amn_IncreaseDecreaseinAccountsReceivablessubcontractor" abstract="false" name="IncreaseDecreaseinAccountsReceivablessubcontractor" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="amn_A4.625SeniorNotesDue2027Member" abstract="true" name="A4.625SeniorNotesDue2027Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="amn_AccruedTravelExpense" abstract="false" name="AccruedTravelExpense" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="amn_OperatingLeaseRightOfUseAssetIncreaseDecreaseFromModification" abstract="false" name="OperatingLeaseRightOfUseAssetIncreaseDecreaseFromModification" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="amn_SupplementalDisclosuresOfNonCashInvestingAndFinancingActivitiesIntangibleAssets" abstract="false" name="SupplementalDisclosuresOfNonCashInvestingAndFinancingActivitiesIntangibleAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="amn_SynziMember" abstract="true" name="SynziMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="amn_OperatingLeaseLiabilityIncreaseDecreaseFromModification" abstract="false" name="OperatingLeaseLiabilityIncreaseDecreaseFromModification" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="amn_Accountsreceivablesubcontractor" abstract="false" name="Accountsreceivablesubcontractor" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="amn_OutsourcedWorkforceMember" abstract="true" name="OutsourcedWorkforceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="amn_NumberOfPhasesOfLeaseTerminationAgreement" abstract="false" name="NumberOfPhasesOfLeaseTerminationAgreement" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="amn_UnallocatedCorporateOverhead" abstract="false" name="UnallocatedCorporateOverhead" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="amn_Purchaseoffixedassetsrecordedinaccountspayableandaccruedexpenses" abstract="false" name="Purchaseoffixedassetsrecordedinaccountspayableandaccruedexpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="amn_GainLossOnDeferredCompensation" abstract="false" name="GainLossOnDeferredCompensation" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="amn_AccruedBonusesAndCommissions" abstract="false" name="AccruedBonusesAndCommissions" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="amn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalentsAndPropertyPlantAndEquipment" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalentsAndPropertyPlantAndEquipment" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="amn_PaymentsOfLeaseTerminationFee" abstract="false" name="PaymentsOfLeaseTerminationFee" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="amn_TotalCashCashEquivalentsAndRestrictedCashCashEquivalentsandInvestments" abstract="false" name="TotalCashCashEquivalentsAndRestrictedCashCashEquivalentsandInvestments" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="amn_TechnologyAndWorkforceSolutionsMember" abstract="true" name="TechnologyAndWorkforceSolutionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="amn_PermanentPlacementMember" abstract="true" name="PermanentPlacementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="amn_InterpreterDatabaseMember" abstract="true" name="InterpreterDatabaseMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="amn_LesseeOperatingLeaseNoncashExpense" abstract="false" name="LesseeOperatingLeaseNoncashExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="amn_B4healthLLCMember" abstract="true" name="B4healthLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>8
<FILENAME>amn-20210930_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:8a0f5122-b6dd-433b-8020-1a2d882303bb,g:c8a2db26-f545-4776-aff0-0a05f8878828-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.amnhealthcare.com/role/CondensedConsolidatedBalanceSheets" xlink:type="simple" xlink:href="amn-20210930.xsd#CondensedConsolidatedBalanceSheets"/>
  <link:calculationLink xlink:role="http://www.amnhealthcare.com/role/CondensedConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_3c5b7d32-16eb-48d5-a2a5-808218782d5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_b4a6da25-8efd-4f29-b776-d489e86d0c0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_3c5b7d32-16eb-48d5-a2a5-808218782d5e" xlink:to="loc_us-gaap_Liabilities_b4a6da25-8efd-4f29-b776-d489e86d0c0b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_75796cbb-f718-4e2a-9386-2c3bc1468dc5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_3c5b7d32-16eb-48d5-a2a5-808218782d5e" xlink:to="loc_us-gaap_StockholdersEquity_75796cbb-f718-4e2a-9386-2c3bc1468dc5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_d24a12ec-5ace-4979-8d2b-626f61990fb9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_3c5b7d32-16eb-48d5-a2a5-808218782d5e" xlink:to="loc_us-gaap_CommitmentsAndContingencies_d24a12ec-5ace-4979-8d2b-626f61990fb9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_7c598f92-03e7-45fd-9a3a-8a46a68baa60" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_fe5af54c-f3da-4a06-9778-1ba63450e787" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_7c598f92-03e7-45fd-9a3a-8a46a68baa60" xlink:to="loc_us-gaap_PreferredStockValue_fe5af54c-f3da-4a06-9778-1ba63450e787" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_7b2f49e3-a219-47aa-b263-332c5a29e1d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_7c598f92-03e7-45fd-9a3a-8a46a68baa60" xlink:to="loc_us-gaap_CommonStockValue_7b2f49e3-a219-47aa-b263-332c5a29e1d8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_a26712e0-3ae1-4387-acf3-d59a357f1e7f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_7c598f92-03e7-45fd-9a3a-8a46a68baa60" xlink:to="loc_us-gaap_AdditionalPaidInCapital_a26712e0-3ae1-4387-acf3-d59a357f1e7f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_98a56481-5a06-40d6-8950-cc98b0bf271c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_7c598f92-03e7-45fd-9a3a-8a46a68baa60" xlink:to="loc_us-gaap_TreasuryStockValue_98a56481-5a06-40d6-8950-cc98b0bf271c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_7fc29376-77c3-4f00-a044-3e1e6b140513" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_7c598f92-03e7-45fd-9a3a-8a46a68baa60" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_7fc29376-77c3-4f00-a044-3e1e6b140513" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_aaaed41a-eb66-414b-9a24-3fe3284f7fdd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_7c598f92-03e7-45fd-9a3a-8a46a68baa60" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_aaaed41a-eb66-414b-9a24-3fe3284f7fdd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_b9aef237-dac5-4fee-af67-4caff624a33f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_c4c4c42c-5e24-4e0a-9c99-dd4a085d4dda" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_b9aef237-dac5-4fee-af67-4caff624a33f" xlink:to="loc_us-gaap_AssetsCurrent_c4c4c42c-5e24-4e0a-9c99-dd4a085d4dda" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_1d8f8241-88af-4195-9512-4571310b691a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_b9aef237-dac5-4fee-af67-4caff624a33f" xlink:to="loc_us-gaap_Goodwill_1d8f8241-88af-4195-9512-4571310b691a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_05f2ac60-e46e-4fec-a855-da57e692e25d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_b9aef237-dac5-4fee-af67-4caff624a33f" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_05f2ac60-e46e-4fec-a855-da57e692e25d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndInvestmentsNoncurrent_a7ab203d-3d93-449c-a1d7-ae44470e78b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndInvestmentsNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_b9aef237-dac5-4fee-af67-4caff624a33f" xlink:to="loc_us-gaap_RestrictedCashAndInvestmentsNoncurrent_a7ab203d-3d93-449c-a1d7-ae44470e78b8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_6a054c27-b96d-4fcc-b11a-629e9b4acd87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_b9aef237-dac5-4fee-af67-4caff624a33f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_6a054c27-b96d-4fcc-b11a-629e9b4acd87" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_deab513f-1326-4162-91cf-eabc63d69d64" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_b9aef237-dac5-4fee-af67-4caff624a33f" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_deab513f-1326-4162-91cf-eabc63d69d64" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_70a09499-6cd9-4d0f-960e-c7eaa90518fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_b9aef237-dac5-4fee-af67-4caff624a33f" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_70a09499-6cd9-4d0f-960e-c7eaa90518fb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_0545ff31-2bd3-4797-bcfd-18473f11776f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_e90f431a-4cfa-41ba-8139-41f097fe1303" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_0545ff31-2bd3-4797-bcfd-18473f11776f" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_e90f431a-4cfa-41ba-8139-41f097fe1303" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_b6ba6b73-73c3-40ee-9069-aa1b06232621" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_0545ff31-2bd3-4797-bcfd-18473f11776f" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_b6ba6b73-73c3-40ee-9069-aa1b06232621" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_amn_Accountsreceivablesubcontractor_fc567ed7-f5a6-43f0-bece-e4ab2f5ea21c" xlink:href="amn-20210930.xsd#amn_Accountsreceivablesubcontractor"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_0545ff31-2bd3-4797-bcfd-18473f11776f" xlink:to="loc_amn_Accountsreceivablesubcontractor_fc567ed7-f5a6-43f0-bece-e4ab2f5ea21c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_e675ebc5-d01a-46be-88e1-1af037fbee86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_0545ff31-2bd3-4797-bcfd-18473f11776f" xlink:to="loc_us-gaap_PrepaidExpenseCurrent_e675ebc5-d01a-46be-88e1-1af037fbee86" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_d66435b0-9d6d-4249-b1cd-cb74aad197ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_0545ff31-2bd3-4797-bcfd-18473f11776f" xlink:to="loc_us-gaap_OtherAssetsCurrent_d66435b0-9d6d-4249-b1cd-cb74aad197ef" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_9eb5bcd2-5a7c-4019-99c7-b921cab80d1b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_80240129-60a1-4040-91f4-8694d4a7a532" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_9eb5bcd2-5a7c-4019-99c7-b921cab80d1b" xlink:to="loc_us-gaap_LiabilitiesCurrent_80240129-60a1-4040-91f4-8694d4a7a532" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermNotesPayable_2c3cd821-ebe0-4552-92d3-6cf87f83be9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermNotesPayable"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_9eb5bcd2-5a7c-4019-99c7-b921cab80d1b" xlink:to="loc_us-gaap_LongTermNotesPayable_2c3cd821-ebe0-4552-92d3-6cf87f83be9d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_c2386fad-21e2-48d0-828e-d387847bb008" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_9eb5bcd2-5a7c-4019-99c7-b921cab80d1b" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_c2386fad-21e2-48d0-828e-d387847bb008" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_79dbeaf5-badd-4f51-ad63-9d0e7b3f65f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_9eb5bcd2-5a7c-4019-99c7-b921cab80d1b" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_79dbeaf5-badd-4f51-ad63-9d0e7b3f65f8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_8ecbc598-051e-47c2-8a40-83d16659c46a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_9eb5bcd2-5a7c-4019-99c7-b921cab80d1b" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_8ecbc598-051e-47c2-8a40-83d16659c46a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_5606bfab-51ed-409a-8445-2efd45ca1314" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_e0589226-8302-44b6-81ee-ed0af8393a76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_5606bfab-51ed-409a-8445-2efd45ca1314" xlink:to="loc_us-gaap_AccountsPayableCurrent_e0589226-8302-44b6-81ee-ed0af8393a76" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_e21fe542-ea88-4741-ae14-b958a8ada4f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_5606bfab-51ed-409a-8445-2efd45ca1314" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_e21fe542-ea88-4741-ae14-b958a8ada4f0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_5ac9f681-22d3-43a7-b425-07e9835ba455" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_5606bfab-51ed-409a-8445-2efd45ca1314" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_5ac9f681-22d3-43a7-b425-07e9835ba455" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_54facb5f-095a-4b90-91b3-3d1cc7b5354a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_5606bfab-51ed-409a-8445-2efd45ca1314" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_54facb5f-095a-4b90-91b3-3d1cc7b5354a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_99c4a635-3ce2-4243-9ade-7b00c0f5d2d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_5606bfab-51ed-409a-8445-2efd45ca1314" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_99c4a635-3ce2-4243-9ade-7b00c0f5d2d0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableCurrent_aba893f6-1d1e-4ac1-963c-56ac1248caf5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesPayableCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_5606bfab-51ed-409a-8445-2efd45ca1314" xlink:to="loc_us-gaap_NotesPayableCurrent_aba893f6-1d1e-4ac1-963c-56ac1248caf5" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofComprehensiveIncome" xlink:type="simple" xlink:href="amn-20210930.xsd#CondensedConsolidatedStatementsofComprehensiveIncome"/>
  <link:calculationLink xlink:role="http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofComprehensiveIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_9ef234b0-9ae7-46d6-8455-95c8bdae04ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossAttributableToParent_05c0db34-8edb-4725-aeb2-4ccab276dc34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossAttributableToParent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_9ef234b0-9ae7-46d6-8455-95c8bdae04ce" xlink:to="loc_us-gaap_IncomeLossAttributableToParent_05c0db34-8edb-4725-aeb2-4ccab276dc34" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_5bab31e8-0940-4c28-a043-c157de8cc9fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_9ef234b0-9ae7-46d6-8455-95c8bdae04ce" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_5bab31e8-0940-4c28-a043-c157de8cc9fc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_5488a6c2-a3b3-4f6c-91ee-cb94dfad7569" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_1d4b3d46-17f3-4d2d-9bf2-a777bf075ff8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_5488a6c2-a3b3-4f6c-91ee-cb94dfad7569" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_1d4b3d46-17f3-4d2d-9bf2-a777bf075ff8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossAttributableToParent_57057b0d-928e-4033-b31e-601ddce36ab6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossAttributableToParent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_5488a6c2-a3b3-4f6c-91ee-cb94dfad7569" xlink:to="loc_us-gaap_IncomeLossAttributableToParent_57057b0d-928e-4033-b31e-601ddce36ab6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_b3a22660-9d27-436d-b782-5303c28682fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_da51eb40-0bac-4d02-9aa4-a142d5059ee8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_b3a22660-9d27-436d-b782-5303c28682fa" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_da51eb40-0bac-4d02-9aa4-a142d5059ee8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_9e5d852f-4ca0-424c-b32a-34955fe1220a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_b3a22660-9d27-436d-b782-5303c28682fa" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_9e5d852f-4ca0-424c-b32a-34955fe1220a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_51bae8a1-2b6d-4f25-8c4e-07d77e725709" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_a1acc61d-0755-44f1-9cdd-42df6afcdb7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_51bae8a1-2b6d-4f25-8c4e-07d77e725709" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_a1acc61d-0755-44f1-9cdd-42df6afcdb7a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_d192715d-1df6-4fa3-9238-507b6f688f44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_51bae8a1-2b6d-4f25-8c4e-07d77e725709" xlink:to="loc_us-gaap_DepreciationAndAmortization_d192715d-1df6-4fa3-9238-507b6f688f44" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_578dd512-0be8-4a49-b52c-e0b920c4fd39" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_873dd7e5-86e1-43a6-8f2b-b47fb2103e30" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_578dd512-0be8-4a49-b52c-e0b920c4fd39" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_873dd7e5-86e1-43a6-8f2b-b47fb2103e30" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_662e2879-3627-4e26-ae2e-d96d93ce9249" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_cececaec-c146-4038-84d9-5259ebfdff08" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_662e2879-3627-4e26-ae2e-d96d93ce9249" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_cececaec-c146-4038-84d9-5259ebfdff08" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_f42cb08f-b715-4190-ac60-0d99474cbaad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_662e2879-3627-4e26-ae2e-d96d93ce9249" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_f42cb08f-b715-4190-ac60-0d99474cbaad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossAttributableToParent_85e225a5-abc7-4081-b21a-bf77babd82a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_2dfbc1a3-440b-4bf2-b105-f3395b8aa20e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossAttributableToParent_85e225a5-abc7-4081-b21a-bf77babd82a1" xlink:to="loc_us-gaap_OperatingIncomeLoss_2dfbc1a3-440b-4bf2-b105-f3395b8aa20e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_ce252f97-01c8-4d0c-abdc-b3716e9721ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossAttributableToParent_85e225a5-abc7-4081-b21a-bf77babd82a1" xlink:to="loc_us-gaap_InterestExpense_ce252f97-01c8-4d0c-abdc-b3716e9721ef" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_46fe6d3c-daa6-4ae3-a77a-48114b980931" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_7ce44444-1469-4cde-9620-e17d8c4c42a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_46fe6d3c-daa6-4ae3-a77a-48114b980931" xlink:to="loc_us-gaap_GrossProfit_7ce44444-1469-4cde-9620-e17d8c4c42a8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_7b39c838-8920-4791-ac6b-b065694eff6b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_46fe6d3c-daa6-4ae3-a77a-48114b980931" xlink:to="loc_us-gaap_OperatingExpenses_7b39c838-8920-4791-ac6b-b065694eff6b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="amn-20210930.xsd#CondensedConsolidatedStatementsofCashFlows"/>
  <link:calculationLink xlink:role="http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_66e716ff-693d-4274-a7d2-3aa8e1d764e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_73dc3961-35e1-4078-b3f7-e125634942ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_66e716ff-693d-4274-a7d2-3aa8e1d764e6" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_73dc3961-35e1-4078-b3f7-e125634942ef" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_385b0913-97b2-453c-b7ba-4f3243e955cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_66e716ff-693d-4274-a7d2-3aa8e1d764e6" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_385b0913-97b2-453c-b7ba-4f3243e955cc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0e343d88-3fa4-448e-b39a-76a499b098c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_66e716ff-693d-4274-a7d2-3aa8e1d764e6" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0e343d88-3fa4-448e-b39a-76a499b098c1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_eb84aa83-0a78-43e4-bceb-b44af0c562f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_66e716ff-693d-4274-a7d2-3aa8e1d764e6" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_eb84aa83-0a78-43e4-bceb-b44af0c562f5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_bcc5a5bf-a3f1-478f-a2d2-59d0bbb29c0e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfSecuredDebt_c2d1d062-d648-4a0e-a8e9-6a191980d527" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfSecuredDebt"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_bcc5a5bf-a3f1-478f-a2d2-59d0bbb29c0e" xlink:to="loc_us-gaap_RepaymentsOfSecuredDebt_c2d1d062-d648-4a0e-a8e9-6a191980d527" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSecuredDebt_db71155b-d8fa-4c78-adc1-288b127be78c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSecuredDebt"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_bcc5a5bf-a3f1-478f-a2d2-59d0bbb29c0e" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSecuredDebt_db71155b-d8fa-4c78-adc1-288b127be78c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit_0798f49c-79d1-479c-b343-786f0c94d5ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_bcc5a5bf-a3f1-478f-a2d2-59d0bbb29c0e" xlink:to="loc_us-gaap_RepaymentsOfLinesOfCredit_0798f49c-79d1-479c-b343-786f0c94d5ef" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit_5634f5ca-aa6f-4ee5-8380-7450dc3ab71b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_bcc5a5bf-a3f1-478f-a2d2-59d0bbb29c0e" xlink:to="loc_us-gaap_ProceedsFromLinesOfCredit_5634f5ca-aa6f-4ee5-8380-7450dc3ab71b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfFinancingCosts_2d2aac81-b4da-43e8-9e6d-cc561dab24ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfFinancingCosts"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_bcc5a5bf-a3f1-478f-a2d2-59d0bbb29c0e" xlink:to="loc_us-gaap_PaymentsOfFinancingCosts_2d2aac81-b4da-43e8-9e6d-cc561dab24ea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_amn_PaymentsForPreviousAcquisitionEarnOutPayment_ca7dbaf1-ecbc-4f71-8951-0218efaeea69" xlink:href="amn-20210930.xsd#amn_PaymentsForPreviousAcquisitionEarnOutPayment"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_bcc5a5bf-a3f1-478f-a2d2-59d0bbb29c0e" xlink:to="loc_amn_PaymentsForPreviousAcquisitionEarnOutPayment_ca7dbaf1-ecbc-4f71-8951-0218efaeea69" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_4b71b17e-90dd-435e-a5c0-36fcf2b06e0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_bcc5a5bf-a3f1-478f-a2d2-59d0bbb29c0e" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_4b71b17e-90dd-435e-a5c0-36fcf2b06e0b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_38db9d42-0b06-4ab8-83a5-dc178f0534ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_bcc5a5bf-a3f1-478f-a2d2-59d0bbb29c0e" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_38db9d42-0b06-4ab8-83a5-dc178f0534ca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6d83ebfd-6c66-47f2-bc6f-f57cc58b0126" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_6fb64822-62d9-4db7-b6f8-a308be2329fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6d83ebfd-6c66-47f2-bc6f-f57cc58b0126" xlink:to="loc_us-gaap_NetIncomeLoss_6fb64822-62d9-4db7-b6f8-a308be2329fb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_547d31b6-04ee-43bb-bad3-91661f52ad40" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6d83ebfd-6c66-47f2-bc6f-f57cc58b0126" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_547d31b6-04ee-43bb-bad3-91661f52ad40" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_c588a535-0f54-4f35-8042-7decb699abdd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6d83ebfd-6c66-47f2-bc6f-f57cc58b0126" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_c588a535-0f54-4f35-8042-7decb699abdd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_a9db1146-4ad9-48cf-8c02-5104dff5d1ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6d83ebfd-6c66-47f2-bc6f-f57cc58b0126" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_a9db1146-4ad9-48cf-8c02-5104dff5d1ec" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_amn_AccountsReceivableAndSalesCreditsCreditLossExpenseReversal_e2439e80-3b63-4c25-a69d-25289e741b60" xlink:href="amn-20210930.xsd#amn_AccountsReceivableAndSalesCreditsCreditLossExpenseReversal"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6d83ebfd-6c66-47f2-bc6f-f57cc58b0126" xlink:to="loc_amn_AccountsReceivableAndSalesCreditsCreditLossExpenseReversal_e2439e80-3b63-4c25-a69d-25289e741b60" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_f72404fe-c493-4930-a8fa-87b0e9306e2d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6d83ebfd-6c66-47f2-bc6f-f57cc58b0126" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_f72404fe-c493-4930-a8fa-87b0e9306e2d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_a9c0263a-949c-4f65-9952-121ec170a7e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6d83ebfd-6c66-47f2-bc6f-f57cc58b0126" xlink:to="loc_us-gaap_ShareBasedCompensation_a9c0263a-949c-4f65-9952-121ec170a7e2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets_4193b1ea-039c-4af5-9c27-f3644a666526" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6d83ebfd-6c66-47f2-bc6f-f57cc58b0126" xlink:to="loc_us-gaap_GainLossOnDispositionOfAssets_4193b1ea-039c-4af5-9c27-f3644a666526" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_b0814588-d180-44e4-9990-40b1f4baafad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6d83ebfd-6c66-47f2-bc6f-f57cc58b0126" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_b0814588-d180-44e4-9990-40b1f4baafad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_amn_IncreaseDecreaseinAccountsReceivablessubcontractor_54b162e2-07f0-489b-b960-f11a632414bc" xlink:href="amn-20210930.xsd#amn_IncreaseDecreaseinAccountsReceivablessubcontractor"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6d83ebfd-6c66-47f2-bc6f-f57cc58b0126" xlink:to="loc_amn_IncreaseDecreaseinAccountsReceivablessubcontractor_54b162e2-07f0-489b-b960-f11a632414bc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable_618d380f-1f07-4a61-8b4c-b9b441ccf643" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInIncomeTaxesReceivable"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6d83ebfd-6c66-47f2-bc6f-f57cc58b0126" xlink:to="loc_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable_618d380f-1f07-4a61-8b4c-b9b441ccf643" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidExpense_bcc65698-6892-473e-a9f9-4e6ad75b4acb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6d83ebfd-6c66-47f2-bc6f-f57cc58b0126" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidExpense_bcc65698-6892-473e-a9f9-4e6ad75b4acb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherCurrentAssets_4b45c549-161f-4558-bee9-ef19b38c9a9c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherCurrentAssets"/>
    <link:calculationArc order="13" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6d83ebfd-6c66-47f2-bc6f-f57cc58b0126" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherCurrentAssets_4b45c549-161f-4558-bee9-ef19b38c9a9c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_bd6488f7-2604-420c-aa00-3a48ce2b35f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:calculationArc order="14" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6d83ebfd-6c66-47f2-bc6f-f57cc58b0126" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_bd6488f7-2604-420c-aa00-3a48ce2b35f5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_409832fd-f89b-4678-ab9c-30b756989f07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:calculationArc order="15" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6d83ebfd-6c66-47f2-bc6f-f57cc58b0126" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_409832fd-f89b-4678-ab9c-30b756989f07" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_c0a982d6-499b-40ce-89d8-da8f179caac0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <link:calculationArc order="16" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6d83ebfd-6c66-47f2-bc6f-f57cc58b0126" xlink:to="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_c0a982d6-499b-40ce-89d8-da8f179caac0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_c7c467aa-9287-47b9-bedb-fd2d50dfebd7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <link:calculationArc order="17" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6d83ebfd-6c66-47f2-bc6f-f57cc58b0126" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_c7c467aa-9287-47b9-bedb-fd2d50dfebd7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_a7d70c69-be91-4810-be60-2406c6cacf13" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:calculationArc order="18" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6d83ebfd-6c66-47f2-bc6f-f57cc58b0126" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_a7d70c69-be91-4810-be60-2406c6cacf13" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInRestrictedCashAndInvestmentsForOperatingActivities_08a8ede4-3978-47e6-8f16-ef159b507233" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInRestrictedCashAndInvestmentsForOperatingActivities"/>
    <link:calculationArc order="19" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6d83ebfd-6c66-47f2-bc6f-f57cc58b0126" xlink:to="loc_us-gaap_IncreaseDecreaseInRestrictedCashAndInvestmentsForOperatingActivities_08a8ede4-3978-47e6-8f16-ef159b507233" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeAmortizationOfDiscount_734625dd-bf9c-4a7a-86ae-ef73adeae1b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeAmortizationOfDiscount"/>
    <link:calculationArc order="20" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6d83ebfd-6c66-47f2-bc6f-f57cc58b0126" xlink:to="loc_us-gaap_InvestmentIncomeAmortizationOfDiscount_734625dd-bf9c-4a7a-86ae-ef73adeae1b4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_amn_GainLossOnDeferredCompensation_906cec49-ee9f-41e0-95b7-bcc46e26f3b4" xlink:href="amn-20210930.xsd#amn_GainLossOnDeferredCompensation"/>
    <link:calculationArc order="21" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6d83ebfd-6c66-47f2-bc6f-f57cc58b0126" xlink:to="loc_amn_GainLossOnDeferredCompensation_906cec49-ee9f-41e0-95b7-bcc46e26f3b4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_amn_LesseeOperatingLeaseNoncashExpense_e3e16ffd-1526-4a66-a2ba-56be0a23105d" xlink:href="amn-20210930.xsd#amn_LesseeOperatingLeaseNoncashExpense"/>
    <link:calculationArc order="22" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6d83ebfd-6c66-47f2-bc6f-f57cc58b0126" xlink:to="loc_amn_LesseeOperatingLeaseNoncashExpense_e3e16ffd-1526-4a66-a2ba-56be0a23105d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WriteOffOfDeferredDebtIssuanceCost_6e3d4c07-8076-419b-8910-c222678fd011" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WriteOffOfDeferredDebtIssuanceCost"/>
    <link:calculationArc order="23" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6d83ebfd-6c66-47f2-bc6f-f57cc58b0126" xlink:to="loc_us-gaap_WriteOffOfDeferredDebtIssuanceCost_6e3d4c07-8076-419b-8910-c222678fd011" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_67c6a338-900c-4f1c-be3c-ac520d1d86ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_0c3c4f11-e635-40f6-91b9-a72535558ecb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_67c6a338-900c-4f1c-be3c-ac520d1d86ed" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_0c3c4f11-e635-40f6-91b9-a72535558ecb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireShortTermInvestments_bc20802d-734a-490d-9075-448eed98cfd0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireShortTermInvestments"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_67c6a338-900c-4f1c-be3c-ac520d1d86ed" xlink:to="loc_us-gaap_PaymentsToAcquireShortTermInvestments_bc20802d-734a-490d-9075-448eed98cfd0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments_0c11f25b-f797-49c2-b4c6-5461c4771364" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_67c6a338-900c-4f1c-be3c-ac520d1d86ed" xlink:to="loc_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments_0c11f25b-f797-49c2-b4c6-5461c4771364" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireLifeInsurancePolicies_7db71ba8-6147-4603-b49d-394eeca29ce8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireLifeInsurancePolicies"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_67c6a338-900c-4f1c-be3c-ac520d1d86ed" xlink:to="loc_us-gaap_PaymentsToAcquireLifeInsurancePolicies_7db71ba8-6147-4603-b49d-394eeca29ce8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireNotesReceivable_95df95e2-66e9-4e23-8f14-75efce14a99d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireNotesReceivable"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_67c6a338-900c-4f1c-be3c-ac520d1d86ed" xlink:to="loc_us-gaap_PaymentsToAcquireNotesReceivable_95df95e2-66e9-4e23-8f14-75efce14a99d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets_4511e68a-d13e-44d9-a4e4-0d239c7329bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_67c6a338-900c-4f1c-be3c-ac520d1d86ed" xlink:to="loc_us-gaap_PaymentsToAcquireIntangibleAssets_4511e68a-d13e-44d9-a4e4-0d239c7329bd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPreviousAcquisition_6a11c449-db7b-4b97-9d2a-254a2f59c366" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromPreviousAcquisition"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_67c6a338-900c-4f1c-be3c-ac520d1d86ed" xlink:to="loc_us-gaap_ProceedsFromPreviousAcquisition_6a11c449-db7b-4b97-9d2a-254a2f59c366" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquitySecuritiesFvNi_904e70f1-14e3-4756-b5a4-498b82c96ce0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireEquitySecuritiesFvNi"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_67c6a338-900c-4f1c-be3c-ac520d1d86ed" xlink:to="loc_us-gaap_PaymentsToAcquireEquitySecuritiesFvNi_904e70f1-14e3-4756-b5a4-498b82c96ce0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_01221305-2b5a-4ad2-ae7d-bd6fffe1d209" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_67c6a338-900c-4f1c-be3c-ac520d1d86ed" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_01221305-2b5a-4ad2-ae7d-bd6fffe1d209" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfTradingSecuritiesHeldforinvestment_1fbb24b6-c9db-4792-a344-a52c07da34b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfTradingSecuritiesHeldforinvestment"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_67c6a338-900c-4f1c-be3c-ac520d1d86ed" xlink:to="loc_us-gaap_ProceedsFromSaleOfTradingSecuritiesHeldforinvestment_1fbb24b6-c9db-4792-a344-a52c07da34b5" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.amnhealthcare.com/role/BasisofPresentationReconciliationofCashCashEquivalentsandRestrictedCashDetails" xlink:type="simple" xlink:href="amn-20210930.xsd#BasisofPresentationReconciliationofCashCashEquivalentsandRestrictedCashDetails"/>
  <link:calculationLink xlink:role="http://www.amnhealthcare.com/role/BasisofPresentationReconciliationofCashCashEquivalentsandRestrictedCashDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_amn_TotalCashCashEquivalentsAndRestrictedCashCashEquivalentsandInvestments_80cd1588-0e26-44cb-b44b-ba6e4ac3a6ea" xlink:href="amn-20210930.xsd#amn_TotalCashCashEquivalentsAndRestrictedCashCashEquivalentsandInvestments"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_c4edd669-d925-4d85-85d9-7e19ae840e29" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_amn_TotalCashCashEquivalentsAndRestrictedCashCashEquivalentsandInvestments_80cd1588-0e26-44cb-b44b-ba6e4ac3a6ea" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_c4edd669-d925-4d85-85d9-7e19ae840e29" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalents_d3c83718-b013-418e-8cff-1eb6b16d61f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalents"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_amn_TotalCashCashEquivalentsAndRestrictedCashCashEquivalentsandInvestments_80cd1588-0e26-44cb-b44b-ba6e4ac3a6ea" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalents_d3c83718-b013-418e-8cff-1eb6b16d61f7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndInvestmentsNoncurrent_fd500d87-47e7-44a7-9566-15bde8a82045" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndInvestmentsNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_amn_TotalCashCashEquivalentsAndRestrictedCashCashEquivalentsandInvestments_80cd1588-0e26-44cb-b44b-ba6e4ac3a6ea" xlink:to="loc_us-gaap_RestrictedCashAndInvestmentsNoncurrent_fd500d87-47e7-44a7-9566-15bde8a82045" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.amnhealthcare.com/role/BasisofPresentationReconciliationofCashCashEquivalentsandRestrictedCashDetails_1" xlink:type="simple" xlink:href="amn-20210930.xsd#BasisofPresentationReconciliationofCashCashEquivalentsandRestrictedCashDetails_1"/>
  <link:calculationLink xlink:role="http://www.amnhealthcare.com/role/BasisofPresentationReconciliationofCashCashEquivalentsandRestrictedCashDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_amn_TotalCashCashEquivalentsAndRestrictedCashCashEquivalentsandInvestments_5e172d3a-1c3c-4a61-a870-cc3f6954e97c" xlink:href="amn-20210930.xsd#amn_TotalCashCashEquivalentsAndRestrictedCashCashEquivalentsandInvestments"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_a575c7f9-0824-46d0-9d21-d6290fa056a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_amn_TotalCashCashEquivalentsAndRestrictedCashCashEquivalentsandInvestments_5e172d3a-1c3c-4a61-a870-cc3f6954e97c" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_a575c7f9-0824-46d0-9d21-d6290fa056a3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedInvestments_16e8a750-af4a-4308-ba92-13f22b024e64" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedInvestments"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_amn_TotalCashCashEquivalentsAndRestrictedCashCashEquivalentsandInvestments_5e172d3a-1c3c-4a61-a870-cc3f6954e97c" xlink:to="loc_us-gaap_RestrictedInvestments_16e8a750-af4a-4308-ba92-13f22b024e64" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.amnhealthcare.com/role/NetIncomePerCommonShareDetails" xlink:type="simple" xlink:href="amn-20210930.xsd#NetIncomePerCommonShareDetails"/>
  <link:calculationLink xlink:role="http://www.amnhealthcare.com/role/NetIncomePerCommonShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_4e81e1c1-a7fb-495a-acef-b5f61e6fc17b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_b699bfbe-4487-49b2-b5c1-0a17d7bc498a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_4e81e1c1-a7fb-495a-acef-b5f61e6fc17b" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_b699bfbe-4487-49b2-b5c1-0a17d7bc498a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_84a5c5e8-c4bb-45ec-8a9f-44861b5d4f62" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_4e81e1c1-a7fb-495a-acef-b5f61e6fc17b" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_84a5c5e8-c4bb-45ec-8a9f-44861b5d4f62" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.amnhealthcare.com/role/SegmentInformationReconciliationofRevenueandSegmentOperatingIncomebyReportableSegmentDetails" xlink:type="simple" xlink:href="amn-20210930.xsd#SegmentInformationReconciliationofRevenueandSegmentOperatingIncomebyReportableSegmentDetails"/>
  <link:calculationLink xlink:role="http://www.amnhealthcare.com/role/SegmentInformationReconciliationofRevenueandSegmentOperatingIncomebyReportableSegmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_4f0fb0c5-c21d-46e8-a97e-dc3e205cb99f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_4f94fb5f-7383-4b82-9ff2-3bd292d926cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_4f0fb0c5-c21d-46e8-a97e-dc3e205cb99f" xlink:to="loc_us-gaap_OperatingIncomeLoss_4f94fb5f-7383-4b82-9ff2-3bd292d926cc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_amn_UnallocatedCorporateOverhead_64d31d34-09a2-4e91-aa91-78558a580add" xlink:href="amn-20210930.xsd#amn_UnallocatedCorporateOverhead"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_4f0fb0c5-c21d-46e8-a97e-dc3e205cb99f" xlink:to="loc_amn_UnallocatedCorporateOverhead_64d31d34-09a2-4e91-aa91-78558a580add" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_fdff63ef-2699-4933-9c89-63d34cec222c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_4f0fb0c5-c21d-46e8-a97e-dc3e205cb99f" xlink:to="loc_us-gaap_DepreciationAndAmortization_fdff63ef-2699-4933-9c89-63d34cec222c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSoldDepreciation_12f75048-b855-4291-b1db-2ee90f6167e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSoldDepreciation"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_4f0fb0c5-c21d-46e8-a97e-dc3e205cb99f" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSoldDepreciation_12f75048-b855-4291-b1db-2ee90f6167e0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_cb4b3320-689e-44a5-81fc-f38942e3b230" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_4f0fb0c5-c21d-46e8-a97e-dc3e205cb99f" xlink:to="loc_us-gaap_ShareBasedCompensation_cb4b3320-689e-44a5-81fc-f38942e3b230" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_490709cf-ee8a-41e1-87b5-736f74b0b518" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_4f0fb0c5-c21d-46e8-a97e-dc3e205cb99f" xlink:to="loc_us-gaap_InterestExpense_490709cf-ee8a-41e1-87b5-736f74b0b518" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.amnhealthcare.com/role/BalanceSheetDetailsDetails" xlink:type="simple" xlink:href="amn-20210930.xsd#BalanceSheetDetailsDetails"/>
  <link:calculationLink xlink:role="http://www.amnhealthcare.com/role/BalanceSheetDetailsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_8bb99ca5-fb51-4abc-9c9b-8469e2f7be6a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMiscellaneousCurrent_06411ac8-9627-40fe-8838-2073bd8ca401" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsMiscellaneousCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsCurrent_8bb99ca5-fb51-4abc-9c9b-8469e2f7be6a" xlink:to="loc_us-gaap_OtherAssetsMiscellaneousCurrent_06411ac8-9627-40fe-8838-2073bd8ca401" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalents_17f3f289-b3a2-40b1-a1aa-ee0991e16411" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalents"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsCurrent_8bb99ca5-fb51-4abc-9c9b-8469e2f7be6a" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalents_17f3f289-b3a2-40b1-a1aa-ee0991e16411" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivable_a7064dfe-64e4-485c-bf5a-2f7c51c666f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesReceivable"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsCurrent_8bb99ca5-fb51-4abc-9c9b-8469e2f7be6a" xlink:to="loc_us-gaap_IncomeTaxesReceivable_a7064dfe-64e4-485c-bf5a-2f7c51c666f8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_81a57799-96b1-492d-a3ca-18796231b91b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherSundryLiabilitiesNoncurrent_a27fbd33-a095-4c56-a39c-e8660ad635e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherSundryLiabilitiesNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_81a57799-96b1-492d-a3ca-18796231b91b" xlink:to="loc_us-gaap_OtherSundryLiabilitiesNoncurrent_a27fbd33-a095-4c56-a39c-e8660ad635e1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SelfInsuranceReserveNoncurrent_4033e42c-aab8-455d-b7db-43e337b70898" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SelfInsuranceReserveNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_81a57799-96b1-492d-a3ca-18796231b91b" xlink:to="loc_us-gaap_SelfInsuranceReserveNoncurrent_4033e42c-aab8-455d-b7db-43e337b70898" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WorkersCompensationLiabilityNoncurrent_bb9969ff-4f58-4613-8999-692d16033aff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WorkersCompensationLiabilityNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_81a57799-96b1-492d-a3ca-18796231b91b" xlink:to="loc_us-gaap_WorkersCompensationLiabilityNoncurrent_bb9969ff-4f58-4613-8999-692d16033aff" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent_d0415687-9842-44a8-adea-0f6a677dab2d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUncertainTaxPositionsNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_81a57799-96b1-492d-a3ca-18796231b91b" xlink:to="loc_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent_d0415687-9842-44a8-adea-0f6a677dab2d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_a7787f3f-e308-4358-a237-d61891d1fb87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesGross_eec4c566-e731-41f1-b516-2006de1a966f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FurnitureAndFixturesGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_a7787f3f-e308-4358-a237-d61891d1fb87" xlink:to="loc_us-gaap_FurnitureAndFixturesGross_eec4c566-e731-41f1-b516-2006de1a966f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareGross_34ff8c14-4081-4cdc-abda-81906792f271" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedComputerSoftwareGross"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_a7787f3f-e308-4358-a237-d61891d1fb87" xlink:to="loc_us-gaap_CapitalizedComputerSoftwareGross_34ff8c14-4081-4cdc-abda-81906792f271" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsGross_a1c22701-7dbc-431c-8c13-5b591e468b91" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsGross"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_a7787f3f-e308-4358-a237-d61891d1fb87" xlink:to="loc_us-gaap_LeaseholdImprovementsGross_a1c22701-7dbc-431c-8c13-5b591e468b91" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_5437086a-30e3-4cd1-8eec-8a8a16de67ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedSalariesCurrent_2251a15b-f87d-47e8-94e6-ad4fe2e2c577" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedSalariesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_5437086a-30e3-4cd1-8eec-8a8a16de67ba" xlink:to="loc_us-gaap_AccruedSalariesCurrent_2251a15b-f87d-47e8-94e6-ad4fe2e2c577" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_amn_AccruedBonusesAndCommissions_56ad1cb7-a8d7-4657-b63d-a10fd54d4cf4" xlink:href="amn-20210930.xsd#amn_AccruedBonusesAndCommissions"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_5437086a-30e3-4cd1-8eec-8a8a16de67ba" xlink:to="loc_amn_AccruedBonusesAndCommissions_56ad1cb7-a8d7-4657-b63d-a10fd54d4cf4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_amn_AccruedTravelExpense_31c920ba-b1b2-478c-b06f-5287856abaf0" xlink:href="amn-20210930.xsd#amn_AccruedTravelExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_5437086a-30e3-4cd1-8eec-8a8a16de67ba" xlink:to="loc_amn_AccruedTravelExpense_31c920ba-b1b2-478c-b06f-5287856abaf0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WorkersCompensationLiabilityCurrent_8cc90db7-ce52-43a9-b424-b69ecf4ab961" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WorkersCompensationLiabilityCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_5437086a-30e3-4cd1-8eec-8a8a16de67ba" xlink:to="loc_us-gaap_WorkersCompensationLiabilityCurrent_8cc90db7-ce52-43a9-b424-b69ecf4ab961" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationLiabilityCurrent_5973ecc2-1a7c-46a0-9bf9-65494f2be885" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCompensationLiabilityCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_5437086a-30e3-4cd1-8eec-8a8a16de67ba" xlink:to="loc_us-gaap_DeferredCompensationLiabilityCurrent_5973ecc2-1a7c-46a0-9bf9-65494f2be885" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherEmployeeRelatedLiabilitiesCurrent_7f3f205d-94ce-427a-97db-1e1e5c669996" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherEmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_5437086a-30e3-4cd1-8eec-8a8a16de67ba" xlink:to="loc_us-gaap_OtherEmployeeRelatedLiabilitiesCurrent_7f3f205d-94ce-427a-97db-1e1e5c669996" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedInsuranceCurrent_8fd7044c-d1f3-4ee5-9f10-95f0c1732bcd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedInsuranceCurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_5437086a-30e3-4cd1-8eec-8a8a16de67ba" xlink:to="loc_us-gaap_AccruedInsuranceCurrent_8fd7044c-d1f3-4ee5-9f10-95f0c1732bcd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_b9db949e-d094-4509-bd6b-9577ebb132a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_dccbb23b-02b0-4ee4-82ba-0e5e783c4401" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_b9db949e-d094-4509-bd6b-9577ebb132a8" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_dccbb23b-02b0-4ee4-82ba-0e5e783c4401" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_4fa9fd99-1d89-4a43-92e5-0caccf73de31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_b9db949e-d094-4509-bd6b-9577ebb132a8" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_4fa9fd99-1d89-4a43-92e5-0caccf73de31" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_460791f0-3ca2-4732-b063-8ada07475a39" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashSurrenderValueOfLifeInsurance_d716106a-cb7f-408e-81b5-afbea1d39d80" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashSurrenderValueOfLifeInsurance"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_460791f0-3ca2-4732-b063-8ada07475a39" xlink:to="loc_us-gaap_CashSurrenderValueOfLifeInsurance_d716106a-cb7f-408e-81b5-afbea1d39d80" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMiscellaneous_25446a71-ae11-454a-938b-f8501250f306" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsMiscellaneous"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_460791f0-3ca2-4732-b063-8ada07475a39" xlink:to="loc_us-gaap_OtherAssetsMiscellaneous_25446a71-ae11-454a-938b-f8501250f306" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_amn_AccountsPayableAndAccruedExpensesExcludingAccruedCompensationAndBenefitsCurrent_a029b9b6-26a2-40b3-8d69-eba691a1cd75" xlink:href="amn-20210930.xsd#amn_AccountsPayableAndAccruedExpensesExcludingAccruedCompensationAndBenefitsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableTradeCurrent_474ed519-03a2-42d8-a9d8-7855b7f8e2a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableTradeCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_amn_AccountsPayableAndAccruedExpensesExcludingAccruedCompensationAndBenefitsCurrent_a029b9b6-26a2-40b3-8d69-eba691a1cd75" xlink:to="loc_us-gaap_AccountsPayableTradeCurrent_474ed519-03a2-42d8-a9d8-7855b7f8e2a4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_amn_AccountsPayableToSubcontractor_319aa9cb-ab63-4702-a795-b8071249e0a5" xlink:href="amn-20210930.xsd#amn_AccountsPayableToSubcontractor"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_amn_AccountsPayableAndAccruedExpensesExcludingAccruedCompensationAndBenefitsCurrent_a029b9b6-26a2-40b3-8d69-eba691a1cd75" xlink:to="loc_amn_AccountsPayableToSubcontractor_319aa9cb-ab63-4702-a795-b8071249e0a5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SelfInsuranceReserveCurrent_81fc68ab-95f1-440d-8209-97fe212f8e9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SelfInsuranceReserveCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_amn_AccountsPayableAndAccruedExpensesExcludingAccruedCompensationAndBenefitsCurrent_a029b9b6-26a2-40b3-8d69-eba691a1cd75" xlink:to="loc_us-gaap_SelfInsuranceReserveCurrent_81fc68ab-95f1-440d-8209-97fe212f8e9f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccountsPayableAndAccruedLiabilities_dd4d6ad9-5da3-48dc-b977-8441ab74c8bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccountsPayableAndAccruedLiabilities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_amn_AccountsPayableAndAccruedExpensesExcludingAccruedCompensationAndBenefitsCurrent_a029b9b6-26a2-40b3-8d69-eba691a1cd75" xlink:to="loc_us-gaap_OtherAccountsPayableAndAccruedLiabilities_dd4d6ad9-5da3-48dc-b977-8441ab74c8bd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_318dcfba-1632-48ac-af9a-b43c3bca78ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_amn_AccountsPayableAndAccruedExpensesExcludingAccruedCompensationAndBenefitsCurrent_a029b9b6-26a2-40b3-8d69-eba691a1cd75" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_318dcfba-1632-48ac-af9a-b43c3bca78ea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualCarryingValueCurrent_3e779130-d1b0-4865-b1c3-457be3aac84d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualCarryingValueCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_amn_AccountsPayableAndAccruedExpensesExcludingAccruedCompensationAndBenefitsCurrent_a029b9b6-26a2-40b3-8d69-eba691a1cd75" xlink:to="loc_us-gaap_LossContingencyAccrualCarryingValueCurrent_3e779130-d1b0-4865-b1c3-457be3aac84d" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>9
<FILENAME>amn-20210930_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:8a0f5122-b6dd-433b-8020-1a2d882303bb,g:c8a2db26-f545-4776-aff0-0a05f8878828-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofStockholdersEquity" xlink:type="simple" xlink:href="amn-20210930.xsd#CondensedConsolidatedStatementsofStockholdersEquity"/>
  <link:definitionLink xlink:role="http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofStockholdersEquity" xlink:type="extended" id="i192d18cb33934f0ab8d4e2045e12fec4_CondensedConsolidatedStatementsofStockholdersEquity">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_e68d608b-6372-4959-a3d8-83a40bfe1989" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_307f3e92-3752-4a98-ba2c-a078b91ccc72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e68d608b-6372-4959-a3d8-83a40bfe1989" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_307f3e92-3752-4a98-ba2c-a078b91ccc72" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_853db9dc-8e23-41fc-bfb7-8e8d59809624" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_307f3e92-3752-4a98-ba2c-a078b91ccc72" xlink:to="loc_us-gaap_SharesIssued_853db9dc-8e23-41fc-bfb7-8e8d59809624" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_75a64560-d1d3-4bc1-9583-ae2b9f8ab77e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_307f3e92-3752-4a98-ba2c-a078b91ccc72" xlink:to="loc_us-gaap_StockholdersEquity_75a64560-d1d3-4bc1-9583-ae2b9f8ab77e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList_ae91fb93-f7e4-416f-b782-2c67d28ea72f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_307f3e92-3752-4a98-ba2c-a078b91ccc72" xlink:to="loc_us-gaap_AccountingStandardsUpdateExtensibleList_ae91fb93-f7e4-416f-b782-2c67d28ea72f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_2e7423a1-69cb-462c-b017-73cda8a1bab8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_307f3e92-3752-4a98-ba2c-a078b91ccc72" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_2e7423a1-69cb-462c-b017-73cda8a1bab8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_cd8deff1-ac44-427e-a523-485d6c991062" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_307f3e92-3752-4a98-ba2c-a078b91ccc72" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_cd8deff1-ac44-427e-a523-485d6c991062" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_458c11e4-dd2e-4082-80b8-0a37f47cf705" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_307f3e92-3752-4a98-ba2c-a078b91ccc72" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_458c11e4-dd2e-4082-80b8-0a37f47cf705" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_569c7806-592f-4bf4-9632-c536a05b6ff7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_307f3e92-3752-4a98-ba2c-a078b91ccc72" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_569c7806-592f-4bf4-9632-c536a05b6ff7" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_94453366-f369-475c-b7ae-1e4330aebe2b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssued"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_f6e08b8b-a534-4231-a165-cb9e2317245c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_c7ee71c7-c42a-4958-859f-bc4d8dc93ae9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_e68d608b-6372-4959-a3d8-83a40bfe1989" xlink:to="loc_us-gaap_StatementTable_c7ee71c7-c42a-4958-859f-bc4d8dc93ae9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_be95a7bc-d77d-4fe6-98ad-873a7a94e870" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_c7ee71c7-c42a-4958-859f-bc4d8dc93ae9" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_be95a7bc-d77d-4fe6-98ad-873a7a94e870" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_be95a7bc-d77d-4fe6-98ad-873a7a94e870_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_be95a7bc-d77d-4fe6-98ad-873a7a94e870" xlink:to="loc_us-gaap_EquityComponentDomain_be95a7bc-d77d-4fe6-98ad-873a7a94e870_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_05a794b1-1f81-426f-a32f-5fa65df40de3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_be95a7bc-d77d-4fe6-98ad-873a7a94e870" xlink:to="loc_us-gaap_EquityComponentDomain_05a794b1-1f81-426f-a32f-5fa65df40de3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_85e63df6-63db-4ef6-90e8-d579ca553d23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_05a794b1-1f81-426f-a32f-5fa65df40de3" xlink:to="loc_us-gaap_CommonStockMember_85e63df6-63db-4ef6-90e8-d579ca553d23" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_9bd3b304-8864-4475-93a6-0a26a97f0cab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_05a794b1-1f81-426f-a32f-5fa65df40de3" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_9bd3b304-8864-4475-93a6-0a26a97f0cab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_a90b5328-fb09-4928-80d4-7557605b6993" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_05a794b1-1f81-426f-a32f-5fa65df40de3" xlink:to="loc_us-gaap_TreasuryStockMember_a90b5328-fb09-4928-80d4-7557605b6993" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_7434b8dc-66b2-465e-8c3a-a7d10a889362" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_05a794b1-1f81-426f-a32f-5fa65df40de3" xlink:to="loc_us-gaap_RetainedEarningsMember_7434b8dc-66b2-465e-8c3a-a7d10a889362" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_0538053f-c2fe-4ed4-ab69-e993b714ace6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_05a794b1-1f81-426f-a32f-5fa65df40de3" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_0538053f-c2fe-4ed4-ab69-e993b714ace6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_3fbcbb86-b8ae-47a5-a680-4ce2999e0a43" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_c7ee71c7-c42a-4958-859f-bc4d8dc93ae9" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_3fbcbb86-b8ae-47a5-a680-4ce2999e0a43" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_3fbcbb86-b8ae-47a5-a680-4ce2999e0a43_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_3fbcbb86-b8ae-47a5-a680-4ce2999e0a43" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_3fbcbb86-b8ae-47a5-a680-4ce2999e0a43_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_3e390836-9d8b-40d3-b73e-3bc260101dd5" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_3fbcbb86-b8ae-47a5-a680-4ce2999e0a43" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_3e390836-9d8b-40d3-b73e-3bc260101dd5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_08d438c0-02f6-4a4c-804f-59b07a37a681" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_3e390836-9d8b-40d3-b73e-3bc260101dd5" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_08d438c0-02f6-4a4c-804f-59b07a37a681" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.amnhealthcare.com/role/BasisofPresentationReconciliationofActivityinAllowanceforCreditLossesforAccountsReceivableDetails" xlink:type="simple" xlink:href="amn-20210930.xsd#BasisofPresentationReconciliationofActivityinAllowanceforCreditLossesforAccountsReceivableDetails"/>
  <link:definitionLink xlink:role="http://www.amnhealthcare.com/role/BasisofPresentationReconciliationofActivityinAllowanceforCreditLossesforAccountsReceivableDetails" xlink:type="extended" id="i76d95fcb23fc48109cfc98646240334b_BasisofPresentationReconciliationofActivityinAllowanceforCreditLossesforAccountsReceivableDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_2dfc8dfe-1e33-4734-8989-c06b171ee2b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_f056aeda-808d-44c4-a4be-241544bf71aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_2dfc8dfe-1e33-4734-8989-c06b171ee2b0" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_f056aeda-808d-44c4-a4be-241544bf71aa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_6d5cb67b-d30a-43be-8aca-5ef2515ba304" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_f056aeda-808d-44c4-a4be-241544bf71aa" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_6d5cb67b-d30a-43be-8aca-5ef2515ba304" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList_e4629760-6bff-4ce4-8274-096ad2972d23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_f056aeda-808d-44c4-a4be-241544bf71aa" xlink:to="loc_us-gaap_AccountingStandardsUpdateExtensibleList_e4629760-6bff-4ce4-8274-096ad2972d23" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_fc8c9181-7f71-4a07-962a-087e64b97820" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_f056aeda-808d-44c4-a4be-241544bf71aa" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_fc8c9181-7f71-4a07-962a-087e64b97820" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_ee18d989-980d-4c1b-bab2-06ea67a65e35" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_f056aeda-808d-44c4-a4be-241544bf71aa" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_ee18d989-980d-4c1b-bab2-06ea67a65e35" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_e18996ed-7768-4d6f-b6de-bdc800dbe764" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_e69239fa-d4ac-4cba-8e8f-9775630ac304" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_2dfc8dfe-1e33-4734-8989-c06b171ee2b0" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_e69239fa-d4ac-4cba-8e8f-9775630ac304" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_5899600c-79e9-409b-bda0-deff248c247d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_e69239fa-d4ac-4cba-8e8f-9775630ac304" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_5899600c-79e9-409b-bda0-deff248c247d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_5899600c-79e9-409b-bda0-deff248c247d_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_5899600c-79e9-409b-bda0-deff248c247d" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_5899600c-79e9-409b-bda0-deff248c247d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_c77d1e6c-8f4b-46eb-b03d-dc2785fb073a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_5899600c-79e9-409b-bda0-deff248c247d" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_c77d1e6c-8f4b-46eb-b03d-dc2785fb073a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_17968efe-fd26-4ded-a7e3-7a4781b6e455" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_c77d1e6c-8f4b-46eb-b03d-dc2785fb073a" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_17968efe-fd26-4ded-a7e3-7a4781b6e455" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.amnhealthcare.com/role/AcquisitionsNarrativeDetails" xlink:type="simple" xlink:href="amn-20210930.xsd#AcquisitionsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.amnhealthcare.com/role/AcquisitionsNarrativeDetails" xlink:type="extended" id="iad173ad2fb82479fa31797a5c3d43d47_AcquisitionsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_dd946ee2-cea2-4063-ab13-92931b72fc0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfBusinessesAcquired_221914b3-c23c-43d7-a2be-f00d92d0551b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfBusinessesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_dd946ee2-cea2-4063-ab13-92931b72fc0b" xlink:to="loc_us-gaap_NumberOfBusinessesAcquired_221914b3-c23c-43d7-a2be-f00d92d0551b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_620181b4-dd9d-48b7-a656-9204869e2897" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_dd946ee2-cea2-4063-ab13-92931b72fc0b" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_620181b4-dd9d-48b7-a656-9204869e2897" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAcquiredFromAcquisition_65441c64-ee2e-4ec3-94c6-06a4c9098d5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAcquiredFromAcquisition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_dd946ee2-cea2-4063-ab13-92931b72fc0b" xlink:to="loc_us-gaap_CashAcquiredFromAcquisition_65441c64-ee2e-4ec3-94c6-06a4c9098d5c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_amn_BusinessCombinationConsiderationTransferredNetOfWorkingCapitalAdjustment_bfca9913-ff9b-4319-9e2e-905a24e333ca" xlink:href="amn-20210930.xsd#amn_BusinessCombinationConsiderationTransferredNetOfWorkingCapitalAdjustment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_dd946ee2-cea2-4063-ab13-92931b72fc0b" xlink:to="loc_amn_BusinessCombinationConsiderationTransferredNetOfWorkingCapitalAdjustment_bfca9913-ff9b-4319-9e2e-905a24e333ca" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_amn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalentsAndPropertyPlantAndEquipment_773e04a9-3a67-47e4-bd0c-7e68d876c6f8" xlink:href="amn-20210930.xsd#amn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalentsAndPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_dd946ee2-cea2-4063-ab13-92931b72fc0b" xlink:to="loc_amn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalentsAndPropertyPlantAndEquipment_773e04a9-3a67-47e4-bd0c-7e68d876c6f8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_01f8245e-fc39-4170-8444-7f785a9518fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_dd946ee2-cea2-4063-ab13-92931b72fc0b" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_01f8245e-fc39-4170-8444-7f785a9518fc" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_67a6320b-b5d9-4b42-8c76-5060ec1a12d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_dd946ee2-cea2-4063-ab13-92931b72fc0b" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_67a6320b-b5d9-4b42-8c76-5060ec1a12d9" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_1cb18591-83d8-4f07-a1a1-d2128b921686" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_dd946ee2-cea2-4063-ab13-92931b72fc0b" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_1cb18591-83d8-4f07-a1a1-d2128b921686" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_2b498411-1c74-4969-9bbd-79ce38077b20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_dd946ee2-cea2-4063-ab13-92931b72fc0b" xlink:to="loc_us-gaap_Goodwill_2b498411-1c74-4969-9bbd-79ce38077b20" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_f5064600-3a7d-4ffb-95c1-2042ca16bf41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_dd946ee2-cea2-4063-ab13-92931b72fc0b" xlink:to="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_f5064600-3a7d-4ffb-95c1-2042ca16bf41" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_17b29bfe-98c2-46be-9296-c1e2b1727d97" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_dd946ee2-cea2-4063-ab13-92931b72fc0b" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_17b29bfe-98c2-46be-9296-c1e2b1727d97" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_dabdb71e-1c1c-4028-8b78-589391930792" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_dd946ee2-cea2-4063-ab13-92931b72fc0b" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_dabdb71e-1c1c-4028-8b78-589391930792" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_78f863df-fb4b-4928-8584-3310d2a0ae93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_dd946ee2-cea2-4063-ab13-92931b72fc0b" xlink:to="loc_us-gaap_LongTermDebt_78f863df-fb4b-4928-8584-3310d2a0ae93" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_17c04caf-feff-4c16-8ce4-965873a57b10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_dd946ee2-cea2-4063-ab13-92931b72fc0b" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_17c04caf-feff-4c16-8ce4-965873a57b10" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_amn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets_3aca1f39-a63e-4803-9342-24f06dc44412" xlink:href="amn-20210930.xsd#amn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_dd946ee2-cea2-4063-ab13-92931b72fc0b" xlink:to="loc_amn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets_3aca1f39-a63e-4803-9342-24f06dc44412" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_be020132-5c2c-4081-a592-be7eb9143ad3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_dd946ee2-cea2-4063-ab13-92931b72fc0b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_be020132-5c2c-4081-a592-be7eb9143ad3" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual_2b6f312a-bd60-4449-b0e5-76cedb51ec19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_dd946ee2-cea2-4063-ab13-92931b72fc0b" xlink:to="loc_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual_2b6f312a-bd60-4449-b0e5-76cedb51ec19" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual_42d744bf-c3fa-42f7-826f-11eefad55efc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_dd946ee2-cea2-4063-ab13-92931b72fc0b" xlink:to="loc_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual_42d744bf-c3fa-42f7-826f-11eefad55efc" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_253c94d2-5980-4036-982c-d40111b6da55" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_dd946ee2-cea2-4063-ab13-92931b72fc0b" xlink:to="loc_us-gaap_NetIncomeLoss_253c94d2-5980-4036-982c-d40111b6da55" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_7fd9cede-3b15-44f9-bce7-9ef94b11bd88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_dd946ee2-cea2-4063-ab13-92931b72fc0b" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_7fd9cede-3b15-44f9-bce7-9ef94b11bd88" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_5768ba1f-0739-4f34-b31d-50576060b69f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_7fd9cede-3b15-44f9-bce7-9ef94b11bd88" xlink:to="loc_us-gaap_CreditFacilityAxis_5768ba1f-0739-4f34-b31d-50576060b69f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_5768ba1f-0739-4f34-b31d-50576060b69f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_5768ba1f-0739-4f34-b31d-50576060b69f" xlink:to="loc_us-gaap_CreditFacilityDomain_5768ba1f-0739-4f34-b31d-50576060b69f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_f55bdeea-6724-4467-a674-84896e0552b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_5768ba1f-0739-4f34-b31d-50576060b69f" xlink:to="loc_us-gaap_CreditFacilityDomain_f55bdeea-6724-4467-a674-84896e0552b4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_1e47f0a8-868e-47d5-9a60-327c7dd2f522" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_f55bdeea-6724-4467-a674-84896e0552b4" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_1e47f0a8-868e-47d5-9a60-327c7dd2f522" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_e5329333-1af6-4861-a505-801572208f38" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_f55bdeea-6724-4467-a674-84896e0552b4" xlink:to="loc_us-gaap_SecuredDebtMember_e5329333-1af6-4861-a505-801572208f38" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_8155fbd0-7c76-453b-97ff-dd7f186182a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_7fd9cede-3b15-44f9-bce7-9ef94b11bd88" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_8155fbd0-7c76-453b-97ff-dd7f186182a7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_8155fbd0-7c76-453b-97ff-dd7f186182a7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_8155fbd0-7c76-453b-97ff-dd7f186182a7" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_8155fbd0-7c76-453b-97ff-dd7f186182a7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_9a075082-5984-4889-993f-fe946944737c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_8155fbd0-7c76-453b-97ff-dd7f186182a7" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_9a075082-5984-4889-993f-fe946944737c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_471b2b59-e76e-462a-a480-6d597cfd6cc5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_9a075082-5984-4889-993f-fe946944737c" xlink:to="loc_us-gaap_LineOfCreditMember_471b2b59-e76e-462a-a480-6d597cfd6cc5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_amn_TermDebtMember_39d802ab-1e31-457b-ae4f-90ab1b5d5a2c" xlink:href="amn-20210930.xsd#amn_TermDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_9a075082-5984-4889-993f-fe946944737c" xlink:to="loc_amn_TermDebtMember_39d802ab-1e31-457b-ae4f-90ab1b5d5a2c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_e830aca8-5a43-4ee7-b64f-4ffb63717469" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_7fd9cede-3b15-44f9-bce7-9ef94b11bd88" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_e830aca8-5a43-4ee7-b64f-4ffb63717469" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e830aca8-5a43-4ee7-b64f-4ffb63717469_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_e830aca8-5a43-4ee7-b64f-4ffb63717469" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e830aca8-5a43-4ee7-b64f-4ffb63717469_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c3d76eed-4b35-4f9b-b18d-5e3d71cdbdf0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_e830aca8-5a43-4ee7-b64f-4ffb63717469" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c3d76eed-4b35-4f9b-b18d-5e3d71cdbdf0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amn_SynziMember_bfd0c9b9-d080-459f-bb38-c5ed11d38716" xlink:href="amn-20210930.xsd#amn_SynziMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c3d76eed-4b35-4f9b-b18d-5e3d71cdbdf0" xlink:to="loc_amn_SynziMember_bfd0c9b9-d080-459f-bb38-c5ed11d38716" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_amn_StratusVideoMember_beed5bdf-1fd9-4dd7-93e1-664e1a13421d" xlink:href="amn-20210930.xsd#amn_StratusVideoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c3d76eed-4b35-4f9b-b18d-5e3d71cdbdf0" xlink:to="loc_amn_StratusVideoMember_beed5bdf-1fd9-4dd7-93e1-664e1a13421d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_551e0070-6065-4eb2-b62c-803638f7f827" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_7fd9cede-3b15-44f9-bce7-9ef94b11bd88" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_551e0070-6065-4eb2-b62c-803638f7f827" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_551e0070-6065-4eb2-b62c-803638f7f827_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_551e0070-6065-4eb2-b62c-803638f7f827" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_551e0070-6065-4eb2-b62c-803638f7f827_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_7b85dc13-7604-4c82-a295-6b6907f19d7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_551e0070-6065-4eb2-b62c-803638f7f827" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_7b85dc13-7604-4c82-a295-6b6907f19d7e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_49f13138-44a7-424d-a711-a25565eb4b37" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_7b85dc13-7604-4c82-a295-6b6907f19d7e" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_49f13138-44a7-424d-a711-a25565eb4b37" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember_f55582a2-79e6-4863-8170-a9e3c32d68f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TrademarksMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_7b85dc13-7604-4c82-a295-6b6907f19d7e" xlink:to="loc_us-gaap_TrademarksMember_f55582a2-79e6-4863-8170-a9e3c32d68f8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksAndTradeNamesMember_af2064c5-540c-4738-af29-bb6c73dc5d61" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TrademarksAndTradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_7b85dc13-7604-4c82-a295-6b6907f19d7e" xlink:to="loc_us-gaap_TrademarksAndTradeNamesMember_af2064c5-540c-4738-af29-bb6c73dc5d61" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonrecurringAdjustmentAxis_daab19a3-f643-491b-8744-a3dc3d2d75ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonrecurringAdjustmentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_7fd9cede-3b15-44f9-bce7-9ef94b11bd88" xlink:to="loc_us-gaap_NonrecurringAdjustmentAxis_daab19a3-f643-491b-8744-a3dc3d2d75ee" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonrecurringAdjustmentDomain_daab19a3-f643-491b-8744-a3dc3d2d75ee_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonrecurringAdjustmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_NonrecurringAdjustmentAxis_daab19a3-f643-491b-8744-a3dc3d2d75ee" xlink:to="loc_us-gaap_NonrecurringAdjustmentDomain_daab19a3-f643-491b-8744-a3dc3d2d75ee_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonrecurringAdjustmentDomain_5bc6105f-18f0-45ac-aa8c-e08377528d18" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonrecurringAdjustmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_NonrecurringAdjustmentAxis_daab19a3-f643-491b-8744-a3dc3d2d75ee" xlink:to="loc_us-gaap_NonrecurringAdjustmentDomain_5bc6105f-18f0-45ac-aa8c-e08377528d18" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquisitionRelatedCostsMember_2c89df52-b12d-4a33-ad08-bb4190b731c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcquisitionRelatedCostsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NonrecurringAdjustmentDomain_5bc6105f-18f0-45ac-aa8c-e08377528d18" xlink:to="loc_us-gaap_AcquisitionRelatedCostsMember_2c89df52-b12d-4a33-ad08-bb4190b731c4" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.amnhealthcare.com/role/AcquisitionsScheduleofIntangibleAssetsAcquiredDetails" xlink:type="simple" xlink:href="amn-20210930.xsd#AcquisitionsScheduleofIntangibleAssetsAcquiredDetails"/>
  <link:definitionLink xlink:role="http://www.amnhealthcare.com/role/AcquisitionsScheduleofIntangibleAssetsAcquiredDetails" xlink:type="extended" id="iffccd84f834c4a0493355cd4772ddb8b_AcquisitionsScheduleofIntangibleAssetsAcquiredDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_be01bcea-a891-482d-9a23-32c7c00c3465" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_c70b309e-042a-4c12-9422-56d1af5e66d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_be01bcea-a891-482d-9a23-32c7c00c3465" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_c70b309e-042a-4c12-9422-56d1af5e66d4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_1848d62c-21df-4eef-8d1f-03e528acb084" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_be01bcea-a891-482d-9a23-32c7c00c3465" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_1848d62c-21df-4eef-8d1f-03e528acb084" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable_157c39a8-df22-4dc8-a017-51cb638708a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_be01bcea-a891-482d-9a23-32c7c00c3465" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable_157c39a8-df22-4dc8-a017-51cb638708a3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_46db4b02-043d-480e-b7ca-e6a145e85354" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable_157c39a8-df22-4dc8-a017-51cb638708a3" xlink:to="loc_srt_RangeAxis_46db4b02-043d-480e-b7ca-e6a145e85354" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_46db4b02-043d-480e-b7ca-e6a145e85354_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_46db4b02-043d-480e-b7ca-e6a145e85354" xlink:to="loc_srt_RangeMember_46db4b02-043d-480e-b7ca-e6a145e85354_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_1758b654-dd62-465f-8aaf-6e621dc842c4" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_46db4b02-043d-480e-b7ca-e6a145e85354" xlink:to="loc_srt_RangeMember_1758b654-dd62-465f-8aaf-6e621dc842c4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_a6615e83-24cb-4450-9d6c-1ad7f5ab3239" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_1758b654-dd62-465f-8aaf-6e621dc842c4" xlink:to="loc_srt_MinimumMember_a6615e83-24cb-4450-9d6c-1ad7f5ab3239" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_1ccbb15d-3e7f-4038-8d58-7ba47a98b82a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_1758b654-dd62-465f-8aaf-6e621dc842c4" xlink:to="loc_srt_MaximumMember_1ccbb15d-3e7f-4038-8d58-7ba47a98b82a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_2358422e-7887-411f-b49c-5b8b3c88750b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable_157c39a8-df22-4dc8-a017-51cb638708a3" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_2358422e-7887-411f-b49c-5b8b3c88750b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2358422e-7887-411f-b49c-5b8b3c88750b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_2358422e-7887-411f-b49c-5b8b3c88750b" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2358422e-7887-411f-b49c-5b8b3c88750b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_91112704-946d-4817-b27d-04f5d1eb16e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_2358422e-7887-411f-b49c-5b8b3c88750b" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_91112704-946d-4817-b27d-04f5d1eb16e2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amn_StratusVideoMember_a93fa4ba-b52e-47c2-85ea-90a10219d69c" xlink:href="amn-20210930.xsd#amn_StratusVideoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_91112704-946d-4817-b27d-04f5d1eb16e2" xlink:to="loc_amn_StratusVideoMember_a93fa4ba-b52e-47c2-85ea-90a10219d69c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_d34c1645-0bb6-4e8b-9e64-0057deaef5e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable_157c39a8-df22-4dc8-a017-51cb638708a3" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_d34c1645-0bb6-4e8b-9e64-0057deaef5e3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_d34c1645-0bb6-4e8b-9e64-0057deaef5e3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_d34c1645-0bb6-4e8b-9e64-0057deaef5e3" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_d34c1645-0bb6-4e8b-9e64-0057deaef5e3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2bdcad93-da3a-45da-99dc-b2f5e8435414" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_d34c1645-0bb6-4e8b-9e64-0057deaef5e3" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2bdcad93-da3a-45da-99dc-b2f5e8435414" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_cdb77205-fd78-4f3f-b15d-28814fcd8f30" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2bdcad93-da3a-45da-99dc-b2f5e8435414" xlink:to="loc_us-gaap_CustomerRelationshipsMember_cdb77205-fd78-4f3f-b15d-28814fcd8f30" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksAndTradeNamesMember_a723308c-df7b-4dde-9507-f451eecbd789" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TrademarksAndTradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2bdcad93-da3a-45da-99dc-b2f5e8435414" xlink:to="loc_us-gaap_TrademarksAndTradeNamesMember_a723308c-df7b-4dde-9507-f451eecbd789" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_13688a60-458f-40ee-a49a-f5cd9ca749f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2bdcad93-da3a-45da-99dc-b2f5e8435414" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_13688a60-458f-40ee-a49a-f5cd9ca749f0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_amn_InterpreterDatabaseMember_5393a43f-3936-482f-aebb-061b733bb726" xlink:href="amn-20210930.xsd#amn_InterpreterDatabaseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2bdcad93-da3a-45da-99dc-b2f5e8435414" xlink:to="loc_amn_InterpreterDatabaseMember_5393a43f-3936-482f-aebb-061b733bb726" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.amnhealthcare.com/role/AcquisitionsScheduleofProFormaFinancialInformationDetails" xlink:type="simple" xlink:href="amn-20210930.xsd#AcquisitionsScheduleofProFormaFinancialInformationDetails"/>
  <link:definitionLink xlink:role="http://www.amnhealthcare.com/role/AcquisitionsScheduleofProFormaFinancialInformationDetails" xlink:type="extended" id="i82435dc890034bcb9785e38e1ec7ad08_AcquisitionsScheduleofProFormaFinancialInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_5d8924e7-3b00-49f7-9b0e-75d848da75fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_9fa0054f-cc00-4134-b089-30345b2be299" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5d8924e7-3b00-49f7-9b0e-75d848da75fe" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_9fa0054f-cc00-4134-b089-30345b2be299" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax_0eb0a5bf-adb7-478b-aa8f-2d40dfb6dbec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5d8924e7-3b00-49f7-9b0e-75d848da75fe" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax_0eb0a5bf-adb7-478b-aa8f-2d40dfb6dbec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_7758048e-e1ef-4d40-87de-5c7707c77011" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5d8924e7-3b00-49f7-9b0e-75d848da75fe" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_7758048e-e1ef-4d40-87de-5c7707c77011" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_5b45cd27-239f-46be-9618-b37c6e36fdb4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5d8924e7-3b00-49f7-9b0e-75d848da75fe" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_5b45cd27-239f-46be-9618-b37c6e36fdb4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_b08e9e6d-b92b-4cc1-af36-204b6b6c63fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_5b45cd27-239f-46be-9618-b37c6e36fdb4" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_b08e9e6d-b92b-4cc1-af36-204b6b6c63fd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b08e9e6d-b92b-4cc1-af36-204b6b6c63fd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_b08e9e6d-b92b-4cc1-af36-204b6b6c63fd" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b08e9e6d-b92b-4cc1-af36-204b6b6c63fd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1d093260-20cd-44c7-8d55-0dc23e2feb38" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_b08e9e6d-b92b-4cc1-af36-204b6b6c63fd" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1d093260-20cd-44c7-8d55-0dc23e2feb38" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amn_StratusVideoMember_d2557e9a-324d-4ec1-b566-91444d1fd063" xlink:href="amn-20210930.xsd#amn_StratusVideoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1d093260-20cd-44c7-8d55-0dc23e2feb38" xlink:to="loc_amn_StratusVideoMember_d2557e9a-324d-4ec1-b566-91444d1fd063" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.amnhealthcare.com/role/SegmentInformationReconciliationofRevenueandSegmentOperatingIncomebyReportableSegmentDetails" xlink:type="simple" xlink:href="amn-20210930.xsd#SegmentInformationReconciliationofRevenueandSegmentOperatingIncomebyReportableSegmentDetails"/>
  <link:definitionLink xlink:role="http://www.amnhealthcare.com/role/SegmentInformationReconciliationofRevenueandSegmentOperatingIncomebyReportableSegmentDetails" xlink:type="extended" id="if8e8601adf9f4912aa19aa9b6fa945ed_SegmentInformationReconciliationofRevenueandSegmentOperatingIncomebyReportableSegmentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_2d7b6413-d6ef-4d4a-a02a-1cec443cebc9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingRevenueReconcilingItemLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_e2b07123-4e29-4c55-b2a8-cd9799bb89bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_2d7b6413-d6ef-4d4a-a02a-1cec443cebc9" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_e2b07123-4e29-4c55-b2a8-cd9799bb89bc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_751d6db3-974f-40ef-8931-407867303c8b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_2d7b6413-d6ef-4d4a-a02a-1cec443cebc9" xlink:to="loc_us-gaap_OperatingIncomeLoss_751d6db3-974f-40ef-8931-407867303c8b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amn_UnallocatedCorporateOverhead_f89d66b1-d348-4ca6-a765-c564af0f9de2" xlink:href="amn-20210930.xsd#amn_UnallocatedCorporateOverhead"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_2d7b6413-d6ef-4d4a-a02a-1cec443cebc9" xlink:to="loc_amn_UnallocatedCorporateOverhead_f89d66b1-d348-4ca6-a765-c564af0f9de2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_a471095a-ca8f-4c92-af31-8a9886919785" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_2d7b6413-d6ef-4d4a-a02a-1cec443cebc9" xlink:to="loc_us-gaap_DepreciationAndAmortization_a471095a-ca8f-4c92-af31-8a9886919785" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSoldDepreciation_9d5036ab-632c-4c14-9318-25c016091f16" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSoldDepreciation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_2d7b6413-d6ef-4d4a-a02a-1cec443cebc9" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSoldDepreciation_9d5036ab-632c-4c14-9318-25c016091f16" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_2daf305c-dc7d-4f03-ab43-6c8dd56bbd0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_2d7b6413-d6ef-4d4a-a02a-1cec443cebc9" xlink:to="loc_us-gaap_ShareBasedCompensation_2daf305c-dc7d-4f03-ab43-6c8dd56bbd0b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_6732da44-10b6-4447-93bf-5b223ca07a4f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_2d7b6413-d6ef-4d4a-a02a-1cec443cebc9" xlink:to="loc_us-gaap_InterestExpense_6732da44-10b6-4447-93bf-5b223ca07a4f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_d3e7eba2-8ab1-4a69-875c-4df4ee370f13" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_2d7b6413-d6ef-4d4a-a02a-1cec443cebc9" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_d3e7eba2-8ab1-4a69-875c-4df4ee370f13" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_f68fd6f0-5dbc-4a03-a4f2-ab8bc88fe4a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_2d7b6413-d6ef-4d4a-a02a-1cec443cebc9" xlink:to="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_f68fd6f0-5dbc-4a03-a4f2-ab8bc88fe4a9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_69865564-97e4-4dc1-9ca8-6e0129be8939" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_f68fd6f0-5dbc-4a03-a4f2-ab8bc88fe4a9" xlink:to="loc_srt_ConsolidationItemsAxis_69865564-97e4-4dc1-9ca8-6e0129be8939" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_69865564-97e4-4dc1-9ca8-6e0129be8939_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_69865564-97e4-4dc1-9ca8-6e0129be8939" xlink:to="loc_srt_ConsolidationItemsDomain_69865564-97e4-4dc1-9ca8-6e0129be8939_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_35430a6b-2166-422b-9f0a-f63653681e4f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_69865564-97e4-4dc1-9ca8-6e0129be8939" xlink:to="loc_srt_ConsolidationItemsDomain_35430a6b-2166-422b-9f0a-f63653681e4f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_25f86592-844f-4622-bf67-400d3a3dd568" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_35430a6b-2166-422b-9f0a-f63653681e4f" xlink:to="loc_us-gaap_OperatingSegmentsMember_25f86592-844f-4622-bf67-400d3a3dd568" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_d850b614-64a3-4e44-a171-b97273bf592a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_35430a6b-2166-422b-9f0a-f63653681e4f" xlink:to="loc_us-gaap_CorporateNonSegmentMember_d850b614-64a3-4e44-a171-b97273bf592a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_a9edae0b-ec9c-48e4-8c55-89dc2dfed41c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_f68fd6f0-5dbc-4a03-a4f2-ab8bc88fe4a9" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_a9edae0b-ec9c-48e4-8c55-89dc2dfed41c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_a9edae0b-ec9c-48e4-8c55-89dc2dfed41c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_a9edae0b-ec9c-48e4-8c55-89dc2dfed41c" xlink:to="loc_us-gaap_SegmentDomain_a9edae0b-ec9c-48e4-8c55-89dc2dfed41c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_a7f0a9dd-45a2-4954-8df2-58d758c2e05e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_a9edae0b-ec9c-48e4-8c55-89dc2dfed41c" xlink:to="loc_us-gaap_SegmentDomain_a7f0a9dd-45a2-4954-8df2-58d758c2e05e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amn_NurseAndAlliedHealthcareStaffingMember_40cc682c-0930-446e-a70e-e3468e4bb1d3" xlink:href="amn-20210930.xsd#amn_NurseAndAlliedHealthcareStaffingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_a7f0a9dd-45a2-4954-8df2-58d758c2e05e" xlink:to="loc_amn_NurseAndAlliedHealthcareStaffingMember_40cc682c-0930-446e-a70e-e3468e4bb1d3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_amn_PhysicianAndLeadershipSolutionsMember_6d60e310-07a7-4284-8f5e-295f3855a0b9" xlink:href="amn-20210930.xsd#amn_PhysicianAndLeadershipSolutionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_a7f0a9dd-45a2-4954-8df2-58d758c2e05e" xlink:to="loc_amn_PhysicianAndLeadershipSolutionsMember_6d60e310-07a7-4284-8f5e-295f3855a0b9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amn_TechnologyAndWorkforceSolutionsMember_ed6a0371-b45a-4104-9537-8a6cf3b72e05" xlink:href="amn-20210930.xsd#amn_TechnologyAndWorkforceSolutionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_a7f0a9dd-45a2-4954-8df2-58d758c2e05e" xlink:to="loc_amn_TechnologyAndWorkforceSolutionsMember_ed6a0371-b45a-4104-9537-8a6cf3b72e05" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.amnhealthcare.com/role/SegmentInformationDisaggregationofRevenueDetails" xlink:type="simple" xlink:href="amn-20210930.xsd#SegmentInformationDisaggregationofRevenueDetails"/>
  <link:definitionLink xlink:role="http://www.amnhealthcare.com/role/SegmentInformationDisaggregationofRevenueDetails" xlink:type="extended" id="i20e81f30ebaf413b95010b40e6ebc8ee_SegmentInformationDisaggregationofRevenueDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_34ecfd15-e9d5-4114-824c-07c867f44dc4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_83598f44-324f-4329-859d-5ebb0ff1a338" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_34ecfd15-e9d5-4114-824c-07c867f44dc4" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_83598f44-324f-4329-859d-5ebb0ff1a338" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_7bcca703-9b04-4464-967f-3763e9ce5a7f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_34ecfd15-e9d5-4114-824c-07c867f44dc4" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_7bcca703-9b04-4464-967f-3763e9ce5a7f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_10f583b6-4eb5-4737-aa57-ebe014a25514" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_7bcca703-9b04-4464-967f-3763e9ce5a7f" xlink:to="loc_srt_ProductOrServiceAxis_10f583b6-4eb5-4737-aa57-ebe014a25514" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_10f583b6-4eb5-4737-aa57-ebe014a25514_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_10f583b6-4eb5-4737-aa57-ebe014a25514" xlink:to="loc_srt_ProductsAndServicesDomain_10f583b6-4eb5-4737-aa57-ebe014a25514_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_de43b145-8517-4fd1-bcb7-353034435b5a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_10f583b6-4eb5-4737-aa57-ebe014a25514" xlink:to="loc_srt_ProductsAndServicesDomain_de43b145-8517-4fd1-bcb7-353034435b5a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amn_TemporaryStaffingMember_87c6e60d-ae4d-440f-97f1-dec36dd348aa" xlink:href="amn-20210930.xsd#amn_TemporaryStaffingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_de43b145-8517-4fd1-bcb7-353034435b5a" xlink:to="loc_amn_TemporaryStaffingMember_87c6e60d-ae4d-440f-97f1-dec36dd348aa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_amn_PermanentPlacementMember_0a5b360b-ae3d-4098-aea3-d61c7aa28b4f" xlink:href="amn-20210930.xsd#amn_PermanentPlacementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_de43b145-8517-4fd1-bcb7-353034435b5a" xlink:to="loc_amn_PermanentPlacementMember_0a5b360b-ae3d-4098-aea3-d61c7aa28b4f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amn_OutsourcedWorkforceMember_6e05ae9d-f1c4-4707-b9f0-00493235813d" xlink:href="amn-20210930.xsd#amn_OutsourcedWorkforceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_de43b145-8517-4fd1-bcb7-353034435b5a" xlink:to="loc_amn_OutsourcedWorkforceMember_6e05ae9d-f1c4-4707-b9f0-00493235813d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_amn_SaaSBasedTechnologiesMember_e24c3d95-031d-402f-afa9-8006796b9b48" xlink:href="amn-20210930.xsd#amn_SaaSBasedTechnologiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_de43b145-8517-4fd1-bcb7-353034435b5a" xlink:to="loc_amn_SaaSBasedTechnologiesMember_e24c3d95-031d-402f-afa9-8006796b9b48" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_ff2d444e-52eb-4e17-b864-7863a88fa899" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_7bcca703-9b04-4464-967f-3763e9ce5a7f" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_ff2d444e-52eb-4e17-b864-7863a88fa899" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_ff2d444e-52eb-4e17-b864-7863a88fa899_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_ff2d444e-52eb-4e17-b864-7863a88fa899" xlink:to="loc_us-gaap_SegmentDomain_ff2d444e-52eb-4e17-b864-7863a88fa899_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_647ed624-6c55-4eb8-b8a6-5771eb7194a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_ff2d444e-52eb-4e17-b864-7863a88fa899" xlink:to="loc_us-gaap_SegmentDomain_647ed624-6c55-4eb8-b8a6-5771eb7194a0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amn_NurseAndAlliedHealthcareStaffingMember_a3bc6155-6cb9-4c43-8e3d-87076a6dd702" xlink:href="amn-20210930.xsd#amn_NurseAndAlliedHealthcareStaffingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_647ed624-6c55-4eb8-b8a6-5771eb7194a0" xlink:to="loc_amn_NurseAndAlliedHealthcareStaffingMember_a3bc6155-6cb9-4c43-8e3d-87076a6dd702" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_amn_PhysicianAndLeadershipSolutionsMember_6809e75c-8a13-4f05-bc27-8e60970fc49c" xlink:href="amn-20210930.xsd#amn_PhysicianAndLeadershipSolutionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_647ed624-6c55-4eb8-b8a6-5771eb7194a0" xlink:to="loc_amn_PhysicianAndLeadershipSolutionsMember_6809e75c-8a13-4f05-bc27-8e60970fc49c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amn_TechnologyAndWorkforceSolutionsMember_31eca133-d209-44a3-99f7-b030e0cdd7d8" xlink:href="amn-20210930.xsd#amn_TechnologyAndWorkforceSolutionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_647ed624-6c55-4eb8-b8a6-5771eb7194a0" xlink:to="loc_amn_TechnologyAndWorkforceSolutionsMember_31eca133-d209-44a3-99f7-b030e0cdd7d8" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.amnhealthcare.com/role/SegmentInformationSummaryofGoodwillbyReportableSegmentDetails" xlink:type="simple" xlink:href="amn-20210930.xsd#SegmentInformationSummaryofGoodwillbyReportableSegmentDetails"/>
  <link:definitionLink xlink:role="http://www.amnhealthcare.com/role/SegmentInformationSummaryofGoodwillbyReportableSegmentDetails" xlink:type="extended" id="i075033b732cc411aa8a85779aa6ecbbe_SegmentInformationSummaryofGoodwillbyReportableSegmentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_36d37a03-aa0e-4586-8ffb-d0fb8c45d4b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_ca4a5e36-6583-4cde-818a-522ac8bdd6c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_36d37a03-aa0e-4586-8ffb-d0fb8c45d4b2" xlink:to="loc_us-gaap_GoodwillRollForward_ca4a5e36-6583-4cde-818a-522ac8bdd6c6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_7de0d131-ae1d-481a-adaa-f6794d43f24d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_ca4a5e36-6583-4cde-818a-522ac8bdd6c6" xlink:to="loc_us-gaap_Goodwill_7de0d131-ae1d-481a-adaa-f6794d43f24d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_c17a812f-58ec-4b71-8c41-369bce63898f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_ca4a5e36-6583-4cde-818a-522ac8bdd6c6" xlink:to="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_c17a812f-58ec-4b71-8c41-369bce63898f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_93c98b03-a26d-40a0-bec7-24e121b50ccf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_ca4a5e36-6583-4cde-818a-522ac8bdd6c6" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_93c98b03-a26d-40a0-bec7-24e121b50ccf" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_9fa7dd6c-3978-4770-bce6-41897aa8bd74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_0610df0f-58d1-4764-9ba4-9a4437cfc664" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_36d37a03-aa0e-4586-8ffb-d0fb8c45d4b2" xlink:to="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_0610df0f-58d1-4764-9ba4-9a4437cfc664" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_442b7815-8a9b-4d45-9bfc-df1a7a25afe8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_36d37a03-aa0e-4586-8ffb-d0fb8c45d4b2" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_442b7815-8a9b-4d45-9bfc-df1a7a25afe8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_9acdc902-05bc-4fb6-a6cc-f240b482567a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_442b7815-8a9b-4d45-9bfc-df1a7a25afe8" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_9acdc902-05bc-4fb6-a6cc-f240b482567a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_9acdc902-05bc-4fb6-a6cc-f240b482567a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_9acdc902-05bc-4fb6-a6cc-f240b482567a" xlink:to="loc_us-gaap_SegmentDomain_9acdc902-05bc-4fb6-a6cc-f240b482567a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_f6377a21-fe6a-46c0-b095-535c744d3901" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_9acdc902-05bc-4fb6-a6cc-f240b482567a" xlink:to="loc_us-gaap_SegmentDomain_f6377a21-fe6a-46c0-b095-535c744d3901" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amn_NurseAndAlliedHealthcareStaffingMember_4471500c-4303-4987-a3d4-18e412b0d449" xlink:href="amn-20210930.xsd#amn_NurseAndAlliedHealthcareStaffingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_f6377a21-fe6a-46c0-b095-535c744d3901" xlink:to="loc_amn_NurseAndAlliedHealthcareStaffingMember_4471500c-4303-4987-a3d4-18e412b0d449" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_amn_PhysicianAndLeadershipSolutionsMember_523c8d18-e23e-4341-825a-b79c6a16b44c" xlink:href="amn-20210930.xsd#amn_PhysicianAndLeadershipSolutionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_f6377a21-fe6a-46c0-b095-535c744d3901" xlink:to="loc_amn_PhysicianAndLeadershipSolutionsMember_523c8d18-e23e-4341-825a-b79c6a16b44c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amn_TechnologyAndWorkforceSolutionsMember_486591dc-e805-47d6-b02b-16c1aa7b8263" xlink:href="amn-20210930.xsd#amn_TechnologyAndWorkforceSolutionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_f6377a21-fe6a-46c0-b095-535c744d3901" xlink:to="loc_amn_TechnologyAndWorkforceSolutionsMember_486591dc-e805-47d6-b02b-16c1aa7b8263" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.amnhealthcare.com/role/NotesPayableandCreditAgreementDetails" xlink:type="simple" xlink:href="amn-20210930.xsd#NotesPayableandCreditAgreementDetails"/>
  <link:definitionLink xlink:role="http://www.amnhealthcare.com/role/NotesPayableandCreditAgreementDetails" xlink:type="extended" id="if958bfe4452447ac8e04fbb347db50f3_NotesPayableandCreditAgreementDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_57d9c70a-6d01-452f-98e8-90bc64cc3e29" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_2f1a9b99-6111-4366-b7fe-bfda6e084365" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_57d9c70a-6d01-452f-98e8-90bc64cc3e29" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_2f1a9b99-6111-4366-b7fe-bfda6e084365" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_3b8e4cc2-b370-4e91-8966-a1e7535f03be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_57d9c70a-6d01-452f-98e8-90bc64cc3e29" xlink:to="loc_us-gaap_LongTermDebt_3b8e4cc2-b370-4e91-8966-a1e7535f03be" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_a31f012c-1ccf-4acc-81d6-f2d484de9d95" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_57d9c70a-6d01-452f-98e8-90bc64cc3e29" xlink:to="loc_us-gaap_DebtInstrumentTable_a31f012c-1ccf-4acc-81d6-f2d484de9d95" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_e63a26f5-947f-4bb1-8f01-b5e0b9745420" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_a31f012c-1ccf-4acc-81d6-f2d484de9d95" xlink:to="loc_us-gaap_CreditFacilityAxis_e63a26f5-947f-4bb1-8f01-b5e0b9745420" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_e63a26f5-947f-4bb1-8f01-b5e0b9745420_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_e63a26f5-947f-4bb1-8f01-b5e0b9745420" xlink:to="loc_us-gaap_CreditFacilityDomain_e63a26f5-947f-4bb1-8f01-b5e0b9745420_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_699f5e83-5bdc-466f-8169-c01797d49a7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_e63a26f5-947f-4bb1-8f01-b5e0b9745420" xlink:to="loc_us-gaap_CreditFacilityDomain_699f5e83-5bdc-466f-8169-c01797d49a7c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_926ec797-1c62-4239-843b-8eb1221a575a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_699f5e83-5bdc-466f-8169-c01797d49a7c" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_926ec797-1c62-4239-843b-8eb1221a575a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_391994b2-04ab-41c6-b6e7-8d8373b7b180" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_699f5e83-5bdc-466f-8169-c01797d49a7c" xlink:to="loc_us-gaap_SecuredDebtMember_391994b2-04ab-41c6-b6e7-8d8373b7b180" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_4ac44ab0-4881-4999-bb3a-e428b324a1d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_a31f012c-1ccf-4acc-81d6-f2d484de9d95" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_4ac44ab0-4881-4999-bb3a-e428b324a1d4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_4ac44ab0-4881-4999-bb3a-e428b324a1d4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_4ac44ab0-4881-4999-bb3a-e428b324a1d4" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_4ac44ab0-4881-4999-bb3a-e428b324a1d4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_2fe7b9cd-082d-4644-8bcb-8d8d1cc9d822" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_4ac44ab0-4881-4999-bb3a-e428b324a1d4" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_2fe7b9cd-082d-4644-8bcb-8d8d1cc9d822" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_c50bef15-0bf1-4d40-ba39-0970aaac4a1b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_2fe7b9cd-082d-4644-8bcb-8d8d1cc9d822" xlink:to="loc_us-gaap_LineOfCreditMember_c50bef15-0bf1-4d40-ba39-0970aaac4a1b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_amn_TermDebtMember_c2fa70cc-1242-4b91-b8e7-442a8d881470" xlink:href="amn-20210930.xsd#amn_TermDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_2fe7b9cd-082d-4644-8bcb-8d8d1cc9d822" xlink:to="loc_amn_TermDebtMember_c2fa70cc-1242-4b91-b8e7-442a8d881470" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.amnhealthcare.com/role/FairValueMeasurementNarrativeDetails" xlink:type="simple" xlink:href="amn-20210930.xsd#FairValueMeasurementNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.amnhealthcare.com/role/FairValueMeasurementNarrativeDetails" xlink:type="extended" id="i061334e20dab45f7857f37b19607ebf5_FairValueMeasurementNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_4a32526c-604e-450f-abf1-657395e385b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetAssetLiability_afa0149b-8787-4283-a9f7-bc098f5d1248" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueNetAssetLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_4a32526c-604e-450f-abf1-657395e385b4" xlink:to="loc_us-gaap_FairValueNetAssetLiability_afa0149b-8787-4283-a9f7-bc098f5d1248" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_33fc9fd8-f92a-40f0-8396-75891fea6b36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_4a32526c-604e-450f-abf1-657395e385b4" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_33fc9fd8-f92a-40f0-8396-75891fea6b36" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_ac35cbf7-8c23-493c-b08f-c30f68402596" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_4a32526c-604e-450f-abf1-657395e385b4" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_ac35cbf7-8c23-493c-b08f-c30f68402596" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_23700c1f-94ee-4726-afd1-f34b560f119b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_4a32526c-604e-450f-abf1-657395e385b4" xlink:to="loc_us-gaap_AssetImpairmentCharges_23700c1f-94ee-4726-afd1-f34b560f119b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_92728304-afe9-47fd-9412-57c302e84f03" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_4a32526c-604e-450f-abf1-657395e385b4" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_92728304-afe9-47fd-9412-57c302e84f03" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c0f77404-9781-41fb-8688-3dc6ab83188f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_4a32526c-604e-450f-abf1-657395e385b4" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c0f77404-9781-41fb-8688-3dc6ab83188f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_d06128ce-bb5b-4234-8a76-ff99722d2780" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c0f77404-9781-41fb-8688-3dc6ab83188f" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_d06128ce-bb5b-4234-8a76-ff99722d2780" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_d06128ce-bb5b-4234-8a76-ff99722d2780_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_d06128ce-bb5b-4234-8a76-ff99722d2780" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_d06128ce-bb5b-4234-8a76-ff99722d2780_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_bfa388af-6be6-4775-afc9-3b1a3d6f90b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_d06128ce-bb5b-4234-8a76-ff99722d2780" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_bfa388af-6be6-4775-afc9-3b1a3d6f90b3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_d0457f50-dbd9-4318-8b74-4ec6cc805898" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_bfa388af-6be6-4775-afc9-3b1a3d6f90b3" xlink:to="loc_us-gaap_CommercialPaperMember_d0457f50-dbd9-4318-8b74-4ec6cc805898" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_7bd789d9-0935-4804-9e97-8725eebfa725" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c0f77404-9781-41fb-8688-3dc6ab83188f" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_7bd789d9-0935-4804-9e97-8725eebfa725" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_7bd789d9-0935-4804-9e97-8725eebfa725_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_7bd789d9-0935-4804-9e97-8725eebfa725" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_7bd789d9-0935-4804-9e97-8725eebfa725_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_ed15782e-27fb-49c8-8f30-d5c2bc214db6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_7bd789d9-0935-4804-9e97-8725eebfa725" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_ed15782e-27fb-49c8-8f30-d5c2bc214db6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_9e433094-ba4d-499e-b970-8d9388a0a274" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_ed15782e-27fb-49c8-8f30-d5c2bc214db6" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_9e433094-ba4d-499e-b970-8d9388a0a274" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsNonrecurringMember_22372a6b-4366-456b-b68e-599a06957cb7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsNonrecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_ed15782e-27fb-49c8-8f30-d5c2bc214db6" xlink:to="loc_us-gaap_FairValueMeasurementsNonrecurringMember_22372a6b-4366-456b-b68e-599a06957cb7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_849973a5-49a5-435d-98a1-3fd1bd8ea45b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c0f77404-9781-41fb-8688-3dc6ab83188f" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_849973a5-49a5-435d-98a1-3fd1bd8ea45b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_849973a5-49a5-435d-98a1-3fd1bd8ea45b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_849973a5-49a5-435d-98a1-3fd1bd8ea45b" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_849973a5-49a5-435d-98a1-3fd1bd8ea45b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_fffb2e73-ff96-405b-b937-d702d63d49a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_849973a5-49a5-435d-98a1-3fd1bd8ea45b" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_fffb2e73-ff96-405b-b937-d702d63d49a0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_a598e0b4-ad90-4d02-ae0f-1bf9cf858153" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_fffb2e73-ff96-405b-b937-d702d63d49a0" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_a598e0b4-ad90-4d02-ae0f-1bf9cf858153" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_2b82caee-5b3a-4cb9-9f75-16582bb78555" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c0f77404-9781-41fb-8688-3dc6ab83188f" xlink:to="loc_us-gaap_DebtInstrumentAxis_2b82caee-5b3a-4cb9-9f75-16582bb78555" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_2b82caee-5b3a-4cb9-9f75-16582bb78555_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_2b82caee-5b3a-4cb9-9f75-16582bb78555" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_2b82caee-5b3a-4cb9-9f75-16582bb78555_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_fd3a099d-8b3f-477a-8c7e-0b4915e1c7eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_2b82caee-5b3a-4cb9-9f75-16582bb78555" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_fd3a099d-8b3f-477a-8c7e-0b4915e1c7eb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amn_A4.625SeniorNotesDue2027Member_a04062c8-67eb-47c3-a595-219b3537710f" xlink:href="amn-20210930.xsd#amn_A4.625SeniorNotesDue2027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_fd3a099d-8b3f-477a-8c7e-0b4915e1c7eb" xlink:to="loc_amn_A4.625SeniorNotesDue2027Member_a04062c8-67eb-47c3-a595-219b3537710f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_amn_A4000SeniorNotesDue2029Member_3de70e07-fd1a-41ea-ace5-f1a338d459ef" xlink:href="amn-20210930.xsd#amn_A4000SeniorNotesDue2029Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_fd3a099d-8b3f-477a-8c7e-0b4915e1c7eb" xlink:to="loc_amn_A4000SeniorNotesDue2029Member_3de70e07-fd1a-41ea-ace5-f1a338d459ef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_eb62b412-c602-457d-bbc2-4c2097cc1e45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c0f77404-9781-41fb-8688-3dc6ab83188f" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_eb62b412-c602-457d-bbc2-4c2097cc1e45" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_eb62b412-c602-457d-bbc2-4c2097cc1e45_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_eb62b412-c602-457d-bbc2-4c2097cc1e45" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_eb62b412-c602-457d-bbc2-4c2097cc1e45_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_551c1ec9-4fc8-4184-9176-227bc9604efa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_eb62b412-c602-457d-bbc2-4c2097cc1e45" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_551c1ec9-4fc8-4184-9176-227bc9604efa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_445e8b64-1ed9-4985-8fc2-e506993895fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_551c1ec9-4fc8-4184-9176-227bc9604efa" xlink:to="loc_us-gaap_SeniorNotesMember_445e8b64-1ed9-4985-8fc2-e506993895fe" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.amnhealthcare.com/role/FairValueMeasurementFinancialAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="amn-20210930.xsd#FairValueMeasurementFinancialAssetsandLiabilitiesDetails"/>
  <link:definitionLink xlink:role="http://www.amnhealthcare.com/role/FairValueMeasurementFinancialAssetsandLiabilitiesDetails" xlink:type="extended" id="ib03608e913d24bb7b812b87bb49eeeac_FairValueMeasurementFinancialAssetsandLiabilitiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_b81f9803-8226-4a1a-a67a-cb76fe73fcc1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetAssetLiability_9733553f-3341-4440-b6e6-817b471d273f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueNetAssetLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_b81f9803-8226-4a1a-a67a-cb76fe73fcc1" xlink:to="loc_us-gaap_FairValueNetAssetLiability_9733553f-3341-4440-b6e6-817b471d273f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_142e7581-2275-41c4-a86c-a4060b73f852" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_b81f9803-8226-4a1a-a67a-cb76fe73fcc1" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_142e7581-2275-41c4-a86c-a4060b73f852" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_5072866f-9f41-498a-8c67-35a7e8bf7ecc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_142e7581-2275-41c4-a86c-a4060b73f852" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_5072866f-9f41-498a-8c67-35a7e8bf7ecc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_5072866f-9f41-498a-8c67-35a7e8bf7ecc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_5072866f-9f41-498a-8c67-35a7e8bf7ecc" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_5072866f-9f41-498a-8c67-35a7e8bf7ecc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_ba66f5df-e782-48c7-8a4a-50c1072a31a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_5072866f-9f41-498a-8c67-35a7e8bf7ecc" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_ba66f5df-e782-48c7-8a4a-50c1072a31a6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_f3c245a6-61dc-4787-b475-bce1e6ba9830" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_ba66f5df-e782-48c7-8a4a-50c1072a31a6" xlink:to="loc_us-gaap_MoneyMarketFundsMember_f3c245a6-61dc-4787-b475-bce1e6ba9830" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_d404c3aa-4811-4cd9-869c-215fe3e7a0b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_ba66f5df-e782-48c7-8a4a-50c1072a31a6" xlink:to="loc_us-gaap_CommercialPaperMember_d404c3aa-4811-4cd9-869c-215fe3e7a0b7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_f2c15fbc-0d29-4016-9e64-077f3d92ac47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_142e7581-2275-41c4-a86c-a4060b73f852" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_f2c15fbc-0d29-4016-9e64-077f3d92ac47" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_f2c15fbc-0d29-4016-9e64-077f3d92ac47_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_f2c15fbc-0d29-4016-9e64-077f3d92ac47" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_f2c15fbc-0d29-4016-9e64-077f3d92ac47_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_db46f4db-ade7-4fd3-8913-ca7e312c7cde" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_f2c15fbc-0d29-4016-9e64-077f3d92ac47" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_db46f4db-ade7-4fd3-8913-ca7e312c7cde" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amn_DeferredCompensationMember_48110cc7-9f55-41b2-a31c-c989bbfb1146" xlink:href="amn-20210930.xsd#amn_DeferredCompensationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_db46f4db-ade7-4fd3-8913-ca7e312c7cde" xlink:to="loc_amn_DeferredCompensationMember_48110cc7-9f55-41b2-a31c-c989bbfb1146" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_amn_ContingentConsiderationMember_451223d3-aec4-4599-a571-e98cd3f42b1c" xlink:href="amn-20210930.xsd#amn_ContingentConsiderationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_db46f4db-ade7-4fd3-8913-ca7e312c7cde" xlink:to="loc_amn_ContingentConsiderationMember_451223d3-aec4-4599-a571-e98cd3f42b1c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_3fd40f0b-a86e-45e8-821d-c2e17fea8666" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_142e7581-2275-41c4-a86c-a4060b73f852" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_3fd40f0b-a86e-45e8-821d-c2e17fea8666" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_3fd40f0b-a86e-45e8-821d-c2e17fea8666_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_3fd40f0b-a86e-45e8-821d-c2e17fea8666" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_3fd40f0b-a86e-45e8-821d-c2e17fea8666_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_e8c1cda7-9254-498a-817f-e2063803a827" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_3fd40f0b-a86e-45e8-821d-c2e17fea8666" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_e8c1cda7-9254-498a-817f-e2063803a827" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_0b025d0b-2dc0-4d8c-8a64-dd9789ba96a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_e8c1cda7-9254-498a-817f-e2063803a827" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_0b025d0b-2dc0-4d8c-8a64-dd9789ba96a0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_353fc2d5-bfcd-4731-9742-6b189c7f7838" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_142e7581-2275-41c4-a86c-a4060b73f852" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_353fc2d5-bfcd-4731-9742-6b189c7f7838" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_353fc2d5-bfcd-4731-9742-6b189c7f7838_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_353fc2d5-bfcd-4731-9742-6b189c7f7838" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_353fc2d5-bfcd-4731-9742-6b189c7f7838_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1093555e-91fa-4952-8acd-23d2f16568f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_353fc2d5-bfcd-4731-9742-6b189c7f7838" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1093555e-91fa-4952-8acd-23d2f16568f2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_462e1acb-d0fa-4cae-9a0c-a610700fe970" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1093555e-91fa-4952-8acd-23d2f16568f2" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_462e1acb-d0fa-4cae-9a0c-a610700fe970" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_a82fb1b7-3cf3-4823-9079-a8ffe8bc6a1d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1093555e-91fa-4952-8acd-23d2f16568f2" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_a82fb1b7-3cf3-4823-9079-a8ffe8bc6a1d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_74ff5261-1936-441d-b327-2e89633f1f2f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1093555e-91fa-4952-8acd-23d2f16568f2" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_74ff5261-1936-441d-b327-2e89633f1f2f" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.amnhealthcare.com/role/FairValueMeasurementReconciliationofChangesinContingentConsiderationLiabilitiesDetails" xlink:type="simple" xlink:href="amn-20210930.xsd#FairValueMeasurementReconciliationofChangesinContingentConsiderationLiabilitiesDetails"/>
  <link:definitionLink xlink:role="http://www.amnhealthcare.com/role/FairValueMeasurementReconciliationofChangesinContingentConsiderationLiabilitiesDetails" xlink:type="extended" id="id7dfa324fef542ceb57ac73bda2e4573_FairValueMeasurementReconciliationofChangesinContingentConsiderationLiabilitiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f56f3352-07ce-4d0b-b9cd-3f6c849707ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_88f33170-00a8-4cf1-823f-e5ee5894451f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f56f3352-07ce-4d0b-b9cd-3f6c849707ca" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_88f33170-00a8-4cf1-823f-e5ee5894451f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_9e8401d5-1c3a-43f4-ba77-0b9b4e7c2a21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_88f33170-00a8-4cf1-823f-e5ee5894451f" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_9e8401d5-1c3a-43f4-ba77-0b9b4e7c2a21" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_a2a8e6cb-c985-4cc1-8274-9293a7242b2b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_88f33170-00a8-4cf1-823f-e5ee5894451f" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_a2a8e6cb-c985-4cc1-8274-9293a7242b2b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_4d70086d-29f4-4a43-99d2-587c6bb1d437" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_88f33170-00a8-4cf1-823f-e5ee5894451f" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_4d70086d-29f4-4a43-99d2-587c6bb1d437" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_47338d77-ff57-41f4-8793-5cefab708dc3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_81fafd2f-4bb3-46b3-9a99-a8dfda41614b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f56f3352-07ce-4d0b-b9cd-3f6c849707ca" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_81fafd2f-4bb3-46b3-9a99-a8dfda41614b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_3d518bc3-c08a-4a2d-8cd8-9c2a1543a67f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_81fafd2f-4bb3-46b3-9a99-a8dfda41614b" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_3d518bc3-c08a-4a2d-8cd8-9c2a1543a67f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3d518bc3-c08a-4a2d-8cd8-9c2a1543a67f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_3d518bc3-c08a-4a2d-8cd8-9c2a1543a67f" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3d518bc3-c08a-4a2d-8cd8-9c2a1543a67f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_a56b28bb-4864-4ca8-bff0-12d0dff715f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_3d518bc3-c08a-4a2d-8cd8-9c2a1543a67f" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_a56b28bb-4864-4ca8-bff0-12d0dff715f9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_5b2ea938-d5c7-4ed6-988e-b870bbc0d5d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_a56b28bb-4864-4ca8-bff0-12d0dff715f9" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_5b2ea938-d5c7-4ed6-988e-b870bbc0d5d1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_d61bdf0e-fa4e-4e3a-8a4e-ccf89b2f5918" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_81fafd2f-4bb3-46b3-9a99-a8dfda41614b" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_d61bdf0e-fa4e-4e3a-8a4e-ccf89b2f5918" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_d61bdf0e-fa4e-4e3a-8a4e-ccf89b2f5918_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_d61bdf0e-fa4e-4e3a-8a4e-ccf89b2f5918" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_d61bdf0e-fa4e-4e3a-8a4e-ccf89b2f5918_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_1cc3ec11-a46d-43ad-99da-da062fda4d5d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_d61bdf0e-fa4e-4e3a-8a4e-ccf89b2f5918" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_1cc3ec11-a46d-43ad-99da-da062fda4d5d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amn_ContingentConsiderationMember_5ac4482b-c1ac-41cc-8d36-d5716cb241ca" xlink:href="amn-20210930.xsd#amn_ContingentConsiderationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_1cc3ec11-a46d-43ad-99da-da062fda4d5d" xlink:to="loc_amn_ContingentConsiderationMember_5ac4482b-c1ac-41cc-8d36-d5716cb241ca" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_4d0be017-57b3-45fb-b7c5-2a6a94864a21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_81fafd2f-4bb3-46b3-9a99-a8dfda41614b" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_4d0be017-57b3-45fb-b7c5-2a6a94864a21" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4d0be017-57b3-45fb-b7c5-2a6a94864a21_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_4d0be017-57b3-45fb-b7c5-2a6a94864a21" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4d0be017-57b3-45fb-b7c5-2a6a94864a21_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_76607681-ab85-4196-b3da-c661b1ccf54b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_4d0be017-57b3-45fb-b7c5-2a6a94864a21" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_76607681-ab85-4196-b3da-c661b1ccf54b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amn_AdvancedMedicalPersonnelServicesInc.Member_f4eb057c-49a8-4811-972b-4c6c9a567fbb" xlink:href="amn-20210930.xsd#amn_AdvancedMedicalPersonnelServicesInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_76607681-ab85-4196-b3da-c661b1ccf54b" xlink:to="loc_amn_AdvancedMedicalPersonnelServicesInc.Member_f4eb057c-49a8-4811-972b-4c6c9a567fbb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_amn_B4healthLLCMember_9e5d3ef0-3bab-4d7c-b26b-2bad0d759a5c" xlink:href="amn-20210930.xsd#amn_B4healthLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_76607681-ab85-4196-b3da-c661b1ccf54b" xlink:to="loc_amn_B4healthLLCMember_9e5d3ef0-3bab-4d7c-b26b-2bad0d759a5c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_0b8d73df-2455-4c25-a1e8-df4d9e584a7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_81fafd2f-4bb3-46b3-9a99-a8dfda41614b" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_0b8d73df-2455-4c25-a1e8-df4d9e584a7e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_0b8d73df-2455-4c25-a1e8-df4d9e584a7e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_0b8d73df-2455-4c25-a1e8-df4d9e584a7e" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_0b8d73df-2455-4c25-a1e8-df4d9e584a7e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_daf6cbaa-855a-44e3-86bc-6c0f89d5879b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_0b8d73df-2455-4c25-a1e8-df4d9e584a7e" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_daf6cbaa-855a-44e3-86bc-6c0f89d5879b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_404931c9-d2dd-4d50-914a-e89f3af88992" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_daf6cbaa-855a-44e3-86bc-6c0f89d5879b" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_404931c9-d2dd-4d50-914a-e89f3af88992" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.amnhealthcare.com/role/FairValueMeasurementFairValueofFinancialInstrumentsDetails" xlink:type="simple" xlink:href="amn-20210930.xsd#FairValueMeasurementFairValueofFinancialInstrumentsDetails"/>
  <link:definitionLink xlink:role="http://www.amnhealthcare.com/role/FairValueMeasurementFairValueofFinancialInstrumentsDetails" xlink:type="extended" id="i949d3a95f804439f9951ceca2ad1f3e1_FairValueMeasurementFairValueofFinancialInstrumentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_708f975e-881d-4028-816f-b735cbcb69f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_ede3177b-5eef-47ad-99fc-cacff8a39d98" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_708f975e-881d-4028-816f-b735cbcb69f6" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_ede3177b-5eef-47ad-99fc-cacff8a39d98" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_8a9886d9-76e0-44bd-a9d7-903e7006ac48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_708f975e-881d-4028-816f-b735cbcb69f6" xlink:to="loc_us-gaap_DebtInstrumentFairValue_8a9886d9-76e0-44bd-a9d7-903e7006ac48" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_4c8b73fe-3b05-4791-8efa-3d8522a1a3a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_708f975e-881d-4028-816f-b735cbcb69f6" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_4c8b73fe-3b05-4791-8efa-3d8522a1a3a1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_cedafbd7-db3c-47aa-ba52-3e1de32c4a90" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_4c8b73fe-3b05-4791-8efa-3d8522a1a3a1" xlink:to="loc_us-gaap_DebtInstrumentAxis_cedafbd7-db3c-47aa-ba52-3e1de32c4a90" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_cedafbd7-db3c-47aa-ba52-3e1de32c4a90_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_cedafbd7-db3c-47aa-ba52-3e1de32c4a90" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_cedafbd7-db3c-47aa-ba52-3e1de32c4a90_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_6cf7ef84-2f80-4e69-8b08-98f1cb11f8a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_cedafbd7-db3c-47aa-ba52-3e1de32c4a90" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_6cf7ef84-2f80-4e69-8b08-98f1cb11f8a0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amn_A4.625SeniorNotesDue2027Member_5d3dd1e0-405d-40c8-a694-853f57d3451b" xlink:href="amn-20210930.xsd#amn_A4.625SeniorNotesDue2027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6cf7ef84-2f80-4e69-8b08-98f1cb11f8a0" xlink:to="loc_amn_A4.625SeniorNotesDue2027Member_5d3dd1e0-405d-40c8-a694-853f57d3451b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_amn_A4000SeniorNotesDue2029Member_63274a2b-8f50-485f-95dd-72b2be2a4185" xlink:href="amn-20210930.xsd#amn_A4000SeniorNotesDue2029Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6cf7ef84-2f80-4e69-8b08-98f1cb11f8a0" xlink:to="loc_amn_A4000SeniorNotesDue2029Member_63274a2b-8f50-485f-95dd-72b2be2a4185" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_858d6229-a7e4-46ec-bb22-28a2f819bd99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_4c8b73fe-3b05-4791-8efa-3d8522a1a3a1" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_858d6229-a7e4-46ec-bb22-28a2f819bd99" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_858d6229-a7e4-46ec-bb22-28a2f819bd99_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_858d6229-a7e4-46ec-bb22-28a2f819bd99" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_858d6229-a7e4-46ec-bb22-28a2f819bd99_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_5b1c4994-a7a3-44a6-9189-ade3f8658a99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_858d6229-a7e4-46ec-bb22-28a2f819bd99" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_5b1c4994-a7a3-44a6-9189-ade3f8658a99" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_1fd56b24-33b1-4c10-a8a7-1f0f114f0e34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_5b1c4994-a7a3-44a6-9189-ade3f8658a99" xlink:to="loc_us-gaap_SeniorNotesMember_1fd56b24-33b1-4c10-a8a7-1f0f114f0e34" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.amnhealthcare.com/role/CommitmentsandContingenciesLegalProceedingsDetails" xlink:type="simple" xlink:href="amn-20210930.xsd#CommitmentsandContingenciesLegalProceedingsDetails"/>
  <link:definitionLink xlink:role="http://www.amnhealthcare.com/role/CommitmentsandContingenciesLegalProceedingsDetails" xlink:type="extended" id="i94fb23ab100f4e82a36f92dd9d886b80_CommitmentsandContingenciesLegalProceedingsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_5950d426-2f85-424c-af3a-09aa28ae0211" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease_a4a20fb5-03f3-4c56-b7df-77fd3408b765" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_5950d426-2f85-424c-af3a-09aa28ae0211" xlink:to="loc_us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease_a4a20fb5-03f3-4c56-b7df-77fd3408b765" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyEstimateOfPossibleLoss_283911dd-e991-43b5-888b-214b4aa57137" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyEstimateOfPossibleLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_5950d426-2f85-424c-af3a-09aa28ae0211" xlink:to="loc_us-gaap_LossContingencyEstimateOfPossibleLoss_283911dd-e991-43b5-888b-214b4aa57137" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_f2c60b73-f968-4b90-9cc2-824a373b0d8b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_5950d426-2f85-424c-af3a-09aa28ae0211" xlink:to="loc_us-gaap_LossContingenciesTable_f2c60b73-f968-4b90-9cc2-824a373b0d8b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_d211c514-6cf5-4943-9630-8124a6296c58" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_f2c60b73-f968-4b90-9cc2-824a373b0d8b" xlink:to="loc_srt_LitigationCaseAxis_d211c514-6cf5-4943-9630-8124a6296c58" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_d211c514-6cf5-4943-9630-8124a6296c58_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_d211c514-6cf5-4943-9630-8124a6296c58" xlink:to="loc_srt_LitigationCaseTypeDomain_d211c514-6cf5-4943-9630-8124a6296c58_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_90d48505-faf1-48a5-b3e5-1032e0c172c2" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_d211c514-6cf5-4943-9630-8124a6296c58" xlink:to="loc_srt_LitigationCaseTypeDomain_90d48505-faf1-48a5-b3e5-1032e0c172c2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_amn_WageAndHourClaimsMember_3aeae698-c18d-46c1-8d09-cefa140e7502" xlink:href="amn-20210930.xsd#amn_WageAndHourClaimsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_90d48505-faf1-48a5-b3e5-1032e0c172c2" xlink:to="loc_amn_WageAndHourClaimsMember_3aeae698-c18d-46c1-8d09-cefa140e7502" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_010d250b-dcd5-4907-bb0b-19d39613e08d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_f2c60b73-f968-4b90-9cc2-824a373b0d8b" xlink:to="loc_us-gaap_LitigationStatusAxis_010d250b-dcd5-4907-bb0b-19d39613e08d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_010d250b-dcd5-4907-bb0b-19d39613e08d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LitigationStatusAxis_010d250b-dcd5-4907-bb0b-19d39613e08d" xlink:to="loc_us-gaap_LitigationStatusDomain_010d250b-dcd5-4907-bb0b-19d39613e08d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_15e9f278-3c74-4358-8c5f-da55ded08a63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LitigationStatusAxis_010d250b-dcd5-4907-bb0b-19d39613e08d" xlink:to="loc_us-gaap_LitigationStatusDomain_15e9f278-3c74-4358-8c5f-da55ded08a63" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember_0357df93-4cff-4bfd-9809-e3ef71969f15" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PendingLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LitigationStatusDomain_15e9f278-3c74-4358-8c5f-da55ded08a63" xlink:to="loc_us-gaap_PendingLitigationMember_0357df93-4cff-4bfd-9809-e3ef71969f15" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_c1058b68-5b60-41ab-ae6f-f52ece9081c3" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_f2c60b73-f968-4b90-9cc2-824a373b0d8b" xlink:to="loc_srt_RangeAxis_c1058b68-5b60-41ab-ae6f-f52ece9081c3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_c1058b68-5b60-41ab-ae6f-f52ece9081c3_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_c1058b68-5b60-41ab-ae6f-f52ece9081c3" xlink:to="loc_srt_RangeMember_c1058b68-5b60-41ab-ae6f-f52ece9081c3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_62a8a467-3206-46ed-b349-becfabb18dbb" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_c1058b68-5b60-41ab-ae6f-f52ece9081c3" xlink:to="loc_srt_RangeMember_62a8a467-3206-46ed-b349-becfabb18dbb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_a14aec17-faef-47a1-9f0f-58e9ceca567f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_62a8a467-3206-46ed-b349-becfabb18dbb" xlink:to="loc_srt_MaximumMember_a14aec17-faef-47a1-9f0f-58e9ceca567f" xlink:type="arc" order="0"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>10
<FILENAME>amn-20210930_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:8a0f5122-b6dd-433b-8020-1a2d882303bb,g:c8a2db26-f545-4776-aff0-0a05f8878828-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_64b431ed-5303-449c-bb26-b736fdc54e04_verboseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental disclosures of cash flow information:</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_14844c1a-f04f-46a2-9e80-3da7768d2170_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income per Common Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TrademarksAndTradeNamesMember_f4e80535-1e00-4287-8993-8eb5f3ed32ca_terseLabel_en-US" xlink:label="lab_us-gaap_TrademarksAndTradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tradenames and Trademarks</link:label>
    <link:label id="lab_us-gaap_TrademarksAndTradeNamesMember_label_en-US" xlink:label="lab_us-gaap_TrademarksAndTradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks and Trade Names [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksAndTradeNamesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TrademarksAndTradeNamesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TrademarksAndTradeNamesMember" xlink:to="lab_us-gaap_TrademarksAndTradeNamesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8e82f910-a482-44d8-b32d-289f3d527b17_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_029f15df-d820-463b-9b01-7d366a4c4eac_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_a362c7f2-ceb0-4bea-a5e1-7a6c64a29d30_negatedLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_cf35e1f7-3240-4140-a931-fdd4eaad003a_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_9ca3291a-aa1b-4076-822a-239130959431_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_e1c37800-c062-4d14-a939-fa66df6e1262_verboseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_0023af0c-0c8b-411e-b36a-6e9c1a9d6a9a_verboseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued compensation and benefits</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_ea7f29ea-3dce-48c6-a697-0a46e861a265_totalLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued compensation and benefits</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_d4104705-4d83-4d2f-87cf-bfdfc60c73fe_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts_fbda61c7-eace-4e1f-8614-f7992af9439d_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition-related costs</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Acquisition Related Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:to="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_eb7138c4-55f4-4fc4-a13b-a2f5dabf98f3_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_d94924ab-cdb3-4c26-acfe-3495ff4ab481_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine2_73e3553c-5512-486f-a7c5-6ddfda035407_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine2_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine2" xlink:to="lab_dei_EntityAddressAddressLine2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseholdImprovementsGross_30cc50dc-a475-4519-ac93-255d4dc8b727_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold improvements</link:label>
    <link:label id="lab_us-gaap_LeaseholdImprovementsGross_label_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold Improvements, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseholdImprovementsGross" xlink:to="lab_us-gaap_LeaseholdImprovementsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock_09e6d357-56e6-4c5f-b87c-7c50a5c4c1da_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Information</link:label>
    <link:label id="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_8006ad22-a210-4624-b8dd-9407ae11ba8b_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity investment balance</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNi" xlink:to="lab_us-gaap_EquitySecuritiesFvNi" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_f008e826-1fa9-4c70-828d-a5eb7f1684ce_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_43ea1a62-53d2-4971-8a6d-7c5b599a396e_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_amn_AccountsReceivableAndSalesCreditsCreditLossExpenseReversal_24c6b6c9-a72f-411a-8af9-d60868c54213_terseLabel_en-US" xlink:label="lab_amn_AccountsReceivableAndSalesCreditsCreditLossExpenseReversal" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in allowance for credit losses and sales credits</link:label>
    <link:label id="lab_amn_AccountsReceivableAndSalesCreditsCreditLossExpenseReversal_label_en-US" xlink:label="lab_amn_AccountsReceivableAndSalesCreditsCreditLossExpenseReversal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable And Sales Credits, Credit Loss Expense (Reversal)</link:label>
    <link:label id="lab_amn_AccountsReceivableAndSalesCreditsCreditLossExpenseReversal_documentation_en-US" xlink:label="lab_amn_AccountsReceivableAndSalesCreditsCreditLossExpenseReversal" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable And Sales Credits, Credit Loss Expense (Reversal)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amn_AccountsReceivableAndSalesCreditsCreditLossExpenseReversal" xlink:href="amn-20210930.xsd#amn_AccountsReceivableAndSalesCreditsCreditLossExpenseReversal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amn_AccountsReceivableAndSalesCreditsCreditLossExpenseReversal" xlink:to="lab_amn_AccountsReceivableAndSalesCreditsCreditLossExpenseReversal" xlink:type="arc" order="1"/>
    <link:label id="lab_amn_AccruedBonusesAndCommissions_a9d75507-712d-44ce-aa1b-3d3888899396_terseLabel_en-US" xlink:label="lab_amn_AccruedBonusesAndCommissions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued bonuses and commissions</link:label>
    <link:label id="lab_amn_AccruedBonusesAndCommissions_label_en-US" xlink:label="lab_amn_AccruedBonusesAndCommissions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Bonuses And Commissions</link:label>
    <link:label id="lab_amn_AccruedBonusesAndCommissions_documentation_en-US" xlink:label="lab_amn_AccruedBonusesAndCommissions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Bonuses And Commissions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amn_AccruedBonusesAndCommissions" xlink:href="amn-20210930.xsd#amn_AccruedBonusesAndCommissions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amn_AccruedBonusesAndCommissions" xlink:to="lab_amn_AccruedBonusesAndCommissions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_7b71393e-d788-457b-89c4-4e47197f367a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_14c95262-653d-460a-a20c-8c9ca3801a2b_totalLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfBusinessesAcquired_775b94c7-264c-4453-a3f9-fa6bff87b5c0_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfBusinessesAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of acquisitions</link:label>
    <link:label id="lab_us-gaap_NumberOfBusinessesAcquired_label_en-US" xlink:label="lab_us-gaap_NumberOfBusinessesAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Businesses Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfBusinessesAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfBusinessesAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfBusinessesAcquired" xlink:to="lab_us-gaap_NumberOfBusinessesAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_0006d24c-861a-46e7-9c12-e9951b97d49e_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_be3dd377-f463-46d9-a913-622691c21b25_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net increase (decrease) in cash, cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_dc4b7494-4ce2-484d-951e-e569c356f4ef_terseLabel_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_23e863a4-9fdc-40ec-a295-98cff31a8f98_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_d8e9664d-6bbf-4d7d-8519-769ec201f4d6_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_d6a0b087-c588-4fac-b267-1cae583c0a2c_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in fair value of contingent consideration liability from acquisition</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillPurchaseAccountingAdjustments_8f9b43b8-565e-4477-9473-4c466d5355e0_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill adjustment for Stratus Video acquisition</link:label>
    <link:label id="lab_us-gaap_GoodwillPurchaseAccountingAdjustments_label_en-US" xlink:label="lab_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Purchase Accounting Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:to="lab_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_83ab8b55-12a6-4689-a8cc-9dae4ad3a26a_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_22d4abc2-ec54-4aff-85fc-88fafca4b261_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_441ca520-c6f3-42d5-acbf-5e9fbb8f6573_terseLabel_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets acquired, weighted average useful life</link:label>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_label_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:to="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfFinancingCosts_57a2d3d8-1be1-478b-ae38-04bc457f4f2b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfFinancingCosts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment of financing costs</link:label>
    <link:label id="lab_us-gaap_PaymentsOfFinancingCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Financing Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfFinancingCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfFinancingCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfFinancingCosts" xlink:to="lab_us-gaap_PaymentsOfFinancingCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_ce1a0fe5-5b19-48f6-8812-4a9484c70a90_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from senior notes</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Senior Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_5fefb406-340f-4cfb-aa52-6da37732c091_verboseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock excluded from calculation of EPS (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_028aae48-f7ae-498c-84c0-ec0ee32bbe47_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Previously deferred revenue recognized during period</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Revenue Recognized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByLiabilityClassAxis_951e84f7-8edb-42a1-a4b8-0636d9e3224b_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByLiabilityClassAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis" xlink:to="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueOfAssetsAcquired_ef837783-f4e5-497d-b677-c6ffbb1487dd_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueOfAssetsAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of tangible assets acquired in acquisitions, net of cash and restricted cash received</link:label>
    <link:label id="lab_us-gaap_FairValueOfAssetsAcquired_label_en-US" xlink:label="lab_us-gaap_FairValueOfAssetsAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value of Assets Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfAssetsAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueOfAssetsAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueOfAssetsAcquired" xlink:to="lab_us-gaap_FairValueOfAssetsAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual_63aa7aa5-7add-4710-a164-cbe9581de70f_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pro forma information, income before income taxes of acquiree since acquisition date</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Pro Forma Information, Earnings or Loss of Acquiree since Acquisition Date, Actual</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual" xlink:to="lab_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination and Asset Acquisition [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:to="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_05168378-4a53-4023-834b-86fdc383e434_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents and Restricted Cash</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:to="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_bf9f4fcd-0c42-453e-bcd1-5106b78d2e33_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_amn_PaymentsForPreviousAcquisitionEarnOutPayment_41651ed2-e4be-4961-8f49-2fb3d55459d0_negatedLabel_en-US" xlink:label="lab_amn_PaymentsForPreviousAcquisitionEarnOutPayment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earn-out payments to settle contingent consideration liabilities for prior acquisitions</link:label>
    <link:label id="lab_amn_PaymentsForPreviousAcquisitionEarnOutPayment_label_en-US" xlink:label="lab_amn_PaymentsForPreviousAcquisitionEarnOutPayment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments For Previous Acquisition, Earn-Out Payment</link:label>
    <link:label id="lab_amn_PaymentsForPreviousAcquisitionEarnOutPayment_documentation_en-US" xlink:label="lab_amn_PaymentsForPreviousAcquisitionEarnOutPayment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments For Previous Acquisition, Earn-Out Payment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amn_PaymentsForPreviousAcquisitionEarnOutPayment" xlink:href="amn-20210930.xsd#amn_PaymentsForPreviousAcquisitionEarnOutPayment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amn_PaymentsForPreviousAcquisitionEarnOutPayment" xlink:to="lab_amn_PaymentsForPreviousAcquisitionEarnOutPayment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermNotesPayable_d27508d4-6db3-4bce-b960-1ebe3c876f30_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermNotesPayable" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes payable, net of unamortized fees and premium</link:label>
    <link:label id="lab_us-gaap_LongTermNotesPayable_label_en-US" xlink:label="lab_us-gaap_LongTermNotesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Payable, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermNotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermNotesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermNotesPayable" xlink:to="lab_us-gaap_LongTermNotesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_9945eaff-ced1-4726-9bdd-5f34c9367dcc_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_ac13185a-0a7e-4c94-98b1-894dccc7dbfe_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsNonrecurringMember_317f9537-35a9-4794-943e-a1e9eddcd69a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurements, Nonrecurring</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsNonrecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Nonrecurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsNonrecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_76be95af-1906-41dc-bc94-bedc40f685fd_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated impairment loss</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impaired, Accumulated Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:to="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax_4a852fa5-eb1d-448d-970d-8debdbfd333a_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from operations</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Income (Loss) from Continuing Operations, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax" xlink:to="lab_us-gaap_BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_e1425f0c-7aa8-40b4-bf22-3a24d1ffedad_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Line Items]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_b7491cca-1e78-4e14-8a2f-6a54270fa623_verboseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, $0.01 par value; 10,000 shares authorized; none issued and outstanding at September&#160;30, 2021 and December&#160;31, 2020</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_amn_DeferredPayrollTaxesCARESAct_9bc8e8a4-7716-4a65-82b1-1a59beedf51b_terseLabel_en-US" xlink:label="lab_amn_DeferredPayrollTaxesCARESAct" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred payroll taxes, CARES Act</link:label>
    <link:label id="lab_amn_DeferredPayrollTaxesCARESAct_label_en-US" xlink:label="lab_amn_DeferredPayrollTaxesCARESAct" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Payroll Taxes, CARES Act</link:label>
    <link:label id="lab_amn_DeferredPayrollTaxesCARESAct_documentation_en-US" xlink:label="lab_amn_DeferredPayrollTaxesCARESAct" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Payroll Taxes, CARES Act</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amn_DeferredPayrollTaxesCARESAct" xlink:href="amn-20210930.xsd#amn_DeferredPayrollTaxesCARESAct"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amn_DeferredPayrollTaxesCARESAct" xlink:to="lab_amn_DeferredPayrollTaxesCARESAct" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_6ef5fcaf-305a-4dc3-8c16-a31e4b67a85d_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Table]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:to="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_65b8950c-fc4d-45f4-b69a-67a6463d5c2b_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_cc949e57-3b25-4e19-a52b-580bc6096992_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_85a1ef57-8543-4aed-bf40-f90806253e14_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_53c2eba2-53c6-42b7-b3f7-250edc3226c1_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Fair Value</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFairValue" xlink:to="lab_us-gaap_DebtInstrumentFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_80a656f9-d27e-4081-8673-bbd2e89305d6_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies: Legal Proceedings</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_amn_IncreaseDecreaseinAccountsReceivablessubcontractor_e17141ac-26c5-45fa-a42a-7c40ab5d0843_negatedTerseLabel_en-US" xlink:label="lab_amn_IncreaseDecreaseinAccountsReceivablessubcontractor" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, subcontractor</link:label>
    <link:label id="lab_amn_IncreaseDecreaseinAccountsReceivablessubcontractor_label_en-US" xlink:label="lab_amn_IncreaseDecreaseinAccountsReceivablessubcontractor" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase Decrease in Accounts Receivables, subcontractor</link:label>
    <link:label id="lab_amn_IncreaseDecreaseinAccountsReceivablessubcontractor_documentation_en-US" xlink:label="lab_amn_IncreaseDecreaseinAccountsReceivablessubcontractor" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase Decrease in Accounts Receivables, subcontractor</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amn_IncreaseDecreaseinAccountsReceivablessubcontractor" xlink:href="amn-20210930.xsd#amn_IncreaseDecreaseinAccountsReceivablessubcontractor"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amn_IncreaseDecreaseinAccountsReceivablessubcontractor" xlink:to="lab_amn_IncreaseDecreaseinAccountsReceivablessubcontractor" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SecuredDebtMember_a5262482-9efe-4ed5-9918-420e51888471_verboseLabel_en-US" xlink:label="lab_us-gaap_SecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan</link:label>
    <link:label id="lab_us-gaap_SecuredDebtMember_label_en-US" xlink:label="lab_us-gaap_SecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuredDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SecuredDebtMember" xlink:to="lab_us-gaap_SecuredDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_05a9470b-091c-4f53-9c51-bb02e222894f_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_7b7af8a4-f0dd-4c39-bb16-1192dc54f615_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Pro Forma Financial Information</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Information [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionProFormaInformationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:to="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_8fb87914-f8f7-4ebf-b474-30f7e25b2667_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_a8832053-f6d2-47eb-ab6d-85576b0706f9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherCurrentAssets_7e2166fd-b570-48a1-ac0a-b3852c985d40_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherCurrentAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Current Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherCurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_97e44d66-5e32-4f98-9d44-cb182d531bf1_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_63d2ddea-1e56-473a-a148-e35f3ca0b339_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of reportable segments</link:label>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Operating Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfOperatingSegments" xlink:to="lab_us-gaap_NumberOfOperatingSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_1dadb460-a952-436a-825f-b58fd5ece453_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_ef803712-7ec8-4fd3-8f15-6e4fbf31d293_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income per common share - basic (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_8559cacb-7616-40f1-8511-88a81b601a5b_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAcquiredFromAcquisition_b7b1f1e0-17b4-41f9-a7b4-e804db3b90fb_verboseLabel_en-US" xlink:label="lab_us-gaap_CashAcquiredFromAcquisition" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash returned to the Company for final working capital settlement</link:label>
    <link:label id="lab_us-gaap_CashAcquiredFromAcquisition_label_en-US" xlink:label="lab_us-gaap_CashAcquiredFromAcquisition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Acquired from Acquisition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAcquiredFromAcquisition" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAcquiredFromAcquisition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAcquiredFromAcquisition" xlink:to="lab_us-gaap_CashAcquiredFromAcquisition" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_30015d9e-1f13-4c2a-afad-97c8778eb47b_negatedPeriodStartLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_b1cd4573-c574-4c7d-bb89-ac91635f92a5_negatedPeriodEndLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_6a962846-2052-4b6e-8490-8dfd0a5bc4a4_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireEquitySecuritiesFvNi_c7aa0478-1fc7-418c-b944-65d8c38362b4_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireEquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of equity investment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireEquitySecuritiesFvNi_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireEquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Equity Securities, FV-NI</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquitySecuritiesFvNi" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireEquitySecuritiesFvNi"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireEquitySecuritiesFvNi" xlink:to="lab_us-gaap_PaymentsToAcquireEquitySecuritiesFvNi" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTextBlock_2b559b53-2018-4e67-b876-c8c825bb394b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value of Financial Instruments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Off-balance Sheet Risks [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTextBlock" xlink:to="lab_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseCurrent_107cf648-02b4-4392-9b0c-64236a53d0ac_verboseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseCurrent" xlink:to="lab_us-gaap_PrepaidExpenseCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_db82077f-8f9b-4ac2-8d31-98610051ffbf_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_9f2adfba-ae0b-4bbf-b219-554b70231c41_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Identifiable intangible assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_17a178cd-4132-45c7-b1f9-6ffb30d927a3_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_a02679aa-ed0f-4827-a3e6-e4588b8478fa_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_d38cd597-a198-4fcd-88c3-354d04c6dbd6_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjustment</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommercialPaperMember_e96648c4-07e5-4ba5-97d6-414eee681168_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial paper</link:label>
    <link:label id="lab_us-gaap_CommercialPaperMember_label_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialPaperMember" xlink:to="lab_us-gaap_CommercialPaperMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasePayments_d49bf27f-2dff-467d-a42a-cf6e290f399c_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for amounts included in the measurement of operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeasePayments_label_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments" xlink:to="lab_us-gaap_OperatingLeasePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_9bb5e710-60a0-446c-912b-1060e7c8e18c_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash interest expense and other</link:label>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncash Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncashIncomeExpense" xlink:to="lab_us-gaap_OtherNoncashIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalents_2e08216e-36ef-4a5a-9f0f-006a431c64e0_verboseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash and cash equivalents (included in other current assets)</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalents_f3ffa3a4-39ab-4310-919a-793221a88d1a_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalents_label_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash and Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalents" xlink:to="lab_us-gaap_RestrictedCashAndCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_amn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalentsAndPropertyPlantAndEquipment_7dbf80f9-e03e-45d8-816a-99a4f12a062f_terseLabel_en-US" xlink:label="lab_amn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalentsAndPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of tangible assets acquired</link:label>
    <link:label id="lab_amn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalentsAndPropertyPlantAndEquipment_label_en-US" xlink:label="lab_amn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalentsAndPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Cash And Equivalents And Property, Plant, And Equipment</link:label>
    <link:label id="lab_amn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalentsAndPropertyPlantAndEquipment_documentation_en-US" xlink:label="lab_amn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalentsAndPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Cash And Equivalents And Property, Plant, And Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalentsAndPropertyPlantAndEquipment" xlink:href="amn-20210930.xsd#amn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalentsAndPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalentsAndPropertyPlantAndEquipment" xlink:to="lab_amn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalentsAndPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_f349f942-524c-46af-a254-b8965fe28773_terseLabel_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for expected credit losses</link:label>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_label_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Credit Loss Expense (Reversal)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:to="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillRollForward_7e8d34de-e1e4-477c-8530-95ba983ddadc_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_GoodwillRollForward_label_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillRollForward" xlink:to="lab_us-gaap_GoodwillRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSecuredDebt_5f9ad0b6-5b3b-4a42-93b9-a37a10aa9eea_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSecuredDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from term loans</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSecuredDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSecuredDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Secured Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSecuredDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSecuredDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfSecuredDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfSecuredDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_456818a7-13a3-4b07-be9a-245b9c008c46_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term loan credit facility</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedInsuranceCurrent_85f74494-bb40-4ad3-96a4-ddee53beddd5_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedInsuranceCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health insurance reserve</link:label>
    <link:label id="lab_us-gaap_AccruedInsuranceCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedInsuranceCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Insurance, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedInsuranceCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedInsuranceCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedInsuranceCurrent" xlink:to="lab_us-gaap_AccruedInsuranceCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_43b20108-98b4-413b-a5d8-cc2967b61d72_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quoted&#160;Prices&#160;in Active&#160;Markets for Identical Assets (Level 1)</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_9dec70d2-0277-42f6-b193-0fa2b5bd84b7_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from investing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_e96ed421-aef4-4660-98a6-94f737e547fc_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value by Liability Class [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value by Liability Class [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_764bdf83-b8eb-45fc-99ac-1fc6a3527252_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_17aae07f-a651-4761-b989-99dc727291bf_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromPreviousAcquisition_edde6064-6b03-49df-bb42-7220b19b8679_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromPreviousAcquisition" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash received for working capital adjustments for prior year acquisitions</link:label>
    <link:label id="lab_us-gaap_ProceedsFromPreviousAcquisition_label_en-US" xlink:label="lab_us-gaap_ProceedsFromPreviousAcquisition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Previous Acquisition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPreviousAcquisition" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromPreviousAcquisition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromPreviousAcquisition" xlink:to="lab_us-gaap_ProceedsFromPreviousAcquisition" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidCapitalized_5ef87e70-ee92-4575-9ed1-645cff7fb2a9_verboseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidCapitalized" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest capitalized</link:label>
    <link:label id="lab_us-gaap_InterestPaidCapitalized_label_en-US" xlink:label="lab_us-gaap_InterestPaidCapitalized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Capitalized, Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidCapitalized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidCapitalized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidCapitalized" xlink:to="lab_us-gaap_InterestPaidCapitalized" xlink:type="arc" order="1"/>
    <link:label id="lab_amn_NumberOfPhasesOfLeaseTerminationAgreement_ecdfcd95-2f40-445e-9aa1-6d40af0fa380_terseLabel_en-US" xlink:label="lab_amn_NumberOfPhasesOfLeaseTerminationAgreement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of phases of lease termination agreement</link:label>
    <link:label id="lab_amn_NumberOfPhasesOfLeaseTerminationAgreement_label_en-US" xlink:label="lab_amn_NumberOfPhasesOfLeaseTerminationAgreement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Phases Of Lease Termination Agreement</link:label>
    <link:label id="lab_amn_NumberOfPhasesOfLeaseTerminationAgreement_documentation_en-US" xlink:label="lab_amn_NumberOfPhasesOfLeaseTerminationAgreement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Phases Of Lease Termination Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amn_NumberOfPhasesOfLeaseTerminationAgreement" xlink:href="amn-20210930.xsd#amn_NumberOfPhasesOfLeaseTerminationAgreement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amn_NumberOfPhasesOfLeaseTerminationAgreement" xlink:to="lab_amn_NumberOfPhasesOfLeaseTerminationAgreement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_7345af31-470a-4429-8d1a-f89fffc800be_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PendingLitigationMember_14005b13-1d77-4f24-84d4-d40495243688_terseLabel_en-US" xlink:label="lab_us-gaap_PendingLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pending Litigation</link:label>
    <link:label id="lab_us-gaap_PendingLitigationMember_label_en-US" xlink:label="lab_us-gaap_PendingLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pending Litigation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PendingLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PendingLitigationMember" xlink:to="lab_us-gaap_PendingLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredCompensationLiabilityCurrent_82f2078c-ced5-4ab5-9c3f-37edfb29ec79_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredCompensationLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred compensation</link:label>
    <link:label id="lab_us-gaap_DeferredCompensationLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_DeferredCompensationLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCompensationLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCompensationLiabilityCurrent" xlink:to="lab_us-gaap_DeferredCompensationLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_b7d9a1ec-716d-4fa5-a3ab-f107f45a45ba_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_a9b0e590-e00d-4618-ba49-2f8bdd97235f_verboseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsAbstract_24d0cd73-0560-44b4-9c14-f4ccd5c8b240_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets:</link:label>
    <link:label id="lab_us-gaap_OtherAssetsAbstract_label_en-US" xlink:label="lab_us-gaap_OtherAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsAbstract" xlink:to="lab_us-gaap_OtherAssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_3db3be3d-cdad-4d29-ac7b-4e89438c10d1_verboseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNetAbstract_b49348cd-8b5b-421e-b164-fcedd9b2b1ec_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed assets:</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNetAbstract_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_amn_SynziMember_58f47ab4-c898-4ed3-ac4d-5e746de04bbb_terseLabel_en-US" xlink:label="lab_amn_SynziMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Synzi</link:label>
    <link:label id="lab_amn_SynziMember_label_en-US" xlink:label="lab_amn_SynziMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Synzi [Member]</link:label>
    <link:label id="lab_amn_SynziMember_documentation_en-US" xlink:label="lab_amn_SynziMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Synzi</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amn_SynziMember" xlink:href="amn-20210930.xsd#amn_SynziMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amn_SynziMember" xlink:to="lab_amn_SynziMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_2893345a-b1f2-4598-aeb6-6b0fe1b42992_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income Per Common Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_9c82c4a2-5bc2-41dc-be5a-7731f0e8eb6d_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating expenses:</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_amn_AccountsPayableAndAccruedExpensesExcludingAccruedCompensationAndBenefitsCurrent_c92909fc-0be6-49aa-83df-887ee312dd21_totalLabel_en-US" xlink:label="lab_amn_AccountsPayableAndAccruedExpensesExcludingAccruedCompensationAndBenefitsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable and accrued expenses</link:label>
    <link:label id="lab_amn_AccountsPayableAndAccruedExpensesExcludingAccruedCompensationAndBenefitsCurrent_label_en-US" xlink:label="lab_amn_AccountsPayableAndAccruedExpensesExcludingAccruedCompensationAndBenefitsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable And Accrued Expenses, Excluding Accrued Compensation And Benefits, Current</link:label>
    <link:label id="lab_amn_AccountsPayableAndAccruedExpensesExcludingAccruedCompensationAndBenefitsCurrent_documentation_en-US" xlink:label="lab_amn_AccountsPayableAndAccruedExpensesExcludingAccruedCompensationAndBenefitsCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable And Accrued Expenses, Excluding Accrued Compensation And Benefits, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amn_AccountsPayableAndAccruedExpensesExcludingAccruedCompensationAndBenefitsCurrent" xlink:href="amn-20210930.xsd#amn_AccountsPayableAndAccruedExpensesExcludingAccruedCompensationAndBenefitsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amn_AccountsPayableAndAccruedExpensesExcludingAccruedCompensationAndBenefitsCurrent" xlink:to="lab_amn_AccountsPayableAndAccruedExpensesExcludingAccruedCompensationAndBenefitsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_adc74472-ea9c-4fd7-9927-603f612d00a4_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonrecurringAdjustmentDomain_d1c2056f-9dd9-4fda-b2f6-6f3e4692bdc9_terseLabel_en-US" xlink:label="lab_us-gaap_NonrecurringAdjustmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonrecurring Adjustment [Domain]</link:label>
    <link:label id="lab_us-gaap_NonrecurringAdjustmentDomain_label_en-US" xlink:label="lab_us-gaap_NonrecurringAdjustmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonrecurring Adjustment [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonrecurringAdjustmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonrecurringAdjustmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonrecurringAdjustmentDomain" xlink:to="lab_us-gaap_NonrecurringAdjustmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesReceivable_46884860-c4a0-4bbe-9b74-81e0decaf7bc_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes receivable</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesReceivable_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Receivable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesReceivable" xlink:to="lab_us-gaap_IncomeTaxesReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_c69f6cdc-3ba8-462e-9b97-e53e28ed78fa_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in fair value of contingent consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent_939d4a78-9a06-413c-b4b8-b9bc03bbb96d_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits</link:label>
    <link:label id="lab_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent_label_en-US" xlink:label="lab_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Uncertainty in Income Taxes, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUncertainTaxPositionsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent" xlink:to="lab_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GrossProfit_51247d22-06a0-46d1-9d6e-544e14570a76_totalLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross profit</link:label>
    <link:label id="lab_us-gaap_GrossProfit_label_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit" xlink:to="lab_us-gaap_GrossProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_865e53a0-c4bd-4930-920b-8ba6d1ebff5d_verboseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of exchange rate changes on cash</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_b555c274-30ce-4ed3-b203-28dbe5850e2a_verboseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general and administrative</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_dba82c95-28d3-46f3-8371-bce7c005d93f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss):</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_amn_OutsourcedWorkforceMember_f4c9e7fa-e142-4616-a1d3-c1498482a6bb_terseLabel_en-US" xlink:label="lab_amn_OutsourcedWorkforceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outsourced workforce</link:label>
    <link:label id="lab_amn_OutsourcedWorkforceMember_label_en-US" xlink:label="lab_amn_OutsourcedWorkforceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outsourced Workforce [Member]</link:label>
    <link:label id="lab_amn_OutsourcedWorkforceMember_documentation_en-US" xlink:label="lab_amn_OutsourcedWorkforceMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outsourced Workforce [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amn_OutsourcedWorkforceMember" xlink:href="amn-20210930.xsd#amn_OutsourcedWorkforceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amn_OutsourcedWorkforceMember" xlink:to="lab_amn_OutsourcedWorkforceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_9147edb1-4147-4497-9046-5e6e35715fc6_verboseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueNetAssetLiability_38088f5c-b9bb-4111-b722-d67ec740fd1b_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueNetAssetLiability" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial paper</link:label>
    <link:label id="lab_us-gaap_FairValueNetAssetLiability_53316405-a220-4ae7-a6b2-55d208262545_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueNetAssetLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets (liabilities) measured at fair value</link:label>
    <link:label id="lab_us-gaap_FairValueNetAssetLiability_label_en-US" xlink:label="lab_us-gaap_FairValueNetAssetLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Net Asset (Liability)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetAssetLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueNetAssetLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueNetAssetLiability" xlink:to="lab_us-gaap_FairValueNetAssetLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_amn_A4.625SeniorNotesDue2027Member_1dda3893-c9b0-4020-baad-58be67174a2b_verboseLabel_en-US" xlink:label="lab_amn_A4.625SeniorNotesDue2027Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027 Notes</link:label>
    <link:label id="lab_amn_A4.625SeniorNotesDue2027Member_label_en-US" xlink:label="lab_amn_A4.625SeniorNotesDue2027Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.625% Senior Notes Due 2027 [Member]</link:label>
    <link:label id="lab_amn_A4.625SeniorNotesDue2027Member_documentation_en-US" xlink:label="lab_amn_A4.625SeniorNotesDue2027Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.625% Senior Notes Due 2027 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amn_A4.625SeniorNotesDue2027Member" xlink:href="amn-20210930.xsd#amn_A4.625SeniorNotesDue2027Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amn_A4.625SeniorNotesDue2027Member" xlink:to="lab_amn_A4.625SeniorNotesDue2027Member" xlink:type="arc" order="1"/>
    <link:label id="lab_amn_NurseAndAlliedHealthcareStaffingMember_fa1525c3-2ec1-415d-bf08-fe3b42fd57aa_verboseLabel_en-US" xlink:label="lab_amn_NurseAndAlliedHealthcareStaffingMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nurse and allied solutions</link:label>
    <link:label id="lab_amn_NurseAndAlliedHealthcareStaffingMember_1963c2c6-4616-4859-95c7-d878ca05896a_terseLabel_en-US" xlink:label="lab_amn_NurseAndAlliedHealthcareStaffingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nurse&#160;and&#160;Allied Solutions</link:label>
    <link:label id="lab_amn_NurseAndAlliedHealthcareStaffingMember_label_en-US" xlink:label="lab_amn_NurseAndAlliedHealthcareStaffingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nurse and Allied Healthcare Staffing [Member]</link:label>
    <link:label id="lab_amn_NurseAndAlliedHealthcareStaffingMember_documentation_en-US" xlink:label="lab_amn_NurseAndAlliedHealthcareStaffingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nurse and allied healthcare staffing.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amn_NurseAndAlliedHealthcareStaffingMember" xlink:href="amn-20210930.xsd#amn_NurseAndAlliedHealthcareStaffingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amn_NurseAndAlliedHealthcareStaffingMember" xlink:to="lab_amn_NurseAndAlliedHealthcareStaffingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_77f12e6a-1cda-41b5-8c46-4947184e7e4c_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period Of Adoption [Axis]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_amn_GainLossOnDeferredCompensation_3aa8846a-9698-415d-9ce1-f3e5a86e814d_negatedTerseLabel_en-US" xlink:label="lab_amn_GainLossOnDeferredCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss on deferred compensation balances</link:label>
    <link:label id="lab_amn_GainLossOnDeferredCompensation_label_en-US" xlink:label="lab_amn_GainLossOnDeferredCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) On Deferred Compensation</link:label>
    <link:label id="lab_amn_GainLossOnDeferredCompensation_documentation_en-US" xlink:label="lab_amn_GainLossOnDeferredCompensation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) On Deferred Compensation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amn_GainLossOnDeferredCompensation" xlink:href="amn-20210930.xsd#amn_GainLossOnDeferredCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amn_GainLossOnDeferredCompensation" xlink:to="lab_amn_GainLossOnDeferredCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_d0b111c4-a976-4d5e-87af-1a30a7834c44_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_15fc411e-fa05-4c8f-90a1-d83793478342_verboseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_83708f6a-dba4-42ad-bd15-7e7bda5d0ab2_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for acquisitions, net of cash and restricted cash received</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_7115e790-fe45-4673-9dbe-73b723282b7a_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash paid for acquisitions</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_377e57b1-5676-48bf-bb07-e16b13ec8c67_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Payable and Credit Agreement</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonrecurringAdjustmentAxis_dfe0ee39-962b-4d59-8575-10ab915fc771_terseLabel_en-US" xlink:label="lab_us-gaap_NonrecurringAdjustmentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonrecurring Adjustment [Axis]</link:label>
    <link:label id="lab_us-gaap_NonrecurringAdjustmentAxis_label_en-US" xlink:label="lab_us-gaap_NonrecurringAdjustmentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonrecurring Adjustment [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonrecurringAdjustmentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonrecurringAdjustmentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonrecurringAdjustmentAxis" xlink:to="lab_us-gaap_NonrecurringAdjustmentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditMember_4248f7d3-382c-4d7c-90aa-c888a6500d08_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit</link:label>
    <link:label id="lab_us-gaap_LineOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditMember" xlink:to="lab_us-gaap_LineOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeniorNotesMember_4b7ffe3d-81a8-439e-9441-3743f2e1c71f_terseLabel_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes</link:label>
    <link:label id="lab_us-gaap_SeniorNotesMember_label_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeniorNotesMember" xlink:to="lab_us-gaap_SeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_9778c6b1-fc38-41ad-a61c-7ff4925a9670_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Unobservable Inputs (Level 3)</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_4806a98c-3972-493e-a4b4-96a22afcaedd_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_amn_DeferredCompensationMember_9b22e0d6-7fa4-4abd-8d6e-875443ba5d77_terseLabel_en-US" xlink:label="lab_amn_DeferredCompensationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred compensation</link:label>
    <link:label id="lab_amn_DeferredCompensationMember_label_en-US" xlink:label="lab_amn_DeferredCompensationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation [Member]</link:label>
    <link:label id="lab_amn_DeferredCompensationMember_documentation_en-US" xlink:label="lab_amn_DeferredCompensationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amn_DeferredCompensationMember" xlink:href="amn-20210930.xsd#amn_DeferredCompensationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amn_DeferredCompensationMember" xlink:to="lab_amn_DeferredCompensationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_amn_TermDebtMember_a4e98e47-ed3f-4eca-8721-87c1fa89aa7a_terseLabel_en-US" xlink:label="lab_amn_TermDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Debt</link:label>
    <link:label id="lab_amn_TermDebtMember_label_en-US" xlink:label="lab_amn_TermDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Debt [Member]</link:label>
    <link:label id="lab_amn_TermDebtMember_documentation_en-US" xlink:label="lab_amn_TermDebtMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amn_TermDebtMember" xlink:href="amn-20210930.xsd#amn_TermDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amn_TermDebtMember" xlink:to="lab_amn_TermDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeAmortizationOfDiscount_e5cd904c-a739-4cfb-93bd-6186d0e79391_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeAmortizationOfDiscount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of discount on investments</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeAmortizationOfDiscount_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeAmortizationOfDiscount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Amortization of Discount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeAmortizationOfDiscount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeAmortizationOfDiscount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeAmortizationOfDiscount" xlink:to="lab_us-gaap_InvestmentIncomeAmortizationOfDiscount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_332526c0-1919-4bf9-b6e6-66ae8602f755_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, $0.01 par value; 200,000 shares authorized; 49,836 issued and 47,275 outstanding at September&#160;30, 2021 and 49,614 issued and 47,053 outstanding at December&#160;31, 2020</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireNotesReceivable_32eb9c9b-7c6e-4b42-9b76-e005262641fd_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireNotesReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of convertible promissory notes</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireNotesReceivable_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireNotesReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Notes Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireNotesReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireNotesReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireNotesReceivable" xlink:to="lab_us-gaap_PaymentsToAcquireNotesReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_ec55be88-682f-41a8-a7e1-819ac6d5a0ae_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill from Synzi and SnapMD acquisition</link:label>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_label_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Acquired During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:to="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_bce4edaa-1d36-4ec7-b543-ec4fe3ea16ba_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_2a7b01a9-1c72-477d-a9ab-ab2e90534b07_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LEASES</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_35bd3d4f-54dc-4035-8f9e-bc9ccc16d887_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive income</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_7cfad42f-34ad-4fa8-a7f8-da5069de23fe_verboseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, allowance</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_d5e76380-d5c9-4479-9bd6-2cb5315a924d_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:to="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_b587785f-7583-45ef-8f49-dc3cf33efb6c_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_22ecbd9f-b5c7-44c7-b0c0-b30fa311f8eb_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Net Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:to="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_802974db-5c05-4bc9-92b8-0c1e11ba4067_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_amn_Purchaseoffixedassetsrecordedinaccountspayableandaccruedexpenses_8d2cc035-253f-47ae-8a45-770590f66de4_terseLabel_en-US" xlink:label="lab_amn_Purchaseoffixedassetsrecordedinaccountspayableandaccruedexpenses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of fixed assets recorded in accounts payable and accrued expenses</link:label>
    <link:label id="lab_amn_Purchaseoffixedassetsrecordedinaccountspayableandaccruedexpenses_label_en-US" xlink:label="lab_amn_Purchaseoffixedassetsrecordedinaccountspayableandaccruedexpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of fixed assets recorded in accounts payable and accrued expenses</link:label>
    <link:label id="lab_amn_Purchaseoffixedassetsrecordedinaccountspayableandaccruedexpenses_documentation_en-US" xlink:label="lab_amn_Purchaseoffixedassetsrecordedinaccountspayableandaccruedexpenses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of fixed assets recorded in accounts payable and accrued expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amn_Purchaseoffixedassetsrecordedinaccountspayableandaccruedexpenses" xlink:href="amn-20210930.xsd#amn_Purchaseoffixedassetsrecordedinaccountspayableandaccruedexpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amn_Purchaseoffixedassetsrecordedinaccountspayableandaccruedexpenses" xlink:to="lab_amn_Purchaseoffixedassetsrecordedinaccountspayableandaccruedexpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockShares_be5a3e3e-89ba-4507-b031-74890dd65802_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockShares_label_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockShares" xlink:to="lab_us-gaap_TreasuryStockShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcquisitionRelatedCostsMember_ea42d733-fc8e-4725-bccc-ee70224bef8a_terseLabel_en-US" xlink:label="lab_us-gaap_AcquisitionRelatedCostsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition-related Costs</link:label>
    <link:label id="lab_us-gaap_AcquisitionRelatedCostsMember_label_en-US" xlink:label="lab_us-gaap_AcquisitionRelatedCostsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition-related Costs [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquisitionRelatedCostsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcquisitionRelatedCostsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcquisitionRelatedCostsMember" xlink:to="lab_us-gaap_AcquisitionRelatedCostsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_amn_BusinessCombinationConsiderationTransferredNetOfWorkingCapitalAdjustment_fe762123-3d64-4a1e-a746-79290d9327c6_terseLabel_en-US" xlink:label="lab_amn_BusinessCombinationConsiderationTransferredNetOfWorkingCapitalAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase price, net of working capital adjustment</link:label>
    <link:label id="lab_amn_BusinessCombinationConsiderationTransferredNetOfWorkingCapitalAdjustment_label_en-US" xlink:label="lab_amn_BusinessCombinationConsiderationTransferredNetOfWorkingCapitalAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Net Of Working Capital Adjustment</link:label>
    <link:label id="lab_amn_BusinessCombinationConsiderationTransferredNetOfWorkingCapitalAdjustment_documentation_en-US" xlink:label="lab_amn_BusinessCombinationConsiderationTransferredNetOfWorkingCapitalAdjustment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Net Of Working Capital Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amn_BusinessCombinationConsiderationTransferredNetOfWorkingCapitalAdjustment" xlink:href="amn-20210930.xsd#amn_BusinessCombinationConsiderationTransferredNetOfWorkingCapitalAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amn_BusinessCombinationConsiderationTransferredNetOfWorkingCapitalAdjustment" xlink:to="lab_amn_BusinessCombinationConsiderationTransferredNetOfWorkingCapitalAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_amn_AdvancedMedicalPersonnelServicesInc.Member_dfd82cfa-2748-464f-83dd-9441f9fbe100_terseLabel_en-US" xlink:label="lab_amn_AdvancedMedicalPersonnelServicesInc.Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advanced</link:label>
    <link:label id="lab_amn_AdvancedMedicalPersonnelServicesInc.Member_label_en-US" xlink:label="lab_amn_AdvancedMedicalPersonnelServicesInc.Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advanced Medical Personnel Services, Inc. [Member]</link:label>
    <link:label id="lab_amn_AdvancedMedicalPersonnelServicesInc.Member_documentation_en-US" xlink:label="lab_amn_AdvancedMedicalPersonnelServicesInc.Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advanced Medical Personnel Services, Inc. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amn_AdvancedMedicalPersonnelServicesInc.Member" xlink:href="amn-20210930.xsd#amn_AdvancedMedicalPersonnelServicesInc.Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amn_AdvancedMedicalPersonnelServicesInc.Member" xlink:to="lab_amn_AdvancedMedicalPersonnelServicesInc.Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_cf169130-25b4-4b04-8a48-4be4fa034e27_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_2f39fd84-6572-4a2f-8fed-a0bc6ee55cfb_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_e5d38644-0df2-4fbe-a493-59ad2316765f_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidExpense_4a1dab56-596c-4478-9893-b9e3210c502f_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidExpense_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Prepaid Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_86509d80-f623-43ed-a629-f03bd3b4cd92_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsDomain_afbaccb6-1548-423d-adda-137683c66479_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:label id="lab_srt_ConsolidationItemsDomain_label_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsDomain" xlink:to="lab_srt_ConsolidationItemsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_456a6ec0-a341-4192-a4f6-94c5e2690955_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_f2ca66af-49fa-4c33-952b-0dbd3dbab2aa_verboseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Information</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_4ebeb617-cda1-41dd-a2d4-f9412b0880d5_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from operations</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_d137c694-8d7c-4bbf-aea4-81a7ebbdb87a_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment operating income</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_0ad78185-7db8-42c8-8779-bb06c4c0c9bb_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_13a37e72-b0ca-4599-8c94-6abe99b60eeb_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_402d4f43-8d2f-44f5-aa69-485d74c827ab_netLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_387330f5-809b-4545-8394-c39d0bfc5814_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_0f48ba89-bcb5-460c-9320-f013f1f7d8c1_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_d2f9879a-f952-49c1-a865-8581eefa18e5_verboseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_e828c59a-b05b-4c3b-b974-d8187a6b72cd_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_8f6f902e-9c0c-42be-9aa9-fb52ac9ba7ad_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual_4f6de231-9ac2-4465-9796-2c6f46f1d903_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pro forma information, revenue of acquiree since acquisition date</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Pro Forma Information, Revenue of Acquiree since Acquisition Date, Actual</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual" xlink:to="lab_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockMember_74122b64-1297-48ef-92db-5a5753e356b2_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockMember_label_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockMember" xlink:to="lab_us-gaap_TreasuryStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_amn_LesseeOperatingLeaseLiabilityToBePaidPostmodification_ff796917-fbad-40ac-82aa-59ad1dc8f401_terseLabel_en-US" xlink:label="lab_amn_LesseeOperatingLeaseLiabilityToBePaidPostmodification" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining lease payments, postmodification</link:label>
    <link:label id="lab_amn_LesseeOperatingLeaseLiabilityToBePaidPostmodification_label_en-US" xlink:label="lab_amn_LesseeOperatingLeaseLiabilityToBePaidPostmodification" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, To Be Paid, Postmodification</link:label>
    <link:label id="lab_amn_LesseeOperatingLeaseLiabilityToBePaidPostmodification_documentation_en-US" xlink:label="lab_amn_LesseeOperatingLeaseLiabilityToBePaidPostmodification" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, To Be Paid, Postmodification</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amn_LesseeOperatingLeaseLiabilityToBePaidPostmodification" xlink:href="amn-20210930.xsd#amn_LesseeOperatingLeaseLiabilityToBePaidPostmodification"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amn_LesseeOperatingLeaseLiabilityToBePaidPostmodification" xlink:to="lab_amn_LesseeOperatingLeaseLiabilityToBePaidPostmodification" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetImpairmentCharges_fd1a2473-f192-45d8-821e-bb400d361358_terseLabel_en-US" xlink:label="lab_us-gaap_AssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment charges</link:label>
    <link:label id="lab_us-gaap_AssetImpairmentCharges_label_en-US" xlink:label="lab_us-gaap_AssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Impairment Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetImpairmentCharges" xlink:to="lab_us-gaap_AssetImpairmentCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromLinesOfCredit_bc6f664b-cadc-49f4-a68c-b7f1b8401f94_verboseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from revolving credit facility</link:label>
    <link:label id="lab_us-gaap_ProceedsFromLinesOfCredit_label_en-US" xlink:label="lab_us-gaap_ProceedsFromLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Lines of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromLinesOfCredit" xlink:to="lab_us-gaap_ProceedsFromLinesOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_amn_ContingentConsiderationMember_aaaadf01-388d-46c7-b25b-245c8cda9eed_verboseLabel_en-US" xlink:label="lab_amn_ContingentConsiderationMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition contingent consideration liabilities</link:label>
    <link:label id="lab_amn_ContingentConsiderationMember_label_en-US" xlink:label="lab_amn_ContingentConsiderationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration [Member]</link:label>
    <link:label id="lab_amn_ContingentConsiderationMember_documentation_en-US" xlink:label="lab_amn_ContingentConsiderationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amn_ContingentConsiderationMember" xlink:href="amn-20210930.xsd#amn_ContingentConsiderationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amn_ContingentConsiderationMember" xlink:to="lab_amn_ContingentConsiderationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_39e1d647-177f-4bc0-b149-75ef97d47d9a_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WorkersCompensationLiabilityCurrent_00418da7-7a15-4225-be58-f867d3cbedac_terseLabel_en-US" xlink:label="lab_us-gaap_WorkersCompensationLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Workers compensation reserve</link:label>
    <link:label id="lab_us-gaap_WorkersCompensationLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_WorkersCompensationLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Workers' Compensation Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WorkersCompensationLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WorkersCompensationLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WorkersCompensationLiabilityCurrent" xlink:to="lab_us-gaap_WorkersCompensationLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_amn_SaaSBasedTechnologiesMember_27b0f524-6273-46b9-aaae-92df6d850910_terseLabel_en-US" xlink:label="lab_amn_SaaSBasedTechnologiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SaaS-based technologies</link:label>
    <link:label id="lab_amn_SaaSBasedTechnologiesMember_label_en-US" xlink:label="lab_amn_SaaSBasedTechnologiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SaaS-Based Technologies [Member]</link:label>
    <link:label id="lab_amn_SaaSBasedTechnologiesMember_documentation_en-US" xlink:label="lab_amn_SaaSBasedTechnologiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SaaS-Based Technologies [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amn_SaaSBasedTechnologiesMember" xlink:href="amn-20210930.xsd#amn_SaaSBasedTechnologiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amn_SaaSBasedTechnologiesMember" xlink:to="lab_amn_SaaSBasedTechnologiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_cb5b4fc6-91a3-461d-8ad8-6c3b81011676_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase and development of fixed assets</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_a8deaccd-9dfe-4ede-8ee7-a99feccc32d9_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_81da4eb8-02a3-42f7-baaf-102ad47007fc_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_8d6b6139-049d-46a8-a6ec-3af7f5ce1f20_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_ee8d9bb8-62a3-417d-a11c-9455e30e7f4e_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingRevenueReconcilingItemLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting, Revenue Reconciling Item [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingRevenueReconcilingItemLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting, Revenue Reconciling Item [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingRevenueReconcilingItemLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems" xlink:to="lab_us-gaap_SegmentReportingRevenueReconcilingItemLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_427fa610-51a6-4948-a51e-56ec16658c7d_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from financing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsAxis_0bfebaa6-a847-49ae-8604-a78c07cf8d2f_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:label id="lab_srt_ConsolidationItemsAxis_label_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsAxis" xlink:to="lab_srt_ConsolidationItemsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_bc1bde75-2691-4a39-ac79-e476fa1bce7b_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_24727fad-b617-4b12-8d94-89e5608d9073_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_f5a49dac-5c0f-482e-ba49-11d96d2f0a26_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_amn_PaymentsOfLeaseTerminationFee_0fae16bd-2a35-4c0b-8ea3-1362ed39eb78_terseLabel_en-US" xlink:label="lab_amn_PaymentsOfLeaseTerminationFee" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of lease termination fee</link:label>
    <link:label id="lab_amn_PaymentsOfLeaseTerminationFee_label_en-US" xlink:label="lab_amn_PaymentsOfLeaseTerminationFee" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments Of Lease Termination Fee</link:label>
    <link:label id="lab_amn_PaymentsOfLeaseTerminationFee_documentation_en-US" xlink:label="lab_amn_PaymentsOfLeaseTerminationFee" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments Of Lease Termination Fee</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amn_PaymentsOfLeaseTerminationFee" xlink:href="amn-20210930.xsd#amn_PaymentsOfLeaseTerminationFee"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amn_PaymentsOfLeaseTerminationFee" xlink:to="lab_amn_PaymentsOfLeaseTerminationFee" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetRelatedDisclosuresAbstract_42b67be8-0860-4f11-95b8-af6f438d764a_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Related Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetRelatedDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Related Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="lab_us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_fbc1abaf-2632-4d1a-b938-bc40099bc199_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_amn_InterpreterDatabaseMember_e585f7a5-77d0-40b3-99e6-86db6d76d64f_terseLabel_en-US" xlink:label="lab_amn_InterpreterDatabaseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interpreter Database</link:label>
    <link:label id="lab_amn_InterpreterDatabaseMember_label_en-US" xlink:label="lab_amn_InterpreterDatabaseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interpreter Database [Member]</link:label>
    <link:label id="lab_amn_InterpreterDatabaseMember_documentation_en-US" xlink:label="lab_amn_InterpreterDatabaseMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interpreter Database [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amn_InterpreterDatabaseMember" xlink:href="amn-20210930.xsd#amn_InterpreterDatabaseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amn_InterpreterDatabaseMember" xlink:to="lab_amn_InterpreterDatabaseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_7ef432fd-da7b-4257-9fd7-0d5ac0d9959e_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_b1ebabae-ecc9-495b-88dd-189567ee1e61_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlement of contingent consideration liability</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_c58e5d1b-2ae2-4072-9c26-13ff7069aaac_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable and accrued expenses</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable and Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_amn_Accountsreceivablesubcontractor_33dd6214-aac6-40c1-8662-1728f5a67816_terseLabel_en-US" xlink:label="lab_amn_Accountsreceivablesubcontractor" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, subcontractor</link:label>
    <link:label id="lab_amn_Accountsreceivablesubcontractor_label_en-US" xlink:label="lab_amn_Accountsreceivablesubcontractor" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, subcontractor</link:label>
    <link:label id="lab_amn_Accountsreceivablesubcontractor_documentation_en-US" xlink:label="lab_amn_Accountsreceivablesubcontractor" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, subcontractor</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amn_Accountsreceivablesubcontractor" xlink:href="amn-20210930.xsd#amn_Accountsreceivablesubcontractor"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amn_Accountsreceivablesubcontractor" xlink:to="lab_amn_Accountsreceivablesubcontractor" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_e10ce8a9-7064-4366-a93b-e464c231b27f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Cash, Cash Equivalents and Restricted Cash</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_5d1e6a37-465b-4c3b-811a-f187034ebef7_verboseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders&#8217; equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NotesPayableCurrent_4692649d-887e-4b5c-9210-0bcf1af88e72_terseLabel_en-US" xlink:label="lab_us-gaap_NotesPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of notes payable</link:label>
    <link:label id="lab_us-gaap_NotesPayableCurrent_label_en-US" xlink:label="lab_us-gaap_NotesPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesPayableCurrent" xlink:to="lab_us-gaap_NotesPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract_229a6c0e-5744-46ce-b62c-c7680029d5c2_terseLabel_en-US" xlink:label="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions:</link:label>
    <link:label id="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract_label_en-US" xlink:label="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash Investing and Financing Items [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_amn_TemporaryStaffingMember_5100fab9-68f5-4dd1-a0fd-a7e055b8e4db_terseLabel_en-US" xlink:label="lab_amn_TemporaryStaffingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary staffing</link:label>
    <link:label id="lab_amn_TemporaryStaffingMember_label_en-US" xlink:label="lab_amn_TemporaryStaffingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Staffing [Member]</link:label>
    <link:label id="lab_amn_TemporaryStaffingMember_documentation_en-US" xlink:label="lab_amn_TemporaryStaffingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Staffing [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amn_TemporaryStaffingMember" xlink:href="amn-20210930.xsd#amn_TemporaryStaffingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amn_TemporaryStaffingMember" xlink:to="lab_amn_TemporaryStaffingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_9d44df74-3011-40f1-95d0-1eaf7dca5975_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashSurrenderValueOfLifeInsurance_4c7396e8-1c6a-4123-9505-16c3e523db2a_terseLabel_en-US" xlink:label="lab_us-gaap_CashSurrenderValueOfLifeInsurance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Life insurance cash surrender value</link:label>
    <link:label id="lab_us-gaap_CashSurrenderValueOfLifeInsurance_label_en-US" xlink:label="lab_us-gaap_CashSurrenderValueOfLifeInsurance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Surrender Value of Life Insurance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashSurrenderValueOfLifeInsurance" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashSurrenderValueOfLifeInsurance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashSurrenderValueOfLifeInsurance" xlink:to="lab_us-gaap_CashSurrenderValueOfLifeInsurance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_a6102c45-035a-4f98-952d-3006f609e601_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_84a73443-5c30-4982-8277-922aa015a07b_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying Amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_485c28d5-798e-474b-aa42-997fa514cad4_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense, net, and other</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_10d75aa8-9bb5-4cf9-b7e4-12190c6c19b8_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued compensation and benefits</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Employee Related Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_amn_PermanentPlacementMember_bb3fff0a-fd9d-4d97-a5f0-f6e0f69dc001_terseLabel_en-US" xlink:label="lab_amn_PermanentPlacementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Permanent placement</link:label>
    <link:label id="lab_amn_PermanentPlacementMember_label_en-US" xlink:label="lab_amn_PermanentPlacementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Permanent Placement [Member]</link:label>
    <link:label id="lab_amn_PermanentPlacementMember_documentation_en-US" xlink:label="lab_amn_PermanentPlacementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Permanent Placement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amn_PermanentPlacementMember" xlink:href="amn-20210930.xsd#amn_PermanentPlacementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amn_PermanentPlacementMember" xlink:to="lab_amn_PermanentPlacementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccountsPayableAndAccruedLiabilities_1c1f6a25-f3ac-40ba-8f6f-241c49d47581_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherAccountsPayableAndAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_OtherAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accounts Payable and Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccountsPayableAndAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccountsPayableAndAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccountsPayableAndAccruedLiabilities" xlink:to="lab_us-gaap_OtherAccountsPayableAndAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_fa15caf8-a75c-4cab-89ed-6607556269e4_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_28c0bb87-cf2e-466f-82f5-309e0d9bdd49_verboseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_7197480f-ca91-448f-ba02-ce4efafa4181_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating segments</link:label>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_label_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingSegmentsMember" xlink:to="lab_us-gaap_OperatingSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseTypeDomain_46f81dd4-c5d0-472e-b866-3c568186306a_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:label id="lab_srt_LitigationCaseTypeDomain_label_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseTypeDomain" xlink:to="lab_srt_LitigationCaseTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SelfInsuranceReserveCurrent_2dfcf695-ef87-4333-bcc6-8a668ce87f10_terseLabel_en-US" xlink:label="lab_us-gaap_SelfInsuranceReserveCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Professional liability reserve</link:label>
    <link:label id="lab_us-gaap_SelfInsuranceReserveCurrent_label_en-US" xlink:label="lab_us-gaap_SelfInsuranceReserveCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Self Insurance Reserve, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SelfInsuranceReserveCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SelfInsuranceReserveCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SelfInsuranceReserveCurrent" xlink:to="lab_us-gaap_SelfInsuranceReserveCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_7a38086e-d28c-41ae-a80f-bd48fed577a6_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherEmployeeRelatedLiabilitiesCurrent_5d135677-1fd5-42e3-af7f-21772e390a27_terseLabel_en-US" xlink:label="lab_us-gaap_OtherEmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherEmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherEmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherEmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherEmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherEmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherEmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_a5fa734a-230c-499e-af0c-9b7e18e2fd1c_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_amn_TotalCashCashEquivalentsAndRestrictedCashCashEquivalentsandInvestments_9577ce95-c60b-4a84-91ef-53526f01d2cd_totalLabel_en-US" xlink:label="lab_amn_TotalCashCashEquivalentsAndRestrictedCashCashEquivalentsandInvestments" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total cash, cash equivalents and restricted cash and investments</link:label>
    <link:label id="lab_amn_TotalCashCashEquivalentsAndRestrictedCashCashEquivalentsandInvestments_label_en-US" xlink:label="lab_amn_TotalCashCashEquivalentsAndRestrictedCashCashEquivalentsandInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Cash, Cash Equivalents, And Restricted Cash, Cash Equivalents, and Investments</link:label>
    <link:label id="lab_amn_TotalCashCashEquivalentsAndRestrictedCashCashEquivalentsandInvestments_documentation_en-US" xlink:label="lab_amn_TotalCashCashEquivalentsAndRestrictedCashCashEquivalentsandInvestments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Cash, Cash Equivalents, And Restricted Cash, Cash Equivalents, and Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amn_TotalCashCashEquivalentsAndRestrictedCashCashEquivalentsandInvestments" xlink:href="amn-20210930.xsd#amn_TotalCashCashEquivalentsAndRestrictedCashCashEquivalentsandInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amn_TotalCashCashEquivalentsAndRestrictedCashCashEquivalentsandInvestments" xlink:to="lab_amn_TotalCashCashEquivalentsAndRestrictedCashCashEquivalentsandInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_03be37f8-1756-47cc-b877-2a283f3b3376_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_ed49448c-abfa-48f3-bbef-473143261db2_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_43fa8605-1dbe-40ba-a8c3-185291ed73c8_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliations of Changes in the Fair Value of Contingent Consideration Liabilities</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLinesOfCredit_b2fc8184-0e2a-4a03-b6f2-aa607890b6e4_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLinesOfCredit" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments on revolving credit facility</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLinesOfCredit_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Lines of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLinesOfCredit" xlink:to="lab_us-gaap_RepaymentsOfLinesOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_4d97edda-69a7-4958-8076-d6a59bcda936_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_1e58f7e4-838b-41eb-aacf-b24117c41b78_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_622832a9-5e70-4030-97ab-fd74229f329e_verboseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net of allowances of $6,148 and $7,043 at September&#160;30, 2021 and December&#160;31, 2020, respectively</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_d75deb67-6c38-489f-b5d3-97c706d3dfdd_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_c9255b1c-47f8-4337-aaa9-14cd00003f17_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_94b1f14b-cce2-4440-bb7c-0e3acb6dd4cb_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract_92a44bcd-2142-44c8-808b-aa1ee6ae2f83_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable and accrued expenses:</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable and Accrued Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_b5008a03-314e-467f-a9ce-1fe67a89886c_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Revenue and Segment Operating Income by Reportable Segment</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_7c4ff4be-19c2-493e-b331-eaf022567e60_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_52087484-eb86-4d95-a030-880b5c0f3761_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_7abfb1ae-1888-465b-87c5-423aa00a677a_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_309a43b1-fe2f-4e2e-a84f-74e729509c18_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value of Assets and Liabilities</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:to="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_069f2565-c8ba-4eee-aefb-f05b047fe0ad_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_bbb47e4b-8c78-4a97-b002-b3c233ff2e42_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_d20cdb5f-3927-4aef-9ad6-34fbc10e3aae_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_69d3693e-9893-471f-b0b1-a7ef44c5c9e8_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccounting_9621beef-3170-48c5-ae07-70e49aea1a81_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccounting" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccounting_label_en-US" xlink:label="lab_us-gaap_BasisOfAccounting" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccounting" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccounting"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccounting" xlink:to="lab_us-gaap_BasisOfAccounting" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_d824621f-f2a0-4f46-84da-a9b23b24bff6_verboseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_e6810003-58f6-47e2-9e4a-1124374f7c4c_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_f818e9c1-aa0a-472a-b3b5-a224fd87c5da_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity awards vested and exercised, net of shares withheld for payroll taxes (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_1244175d-139d-42c9-b67d-ecb1eab130f8_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseAxis_608a6a04-2552-4d56-9e9c-01d23df475e5_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:label id="lab_srt_LitigationCaseAxis_label_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseAxis" xlink:to="lab_srt_LitigationCaseAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_fceebe22-ff0d-4ff2-a3ca-0b1593675c46_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:to="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnDispositionOfAssets_6879b5d5-fc64-4ed8-b24f-063ff03f208f_negatedLabel_en-US" xlink:label="lab_us-gaap_GainLossOnDispositionOfAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on disposal or sale of fixed assets</link:label>
    <link:label id="lab_us-gaap_GainLossOnDispositionOfAssets_label_en-US" xlink:label="lab_us-gaap_GainLossOnDispositionOfAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnDispositionOfAssets" xlink:to="lab_us-gaap_GainLossOnDispositionOfAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_dc1f41a4-445c-4549-bb0a-9c69b7dba0ca_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity awards vested and exercised, net of shares withheld for payroll taxes</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_796bd712-e29f-4d6e-ab93-f5492d90b796_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-for-sale securities</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_amn_AccountsPayableToSubcontractor_d0e49fac-05f0-4d03-83ce-b68afbf7036d_terseLabel_en-US" xlink:label="lab_amn_AccountsPayableToSubcontractor" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subcontractor payable</link:label>
    <link:label id="lab_amn_AccountsPayableToSubcontractor_label_en-US" xlink:label="lab_amn_AccountsPayableToSubcontractor" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable to Subcontractor</link:label>
    <link:label id="lab_amn_AccountsPayableToSubcontractor_documentation_en-US" xlink:label="lab_amn_AccountsPayableToSubcontractor" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable to subcontractor.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amn_AccountsPayableToSubcontractor" xlink:href="amn-20210930.xsd#amn_AccountsPayableToSubcontractor"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amn_AccountsPayableToSubcontractor" xlink:to="lab_amn_AccountsPayableToSubcontractor" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments_d406c3c3-a507-4e1f-8a8a-4606c1ba6c12_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from maturity of investments</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale, Maturity and Collection of Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments" xlink:to="lab_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_718f7bb2-d822-4748-98ea-950250dc3a36_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable_b7be632f-bf20-4259-af7d-bf14bbaf1acd_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets Acquired as Part of Business Combination [Table]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets Acquired as Part of Business Combination [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_9dc90ebd-b7e6-491c-a0dc-fc33be215160_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_amn_LesseeOperatingLeaseNoncashExpense_9fd31641-b409-4cd0-972d-d35ef24eb3f9_terseLabel_en-US" xlink:label="lab_amn_LesseeOperatingLeaseNoncashExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash lease expense</link:label>
    <link:label id="lab_amn_LesseeOperatingLeaseNoncashExpense_label_en-US" xlink:label="lab_amn_LesseeOperatingLeaseNoncashExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Noncash Expense</link:label>
    <link:label id="lab_amn_LesseeOperatingLeaseNoncashExpense_documentation_en-US" xlink:label="lab_amn_LesseeOperatingLeaseNoncashExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amn_LesseeOperatingLeaseNoncashExpense" xlink:href="amn-20210930.xsd#amn_LesseeOperatingLeaseNoncashExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amn_LesseeOperatingLeaseNoncashExpense" xlink:to="lab_amn_LesseeOperatingLeaseNoncashExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1bd95e2a-49c8-4fa7-b3ab-2b3892261931_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_515f99ca-bae6-4ed8-8c4c-28bf129f97d5_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_a4a68e11-4708-44ce-8d2d-40ef6c2e95cf_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Other Observable Inputs (Level 2)</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SelfInsuranceReserveNoncurrent_2f4f9bdb-1e5f-40cd-894c-1e55b2e90b1e_terseLabel_en-US" xlink:label="lab_us-gaap_SelfInsuranceReserveNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Professional liability reserve</link:label>
    <link:label id="lab_us-gaap_SelfInsuranceReserveNoncurrent_label_en-US" xlink:label="lab_us-gaap_SelfInsuranceReserveNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Self Insurance Reserve, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SelfInsuranceReserveNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SelfInsuranceReserveNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SelfInsuranceReserveNoncurrent" xlink:to="lab_us-gaap_SelfInsuranceReserveNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_amn_A4000SeniorNotesDue2029Member_03911a3c-e65b-429f-86e1-bfaec15bbef2_terseLabel_en-US" xlink:label="lab_amn_A4000SeniorNotesDue2029Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2029 Notes</link:label>
    <link:label id="lab_amn_A4000SeniorNotesDue2029Member_label_en-US" xlink:label="lab_amn_A4000SeniorNotesDue2029Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.000% Senior Notes Due 2029 [Member]</link:label>
    <link:label id="lab_amn_A4000SeniorNotesDue2029Member_documentation_en-US" xlink:label="lab_amn_A4000SeniorNotesDue2029Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.000% Senior Notes Due 2029</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amn_A4000SeniorNotesDue2029Member" xlink:href="amn-20210930.xsd#amn_A4000SeniorNotesDue2029Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amn_A4000SeniorNotesDue2029Member" xlink:to="lab_amn_A4000SeniorNotesDue2029Member" xlink:type="arc" order="1"/>
    <link:label id="lab_amn_SupplementalDisclosuresOfNonCashInvestingAndFinancingActivitiesGoodwill_e6727152-84c4-4ae3-9a9c-ce8a98b489d7_terseLabel_en-US" xlink:label="lab_amn_SupplementalDisclosuresOfNonCashInvestingAndFinancingActivitiesGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_amn_SupplementalDisclosuresOfNonCashInvestingAndFinancingActivitiesGoodwill_label_en-US" xlink:label="lab_amn_SupplementalDisclosuresOfNonCashInvestingAndFinancingActivitiesGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Disclosures Of Non Cash Investing And Financing Activities, Goodwill</link:label>
    <link:label id="lab_amn_SupplementalDisclosuresOfNonCashInvestingAndFinancingActivitiesGoodwill_documentation_en-US" xlink:label="lab_amn_SupplementalDisclosuresOfNonCashInvestingAndFinancingActivitiesGoodwill" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Disclosures Of Non Cash Investing And Financing Activities, Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amn_SupplementalDisclosuresOfNonCashInvestingAndFinancingActivitiesGoodwill" xlink:href="amn-20210930.xsd#amn_SupplementalDisclosuresOfNonCashInvestingAndFinancingActivitiesGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amn_SupplementalDisclosuresOfNonCashInvestingAndFinancingActivitiesGoodwill" xlink:to="lab_amn_SupplementalDisclosuresOfNonCashInvestingAndFinancingActivitiesGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_336cd68b-2932-4635-bcb7-f103fd756279_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unallocated corporate overhead</link:label>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_label_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate, Non-Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateNonSegmentMember" xlink:to="lab_us-gaap_CorporateNonSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_72643c32-5758-4f7f-b955-aaba1c30cff7_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_amn_StratusVideoMember_831b5e41-6a0a-420d-a548-84edeb562afc_terseLabel_en-US" xlink:label="lab_amn_StratusVideoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stratus Video</link:label>
    <link:label id="lab_amn_StratusVideoMember_label_en-US" xlink:label="lab_amn_StratusVideoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stratus Video [Member]</link:label>
    <link:label id="lab_amn_StratusVideoMember_documentation_en-US" xlink:label="lab_amn_StratusVideoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stratus Video [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amn_StratusVideoMember" xlink:href="amn-20210930.xsd#amn_StratusVideoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amn_StratusVideoMember" xlink:to="lab_amn_StratusVideoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_amn_B4healthLLCMember_a1f5fa50-526e-4586-91ff-a75ae2d45b73_terseLabel_en-US" xlink:label="lab_amn_B4healthLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">b4health</link:label>
    <link:label id="lab_amn_B4healthLLCMember_label_en-US" xlink:label="lab_amn_B4healthLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">b4health, LLC [Member]</link:label>
    <link:label id="lab_amn_B4healthLLCMember_documentation_en-US" xlink:label="lab_amn_B4healthLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">b4health, LLC [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amn_B4healthLLCMember" xlink:href="amn-20210930.xsd#amn_B4healthLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amn_B4healthLLCMember" xlink:to="lab_amn_B4healthLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_8f802d8b-1a22-4a38-8942-1a54864a3630_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Useful Life</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireShortTermInvestments_5c636fcb-d2c3-423b-bd1c-3a9794bdc439_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireShortTermInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of investments</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireShortTermInvestments_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Short-term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireShortTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireShortTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireShortTermInvestments" xlink:to="lab_us-gaap_PaymentsToAcquireShortTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_5db28195-e9d4-4392-b8fa-2d3b28c2b3ae_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_37a6357e-c8f0-4c3c-99c5-4c31682e6396_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computation of Basic and Diluted Net Income Per Common Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_4b9709ac-99f3-434c-8ebe-8142075ab8e6_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_01fde17e-809b-490e-b73f-efcd41183f51_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByAssetClassAxis_f90e0719-4c07-497c-b65d-0d0c3e3a2e54_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByAssetClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByAssetClassAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByAssetClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByAssetClassAxis" xlink:to="lab_us-gaap_FairValueByAssetClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_a23262bc-fc30-471e-8c75-7b29cf5af086_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_fd2d64fb-f33f-443c-90e9-222e2d56bd06_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_1870b872-7c7a-462b-a9f4-132d5a9a3f96_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_9e271ff9-5dbf-4450-a10b-9d08bb21d0bc_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashAndInvestmentsNoncurrent_5b890acc-982e-4f61-b243-93180b5c0078_verboseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndInvestmentsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash, cash equivalents and investments</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndInvestmentsNoncurrent_0f0ff3c3-4aa9-4e1a-b5c1-87c23772532f_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndInvestmentsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash, cash equivalents and investments</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndInvestmentsNoncurrent_label_en-US" xlink:label="lab_us-gaap_RestrictedCashAndInvestmentsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash and Investments, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndInvestmentsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndInvestmentsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndInvestmentsNoncurrent" xlink:to="lab_us-gaap_RestrictedCashAndInvestmentsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_72107681-370e-413e-accc-e24f9124b321_verboseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for interest (net of $248 and $300 capitalized for the nine months ended September 30, 2021 and 2020, respectively)</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_8a2e1dc8-0fce-42ef-980d-ce631c2d2abe_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_83ce8275-29f8-439c-aade-127e9fcbc889_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income - diluted</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfSecuredDebt_aa68fdbb-cded-429b-8e24-b1ae5899e23b_negatedLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfSecuredDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments on term loans</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfSecuredDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfSecuredDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Secured Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfSecuredDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfSecuredDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfSecuredDebt" xlink:to="lab_us-gaap_RepaymentsOfSecuredDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_amn_UnallocatedCorporateOverhead_dd18fa30-7e3e-44cf-aaec-5582f9683cd5_verboseLabel_en-US" xlink:label="lab_amn_UnallocatedCorporateOverhead" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unallocated corporate overhead</link:label>
    <link:label id="lab_amn_UnallocatedCorporateOverhead_label_en-US" xlink:label="lab_amn_UnallocatedCorporateOverhead" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unallocated Corporate Overhead</link:label>
    <link:label id="lab_amn_UnallocatedCorporateOverhead_documentation_en-US" xlink:label="lab_amn_UnallocatedCorporateOverhead" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unallocated corporate overhead.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amn_UnallocatedCorporateOverhead" xlink:href="amn-20210930.xsd#amn_UnallocatedCorporateOverhead"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amn_UnallocatedCorporateOverhead" xlink:to="lab_amn_UnallocatedCorporateOverhead" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_d9d85085-aee1-4c14-ae46-5d29b4d7eb2e_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_f29ce074-7af7-43e9-b55c-b0fefe9ddce5_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_8c20386a-5be9-4367-a5a9-17525a4905df_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_167dd1ec-2b4f-4d52-88f0-23ae5ecfb327_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Details</link:label>
    <link:label id="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Balance Sheet Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalBalanceSheetDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:to="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_amn_LesseeOperatingLeaseLiabilityToBePaidPremodification_d8ece9a2-349b-4473-adae-b1714467590e_terseLabel_en-US" xlink:label="lab_amn_LesseeOperatingLeaseLiabilityToBePaidPremodification" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining lease payments, premodification</link:label>
    <link:label id="lab_amn_LesseeOperatingLeaseLiabilityToBePaidPremodification_label_en-US" xlink:label="lab_amn_LesseeOperatingLeaseLiabilityToBePaidPremodification" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, To Be Paid, Premodification</link:label>
    <link:label id="lab_amn_LesseeOperatingLeaseLiabilityToBePaidPremodification_documentation_en-US" xlink:label="lab_amn_LesseeOperatingLeaseLiabilityToBePaidPremodification" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, To Be Paid, Premodification</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amn_LesseeOperatingLeaseLiabilityToBePaidPremodification" xlink:href="amn-20210930.xsd#amn_LesseeOperatingLeaseLiabilityToBePaidPremodification"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amn_LesseeOperatingLeaseLiabilityToBePaidPremodification" xlink:to="lab_amn_LesseeOperatingLeaseLiabilityToBePaidPremodification" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationAndAmortization_89970883-e778-4042-b565-652edbec8171_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization (exclusive of depreciation included in cost of revenue)</link:label>
    <link:label id="lab_us-gaap_DepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization, Nonproduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationAndAmortization" xlink:to="lab_us-gaap_DepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_dc45ef73-c03f-4824-853e-3c6af93a6c79_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedInvestments_db1a11f1-8ee3-4b20-97d2-5f8d89338fb7_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RestrictedInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less restricted investments</link:label>
    <link:label id="lab_us-gaap_RestrictedInvestments_label_en-US" xlink:label="lab_us-gaap_RestrictedInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedInvestments" xlink:to="lab_us-gaap_RestrictedInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyAccrualCarryingValueCurrent_5e79c784-18a7-472a-b658-a06b3a63b861_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualCarryingValueCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss contingencies</link:label>
    <link:label id="lab_us-gaap_LossContingencyAccrualCarryingValueCurrent_label_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualCarryingValueCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Accrual, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualCarryingValueCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualCarryingValueCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyAccrualCarryingValueCurrent" xlink:to="lab_us-gaap_LossContingencyAccrualCarryingValueCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_be78d03e-92a9-4e6a-b7cd-5b0daa8220e3_verboseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_f068d68f-494e-43f7-bce4-37da36ca8923_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Credit Facility</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_d42b2342-bd6f-43ee-a83a-6ba5d46a5077_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period Of Adoption [Domain]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_56f04876-d7a6-44b7-8027-ba54bc8c9e1a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_ad214fbd-94c9-4a06-a3e7-a815dce30f38_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationStatusAxis_e686a709-068a-44fc-8c02-3b3319f86097_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationStatusAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Axis]</link:label>
    <link:label id="lab_us-gaap_LitigationStatusAxis_label_en-US" xlink:label="lab_us-gaap_LitigationStatusAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationStatusAxis" xlink:to="lab_us-gaap_LitigationStatusAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_5238ece4-e853-497b-8fac-60d75047239b_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_003716f8-cef4-48ed-aff7-9806144309ea_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_e30a82f8-9853-4cff-b85d-52acd871a9a2_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_a049c4fa-bec8-4fa9-8079-22e4077e8d47_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsMiscellaneousCurrent_12e5ea26-0005-49ed-98df-4e3e3e1a2f54_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsMiscellaneousCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherAssetsMiscellaneousCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsMiscellaneousCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Miscellaneous, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMiscellaneousCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsMiscellaneousCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsMiscellaneousCurrent" xlink:to="lab_us-gaap_OtherAssetsMiscellaneousCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_amn_OperatingLeaseLiabilityIncreaseDecreaseFromModification_9123b1f2-e748-48f7-9072-1472d7bc7c2a_negatedLabel_en-US" xlink:label="lab_amn_OperatingLeaseLiabilityIncreaseDecreaseFromModification" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease, liability, decrease from modification</link:label>
    <link:label id="lab_amn_OperatingLeaseLiabilityIncreaseDecreaseFromModification_label_en-US" xlink:label="lab_amn_OperatingLeaseLiabilityIncreaseDecreaseFromModification" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Increase (Decrease) From Modification</link:label>
    <link:label id="lab_amn_OperatingLeaseLiabilityIncreaseDecreaseFromModification_documentation_en-US" xlink:label="lab_amn_OperatingLeaseLiabilityIncreaseDecreaseFromModification" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Increase (Decrease) From Modification</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amn_OperatingLeaseLiabilityIncreaseDecreaseFromModification" xlink:href="amn-20210930.xsd#amn_OperatingLeaseLiabilityIncreaseDecreaseFromModification"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amn_OperatingLeaseLiabilityIncreaseDecreaseFromModification" xlink:to="lab_amn_OperatingLeaseLiabilityIncreaseDecreaseFromModification" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_515c2e09-87d2-407b-9b16-b9ea8daa017b_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_5aa6d819-390f-44d7-a98c-07355e514e0d_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average common shares outstanding - basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_c6930b6f-0997-4477-add6-c6aaef87e41f_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_a5c192e0-281a-45b4-b36e-f5199650fe2e_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income per common share - diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrentAbstract_e1b11b75-4a99-48bd-af72-2f12dddfaa0f_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued compensation and benefits:</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrentAbstract_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrentAbstract" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_750024e8-b416-4527-985c-4bbe6fbd35dd_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_795a8d9f-c499-4eb2-85d1-7ab757e04001_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plus dilutive effect of potential common shares (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number Diluted Shares Outstanding Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:to="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_08beb620-6308-41bd-ad92-80daa566eca9_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Paid, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaidNet" xlink:to="lab_us-gaap_IncomeTaxesPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingStandardsUpdateExtensibleList_d9f1d99f-3390-482d-ad49-35da3f64912e_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_AccountingStandardsUpdateExtensibleList_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:to="lab_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_1573db88-efa6-4497-8379-525982b815d6_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_67f1ff40-552c-463c-b203-99bc419ccf7f_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_35c8fd5a-775f-44e0-8db4-71417dde160e_verboseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, net of accumulated amortization of $262,253 and $215,234 at September&#160;30, 2021 and December&#160;31, 2020, respectively</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_8007d5b0-4fa8-46bb-8ca2-457c25f12745_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill expected to be deductible for tax purposes</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Goodwill, Expected Tax Deductible Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:to="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_a67ee1c3-029b-4b6a-8735-facad51585c7_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by (used in) financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValue_d567435d-d750-44f4-9b5c-a72faa1270fb_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock, at cost; 2,561 shares at September&#160;30, 2021 and December&#160;31, 2020</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValue_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValue" xlink:to="lab_us-gaap_TreasuryStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_c1ba9d83-0672-4290-8f1a-0dbc436aa6e2_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average common shares outstanding:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_daf406a2-7004-48a0-8193-daace7a33119_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes, net</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsMiscellaneous_747a518e-0484-45d3-945b-94e07c62149c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsMiscellaneous" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherAssetsMiscellaneous_label_en-US" xlink:label="lab_us-gaap_OtherAssetsMiscellaneous" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Miscellaneous</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMiscellaneous" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsMiscellaneous"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsMiscellaneous" xlink:to="lab_us-gaap_OtherAssetsMiscellaneous" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_adee76f8-2dc9-4527-b578-10afdc754129_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_amn_EmployeeRetentionEmploymentTaxCreditCARESAct_54e12a0e-35cc-4936-b152-041f6e65a371_terseLabel_en-US" xlink:label="lab_amn_EmployeeRetentionEmploymentTaxCreditCARESAct" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee retention employment tax credit, CARES Act</link:label>
    <link:label id="lab_amn_EmployeeRetentionEmploymentTaxCreditCARESAct_label_en-US" xlink:label="lab_amn_EmployeeRetentionEmploymentTaxCreditCARESAct" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Retention Employment Tax Credit, CARES Act</link:label>
    <link:label id="lab_amn_EmployeeRetentionEmploymentTaxCreditCARESAct_documentation_en-US" xlink:label="lab_amn_EmployeeRetentionEmploymentTaxCreditCARESAct" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Retention Employment Tax Credit, CARES Act</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amn_EmployeeRetentionEmploymentTaxCreditCARESAct" xlink:href="amn-20210930.xsd#amn_EmployeeRetentionEmploymentTaxCreditCARESAct"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amn_EmployeeRetentionEmploymentTaxCreditCARESAct" xlink:to="lab_amn_EmployeeRetentionEmploymentTaxCreditCARESAct" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WorkersCompensationLiabilityNoncurrent_4303ad50-1721-4025-a751-a01e9143d1d7_terseLabel_en-US" xlink:label="lab_us-gaap_WorkersCompensationLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Workers compensation reserve</link:label>
    <link:label id="lab_us-gaap_WorkersCompensationLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_WorkersCompensationLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Workers' Compensation Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WorkersCompensationLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WorkersCompensationLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WorkersCompensationLiabilityNoncurrent" xlink:to="lab_us-gaap_WorkersCompensationLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_aa739fff-5d1e-440f-a4fd-b98c0c4c2281_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossAttributableToParent_9a1a5392-25da-4700-b187-4e3d74321d9c_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossAttributableToParent_label_en-US" xlink:label="lab_us-gaap_IncomeLossAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) Attributable to Parent, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossAttributableToParent" xlink:to="lab_us-gaap_IncomeLossAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_4cad672b-240d-4386-a97f-0422337ec6bc_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable and accrued expenses</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_510ff90e-9083-4044-a094-c1550b2c6396_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization (inclusive of depreciation included in cost of revenue)</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedSalariesCurrent_c3ece351-94cb-4beb-901a-4542d268c197_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedSalariesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued payroll</link:label>
    <link:label id="lab_us-gaap_AccruedSalariesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedSalariesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Salaries, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedSalariesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedSalariesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedSalariesCurrent" xlink:to="lab_us-gaap_AccruedSalariesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_489c4c2e-b570-45e8-b188-963bedc585a9_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Financial Assets and Liabilities Measured at Fair Value on Recurring Basis</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_0104f662-7e1e-4ee9-acf2-52694a2c47e6_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_005da944-ccf7-4ed3-8db1-0dbb45982df0_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAssumed1_59cdb323-1f2e-4b9b-b233-61f528972daa_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAssumed1" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities assumed</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAssumed1_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAssumed1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities Assumed</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAssumed1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAssumed1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAssumed1" xlink:to="lab_us-gaap_LiabilitiesAssumed1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_ce2990c3-4c67-4802-af06-21eecb6c253b_verboseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of revenue</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherSundryLiabilitiesNoncurrent_ac732796-6be0-4300-902e-b20899005c7f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherSundryLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherSundryLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherSundryLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Sundry Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherSundryLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherSundryLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherSundryLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherSundryLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireIntangibleAssets_19117587-21e2-479f-87de-f2c302ad50b2_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for other intangibles</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:to="lab_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInRestrictedCashAndInvestmentsForOperatingActivities_e4be0d24-cce9-4fe6-8bec-66af47a1a453_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInRestrictedCashAndInvestmentsForOperatingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted investments balance</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInRestrictedCashAndInvestmentsForOperatingActivities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInRestrictedCashAndInvestmentsForOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Restricted Investments for Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInRestrictedCashAndInvestmentsForOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInRestrictedCashAndInvestmentsForOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInRestrictedCashAndInvestmentsForOperatingActivities" xlink:to="lab_us-gaap_IncreaseDecreaseInRestrictedCashAndInvestmentsForOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSoldDepreciation_fcd8e4b9-6df1-40ea-84b0-440eae53c3cf_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSoldDepreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation (included in cost of revenue)</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSoldDepreciation_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSoldDepreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost, Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSoldDepreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSoldDepreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSoldDepreciation" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSoldDepreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_amn_ScheduleofSupplementalBalanceSheetDisclosuresTableTextBlock_7bc5ca0d-1e2b-426d-8828-d4f9fe37d0d3_terseLabel_en-US" xlink:label="lab_amn_ScheduleofSupplementalBalanceSheetDisclosuresTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Supplemental Balance Sheet Disclosures</link:label>
    <link:label id="lab_amn_ScheduleofSupplementalBalanceSheetDisclosuresTableTextBlock_label_en-US" xlink:label="lab_amn_ScheduleofSupplementalBalanceSheetDisclosuresTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Supplemental Balance Sheet Disclosures [Table Text Block]</link:label>
    <link:label id="lab_amn_ScheduleofSupplementalBalanceSheetDisclosuresTableTextBlock_documentation_en-US" xlink:label="lab_amn_ScheduleofSupplementalBalanceSheetDisclosuresTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Supplemental Balance Sheet Disclosures [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amn_ScheduleofSupplementalBalanceSheetDisclosuresTableTextBlock" xlink:href="amn-20210930.xsd#amn_ScheduleofSupplementalBalanceSheetDisclosuresTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amn_ScheduleofSupplementalBalanceSheetDisclosuresTableTextBlock" xlink:to="lab_amn_ScheduleofSupplementalBalanceSheetDisclosuresTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfTradingSecuritiesHeldforinvestment_6a509fea-ebef-4df7-8f5b-b3408ffdbc95_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfTradingSecuritiesHeldforinvestment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of equity investment</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfTradingSecuritiesHeldforinvestment_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfTradingSecuritiesHeldforinvestment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Debt and Equity Securities, FV-NI, Held-for-investment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfTradingSecuritiesHeldforinvestment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfTradingSecuritiesHeldforinvestment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfTradingSecuritiesHeldforinvestment" xlink:to="lab_us-gaap_ProceedsFromSaleOfTradingSecuritiesHeldforinvestment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_c1b25c94-a174-4c12-b2e7-4913a9e2c5ca_verboseLabel_en-US" xlink:label="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental disclosures of non-cash investing and financing activities:</link:label>
    <link:label id="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_dd22a7a6-4e24-4bcb-a0d9-8c9ff8858137_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_label_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelationshipsMember" xlink:to="lab_us-gaap_CustomerRelationshipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FurnitureAndFixturesGross_a69db1e1-f77f-4177-b3e8-db7af15a8f9f_terseLabel_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and equipment</link:label>
    <link:label id="lab_us-gaap_FurnitureAndFixturesGross_label_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and Fixtures, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FurnitureAndFixturesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FurnitureAndFixturesGross" xlink:to="lab_us-gaap_FurnitureAndFixturesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_67a2b12f-829c-4f78-9ee7-1485135ba39b_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_label_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesLineItems" xlink:to="lab_us-gaap_LossContingenciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_bf83514e-f2bb-4ddd-ba3d-738136aeb088_verboseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed assets, net of accumulated depreciation of $190,578 and $161,752 at September&#160;30, 2021 and December&#160;31, 2020, respectively</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_63b819e6-cee2-46d7-beb3-7d634a55afb7_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed assets, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenses_0c0836c9-62d0-4207-bd97-4d82af4f31af_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_d08bc6b3-cf5c-4878-9fdc-9ecabf646f3a_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_8688f6a2-66bf-48f0-a732-5510ddb477ca_totalLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalizedComputerSoftwareGross_811f1b27-bfe6-4683-ad1b-7317c15ed05f_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalizedComputerSoftwareGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Software</link:label>
    <link:label id="lab_us-gaap_CapitalizedComputerSoftwareGross_label_en-US" xlink:label="lab_us-gaap_CapitalizedComputerSoftwareGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Computer Software, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedComputerSoftwareGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalizedComputerSoftwareGross" xlink:to="lab_us-gaap_CapitalizedComputerSoftwareGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_57944d2a-d67f-404d-8517-97d17c748222_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_e74f0ae3-ee6c-4740-92a1-31925d92efc0_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income per common share:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_bdefc33e-df36-4bab-b52e-28cddef75758_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaRevenue_87d674f6-74cc-48ea-8088-a33368fbe6a8_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaRevenue_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:to="lab_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_fe3b5e6c-f2c6-4e46-88d8-3e734513f85c_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed assets, gross</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_4b4490eb-5458-477b-b4de-96e42d9843b1_periodStartLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_bfaa9242-a6bc-4085-b48a-c6874717019a_periodEndLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_311711d6-3258-432e-ac33-050d583523dc_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation and other</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_6c629e89-a4ea-4768-824d-85bc291d8729_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TrademarksMember_900277bd-885e-421c-84a8-4f062e1b6737_terseLabel_en-US" xlink:label="lab_us-gaap_TrademarksMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks</link:label>
    <link:label id="lab_us-gaap_TrademarksMember_label_en-US" xlink:label="lab_us-gaap_TrademarksMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TrademarksMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TrademarksMember" xlink:to="lab_us-gaap_TrademarksMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireLifeInsurancePolicies_3b1ca857-ced0-44a0-b18f-4a12287ce252_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireLifeInsurancePolicies" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to fund deferred compensation plan</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireLifeInsurancePolicies_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireLifeInsurancePolicies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment to Acquire Life Insurance Policy, Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireLifeInsurancePolicies" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireLifeInsurancePolicies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireLifeInsurancePolicies" xlink:to="lab_us-gaap_PaymentsToAcquireLifeInsurancePolicies" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_98c5448f-a194-4747-ae35-20cca2c12b93_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding (excluding treasury shares)</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_amn_AccruedTravelExpense_13514888-b47c-4b1d-baf2-aa8695d1c9f9_terseLabel_en-US" xlink:label="lab_amn_AccruedTravelExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued travel expense</link:label>
    <link:label id="lab_amn_AccruedTravelExpense_label_en-US" xlink:label="lab_amn_AccruedTravelExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Travel Expense</link:label>
    <link:label id="lab_amn_AccruedTravelExpense_documentation_en-US" xlink:label="lab_amn_AccruedTravelExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Travel Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amn_AccruedTravelExpense" xlink:href="amn-20210930.xsd#amn_AccruedTravelExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amn_AccruedTravelExpense" xlink:to="lab_amn_AccruedTravelExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_968cc36a-9f55-4a61-bb67-0b783c2b65ca_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyEstimateOfPossibleLoss_5faf3dde-69cb-4649-a0c9-66353ba25c74_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyEstimateOfPossibleLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimate of possible loss</link:label>
    <link:label id="lab_us-gaap_LossContingencyEstimateOfPossibleLoss_label_en-US" xlink:label="lab_us-gaap_LossContingencyEstimateOfPossibleLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Estimate of Possible Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyEstimateOfPossibleLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyEstimateOfPossibleLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyEstimateOfPossibleLoss" xlink:to="lab_us-gaap_LossContingencyEstimateOfPossibleLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_amn_TechnologyAndWorkforceSolutionsMember_c9728d41-2be2-4e91-9be2-77d4627b5daa_terseLabel_en-US" xlink:label="lab_amn_TechnologyAndWorkforceSolutionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technology and workforce solutions</link:label>
    <link:label id="lab_amn_TechnologyAndWorkforceSolutionsMember_label_en-US" xlink:label="lab_amn_TechnologyAndWorkforceSolutionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technology And Workforce Solutions [Member]</link:label>
    <link:label id="lab_amn_TechnologyAndWorkforceSolutionsMember_documentation_en-US" xlink:label="lab_amn_TechnologyAndWorkforceSolutionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technology And Workforce Solutions [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amn_TechnologyAndWorkforceSolutionsMember" xlink:href="amn-20210930.xsd#amn_TechnologyAndWorkforceSolutionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amn_TechnologyAndWorkforceSolutionsMember" xlink:to="lab_amn_TechnologyAndWorkforceSolutionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_c613148d-06e5-434b-b3ca-5820cbd58a62_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities assumed</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_e3c132cb-d3bc-4d75-804a-623b77e0436c_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash at beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_d650ccb5-1307-4741-b271-fb4f5a2482bb_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash at end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_cb4c7ce5-8bdd-4f68-ac3e-54f072eb799b_verboseLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total cash, cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesIssued_357effa4-6352-48a5-8af5-d2f001ffda7b_periodStartLabel_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesIssued_d626d013-7647-4d2a-b570-417b56774196_periodEndLabel_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesIssued_label_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesIssued" xlink:to="lab_us-gaap_SharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_6e82ca01-72d7-44e3-a59e-286e963e0cfa_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_2f77cbf0-77aa-4f93-b7a8-7d4c503d4618_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_6f48df35-a590-4a48-8dce-dad9f720f806_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_dc83d824-9851-44c9-95b3-32a3d6863e11_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_2a443cef-8003-4cdc-8686-a2afa07aa0d3_terseLabel_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_6d00ac28-f079-444f-82dd-6d0895a45607_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_6ecf482d-281f-4834-af4a-75e2bfbfc77b_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_9f4e622b-6972-40b5-99b2-c21c8bfe639c_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_277dc116-ed21-4198-b32a-174bd29cd2b2_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_b8605297-74dd-4b15-9c56-bef67f18205c_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average common shares outstanding - diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_e54159e7-bc5e-4bd6-8531-b17d7ec16918_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurements, Recurring</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_amn_SupplementalDisclosuresOfNonCashInvestingAndFinancingActivitiesIntangibleAssets_b8d85776-7fb6-40ea-8307-0c4fb0279897_terseLabel_en-US" xlink:label="lab_amn_SupplementalDisclosuresOfNonCashInvestingAndFinancingActivitiesIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets</link:label>
    <link:label id="lab_amn_SupplementalDisclosuresOfNonCashInvestingAndFinancingActivitiesIntangibleAssets_label_en-US" xlink:label="lab_amn_SupplementalDisclosuresOfNonCashInvestingAndFinancingActivitiesIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Disclosures Of Non Cash Investing And Financing Activities, Intangible Assets</link:label>
    <link:label id="lab_amn_SupplementalDisclosuresOfNonCashInvestingAndFinancingActivitiesIntangibleAssets_documentation_en-US" xlink:label="lab_amn_SupplementalDisclosuresOfNonCashInvestingAndFinancingActivitiesIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Disclosures Of Non Cash Investing And Financing Activities, Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amn_SupplementalDisclosuresOfNonCashInvestingAndFinancingActivitiesIntangibleAssets" xlink:href="amn-20210930.xsd#amn_SupplementalDisclosuresOfNonCashInvestingAndFinancingActivitiesIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amn_SupplementalDisclosuresOfNonCashInvestingAndFinancingActivitiesIntangibleAssets" xlink:to="lab_amn_SupplementalDisclosuresOfNonCashInvestingAndFinancingActivitiesIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_ed2b6532-41cf-452f-af02-5916a597ac90_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_e8270e1a-a03b-45b8-aa08-1b259311bdf2_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_35788874-4d99-42e7-8bfa-20624b939e1a_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_607c377c-8faf-47b3-beca-ccc3aa0f9ad5_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation Of Revenue From Segments To Consolidated [Table]</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Revenue from Segments to Consolidated [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable" xlink:to="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_b54b82d7-6e6a-4449-b3bc-1c653bbf9858_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts written off charged against the allowance</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Writeoff</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrentAbstract_588cd70c-22b9-4a3e-a475-83d02bc1c91c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities:</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrentAbstract_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrentAbstract" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_de2fd51b-0c44-4c3c-913f-e4dc7eb486c4_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_08132e59-30ec-4d1e-bf27-8d2e05b7cfd8_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_1d0d4ace-ea67-47ae-8fe4-650f76e036d3_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_505c3459-d3f5-4d80-b923-d27e4bd3beb3_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_86a50df7-20ee-4b5e-8e0e-9f06444402d9_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in assets and liabilities, net of effects from acquisitions:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_c419dbf9-b408-4ed3-8fee-d4f1611beb5d_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated depreciation - fixed assets</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_6232673a-2603-4e95-ad4f-2636582fe172_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated depreciation</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_d607b471-6778-4a67-b5e1-a2d37af4480c_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from operating activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable_0bbfa8a4-7988-484b-a252-4fcf11dfafe8_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Income Taxes Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInIncomeTaxesReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_f6ea2462-4568-4956-88c5-8e638932feaa_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_5c929d03-7fb2-4995-85fe-12b9fba7f9c2_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for shares withheld for taxes</link:label>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment, Tax Withholding, Share-based Payment Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_fa8da32b-2b37-4917-be8c-941364d9a8a0_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash consideration</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_amn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets_fb6ce248-20f4-4524-b1de-cd5a7b26873f_terseLabel_en-US" xlink:label="lab_amn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of tangible assets acquired</link:label>
    <link:label id="lab_amn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets_label_en-US" xlink:label="lab_amn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Tangible Assets</link:label>
    <link:label id="lab_amn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets_documentation_en-US" xlink:label="lab_amn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Tangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets" xlink:href="amn-20210930.xsd#amn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets" xlink:to="lab_amn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationStatusDomain_4b67e4e0-3e74-444f-bf0e-c5764e8c68f4_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationStatusDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Domain]</link:label>
    <link:label id="lab_us-gaap_LitigationStatusDomain_label_en-US" xlink:label="lab_us-gaap_LitigationStatusDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationStatusDomain" xlink:to="lab_us-gaap_LitigationStatusDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_amn_PhysicianAndLeadershipSolutionsMember_bc54cfce-dcac-4f56-beed-2bd0100e864b_terseLabel_en-US" xlink:label="lab_amn_PhysicianAndLeadershipSolutionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Physician and leadership solutions</link:label>
    <link:label id="lab_amn_PhysicianAndLeadershipSolutionsMember_f22a8f7b-cb77-443a-8e00-28ba758eab90_verboseLabel_en-US" xlink:label="lab_amn_PhysicianAndLeadershipSolutionsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Physician and Leadership Solutions</link:label>
    <link:label id="lab_amn_PhysicianAndLeadershipSolutionsMember_label_en-US" xlink:label="lab_amn_PhysicianAndLeadershipSolutionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Physician And Leadership Solutions [Member]</link:label>
    <link:label id="lab_amn_PhysicianAndLeadershipSolutionsMember_documentation_en-US" xlink:label="lab_amn_PhysicianAndLeadershipSolutionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Physician And Leadership Solutions [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amn_PhysicianAndLeadershipSolutionsMember" xlink:href="amn-20210930.xsd#amn_PhysicianAndLeadershipSolutionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amn_PhysicianAndLeadershipSolutionsMember" xlink:to="lab_amn_PhysicianAndLeadershipSolutionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_72f1442f-2d87-4dbc-9b7b-254344d95b7f_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum borrowing capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableTradeCurrent_0f818709-c36b-46cb-9724-a2d085d98183_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableTradeCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableTradeCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableTradeCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Trade, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableTradeCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableTradeCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableTradeCurrent" xlink:to="lab_us-gaap_AccountsPayableTradeCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MoneyMarketFundsMember_260ac897-d973-4e90-84fb-a051588bd9ab_terseLabel_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Money market funds</link:label>
    <link:label id="lab_us-gaap_MoneyMarketFundsMember_label_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Money Market Funds [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MoneyMarketFundsMember" xlink:to="lab_us-gaap_MoneyMarketFundsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesTable_7736b739-ee72-4c2d-97d9-49b9826cf777_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesTable_label_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesTable" xlink:to="lab_us-gaap_LossContingenciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_95f2ecce-260a-4160-8a70-b96dd26e2763_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash received</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock_697ca67b-374b-43ba-9f34-031a92587f15_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Intangible Assets Acquired</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets Acquired as Part of Business Combination [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_beb4ed59-244c-49eb-809f-25fd7fb53c74_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_864605a0-3b78-4991-b830-dfdd5121e683_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_932bc8f3-5a7a-45ec-b3ce-356f459790a8_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_af1eff0e-f978-4441-8abc-ccab1e81ac0e_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_bb1ff53d-0878-45b4-a418-b297607d5412_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_f7e3e51b-0a53-49b8-9363-b3d88448bda4_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_98833290-c435-4881-a5ae-77c5c6977087_totalLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsCurrent" xlink:to="lab_us-gaap_OtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_f5e8daec-d9a2-4f20-bef0-7f02044074e4_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recently Adopted Accounting Pronouncements</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_590e87c6-7ee9-4b5c-a901-c69b1eeba8b7_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Noncurrent Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_492b8684-624e-4be7-a849-799a7aceeaef_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy_ee3328c1-179a-4247-bed4-18e892f3cf30_terseLabel_en-US" xlink:label="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable</link:label>
    <link:label id="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy_label_en-US" xlink:label="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradeAndOtherAccountsReceivablePolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:to="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_eb3b4a50-06b1-4fbb-9e45-ce15155d84f5_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_9f93d29e-b5de-4ff5-80dc-ea9aeeb92c64_verboseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_b92b2d5e-425a-4f29-b65f-7077f1052592_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_3c6c343d-6d89-41b9-a84f-a58f6f10e8df_periodStartLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, beginning balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_6f9a4b9e-d7b5-4c4f-8aa6-f083d20fb2d8_periodEndLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, ending balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WriteOffOfDeferredDebtIssuanceCost_cee6b3c8-c6ce-49c3-9791-2ecc2a8f4d51_terseLabel_en-US" xlink:label="lab_us-gaap_WriteOffOfDeferredDebtIssuanceCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Write-off of fees on credit facilities and senior notes</link:label>
    <link:label id="lab_us-gaap_WriteOffOfDeferredDebtIssuanceCost_label_en-US" xlink:label="lab_us-gaap_WriteOffOfDeferredDebtIssuanceCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Write off of Deferred Debt Issuance Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WriteOffOfDeferredDebtIssuanceCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WriteOffOfDeferredDebtIssuanceCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WriteOffOfDeferredDebtIssuanceCost" xlink:to="lab_us-gaap_WriteOffOfDeferredDebtIssuanceCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_96e5acac-0066-40d8-bfdd-f882b24d311e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Goodwill by Reportable Segment</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e411ad10-457b-4219-a438-ebff443fec2e_verboseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net income to net cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DevelopedTechnologyRightsMember_0d68e9fe-6989-46eb-895e-f13229ea6e03_terseLabel_en-US" xlink:label="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed Technology</link:label>
    <link:label id="lab_us-gaap_DevelopedTechnologyRightsMember_label_en-US" xlink:label="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed Technology Rights [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DevelopedTechnologyRightsMember" xlink:to="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock_7c1e6f74-e2ae-4814-bd22-7091a74e23fe_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Activity in Allowance for Credit Losses for Accounts Receivable</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock" xlink:to="lab_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease_e1fb9730-26da-41ed-ba3c-36813c874688_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase to loss contingency accruals</link:label>
    <link:label id="lab_us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Accrual, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease" xlink:to="lab_us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_amn_WageAndHourClaimsMember_ae8e6109-8f74-4ee0-98c8-82258990980f_terseLabel_en-US" xlink:label="lab_amn_WageAndHourClaimsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Wage and Hour claims</link:label>
    <link:label id="lab_amn_WageAndHourClaimsMember_label_en-US" xlink:label="lab_amn_WageAndHourClaimsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Wage And Hour Claims [Member]</link:label>
    <link:label id="lab_amn_WageAndHourClaimsMember_documentation_en-US" xlink:label="lab_amn_WageAndHourClaimsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Wage And Hour Claims [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amn_WageAndHourClaimsMember" xlink:href="amn-20210930.xsd#amn_WageAndHourClaimsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amn_WageAndHourClaimsMember" xlink:to="lab_amn_WageAndHourClaimsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_9a862425-5fd4-4662-9342-0e84a73621ad_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_amn_OperatingLeaseRightOfUseAssetIncreaseDecreaseFromModification_b0078bce-9cfd-4a3a-ac99-f1f3d8566de7_negatedTerseLabel_en-US" xlink:label="lab_amn_OperatingLeaseRightOfUseAssetIncreaseDecreaseFromModification" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease, right-of-use asset, decrease from modification</link:label>
    <link:label id="lab_amn_OperatingLeaseRightOfUseAssetIncreaseDecreaseFromModification_label_en-US" xlink:label="lab_amn_OperatingLeaseRightOfUseAssetIncreaseDecreaseFromModification" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-Of-Use Asset, Increase (Decrease) From Modification</link:label>
    <link:label id="lab_amn_OperatingLeaseRightOfUseAssetIncreaseDecreaseFromModification_documentation_en-US" xlink:label="lab_amn_OperatingLeaseRightOfUseAssetIncreaseDecreaseFromModification" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-Of-Use Asset, Increase (Decrease) From Modification</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_amn_OperatingLeaseRightOfUseAssetIncreaseDecreaseFromModification" xlink:href="amn-20210930.xsd#amn_OperatingLeaseRightOfUseAssetIncreaseDecreaseFromModification"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_amn_OperatingLeaseRightOfUseAssetIncreaseDecreaseFromModification" xlink:to="lab_amn_OperatingLeaseRightOfUseAssetIncreaseDecreaseFromModification" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201613Member_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201613Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2016-13 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201613Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdate201613Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdate201613Member" xlink:to="lab_us-gaap_AccountingStandardsUpdate201613Member" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>11
<FILENAME>amn-20210930_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:8a0f5122-b6dd-433b-8020-1a2d882303bb,g:c8a2db26-f545-4776-aff0-0a05f8878828-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.amnhealthcare.com/role/CoverPage" xlink:type="simple" xlink:href="amn-20210930.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://www.amnhealthcare.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_fe6cfcb5-883a-4025-a22d-0675c0e56c77" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_751b9a63-c6aa-4009-8f22-99344a0ab4d1" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fe6cfcb5-883a-4025-a22d-0675c0e56c77" xlink:to="loc_dei_DocumentType_751b9a63-c6aa-4009-8f22-99344a0ab4d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_7c2c0386-6af1-4f24-8744-48a19e6fab2d" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fe6cfcb5-883a-4025-a22d-0675c0e56c77" xlink:to="loc_dei_DocumentQuarterlyReport_7c2c0386-6af1-4f24-8744-48a19e6fab2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_bb23c12c-2c2c-4f4d-ba07-63b740cd4bd8" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fe6cfcb5-883a-4025-a22d-0675c0e56c77" xlink:to="loc_dei_DocumentPeriodEndDate_bb23c12c-2c2c-4f4d-ba07-63b740cd4bd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_5811bad4-f9f8-4498-a95d-f4ded9c34f2e" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fe6cfcb5-883a-4025-a22d-0675c0e56c77" xlink:to="loc_dei_DocumentTransitionReport_5811bad4-f9f8-4498-a95d-f4ded9c34f2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_0eb2df6b-3a6a-4d47-b8d5-5611312a5a58" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fe6cfcb5-883a-4025-a22d-0675c0e56c77" xlink:to="loc_dei_EntityFileNumber_0eb2df6b-3a6a-4d47-b8d5-5611312a5a58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_e41ebdfe-3ba7-421f-857d-e8686bf02feb" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fe6cfcb5-883a-4025-a22d-0675c0e56c77" xlink:to="loc_dei_EntityRegistrantName_e41ebdfe-3ba7-421f-857d-e8686bf02feb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_b50d9cc2-d7af-444c-9016-a5549375c889" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fe6cfcb5-883a-4025-a22d-0675c0e56c77" xlink:to="loc_dei_EntityIncorporationStateCountryCode_b50d9cc2-d7af-444c-9016-a5549375c889" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_164821f5-c76e-4f3a-a904-03e082d0b5e5" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fe6cfcb5-883a-4025-a22d-0675c0e56c77" xlink:to="loc_dei_EntityTaxIdentificationNumber_164821f5-c76e-4f3a-a904-03e082d0b5e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_4373994d-dca4-427a-8761-caa67d4ffcaa" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fe6cfcb5-883a-4025-a22d-0675c0e56c77" xlink:to="loc_dei_EntityAddressAddressLine1_4373994d-dca4-427a-8761-caa67d4ffcaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2_9407962a-4ece-4c51-a0aa-7e5c86a76aa9" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine2"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fe6cfcb5-883a-4025-a22d-0675c0e56c77" xlink:to="loc_dei_EntityAddressAddressLine2_9407962a-4ece-4c51-a0aa-7e5c86a76aa9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_14d85945-9b0f-4c3b-89a5-520930105bd3" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fe6cfcb5-883a-4025-a22d-0675c0e56c77" xlink:to="loc_dei_EntityAddressCityOrTown_14d85945-9b0f-4c3b-89a5-520930105bd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_2d605a66-bb08-4d06-88a0-449c329a523a" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fe6cfcb5-883a-4025-a22d-0675c0e56c77" xlink:to="loc_dei_EntityAddressStateOrProvince_2d605a66-bb08-4d06-88a0-449c329a523a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_dabb45d5-6920-48be-b7ce-1187b94279cd" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fe6cfcb5-883a-4025-a22d-0675c0e56c77" xlink:to="loc_dei_EntityAddressPostalZipCode_dabb45d5-6920-48be-b7ce-1187b94279cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_bb4211ec-e18c-4491-b113-0c0c3d50c43d" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fe6cfcb5-883a-4025-a22d-0675c0e56c77" xlink:to="loc_dei_CityAreaCode_bb4211ec-e18c-4491-b113-0c0c3d50c43d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_1004b39d-35b7-471b-b731-8ae91dce0743" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fe6cfcb5-883a-4025-a22d-0675c0e56c77" xlink:to="loc_dei_LocalPhoneNumber_1004b39d-35b7-471b-b731-8ae91dce0743" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_5579c837-54bc-4ab0-9164-6e6a7dc22b79" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fe6cfcb5-883a-4025-a22d-0675c0e56c77" xlink:to="loc_dei_Security12bTitle_5579c837-54bc-4ab0-9164-6e6a7dc22b79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_9c4d8aa4-14d4-4891-8485-14fc4aba8760" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fe6cfcb5-883a-4025-a22d-0675c0e56c77" xlink:to="loc_dei_TradingSymbol_9c4d8aa4-14d4-4891-8485-14fc4aba8760" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_4bf98f7c-b042-494c-9b17-c288c1b00003" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fe6cfcb5-883a-4025-a22d-0675c0e56c77" xlink:to="loc_dei_SecurityExchangeName_4bf98f7c-b042-494c-9b17-c288c1b00003" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_f0deee4d-771b-4707-bead-000e21107043" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fe6cfcb5-883a-4025-a22d-0675c0e56c77" xlink:to="loc_dei_EntityCurrentReportingStatus_f0deee4d-771b-4707-bead-000e21107043" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_84d089dc-69e1-440e-be0c-5cb92fb5b5be" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fe6cfcb5-883a-4025-a22d-0675c0e56c77" xlink:to="loc_dei_EntityInteractiveDataCurrent_84d089dc-69e1-440e-be0c-5cb92fb5b5be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_9037dd9f-f16a-4696-8e9f-3e67e681041c" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fe6cfcb5-883a-4025-a22d-0675c0e56c77" xlink:to="loc_dei_EntityFilerCategory_9037dd9f-f16a-4696-8e9f-3e67e681041c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_61d243d7-cbe1-4008-958c-98b3488b2323" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fe6cfcb5-883a-4025-a22d-0675c0e56c77" xlink:to="loc_dei_EntitySmallBusiness_61d243d7-cbe1-4008-958c-98b3488b2323" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_5382cce3-bd85-4a8f-a6f8-86a304060e89" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fe6cfcb5-883a-4025-a22d-0675c0e56c77" xlink:to="loc_dei_EntityEmergingGrowthCompany_5382cce3-bd85-4a8f-a6f8-86a304060e89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_595b5109-9265-4304-a9a4-decbae76fb2c" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fe6cfcb5-883a-4025-a22d-0675c0e56c77" xlink:to="loc_dei_EntityShellCompany_595b5109-9265-4304-a9a4-decbae76fb2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_6c12627e-a215-4c19-a650-25a912358f15" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fe6cfcb5-883a-4025-a22d-0675c0e56c77" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_6c12627e-a215-4c19-a650-25a912358f15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_681c2466-4540-4543-8c1d-fc9a5d908cfd" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fe6cfcb5-883a-4025-a22d-0675c0e56c77" xlink:to="loc_dei_EntityCentralIndexKey_681c2466-4540-4543-8c1d-fc9a5d908cfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_0f87b8a5-3eee-4ad5-a59f-eefb8c309e4b" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fe6cfcb5-883a-4025-a22d-0675c0e56c77" xlink:to="loc_dei_CurrentFiscalYearEndDate_0f87b8a5-3eee-4ad5-a59f-eefb8c309e4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_fbb17c55-58c2-4ed0-ad29-7fb5fb4631d7" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fe6cfcb5-883a-4025-a22d-0675c0e56c77" xlink:to="loc_dei_DocumentFiscalYearFocus_fbb17c55-58c2-4ed0-ad29-7fb5fb4631d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_6d186740-e865-472f-9353-3c1fdcc53698" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fe6cfcb5-883a-4025-a22d-0675c0e56c77" xlink:to="loc_dei_DocumentFiscalPeriodFocus_6d186740-e865-472f-9353-3c1fdcc53698" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_36fa09d0-8781-4a5d-838a-f49421c014dc" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fe6cfcb5-883a-4025-a22d-0675c0e56c77" xlink:to="loc_dei_AmendmentFlag_36fa09d0-8781-4a5d-838a-f49421c014dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.amnhealthcare.com/role/CondensedConsolidatedBalanceSheets" xlink:type="simple" xlink:href="amn-20210930.xsd#CondensedConsolidatedBalanceSheets"/>
  <link:presentationLink xlink:role="http://www.amnhealthcare.com/role/CondensedConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_f31d13cb-efab-4827-be0f-7331a793ee48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_71cf44f2-51b3-4778-806e-62f919a5b2d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_f31d13cb-efab-4827-be0f-7331a793ee48" xlink:to="loc_us-gaap_AssetsAbstract_71cf44f2-51b3-4778-806e-62f919a5b2d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_4cab2aee-58e3-4179-b47a-0acb560d3165" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_71cf44f2-51b3-4778-806e-62f919a5b2d8" xlink:to="loc_us-gaap_AssetsCurrentAbstract_4cab2aee-58e3-4179-b47a-0acb560d3165" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_69ab52ba-c504-49e2-95a3-d4afb8891d76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_4cab2aee-58e3-4179-b47a-0acb560d3165" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_69ab52ba-c504-49e2-95a3-d4afb8891d76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_b575bdc1-8909-4809-a471-3f58f12b13f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_4cab2aee-58e3-4179-b47a-0acb560d3165" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_b575bdc1-8909-4809-a471-3f58f12b13f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amn_Accountsreceivablesubcontractor_11f762dd-91e4-4572-984c-e0638d6074db" xlink:href="amn-20210930.xsd#amn_Accountsreceivablesubcontractor"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_4cab2aee-58e3-4179-b47a-0acb560d3165" xlink:to="loc_amn_Accountsreceivablesubcontractor_11f762dd-91e4-4572-984c-e0638d6074db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_6da8f3b5-a195-49d9-a3e4-5b253068a58e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_4cab2aee-58e3-4179-b47a-0acb560d3165" xlink:to="loc_us-gaap_PrepaidExpenseCurrent_6da8f3b5-a195-49d9-a3e4-5b253068a58e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_c23d8dde-c6c1-4952-93e7-747c46b4180a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_4cab2aee-58e3-4179-b47a-0acb560d3165" xlink:to="loc_us-gaap_OtherAssetsCurrent_c23d8dde-c6c1-4952-93e7-747c46b4180a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_9d966cc0-304d-444d-810b-26298a996f2e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_4cab2aee-58e3-4179-b47a-0acb560d3165" xlink:to="loc_us-gaap_AssetsCurrent_9d966cc0-304d-444d-810b-26298a996f2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndInvestmentsNoncurrent_34ab15e1-5e7b-4ccc-8b8c-027f5e9c2381" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndInvestmentsNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_71cf44f2-51b3-4778-806e-62f919a5b2d8" xlink:to="loc_us-gaap_RestrictedCashAndInvestmentsNoncurrent_34ab15e1-5e7b-4ccc-8b8c-027f5e9c2381" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_eb985379-ef90-4205-916a-619382046198" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_71cf44f2-51b3-4778-806e-62f919a5b2d8" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_eb985379-ef90-4205-916a-619382046198" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_0f3c0439-817b-4add-bd55-ec01d8a8485c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_71cf44f2-51b3-4778-806e-62f919a5b2d8" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_0f3c0439-817b-4add-bd55-ec01d8a8485c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_6dba1ae8-2b9b-453a-a2bc-83f5d7082ba6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_71cf44f2-51b3-4778-806e-62f919a5b2d8" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_6dba1ae8-2b9b-453a-a2bc-83f5d7082ba6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_3822cd32-72be-420a-9835-a23bcb1b7020" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_71cf44f2-51b3-4778-806e-62f919a5b2d8" xlink:to="loc_us-gaap_Goodwill_3822cd32-72be-420a-9835-a23bcb1b7020" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_2859495b-eff8-4e79-bb08-6a648402eb7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_71cf44f2-51b3-4778-806e-62f919a5b2d8" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_2859495b-eff8-4e79-bb08-6a648402eb7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_00872324-632c-4013-b37a-4a3ec1f4e13b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_71cf44f2-51b3-4778-806e-62f919a5b2d8" xlink:to="loc_us-gaap_Assets_00872324-632c-4013-b37a-4a3ec1f4e13b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_3f530e95-3008-4482-a386-08a95e992c85" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_f31d13cb-efab-4827-be0f-7331a793ee48" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_3f530e95-3008-4482-a386-08a95e992c85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_58057125-4ece-4dc8-80a2-91f6718bb69a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_3f530e95-3008-4482-a386-08a95e992c85" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_58057125-4ece-4dc8-80a2-91f6718bb69a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_0b569500-9411-4ddd-a24f-e42adf445f6a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_58057125-4ece-4dc8-80a2-91f6718bb69a" xlink:to="loc_us-gaap_AccountsPayableCurrent_0b569500-9411-4ddd-a24f-e42adf445f6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_573fb42b-28f2-4b16-b931-e30060aaff10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_58057125-4ece-4dc8-80a2-91f6718bb69a" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_573fb42b-28f2-4b16-b931-e30060aaff10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableCurrent_b37e7fc4-d44e-494e-aae0-dc76910d642d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesPayableCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_58057125-4ece-4dc8-80a2-91f6718bb69a" xlink:to="loc_us-gaap_NotesPayableCurrent_b37e7fc4-d44e-494e-aae0-dc76910d642d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_7b066308-ec46-4f0b-80da-0005e0381c0d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_58057125-4ece-4dc8-80a2-91f6718bb69a" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_7b066308-ec46-4f0b-80da-0005e0381c0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_b89bc969-4ea1-4f48-bef3-2ef2240114a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_58057125-4ece-4dc8-80a2-91f6718bb69a" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_b89bc969-4ea1-4f48-bef3-2ef2240114a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_c14cc19d-74e3-4bd8-92e3-5b20a966c42b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_58057125-4ece-4dc8-80a2-91f6718bb69a" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_c14cc19d-74e3-4bd8-92e3-5b20a966c42b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_96a298f5-9889-4eef-901c-1d177a020e11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_58057125-4ece-4dc8-80a2-91f6718bb69a" xlink:to="loc_us-gaap_LiabilitiesCurrent_96a298f5-9889-4eef-901c-1d177a020e11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermNotesPayable_90915dd0-150f-4a7f-a066-02b2c2224c12" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermNotesPayable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_3f530e95-3008-4482-a386-08a95e992c85" xlink:to="loc_us-gaap_LongTermNotesPayable_90915dd0-150f-4a7f-a066-02b2c2224c12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_2228ffc2-4a30-41dc-81c0-41351924c3ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_3f530e95-3008-4482-a386-08a95e992c85" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_2228ffc2-4a30-41dc-81c0-41351924c3ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_abf11d78-c856-4d5b-b6cd-c30b1bd76d51" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_3f530e95-3008-4482-a386-08a95e992c85" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_abf11d78-c856-4d5b-b6cd-c30b1bd76d51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_e9d53cab-0a98-4e65-8125-cf2dc0569b0e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_3f530e95-3008-4482-a386-08a95e992c85" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_e9d53cab-0a98-4e65-8125-cf2dc0569b0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_3d533cfa-6f82-4a2a-8303-f22a06fc8c5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_3f530e95-3008-4482-a386-08a95e992c85" xlink:to="loc_us-gaap_Liabilities_3d533cfa-6f82-4a2a-8303-f22a06fc8c5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_43f4ae74-9ff4-46db-9b93-4520f6bc3973" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_3f530e95-3008-4482-a386-08a95e992c85" xlink:to="loc_us-gaap_CommitmentsAndContingencies_43f4ae74-9ff4-46db-9b93-4520f6bc3973" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_f79c6428-ad51-4b70-9b3a-cf5350719904" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_3f530e95-3008-4482-a386-08a95e992c85" xlink:to="loc_us-gaap_StockholdersEquityAbstract_f79c6428-ad51-4b70-9b3a-cf5350719904" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_472bdd7e-c53c-4596-8224-8e36450b6d14" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_f79c6428-ad51-4b70-9b3a-cf5350719904" xlink:to="loc_us-gaap_PreferredStockValue_472bdd7e-c53c-4596-8224-8e36450b6d14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_01ac373a-6f7b-48ab-9e40-88863e230c8c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_f79c6428-ad51-4b70-9b3a-cf5350719904" xlink:to="loc_us-gaap_CommonStockValue_01ac373a-6f7b-48ab-9e40-88863e230c8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_e777898d-0dd6-48a0-a1ef-6e6d907718a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_f79c6428-ad51-4b70-9b3a-cf5350719904" xlink:to="loc_us-gaap_AdditionalPaidInCapital_e777898d-0dd6-48a0-a1ef-6e6d907718a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_369e27d9-e9a6-4146-a34b-3fff85300120" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_f79c6428-ad51-4b70-9b3a-cf5350719904" xlink:to="loc_us-gaap_TreasuryStockValue_369e27d9-e9a6-4146-a34b-3fff85300120" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_4a947f19-8d1d-4369-8c29-639e99caa315" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_f79c6428-ad51-4b70-9b3a-cf5350719904" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_4a947f19-8d1d-4369-8c29-639e99caa315" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_7b009728-c486-49ff-b1a0-8ddddbda2984" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_f79c6428-ad51-4b70-9b3a-cf5350719904" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_7b009728-c486-49ff-b1a0-8ddddbda2984" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_2033c860-e12a-4a40-903a-6bbc48a3394e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_f79c6428-ad51-4b70-9b3a-cf5350719904" xlink:to="loc_us-gaap_StockholdersEquity_2033c860-e12a-4a40-903a-6bbc48a3394e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_9ca799e9-d0af-470b-828c-64677f86b6f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_3f530e95-3008-4482-a386-08a95e992c85" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_9ca799e9-d0af-470b-828c-64677f86b6f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.amnhealthcare.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="amn-20210930.xsd#CondensedConsolidatedBalanceSheetsParenthetical"/>
  <link:presentationLink xlink:role="http://www.amnhealthcare.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_4bb806f8-f5e7-47cc-8932-42dd8c577f14" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_9668dfc5-4511-4590-9a3c-bd88f12cbcfb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_4bb806f8-f5e7-47cc-8932-42dd8c577f14" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_9668dfc5-4511-4590-9a3c-bd88f12cbcfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_752e9dd5-d0b6-45f5-ab56-eddf0db2a605" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_4bb806f8-f5e7-47cc-8932-42dd8c577f14" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_752e9dd5-d0b6-45f5-ab56-eddf0db2a605" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_bebc72a0-54e7-4a5b-943a-3b0404a4bdf6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_4bb806f8-f5e7-47cc-8932-42dd8c577f14" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_bebc72a0-54e7-4a5b-943a-3b0404a4bdf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_bc14e687-e471-4254-9aff-4760925e0df9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_4bb806f8-f5e7-47cc-8932-42dd8c577f14" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_bc14e687-e471-4254-9aff-4760925e0df9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_1dc5a4f6-a70e-49b4-9065-f4258a88b88b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_4bb806f8-f5e7-47cc-8932-42dd8c577f14" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_1dc5a4f6-a70e-49b4-9065-f4258a88b88b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_131b7202-3af4-4a81-a593-61c45b6c6d44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_4bb806f8-f5e7-47cc-8932-42dd8c577f14" xlink:to="loc_us-gaap_PreferredStockSharesIssued_131b7202-3af4-4a81-a593-61c45b6c6d44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_d8c49e49-566c-413c-a01a-fef678e8eb7f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_4bb806f8-f5e7-47cc-8932-42dd8c577f14" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_d8c49e49-566c-413c-a01a-fef678e8eb7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_9bc3f3b7-ad69-4c8e-8cb2-44f0bb295f10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_4bb806f8-f5e7-47cc-8932-42dd8c577f14" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_9bc3f3b7-ad69-4c8e-8cb2-44f0bb295f10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_6c8d7525-78b6-49e7-b3b3-de9ea8dd6850" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_4bb806f8-f5e7-47cc-8932-42dd8c577f14" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_6c8d7525-78b6-49e7-b3b3-de9ea8dd6850" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_ecc05db0-6041-45b1-9f3c-a7459619c3a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_4bb806f8-f5e7-47cc-8932-42dd8c577f14" xlink:to="loc_us-gaap_CommonStockSharesIssued_ecc05db0-6041-45b1-9f3c-a7459619c3a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_bdeb8b10-8cd5-4ecf-904a-208359be386a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_4bb806f8-f5e7-47cc-8932-42dd8c577f14" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_bdeb8b10-8cd5-4ecf-904a-208359be386a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_dca52e1b-015b-4bb0-9bdf-46b2cbe12ad3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_4bb806f8-f5e7-47cc-8932-42dd8c577f14" xlink:to="loc_us-gaap_TreasuryStockShares_dca52e1b-015b-4bb0-9bdf-46b2cbe12ad3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofComprehensiveIncome" xlink:type="simple" xlink:href="amn-20210930.xsd#CondensedConsolidatedStatementsofComprehensiveIncome"/>
  <link:presentationLink xlink:role="http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofComprehensiveIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_cb3c55e8-98a5-4f5b-9e7b-8376beb74a3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_390e3cd4-5b16-4c0a-98e5-0b5ceca318f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_cb3c55e8-98a5-4f5b-9e7b-8376beb74a3e" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_390e3cd4-5b16-4c0a-98e5-0b5ceca318f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_65616475-47d1-4bf3-9532-6042e24b218b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_cb3c55e8-98a5-4f5b-9e7b-8376beb74a3e" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_65616475-47d1-4bf3-9532-6042e24b218b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_2aee4c58-8e37-4e65-a571-3874f02242de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_cb3c55e8-98a5-4f5b-9e7b-8376beb74a3e" xlink:to="loc_us-gaap_GrossProfit_2aee4c58-8e37-4e65-a571-3874f02242de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_38ecd592-9e9c-491a-9407-beb60aa5d651" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_cb3c55e8-98a5-4f5b-9e7b-8376beb74a3e" xlink:to="loc_us-gaap_OperatingExpensesAbstract_38ecd592-9e9c-491a-9407-beb60aa5d651" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_94811391-18bf-4bdb-94eb-e39b409dca94" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_38ecd592-9e9c-491a-9407-beb60aa5d651" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_94811391-18bf-4bdb-94eb-e39b409dca94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_39b3a522-35d7-410a-bafe-2d2125c7f1f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_38ecd592-9e9c-491a-9407-beb60aa5d651" xlink:to="loc_us-gaap_DepreciationAndAmortization_39b3a522-35d7-410a-bafe-2d2125c7f1f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_1ad87e99-1c68-4798-9040-3886acf11079" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_38ecd592-9e9c-491a-9407-beb60aa5d651" xlink:to="loc_us-gaap_OperatingExpenses_1ad87e99-1c68-4798-9040-3886acf11079" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_d9b6a9e8-9326-4c11-aa5f-1fb3a67ce4d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_cb3c55e8-98a5-4f5b-9e7b-8376beb74a3e" xlink:to="loc_us-gaap_OperatingIncomeLoss_d9b6a9e8-9326-4c11-aa5f-1fb3a67ce4d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_d0bd004a-cc67-4f53-9882-ceb2ff931e3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_cb3c55e8-98a5-4f5b-9e7b-8376beb74a3e" xlink:to="loc_us-gaap_InterestExpense_d0bd004a-cc67-4f53-9882-ceb2ff931e3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossAttributableToParent_d9f99772-f5c6-4a19-975a-3cf872915bf5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossAttributableToParent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_cb3c55e8-98a5-4f5b-9e7b-8376beb74a3e" xlink:to="loc_us-gaap_IncomeLossAttributableToParent_d9f99772-f5c6-4a19-975a-3cf872915bf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_2baa0162-474e-43dc-9589-4bee370e24d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_cb3c55e8-98a5-4f5b-9e7b-8376beb74a3e" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_2baa0162-474e-43dc-9589-4bee370e24d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_62eb9cd2-e277-429c-8d7f-b50c5f1d908a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_cb3c55e8-98a5-4f5b-9e7b-8376beb74a3e" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_62eb9cd2-e277-429c-8d7f-b50c5f1d908a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_82ee751e-c566-4f52-bef9-e4e351288edc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_cb3c55e8-98a5-4f5b-9e7b-8376beb74a3e" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_82ee751e-c566-4f52-bef9-e4e351288edc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_f3de07b9-fa3e-4dd2-a604-b469c1c6fd65" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_cb3c55e8-98a5-4f5b-9e7b-8376beb74a3e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_f3de07b9-fa3e-4dd2-a604-b469c1c6fd65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_8fc72806-8060-4753-9904-c0e8ff5cc556" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_f3de07b9-fa3e-4dd2-a604-b469c1c6fd65" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_8fc72806-8060-4753-9904-c0e8ff5cc556" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_928a4825-efa1-4f35-a54d-e5ededcc7ee0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_f3de07b9-fa3e-4dd2-a604-b469c1c6fd65" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_928a4825-efa1-4f35-a54d-e5ededcc7ee0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_6c792296-1317-4197-b0c8-06f766e6897f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_cb3c55e8-98a5-4f5b-9e7b-8376beb74a3e" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_6c792296-1317-4197-b0c8-06f766e6897f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_ce46aa70-0d78-4b87-9046-fd6bdc8149d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_cb3c55e8-98a5-4f5b-9e7b-8376beb74a3e" xlink:to="loc_us-gaap_EarningsPerShareAbstract_ce46aa70-0d78-4b87-9046-fd6bdc8149d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_59349f38-fc2b-4d98-bbab-87d09a8bab48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_ce46aa70-0d78-4b87-9046-fd6bdc8149d3" xlink:to="loc_us-gaap_EarningsPerShareBasic_59349f38-fc2b-4d98-bbab-87d09a8bab48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_48852f46-6ca5-4287-acb9-3973a1e423be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_ce46aa70-0d78-4b87-9046-fd6bdc8149d3" xlink:to="loc_us-gaap_EarningsPerShareDiluted_48852f46-6ca5-4287-acb9-3973a1e423be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_730f847d-4ee2-43e3-b073-4913e43473ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_cb3c55e8-98a5-4f5b-9e7b-8376beb74a3e" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_730f847d-4ee2-43e3-b073-4913e43473ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_cfa7eb2a-577e-4e2b-abb5-3ab987fa86a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_730f847d-4ee2-43e3-b073-4913e43473ab" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_cfa7eb2a-577e-4e2b-abb5-3ab987fa86a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_6361455a-57cd-47d1-9024-90e400d323b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_730f847d-4ee2-43e3-b073-4913e43473ab" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_6361455a-57cd-47d1-9024-90e400d323b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofStockholdersEquity" xlink:type="simple" xlink:href="amn-20210930.xsd#CondensedConsolidatedStatementsofStockholdersEquity"/>
  <link:presentationLink xlink:role="http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofStockholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_d95f95ba-155d-4366-9bf5-52dab5574e51" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_c7ee71c7-c42a-4958-859f-bc4d8dc93ae9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_d95f95ba-155d-4366-9bf5-52dab5574e51" xlink:to="loc_us-gaap_StatementTable_c7ee71c7-c42a-4958-859f-bc4d8dc93ae9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_be95a7bc-d77d-4fe6-98ad-873a7a94e870" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_c7ee71c7-c42a-4958-859f-bc4d8dc93ae9" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_be95a7bc-d77d-4fe6-98ad-873a7a94e870" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_05a794b1-1f81-426f-a32f-5fa65df40de3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_be95a7bc-d77d-4fe6-98ad-873a7a94e870" xlink:to="loc_us-gaap_EquityComponentDomain_05a794b1-1f81-426f-a32f-5fa65df40de3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_85e63df6-63db-4ef6-90e8-d579ca553d23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_05a794b1-1f81-426f-a32f-5fa65df40de3" xlink:to="loc_us-gaap_CommonStockMember_85e63df6-63db-4ef6-90e8-d579ca553d23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_9bd3b304-8864-4475-93a6-0a26a97f0cab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_05a794b1-1f81-426f-a32f-5fa65df40de3" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_9bd3b304-8864-4475-93a6-0a26a97f0cab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_a90b5328-fb09-4928-80d4-7557605b6993" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_05a794b1-1f81-426f-a32f-5fa65df40de3" xlink:to="loc_us-gaap_TreasuryStockMember_a90b5328-fb09-4928-80d4-7557605b6993" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_7434b8dc-66b2-465e-8c3a-a7d10a889362" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_05a794b1-1f81-426f-a32f-5fa65df40de3" xlink:to="loc_us-gaap_RetainedEarningsMember_7434b8dc-66b2-465e-8c3a-a7d10a889362" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_0538053f-c2fe-4ed4-ab69-e993b714ace6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_05a794b1-1f81-426f-a32f-5fa65df40de3" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_0538053f-c2fe-4ed4-ab69-e993b714ace6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_3fbcbb86-b8ae-47a5-a680-4ce2999e0a43" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_c7ee71c7-c42a-4958-859f-bc4d8dc93ae9" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_3fbcbb86-b8ae-47a5-a680-4ce2999e0a43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_3e390836-9d8b-40d3-b73e-3bc260101dd5" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_3fbcbb86-b8ae-47a5-a680-4ce2999e0a43" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_3e390836-9d8b-40d3-b73e-3bc260101dd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_08d438c0-02f6-4a4c-804f-59b07a37a681" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_3e390836-9d8b-40d3-b73e-3bc260101dd5" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_08d438c0-02f6-4a4c-804f-59b07a37a681" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_e68d608b-6372-4959-a3d8-83a40bfe1989" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_c7ee71c7-c42a-4958-859f-bc4d8dc93ae9" xlink:to="loc_us-gaap_StatementLineItems_e68d608b-6372-4959-a3d8-83a40bfe1989" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_307f3e92-3752-4a98-ba2c-a078b91ccc72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e68d608b-6372-4959-a3d8-83a40bfe1989" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_307f3e92-3752-4a98-ba2c-a078b91ccc72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_853db9dc-8e23-41fc-bfb7-8e8d59809624" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssued"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_307f3e92-3752-4a98-ba2c-a078b91ccc72" xlink:to="loc_us-gaap_SharesIssued_853db9dc-8e23-41fc-bfb7-8e8d59809624" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_75a64560-d1d3-4bc1-9583-ae2b9f8ab77e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_307f3e92-3752-4a98-ba2c-a078b91ccc72" xlink:to="loc_us-gaap_StockholdersEquity_75a64560-d1d3-4bc1-9583-ae2b9f8ab77e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList_ae91fb93-f7e4-416f-b782-2c67d28ea72f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_307f3e92-3752-4a98-ba2c-a078b91ccc72" xlink:to="loc_us-gaap_AccountingStandardsUpdateExtensibleList_ae91fb93-f7e4-416f-b782-2c67d28ea72f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_2e7423a1-69cb-462c-b017-73cda8a1bab8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_307f3e92-3752-4a98-ba2c-a078b91ccc72" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_2e7423a1-69cb-462c-b017-73cda8a1bab8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_cd8deff1-ac44-427e-a523-485d6c991062" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_307f3e92-3752-4a98-ba2c-a078b91ccc72" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_cd8deff1-ac44-427e-a523-485d6c991062" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_458c11e4-dd2e-4082-80b8-0a37f47cf705" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_307f3e92-3752-4a98-ba2c-a078b91ccc72" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_458c11e4-dd2e-4082-80b8-0a37f47cf705" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_569c7806-592f-4bf4-9632-c536a05b6ff7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_307f3e92-3752-4a98-ba2c-a078b91ccc72" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_569c7806-592f-4bf4-9632-c536a05b6ff7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_94453366-f369-475c-b7ae-1e4330aebe2b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssued"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_307f3e92-3752-4a98-ba2c-a078b91ccc72" xlink:to="loc_us-gaap_SharesIssued_94453366-f369-475c-b7ae-1e4330aebe2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_f6e08b8b-a534-4231-a165-cb9e2317245c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_307f3e92-3752-4a98-ba2c-a078b91ccc72" xlink:to="loc_us-gaap_StockholdersEquity_f6e08b8b-a534-4231-a165-cb9e2317245c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="amn-20210930.xsd#CondensedConsolidatedStatementsofCashFlows"/>
  <link:presentationLink xlink:role="http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_1b464321-2503-4a9b-954e-015dd7764f22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_90658af9-86dd-4749-9c24-8df55e006e8b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_1b464321-2503-4a9b-954e-015dd7764f22" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_90658af9-86dd-4749-9c24-8df55e006e8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_4ad7098d-c45c-4287-9b8a-3b0a5ba53fb0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_90658af9-86dd-4749-9c24-8df55e006e8b" xlink:to="loc_us-gaap_NetIncomeLoss_4ad7098d-c45c-4287-9b8a-3b0a5ba53fb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_f900068c-da10-4c50-9883-d3261e94dbac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_90658af9-86dd-4749-9c24-8df55e006e8b" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_f900068c-da10-4c50-9883-d3261e94dbac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_4d978161-6dc1-44b0-98f6-b488c754241b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_f900068c-da10-4c50-9883-d3261e94dbac" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_4d978161-6dc1-44b0-98f6-b488c754241b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_c76eb226-a99c-4c35-9464-eae6ce59b3ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_f900068c-da10-4c50-9883-d3261e94dbac" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_c76eb226-a99c-4c35-9464-eae6ce59b3ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WriteOffOfDeferredDebtIssuanceCost_ecc8e72d-d842-4940-a805-aa2195ef4fc8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WriteOffOfDeferredDebtIssuanceCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_f900068c-da10-4c50-9883-d3261e94dbac" xlink:to="loc_us-gaap_WriteOffOfDeferredDebtIssuanceCost_ecc8e72d-d842-4940-a805-aa2195ef4fc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_3e47c232-cf82-4e0b-9b8b-1af529f7cd43" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_f900068c-da10-4c50-9883-d3261e94dbac" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_3e47c232-cf82-4e0b-9b8b-1af529f7cd43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amn_AccountsReceivableAndSalesCreditsCreditLossExpenseReversal_8e9f0615-ee06-4103-94f1-1dd5241620c1" xlink:href="amn-20210930.xsd#amn_AccountsReceivableAndSalesCreditsCreditLossExpenseReversal"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_f900068c-da10-4c50-9883-d3261e94dbac" xlink:to="loc_amn_AccountsReceivableAndSalesCreditsCreditLossExpenseReversal_8e9f0615-ee06-4103-94f1-1dd5241620c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_6bd504b2-836c-401e-a239-3ff58acce287" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_f900068c-da10-4c50-9883-d3261e94dbac" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_6bd504b2-836c-401e-a239-3ff58acce287" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_80299180-714b-4622-a45f-cfc84fede72c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_f900068c-da10-4c50-9883-d3261e94dbac" xlink:to="loc_us-gaap_ShareBasedCompensation_80299180-714b-4622-a45f-cfc84fede72c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets_e32f961a-5a08-4bb5-8a21-3601b4411414" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_f900068c-da10-4c50-9883-d3261e94dbac" xlink:to="loc_us-gaap_GainLossOnDispositionOfAssets_e32f961a-5a08-4bb5-8a21-3601b4411414" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeAmortizationOfDiscount_4a1b3018-8b41-46ff-b134-5301eae7ea56" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeAmortizationOfDiscount"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_f900068c-da10-4c50-9883-d3261e94dbac" xlink:to="loc_us-gaap_InvestmentIncomeAmortizationOfDiscount_4a1b3018-8b41-46ff-b134-5301eae7ea56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amn_GainLossOnDeferredCompensation_9115e3b9-4c6a-45d0-89df-e079d92fe6cd" xlink:href="amn-20210930.xsd#amn_GainLossOnDeferredCompensation"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_f900068c-da10-4c50-9883-d3261e94dbac" xlink:to="loc_amn_GainLossOnDeferredCompensation_9115e3b9-4c6a-45d0-89df-e079d92fe6cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amn_LesseeOperatingLeaseNoncashExpense_787e87b5-8175-42cf-a287-e055540d42fd" xlink:href="amn-20210930.xsd#amn_LesseeOperatingLeaseNoncashExpense"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_f900068c-da10-4c50-9883-d3261e94dbac" xlink:to="loc_amn_LesseeOperatingLeaseNoncashExpense_787e87b5-8175-42cf-a287-e055540d42fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_917267a1-0f4c-47d7-9a78-f0b525394003" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_f900068c-da10-4c50-9883-d3261e94dbac" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_917267a1-0f4c-47d7-9a78-f0b525394003" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_8b66b705-e934-443e-9872-02315af32e34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_917267a1-0f4c-47d7-9a78-f0b525394003" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_8b66b705-e934-443e-9872-02315af32e34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amn_IncreaseDecreaseinAccountsReceivablessubcontractor_6ad150d9-cb94-4049-bbc8-9a19e221f8f8" xlink:href="amn-20210930.xsd#amn_IncreaseDecreaseinAccountsReceivablessubcontractor"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_917267a1-0f4c-47d7-9a78-f0b525394003" xlink:to="loc_amn_IncreaseDecreaseinAccountsReceivablessubcontractor_6ad150d9-cb94-4049-bbc8-9a19e221f8f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable_517642de-e893-498b-9654-d678f1842aff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInIncomeTaxesReceivable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_917267a1-0f4c-47d7-9a78-f0b525394003" xlink:to="loc_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable_517642de-e893-498b-9654-d678f1842aff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidExpense_35faeff1-9c91-4416-a171-a2b296ea9709" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_917267a1-0f4c-47d7-9a78-f0b525394003" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidExpense_35faeff1-9c91-4416-a171-a2b296ea9709" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherCurrentAssets_f147ced2-34e9-4d63-850f-ef724a33b11e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherCurrentAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_917267a1-0f4c-47d7-9a78-f0b525394003" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherCurrentAssets_f147ced2-34e9-4d63-850f-ef724a33b11e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_939a46e2-8d8a-4637-ae1c-977286c12224" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_917267a1-0f4c-47d7-9a78-f0b525394003" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_939a46e2-8d8a-4637-ae1c-977286c12224" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_24c6ca8c-5f4a-4219-a047-76f877a61d5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_917267a1-0f4c-47d7-9a78-f0b525394003" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_24c6ca8c-5f4a-4219-a047-76f877a61d5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_6d9eb7b3-7dfa-4086-8702-158943918483" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_917267a1-0f4c-47d7-9a78-f0b525394003" xlink:to="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_6d9eb7b3-7dfa-4086-8702-158943918483" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_e46076cb-0e78-40ed-b319-80eaab9dfc12" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_917267a1-0f4c-47d7-9a78-f0b525394003" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_e46076cb-0e78-40ed-b319-80eaab9dfc12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_ad0ea84a-e4e9-43ca-9b41-49b0619a2cdd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_917267a1-0f4c-47d7-9a78-f0b525394003" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_ad0ea84a-e4e9-43ca-9b41-49b0619a2cdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInRestrictedCashAndInvestmentsForOperatingActivities_a1a2c16a-1e51-49f4-9202-76e4bfc02510" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInRestrictedCashAndInvestmentsForOperatingActivities"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_917267a1-0f4c-47d7-9a78-f0b525394003" xlink:to="loc_us-gaap_IncreaseDecreaseInRestrictedCashAndInvestmentsForOperatingActivities_a1a2c16a-1e51-49f4-9202-76e4bfc02510" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8a1bc934-5fb2-4257-bc15-f6c9bb6a6727" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_90658af9-86dd-4749-9c24-8df55e006e8b" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8a1bc934-5fb2-4257-bc15-f6c9bb6a6727" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_8bae860d-5fe9-4dd8-a5e6-d88b4804cddb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_1b464321-2503-4a9b-954e-015dd7764f22" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_8bae860d-5fe9-4dd8-a5e6-d88b4804cddb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_4c4dddfc-01ee-4d40-9aa3-00a2b097b861" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_8bae860d-5fe9-4dd8-a5e6-d88b4804cddb" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_4c4dddfc-01ee-4d40-9aa3-00a2b097b861" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireShortTermInvestments_af499ebd-a335-46f1-b964-b6124e7d8258" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireShortTermInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_8bae860d-5fe9-4dd8-a5e6-d88b4804cddb" xlink:to="loc_us-gaap_PaymentsToAcquireShortTermInvestments_af499ebd-a335-46f1-b964-b6124e7d8258" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments_47b7e6af-f852-46f7-a54b-d5dc3335193f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_8bae860d-5fe9-4dd8-a5e6-d88b4804cddb" xlink:to="loc_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments_47b7e6af-f852-46f7-a54b-d5dc3335193f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquitySecuritiesFvNi_c4448208-9aaa-4c8c-b4a7-fb70cf5ed186" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireEquitySecuritiesFvNi"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_8bae860d-5fe9-4dd8-a5e6-d88b4804cddb" xlink:to="loc_us-gaap_PaymentsToAcquireEquitySecuritiesFvNi_c4448208-9aaa-4c8c-b4a7-fb70cf5ed186" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireLifeInsurancePolicies_3c1fbf77-a8f7-480e-a7b9-2630e70875f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireLifeInsurancePolicies"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_8bae860d-5fe9-4dd8-a5e6-d88b4804cddb" xlink:to="loc_us-gaap_PaymentsToAcquireLifeInsurancePolicies_3c1fbf77-a8f7-480e-a7b9-2630e70875f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfTradingSecuritiesHeldforinvestment_6ca56467-41a7-4c60-b324-c3a6a01fffc4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfTradingSecuritiesHeldforinvestment"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_8bae860d-5fe9-4dd8-a5e6-d88b4804cddb" xlink:to="loc_us-gaap_ProceedsFromSaleOfTradingSecuritiesHeldforinvestment_6ca56467-41a7-4c60-b324-c3a6a01fffc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireNotesReceivable_8591a30b-2438-4047-baf2-145bf0d48189" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireNotesReceivable"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_8bae860d-5fe9-4dd8-a5e6-d88b4804cddb" xlink:to="loc_us-gaap_PaymentsToAcquireNotesReceivable_8591a30b-2438-4047-baf2-145bf0d48189" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_ccf8bf60-eff7-4943-b968-1d4efb7a3f7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_8bae860d-5fe9-4dd8-a5e6-d88b4804cddb" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_ccf8bf60-eff7-4943-b968-1d4efb7a3f7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets_9b1d0aa8-3756-4b6d-8913-d7163cb12855" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_8bae860d-5fe9-4dd8-a5e6-d88b4804cddb" xlink:to="loc_us-gaap_PaymentsToAcquireIntangibleAssets_9b1d0aa8-3756-4b6d-8913-d7163cb12855" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPreviousAcquisition_c3063143-b30e-4c3c-9f0e-04df9b9f77e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromPreviousAcquisition"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_8bae860d-5fe9-4dd8-a5e6-d88b4804cddb" xlink:to="loc_us-gaap_ProceedsFromPreviousAcquisition_c3063143-b30e-4c3c-9f0e-04df9b9f77e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_4e8bd236-d667-43b6-a60a-613eba2b519c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_8bae860d-5fe9-4dd8-a5e6-d88b4804cddb" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_4e8bd236-d667-43b6-a60a-613eba2b519c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_0b27cdaf-dbeb-4fdb-b9c4-9577578147bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_1b464321-2503-4a9b-954e-015dd7764f22" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_0b27cdaf-dbeb-4fdb-b9c4-9577578147bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfSecuredDebt_8b99d90b-373e-40bc-93b8-f1262f3e49e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfSecuredDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_0b27cdaf-dbeb-4fdb-b9c4-9577578147bc" xlink:to="loc_us-gaap_RepaymentsOfSecuredDebt_8b99d90b-373e-40bc-93b8-f1262f3e49e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSecuredDebt_ae769d8a-8c19-4774-8b9b-569ca1fba068" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSecuredDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_0b27cdaf-dbeb-4fdb-b9c4-9577578147bc" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSecuredDebt_ae769d8a-8c19-4774-8b9b-569ca1fba068" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit_4eaee7c4-4841-4c26-ac94-c18d841f4462" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_0b27cdaf-dbeb-4fdb-b9c4-9577578147bc" xlink:to="loc_us-gaap_RepaymentsOfLinesOfCredit_4eaee7c4-4841-4c26-ac94-c18d841f4462" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit_75e442ab-96ee-4f6c-8316-a2bcc7866fbc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_0b27cdaf-dbeb-4fdb-b9c4-9577578147bc" xlink:to="loc_us-gaap_ProceedsFromLinesOfCredit_75e442ab-96ee-4f6c-8316-a2bcc7866fbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_8300e71b-1e63-4e7f-9b1b-47606e45453d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_0b27cdaf-dbeb-4fdb-b9c4-9577578147bc" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_8300e71b-1e63-4e7f-9b1b-47606e45453d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfFinancingCosts_3ea7b411-017b-4e83-a245-92e6d04818d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfFinancingCosts"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_0b27cdaf-dbeb-4fdb-b9c4-9577578147bc" xlink:to="loc_us-gaap_PaymentsOfFinancingCosts_3ea7b411-017b-4e83-a245-92e6d04818d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amn_PaymentsForPreviousAcquisitionEarnOutPayment_2d98e316-8e89-4d04-945f-d803264c724f" xlink:href="amn-20210930.xsd#amn_PaymentsForPreviousAcquisitionEarnOutPayment"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_0b27cdaf-dbeb-4fdb-b9c4-9577578147bc" xlink:to="loc_amn_PaymentsForPreviousAcquisitionEarnOutPayment_2d98e316-8e89-4d04-945f-d803264c724f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_bf5bb58c-7f8d-43c2-bc8b-36544c32466a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_0b27cdaf-dbeb-4fdb-b9c4-9577578147bc" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_bf5bb58c-7f8d-43c2-bc8b-36544c32466a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_aa89099a-a0d0-4ba7-8536-f89035081601" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_0b27cdaf-dbeb-4fdb-b9c4-9577578147bc" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_aa89099a-a0d0-4ba7-8536-f89035081601" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2b938202-45a1-41d6-9c4e-f10fcff40171" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_1b464321-2503-4a9b-954e-015dd7764f22" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2b938202-45a1-41d6-9c4e-f10fcff40171" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_b1f0f4ee-3842-417b-8b97-3439c82a700d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_1b464321-2503-4a9b-954e-015dd7764f22" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_b1f0f4ee-3842-417b-8b97-3439c82a700d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_a51fae84-b436-4c47-8b15-aac32e061f2b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_1b464321-2503-4a9b-954e-015dd7764f22" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_a51fae84-b436-4c47-8b15-aac32e061f2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_c9cecbc5-0f78-44bf-afa7-660001d00a77" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_1b464321-2503-4a9b-954e-015dd7764f22" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_c9cecbc5-0f78-44bf-afa7-660001d00a77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_00baf83e-15f7-4bb6-956a-6c5bd4237f99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_1b464321-2503-4a9b-954e-015dd7764f22" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_00baf83e-15f7-4bb6-956a-6c5bd4237f99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_93ef8a52-768e-4d72-a401-b475a306d7a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_00baf83e-15f7-4bb6-956a-6c5bd4237f99" xlink:to="loc_us-gaap_OperatingLeasePayments_93ef8a52-768e-4d72-a401-b475a306d7a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_40f72211-cf21-4f90-90b3-5af62fbbcd04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_00baf83e-15f7-4bb6-956a-6c5bd4237f99" xlink:to="loc_us-gaap_InterestPaidNet_40f72211-cf21-4f90-90b3-5af62fbbcd04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet_cd3ad064-4ed5-4627-8044-c7d467bbb52e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_00baf83e-15f7-4bb6-956a-6c5bd4237f99" xlink:to="loc_us-gaap_IncomeTaxesPaidNet_cd3ad064-4ed5-4627-8044-c7d467bbb52e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_65d21ef1-5fc7-461d-b17f-e53e45085e96" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_00baf83e-15f7-4bb6-956a-6c5bd4237f99" xlink:to="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_65d21ef1-5fc7-461d-b17f-e53e45085e96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfAssetsAcquired_e77b5126-b422-4d49-8f7a-dab7dfa2e90b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueOfAssetsAcquired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_65d21ef1-5fc7-461d-b17f-e53e45085e96" xlink:to="loc_us-gaap_FairValueOfAssetsAcquired_e77b5126-b422-4d49-8f7a-dab7dfa2e90b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amn_SupplementalDisclosuresOfNonCashInvestingAndFinancingActivitiesGoodwill_9449f01d-f7fc-4c6a-8314-70dded1f8acc" xlink:href="amn-20210930.xsd#amn_SupplementalDisclosuresOfNonCashInvestingAndFinancingActivitiesGoodwill"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_65d21ef1-5fc7-461d-b17f-e53e45085e96" xlink:to="loc_amn_SupplementalDisclosuresOfNonCashInvestingAndFinancingActivitiesGoodwill_9449f01d-f7fc-4c6a-8314-70dded1f8acc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amn_SupplementalDisclosuresOfNonCashInvestingAndFinancingActivitiesIntangibleAssets_5ce76d93-97e0-417f-a166-7e2a7190589a" xlink:href="amn-20210930.xsd#amn_SupplementalDisclosuresOfNonCashInvestingAndFinancingActivitiesIntangibleAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_65d21ef1-5fc7-461d-b17f-e53e45085e96" xlink:to="loc_amn_SupplementalDisclosuresOfNonCashInvestingAndFinancingActivitiesIntangibleAssets_5ce76d93-97e0-417f-a166-7e2a7190589a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAssumed1_d30973ef-4d3e-4518-9e7b-b655b778c895" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAssumed1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_65d21ef1-5fc7-461d-b17f-e53e45085e96" xlink:to="loc_us-gaap_LiabilitiesAssumed1_d30973ef-4d3e-4518-9e7b-b655b778c895" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_752accef-80c6-4cbc-a367-7a2785af4fea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_65d21ef1-5fc7-461d-b17f-e53e45085e96" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_752accef-80c6-4cbc-a367-7a2785af4fea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_db12f063-23ee-4f4d-a6a0-9a4e13be69ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_1b464321-2503-4a9b-954e-015dd7764f22" xlink:to="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_db12f063-23ee-4f4d-a6a0-9a4e13be69ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amn_Purchaseoffixedassetsrecordedinaccountspayableandaccruedexpenses_35150b0c-c0e5-4b26-a5bc-24567e8bc09b" xlink:href="amn-20210930.xsd#amn_Purchaseoffixedassetsrecordedinaccountspayableandaccruedexpenses"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_db12f063-23ee-4f4d-a6a0-9a4e13be69ad" xlink:to="loc_amn_Purchaseoffixedassetsrecordedinaccountspayableandaccruedexpenses_35150b0c-c0e5-4b26-a5bc-24567e8bc09b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofCashFlowsParenthetical" xlink:type="simple" xlink:href="amn-20210930.xsd#CondensedConsolidatedStatementsofCashFlowsParenthetical"/>
  <link:presentationLink xlink:role="http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofCashFlowsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_7256fe46-be6e-4e2a-96b8-5647c182ff53" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidCapitalized_728b632a-9326-4948-9ec6-b17dbbeabe36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidCapitalized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_7256fe46-be6e-4e2a-96b8-5647c182ff53" xlink:to="loc_us-gaap_InterestPaidCapitalized_728b632a-9326-4948-9ec6-b17dbbeabe36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.amnhealthcare.com/role/BasisofPresentation" xlink:type="simple" xlink:href="amn-20210930.xsd#BasisofPresentation"/>
  <link:presentationLink xlink:role="http://www.amnhealthcare.com/role/BasisofPresentation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e2acf4b8-a435-4c87-8888-0626137f2983" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccounting_40c5d571-a162-42fd-aea1-590df0efbbf9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccounting"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e2acf4b8-a435-4c87-8888-0626137f2983" xlink:to="loc_us-gaap_BasisOfAccounting_40c5d571-a162-42fd-aea1-590df0efbbf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.amnhealthcare.com/role/BasisofPresentationPolicies" xlink:type="simple" xlink:href="amn-20210930.xsd#BasisofPresentationPolicies"/>
  <link:presentationLink xlink:role="http://www.amnhealthcare.com/role/BasisofPresentationPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_82d1d591-7ce8-4c65-80a9-b16937353b79" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_bd6f8b05-63c9-4e98-9068-c3d5579fe38c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_82d1d591-7ce8-4c65-80a9-b16937353b79" xlink:to="loc_us-gaap_UseOfEstimates_bd6f8b05-63c9-4e98-9068-c3d5579fe38c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_bf350bd7-17dc-4b0e-9760-7f91cc884ff3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_82d1d591-7ce8-4c65-80a9-b16937353b79" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_bf350bd7-17dc-4b0e-9760-7f91cc884ff3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_1ac0b18f-965c-404f-9e53-77595da6e0f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_82d1d591-7ce8-4c65-80a9-b16937353b79" xlink:to="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_1ac0b18f-965c-404f-9e53-77595da6e0f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeAndOtherAccountsReceivablePolicy_398d9f12-70e0-455f-b1dd-fad688e9bdd6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradeAndOtherAccountsReceivablePolicy"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_82d1d591-7ce8-4c65-80a9-b16937353b79" xlink:to="loc_us-gaap_TradeAndOtherAccountsReceivablePolicy_398d9f12-70e0-455f-b1dd-fad688e9bdd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_66b3ce9b-9660-4d09-9830-4ec92fa86928" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_82d1d591-7ce8-4c65-80a9-b16937353b79" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_66b3ce9b-9660-4d09-9830-4ec92fa86928" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_b47a8fc3-41e7-4493-9e6c-16b83f7e1030" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_82d1d591-7ce8-4c65-80a9-b16937353b79" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_b47a8fc3-41e7-4493-9e6c-16b83f7e1030" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_654ebe2b-e115-4b54-a87e-bef56ccac3de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_82d1d591-7ce8-4c65-80a9-b16937353b79" xlink:to="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_654ebe2b-e115-4b54-a87e-bef56ccac3de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_04e65ae5-1bc4-4ba4-8582-00126b9ebace" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_82d1d591-7ce8-4c65-80a9-b16937353b79" xlink:to="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_04e65ae5-1bc4-4ba4-8582-00126b9ebace" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.amnhealthcare.com/role/BasisofPresentationTables" xlink:type="simple" xlink:href="amn-20210930.xsd#BasisofPresentationTables"/>
  <link:presentationLink xlink:role="http://www.amnhealthcare.com/role/BasisofPresentationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_06fb6c31-8810-468e-a541-9488b57c1552" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_181f3cfe-7ad4-42a5-909e-558538275bf4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_06fb6c31-8810-468e-a541-9488b57c1552" xlink:to="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_181f3cfe-7ad4-42a5-909e-558538275bf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock_535498b1-654b-4c3f-8d29-241ad0a074bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_06fb6c31-8810-468e-a541-9488b57c1552" xlink:to="loc_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock_535498b1-654b-4c3f-8d29-241ad0a074bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.amnhealthcare.com/role/BasisofPresentationReconciliationofCashCashEquivalentsandRestrictedCashDetails" xlink:type="simple" xlink:href="amn-20210930.xsd#BasisofPresentationReconciliationofCashCashEquivalentsandRestrictedCashDetails"/>
  <link:presentationLink xlink:role="http://www.amnhealthcare.com/role/BasisofPresentationReconciliationofCashCashEquivalentsandRestrictedCashDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_b42d0ed9-d8c3-4098-be7d-4b8fe8ab193d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_df158632-f973-4a9a-a4d4-a5e427836116" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b42d0ed9-d8c3-4098-be7d-4b8fe8ab193d" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_df158632-f973-4a9a-a4d4-a5e427836116" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalents_0f1fb555-ee3b-4835-bf44-7a822decc959" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalents"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b42d0ed9-d8c3-4098-be7d-4b8fe8ab193d" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalents_0f1fb555-ee3b-4835-bf44-7a822decc959" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndInvestmentsNoncurrent_aa094620-fcb1-4b14-b24f-fd2e317e4f78" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndInvestmentsNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b42d0ed9-d8c3-4098-be7d-4b8fe8ab193d" xlink:to="loc_us-gaap_RestrictedCashAndInvestmentsNoncurrent_aa094620-fcb1-4b14-b24f-fd2e317e4f78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amn_TotalCashCashEquivalentsAndRestrictedCashCashEquivalentsandInvestments_2ccc7b3d-c833-4e48-ab01-33603157ce44" xlink:href="amn-20210930.xsd#amn_TotalCashCashEquivalentsAndRestrictedCashCashEquivalentsandInvestments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b42d0ed9-d8c3-4098-be7d-4b8fe8ab193d" xlink:to="loc_amn_TotalCashCashEquivalentsAndRestrictedCashCashEquivalentsandInvestments_2ccc7b3d-c833-4e48-ab01-33603157ce44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedInvestments_09693d42-3c74-4be1-a015-85f01f214d88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedInvestments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b42d0ed9-d8c3-4098-be7d-4b8fe8ab193d" xlink:to="loc_us-gaap_RestrictedInvestments_09693d42-3c74-4be1-a015-85f01f214d88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_d65efe78-4956-4096-9bb2-9a6f3204160d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b42d0ed9-d8c3-4098-be7d-4b8fe8ab193d" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_d65efe78-4956-4096-9bb2-9a6f3204160d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.amnhealthcare.com/role/BasisofPresentationReconciliationofCashCashEquivalentsandRestrictedCashDetails_1" xlink:type="simple" xlink:href="amn-20210930.xsd#BasisofPresentationReconciliationofCashCashEquivalentsandRestrictedCashDetails_1"/>
  <link:presentationLink xlink:role="http://www.amnhealthcare.com/role/BasisofPresentationReconciliationofCashCashEquivalentsandRestrictedCashDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.amnhealthcare.com/role/BasisofPresentationReconciliationofActivityinAllowanceforCreditLossesforAccountsReceivableDetails" xlink:type="simple" xlink:href="amn-20210930.xsd#BasisofPresentationReconciliationofActivityinAllowanceforCreditLossesforAccountsReceivableDetails"/>
  <link:presentationLink xlink:role="http://www.amnhealthcare.com/role/BasisofPresentationReconciliationofActivityinAllowanceforCreditLossesforAccountsReceivableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_88136a47-e03e-4598-bdf7-60670470bbf6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_e69239fa-d4ac-4cba-8e8f-9775630ac304" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_88136a47-e03e-4598-bdf7-60670470bbf6" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_e69239fa-d4ac-4cba-8e8f-9775630ac304" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_5899600c-79e9-409b-bda0-deff248c247d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_e69239fa-d4ac-4cba-8e8f-9775630ac304" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_5899600c-79e9-409b-bda0-deff248c247d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_c77d1e6c-8f4b-46eb-b03d-dc2785fb073a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_5899600c-79e9-409b-bda0-deff248c247d" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_c77d1e6c-8f4b-46eb-b03d-dc2785fb073a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_17968efe-fd26-4ded-a7e3-7a4781b6e455" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_c77d1e6c-8f4b-46eb-b03d-dc2785fb073a" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_17968efe-fd26-4ded-a7e3-7a4781b6e455" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_2dfc8dfe-1e33-4734-8989-c06b171ee2b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_e69239fa-d4ac-4cba-8e8f-9775630ac304" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_2dfc8dfe-1e33-4734-8989-c06b171ee2b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_f056aeda-808d-44c4-a4be-241544bf71aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_2dfc8dfe-1e33-4734-8989-c06b171ee2b0" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_f056aeda-808d-44c4-a4be-241544bf71aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_6d5cb67b-d30a-43be-8aca-5ef2515ba304" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_f056aeda-808d-44c4-a4be-241544bf71aa" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_6d5cb67b-d30a-43be-8aca-5ef2515ba304" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList_e4629760-6bff-4ce4-8274-096ad2972d23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_f056aeda-808d-44c4-a4be-241544bf71aa" xlink:to="loc_us-gaap_AccountingStandardsUpdateExtensibleList_e4629760-6bff-4ce4-8274-096ad2972d23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_fc8c9181-7f71-4a07-962a-087e64b97820" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_f056aeda-808d-44c4-a4be-241544bf71aa" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_fc8c9181-7f71-4a07-962a-087e64b97820" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_ee18d989-980d-4c1b-bab2-06ea67a65e35" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_f056aeda-808d-44c4-a4be-241544bf71aa" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_ee18d989-980d-4c1b-bab2-06ea67a65e35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_e18996ed-7768-4d6f-b6de-bdc800dbe764" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_f056aeda-808d-44c4-a4be-241544bf71aa" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_e18996ed-7768-4d6f-b6de-bdc800dbe764" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.amnhealthcare.com/role/Acquisitions" xlink:type="simple" xlink:href="amn-20210930.xsd#Acquisitions"/>
  <link:presentationLink xlink:role="http://www.amnhealthcare.com/role/Acquisitions" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_45e34745-1dd1-4ea5-9d94-76d00d037590" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock_5bfb7db5-5f2a-4cb1-9d6b-9445878b3d79" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_45e34745-1dd1-4ea5-9d94-76d00d037590" xlink:to="loc_us-gaap_BusinessCombinationDisclosureTextBlock_5bfb7db5-5f2a-4cb1-9d6b-9445878b3d79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.amnhealthcare.com/role/AcquisitionsTables" xlink:type="simple" xlink:href="amn-20210930.xsd#AcquisitionsTables"/>
  <link:presentationLink xlink:role="http://www.amnhealthcare.com/role/AcquisitionsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_28222ab8-f2db-4c96-ba07-298a19674b4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock_5d27b295-4873-4001-a274-32c56967baa4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_28222ab8-f2db-4c96-ba07-298a19674b4b" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock_5d27b295-4873-4001-a274-32c56967baa4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_7ba46d6e-233d-48dc-bd32-02d1ab400ec8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionProFormaInformationTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_28222ab8-f2db-4c96-ba07-298a19674b4b" xlink:to="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_7ba46d6e-233d-48dc-bd32-02d1ab400ec8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.amnhealthcare.com/role/AcquisitionsNarrativeDetails" xlink:type="simple" xlink:href="amn-20210930.xsd#AcquisitionsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.amnhealthcare.com/role/AcquisitionsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_ac8adf2f-c3e2-4f85-a5ee-afcb5f38ae61" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_7fd9cede-3b15-44f9-bce7-9ef94b11bd88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_ac8adf2f-c3e2-4f85-a5ee-afcb5f38ae61" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_7fd9cede-3b15-44f9-bce7-9ef94b11bd88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_5768ba1f-0739-4f34-b31d-50576060b69f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_7fd9cede-3b15-44f9-bce7-9ef94b11bd88" xlink:to="loc_us-gaap_CreditFacilityAxis_5768ba1f-0739-4f34-b31d-50576060b69f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_f55bdeea-6724-4467-a674-84896e0552b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_5768ba1f-0739-4f34-b31d-50576060b69f" xlink:to="loc_us-gaap_CreditFacilityDomain_f55bdeea-6724-4467-a674-84896e0552b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_1e47f0a8-868e-47d5-9a60-327c7dd2f522" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_f55bdeea-6724-4467-a674-84896e0552b4" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_1e47f0a8-868e-47d5-9a60-327c7dd2f522" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_e5329333-1af6-4861-a505-801572208f38" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuredDebtMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_f55bdeea-6724-4467-a674-84896e0552b4" xlink:to="loc_us-gaap_SecuredDebtMember_e5329333-1af6-4861-a505-801572208f38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_8155fbd0-7c76-453b-97ff-dd7f186182a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_7fd9cede-3b15-44f9-bce7-9ef94b11bd88" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_8155fbd0-7c76-453b-97ff-dd7f186182a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_9a075082-5984-4889-993f-fe946944737c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_8155fbd0-7c76-453b-97ff-dd7f186182a7" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_9a075082-5984-4889-993f-fe946944737c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_471b2b59-e76e-462a-a480-6d597cfd6cc5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_9a075082-5984-4889-993f-fe946944737c" xlink:to="loc_us-gaap_LineOfCreditMember_471b2b59-e76e-462a-a480-6d597cfd6cc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amn_TermDebtMember_39d802ab-1e31-457b-ae4f-90ab1b5d5a2c" xlink:href="amn-20210930.xsd#amn_TermDebtMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_9a075082-5984-4889-993f-fe946944737c" xlink:to="loc_amn_TermDebtMember_39d802ab-1e31-457b-ae4f-90ab1b5d5a2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_e830aca8-5a43-4ee7-b64f-4ffb63717469" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_7fd9cede-3b15-44f9-bce7-9ef94b11bd88" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_e830aca8-5a43-4ee7-b64f-4ffb63717469" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c3d76eed-4b35-4f9b-b18d-5e3d71cdbdf0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_e830aca8-5a43-4ee7-b64f-4ffb63717469" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c3d76eed-4b35-4f9b-b18d-5e3d71cdbdf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amn_SynziMember_bfd0c9b9-d080-459f-bb38-c5ed11d38716" xlink:href="amn-20210930.xsd#amn_SynziMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c3d76eed-4b35-4f9b-b18d-5e3d71cdbdf0" xlink:to="loc_amn_SynziMember_bfd0c9b9-d080-459f-bb38-c5ed11d38716" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amn_StratusVideoMember_beed5bdf-1fd9-4dd7-93e1-664e1a13421d" xlink:href="amn-20210930.xsd#amn_StratusVideoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c3d76eed-4b35-4f9b-b18d-5e3d71cdbdf0" xlink:to="loc_amn_StratusVideoMember_beed5bdf-1fd9-4dd7-93e1-664e1a13421d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_551e0070-6065-4eb2-b62c-803638f7f827" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_7fd9cede-3b15-44f9-bce7-9ef94b11bd88" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_551e0070-6065-4eb2-b62c-803638f7f827" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_7b85dc13-7604-4c82-a295-6b6907f19d7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_551e0070-6065-4eb2-b62c-803638f7f827" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_7b85dc13-7604-4c82-a295-6b6907f19d7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_49f13138-44a7-424d-a711-a25565eb4b37" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_7b85dc13-7604-4c82-a295-6b6907f19d7e" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_49f13138-44a7-424d-a711-a25565eb4b37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember_f55582a2-79e6-4863-8170-a9e3c32d68f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TrademarksMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_7b85dc13-7604-4c82-a295-6b6907f19d7e" xlink:to="loc_us-gaap_TrademarksMember_f55582a2-79e6-4863-8170-a9e3c32d68f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksAndTradeNamesMember_af2064c5-540c-4738-af29-bb6c73dc5d61" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TrademarksAndTradeNamesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_7b85dc13-7604-4c82-a295-6b6907f19d7e" xlink:to="loc_us-gaap_TrademarksAndTradeNamesMember_af2064c5-540c-4738-af29-bb6c73dc5d61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonrecurringAdjustmentAxis_daab19a3-f643-491b-8744-a3dc3d2d75ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonrecurringAdjustmentAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_7fd9cede-3b15-44f9-bce7-9ef94b11bd88" xlink:to="loc_us-gaap_NonrecurringAdjustmentAxis_daab19a3-f643-491b-8744-a3dc3d2d75ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonrecurringAdjustmentDomain_5bc6105f-18f0-45ac-aa8c-e08377528d18" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonrecurringAdjustmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonrecurringAdjustmentAxis_daab19a3-f643-491b-8744-a3dc3d2d75ee" xlink:to="loc_us-gaap_NonrecurringAdjustmentDomain_5bc6105f-18f0-45ac-aa8c-e08377528d18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquisitionRelatedCostsMember_2c89df52-b12d-4a33-ad08-bb4190b731c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcquisitionRelatedCostsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonrecurringAdjustmentDomain_5bc6105f-18f0-45ac-aa8c-e08377528d18" xlink:to="loc_us-gaap_AcquisitionRelatedCostsMember_2c89df52-b12d-4a33-ad08-bb4190b731c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_dd946ee2-cea2-4063-ab13-92931b72fc0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_7fd9cede-3b15-44f9-bce7-9ef94b11bd88" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_dd946ee2-cea2-4063-ab13-92931b72fc0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfBusinessesAcquired_221914b3-c23c-43d7-a2be-f00d92d0551b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfBusinessesAcquired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_dd946ee2-cea2-4063-ab13-92931b72fc0b" xlink:to="loc_us-gaap_NumberOfBusinessesAcquired_221914b3-c23c-43d7-a2be-f00d92d0551b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_620181b4-dd9d-48b7-a656-9204869e2897" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_dd946ee2-cea2-4063-ab13-92931b72fc0b" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_620181b4-dd9d-48b7-a656-9204869e2897" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAcquiredFromAcquisition_65441c64-ee2e-4ec3-94c6-06a4c9098d5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAcquiredFromAcquisition"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_dd946ee2-cea2-4063-ab13-92931b72fc0b" xlink:to="loc_us-gaap_CashAcquiredFromAcquisition_65441c64-ee2e-4ec3-94c6-06a4c9098d5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amn_BusinessCombinationConsiderationTransferredNetOfWorkingCapitalAdjustment_bfca9913-ff9b-4319-9e2e-905a24e333ca" xlink:href="amn-20210930.xsd#amn_BusinessCombinationConsiderationTransferredNetOfWorkingCapitalAdjustment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_dd946ee2-cea2-4063-ab13-92931b72fc0b" xlink:to="loc_amn_BusinessCombinationConsiderationTransferredNetOfWorkingCapitalAdjustment_bfca9913-ff9b-4319-9e2e-905a24e333ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalentsAndPropertyPlantAndEquipment_773e04a9-3a67-47e4-bd0c-7e68d876c6f8" xlink:href="amn-20210930.xsd#amn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalentsAndPropertyPlantAndEquipment"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_dd946ee2-cea2-4063-ab13-92931b72fc0b" xlink:to="loc_amn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalentsAndPropertyPlantAndEquipment_773e04a9-3a67-47e4-bd0c-7e68d876c6f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_01f8245e-fc39-4170-8444-7f785a9518fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_dd946ee2-cea2-4063-ab13-92931b72fc0b" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_01f8245e-fc39-4170-8444-7f785a9518fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_67a6320b-b5d9-4b42-8c76-5060ec1a12d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_dd946ee2-cea2-4063-ab13-92931b72fc0b" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_67a6320b-b5d9-4b42-8c76-5060ec1a12d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_1cb18591-83d8-4f07-a1a1-d2128b921686" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_dd946ee2-cea2-4063-ab13-92931b72fc0b" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_1cb18591-83d8-4f07-a1a1-d2128b921686" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_2b498411-1c74-4969-9bbd-79ce38077b20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_dd946ee2-cea2-4063-ab13-92931b72fc0b" xlink:to="loc_us-gaap_Goodwill_2b498411-1c74-4969-9bbd-79ce38077b20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_f5064600-3a7d-4ffb-95c1-2042ca16bf41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_dd946ee2-cea2-4063-ab13-92931b72fc0b" xlink:to="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_f5064600-3a7d-4ffb-95c1-2042ca16bf41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_17b29bfe-98c2-46be-9296-c1e2b1727d97" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_dd946ee2-cea2-4063-ab13-92931b72fc0b" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_17b29bfe-98c2-46be-9296-c1e2b1727d97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_dabdb71e-1c1c-4028-8b78-589391930792" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_dd946ee2-cea2-4063-ab13-92931b72fc0b" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_dabdb71e-1c1c-4028-8b78-589391930792" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_78f863df-fb4b-4928-8584-3310d2a0ae93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_dd946ee2-cea2-4063-ab13-92931b72fc0b" xlink:to="loc_us-gaap_LongTermDebt_78f863df-fb4b-4928-8584-3310d2a0ae93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_17c04caf-feff-4c16-8ce4-965873a57b10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_dd946ee2-cea2-4063-ab13-92931b72fc0b" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_17c04caf-feff-4c16-8ce4-965873a57b10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets_3aca1f39-a63e-4803-9342-24f06dc44412" xlink:href="amn-20210930.xsd#amn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_dd946ee2-cea2-4063-ab13-92931b72fc0b" xlink:to="loc_amn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets_3aca1f39-a63e-4803-9342-24f06dc44412" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_be020132-5c2c-4081-a592-be7eb9143ad3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_dd946ee2-cea2-4063-ab13-92931b72fc0b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_be020132-5c2c-4081-a592-be7eb9143ad3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual_2b6f312a-bd60-4449-b0e5-76cedb51ec19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_dd946ee2-cea2-4063-ab13-92931b72fc0b" xlink:to="loc_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual_2b6f312a-bd60-4449-b0e5-76cedb51ec19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual_42d744bf-c3fa-42f7-826f-11eefad55efc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_dd946ee2-cea2-4063-ab13-92931b72fc0b" xlink:to="loc_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual_42d744bf-c3fa-42f7-826f-11eefad55efc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_253c94d2-5980-4036-982c-d40111b6da55" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_dd946ee2-cea2-4063-ab13-92931b72fc0b" xlink:to="loc_us-gaap_NetIncomeLoss_253c94d2-5980-4036-982c-d40111b6da55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.amnhealthcare.com/role/AcquisitionsScheduleofIntangibleAssetsAcquiredDetails" xlink:type="simple" xlink:href="amn-20210930.xsd#AcquisitionsScheduleofIntangibleAssetsAcquiredDetails"/>
  <link:presentationLink xlink:role="http://www.amnhealthcare.com/role/AcquisitionsScheduleofIntangibleAssetsAcquiredDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_9831afbf-0cad-4787-84d6-6553fe514aa9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable_157c39a8-df22-4dc8-a017-51cb638708a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_9831afbf-0cad-4787-84d6-6553fe514aa9" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable_157c39a8-df22-4dc8-a017-51cb638708a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_46db4b02-043d-480e-b7ca-e6a145e85354" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable_157c39a8-df22-4dc8-a017-51cb638708a3" xlink:to="loc_srt_RangeAxis_46db4b02-043d-480e-b7ca-e6a145e85354" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_1758b654-dd62-465f-8aaf-6e621dc842c4" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_46db4b02-043d-480e-b7ca-e6a145e85354" xlink:to="loc_srt_RangeMember_1758b654-dd62-465f-8aaf-6e621dc842c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_a6615e83-24cb-4450-9d6c-1ad7f5ab3239" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_1758b654-dd62-465f-8aaf-6e621dc842c4" xlink:to="loc_srt_MinimumMember_a6615e83-24cb-4450-9d6c-1ad7f5ab3239" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_1ccbb15d-3e7f-4038-8d58-7ba47a98b82a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_1758b654-dd62-465f-8aaf-6e621dc842c4" xlink:to="loc_srt_MaximumMember_1ccbb15d-3e7f-4038-8d58-7ba47a98b82a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_2358422e-7887-411f-b49c-5b8b3c88750b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable_157c39a8-df22-4dc8-a017-51cb638708a3" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_2358422e-7887-411f-b49c-5b8b3c88750b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_91112704-946d-4817-b27d-04f5d1eb16e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_2358422e-7887-411f-b49c-5b8b3c88750b" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_91112704-946d-4817-b27d-04f5d1eb16e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amn_StratusVideoMember_a93fa4ba-b52e-47c2-85ea-90a10219d69c" xlink:href="amn-20210930.xsd#amn_StratusVideoMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_91112704-946d-4817-b27d-04f5d1eb16e2" xlink:to="loc_amn_StratusVideoMember_a93fa4ba-b52e-47c2-85ea-90a10219d69c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_d34c1645-0bb6-4e8b-9e64-0057deaef5e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable_157c39a8-df22-4dc8-a017-51cb638708a3" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_d34c1645-0bb6-4e8b-9e64-0057deaef5e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2bdcad93-da3a-45da-99dc-b2f5e8435414" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_d34c1645-0bb6-4e8b-9e64-0057deaef5e3" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2bdcad93-da3a-45da-99dc-b2f5e8435414" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_cdb77205-fd78-4f3f-b15d-28814fcd8f30" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2bdcad93-da3a-45da-99dc-b2f5e8435414" xlink:to="loc_us-gaap_CustomerRelationshipsMember_cdb77205-fd78-4f3f-b15d-28814fcd8f30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksAndTradeNamesMember_a723308c-df7b-4dde-9507-f451eecbd789" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TrademarksAndTradeNamesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2bdcad93-da3a-45da-99dc-b2f5e8435414" xlink:to="loc_us-gaap_TrademarksAndTradeNamesMember_a723308c-df7b-4dde-9507-f451eecbd789" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_13688a60-458f-40ee-a49a-f5cd9ca749f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2bdcad93-da3a-45da-99dc-b2f5e8435414" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_13688a60-458f-40ee-a49a-f5cd9ca749f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amn_InterpreterDatabaseMember_5393a43f-3936-482f-aebb-061b733bb726" xlink:href="amn-20210930.xsd#amn_InterpreterDatabaseMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2bdcad93-da3a-45da-99dc-b2f5e8435414" xlink:to="loc_amn_InterpreterDatabaseMember_5393a43f-3936-482f-aebb-061b733bb726" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_be01bcea-a891-482d-9a23-32c7c00c3465" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable_157c39a8-df22-4dc8-a017-51cb638708a3" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_be01bcea-a891-482d-9a23-32c7c00c3465" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_c70b309e-042a-4c12-9422-56d1af5e66d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_be01bcea-a891-482d-9a23-32c7c00c3465" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_c70b309e-042a-4c12-9422-56d1af5e66d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_1848d62c-21df-4eef-8d1f-03e528acb084" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_be01bcea-a891-482d-9a23-32c7c00c3465" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_1848d62c-21df-4eef-8d1f-03e528acb084" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.amnhealthcare.com/role/AcquisitionsScheduleofProFormaFinancialInformationDetails" xlink:type="simple" xlink:href="amn-20210930.xsd#AcquisitionsScheduleofProFormaFinancialInformationDetails"/>
  <link:presentationLink xlink:role="http://www.amnhealthcare.com/role/AcquisitionsScheduleofProFormaFinancialInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_3a3442cf-f433-4429-8e33-120363e1b080" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_5b45cd27-239f-46be-9618-b37c6e36fdb4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_3a3442cf-f433-4429-8e33-120363e1b080" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_5b45cd27-239f-46be-9618-b37c6e36fdb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_b08e9e6d-b92b-4cc1-af36-204b6b6c63fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_5b45cd27-239f-46be-9618-b37c6e36fdb4" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_b08e9e6d-b92b-4cc1-af36-204b6b6c63fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1d093260-20cd-44c7-8d55-0dc23e2feb38" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_b08e9e6d-b92b-4cc1-af36-204b6b6c63fd" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1d093260-20cd-44c7-8d55-0dc23e2feb38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amn_StratusVideoMember_d2557e9a-324d-4ec1-b566-91444d1fd063" xlink:href="amn-20210930.xsd#amn_StratusVideoMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1d093260-20cd-44c7-8d55-0dc23e2feb38" xlink:to="loc_amn_StratusVideoMember_d2557e9a-324d-4ec1-b566-91444d1fd063" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_5d8924e7-3b00-49f7-9b0e-75d848da75fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_5b45cd27-239f-46be-9618-b37c6e36fdb4" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_5d8924e7-3b00-49f7-9b0e-75d848da75fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_9fa0054f-cc00-4134-b089-30345b2be299" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5d8924e7-3b00-49f7-9b0e-75d848da75fe" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_9fa0054f-cc00-4134-b089-30345b2be299" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax_0eb0a5bf-adb7-478b-aa8f-2d40dfb6dbec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5d8924e7-3b00-49f7-9b0e-75d848da75fe" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax_0eb0a5bf-adb7-478b-aa8f-2d40dfb6dbec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_7758048e-e1ef-4d40-87de-5c7707c77011" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5d8924e7-3b00-49f7-9b0e-75d848da75fe" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_7758048e-e1ef-4d40-87de-5c7707c77011" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.amnhealthcare.com/role/RevenueRecognition" xlink:type="simple" xlink:href="amn-20210930.xsd#RevenueRecognition"/>
  <link:presentationLink xlink:role="http://www.amnhealthcare.com/role/RevenueRecognition" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_05675b15-50c3-48e4-b477-54df5b549873" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_c0bf154f-0de5-49f4-bb57-dc5d7b4ce6cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_05675b15-50c3-48e4-b477-54df5b549873" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_c0bf154f-0de5-49f4-bb57-dc5d7b4ce6cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.amnhealthcare.com/role/RevenueRecognitionDetails" xlink:type="simple" xlink:href="amn-20210930.xsd#RevenueRecognitionDetails"/>
  <link:presentationLink xlink:role="http://www.amnhealthcare.com/role/RevenueRecognitionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_55b64c85-059b-44ab-9a8c-2c7b4a3d0350" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_a0033f75-4184-49ac-baad-bb867a648833" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_55b64c85-059b-44ab-9a8c-2c7b4a3d0350" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_a0033f75-4184-49ac-baad-bb867a648833" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.amnhealthcare.com/role/NetIncomePerCommonShare" xlink:type="simple" xlink:href="amn-20210930.xsd#NetIncomePerCommonShare"/>
  <link:presentationLink xlink:role="http://www.amnhealthcare.com/role/NetIncomePerCommonShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_5df46584-3459-4583-a2f4-cc78fc07a367" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_f48e48b2-3fb1-4262-b416-e74d95292ad6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_5df46584-3459-4583-a2f4-cc78fc07a367" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_f48e48b2-3fb1-4262-b416-e74d95292ad6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.amnhealthcare.com/role/NetIncomePerCommonShareTables" xlink:type="simple" xlink:href="amn-20210930.xsd#NetIncomePerCommonShareTables"/>
  <link:presentationLink xlink:role="http://www.amnhealthcare.com/role/NetIncomePerCommonShareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_a6853a67-ca01-4694-91ee-979d1ce062ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_79afdeb7-acaf-49f5-a780-1afeaaa26f2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_a6853a67-ca01-4694-91ee-979d1ce062ac" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_79afdeb7-acaf-49f5-a780-1afeaaa26f2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.amnhealthcare.com/role/NetIncomePerCommonShareDetails" xlink:type="simple" xlink:href="amn-20210930.xsd#NetIncomePerCommonShareDetails"/>
  <link:presentationLink xlink:role="http://www.amnhealthcare.com/role/NetIncomePerCommonShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_b260db89-5ab3-44e6-a5c0-06a888177aa4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_33c0005b-424d-40b3-a991-d3a6057933c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_b260db89-5ab3-44e6-a5c0-06a888177aa4" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_33c0005b-424d-40b3-a991-d3a6057933c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_97db213a-e685-48eb-ba48-cca79aef4beb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_b260db89-5ab3-44e6-a5c0-06a888177aa4" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_97db213a-e685-48eb-ba48-cca79aef4beb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_7f466ead-6c83-44a8-9cf3-3d12b4e7538b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_b260db89-5ab3-44e6-a5c0-06a888177aa4" xlink:to="loc_us-gaap_EarningsPerShareBasic_7f466ead-6c83-44a8-9cf3-3d12b4e7538b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_98197b3a-9861-452d-bce6-c44b8c5218aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_b260db89-5ab3-44e6-a5c0-06a888177aa4" xlink:to="loc_us-gaap_EarningsPerShareDiluted_98197b3a-9861-452d-bce6-c44b8c5218aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_812c996d-6e88-4aaf-9d06-9adf5ad61346" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_b260db89-5ab3-44e6-a5c0-06a888177aa4" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_812c996d-6e88-4aaf-9d06-9adf5ad61346" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_9edf208e-e251-41ff-9947-ad3297ad70f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_b260db89-5ab3-44e6-a5c0-06a888177aa4" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_9edf208e-e251-41ff-9947-ad3297ad70f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_dc223221-d254-4791-80e8-2a062147d0bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_b260db89-5ab3-44e6-a5c0-06a888177aa4" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_dc223221-d254-4791-80e8-2a062147d0bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_9b4ece0e-cc8c-47e7-b65f-c2a186ebd0af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_b260db89-5ab3-44e6-a5c0-06a888177aa4" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_9b4ece0e-cc8c-47e7-b65f-c2a186ebd0af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.amnhealthcare.com/role/SegmentInformation" xlink:type="simple" xlink:href="amn-20210930.xsd#SegmentInformation"/>
  <link:presentationLink xlink:role="http://www.amnhealthcare.com/role/SegmentInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_54ecc9b9-00b1-4e70-b4ae-f13aff13ccc7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_57c0f4c8-61f7-4297-ae6f-b8ee6d9c96c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_54ecc9b9-00b1-4e70-b4ae-f13aff13ccc7" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_57c0f4c8-61f7-4297-ae6f-b8ee6d9c96c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.amnhealthcare.com/role/SegmentInformationTables" xlink:type="simple" xlink:href="amn-20210930.xsd#SegmentInformationTables"/>
  <link:presentationLink xlink:role="http://www.amnhealthcare.com/role/SegmentInformationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_bdb002dd-cf61-4369-8ce5-b512bcdfb72f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_6562deb6-e517-4be6-98fb-2b3cc8ba41a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_bdb002dd-cf61-4369-8ce5-b512bcdfb72f" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_6562deb6-e517-4be6-98fb-2b3cc8ba41a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_76999df1-0a37-427a-ba4e-69eefc961830" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_bdb002dd-cf61-4369-8ce5-b512bcdfb72f" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_76999df1-0a37-427a-ba4e-69eefc961830" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_8b8476f5-44f0-43ab-b4bf-b6ca5d14b0ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_bdb002dd-cf61-4369-8ce5-b512bcdfb72f" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_8b8476f5-44f0-43ab-b4bf-b6ca5d14b0ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.amnhealthcare.com/role/SegmentInformationNarrativeDetails" xlink:type="simple" xlink:href="amn-20210930.xsd#SegmentInformationNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.amnhealthcare.com/role/SegmentInformationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_08229d5c-f292-4071-aa8a-502330e4c332" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_ff556f1e-7f2a-4f07-9d5d-074208c13a5f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_08229d5c-f292-4071-aa8a-502330e4c332" xlink:to="loc_us-gaap_NumberOfOperatingSegments_ff556f1e-7f2a-4f07-9d5d-074208c13a5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.amnhealthcare.com/role/SegmentInformationReconciliationofRevenueandSegmentOperatingIncomebyReportableSegmentDetails" xlink:type="simple" xlink:href="amn-20210930.xsd#SegmentInformationReconciliationofRevenueandSegmentOperatingIncomebyReportableSegmentDetails"/>
  <link:presentationLink xlink:role="http://www.amnhealthcare.com/role/SegmentInformationReconciliationofRevenueandSegmentOperatingIncomebyReportableSegmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_cbbc95c3-81de-4768-b7ff-16243ee55b02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_f68fd6f0-5dbc-4a03-a4f2-ab8bc88fe4a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_cbbc95c3-81de-4768-b7ff-16243ee55b02" xlink:to="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_f68fd6f0-5dbc-4a03-a4f2-ab8bc88fe4a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_69865564-97e4-4dc1-9ca8-6e0129be8939" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_f68fd6f0-5dbc-4a03-a4f2-ab8bc88fe4a9" xlink:to="loc_srt_ConsolidationItemsAxis_69865564-97e4-4dc1-9ca8-6e0129be8939" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_35430a6b-2166-422b-9f0a-f63653681e4f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_69865564-97e4-4dc1-9ca8-6e0129be8939" xlink:to="loc_srt_ConsolidationItemsDomain_35430a6b-2166-422b-9f0a-f63653681e4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_25f86592-844f-4622-bf67-400d3a3dd568" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_35430a6b-2166-422b-9f0a-f63653681e4f" xlink:to="loc_us-gaap_OperatingSegmentsMember_25f86592-844f-4622-bf67-400d3a3dd568" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_d850b614-64a3-4e44-a171-b97273bf592a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_35430a6b-2166-422b-9f0a-f63653681e4f" xlink:to="loc_us-gaap_CorporateNonSegmentMember_d850b614-64a3-4e44-a171-b97273bf592a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_a9edae0b-ec9c-48e4-8c55-89dc2dfed41c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_f68fd6f0-5dbc-4a03-a4f2-ab8bc88fe4a9" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_a9edae0b-ec9c-48e4-8c55-89dc2dfed41c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_a7f0a9dd-45a2-4954-8df2-58d758c2e05e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_a9edae0b-ec9c-48e4-8c55-89dc2dfed41c" xlink:to="loc_us-gaap_SegmentDomain_a7f0a9dd-45a2-4954-8df2-58d758c2e05e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amn_NurseAndAlliedHealthcareStaffingMember_40cc682c-0930-446e-a70e-e3468e4bb1d3" xlink:href="amn-20210930.xsd#amn_NurseAndAlliedHealthcareStaffingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_a7f0a9dd-45a2-4954-8df2-58d758c2e05e" xlink:to="loc_amn_NurseAndAlliedHealthcareStaffingMember_40cc682c-0930-446e-a70e-e3468e4bb1d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amn_PhysicianAndLeadershipSolutionsMember_6d60e310-07a7-4284-8f5e-295f3855a0b9" xlink:href="amn-20210930.xsd#amn_PhysicianAndLeadershipSolutionsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_a7f0a9dd-45a2-4954-8df2-58d758c2e05e" xlink:to="loc_amn_PhysicianAndLeadershipSolutionsMember_6d60e310-07a7-4284-8f5e-295f3855a0b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amn_TechnologyAndWorkforceSolutionsMember_ed6a0371-b45a-4104-9537-8a6cf3b72e05" xlink:href="amn-20210930.xsd#amn_TechnologyAndWorkforceSolutionsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_a7f0a9dd-45a2-4954-8df2-58d758c2e05e" xlink:to="loc_amn_TechnologyAndWorkforceSolutionsMember_ed6a0371-b45a-4104-9537-8a6cf3b72e05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_2d7b6413-d6ef-4d4a-a02a-1cec443cebc9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingRevenueReconcilingItemLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_f68fd6f0-5dbc-4a03-a4f2-ab8bc88fe4a9" xlink:to="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_2d7b6413-d6ef-4d4a-a02a-1cec443cebc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_e2b07123-4e29-4c55-b2a8-cd9799bb89bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_2d7b6413-d6ef-4d4a-a02a-1cec443cebc9" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_e2b07123-4e29-4c55-b2a8-cd9799bb89bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_751d6db3-974f-40ef-8931-407867303c8b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_2d7b6413-d6ef-4d4a-a02a-1cec443cebc9" xlink:to="loc_us-gaap_OperatingIncomeLoss_751d6db3-974f-40ef-8931-407867303c8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amn_UnallocatedCorporateOverhead_f89d66b1-d348-4ca6-a765-c564af0f9de2" xlink:href="amn-20210930.xsd#amn_UnallocatedCorporateOverhead"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_2d7b6413-d6ef-4d4a-a02a-1cec443cebc9" xlink:to="loc_amn_UnallocatedCorporateOverhead_f89d66b1-d348-4ca6-a765-c564af0f9de2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_a471095a-ca8f-4c92-af31-8a9886919785" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_2d7b6413-d6ef-4d4a-a02a-1cec443cebc9" xlink:to="loc_us-gaap_DepreciationAndAmortization_a471095a-ca8f-4c92-af31-8a9886919785" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSoldDepreciation_9d5036ab-632c-4c14-9318-25c016091f16" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSoldDepreciation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_2d7b6413-d6ef-4d4a-a02a-1cec443cebc9" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSoldDepreciation_9d5036ab-632c-4c14-9318-25c016091f16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_2daf305c-dc7d-4f03-ab43-6c8dd56bbd0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_2d7b6413-d6ef-4d4a-a02a-1cec443cebc9" xlink:to="loc_us-gaap_ShareBasedCompensation_2daf305c-dc7d-4f03-ab43-6c8dd56bbd0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_6732da44-10b6-4447-93bf-5b223ca07a4f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_2d7b6413-d6ef-4d4a-a02a-1cec443cebc9" xlink:to="loc_us-gaap_InterestExpense_6732da44-10b6-4447-93bf-5b223ca07a4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_d3e7eba2-8ab1-4a69-875c-4df4ee370f13" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_2d7b6413-d6ef-4d4a-a02a-1cec443cebc9" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_d3e7eba2-8ab1-4a69-875c-4df4ee370f13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.amnhealthcare.com/role/SegmentInformationDisaggregationofRevenueDetails" xlink:type="simple" xlink:href="amn-20210930.xsd#SegmentInformationDisaggregationofRevenueDetails"/>
  <link:presentationLink xlink:role="http://www.amnhealthcare.com/role/SegmentInformationDisaggregationofRevenueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_a30a59f3-5296-4608-ba1b-eaabaca1e58f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_7bcca703-9b04-4464-967f-3763e9ce5a7f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_a30a59f3-5296-4608-ba1b-eaabaca1e58f" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_7bcca703-9b04-4464-967f-3763e9ce5a7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_10f583b6-4eb5-4737-aa57-ebe014a25514" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_7bcca703-9b04-4464-967f-3763e9ce5a7f" xlink:to="loc_srt_ProductOrServiceAxis_10f583b6-4eb5-4737-aa57-ebe014a25514" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_de43b145-8517-4fd1-bcb7-353034435b5a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_10f583b6-4eb5-4737-aa57-ebe014a25514" xlink:to="loc_srt_ProductsAndServicesDomain_de43b145-8517-4fd1-bcb7-353034435b5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amn_TemporaryStaffingMember_87c6e60d-ae4d-440f-97f1-dec36dd348aa" xlink:href="amn-20210930.xsd#amn_TemporaryStaffingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_de43b145-8517-4fd1-bcb7-353034435b5a" xlink:to="loc_amn_TemporaryStaffingMember_87c6e60d-ae4d-440f-97f1-dec36dd348aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amn_PermanentPlacementMember_0a5b360b-ae3d-4098-aea3-d61c7aa28b4f" xlink:href="amn-20210930.xsd#amn_PermanentPlacementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_de43b145-8517-4fd1-bcb7-353034435b5a" xlink:to="loc_amn_PermanentPlacementMember_0a5b360b-ae3d-4098-aea3-d61c7aa28b4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amn_OutsourcedWorkforceMember_6e05ae9d-f1c4-4707-b9f0-00493235813d" xlink:href="amn-20210930.xsd#amn_OutsourcedWorkforceMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_de43b145-8517-4fd1-bcb7-353034435b5a" xlink:to="loc_amn_OutsourcedWorkforceMember_6e05ae9d-f1c4-4707-b9f0-00493235813d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amn_SaaSBasedTechnologiesMember_e24c3d95-031d-402f-afa9-8006796b9b48" xlink:href="amn-20210930.xsd#amn_SaaSBasedTechnologiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_de43b145-8517-4fd1-bcb7-353034435b5a" xlink:to="loc_amn_SaaSBasedTechnologiesMember_e24c3d95-031d-402f-afa9-8006796b9b48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_ff2d444e-52eb-4e17-b864-7863a88fa899" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_7bcca703-9b04-4464-967f-3763e9ce5a7f" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_ff2d444e-52eb-4e17-b864-7863a88fa899" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_647ed624-6c55-4eb8-b8a6-5771eb7194a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_ff2d444e-52eb-4e17-b864-7863a88fa899" xlink:to="loc_us-gaap_SegmentDomain_647ed624-6c55-4eb8-b8a6-5771eb7194a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amn_NurseAndAlliedHealthcareStaffingMember_a3bc6155-6cb9-4c43-8e3d-87076a6dd702" xlink:href="amn-20210930.xsd#amn_NurseAndAlliedHealthcareStaffingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_647ed624-6c55-4eb8-b8a6-5771eb7194a0" xlink:to="loc_amn_NurseAndAlliedHealthcareStaffingMember_a3bc6155-6cb9-4c43-8e3d-87076a6dd702" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amn_PhysicianAndLeadershipSolutionsMember_6809e75c-8a13-4f05-bc27-8e60970fc49c" xlink:href="amn-20210930.xsd#amn_PhysicianAndLeadershipSolutionsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_647ed624-6c55-4eb8-b8a6-5771eb7194a0" xlink:to="loc_amn_PhysicianAndLeadershipSolutionsMember_6809e75c-8a13-4f05-bc27-8e60970fc49c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amn_TechnologyAndWorkforceSolutionsMember_31eca133-d209-44a3-99f7-b030e0cdd7d8" xlink:href="amn-20210930.xsd#amn_TechnologyAndWorkforceSolutionsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_647ed624-6c55-4eb8-b8a6-5771eb7194a0" xlink:to="loc_amn_TechnologyAndWorkforceSolutionsMember_31eca133-d209-44a3-99f7-b030e0cdd7d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_34ecfd15-e9d5-4114-824c-07c867f44dc4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_7bcca703-9b04-4464-967f-3763e9ce5a7f" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_34ecfd15-e9d5-4114-824c-07c867f44dc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_83598f44-324f-4329-859d-5ebb0ff1a338" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_34ecfd15-e9d5-4114-824c-07c867f44dc4" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_83598f44-324f-4329-859d-5ebb0ff1a338" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.amnhealthcare.com/role/SegmentInformationSummaryofGoodwillbyReportableSegmentDetails" xlink:type="simple" xlink:href="amn-20210930.xsd#SegmentInformationSummaryofGoodwillbyReportableSegmentDetails"/>
  <link:presentationLink xlink:role="http://www.amnhealthcare.com/role/SegmentInformationSummaryofGoodwillbyReportableSegmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_95a9ea3a-bb69-42ba-b169-2aac0fbf8e72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_442b7815-8a9b-4d45-9bfc-df1a7a25afe8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_95a9ea3a-bb69-42ba-b169-2aac0fbf8e72" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_442b7815-8a9b-4d45-9bfc-df1a7a25afe8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_9acdc902-05bc-4fb6-a6cc-f240b482567a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_442b7815-8a9b-4d45-9bfc-df1a7a25afe8" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_9acdc902-05bc-4fb6-a6cc-f240b482567a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_f6377a21-fe6a-46c0-b095-535c744d3901" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_9acdc902-05bc-4fb6-a6cc-f240b482567a" xlink:to="loc_us-gaap_SegmentDomain_f6377a21-fe6a-46c0-b095-535c744d3901" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amn_NurseAndAlliedHealthcareStaffingMember_4471500c-4303-4987-a3d4-18e412b0d449" xlink:href="amn-20210930.xsd#amn_NurseAndAlliedHealthcareStaffingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_f6377a21-fe6a-46c0-b095-535c744d3901" xlink:to="loc_amn_NurseAndAlliedHealthcareStaffingMember_4471500c-4303-4987-a3d4-18e412b0d449" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amn_PhysicianAndLeadershipSolutionsMember_523c8d18-e23e-4341-825a-b79c6a16b44c" xlink:href="amn-20210930.xsd#amn_PhysicianAndLeadershipSolutionsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_f6377a21-fe6a-46c0-b095-535c744d3901" xlink:to="loc_amn_PhysicianAndLeadershipSolutionsMember_523c8d18-e23e-4341-825a-b79c6a16b44c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amn_TechnologyAndWorkforceSolutionsMember_486591dc-e805-47d6-b02b-16c1aa7b8263" xlink:href="amn-20210930.xsd#amn_TechnologyAndWorkforceSolutionsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_f6377a21-fe6a-46c0-b095-535c744d3901" xlink:to="loc_amn_TechnologyAndWorkforceSolutionsMember_486591dc-e805-47d6-b02b-16c1aa7b8263" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_36d37a03-aa0e-4586-8ffb-d0fb8c45d4b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_442b7815-8a9b-4d45-9bfc-df1a7a25afe8" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_36d37a03-aa0e-4586-8ffb-d0fb8c45d4b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_ca4a5e36-6583-4cde-818a-522ac8bdd6c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_36d37a03-aa0e-4586-8ffb-d0fb8c45d4b2" xlink:to="loc_us-gaap_GoodwillRollForward_ca4a5e36-6583-4cde-818a-522ac8bdd6c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_7de0d131-ae1d-481a-adaa-f6794d43f24d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_ca4a5e36-6583-4cde-818a-522ac8bdd6c6" xlink:to="loc_us-gaap_Goodwill_7de0d131-ae1d-481a-adaa-f6794d43f24d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_c17a812f-58ec-4b71-8c41-369bce63898f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_ca4a5e36-6583-4cde-818a-522ac8bdd6c6" xlink:to="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_c17a812f-58ec-4b71-8c41-369bce63898f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_93c98b03-a26d-40a0-bec7-24e121b50ccf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_ca4a5e36-6583-4cde-818a-522ac8bdd6c6" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_93c98b03-a26d-40a0-bec7-24e121b50ccf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_9fa7dd6c-3978-4770-bce6-41897aa8bd74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_ca4a5e36-6583-4cde-818a-522ac8bdd6c6" xlink:to="loc_us-gaap_Goodwill_9fa7dd6c-3978-4770-bce6-41897aa8bd74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_0610df0f-58d1-4764-9ba4-9a4437cfc664" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_36d37a03-aa0e-4586-8ffb-d0fb8c45d4b2" xlink:to="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_0610df0f-58d1-4764-9ba4-9a4437cfc664" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.amnhealthcare.com/role/NotesPayableandCreditAgreement" xlink:type="simple" xlink:href="amn-20210930.xsd#NotesPayableandCreditAgreement"/>
  <link:presentationLink xlink:role="http://www.amnhealthcare.com/role/NotesPayableandCreditAgreement" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_fe75b2cb-5486-43d5-8c9e-13d3170f9459" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_5f359222-9efd-49fb-9719-48bfa23804fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_fe75b2cb-5486-43d5-8c9e-13d3170f9459" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_5f359222-9efd-49fb-9719-48bfa23804fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.amnhealthcare.com/role/NotesPayableandCreditAgreementDetails" xlink:type="simple" xlink:href="amn-20210930.xsd#NotesPayableandCreditAgreementDetails"/>
  <link:presentationLink xlink:role="http://www.amnhealthcare.com/role/NotesPayableandCreditAgreementDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_f785c8d2-0421-431a-9b55-edebc9409b27" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_a31f012c-1ccf-4acc-81d6-f2d484de9d95" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_f785c8d2-0421-431a-9b55-edebc9409b27" xlink:to="loc_us-gaap_DebtInstrumentTable_a31f012c-1ccf-4acc-81d6-f2d484de9d95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_e63a26f5-947f-4bb1-8f01-b5e0b9745420" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_a31f012c-1ccf-4acc-81d6-f2d484de9d95" xlink:to="loc_us-gaap_CreditFacilityAxis_e63a26f5-947f-4bb1-8f01-b5e0b9745420" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_699f5e83-5bdc-466f-8169-c01797d49a7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_e63a26f5-947f-4bb1-8f01-b5e0b9745420" xlink:to="loc_us-gaap_CreditFacilityDomain_699f5e83-5bdc-466f-8169-c01797d49a7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_926ec797-1c62-4239-843b-8eb1221a575a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_699f5e83-5bdc-466f-8169-c01797d49a7c" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_926ec797-1c62-4239-843b-8eb1221a575a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_391994b2-04ab-41c6-b6e7-8d8373b7b180" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuredDebtMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_699f5e83-5bdc-466f-8169-c01797d49a7c" xlink:to="loc_us-gaap_SecuredDebtMember_391994b2-04ab-41c6-b6e7-8d8373b7b180" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_4ac44ab0-4881-4999-bb3a-e428b324a1d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_a31f012c-1ccf-4acc-81d6-f2d484de9d95" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_4ac44ab0-4881-4999-bb3a-e428b324a1d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_2fe7b9cd-082d-4644-8bcb-8d8d1cc9d822" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_4ac44ab0-4881-4999-bb3a-e428b324a1d4" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_2fe7b9cd-082d-4644-8bcb-8d8d1cc9d822" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_c50bef15-0bf1-4d40-ba39-0970aaac4a1b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_2fe7b9cd-082d-4644-8bcb-8d8d1cc9d822" xlink:to="loc_us-gaap_LineOfCreditMember_c50bef15-0bf1-4d40-ba39-0970aaac4a1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amn_TermDebtMember_c2fa70cc-1242-4b91-b8e7-442a8d881470" xlink:href="amn-20210930.xsd#amn_TermDebtMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_2fe7b9cd-082d-4644-8bcb-8d8d1cc9d822" xlink:to="loc_amn_TermDebtMember_c2fa70cc-1242-4b91-b8e7-442a8d881470" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_57d9c70a-6d01-452f-98e8-90bc64cc3e29" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_a31f012c-1ccf-4acc-81d6-f2d484de9d95" xlink:to="loc_us-gaap_DebtInstrumentLineItems_57d9c70a-6d01-452f-98e8-90bc64cc3e29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_2f1a9b99-6111-4366-b7fe-bfda6e084365" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_57d9c70a-6d01-452f-98e8-90bc64cc3e29" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_2f1a9b99-6111-4366-b7fe-bfda6e084365" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_3b8e4cc2-b370-4e91-8966-a1e7535f03be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_57d9c70a-6d01-452f-98e8-90bc64cc3e29" xlink:to="loc_us-gaap_LongTermDebt_3b8e4cc2-b370-4e91-8966-a1e7535f03be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.amnhealthcare.com/role/FairValueMeasurement" xlink:type="simple" xlink:href="amn-20210930.xsd#FairValueMeasurement"/>
  <link:presentationLink xlink:role="http://www.amnhealthcare.com/role/FairValueMeasurement" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_ddab6b51-a933-4aa5-9af5-d0fe4d49599d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_fe49506b-c981-4bbd-9e00-01053b67d765" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_ddab6b51-a933-4aa5-9af5-d0fe4d49599d" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_fe49506b-c981-4bbd-9e00-01053b67d765" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.amnhealthcare.com/role/FairValueMeasurementTables" xlink:type="simple" xlink:href="amn-20210930.xsd#FairValueMeasurementTables"/>
  <link:presentationLink xlink:role="http://www.amnhealthcare.com/role/FairValueMeasurementTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_cf0f40ad-071c-4a73-807a-6dda0985fe6a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_baf9690e-9bde-4c4e-b3a7-64a564ccccd3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_cf0f40ad-071c-4a73-807a-6dda0985fe6a" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_baf9690e-9bde-4c4e-b3a7-64a564ccccd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_8b217091-2785-4777-b9ea-07adc78ffa05" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_cf0f40ad-071c-4a73-807a-6dda0985fe6a" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_8b217091-2785-4777-b9ea-07adc78ffa05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTextBlock_87a0a0cb-0d9e-4813-8aab-cfca019beeb6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_cf0f40ad-071c-4a73-807a-6dda0985fe6a" xlink:to="loc_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTextBlock_87a0a0cb-0d9e-4813-8aab-cfca019beeb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.amnhealthcare.com/role/FairValueMeasurementNarrativeDetails" xlink:type="simple" xlink:href="amn-20210930.xsd#FairValueMeasurementNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.amnhealthcare.com/role/FairValueMeasurementNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_4dd15cf0-e235-4911-8639-15824bf3590f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c0f77404-9781-41fb-8688-3dc6ab83188f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_4dd15cf0-e235-4911-8639-15824bf3590f" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c0f77404-9781-41fb-8688-3dc6ab83188f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_d06128ce-bb5b-4234-8a76-ff99722d2780" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c0f77404-9781-41fb-8688-3dc6ab83188f" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_d06128ce-bb5b-4234-8a76-ff99722d2780" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_bfa388af-6be6-4775-afc9-3b1a3d6f90b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_d06128ce-bb5b-4234-8a76-ff99722d2780" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_bfa388af-6be6-4775-afc9-3b1a3d6f90b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_d0457f50-dbd9-4318-8b74-4ec6cc805898" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_bfa388af-6be6-4775-afc9-3b1a3d6f90b3" xlink:to="loc_us-gaap_CommercialPaperMember_d0457f50-dbd9-4318-8b74-4ec6cc805898" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_7bd789d9-0935-4804-9e97-8725eebfa725" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c0f77404-9781-41fb-8688-3dc6ab83188f" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_7bd789d9-0935-4804-9e97-8725eebfa725" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_ed15782e-27fb-49c8-8f30-d5c2bc214db6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_7bd789d9-0935-4804-9e97-8725eebfa725" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_ed15782e-27fb-49c8-8f30-d5c2bc214db6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_9e433094-ba4d-499e-b970-8d9388a0a274" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_ed15782e-27fb-49c8-8f30-d5c2bc214db6" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_9e433094-ba4d-499e-b970-8d9388a0a274" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsNonrecurringMember_22372a6b-4366-456b-b68e-599a06957cb7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsNonrecurringMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_ed15782e-27fb-49c8-8f30-d5c2bc214db6" xlink:to="loc_us-gaap_FairValueMeasurementsNonrecurringMember_22372a6b-4366-456b-b68e-599a06957cb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_849973a5-49a5-435d-98a1-3fd1bd8ea45b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c0f77404-9781-41fb-8688-3dc6ab83188f" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_849973a5-49a5-435d-98a1-3fd1bd8ea45b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_fffb2e73-ff96-405b-b937-d702d63d49a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_849973a5-49a5-435d-98a1-3fd1bd8ea45b" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_fffb2e73-ff96-405b-b937-d702d63d49a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_a598e0b4-ad90-4d02-ae0f-1bf9cf858153" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_fffb2e73-ff96-405b-b937-d702d63d49a0" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_a598e0b4-ad90-4d02-ae0f-1bf9cf858153" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_2b82caee-5b3a-4cb9-9f75-16582bb78555" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c0f77404-9781-41fb-8688-3dc6ab83188f" xlink:to="loc_us-gaap_DebtInstrumentAxis_2b82caee-5b3a-4cb9-9f75-16582bb78555" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_fd3a099d-8b3f-477a-8c7e-0b4915e1c7eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_2b82caee-5b3a-4cb9-9f75-16582bb78555" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_fd3a099d-8b3f-477a-8c7e-0b4915e1c7eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amn_A4.625SeniorNotesDue2027Member_a04062c8-67eb-47c3-a595-219b3537710f" xlink:href="amn-20210930.xsd#amn_A4.625SeniorNotesDue2027Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_fd3a099d-8b3f-477a-8c7e-0b4915e1c7eb" xlink:to="loc_amn_A4.625SeniorNotesDue2027Member_a04062c8-67eb-47c3-a595-219b3537710f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amn_A4000SeniorNotesDue2029Member_3de70e07-fd1a-41ea-ace5-f1a338d459ef" xlink:href="amn-20210930.xsd#amn_A4000SeniorNotesDue2029Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_fd3a099d-8b3f-477a-8c7e-0b4915e1c7eb" xlink:to="loc_amn_A4000SeniorNotesDue2029Member_3de70e07-fd1a-41ea-ace5-f1a338d459ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_eb62b412-c602-457d-bbc2-4c2097cc1e45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c0f77404-9781-41fb-8688-3dc6ab83188f" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_eb62b412-c602-457d-bbc2-4c2097cc1e45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_551c1ec9-4fc8-4184-9176-227bc9604efa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_eb62b412-c602-457d-bbc2-4c2097cc1e45" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_551c1ec9-4fc8-4184-9176-227bc9604efa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_445e8b64-1ed9-4985-8fc2-e506993895fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_551c1ec9-4fc8-4184-9176-227bc9604efa" xlink:to="loc_us-gaap_SeniorNotesMember_445e8b64-1ed9-4985-8fc2-e506993895fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_4a32526c-604e-450f-abf1-657395e385b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c0f77404-9781-41fb-8688-3dc6ab83188f" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_4a32526c-604e-450f-abf1-657395e385b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetAssetLiability_afa0149b-8787-4283-a9f7-bc098f5d1248" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueNetAssetLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_4a32526c-604e-450f-abf1-657395e385b4" xlink:to="loc_us-gaap_FairValueNetAssetLiability_afa0149b-8787-4283-a9f7-bc098f5d1248" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_33fc9fd8-f92a-40f0-8396-75891fea6b36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_4a32526c-604e-450f-abf1-657395e385b4" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_33fc9fd8-f92a-40f0-8396-75891fea6b36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_ac35cbf7-8c23-493c-b08f-c30f68402596" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_4a32526c-604e-450f-abf1-657395e385b4" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_ac35cbf7-8c23-493c-b08f-c30f68402596" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_23700c1f-94ee-4726-afd1-f34b560f119b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_4a32526c-604e-450f-abf1-657395e385b4" xlink:to="loc_us-gaap_AssetImpairmentCharges_23700c1f-94ee-4726-afd1-f34b560f119b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_92728304-afe9-47fd-9412-57c302e84f03" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_4a32526c-604e-450f-abf1-657395e385b4" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_92728304-afe9-47fd-9412-57c302e84f03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.amnhealthcare.com/role/FairValueMeasurementFinancialAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="amn-20210930.xsd#FairValueMeasurementFinancialAssetsandLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.amnhealthcare.com/role/FairValueMeasurementFinancialAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_0e44bd29-3cc0-44fe-817d-cf55cad89550" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_142e7581-2275-41c4-a86c-a4060b73f852" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_0e44bd29-3cc0-44fe-817d-cf55cad89550" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_142e7581-2275-41c4-a86c-a4060b73f852" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_5072866f-9f41-498a-8c67-35a7e8bf7ecc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_142e7581-2275-41c4-a86c-a4060b73f852" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_5072866f-9f41-498a-8c67-35a7e8bf7ecc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_ba66f5df-e782-48c7-8a4a-50c1072a31a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_5072866f-9f41-498a-8c67-35a7e8bf7ecc" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_ba66f5df-e782-48c7-8a4a-50c1072a31a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_f3c245a6-61dc-4787-b475-bce1e6ba9830" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_ba66f5df-e782-48c7-8a4a-50c1072a31a6" xlink:to="loc_us-gaap_MoneyMarketFundsMember_f3c245a6-61dc-4787-b475-bce1e6ba9830" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_d404c3aa-4811-4cd9-869c-215fe3e7a0b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_ba66f5df-e782-48c7-8a4a-50c1072a31a6" xlink:to="loc_us-gaap_CommercialPaperMember_d404c3aa-4811-4cd9-869c-215fe3e7a0b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_f2c15fbc-0d29-4016-9e64-077f3d92ac47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_142e7581-2275-41c4-a86c-a4060b73f852" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_f2c15fbc-0d29-4016-9e64-077f3d92ac47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_db46f4db-ade7-4fd3-8913-ca7e312c7cde" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_f2c15fbc-0d29-4016-9e64-077f3d92ac47" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_db46f4db-ade7-4fd3-8913-ca7e312c7cde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amn_DeferredCompensationMember_48110cc7-9f55-41b2-a31c-c989bbfb1146" xlink:href="amn-20210930.xsd#amn_DeferredCompensationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_db46f4db-ade7-4fd3-8913-ca7e312c7cde" xlink:to="loc_amn_DeferredCompensationMember_48110cc7-9f55-41b2-a31c-c989bbfb1146" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amn_ContingentConsiderationMember_451223d3-aec4-4599-a571-e98cd3f42b1c" xlink:href="amn-20210930.xsd#amn_ContingentConsiderationMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_db46f4db-ade7-4fd3-8913-ca7e312c7cde" xlink:to="loc_amn_ContingentConsiderationMember_451223d3-aec4-4599-a571-e98cd3f42b1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_3fd40f0b-a86e-45e8-821d-c2e17fea8666" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_142e7581-2275-41c4-a86c-a4060b73f852" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_3fd40f0b-a86e-45e8-821d-c2e17fea8666" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_e8c1cda7-9254-498a-817f-e2063803a827" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_3fd40f0b-a86e-45e8-821d-c2e17fea8666" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_e8c1cda7-9254-498a-817f-e2063803a827" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_0b025d0b-2dc0-4d8c-8a64-dd9789ba96a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_e8c1cda7-9254-498a-817f-e2063803a827" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_0b025d0b-2dc0-4d8c-8a64-dd9789ba96a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_353fc2d5-bfcd-4731-9742-6b189c7f7838" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_142e7581-2275-41c4-a86c-a4060b73f852" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_353fc2d5-bfcd-4731-9742-6b189c7f7838" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1093555e-91fa-4952-8acd-23d2f16568f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_353fc2d5-bfcd-4731-9742-6b189c7f7838" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1093555e-91fa-4952-8acd-23d2f16568f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_462e1acb-d0fa-4cae-9a0c-a610700fe970" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1093555e-91fa-4952-8acd-23d2f16568f2" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_462e1acb-d0fa-4cae-9a0c-a610700fe970" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_a82fb1b7-3cf3-4823-9079-a8ffe8bc6a1d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1093555e-91fa-4952-8acd-23d2f16568f2" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_a82fb1b7-3cf3-4823-9079-a8ffe8bc6a1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_74ff5261-1936-441d-b327-2e89633f1f2f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1093555e-91fa-4952-8acd-23d2f16568f2" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_74ff5261-1936-441d-b327-2e89633f1f2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_b81f9803-8226-4a1a-a67a-cb76fe73fcc1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_142e7581-2275-41c4-a86c-a4060b73f852" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_b81f9803-8226-4a1a-a67a-cb76fe73fcc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetAssetLiability_9733553f-3341-4440-b6e6-817b471d273f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueNetAssetLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_b81f9803-8226-4a1a-a67a-cb76fe73fcc1" xlink:to="loc_us-gaap_FairValueNetAssetLiability_9733553f-3341-4440-b6e6-817b471d273f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.amnhealthcare.com/role/FairValueMeasurementReconciliationofChangesinContingentConsiderationLiabilitiesDetails" xlink:type="simple" xlink:href="amn-20210930.xsd#FairValueMeasurementReconciliationofChangesinContingentConsiderationLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.amnhealthcare.com/role/FairValueMeasurementReconciliationofChangesinContingentConsiderationLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_8baa2177-189c-49c6-ae1d-b94e781d3314" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_81fafd2f-4bb3-46b3-9a99-a8dfda41614b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_8baa2177-189c-49c6-ae1d-b94e781d3314" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_81fafd2f-4bb3-46b3-9a99-a8dfda41614b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_3d518bc3-c08a-4a2d-8cd8-9c2a1543a67f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_81fafd2f-4bb3-46b3-9a99-a8dfda41614b" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_3d518bc3-c08a-4a2d-8cd8-9c2a1543a67f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_a56b28bb-4864-4ca8-bff0-12d0dff715f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_3d518bc3-c08a-4a2d-8cd8-9c2a1543a67f" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_a56b28bb-4864-4ca8-bff0-12d0dff715f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_5b2ea938-d5c7-4ed6-988e-b870bbc0d5d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_a56b28bb-4864-4ca8-bff0-12d0dff715f9" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_5b2ea938-d5c7-4ed6-988e-b870bbc0d5d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_d61bdf0e-fa4e-4e3a-8a4e-ccf89b2f5918" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_81fafd2f-4bb3-46b3-9a99-a8dfda41614b" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_d61bdf0e-fa4e-4e3a-8a4e-ccf89b2f5918" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_1cc3ec11-a46d-43ad-99da-da062fda4d5d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_d61bdf0e-fa4e-4e3a-8a4e-ccf89b2f5918" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_1cc3ec11-a46d-43ad-99da-da062fda4d5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amn_ContingentConsiderationMember_5ac4482b-c1ac-41cc-8d36-d5716cb241ca" xlink:href="amn-20210930.xsd#amn_ContingentConsiderationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_1cc3ec11-a46d-43ad-99da-da062fda4d5d" xlink:to="loc_amn_ContingentConsiderationMember_5ac4482b-c1ac-41cc-8d36-d5716cb241ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_4d0be017-57b3-45fb-b7c5-2a6a94864a21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_81fafd2f-4bb3-46b3-9a99-a8dfda41614b" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_4d0be017-57b3-45fb-b7c5-2a6a94864a21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_76607681-ab85-4196-b3da-c661b1ccf54b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_4d0be017-57b3-45fb-b7c5-2a6a94864a21" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_76607681-ab85-4196-b3da-c661b1ccf54b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amn_AdvancedMedicalPersonnelServicesInc.Member_f4eb057c-49a8-4811-972b-4c6c9a567fbb" xlink:href="amn-20210930.xsd#amn_AdvancedMedicalPersonnelServicesInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_76607681-ab85-4196-b3da-c661b1ccf54b" xlink:to="loc_amn_AdvancedMedicalPersonnelServicesInc.Member_f4eb057c-49a8-4811-972b-4c6c9a567fbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amn_B4healthLLCMember_9e5d3ef0-3bab-4d7c-b26b-2bad0d759a5c" xlink:href="amn-20210930.xsd#amn_B4healthLLCMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_76607681-ab85-4196-b3da-c661b1ccf54b" xlink:to="loc_amn_B4healthLLCMember_9e5d3ef0-3bab-4d7c-b26b-2bad0d759a5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_0b8d73df-2455-4c25-a1e8-df4d9e584a7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_81fafd2f-4bb3-46b3-9a99-a8dfda41614b" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_0b8d73df-2455-4c25-a1e8-df4d9e584a7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_daf6cbaa-855a-44e3-86bc-6c0f89d5879b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_0b8d73df-2455-4c25-a1e8-df4d9e584a7e" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_daf6cbaa-855a-44e3-86bc-6c0f89d5879b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_404931c9-d2dd-4d50-914a-e89f3af88992" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_daf6cbaa-855a-44e3-86bc-6c0f89d5879b" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_404931c9-d2dd-4d50-914a-e89f3af88992" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f56f3352-07ce-4d0b-b9cd-3f6c849707ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_81fafd2f-4bb3-46b3-9a99-a8dfda41614b" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f56f3352-07ce-4d0b-b9cd-3f6c849707ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_88f33170-00a8-4cf1-823f-e5ee5894451f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f56f3352-07ce-4d0b-b9cd-3f6c849707ca" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_88f33170-00a8-4cf1-823f-e5ee5894451f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_9e8401d5-1c3a-43f4-ba77-0b9b4e7c2a21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_88f33170-00a8-4cf1-823f-e5ee5894451f" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_9e8401d5-1c3a-43f4-ba77-0b9b4e7c2a21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_a2a8e6cb-c985-4cc1-8274-9293a7242b2b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_88f33170-00a8-4cf1-823f-e5ee5894451f" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_a2a8e6cb-c985-4cc1-8274-9293a7242b2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_4d70086d-29f4-4a43-99d2-587c6bb1d437" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_88f33170-00a8-4cf1-823f-e5ee5894451f" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_4d70086d-29f4-4a43-99d2-587c6bb1d437" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_47338d77-ff57-41f4-8793-5cefab708dc3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_88f33170-00a8-4cf1-823f-e5ee5894451f" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_47338d77-ff57-41f4-8793-5cefab708dc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.amnhealthcare.com/role/FairValueMeasurementFairValueofFinancialInstrumentsDetails" xlink:type="simple" xlink:href="amn-20210930.xsd#FairValueMeasurementFairValueofFinancialInstrumentsDetails"/>
  <link:presentationLink xlink:role="http://www.amnhealthcare.com/role/FairValueMeasurementFairValueofFinancialInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_55ae0a7c-9efb-4ef9-aa9c-5eaea50827fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_4c8b73fe-3b05-4791-8efa-3d8522a1a3a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_55ae0a7c-9efb-4ef9-aa9c-5eaea50827fc" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_4c8b73fe-3b05-4791-8efa-3d8522a1a3a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_cedafbd7-db3c-47aa-ba52-3e1de32c4a90" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_4c8b73fe-3b05-4791-8efa-3d8522a1a3a1" xlink:to="loc_us-gaap_DebtInstrumentAxis_cedafbd7-db3c-47aa-ba52-3e1de32c4a90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_6cf7ef84-2f80-4e69-8b08-98f1cb11f8a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_cedafbd7-db3c-47aa-ba52-3e1de32c4a90" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_6cf7ef84-2f80-4e69-8b08-98f1cb11f8a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amn_A4.625SeniorNotesDue2027Member_5d3dd1e0-405d-40c8-a694-853f57d3451b" xlink:href="amn-20210930.xsd#amn_A4.625SeniorNotesDue2027Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6cf7ef84-2f80-4e69-8b08-98f1cb11f8a0" xlink:to="loc_amn_A4.625SeniorNotesDue2027Member_5d3dd1e0-405d-40c8-a694-853f57d3451b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amn_A4000SeniorNotesDue2029Member_63274a2b-8f50-485f-95dd-72b2be2a4185" xlink:href="amn-20210930.xsd#amn_A4000SeniorNotesDue2029Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6cf7ef84-2f80-4e69-8b08-98f1cb11f8a0" xlink:to="loc_amn_A4000SeniorNotesDue2029Member_63274a2b-8f50-485f-95dd-72b2be2a4185" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_858d6229-a7e4-46ec-bb22-28a2f819bd99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_4c8b73fe-3b05-4791-8efa-3d8522a1a3a1" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_858d6229-a7e4-46ec-bb22-28a2f819bd99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_5b1c4994-a7a3-44a6-9189-ade3f8658a99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_858d6229-a7e4-46ec-bb22-28a2f819bd99" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_5b1c4994-a7a3-44a6-9189-ade3f8658a99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_1fd56b24-33b1-4c10-a8a7-1f0f114f0e34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_5b1c4994-a7a3-44a6-9189-ade3f8658a99" xlink:to="loc_us-gaap_SeniorNotesMember_1fd56b24-33b1-4c10-a8a7-1f0f114f0e34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_708f975e-881d-4028-816f-b735cbcb69f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_4c8b73fe-3b05-4791-8efa-3d8522a1a3a1" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_708f975e-881d-4028-816f-b735cbcb69f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_ede3177b-5eef-47ad-99fc-cacff8a39d98" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_708f975e-881d-4028-816f-b735cbcb69f6" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_ede3177b-5eef-47ad-99fc-cacff8a39d98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_8a9886d9-76e0-44bd-a9d7-903e7006ac48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_708f975e-881d-4028-816f-b735cbcb69f6" xlink:to="loc_us-gaap_DebtInstrumentFairValue_8a9886d9-76e0-44bd-a9d7-903e7006ac48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.amnhealthcare.com/role/Leases" xlink:type="simple" xlink:href="amn-20210930.xsd#Leases"/>
  <link:presentationLink xlink:role="http://www.amnhealthcare.com/role/Leases" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_2f82b462-903a-4864-8207-2b8c4735d389" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_dfb5cd97-a3bb-43fa-940f-a918709eaf3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_2f82b462-903a-4864-8207-2b8c4735d389" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_dfb5cd97-a3bb-43fa-940f-a918709eaf3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.amnhealthcare.com/role/LeasesDetails" xlink:type="simple" xlink:href="amn-20210930.xsd#LeasesDetails"/>
  <link:presentationLink xlink:role="http://www.amnhealthcare.com/role/LeasesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_5679185b-c313-4be3-bba8-addfc25a220f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_amn_NumberOfPhasesOfLeaseTerminationAgreement_9d99aeb2-5a9a-41e3-8ed8-ce633aa41470" xlink:href="amn-20210930.xsd#amn_NumberOfPhasesOfLeaseTerminationAgreement"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_5679185b-c313-4be3-bba8-addfc25a220f" xlink:to="loc_amn_NumberOfPhasesOfLeaseTerminationAgreement_9d99aeb2-5a9a-41e3-8ed8-ce633aa41470" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amn_PaymentsOfLeaseTerminationFee_c7cd8ce5-e652-42e1-b4f2-e9a9bf42105a" xlink:href="amn-20210930.xsd#amn_PaymentsOfLeaseTerminationFee"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_5679185b-c313-4be3-bba8-addfc25a220f" xlink:to="loc_amn_PaymentsOfLeaseTerminationFee_c7cd8ce5-e652-42e1-b4f2-e9a9bf42105a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amn_OperatingLeaseRightOfUseAssetIncreaseDecreaseFromModification_c5da24d5-5644-4dbe-987c-59add339b232" xlink:href="amn-20210930.xsd#amn_OperatingLeaseRightOfUseAssetIncreaseDecreaseFromModification"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_5679185b-c313-4be3-bba8-addfc25a220f" xlink:to="loc_amn_OperatingLeaseRightOfUseAssetIncreaseDecreaseFromModification_c5da24d5-5644-4dbe-987c-59add339b232" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amn_OperatingLeaseLiabilityIncreaseDecreaseFromModification_27dfd842-5753-48e5-810e-f010df5049fb" xlink:href="amn-20210930.xsd#amn_OperatingLeaseLiabilityIncreaseDecreaseFromModification"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_5679185b-c313-4be3-bba8-addfc25a220f" xlink:to="loc_amn_OperatingLeaseLiabilityIncreaseDecreaseFromModification_27dfd842-5753-48e5-810e-f010df5049fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amn_LesseeOperatingLeaseLiabilityToBePaidPremodification_c86339fc-b65f-46fa-af8c-12bd576f8f90" xlink:href="amn-20210930.xsd#amn_LesseeOperatingLeaseLiabilityToBePaidPremodification"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_5679185b-c313-4be3-bba8-addfc25a220f" xlink:to="loc_amn_LesseeOperatingLeaseLiabilityToBePaidPremodification_c86339fc-b65f-46fa-af8c-12bd576f8f90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amn_LesseeOperatingLeaseLiabilityToBePaidPostmodification_dd80f2c0-9d1a-4929-9d40-a5eca8147e6e" xlink:href="amn-20210930.xsd#amn_LesseeOperatingLeaseLiabilityToBePaidPostmodification"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_5679185b-c313-4be3-bba8-addfc25a220f" xlink:to="loc_amn_LesseeOperatingLeaseLiabilityToBePaidPostmodification_dd80f2c0-9d1a-4929-9d40-a5eca8147e6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.amnhealthcare.com/role/IncomeTaxes" xlink:type="simple" xlink:href="amn-20210930.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://www.amnhealthcare.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_235d2eab-9b9c-42a0-b155-f78618df2a75" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_c8720979-1da2-4eee-b30c-bffb9edf013b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_235d2eab-9b9c-42a0-b155-f78618df2a75" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_c8720979-1da2-4eee-b30c-bffb9edf013b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.amnhealthcare.com/role/IncomeTaxesDetails" xlink:type="simple" xlink:href="amn-20210930.xsd#IncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://www.amnhealthcare.com/role/IncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_ad908cfb-04d2-45fe-8f63-12a2d941b884" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_amn_DeferredPayrollTaxesCARESAct_ac100c8e-7de1-420f-bf18-f4f0be876d1f" xlink:href="amn-20210930.xsd#amn_DeferredPayrollTaxesCARESAct"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ad908cfb-04d2-45fe-8f63-12a2d941b884" xlink:to="loc_amn_DeferredPayrollTaxesCARESAct_ac100c8e-7de1-420f-bf18-f4f0be876d1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amn_EmployeeRetentionEmploymentTaxCreditCARESAct_4fbd01ca-b254-40ce-97cd-967fc17cbc73" xlink:href="amn-20210930.xsd#amn_EmployeeRetentionEmploymentTaxCreditCARESAct"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ad908cfb-04d2-45fe-8f63-12a2d941b884" xlink:to="loc_amn_EmployeeRetentionEmploymentTaxCreditCARESAct_4fbd01ca-b254-40ce-97cd-967fc17cbc73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.amnhealthcare.com/role/CommitmentsandContingenciesLegalProceedings" xlink:type="simple" xlink:href="amn-20210930.xsd#CommitmentsandContingenciesLegalProceedings"/>
  <link:presentationLink xlink:role="http://www.amnhealthcare.com/role/CommitmentsandContingenciesLegalProceedings" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_39daa312-c3b5-48a0-b345-05cf3510489e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_246a5bcd-2823-4e86-b98c-4e314d6ac9a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_39daa312-c3b5-48a0-b345-05cf3510489e" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_246a5bcd-2823-4e86-b98c-4e314d6ac9a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.amnhealthcare.com/role/CommitmentsandContingenciesLegalProceedingsDetails" xlink:type="simple" xlink:href="amn-20210930.xsd#CommitmentsandContingenciesLegalProceedingsDetails"/>
  <link:presentationLink xlink:role="http://www.amnhealthcare.com/role/CommitmentsandContingenciesLegalProceedingsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_1cf7a9c0-df04-43b8-aeb6-a764890b5b53" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_f2c60b73-f968-4b90-9cc2-824a373b0d8b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_1cf7a9c0-df04-43b8-aeb6-a764890b5b53" xlink:to="loc_us-gaap_LossContingenciesTable_f2c60b73-f968-4b90-9cc2-824a373b0d8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_d211c514-6cf5-4943-9630-8124a6296c58" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_f2c60b73-f968-4b90-9cc2-824a373b0d8b" xlink:to="loc_srt_LitigationCaseAxis_d211c514-6cf5-4943-9630-8124a6296c58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_90d48505-faf1-48a5-b3e5-1032e0c172c2" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_d211c514-6cf5-4943-9630-8124a6296c58" xlink:to="loc_srt_LitigationCaseTypeDomain_90d48505-faf1-48a5-b3e5-1032e0c172c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amn_WageAndHourClaimsMember_3aeae698-c18d-46c1-8d09-cefa140e7502" xlink:href="amn-20210930.xsd#amn_WageAndHourClaimsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_90d48505-faf1-48a5-b3e5-1032e0c172c2" xlink:to="loc_amn_WageAndHourClaimsMember_3aeae698-c18d-46c1-8d09-cefa140e7502" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_010d250b-dcd5-4907-bb0b-19d39613e08d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_f2c60b73-f968-4b90-9cc2-824a373b0d8b" xlink:to="loc_us-gaap_LitigationStatusAxis_010d250b-dcd5-4907-bb0b-19d39613e08d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_15e9f278-3c74-4358-8c5f-da55ded08a63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusAxis_010d250b-dcd5-4907-bb0b-19d39613e08d" xlink:to="loc_us-gaap_LitigationStatusDomain_15e9f278-3c74-4358-8c5f-da55ded08a63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember_0357df93-4cff-4bfd-9809-e3ef71969f15" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PendingLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusDomain_15e9f278-3c74-4358-8c5f-da55ded08a63" xlink:to="loc_us-gaap_PendingLitigationMember_0357df93-4cff-4bfd-9809-e3ef71969f15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_c1058b68-5b60-41ab-ae6f-f52ece9081c3" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_f2c60b73-f968-4b90-9cc2-824a373b0d8b" xlink:to="loc_srt_RangeAxis_c1058b68-5b60-41ab-ae6f-f52ece9081c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_62a8a467-3206-46ed-b349-becfabb18dbb" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_c1058b68-5b60-41ab-ae6f-f52ece9081c3" xlink:to="loc_srt_RangeMember_62a8a467-3206-46ed-b349-becfabb18dbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_a14aec17-faef-47a1-9f0f-58e9ceca567f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_62a8a467-3206-46ed-b349-becfabb18dbb" xlink:to="loc_srt_MaximumMember_a14aec17-faef-47a1-9f0f-58e9ceca567f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_5950d426-2f85-424c-af3a-09aa28ae0211" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_f2c60b73-f968-4b90-9cc2-824a373b0d8b" xlink:to="loc_us-gaap_LossContingenciesLineItems_5950d426-2f85-424c-af3a-09aa28ae0211" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease_a4a20fb5-03f3-4c56-b7df-77fd3408b765" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_5950d426-2f85-424c-af3a-09aa28ae0211" xlink:to="loc_us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease_a4a20fb5-03f3-4c56-b7df-77fd3408b765" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyEstimateOfPossibleLoss_283911dd-e991-43b5-888b-214b4aa57137" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyEstimateOfPossibleLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_5950d426-2f85-424c-af3a-09aa28ae0211" xlink:to="loc_us-gaap_LossContingencyEstimateOfPossibleLoss_283911dd-e991-43b5-888b-214b4aa57137" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.amnhealthcare.com/role/BalanceSheetDetails" xlink:type="simple" xlink:href="amn-20210930.xsd#BalanceSheetDetails"/>
  <link:presentationLink xlink:role="http://www.amnhealthcare.com/role/BalanceSheetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_ce8d15c4-9a3b-435f-af03-86b5ec15c2b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_a0bb3d59-9a7b-43c6-8cc9-fbffe588fc30" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalBalanceSheetDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_ce8d15c4-9a3b-435f-af03-86b5ec15c2b8" xlink:to="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_a0bb3d59-9a7b-43c6-8cc9-fbffe588fc30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.amnhealthcare.com/role/BalanceSheetDetailsTables" xlink:type="simple" xlink:href="amn-20210930.xsd#BalanceSheetDetailsTables"/>
  <link:presentationLink xlink:role="http://www.amnhealthcare.com/role/BalanceSheetDetailsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_8ad03e13-4288-4a2c-8adf-905cde833e93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_amn_ScheduleofSupplementalBalanceSheetDisclosuresTableTextBlock_49e40967-aa55-449a-b1fe-53db41037bb7" xlink:href="amn-20210930.xsd#amn_ScheduleofSupplementalBalanceSheetDisclosuresTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_8ad03e13-4288-4a2c-8adf-905cde833e93" xlink:to="loc_amn_ScheduleofSupplementalBalanceSheetDisclosuresTableTextBlock_49e40967-aa55-449a-b1fe-53db41037bb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.amnhealthcare.com/role/BalanceSheetDetailsDetails" xlink:type="simple" xlink:href="amn-20210930.xsd#BalanceSheetDetailsDetails"/>
  <link:presentationLink xlink:role="http://www.amnhealthcare.com/role/BalanceSheetDetailsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_3a26b2be-ee96-4b26-99eb-d1140807457a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_78660d10-bc0b-4f64-bbf6-67f48deb1fdc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_3a26b2be-ee96-4b26-99eb-d1140807457a" xlink:to="loc_us-gaap_AssetsCurrentAbstract_78660d10-bc0b-4f64-bbf6-67f48deb1fdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalents_83efb80c-f14e-453c-9641-9b30704a6708" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalents"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_78660d10-bc0b-4f64-bbf6-67f48deb1fdc" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalents_83efb80c-f14e-453c-9641-9b30704a6708" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivable_f2d7c9d6-1ead-40f3-8321-a968800368df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesReceivable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_78660d10-bc0b-4f64-bbf6-67f48deb1fdc" xlink:to="loc_us-gaap_IncomeTaxesReceivable_f2d7c9d6-1ead-40f3-8321-a968800368df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMiscellaneousCurrent_209a6144-1cde-4b46-9035-a592cf8a5eb9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsMiscellaneousCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_78660d10-bc0b-4f64-bbf6-67f48deb1fdc" xlink:to="loc_us-gaap_OtherAssetsMiscellaneousCurrent_209a6144-1cde-4b46-9035-a592cf8a5eb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_dc11ec38-9f0b-48bc-a844-36ace2f6e35b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_78660d10-bc0b-4f64-bbf6-67f48deb1fdc" xlink:to="loc_us-gaap_OtherAssetsCurrent_dc11ec38-9f0b-48bc-a844-36ace2f6e35b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract_a4010d99-6ca2-4795-a113-79a25951c71e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNetAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_3a26b2be-ee96-4b26-99eb-d1140807457a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract_a4010d99-6ca2-4795-a113-79a25951c71e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesGross_d5f45520-766e-4e35-ba6f-d7e10972527a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FurnitureAndFixturesGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract_a4010d99-6ca2-4795-a113-79a25951c71e" xlink:to="loc_us-gaap_FurnitureAndFixturesGross_d5f45520-766e-4e35-ba6f-d7e10972527a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareGross_e6780bc5-0fd3-4b5c-9814-7e307cccdf71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedComputerSoftwareGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract_a4010d99-6ca2-4795-a113-79a25951c71e" xlink:to="loc_us-gaap_CapitalizedComputerSoftwareGross_e6780bc5-0fd3-4b5c-9814-7e307cccdf71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsGross_30216fd1-a61b-429f-a3cb-b2b28164dd7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsGross"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract_a4010d99-6ca2-4795-a113-79a25951c71e" xlink:to="loc_us-gaap_LeaseholdImprovementsGross_30216fd1-a61b-429f-a3cb-b2b28164dd7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_cdf69b2c-05cb-49d6-b1fd-9c71d9005f7f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract_a4010d99-6ca2-4795-a113-79a25951c71e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_cdf69b2c-05cb-49d6-b1fd-9c71d9005f7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_3e895bf5-936d-4041-80ef-52c829da4a85" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract_a4010d99-6ca2-4795-a113-79a25951c71e" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_3e895bf5-936d-4041-80ef-52c829da4a85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_3fd9c45c-69dc-468e-91d4-2b4bf710d416" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract_a4010d99-6ca2-4795-a113-79a25951c71e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_3fd9c45c-69dc-468e-91d4-2b4bf710d416" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsAbstract_1acd40fd-2a32-46e3-9810-87233926556a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_3a26b2be-ee96-4b26-99eb-d1140807457a" xlink:to="loc_us-gaap_OtherAssetsAbstract_1acd40fd-2a32-46e3-9810-87233926556a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashSurrenderValueOfLifeInsurance_ff0466af-a9a2-4e11-a7f4-3511afb0b889" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashSurrenderValueOfLifeInsurance"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsAbstract_1acd40fd-2a32-46e3-9810-87233926556a" xlink:to="loc_us-gaap_CashSurrenderValueOfLifeInsurance_ff0466af-a9a2-4e11-a7f4-3511afb0b889" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMiscellaneous_22396ef5-6ec9-4800-ab36-921b276fe483" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsMiscellaneous"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsAbstract_1acd40fd-2a32-46e3-9810-87233926556a" xlink:to="loc_us-gaap_OtherAssetsMiscellaneous_22396ef5-6ec9-4800-ab36-921b276fe483" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_2e78466a-6ef2-45ea-8337-e87eb7c30fdc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsAbstract_1acd40fd-2a32-46e3-9810-87233926556a" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_2e78466a-6ef2-45ea-8337-e87eb7c30fdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract_e51b9903-67db-4e56-aac4-860c2bd54d8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_3a26b2be-ee96-4b26-99eb-d1140807457a" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract_e51b9903-67db-4e56-aac4-860c2bd54d8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableTradeCurrent_ec4e395d-2f4b-4423-9750-c23e7734bc03" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableTradeCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract_e51b9903-67db-4e56-aac4-860c2bd54d8a" xlink:to="loc_us-gaap_AccountsPayableTradeCurrent_ec4e395d-2f4b-4423-9750-c23e7734bc03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amn_AccountsPayableToSubcontractor_a5f71487-d722-436d-b941-868b56be3c32" xlink:href="amn-20210930.xsd#amn_AccountsPayableToSubcontractor"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract_e51b9903-67db-4e56-aac4-860c2bd54d8a" xlink:to="loc_amn_AccountsPayableToSubcontractor_a5f71487-d722-436d-b941-868b56be3c32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_ae5b1b52-402b-4023-afa2-7f5bc4df184a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract_e51b9903-67db-4e56-aac4-860c2bd54d8a" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_ae5b1b52-402b-4023-afa2-7f5bc4df184a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualCarryingValueCurrent_6fbdd6f4-1b7c-4f57-ac5a-f26541790ebb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualCarryingValueCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract_e51b9903-67db-4e56-aac4-860c2bd54d8a" xlink:to="loc_us-gaap_LossContingencyAccrualCarryingValueCurrent_6fbdd6f4-1b7c-4f57-ac5a-f26541790ebb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SelfInsuranceReserveCurrent_cba642ca-d5b2-4627-8d93-09fc7ccca67c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SelfInsuranceReserveCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract_e51b9903-67db-4e56-aac4-860c2bd54d8a" xlink:to="loc_us-gaap_SelfInsuranceReserveCurrent_cba642ca-d5b2-4627-8d93-09fc7ccca67c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccountsPayableAndAccruedLiabilities_6fba843c-b776-4a85-82c8-d160bd3a6fab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccountsPayableAndAccruedLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract_e51b9903-67db-4e56-aac4-860c2bd54d8a" xlink:to="loc_us-gaap_OtherAccountsPayableAndAccruedLiabilities_6fba843c-b776-4a85-82c8-d160bd3a6fab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amn_AccountsPayableAndAccruedExpensesExcludingAccruedCompensationAndBenefitsCurrent_29ab3947-7b9d-4159-b16d-a2468acaf29c" xlink:href="amn-20210930.xsd#amn_AccountsPayableAndAccruedExpensesExcludingAccruedCompensationAndBenefitsCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract_e51b9903-67db-4e56-aac4-860c2bd54d8a" xlink:to="loc_amn_AccountsPayableAndAccruedExpensesExcludingAccruedCompensationAndBenefitsCurrent_29ab3947-7b9d-4159-b16d-a2468acaf29c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrentAbstract_1e7ade3c-f820-483a-b5ec-00108797628a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrentAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_3a26b2be-ee96-4b26-99eb-d1140807457a" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrentAbstract_1e7ade3c-f820-483a-b5ec-00108797628a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedSalariesCurrent_3183f621-c531-4e0c-917b-3a0e9b91a8f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedSalariesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrentAbstract_1e7ade3c-f820-483a-b5ec-00108797628a" xlink:to="loc_us-gaap_AccruedSalariesCurrent_3183f621-c531-4e0c-917b-3a0e9b91a8f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amn_AccruedBonusesAndCommissions_10814a87-a629-4b65-97e2-21a59afd685d" xlink:href="amn-20210930.xsd#amn_AccruedBonusesAndCommissions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrentAbstract_1e7ade3c-f820-483a-b5ec-00108797628a" xlink:to="loc_amn_AccruedBonusesAndCommissions_10814a87-a629-4b65-97e2-21a59afd685d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_amn_AccruedTravelExpense_372547c6-1853-494c-97c0-c9617772d2c5" xlink:href="amn-20210930.xsd#amn_AccruedTravelExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrentAbstract_1e7ade3c-f820-483a-b5ec-00108797628a" xlink:to="loc_amn_AccruedTravelExpense_372547c6-1853-494c-97c0-c9617772d2c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedInsuranceCurrent_3bcf97d1-c5b3-4c47-be7a-bec29a9e0eb5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedInsuranceCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrentAbstract_1e7ade3c-f820-483a-b5ec-00108797628a" xlink:to="loc_us-gaap_AccruedInsuranceCurrent_3bcf97d1-c5b3-4c47-be7a-bec29a9e0eb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WorkersCompensationLiabilityCurrent_161b8d1a-847c-4659-a9a0-79f7ca2f610d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WorkersCompensationLiabilityCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrentAbstract_1e7ade3c-f820-483a-b5ec-00108797628a" xlink:to="loc_us-gaap_WorkersCompensationLiabilityCurrent_161b8d1a-847c-4659-a9a0-79f7ca2f610d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationLiabilityCurrent_2bfbd85d-044b-4c5f-be8f-55af95f4f646" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCompensationLiabilityCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrentAbstract_1e7ade3c-f820-483a-b5ec-00108797628a" xlink:to="loc_us-gaap_DeferredCompensationLiabilityCurrent_2bfbd85d-044b-4c5f-be8f-55af95f4f646" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherEmployeeRelatedLiabilitiesCurrent_9d084eae-58d5-4a65-813e-539ddd1ef9b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherEmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrentAbstract_1e7ade3c-f820-483a-b5ec-00108797628a" xlink:to="loc_us-gaap_OtherEmployeeRelatedLiabilitiesCurrent_9d084eae-58d5-4a65-813e-539ddd1ef9b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_58e14678-bd6d-4ec9-bc38-6044b5977c90" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrentAbstract_1e7ade3c-f820-483a-b5ec-00108797628a" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_58e14678-bd6d-4ec9-bc38-6044b5977c90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrentAbstract_7eaa5d97-5dff-4bff-8b6c-8534e92d6aac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrentAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_3a26b2be-ee96-4b26-99eb-d1140807457a" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrentAbstract_7eaa5d97-5dff-4bff-8b6c-8534e92d6aac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WorkersCompensationLiabilityNoncurrent_7599c309-d0dc-4044-bc39-02b6fc1249a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WorkersCompensationLiabilityNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrentAbstract_7eaa5d97-5dff-4bff-8b6c-8534e92d6aac" xlink:to="loc_us-gaap_WorkersCompensationLiabilityNoncurrent_7599c309-d0dc-4044-bc39-02b6fc1249a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SelfInsuranceReserveNoncurrent_3ae0c2d6-ef8c-45c5-86fb-681cda154764" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SelfInsuranceReserveNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrentAbstract_7eaa5d97-5dff-4bff-8b6c-8534e92d6aac" xlink:to="loc_us-gaap_SelfInsuranceReserveNoncurrent_3ae0c2d6-ef8c-45c5-86fb-681cda154764" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent_e373cad3-f769-446b-9792-0e2c0b2e4c5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUncertainTaxPositionsNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrentAbstract_7eaa5d97-5dff-4bff-8b6c-8534e92d6aac" xlink:to="loc_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent_e373cad3-f769-446b-9792-0e2c0b2e4c5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherSundryLiabilitiesNoncurrent_929c2fdb-2b8c-4cc1-9ced-b711b3606928" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherSundryLiabilitiesNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrentAbstract_7eaa5d97-5dff-4bff-8b6c-8534e92d6aac" xlink:to="loc_us-gaap_OtherSundryLiabilitiesNoncurrent_929c2fdb-2b8c-4cc1-9ced-b711b3606928" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_f593696f-267b-470a-9914-a7e761ea54f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrentAbstract_7eaa5d97-5dff-4bff-8b6c-8534e92d6aac" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_f593696f-267b-470a-9914-a7e761ea54f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>amn-20210930_g1.jpg
<TEXT>
begin 644 amn-20210930_g1.jpg
M_]C_X  02D9)1@ ! @$ 8 !@  #_[0TP4&AO=&]S:&]P(#,N,  X0DE- ^T
M     !  8     $  0!@     0 !.$))300-       $    'CA"24T$&0
M    !    !XX0DE- _,       D           $ .$))300*       !   X
M0DE-)Q        H  0         ".$))30/U      !( "]F9@ ! &QF9@ &
M       ! "]F9@ ! *&9F@ &       ! #(    ! %H    &       ! #4
M   ! "T    &       !.$))30/X      !P  #_____________________
M________ ^@     _____________________________P/H     /______
M______________________\#Z     #_____________________________
M ^@  #A"24T$"       $     $   )    "0      X0DE-!!X       0
M    .$))300:      !M    !@              -0   *     & &< .0 W
M &$ ,@ V     0                         !              "@
M-0                                             X0DE-!!$
M  $! #A"24T$%       !     (X0DE-! P     "I0    !    <    "4
M  %0   PD   "G@ &  !_]C_X  02D9)1@ ! @$ 2 !(  #_[@ .061O8F4
M9(     !_]L A  ," @("0@,"0D,$0L*"Q$5#PP,#Q48$Q,5$Q,8$0P,# P,
M#!$,# P,# P,# P,# P,# P,# P,# P,# P,# P, 0T+"PT.#1 .#A 4#@X.
M%!0.#@X.%!$,# P,#!$1# P,# P,$0P,# P,# P,# P,# P,# P,# P,# P,
M# P,# S_P  1"  E ' # 2(  A$! Q$!_]T !  '_\0!/P   04! 0$! 0$
M         P ! @0%!@<("0H+ 0 !!0$! 0$! 0         !  (#! 4&!P@)
M"@L0  $$ 0,"! (%!P8(!0,,,P$  A$#!"$2,05!46$3(G&!,@84D:&Q0B,D
M%5+!8C,T<H+10P<EDE/PX?%C<S46HK*#)D235&1%PJ-T-A?25>)E\K.$P]-U
MX_-&)Y2DA;25Q-3D]*6UQ=7E]59F=H:6IK;&UN;V-T=79W>'EZ>WQ]?G]Q$
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MK+<>USJZ[6VONNS=K'?9ZV^G_AVU>E^D24\;Z%_[3^OQ])\6XUHK]KO<??\
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M(0      50    $!    #P!! &0 ;P!B &4 ( !0 &@ ;P!T &\ <P!H &\
M<    !, 00!D &\ 8@!E "  4 !H &\ = !O ', : !O '  (  V "X ,
M  $ .$))300&       '  @  0 ! 0#_[@ .061O8F4 9$     !_]L A  !
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! @("
M @(" @(" @(# P,# P,# P,# 0$! 0$! 0$! 0$" @$" @,# P,# P,# P,#
M P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P/_P  1"  U
M * # 1$  A$! Q$!_]T !  4_\0 ?@   P " @,!            " D*!0<&
M"P$#!  ! 0                     0   & @$# @0% @('"0    $" P0%
M!@<($0 2"2$3,4$4%5%A(B,*%A<R0O!Q@:$E&!G1DC,T1#<I&CH1 0
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"_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>amn-20210930_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:amn="http://www.amnhealthcare.com/20210930"
  xmlns:dei="http://xbrl.sec.gov/dei/2021"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2021-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="amn-20210930.xsd" xlink:type="simple"/>
    <context id="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i59e42fb4c1064ece98100d592cf3657c_I20211103">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
        </entity>
        <period>
            <instant>2021-11-03</instant>
        </period>
    </context>
    <context id="i68ecd84e8da440808154baac134e839e_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i61f65cd0793e47078410af8ea7c03faa_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i150492f298fa47a78ef2c10a285a64f8_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i6cb0c51ba8fa45fda70ec7e5df8b4ef1_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i2f727815e2874946b60bd2e1bb5e93be_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="iaa1c76ff437b4f6ab9cb7b6cfe222bf4_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="if7393c775ca64e5aad76fe5c6f242546_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i42390657f50c458e90b81cff65ca34a5_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i60d729ea22d44fd2a79b8bf55e800ca9_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i73ad7702c4f241548c42eab7eb506186_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ib229d5f30fdf41e28a8c14b58ac7f71a_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i58a3e48055114d67b6bc5e307451f03b_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ifb81bab0961842fb8ad3378a3b9343b6_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i7dde690144bc4ace94b25dc75e54f674_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i1289950aefbc4d06a62bac0d92b90879_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i55f9e8f7bfb74ed0a97dc5b843a44941_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i718b700dbfbb43239149794d4ebae58b_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i4f7d797c1d4844499f22b04b3704142b_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ib9bfddb010034bb38eded0804243bd37_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i97238f9b66054193b28698bcbd56bffd_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i8374f5c37e3c42bcb5d46ed38d202316_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i3fdc200320734b32ba399fb32a98810b_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i21ae371fccca46019f452281282a8e2e_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ie4c03c1bf0694cdb83793beff3d0c14d_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ice0ddb5cd06441b9bbeccf3e4c82794d_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i22cbe5469ffd4ae29750942feb990e4a_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i6d7b8b207f474903b3f67df5d7afc0b7_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ic9ff33a69ee247cca762b7fc9c84ab44_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="iba98b023b51845efaf19bbdbfccdd906_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i31b9aece0de343d4938455d196c5db4d_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i2b53f2fafe1d4e4db0704085cd21df06_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i7d335e9ab53a4968a587f6a232b63ae6_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i171378b7da944f48bc6e24f7e01f7ba2_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i7a73aec65e1645e497b0db29a7acbd13_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i864c53255b1c4eecafc3c0eac9341add_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i61d471d96d2b497e850b061f9eed0d11_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i226e8207b95f41d1ad9ee9df88356228_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i1318bf5c6a9f40ae8b4706d6aadc9c71_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="if2cb1f3c6ed840009dec907fba58a43d_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i6e14eb9c93e74f3296e6b86f12a28f94_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i912fae7382c74520a36b966d54d94e55_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i1204f31b85134c68b260fb9d3a28ba82_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="iaa7b25fceae44920a18c86a32eb37837_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="if2981eb3d48d4b619016fcb5f4dcabdc_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i041c1c8fe78444f88611087c404a5e99_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i3656a73d18b94b609e6f1990823c9b89_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8479ccefea534b2dad7f94b83fe989f0_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iaee22aaa9ae44b1391c0b85a98440ff2_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i04614019537444e7b0521086b438b3b9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7af796f0576e42eca232001f8709a3b5_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i02f81d784dce4b24a61070fc9496df23_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ie5a0923496204e499de51398c3adbec5_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ib2a70c6698bc4fb2a2ee6a77c38e17e7_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i88adf94124da4574a028c28b388799d6_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="iac59e5529bc54834bcd03309405d87e9_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i9dafaa37d5364e1ba2bb35e85967fa2c_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i1ce2b693b671480e806a25a643c7f12d_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i403d2a055ccd43bb8b88f5d7cab63117_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="idbce5210eba9474d85e1137c4859a231_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ic160cb42fea14c7584293e11e1aa33d3_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i705012913b884ada9d0c3c4d270ed4d2_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i3ef4f52f779e4faf95d4601d80832007_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i32dfbd39eb3d43cb911abb42fa8a42ef_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i77c68cc8659943eea02704a6a078bf18_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ib57f7397b0a0419fb8f2b4cb5a7b0ff7_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ibfb3f98525f24d859c4abcde0f73f237_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i5577c5bda907400ea634496c766b83e8_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="id73c4bc3bbf84e21b5f04cbfc8a138a4_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="id04a12fb0c1a4d8cb8704c13c181f0c8_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i57a944b08046487db5fbee0222d76c46_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i054622b9ff6b45d094e6d62e718bb40a_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i65cb728c1968429faa88cef83eef8a65_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ifce17ccf7b614cb3aeb8d263bb97ccf5_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="id10a5dbf399445d3b8969edabe30751a_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i14e64987a4644969a8cf482d758cef56_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ic432083dde80448887610e8035a6b032_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ide77a3fd11044dd3926be5b05e61a140_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ib42c30aaa2d7465e8f21c1e6a8e2a52f_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="iee8941b97b824762bb44d764f5549f5f_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i1754ebd74a03401da95dc00b4abde2a7_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i02fea62d4d29457fb6f838bf4cba33b5_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="iae23414cbc0f4638aab5dbaabe6e5cc4_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i3540c67ef3ad4b86931989fd054e0b50_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ifa30b8cb72094c7ca771fc176115f67e_D20210407-20210407">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">amn:SynziMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-07</startDate>
            <endDate>2021-04-07</endDate>
        </period>
    </context>
    <context id="i202e46c5ac0646f8b3354ce9a1eb5b00_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">amn:SynziMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ieff88e899cdb408197ed1ff99234a795_D20210930-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">amn:SynziMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-30</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="icbbe0cb0e30e4fc195db16971b04921b_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">amn:SynziMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="id8a8066df2cd49fb99c9a296eb4b267d_I20210407">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">amn:SynziMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-07</instant>
        </period>
    </context>
    <context id="i2ddc12eab3644117aaadf0ffbc24c476_I20210407">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">amn:SynziMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-07</instant>
        </period>
    </context>
    <context id="i750e5ac42b744b7999aafb93dd8e3926_D20200214-20200214">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">amn:StratusVideoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-02-14</startDate>
            <endDate>2020-02-14</endDate>
        </period>
    </context>
    <context id="i1809609cdf714d66916ae3141253f6cd_I20180209">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-02-09</instant>
        </period>
    </context>
    <context id="ie9d4571d2fdf44c6ba87db28c14cb175_I20200214">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">amn:TermDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-02-14</instant>
        </period>
    </context>
    <context id="ib98f074e5878463f913e950ba5784162_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">amn:StratusVideoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i87dc697cd0464e2c938ed8477a3a3237_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">amn:StratusVideoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="id09df577cd134e6994ece5aa31598ed7_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">amn:StratusVideoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i2a27a4a6c0964a5194ffc4f8f4176fbf_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">amn:StratusVideoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i3d55955405794cb789f5432f8c06331e_I20200214">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">amn:StratusVideoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-02-14</instant>
        </period>
    </context>
    <context id="ia69287e7ab6c43f095adc3cb43556c44_D20200214-20200214">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">amn:StratusVideoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-02-14</startDate>
            <endDate>2020-02-14</endDate>
        </period>
    </context>
    <context id="i3dad049f61fe4171831aea7245fff5c6_I20200214">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">amn:StratusVideoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-02-14</instant>
        </period>
    </context>
    <context id="idd4f7d02ac0c4fbcab236ee010c28075_D20200214-20200214">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">amn:StratusVideoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-02-14</startDate>
            <endDate>2020-02-14</endDate>
        </period>
    </context>
    <context id="i450e36d3b7b24a9a930abcbcebb33f8b_D20200214-20200214">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">amn:StratusVideoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-02-14</startDate>
            <endDate>2020-02-14</endDate>
        </period>
    </context>
    <context id="id060857eed0b4cc5a5f2798ea3dcc0c1_I20200214">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">amn:StratusVideoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-02-14</instant>
        </period>
    </context>
    <context id="i4c6a14bbd81143a7b0ccd248e1c2ea39_D20200214-20200214">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">amn:StratusVideoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-02-14</startDate>
            <endDate>2020-02-14</endDate>
        </period>
    </context>
    <context id="ic43cd4c81a97471aa9a13d84fb4031e2_I20200214">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">amn:StratusVideoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">amn:InterpreterDatabaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-02-14</instant>
        </period>
    </context>
    <context id="i5699c9a4945c4f429b834511a0a22cbc_D20200214-20200214">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">amn:StratusVideoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">amn:InterpreterDatabaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-02-14</startDate>
            <endDate>2020-02-14</endDate>
        </period>
    </context>
    <context id="i67759f1dfa1b4429aabe1215e03414dc_I20200214">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">amn:StratusVideoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-02-14</instant>
        </period>
    </context>
    <context id="ic87fd517c51345a2a17d4c391a7c46c3_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">amn:StratusVideoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ic430d291a7804180aa0b06c38d0c7c55_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">amn:StratusVideoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="id449bccf189e469e8b6a234845cba859_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">amn:StratusVideoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:NonrecurringAdjustmentAxis">us-gaap:AcquisitionRelatedCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i2450926f8adf4dedb94c370247e5310b_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">amn:StratusVideoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:NonrecurringAdjustmentAxis">us-gaap:AcquisitionRelatedCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i72bc6814293d41ce8300f2c38fcdd1bc_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:NurseAndAlliedHealthcareStaffingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i3473b76faf004446b11d60f76e27591c_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:NurseAndAlliedHealthcareStaffingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i5021bcb8a5144f2e92e4d17294f25756_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:NurseAndAlliedHealthcareStaffingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ib58839822ae8478c8d8ef1cb827d2ebe_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:NurseAndAlliedHealthcareStaffingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i5bb9c1ce74924d3fb6c80bf5bc7070ca_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:PhysicianAndLeadershipSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i3bdfcb612866449f8fc82428772bc4e0_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:PhysicianAndLeadershipSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ifd4b5ea0c6464abaafa771245dd4872b_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:PhysicianAndLeadershipSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i8096536e07244cbc88570b4cd0b1df3b_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:PhysicianAndLeadershipSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i286479f51b3847f180927296005817b3_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:TechnologyAndWorkforceSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="iebe1c6905368491eb38b8213c9304590_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:TechnologyAndWorkforceSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i9f81f9d1a6314e098bdd58b74619a28f_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:TechnologyAndWorkforceSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ib31de07b75904e5cb9fd99c168d04547_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:TechnologyAndWorkforceSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i1a24f793f440442085a27968a5583766_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="icdd1cb3977024d5d959ea51ad54b783d_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i5479404ee04b498ab6fd8545f90d86b9_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i703fc84123784c69b090877fb4125906_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ie946fae8ec0046439446bb138d525757_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i674c8f2758bf45ae8bb93948b5860e97_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ib14ea5527ced44f5979f01683cbc7fc4_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ieeebf848246c441ba6ab2c571e599296_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i6841006ed66046048b923a10d1f02618_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amn:TemporaryStaffingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:NurseAndAlliedHealthcareStaffingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i8aaeb4e7d78e45c4afa1ea8345243c26_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amn:TemporaryStaffingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:PhysicianAndLeadershipSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ie7ed1c91706145b489b11684ae9f8f91_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amn:TemporaryStaffingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:TechnologyAndWorkforceSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i6aff1598e94c41a9a49290be61afbb6c_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amn:TemporaryStaffingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i830444b4b4eb4bc49ed555e461733a60_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amn:PermanentPlacementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:NurseAndAlliedHealthcareStaffingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i1dcde31709c646a282f435f6c32eace5_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amn:PermanentPlacementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:PhysicianAndLeadershipSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i8a01cf9bd5e742be9ad5969b5dd25b9f_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amn:PermanentPlacementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:TechnologyAndWorkforceSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i469189243c1643a29f2acd332c552f64_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amn:PermanentPlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i97bcb414c2014844b1112de85e955858_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amn:OutsourcedWorkforceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:NurseAndAlliedHealthcareStaffingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i0f2791f2f77d4b30b30f4f41b86a32be_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amn:OutsourcedWorkforceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:PhysicianAndLeadershipSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i8d6328bac8bb4c5c9bc2c8b9292f8422_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amn:OutsourcedWorkforceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:TechnologyAndWorkforceSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ica26aea190054f37883620f719402399_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amn:OutsourcedWorkforceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="iebe807a1030c4daab052b4d1c1386537_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amn:SaaSBasedTechnologiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:NurseAndAlliedHealthcareStaffingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i3d75e1df27914f09a7b8252950f87b6b_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amn:SaaSBasedTechnologiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:PhysicianAndLeadershipSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i71d6cb2f38004881a4b6bd6017255a7a_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amn:SaaSBasedTechnologiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:TechnologyAndWorkforceSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ibc6ef11462fa4624a5db4ae2d23f8e83_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amn:SaaSBasedTechnologiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i01269464f14e481692beaf81a76fb87d_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:NurseAndAlliedHealthcareStaffingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="icc871800a2a54344bc972988728aa887_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:PhysicianAndLeadershipSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="id0250f51d2d145cfa3b9c421cb969cfb_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:TechnologyAndWorkforceSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ia6d8015a18974a7b896656aecc3ec4b4_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amn:TemporaryStaffingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:NurseAndAlliedHealthcareStaffingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ifc8564de3068430abe113d5c5abeabe1_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amn:TemporaryStaffingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:PhysicianAndLeadershipSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i386e01817e9d4c42b6cd2228fb3796c2_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amn:TemporaryStaffingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:TechnologyAndWorkforceSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i8d235eb71df14e8b9908f2e396c873cb_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amn:TemporaryStaffingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i44c7ce7db7f54f14969af01502dd38a0_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amn:PermanentPlacementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:NurseAndAlliedHealthcareStaffingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ie04ed0997a484867b8fe5f9956a3292d_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amn:PermanentPlacementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:PhysicianAndLeadershipSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="if26529ce715f495dafc6d4b52493ea02_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amn:PermanentPlacementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:TechnologyAndWorkforceSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="if818b67b623c45a8aff218e40a7005c3_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amn:PermanentPlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i9aba0cbe92634056880604c35ba04d52_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amn:OutsourcedWorkforceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:NurseAndAlliedHealthcareStaffingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ieee345988a9b4cc4937342242689e98e_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amn:OutsourcedWorkforceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:PhysicianAndLeadershipSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i76440e2d28744cc98ead1974809c865f_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amn:OutsourcedWorkforceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:TechnologyAndWorkforceSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i3d7b5abbd0ee4fca9a5b3efb81d07d5d_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amn:OutsourcedWorkforceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i5893522597a942f38cbfe46a853546eb_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amn:SaaSBasedTechnologiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:NurseAndAlliedHealthcareStaffingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="id296025a7e114f8b9f9b44d6b14233f1_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amn:SaaSBasedTechnologiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:PhysicianAndLeadershipSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i9568bc87c368403cbb9e4180b3a0d538_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amn:SaaSBasedTechnologiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:TechnologyAndWorkforceSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i0e447016b010458c883c1ef90a609651_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amn:SaaSBasedTechnologiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ic8d64c3d8e5a47489226ba7a492dae32_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:NurseAndAlliedHealthcareStaffingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i44b9c9fa813d4c3688eab2f7ea808291_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:PhysicianAndLeadershipSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i6460c9bf442443d3abf247bad9d30336_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:TechnologyAndWorkforceSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ida0f30c7727943e798527294cdf4394a_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amn:TemporaryStaffingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:NurseAndAlliedHealthcareStaffingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="idcab03e09bc1437399cc7a03d8fc8b57_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amn:TemporaryStaffingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:PhysicianAndLeadershipSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i89958f0ec7cf446b98d11c657f7ee603_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amn:TemporaryStaffingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:TechnologyAndWorkforceSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i90eb3e7675a044e992b317175d9afcd9_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amn:TemporaryStaffingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i8750be21113a4757ac053b8f62cd2ad2_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amn:PermanentPlacementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:NurseAndAlliedHealthcareStaffingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i30aa16b5b25048ca8dfeff42d533a177_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amn:PermanentPlacementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:PhysicianAndLeadershipSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i3cfc2a42fe0e4807b29bf91ce0a45f43_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amn:PermanentPlacementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:TechnologyAndWorkforceSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ibbdabae4c4224976a6088e48ddb040ba_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amn:PermanentPlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i536910b4999c4e32a95c6a8ac9c30f1d_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amn:OutsourcedWorkforceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:NurseAndAlliedHealthcareStaffingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i4c17ffb386c649368efa203669f28351_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amn:OutsourcedWorkforceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:PhysicianAndLeadershipSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="idf8b667f2cd34632a587e2d17a82e3fd_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amn:OutsourcedWorkforceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:TechnologyAndWorkforceSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="iedbce8552e1b455082a65e938d6dec5b_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amn:OutsourcedWorkforceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i9bb701054c8d4b2ca7bb36f5445e6a6a_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amn:SaaSBasedTechnologiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:NurseAndAlliedHealthcareStaffingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i80d03ebd1c054ee9977c5f826afd98f7_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amn:SaaSBasedTechnologiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:PhysicianAndLeadershipSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i85f859e6dc0a4f40aef7f8f521affd1c_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amn:SaaSBasedTechnologiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:TechnologyAndWorkforceSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="icf4e0ac3bff74d3c81967d52a934245e_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amn:SaaSBasedTechnologiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i70417b2a548f4dc8aa5f1b5e01ea94f6_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:NurseAndAlliedHealthcareStaffingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ic7cb32a8e20f4e59b29cb208784742f9_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:PhysicianAndLeadershipSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i19bf0b91fc2e4d4088d260a4a7291a68_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:TechnologyAndWorkforceSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="if95e75fc39f542e0937abe52bd16b043_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amn:TemporaryStaffingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:NurseAndAlliedHealthcareStaffingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i41fa2315f758457689e492a76a31c2bc_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amn:TemporaryStaffingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:PhysicianAndLeadershipSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="id149b105ef884b0d9c47f05bec237702_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amn:TemporaryStaffingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:TechnologyAndWorkforceSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i8ee31b74c9154f7b815c08300a1950e0_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amn:TemporaryStaffingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i38ab08218c234821bc589e3cc2c80f3c_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amn:PermanentPlacementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:NurseAndAlliedHealthcareStaffingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i4c3268cc1706415686fd7683f6ed1d51_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amn:PermanentPlacementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:PhysicianAndLeadershipSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i4167819349934cd59d501e7c4c7ddcfc_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amn:PermanentPlacementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:TechnologyAndWorkforceSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i43362dd8fe0949449a39af825a732e7a_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amn:PermanentPlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i88f59cdb95f040e2b571b678226a7fec_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amn:OutsourcedWorkforceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:NurseAndAlliedHealthcareStaffingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="iee45b2697e73423393102240edfca12a_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amn:OutsourcedWorkforceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:PhysicianAndLeadershipSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="if3d5b12a279d423b9852c9ec50634277_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amn:OutsourcedWorkforceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:TechnologyAndWorkforceSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i93145b50299a45b0b7e234415765c760_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amn:OutsourcedWorkforceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ia3589685d5bf494da6ce3464e2194081_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amn:SaaSBasedTechnologiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:NurseAndAlliedHealthcareStaffingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i683c901af8234ee8b34a8de537a4faed_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amn:SaaSBasedTechnologiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:PhysicianAndLeadershipSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i9c392d9ab824476a96a3f41148cbe7fe_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amn:SaaSBasedTechnologiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:TechnologyAndWorkforceSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i598b74681e034171b491236964be10f1_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">amn:SaaSBasedTechnologiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i2a46e165877d46f7b437d72073d883c6_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:NurseAndAlliedHealthcareStaffingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="if3be0a64ed0349d3ae2297e6a8a914d7_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:PhysicianAndLeadershipSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i11efb6327d494ef79b4c1a4e768e70bf_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:TechnologyAndWorkforceSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ia707a5ecf30d4576a74a17b34e193c15_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:NurseAndAlliedHealthcareStaffingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ifb5e6237d7d54806a979a6a53e302a7a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:PhysicianAndLeadershipSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ibd0be51207114cd1b17f02ebecffc197_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:TechnologyAndWorkforceSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iff2345b9439d4c93833b660edbe6ce7f_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:NurseAndAlliedHealthcareStaffingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i4161c5f102584f0fbecf9454461d6028_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:PhysicianAndLeadershipSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i33f34f84f7e146998551e4e55f51111a_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">amn:TechnologyAndWorkforceSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i8962b4b53b6140de975c8a15752edd5d_I20190614">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">amn:TermDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-14</instant>
        </period>
    </context>
    <context id="i75b241ded9e04282a87e07b5ca93bb10_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ibdfd9e1e6a6a4aea800ca23a42cc6d9c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic8ecfcf890884810930a3db121a37947_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i46feda5d0d364eabb7ec42a6d33247c6_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i98888a04caa94c449d58020688cc10b7_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i9aeb16c096e94fd18a6a4407369f7baf_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i7406af186f1f431ba3a5cae4e80d7461_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">amn:DeferredCompensationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i148698ba11334fa7962b91a16b3e7880_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">amn:DeferredCompensationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i975bc3f2b0594c2996194a6fa3fd0687_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">amn:DeferredCompensationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ia0adbc48e0574d688983232e62d3bdfa_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">amn:DeferredCompensationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i9f2f077331ea49d9a65ccd6f803814da_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i12f5a5f263ab4ab69a41578d13ee6032_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i1643e3ce569e435e90215e4c1f80cc45_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i04416ccdf99b4368b4ae3bb3d5c50522_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2779feaa7ca44c64a5d0144e462d669e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie85028cf6e7e4291811ded1080e9ccef_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i12292bac56af415ebe14864b760b6aee_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iaad52f29996b478daad64bf29bf17dbe_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">amn:DeferredCompensationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i90ee55464c34456ab9205a90173c745d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">amn:DeferredCompensationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2dae041f1c2049bc8a78d41d20bd5c01_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">amn:DeferredCompensationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i01af2c6807964bd3a70f87bed11d7f18_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">amn:DeferredCompensationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i52afbebb62d24268b4227e4d0ecbfbd0_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i33219b4f757444d0acfe2defee9c77a2_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="icabd932ac65d40a9ad263428cb023998_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia2321e23f81c49fca30df6d0483acd39_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">amn:ContingentConsiderationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie87be00cfa4e4645b636d077357bfaaa_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">amn:ContingentConsiderationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ibe1edb1c0b7d484da43d71c0fcdd0d28_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">amn:ContingentConsiderationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6181153aab9d4bf1a9ac5e86d83189ec_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">amn:ContingentConsiderationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id213a9f9047d4508aeef40c71a6fe7f3_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">amn:ContingentConsiderationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i26375226748e457a83389380abbeabb8_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">amn:ContingentConsiderationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ia06522632d4f4b51b495d744af0113af_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">amn:B4healthLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">amn:ContingentConsiderationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i3225a1c038234fd6ad8decf2eea09642_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">amn:B4healthLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">amn:ContingentConsiderationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ia1c38f520570446e977fefc12947c6df_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">amn:ContingentConsiderationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="if25b9265f3954756bd8d09991a579c63_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">amn:ContingentConsiderationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i27f0dfb23ddc496989d2606c383df2c5_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">amn:ContingentConsiderationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ia74ee65117cd4be980399efaba0fd27f_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">amn:AdvancedMedicalPersonnelServicesInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">amn:ContingentConsiderationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i3dced23531a14782bb18a2d74864eba6_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">amn:AdvancedMedicalPersonnelServicesInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">amn:ContingentConsiderationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ia8887638bb5c4199a5d785b2a07d5378_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">amn:B4healthLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">amn:ContingentConsiderationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i8797e43b32204823b6a3ad14b6669a69_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">amn:B4healthLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">amn:ContingentConsiderationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i77b494fe460f4789ba120f413470a8d9_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ic05278c1e0a647149ea04d2fc5ffc568_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic9968f7f2c454182aab2b88a2b279e04_I20200813">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">amn:A4.625SeniorNotesDue2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-13</instant>
        </period>
    </context>
    <context id="i2f6d79fdc037408d9dc6b393a68f3b3f_I20201020">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">amn:A4000SeniorNotesDue2029Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-20</instant>
        </period>
    </context>
    <context id="i74b3184e58994da0b7590f17370f09da_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">amn:A4.625SeniorNotesDue2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ia140cdbfeac94d9dbe04b0a64460ff19_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">amn:A4.625SeniorNotesDue2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia9ea250e0d094ba5b694f077af429acd_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">amn:A4000SeniorNotesDue2029Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i17ce2ad3d6e849fc9dea40319a4961e3_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">amn:A4000SeniorNotesDue2029Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ibdd33d48b3ef404689d6e95d9989f154_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">amn:WageAndHourClaimsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic4d0f83036ab4e5a816bee3070f588e7_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001142750</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">amn:WageAndHourClaimsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="acquisition">
        <measure>amn:acquisition</measure>
    </unit>
    <unit id="segment">
        <measure>amn:segment</measure>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="phase">
        <measure>amn:phase</measure>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180L2ZyYWc6MTQ1NjJkMDY4ZWM5NDA2ZWI2OTU1MjZmZjUyZDRjYzYvdGFibGU6YWQ3N2I3ZWU1ODM1NDE3MDhkMDVjZDhlOTQ1ODE3YjgvdGFibGVyYW5nZTphZDc3YjdlZTU4MzU0MTcwOGQwNWNkOGU5NDU4MTdiOF8zLTEtMS0xLTEwNzcw_c38269af-3fcd-49e8-885d-99c27a5a46a4">0001142750</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180L2ZyYWc6MTQ1NjJkMDY4ZWM5NDA2ZWI2OTU1MjZmZjUyZDRjYzYvdGFibGU6YWQ3N2I3ZWU1ODM1NDE3MDhkMDVjZDhlOTQ1ODE3YjgvdGFibGVyYW5nZTphZDc3YjdlZTU4MzU0MTcwOGQwNWNkOGU5NDU4MTdiOF80LTEtMS0xLTEwNzcw_03787563-38fb-4611-8325-40e81e598322">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180L2ZyYWc6MTQ1NjJkMDY4ZWM5NDA2ZWI2OTU1MjZmZjUyZDRjYzYvdGFibGU6YWQ3N2I3ZWU1ODM1NDE3MDhkMDVjZDhlOTQ1ODE3YjgvdGFibGVyYW5nZTphZDc3YjdlZTU4MzU0MTcwOGQwNWNkOGU5NDU4MTdiOF81LTEtMS0xLTEwNzcw_34650222-16db-41a4-8f88-06455f61b355">2021</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180L2ZyYWc6MTQ1NjJkMDY4ZWM5NDA2ZWI2OTU1MjZmZjUyZDRjYzYvdGFibGU6YWQ3N2I3ZWU1ODM1NDE3MDhkMDVjZDhlOTQ1ODE3YjgvdGFibGVyYW5nZTphZDc3YjdlZTU4MzU0MTcwOGQwNWNkOGU5NDU4MTdiOF82LTEtMS0xLTEwNzcw_55b778f5-88c5-4170-9c2c-8982ee0ea5f4">Q3</dei:DocumentFiscalPeriodFocus>
    <dei:AmendmentFlag
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180L2ZyYWc6MTQ1NjJkMDY4ZWM5NDA2ZWI2OTU1MjZmZjUyZDRjYzYvdGFibGU6YWQ3N2I3ZWU1ODM1NDE3MDhkMDVjZDhlOTQ1ODE3YjgvdGFibGVyYW5nZTphZDc3YjdlZTU4MzU0MTcwOGQwNWNkOGU5NDU4MTdiOF83LTEtMS0xLTEwNzcw_2f8874e9-f026-4c18-b23d-56c4411be7ea">false</dei:AmendmentFlag>
    <us-gaap:AccountingStandardsUpdateExtensibleList
      contextRef="i7dde690144bc4ace94b25dc75e54f674_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjA4YjkwYmJkYmMzNDRhY2Q4MjczNzY0OGJhM2FmNzY2L3RhYmxlcmFuZ2U6MDhiOTBiYmRiYzM0NGFjZDgyNzM3NjQ4YmEzYWY3NjZfNS0wLTEtMS0xMDc3MA_9cc5eab4-fa7b-478b-ad5a-e122472c78ab">http://fasb.org/us-gaap/2021-01-31#AccountingStandardsUpdate201613Member</us-gaap:AccountingStandardsUpdateExtensibleList>
    <us-gaap:AccountingStandardsUpdateExtensibleList
      contextRef="iae23414cbc0f4638aab5dbaabe6e5cc4_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zMS9mcmFnOmNlNDgxOGVmYTM1YjQ2NDI4NGUxN2Q2NWEwYThiNjc3L3RhYmxlOmU5MmY2N2EzMmZkYjRlZmY5MmRhZThhMjE3M2M0NzBmL3RhYmxlcmFuZ2U6ZTkyZjY3YTMyZmRiNGVmZjkyZGFlOGEyMTczYzQ3MGZfMi0wLTEtMS0xMDc3MA_2e5b46ce-627c-4ad2-9f91-f5ecc232b823">http://fasb.org/us-gaap/2021-01-31#AccountingStandardsUpdate201613Member</us-gaap:AccountingStandardsUpdateExtensibleList>
    <us-gaap:AccountingStandardsUpdateExtensibleList
      contextRef="i7dde690144bc4ace94b25dc75e54f674_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zMS9mcmFnOmNlNDgxOGVmYTM1YjQ2NDI4NGUxN2Q2NWEwYThiNjc3L3RhYmxlOmU5MmY2N2EzMmZkYjRlZmY5MmRhZThhMjE3M2M0NzBmL3RhYmxlcmFuZ2U6ZTkyZjY3YTMyZmRiNGVmZjkyZGFlOGEyMTczYzQ3MGZfMi0wLTEtMS0xMDc3MA_5c495df8-c4dc-4a11-8dcb-5b212c885604">http://fasb.org/us-gaap/2021-01-31#AccountingStandardsUpdate201613Member</us-gaap:AccountingStandardsUpdateExtensibleList>
    <dei:DocumentType
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xL2ZyYWc6NzNkMzI5ZjYwZjM0NDA1M2E5YzhlMGIzYzI4MjZhNzMvdGV4dHJlZ2lvbjo3M2QzMjlmNjBmMzQ0MDUzYTljOGUwYjNjMjgyNmE3M18xOTk0_e22facaf-c616-4aed-94e5-3312b9176b2f">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xL2ZyYWc6NzNkMzI5ZjYwZjM0NDA1M2E5YzhlMGIzYzI4MjZhNzMvdGFibGU6YTllMzI2OTZhZWE1NDlmM2I3MjlkMzgxMTk1MDFjMDEvdGFibGVyYW5nZTphOWUzMjY5NmFlYTU0OWYzYjcyOWQzODExOTUwMWMwMV8wLTAtMS0xLTEwNzcw_5d4d57d1-eedc-495c-aa08-468e27c022e0">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xL2ZyYWc6NzNkMzI5ZjYwZjM0NDA1M2E5YzhlMGIzYzI4MjZhNzMvdGV4dHJlZ2lvbjo3M2QzMjlmNjBmMzQ0MDUzYTljOGUwYjNjMjgyNmE3M18xNjU_4d45d63f-f04f-402c-ae06-7613fc412d4f">2021-09-30</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xL2ZyYWc6NzNkMzI5ZjYwZjM0NDA1M2E5YzhlMGIzYzI4MjZhNzMvdGFibGU6ZWMzYjIzMjgxOTYwNDVhMmFlYWVmZTMzYjhlM2VjZTYvdGFibGVyYW5nZTplYzNiMjMyODE5NjA0NWEyYWVhZWZlMzNiOGUzZWNlNl8xLTAtMS0xLTEwNzcw_b01c5964-dc91-4280-abb1-72d8492f8c66">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xL2ZyYWc6NzNkMzI5ZjYwZjM0NDA1M2E5YzhlMGIzYzI4MjZhNzMvdGV4dHJlZ2lvbjo3M2QzMjlmNjBmMzQ0MDUzYTljOGUwYjNjMjgyNmE3M18xOTg5_e5d762cf-0bdc-48a7-b080-acf27cc25f3a">001-16753</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xL2ZyYWc6NzNkMzI5ZjYwZjM0NDA1M2E5YzhlMGIzYzI4MjZhNzMvdGV4dHJlZ2lvbjo3M2QzMjlmNjBmMzQ0MDUzYTljOGUwYjNjMjgyNmE3M18xOTkw_470193bd-222e-44e7-acae-4b2896d782b8">AMN HEALTHCARE SERVICES, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xL2ZyYWc6NzNkMzI5ZjYwZjM0NDA1M2E5YzhlMGIzYzI4MjZhNzMvdGFibGU6NTIyNDM3NTViM2YzNDE3YmE5NGU3OTcyMDU1ZjVjOTQvdGFibGVyYW5nZTo1MjI0Mzc1NWIzZjM0MTdiYTk0ZTc5NzIwNTVmNWM5NF8wLTAtMS0xLTEwNzcw_159634ef-78ac-4c33-90c1-45b6d23bc108">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xL2ZyYWc6NzNkMzI5ZjYwZjM0NDA1M2E5YzhlMGIzYzI4MjZhNzMvdGFibGU6NTIyNDM3NTViM2YzNDE3YmE5NGU3OTcyMDU1ZjVjOTQvdGFibGVyYW5nZTo1MjI0Mzc1NWIzZjM0MTdiYTk0ZTc5NzIwNTVmNWM5NF8wLTItMS0xLTEwNzcw_83fd3c3c-0b20-4006-aa4c-45db5ef02fc6">06-1500476</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xL2ZyYWc6NzNkMzI5ZjYwZjM0NDA1M2E5YzhlMGIzYzI4MjZhNzMvdGFibGU6NTIyNDM3NTViM2YzNDE3YmE5NGU3OTcyMDU1ZjVjOTQvdGFibGVyYW5nZTo1MjI0Mzc1NWIzZjM0MTdiYTk0ZTc5NzIwNTVmNWM5NF8zLTAtMS0xLTEwNzcw_0f9505bd-6830-4b2f-95de-3e24ae1ec9ae">8840 Cypress Waters Boulevard</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xL2ZyYWc6NzNkMzI5ZjYwZjM0NDA1M2E5YzhlMGIzYzI4MjZhNzMvdGFibGU6NTIyNDM3NTViM2YzNDE3YmE5NGU3OTcyMDU1ZjVjOTQvdGFibGVyYW5nZTo1MjI0Mzc1NWIzZjM0MTdiYTk0ZTc5NzIwNTVmNWM5NF8zLTEtMS0xLTEwNzcw_c27fbfdb-01c0-4087-93dc-ec5f004b4412">Suite 300</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xL2ZyYWc6NzNkMzI5ZjYwZjM0NDA1M2E5YzhlMGIzYzI4MjZhNzMvdGFibGU6NTIyNDM3NTViM2YzNDE3YmE5NGU3OTcyMDU1ZjVjOTQvdGFibGVyYW5nZTo1MjI0Mzc1NWIzZjM0MTdiYTk0ZTc5NzIwNTVmNWM5NF80LTAtMS0xLTEwNzcw_d463a581-fe3d-4766-95b1-39de9b006fb1">Dallas</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xL2ZyYWc6NzNkMzI5ZjYwZjM0NDA1M2E5YzhlMGIzYzI4MjZhNzMvdGFibGU6NTIyNDM3NTViM2YzNDE3YmE5NGU3OTcyMDU1ZjVjOTQvdGFibGVyYW5nZTo1MjI0Mzc1NWIzZjM0MTdiYTk0ZTc5NzIwNTVmNWM5NF80LTEtMS0xLTEwNzcw_e165d90f-375f-4785-b9df-a423484c0857">TX</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xL2ZyYWc6NzNkMzI5ZjYwZjM0NDA1M2E5YzhlMGIzYzI4MjZhNzMvdGFibGU6NTIyNDM3NTViM2YzNDE3YmE5NGU3OTcyMDU1ZjVjOTQvdGFibGVyYW5nZTo1MjI0Mzc1NWIzZjM0MTdiYTk0ZTc5NzIwNTVmNWM5NF80LTItMS0xLTEwNzcw_ef34af38-bd1d-4760-97b9-9cfa14ae411f">75019</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xL2ZyYWc6NzNkMzI5ZjYwZjM0NDA1M2E5YzhlMGIzYzI4MjZhNzMvdGV4dHJlZ2lvbjo3M2QzMjlmNjBmMzQ0MDUzYTljOGUwYjNjMjgyNmE3M18xOTkx_6f3b3bdf-5e32-4c69-88c1-83619fd0e5a6">866</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xL2ZyYWc6NzNkMzI5ZjYwZjM0NDA1M2E5YzhlMGIzYzI4MjZhNzMvdGV4dHJlZ2lvbjo3M2QzMjlmNjBmMzQ0MDUzYTljOGUwYjNjMjgyNmE3M18xOTk1_bdd4b6bc-b929-438b-b5e1-1fd177bcb613">871-8519</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xL2ZyYWc6NzNkMzI5ZjYwZjM0NDA1M2E5YzhlMGIzYzI4MjZhNzMvdGFibGU6ZjI1ZWUzODJmZWY0NDFmNzg0YTEzNjc3OGRiMTRhZDcvdGFibGVyYW5nZTpmMjVlZTM4MmZlZjQ0MWY3ODRhMTM2Nzc4ZGIxNGFkN18xLTAtMS0xLTEwNzcw_fada2aad-1ae9-482e-8ec7-ce2dcda4d0b5">Common Stock, $0.01 par value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xL2ZyYWc6NzNkMzI5ZjYwZjM0NDA1M2E5YzhlMGIzYzI4MjZhNzMvdGFibGU6ZjI1ZWUzODJmZWY0NDFmNzg0YTEzNjc3OGRiMTRhZDcvdGFibGVyYW5nZTpmMjVlZTM4MmZlZjQ0MWY3ODRhMTM2Nzc4ZGIxNGFkN18xLTEtMS0xLTEwNzcw_467bfd66-d429-4cda-a6ab-4963a1c55c0e">AMN</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xL2ZyYWc6NzNkMzI5ZjYwZjM0NDA1M2E5YzhlMGIzYzI4MjZhNzMvdGFibGU6ZjI1ZWUzODJmZWY0NDFmNzg0YTEzNjc3OGRiMTRhZDcvdGFibGVyYW5nZTpmMjVlZTM4MmZlZjQ0MWY3ODRhMTM2Nzc4ZGIxNGFkN18xLTItMS0xLTEwNzcw_99ddceb1-7ab4-474e-892e-732be70aaaa4">NYSE</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xL2ZyYWc6NzNkMzI5ZjYwZjM0NDA1M2E5YzhlMGIzYzI4MjZhNzMvdGV4dHJlZ2lvbjo3M2QzMjlmNjBmMzQ0MDUzYTljOGUwYjNjMjgyNmE3M18xOTky_a1893182-5d33-4dbd-b970-9ff8624bbdb1">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xL2ZyYWc6NzNkMzI5ZjYwZjM0NDA1M2E5YzhlMGIzYzI4MjZhNzMvdGV4dHJlZ2lvbjo3M2QzMjlmNjBmMzQ0MDUzYTljOGUwYjNjMjgyNmE3M18xOTk2_887c75e3-55af-4367-9255-d66b00f80f71">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xL2ZyYWc6NzNkMzI5ZjYwZjM0NDA1M2E5YzhlMGIzYzI4MjZhNzMvdGFibGU6YmRjMWU1YWRiZmU5NGNlNWJhNjE3NmFiZTQ1ZDliOTkvdGFibGVyYW5nZTpiZGMxZTVhZGJmZTk0Y2U1YmE2MTc2YWJlNDVkOWI5OV8wLTAtMS0xLTEwNzcw_d628f575-cb71-42b2-b1a1-998bb5d6176c">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xL2ZyYWc6NzNkMzI5ZjYwZjM0NDA1M2E5YzhlMGIzYzI4MjZhNzMvdGFibGU6YmRjMWU1YWRiZmU5NGNlNWJhNjE3NmFiZTQ1ZDliOTkvdGFibGVyYW5nZTpiZGMxZTVhZGJmZTk0Y2U1YmE2MTc2YWJlNDVkOWI5OV8xLTEtMS0xLTEwNzcw_998f96e5-f0a7-4cc5-a37a-9728d59934b2">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xL2ZyYWc6NzNkMzI5ZjYwZjM0NDA1M2E5YzhlMGIzYzI4MjZhNzMvdGFibGU6YmRjMWU1YWRiZmU5NGNlNWJhNjE3NmFiZTQ1ZDliOTkvdGFibGVyYW5nZTpiZGMxZTVhZGJmZTk0Y2U1YmE2MTc2YWJlNDVkOWI5OV8xLTQtMS0xLTEwNzcw_2484858c-b30f-4548-a081-9f3bb0ebba6a">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xL2ZyYWc6NzNkMzI5ZjYwZjM0NDA1M2E5YzhlMGIzYzI4MjZhNzMvdGV4dHJlZ2lvbjo3M2QzMjlmNjBmMzQ0MDUzYTljOGUwYjNjMjgyNmE3M18xOTkz_37783520-944e-4003-8009-5d6c3def741b">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="i59e42fb4c1064ece98100d592cf3657c_I20211103"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xL2ZyYWc6NzNkMzI5ZjYwZjM0NDA1M2E5YzhlMGIzYzI4MjZhNzMvdGV4dHJlZ2lvbjo3M2QzMjlmNjBmMzQ0MDUzYTljOGUwYjNjMjgyNmE3M18xOTM1_102991ea-bd9c-4289-9939-4bb03420ccb4"
      unitRef="shares">47275009</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i68ecd84e8da440808154baac134e839e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMy0xLTEtMS0xMDc3MA_2dddca1c-8b75-486b-81f3-142f93be4e11"
      unitRef="usd">137041000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMy0zLTEtMS0xMDc3MA_96b805d4-e705-4858-b08f-4f7da814ae15"
      unitRef="usd">29213000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i68ecd84e8da440808154baac134e839e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfNC0wLTEtMS0xMDc3MC90ZXh0cmVnaW9uOjkzZDI2MjBjYzI3YjRkZmRhNDNiZmFkZjdjNTE2NmJmXzQ2_9e88f6c6-4e59-4bb6-bde3-7879fdf9656f"
      unitRef="usd">6148000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfNC0wLTEtMS0xMDc3MC90ZXh0cmVnaW9uOjkzZDI2MjBjYzI3YjRkZmRhNDNiZmFkZjdjNTE2NmJmXzUz_f90e3cad-fb7f-46bf-9c31-8fd5733909f6"
      unitRef="usd">7043000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i68ecd84e8da440808154baac134e839e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfNC0xLTEtMS0xMDc3MA_18286281-b9ec-4067-93ed-309308997739"
      unitRef="usd">570101000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfNC0zLTEtMS0xMDc3MA_8c522d90-0b18-4e4a-bc61-1be169a8ee99"
      unitRef="usd">376099000</us-gaap:AccountsReceivableNetCurrent>
    <amn:Accountsreceivablesubcontractor
      contextRef="i68ecd84e8da440808154baac134e839e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfNS0xLTEtMS0xMDc3MA_49a275bb-edff-4e1f-8095-241ad4eb7a45"
      unitRef="usd">141626000</amn:Accountsreceivablesubcontractor>
    <amn:Accountsreceivablesubcontractor
      contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfNS0zLTEtMS0xMDc3MA_336cdaf6-4db0-4361-ad94-1e8e0f49de82"
      unitRef="usd">73985000</amn:Accountsreceivablesubcontractor>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="i68ecd84e8da440808154baac134e839e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfNi0xLTEtMS0xMDc3MA_6ca4e8cc-5810-45ed-9a28-651bfe4913e3"
      unitRef="usd">19367000</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfNi0zLTEtMS0xMDc3MA_8adcfbfc-ea6f-4461-b9fe-56ce6e2374a8"
      unitRef="usd">13629000</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="i68ecd84e8da440808154baac134e839e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfNy0xLTEtMS0xMDc3MA_f8298dee-67a6-45c9-a7b9-f275758055d8"
      unitRef="usd">31396000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfNy0zLTEtMS0xMDc3MA_8102482b-ad0f-45a9-98ed-473f2bf9306a"
      unitRef="usd">40809000</us-gaap:OtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i68ecd84e8da440808154baac134e839e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfOC0xLTEtMS0xMDc3MA_d2033efd-6eaf-4a01-903c-41e12b4a81d0"
      unitRef="usd">899531000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfOC0zLTEtMS0xMDc3MA_4e770a1b-b29a-4417-a744-3793e5871ab1"
      unitRef="usd">533735000</us-gaap:AssetsCurrent>
    <us-gaap:RestrictedCashAndInvestmentsNoncurrent
      contextRef="i68ecd84e8da440808154baac134e839e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfOS0xLTEtMS0xMDc3MA_a1bfc46b-1315-415d-8bab-b11a111cc1d6"
      unitRef="usd">63603000</us-gaap:RestrictedCashAndInvestmentsNoncurrent>
    <us-gaap:RestrictedCashAndInvestmentsNoncurrent
      contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfOS0zLTEtMS0xMDc3MA_787effc6-f2ed-4ab4-b7e9-2b30cbd56147"
      unitRef="usd">61347000</us-gaap:RestrictedCashAndInvestmentsNoncurrent>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i68ecd84e8da440808154baac134e839e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMTAtMC0xLTEtMTA3NzAvdGV4dHJlZ2lvbjo4MDJlMjIzYzhmZTc0NjM3OTUxNjU5NDk0N2RhMWI4Ml81Mw_aacac55a-bcd4-4b47-b9c7-747a7cbaad2a"
      unitRef="usd">190578000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMTAtMC0xLTEtMTA3NzAvdGV4dHJlZ2lvbjo4MDJlMjIzYzhmZTc0NjM3OTUxNjU5NDk0N2RhMWI4Ml82MA_22ccd6fb-e531-4528-8677-a86176073586"
      unitRef="usd">161752000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i68ecd84e8da440808154baac134e839e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMTAtMS0xLTEtMTA3NzA_d952ecc0-afc5-415f-bcd0-7b8dcbc2643c"
      unitRef="usd">127762000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMTAtMy0xLTEtMTA3NzA_b041c62c-5605-4f50-819b-9887cd8de8ab"
      unitRef="usd">116174000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i68ecd84e8da440808154baac134e839e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMTEtMS0xLTEtMTA3NzA_767277e6-19b2-49cb-9399-742b4021b89d"
      unitRef="usd">36487000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMTEtMy0xLTEtMTA3NzA_bffbbd54-724e-40c6-b231-c6a25a93cec1"
      unitRef="usd">77735000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i68ecd84e8da440808154baac134e839e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMTItMS0xLTEtMTA3NzA_1a356eef-2005-4308-b27d-06cc591d1b63"
      unitRef="usd">157909000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMTItMy0xLTEtMTA3NzA_9327f8ee-4f1d-4610-9a37-834abcc9a3c8"
      unitRef="usd">135120000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Goodwill
      contextRef="i68ecd84e8da440808154baac134e839e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMTMtMS0xLTEtMTA3NzA_58517117-5a65-480a-b8ed-c965db6664cf"
      unitRef="usd">893283000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMTMtMy0xLTEtMTA3NzA_02cece42-1d68-4439-92d7-cf20704925c4"
      unitRef="usd">864485000</us-gaap:Goodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i68ecd84e8da440808154baac134e839e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMTQtMC0xLTEtMTA3NzAvdGV4dHJlZ2lvbjoxYzRkNWYzZTQ5MDQ0NTdkYTFjMTMxZjMwMGUwMjgxM181OA_db80bf26-ed49-429c-b323-f7636a895cec"
      unitRef="usd">262253000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMTQtMC0xLTEtMTA3NzAvdGV4dHJlZ2lvbjoxYzRkNWYzZTQ5MDQ0NTdkYTFjMTMxZjMwMGUwMjgxM182NQ_59e296bb-010b-4d1d-8071-4e9e68af68b4"
      unitRef="usd">215234000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i68ecd84e8da440808154baac134e839e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMTQtMS0xLTEtMTA3NzA_0b30d31c-d85a-4f56-a8f1-ecfa9315e97d"
      unitRef="usd">530422000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMTQtMy0xLTEtMTA3NzA_8fe02f86-8872-4602-a3ae-5eb7012f1b1a"
      unitRef="usd">564911000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:Assets
      contextRef="i68ecd84e8da440808154baac134e839e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMTUtMS0xLTEtMTA3NzA_f1086c3d-f0e2-4089-81cd-55fdc03f7c6c"
      unitRef="usd">2708997000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMTUtMy0xLTEtMTA3NzA_05b7aa01-21f0-44a8-8285-d2f2cb4c1903"
      unitRef="usd">2353507000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="i68ecd84e8da440808154baac134e839e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMTgtMS0xLTEtMTA3NzA_3d3d69aa-1ef8-4800-9e99-81e135ebc998"
      unitRef="usd">284094000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMTgtMy0xLTEtMTA3NzA_faf532d6-2bed-4a6e-bb25-e78d1b49d0bd"
      unitRef="usd">167881000</us-gaap:AccountsPayableCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i68ecd84e8da440808154baac134e839e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMTktMS0xLTEtMTA3NzA_f6011f53-5218-4d5e-807a-338b76b627cc"
      unitRef="usd">321938000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMTktMy0xLTEtMTA3NzA_d6f0031a-04e7-4b5c-a0f9-d6c763ebb294"
      unitRef="usd">213414000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:NotesPayableCurrent
      contextRef="i68ecd84e8da440808154baac134e839e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMjEtMS0xLTEtMTA3NzA_81506363-96cd-4e43-9632-01f7d3943226"
      unitRef="usd">0</us-gaap:NotesPayableCurrent>
    <us-gaap:NotesPayableCurrent
      contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMjEtMy0xLTEtMTA3NzA_186bbe32-ab86-492f-a899-e01e056bd5b8"
      unitRef="usd">4688000</us-gaap:NotesPayableCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i68ecd84e8da440808154baac134e839e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMjItMS0xLTEtMTA3NzA_0b88b286-518c-4290-be36-f86aef93cb8f"
      unitRef="usd">14396000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMjItMy0xLTEtMTA3NzA_68caba2c-c28b-4f08-9c6c-37d41692a6cc"
      unitRef="usd">15032000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="i68ecd84e8da440808154baac134e839e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMjMtMS0xLTEtMTA3NzA_a2f0c72a-3950-4bc0-a1bd-75497d14dc4a"
      unitRef="usd">17904000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMjMtMy0xLTEtMTA3NzA_cff6d15c-4015-41c4-bc91-da8109bc6c9c"
      unitRef="usd">11004000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="i68ecd84e8da440808154baac134e839e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMjQtMS0xLTEtMTA3NzA_44abd235-a7fc-475d-b36e-499062e21c26"
      unitRef="usd">2854000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMjQtMy0xLTEtMTA3NzA_505ea3f4-8a8c-40c5-927e-b102666f4b83"
      unitRef="usd">10938000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i68ecd84e8da440808154baac134e839e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMjUtMS0xLTEtMTA3NzA_9ef65c41-72b7-4701-92b4-da8a3e72e646"
      unitRef="usd">641186000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMjUtMy0xLTEtMTA3NzA_fe273ea2-4caf-4381-a93f-ead513bc84dc"
      unitRef="usd">422957000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermNotesPayable
      contextRef="i68ecd84e8da440808154baac134e839e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMjctMS0xLTEtMTA3NzA_5edbbacc-0c2d-4b70-9686-35c656232967"
      unitRef="usd">842027000</us-gaap:LongTermNotesPayable>
    <us-gaap:LongTermNotesPayable
      contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMjctMy0xLTEtMTA3NzA_f449607c-484d-46e3-9516-2b33f7ccb051"
      unitRef="usd">857961000</us-gaap:LongTermNotesPayable>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i68ecd84e8da440808154baac134e839e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMjgtMS0xLTEtMTA3NzA_a8a1bbd0-06d7-47d1-8506-7cca8b06fb63"
      unitRef="usd">61187000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMjgtMy0xLTEtMTA3NzA_37ac2f76-948e-4555-b342-6e7c5ad998aa"
      unitRef="usd">67205000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i68ecd84e8da440808154baac134e839e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMjktMS0xLTEtMTA3NzA_6a6057aa-6135-4280-99d2-0a3f372e62c6"
      unitRef="usd">15004000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMjktMy0xLTEtMTA3NzA_e50e32bd-d434-4a25-9d89-4c977da0bed9"
      unitRef="usd">77800000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i68ecd84e8da440808154baac134e839e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMzAtMS0xLTEtMTA3NzA_abb32972-6fbc-4034-9a89-5fd6fd20b4ff"
      unitRef="usd">107115000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMzAtMy0xLTEtMTA3NzA_232b5a17-1d6a-4ec1-b5fe-5e796e4f537b"
      unitRef="usd">107907000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="i68ecd84e8da440808154baac134e839e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMzEtMS0xLTEtMTA3NzA_fb3a6902-887f-45a5-b05d-e18c3ea36545"
      unitRef="usd">1666519000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMzEtMy0xLTEtMTA3NzA_e0adff35-5255-4c08-b4c7-dd0f24eadc15"
      unitRef="usd">1533830000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i68ecd84e8da440808154baac134e839e_I20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMzItMS0xLTEtMTA3NzA_25bcb95b-c675-4d0c-b2d7-ec206c9e7bbd"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMzItMy0xLTEtMTA3NzA_9d564697-ede8-44f2-a54f-a200a773701e"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i68ecd84e8da440808154baac134e839e_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMzQtMC0xLTEtMTA3NzAvdGV4dHJlZ2lvbjo5ZDc5NWRkZTcwZWI0YTQ4YTRhM2NjZjBmNTc0MTVkMl8yMQ_373cc3e0-1a5e-452a-b8b3-bd425568749d"
      unitRef="usdPerShare">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMzQtMC0xLTEtMTA3NzAvdGV4dHJlZ2lvbjo5ZDc5NWRkZTcwZWI0YTQ4YTRhM2NjZjBmNTc0MTVkMl8yMQ_b2c79572-d9cc-4c88-a0f8-cf52e51badd8"
      unitRef="usdPerShare">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i68ecd84e8da440808154baac134e839e_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMzQtMC0xLTEtMTA3NzAvdGV4dHJlZ2lvbjo5ZDc5NWRkZTcwZWI0YTQ4YTRhM2NjZjBmNTc0MTVkMl8zNQ_4b7b1b7e-2c79-47ff-b7ec-96f33928d6fb"
      unitRef="shares">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMzQtMC0xLTEtMTA3NzAvdGV4dHJlZ2lvbjo5ZDc5NWRkZTcwZWI0YTQ4YTRhM2NjZjBmNTc0MTVkMl8zNQ_b520c63b-c9d3-463a-a293-7385dd77b3aa"
      unitRef="shares">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i68ecd84e8da440808154baac134e839e_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMzQtMC0xLTEtMTA3NzAvdGV4dHJlZ2lvbjo5ZDc5NWRkZTcwZWI0YTQ4YTRhM2NjZjBmNTc0MTVkMl81Nw_4b532aac-a6bd-4209-8e75-8b6f9ee2a779"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMzQtMC0xLTEtMTA3NzAvdGV4dHJlZ2lvbjo5ZDc5NWRkZTcwZWI0YTQ4YTRhM2NjZjBmNTc0MTVkMl81Nw_d9b522f0-2112-4b3c-8735-1ec233257281"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i68ecd84e8da440808154baac134e839e_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMzQtMC0xLTEtMTA3NzAvdGV4dHJlZ2lvbjo5ZDc5NWRkZTcwZWI0YTQ4YTRhM2NjZjBmNTc0MTVkMl81Nw_e8aeec39-1f0e-4b8b-a654-a901c7e9f346"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMzQtMC0xLTEtMTA3NzAvdGV4dHJlZ2lvbjo5ZDc5NWRkZTcwZWI0YTQ4YTRhM2NjZjBmNTc0MTVkMl81Nw_fb5218b0-410f-4cf0-b2b7-188cadd96e46"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockValue
      contextRef="i68ecd84e8da440808154baac134e839e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMzQtMS0xLTEtMTA3NzA_ec520393-14a7-48dd-9315-ff9b5ad384d4"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMzQtMy0xLTEtMTA3NzA_ffa0279b-6f6b-49b8-b68d-02e8e0275a32"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMzUtMC0xLTEtMTA3NzAvdGV4dHJlZ2lvbjowZTk2OWY3NThhM2E0MGMzODM4NGM2NTY3MWJkZTJkZF8xOA_3d03b700-fc06-41a9-94d4-5adc22554c20"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i68ecd84e8da440808154baac134e839e_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMzUtMC0xLTEtMTA3NzAvdGV4dHJlZ2lvbjowZTk2OWY3NThhM2E0MGMzODM4NGM2NTY3MWJkZTJkZF8xOA_d090eb86-3868-4c7a-936d-7ce1c49e670a"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMzUtMC0xLTEtMTA3NzAvdGV4dHJlZ2lvbjowZTk2OWY3NThhM2E0MGMzODM4NGM2NTY3MWJkZTJkZF8zMg_94be7f00-0d5b-448c-9b2b-9582bf2cc972"
      unitRef="shares">200000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i68ecd84e8da440808154baac134e839e_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMzUtMC0xLTEtMTA3NzAvdGV4dHJlZ2lvbjowZTk2OWY3NThhM2E0MGMzODM4NGM2NTY3MWJkZTJkZF8zMg_ccbde74e-efff-4b43-a6cd-05a1e56777cc"
      unitRef="shares">200000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="i68ecd84e8da440808154baac134e839e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMzUtMC0xLTEtMTA3NzAvdGV4dHJlZ2lvbjowZTk2OWY3NThhM2E0MGMzODM4NGM2NTY3MWJkZTJkZF81NA_91702a2b-fb55-4810-ba00-1e45c859d5d9"
      unitRef="shares">49836000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i68ecd84e8da440808154baac134e839e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMzUtMC0xLTEtMTA3NzAvdGV4dHJlZ2lvbjowZTk2OWY3NThhM2E0MGMzODM4NGM2NTY3MWJkZTJkZF82OA_8e611149-d5e3-4339-ab03-d51bab7f3883"
      unitRef="shares">47275000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMzUtMC0xLTEtMTA3NzAvdGV4dHJlZ2lvbjowZTk2OWY3NThhM2E0MGMzODM4NGM2NTY3MWJkZTJkZF85Mw_e65001c6-01c7-4e6d-baba-e7c502bf05c5"
      unitRef="shares">49614000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMzUtMC0xLTEtMTA3NzAvdGV4dHJlZ2lvbjowZTk2OWY3NThhM2E0MGMzODM4NGM2NTY3MWJkZTJkZF8xMDc_683b2fc8-3439-485c-a7a2-3a22cd7d6cf0"
      unitRef="shares">47053000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="i68ecd84e8da440808154baac134e839e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMzUtMS0xLTEtMTA3NzA_07e282b8-2236-47bd-8d67-f141278de5e8"
      unitRef="usd">498000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMzUtMy0xLTEtMTA3NzA_b7ee6a4b-7b76-47bf-b9ab-09c962b349f6"
      unitRef="usd">496000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i68ecd84e8da440808154baac134e839e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMzYtMS0xLTEtMTA3NzA_a304a8f2-238a-4b18-8d15-cf6acbb666f2"
      unitRef="usd">480364000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMzYtMy0xLTEtMTA3NzA_0a6686b8-9e44-41c0-9a78-8cbd5765f4fb"
      unitRef="usd">468726000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:TreasuryStockShares
      contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMzctMC0xLTEtMTA3NzAvdGV4dHJlZ2lvbjpkODU2MTFkNjAyYjY0MWE2OWQzNzlmMzMwN2ZmZTE4NV8yOQ_3d4976b5-e54e-46c5-9ad6-78c3a90fbb4a"
      unitRef="shares">2561000</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockShares
      contextRef="i68ecd84e8da440808154baac134e839e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMzctMC0xLTEtMTA3NzAvdGV4dHJlZ2lvbjpkODU2MTFkNjAyYjY0MWE2OWQzNzlmMzMwN2ZmZTE4NV8yOQ_96faad55-187f-4704-935a-ff973e1a268e"
      unitRef="shares">2561000</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockValue
      contextRef="i68ecd84e8da440808154baac134e839e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMzctMS0xLTEtMTA3NzA_93ba46a2-9ab2-45d2-9913-c85867461bdd"
      unitRef="usd">119143000</us-gaap:TreasuryStockValue>
    <us-gaap:TreasuryStockValue
      contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMzctMy0xLTEtMTA3NzA_ad86767a-1001-4280-96e9-e0dfe6a44761"
      unitRef="usd">119143000</us-gaap:TreasuryStockValue>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i68ecd84e8da440808154baac134e839e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMzgtMS0xLTEtMTA3NzA_1c235a21-47b6-4b3d-9394-c23f8fcd7924"
      unitRef="usd">680729000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMzgtMy0xLTEtMTA3NzA_1d4bc51c-109f-4c04-bce4-c9b0335ee34c"
      unitRef="usd">469558000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i68ecd84e8da440808154baac134e839e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMzktMS0xLTEtMTA3NzA_2c277a10-4a69-44a5-8e2a-9541c3ed1934"
      unitRef="usd">30000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfMzktMy0xLTEtMTA3NzA_90093d5b-c55e-4492-bf14-395f5cc56aef"
      unitRef="usd">40000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquity
      contextRef="i68ecd84e8da440808154baac134e839e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfNDAtMS0xLTEtMTA3NzA_d8584ff6-e66a-4bb7-87e7-fdbfa98f9f7a"
      unitRef="usd">1042478000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfNDAtMy0xLTEtMTA3NzA_1d399107-5894-453d-be86-51ad6724fafb"
      unitRef="usd">819677000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i68ecd84e8da440808154baac134e839e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfNDEtMS0xLTEtMTA3NzA_a2491eca-eb9e-42a5-8fc9-ecee619fbd9c"
      unitRef="usd">2708997000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xNi9mcmFnOjQyM2U5NGE3ZDlhYzQ1NjE4NzgwNGRhOWMyNTUxZTUwL3RhYmxlOmFkOWQwYmQyN2U3MzRmMmViZWUwNmViY2RiNTdiYWI3L3RhYmxlcmFuZ2U6YWQ5ZDBiZDI3ZTczNGYyZWJlZTA2ZWJjZGI1N2JhYjdfNDEtMy0xLTEtMTA3NzA_35ad0f03-9ac0-48e7-a309-f02856ede75c"
      unitRef="usd">2353507000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i150492f298fa47a78ef2c10a285a64f8_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfMi0xLTEtMS0xMDc3MA_6f63bef5-0ce3-4459-8744-42069eeca06a"
      unitRef="usd">877800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6cb0c51ba8fa45fda70ec7e5df8b4ef1_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfMi0zLTEtMS0xMDc3MA_2a73aa5a-6ab0-45fd-becc-5e088c3e57b2"
      unitRef="usd">551631000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfMi01LTEtMS0xMDc3MA_ad3f08b8-ccb8-4a8c-bbea-18f6ceafb9aa"
      unitRef="usd">2621190000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfMi03LTEtMS0xMDc3MA_86ecc28f-0f27-4705-8024-96230f0821da"
      unitRef="usd">1762443000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i150492f298fa47a78ef2c10a285a64f8_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfMy0xLTEtMS0xMDc3MA_cab17c80-ae00-48d9-b4b1-da594cd7bf42"
      unitRef="usd">571935000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i6cb0c51ba8fa45fda70ec7e5df8b4ef1_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfMy0zLTEtMS0xMDc3MA_d698df13-69f8-4d67-8ac7-240bb1ddde78"
      unitRef="usd">366998000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfMy01LTEtMS0xMDc3MA_672b0b16-37ed-42fe-b2bc-eb17a9fc0031"
      unitRef="usd">1745914000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfMy03LTEtMS0xMDc3MA_1a60e29b-9861-4bdc-9d7c-7a4ad471e27e"
      unitRef="usd">1178204000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:GrossProfit
      contextRef="i150492f298fa47a78ef2c10a285a64f8_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfNC0xLTEtMS0xMDc3MA_504edfd3-aea3-4bac-8216-c17f79461681"
      unitRef="usd">305865000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i6cb0c51ba8fa45fda70ec7e5df8b4ef1_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfNC0zLTEtMS0xMDc3MA_bd26b512-46db-4fdd-a212-894fc847fd2a"
      unitRef="usd">184633000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfNC01LTEtMS0xMDc3MA_24fdd701-1754-4bda-a223-4309246c402d"
      unitRef="usd">875276000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfNC03LTEtMS0xMDc3MA_e041e902-76e0-4375-b9ac-1193fce19420"
      unitRef="usd">584239000</us-gaap:GrossProfit>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i150492f298fa47a78ef2c10a285a64f8_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfNi0xLTEtMS0xMDc3MA_b0e5d288-7c1a-456d-b295-50bfdd5cda6b"
      unitRef="usd">173932000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i6cb0c51ba8fa45fda70ec7e5df8b4ef1_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfNi0zLTEtMS0xMDc3MA_f2ccd686-0481-4cfc-ab45-6e1c8769b85a"
      unitRef="usd">111235000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfNi01LTEtMS0xMDc3MA_91c94ded-59bd-4cea-ac0f-5ba28008bdfd"
      unitRef="usd">491773000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfNi03LTEtMS0xMDc3MA_91fa4bc6-4065-419d-9f8e-36df4acd0458"
      unitRef="usd">394537000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:DepreciationAndAmortization
      contextRef="i150492f298fa47a78ef2c10a285a64f8_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfNy0xLTEtMS0xMDc3MA_23f7d0fb-d7cd-4cbc-bb28-0345496c6031"
      unitRef="usd">26104000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i6cb0c51ba8fa45fda70ec7e5df8b4ef1_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfNy0zLTEtMS0xMDc3MA_779fb29c-ae66-4901-abb1-272d503ab59e"
      unitRef="usd">26936000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfNy01LTEtMS0xMDc3MA_451822a7-bf2c-473d-93e9-ebd8996d7120"
      unitRef="usd">74098000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfNy03LTEtMS0xMDc3MA_877a6af8-e8a0-42af-8175-42008e79ce7b"
      unitRef="usd">69096000</us-gaap:DepreciationAndAmortization>
    <us-gaap:OperatingExpenses
      contextRef="i150492f298fa47a78ef2c10a285a64f8_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfOC0xLTEtMS0xMDc3MA_dc19e92c-98e4-41b4-8fd8-6aa2fda749d9"
      unitRef="usd">200036000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i6cb0c51ba8fa45fda70ec7e5df8b4ef1_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfOC0zLTEtMS0xMDc3MA_baff416d-d55c-4eea-b3af-aeb7be95eacb"
      unitRef="usd">138171000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfOC01LTEtMS0xMDc3MA_f86118b6-5a59-4d64-b620-a73fd2f0d739"
      unitRef="usd">565871000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfOC03LTEtMS0xMDc3MA_fd39b9e5-98ab-446a-b903-b4e76d68b647"
      unitRef="usd">463633000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="i150492f298fa47a78ef2c10a285a64f8_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfOS0xLTEtMS0xMDc3MA_8b6f2bcd-d2b3-4232-ab7a-fc192a21a6ca"
      unitRef="usd">105829000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i6cb0c51ba8fa45fda70ec7e5df8b4ef1_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfOS0zLTEtMS0xMDc3MA_8f42725c-f8e4-4ab0-af2d-43462836acc2"
      unitRef="usd">46462000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfOS01LTEtMS0xMDc3MA_3a99b741-dde2-4ad1-98b2-75820ddf9d98"
      unitRef="usd">309405000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfOS03LTEtMS0xMDc3MA_3383adfb-cb3d-499e-92d2-e800df90551a"
      unitRef="usd">120606000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestExpense
      contextRef="i150492f298fa47a78ef2c10a285a64f8_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfMTAtMS0xLTEtMTA3NzA_f6feada2-51ac-47dd-9a25-b95779e0ccef"
      unitRef="usd">5223000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i6cb0c51ba8fa45fda70ec7e5df8b4ef1_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfMTAtMy0xLTEtMTA3NzA_2bec96e8-7e8c-43ec-a1f3-aa9bfff5926d"
      unitRef="usd">12564000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfMTAtNS0xLTEtMTA3NzA_9fec3880-99dd-4aeb-9b39-d4226c7010d2"
      unitRef="usd">24278000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfMTAtNy0xLTEtMTA3NzA_38c5ca37-3fac-4093-a5b0-8c5a4ddc68b5"
      unitRef="usd">35061000</us-gaap:InterestExpense>
    <us-gaap:IncomeLossAttributableToParent
      contextRef="i150492f298fa47a78ef2c10a285a64f8_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfMTEtMS0xLTEtMTA3NzA_e0e03aac-7005-4abf-acce-4cf58e7fdf71"
      unitRef="usd">100606000</us-gaap:IncomeLossAttributableToParent>
    <us-gaap:IncomeLossAttributableToParent
      contextRef="i6cb0c51ba8fa45fda70ec7e5df8b4ef1_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfMTEtMy0xLTEtMTA3NzA_73ea7389-837b-41ed-98fe-0fbc4160fe44"
      unitRef="usd">33898000</us-gaap:IncomeLossAttributableToParent>
    <us-gaap:IncomeLossAttributableToParent
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfMTEtNS0xLTEtMTA3NzA_646dbc86-fb59-42ac-8bcf-dac906f55097"
      unitRef="usd">285127000</us-gaap:IncomeLossAttributableToParent>
    <us-gaap:IncomeLossAttributableToParent
      contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfMTEtNy0xLTEtMTA3NzA_a86055ca-66e1-45d6-ae3f-954d973c466b"
      unitRef="usd">85545000</us-gaap:IncomeLossAttributableToParent>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i150492f298fa47a78ef2c10a285a64f8_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfMTItMS0xLTEtMTA3NzA_5efb859a-9040-4c01-9b05-a17f5d71691e"
      unitRef="usd">26583000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i6cb0c51ba8fa45fda70ec7e5df8b4ef1_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfMTItMy0xLTEtMTA3NzA_5f86cf77-36e3-4ce4-b913-224412d9185d"
      unitRef="usd">7831000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfMTItNS0xLTEtMTA3NzA_c9c0fad8-13d2-4273-b32e-70c31159139d"
      unitRef="usd">73956000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfMTItNy0xLTEtMTA3NzA_470364e9-23cd-43f2-baa9-72337e3aae0f"
      unitRef="usd">24188000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="i150492f298fa47a78ef2c10a285a64f8_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfMTMtMS0xLTEtMTA3NzA_e2d3a336-8dad-4f3e-8786-77b7cea81a01"
      unitRef="usd">74023000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i150492f298fa47a78ef2c10a285a64f8_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfMTMtMS0xLTEtMTA3NzA_efff5a03-8551-4e93-a0e5-a22a1e915046"
      unitRef="usd">74023000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="i6cb0c51ba8fa45fda70ec7e5df8b4ef1_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfMTMtMy0xLTEtMTA3NzA_55f14d18-0e78-4532-8438-964eb731efe6"
      unitRef="usd">26067000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i6cb0c51ba8fa45fda70ec7e5df8b4ef1_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfMTMtMy0xLTEtMTA3NzA_f0ff9ce4-8dd3-48a3-bf23-a7dd3a16d444"
      unitRef="usd">26067000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfMTMtNS0xLTEtMTA3NzA_eb0c20d2-b18d-490a-bbce-9f275d8a448b"
      unitRef="usd">211171000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfMTMtNS0xLTEtMTA3NzA_f14545f9-8870-499b-943c-0688cc9fb12b"
      unitRef="usd">211171000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfMTMtNy0xLTEtMTA3NzA_172b8971-f392-48a3-afb9-66a3fda40494"
      unitRef="usd">61357000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfMTMtNy0xLTEtMTA3NzA_97d2cddd-93ac-40ee-9644-9af6f298d471"
      unitRef="usd">61357000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i150492f298fa47a78ef2c10a285a64f8_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfMTYtMS0xLTEtMTA3NzA_cf43af2f-ddb9-415d-b99e-d01131953c0b"
      unitRef="usd">11000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i6cb0c51ba8fa45fda70ec7e5df8b4ef1_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfMTYtMy0xLTEtMTA3NzA_1f687ea9-f363-48ef-bcaa-5563bc97943e"
      unitRef="usd">-14000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfMTYtNS0xLTEtMTA3NzA_41da66b2-4330-49da-a4fa-88b9c598ad34"
      unitRef="usd">-10000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfMTYtNy0xLTEtMTA3NzA_67a363e1-14a6-40c2-8c84-158aa0f88f2b"
      unitRef="usd">-119000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i150492f298fa47a78ef2c10a285a64f8_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfMTctMS0xLTEtMTA3NzA_6f338eec-a366-4426-8ebf-f7d98f507c0b"
      unitRef="usd">11000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i6cb0c51ba8fa45fda70ec7e5df8b4ef1_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfMTctMy0xLTEtMTA3NzA_d84fcb1d-4962-464d-b1fa-90504f4ee12c"
      unitRef="usd">-14000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfMTctNS0xLTEtMTA3NzA_cf48e684-e1b1-463d-8478-404edc358b23"
      unitRef="usd">-10000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfMTctNy0xLTEtMTA3NzA_27f3eff7-23db-440b-8e01-b98e7b44a932"
      unitRef="usd">-119000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i150492f298fa47a78ef2c10a285a64f8_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfMTktMS0xLTEtMTA3NzA_cf0d65b8-93d4-4c55-bc6b-af34320d0e0d"
      unitRef="usd">74034000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i6cb0c51ba8fa45fda70ec7e5df8b4ef1_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfMTktMy0xLTEtMTA3NzA_01541bd0-4542-4f6e-9ce0-9c3be7164eb7"
      unitRef="usd">26053000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfMTktNS0xLTEtMTA3NzA_dcd03498-fe8e-44a6-92c5-0af15b0bffbe"
      unitRef="usd">211161000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfMTktNy0xLTEtMTA3NzA_340c5680-caea-4117-abba-745040d96eec"
      unitRef="usd">61238000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:EarningsPerShareBasic
      contextRef="i150492f298fa47a78ef2c10a285a64f8_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfMjItMS0xLTEtMTA3NzA_8314d84c-6e2c-4558-bffb-6c297070d87a"
      unitRef="usdPerShare">1.55</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i6cb0c51ba8fa45fda70ec7e5df8b4ef1_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfMjItMy0xLTEtMTA3NzA_b64cf2a6-69cc-4df5-9345-474db05102e4"
      unitRef="usdPerShare">0.55</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfMjItNS0xLTEtMTA3NzA_bbc95430-281c-4460-be37-bd802729d7c4"
      unitRef="usdPerShare">4.43</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfMjItNy0xLTEtMTA3NzA_2507c2f5-a080-4b59-a213-4679efd005f0"
      unitRef="usdPerShare">1.29</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i150492f298fa47a78ef2c10a285a64f8_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfMjMtMS0xLTEtMTA3NzA_68108a81-89cf-472e-a675-f3ea82c9b24c"
      unitRef="usdPerShare">1.54</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i6cb0c51ba8fa45fda70ec7e5df8b4ef1_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfMjMtMy0xLTEtMTA3NzA_21bf28e6-d12f-4ae8-9a88-16867419609e"
      unitRef="usdPerShare">0.55</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfMjMtNS0xLTEtMTA3NzA_caeeeba4-0685-4ded-aca7-0571d2670794"
      unitRef="usdPerShare">4.40</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfMjMtNy0xLTEtMTA3NzA_5daa6dc6-a987-4860-9a90-55b3874308be"
      unitRef="usdPerShare">1.29</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i150492f298fa47a78ef2c10a285a64f8_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfMjUtMS0xLTEtMTA3NzA_94f3875a-ca98-4798-b091-550316b6d3a6"
      unitRef="shares">47737000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i6cb0c51ba8fa45fda70ec7e5df8b4ef1_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfMjUtMy0xLTEtMTA3NzA_76f2b2c3-8dc5-4cfc-acbb-14d20b33e78a"
      unitRef="shares">47476000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfMjUtNS0xLTEtMTA3NzA_6f7eb06b-b539-47cd-b69d-40eec1446325"
      unitRef="shares">47666000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfMjUtNy0xLTEtMTA3NzA_3dd0e067-e76a-4bd6-ae5b-dc552906c44c"
      unitRef="shares">47406000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i150492f298fa47a78ef2c10a285a64f8_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfMjYtMS0xLTEtMTA3NzA_afbada0d-3f26-4dc1-9e2d-85c01ffe3ef2"
      unitRef="shares">48080000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i6cb0c51ba8fa45fda70ec7e5df8b4ef1_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfMjYtMy0xLTEtMTA3NzA_f72ee4fa-516e-46ee-b9e5-1fad92bc2645"
      unitRef="shares">47676000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfMjYtNS0xLTEtMTA3NzA_af6b7a84-e486-42b4-97b7-ee1400537b6c"
      unitRef="shares">48022000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18xOS9mcmFnOjg4ZGYwOTVmZTVmYjQ0ZjU5ZTExMGVjODdjNTU4NmE5L3RhYmxlOjAxYjhmNDMyNzg4ZjRhNjk4NTFhNDNmNTQ3YTVlODYyL3RhYmxlcmFuZ2U6MDFiOGY0MzI3ODhmNGE2OTg1MWE0M2Y1NDdhNWU4NjJfMjYtNy0xLTEtMTA3NzA_e3f9bb21-fb60-4b9f-95bb-6e038f36c2cd"
      unitRef="shares">47647000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:SharesIssued
      contextRef="i2f727815e2874946b60bd2e1bb5e93be_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjA4YjkwYmJkYmMzNDRhY2Q4MjczNzY0OGJhM2FmNzY2L3RhYmxlcmFuZ2U6MDhiOTBiYmRiYzM0NGFjZDgyNzM3NjQ4YmEzYWY3NjZfMi0xLTEtMS0xMDc3MA_acd1daf7-e0b9-4db2-8c71-55f2b3939efa"
      unitRef="shares">49283000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i2f727815e2874946b60bd2e1bb5e93be_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjA4YjkwYmJkYmMzNDRhY2Q4MjczNzY0OGJhM2FmNzY2L3RhYmxlcmFuZ2U6MDhiOTBiYmRiYzM0NGFjZDgyNzM3NjQ4YmEzYWY3NjZfMi0zLTEtMS0xMDc3MA_f34d1ce6-0c8f-48f2-ab0e-8945c51d7c1f"
      unitRef="usd">493000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="iaa1c76ff437b4f6ab9cb7b6cfe222bf4_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjA4YjkwYmJkYmMzNDRhY2Q4MjczNzY0OGJhM2FmNzY2L3RhYmxlcmFuZ2U6MDhiOTBiYmRiYzM0NGFjZDgyNzM3NjQ4YmEzYWY3NjZfMi01LTEtMS0xMDc3MA_176d3294-f6c4-416c-9c46-4b0d652eb0cf"
      unitRef="usd">455193000</us-gaap:StockholdersEquity>
    <us-gaap:SharesIssued
      contextRef="if7393c775ca64e5aad76fe5c6f242546_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjA4YjkwYmJkYmMzNDRhY2Q4MjczNzY0OGJhM2FmNzY2L3RhYmxlcmFuZ2U6MDhiOTBiYmRiYzM0NGFjZDgyNzM3NjQ4YmEzYWY3NjZfMi03LTEtMS0xMDc3MA_7a8bca33-3f4b-48b3-8a00-01f1f50c574a"
      unitRef="shares">2561000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="if7393c775ca64e5aad76fe5c6f242546_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjA4YjkwYmJkYmMzNDRhY2Q4MjczNzY0OGJhM2FmNzY2L3RhYmxlcmFuZ2U6MDhiOTBiYmRiYzM0NGFjZDgyNzM3NjQ4YmEzYWY3NjZfMi05LTEtMS0xMDc3MA_602be9db-2820-4e86-a5cf-05f81371092b"
      unitRef="usd">-119143000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i42390657f50c458e90b81cff65ca34a5_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjA4YjkwYmJkYmMzNDRhY2Q4MjczNzY0OGJhM2FmNzY2L3RhYmxlcmFuZ2U6MDhiOTBiYmRiYzM0NGFjZDgyNzM3NjQ4YmEzYWY3NjZfMi0xMS0xLTEtMTA3NzA_cdfbb519-ecbb-4485-b30c-c684d11fae5f"
      unitRef="usd">400047000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i60d729ea22d44fd2a79b8bf55e800ca9_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjA4YjkwYmJkYmMzNDRhY2Q4MjczNzY0OGJhM2FmNzY2L3RhYmxlcmFuZ2U6MDhiOTBiYmRiYzM0NGFjZDgyNzM3NjQ4YmEzYWY3NjZfMi0xMy0xLTEtMTA3NzA_b098d0d9-e9ae-40d5-ac35-e7da618481fa"
      unitRef="usd">152000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i73ad7702c4f241548c42eab7eb506186_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjA4YjkwYmJkYmMzNDRhY2Q4MjczNzY0OGJhM2FmNzY2L3RhYmxlcmFuZ2U6MDhiOTBiYmRiYzM0NGFjZDgyNzM3NjQ4YmEzYWY3NjZfMi0xNS0xLTEtMTA3NzA_4bb74887-864a-476d-b37f-15126c207f93"
      unitRef="usd">736742000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="ib229d5f30fdf41e28a8c14b58ac7f71a_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjA4YjkwYmJkYmMzNDRhY2Q4MjczNzY0OGJhM2FmNzY2L3RhYmxlcmFuZ2U6MDhiOTBiYmRiYzM0NGFjZDgyNzM3NjQ4YmEzYWY3NjZfNC0xLTEtMS0xMDc3MA_673a2f77-ac8f-4ded-9742-0bc30c625e27"
      unitRef="shares">140000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ib229d5f30fdf41e28a8c14b58ac7f71a_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjA4YjkwYmJkYmMzNDRhY2Q4MjczNzY0OGJhM2FmNzY2L3RhYmxlcmFuZ2U6MDhiOTBiYmRiYzM0NGFjZDgyNzM3NjQ4YmEzYWY3NjZfNC0zLTEtMS0xMDc3MA_136dd7d1-a2b3-46ec-a5c4-6a2c2b395fc3"
      unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i58a3e48055114d67b6bc5e307451f03b_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjA4YjkwYmJkYmMzNDRhY2Q4MjczNzY0OGJhM2FmNzY2L3RhYmxlcmFuZ2U6MDhiOTBiYmRiYzM0NGFjZDgyNzM3NjQ4YmEzYWY3NjZfNC01LTEtMS0xMDc3MA_59a6183c-584e-4043-82ed-78453f8658d0"
      unitRef="usd">-4354000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ifb81bab0961842fb8ad3378a3b9343b6_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjA4YjkwYmJkYmMzNDRhY2Q4MjczNzY0OGJhM2FmNzY2L3RhYmxlcmFuZ2U6MDhiOTBiYmRiYzM0NGFjZDgyNzM3NjQ4YmEzYWY3NjZfNC0xNS0xLTEtMTA3NzA_e13cb1b6-fe1c-496e-b11c-8fcfd38e4389"
      unitRef="usd">-4353000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockholdersEquity
      contextRef="i1289950aefbc4d06a62bac0d92b90879_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjA4YjkwYmJkYmMzNDRhY2Q4MjczNzY0OGJhM2FmNzY2L3RhYmxlcmFuZ2U6MDhiOTBiYmRiYzM0NGFjZDgyNzM3NjQ4YmEzYWY3NjZfNS0xMS0xLTEtMTA3NzA_d86fc26b-56bd-45b0-9697-fbc67ad807fc"
      unitRef="usd">-1154000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i55f9e8f7bfb74ed0a97dc5b843a44941_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjA4YjkwYmJkYmMzNDRhY2Q4MjczNzY0OGJhM2FmNzY2L3RhYmxlcmFuZ2U6MDhiOTBiYmRiYzM0NGFjZDgyNzM3NjQ4YmEzYWY3NjZfNS0xNS0xLTEtMTA3NzA_4a191b28-9656-429a-bf5d-f2dc3a9be778"
      unitRef="usd">-1154000</us-gaap:StockholdersEquity>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i58a3e48055114d67b6bc5e307451f03b_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjA4YjkwYmJkYmMzNDRhY2Q4MjczNzY0OGJhM2FmNzY2L3RhYmxlcmFuZ2U6MDhiOTBiYmRiYzM0NGFjZDgyNzM3NjQ4YmEzYWY3NjZfNi01LTEtMS0xMDc3MA_47e3d408-323f-4070-8c31-a42cde42ca53"
      unitRef="usd">4927000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ifb81bab0961842fb8ad3378a3b9343b6_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjA4YjkwYmJkYmMzNDRhY2Q4MjczNzY0OGJhM2FmNzY2L3RhYmxlcmFuZ2U6MDhiOTBiYmRiYzM0NGFjZDgyNzM3NjQ4YmEzYWY3NjZfNi0xNS0xLTEtMTA3NzA_19833fd0-15d2-4574-8d0a-e04520bf9d25"
      unitRef="usd">4927000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i718b700dbfbb43239149794d4ebae58b_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjA4YjkwYmJkYmMzNDRhY2Q4MjczNzY0OGJhM2FmNzY2L3RhYmxlcmFuZ2U6MDhiOTBiYmRiYzM0NGFjZDgyNzM3NjQ4YmEzYWY3NjZfNy0xMS0xLTEtMTA3NzA_0f23133e-f2eb-4943-b889-090a3010c8c6"
      unitRef="usd">12965000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i4f7d797c1d4844499f22b04b3704142b_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjA4YjkwYmJkYmMzNDRhY2Q4MjczNzY0OGJhM2FmNzY2L3RhYmxlcmFuZ2U6MDhiOTBiYmRiYzM0NGFjZDgyNzM3NjQ4YmEzYWY3NjZfNy0xMy0xLTEtMTA3NzA_81ad605b-7f98-4768-85a4-d704e039a9a3"
      unitRef="usd">-47000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ifb81bab0961842fb8ad3378a3b9343b6_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjA4YjkwYmJkYmMzNDRhY2Q4MjczNzY0OGJhM2FmNzY2L3RhYmxlcmFuZ2U6MDhiOTBiYmRiYzM0NGFjZDgyNzM3NjQ4YmEzYWY3NjZfNy0xNS0xLTEtMTA3NzA_3698d0da-20f6-4266-85a3-fe750ff4f53e"
      unitRef="usd">12918000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:SharesIssued
      contextRef="ib9bfddb010034bb38eded0804243bd37_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjA4YjkwYmJkYmMzNDRhY2Q4MjczNzY0OGJhM2FmNzY2L3RhYmxlcmFuZ2U6MDhiOTBiYmRiYzM0NGFjZDgyNzM3NjQ4YmEzYWY3NjZfOC0xLTEtMS0xMDc3MA_2168e6c9-07e7-4a19-8edd-64a0a3dbf00f"
      unitRef="shares">49423000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="ib9bfddb010034bb38eded0804243bd37_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjA4YjkwYmJkYmMzNDRhY2Q4MjczNzY0OGJhM2FmNzY2L3RhYmxlcmFuZ2U6MDhiOTBiYmRiYzM0NGFjZDgyNzM3NjQ4YmEzYWY3NjZfOC0zLTEtMS0xMDc3MA_d5bde639-ff42-47e0-95d8-fb188cf87a2f"
      unitRef="usd">494000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i97238f9b66054193b28698bcbd56bffd_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjA4YjkwYmJkYmMzNDRhY2Q4MjczNzY0OGJhM2FmNzY2L3RhYmxlcmFuZ2U6MDhiOTBiYmRiYzM0NGFjZDgyNzM3NjQ4YmEzYWY3NjZfOC01LTEtMS0xMDc3MA_8db1f845-6c5b-442a-b1cf-e7318e751421"
      unitRef="usd">455766000</us-gaap:StockholdersEquity>
    <us-gaap:SharesIssued
      contextRef="i8374f5c37e3c42bcb5d46ed38d202316_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjA4YjkwYmJkYmMzNDRhY2Q4MjczNzY0OGJhM2FmNzY2L3RhYmxlcmFuZ2U6MDhiOTBiYmRiYzM0NGFjZDgyNzM3NjQ4YmEzYWY3NjZfOC03LTEtMS0xMDc3MA_7fa22ebc-249d-49c0-9c1d-796028cf65c4"
      unitRef="shares">2561000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i8374f5c37e3c42bcb5d46ed38d202316_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjA4YjkwYmJkYmMzNDRhY2Q4MjczNzY0OGJhM2FmNzY2L3RhYmxlcmFuZ2U6MDhiOTBiYmRiYzM0NGFjZDgyNzM3NjQ4YmEzYWY3NjZfOC05LTEtMS0xMDc3MA_763254c1-5771-4e34-874d-c805043bed93"
      unitRef="usd">-119143000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i3fdc200320734b32ba399fb32a98810b_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjA4YjkwYmJkYmMzNDRhY2Q4MjczNzY0OGJhM2FmNzY2L3RhYmxlcmFuZ2U6MDhiOTBiYmRiYzM0NGFjZDgyNzM3NjQ4YmEzYWY3NjZfOC0xMS0xLTEtMTA3NzA_4db7e1ef-da2e-4d6b-8366-b9f00a471c28"
      unitRef="usd">411858000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i21ae371fccca46019f452281282a8e2e_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjA4YjkwYmJkYmMzNDRhY2Q4MjczNzY0OGJhM2FmNzY2L3RhYmxlcmFuZ2U6MDhiOTBiYmRiYzM0NGFjZDgyNzM3NjQ4YmEzYWY3NjZfOC0xMy0xLTEtMTA3NzA_2435364d-97f9-4741-b636-77d77b22e3db"
      unitRef="usd">105000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ie4c03c1bf0694cdb83793beff3d0c14d_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjA4YjkwYmJkYmMzNDRhY2Q4MjczNzY0OGJhM2FmNzY2L3RhYmxlcmFuZ2U6MDhiOTBiYmRiYzM0NGFjZDgyNzM3NjQ4YmEzYWY3NjZfOC0xNS0xLTEtMTA3NzA_eaf5e12e-6056-40ef-a6a9-2c91812721ab"
      unitRef="usd">749080000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="ice0ddb5cd06441b9bbeccf3e4c82794d_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjA4YjkwYmJkYmMzNDRhY2Q4MjczNzY0OGJhM2FmNzY2L3RhYmxlcmFuZ2U6MDhiOTBiYmRiYzM0NGFjZDgyNzM3NjQ4YmEzYWY3NjZfMTAtMS0xLTEtMTA3NzA_25266298-b336-4b71-9ec8-68ac24f0378c"
      unitRef="shares">119000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ice0ddb5cd06441b9bbeccf3e4c82794d_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjA4YjkwYmJkYmMzNDRhY2Q4MjczNzY0OGJhM2FmNzY2L3RhYmxlcmFuZ2U6MDhiOTBiYmRiYzM0NGFjZDgyNzM3NjQ4YmEzYWY3NjZfMTAtMy0xLTEtMTA3NzA_e10cce3f-5bb3-4ea2-bee6-d5d40c1ff46c"
      unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i22cbe5469ffd4ae29750942feb990e4a_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjA4YjkwYmJkYmMzNDRhY2Q4MjczNzY0OGJhM2FmNzY2L3RhYmxlcmFuZ2U6MDhiOTBiYmRiYzM0NGFjZDgyNzM3NjQ4YmEzYWY3NjZfMTAtNS0xLTEtMTA3NzA_d75a3e5a-75d9-46f1-aa7c-3bce9f7564fc"
      unitRef="usd">-289000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i6d7b8b207f474903b3f67df5d7afc0b7_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjA4YjkwYmJkYmMzNDRhY2Q4MjczNzY0OGJhM2FmNzY2L3RhYmxlcmFuZ2U6MDhiOTBiYmRiYzM0NGFjZDgyNzM3NjQ4YmEzYWY3NjZfMTAtMTUtMS0xLTEwNzcw_b2b9fbce-0486-490d-b3ab-96730591df03"
      unitRef="usd">-288000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i22cbe5469ffd4ae29750942feb990e4a_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjA4YjkwYmJkYmMzNDRhY2Q4MjczNzY0OGJhM2FmNzY2L3RhYmxlcmFuZ2U6MDhiOTBiYmRiYzM0NGFjZDgyNzM3NjQ4YmEzYWY3NjZfMTEtNS0xLTEtMTA3NzA_88d12bff-abda-4a19-99e5-86c9bc9d1614"
      unitRef="usd">6347000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i6d7b8b207f474903b3f67df5d7afc0b7_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjA4YjkwYmJkYmMzNDRhY2Q4MjczNzY0OGJhM2FmNzY2L3RhYmxlcmFuZ2U6MDhiOTBiYmRiYzM0NGFjZDgyNzM3NjQ4YmEzYWY3NjZfMTEtMTUtMS0xLTEwNzcw_68d22ed6-0c6e-47cf-a2a5-3c11814bf230"
      unitRef="usd">6347000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ic9ff33a69ee247cca762b7fc9c84ab44_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjA4YjkwYmJkYmMzNDRhY2Q4MjczNzY0OGJhM2FmNzY2L3RhYmxlcmFuZ2U6MDhiOTBiYmRiYzM0NGFjZDgyNzM3NjQ4YmEzYWY3NjZfMTItMTEtMS0xLTEwNzcw_64605a96-2a5d-4e42-b1a5-6d4829bc1bcf"
      unitRef="usd">22325000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="iba98b023b51845efaf19bbdbfccdd906_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjA4YjkwYmJkYmMzNDRhY2Q4MjczNzY0OGJhM2FmNzY2L3RhYmxlcmFuZ2U6MDhiOTBiYmRiYzM0NGFjZDgyNzM3NjQ4YmEzYWY3NjZfMTItMTMtMS0xLTEwNzcw_9d615b98-6bdd-4252-a97a-1c02d4765fe6"
      unitRef="usd">-58000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i6d7b8b207f474903b3f67df5d7afc0b7_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjA4YjkwYmJkYmMzNDRhY2Q4MjczNzY0OGJhM2FmNzY2L3RhYmxlcmFuZ2U6MDhiOTBiYmRiYzM0NGFjZDgyNzM3NjQ4YmEzYWY3NjZfMTItMTUtMS0xLTEwNzcw_9c92cefe-24c7-4198-9579-8698200804ba"
      unitRef="usd">22267000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:SharesIssued
      contextRef="i31b9aece0de343d4938455d196c5db4d_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjA4YjkwYmJkYmMzNDRhY2Q4MjczNzY0OGJhM2FmNzY2L3RhYmxlcmFuZ2U6MDhiOTBiYmRiYzM0NGFjZDgyNzM3NjQ4YmEzYWY3NjZfMTMtMS0xLTEtMTA3NzA_eaa8da70-181d-4737-a432-69aeaa787d58"
      unitRef="shares">49542000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i31b9aece0de343d4938455d196c5db4d_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjA4YjkwYmJkYmMzNDRhY2Q4MjczNzY0OGJhM2FmNzY2L3RhYmxlcmFuZ2U6MDhiOTBiYmRiYzM0NGFjZDgyNzM3NjQ4YmEzYWY3NjZfMTMtMy0xLTEtMTA3NzA_7c0d2ad6-163f-4f46-b162-f1d0e24c1077"
      unitRef="usd">495000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i2b53f2fafe1d4e4db0704085cd21df06_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjA4YjkwYmJkYmMzNDRhY2Q4MjczNzY0OGJhM2FmNzY2L3RhYmxlcmFuZ2U6MDhiOTBiYmRiYzM0NGFjZDgyNzM3NjQ4YmEzYWY3NjZfMTMtNS0xLTEtMTA3NzA_3167fed0-3559-4b13-b02b-053f031b9954"
      unitRef="usd">461824000</us-gaap:StockholdersEquity>
    <us-gaap:SharesIssued
      contextRef="i7d335e9ab53a4968a587f6a232b63ae6_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjA4YjkwYmJkYmMzNDRhY2Q4MjczNzY0OGJhM2FmNzY2L3RhYmxlcmFuZ2U6MDhiOTBiYmRiYzM0NGFjZDgyNzM3NjQ4YmEzYWY3NjZfMTMtNy0xLTEtMTA3NzA_b5b82d93-a770-458a-873d-9576df7cd310"
      unitRef="shares">2561000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i7d335e9ab53a4968a587f6a232b63ae6_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjA4YjkwYmJkYmMzNDRhY2Q4MjczNzY0OGJhM2FmNzY2L3RhYmxlcmFuZ2U6MDhiOTBiYmRiYzM0NGFjZDgyNzM3NjQ4YmEzYWY3NjZfMTMtOS0xLTEtMTA3NzA_b6de3008-5844-4c61-833b-94f99a5fc364"
      unitRef="usd">-119143000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i171378b7da944f48bc6e24f7e01f7ba2_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjA4YjkwYmJkYmMzNDRhY2Q4MjczNzY0OGJhM2FmNzY2L3RhYmxlcmFuZ2U6MDhiOTBiYmRiYzM0NGFjZDgyNzM3NjQ4YmEzYWY3NjZfMTMtMTEtMS0xLTEwNzcw_861dee3e-5f9e-4eaa-aba4-1d7b2b5a7700"
      unitRef="usd">434183000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i7a73aec65e1645e497b0db29a7acbd13_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjA4YjkwYmJkYmMzNDRhY2Q4MjczNzY0OGJhM2FmNzY2L3RhYmxlcmFuZ2U6MDhiOTBiYmRiYzM0NGFjZDgyNzM3NjQ4YmEzYWY3NjZfMTMtMTMtMS0xLTEwNzcw_6c513b8b-233b-4235-bd0f-1f76fa12cd0a"
      unitRef="usd">47000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i864c53255b1c4eecafc3c0eac9341add_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjA4YjkwYmJkYmMzNDRhY2Q4MjczNzY0OGJhM2FmNzY2L3RhYmxlcmFuZ2U6MDhiOTBiYmRiYzM0NGFjZDgyNzM3NjQ4YmEzYWY3NjZfMTMtMTUtMS0xLTEwNzcw_8e50ea91-27a7-42a5-adcb-bc427a2edf72"
      unitRef="usd">777406000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i61d471d96d2b497e850b061f9eed0d11_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjA4YjkwYmJkYmMzNDRhY2Q4MjczNzY0OGJhM2FmNzY2L3RhYmxlcmFuZ2U6MDhiOTBiYmRiYzM0NGFjZDgyNzM3NjQ4YmEzYWY3NjZfMTUtMS0xLTEtMTA3NzA_9377718c-7c15-4859-8b11-6694f33af039"
      unitRef="shares">8000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i226e8207b95f41d1ad9ee9df88356228_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjA4YjkwYmJkYmMzNDRhY2Q4MjczNzY0OGJhM2FmNzY2L3RhYmxlcmFuZ2U6MDhiOTBiYmRiYzM0NGFjZDgyNzM3NjQ4YmEzYWY3NjZfMTUtNS0xLTEtMTA3NzA_f2f96fd8-e393-4092-8870-b33151bc3052"
      unitRef="usd">-158000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i6cb0c51ba8fa45fda70ec7e5df8b4ef1_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjA4YjkwYmJkYmMzNDRhY2Q4MjczNzY0OGJhM2FmNzY2L3RhYmxlcmFuZ2U6MDhiOTBiYmRiYzM0NGFjZDgyNzM3NjQ4YmEzYWY3NjZfMTUtMTUtMS0xLTEwNzcw_ae8e4603-60f7-45e5-92e0-eb8a8c3f1792"
      unitRef="usd">-158000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i226e8207b95f41d1ad9ee9df88356228_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjA4YjkwYmJkYmMzNDRhY2Q4MjczNzY0OGJhM2FmNzY2L3RhYmxlcmFuZ2U6MDhiOTBiYmRiYzM0NGFjZDgyNzM3NjQ4YmEzYWY3NjZfMTYtNS0xLTEtMTA3NzA_6a5b0438-ef26-4acf-b883-c73af7197acc"
      unitRef="usd">3772000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i6cb0c51ba8fa45fda70ec7e5df8b4ef1_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjA4YjkwYmJkYmMzNDRhY2Q4MjczNzY0OGJhM2FmNzY2L3RhYmxlcmFuZ2U6MDhiOTBiYmRiYzM0NGFjZDgyNzM3NjQ4YmEzYWY3NjZfMTYtMTUtMS0xLTEwNzcw_be3cdeea-bbba-48b3-a34d-39fbe88982ab"
      unitRef="usd">3772000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i1318bf5c6a9f40ae8b4706d6aadc9c71_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjA4YjkwYmJkYmMzNDRhY2Q4MjczNzY0OGJhM2FmNzY2L3RhYmxlcmFuZ2U6MDhiOTBiYmRiYzM0NGFjZDgyNzM3NjQ4YmEzYWY3NjZfMTctMTEtMS0xLTEwNzcw_1ed17b3c-d3a3-4d48-8147-7d6f2b15d18a"
      unitRef="usd">26067000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="if2cb1f3c6ed840009dec907fba58a43d_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjA4YjkwYmJkYmMzNDRhY2Q4MjczNzY0OGJhM2FmNzY2L3RhYmxlcmFuZ2U6MDhiOTBiYmRiYzM0NGFjZDgyNzM3NjQ4YmEzYWY3NjZfMTctMTMtMS0xLTEwNzcw_a82e7c1e-b6a2-4569-b27c-baf45011864c"
      unitRef="usd">-14000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i6cb0c51ba8fa45fda70ec7e5df8b4ef1_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjA4YjkwYmJkYmMzNDRhY2Q4MjczNzY0OGJhM2FmNzY2L3RhYmxlcmFuZ2U6MDhiOTBiYmRiYzM0NGFjZDgyNzM3NjQ4YmEzYWY3NjZfMTctMTUtMS0xLTEwNzcw_598dfff4-036f-49b7-9359-2b19b3a00c74"
      unitRef="usd">26053000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:SharesIssued
      contextRef="i6e14eb9c93e74f3296e6b86f12a28f94_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjA4YjkwYmJkYmMzNDRhY2Q4MjczNzY0OGJhM2FmNzY2L3RhYmxlcmFuZ2U6MDhiOTBiYmRiYzM0NGFjZDgyNzM3NjQ4YmEzYWY3NjZfMTgtMS0xLTEtMTA3NzA_03af8653-7475-4f12-81c0-01393f986cf7"
      unitRef="shares">49550000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i6e14eb9c93e74f3296e6b86f12a28f94_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjA4YjkwYmJkYmMzNDRhY2Q4MjczNzY0OGJhM2FmNzY2L3RhYmxlcmFuZ2U6MDhiOTBiYmRiYzM0NGFjZDgyNzM3NjQ4YmEzYWY3NjZfMTgtMy0xLTEtMTA3NzA_8e0270c3-3b09-482a-be83-bff54549f72a"
      unitRef="usd">495000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i912fae7382c74520a36b966d54d94e55_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjA4YjkwYmJkYmMzNDRhY2Q4MjczNzY0OGJhM2FmNzY2L3RhYmxlcmFuZ2U6MDhiOTBiYmRiYzM0NGFjZDgyNzM3NjQ4YmEzYWY3NjZfMTgtNS0xLTEtMTA3NzA_585952b1-e322-4520-932e-e2f6f3082636"
      unitRef="usd">465438000</us-gaap:StockholdersEquity>
    <us-gaap:SharesIssued
      contextRef="i1204f31b85134c68b260fb9d3a28ba82_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjA4YjkwYmJkYmMzNDRhY2Q4MjczNzY0OGJhM2FmNzY2L3RhYmxlcmFuZ2U6MDhiOTBiYmRiYzM0NGFjZDgyNzM3NjQ4YmEzYWY3NjZfMTgtNy0xLTEtMTA3NzA_24d11879-439e-40d8-80f5-8c61d69b3a22"
      unitRef="shares">2561000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i1204f31b85134c68b260fb9d3a28ba82_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjA4YjkwYmJkYmMzNDRhY2Q4MjczNzY0OGJhM2FmNzY2L3RhYmxlcmFuZ2U6MDhiOTBiYmRiYzM0NGFjZDgyNzM3NjQ4YmEzYWY3NjZfMTgtOS0xLTEtMTA3NzA_fb4e57f9-63cd-416f-aa02-9eca922f9393"
      unitRef="usd">-119143000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="iaa7b25fceae44920a18c86a32eb37837_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjA4YjkwYmJkYmMzNDRhY2Q4MjczNzY0OGJhM2FmNzY2L3RhYmxlcmFuZ2U6MDhiOTBiYmRiYzM0NGFjZDgyNzM3NjQ4YmEzYWY3NjZfMTgtMTEtMS0xLTEwNzcw_a89ef210-91a4-48aa-ad46-ae46fa7c61bb"
      unitRef="usd">460250000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="if2981eb3d48d4b619016fcb5f4dcabdc_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjA4YjkwYmJkYmMzNDRhY2Q4MjczNzY0OGJhM2FmNzY2L3RhYmxlcmFuZ2U6MDhiOTBiYmRiYzM0NGFjZDgyNzM3NjQ4YmEzYWY3NjZfMTgtMTMtMS0xLTEwNzcw_f3274afe-08e3-489d-81c6-108844655db2"
      unitRef="usd">33000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i041c1c8fe78444f88611087c404a5e99_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjA4YjkwYmJkYmMzNDRhY2Q4MjczNzY0OGJhM2FmNzY2L3RhYmxlcmFuZ2U6MDhiOTBiYmRiYzM0NGFjZDgyNzM3NjQ4YmEzYWY3NjZfMTgtMTUtMS0xLTEwNzcw_dae28612-14d1-4365-ad5b-db77c5ae9742"
      unitRef="usd">807073000</us-gaap:StockholdersEquity>
    <us-gaap:SharesIssued
      contextRef="i3656a73d18b94b609e6f1990823c9b89_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjMwOGUyY2ZiZWRlNDQ5Njk5YjAyNmU5MGNmNjUwYzVlL3RhYmxlcmFuZ2U6MzA4ZTJjZmJlZGU0NDk2OTliMDI2ZTkwY2Y2NTBjNWVfMi0xLTEtMS0xMDc3MA_0a894a0d-d384-43fd-826d-82e761a61d55"
      unitRef="shares">49614000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i3656a73d18b94b609e6f1990823c9b89_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjMwOGUyY2ZiZWRlNDQ5Njk5YjAyNmU5MGNmNjUwYzVlL3RhYmxlcmFuZ2U6MzA4ZTJjZmJlZGU0NDk2OTliMDI2ZTkwY2Y2NTBjNWVfMi0zLTEtMS0xMDc3MA_64248850-f201-4abe-a41b-c1adf62bbaa6"
      unitRef="usd">496000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i8479ccefea534b2dad7f94b83fe989f0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjMwOGUyY2ZiZWRlNDQ5Njk5YjAyNmU5MGNmNjUwYzVlL3RhYmxlcmFuZ2U6MzA4ZTJjZmJlZGU0NDk2OTliMDI2ZTkwY2Y2NTBjNWVfMi01LTEtMS0xMDc3MA_10355639-5e4b-43bd-b82e-5d01d3e46a1e"
      unitRef="usd">468726000</us-gaap:StockholdersEquity>
    <us-gaap:SharesIssued
      contextRef="iaee22aaa9ae44b1391c0b85a98440ff2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjMwOGUyY2ZiZWRlNDQ5Njk5YjAyNmU5MGNmNjUwYzVlL3RhYmxlcmFuZ2U6MzA4ZTJjZmJlZGU0NDk2OTliMDI2ZTkwY2Y2NTBjNWVfMi03LTEtMS0xMDc3MA_bf564c7c-9a78-4a02-baeb-bc0cb0b20678"
      unitRef="shares">2561000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="iaee22aaa9ae44b1391c0b85a98440ff2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjMwOGUyY2ZiZWRlNDQ5Njk5YjAyNmU5MGNmNjUwYzVlL3RhYmxlcmFuZ2U6MzA4ZTJjZmJlZGU0NDk2OTliMDI2ZTkwY2Y2NTBjNWVfMi05LTEtMS0xMDc3MA_96d62dac-7b4d-4529-97dc-66c71c59b46d"
      unitRef="usd">-119143000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i04614019537444e7b0521086b438b3b9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjMwOGUyY2ZiZWRlNDQ5Njk5YjAyNmU5MGNmNjUwYzVlL3RhYmxlcmFuZ2U6MzA4ZTJjZmJlZGU0NDk2OTliMDI2ZTkwY2Y2NTBjNWVfMi0xMS0xLTEtMTA3NzA_51b02432-94d9-4934-80a2-23b23019fdd3"
      unitRef="usd">469558000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i7af796f0576e42eca232001f8709a3b5_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjMwOGUyY2ZiZWRlNDQ5Njk5YjAyNmU5MGNmNjUwYzVlL3RhYmxlcmFuZ2U6MzA4ZTJjZmJlZGU0NDk2OTliMDI2ZTkwY2Y2NTBjNWVfMi0xMy0xLTEtMTA3NzA_586ee00f-f0eb-4dc8-ab57-2ed0f1b38b79"
      unitRef="usd">40000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjMwOGUyY2ZiZWRlNDQ5Njk5YjAyNmU5MGNmNjUwYzVlL3RhYmxlcmFuZ2U6MzA4ZTJjZmJlZGU0NDk2OTliMDI2ZTkwY2Y2NTBjNWVfMi0xNS0xLTEtMTA3NzA_c1eca1a6-9ec4-4083-996f-17173a88aca4"
      unitRef="usd">819677000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i02f81d784dce4b24a61070fc9496df23_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjMwOGUyY2ZiZWRlNDQ5Njk5YjAyNmU5MGNmNjUwYzVlL3RhYmxlcmFuZ2U6MzA4ZTJjZmJlZGU0NDk2OTliMDI2ZTkwY2Y2NTBjNWVfNC0xLTEtMS0xMDc3MA_8cc3c158-66d8-46d5-a4bd-196d1a6233c9"
      unitRef="shares">132000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i02f81d784dce4b24a61070fc9496df23_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjMwOGUyY2ZiZWRlNDQ5Njk5YjAyNmU5MGNmNjUwYzVlL3RhYmxlcmFuZ2U6MzA4ZTJjZmJlZGU0NDk2OTliMDI2ZTkwY2Y2NTBjNWVfNC0zLTEtMS0xMDc3MA_e2819f8b-be65-4b62-82c2-31a02ed52f09"
      unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ie5a0923496204e499de51398c3adbec5_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjMwOGUyY2ZiZWRlNDQ5Njk5YjAyNmU5MGNmNjUwYzVlL3RhYmxlcmFuZ2U6MzA4ZTJjZmJlZGU0NDk2OTliMDI2ZTkwY2Y2NTBjNWVfNC01LTEtMS0xMDc3MA_9f1e13b4-d659-4a72-b38b-570fea45c0fc"
      unitRef="usd">-5259000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ib2a70c6698bc4fb2a2ee6a77c38e17e7_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjMwOGUyY2ZiZWRlNDQ5Njk5YjAyNmU5MGNmNjUwYzVlL3RhYmxlcmFuZ2U6MzA4ZTJjZmJlZGU0NDk2OTliMDI2ZTkwY2Y2NTBjNWVfNC0xNS0xLTEtMTA3NzA_57266f2e-db16-4f68-9f70-be94d08d3a9e"
      unitRef="usd">-5258000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ie5a0923496204e499de51398c3adbec5_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjMwOGUyY2ZiZWRlNDQ5Njk5YjAyNmU5MGNmNjUwYzVlL3RhYmxlcmFuZ2U6MzA4ZTJjZmJlZGU0NDk2OTliMDI2ZTkwY2Y2NTBjNWVfNi01LTEtMS0xMDc3MA_05f70803-cd63-4364-a281-c32699b0e745"
      unitRef="usd">9287000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ib2a70c6698bc4fb2a2ee6a77c38e17e7_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjMwOGUyY2ZiZWRlNDQ5Njk5YjAyNmU5MGNmNjUwYzVlL3RhYmxlcmFuZ2U6MzA4ZTJjZmJlZGU0NDk2OTliMDI2ZTkwY2Y2NTBjNWVfNi0xNS0xLTEtMTA3NzA_f3e503f2-eaa7-446b-8322-bfeb6deaeae3"
      unitRef="usd">9287000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i88adf94124da4574a028c28b388799d6_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjMwOGUyY2ZiZWRlNDQ5Njk5YjAyNmU5MGNmNjUwYzVlL3RhYmxlcmFuZ2U6MzA4ZTJjZmJlZGU0NDk2OTliMDI2ZTkwY2Y2NTBjNWVfNy0xMS0xLTEtMTA3NzA_ff4787b2-1ec7-4344-a482-94b2804bb78d"
      unitRef="usd">70378000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="iac59e5529bc54834bcd03309405d87e9_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjMwOGUyY2ZiZWRlNDQ5Njk5YjAyNmU5MGNmNjUwYzVlL3RhYmxlcmFuZ2U6MzA4ZTJjZmJlZGU0NDk2OTliMDI2ZTkwY2Y2NTBjNWVfNy0xMy0xLTEtMTA3NzA_4688f349-bc71-4704-a70c-5bf19ae14b2e"
      unitRef="usd">-24000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ib2a70c6698bc4fb2a2ee6a77c38e17e7_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjMwOGUyY2ZiZWRlNDQ5Njk5YjAyNmU5MGNmNjUwYzVlL3RhYmxlcmFuZ2U6MzA4ZTJjZmJlZGU0NDk2OTliMDI2ZTkwY2Y2NTBjNWVfNy0xNS0xLTEtMTA3NzA_ee8ae11b-2ab3-4172-a8eb-12ef1c3472b5"
      unitRef="usd">70354000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:SharesIssued
      contextRef="i9dafaa37d5364e1ba2bb35e85967fa2c_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjMwOGUyY2ZiZWRlNDQ5Njk5YjAyNmU5MGNmNjUwYzVlL3RhYmxlcmFuZ2U6MzA4ZTJjZmJlZGU0NDk2OTliMDI2ZTkwY2Y2NTBjNWVfOC0xLTEtMS0xMDc3MA_e0b32bdb-da48-48c4-8b8f-2579b2391972"
      unitRef="shares">49746000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i9dafaa37d5364e1ba2bb35e85967fa2c_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjMwOGUyY2ZiZWRlNDQ5Njk5YjAyNmU5MGNmNjUwYzVlL3RhYmxlcmFuZ2U6MzA4ZTJjZmJlZGU0NDk2OTliMDI2ZTkwY2Y2NTBjNWVfOC0zLTEtMS0xMDc3MA_e704f4d2-59d1-4dfd-a9cf-d6817fcbd260"
      unitRef="usd">497000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i1ce2b693b671480e806a25a643c7f12d_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjMwOGUyY2ZiZWRlNDQ5Njk5YjAyNmU5MGNmNjUwYzVlL3RhYmxlcmFuZ2U6MzA4ZTJjZmJlZGU0NDk2OTliMDI2ZTkwY2Y2NTBjNWVfOC01LTEtMS0xMDc3MA_9ffe0b11-e825-4300-817f-0167a46ac26e"
      unitRef="usd">472754000</us-gaap:StockholdersEquity>
    <us-gaap:SharesIssued
      contextRef="i403d2a055ccd43bb8b88f5d7cab63117_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjMwOGUyY2ZiZWRlNDQ5Njk5YjAyNmU5MGNmNjUwYzVlL3RhYmxlcmFuZ2U6MzA4ZTJjZmJlZGU0NDk2OTliMDI2ZTkwY2Y2NTBjNWVfOC03LTEtMS0xMDc3MA_ce192a89-8f7b-491a-8fe1-85640ebaeb7e"
      unitRef="shares">2561000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i403d2a055ccd43bb8b88f5d7cab63117_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjMwOGUyY2ZiZWRlNDQ5Njk5YjAyNmU5MGNmNjUwYzVlL3RhYmxlcmFuZ2U6MzA4ZTJjZmJlZGU0NDk2OTliMDI2ZTkwY2Y2NTBjNWVfOC05LTEtMS0xMDc3MA_e0200161-ba1c-4da9-a9bd-bd929ea4b502"
      unitRef="usd">-119143000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="idbce5210eba9474d85e1137c4859a231_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjMwOGUyY2ZiZWRlNDQ5Njk5YjAyNmU5MGNmNjUwYzVlL3RhYmxlcmFuZ2U6MzA4ZTJjZmJlZGU0NDk2OTliMDI2ZTkwY2Y2NTBjNWVfOC0xMS0xLTEtMTA3NzA_6459c648-0943-4827-a70e-8bae422cbbaf"
      unitRef="usd">539936000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ic160cb42fea14c7584293e11e1aa33d3_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjMwOGUyY2ZiZWRlNDQ5Njk5YjAyNmU5MGNmNjUwYzVlL3RhYmxlcmFuZ2U6MzA4ZTJjZmJlZGU0NDk2OTliMDI2ZTkwY2Y2NTBjNWVfOC0xMy0xLTEtMTA3NzA_9f21abb0-8ec8-4e06-a38c-e33c2b6873d3"
      unitRef="usd">16000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i705012913b884ada9d0c3c4d270ed4d2_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjMwOGUyY2ZiZWRlNDQ5Njk5YjAyNmU5MGNmNjUwYzVlL3RhYmxlcmFuZ2U6MzA4ZTJjZmJlZGU0NDk2OTliMDI2ZTkwY2Y2NTBjNWVfOC0xNS0xLTEtMTA3NzA_90395ff7-4808-4ed1-91ee-e57ae17d0d6d"
      unitRef="usd">894060000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i3ef4f52f779e4faf95d4601d80832007_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjMwOGUyY2ZiZWRlNDQ5Njk5YjAyNmU5MGNmNjUwYzVlL3RhYmxlcmFuZ2U6MzA4ZTJjZmJlZGU0NDk2OTliMDI2ZTkwY2Y2NTBjNWVfMTAtMS0xLTEtMTA3NzA_90bcba39-4f30-4c88-9600-37ee744b7cb8"
      unitRef="shares">78000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i3ef4f52f779e4faf95d4601d80832007_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjMwOGUyY2ZiZWRlNDQ5Njk5YjAyNmU5MGNmNjUwYzVlL3RhYmxlcmFuZ2U6MzA4ZTJjZmJlZGU0NDk2OTliMDI2ZTkwY2Y2NTBjNWVfMTAtMy0xLTEtMTA3NzA_96920b25-9ba8-4646-ac2a-3117fc6861bc"
      unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i32dfbd39eb3d43cb911abb42fa8a42ef_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjMwOGUyY2ZiZWRlNDQ5Njk5YjAyNmU5MGNmNjUwYzVlL3RhYmxlcmFuZ2U6MzA4ZTJjZmJlZGU0NDk2OTliMDI2ZTkwY2Y2NTBjNWVfMTAtNS0xLTEtMTA3NzA_9b51a1be-2279-43bf-949c-e7506670e372"
      unitRef="usd">-471000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i77c68cc8659943eea02704a6a078bf18_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjMwOGUyY2ZiZWRlNDQ5Njk5YjAyNmU5MGNmNjUwYzVlL3RhYmxlcmFuZ2U6MzA4ZTJjZmJlZGU0NDk2OTliMDI2ZTkwY2Y2NTBjNWVfMTAtMTUtMS0xLTEwNzcw_1749a2bd-2c3d-45dc-b65a-428e341bcba6"
      unitRef="usd">-470000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i32dfbd39eb3d43cb911abb42fa8a42ef_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjMwOGUyY2ZiZWRlNDQ5Njk5YjAyNmU5MGNmNjUwYzVlL3RhYmxlcmFuZ2U6MzA4ZTJjZmJlZGU0NDk2OTliMDI2ZTkwY2Y2NTBjNWVfMTEtNS0xLTEtMTA3NzA_9faaa1d0-ffbf-4e54-81fd-b4b93127f6d4"
      unitRef="usd">6019000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i77c68cc8659943eea02704a6a078bf18_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjMwOGUyY2ZiZWRlNDQ5Njk5YjAyNmU5MGNmNjUwYzVlL3RhYmxlcmFuZ2U6MzA4ZTJjZmJlZGU0NDk2OTliMDI2ZTkwY2Y2NTBjNWVfMTEtMTUtMS0xLTEwNzcw_b5bdea00-85eb-4d74-acab-9d685ee6e980"
      unitRef="usd">6019000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ib57f7397b0a0419fb8f2b4cb5a7b0ff7_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjMwOGUyY2ZiZWRlNDQ5Njk5YjAyNmU5MGNmNjUwYzVlL3RhYmxlcmFuZ2U6MzA4ZTJjZmJlZGU0NDk2OTliMDI2ZTkwY2Y2NTBjNWVfMTItMTEtMS0xLTEwNzcw_2ff6854b-843b-4dc3-8620-efcebd7d1bdb"
      unitRef="usd">66770000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ibfb3f98525f24d859c4abcde0f73f237_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjMwOGUyY2ZiZWRlNDQ5Njk5YjAyNmU5MGNmNjUwYzVlL3RhYmxlcmFuZ2U6MzA4ZTJjZmJlZGU0NDk2OTliMDI2ZTkwY2Y2NTBjNWVfMTItMTMtMS0xLTEwNzcw_ee995681-b8e8-4b54-82c2-f3deb9734e61"
      unitRef="usd">3000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i77c68cc8659943eea02704a6a078bf18_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjMwOGUyY2ZiZWRlNDQ5Njk5YjAyNmU5MGNmNjUwYzVlL3RhYmxlcmFuZ2U6MzA4ZTJjZmJlZGU0NDk2OTliMDI2ZTkwY2Y2NTBjNWVfMTItMTUtMS0xLTEwNzcw_599d3e8d-7a0d-4380-980d-8538b812fe75"
      unitRef="usd">66773000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:SharesIssued
      contextRef="i5577c5bda907400ea634496c766b83e8_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjMwOGUyY2ZiZWRlNDQ5Njk5YjAyNmU5MGNmNjUwYzVlL3RhYmxlcmFuZ2U6MzA4ZTJjZmJlZGU0NDk2OTliMDI2ZTkwY2Y2NTBjNWVfMTMtMS0xLTEtMTA3NzA_32b4e843-928d-4190-b62d-bbc74cd694bd"
      unitRef="shares">49824000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i5577c5bda907400ea634496c766b83e8_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjMwOGUyY2ZiZWRlNDQ5Njk5YjAyNmU5MGNmNjUwYzVlL3RhYmxlcmFuZ2U6MzA4ZTJjZmJlZGU0NDk2OTliMDI2ZTkwY2Y2NTBjNWVfMTMtMy0xLTEtMTA3NzA_00d18ed2-8668-4aea-a743-0fbd72198287"
      unitRef="usd">498000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id73c4bc3bbf84e21b5f04cbfc8a138a4_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjMwOGUyY2ZiZWRlNDQ5Njk5YjAyNmU5MGNmNjUwYzVlL3RhYmxlcmFuZ2U6MzA4ZTJjZmJlZGU0NDk2OTliMDI2ZTkwY2Y2NTBjNWVfMTMtNS0xLTEtMTA3NzA_f8cb0b3c-23cb-4d21-8e72-2962b2f19d79"
      unitRef="usd">478302000</us-gaap:StockholdersEquity>
    <us-gaap:SharesIssued
      contextRef="id04a12fb0c1a4d8cb8704c13c181f0c8_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjMwOGUyY2ZiZWRlNDQ5Njk5YjAyNmU5MGNmNjUwYzVlL3RhYmxlcmFuZ2U6MzA4ZTJjZmJlZGU0NDk2OTliMDI2ZTkwY2Y2NTBjNWVfMTMtNy0xLTEtMTA3NzA_a58dd925-eddb-4281-a0af-e5f51012ac1a"
      unitRef="shares">2561000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="id04a12fb0c1a4d8cb8704c13c181f0c8_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjMwOGUyY2ZiZWRlNDQ5Njk5YjAyNmU5MGNmNjUwYzVlL3RhYmxlcmFuZ2U6MzA4ZTJjZmJlZGU0NDk2OTliMDI2ZTkwY2Y2NTBjNWVfMTMtOS0xLTEtMTA3NzA_365724e3-bf13-46bb-8043-b9eb7225f0bd"
      unitRef="usd">-119143000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i57a944b08046487db5fbee0222d76c46_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjMwOGUyY2ZiZWRlNDQ5Njk5YjAyNmU5MGNmNjUwYzVlL3RhYmxlcmFuZ2U6MzA4ZTJjZmJlZGU0NDk2OTliMDI2ZTkwY2Y2NTBjNWVfMTMtMTEtMS0xLTEwNzcw_05cb8de0-460a-424c-abb5-32db1757bd4d"
      unitRef="usd">606706000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i054622b9ff6b45d094e6d62e718bb40a_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjMwOGUyY2ZiZWRlNDQ5Njk5YjAyNmU5MGNmNjUwYzVlL3RhYmxlcmFuZ2U6MzA4ZTJjZmJlZGU0NDk2OTliMDI2ZTkwY2Y2NTBjNWVfMTMtMTMtMS0xLTEwNzcw_082dc435-8ac1-4326-9ab9-848bb032ccef"
      unitRef="usd">19000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i65cb728c1968429faa88cef83eef8a65_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjMwOGUyY2ZiZWRlNDQ5Njk5YjAyNmU5MGNmNjUwYzVlL3RhYmxlcmFuZ2U6MzA4ZTJjZmJlZGU0NDk2OTliMDI2ZTkwY2Y2NTBjNWVfMTMtMTUtMS0xLTEwNzcw_64912312-7e31-4526-8a46-efcbf1975167"
      unitRef="usd">966382000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="ifce17ccf7b614cb3aeb8d263bb97ccf5_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjMwOGUyY2ZiZWRlNDQ5Njk5YjAyNmU5MGNmNjUwYzVlL3RhYmxlcmFuZ2U6MzA4ZTJjZmJlZGU0NDk2OTliMDI2ZTkwY2Y2NTBjNWVfMTUtMS0xLTEtMTA3NzA_3abf744f-79f4-4a68-9ef8-68fdd4a2e126"
      unitRef="shares">12000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="id10a5dbf399445d3b8969edabe30751a_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjMwOGUyY2ZiZWRlNDQ5Njk5YjAyNmU5MGNmNjUwYzVlL3RhYmxlcmFuZ2U6MzA4ZTJjZmJlZGU0NDk2OTliMDI2ZTkwY2Y2NTBjNWVfMTUtNS0xLTEtMTA3NzA_7216db91-39f5-4702-ba97-dc3710494b80"
      unitRef="usd">-527000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i150492f298fa47a78ef2c10a285a64f8_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjMwOGUyY2ZiZWRlNDQ5Njk5YjAyNmU5MGNmNjUwYzVlL3RhYmxlcmFuZ2U6MzA4ZTJjZmJlZGU0NDk2OTliMDI2ZTkwY2Y2NTBjNWVfMTUtMTUtMS0xLTEwNzcw_2dbeff58-9db9-4087-af8a-b14379495743"
      unitRef="usd">-527000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="id10a5dbf399445d3b8969edabe30751a_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjMwOGUyY2ZiZWRlNDQ5Njk5YjAyNmU5MGNmNjUwYzVlL3RhYmxlcmFuZ2U6MzA4ZTJjZmJlZGU0NDk2OTliMDI2ZTkwY2Y2NTBjNWVfMTYtNS0xLTEtMTA3NzA_79e154bc-7679-448f-a4e9-40ea0193db46"
      unitRef="usd">2589000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i150492f298fa47a78ef2c10a285a64f8_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjMwOGUyY2ZiZWRlNDQ5Njk5YjAyNmU5MGNmNjUwYzVlL3RhYmxlcmFuZ2U6MzA4ZTJjZmJlZGU0NDk2OTliMDI2ZTkwY2Y2NTBjNWVfMTYtMTUtMS0xLTEwNzcw_fa0e262d-606a-4cc4-90df-3d0d06055217"
      unitRef="usd">2589000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i14e64987a4644969a8cf482d758cef56_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjMwOGUyY2ZiZWRlNDQ5Njk5YjAyNmU5MGNmNjUwYzVlL3RhYmxlcmFuZ2U6MzA4ZTJjZmJlZGU0NDk2OTliMDI2ZTkwY2Y2NTBjNWVfMTctMTEtMS0xLTEwNzcw_901c61f4-f8b4-4e03-8661-05756d98ab55"
      unitRef="usd">74023000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ic432083dde80448887610e8035a6b032_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjMwOGUyY2ZiZWRlNDQ5Njk5YjAyNmU5MGNmNjUwYzVlL3RhYmxlcmFuZ2U6MzA4ZTJjZmJlZGU0NDk2OTliMDI2ZTkwY2Y2NTBjNWVfMTctMTMtMS0xLTEwNzcw_61206cd3-63ac-4e5a-b944-f5c8a82eea51"
      unitRef="usd">11000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i150492f298fa47a78ef2c10a285a64f8_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjMwOGUyY2ZiZWRlNDQ5Njk5YjAyNmU5MGNmNjUwYzVlL3RhYmxlcmFuZ2U6MzA4ZTJjZmJlZGU0NDk2OTliMDI2ZTkwY2Y2NTBjNWVfMTctMTUtMS0xLTEwNzcw_fc02047d-9b87-4017-ab23-53980207a3d6"
      unitRef="usd">74034000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:SharesIssued
      contextRef="ide77a3fd11044dd3926be5b05e61a140_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjMwOGUyY2ZiZWRlNDQ5Njk5YjAyNmU5MGNmNjUwYzVlL3RhYmxlcmFuZ2U6MzA4ZTJjZmJlZGU0NDk2OTliMDI2ZTkwY2Y2NTBjNWVfMTgtMS0xLTEtMTA3NzA_de6b1ac5-e0d8-4428-bdc4-555d8c1c80a5"
      unitRef="shares">49836000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="ide77a3fd11044dd3926be5b05e61a140_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjMwOGUyY2ZiZWRlNDQ5Njk5YjAyNmU5MGNmNjUwYzVlL3RhYmxlcmFuZ2U6MzA4ZTJjZmJlZGU0NDk2OTliMDI2ZTkwY2Y2NTBjNWVfMTgtMy0xLTEtMTA3NzA_a10ecb95-f0a4-4a5d-bf59-60a331f82e99"
      unitRef="usd">498000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib42c30aaa2d7465e8f21c1e6a8e2a52f_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjMwOGUyY2ZiZWRlNDQ5Njk5YjAyNmU5MGNmNjUwYzVlL3RhYmxlcmFuZ2U6MzA4ZTJjZmJlZGU0NDk2OTliMDI2ZTkwY2Y2NTBjNWVfMTgtNS0xLTEtMTA3NzA_113d2009-3f63-4428-9c9c-60dc53962b45"
      unitRef="usd">480364000</us-gaap:StockholdersEquity>
    <us-gaap:SharesIssued
      contextRef="iee8941b97b824762bb44d764f5549f5f_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjMwOGUyY2ZiZWRlNDQ5Njk5YjAyNmU5MGNmNjUwYzVlL3RhYmxlcmFuZ2U6MzA4ZTJjZmJlZGU0NDk2OTliMDI2ZTkwY2Y2NTBjNWVfMTgtNy0xLTEtMTA3NzA_4aa15d5a-00c1-408b-bf21-8f599af17e3f"
      unitRef="shares">2561000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="iee8941b97b824762bb44d764f5549f5f_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjMwOGUyY2ZiZWRlNDQ5Njk5YjAyNmU5MGNmNjUwYzVlL3RhYmxlcmFuZ2U6MzA4ZTJjZmJlZGU0NDk2OTliMDI2ZTkwY2Y2NTBjNWVfMTgtOS0xLTEtMTA3NzA_e82131a4-8b20-41f3-8c11-c620963a8464"
      unitRef="usd">-119143000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i1754ebd74a03401da95dc00b4abde2a7_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjMwOGUyY2ZiZWRlNDQ5Njk5YjAyNmU5MGNmNjUwYzVlL3RhYmxlcmFuZ2U6MzA4ZTJjZmJlZGU0NDk2OTliMDI2ZTkwY2Y2NTBjNWVfMTgtMTEtMS0xLTEwNzcw_4aceeae0-77af-422a-9741-746b6ce29de8"
      unitRef="usd">680729000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i02fea62d4d29457fb6f838bf4cba33b5_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjMwOGUyY2ZiZWRlNDQ5Njk5YjAyNmU5MGNmNjUwYzVlL3RhYmxlcmFuZ2U6MzA4ZTJjZmJlZGU0NDk2OTliMDI2ZTkwY2Y2NTBjNWVfMTgtMTMtMS0xLTEwNzcw_59d3bb54-2f8e-4bd8-ac0b-bcf939b9e7e2"
      unitRef="usd">30000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i68ecd84e8da440808154baac134e839e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yMi9mcmFnOmFlMGVjNGU1MTgwYTQ5MTFhZGI3Yjg1NWQ3NTQ4Njg1L3RhYmxlOjMwOGUyY2ZiZWRlNDQ5Njk5YjAyNmU5MGNmNjUwYzVlL3RhYmxlcmFuZ2U6MzA4ZTJjZmJlZGU0NDk2OTliMDI2ZTkwY2Y2NTBjNWVfMTgtMTUtMS0xLTEwNzcw_ffbb117f-9e80-4fff-bf95-5a329b2bdcc6"
      unitRef="usd">1042478000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfMy0xLTEtMS0xMDc3MA_939e552b-7180-4cbc-aafa-4cea112fcc7d"
      unitRef="usd">211171000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfMy0zLTEtMS0xMDc3MA_1d057cf5-6214-4e1a-84af-27e3371a9f2b"
      unitRef="usd">61357000</us-gaap:NetIncomeLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfNS0xLTEtMS0xMDc3MA_de437844-56f4-42a0-969d-72e09674024d"
      unitRef="usd">75871000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfNS0zLTEtMS0xMDc3MA_9355c0b6-eb4d-417a-b208-60bbb55a8027"
      unitRef="usd">70077000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfNi0xLTEtMS0xMDc3MA_6954acfd-6f1a-4be3-8b53-d0df332b68a3"
      unitRef="usd">4541000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfNi0zLTEtMS0xMDc3MA_3cb68350-2093-419c-98a7-c26cc6ef0b97"
      unitRef="usd">-3727000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:WriteOffOfDeferredDebtIssuanceCost
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfNy0xLTEtMS0xMDc3MA_08f63641-c507-4e33-858b-1cded9c16267"
      unitRef="usd">158000</us-gaap:WriteOffOfDeferredDebtIssuanceCost>
    <us-gaap:WriteOffOfDeferredDebtIssuanceCost
      contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfNy0zLTEtMS0xMDc3MA_ab8fe1e4-2d14-4039-b4cf-a7f48b27d287"
      unitRef="usd">1773000</us-gaap:WriteOffOfDeferredDebtIssuanceCost>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfOC0xLTEtMS0xMDc3MA_0df3d00d-41ac-462d-8047-e5df746c88c3"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfOC0zLTEtMS0xMDc3MA_832c1570-1fb7-4f40-ba11-4183e856ef1a"
      unitRef="usd">-1700000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <amn:AccountsReceivableAndSalesCreditsCreditLossExpenseReversal
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfOS0xLTEtMS0xMDc3MA_bfee5c86-e196-470a-8f45-cc23ea76bcb4"
      unitRef="usd">2103000</amn:AccountsReceivableAndSalesCreditsCreditLossExpenseReversal>
    <amn:AccountsReceivableAndSalesCreditsCreditLossExpenseReversal
      contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfOS0zLTEtMS0xMDc3MA_3b891c74-829b-4689-b88d-469774eb0b1e"
      unitRef="usd">7580000</amn:AccountsReceivableAndSalesCreditsCreditLossExpenseReversal>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfMTAtMS0xLTEtMTA3NzA_e54ac168-28df-4e0f-8068-ef9a4f703b35"
      unitRef="usd">-4328000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfMTAtMy0xLTEtMTA3NzA_315037f3-a8d5-4673-a70f-97df5484579c"
      unitRef="usd">-17923000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:ShareBasedCompensation
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfMTEtMS0xLTEtMTA3NzA_47f74999-7b4e-4b2b-9731-2ae3fa3a00b3"
      unitRef="usd">17895000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfMTEtMy0xLTEtMTA3NzA_81356293-d230-4705-9099-1c503f3e7bf9"
      unitRef="usd">15046000</us-gaap:ShareBasedCompensation>
    <us-gaap:GainLossOnDispositionOfAssets
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfMTItMS0xLTEtMTA3NzA_8d1c08e3-9cc6-4411-b38a-8b9666d68fd0"
      unitRef="usd">-386000</us-gaap:GainLossOnDispositionOfAssets>
    <us-gaap:GainLossOnDispositionOfAssets
      contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfMTItMy0xLTEtMTA3NzA_56658b4c-11d8-4955-82be-950c38e81f17"
      unitRef="usd">-3664000</us-gaap:GainLossOnDispositionOfAssets>
    <us-gaap:InvestmentIncomeAmortizationOfDiscount
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfMTMtMS0xLTEtMTA3NzA_ff95a47a-d45a-4e9c-b0f6-1b189881f8d4"
      unitRef="usd">41000</us-gaap:InvestmentIncomeAmortizationOfDiscount>
    <us-gaap:InvestmentIncomeAmortizationOfDiscount
      contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfMTMtMy0xLTEtMTA3NzA_b2b3ac23-771f-4755-972a-33e169386a33"
      unitRef="usd">96000</us-gaap:InvestmentIncomeAmortizationOfDiscount>
    <amn:GainLossOnDeferredCompensation
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfMTQtMS0xLTEtMTA3NzA_1330d729-c538-448a-8ee9-aaace1d4b217"
      unitRef="usd">-96000</amn:GainLossOnDeferredCompensation>
    <amn:GainLossOnDeferredCompensation
      contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfMTQtMy0xLTEtMTA3NzA_35a41411-3cdc-4e6c-84cf-caf210b8b349"
      unitRef="usd">-798000</amn:GainLossOnDeferredCompensation>
    <amn:LesseeOperatingLeaseNoncashExpense
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfMTUtMS0xLTEtMTA3NzA_b95279d2-b940-4603-ab00-3d1207138ee1"
      unitRef="usd">-257000</amn:LesseeOperatingLeaseNoncashExpense>
    <amn:LesseeOperatingLeaseNoncashExpense
      contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfMTUtMy0xLTEtMTA3NzA_f4bff9af-5282-4cc8-82ed-0e782b8f5912"
      unitRef="usd">244000</amn:LesseeOperatingLeaseNoncashExpense>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfMTctMS0xLTEtMTA3NzA_bf94c866-57a4-4456-b8c6-9869740e0b4f"
      unitRef="usd">196342000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfMTctMy0xLTEtMTA3NzA_9b497ba6-5dc4-413d-b05b-5cdc472ac982"
      unitRef="usd">-15151000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <amn:IncreaseDecreaseinAccountsReceivablessubcontractor
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfMTgtMS0xLTEtMTA3NzA_90ed8979-b9a0-499c-9fed-ac46df34e45e"
      unitRef="usd">67641000</amn:IncreaseDecreaseinAccountsReceivablessubcontractor>
    <amn:IncreaseDecreaseinAccountsReceivablessubcontractor
      contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfMTgtMy0xLTEtMTA3NzA_0c1284ac-47a2-4908-b504-e0d2d3947c47"
      unitRef="usd">-16414000</amn:IncreaseDecreaseinAccountsReceivablessubcontractor>
    <us-gaap:IncreaseDecreaseInIncomeTaxesReceivable
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfMTktMS0xLTEtMTA3NzA_b129665d-4d6e-46d3-97a4-f41a467afe3a"
      unitRef="usd">-5472000</us-gaap:IncreaseDecreaseInIncomeTaxesReceivable>
    <us-gaap:IncreaseDecreaseInIncomeTaxesReceivable
      contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfMTktMy0xLTEtMTA3NzA_c5057641-399c-4dff-b842-b0d6b94798f9"
      unitRef="usd">-6157000</us-gaap:IncreaseDecreaseInIncomeTaxesReceivable>
    <us-gaap:IncreaseDecreaseInPrepaidExpense
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfMjAtMS0xLTEtMTA3NzA_2aee3c39-e4e9-4f03-852a-f677dde51775"
      unitRef="usd">5695000</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInPrepaidExpense
      contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfMjAtMy0xLTEtMTA3NzA_fbbc9156-ac17-4463-915c-8e4392eed91c"
      unitRef="usd">3361000</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInOtherCurrentAssets
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfMjEtMS0xLTEtMTA3NzA_25e035a0-1713-4efb-be6e-ac03097ebf21"
      unitRef="usd">-3411000</us-gaap:IncreaseDecreaseInOtherCurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherCurrentAssets
      contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfMjEtMy0xLTEtMTA3NzA_7815e0a9-2787-4ee4-8e54-73ae1386a4fd"
      unitRef="usd">-2977000</us-gaap:IncreaseDecreaseInOtherCurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfMjItMS0xLTEtMTA3NzA_07d37b86-e084-4f02-9114-c138ef0d1f9c"
      unitRef="usd">-780000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets
      contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfMjItMy0xLTEtMTA3NzA_9857a0c8-3678-4140-9bbc-46841262e7cc"
      unitRef="usd">-3378000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfMjQtMS0xLTEtMTA3NzA_081ef706-182c-4d0f-8e0e-2693052c0027"
      unitRef="usd">112183000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfMjQtMy0xLTEtMTA3NzA_a7fc5b8c-94c8-4720-9f82-36ad9fb2019f"
      unitRef="usd">-5484000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfMjUtMS0xLTEtMTA3NzA_0f2c3747-f6fd-4c86-ba26-317c92345ea1"
      unitRef="usd">96666000</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities
      contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfMjUtMy0xLTEtMTA3NzA_95d3d5d4-d645-4435-ab0f-4bc20bdfea79"
      unitRef="usd">7630000</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfMjYtMS0xLTEtMTA3NzA_aecf59eb-ee6b-40ec-af9d-fe98727f5a44"
      unitRef="usd">-26268000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities
      contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfMjYtMy0xLTEtMTA3NzA_769e785f-da38-42c1-97c3-2f2a881fefb4"
      unitRef="usd">29592000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfMjgtMS0xLTEtMTA3NzA_d3c920dd-51f5-4c13-9366-e892a0e45f00"
      unitRef="usd">6276000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfMjgtMy0xLTEtMTA3NzA_0bcaaf66-c00a-4d77-b7e4-6ef6f70a4394"
      unitRef="usd">-32000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInRestrictedCashAndInvestmentsForOperatingActivities
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfMjktMS0xLTEtMTA3NzA_5b557914-6de5-4072-96b1-3ba747863398"
      unitRef="usd">-16000</us-gaap:IncreaseDecreaseInRestrictedCashAndInvestmentsForOperatingActivities>
    <us-gaap:IncreaseDecreaseInRestrictedCashAndInvestmentsForOperatingActivities
      contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfMjktMy0xLTEtMTA3NzA_01997fee-a590-4c7d-9045-799cbe0a1936"
      unitRef="usd">-12000</us-gaap:IncreaseDecreaseInRestrictedCashAndInvestmentsForOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfMzAtMS0xLTEtMTA3NzA_f22fec8f-8fb1-4a1f-bfad-0e68827cd3a0"
      unitRef="usd">227371000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfMzAtMy0xLTEtMTA3NzA_18d2c40b-421e-458d-94af-9a5d0b8332e2"
      unitRef="usd">216981000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfMzMtMS0xLTEtMTA3NzA_c8b09f1d-00a6-4b60-bcba-6d6a71181544"
      unitRef="usd">38710000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfMzMtMy0xLTEtMTA3NzA_7afeacdf-3ce8-411a-b056-48f1113c8453"
      unitRef="usd">27357000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireShortTermInvestments
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfMzQtMS0xLTEtMTA3NzA_88da5c43-4286-4631-a601-a0354337f335"
      unitRef="usd">32437000</us-gaap:PaymentsToAcquireShortTermInvestments>
    <us-gaap:PaymentsToAcquireShortTermInvestments
      contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfMzQtMy0xLTEtMTA3NzA_058ee66d-90ef-4f6c-b427-e428b2c40f83"
      unitRef="usd">37418000</us-gaap:PaymentsToAcquireShortTermInvestments>
    <us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfMzUtMS0xLTEtMTA3NzA_e78ef4d8-7500-4c20-ae1d-e28a6adf8816"
      unitRef="usd">40000000</us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments>
    <us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments
      contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfMzUtMy0xLTEtMTA3NzA_715b0d2f-d74f-44e2-a73b-2084b259c052"
      unitRef="usd">21500000</us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments>
    <us-gaap:PaymentsToAcquireEquitySecuritiesFvNi
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfMzYtMS0xLTEtMTA3NzA_fb1cdede-ae22-461a-8944-598c384b05dd"
      unitRef="usd">500000</us-gaap:PaymentsToAcquireEquitySecuritiesFvNi>
    <us-gaap:PaymentsToAcquireEquitySecuritiesFvNi
      contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfMzYtMy0xLTEtMTA3NzA_266bf573-bede-452b-af8b-1d44388a10cf"
      unitRef="usd">0</us-gaap:PaymentsToAcquireEquitySecuritiesFvNi>
    <us-gaap:PaymentsToAcquireLifeInsurancePolicies
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfMzctMS0xLTEtMTA3NzA_60078bf3-8c60-44a4-a8b5-df85b444879a"
      unitRef="usd">6094000</us-gaap:PaymentsToAcquireLifeInsurancePolicies>
    <us-gaap:PaymentsToAcquireLifeInsurancePolicies
      contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfMzctMy0xLTEtMTA3NzA_ed075981-3de3-4a5b-9512-b3174b16a5e8"
      unitRef="usd">7171000</us-gaap:PaymentsToAcquireLifeInsurancePolicies>
    <us-gaap:ProceedsFromSaleOfTradingSecuritiesHeldforinvestment
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfMzgtMS0xLTEtMTA3NzA_8c992a36-7ff2-4258-9b99-1c4f57f773c6"
      unitRef="usd">78000</us-gaap:ProceedsFromSaleOfTradingSecuritiesHeldforinvestment>
    <us-gaap:ProceedsFromSaleOfTradingSecuritiesHeldforinvestment
      contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfMzgtMy0xLTEtMTA3NzA_d4e6eab5-d73a-46d0-8b70-8e778330dcee"
      unitRef="usd">303000</us-gaap:ProceedsFromSaleOfTradingSecuritiesHeldforinvestment>
    <us-gaap:PaymentsToAcquireNotesReceivable
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfMzktMS0xLTEtMTA3NzA_389edb30-3c72-4643-a12c-496c788a5ed6"
      unitRef="usd">0</us-gaap:PaymentsToAcquireNotesReceivable>
    <us-gaap:PaymentsToAcquireNotesReceivable
      contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfMzktMy0xLTEtMTA3NzA_ec785a9a-ff6b-40fa-a8c6-efa478950091"
      unitRef="usd">490000</us-gaap:PaymentsToAcquireNotesReceivable>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfNDAtMS0xLTEtMTA3NzA_99f89f19-24e2-4300-af09-4620f8d9cfb6"
      unitRef="usd">41264000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfNDAtMy0xLTEtMTA3NzA_74a5e5c9-5dce-4c8f-856a-0e3486106a00"
      unitRef="usd">476491000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireIntangibleAssets
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfNDEtMS0xLTEtMTA3NzA_1decb077-062d-4bb6-aab7-f93e860208c9"
      unitRef="usd">90000</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:PaymentsToAcquireIntangibleAssets
      contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfNDEtMy0xLTEtMTA3NzA_eb4cc02c-0324-4443-9d8c-c136f2b5965c"
      unitRef="usd">1400000</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:ProceedsFromPreviousAcquisition
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfNDItMS0xLTEtMTA3NzA_8d7a08e9-caa5-40c3-8ce7-c7a6ddf6dc2f"
      unitRef="usd">0</us-gaap:ProceedsFromPreviousAcquisition>
    <us-gaap:ProceedsFromPreviousAcquisition
      contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfNDItMy0xLTEtMTA3NzA_c5e780e0-ade9-44b5-92cb-887cfb46aac4"
      unitRef="usd">66000</us-gaap:ProceedsFromPreviousAcquisition>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfNDMtMS0xLTEtMTA3NzA_c64fcc89-253f-46be-a246-5ba43315b9e4"
      unitRef="usd">-79017000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfNDMtMy0xLTEtMTA3NzA_7437b4b9-646d-41d9-aa65-3d9149035053"
      unitRef="usd">-528458000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:RepaymentsOfSecuredDebt
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfNDYtMS0xLTEtMTA3NzA_38af2000-0fb8-476e-ada2-011ce5e6e778"
      unitRef="usd">21875000</us-gaap:RepaymentsOfSecuredDebt>
    <us-gaap:RepaymentsOfSecuredDebt
      contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfNDYtMy0xLTEtMTA3NzA_528f6ecf-d969-453a-922a-b2ddbe3dbb2c"
      unitRef="usd">203125000</us-gaap:RepaymentsOfSecuredDebt>
    <us-gaap:ProceedsFromIssuanceOfSecuredDebt
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfNDctMS0xLTEtMTA3NzA_c90eec2e-db44-4f8a-a26d-99f887d52bd0"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfSecuredDebt>
    <us-gaap:ProceedsFromIssuanceOfSecuredDebt
      contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfNDctMy0xLTEtMTA3NzA_31ac7540-4c83-44a5-9a3c-a958e26e78a2"
      unitRef="usd">250000000</us-gaap:ProceedsFromIssuanceOfSecuredDebt>
    <us-gaap:RepaymentsOfLinesOfCredit
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfNDgtMS0xLTEtMTA3NzA_e345093f-3f9c-4407-ac01-2ea0a8e543cf"
      unitRef="usd">70000000</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:RepaymentsOfLinesOfCredit
      contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfNDgtMy0xLTEtMTA3NzA_4169bf38-3689-4de9-9a3d-4e9519b39598"
      unitRef="usd">205000000</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:ProceedsFromLinesOfCredit
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfNDktMS0xLTEtMTA3NzA_e622df79-1a5e-4fa7-bf9e-96f680abcfa6"
      unitRef="usd">70000000</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:ProceedsFromLinesOfCredit
      contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfNDktMy0xLTEtMTA3NzA_5a7eb5e0-1094-4843-a2c8-dd8aeef4187d"
      unitRef="usd">245000000</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfNTAtMS0xLTEtMTA3NzA_6fc8c491-5d62-4bdc-9c83-a63041f91ea5"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt
      contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfNTAtMy0xLTEtMTA3NzA_81aba7a9-40c5-4c40-869f-b09e7c966ee1"
      unitRef="usd">202000000</us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt>
    <us-gaap:PaymentsOfFinancingCosts
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfNTMtMS0xLTEtMTA3NzA_1a2f3545-d59f-444d-b2ad-c5ada00c8c94"
      unitRef="usd">0</us-gaap:PaymentsOfFinancingCosts>
    <us-gaap:PaymentsOfFinancingCosts
      contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfNTMtMy0xLTEtMTA3NzA_6221beb0-f3cc-4870-9fa1-5d486debfe45"
      unitRef="usd">6898000</us-gaap:PaymentsOfFinancingCosts>
    <amn:PaymentsForPreviousAcquisitionEarnOutPayment
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfNTQtMS0xLTEtMTA3NzA_297f0a64-f624-4908-9b8a-4a05f72a6222"
      unitRef="usd">3100000</amn:PaymentsForPreviousAcquisitionEarnOutPayment>
    <amn:PaymentsForPreviousAcquisitionEarnOutPayment
      contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfNTQtMy0xLTEtMTA3NzA_ea904880-2a53-420f-ab7d-1bf80e76f65c"
      unitRef="usd">10622000</amn:PaymentsForPreviousAcquisitionEarnOutPayment>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfNTUtMS0xLTEtMTA3NzA_807a25a1-b9de-4dda-83c0-850117aea8d3"
      unitRef="usd">6255000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfNTUtMy0xLTEtMTA3NzA_6fce0fec-65c1-4d03-95b3-387775c83be6"
      unitRef="usd">4798000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfNTYtMS0xLTEtMTA3NzA_ab5d4c10-bf30-4946-b2ce-5ca572c67235"
      unitRef="usd">-31230000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfNTYtMy0xLTEtMTA3NzA_3b09c97e-ddac-4360-9c33-c727e3f61d54"
      unitRef="usd">266557000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfNTctMS0xLTEtMTA3NzA_c4cbd814-107a-45ba-9cf0-9872ab349aac"
      unitRef="usd">-10000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfNTctMy0xLTEtMTA3NzA_1172e0da-b2ab-4fe2-acc7-81b8652cffe1"
      unitRef="usd">-119000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfNTgtMS0xLTEtMTA3NzA_723f2b55-862d-427f-8232-75761eccda9c"
      unitRef="usd">117114000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfNTgtMy0xLTEtMTA3NzA_56b90937-03e3-4f5f-a9a5-9f8ad41ba3b6"
      unitRef="usd">-45039000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfNTktMS0xLTEtMTA3NzA_0458445b-bf67-4e9a-8380-4998e4ca7d6b"
      unitRef="usd">83990000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i73ad7702c4f241548c42eab7eb506186_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfNTktMy0xLTEtMTA3NzA_c44942f4-c7a7-4e8d-9e13-8b8141097742"
      unitRef="usd">153962000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i68ecd84e8da440808154baac134e839e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfNjAtMS0xLTEtMTA3NzA_40fd6bf2-ba5b-40b9-acb0-13baf2ce9465"
      unitRef="usd">201104000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i041c1c8fe78444f88611087c404a5e99_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfNjAtMy0xLTEtMTA3NzA_92b46ba1-216f-407f-b885-0143d507938f"
      unitRef="usd">108923000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:OperatingLeasePayments
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfNjMtMS0xLTEtMTA3NzA_dc310d8f-7842-4bc3-a1a6-56ea1de3a67e"
      unitRef="usd">35066000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfNjMtMy0xLTEtMTA3NzA_e47d9ef5-cf3d-40e5-bdae-401b9339760c"
      unitRef="usd">15079000</us-gaap:OperatingLeasePayments>
    <us-gaap:InterestPaidCapitalized
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfNjQtMC0xLTEtMTA3NzAvdGV4dHJlZ2lvbjoyZjQ1MWNhZDdlNTY0ZTQ5OTIxMzcwZmJiODQxMDViYV8zNQ_a116f33c-1f35-471c-ac96-1737b7b113b0"
      unitRef="usd">248000</us-gaap:InterestPaidCapitalized>
    <us-gaap:InterestPaidCapitalized
      contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfNjQtMC0xLTEtMTA3NzAvdGV4dHJlZ2lvbjoyZjQ1MWNhZDdlNTY0ZTQ5OTIxMzcwZmJiODQxMDViYV80Mg_c7ddcf84-e504-4807-9256-21946e6dd1bf"
      unitRef="usd">300000</us-gaap:InterestPaidCapitalized>
    <us-gaap:InterestPaidNet
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfNjQtMS0xLTEtMTA3NzA_ff188d57-62f8-4f7f-bc45-03560a61f8b7"
      unitRef="usd">19301000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfNjQtMy0xLTEtMTA3NzA_cbdea969-97e7-49ec-9c1b-d2c302bfdb83"
      unitRef="usd">13848000</us-gaap:InterestPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfNjUtMS0xLTEtMTA3NzA_4915f8f7-abc1-4a3a-8d7f-2fbd8ddd74b4"
      unitRef="usd">72863000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfNjUtMy0xLTEtMTA3NzA_7bac97ad-4ccb-4c17-8d23-fa0c401bdc87"
      unitRef="usd">30727000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:FairValueOfAssetsAcquired
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfNjctMS0xLTEtMTA3NzA_7be587c9-0911-419d-ac7d-960827d802b9"
      unitRef="usd">1906000</us-gaap:FairValueOfAssetsAcquired>
    <us-gaap:FairValueOfAssetsAcquired
      contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfNjctMy0xLTEtMTA3NzA_19ccf923-64dd-4dd9-a460-063a4f2aa520"
      unitRef="usd">35704000</us-gaap:FairValueOfAssetsAcquired>
    <amn:SupplementalDisclosuresOfNonCashInvestingAndFinancingActivitiesGoodwill
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfNjgtMS0xLTEtMTA3NzA_73746a15-32ef-46dd-92e3-6b96df182a9e"
      unitRef="usd">28135000</amn:SupplementalDisclosuresOfNonCashInvestingAndFinancingActivitiesGoodwill>
    <amn:SupplementalDisclosuresOfNonCashInvestingAndFinancingActivitiesGoodwill
      contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfNjgtMy0xLTEtMTA3NzA_a68f504b-39a6-48ee-8729-029d703fe202"
      unitRef="usd">274427000</amn:SupplementalDisclosuresOfNonCashInvestingAndFinancingActivitiesGoodwill>
    <amn:SupplementalDisclosuresOfNonCashInvestingAndFinancingActivitiesIntangibleAssets
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfNjktMS0xLTEtMTA3NzA_76385c42-2932-4af5-8893-bcd83a89f812"
      unitRef="usd">12440000</amn:SupplementalDisclosuresOfNonCashInvestingAndFinancingActivitiesIntangibleAssets>
    <amn:SupplementalDisclosuresOfNonCashInvestingAndFinancingActivitiesIntangibleAssets
      contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfNjktMy0xLTEtMTA3NzA_79c995fe-4cfa-4733-996c-ea77eb7bf42f"
      unitRef="usd">228000000</amn:SupplementalDisclosuresOfNonCashInvestingAndFinancingActivitiesIntangibleAssets>
    <us-gaap:LiabilitiesAssumed1
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfNzAtMS0xLTEtMTA3NzA_3f367c6b-541d-4006-b380-ccb7fe902bcc"
      unitRef="usd">1217000</us-gaap:LiabilitiesAssumed1>
    <us-gaap:LiabilitiesAssumed1
      contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfNzAtMy0xLTEtMTA3NzA_28a3a97f-c5af-41e6-923e-4964813b418a"
      unitRef="usd">61640000</us-gaap:LiabilitiesAssumed1>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfNzQtMS0xLTEtMTA3NzA_321a691d-4512-4841-acd5-bd33ee743716"
      unitRef="usd">41264000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfNzQtMy0xLTEtMTA3NzA_223f19f5-b619-4901-80ac-04b1f76dcfd6"
      unitRef="usd">476491000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <amn:Purchaseoffixedassetsrecordedinaccountspayableandaccruedexpenses
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfNzYtMS0xLTEtMTA3NzA_9666f2a2-1f59-4bf7-9cee-b15d0a6c0f1a"
      unitRef="usd">5080000</amn:Purchaseoffixedassetsrecordedinaccountspayableandaccruedexpenses>
    <amn:Purchaseoffixedassetsrecordedinaccountspayableandaccruedexpenses
      contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18yNS9mcmFnOmRlODJkNDg4MzExZDRiMzA5OThmMjg3ZDI1ZGZmM2EzL3RhYmxlOjA2Mjc2MGQyYzc2ZDQ3YTM4NGIyZDZhNDYwMTkxMDUyL3RhYmxlcmFuZ2U6MDYyNzYwZDJjNzZkNDdhMzg0YjJkNmE0NjAxOTEwNTJfNzYtMy0xLTEtMTA3NzA_5c57144e-b124-4aef-9dac-3e351e9d6f97"
      unitRef="usd">1007000</amn:Purchaseoffixedassetsrecordedinaccountspayableandaccruedexpenses>
    <us-gaap:BasisOfAccounting
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zMS9mcmFnOmNlNDgxOGVmYTM1YjQ2NDI4NGUxN2Q2NWEwYThiNjc3L3RleHRyZWdpb246Y2U0ODE4ZWZhMzViNDY0Mjg0ZTE3ZDY1YTBhOGI2NzdfNTI0Mw_84eecb3d-8132-48b6-9bcd-740428a915f2">BASIS OF PRESENTATION&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The condensed consolidated balance sheets and related condensed consolidated statements of comprehensive income and cash flows contained in this Quarterly Report on Form&#160;10-Q (this &#x201c;Quarterly Report&#x201d;), which are unaudited, include the accounts of AMN&#160;Healthcare Services, Inc. and its wholly-owned subsidiaries (collectively, the &#x201c;Company&#x201d;). All significant intercompany balances and transactions have been eliminated in consolidation. In the opinion of management, all entries necessary for a fair presentation of such unaudited condensed consolidated financial statements have been included. These entries consisted of all normal recurring items. The results of operations for the interim period are not necessarily indicative of the results to be expected for any other interim period or for the entire fiscal year or for any future period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The unaudited condensed consolidated financial statements do not include all information and notes necessary for a complete presentation of financial position, results of operations and cash flows in conformity with accounting principles generally accepted in the United States (&#x201c;U.S. GAAP&#x201d;). Please refer to the Company&#x2019;s audited consolidated financial statements and the related notes for the fiscal year ended December&#160;31, 2020, contained in the Company&#x2019;s Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2020, filed with the Securities and Exchange Commission on February 26, 2021 (&#x201c;2020 Annual Report&#x201d;). &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of financial statements in conformity with U.S. GAAP requires management to make a number of estimates and assumptions relating to the reporting of assets and liabilities and the disclosure of contingent assets and liabilities at the dates of the financial statements and the reported amounts of revenue and expenses during the reporting periods. On an ongoing basis, the Company evaluates its estimates, including those related to intangible assets purchased in a business combination, asset impairments, accruals for self-insurance, compensation and related benefits, accounts receivable, contingencies and litigation, contingent consideration liabilities associated with acquisitions, and income taxes. Actual results could differ from those estimates under different assumptions or conditions. The impact of the novel coronavirus (COVID-19) pandemic did not have a material effect on the Company&#x2019;s estimates as of September&#160;30, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recently Adopted Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2019, the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued Accounting Standard Update (&#x201c;ASU&#x201d;) 2019-12, &#x201c;Simplifying the Accounting for Income Taxes.&#x201d; The standard is expected to reduce cost and complexity related to accounting for income taxes. The new guidance eliminates certain exceptions and clarifies and amends existing guidance to promote consistent application among reporting entities. Depending on the amended guidance within this standard, adoption is to be applied on a retrospective, modified retrospective or prospective basis. The Company adopted this standard effective January 1, 2021, and the adoption did not have a material effect on the Company&#x2019;s consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2020, the FASB issued ASU 2020-01, &#x201c;Clarifying the Interactions between Topic 321, Topic 323, and Topic 815.&#x201d; The new guidance clarifies the interactions between accounting standards that apply to equity investments without readily determinable fair values. Specifically, it addresses the accounting for the transition into and out of the equity method. The Company adopted this standard effective January 1, 2021 on a prospective basis, and the adoption did not have a material effect on the Company&#x2019;s consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cash, Cash Equivalents and Restricted Cash&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents. Cash and cash equivalents include currency on hand, deposits with financial institutions, money market funds, commercial paper and other highly liquid investments. Restricted cash and cash equivalents primarily includes cash and commercial paper that serve as collateral for the Company&#x2019;s captive insurance subsidiary claim payments. See Note (7), &#x201c;Fair Value Measurement&#x201d; for additional information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the accompanying condensed consolidated balance sheets and related notes to the amounts presented in the accompanying condensed consolidated statements of cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:14pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.590%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;137,041&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash and cash equivalents (included in other current assets)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,626&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash, cash equivalents and investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63,603&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61,347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cash, cash equivalents and restricted cash and investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;218,762&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109,186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less restricted investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17,658)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25,196)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cash, cash equivalents and restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;201,104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83,990&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:4pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accounts Receivable&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:24.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company records accounts receivable at the invoiced amount. Accounts receivable are non-interest bearing. The Company maintains an allowance for expected credit losses based on the Company&#x2019;s historical write-off experience, an assessment of its customers&#x2019; financial conditions and available information that is relevant to assessing the collectability of cash flows, which includes current conditions and forecasts about future economic conditions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides a reconciliation of activity in the allowance for credit losses for accounts receivable:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:14pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.590%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of January 1,&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,043&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,332&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zMS9mcmFnOmNlNDgxOGVmYTM1YjQ2NDI4NGUxN2Q2NWEwYThiNjc3L3RhYmxlOmU5MmY2N2EzMmZkYjRlZmY5MmRhZThhMjE3M2M0NzBmL3RhYmxlcmFuZ2U6ZTkyZjY3YTMyZmRiNGVmZjkyZGFlOGEyMTczYzQ3MGZfMi0wLTEtMS0xMDc3MA_2e5b46ce-627c-4ad2-9f91-f5ecc232b823"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zMS9mcmFnOmNlNDgxOGVmYTM1YjQ2NDI4NGUxN2Q2NWEwYThiNjc3L3RhYmxlOmU5MmY2N2EzMmZkYjRlZmY5MmRhZThhMjE3M2M0NzBmL3RhYmxlcmFuZ2U6ZTkyZjY3YTMyZmRiNGVmZjkyZGFlOGEyMTczYzQ3MGZfMi0wLTEtMS0xMDc3MA_5c495df8-c4dc-4a11-8dcb-5b212c885604"&gt;Adoption of the credit loss standard, cumulative-effect adjustment to retained earnings&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provision for expected credit losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts written off charged against the allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,220)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,333)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of September 30,&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,511&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:BasisOfAccounting>
    <us-gaap:UseOfEstimates
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zMS9mcmFnOmNlNDgxOGVmYTM1YjQ2NDI4NGUxN2Q2NWEwYThiNjc3L3RleHRyZWdpb246Y2U0ODE4ZWZhMzViNDY0Mjg0ZTE3ZDY1YTBhOGI2NzdfNTI1Mg_83ba779b-24f9-453f-a2fb-51a886fe7d71">The preparation of financial statements in conformity with U.S. GAAP requires management to make a number of estimates and assumptions relating to the reporting of assets and liabilities and the disclosure of contingent assets and liabilities at the dates of the financial statements and the reported amounts of revenue and expenses during the reporting periods. On an ongoing basis, the Company evaluates its estimates, including those related to intangible assets purchased in a business combination, asset impairments, accruals for self-insurance, compensation and related benefits, accounts receivable, contingencies and litigation, contingent consideration liabilities associated with acquisitions, and income taxes. Actual results could differ from those estimates under different assumptions or conditions. The impact of the novel coronavirus (COVID-19) pandemic did not have a material effect on the Company&#x2019;s estimates as of September&#160;30, 2021.</us-gaap:UseOfEstimates>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zMS9mcmFnOmNlNDgxOGVmYTM1YjQ2NDI4NGUxN2Q2NWEwYThiNjc3L3RleHRyZWdpb246Y2U0ODE4ZWZhMzViNDY0Mjg0ZTE3ZDY1YTBhOGI2NzdfNTI1OQ_c628c7fd-4d69-4aa3-b8aa-3401b2450959">&lt;div style="margin-top:9pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recently Adopted Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2019, the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued Accounting Standard Update (&#x201c;ASU&#x201d;) 2019-12, &#x201c;Simplifying the Accounting for Income Taxes.&#x201d; The standard is expected to reduce cost and complexity related to accounting for income taxes. The new guidance eliminates certain exceptions and clarifies and amends existing guidance to promote consistent application among reporting entities. Depending on the amended guidance within this standard, adoption is to be applied on a retrospective, modified retrospective or prospective basis. The Company adopted this standard effective January 1, 2021, and the adoption did not have a material effect on the Company&#x2019;s consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2020, the FASB issued ASU 2020-01, &#x201c;Clarifying the Interactions between Topic 321, Topic 323, and Topic 815.&#x201d; The new guidance clarifies the interactions between accounting standards that apply to equity investments without readily determinable fair values. Specifically, it addresses the accounting for the transition into and out of the equity method. The Company adopted this standard effective January 1, 2021 on a prospective basis, and the adoption did not have a material effect on the Company&#x2019;s consolidated financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zMS9mcmFnOmNlNDgxOGVmYTM1YjQ2NDI4NGUxN2Q2NWEwYThiNjc3L3RleHRyZWdpb246Y2U0ODE4ZWZhMzViNDY0Mjg0ZTE3ZDY1YTBhOGI2NzdfNTIzOQ_8ec10dbf-37b8-4890-97d1-6377a9acc4ee">&lt;div style="margin-top:9pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cash, Cash Equivalents and Restricted Cash&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents. Cash and cash equivalents include currency on hand, deposits with financial institutions, money market funds, commercial paper and other highly liquid investments. Restricted cash and cash equivalents primarily includes cash and commercial paper that serve as collateral for the Company&#x2019;s captive insurance subsidiary claim payments. See Note (7), &#x201c;Fair Value Measurement&#x201d; for additional information.&lt;/span&gt;&lt;/div&gt;</us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy>
    <us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zMS9mcmFnOmNlNDgxOGVmYTM1YjQ2NDI4NGUxN2Q2NWEwYThiNjc3L3RleHRyZWdpb246Y2U0ODE4ZWZhMzViNDY0Mjg0ZTE3ZDY1YTBhOGI2NzdfNTI0MQ_ac208b29-d8ab-46a4-a559-0f0df6906f25">The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the accompanying condensed consolidated balance sheets and related notes to the amounts presented in the accompanying condensed consolidated statements of cash flows.&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.590%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;137,041&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash and cash equivalents (included in other current assets)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,626&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash, cash equivalents and investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63,603&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61,347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cash, cash equivalents and restricted cash and investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;218,762&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109,186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less restricted investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17,658)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25,196)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cash, cash equivalents and restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;201,104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83,990&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i68ecd84e8da440808154baac134e839e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zMS9mcmFnOmNlNDgxOGVmYTM1YjQ2NDI4NGUxN2Q2NWEwYThiNjc3L3RhYmxlOjQzOWJjNmFhNmQyNDRiNDM4MGYxNjI3ZmY3MTAwNTg4L3RhYmxlcmFuZ2U6NDM5YmM2YWE2ZDI0NGI0MzgwZjE2MjdmZjcxMDA1ODhfMS0xLTEtMS0xMDc3MA_2dddca1c-8b75-486b-81f3-142f93be4e11"
      unitRef="usd">137041000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zMS9mcmFnOmNlNDgxOGVmYTM1YjQ2NDI4NGUxN2Q2NWEwYThiNjc3L3RhYmxlOjQzOWJjNmFhNmQyNDRiNDM4MGYxNjI3ZmY3MTAwNTg4L3RhYmxlcmFuZ2U6NDM5YmM2YWE2ZDI0NGI0MzgwZjE2MjdmZjcxMDA1ODhfMS0zLTEtMS0xMDc3MA_96b805d4-e705-4858-b08f-4f7da814ae15"
      unitRef="usd">29213000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashAndCashEquivalents
      contextRef="i68ecd84e8da440808154baac134e839e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zMS9mcmFnOmNlNDgxOGVmYTM1YjQ2NDI4NGUxN2Q2NWEwYThiNjc3L3RhYmxlOjQzOWJjNmFhNmQyNDRiNDM4MGYxNjI3ZmY3MTAwNTg4L3RhYmxlcmFuZ2U6NDM5YmM2YWE2ZDI0NGI0MzgwZjE2MjdmZjcxMDA1ODhfMi0xLTEtMS0xMDc3MA_8a79ba97-a211-4859-bdfd-afc80ef17b7d"
      unitRef="usd">18118000</us-gaap:RestrictedCashAndCashEquivalents>
    <us-gaap:RestrictedCashAndCashEquivalents
      contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zMS9mcmFnOmNlNDgxOGVmYTM1YjQ2NDI4NGUxN2Q2NWEwYThiNjc3L3RhYmxlOjQzOWJjNmFhNmQyNDRiNDM4MGYxNjI3ZmY3MTAwNTg4L3RhYmxlcmFuZ2U6NDM5YmM2YWE2ZDI0NGI0MzgwZjE2MjdmZjcxMDA1ODhfMi0zLTEtMS0xMDc3MA_f9f4de69-3538-43af-a115-d1d1fa4cb178"
      unitRef="usd">18626000</us-gaap:RestrictedCashAndCashEquivalents>
    <us-gaap:RestrictedCashAndInvestmentsNoncurrent
      contextRef="i68ecd84e8da440808154baac134e839e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zMS9mcmFnOmNlNDgxOGVmYTM1YjQ2NDI4NGUxN2Q2NWEwYThiNjc3L3RhYmxlOjQzOWJjNmFhNmQyNDRiNDM4MGYxNjI3ZmY3MTAwNTg4L3RhYmxlcmFuZ2U6NDM5YmM2YWE2ZDI0NGI0MzgwZjE2MjdmZjcxMDA1ODhfMy0xLTEtMS0xMDc3MA_a1bfc46b-1315-415d-8bab-b11a111cc1d6"
      unitRef="usd">63603000</us-gaap:RestrictedCashAndInvestmentsNoncurrent>
    <us-gaap:RestrictedCashAndInvestmentsNoncurrent
      contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zMS9mcmFnOmNlNDgxOGVmYTM1YjQ2NDI4NGUxN2Q2NWEwYThiNjc3L3RhYmxlOjQzOWJjNmFhNmQyNDRiNDM4MGYxNjI3ZmY3MTAwNTg4L3RhYmxlcmFuZ2U6NDM5YmM2YWE2ZDI0NGI0MzgwZjE2MjdmZjcxMDA1ODhfMy0zLTEtMS0xMDc3MA_787effc6-f2ed-4ab4-b7e9-2b30cbd56147"
      unitRef="usd">61347000</us-gaap:RestrictedCashAndInvestmentsNoncurrent>
    <amn:TotalCashCashEquivalentsAndRestrictedCashCashEquivalentsandInvestments
      contextRef="i68ecd84e8da440808154baac134e839e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zMS9mcmFnOmNlNDgxOGVmYTM1YjQ2NDI4NGUxN2Q2NWEwYThiNjc3L3RhYmxlOjQzOWJjNmFhNmQyNDRiNDM4MGYxNjI3ZmY3MTAwNTg4L3RhYmxlcmFuZ2U6NDM5YmM2YWE2ZDI0NGI0MzgwZjE2MjdmZjcxMDA1ODhfNC0xLTEtMS0xMDc3MA_bd2326c3-2da6-4a20-b542-66de445743e9"
      unitRef="usd">218762000</amn:TotalCashCashEquivalentsAndRestrictedCashCashEquivalentsandInvestments>
    <amn:TotalCashCashEquivalentsAndRestrictedCashCashEquivalentsandInvestments
      contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zMS9mcmFnOmNlNDgxOGVmYTM1YjQ2NDI4NGUxN2Q2NWEwYThiNjc3L3RhYmxlOjQzOWJjNmFhNmQyNDRiNDM4MGYxNjI3ZmY3MTAwNTg4L3RhYmxlcmFuZ2U6NDM5YmM2YWE2ZDI0NGI0MzgwZjE2MjdmZjcxMDA1ODhfNC0zLTEtMS0xMDc3MA_167c74cf-eecf-45ca-b172-ccf91dc73e7e"
      unitRef="usd">109186000</amn:TotalCashCashEquivalentsAndRestrictedCashCashEquivalentsandInvestments>
    <us-gaap:RestrictedInvestments
      contextRef="i68ecd84e8da440808154baac134e839e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zMS9mcmFnOmNlNDgxOGVmYTM1YjQ2NDI4NGUxN2Q2NWEwYThiNjc3L3RhYmxlOjQzOWJjNmFhNmQyNDRiNDM4MGYxNjI3ZmY3MTAwNTg4L3RhYmxlcmFuZ2U6NDM5YmM2YWE2ZDI0NGI0MzgwZjE2MjdmZjcxMDA1ODhfNS0xLTEtMS0xMDc3MA_07ed54fc-df2b-44af-a4fe-d15b034fed6c"
      unitRef="usd">17658000</us-gaap:RestrictedInvestments>
    <us-gaap:RestrictedInvestments
      contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zMS9mcmFnOmNlNDgxOGVmYTM1YjQ2NDI4NGUxN2Q2NWEwYThiNjc3L3RhYmxlOjQzOWJjNmFhNmQyNDRiNDM4MGYxNjI3ZmY3MTAwNTg4L3RhYmxlcmFuZ2U6NDM5YmM2YWE2ZDI0NGI0MzgwZjE2MjdmZjcxMDA1ODhfNS0zLTEtMS0xMDc3MA_e55afd58-b2d5-4ab3-999b-69c3f4596905"
      unitRef="usd">25196000</us-gaap:RestrictedInvestments>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i68ecd84e8da440808154baac134e839e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zMS9mcmFnOmNlNDgxOGVmYTM1YjQ2NDI4NGUxN2Q2NWEwYThiNjc3L3RhYmxlOjQzOWJjNmFhNmQyNDRiNDM4MGYxNjI3ZmY3MTAwNTg4L3RhYmxlcmFuZ2U6NDM5YmM2YWE2ZDI0NGI0MzgwZjE2MjdmZjcxMDA1ODhfNi0xLTEtMS0xMDc3MA_ddd3c432-3c13-4f56-b0e1-936a189eb39b"
      unitRef="usd">201104000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zMS9mcmFnOmNlNDgxOGVmYTM1YjQ2NDI4NGUxN2Q2NWEwYThiNjc3L3RhYmxlOjQzOWJjNmFhNmQyNDRiNDM4MGYxNjI3ZmY3MTAwNTg4L3RhYmxlcmFuZ2U6NDM5YmM2YWE2ZDI0NGI0MzgwZjE2MjdmZjcxMDA1ODhfNi0zLTEtMS0xMDc3MA_ff5cb12d-e68b-4eaa-9f1f-33b337c22e92"
      unitRef="usd">83990000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:TradeAndOtherAccountsReceivablePolicy
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zMS9mcmFnOmNlNDgxOGVmYTM1YjQ2NDI4NGUxN2Q2NWEwYThiNjc3L3RleHRyZWdpb246Y2U0ODE4ZWZhMzViNDY0Mjg0ZTE3ZDY1YTBhOGI2NzdfNTI2OQ_3e486ccb-ca84-4233-867f-21fbc840b2b3">&lt;div style="margin-top:4pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accounts Receivable&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:24.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company records accounts receivable at the invoiced amount. Accounts receivable are non-interest bearing. The Company maintains an allowance for expected credit losses based on the Company&#x2019;s historical write-off experience, an assessment of its customers&#x2019; financial conditions and available information that is relevant to assessing the collectability of cash flows, which includes current conditions and forecasts about future economic conditions.&lt;/span&gt;&lt;/div&gt;</us-gaap:TradeAndOtherAccountsReceivablePolicy>
    <us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zMS9mcmFnOmNlNDgxOGVmYTM1YjQ2NDI4NGUxN2Q2NWEwYThiNjc3L3RleHRyZWdpb246Y2U0ODE4ZWZhMzViNDY0Mjg0ZTE3ZDY1YTBhOGI2NzdfNTI0Mg_aa25166b-388e-4395-ab92-b4c66f69975d">&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides a reconciliation of activity in the allowance for credit losses for accounts receivable:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:14pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.590%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of January 1,&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,043&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,332&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zMS9mcmFnOmNlNDgxOGVmYTM1YjQ2NDI4NGUxN2Q2NWEwYThiNjc3L3RhYmxlOmU5MmY2N2EzMmZkYjRlZmY5MmRhZThhMjE3M2M0NzBmL3RhYmxlcmFuZ2U6ZTkyZjY3YTMyZmRiNGVmZjkyZGFlOGEyMTczYzQ3MGZfMi0wLTEtMS0xMDc3MA_2e5b46ce-627c-4ad2-9f91-f5ecc232b823"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zMS9mcmFnOmNlNDgxOGVmYTM1YjQ2NDI4NGUxN2Q2NWEwYThiNjc3L3RhYmxlOmU5MmY2N2EzMmZkYjRlZmY5MmRhZThhMjE3M2M0NzBmL3RhYmxlcmFuZ2U6ZTkyZjY3YTMyZmRiNGVmZjkyZGFlOGEyMTczYzQ3MGZfMi0wLTEtMS0xMDc3MA_5c495df8-c4dc-4a11-8dcb-5b212c885604"&gt;Adoption of the credit loss standard, cumulative-effect adjustment to retained earnings&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provision for expected credit losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts written off charged against the allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,220)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,333)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of September 30,&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,511&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zMS9mcmFnOmNlNDgxOGVmYTM1YjQ2NDI4NGUxN2Q2NWEwYThiNjc3L3RhYmxlOmU5MmY2N2EzMmZkYjRlZmY5MmRhZThhMjE3M2M0NzBmL3RhYmxlcmFuZ2U6ZTkyZjY3YTMyZmRiNGVmZjkyZGFlOGEyMTczYzQ3MGZfMS0xLTEtMS0xMDc3MA_d937108a-24a5-42bd-8adb-d84460a7bde2"
      unitRef="usd">7043000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="i73ad7702c4f241548c42eab7eb506186_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zMS9mcmFnOmNlNDgxOGVmYTM1YjQ2NDI4NGUxN2Q2NWEwYThiNjc3L3RhYmxlOmU5MmY2N2EzMmZkYjRlZmY5MmRhZThhMjE3M2M0NzBmL3RhYmxlcmFuZ2U6ZTkyZjY3YTMyZmRiNGVmZjkyZGFlOGEyMTczYzQ3MGZfMS0zLTEtMS0xMDc3MA_f1fc732e-51f3-48c5-98a5-2ac894f56a96"
      unitRef="usd">3332000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="i3540c67ef3ad4b86931989fd054e0b50_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zMS9mcmFnOmNlNDgxOGVmYTM1YjQ2NDI4NGUxN2Q2NWEwYThiNjc3L3RhYmxlOmU5MmY2N2EzMmZkYjRlZmY5MmRhZThhMjE3M2M0NzBmL3RhYmxlcmFuZ2U6ZTkyZjY3YTMyZmRiNGVmZjkyZGFlOGEyMTczYzQ3MGZfMi0xLTEtMS0xMDc3MA_7a1621e3-584c-4d38-a7cb-3b88c67b588f"
      unitRef="usd">0</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="i55f9e8f7bfb74ed0a97dc5b843a44941_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zMS9mcmFnOmNlNDgxOGVmYTM1YjQ2NDI4NGUxN2Q2NWEwYThiNjc3L3RhYmxlOmU5MmY2N2EzMmZkYjRlZmY5MmRhZThhMjE3M2M0NzBmL3RhYmxlcmFuZ2U6ZTkyZjY3YTMyZmRiNGVmZjkyZGFlOGEyMTczYzQ3MGZfMi0zLTEtMS0xMDc3MA_2204efc1-3d98-4bd3-824b-f164dd57ceaa"
      unitRef="usd">1334000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zMS9mcmFnOmNlNDgxOGVmYTM1YjQ2NDI4NGUxN2Q2NWEwYThiNjc3L3RhYmxlOmU5MmY2N2EzMmZkYjRlZmY5MmRhZThhMjE3M2M0NzBmL3RhYmxlcmFuZ2U6ZTkyZjY3YTMyZmRiNGVmZjkyZGFlOGEyMTczYzQ3MGZfMy0xLTEtMS0xMDc3MA_227777b1-171c-4fe8-9c25-4a5882264760"
      unitRef="usd">325000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zMS9mcmFnOmNlNDgxOGVmYTM1YjQ2NDI4NGUxN2Q2NWEwYThiNjc3L3RhYmxlOmU5MmY2N2EzMmZkYjRlZmY5MmRhZThhMjE3M2M0NzBmL3RhYmxlcmFuZ2U6ZTkyZjY3YTMyZmRiNGVmZjkyZGFlOGEyMTczYzQ3MGZfMy0zLTEtMS0xMDc3MA_8657b526-c9e4-4818-9a8b-c2e3a011b3a0"
      unitRef="usd">5178000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zMS9mcmFnOmNlNDgxOGVmYTM1YjQ2NDI4NGUxN2Q2NWEwYThiNjc3L3RhYmxlOmU5MmY2N2EzMmZkYjRlZmY5MmRhZThhMjE3M2M0NzBmL3RhYmxlcmFuZ2U6ZTkyZjY3YTMyZmRiNGVmZjkyZGFlOGEyMTczYzQ3MGZfNC0xLTEtMS0xMDc3MA_a7e14b4d-6309-4e0a-ad82-564a4aa081bb"
      unitRef="usd">1220000</us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs
      contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zMS9mcmFnOmNlNDgxOGVmYTM1YjQ2NDI4NGUxN2Q2NWEwYThiNjc3L3RhYmxlOmU5MmY2N2EzMmZkYjRlZmY5MmRhZThhMjE3M2M0NzBmL3RhYmxlcmFuZ2U6ZTkyZjY3YTMyZmRiNGVmZjkyZGFlOGEyMTczYzQ3MGZfNC0zLTEtMS0xMDc3MA_c5563743-6fcd-4a80-8f08-2bf18d28f901"
      unitRef="usd">1333000</us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="i68ecd84e8da440808154baac134e839e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zMS9mcmFnOmNlNDgxOGVmYTM1YjQ2NDI4NGUxN2Q2NWEwYThiNjc3L3RhYmxlOmU5MmY2N2EzMmZkYjRlZmY5MmRhZThhMjE3M2M0NzBmL3RhYmxlcmFuZ2U6ZTkyZjY3YTMyZmRiNGVmZjkyZGFlOGEyMTczYzQ3MGZfNi0xLTEtMS0xMDc3MA_60f1d2f6-5466-47a0-bb7b-82aa9868e3b9"
      unitRef="usd">6148000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="i041c1c8fe78444f88611087c404a5e99_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zMS9mcmFnOmNlNDgxOGVmYTM1YjQ2NDI4NGUxN2Q2NWEwYThiNjc3L3RhYmxlOmU5MmY2N2EzMmZkYjRlZmY5MmRhZThhMjE3M2M0NzBmL3RhYmxlcmFuZ2U6ZTkyZjY3YTMyZmRiNGVmZjkyZGFlOGEyMTczYzQ3MGZfNi0zLTEtMS0xMDc3MA_1fece7ef-d57a-44c9-8f84-596898485eb5"
      unitRef="usd">8511000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:BusinessCombinationDisclosureTextBlock
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zNC9mcmFnOjM2YTE4ODM3NmY3ZTQ1NDliNzA0ZjYxNGI1M2Q0NDA3L3RleHRyZWdpb246MzZhMTg4Mzc2ZjdlNDU0OWI3MDRmNjE0YjUzZDQ0MDdfNjAyOA_9ceba31f-4b71-426c-91fd-2baeac3b1b52">ACQUISITIONS &lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As set forth below, the Company completed two acquisitions from January&#160;1, 2020 through September&#160;30, 2021, which were accounted for using the acquisition method of accounting. Accordingly, the Company recorded the tangible and intangible assets acquired and liabilities assumed at their estimated fair values as of the applicable date of acquisition. Since the applicable date of acquisition, the Company has revised the allocation of the purchase price to the tangible and intangible assets acquired and liabilities assumed based on analysis of information that has been made available through September&#160;30, 2021. The allocations will continue to be updated through the measurement period, if necessary. The Company recognizes acquisition-related costs in selling, general and administrative expenses in the consolidated statements of comprehensive income.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Synzi and SnapMD Acquisition&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 7, 2021, the Company completed its acquisition of Synzi Holdings, Inc. (&#x201c;Synzi&#x201d;) and its wholly-owned subsidiary, SnapMD, LLC (&#x201c;SnapMD&#x201d;). Synzi is a virtual care communication platform that enables organizations to conduct virtual visits and use secure messaging, text, and email for clinician-to-patient and clinician-to-clinician communications. SnapMD is a full-service virtual care management company, specializing in providing software to enable healthcare providers to better engage with their patients. The initial purchase price of $42,240 consisted entirely of cash consideration paid upon acquisition. The acquisition was funded primarily through borrowings under the Senior Credit Facility (as defined below). The results of Synzi and SnapMD have been included in the Company&#x2019;s technology and workforce solutions segment since the date of acquisition. During the second quarter of 2021, $92 was returned to the Company in respect of the final working capital settlement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preliminary allocation of the $42,148 purchase price, which was reduced by the final working capital settlement, consisted of (1) $2,790 of fair value of tangible assets acquired, which included $884 cash received, (2) $1,217 of liabilities assumed, (3) $12,440 of identified intangible assets, and (4) $28,135 of goodwill, of which $6,085 is deductible for tax purposes. The provisional items pending finalization are income tax related matters and the assessment of additional information related to determining the fair value of certain assets acquired and liabilities assumed. The fair value of intangible assets primarily includes $10,890 of developed technology and $1,220 of trademarks with a weighted average useful life of approximately seven years. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stratus Video Acquisition&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On February 14, 2020, the Company completed its acquisition of Stratus Video, a remote video interpreting company that provides healthcare interpretation via remote video, over the phone, and onsite in-person, all supported by proprietary technology platforms. The initial purchase price of $485,568 consisted entirely of cash consideration paid upon acquisition. The acquisition was funded primarily through (1) borrowings under the Company&#x2019;s $400,000 secured revolving credit facility (the &#x201c;Senior Credit Facility&#x201d;), provided for under a credit agreement (the &#x201c;New Credit Agreement&#x201d;), and (2) the Second Amendment (as defined in Note (6) below) to the New Credit Agreement, which provided $250,000 of additional available borrowings to the Company. The Senior Credit Facility, New Credit Agreement and Second Amendment are more fully described in Note (6), &#x201c;Notes Payable and Credit Agreement.&#x201d; The results of Stratus Video have been included in the Company&#x2019;s technology and workforce solutions segment since the date of acquisition. During the second quarter of 2020, an additional $99 of cash consideration was paid to the selling shareholders in respect of the final working capital settlement. The Company incurred $10,548 of acquisition-related costs during the nine months ended September 30, 2020 as a result of its acquisition of Stratus Video.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The allocation of the $485,667 purchase price, which included the additional cash consideration paid for the final working capital settlement and was finalized during the first quarter of 2021, consisted of (1) $44,092&lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;of fair value of tangible assets acquired, which included $9,176 cash received, (2) $56,059 of liabilities assumed, (3) $228,000 of identified intangible assets, and (4) $269,634 of goodwill, of which $10,182 is deductible for tax purposes. The intangible assets acquired have a weighted average useful life of approximately seventeen years. The following table summarizes the fair value and useful life of each intangible asset acquired as of the acquisition date:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:14pt;text-align:center;text-indent:13.5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:68.128%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.693%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:38.170%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.423%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.423%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:3.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.856%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Useful Life&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in years)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Identifiable intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer Relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tradenames and Trademarks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5 - 10&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Developed Technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interpreter Database&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;228,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:4pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the third quarter of 2020, the Company revised the estimated useful lives for the tradenames and trademarks intangible assets as a result of its plan to rebrand the language services business. Based on this change in circumstances since the date of acquisition, the Company determined that the remaining useful lives of the assets are 5 years and is amortizing the remaining value on a straight-line basis over the remaining useful life. The Company will continue to evaluate the remaining useful lives of other intangible assets impacted by its brand consolidation efforts.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Approximately $35,329 of revenue and $8,322 of income before income taxes of Stratus Video were included in the unaudited condensed consolidated statement of comprehensive income for the three months ended September 30, 2020. Approximately $78,080 of revenue and $13,787 of income before income taxes of Stratus Video were included in the unaudited condensed consolidated statement of comprehensive income for the nine months ended September 30, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Pro Forma Financial Information (Unaudited)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following summary presents unaudited pro forma consolidated results of operations of the Company as if the acquisition of Stratus Video had occurred on January 1, 2019, which gives effect to certain adjustments, including acquisition-related costs of $1,023 and $11,662, that were reclassified from the three and nine months ended September 30, 2020, respectively, to the three and nine months ended September 30, 2019, respectively. The unaudited pro forma financial information is not necessarily indicative of the operating results that would have occurred had the acquisition been consummated as of the date indicated, nor is it necessarily indicative of the Company&#x2019;s future operating results. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.584%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.215%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.317%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;551,631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,776,315&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income from operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;135,618&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,030&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71,434&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:BusinessCombinationDisclosureTextBlock>
    <us-gaap:NumberOfBusinessesAcquired
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zNC9mcmFnOjM2YTE4ODM3NmY3ZTQ1NDliNzA0ZjYxNGI1M2Q0NDA3L3RleHRyZWdpb246MzZhMTg4Mzc2ZjdlNDU0OWI3MDRmNjE0YjUzZDQ0MDdfNjQ_c8a548bf-7811-4d51-a341-f42079d44458"
      unitRef="acquisition">2</us-gaap:NumberOfBusinessesAcquired>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="ifa30b8cb72094c7ca771fc176115f67e_D20210407-20210407"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zNC9mcmFnOjM2YTE4ODM3NmY3ZTQ1NDliNzA0ZjYxNGI1M2Q0NDA3L3RleHRyZWdpb246MzZhMTg4Mzc2ZjdlNDU0OWI3MDRmNjE0YjUzZDQ0MDdfMTQxMw_90751307-96df-4bc5-aa73-313b182f3d2c"
      unitRef="usd">42240000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:CashAcquiredFromAcquisition
      contextRef="i202e46c5ac0646f8b3354ce9a1eb5b00_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zNC9mcmFnOjM2YTE4ODM3NmY3ZTQ1NDliNzA0ZjYxNGI1M2Q0NDA3L3RleHRyZWdpb246MzZhMTg4Mzc2ZjdlNDU0OWI3MDRmNjE0YjUzZDQ0MDdfMTc2Ng_eb5cb6e0-dea4-493d-a505-ba7ac018d7fa"
      unitRef="usd">92000</us-gaap:CashAcquiredFromAcquisition>
    <amn:BusinessCombinationConsiderationTransferredNetOfWorkingCapitalAdjustment
      contextRef="ieff88e899cdb408197ed1ff99234a795_D20210930-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zNC9mcmFnOjM2YTE4ODM3NmY3ZTQ1NDliNzA0ZjYxNGI1M2Q0NDA3L3RleHRyZWdpb246MzZhMTg4Mzc2ZjdlNDU0OWI3MDRmNjE0YjUzZDQ0MDdfMTg4Mw_aab77bea-7be6-4eb9-8e4b-29d1ef112281"
      unitRef="usd">42148000</amn:BusinessCombinationConsiderationTransferredNetOfWorkingCapitalAdjustment>
    <amn:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalentsAndPropertyPlantAndEquipment
      contextRef="icbbe0cb0e30e4fc195db16971b04921b_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zNC9mcmFnOjM2YTE4ODM3NmY3ZTQ1NDliNzA0ZjYxNGI1M2Q0NDA3L3RleHRyZWdpb246MzZhMTg4Mzc2ZjdlNDU0OWI3MDRmNjE0YjUzZDQ0MDdfMTk3OA_b51e6d17-cacc-4e77-b898-3ea0f0381fc6"
      unitRef="usd">2790000</amn:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalentsAndPropertyPlantAndEquipment>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
      contextRef="icbbe0cb0e30e4fc195db16971b04921b_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zNC9mcmFnOjM2YTE4ODM3NmY3ZTQ1NDliNzA0ZjYxNGI1M2Q0NDA3L3RleHRyZWdpb246MzZhMTg4Mzc2ZjdlNDU0OWI3MDRmNjE0YjUzZDQ0MDdfMjAzOQ_38d98faa-6801-40a0-b0eb-380e66ec2850"
      unitRef="usd">884000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
      contextRef="icbbe0cb0e30e4fc195db16971b04921b_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zNC9mcmFnOjM2YTE4ODM3NmY3ZTQ1NDliNzA0ZjYxNGI1M2Q0NDA3L3RleHRyZWdpb246MzZhMTg4Mzc2ZjdlNDU0OWI3MDRmNjE0YjUzZDQ0MDdfMjA2MQ_ee3d069f-8fb9-435a-ba37-e77c920a0fda"
      unitRef="usd">1217000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="icbbe0cb0e30e4fc195db16971b04921b_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zNC9mcmFnOjM2YTE4ODM3NmY3ZTQ1NDliNzA0ZjYxNGI1M2Q0NDA3L3RleHRyZWdpb246MzZhMTg4Mzc2ZjdlNDU0OWI3MDRmNjE0YjUzZDQ0MDdfMjA5Mg_a05f4c32-5cb0-46b2-b1c1-b3fe6fb30d83"
      unitRef="usd">12440000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:Goodwill
      contextRef="icbbe0cb0e30e4fc195db16971b04921b_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zNC9mcmFnOjM2YTE4ODM3NmY3ZTQ1NDliNzA0ZjYxNGI1M2Q0NDA3L3RleHRyZWdpb246MzZhMTg4Mzc2ZjdlNDU0OWI3MDRmNjE0YjUzZDQ0MDdfMjEzNg_4a7449e8-6a98-42f7-a5cd-104be676d68f"
      unitRef="usd">28135000</us-gaap:Goodwill>
    <us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount
      contextRef="icbbe0cb0e30e4fc195db16971b04921b_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zNC9mcmFnOjM2YTE4ODM3NmY3ZTQ1NDliNzA0ZjYxNGI1M2Q0NDA3L3RleHRyZWdpb246MzZhMTg4Mzc2ZjdlNDU0OWI3MDRmNjE0YjUzZDQ0MDdfMjE2MQ_e7e15a88-751e-498f-9aa7-0631575c7a9d"
      unitRef="usd">6085000</us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="id8a8066df2cd49fb99c9a296eb4b267d_I20210407"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zNC9mcmFnOjM2YTE4ODM3NmY3ZTQ1NDliNzA0ZjYxNGI1M2Q0NDA3L3RleHRyZWdpb246MzZhMTg4Mzc2ZjdlNDU0OWI3MDRmNjE0YjUzZDQ0MDdfMjM2OA_7b408d69-5e95-41d0-80eb-bf96cfab23c1"
      unitRef="usd">10890000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i2ddc12eab3644117aaadf0ffbc24c476_I20210407"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zNC9mcmFnOjM2YTE4ODM3NmY3ZTQ1NDliNzA0ZjYxNGI1M2Q0NDA3L3RleHRyZWdpb246MzZhMTg4Mzc2ZjdlNDU0OWI3MDRmNjE0YjUzZDQ0MDdfMjM5OQ_155e0a96-f1a5-4406-9945-287019f7bb87"
      unitRef="usd">1220000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="ifa30b8cb72094c7ca771fc176115f67e_D20210407-20210407"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zNC9mcmFnOjM2YTE4ODM3NmY3ZTQ1NDliNzA0ZjYxNGI1M2Q0NDA3L3RleHRyZWdpb246MzZhMTg4Mzc2ZjdlNDU0OWI3MDRmNjE0YjUzZDQ0MDdfMjQ2OQ_fe625a21-d82b-4692-b1b3-ffc6686bcc72">P7Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i750e5ac42b744b7999aafb93dd8e3926_D20200214-20200214"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zNC9mcmFnOjM2YTE4ODM3NmY3ZTQ1NDliNzA0ZjYxNGI1M2Q0NDA3L3RleHRyZWdpb246MzZhMTg4Mzc2ZjdlNDU0OWI3MDRmNjE0YjUzZDQ0MDdfMjc5MQ_0b44c698-cddc-4954-8ee1-6d8df3165465"
      unitRef="usd">485568000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i1809609cdf714d66916ae3141253f6cd_I20180209"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zNC9mcmFnOjM2YTE4ODM3NmY3ZTQ1NDliNzA0ZjYxNGI1M2Q0NDA3L3RleHRyZWdpb246MzZhMTg4Mzc2ZjdlNDU0OWI3MDRmNjE0YjUzZDQ0MDdfMjkzOA_49c6bee4-b5cb-47e2-b2a9-ea00df86de98"
      unitRef="usd">400000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LongTermDebt
      contextRef="ie9d4571d2fdf44c6ba87db28c14cb175_I20200214"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zNC9mcmFnOjM2YTE4ODM3NmY3ZTQ1NDliNzA0ZjYxNGI1M2Q0NDA3L3RleHRyZWdpb246MzZhMTg4Mzc2ZjdlNDU0OWI3MDRmNjE0YjUzZDQ0MDdfMzE3OQ_3aeacd78-d4ed-47b5-8fc4-6c23c4691acc"
      unitRef="usd">250000000</us-gaap:LongTermDebt>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="ib98f074e5878463f913e950ba5784162_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zNC9mcmFnOjM2YTE4ODM3NmY3ZTQ1NDliNzA0ZjYxNGI1M2Q0NDA3L3RleHRyZWdpb246MzZhMTg4Mzc2ZjdlNDU0OWI3MDRmNjE0YjUzZDQ0MDdfMzU2Nw_df2bd5e6-eb3c-493c-8e45-0e5cc116e5ec"
      unitRef="usd">99000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="i87dc697cd0464e2c938ed8477a3a3237_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zNC9mcmFnOjM2YTE4ODM3NmY3ZTQ1NDliNzA0ZjYxNGI1M2Q0NDA3L3RleHRyZWdpb246MzZhMTg4Mzc2ZjdlNDU0OWI3MDRmNjE0YjUzZDQ0MDdfMzcwMg_2e9d0fcb-f9ba-4e8d-beb9-ab06e7830a36"
      unitRef="usd">10548000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <amn:BusinessCombinationConsiderationTransferredNetOfWorkingCapitalAdjustment
      contextRef="id09df577cd134e6994ece5aa31598ed7_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zNC9mcmFnOjM2YTE4ODM3NmY3ZTQ1NDliNzA0ZjYxNGI1M2Q0NDA3L3RleHRyZWdpb246MzZhMTg4Mzc2ZjdlNDU0OWI3MDRmNjE0YjUzZDQ0MDdfMzgxOQ_62044b04-2a44-4a40-87a7-c8689506c773"
      unitRef="usd">485667000</amn:BusinessCombinationConsiderationTransferredNetOfWorkingCapitalAdjustment>
    <amn:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets
      contextRef="i2a27a4a6c0964a5194ffc4f8f4176fbf_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zNC9mcmFnOjM2YTE4ODM3NmY3ZTQ1NDliNzA0ZjYxNGI1M2Q0NDA3L3RleHRyZWdpb246MzZhMTg4Mzc2ZjdlNDU0OWI3MDRmNjE0YjUzZDQ0MDdfNDAwMg_5185ad9c-19dd-4d57-a8d9-63ee21c29104"
      unitRef="usd">44092000</amn:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
      contextRef="i2a27a4a6c0964a5194ffc4f8f4176fbf_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zNC9mcmFnOjM2YTE4ODM3NmY3ZTQ1NDliNzA0ZjYxNGI1M2Q0NDA3L3RleHRyZWdpb246MzZhMTg4Mzc2ZjdlNDU0OWI3MDRmNjE0YjUzZDQ0MDdfNDA2Mw_cbe242ab-de81-428e-a22b-5d9431794429"
      unitRef="usd">9176000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
      contextRef="i2a27a4a6c0964a5194ffc4f8f4176fbf_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zNC9mcmFnOjM2YTE4ODM3NmY3ZTQ1NDliNzA0ZjYxNGI1M2Q0NDA3L3RleHRyZWdpb246MzZhMTg4Mzc2ZjdlNDU0OWI3MDRmNjE0YjUzZDQ0MDdfNDA4NQ_17614277-ca1b-423e-a90f-04548021bc13"
      unitRef="usd">56059000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i2a27a4a6c0964a5194ffc4f8f4176fbf_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zNC9mcmFnOjM2YTE4ODM3NmY3ZTQ1NDliNzA0ZjYxNGI1M2Q0NDA3L3RleHRyZWdpb246MzZhMTg4Mzc2ZjdlNDU0OWI3MDRmNjE0YjUzZDQ0MDdfNDExNg_8e430880-74c1-4b79-8662-696e309446f8"
      unitRef="usd">228000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:Goodwill
      contextRef="i2a27a4a6c0964a5194ffc4f8f4176fbf_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zNC9mcmFnOjM2YTE4ODM3NmY3ZTQ1NDliNzA0ZjYxNGI1M2Q0NDA3L3RleHRyZWdpb246MzZhMTg4Mzc2ZjdlNDU0OWI3MDRmNjE0YjUzZDQ0MDdfNDE2MA_83813aff-be15-4edd-aa30-e05951e86606"
      unitRef="usd">269634000</us-gaap:Goodwill>
    <us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount
      contextRef="i2a27a4a6c0964a5194ffc4f8f4176fbf_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zNC9mcmFnOjM2YTE4ODM3NmY3ZTQ1NDliNzA0ZjYxNGI1M2Q0NDA3L3RleHRyZWdpb246MzZhMTg4Mzc2ZjdlNDU0OWI3MDRmNjE0YjUzZDQ0MDdfNDE4NQ_93198d5f-7d7b-4630-a6ec-88215d091dbe"
      unitRef="usd">10182000</us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i750e5ac42b744b7999aafb93dd8e3926_D20200214-20200214"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zNC9mcmFnOjM2YTE4ODM3NmY3ZTQ1NDliNzA0ZjYxNGI1M2Q0NDA3L3RleHRyZWdpb246MzZhMTg4Mzc2ZjdlNDU0OWI3MDRmNjE0YjUzZDQ0MDdfNDMwNA_cad41909-bb28-4cb5-a8c5-eeba39e0bf0f">P17Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zNC9mcmFnOjM2YTE4ODM3NmY3ZTQ1NDliNzA0ZjYxNGI1M2Q0NDA3L3RleHRyZWdpb246MzZhMTg4Mzc2ZjdlNDU0OWI3MDRmNjE0YjUzZDQ0MDdfNjAzMA_fdb730bc-e23b-45f1-8e93-838e6bdac188">The following table summarizes the fair value and useful life of each intangible asset acquired as of the acquisition date:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:68.128%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.693%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:38.170%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.423%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.423%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:3.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.856%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Useful Life&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in years)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Identifiable intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer Relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tradenames and Trademarks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5 - 10&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Developed Technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interpreter Database&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;228,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i3d55955405794cb789f5432f8c06331e_I20200214"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zNC9mcmFnOjM2YTE4ODM3NmY3ZTQ1NDliNzA0ZjYxNGI1M2Q0NDA3L3RhYmxlOmIxNTAxNDQ1ODkxYjRjYTY4YmVjYmU2NzdhOGU5NjkwL3RhYmxlcmFuZ2U6YjE1MDE0NDU4OTFiNGNhNjhiZWNiZTY3N2E4ZTk2OTBfMy0zLTEtMS0xMDc3MA_aa1347fb-e8ce-447c-84a3-558bf7dd94c3"
      unitRef="usd">171000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="ia69287e7ab6c43f095adc3cb43556c44_D20200214-20200214"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zNC9mcmFnOjM2YTE4ODM3NmY3ZTQ1NDliNzA0ZjYxNGI1M2Q0NDA3L3RhYmxlOmIxNTAxNDQ1ODkxYjRjYTY4YmVjYmU2NzdhOGU5NjkwL3RhYmxlcmFuZ2U6YjE1MDE0NDU4OTFiNGNhNjhiZWNiZTY3N2E4ZTk2OTBfMy01LTEtMS0xMDc3MA_197fb07e-9d5a-477c-9d4a-499ebc71f76e">P20Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i3dad049f61fe4171831aea7245fff5c6_I20200214"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zNC9mcmFnOjM2YTE4ODM3NmY3ZTQ1NDliNzA0ZjYxNGI1M2Q0NDA3L3RhYmxlOmIxNTAxNDQ1ODkxYjRjYTY4YmVjYmU2NzdhOGU5NjkwL3RhYmxlcmFuZ2U6YjE1MDE0NDU4OTFiNGNhNjhiZWNiZTY3N2E4ZTk2OTBfNC0zLTEtMS0xMDc3MA_31dfb657-cd7e-4097-a302-b502538c6244"
      unitRef="usd">40000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="idd4f7d02ac0c4fbcab236ee010c28075_D20200214-20200214"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zNC9mcmFnOjM2YTE4ODM3NmY3ZTQ1NDliNzA0ZjYxNGI1M2Q0NDA3L3RhYmxlOmIxNTAxNDQ1ODkxYjRjYTY4YmVjYmU2NzdhOGU5NjkwL3RhYmxlcmFuZ2U6YjE1MDE0NDU4OTFiNGNhNjhiZWNiZTY3N2E4ZTk2OTBfNC01LTEtMS0xMDc3MC90ZXh0cmVnaW9uOmU2NTc1ZjkzODY0MDQzZDg4MWMzZDk2NTFlZTJkODY4XzQ_3c46e051-6ab8-4076-b1dd-4d452b5d9eed">P5Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i450e36d3b7b24a9a930abcbcebb33f8b_D20200214-20200214"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zNC9mcmFnOjM2YTE4ODM3NmY3ZTQ1NDliNzA0ZjYxNGI1M2Q0NDA3L3RhYmxlOmIxNTAxNDQ1ODkxYjRjYTY4YmVjYmU2NzdhOGU5NjkwL3RhYmxlcmFuZ2U6YjE1MDE0NDU4OTFiNGNhNjhiZWNiZTY3N2E4ZTk2OTBfNC01LTEtMS0xMDc3MC90ZXh0cmVnaW9uOmU2NTc1ZjkzODY0MDQzZDg4MWMzZDk2NTFlZTJkODY4Xzk_db7eeaa2-1894-4c56-910a-f88741c7a7f8">P10Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="id060857eed0b4cc5a5f2798ea3dcc0c1_I20200214"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zNC9mcmFnOjM2YTE4ODM3NmY3ZTQ1NDliNzA0ZjYxNGI1M2Q0NDA3L3RhYmxlOmIxNTAxNDQ1ODkxYjRjYTY4YmVjYmU2NzdhOGU5NjkwL3RhYmxlcmFuZ2U6YjE1MDE0NDU4OTFiNGNhNjhiZWNiZTY3N2E4ZTk2OTBfNS0zLTEtMS0xMDc3MA_6ee828d8-2f4a-41c6-89b1-4c2aeb1660ed"
      unitRef="usd">16000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i4c6a14bbd81143a7b0ccd248e1c2ea39_D20200214-20200214"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zNC9mcmFnOjM2YTE4ODM3NmY3ZTQ1NDliNzA0ZjYxNGI1M2Q0NDA3L3RhYmxlOmIxNTAxNDQ1ODkxYjRjYTY4YmVjYmU2NzdhOGU5NjkwL3RhYmxlcmFuZ2U6YjE1MDE0NDU4OTFiNGNhNjhiZWNiZTY3N2E4ZTk2OTBfNS01LTEtMS0xMDc3MA_cb990ab5-1d4f-4f22-930c-dde4b8de224c">P5Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="ic43cd4c81a97471aa9a13d84fb4031e2_I20200214"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zNC9mcmFnOjM2YTE4ODM3NmY3ZTQ1NDliNzA0ZjYxNGI1M2Q0NDA3L3RhYmxlOmIxNTAxNDQ1ODkxYjRjYTY4YmVjYmU2NzdhOGU5NjkwL3RhYmxlcmFuZ2U6YjE1MDE0NDU4OTFiNGNhNjhiZWNiZTY3N2E4ZTk2OTBfNi0zLTEtMS0xMDc3MA_d67f59e0-8fff-4203-936f-d56d0d90a40e"
      unitRef="usd">1000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i5699c9a4945c4f429b834511a0a22cbc_D20200214-20200214"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zNC9mcmFnOjM2YTE4ODM3NmY3ZTQ1NDliNzA0ZjYxNGI1M2Q0NDA3L3RhYmxlOmIxNTAxNDQ1ODkxYjRjYTY4YmVjYmU2NzdhOGU5NjkwL3RhYmxlcmFuZ2U6YjE1MDE0NDU4OTFiNGNhNjhiZWNiZTY3N2E4ZTk2OTBfNi01LTEtMS0xMDc3MA_75298366-c280-43a5-8691-30d6c4f4edcf">P4Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i67759f1dfa1b4429aabe1215e03414dc_I20200214"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zNC9mcmFnOjM2YTE4ODM3NmY3ZTQ1NDliNzA0ZjYxNGI1M2Q0NDA3L3RhYmxlOmIxNTAxNDQ1ODkxYjRjYTY4YmVjYmU2NzdhOGU5NjkwL3RhYmxlcmFuZ2U6YjE1MDE0NDU4OTFiNGNhNjhiZWNiZTY3N2E4ZTk2OTBfNy0zLTEtMS0xMDc3MA_ddc3c500-9c33-4406-abaa-959b1247705e"
      unitRef="usd">228000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="ic87fd517c51345a2a17d4c391a7c46c3_D20200701-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zNC9mcmFnOjM2YTE4ODM3NmY3ZTQ1NDliNzA0ZjYxNGI1M2Q0NDA3L3RleHRyZWdpb246MzZhMTg4Mzc2ZjdlNDU0OWI3MDRmNjE0YjUzZDQ0MDdfNDc3Ng_39101564-1b59-4421-b712-4631ca9f37c9">P5Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual
      contextRef="ic430d291a7804180aa0b06c38d0c7c55_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zNC9mcmFnOjM2YTE4ODM3NmY3ZTQ1NDliNzA0ZjYxNGI1M2Q0NDA3L3RleHRyZWdpb246MzZhMTg4Mzc2ZjdlNDU0OWI3MDRmNjE0YjUzZDQ0MDdfNTAyNQ_725f6daa-6b36-427b-9e35-1a0dd23e275d"
      unitRef="usd">35329000</us-gaap:BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual>
    <us-gaap:BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual
      contextRef="ic430d291a7804180aa0b06c38d0c7c55_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zNC9mcmFnOjM2YTE4ODM3NmY3ZTQ1NDliNzA0ZjYxNGI1M2Q0NDA3L3RleHRyZWdpb246MzZhMTg4Mzc2ZjdlNDU0OWI3MDRmNjE0YjUzZDQ0MDdfNTA0Mw_9eb738d1-1777-4d3a-94b2-5be08e544df5"
      unitRef="usd">8322000</us-gaap:BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual>
    <us-gaap:BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual
      contextRef="i87dc697cd0464e2c938ed8477a3a3237_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zNC9mcmFnOjM2YTE4ODM3NmY3ZTQ1NDliNzA0ZjYxNGI1M2Q0NDA3L3RleHRyZWdpb246MzZhMTg4Mzc2ZjdlNDU0OWI3MDRmNjE0YjUzZDQ0MDdfNTIwNw_a69ced45-7636-4cbb-9b6c-fb3ba75088b2"
      unitRef="usd">78080000</us-gaap:BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual>
    <us-gaap:BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual
      contextRef="i87dc697cd0464e2c938ed8477a3a3237_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zNC9mcmFnOjM2YTE4ODM3NmY3ZTQ1NDliNzA0ZjYxNGI1M2Q0NDA3L3RleHRyZWdpb246MzZhMTg4Mzc2ZjdlNDU0OWI3MDRmNjE0YjUzZDQ0MDdfNTIyNQ_7e588265-6a33-47c5-9c9a-5d42b6c98122"
      unitRef="usd">13787000</us-gaap:BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual>
    <us-gaap:NetIncomeLoss
      contextRef="id449bccf189e469e8b6a234845cba859_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zNC9mcmFnOjM2YTE4ODM3NmY3ZTQ1NDliNzA0ZjYxNGI1M2Q0NDA3L3RleHRyZWdpb246MzZhMTg4Mzc2ZjdlNDU0OWI3MDRmNjE0YjUzZDQ0MDdfNTY3NA_1e9e644d-5ac0-41b5-8ae6-cbde6815d935"
      unitRef="usd">-1023000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i2450926f8adf4dedb94c370247e5310b_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zNC9mcmFnOjM2YTE4ODM3NmY3ZTQ1NDliNzA0ZjYxNGI1M2Q0NDA3L3RleHRyZWdpb246MzZhMTg4Mzc2ZjdlNDU0OWI3MDRmNjE0YjUzZDQ0MDdfNTY4MQ_877effb9-bc54-4474-af84-a7754160065f"
      unitRef="usd">-11662000</us-gaap:NetIncomeLoss>
    <us-gaap:BusinessAcquisitionProFormaInformationTextBlock
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zNC9mcmFnOjM2YTE4ODM3NmY3ZTQ1NDliNzA0ZjYxNGI1M2Q0NDA3L3RleHRyZWdpb246MzZhMTg4Mzc2ZjdlNDU0OWI3MDRmNjE0YjUzZDQ0MDdfNjAzMQ_d7fe18a1-3f54-4556-af11-93f148f82313">The unaudited pro forma financial information is not necessarily indicative of the operating results that would have occurred had the acquisition been consummated as of the date indicated, nor is it necessarily indicative of the Company&#x2019;s future operating results. &lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.584%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.215%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.317%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;551,631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,776,315&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income from operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;135,618&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,030&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71,434&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:BusinessAcquisitionProFormaInformationTextBlock>
    <us-gaap:BusinessAcquisitionsProFormaRevenue
      contextRef="ic430d291a7804180aa0b06c38d0c7c55_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zNC9mcmFnOjM2YTE4ODM3NmY3ZTQ1NDliNzA0ZjYxNGI1M2Q0NDA3L3RhYmxlOjE5MmRiMzFlMjRkNTRjNTQ4OTlkOGRjZTcwMmFlNjNkL3RhYmxlcmFuZ2U6MTkyZGIzMWUyNGQ1NGM1NDg5OWQ4ZGNlNzAyYWU2M2RfMi0xLTEtMS0xMDc3MA_63e81e56-3dcb-48ea-88fb-d35a5fa428f7"
      unitRef="usd">551631000</us-gaap:BusinessAcquisitionsProFormaRevenue>
    <us-gaap:BusinessAcquisitionsProFormaRevenue
      contextRef="i87dc697cd0464e2c938ed8477a3a3237_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zNC9mcmFnOjM2YTE4ODM3NmY3ZTQ1NDliNzA0ZjYxNGI1M2Q0NDA3L3RhYmxlOjE5MmRiMzFlMjRkNTRjNTQ4OTlkOGRjZTcwMmFlNjNkL3RhYmxlcmFuZ2U6MTkyZGIzMWUyNGQ1NGM1NDg5OWQ4ZGNlNzAyYWU2M2RfMi01LTEtMS0xMDc3MA_11260824-9887-40b1-bcf4-4e593618266f"
      unitRef="usd">1776315000</us-gaap:BusinessAcquisitionsProFormaRevenue>
    <us-gaap:BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax
      contextRef="ic430d291a7804180aa0b06c38d0c7c55_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zNC9mcmFnOjM2YTE4ODM3NmY3ZTQ1NDliNzA0ZjYxNGI1M2Q0NDA3L3RhYmxlOjE5MmRiMzFlMjRkNTRjNTQ4OTlkOGRjZTcwMmFlNjNkL3RhYmxlcmFuZ2U6MTkyZGIzMWUyNGQ1NGM1NDg5OWQ4ZGNlNzAyYWU2M2RfMy0xLTEtMS0xMDc3MA_baad55c0-e892-4296-b850-69008af49e1e"
      unitRef="usd">50465000</us-gaap:BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax>
    <us-gaap:BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax
      contextRef="i87dc697cd0464e2c938ed8477a3a3237_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zNC9mcmFnOjM2YTE4ODM3NmY3ZTQ1NDliNzA0ZjYxNGI1M2Q0NDA3L3RhYmxlOjE5MmRiMzFlMjRkNTRjNTQ4OTlkOGRjZTcwMmFlNjNkL3RhYmxlcmFuZ2U6MTkyZGIzMWUyNGQ1NGM1NDg5OWQ4ZGNlNzAyYWU2M2RfMy01LTEtMS0xMDc3MA_d482efdd-564a-4a9d-a95b-99f15bda71fb"
      unitRef="usd">135618000</us-gaap:BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax>
    <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss
      contextRef="ic430d291a7804180aa0b06c38d0c7c55_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zNC9mcmFnOjM2YTE4ODM3NmY3ZTQ1NDliNzA0ZjYxNGI1M2Q0NDA3L3RhYmxlOjE5MmRiMzFlMjRkNTRjNTQ4OTlkOGRjZTcwMmFlNjNkL3RhYmxlcmFuZ2U6MTkyZGIzMWUyNGQ1NGM1NDg5OWQ4ZGNlNzAyYWU2M2RfNC0xLTEtMS0xMDc3MA_4f6749df-56e7-497c-9372-501cd44ef297"
      unitRef="usd">29030000</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
    <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss
      contextRef="i87dc697cd0464e2c938ed8477a3a3237_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zNC9mcmFnOjM2YTE4ODM3NmY3ZTQ1NDliNzA0ZjYxNGI1M2Q0NDA3L3RhYmxlOjE5MmRiMzFlMjRkNTRjNTQ4OTlkOGRjZTcwMmFlNjNkL3RhYmxlcmFuZ2U6MTkyZGIzMWUyNGQ1NGM1NDg5OWQ4ZGNlNzAyYWU2M2RfNC01LTEtMS0xMDc3MA_531a22a4-ef1b-40be-9d6f-942fe61f5b73"
      unitRef="usd">71434000</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
    <us-gaap:RevenueFromContractWithCustomerTextBlock
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zNy9mcmFnOjIwYjczNDZiODJiZDQxYzc4NGZhMWViNWQ3YTdiNGYxL3RleHRyZWdpb246MjBiNzM0NmI4MmJkNDFjNzg0ZmExZWI1ZDdhN2I0ZjFfMzI3Ng_41f7519f-ca88-49d4-9f14-c4b31086645a">REVENUE RECOGNITION&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue primarily consists of fees earned from the temporary staffing and permanent placement of healthcare professionals, executives, and leaders (clinical and operational). The Company also generates revenue from its software as a service (&#x201c;SaaS&#x201d;)-based technologies, including vendor management systems and scheduling software, and outsourced workforce services, including language interpretation and recruitment process outsourcing. The Company recognizes revenue when control of its services is transferred to its customers, in an amount that reflects the consideration the Company expects to be entitled to receive in exchange for those services. Revenue from temporary staffing services is recognized as the services are rendered by clinical and non-clinical healthcare professionals. Under the Company&#x2019;s managed services program (&#x201c;MSP&#x201d;) arrangements, the Company manages all or a part of a customer&#x2019;s supplemental workforce needs utilizing its own network of healthcare professionals along with those of third-party subcontractors. Revenue and the related direct costs under MSP arrangements are recorded in accordance with the accounting guidance on reporting revenue gross as a principal versus net as an agent. When the Company uses subcontractors and acts as an agent, revenue is recorded net of the related subcontractor&#x2019;s expense. Revenue from permanent placement and outsourced workforce services is recognized as the services are rendered. Depending on the arrangement, the Company&#x2019;s SaaS-based revenue is recognized either as the services are rendered or ratably over the applicable arrangement&#x2019;s service period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s customers are primarily billed as services are rendered. Any fees billed in advance of being earned are recorded as deferred revenue. While payment terms vary by the type of customer and the services rendered, the term between invoicing and when payment is due is not significant. During the nine months ended September 30, 2021 and 2020, previously deferred revenue recognized as revenue was $10,515 and $11,408, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has elected to apply the following practical expedients and optional exemptions related to contract costs and revenue recognition:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Recognize incremental costs of obtaining a contract with amortization periods of one year or less as expense when incurred. These costs are recorded within selling, general and administrative expenses.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Recognize revenue in the amount of consideration that the Company has a right to invoice the customer if that amount corresponds directly with the value to the customer of the Company&#x2019;s services completed to date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Exemptions from disclosing the value of unsatisfied performance obligations for (i) contracts with an original expected length of one year or less, (ii) contracts for which revenue is recognized in the amount of consideration that the Company has a right to invoice for services performed and (iii) contracts for which variable consideration is allocated entirely to a wholly unsatisfied performance obligation or to a wholly unsatisfied promise to transfer a distinct service that forms part of a single performance obligation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;See Note (5), &#x201c;Segment Information,&#x201d; for additional information regarding the Company&#x2019;s revenue disaggregated by service type.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zNy9mcmFnOjIwYjczNDZiODJiZDQxYzc4NGZhMWViNWQ3YTdiNGYxL3RleHRyZWdpb246MjBiNzM0NmI4MmJkNDFjNzg0ZmExZWI1ZDdhN2I0ZjFfMzI3Mw_a896d88d-6e4e-4946-8b76-977e484291fa">&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue primarily consists of fees earned from the temporary staffing and permanent placement of healthcare professionals, executives, and leaders (clinical and operational). The Company also generates revenue from its software as a service (&#x201c;SaaS&#x201d;)-based technologies, including vendor management systems and scheduling software, and outsourced workforce services, including language interpretation and recruitment process outsourcing. The Company recognizes revenue when control of its services is transferred to its customers, in an amount that reflects the consideration the Company expects to be entitled to receive in exchange for those services. Revenue from temporary staffing services is recognized as the services are rendered by clinical and non-clinical healthcare professionals. Under the Company&#x2019;s managed services program (&#x201c;MSP&#x201d;) arrangements, the Company manages all or a part of a customer&#x2019;s supplemental workforce needs utilizing its own network of healthcare professionals along with those of third-party subcontractors. Revenue and the related direct costs under MSP arrangements are recorded in accordance with the accounting guidance on reporting revenue gross as a principal versus net as an agent. When the Company uses subcontractors and acts as an agent, revenue is recorded net of the related subcontractor&#x2019;s expense. Revenue from permanent placement and outsourced workforce services is recognized as the services are rendered. Depending on the arrangement, the Company&#x2019;s SaaS-based revenue is recognized either as the services are rendered or ratably over the applicable arrangement&#x2019;s service period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s customers are primarily billed as services are rendered. Any fees billed in advance of being earned are recorded as deferred revenue. While payment terms vary by the type of customer and the services rendered, the term between invoicing and when payment is due is not significant. During the nine months ended September 30, 2021 and 2020, previously deferred revenue recognized as revenue was $10,515 and $11,408, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has elected to apply the following practical expedients and optional exemptions related to contract costs and revenue recognition:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Recognize incremental costs of obtaining a contract with amortization periods of one year or less as expense when incurred. These costs are recorded within selling, general and administrative expenses.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Recognize revenue in the amount of consideration that the Company has a right to invoice the customer if that amount corresponds directly with the value to the customer of the Company&#x2019;s services completed to date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Exemptions from disclosing the value of unsatisfied performance obligations for (i) contracts with an original expected length of one year or less, (ii) contracts for which revenue is recognized in the amount of consideration that the Company has a right to invoice for services performed and (iii) contracts for which variable consideration is allocated entirely to a wholly unsatisfied performance obligation or to a wholly unsatisfied promise to transfer a distinct service that forms part of a single performance obligation.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zNy9mcmFnOjIwYjczNDZiODJiZDQxYzc4NGZhMWViNWQ3YTdiNGYxL3RleHRyZWdpb246MjBiNzM0NmI4MmJkNDFjNzg0ZmExZWI1ZDdhN2I0ZjFfMjAyOQ_e959c5ca-0462-4555-bd8c-f97435256f4e"
      unitRef="usd">10515000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zNy9mcmFnOjIwYjczNDZiODJiZDQxYzc4NGZhMWViNWQ3YTdiNGYxL3RleHRyZWdpb246MjBiNzM0NmI4MmJkNDFjNzg0ZmExZWI1ZDdhN2I0ZjFfMjAzNg_9c6f5766-d12a-48d1-9390-a62488b9748b"
      unitRef="usd">11408000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180MC9mcmFnOjJmMGFiN2EwZjhkNjQyZGViODZhNzAyNzUzZWNkZTBmL3RleHRyZWdpb246MmYwYWI3YTBmOGQ2NDJkZWI4NmE3MDI3NTNlY2RlMGZfNzY2_3369b548-16a1-4230-849f-0a5781a5f8e2">NET INCOME PER COMMON SHARE&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic net income per common share is calculated by dividing net income by the weighted average number of common shares outstanding during the reporting period. The following table sets forth the computation of basic and diluted net income per common share:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.724%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.429%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74,023&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,067&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;211,171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61,357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income per common share - basic &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income per common share - diluted &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average common shares outstanding - basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,737&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,476&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,666&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Plus dilutive effect of potential common shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;356&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average common shares outstanding - diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,080&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,676&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,022&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:4pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Share-based awards to purchase 21 and 26 shares of common stock were not included in the above calculation of diluted net income per common share for the three and nine months ended September 30, 2021, respectively, because the effect of these instruments was anti-dilutive. Share-based awards to purchase 84 and 79 shares of common stock were not included in the above calculation of diluted net income per common share for the three and nine months ended September 30, 2020, respectively, because the effect of these instruments was anti-dilutive.&lt;/span&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:EarningsPerSharePolicyTextBlock
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180MC9mcmFnOjJmMGFiN2EwZjhkNjQyZGViODZhNzAyNzUzZWNkZTBmL3RleHRyZWdpb246MmYwYWI3YTBmOGQ2NDJkZWI4NmE3MDI3NTNlY2RlMGZfNzcw_9883a0eb-f847-4ca4-8c3b-959a7b7bd4af">Basic net income per common share is calculated by dividing net income by the weighted average number of common shares outstanding during the reporting period.</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180MC9mcmFnOjJmMGFiN2EwZjhkNjQyZGViODZhNzAyNzUzZWNkZTBmL3RleHRyZWdpb246MmYwYWI3YTBmOGQ2NDJkZWI4NmE3MDI3NTNlY2RlMGZfNzgw_98125249-6f3e-4c70-8af3-27a82852ea34">The following table sets forth the computation of basic and diluted net income per common share:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.724%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.429%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74,023&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,067&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;211,171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61,357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income per common share - basic &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income per common share - diluted &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average common shares outstanding - basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,737&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,476&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,666&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Plus dilutive effect of potential common shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;356&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average common shares outstanding - diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,080&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,676&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,022&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="i150492f298fa47a78ef2c10a285a64f8_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180MC9mcmFnOjJmMGFiN2EwZjhkNjQyZGViODZhNzAyNzUzZWNkZTBmL3RhYmxlOjBiNTU0ZDg1MWE1ODQwOThhZjkwZWI4ZTdmZTVjNWNiL3RhYmxlcmFuZ2U6MGI1NTRkODUxYTU4NDA5OGFmOTBlYjhlN2ZlNWM1Y2JfMi0xLTEtMS0xMDc3MA_e2d3a336-8dad-4f3e-8786-77b7cea81a01"
      unitRef="usd">74023000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i150492f298fa47a78ef2c10a285a64f8_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180MC9mcmFnOjJmMGFiN2EwZjhkNjQyZGViODZhNzAyNzUzZWNkZTBmL3RhYmxlOjBiNTU0ZDg1MWE1ODQwOThhZjkwZWI4ZTdmZTVjNWNiL3RhYmxlcmFuZ2U6MGI1NTRkODUxYTU4NDA5OGFmOTBlYjhlN2ZlNWM1Y2JfMi0xLTEtMS0xMDc3MA_efff5a03-8551-4e93-a0e5-a22a1e915046"
      unitRef="usd">74023000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="i6cb0c51ba8fa45fda70ec7e5df8b4ef1_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180MC9mcmFnOjJmMGFiN2EwZjhkNjQyZGViODZhNzAyNzUzZWNkZTBmL3RhYmxlOjBiNTU0ZDg1MWE1ODQwOThhZjkwZWI4ZTdmZTVjNWNiL3RhYmxlcmFuZ2U6MGI1NTRkODUxYTU4NDA5OGFmOTBlYjhlN2ZlNWM1Y2JfMi0zLTEtMS0xMDc3MA_55f14d18-0e78-4532-8438-964eb731efe6"
      unitRef="usd">26067000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i6cb0c51ba8fa45fda70ec7e5df8b4ef1_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180MC9mcmFnOjJmMGFiN2EwZjhkNjQyZGViODZhNzAyNzUzZWNkZTBmL3RhYmxlOjBiNTU0ZDg1MWE1ODQwOThhZjkwZWI4ZTdmZTVjNWNiL3RhYmxlcmFuZ2U6MGI1NTRkODUxYTU4NDA5OGFmOTBlYjhlN2ZlNWM1Y2JfMi0zLTEtMS0xMDc3MA_f0ff9ce4-8dd3-48a3-bf23-a7dd3a16d444"
      unitRef="usd">26067000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180MC9mcmFnOjJmMGFiN2EwZjhkNjQyZGViODZhNzAyNzUzZWNkZTBmL3RhYmxlOjBiNTU0ZDg1MWE1ODQwOThhZjkwZWI4ZTdmZTVjNWNiL3RhYmxlcmFuZ2U6MGI1NTRkODUxYTU4NDA5OGFmOTBlYjhlN2ZlNWM1Y2JfMi01LTEtMS0xMDc3MA_eb0c20d2-b18d-490a-bbce-9f275d8a448b"
      unitRef="usd">211171000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180MC9mcmFnOjJmMGFiN2EwZjhkNjQyZGViODZhNzAyNzUzZWNkZTBmL3RhYmxlOjBiNTU0ZDg1MWE1ODQwOThhZjkwZWI4ZTdmZTVjNWNiL3RhYmxlcmFuZ2U6MGI1NTRkODUxYTU4NDA5OGFmOTBlYjhlN2ZlNWM1Y2JfMi01LTEtMS0xMDc3MA_f14545f9-8870-499b-943c-0688cc9fb12b"
      unitRef="usd">211171000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180MC9mcmFnOjJmMGFiN2EwZjhkNjQyZGViODZhNzAyNzUzZWNkZTBmL3RhYmxlOjBiNTU0ZDg1MWE1ODQwOThhZjkwZWI4ZTdmZTVjNWNiL3RhYmxlcmFuZ2U6MGI1NTRkODUxYTU4NDA5OGFmOTBlYjhlN2ZlNWM1Y2JfMi03LTEtMS0xMDc3MA_172b8971-f392-48a3-afb9-66a3fda40494"
      unitRef="usd">61357000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180MC9mcmFnOjJmMGFiN2EwZjhkNjQyZGViODZhNzAyNzUzZWNkZTBmL3RhYmxlOjBiNTU0ZDg1MWE1ODQwOThhZjkwZWI4ZTdmZTVjNWNiL3RhYmxlcmFuZ2U6MGI1NTRkODUxYTU4NDA5OGFmOTBlYjhlN2ZlNWM1Y2JfMi03LTEtMS0xMDc3MA_97d2cddd-93ac-40ee-9644-9af6f298d471"
      unitRef="usd">61357000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="i150492f298fa47a78ef2c10a285a64f8_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180MC9mcmFnOjJmMGFiN2EwZjhkNjQyZGViODZhNzAyNzUzZWNkZTBmL3RhYmxlOjBiNTU0ZDg1MWE1ODQwOThhZjkwZWI4ZTdmZTVjNWNiL3RhYmxlcmFuZ2U6MGI1NTRkODUxYTU4NDA5OGFmOTBlYjhlN2ZlNWM1Y2JfNC0xLTEtMS0xMDc3MA_8314d84c-6e2c-4558-bffb-6c297070d87a"
      unitRef="usdPerShare">1.55</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i6cb0c51ba8fa45fda70ec7e5df8b4ef1_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180MC9mcmFnOjJmMGFiN2EwZjhkNjQyZGViODZhNzAyNzUzZWNkZTBmL3RhYmxlOjBiNTU0ZDg1MWE1ODQwOThhZjkwZWI4ZTdmZTVjNWNiL3RhYmxlcmFuZ2U6MGI1NTRkODUxYTU4NDA5OGFmOTBlYjhlN2ZlNWM1Y2JfNC0zLTEtMS0xMDc3MA_b64cf2a6-69cc-4df5-9345-474db05102e4"
      unitRef="usdPerShare">0.55</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180MC9mcmFnOjJmMGFiN2EwZjhkNjQyZGViODZhNzAyNzUzZWNkZTBmL3RhYmxlOjBiNTU0ZDg1MWE1ODQwOThhZjkwZWI4ZTdmZTVjNWNiL3RhYmxlcmFuZ2U6MGI1NTRkODUxYTU4NDA5OGFmOTBlYjhlN2ZlNWM1Y2JfNC01LTEtMS0xMDc3MA_bbc95430-281c-4460-be37-bd802729d7c4"
      unitRef="usdPerShare">4.43</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180MC9mcmFnOjJmMGFiN2EwZjhkNjQyZGViODZhNzAyNzUzZWNkZTBmL3RhYmxlOjBiNTU0ZDg1MWE1ODQwOThhZjkwZWI4ZTdmZTVjNWNiL3RhYmxlcmFuZ2U6MGI1NTRkODUxYTU4NDA5OGFmOTBlYjhlN2ZlNWM1Y2JfNC03LTEtMS0xMDc3MA_2507c2f5-a080-4b59-a213-4679efd005f0"
      unitRef="usdPerShare">1.29</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i150492f298fa47a78ef2c10a285a64f8_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180MC9mcmFnOjJmMGFiN2EwZjhkNjQyZGViODZhNzAyNzUzZWNkZTBmL3RhYmxlOjBiNTU0ZDg1MWE1ODQwOThhZjkwZWI4ZTdmZTVjNWNiL3RhYmxlcmFuZ2U6MGI1NTRkODUxYTU4NDA5OGFmOTBlYjhlN2ZlNWM1Y2JfNS0xLTEtMS0xMDc3MA_68108a81-89cf-472e-a675-f3ea82c9b24c"
      unitRef="usdPerShare">1.54</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i6cb0c51ba8fa45fda70ec7e5df8b4ef1_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180MC9mcmFnOjJmMGFiN2EwZjhkNjQyZGViODZhNzAyNzUzZWNkZTBmL3RhYmxlOjBiNTU0ZDg1MWE1ODQwOThhZjkwZWI4ZTdmZTVjNWNiL3RhYmxlcmFuZ2U6MGI1NTRkODUxYTU4NDA5OGFmOTBlYjhlN2ZlNWM1Y2JfNS0zLTEtMS0xMDc3MA_21bf28e6-d12f-4ae8-9a88-16867419609e"
      unitRef="usdPerShare">0.55</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180MC9mcmFnOjJmMGFiN2EwZjhkNjQyZGViODZhNzAyNzUzZWNkZTBmL3RhYmxlOjBiNTU0ZDg1MWE1ODQwOThhZjkwZWI4ZTdmZTVjNWNiL3RhYmxlcmFuZ2U6MGI1NTRkODUxYTU4NDA5OGFmOTBlYjhlN2ZlNWM1Y2JfNS01LTEtMS0xMDc3MA_caeeeba4-0685-4ded-aca7-0571d2670794"
      unitRef="usdPerShare">4.40</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180MC9mcmFnOjJmMGFiN2EwZjhkNjQyZGViODZhNzAyNzUzZWNkZTBmL3RhYmxlOjBiNTU0ZDg1MWE1ODQwOThhZjkwZWI4ZTdmZTVjNWNiL3RhYmxlcmFuZ2U6MGI1NTRkODUxYTU4NDA5OGFmOTBlYjhlN2ZlNWM1Y2JfNS03LTEtMS0xMDc3MA_5daa6dc6-a987-4860-9a90-55b3874308be"
      unitRef="usdPerShare">1.29</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i150492f298fa47a78ef2c10a285a64f8_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180MC9mcmFnOjJmMGFiN2EwZjhkNjQyZGViODZhNzAyNzUzZWNkZTBmL3RhYmxlOjBiNTU0ZDg1MWE1ODQwOThhZjkwZWI4ZTdmZTVjNWNiL3RhYmxlcmFuZ2U6MGI1NTRkODUxYTU4NDA5OGFmOTBlYjhlN2ZlNWM1Y2JfNy0xLTEtMS0xMDc3MA_94f3875a-ca98-4798-b091-550316b6d3a6"
      unitRef="shares">47737000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i6cb0c51ba8fa45fda70ec7e5df8b4ef1_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180MC9mcmFnOjJmMGFiN2EwZjhkNjQyZGViODZhNzAyNzUzZWNkZTBmL3RhYmxlOjBiNTU0ZDg1MWE1ODQwOThhZjkwZWI4ZTdmZTVjNWNiL3RhYmxlcmFuZ2U6MGI1NTRkODUxYTU4NDA5OGFmOTBlYjhlN2ZlNWM1Y2JfNy0zLTEtMS0xMDc3MA_76f2b2c3-8dc5-4cfc-acbb-14d20b33e78a"
      unitRef="shares">47476000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180MC9mcmFnOjJmMGFiN2EwZjhkNjQyZGViODZhNzAyNzUzZWNkZTBmL3RhYmxlOjBiNTU0ZDg1MWE1ODQwOThhZjkwZWI4ZTdmZTVjNWNiL3RhYmxlcmFuZ2U6MGI1NTRkODUxYTU4NDA5OGFmOTBlYjhlN2ZlNWM1Y2JfNy01LTEtMS0xMDc3MA_6f7eb06b-b539-47cd-b69d-40eec1446325"
      unitRef="shares">47666000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180MC9mcmFnOjJmMGFiN2EwZjhkNjQyZGViODZhNzAyNzUzZWNkZTBmL3RhYmxlOjBiNTU0ZDg1MWE1ODQwOThhZjkwZWI4ZTdmZTVjNWNiL3RhYmxlcmFuZ2U6MGI1NTRkODUxYTU4NDA5OGFmOTBlYjhlN2ZlNWM1Y2JfNy03LTEtMS0xMDc3MA_3dd0e067-e76a-4bd6-ae5b-dc552906c44c"
      unitRef="shares">47406000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="i150492f298fa47a78ef2c10a285a64f8_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180MC9mcmFnOjJmMGFiN2EwZjhkNjQyZGViODZhNzAyNzUzZWNkZTBmL3RhYmxlOjBiNTU0ZDg1MWE1ODQwOThhZjkwZWI4ZTdmZTVjNWNiL3RhYmxlcmFuZ2U6MGI1NTRkODUxYTU4NDA5OGFmOTBlYjhlN2ZlNWM1Y2JfOC0xLTEtMS0xMDc3MA_59cd98ee-2eb7-4d08-bee9-064e9eb3a00c"
      unitRef="shares">343000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="i6cb0c51ba8fa45fda70ec7e5df8b4ef1_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180MC9mcmFnOjJmMGFiN2EwZjhkNjQyZGViODZhNzAyNzUzZWNkZTBmL3RhYmxlOjBiNTU0ZDg1MWE1ODQwOThhZjkwZWI4ZTdmZTVjNWNiL3RhYmxlcmFuZ2U6MGI1NTRkODUxYTU4NDA5OGFmOTBlYjhlN2ZlNWM1Y2JfOC0zLTEtMS0xMDc3MA_819b8f50-cf6f-4507-badf-6a3565d48282"
      unitRef="shares">200000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180MC9mcmFnOjJmMGFiN2EwZjhkNjQyZGViODZhNzAyNzUzZWNkZTBmL3RhYmxlOjBiNTU0ZDg1MWE1ODQwOThhZjkwZWI4ZTdmZTVjNWNiL3RhYmxlcmFuZ2U6MGI1NTRkODUxYTU4NDA5OGFmOTBlYjhlN2ZlNWM1Y2JfOC01LTEtMS0xMDc3MA_b4a3d9fa-19eb-4267-8440-7832873e8d02"
      unitRef="shares">356000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180MC9mcmFnOjJmMGFiN2EwZjhkNjQyZGViODZhNzAyNzUzZWNkZTBmL3RhYmxlOjBiNTU0ZDg1MWE1ODQwOThhZjkwZWI4ZTdmZTVjNWNiL3RhYmxlcmFuZ2U6MGI1NTRkODUxYTU4NDA5OGFmOTBlYjhlN2ZlNWM1Y2JfOC03LTEtMS0xMDc3MA_2dd210be-806e-4bc9-9360-09b9f43ef7fb"
      unitRef="shares">241000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i150492f298fa47a78ef2c10a285a64f8_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180MC9mcmFnOjJmMGFiN2EwZjhkNjQyZGViODZhNzAyNzUzZWNkZTBmL3RhYmxlOjBiNTU0ZDg1MWE1ODQwOThhZjkwZWI4ZTdmZTVjNWNiL3RhYmxlcmFuZ2U6MGI1NTRkODUxYTU4NDA5OGFmOTBlYjhlN2ZlNWM1Y2JfOS0xLTEtMS0xMDc3MA_afbada0d-3f26-4dc1-9e2d-85c01ffe3ef2"
      unitRef="shares">48080000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i6cb0c51ba8fa45fda70ec7e5df8b4ef1_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180MC9mcmFnOjJmMGFiN2EwZjhkNjQyZGViODZhNzAyNzUzZWNkZTBmL3RhYmxlOjBiNTU0ZDg1MWE1ODQwOThhZjkwZWI4ZTdmZTVjNWNiL3RhYmxlcmFuZ2U6MGI1NTRkODUxYTU4NDA5OGFmOTBlYjhlN2ZlNWM1Y2JfOS0zLTEtMS0xMDc3MA_f72ee4fa-516e-46ee-b9e5-1fad92bc2645"
      unitRef="shares">47676000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180MC9mcmFnOjJmMGFiN2EwZjhkNjQyZGViODZhNzAyNzUzZWNkZTBmL3RhYmxlOjBiNTU0ZDg1MWE1ODQwOThhZjkwZWI4ZTdmZTVjNWNiL3RhYmxlcmFuZ2U6MGI1NTRkODUxYTU4NDA5OGFmOTBlYjhlN2ZlNWM1Y2JfOS01LTEtMS0xMDc3MA_af6b7a84-e486-42b4-97b7-ee1400537b6c"
      unitRef="shares">48022000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180MC9mcmFnOjJmMGFiN2EwZjhkNjQyZGViODZhNzAyNzUzZWNkZTBmL3RhYmxlOjBiNTU0ZDg1MWE1ODQwOThhZjkwZWI4ZTdmZTVjNWNiL3RhYmxlcmFuZ2U6MGI1NTRkODUxYTU4NDA5OGFmOTBlYjhlN2ZlNWM1Y2JfOS03LTEtMS0xMDc3MA_e3f9bb21-fb60-4b9f-95bb-6e038f36c2cd"
      unitRef="shares">47647000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i150492f298fa47a78ef2c10a285a64f8_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180MC9mcmFnOjJmMGFiN2EwZjhkNjQyZGViODZhNzAyNzUzZWNkZTBmL3RleHRyZWdpb246MmYwYWI3YTBmOGQ2NDJkZWI4NmE3MDI3NTNlY2RlMGZfMzI2_e691661b-39d1-47a8-8dbe-cb981178071b"
      unitRef="shares">21000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180MC9mcmFnOjJmMGFiN2EwZjhkNjQyZGViODZhNzAyNzUzZWNkZTBmL3RleHRyZWdpb246MmYwYWI3YTBmOGQ2NDJkZWI4NmE3MDI3NTNlY2RlMGZfMzMz_6f9fa4ce-728e-453e-b70d-368801f932d8"
      unitRef="shares">26000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i6cb0c51ba8fa45fda70ec7e5df8b4ef1_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180MC9mcmFnOjJmMGFiN2EwZjhkNjQyZGViODZhNzAyNzUzZWNkZTBmL3RleHRyZWdpb246MmYwYWI3YTBmOGQ2NDJkZWI4NmE3MDI3NTNlY2RlMGZfNTU3_abf8cf21-c506-412a-a5b4-652a7ca1bb88"
      unitRef="shares">84000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180MC9mcmFnOjJmMGFiN2EwZjhkNjQyZGViODZhNzAyNzUzZWNkZTBmL3RleHRyZWdpb246MmYwYWI3YTBmOGQ2NDJkZWI4NmE3MDI3NTNlY2RlMGZfNTY0_44805654-aa83-4c18-8060-56ae792f411a"
      unitRef="shares">79000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RleHRyZWdpb246YWI0MTJlMTlmYzY0NDFmMGFiZGVhYTE2ODgxYmJmYjRfMjMzNg_a108f409-082c-4d1b-8c58-b34e099803ca">SEGMENT INFORMATION&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s operating segments are identified in the same manner as they are reported internally and used by the Company&#x2019;s chief operating decision maker for the purpose of evaluating performance and allocating resources. The Company has three reportable segments: (1) nurse and allied solutions, (2) physician and leadership solutions, and (3) technology and workforce solutions. The nurse and allied solutions segment includes the Company&#x2019;s travel nurse staffing, rapid response nurse staffing and labor disruption, allied staffing, local staffing, and revenue cycle solutions businesses. The physician and leadership solutions segment includes the Company&#x2019;s locum tenens staffing, healthcare interim leadership staffing, executive search, and physician permanent placement businesses. The technology and workforce solutions segment includes the Company&#x2019;s language services, vendor management systems, workforce optimization, recruitment process outsourcing, telehealth, credentialing, and flex pool management and other outsourced solutions businesses.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s chief operating decision maker relies on internal management reporting processes that provide revenue and operating income by reportable segment for making financial decisions and allocating resources. Segment operating income represents income before income taxes plus depreciation, amortization of intangible assets, share-based compensation, interest expense, net, and other, and unallocated corporate overhead. The Company&#x2019;s management does not evaluate, manage or measure performance of segments using asset information; accordingly, asset information by segment is not prepared or disclosed.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides a reconciliation of revenue and operating income by reportable segment to consolidated results and was derived from each segment&#x2019;s internal financial information as used for corporate management purposes:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.227%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.227%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.227%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.184%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nurse and allied solutions&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;627,049&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;382,699&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,908,195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,251,509&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Physician and leadership solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150,663&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109,116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;430,523&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;355,580&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Technology and workforce solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100,088&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59,816&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;282,472&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155,354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;877,800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;551,631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,621,190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,762,443&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Segment operating income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nurse and allied solutions&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92,564&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,923&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;283,768&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;173,706&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Physician and leadership solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,538&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62,366&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,432&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Technology and workforce solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131,952&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62,814&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;159,075&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94,141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;478,086&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;281,952&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unallocated corporate overhead&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,867&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,490&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74,915&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76,223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,936&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74,098&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69,096&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation (included in cost of revenue)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;686&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;481&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,773&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;981&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,772&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,895&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense, net, and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,564&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,278&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,061&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100,606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,898&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;285,127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85,545&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables present the Company&#x2019;s revenue disaggregated by service type:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.350%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.524%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nurse&#160;and&#160;Allied Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Physician and Leadership Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Technology and Workforce Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Temporary staffing&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;627,049&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132,848&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;759,897&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Permanent placement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,815&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,815&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outsourced workforce&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58,802&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58,802&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;SaaS-based technologies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;627,049&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150,663&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100,088&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;877,800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.350%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.524%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nurse&#160;and&#160;Allied Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Physician and Leadership Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Technology and Workforce Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Temporary staffing&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;382,699&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95,648&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;478,347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Permanent placement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,468&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,468&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outsourced workforce&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;SaaS-based technologies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,657&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,657&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;382,699&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109,116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59,816&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;551,631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.350%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.524%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nurse&#160;and&#160;Allied Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Physician and Leadership Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Technology and Workforce Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Temporary staffing&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,908,195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;379,814&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,288,009&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Permanent placement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,709&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,709&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outsourced workforce&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;164,595&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;164,595&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;SaaS-based technologies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117,877&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117,877&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,908,195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;430,523&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;282,472&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,621,190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.350%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.524%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nurse&#160;and&#160;Allied Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Physician and Leadership Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Technology and Workforce Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Temporary staffing&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,251,509&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;310,945&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,562,454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Permanent placement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,635&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,635&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outsourced workforce&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87,705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87,705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;SaaS-based technologies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67,649&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67,649&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,251,509&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;355,580&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155,354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,762,443&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the activity related to the carrying value of goodwill by reportable segment:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.111%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nurse&#160;and&#160;Allied Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Physician and Leadership Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Technology and Workforce Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, January 1, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;339,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;152,800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;372,670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;864,485&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill adjustment for Stratus Video acquisition&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;663&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;663&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill from Synzi and SnapMD acquisition&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;339,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;152,800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;401,468&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;893,283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated impairment loss as of December 31, 2020 and September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;154,444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;214,939&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfOperatingSegments
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RleHRyZWdpb246YWI0MTJlMTlmYzY0NDFmMGFiZGVhYTE2ODgxYmJmYjRfMjY5_20e8f03e-3f48-4cdd-8483-0e9b08bac58d"
      unitRef="segment">3</us-gaap:NumberOfOperatingSegments>
    <us-gaap:SegmentReportingPolicyPolicyTextBlock
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RleHRyZWdpb246YWI0MTJlMTlmYzY0NDFmMGFiZGVhYTE2ODgxYmJmYjRfMjMwOQ_4db11190-038e-4e9e-ac67-07c58f510ff9">The Company&#x2019;s chief operating decision maker relies on internal management reporting processes that provide revenue and operating income by reportable segment for making financial decisions and allocating resources. Segment operating income represents income before income taxes plus depreciation, amortization of intangible assets, share-based compensation, interest expense, net, and other, and unallocated corporate overhead. The Company&#x2019;s management does not evaluate, manage or measure performance of segments using asset information; accordingly, asset information by segment is not prepared or disclosed.</us-gaap:SegmentReportingPolicyPolicyTextBlock>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RleHRyZWdpb246YWI0MTJlMTlmYzY0NDFmMGFiZGVhYTE2ODgxYmJmYjRfMjMxMQ_4bf79877-2d10-48e0-82a1-2412bfbf6193">&lt;div style="margin-bottom:3pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides a reconciliation of revenue and operating income by reportable segment to consolidated results and was derived from each segment&#x2019;s internal financial information as used for corporate management purposes:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.227%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.227%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.227%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.184%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nurse and allied solutions&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;627,049&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;382,699&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,908,195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,251,509&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Physician and leadership solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150,663&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109,116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;430,523&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;355,580&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Technology and workforce solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100,088&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59,816&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;282,472&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155,354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;877,800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;551,631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,621,190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,762,443&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Segment operating income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nurse and allied solutions&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92,564&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,923&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;283,768&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;173,706&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Physician and leadership solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,538&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62,366&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,432&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Technology and workforce solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131,952&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62,814&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;159,075&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94,141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;478,086&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;281,952&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unallocated corporate overhead&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,867&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,490&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74,915&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76,223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,936&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74,098&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69,096&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation (included in cost of revenue)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;686&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;481&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,773&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;981&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,772&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,895&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense, net, and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,564&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,278&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,061&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100,606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,898&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;285,127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85,545&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i72bc6814293d41ce8300f2c38fcdd1bc_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmE5ZTY5YjA5Zjk1NzQ2Y2Y4MzU0OTEyYjQwYTE0MTI4L3RhYmxlcmFuZ2U6YTllNjliMDlmOTU3NDZjZjgzNTQ5MTJiNDBhMTQxMjhfMy0xLTEtMS0xMDc3MA_e2ca27ce-569e-48da-90e4-1bc6174425c9"
      unitRef="usd">627049000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3473b76faf004446b11d60f76e27591c_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmE5ZTY5YjA5Zjk1NzQ2Y2Y4MzU0OTEyYjQwYTE0MTI4L3RhYmxlcmFuZ2U6YTllNjliMDlmOTU3NDZjZjgzNTQ5MTJiNDBhMTQxMjhfMy0zLTEtMS0xMDc3MA_68efd4b1-7952-4a4a-9f15-f5106987c800"
      unitRef="usd">382699000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5021bcb8a5144f2e92e4d17294f25756_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmE5ZTY5YjA5Zjk1NzQ2Y2Y4MzU0OTEyYjQwYTE0MTI4L3RhYmxlcmFuZ2U6YTllNjliMDlmOTU3NDZjZjgzNTQ5MTJiNDBhMTQxMjhfMy01LTEtMS0xMDc3MA_be8b08a7-c17b-43ff-b8cb-5fb98c97d36e"
      unitRef="usd">1908195000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib58839822ae8478c8d8ef1cb827d2ebe_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmE5ZTY5YjA5Zjk1NzQ2Y2Y4MzU0OTEyYjQwYTE0MTI4L3RhYmxlcmFuZ2U6YTllNjliMDlmOTU3NDZjZjgzNTQ5MTJiNDBhMTQxMjhfMy03LTEtMS0xMDc3MA_6523e766-a942-4b38-928f-eb810112172e"
      unitRef="usd">1251509000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5bb9c1ce74924d3fb6c80bf5bc7070ca_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmE5ZTY5YjA5Zjk1NzQ2Y2Y4MzU0OTEyYjQwYTE0MTI4L3RhYmxlcmFuZ2U6YTllNjliMDlmOTU3NDZjZjgzNTQ5MTJiNDBhMTQxMjhfNC0xLTEtMS0xMDc3MA_53ea9bc5-16ce-4f45-9246-59d860058452"
      unitRef="usd">150663000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3bdfcb612866449f8fc82428772bc4e0_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmE5ZTY5YjA5Zjk1NzQ2Y2Y4MzU0OTEyYjQwYTE0MTI4L3RhYmxlcmFuZ2U6YTllNjliMDlmOTU3NDZjZjgzNTQ5MTJiNDBhMTQxMjhfNC0zLTEtMS0xMDc3MA_7ee5bd73-7628-4b7f-8a44-b6ded88b84c5"
      unitRef="usd">109116000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifd4b5ea0c6464abaafa771245dd4872b_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmE5ZTY5YjA5Zjk1NzQ2Y2Y4MzU0OTEyYjQwYTE0MTI4L3RhYmxlcmFuZ2U6YTllNjliMDlmOTU3NDZjZjgzNTQ5MTJiNDBhMTQxMjhfNC01LTEtMS0xMDc3MA_4544fdab-e6de-44ee-9f5b-a4ee21f6e8ed"
      unitRef="usd">430523000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8096536e07244cbc88570b4cd0b1df3b_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmE5ZTY5YjA5Zjk1NzQ2Y2Y4MzU0OTEyYjQwYTE0MTI4L3RhYmxlcmFuZ2U6YTllNjliMDlmOTU3NDZjZjgzNTQ5MTJiNDBhMTQxMjhfNC03LTEtMS0xMDc3MA_51b0d525-158e-4fa0-9d02-36840a381655"
      unitRef="usd">355580000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i286479f51b3847f180927296005817b3_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmE5ZTY5YjA5Zjk1NzQ2Y2Y4MzU0OTEyYjQwYTE0MTI4L3RhYmxlcmFuZ2U6YTllNjliMDlmOTU3NDZjZjgzNTQ5MTJiNDBhMTQxMjhfNS0xLTEtMS0xMDc3MA_8af21e7d-91f2-4fa9-8352-d815ea6aa769"
      unitRef="usd">100088000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iebe1c6905368491eb38b8213c9304590_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmE5ZTY5YjA5Zjk1NzQ2Y2Y4MzU0OTEyYjQwYTE0MTI4L3RhYmxlcmFuZ2U6YTllNjliMDlmOTU3NDZjZjgzNTQ5MTJiNDBhMTQxMjhfNS0zLTEtMS0xMDc3MA_90ccb7d7-1914-42ae-8f8b-5f750584305a"
      unitRef="usd">59816000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9f81f9d1a6314e098bdd58b74619a28f_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmE5ZTY5YjA5Zjk1NzQ2Y2Y4MzU0OTEyYjQwYTE0MTI4L3RhYmxlcmFuZ2U6YTllNjliMDlmOTU3NDZjZjgzNTQ5MTJiNDBhMTQxMjhfNS01LTEtMS0xMDc3MA_6cd9680f-736a-4320-a007-1d74eee9ab19"
      unitRef="usd">282472000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib31de07b75904e5cb9fd99c168d04547_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmE5ZTY5YjA5Zjk1NzQ2Y2Y4MzU0OTEyYjQwYTE0MTI4L3RhYmxlcmFuZ2U6YTllNjliMDlmOTU3NDZjZjgzNTQ5MTJiNDBhMTQxMjhfNS03LTEtMS0xMDc3MA_83d63a8e-6f61-4e18-8ac2-f69df5ac5228"
      unitRef="usd">155354000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1a24f793f440442085a27968a5583766_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmE5ZTY5YjA5Zjk1NzQ2Y2Y4MzU0OTEyYjQwYTE0MTI4L3RhYmxlcmFuZ2U6YTllNjliMDlmOTU3NDZjZjgzNTQ5MTJiNDBhMTQxMjhfNi0xLTEtMS0xMDc3MA_20b79833-16af-47ae-8958-261eb3d10e5b"
      unitRef="usd">877800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icdd1cb3977024d5d959ea51ad54b783d_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmE5ZTY5YjA5Zjk1NzQ2Y2Y4MzU0OTEyYjQwYTE0MTI4L3RhYmxlcmFuZ2U6YTllNjliMDlmOTU3NDZjZjgzNTQ5MTJiNDBhMTQxMjhfNi0zLTEtMS0xMDc3MA_a38f2b84-2031-4841-8659-3222ec023c1f"
      unitRef="usd">551631000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5479404ee04b498ab6fd8545f90d86b9_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmE5ZTY5YjA5Zjk1NzQ2Y2Y4MzU0OTEyYjQwYTE0MTI4L3RhYmxlcmFuZ2U6YTllNjliMDlmOTU3NDZjZjgzNTQ5MTJiNDBhMTQxMjhfNi01LTEtMS0xMDc3MA_16ce8a88-4f02-416a-8c69-0f88fb3bd0b2"
      unitRef="usd">2621190000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i703fc84123784c69b090877fb4125906_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmE5ZTY5YjA5Zjk1NzQ2Y2Y4MzU0OTEyYjQwYTE0MTI4L3RhYmxlcmFuZ2U6YTllNjliMDlmOTU3NDZjZjgzNTQ5MTJiNDBhMTQxMjhfNi03LTEtMS0xMDc3MA_cfd59e8b-8019-43db-b45c-cdc5c97f2b6b"
      unitRef="usd">1762443000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:OperatingIncomeLoss
      contextRef="i72bc6814293d41ce8300f2c38fcdd1bc_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmE5ZTY5YjA5Zjk1NzQ2Y2Y4MzU0OTEyYjQwYTE0MTI4L3RhYmxlcmFuZ2U6YTllNjliMDlmOTU3NDZjZjgzNTQ5MTJiNDBhMTQxMjhfOC0xLTEtMS0xMDc3MA_a49d5c0b-bf37-4db8-b7a9-4842a6a74a27"
      unitRef="usd">92564000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i3473b76faf004446b11d60f76e27591c_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmE5ZTY5YjA5Zjk1NzQ2Y2Y4MzU0OTEyYjQwYTE0MTI4L3RhYmxlcmFuZ2U6YTllNjliMDlmOTU3NDZjZjgzNTQ5MTJiNDBhMTQxMjhfOC0zLTEtMS0xMDc3MA_99b10b57-8fb1-4812-affe-254be2ad9952"
      unitRef="usd">52923000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i5021bcb8a5144f2e92e4d17294f25756_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmE5ZTY5YjA5Zjk1NzQ2Y2Y4MzU0OTEyYjQwYTE0MTI4L3RhYmxlcmFuZ2U6YTllNjliMDlmOTU3NDZjZjgzNTQ5MTJiNDBhMTQxMjhfOC01LTEtMS0xMDc3MA_7eb51800-4a08-486e-b3c4-d99c97a583fc"
      unitRef="usd">283768000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ib58839822ae8478c8d8ef1cb827d2ebe_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmE5ZTY5YjA5Zjk1NzQ2Y2Y4MzU0OTEyYjQwYTE0MTI4L3RhYmxlcmFuZ2U6YTllNjliMDlmOTU3NDZjZjgzNTQ5MTJiNDBhMTQxMjhfOC03LTEtMS0xMDc3MA_34684db9-270e-40fb-a4ed-8da1b4413a30"
      unitRef="usd">173706000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i5bb9c1ce74924d3fb6c80bf5bc7070ca_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmE5ZTY5YjA5Zjk1NzQ2Y2Y4MzU0OTEyYjQwYTE0MTI4L3RhYmxlcmFuZ2U6YTllNjliMDlmOTU3NDZjZjgzNTQ5MTJiNDBhMTQxMjhfOS0xLTEtMS0xMDc3MA_529c0182-037a-447c-b6ab-07eb722930ee"
      unitRef="usd">19301000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i3bdfcb612866449f8fc82428772bc4e0_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmE5ZTY5YjA5Zjk1NzQ2Y2Y4MzU0OTEyYjQwYTE0MTI4L3RhYmxlcmFuZ2U6YTllNjliMDlmOTU3NDZjZjgzNTQ5MTJiNDBhMTQxMjhfOS0zLTEtMS0xMDc3MA_0b97eed8-62a2-4a0b-922d-204c791b7c7d"
      unitRef="usd">15538000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ifd4b5ea0c6464abaafa771245dd4872b_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmE5ZTY5YjA5Zjk1NzQ2Y2Y4MzU0OTEyYjQwYTE0MTI4L3RhYmxlcmFuZ2U6YTllNjliMDlmOTU3NDZjZjgzNTQ5MTJiNDBhMTQxMjhfOS01LTEtMS0xMDc3MA_dc09d62a-5817-4552-be67-4c98294e3b43"
      unitRef="usd">62366000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i8096536e07244cbc88570b4cd0b1df3b_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmE5ZTY5YjA5Zjk1NzQ2Y2Y4MzU0OTEyYjQwYTE0MTI4L3RhYmxlcmFuZ2U6YTllNjliMDlmOTU3NDZjZjgzNTQ5MTJiNDBhMTQxMjhfOS03LTEtMS0xMDc3MA_de328345-8240-4b40-b7b2-d76e727a02ae"
      unitRef="usd">45432000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i286479f51b3847f180927296005817b3_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmE5ZTY5YjA5Zjk1NzQ2Y2Y4MzU0OTEyYjQwYTE0MTI4L3RhYmxlcmFuZ2U6YTllNjliMDlmOTU3NDZjZjgzNTQ5MTJiNDBhMTQxMjhfMTAtMS0xLTEtMTA3NzA_390ad566-f261-412a-b5a3-172946a99483"
      unitRef="usd">47210000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="iebe1c6905368491eb38b8213c9304590_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmE5ZTY5YjA5Zjk1NzQ2Y2Y4MzU0OTEyYjQwYTE0MTI4L3RhYmxlcmFuZ2U6YTllNjliMDlmOTU3NDZjZjgzNTQ5MTJiNDBhMTQxMjhfMTAtMy0xLTEtMTA3NzA_50b7030f-0a4b-4618-b3fd-e17d5ef11b10"
      unitRef="usd">25680000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i9f81f9d1a6314e098bdd58b74619a28f_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmE5ZTY5YjA5Zjk1NzQ2Y2Y4MzU0OTEyYjQwYTE0MTI4L3RhYmxlcmFuZ2U6YTllNjliMDlmOTU3NDZjZjgzNTQ5MTJiNDBhMTQxMjhfMTAtNS0xLTEtMTA3NzA_0e5bfdbc-19b5-42fa-94df-46a600167b24"
      unitRef="usd">131952000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ib31de07b75904e5cb9fd99c168d04547_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmE5ZTY5YjA5Zjk1NzQ2Y2Y4MzU0OTEyYjQwYTE0MTI4L3RhYmxlcmFuZ2U6YTllNjliMDlmOTU3NDZjZjgzNTQ5MTJiNDBhMTQxMjhfMTAtNy0xLTEtMTA3NzA_ec16ee88-de02-41c2-8581-81be42b2e38b"
      unitRef="usd">62814000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i1a24f793f440442085a27968a5583766_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmE5ZTY5YjA5Zjk1NzQ2Y2Y4MzU0OTEyYjQwYTE0MTI4L3RhYmxlcmFuZ2U6YTllNjliMDlmOTU3NDZjZjgzNTQ5MTJiNDBhMTQxMjhfMTEtMS0xLTEtMTA3NzA_db1fa800-fb7b-482b-9bf0-2c27ee16292f"
      unitRef="usd">159075000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="icdd1cb3977024d5d959ea51ad54b783d_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmE5ZTY5YjA5Zjk1NzQ2Y2Y4MzU0OTEyYjQwYTE0MTI4L3RhYmxlcmFuZ2U6YTllNjliMDlmOTU3NDZjZjgzNTQ5MTJiNDBhMTQxMjhfMTEtMy0xLTEtMTA3NzA_2a2b6f38-6237-4c50-9f5e-a72c6872d805"
      unitRef="usd">94141000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i5479404ee04b498ab6fd8545f90d86b9_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmE5ZTY5YjA5Zjk1NzQ2Y2Y4MzU0OTEyYjQwYTE0MTI4L3RhYmxlcmFuZ2U6YTllNjliMDlmOTU3NDZjZjgzNTQ5MTJiNDBhMTQxMjhfMTEtNS0xLTEtMTA3NzA_dea4621c-e5e1-441e-a3c1-9bedfc3873df"
      unitRef="usd">478086000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i703fc84123784c69b090877fb4125906_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmE5ZTY5YjA5Zjk1NzQ2Y2Y4MzU0OTEyYjQwYTE0MTI4L3RhYmxlcmFuZ2U6YTllNjliMDlmOTU3NDZjZjgzNTQ5MTJiNDBhMTQxMjhfMTEtNy0xLTEtMTA3NzA_da5c8785-3de3-411a-94fc-376a163781c9"
      unitRef="usd">281952000</us-gaap:OperatingIncomeLoss>
    <amn:UnallocatedCorporateOverhead
      contextRef="ie946fae8ec0046439446bb138d525757_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmE5ZTY5YjA5Zjk1NzQ2Y2Y4MzU0OTEyYjQwYTE0MTI4L3RhYmxlcmFuZ2U6YTllNjliMDlmOTU3NDZjZjgzNTQ5MTJiNDBhMTQxMjhfMTItMS0xLTEtMTA3NzA_d3c6d9f0-e970-4984-a7d0-6e3f4c4c9ff2"
      unitRef="usd">23867000</amn:UnallocatedCorporateOverhead>
    <amn:UnallocatedCorporateOverhead
      contextRef="i674c8f2758bf45ae8bb93948b5860e97_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmE5ZTY5YjA5Zjk1NzQ2Y2Y4MzU0OTEyYjQwYTE0MTI4L3RhYmxlcmFuZ2U6YTllNjliMDlmOTU3NDZjZjgzNTQ5MTJiNDBhMTQxMjhfMTItMy0xLTEtMTA3NzA_55d9b18d-5ef4-4381-b9b0-8e5dbb89500c"
      unitRef="usd">16490000</amn:UnallocatedCorporateOverhead>
    <amn:UnallocatedCorporateOverhead
      contextRef="ib14ea5527ced44f5979f01683cbc7fc4_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmE5ZTY5YjA5Zjk1NzQ2Y2Y4MzU0OTEyYjQwYTE0MTI4L3RhYmxlcmFuZ2U6YTllNjliMDlmOTU3NDZjZjgzNTQ5MTJiNDBhMTQxMjhfMTItNS0xLTEtMTA3NzA_271ad980-f267-4c07-a628-742c04d849fc"
      unitRef="usd">74915000</amn:UnallocatedCorporateOverhead>
    <amn:UnallocatedCorporateOverhead
      contextRef="ieeebf848246c441ba6ab2c571e599296_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmE5ZTY5YjA5Zjk1NzQ2Y2Y4MzU0OTEyYjQwYTE0MTI4L3RhYmxlcmFuZ2U6YTllNjliMDlmOTU3NDZjZjgzNTQ5MTJiNDBhMTQxMjhfMTItNy0xLTEtMTA3NzA_8ed85987-514a-492a-a6d0-2a9dabbca339"
      unitRef="usd">76223000</amn:UnallocatedCorporateOverhead>
    <us-gaap:DepreciationAndAmortization
      contextRef="i150492f298fa47a78ef2c10a285a64f8_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmE5ZTY5YjA5Zjk1NzQ2Y2Y4MzU0OTEyYjQwYTE0MTI4L3RhYmxlcmFuZ2U6YTllNjliMDlmOTU3NDZjZjgzNTQ5MTJiNDBhMTQxMjhfMTMtMS0xLTEtMTA3NzA_919daf11-4d88-468e-b799-95a1395be40f"
      unitRef="usd">26104000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i6cb0c51ba8fa45fda70ec7e5df8b4ef1_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmE5ZTY5YjA5Zjk1NzQ2Y2Y4MzU0OTEyYjQwYTE0MTI4L3RhYmxlcmFuZ2U6YTllNjliMDlmOTU3NDZjZjgzNTQ5MTJiNDBhMTQxMjhfMTMtMy0xLTEtMTA3NzA_3c152c63-82de-43a3-bca1-86ecb8c35751"
      unitRef="usd">26936000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmE5ZTY5YjA5Zjk1NzQ2Y2Y4MzU0OTEyYjQwYTE0MTI4L3RhYmxlcmFuZ2U6YTllNjliMDlmOTU3NDZjZjgzNTQ5MTJiNDBhMTQxMjhfMTMtNS0xLTEtMTA3NzA_ab1906db-d846-45c7-80b8-991a007f3a11"
      unitRef="usd">74098000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmE5ZTY5YjA5Zjk1NzQ2Y2Y4MzU0OTEyYjQwYTE0MTI4L3RhYmxlcmFuZ2U6YTllNjliMDlmOTU3NDZjZjgzNTQ5MTJiNDBhMTQxMjhfMTMtNy0xLTEtMTA3NzA_b8f65d2f-9d19-4d5c-8eb9-440140bbe6e8"
      unitRef="usd">69096000</us-gaap:DepreciationAndAmortization>
    <us-gaap:CostOfGoodsAndServicesSoldDepreciation
      contextRef="i150492f298fa47a78ef2c10a285a64f8_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmE5ZTY5YjA5Zjk1NzQ2Y2Y4MzU0OTEyYjQwYTE0MTI4L3RhYmxlcmFuZ2U6YTllNjliMDlmOTU3NDZjZjgzNTQ5MTJiNDBhMTQxMjhfMTQtMS0xLTEtMTA3NzA_96a803a0-d445-4edf-bb64-bcedeab55753"
      unitRef="usd">686000</us-gaap:CostOfGoodsAndServicesSoldDepreciation>
    <us-gaap:CostOfGoodsAndServicesSoldDepreciation
      contextRef="i6cb0c51ba8fa45fda70ec7e5df8b4ef1_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmE5ZTY5YjA5Zjk1NzQ2Y2Y4MzU0OTEyYjQwYTE0MTI4L3RhYmxlcmFuZ2U6YTllNjliMDlmOTU3NDZjZjgzNTQ5MTJiNDBhMTQxMjhfMTQtMy0xLTEtMTA3NzA_ed87fcce-903e-421b-a600-05fefb48672f"
      unitRef="usd">481000</us-gaap:CostOfGoodsAndServicesSoldDepreciation>
    <us-gaap:CostOfGoodsAndServicesSoldDepreciation
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmE5ZTY5YjA5Zjk1NzQ2Y2Y4MzU0OTEyYjQwYTE0MTI4L3RhYmxlcmFuZ2U6YTllNjliMDlmOTU3NDZjZjgzNTQ5MTJiNDBhMTQxMjhfMTQtNS0xLTEtMTA3NzA_0ded31be-af68-4360-9975-fe614eecc3c1"
      unitRef="usd">1773000</us-gaap:CostOfGoodsAndServicesSoldDepreciation>
    <us-gaap:CostOfGoodsAndServicesSoldDepreciation
      contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmE5ZTY5YjA5Zjk1NzQ2Y2Y4MzU0OTEyYjQwYTE0MTI4L3RhYmxlcmFuZ2U6YTllNjliMDlmOTU3NDZjZjgzNTQ5MTJiNDBhMTQxMjhfMTQtNy0xLTEtMTA3NzA_ed73e99c-6c78-412c-9d16-45eceb364ba0"
      unitRef="usd">981000</us-gaap:CostOfGoodsAndServicesSoldDepreciation>
    <us-gaap:ShareBasedCompensation
      contextRef="i150492f298fa47a78ef2c10a285a64f8_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmE5ZTY5YjA5Zjk1NzQ2Y2Y4MzU0OTEyYjQwYTE0MTI4L3RhYmxlcmFuZ2U6YTllNjliMDlmOTU3NDZjZjgzNTQ5MTJiNDBhMTQxMjhfMTUtMS0xLTEtMTA3NzA_8f2e6191-c972-4d3e-bbdf-b4f05aeb2d02"
      unitRef="usd">2589000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i6cb0c51ba8fa45fda70ec7e5df8b4ef1_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmE5ZTY5YjA5Zjk1NzQ2Y2Y4MzU0OTEyYjQwYTE0MTI4L3RhYmxlcmFuZ2U6YTllNjliMDlmOTU3NDZjZjgzNTQ5MTJiNDBhMTQxMjhfMTUtMy0xLTEtMTA3NzA_97d27a6e-85e4-427e-b410-9276092db770"
      unitRef="usd">3772000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmE5ZTY5YjA5Zjk1NzQ2Y2Y4MzU0OTEyYjQwYTE0MTI4L3RhYmxlcmFuZ2U6YTllNjliMDlmOTU3NDZjZjgzNTQ5MTJiNDBhMTQxMjhfMTUtNS0xLTEtMTA3NzA_5d058e0a-981d-4fa3-9d37-208096ebcb12"
      unitRef="usd">17895000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmE5ZTY5YjA5Zjk1NzQ2Y2Y4MzU0OTEyYjQwYTE0MTI4L3RhYmxlcmFuZ2U6YTllNjliMDlmOTU3NDZjZjgzNTQ5MTJiNDBhMTQxMjhfMTUtNy0xLTEtMTA3NzA_d56baada-3cd6-48a4-afcb-0d0832d64e89"
      unitRef="usd">15046000</us-gaap:ShareBasedCompensation>
    <us-gaap:InterestExpense
      contextRef="i150492f298fa47a78ef2c10a285a64f8_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmE5ZTY5YjA5Zjk1NzQ2Y2Y4MzU0OTEyYjQwYTE0MTI4L3RhYmxlcmFuZ2U6YTllNjliMDlmOTU3NDZjZjgzNTQ5MTJiNDBhMTQxMjhfMTYtMS0xLTEtMTA3NzA_6c57492d-3192-4133-8353-5501b1fa0b2d"
      unitRef="usd">5223000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i6cb0c51ba8fa45fda70ec7e5df8b4ef1_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmE5ZTY5YjA5Zjk1NzQ2Y2Y4MzU0OTEyYjQwYTE0MTI4L3RhYmxlcmFuZ2U6YTllNjliMDlmOTU3NDZjZjgzNTQ5MTJiNDBhMTQxMjhfMTYtMy0xLTEtMTA3NzA_082f35a4-3fc6-4718-9606-4dfda040c201"
      unitRef="usd">12564000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmE5ZTY5YjA5Zjk1NzQ2Y2Y4MzU0OTEyYjQwYTE0MTI4L3RhYmxlcmFuZ2U6YTllNjliMDlmOTU3NDZjZjgzNTQ5MTJiNDBhMTQxMjhfMTYtNS0xLTEtMTA3NzA_21aaab3c-dfb5-4a83-9f36-f04e9272fd2f"
      unitRef="usd">24278000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmE5ZTY5YjA5Zjk1NzQ2Y2Y4MzU0OTEyYjQwYTE0MTI4L3RhYmxlcmFuZ2U6YTllNjliMDlmOTU3NDZjZjgzNTQ5MTJiNDBhMTQxMjhfMTYtNy0xLTEtMTA3NzA_60c90ec7-84ff-43df-a51c-340f3a7b418c"
      unitRef="usd">35061000</us-gaap:InterestExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i150492f298fa47a78ef2c10a285a64f8_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmE5ZTY5YjA5Zjk1NzQ2Y2Y4MzU0OTEyYjQwYTE0MTI4L3RhYmxlcmFuZ2U6YTllNjliMDlmOTU3NDZjZjgzNTQ5MTJiNDBhMTQxMjhfMTctMS0xLTEtMTA3NzA_6fd9a117-688b-4da8-b6a6-54755dcc6eb2"
      unitRef="usd">100606000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i6cb0c51ba8fa45fda70ec7e5df8b4ef1_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmE5ZTY5YjA5Zjk1NzQ2Y2Y4MzU0OTEyYjQwYTE0MTI4L3RhYmxlcmFuZ2U6YTllNjliMDlmOTU3NDZjZjgzNTQ5MTJiNDBhMTQxMjhfMTctMy0xLTEtMTA3NzA_05f7df4e-04c0-4bd4-b368-39e1cdb83442"
      unitRef="usd">33898000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmE5ZTY5YjA5Zjk1NzQ2Y2Y4MzU0OTEyYjQwYTE0MTI4L3RhYmxlcmFuZ2U6YTllNjliMDlmOTU3NDZjZjgzNTQ5MTJiNDBhMTQxMjhfMTctNS0xLTEtMTA3NzA_b09b4bbc-4bb2-483e-bb95-06147eef4794"
      unitRef="usd">285127000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmE5ZTY5YjA5Zjk1NzQ2Y2Y4MzU0OTEyYjQwYTE0MTI4L3RhYmxlcmFuZ2U6YTllNjliMDlmOTU3NDZjZjgzNTQ5MTJiNDBhMTQxMjhfMTctNy0xLTEtMTA3NzA_ee4fbbaf-7a00-4a5f-96f2-26980a623f0e"
      unitRef="usd">85545000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:DisaggregationOfRevenueTableTextBlock
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RleHRyZWdpb246YWI0MTJlMTlmYzY0NDFmMGFiZGVhYTE2ODgxYmJmYjRfMjMyMA_6856f52c-5ef5-42cd-96fd-2331fe928389">&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables present the Company&#x2019;s revenue disaggregated by service type:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.350%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.524%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nurse&#160;and&#160;Allied Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Physician and Leadership Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Technology and Workforce Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Temporary staffing&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;627,049&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132,848&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;759,897&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Permanent placement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,815&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,815&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outsourced workforce&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58,802&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58,802&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;SaaS-based technologies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;627,049&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150,663&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100,088&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;877,800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.350%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.524%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nurse&#160;and&#160;Allied Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Physician and Leadership Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Technology and Workforce Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Temporary staffing&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;382,699&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95,648&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;478,347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Permanent placement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,468&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,468&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outsourced workforce&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;SaaS-based technologies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,657&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,657&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;382,699&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109,116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59,816&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;551,631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.350%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.524%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nurse&#160;and&#160;Allied Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Physician and Leadership Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Technology and Workforce Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Temporary staffing&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,908,195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;379,814&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,288,009&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Permanent placement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,709&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,709&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outsourced workforce&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;164,595&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;164,595&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;SaaS-based technologies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117,877&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117,877&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,908,195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;430,523&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;282,472&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,621,190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.350%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.524%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nurse&#160;and&#160;Allied Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Physician and Leadership Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Technology and Workforce Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Temporary staffing&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,251,509&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;310,945&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,562,454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Permanent placement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,635&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,635&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outsourced workforce&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87,705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87,705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;SaaS-based technologies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67,649&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67,649&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,251,509&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;355,580&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155,354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,762,443&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6841006ed66046048b923a10d1f02618_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOjg2NDJlYjFjODMwNDRmZGI4NTFkZDUwNjJiYmY4NzY4L3RhYmxlcmFuZ2U6ODY0MmViMWM4MzA0NGZkYjg1MWRkNTA2MmJiZjg3NjhfMi0xLTEtMS0xMDc3MA_26f54ce5-9c86-4d94-aa4c-1dbdc430b829"
      unitRef="usd">627049000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8aaeb4e7d78e45c4afa1ea8345243c26_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOjg2NDJlYjFjODMwNDRmZGI4NTFkZDUwNjJiYmY4NzY4L3RhYmxlcmFuZ2U6ODY0MmViMWM4MzA0NGZkYjg1MWRkNTA2MmJiZjg3NjhfMi0zLTEtMS0xMDc3MA_6d86e31d-a690-4942-8f40-f4d192d1ebd7"
      unitRef="usd">132848000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie7ed1c91706145b489b11684ae9f8f91_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOjg2NDJlYjFjODMwNDRmZGI4NTFkZDUwNjJiYmY4NzY4L3RhYmxlcmFuZ2U6ODY0MmViMWM4MzA0NGZkYjg1MWRkNTA2MmJiZjg3NjhfMi01LTEtMS0xMDc3MA_b0a5c141-18d0-4fea-aa62-79f4da448a2d"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6aff1598e94c41a9a49290be61afbb6c_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOjg2NDJlYjFjODMwNDRmZGI4NTFkZDUwNjJiYmY4NzY4L3RhYmxlcmFuZ2U6ODY0MmViMWM4MzA0NGZkYjg1MWRkNTA2MmJiZjg3NjhfMi03LTEtMS0xMDc3MA_aeb52424-677a-446b-9414-4f46e04c2786"
      unitRef="usd">759897000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i830444b4b4eb4bc49ed555e461733a60_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOjg2NDJlYjFjODMwNDRmZGI4NTFkZDUwNjJiYmY4NzY4L3RhYmxlcmFuZ2U6ODY0MmViMWM4MzA0NGZkYjg1MWRkNTA2MmJiZjg3NjhfMy0xLTEtMS0xMDc3MA_20592bc0-322f-4b77-bd7b-d7ef47391b33"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1dcde31709c646a282f435f6c32eace5_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOjg2NDJlYjFjODMwNDRmZGI4NTFkZDUwNjJiYmY4NzY4L3RhYmxlcmFuZ2U6ODY0MmViMWM4MzA0NGZkYjg1MWRkNTA2MmJiZjg3NjhfMy0zLTEtMS0xMDc3MA_df377e0d-8188-4ec1-a375-e77824580c06"
      unitRef="usd">17815000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8a01cf9bd5e742be9ad5969b5dd25b9f_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOjg2NDJlYjFjODMwNDRmZGI4NTFkZDUwNjJiYmY4NzY4L3RhYmxlcmFuZ2U6ODY0MmViMWM4MzA0NGZkYjg1MWRkNTA2MmJiZjg3NjhfMy01LTEtMS0xMDc3MA_1a93472a-d069-41db-86c3-60001cf3bb5a"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i469189243c1643a29f2acd332c552f64_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOjg2NDJlYjFjODMwNDRmZGI4NTFkZDUwNjJiYmY4NzY4L3RhYmxlcmFuZ2U6ODY0MmViMWM4MzA0NGZkYjg1MWRkNTA2MmJiZjg3NjhfMy03LTEtMS0xMDc3MA_d0f2dc3c-126a-4a48-90c6-d4a8937fb7fb"
      unitRef="usd">17815000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i97bcb414c2014844b1112de85e955858_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOjg2NDJlYjFjODMwNDRmZGI4NTFkZDUwNjJiYmY4NzY4L3RhYmxlcmFuZ2U6ODY0MmViMWM4MzA0NGZkYjg1MWRkNTA2MmJiZjg3NjhfNC0xLTEtMS0xMDc3MA_313c0dd8-3844-4f21-9873-57ca6f4a9874"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0f2791f2f77d4b30b30f4f41b86a32be_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOjg2NDJlYjFjODMwNDRmZGI4NTFkZDUwNjJiYmY4NzY4L3RhYmxlcmFuZ2U6ODY0MmViMWM4MzA0NGZkYjg1MWRkNTA2MmJiZjg3NjhfNC0zLTEtMS0xMDc3MA_c77b1ce0-e5b9-43c6-9124-e9225113a149"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8d6328bac8bb4c5c9bc2c8b9292f8422_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOjg2NDJlYjFjODMwNDRmZGI4NTFkZDUwNjJiYmY4NzY4L3RhYmxlcmFuZ2U6ODY0MmViMWM4MzA0NGZkYjg1MWRkNTA2MmJiZjg3NjhfNC01LTEtMS0xMDc3MA_f23ca4d8-60fd-4c37-b031-ed34d20c9abd"
      unitRef="usd">58802000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ica26aea190054f37883620f719402399_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOjg2NDJlYjFjODMwNDRmZGI4NTFkZDUwNjJiYmY4NzY4L3RhYmxlcmFuZ2U6ODY0MmViMWM4MzA0NGZkYjg1MWRkNTA2MmJiZjg3NjhfNC03LTEtMS0xMDc3MA_ff7e47aa-872c-4d24-a237-7df858d7d36a"
      unitRef="usd">58802000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iebe807a1030c4daab052b4d1c1386537_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOjg2NDJlYjFjODMwNDRmZGI4NTFkZDUwNjJiYmY4NzY4L3RhYmxlcmFuZ2U6ODY0MmViMWM4MzA0NGZkYjg1MWRkNTA2MmJiZjg3NjhfNS0xLTEtMS0xMDc3MA_5dcd7bb7-5774-4c55-8ed1-645b0b4493ae"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3d75e1df27914f09a7b8252950f87b6b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOjg2NDJlYjFjODMwNDRmZGI4NTFkZDUwNjJiYmY4NzY4L3RhYmxlcmFuZ2U6ODY0MmViMWM4MzA0NGZkYjg1MWRkNTA2MmJiZjg3NjhfNS0zLTEtMS0xMDc3MA_39780147-4281-48fc-b151-8a9ec2393728"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i71d6cb2f38004881a4b6bd6017255a7a_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOjg2NDJlYjFjODMwNDRmZGI4NTFkZDUwNjJiYmY4NzY4L3RhYmxlcmFuZ2U6ODY0MmViMWM4MzA0NGZkYjg1MWRkNTA2MmJiZjg3NjhfNS01LTEtMS0xMDc3MA_b8ba1e37-6dc5-4a9e-b4b5-05959f20d809"
      unitRef="usd">41286000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibc6ef11462fa4624a5db4ae2d23f8e83_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOjg2NDJlYjFjODMwNDRmZGI4NTFkZDUwNjJiYmY4NzY4L3RhYmxlcmFuZ2U6ODY0MmViMWM4MzA0NGZkYjg1MWRkNTA2MmJiZjg3NjhfNS03LTEtMS0xMDc3MA_057fd6dd-989d-4ea4-a84a-daee0f691c94"
      unitRef="usd">41286000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i01269464f14e481692beaf81a76fb87d_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOjg2NDJlYjFjODMwNDRmZGI4NTFkZDUwNjJiYmY4NzY4L3RhYmxlcmFuZ2U6ODY0MmViMWM4MzA0NGZkYjg1MWRkNTA2MmJiZjg3NjhfNi0xLTEtMS0xMDc3MA_e015b155-1fa5-44fd-b0cb-cb8d2094b61a"
      unitRef="usd">627049000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icc871800a2a54344bc972988728aa887_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOjg2NDJlYjFjODMwNDRmZGI4NTFkZDUwNjJiYmY4NzY4L3RhYmxlcmFuZ2U6ODY0MmViMWM4MzA0NGZkYjg1MWRkNTA2MmJiZjg3NjhfNi0zLTEtMS0xMDc3MA_1750a340-6530-4c1e-b7b9-10c092503cbf"
      unitRef="usd">150663000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id0250f51d2d145cfa3b9c421cb969cfb_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOjg2NDJlYjFjODMwNDRmZGI4NTFkZDUwNjJiYmY4NzY4L3RhYmxlcmFuZ2U6ODY0MmViMWM4MzA0NGZkYjg1MWRkNTA2MmJiZjg3NjhfNi01LTEtMS0xMDc3MA_8fd72fa3-ac78-4833-97b5-f4b4bb31ac5c"
      unitRef="usd">100088000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i150492f298fa47a78ef2c10a285a64f8_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOjg2NDJlYjFjODMwNDRmZGI4NTFkZDUwNjJiYmY4NzY4L3RhYmxlcmFuZ2U6ODY0MmViMWM4MzA0NGZkYjg1MWRkNTA2MmJiZjg3NjhfNi03LTEtMS0xMDc3MA_1a3a33c4-7ba9-4d2b-a162-be34e7509bc8"
      unitRef="usd">877800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia6d8015a18974a7b896656aecc3ec4b4_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmJkMGZhZjI0NzhlNzQ0Mzk4YTUyZDU4NmY0OWRmOTY4L3RhYmxlcmFuZ2U6YmQwZmFmMjQ3OGU3NDQzOThhNTJkNTg2ZjQ5ZGY5NjhfMi0xLTEtMS0xMDc3MA_1f6e00cd-881c-4feb-b97f-f65309d17f63"
      unitRef="usd">382699000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifc8564de3068430abe113d5c5abeabe1_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmJkMGZhZjI0NzhlNzQ0Mzk4YTUyZDU4NmY0OWRmOTY4L3RhYmxlcmFuZ2U6YmQwZmFmMjQ3OGU3NDQzOThhNTJkNTg2ZjQ5ZGY5NjhfMi0zLTEtMS0xMDc3MA_24966a28-8837-4fef-b95d-3e2626bafe43"
      unitRef="usd">95648000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i386e01817e9d4c42b6cd2228fb3796c2_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmJkMGZhZjI0NzhlNzQ0Mzk4YTUyZDU4NmY0OWRmOTY4L3RhYmxlcmFuZ2U6YmQwZmFmMjQ3OGU3NDQzOThhNTJkNTg2ZjQ5ZGY5NjhfMi01LTEtMS0xMDc3MA_42f5aea1-eebf-4d4f-b133-5415c4cb61db"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8d235eb71df14e8b9908f2e396c873cb_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmJkMGZhZjI0NzhlNzQ0Mzk4YTUyZDU4NmY0OWRmOTY4L3RhYmxlcmFuZ2U6YmQwZmFmMjQ3OGU3NDQzOThhNTJkNTg2ZjQ5ZGY5NjhfMi03LTEtMS0xMDc3MA_9da1da44-ccc7-4d71-a343-f5eb63907978"
      unitRef="usd">478347000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i44c7ce7db7f54f14969af01502dd38a0_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmJkMGZhZjI0NzhlNzQ0Mzk4YTUyZDU4NmY0OWRmOTY4L3RhYmxlcmFuZ2U6YmQwZmFmMjQ3OGU3NDQzOThhNTJkNTg2ZjQ5ZGY5NjhfMy0xLTEtMS0xMDc3MA_da44ce74-c896-4ff6-860b-41166ffa7a94"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie04ed0997a484867b8fe5f9956a3292d_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmJkMGZhZjI0NzhlNzQ0Mzk4YTUyZDU4NmY0OWRmOTY4L3RhYmxlcmFuZ2U6YmQwZmFmMjQ3OGU3NDQzOThhNTJkNTg2ZjQ5ZGY5NjhfMy0zLTEtMS0xMDc3MA_1353a456-8baf-4bd4-85d2-c86c21bf53ba"
      unitRef="usd">13468000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if26529ce715f495dafc6d4b52493ea02_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmJkMGZhZjI0NzhlNzQ0Mzk4YTUyZDU4NmY0OWRmOTY4L3RhYmxlcmFuZ2U6YmQwZmFmMjQ3OGU3NDQzOThhNTJkNTg2ZjQ5ZGY5NjhfMy01LTEtMS0xMDc3MA_2a212d5e-6fe3-4445-af18-9ba62ede99fd"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if818b67b623c45a8aff218e40a7005c3_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmJkMGZhZjI0NzhlNzQ0Mzk4YTUyZDU4NmY0OWRmOTY4L3RhYmxlcmFuZ2U6YmQwZmFmMjQ3OGU3NDQzOThhNTJkNTg2ZjQ5ZGY5NjhfMy03LTEtMS0xMDc3MA_6e307f4c-9e4d-47d6-9c18-97bbbe25ad49"
      unitRef="usd">13468000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9aba0cbe92634056880604c35ba04d52_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmJkMGZhZjI0NzhlNzQ0Mzk4YTUyZDU4NmY0OWRmOTY4L3RhYmxlcmFuZ2U6YmQwZmFmMjQ3OGU3NDQzOThhNTJkNTg2ZjQ5ZGY5NjhfNC0xLTEtMS0xMDc3MA_bfcdb727-bfbf-4572-a87b-edc3b2160fc6"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ieee345988a9b4cc4937342242689e98e_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmJkMGZhZjI0NzhlNzQ0Mzk4YTUyZDU4NmY0OWRmOTY4L3RhYmxlcmFuZ2U6YmQwZmFmMjQ3OGU3NDQzOThhNTJkNTg2ZjQ5ZGY5NjhfNC0zLTEtMS0xMDc3MA_e1983fec-f43b-499b-8417-a210264023d2"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i76440e2d28744cc98ead1974809c865f_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmJkMGZhZjI0NzhlNzQ0Mzk4YTUyZDU4NmY0OWRmOTY4L3RhYmxlcmFuZ2U6YmQwZmFmMjQ3OGU3NDQzOThhNTJkNTg2ZjQ5ZGY5NjhfNC01LTEtMS0xMDc3MA_c437531d-c339-452f-beac-ae0a0f7363d1"
      unitRef="usd">38159000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3d7b5abbd0ee4fca9a5b3efb81d07d5d_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmJkMGZhZjI0NzhlNzQ0Mzk4YTUyZDU4NmY0OWRmOTY4L3RhYmxlcmFuZ2U6YmQwZmFmMjQ3OGU3NDQzOThhNTJkNTg2ZjQ5ZGY5NjhfNC03LTEtMS0xMDc3MA_1e1cdaca-fa4f-47e9-8c6a-3f3c2f73bb12"
      unitRef="usd">38159000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5893522597a942f38cbfe46a853546eb_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmJkMGZhZjI0NzhlNzQ0Mzk4YTUyZDU4NmY0OWRmOTY4L3RhYmxlcmFuZ2U6YmQwZmFmMjQ3OGU3NDQzOThhNTJkNTg2ZjQ5ZGY5NjhfNS0xLTEtMS0xMDc3MA_763abe8e-54ec-445a-a124-fdc487056376"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id296025a7e114f8b9f9b44d6b14233f1_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmJkMGZhZjI0NzhlNzQ0Mzk4YTUyZDU4NmY0OWRmOTY4L3RhYmxlcmFuZ2U6YmQwZmFmMjQ3OGU3NDQzOThhNTJkNTg2ZjQ5ZGY5NjhfNS0zLTEtMS0xMDc3MA_a570bcf6-b1b2-4f9e-b114-9f1f6b0e79ce"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9568bc87c368403cbb9e4180b3a0d538_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmJkMGZhZjI0NzhlNzQ0Mzk4YTUyZDU4NmY0OWRmOTY4L3RhYmxlcmFuZ2U6YmQwZmFmMjQ3OGU3NDQzOThhNTJkNTg2ZjQ5ZGY5NjhfNS01LTEtMS0xMDc3MA_b80db23c-5974-4392-b57b-a5ec4680dbea"
      unitRef="usd">21657000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0e447016b010458c883c1ef90a609651_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmJkMGZhZjI0NzhlNzQ0Mzk4YTUyZDU4NmY0OWRmOTY4L3RhYmxlcmFuZ2U6YmQwZmFmMjQ3OGU3NDQzOThhNTJkNTg2ZjQ5ZGY5NjhfNS03LTEtMS0xMDc3MA_fa5e8e35-4f81-486a-930d-c4520be0806f"
      unitRef="usd">21657000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic8d64c3d8e5a47489226ba7a492dae32_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmJkMGZhZjI0NzhlNzQ0Mzk4YTUyZDU4NmY0OWRmOTY4L3RhYmxlcmFuZ2U6YmQwZmFmMjQ3OGU3NDQzOThhNTJkNTg2ZjQ5ZGY5NjhfNi0xLTEtMS0xMDc3MA_019b4d2a-4a64-41e7-89d0-8503e7cd8062"
      unitRef="usd">382699000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i44b9c9fa813d4c3688eab2f7ea808291_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmJkMGZhZjI0NzhlNzQ0Mzk4YTUyZDU4NmY0OWRmOTY4L3RhYmxlcmFuZ2U6YmQwZmFmMjQ3OGU3NDQzOThhNTJkNTg2ZjQ5ZGY5NjhfNi0zLTEtMS0xMDc3MA_b5d74d8b-27f3-4f84-b34a-fb8ad80dbd0b"
      unitRef="usd">109116000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6460c9bf442443d3abf247bad9d30336_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmJkMGZhZjI0NzhlNzQ0Mzk4YTUyZDU4NmY0OWRmOTY4L3RhYmxlcmFuZ2U6YmQwZmFmMjQ3OGU3NDQzOThhNTJkNTg2ZjQ5ZGY5NjhfNi01LTEtMS0xMDc3MA_a934a262-e4df-414c-ba61-aa1dfb344e58"
      unitRef="usd">59816000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6cb0c51ba8fa45fda70ec7e5df8b4ef1_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmJkMGZhZjI0NzhlNzQ0Mzk4YTUyZDU4NmY0OWRmOTY4L3RhYmxlcmFuZ2U6YmQwZmFmMjQ3OGU3NDQzOThhNTJkNTg2ZjQ5ZGY5NjhfNi03LTEtMS0xMDc3MA_793b5e9d-d9e2-414e-99ea-18e0f40b5691"
      unitRef="usd">551631000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ida0f30c7727943e798527294cdf4394a_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmIyMWFkZjZkMmZlMDQzZmVhMTc5MTJhYmFhMTk1NGFjL3RhYmxlcmFuZ2U6YjIxYWRmNmQyZmUwNDNmZWExNzkxMmFiYWExOTU0YWNfMi0xLTEtMS0xMDc3MA_9475f4e5-4f92-401a-b9b8-4f671794c367"
      unitRef="usd">1908195000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idcab03e09bc1437399cc7a03d8fc8b57_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmIyMWFkZjZkMmZlMDQzZmVhMTc5MTJhYmFhMTk1NGFjL3RhYmxlcmFuZ2U6YjIxYWRmNmQyZmUwNDNmZWExNzkxMmFiYWExOTU0YWNfMi0zLTEtMS0xMDc3MA_ddc4b124-a8b7-4247-86f8-23c23e35c32e"
      unitRef="usd">379814000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i89958f0ec7cf446b98d11c657f7ee603_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmIyMWFkZjZkMmZlMDQzZmVhMTc5MTJhYmFhMTk1NGFjL3RhYmxlcmFuZ2U6YjIxYWRmNmQyZmUwNDNmZWExNzkxMmFiYWExOTU0YWNfMi01LTEtMS0xMDc3MA_071453f7-c909-456f-9d99-239aeced9b1e"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i90eb3e7675a044e992b317175d9afcd9_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmIyMWFkZjZkMmZlMDQzZmVhMTc5MTJhYmFhMTk1NGFjL3RhYmxlcmFuZ2U6YjIxYWRmNmQyZmUwNDNmZWExNzkxMmFiYWExOTU0YWNfMi03LTEtMS0xMDc3MA_87f721fe-324f-4a12-b8c1-78f09c7a855b"
      unitRef="usd">2288009000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8750be21113a4757ac053b8f62cd2ad2_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmIyMWFkZjZkMmZlMDQzZmVhMTc5MTJhYmFhMTk1NGFjL3RhYmxlcmFuZ2U6YjIxYWRmNmQyZmUwNDNmZWExNzkxMmFiYWExOTU0YWNfMy0xLTEtMS0xMDc3MA_0233b2f8-6620-4e1b-af02-68526427e761"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i30aa16b5b25048ca8dfeff42d533a177_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmIyMWFkZjZkMmZlMDQzZmVhMTc5MTJhYmFhMTk1NGFjL3RhYmxlcmFuZ2U6YjIxYWRmNmQyZmUwNDNmZWExNzkxMmFiYWExOTU0YWNfMy0zLTEtMS0xMDc3MA_dd302890-b05c-45cf-9bc4-5d21b7354b62"
      unitRef="usd">50709000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3cfc2a42fe0e4807b29bf91ce0a45f43_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmIyMWFkZjZkMmZlMDQzZmVhMTc5MTJhYmFhMTk1NGFjL3RhYmxlcmFuZ2U6YjIxYWRmNmQyZmUwNDNmZWExNzkxMmFiYWExOTU0YWNfMy01LTEtMS0xMDc3MA_bf992596-6f3e-45a1-a511-b97bab9147ce"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibbdabae4c4224976a6088e48ddb040ba_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmIyMWFkZjZkMmZlMDQzZmVhMTc5MTJhYmFhMTk1NGFjL3RhYmxlcmFuZ2U6YjIxYWRmNmQyZmUwNDNmZWExNzkxMmFiYWExOTU0YWNfMy03LTEtMS0xMDc3MA_f2f12093-3c6c-448a-97a1-be48ace82e85"
      unitRef="usd">50709000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i536910b4999c4e32a95c6a8ac9c30f1d_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmIyMWFkZjZkMmZlMDQzZmVhMTc5MTJhYmFhMTk1NGFjL3RhYmxlcmFuZ2U6YjIxYWRmNmQyZmUwNDNmZWExNzkxMmFiYWExOTU0YWNfNC0xLTEtMS0xMDc3MA_0a576fba-8137-4758-93a5-1931b622cfdc"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4c17ffb386c649368efa203669f28351_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmIyMWFkZjZkMmZlMDQzZmVhMTc5MTJhYmFhMTk1NGFjL3RhYmxlcmFuZ2U6YjIxYWRmNmQyZmUwNDNmZWExNzkxMmFiYWExOTU0YWNfNC0zLTEtMS0xMDc3MA_a22cd30a-8917-41a5-8c8a-ebd5a4e681e4"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idf8b667f2cd34632a587e2d17a82e3fd_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmIyMWFkZjZkMmZlMDQzZmVhMTc5MTJhYmFhMTk1NGFjL3RhYmxlcmFuZ2U6YjIxYWRmNmQyZmUwNDNmZWExNzkxMmFiYWExOTU0YWNfNC01LTEtMS0xMDc3MA_a1d9323a-95fa-45e5-8944-cd6f10d7f5fd"
      unitRef="usd">164595000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iedbce8552e1b455082a65e938d6dec5b_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmIyMWFkZjZkMmZlMDQzZmVhMTc5MTJhYmFhMTk1NGFjL3RhYmxlcmFuZ2U6YjIxYWRmNmQyZmUwNDNmZWExNzkxMmFiYWExOTU0YWNfNC03LTEtMS0xMDc3MA_182a64b2-7332-4d17-9d1d-91d69d5ef4f4"
      unitRef="usd">164595000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9bb701054c8d4b2ca7bb36f5445e6a6a_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmIyMWFkZjZkMmZlMDQzZmVhMTc5MTJhYmFhMTk1NGFjL3RhYmxlcmFuZ2U6YjIxYWRmNmQyZmUwNDNmZWExNzkxMmFiYWExOTU0YWNfNS0xLTEtMS0xMDc3MA_7c157b85-86b4-4da4-987e-1b322454e18e"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i80d03ebd1c054ee9977c5f826afd98f7_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmIyMWFkZjZkMmZlMDQzZmVhMTc5MTJhYmFhMTk1NGFjL3RhYmxlcmFuZ2U6YjIxYWRmNmQyZmUwNDNmZWExNzkxMmFiYWExOTU0YWNfNS0zLTEtMS0xMDc3MA_e80634fd-e1de-4422-8684-4c04dbbebe73"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i85f859e6dc0a4f40aef7f8f521affd1c_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmIyMWFkZjZkMmZlMDQzZmVhMTc5MTJhYmFhMTk1NGFjL3RhYmxlcmFuZ2U6YjIxYWRmNmQyZmUwNDNmZWExNzkxMmFiYWExOTU0YWNfNS01LTEtMS0xMDc3MA_dffa2964-2394-4146-851d-ba91a3335546"
      unitRef="usd">117877000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icf4e0ac3bff74d3c81967d52a934245e_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmIyMWFkZjZkMmZlMDQzZmVhMTc5MTJhYmFhMTk1NGFjL3RhYmxlcmFuZ2U6YjIxYWRmNmQyZmUwNDNmZWExNzkxMmFiYWExOTU0YWNfNS03LTEtMS0xMDc3MA_8ca8889e-1652-4848-b39d-e7aa01859ab2"
      unitRef="usd">117877000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i70417b2a548f4dc8aa5f1b5e01ea94f6_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmIyMWFkZjZkMmZlMDQzZmVhMTc5MTJhYmFhMTk1NGFjL3RhYmxlcmFuZ2U6YjIxYWRmNmQyZmUwNDNmZWExNzkxMmFiYWExOTU0YWNfNi0xLTEtMS0xMDc3MA_0e128e78-9d71-4ee9-be8d-aa818ba6eea5"
      unitRef="usd">1908195000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic7cb32a8e20f4e59b29cb208784742f9_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmIyMWFkZjZkMmZlMDQzZmVhMTc5MTJhYmFhMTk1NGFjL3RhYmxlcmFuZ2U6YjIxYWRmNmQyZmUwNDNmZWExNzkxMmFiYWExOTU0YWNfNi0zLTEtMS0xMDc3MA_c23046d7-38ae-478e-acd6-0fe86ab0e0b1"
      unitRef="usd">430523000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i19bf0b91fc2e4d4088d260a4a7291a68_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmIyMWFkZjZkMmZlMDQzZmVhMTc5MTJhYmFhMTk1NGFjL3RhYmxlcmFuZ2U6YjIxYWRmNmQyZmUwNDNmZWExNzkxMmFiYWExOTU0YWNfNi01LTEtMS0xMDc3MA_0775fff7-fd21-4bd2-b039-d7bcaa79964c"
      unitRef="usd">282472000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOmIyMWFkZjZkMmZlMDQzZmVhMTc5MTJhYmFhMTk1NGFjL3RhYmxlcmFuZ2U6YjIxYWRmNmQyZmUwNDNmZWExNzkxMmFiYWExOTU0YWNfNi03LTEtMS0xMDc3MA_0108ca54-6df9-4cec-afc7-c05ecb91f790"
      unitRef="usd">2621190000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if95e75fc39f542e0937abe52bd16b043_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOjY5ZWZjNzMyNmYwMDQ4MTFiY2FmMTAyOGU1ZTczN2RmL3RhYmxlcmFuZ2U6NjllZmM3MzI2ZjAwNDgxMWJjYWYxMDI4ZTVlNzM3ZGZfMi0xLTEtMS0xMDc3MA_45835ab5-5c1d-4151-9b44-c10690910190"
      unitRef="usd">1251509000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i41fa2315f758457689e492a76a31c2bc_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOjY5ZWZjNzMyNmYwMDQ4MTFiY2FmMTAyOGU1ZTczN2RmL3RhYmxlcmFuZ2U6NjllZmM3MzI2ZjAwNDgxMWJjYWYxMDI4ZTVlNzM3ZGZfMi0zLTEtMS0xMDc3MA_bca5fc00-a55f-4142-8d68-e554e3d264d9"
      unitRef="usd">310945000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id149b105ef884b0d9c47f05bec237702_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOjY5ZWZjNzMyNmYwMDQ4MTFiY2FmMTAyOGU1ZTczN2RmL3RhYmxlcmFuZ2U6NjllZmM3MzI2ZjAwNDgxMWJjYWYxMDI4ZTVlNzM3ZGZfMi01LTEtMS0xMDc3MA_d7b732ca-08e0-411e-990d-e7df583110da"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8ee31b74c9154f7b815c08300a1950e0_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOjY5ZWZjNzMyNmYwMDQ4MTFiY2FmMTAyOGU1ZTczN2RmL3RhYmxlcmFuZ2U6NjllZmM3MzI2ZjAwNDgxMWJjYWYxMDI4ZTVlNzM3ZGZfMi03LTEtMS0xMDc3MA_77b471f2-a3ae-48da-bfb6-7e6e378b0a01"
      unitRef="usd">1562454000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i38ab08218c234821bc589e3cc2c80f3c_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOjY5ZWZjNzMyNmYwMDQ4MTFiY2FmMTAyOGU1ZTczN2RmL3RhYmxlcmFuZ2U6NjllZmM3MzI2ZjAwNDgxMWJjYWYxMDI4ZTVlNzM3ZGZfMy0xLTEtMS0xMDc3MA_66896f3b-2028-4862-99fb-5a0e36a7718b"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4c3268cc1706415686fd7683f6ed1d51_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOjY5ZWZjNzMyNmYwMDQ4MTFiY2FmMTAyOGU1ZTczN2RmL3RhYmxlcmFuZ2U6NjllZmM3MzI2ZjAwNDgxMWJjYWYxMDI4ZTVlNzM3ZGZfMy0zLTEtMS0xMDc3MA_f0fdf079-7847-419e-a55d-1c787173015d"
      unitRef="usd">44635000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4167819349934cd59d501e7c4c7ddcfc_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOjY5ZWZjNzMyNmYwMDQ4MTFiY2FmMTAyOGU1ZTczN2RmL3RhYmxlcmFuZ2U6NjllZmM3MzI2ZjAwNDgxMWJjYWYxMDI4ZTVlNzM3ZGZfMy01LTEtMS0xMDc3MA_0b9231ee-d6ab-4cc6-b2ed-496c8c3480af"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i43362dd8fe0949449a39af825a732e7a_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOjY5ZWZjNzMyNmYwMDQ4MTFiY2FmMTAyOGU1ZTczN2RmL3RhYmxlcmFuZ2U6NjllZmM3MzI2ZjAwNDgxMWJjYWYxMDI4ZTVlNzM3ZGZfMy03LTEtMS0xMDc3MA_2b81445f-3652-474c-9be0-7746f545870e"
      unitRef="usd">44635000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i88f59cdb95f040e2b571b678226a7fec_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOjY5ZWZjNzMyNmYwMDQ4MTFiY2FmMTAyOGU1ZTczN2RmL3RhYmxlcmFuZ2U6NjllZmM3MzI2ZjAwNDgxMWJjYWYxMDI4ZTVlNzM3ZGZfNC0xLTEtMS0xMDc3MA_0b28988e-afbb-42e5-891d-64d52dcb45ba"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iee45b2697e73423393102240edfca12a_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOjY5ZWZjNzMyNmYwMDQ4MTFiY2FmMTAyOGU1ZTczN2RmL3RhYmxlcmFuZ2U6NjllZmM3MzI2ZjAwNDgxMWJjYWYxMDI4ZTVlNzM3ZGZfNC0zLTEtMS0xMDc3MA_9f7d4bba-35b9-4edd-9e79-55311fd30703"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if3d5b12a279d423b9852c9ec50634277_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOjY5ZWZjNzMyNmYwMDQ4MTFiY2FmMTAyOGU1ZTczN2RmL3RhYmxlcmFuZ2U6NjllZmM3MzI2ZjAwNDgxMWJjYWYxMDI4ZTVlNzM3ZGZfNC01LTEtMS0xMDc3MA_16a972bd-55f4-4e8c-8cc4-02f11775c576"
      unitRef="usd">87705000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i93145b50299a45b0b7e234415765c760_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOjY5ZWZjNzMyNmYwMDQ4MTFiY2FmMTAyOGU1ZTczN2RmL3RhYmxlcmFuZ2U6NjllZmM3MzI2ZjAwNDgxMWJjYWYxMDI4ZTVlNzM3ZGZfNC03LTEtMS0xMDc3MA_2d59c568-b4dd-4899-ab02-cab9498dafea"
      unitRef="usd">87705000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia3589685d5bf494da6ce3464e2194081_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOjY5ZWZjNzMyNmYwMDQ4MTFiY2FmMTAyOGU1ZTczN2RmL3RhYmxlcmFuZ2U6NjllZmM3MzI2ZjAwNDgxMWJjYWYxMDI4ZTVlNzM3ZGZfNS0xLTEtMS0xMDc3MA_d8724b17-6d96-46da-a78f-065cfdb198d9"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i683c901af8234ee8b34a8de537a4faed_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOjY5ZWZjNzMyNmYwMDQ4MTFiY2FmMTAyOGU1ZTczN2RmL3RhYmxlcmFuZ2U6NjllZmM3MzI2ZjAwNDgxMWJjYWYxMDI4ZTVlNzM3ZGZfNS0zLTEtMS0xMDc3MA_8213ce08-664b-4a28-a33f-edb06702e3b7"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9c392d9ab824476a96a3f41148cbe7fe_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOjY5ZWZjNzMyNmYwMDQ4MTFiY2FmMTAyOGU1ZTczN2RmL3RhYmxlcmFuZ2U6NjllZmM3MzI2ZjAwNDgxMWJjYWYxMDI4ZTVlNzM3ZGZfNS01LTEtMS0xMDc3MA_dd5a2092-dc17-4985-9966-94378bd98c0d"
      unitRef="usd">67649000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i598b74681e034171b491236964be10f1_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOjY5ZWZjNzMyNmYwMDQ4MTFiY2FmMTAyOGU1ZTczN2RmL3RhYmxlcmFuZ2U6NjllZmM3MzI2ZjAwNDgxMWJjYWYxMDI4ZTVlNzM3ZGZfNS03LTEtMS0xMDc3MA_13b90327-50f6-4d6f-9547-cd0e4f71f917"
      unitRef="usd">67649000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2a46e165877d46f7b437d72073d883c6_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOjY5ZWZjNzMyNmYwMDQ4MTFiY2FmMTAyOGU1ZTczN2RmL3RhYmxlcmFuZ2U6NjllZmM3MzI2ZjAwNDgxMWJjYWYxMDI4ZTVlNzM3ZGZfNi0xLTEtMS0xMDc3MA_9658fd4c-ed30-4db8-8dfe-ee73ce285cdc"
      unitRef="usd">1251509000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if3be0a64ed0349d3ae2297e6a8a914d7_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOjY5ZWZjNzMyNmYwMDQ4MTFiY2FmMTAyOGU1ZTczN2RmL3RhYmxlcmFuZ2U6NjllZmM3MzI2ZjAwNDgxMWJjYWYxMDI4ZTVlNzM3ZGZfNi0zLTEtMS0xMDc3MA_fd85d91b-4fd7-4a8e-b86c-cdbc65d81aad"
      unitRef="usd">355580000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i11efb6327d494ef79b4c1a4e768e70bf_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOjY5ZWZjNzMyNmYwMDQ4MTFiY2FmMTAyOGU1ZTczN2RmL3RhYmxlcmFuZ2U6NjllZmM3MzI2ZjAwNDgxMWJjYWYxMDI4ZTVlNzM3ZGZfNi01LTEtMS0xMDc3MA_f9e1bc91-6e7b-4326-b6a3-fbb455648ddb"
      unitRef="usd">155354000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOjY5ZWZjNzMyNmYwMDQ4MTFiY2FmMTAyOGU1ZTczN2RmL3RhYmxlcmFuZ2U6NjllZmM3MzI2ZjAwNDgxMWJjYWYxMDI4ZTVlNzM3ZGZfNi03LTEtMS0xMDc3MA_c898766d-7522-41da-8a27-7ff1c6632514"
      unitRef="usd">1762443000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ScheduleOfGoodwillTextBlock
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RleHRyZWdpb246YWI0MTJlMTlmYzY0NDFmMGFiZGVhYTE2ODgxYmJmYjRfMjMzMw_018bc651-58b0-469e-814a-ca32cc301dd5">&lt;div style="margin-top:9pt;padding-left:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the activity related to the carrying value of goodwill by reportable segment:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.111%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nurse&#160;and&#160;Allied Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Physician and Leadership Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Technology and Workforce Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, January 1, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;339,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;152,800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;372,670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;864,485&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill adjustment for Stratus Video acquisition&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;663&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;663&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill from Synzi and SnapMD acquisition&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;339,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;152,800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;401,468&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;893,283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated impairment loss as of December 31, 2020 and September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;154,444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;214,939&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:Goodwill
      contextRef="ia707a5ecf30d4576a74a17b34e193c15_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOjMzODhiZTY0MWM3NjRjNjdiMTFiMzljODZmNTRmNWQ0L3RhYmxlcmFuZ2U6MzM4OGJlNjQxYzc2NGM2N2IxMWIzOWM4NmY1NGY1ZDRfMS0xLTEtMS0xMDc3MA_07820268-81da-4ede-8cc0-236105913cf5"
      unitRef="usd">339015000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ifb5e6237d7d54806a979a6a53e302a7a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOjMzODhiZTY0MWM3NjRjNjdiMTFiMzljODZmNTRmNWQ0L3RhYmxlcmFuZ2U6MzM4OGJlNjQxYzc2NGM2N2IxMWIzOWM4NmY1NGY1ZDRfMS0zLTEtMS0xMDc3MA_719e35be-9df8-461b-a9a9-64bad2022234"
      unitRef="usd">152800000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ibd0be51207114cd1b17f02ebecffc197_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOjMzODhiZTY0MWM3NjRjNjdiMTFiMzljODZmNTRmNWQ0L3RhYmxlcmFuZ2U6MzM4OGJlNjQxYzc2NGM2N2IxMWIzOWM4NmY1NGY1ZDRfMS01LTEtMS0xMDc3MA_ae7d6f84-c2d1-4e31-95d7-2228944134ad"
      unitRef="usd">372670000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOjMzODhiZTY0MWM3NjRjNjdiMTFiMzljODZmNTRmNWQ0L3RhYmxlcmFuZ2U6MzM4OGJlNjQxYzc2NGM2N2IxMWIzOWM4NmY1NGY1ZDRfMS03LTEtMS0xMDc3MA_86f3101e-dcc9-4762-abd8-e4e8637e3bcf"
      unitRef="usd">864485000</us-gaap:Goodwill>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="i70417b2a548f4dc8aa5f1b5e01ea94f6_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOjMzODhiZTY0MWM3NjRjNjdiMTFiMzljODZmNTRmNWQ0L3RhYmxlcmFuZ2U6MzM4OGJlNjQxYzc2NGM2N2IxMWIzOWM4NmY1NGY1ZDRfMi0xLTEtMS0xMDc3MA_e1bddae2-664a-4c64-9736-a6eac45fc95a"
      unitRef="usd">0</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="ic7cb32a8e20f4e59b29cb208784742f9_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOjMzODhiZTY0MWM3NjRjNjdiMTFiMzljODZmNTRmNWQ0L3RhYmxlcmFuZ2U6MzM4OGJlNjQxYzc2NGM2N2IxMWIzOWM4NmY1NGY1ZDRfMi0zLTEtMS0xMDc3MA_9eefd3aa-559f-4a01-bb87-f7d2d1c5c9cf"
      unitRef="usd">0</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="i19bf0b91fc2e4d4088d260a4a7291a68_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOjMzODhiZTY0MWM3NjRjNjdiMTFiMzljODZmNTRmNWQ0L3RhYmxlcmFuZ2U6MzM4OGJlNjQxYzc2NGM2N2IxMWIzOWM4NmY1NGY1ZDRfMi01LTEtMS0xMDc3MA_5dee2990-fe02-41b8-90c1-95f691d0e069"
      unitRef="usd">663000</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOjMzODhiZTY0MWM3NjRjNjdiMTFiMzljODZmNTRmNWQ0L3RhYmxlcmFuZ2U6MzM4OGJlNjQxYzc2NGM2N2IxMWIzOWM4NmY1NGY1ZDRfMi03LTEtMS0xMDc3MA_471b3157-1c11-4be1-b7e7-86f7f7187a39"
      unitRef="usd">663000</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i70417b2a548f4dc8aa5f1b5e01ea94f6_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOjMzODhiZTY0MWM3NjRjNjdiMTFiMzljODZmNTRmNWQ0L3RhYmxlcmFuZ2U6MzM4OGJlNjQxYzc2NGM2N2IxMWIzOWM4NmY1NGY1ZDRfNC0xLTEtMS0xMDc3MA_548aa83e-5fd4-4295-9cfe-5c4720801e63"
      unitRef="usd">0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="ic7cb32a8e20f4e59b29cb208784742f9_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOjMzODhiZTY0MWM3NjRjNjdiMTFiMzljODZmNTRmNWQ0L3RhYmxlcmFuZ2U6MzM4OGJlNjQxYzc2NGM2N2IxMWIzOWM4NmY1NGY1ZDRfNC0zLTEtMS0xMDc3MA_b485feb2-a230-43e5-a19b-3713624a4f1d"
      unitRef="usd">0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i19bf0b91fc2e4d4088d260a4a7291a68_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOjMzODhiZTY0MWM3NjRjNjdiMTFiMzljODZmNTRmNWQ0L3RhYmxlcmFuZ2U6MzM4OGJlNjQxYzc2NGM2N2IxMWIzOWM4NmY1NGY1ZDRfNC01LTEtMS0xMDc3MA_57a35d38-cfe9-4d78-9572-02ffe7f87666"
      unitRef="usd">28135000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOjMzODhiZTY0MWM3NjRjNjdiMTFiMzljODZmNTRmNWQ0L3RhYmxlcmFuZ2U6MzM4OGJlNjQxYzc2NGM2N2IxMWIzOWM4NmY1NGY1ZDRfNC03LTEtMS0xMDc3MA_2c01624e-5b16-43bd-8f4b-8d6144cb91e8"
      unitRef="usd">28135000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:Goodwill
      contextRef="iff2345b9439d4c93833b660edbe6ce7f_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOjMzODhiZTY0MWM3NjRjNjdiMTFiMzljODZmNTRmNWQ0L3RhYmxlcmFuZ2U6MzM4OGJlNjQxYzc2NGM2N2IxMWIzOWM4NmY1NGY1ZDRfNi0xLTEtMS0xMDc3MA_2906e5a7-ec9f-43ec-a146-856b698b34ec"
      unitRef="usd">339015000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i4161c5f102584f0fbecf9454461d6028_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOjMzODhiZTY0MWM3NjRjNjdiMTFiMzljODZmNTRmNWQ0L3RhYmxlcmFuZ2U6MzM4OGJlNjQxYzc2NGM2N2IxMWIzOWM4NmY1NGY1ZDRfNi0zLTEtMS0xMDc3MA_87759bcc-2fe5-4915-8990-dc89df22a8b1"
      unitRef="usd">152800000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i33f34f84f7e146998551e4e55f51111a_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOjMzODhiZTY0MWM3NjRjNjdiMTFiMzljODZmNTRmNWQ0L3RhYmxlcmFuZ2U6MzM4OGJlNjQxYzc2NGM2N2IxMWIzOWM4NmY1NGY1ZDRfNi01LTEtMS0xMDc3MA_ba3d6da6-73bc-4211-a490-c246bf5aa5fc"
      unitRef="usd">401468000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i68ecd84e8da440808154baac134e839e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOjMzODhiZTY0MWM3NjRjNjdiMTFiMzljODZmNTRmNWQ0L3RhYmxlcmFuZ2U6MzM4OGJlNjQxYzc2NGM2N2IxMWIzOWM4NmY1NGY1ZDRfNi03LTEtMS0xMDc3MA_b9a2dc14-45cc-433d-bd0b-6a15151013c3"
      unitRef="usd">893283000</us-gaap:Goodwill>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="iff2345b9439d4c93833b660edbe6ce7f_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOjMzODhiZTY0MWM3NjRjNjdiMTFiMzljODZmNTRmNWQ0L3RhYmxlcmFuZ2U6MzM4OGJlNjQxYzc2NGM2N2IxMWIzOWM4NmY1NGY1ZDRfNy0xLTEtMS0xMDc3MA_17208002-cfa1-4c46-a731-efe9c869dc49"
      unitRef="usd">154444000</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="ia707a5ecf30d4576a74a17b34e193c15_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOjMzODhiZTY0MWM3NjRjNjdiMTFiMzljODZmNTRmNWQ0L3RhYmxlcmFuZ2U6MzM4OGJlNjQxYzc2NGM2N2IxMWIzOWM4NmY1NGY1ZDRfNy0xLTEtMS0xMDc3MA_f144216d-3322-4e6a-b1e4-674a3701cd78"
      unitRef="usd">154444000</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="ifb5e6237d7d54806a979a6a53e302a7a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOjMzODhiZTY0MWM3NjRjNjdiMTFiMzljODZmNTRmNWQ0L3RhYmxlcmFuZ2U6MzM4OGJlNjQxYzc2NGM2N2IxMWIzOWM4NmY1NGY1ZDRfNy0zLTEtMS0xMDc3MA_67f33fec-2dfa-4de3-b5d2-1eb0a2280ef1"
      unitRef="usd">60495000</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="i4161c5f102584f0fbecf9454461d6028_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOjMzODhiZTY0MWM3NjRjNjdiMTFiMzljODZmNTRmNWQ0L3RhYmxlcmFuZ2U6MzM4OGJlNjQxYzc2NGM2N2IxMWIzOWM4NmY1NGY1ZDRfNy0zLTEtMS0xMDc3MA_8bcb9fc1-edd6-497b-b0f7-647ecd8103b8"
      unitRef="usd">60495000</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="i33f34f84f7e146998551e4e55f51111a_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOjMzODhiZTY0MWM3NjRjNjdiMTFiMzljODZmNTRmNWQ0L3RhYmxlcmFuZ2U6MzM4OGJlNjQxYzc2NGM2N2IxMWIzOWM4NmY1NGY1ZDRfNy01LTEtMS0xMDc3MA_19fdcfb6-d1b9-4241-abe0-dca7540f9ffb"
      unitRef="usd">0</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="ibd0be51207114cd1b17f02ebecffc197_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOjMzODhiZTY0MWM3NjRjNjdiMTFiMzljODZmNTRmNWQ0L3RhYmxlcmFuZ2U6MzM4OGJlNjQxYzc2NGM2N2IxMWIzOWM4NmY1NGY1ZDRfNy01LTEtMS0xMDc3MA_1dbc6b33-9425-49c1-bea9-68abf81ca489"
      unitRef="usd">0</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOjMzODhiZTY0MWM3NjRjNjdiMTFiMzljODZmNTRmNWQ0L3RhYmxlcmFuZ2U6MzM4OGJlNjQxYzc2NGM2N2IxMWIzOWM4NmY1NGY1ZDRfNy03LTEtMS0xMDc3MA_2aa1ab44-3136-4c5d-8d92-24474997c8f8"
      unitRef="usd">214939000</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="i68ecd84e8da440808154baac134e839e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180My9mcmFnOmFiNDEyZTE5ZmM2NDQxZjBhYmRlYWExNjg4MWJiZmI0L3RhYmxlOjMzODhiZTY0MWM3NjRjNjdiMTFiMzljODZmNTRmNWQ0L3RhYmxlcmFuZ2U6MzM4OGJlNjQxYzc2NGM2N2IxMWIzOWM4NmY1NGY1ZDRfNy03LTEtMS0xMDc3MA_c417c356-7248-4073-b4dc-e7d34dfa1162"
      unitRef="usd">214939000</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180Ni9mcmFnOjFjN2FiODMzZjc4NjQxMjFiYWYxYWM1ZmJiYzhjMTdhL3RleHRyZWdpb246MWM3YWI4MzNmNzg2NDEyMWJhZjFhYzVmYmJjOGMxN2FfMTM3Mw_598b3b3e-0ac9-492c-85b5-62371f9230cb">NOTES PAYABLE AND CREDIT AGREEMENTOn February 9, 2018, the Company entered into the New Credit Agreement with several lenders to provide for the $400,000 Senior Credit Facility to replace its then-existing credit facilities. On June 14, 2019, the Company entered into the first amendment to the New Credit Agreement (the &#x201c;First Amendment&#x201d;) to provide for, among other things, a $150,000 secured term loan credit facility (the &#x201c;Term Loan&#x201d;). The Company fully repaid all amounts under the Term Loan in 2019. On February 14, 2020, the Company entered into the second amendment to the New Credit Agreement (the &#x201c;Second Amendment&#x201d;) to provide for, among other things, a $250,000 secured term loan credit facility (the &#x201c;Additional Term Loan&#x201d;). The Second Amendment (together with the New Credit Agreement and the First Amendment, collectively, the &#x201c;Amended Credit Agreement&#x201d;) extended the maturity date of the Senior Credit Facility to be coterminous with the Additional Term Loan. The Company used the proceeds from the Additional Term Loan, together with a drawdown of a portion of the Senior Credit Facility, to complete its acquisition of Stratus Video as more fully described in Note (2), &#x201c;Acquisitions.&#x201d; The Company repaid its outstanding indebtedness under the Additional Term Loan in the first quarter of 2021. The maturity date of the Senior Credit Facility is February 14, 2025.</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i1809609cdf714d66916ae3141253f6cd_I20180209"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180Ni9mcmFnOjFjN2FiODMzZjc4NjQxMjFiYWYxYWM1ZmJiYzhjMTdhL3RleHRyZWdpb246MWM3YWI4MzNmNzg2NDEyMWJhZjFhYzVmYmJjOGMxN2FfMTU0_49c6bee4-b5cb-47e2-b2a9-ea00df86de98"
      unitRef="usd">400000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LongTermDebt
      contextRef="i8962b4b53b6140de975c8a15752edd5d_I20190614"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180Ni9mcmFnOjFjN2FiODMzZjc4NjQxMjFiYWYxYWM1ZmJiYzhjMTdhL3RleHRyZWdpb246MWM3YWI4MzNmNzg2NDEyMWJhZjFhYzVmYmJjOGMxN2FfMzgx_79a5099a-06aa-40b7-bdab-80fe408402ff"
      unitRef="usd">150000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="ie9d4571d2fdf44c6ba87db28c14cb175_I20200214"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180Ni9mcmFnOjFjN2FiODMzZjc4NjQxMjFiYWYxYWM1ZmJiYzhjMTdhL3RleHRyZWdpb246MWM3YWI4MzNmNzg2NDEyMWJhZjFhYzVmYmJjOGMxN2FfNjYy_3aeacd78-d4ed-47b5-8fc4-6c23c4691acc"
      unitRef="usd">250000000</us-gaap:LongTermDebt>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180OS9mcmFnOjlmMmE0ZDZjODMwODRlMDJiOTY5OWMxNjM4MWY4NzFlL3RleHRyZWdpb246OWYyYTRkNmM4MzA4NGUwMmI5Njk5YzE2MzgxZjg3MWVfNTU3Ng_5d72a708-1571-4868-8724-969619cfe201">FAIR VALUE MEASUREMENT&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s valuation techniques and inputs used to measure fair value and the definition of the three levels (Level 1, Level 2, and Level 3) of the fair value hierarchy are disclosed in Part II, Item 8, &#x201c;Financial Statements and Supplementary Data&#x2014;Notes to Consolidated Financial Statements&#x2014;Note 3&#x2014;Fair Value Measurement&#x201d; of the 2020 Annual Report. The Company has not changed the valuation techniques or inputs it uses for its fair value measurement during the nine months ended September 30, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Assets and Liabilities Measured on a Recurring Basis&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Beginning in the third quarter of 2021, the Company invests a portion of its cash and cash equivalents in non-federally insured money market funds that are measured at fair value based on quoted prices, which are Level 1 inputs.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has a deferred compensation plan for certain executives and employees, which is composed of deferred compensation and all related income and losses attributable thereto. The Company&#x2019;s obligation under its deferred compensation plan is measured at fair value based on quoted market prices of the participants&#x2019; elected investments, which are Level 1 inputs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s restricted cash equivalents and investments that serve as collateral for the Company&#x2019;s captive insurance company primarily consist of commercial paper that is measured at observable market prices for identical securities that are traded in less active markets, which are Level 2 inputs. The Company&#x2019;s cash equivalents also include commercial paper classified as Level 2 in the fair value hierarchy. Of the $126,584 commercial paper issued and outstanding as of September&#160;30, 2021, $17,658 had original maturities greater than three months, which were considered available-for-sale securities. As of December&#160;31, 2020, the Company had $58,345 commercial paper issued and outstanding, of which $25,196 had original maturities greater than three months and were considered available-for-sale securities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s contingent consideration liabilities associated with acquisitions are measured at fair value using a probability-weighted discounted cash flow analysis or a simulation-based methodology for the acquired companies, which are Level 3 inputs. The Company recognizes changes to the fair value of its contingent consideration liabilities in selling, general and administrative expenses in the condensed consolidated statements of comprehensive income.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables present information about the above-referenced assets and liabilities and indicate the fair value hierarchy of the valuation techniques utilized to determine such fair value: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:43.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.765%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.208%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value Measurements as of September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Quoted&#160;Prices&#160;in&lt;br/&gt;Active&#160;Markets&lt;br/&gt;for Identical&lt;br/&gt;Assets&lt;br/&gt;(Level 1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Significant Other Observable Inputs&lt;br/&gt;(Level 2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Significant Unobservable Inputs&lt;br/&gt;(Level 3)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,569&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,569&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(117,020)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(117,020)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126,584&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126,584&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:43.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.765%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.208%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value Measurements as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Quoted&#160;Prices&#160;in&lt;br/&gt;Active&#160;Markets&lt;br/&gt;for Identical&lt;br/&gt;Assets&lt;br/&gt;(Level 1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Significant Other Observable Inputs&lt;br/&gt;(Level 2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Significant Unobservable Inputs&lt;br/&gt;(Level 3)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(97,184)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(97,184)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58,345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58,345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisition contingent consideration liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:4pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Level 3 Information&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables set forth a reconciliation of changes in the fair value of contingent consideration liabilities classified as Level 3 in the fair value hierarchy:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.291%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.192%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.194%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of July 1,&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,100)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in fair value of contingent consideration liability from b4health acquisition &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of September 30,&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,400)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.291%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.192%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.194%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of January 1,&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23,100)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settlement of Advanced contingent consideration liability for year ended December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settlement of b4health contingent consideration liability for year ended December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in fair value of contingent consideration liability from b4health acquisition &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of September 30,&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,400)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Assets Measured on a Non-Recurring Basis&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company applies fair value techniques on a non-recurring basis associated with valuing potential impairment losses related to its goodwill, indefinite-lived intangible assets, long-lived assets, and equity investments. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company evaluates goodwill and indefinite-lived intangible assets annually for impairment and whenever events or changes in circumstances indicate that it is more likely than not that an impairment exists. The Company determines the fair value of its reporting units based on a combination of inputs, including the market capitalization of the Company, as well as Level 3 inputs such as discounted cash flows, which are not observable from the market, directly or indirectly. The Company determines the fair value of its indefinite-lived intangible assets using the income approach (relief-from-royalty method) based on Level 3 inputs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s equity investment represents an investment in a non-controlled corporation without a readily determinable market value. The Company has elected to measure the investment at cost minus impairment, if any, plus or minus changes resulting from observable price changes. The fair value is determined by using quoted prices for identical or similar investments of the same issuer, which are Level 2 inputs, and other information available to the Company such as the rights and obligations of the securities. The Company recognizes changes to the fair value of its equity investment in interest expense, net, and other in the condensed consolidated statements of comprehensive income. The balance of the equity investment was $22,633 and $15,449 as of September&#160;30, 2021 and December&#160;31, 2020, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:4pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were no triggering events identified, no indication of impairment of the Company&#x2019;s goodwill, indefinite-lived intangible assets, long-lived assets, or equity investments, and no impairment charges recorded during the nine months ended September 30, 2021 and 2020. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Fair Value of Financial Instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is required to disclose the fair value of financial instruments for which it is practicable to estimate the value, even though these instruments are not recognized at fair value in the consolidated balance sheets. The fair value of the Company&#x2019;s 4.625% senior notes due 2027 (the &#x201c;2027 Notes&#x201d;) and 4.000% senior notes due 2029 (the &#x201c;2029 Notes&#x201d;) was estimated using quoted market prices in active markets for identical liabilities, which are Level 1 inputs. The carrying amounts and estimated fair value of the 2027 Notes and the 2029 Notes are presented in the following table. See additional information regarding the 2027 Notes and the 2029 Notes in Part II, Item 8, &#x201c;Financial Statements and Supplementary Data&#x2014;Notes to Consolidated Financial Statements&#x2014;Note (8), Notes Payable and Credit Agreement&#x201d; of the 2020 Annual Report. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:14pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:38.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.960%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027 Notes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;518,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;521,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2029 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;350,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;359,625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;350,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;357,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;The fair value of the Company&#x2019;s long-term self-insurance accruals cannot be estimated as the Company cannot reasonably determine the timing of future payments.</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:FairValueMeasurementPolicyPolicyTextBlock
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180OS9mcmFnOjlmMmE0ZDZjODMwODRlMDJiOTY5OWMxNjM4MWY4NzFlL3RleHRyZWdpb246OWYyYTRkNmM4MzA4NGUwMmI5Njk5YzE2MzgxZjg3MWVfNTU3Mw_8319de36-75b9-46c9-a3d3-7f0b350dfa7c">&lt;div style="margin-top:9pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Assets and Liabilities Measured on a Recurring Basis&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Beginning in the third quarter of 2021, the Company invests a portion of its cash and cash equivalents in non-federally insured money market funds that are measured at fair value based on quoted prices, which are Level 1 inputs.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has a deferred compensation plan for certain executives and employees, which is composed of deferred compensation and all related income and losses attributable thereto. The Company&#x2019;s obligation under its deferred compensation plan is measured at fair value based on quoted market prices of the participants&#x2019; elected investments, which are Level 1 inputs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s restricted cash equivalents and investments that serve as collateral for the Company&#x2019;s captive insurance company primarily consist of commercial paper that is measured at observable market prices for identical securities that are traded in less active markets, which are Level 2 inputs. The Company&#x2019;s cash equivalents also include commercial paper classified as Level 2 in the fair value hierarchy. Of the $126,584 commercial paper issued and outstanding as of September&#160;30, 2021, $17,658 had original maturities greater than three months, which were considered available-for-sale securities. As of December&#160;31, 2020, the Company had $58,345 commercial paper issued and outstanding, of which $25,196 had original maturities greater than three months and were considered available-for-sale securities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s contingent consideration liabilities associated with acquisitions are measured at fair value using a probability-weighted discounted cash flow analysis or a simulation-based methodology for the acquired companies, which are Level 3 inputs. The Company recognizes changes to the fair value of its contingent consideration liabilities in selling, general and administrative expenses in the condensed consolidated statements of comprehensive income.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Assets Measured on a Non-Recurring Basis&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company applies fair value techniques on a non-recurring basis associated with valuing potential impairment losses related to its goodwill, indefinite-lived intangible assets, long-lived assets, and equity investments. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company evaluates goodwill and indefinite-lived intangible assets annually for impairment and whenever events or changes in circumstances indicate that it is more likely than not that an impairment exists. The Company determines the fair value of its reporting units based on a combination of inputs, including the market capitalization of the Company, as well as Level 3 inputs such as discounted cash flows, which are not observable from the market, directly or indirectly. The Company determines the fair value of its indefinite-lived intangible assets using the income approach (relief-from-royalty method) based on Level 3 inputs.&lt;/span&gt;&lt;/div&gt;The Company&#x2019;s equity investment represents an investment in a non-controlled corporation without a readily determinable market value. The Company has elected to measure the investment at cost minus impairment, if any, plus or minus changes resulting from observable price changes. The fair value is determined by using quoted prices for identical or similar investments of the same issuer, which are Level 2 inputs, and other information available to the Company such as the rights and obligations of the securities. The Company recognizes changes to the fair value of its equity investment in interest expense, net, and other in the condensed consolidated statements of comprehensive income.&lt;div style="margin-top:9pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Fair Value of Financial Instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is required to disclose the fair value of financial instruments for which it is practicable to estimate the value, even though these instruments are not recognized at fair value in the consolidated balance sheets. The fair value of the Company&#x2019;s 4.625% senior notes due 2027 (the &#x201c;2027 Notes&#x201d;) and 4.000% senior notes due 2029 (the &#x201c;2029 Notes&#x201d;) was estimated using quoted market prices in active markets for identical liabilities, which are Level 1 inputs. The carrying amounts and estimated fair value of the 2027 Notes and the 2029 Notes are presented in the following table. See additional information regarding the 2027 Notes and the 2029 Notes in Part II, Item 8, &#x201c;Financial Statements and Supplementary Data&#x2014;Notes to Consolidated Financial Statements&#x2014;Note (8), Notes Payable and Credit Agreement&#x201d; of the 2020 Annual Report. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:14pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:38.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.960%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027 Notes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;518,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;521,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2029 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;350,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;359,625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;350,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;357,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;The fair value of the Company&#x2019;s long-term self-insurance accruals cannot be estimated as the Company cannot reasonably determine the timing of future payments.</us-gaap:FairValueMeasurementPolicyPolicyTextBlock>
    <us-gaap:FairValueNetAssetLiability
      contextRef="i75b241ded9e04282a87e07b5ca93bb10_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180OS9mcmFnOjlmMmE0ZDZjODMwODRlMDJiOTY5OWMxNjM4MWY4NzFlL3RleHRyZWdpb246OWYyYTRkNmM4MzA4NGUwMmI5Njk5YzE2MzgxZjg3MWVfMTQ2Nw_c9fccd82-9872-4db5-818a-0ac32da069ba"
      unitRef="usd">126584000</us-gaap:FairValueNetAssetLiability>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i75b241ded9e04282a87e07b5ca93bb10_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180OS9mcmFnOjlmMmE0ZDZjODMwODRlMDJiOTY5OWMxNjM4MWY4NzFlL3RleHRyZWdpb246OWYyYTRkNmM4MzA4NGUwMmI5Njk5YzE2MzgxZjg3MWVfMTUyMA_0432d339-2826-408e-898a-48fb68831509"
      unitRef="usd">17658000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:FairValueNetAssetLiability
      contextRef="ibdfd9e1e6a6a4aea800ca23a42cc6d9c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180OS9mcmFnOjlmMmE0ZDZjODMwODRlMDJiOTY5OWMxNjM4MWY4NzFlL3RleHRyZWdpb246OWYyYTRkNmM4MzA4NGUwMmI5Njk5YzE2MzgxZjg3MWVfMTY1Mw_77ae5813-83e0-4d06-9eaa-4283df27a0ff"
      unitRef="usd">58345000</us-gaap:FairValueNetAssetLiability>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ibdfd9e1e6a6a4aea800ca23a42cc6d9c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180OS9mcmFnOjlmMmE0ZDZjODMwODRlMDJiOTY5OWMxNjM4MWY4NzFlL3RleHRyZWdpb246OWYyYTRkNmM4MzA4NGUwMmI5Njk5YzE2MzgxZjg3MWVfMTcwNg_1fc19c06-0619-4485-8aa7-8a8684187ba9"
      unitRef="usd">25196000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180OS9mcmFnOjlmMmE0ZDZjODMwODRlMDJiOTY5OWMxNjM4MWY4NzFlL3RleHRyZWdpb246OWYyYTRkNmM4MzA4NGUwMmI5Njk5YzE2MzgxZjg3MWVfNTU4Nw_d06a946c-9a02-4b01-ba18-72dc3627ffe0">&lt;div style="margin-bottom:3pt;margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables present information about the above-referenced assets and liabilities and indicate the fair value hierarchy of the valuation techniques utilized to determine such fair value: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:43.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.765%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.208%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value Measurements as of September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Quoted&#160;Prices&#160;in&lt;br/&gt;Active&#160;Markets&lt;br/&gt;for Identical&lt;br/&gt;Assets&lt;br/&gt;(Level 1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Significant Other Observable Inputs&lt;br/&gt;(Level 2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Significant Unobservable Inputs&lt;br/&gt;(Level 3)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,569&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,569&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(117,020)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(117,020)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126,584&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126,584&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:43.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.765%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.208%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value Measurements as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Quoted&#160;Prices&#160;in&lt;br/&gt;Active&#160;Markets&lt;br/&gt;for Identical&lt;br/&gt;Assets&lt;br/&gt;(Level 1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Significant Other Observable Inputs&lt;br/&gt;(Level 2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Significant Unobservable Inputs&lt;br/&gt;(Level 3)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(97,184)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(97,184)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58,345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58,345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisition contingent consideration liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:FairValueNetAssetLiability
      contextRef="ic8ecfcf890884810930a3db121a37947_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180OS9mcmFnOjlmMmE0ZDZjODMwODRlMDJiOTY5OWMxNjM4MWY4NzFlL3RhYmxlOmQ3YWIxN2VkMzBiZTQyOTRhZDY5Y2ZiZmM0YzIwNzgwL3RhYmxlcmFuZ2U6ZDdhYjE3ZWQzMGJlNDI5NGFkNjljZmJmYzRjMjA3ODBfMi0xLTEtMS0xMDc3MA_dd839856-6a96-4367-b0d7-e95df6aaa68d"
      unitRef="usd">31569000</us-gaap:FairValueNetAssetLiability>
    <us-gaap:FairValueNetAssetLiability
      contextRef="i46feda5d0d364eabb7ec42a6d33247c6_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180OS9mcmFnOjlmMmE0ZDZjODMwODRlMDJiOTY5OWMxNjM4MWY4NzFlL3RhYmxlOmQ3YWIxN2VkMzBiZTQyOTRhZDY5Y2ZiZmM0YzIwNzgwL3RhYmxlcmFuZ2U6ZDdhYjE3ZWQzMGJlNDI5NGFkNjljZmJmYzRjMjA3ODBfMi0zLTEtMS0xMDc3MA_f3f71249-3115-49e5-9aab-73baed645845"
      unitRef="usd">31569000</us-gaap:FairValueNetAssetLiability>
    <us-gaap:FairValueNetAssetLiability
      contextRef="i98888a04caa94c449d58020688cc10b7_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180OS9mcmFnOjlmMmE0ZDZjODMwODRlMDJiOTY5OWMxNjM4MWY4NzFlL3RhYmxlOmQ3YWIxN2VkMzBiZTQyOTRhZDY5Y2ZiZmM0YzIwNzgwL3RhYmxlcmFuZ2U6ZDdhYjE3ZWQzMGJlNDI5NGFkNjljZmJmYzRjMjA3ODBfMi01LTEtMS0xMDc3MA_c5950c06-a884-4cf6-acd0-a0b53a03e30b"
      unitRef="usd">0</us-gaap:FairValueNetAssetLiability>
    <us-gaap:FairValueNetAssetLiability
      contextRef="i9aeb16c096e94fd18a6a4407369f7baf_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180OS9mcmFnOjlmMmE0ZDZjODMwODRlMDJiOTY5OWMxNjM4MWY4NzFlL3RhYmxlOmQ3YWIxN2VkMzBiZTQyOTRhZDY5Y2ZiZmM0YzIwNzgwL3RhYmxlcmFuZ2U6ZDdhYjE3ZWQzMGJlNDI5NGFkNjljZmJmYzRjMjA3ODBfMi03LTEtMS0xMDc3MA_dc126938-a67b-4c68-8953-76a6fee74708"
      unitRef="usd">0</us-gaap:FairValueNetAssetLiability>
    <us-gaap:FairValueNetAssetLiability
      contextRef="i7406af186f1f431ba3a5cae4e80d7461_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180OS9mcmFnOjlmMmE0ZDZjODMwODRlMDJiOTY5OWMxNjM4MWY4NzFlL3RhYmxlOmQ3YWIxN2VkMzBiZTQyOTRhZDY5Y2ZiZmM0YzIwNzgwL3RhYmxlcmFuZ2U6ZDdhYjE3ZWQzMGJlNDI5NGFkNjljZmJmYzRjMjA3ODBfMy0xLTEtMS0xMDc3MA_9dfffd18-d206-4a16-9d5c-187beaa046ca"
      unitRef="usd">-117020000</us-gaap:FairValueNetAssetLiability>
    <us-gaap:FairValueNetAssetLiability
      contextRef="i148698ba11334fa7962b91a16b3e7880_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180OS9mcmFnOjlmMmE0ZDZjODMwODRlMDJiOTY5OWMxNjM4MWY4NzFlL3RhYmxlOmQ3YWIxN2VkMzBiZTQyOTRhZDY5Y2ZiZmM0YzIwNzgwL3RhYmxlcmFuZ2U6ZDdhYjE3ZWQzMGJlNDI5NGFkNjljZmJmYzRjMjA3ODBfMy0zLTEtMS0xMDc3MA_12bac602-4073-4e23-bfa3-9265fcea6af1"
      unitRef="usd">-117020000</us-gaap:FairValueNetAssetLiability>
    <us-gaap:FairValueNetAssetLiability
      contextRef="i975bc3f2b0594c2996194a6fa3fd0687_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180OS9mcmFnOjlmMmE0ZDZjODMwODRlMDJiOTY5OWMxNjM4MWY4NzFlL3RhYmxlOmQ3YWIxN2VkMzBiZTQyOTRhZDY5Y2ZiZmM0YzIwNzgwL3RhYmxlcmFuZ2U6ZDdhYjE3ZWQzMGJlNDI5NGFkNjljZmJmYzRjMjA3ODBfMy01LTEtMS0xMDc3MA_97c58850-d43a-42e6-951a-03f001ec6071"
      unitRef="usd">0</us-gaap:FairValueNetAssetLiability>
    <us-gaap:FairValueNetAssetLiability
      contextRef="ia0adbc48e0574d688983232e62d3bdfa_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180OS9mcmFnOjlmMmE0ZDZjODMwODRlMDJiOTY5OWMxNjM4MWY4NzFlL3RhYmxlOmQ3YWIxN2VkMzBiZTQyOTRhZDY5Y2ZiZmM0YzIwNzgwL3RhYmxlcmFuZ2U6ZDdhYjE3ZWQzMGJlNDI5NGFkNjljZmJmYzRjMjA3ODBfMy03LTEtMS0xMDc3MA_5d65f87a-73e5-42ab-85d4-4901ff58769f"
      unitRef="usd">0</us-gaap:FairValueNetAssetLiability>
    <us-gaap:FairValueNetAssetLiability
      contextRef="i9f2f077331ea49d9a65ccd6f803814da_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180OS9mcmFnOjlmMmE0ZDZjODMwODRlMDJiOTY5OWMxNjM4MWY4NzFlL3RhYmxlOmQ3YWIxN2VkMzBiZTQyOTRhZDY5Y2ZiZmM0YzIwNzgwL3RhYmxlcmFuZ2U6ZDdhYjE3ZWQzMGJlNDI5NGFkNjljZmJmYzRjMjA3ODBfNC0xLTEtMS0xMDc3MA_4906e47c-49ea-450c-8d32-0fcd29bb4553"
      unitRef="usd">126584000</us-gaap:FairValueNetAssetLiability>
    <us-gaap:FairValueNetAssetLiability
      contextRef="i12f5a5f263ab4ab69a41578d13ee6032_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180OS9mcmFnOjlmMmE0ZDZjODMwODRlMDJiOTY5OWMxNjM4MWY4NzFlL3RhYmxlOmQ3YWIxN2VkMzBiZTQyOTRhZDY5Y2ZiZmM0YzIwNzgwL3RhYmxlcmFuZ2U6ZDdhYjE3ZWQzMGJlNDI5NGFkNjljZmJmYzRjMjA3ODBfNC0zLTEtMS0xMDc3MA_3d13417d-619d-482c-be4d-e365a4448892"
      unitRef="usd">0</us-gaap:FairValueNetAssetLiability>
    <us-gaap:FairValueNetAssetLiability
      contextRef="i75b241ded9e04282a87e07b5ca93bb10_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180OS9mcmFnOjlmMmE0ZDZjODMwODRlMDJiOTY5OWMxNjM4MWY4NzFlL3RhYmxlOmQ3YWIxN2VkMzBiZTQyOTRhZDY5Y2ZiZmM0YzIwNzgwL3RhYmxlcmFuZ2U6ZDdhYjE3ZWQzMGJlNDI5NGFkNjljZmJmYzRjMjA3ODBfNC01LTEtMS0xMDc3MA_dc66bb38-2fe9-4740-8adb-b9dfc5a40af4"
      unitRef="usd">126584000</us-gaap:FairValueNetAssetLiability>
    <us-gaap:FairValueNetAssetLiability
      contextRef="i1643e3ce569e435e90215e4c1f80cc45_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180OS9mcmFnOjlmMmE0ZDZjODMwODRlMDJiOTY5OWMxNjM4MWY4NzFlL3RhYmxlOmQ3YWIxN2VkMzBiZTQyOTRhZDY5Y2ZiZmM0YzIwNzgwL3RhYmxlcmFuZ2U6ZDdhYjE3ZWQzMGJlNDI5NGFkNjljZmJmYzRjMjA3ODBfNC03LTEtMS0xMDc3MA_a0ab9156-f09a-4904-b96b-2cc46db7fd77"
      unitRef="usd">0</us-gaap:FairValueNetAssetLiability>
    <us-gaap:FairValueNetAssetLiability
      contextRef="i04416ccdf99b4368b4ae3bb3d5c50522_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180OS9mcmFnOjlmMmE0ZDZjODMwODRlMDJiOTY5OWMxNjM4MWY4NzFlL3RhYmxlOjI2N2I0M2YzZGMzMjQwYzA4NjI4MjU2N2M5ZDJjZmJiL3RhYmxlcmFuZ2U6MjY3YjQzZjNkYzMyNDBjMDg2MjgyNTY3YzlkMmNmYmJfMi0xLTEtMS0xMDc3MA_1b30c773-7cf4-4c70-9bd8-836c9a510042"
      unitRef="usd">2198000</us-gaap:FairValueNetAssetLiability>
    <us-gaap:FairValueNetAssetLiability
      contextRef="i2779feaa7ca44c64a5d0144e462d669e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180OS9mcmFnOjlmMmE0ZDZjODMwODRlMDJiOTY5OWMxNjM4MWY4NzFlL3RhYmxlOjI2N2I0M2YzZGMzMjQwYzA4NjI4MjU2N2M5ZDJjZmJiL3RhYmxlcmFuZ2U6MjY3YjQzZjNkYzMyNDBjMDg2MjgyNTY3YzlkMmNmYmJfMi0zLTEtMS0xMDc3MA_e3f31b79-d467-4014-8477-53accdbfbb4c"
      unitRef="usd">2198000</us-gaap:FairValueNetAssetLiability>
    <us-gaap:FairValueNetAssetLiability
      contextRef="ie85028cf6e7e4291811ded1080e9ccef_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180OS9mcmFnOjlmMmE0ZDZjODMwODRlMDJiOTY5OWMxNjM4MWY4NzFlL3RhYmxlOjI2N2I0M2YzZGMzMjQwYzA4NjI4MjU2N2M5ZDJjZmJiL3RhYmxlcmFuZ2U6MjY3YjQzZjNkYzMyNDBjMDg2MjgyNTY3YzlkMmNmYmJfMi01LTEtMS0xMDc3MA_f2cd669c-312f-4e48-90d8-2aeb8de8c276"
      unitRef="usd">0</us-gaap:FairValueNetAssetLiability>
    <us-gaap:FairValueNetAssetLiability
      contextRef="i12292bac56af415ebe14864b760b6aee_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180OS9mcmFnOjlmMmE0ZDZjODMwODRlMDJiOTY5OWMxNjM4MWY4NzFlL3RhYmxlOjI2N2I0M2YzZGMzMjQwYzA4NjI4MjU2N2M5ZDJjZmJiL3RhYmxlcmFuZ2U6MjY3YjQzZjNkYzMyNDBjMDg2MjgyNTY3YzlkMmNmYmJfMi03LTEtMS0xMDc3MA_524a172a-50ed-4391-9a33-cba25c49e3fc"
      unitRef="usd">0</us-gaap:FairValueNetAssetLiability>
    <us-gaap:FairValueNetAssetLiability
      contextRef="iaad52f29996b478daad64bf29bf17dbe_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180OS9mcmFnOjlmMmE0ZDZjODMwODRlMDJiOTY5OWMxNjM4MWY4NzFlL3RhYmxlOjI2N2I0M2YzZGMzMjQwYzA4NjI4MjU2N2M5ZDJjZmJiL3RhYmxlcmFuZ2U6MjY3YjQzZjNkYzMyNDBjMDg2MjgyNTY3YzlkMmNmYmJfMy0xLTEtMS0xMDc3MA_12e36d84-5981-4069-86ac-0b8748699963"
      unitRef="usd">-97184000</us-gaap:FairValueNetAssetLiability>
    <us-gaap:FairValueNetAssetLiability
      contextRef="i90ee55464c34456ab9205a90173c745d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180OS9mcmFnOjlmMmE0ZDZjODMwODRlMDJiOTY5OWMxNjM4MWY4NzFlL3RhYmxlOjI2N2I0M2YzZGMzMjQwYzA4NjI4MjU2N2M5ZDJjZmJiL3RhYmxlcmFuZ2U6MjY3YjQzZjNkYzMyNDBjMDg2MjgyNTY3YzlkMmNmYmJfMy0zLTEtMS0xMDc3MA_c14f187c-61e2-495d-aff4-3c9c431c8bfb"
      unitRef="usd">-97184000</us-gaap:FairValueNetAssetLiability>
    <us-gaap:FairValueNetAssetLiability
      contextRef="i2dae041f1c2049bc8a78d41d20bd5c01_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180OS9mcmFnOjlmMmE0ZDZjODMwODRlMDJiOTY5OWMxNjM4MWY4NzFlL3RhYmxlOjI2N2I0M2YzZGMzMjQwYzA4NjI4MjU2N2M5ZDJjZmJiL3RhYmxlcmFuZ2U6MjY3YjQzZjNkYzMyNDBjMDg2MjgyNTY3YzlkMmNmYmJfMy01LTEtMS0xMDc3MA_0e94335a-46cb-46f5-b320-8e552c3a4b3b"
      unitRef="usd">0</us-gaap:FairValueNetAssetLiability>
    <us-gaap:FairValueNetAssetLiability
      contextRef="i01af2c6807964bd3a70f87bed11d7f18_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180OS9mcmFnOjlmMmE0ZDZjODMwODRlMDJiOTY5OWMxNjM4MWY4NzFlL3RhYmxlOjI2N2I0M2YzZGMzMjQwYzA4NjI4MjU2N2M5ZDJjZmJiL3RhYmxlcmFuZ2U6MjY3YjQzZjNkYzMyNDBjMDg2MjgyNTY3YzlkMmNmYmJfMy03LTEtMS0xMDc3MA_099d1f7c-6505-445c-beeb-3416bb47128a"
      unitRef="usd">0</us-gaap:FairValueNetAssetLiability>
    <us-gaap:FairValueNetAssetLiability
      contextRef="i52afbebb62d24268b4227e4d0ecbfbd0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180OS9mcmFnOjlmMmE0ZDZjODMwODRlMDJiOTY5OWMxNjM4MWY4NzFlL3RhYmxlOjI2N2I0M2YzZGMzMjQwYzA4NjI4MjU2N2M5ZDJjZmJiL3RhYmxlcmFuZ2U6MjY3YjQzZjNkYzMyNDBjMDg2MjgyNTY3YzlkMmNmYmJfNC0xLTEtMS0xMDc3MA_f39a711e-e16b-4d57-b4c9-862c354fdf57"
      unitRef="usd">58345000</us-gaap:FairValueNetAssetLiability>
    <us-gaap:FairValueNetAssetLiability
      contextRef="i33219b4f757444d0acfe2defee9c77a2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180OS9mcmFnOjlmMmE0ZDZjODMwODRlMDJiOTY5OWMxNjM4MWY4NzFlL3RhYmxlOjI2N2I0M2YzZGMzMjQwYzA4NjI4MjU2N2M5ZDJjZmJiL3RhYmxlcmFuZ2U6MjY3YjQzZjNkYzMyNDBjMDg2MjgyNTY3YzlkMmNmYmJfNC0zLTEtMS0xMDc3MA_1bb6592c-6a71-4ba0-96b6-c2aa8c9ca554"
      unitRef="usd">0</us-gaap:FairValueNetAssetLiability>
    <us-gaap:FairValueNetAssetLiability
      contextRef="ibdfd9e1e6a6a4aea800ca23a42cc6d9c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180OS9mcmFnOjlmMmE0ZDZjODMwODRlMDJiOTY5OWMxNjM4MWY4NzFlL3RhYmxlOjI2N2I0M2YzZGMzMjQwYzA4NjI4MjU2N2M5ZDJjZmJiL3RhYmxlcmFuZ2U6MjY3YjQzZjNkYzMyNDBjMDg2MjgyNTY3YzlkMmNmYmJfNC01LTEtMS0xMDc3MA_e544910b-46cd-430c-a1c4-d71f9770670e"
      unitRef="usd">58345000</us-gaap:FairValueNetAssetLiability>
    <us-gaap:FairValueNetAssetLiability
      contextRef="icabd932ac65d40a9ad263428cb023998_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180OS9mcmFnOjlmMmE0ZDZjODMwODRlMDJiOTY5OWMxNjM4MWY4NzFlL3RhYmxlOjI2N2I0M2YzZGMzMjQwYzA4NjI4MjU2N2M5ZDJjZmJiL3RhYmxlcmFuZ2U6MjY3YjQzZjNkYzMyNDBjMDg2MjgyNTY3YzlkMmNmYmJfNC03LTEtMS0xMDc3MA_93af0c08-6677-42bb-830a-4a803504387e"
      unitRef="usd">0</us-gaap:FairValueNetAssetLiability>
    <us-gaap:FairValueNetAssetLiability
      contextRef="ia2321e23f81c49fca30df6d0483acd39_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180OS9mcmFnOjlmMmE0ZDZjODMwODRlMDJiOTY5OWMxNjM4MWY4NzFlL3RhYmxlOjI2N2I0M2YzZGMzMjQwYzA4NjI4MjU2N2M5ZDJjZmJiL3RhYmxlcmFuZ2U6MjY3YjQzZjNkYzMyNDBjMDg2MjgyNTY3YzlkMmNmYmJfNS0xLTEtMS0xMDc3MA_44244836-be28-4f0f-a82d-b3df6b056c49"
      unitRef="usd">-8000000</us-gaap:FairValueNetAssetLiability>
    <us-gaap:FairValueNetAssetLiability
      contextRef="ie87be00cfa4e4645b636d077357bfaaa_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180OS9mcmFnOjlmMmE0ZDZjODMwODRlMDJiOTY5OWMxNjM4MWY4NzFlL3RhYmxlOjI2N2I0M2YzZGMzMjQwYzA4NjI4MjU2N2M5ZDJjZmJiL3RhYmxlcmFuZ2U6MjY3YjQzZjNkYzMyNDBjMDg2MjgyNTY3YzlkMmNmYmJfNS0zLTEtMS0xMDc3MA_89016cc2-55de-4158-979c-4debb8db5eab"
      unitRef="usd">0</us-gaap:FairValueNetAssetLiability>
    <us-gaap:FairValueNetAssetLiability
      contextRef="ibe1edb1c0b7d484da43d71c0fcdd0d28_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180OS9mcmFnOjlmMmE0ZDZjODMwODRlMDJiOTY5OWMxNjM4MWY4NzFlL3RhYmxlOjI2N2I0M2YzZGMzMjQwYzA4NjI4MjU2N2M5ZDJjZmJiL3RhYmxlcmFuZ2U6MjY3YjQzZjNkYzMyNDBjMDg2MjgyNTY3YzlkMmNmYmJfNS01LTEtMS0xMDc3MA_8f6dd47d-7583-4964-acb4-5d8465c44db2"
      unitRef="usd">0</us-gaap:FairValueNetAssetLiability>
    <us-gaap:FairValueNetAssetLiability
      contextRef="i6181153aab9d4bf1a9ac5e86d83189ec_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180OS9mcmFnOjlmMmE0ZDZjODMwODRlMDJiOTY5OWMxNjM4MWY4NzFlL3RhYmxlOjI2N2I0M2YzZGMzMjQwYzA4NjI4MjU2N2M5ZDJjZmJiL3RhYmxlcmFuZ2U6MjY3YjQzZjNkYzMyNDBjMDg2MjgyNTY3YzlkMmNmYmJfNS03LTEtMS0xMDc3MA_f2e3597a-4a52-4c87-a07d-647d2a1252e8"
      unitRef="usd">-8000000</us-gaap:FairValueNetAssetLiability>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180OS9mcmFnOjlmMmE0ZDZjODMwODRlMDJiOTY5OWMxNjM4MWY4NzFlL3RleHRyZWdpb246OWYyYTRkNmM4MzA4NGUwMmI5Njk5YzE2MzgxZjg3MWVfNTU3NA_a3eb3636-256d-461f-9133-35b9fa3ebcfe">&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables set forth a reconciliation of changes in the fair value of contingent consideration liabilities classified as Level 3 in the fair value hierarchy:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.291%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.192%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.194%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of July 1,&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,100)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in fair value of contingent consideration liability from b4health acquisition &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of September 30,&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,400)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.291%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.192%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.194%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of January 1,&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23,100)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settlement of Advanced contingent consideration liability for year ended December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settlement of b4health contingent consideration liability for year ended December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in fair value of contingent consideration liability from b4health acquisition &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of September 30,&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,400)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="id213a9f9047d4508aeef40c71a6fe7f3_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180OS9mcmFnOjlmMmE0ZDZjODMwODRlMDJiOTY5OWMxNjM4MWY4NzFlL3RhYmxlOjRiYTM1NzIyNWY0MjQ3NWM4YzgxNzk5ZmVjYzljMzRiL3RhYmxlcmFuZ2U6NGJhMzU3MjI1ZjQyNDc1YzhjODE3OTlmZWNjOWMzNGJfMS0xLTEtMS0xMDc3MA_39cabb96-48bc-42a8-9ce4-78ac31f5b430"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i26375226748e457a83389380abbeabb8_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180OS9mcmFnOjlmMmE0ZDZjODMwODRlMDJiOTY5OWMxNjM4MWY4NzFlL3RhYmxlOjRiYTM1NzIyNWY0MjQ3NWM4YzgxNzk5ZmVjYzljMzRiL3RhYmxlcmFuZ2U6NGJhMzU3MjI1ZjQyNDc1YzhjODE3OTlmZWNjOWMzNGJfMS0zLTEtMS0xMDc3MA_43093abd-ba98-4518-969f-53868a26cbba"
      unitRef="usd">8100000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="ia06522632d4f4b51b495d744af0113af_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180OS9mcmFnOjlmMmE0ZDZjODMwODRlMDJiOTY5OWMxNjM4MWY4NzFlL3RhYmxlOjRiYTM1NzIyNWY0MjQ3NWM4YzgxNzk5ZmVjYzljMzRiL3RhYmxlcmFuZ2U6NGJhMzU3MjI1ZjQyNDc1YzhjODE3OTlmZWNjOWMzNGJfNi0xLTEtMS0xMDc3MA_8ece0c65-6159-457d-92de-c81888a6e6b3"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="i3225a1c038234fd6ad8decf2eea09642_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180OS9mcmFnOjlmMmE0ZDZjODMwODRlMDJiOTY5OWMxNjM4MWY4NzFlL3RhYmxlOjRiYTM1NzIyNWY0MjQ3NWM4YzgxNzk5ZmVjYzljMzRiL3RhYmxlcmFuZ2U6NGJhMzU3MjI1ZjQyNDc1YzhjODE3OTlmZWNjOWMzNGJfNi0zLTEtMS0xMDc3MA_139d62fe-6ce6-4386-8b70-77e121ca8387"
      unitRef="usd">6700000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="ia1c38f520570446e977fefc12947c6df_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180OS9mcmFnOjlmMmE0ZDZjODMwODRlMDJiOTY5OWMxNjM4MWY4NzFlL3RhYmxlOjRiYTM1NzIyNWY0MjQ3NWM4YzgxNzk5ZmVjYzljMzRiL3RhYmxlcmFuZ2U6NGJhMzU3MjI1ZjQyNDc1YzhjODE3OTlmZWNjOWMzNGJfNy0xLTEtMS0xMDc3MA_0e73d772-671c-455d-bb70-822991ce0494"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="if25b9265f3954756bd8d09991a579c63_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180OS9mcmFnOjlmMmE0ZDZjODMwODRlMDJiOTY5OWMxNjM4MWY4NzFlL3RhYmxlOjRiYTM1NzIyNWY0MjQ3NWM4YzgxNzk5ZmVjYzljMzRiL3RhYmxlcmFuZ2U6NGJhMzU3MjI1ZjQyNDc1YzhjODE3OTlmZWNjOWMzNGJfNy0zLTEtMS0xMDc3MA_92c9d61e-f4a9-47b8-9241-dfb534b7b015"
      unitRef="usd">1400000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i6181153aab9d4bf1a9ac5e86d83189ec_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180OS9mcmFnOjlmMmE0ZDZjODMwODRlMDJiOTY5OWMxNjM4MWY4NzFlL3RhYmxlOjZiMjE1MGZlM2UwZTRkMWM5NTliNGM3ZTc1MjkyY2I3L3RhYmxlcmFuZ2U6NmIyMTUwZmUzZTBlNGQxYzk1OWI0YzdlNzUyOTJjYjdfMS0xLTEtMS0xMDc3MA_e378e1d9-305b-468d-9c46-857b6d8803e3"
      unitRef="usd">8000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i27f0dfb23ddc496989d2606c383df2c5_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180OS9mcmFnOjlmMmE0ZDZjODMwODRlMDJiOTY5OWMxNjM4MWY4NzFlL3RhYmxlOjZiMjE1MGZlM2UwZTRkMWM5NTliNGM3ZTc1MjkyY2I3L3RhYmxlcmFuZ2U6NmIyMTUwZmUzZTBlNGQxYzk1OWI0YzdlNzUyOTJjYjdfMS0zLTEtMS0xMDc3MA_939ca570-d717-4959-b058-1a0874772326"
      unitRef="usd">23100000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
      contextRef="ia74ee65117cd4be980399efaba0fd27f_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180OS9mcmFnOjlmMmE0ZDZjODMwODRlMDJiOTY5OWMxNjM4MWY4NzFlL3RhYmxlOjZiMjE1MGZlM2UwZTRkMWM5NTliNGM3ZTc1MjkyY2I3L3RhYmxlcmFuZ2U6NmIyMTUwZmUzZTBlNGQxYzk1OWI0YzdlNzUyOTJjYjdfMi0xLTEtMS0xMDc3MA_f8cd506b-b672-4513-bee6-7d31e08c15e9"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
      contextRef="i3dced23531a14782bb18a2d74864eba6_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180OS9mcmFnOjlmMmE0ZDZjODMwODRlMDJiOTY5OWMxNjM4MWY4NzFlL3RhYmxlOjZiMjE1MGZlM2UwZTRkMWM5NTliNGM3ZTc1MjkyY2I3L3RhYmxlcmFuZ2U6NmIyMTUwZmUzZTBlNGQxYzk1OWI0YzdlNzUyOTJjYjdfMi0zLTEtMS0xMDc3MA_fcd1b8b3-8d42-426b-8be6-5ca1de70d138"
      unitRef="usd">20000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
      contextRef="ia8887638bb5c4199a5d785b2a07d5378_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180OS9mcmFnOjlmMmE0ZDZjODMwODRlMDJiOTY5OWMxNjM4MWY4NzFlL3RhYmxlOjZiMjE1MGZlM2UwZTRkMWM5NTliNGM3ZTc1MjkyY2I3L3RhYmxlcmFuZ2U6NmIyMTUwZmUzZTBlNGQxYzk1OWI0YzdlNzUyOTJjYjdfMy0xLTEtMS0xMDc3MA_8406a298-321e-4c06-8f1b-4a129b86f836"
      unitRef="usd">8000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
      contextRef="i8797e43b32204823b6a3ad14b6669a69_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180OS9mcmFnOjlmMmE0ZDZjODMwODRlMDJiOTY5OWMxNjM4MWY4NzFlL3RhYmxlOjZiMjE1MGZlM2UwZTRkMWM5NTliNGM3ZTc1MjkyY2I3L3RhYmxlcmFuZ2U6NmIyMTUwZmUzZTBlNGQxYzk1OWI0YzdlNzUyOTJjYjdfMy0zLTEtMS0xMDc3MA_f84dfa57-c525-464e-9027-ee2eaeebd909"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="ia8887638bb5c4199a5d785b2a07d5378_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180OS9mcmFnOjlmMmE0ZDZjODMwODRlMDJiOTY5OWMxNjM4MWY4NzFlL3RhYmxlOjZiMjE1MGZlM2UwZTRkMWM5NTliNGM3ZTc1MjkyY2I3L3RhYmxlcmFuZ2U6NmIyMTUwZmUzZTBlNGQxYzk1OWI0YzdlNzUyOTJjYjdfOS0xLTEtMS0xMDc3MA_bd59fb7e-507e-48e7-95b2-74f177b20f0e"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="i8797e43b32204823b6a3ad14b6669a69_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180OS9mcmFnOjlmMmE0ZDZjODMwODRlMDJiOTY5OWMxNjM4MWY4NzFlL3RhYmxlOjZiMjE1MGZlM2UwZTRkMWM5NTliNGM3ZTc1MjkyY2I3L3RhYmxlcmFuZ2U6NmIyMTUwZmUzZTBlNGQxYzk1OWI0YzdlNzUyOTJjYjdfOS0zLTEtMS0xMDc3MA_22a50de5-ad25-4231-b8ae-2a717441269d"
      unitRef="usd">1700000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="ia1c38f520570446e977fefc12947c6df_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180OS9mcmFnOjlmMmE0ZDZjODMwODRlMDJiOTY5OWMxNjM4MWY4NzFlL3RhYmxlOjZiMjE1MGZlM2UwZTRkMWM5NTliNGM3ZTc1MjkyY2I3L3RhYmxlcmFuZ2U6NmIyMTUwZmUzZTBlNGQxYzk1OWI0YzdlNzUyOTJjYjdfMTAtMS0xLTEtMTA3NzA_0e73d772-671c-455d-bb70-822991ce0494"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="if25b9265f3954756bd8d09991a579c63_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180OS9mcmFnOjlmMmE0ZDZjODMwODRlMDJiOTY5OWMxNjM4MWY4NzFlL3RhYmxlOjZiMjE1MGZlM2UwZTRkMWM5NTliNGM3ZTc1MjkyY2I3L3RhYmxlcmFuZ2U6NmIyMTUwZmUzZTBlNGQxYzk1OWI0YzdlNzUyOTJjYjdfMTAtMy0xLTEtMTA3NzA_92c9d61e-f4a9-47b8-9241-dfb534b7b015"
      unitRef="usd">1400000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i77b494fe460f4789ba120f413470a8d9_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180OS9mcmFnOjlmMmE0ZDZjODMwODRlMDJiOTY5OWMxNjM4MWY4NzFlL3RleHRyZWdpb246OWYyYTRkNmM4MzA4NGUwMmI5Njk5YzE2MzgxZjg3MWVfNDI1NA_01ec4095-c9cf-492e-a04f-b3741537eb7e"
      unitRef="usd">22633000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="ic05278c1e0a647149ea04d2fc5ffc568_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180OS9mcmFnOjlmMmE0ZDZjODMwODRlMDJiOTY5OWMxNjM4MWY4NzFlL3RleHRyZWdpb246OWYyYTRkNmM4MzA4NGUwMmI5Njk5YzE2MzgxZjg3MWVfNDI2MQ_f2eec956-29a2-421b-9687-9bd7528c67a7"
      unitRef="usd">15449000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:AssetImpairmentCharges
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180OS9mcmFnOjlmMmE0ZDZjODMwODRlMDJiOTY5OWMxNjM4MWY4NzFlL3RleHRyZWdpb246OWYyYTRkNmM4MzA4NGUwMmI5Njk5YzE2MzgxZjg3MWVfNDQ3Ng_85b9e44a-cfc9-4c0c-8ef0-39e8e30f2f52"
      unitRef="usd">0</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="i22eba0e0c0884f67a51dbdd598304e97_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180OS9mcmFnOjlmMmE0ZDZjODMwODRlMDJiOTY5OWMxNjM4MWY4NzFlL3RleHRyZWdpb246OWYyYTRkNmM4MzA4NGUwMmI5Njk5YzE2MzgxZjg3MWVfNDQ3Ng_b77ea092-bc3b-43cb-b950-d51a39c45095"
      unitRef="usd">0</us-gaap:AssetImpairmentCharges>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ic9968f7f2c454182aab2b88a2b279e04_I20200813"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180OS9mcmFnOjlmMmE0ZDZjODMwODRlMDJiOTY5OWMxNjM4MWY4NzFlL3RleHRyZWdpb246OWYyYTRkNmM4MzA4NGUwMmI5Njk5YzE2MzgxZjg3MWVfNDgyNA_7db26a25-1638-4384-bcbc-c33ce99c459f"
      unitRef="number">0.04625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i2f6d79fdc037408d9dc6b393a68f3b3f_I20201020"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180OS9mcmFnOjlmMmE0ZDZjODMwODRlMDJiOTY5OWMxNjM4MWY4NzFlL3RleHRyZWdpb246OWYyYTRkNmM4MzA4NGUwMmI5Njk5YzE2MzgxZjg3MWVfNDg3Mg_37a7c628-59d8-4008-991b-890bfcfddfe9"
      unitRef="number">0.04000</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ScheduleOfFairValueOffBalanceSheetRisksTextBlock
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180OS9mcmFnOjlmMmE0ZDZjODMwODRlMDJiOTY5OWMxNjM4MWY4NzFlL3RleHRyZWdpb246OWYyYTRkNmM4MzA4NGUwMmI5Njk5YzE2MzgxZjg3MWVfNTYwNg_f9da9739-41ba-40be-9d0c-1a74b5562384">See additional information regarding the 2027 Notes and the 2029 Notes in Part II, Item 8, &#x201c;Financial Statements and Supplementary Data&#x2014;Notes to Consolidated Financial Statements&#x2014;Note (8), Notes Payable and Credit Agreement&#x201d; of the 2020 Annual Report. &lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:38.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.960%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027 Notes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;518,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;521,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2029 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;350,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;359,625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;350,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;357,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfFairValueOffBalanceSheetRisksTextBlock>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i74b3184e58994da0b7590f17370f09da_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180OS9mcmFnOjlmMmE0ZDZjODMwODRlMDJiOTY5OWMxNjM4MWY4NzFlL3RhYmxlOjI3NWFhOTk3NjlmMDQ2OTI5MDRlZmRhNmYwOWVkYWM0L3RhYmxlcmFuZ2U6Mjc1YWE5OTc2OWYwNDY5MjkwNGVmZGE2ZjA5ZWRhYzRfMi0xLTEtMS0xMDc3MA_8ed0b227-8774-4cc3-bde6-50d9cabc5886"
      unitRef="usd">500000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i74b3184e58994da0b7590f17370f09da_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180OS9mcmFnOjlmMmE0ZDZjODMwODRlMDJiOTY5OWMxNjM4MWY4NzFlL3RhYmxlOjI3NWFhOTk3NjlmMDQ2OTI5MDRlZmRhNmYwOWVkYWM0L3RhYmxlcmFuZ2U6Mjc1YWE5OTc2OWYwNDY5MjkwNGVmZGE2ZjA5ZWRhYzRfMi0yLTEtMS0xMDc3MA_fbe47aac-eaa2-4e00-a12e-5feae209ec32"
      unitRef="usd">518750000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ia140cdbfeac94d9dbe04b0a64460ff19_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180OS9mcmFnOjlmMmE0ZDZjODMwODRlMDJiOTY5OWMxNjM4MWY4NzFlL3RhYmxlOjI3NWFhOTk3NjlmMDQ2OTI5MDRlZmRhNmYwOWVkYWM0L3RhYmxlcmFuZ2U6Mjc1YWE5OTc2OWYwNDY5MjkwNGVmZGE2ZjA5ZWRhYzRfMi00LTEtMS0xMDc3MA_1e8efb34-9510-49ab-81f5-bad28b279945"
      unitRef="usd">500000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFairValue
      contextRef="ia140cdbfeac94d9dbe04b0a64460ff19_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180OS9mcmFnOjlmMmE0ZDZjODMwODRlMDJiOTY5OWMxNjM4MWY4NzFlL3RhYmxlOjI3NWFhOTk3NjlmMDQ2OTI5MDRlZmRhNmYwOWVkYWM0L3RhYmxlcmFuZ2U6Mjc1YWE5OTc2OWYwNDY5MjkwNGVmZGE2ZjA5ZWRhYzRfMi01LTEtMS0xMDc3MA_e3493e2b-9a26-4cfa-896e-b94abb1fcfab"
      unitRef="usd">521250000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ia9ea250e0d094ba5b694f077af429acd_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180OS9mcmFnOjlmMmE0ZDZjODMwODRlMDJiOTY5OWMxNjM4MWY4NzFlL3RhYmxlOjI3NWFhOTk3NjlmMDQ2OTI5MDRlZmRhNmYwOWVkYWM0L3RhYmxlcmFuZ2U6Mjc1YWE5OTc2OWYwNDY5MjkwNGVmZGE2ZjA5ZWRhYzRfMy0xLTEtMS0xMDc3MA_cc94ed98-dc4f-47fc-b8ae-fe2362bb8c1d"
      unitRef="usd">350000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFairValue
      contextRef="ia9ea250e0d094ba5b694f077af429acd_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180OS9mcmFnOjlmMmE0ZDZjODMwODRlMDJiOTY5OWMxNjM4MWY4NzFlL3RhYmxlOjI3NWFhOTk3NjlmMDQ2OTI5MDRlZmRhNmYwOWVkYWM0L3RhYmxlcmFuZ2U6Mjc1YWE5OTc2OWYwNDY5MjkwNGVmZGE2ZjA5ZWRhYzRfMy0yLTEtMS0xMDc3MA_ba728a77-8685-42a4-97e3-44104bd28710"
      unitRef="usd">359625000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i17ce2ad3d6e849fc9dea40319a4961e3_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180OS9mcmFnOjlmMmE0ZDZjODMwODRlMDJiOTY5OWMxNjM4MWY4NzFlL3RhYmxlOjI3NWFhOTk3NjlmMDQ2OTI5MDRlZmRhNmYwOWVkYWM0L3RhYmxlcmFuZ2U6Mjc1YWE5OTc2OWYwNDY5MjkwNGVmZGE2ZjA5ZWRhYzRfMy00LTEtMS0xMDc3MA_94839132-e695-4002-8d4c-02bee5728910"
      unitRef="usd">350000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i17ce2ad3d6e849fc9dea40319a4961e3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y180OS9mcmFnOjlmMmE0ZDZjODMwODRlMDJiOTY5OWMxNjM4MWY4NzFlL3RhYmxlOjI3NWFhOTk3NjlmMDQ2OTI5MDRlZmRhNmYwOWVkYWM0L3RhYmxlcmFuZ2U6Mjc1YWE5OTc2OWYwNDY5MjkwNGVmZGE2ZjA5ZWRhYzRfMy01LTEtMS0xMDc3MA_bd0ca8b6-3032-4786-9c42-bd6c92c6a457"
      unitRef="usd">357000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:LesseeOperatingLeasesTextBlock
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y181Mi9mcmFnOjY1YzQyZmU5ZTlmODQ2MTI4NjhlMjRlNjkxMmZmMWExL3RleHRyZWdpb246NjVjNDJmZTllOWY4NDYxMjg2OGUyNGU2OTEyZmYxYTFfMzg0ODI5MDY5ODI4Ng_fdec650e-1f3f-4030-a7de-cacd9936b939">LEASESDuring the three months ended September 30, 2021, the Company entered into an arrangement to terminate the lease agreement (as amended to date) for its office space in San Diego. The termination will occur in two phases: the first phase terminates the Company&#x2019;s right to use certain floors effective February 28, 2022 and the second phase reduces the remaining lease term to December 31, 2024 from its original termination date of July 31, 2027. As a result of the arrangement, which was accounted for as a modification, the Company paid a termination fee of $17,000, remeasured the lease liability using its incremental borrowing rate as the discount rate, and recorded decreases to its operating lease liabilities and right-of-use assets of $27,340 during the three months ended September 30, 2021. Prior to the modification, the total remaining lease payments for this office lease were $62,487. Under the modified lease terms, the total remaining lease payments (excluding the termination fee paid during the three months ended September 30, 2021) are $9,564.</us-gaap:LesseeOperatingLeasesTextBlock>
    <amn:NumberOfPhasesOfLeaseTerminationAgreement
      contextRef="i150492f298fa47a78ef2c10a285a64f8_D20210701-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y181Mi9mcmFnOjY1YzQyZmU5ZTlmODQ2MTI4NjhlMjRlNjkxMmZmMWExL3RleHRyZWdpb246NjVjNDJmZTllOWY4NDYxMjg2OGUyNGU2OTEyZmYxYTFfMzg0ODI5MDcwNTYzNA_eef8c47b-6ae3-40e6-a09b-36a3f360fe31"
      unitRef="phase">2</amn:NumberOfPhasesOfLeaseTerminationAgreement>
    <amn:PaymentsOfLeaseTerminationFee
      contextRef="i150492f298fa47a78ef2c10a285a64f8_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y181Mi9mcmFnOjY1YzQyZmU5ZTlmODQ2MTI4NjhlMjRlNjkxMmZmMWExL3RleHRyZWdpb246NjVjNDJmZTllOWY4NDYxMjg2OGUyNGU2OTEyZmYxYTFfMTY0OTI2NzQ0NzE4OA_51a56f1d-f64b-4c7e-8907-e431285bc2c9"
      unitRef="usd">17000000</amn:PaymentsOfLeaseTerminationFee>
    <amn:OperatingLeaseLiabilityIncreaseDecreaseFromModification
      contextRef="i150492f298fa47a78ef2c10a285a64f8_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y181Mi9mcmFnOjY1YzQyZmU5ZTlmODQ2MTI4NjhlMjRlNjkxMmZmMWExL3RleHRyZWdpb246NjVjNDJmZTllOWY4NDYxMjg2OGUyNGU2OTEyZmYxYTFfMTY0OTI2NzQ0NzE5Nw_3f5055ca-e02f-422e-9f26-60fa95891a45"
      unitRef="usd">-27340000</amn:OperatingLeaseLiabilityIncreaseDecreaseFromModification>
    <amn:OperatingLeaseRightOfUseAssetIncreaseDecreaseFromModification
      contextRef="i150492f298fa47a78ef2c10a285a64f8_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y181Mi9mcmFnOjY1YzQyZmU5ZTlmODQ2MTI4NjhlMjRlNjkxMmZmMWExL3RleHRyZWdpb246NjVjNDJmZTllOWY4NDYxMjg2OGUyNGU2OTEyZmYxYTFfMTY0OTI2NzQ0NzE5Nw_aaff58c3-65cf-4e03-8c76-40602d94403a"
      unitRef="usd">-27340000</amn:OperatingLeaseRightOfUseAssetIncreaseDecreaseFromModification>
    <amn:LesseeOperatingLeaseLiabilityToBePaidPremodification
      contextRef="i68ecd84e8da440808154baac134e839e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y181Mi9mcmFnOjY1YzQyZmU5ZTlmODQ2MTI4NjhlMjRlNjkxMmZmMWExL3RleHRyZWdpb246NjVjNDJmZTllOWY4NDYxMjg2OGUyNGU2OTEyZmYxYTFfMTY0OTI2NzQ0NzIwNg_6a085e13-c5d6-46b4-bd70-a56a01610498"
      unitRef="usd">62487000</amn:LesseeOperatingLeaseLiabilityToBePaidPremodification>
    <amn:LesseeOperatingLeaseLiabilityToBePaidPostmodification
      contextRef="i68ecd84e8da440808154baac134e839e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y181Mi9mcmFnOjY1YzQyZmU5ZTlmODQ2MTI4NjhlMjRlNjkxMmZmMWExL3RleHRyZWdpb246NjVjNDJmZTllOWY4NDYxMjg2OGUyNGU2OTEyZmYxYTFfMTY0OTI2NzQ0NzIxNQ_c1205e2e-eb9a-4aa8-8f76-cee3f4108ce9"
      unitRef="usd">9564000</amn:LesseeOperatingLeaseLiabilityToBePaidPostmodification>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y181NS9mcmFnOmM4Zjg1OTM3MTUzYTRkN2U5NGNmMjYxZGVhMDVhMmQ2L3RleHRyZWdpb246YzhmODU5MzcxNTNhNGQ3ZTk0Y2YyNjFkZWEwNWEyZDZfMTI5NA_467dc3e4-713a-4e7c-84d0-7f6d5232c9d4">INCOME TAXES&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The Company is subject to taxation in the U.S. and various states and foreign jurisdictions. With few exceptions, as of September&#160;30, 2021, the Company is no longer subject to state, local or foreign examinations by tax authorities for tax years before 2011, and the Company is no longer subject to U.S. federal income or payroll tax examinations for tax years before 2017. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:24.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Notwithstanding the foregoing, the Company could adjust its provision for income taxes and contingent tax liability based on future developments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;CARES Act&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 27, 2020, the Coronavirus Aid, Relief, and Economic Security Act (the &#x201c;CARES Act&#x201d;) was enacted and signed into law in response to the COVID-19 pandemic. Among other things, the CARES Act contains significant business tax provisions, including a deferral of payment of employer payroll taxes and an employer retention credit for employer payroll taxes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has deferred payment of the employer&#x2019;s share of payroll taxes of $48,452, which is included in accrued compensation and benefits and other long-term liabilities in the consolidated balance sheet as of September&#160;30, 2021, with half of such taxes to be paid by the end of 2021 and the other half to be paid by the end of 2022. The Company has claimed an employee retention employment tax credit of $1,756.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <amn:DeferredPayrollTaxesCARESAct
      contextRef="i68ecd84e8da440808154baac134e839e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y181NS9mcmFnOmM4Zjg1OTM3MTUzYTRkN2U5NGNmMjYxZGVhMDVhMmQ2L3RleHRyZWdpb246YzhmODU5MzcxNTNhNGQ3ZTk0Y2YyNjFkZWEwNWEyZDZfOTc1_14d47c88-de54-4c7c-aaad-cb8481e8fd0b"
      unitRef="usd">48452000</amn:DeferredPayrollTaxesCARESAct>
    <amn:EmployeeRetentionEmploymentTaxCreditCARESAct
      contextRef="i68ecd84e8da440808154baac134e839e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y181NS9mcmFnOmM4Zjg1OTM3MTUzYTRkN2U5NGNmMjYxZGVhMDVhMmQ2L3RleHRyZWdpb246YzhmODU5MzcxNTNhNGQ3ZTk0Y2YyNjFkZWEwNWEyZDZfMTI4NQ_b32cd390-d8e6-4880-b93a-335b4063b19a"
      unitRef="usd">1756000</amn:EmployeeRetentionEmploymentTaxCreditCARESAct>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y181OC9mcmFnOmJhMmQ1ZmU2ZTljNTRkNWFhZjFkYjlmZTk5YzhmZWQ2L3RleHRyZWdpb246YmEyZDVmZTZlOWM1NGQ1YWFmMWRiOWZlOTljOGZlZDZfNTM2MQ_aa960888-64ab-41b5-a552-7ac24f51927e">COMMITMENTS AND CONTINGENCIES: LEGAL PROCEEDINGSFrom time to time, the Company is involved in various lawsuits, claims, investigations, and proceedings that arise in the ordinary course of business. These matters typically relate to professional liability, tax, compensation, contract, competitor disputes and employee-related matters and include individual and class action lawsuits, as well as inquiries and investigations by governmental agencies regarding the Company&#x2019;s employment and compensation practices. Additionally, some of the Company&#x2019;s clients may also become subject to claims, governmental inquiries and investigations, and legal actions relating to services provided by the Company&#x2019;s healthcare professionals. Depending upon the particular facts and circumstances, the &lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Company may also be subject to indemnification obligations under its contracts with such clients relating to these matters. The Company accrues for contingencies and records a liability when management believes an adverse outcome from a loss contingency is both probable and the amount, or a range, can be reasonably estimated. Significant judgment is required to determine both probability of loss and the estimated amount. The Company reviews its loss contingencies at least quarterly and adjusts its accruals and/or disclosures to reflect the impact of negotiations, settlements, rulings, advice of legal counsel, or other new information, as deemed necessary. The most significant matters for which the Company has established loss contingencies are class actions related to wage and hour claims under California and Federal law. Specifically, among other claims in these lawsuits, it is alleged that certain expense reimbursements should be considered wages and included in the regular rate of pay for purposes of calculating overtime rates. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;On May 26, 2016, former travel nurse Verna Maxwell Clarke filed a complaint against AMN Services, LLC, in California Superior Court in Los Angeles County. The Company removed the case to the United States District Court for the Central District of California (Case No. 2:16-cv-04132-DSF-KS) (the &#x201c;Clarke Matter&#x201d;). The complaint asserts that, due to the Company&#x2019;s per diem adjustment practices, traveling nurses&#x2019; per diem benefits should be included in their regular rate of pay for the purposes of calculating their overtime compensation. On June 26, 2018, the district court denied the plaintiffs&#x2019; Motion for Summary Judgment in its entirety, and granted the Company&#x2019;s Motion for Summary Judgment with respect to the Plaintiffs&#x2019; per diem and overtime claims. The plaintiffs filed an appeal of the judgment relating to the per diem claims with the Ninth Circuit Court of Appeals (the &#x201c;Ninth Circuit&#x201d;). On February 8, 2021, a three-judge panel of the Ninth Circuit issued an opinion that reversed the district court&#x2019;s granting of the Company&#x2019;s Motion for Summary Judgment and remanded the matter to the district court instructing the district to enter partial summary judgment in favor of the Plaintiffs. On May 7, 2021, the Ninth Circuit issued an order denying the Company&#x2019;s petition for rehearing. On August 26, 2021, the Company filed a Petition for Writ of Certiorari in the United States Supreme Court seeking review of the Ninth Circuit&#x2019;s decision. At this time, it is unknown whether the Supreme Court will consider the appeal.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;On May 2, 2019, former travel nurse Sara Woehrle filed a complaint against AMN Services, LLC, and Providence Health System &#x2013; Southern California in California Superior Court in Los Angeles County. The Company removed the case to the United States District Court for the Central District of California (Case No. 2:19-cv-05282 DSF-KS). The complaint asserts that, due to the Company&#x2019;s per diem adjustment practices, traveling nurses&#x2019; per diem benefits should be included in their regular rate of pay for the purposes of calculating their overtime compensation. The Complaint also alleges that the putative class members were denied required meal periods, denied proper overtime compensation, were not compensated for all time worked, including reporting time and training time, and received non-compliant wage statements. The Company has reached a preliminary agreement to settle this matter in its entirety. Final settlement is not expected until the fourth quarter of 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The Company believes that its wage and hour practices, including those associated with the cases described above, conform with the applicable law in all material respects. However, because of the February 2021 ruling by the Ninth Circuit in the Clarke Matter and the inherent uncertainty of litigation, the Company is not able to reasonably predict if any matter will be resolved in a manner that is materially adverse to the Company. Accordingly, the Company recorded an increase to its accruals established in connection with the matters described above amounting to $20,000 during the fourth quarter of 2020, and the ultimate resolution could result in a loss of up to $15,000, excluding penalties, in excess of the amounts currently accrued. For all other matters, the Company is unable to currently estimate the possible loss or range of loss beyond the amounts already accrued. Loss contingencies accrued as of September&#160;30, 2021 are included in accounts payable and accrued expenses and other long-term liabilities in the consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:LossContingencyAccrualCarryingValuePeriodIncreaseDecrease
      contextRef="ibdd33d48b3ef404689d6e95d9989f154_D20201001-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y181OC9mcmFnOmJhMmQ1ZmU2ZTljNTRkNWFhZjFkYjlmZTk5YzhmZWQ2L3RleHRyZWdpb246YmEyZDVmZTZlOWM1NGQ1YWFmMWRiOWZlOTljOGZlZDZfNDc2NA_f7b7f940-9d11-4a6f-99fc-07e6fab2fbe4"
      unitRef="usd">20000000</us-gaap:LossContingencyAccrualCarryingValuePeriodIncreaseDecrease>
    <us-gaap:LossContingencyEstimateOfPossibleLoss
      contextRef="ic4d0f83036ab4e5a816bee3070f588e7_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y181OC9mcmFnOmJhMmQ1ZmU2ZTljNTRkNWFhZjFkYjlmZTk5YzhmZWQ2L3RleHRyZWdpb246YmEyZDVmZTZlOWM1NGQ1YWFmMWRiOWZlOTljOGZlZDZfNDk4Mg_7d91065a-11fa-43e1-90ad-793e551383b2"
      unitRef="usd">15000000</us-gaap:LossContingencyEstimateOfPossibleLoss>
    <us-gaap:SupplementalBalanceSheetDisclosuresTextBlock
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y182MS9mcmFnOmU0Njg0NTE5ODc2ZjRiN2M5ZGYzNmRjOGVjZjA4ZTJmL3RleHRyZWdpb246ZTQ2ODQ1MTk4NzZmNGI3YzlkZjM2ZGM4ZWNmMDhlMmZfOTM_4ce88c5d-d4ac-495e-b6a4-f5cd299a412e">BALANCE SHEET DETAILS&lt;div style="margin-bottom:3pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The consolidated balance sheets detail is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.946%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.771%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.931%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,626&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income taxes receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,809&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54,634&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,355&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;254,090&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;220,971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,616&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;318,340&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;277,926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(190,578)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(161,752)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127,762&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116,174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Life insurance cash surrender value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114,037&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98,161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,872&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,959&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157,909&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;135,120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable and accrued expenses:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,468&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,089&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Subcontractor payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;147,776&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79,364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,849&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss contingencies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,627&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,613&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Professional liability reserve&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,773&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,897&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,036&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,069&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable and accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;284,094&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;167,881&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued compensation and benefits:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued payroll&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114,299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59,721&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued bonuses and commissions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66,215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,514&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued travel expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,673&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,998&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health insurance reserve&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,627&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,590&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Workers compensation reserve&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117,020&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97,184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,807&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued compensation and benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;321,938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;213,414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Workers compensation reserve&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,716&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,930&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Professional liability reserve&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,768&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrecognized tax benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,447&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107,115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107,907&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SupplementalBalanceSheetDisclosuresTextBlock>
    <amn:ScheduleofSupplementalBalanceSheetDisclosuresTableTextBlock
      contextRef="i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y182MS9mcmFnOmU0Njg0NTE5ODc2ZjRiN2M5ZGYzNmRjOGVjZjA4ZTJmL3RleHRyZWdpb246ZTQ2ODQ1MTk4NzZmNGI3YzlkZjM2ZGM4ZWNmMDhlMmZfOTI_c491051c-bb02-49c8-a7a5-227bdc754841">&lt;div style="margin-bottom:3pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The consolidated balance sheets detail is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.946%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.771%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.931%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,626&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income taxes receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,809&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54,634&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,355&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;254,090&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;220,971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,616&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;318,340&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;277,926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(190,578)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(161,752)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127,762&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116,174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Life insurance cash surrender value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114,037&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98,161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,872&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,959&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157,909&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;135,120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable and accrued expenses:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,468&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,089&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Subcontractor payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;147,776&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79,364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,849&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss contingencies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,627&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,613&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Professional liability reserve&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,773&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,897&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,036&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,069&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable and accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;284,094&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;167,881&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued compensation and benefits:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued payroll&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114,299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59,721&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued bonuses and commissions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66,215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,514&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued travel expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,673&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,998&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health insurance reserve&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,627&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,590&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Workers compensation reserve&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117,020&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97,184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,807&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued compensation and benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;321,938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;213,414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Workers compensation reserve&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,716&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,930&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Professional liability reserve&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,768&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrecognized tax benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,447&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107,115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107,907&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</amn:ScheduleofSupplementalBalanceSheetDisclosuresTableTextBlock>
    <us-gaap:RestrictedCashAndCashEquivalents
      contextRef="i68ecd84e8da440808154baac134e839e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y182MS9mcmFnOmU0Njg0NTE5ODc2ZjRiN2M5ZGYzNmRjOGVjZjA4ZTJmL3RhYmxlOjNhZTAyZjQ4MjgzYzQxMWQ5YzcwZmUyZGIwYjU2ODYyL3RhYmxlcmFuZ2U6M2FlMDJmNDgyODNjNDExZDljNzBmZTJkYjBiNTY4NjJfMi0yLTEtMS0xMDc3MA_8a79ba97-a211-4859-bdfd-afc80ef17b7d"
      unitRef="usd">18118000</us-gaap:RestrictedCashAndCashEquivalents>
    <us-gaap:RestrictedCashAndCashEquivalents
      contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y182MS9mcmFnOmU0Njg0NTE5ODc2ZjRiN2M5ZGYzNmRjOGVjZjA4ZTJmL3RhYmxlOjNhZTAyZjQ4MjgzYzQxMWQ5YzcwZmUyZGIwYjU2ODYyL3RhYmxlcmFuZ2U6M2FlMDJmNDgyODNjNDExZDljNzBmZTJkYjBiNTY4NjJfMi00LTEtMS0xMDc3MA_f9f4de69-3538-43af-a115-d1d1fa4cb178"
      unitRef="usd">18626000</us-gaap:RestrictedCashAndCashEquivalents>
    <us-gaap:IncomeTaxesReceivable
      contextRef="i68ecd84e8da440808154baac134e839e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y182MS9mcmFnOmU0Njg0NTE5ODc2ZjRiN2M5ZGYzNmRjOGVjZjA4ZTJmL3RhYmxlOjNhZTAyZjQ4MjgzYzQxMWQ5YzcwZmUyZGIwYjU2ODYyL3RhYmxlcmFuZ2U6M2FlMDJmNDgyODNjNDExZDljNzBmZTJkYjBiNTY4NjJfMy0yLTEtMS0xMDc3MA_8b8a575b-c20d-49ff-8642-b99ffff9e588"
      unitRef="usd">1119000</us-gaap:IncomeTaxesReceivable>
    <us-gaap:IncomeTaxesReceivable
      contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y182MS9mcmFnOmU0Njg0NTE5ODc2ZjRiN2M5ZGYzNmRjOGVjZjA4ZTJmL3RhYmxlOjNhZTAyZjQ4MjgzYzQxMWQ5YzcwZmUyZGIwYjU2ODYyL3RhYmxlcmFuZ2U6M2FlMDJmNDgyODNjNDExZDljNzBmZTJkYjBiNTY4NjJfMy00LTEtMS0xMDc3MA_c931a6c8-46d9-41d4-8d0a-a124eb95a216"
      unitRef="usd">6591000</us-gaap:IncomeTaxesReceivable>
    <us-gaap:OtherAssetsMiscellaneousCurrent
      contextRef="i68ecd84e8da440808154baac134e839e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y182MS9mcmFnOmU0Njg0NTE5ODc2ZjRiN2M5ZGYzNmRjOGVjZjA4ZTJmL3RhYmxlOjNhZTAyZjQ4MjgzYzQxMWQ5YzcwZmUyZGIwYjU2ODYyL3RhYmxlcmFuZ2U6M2FlMDJmNDgyODNjNDExZDljNzBmZTJkYjBiNTY4NjJfNC0yLTEtMS0xMDc3MA_4ea8a3ed-6763-413e-bee5-872f99edf311"
      unitRef="usd">12159000</us-gaap:OtherAssetsMiscellaneousCurrent>
    <us-gaap:OtherAssetsMiscellaneousCurrent
      contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y182MS9mcmFnOmU0Njg0NTE5ODc2ZjRiN2M5ZGYzNmRjOGVjZjA4ZTJmL3RhYmxlOjNhZTAyZjQ4MjgzYzQxMWQ5YzcwZmUyZGIwYjU2ODYyL3RhYmxlcmFuZ2U6M2FlMDJmNDgyODNjNDExZDljNzBmZTJkYjBiNTY4NjJfNC00LTEtMS0xMDc3MA_3f787d8b-4c98-432a-b3f0-c98e46cc2500"
      unitRef="usd">15592000</us-gaap:OtherAssetsMiscellaneousCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="i68ecd84e8da440808154baac134e839e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y182MS9mcmFnOmU0Njg0NTE5ODc2ZjRiN2M5ZGYzNmRjOGVjZjA4ZTJmL3RhYmxlOjNhZTAyZjQ4MjgzYzQxMWQ5YzcwZmUyZGIwYjU2ODYyL3RhYmxlcmFuZ2U6M2FlMDJmNDgyODNjNDExZDljNzBmZTJkYjBiNTY4NjJfNS0yLTEtMS0xMDc3MA_00eafeb6-aadb-4b73-93ee-1a719ca5a40a"
      unitRef="usd">31396000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y182MS9mcmFnOmU0Njg0NTE5ODc2ZjRiN2M5ZGYzNmRjOGVjZjA4ZTJmL3RhYmxlOjNhZTAyZjQ4MjgzYzQxMWQ5YzcwZmUyZGIwYjU2ODYyL3RhYmxlcmFuZ2U6M2FlMDJmNDgyODNjNDExZDljNzBmZTJkYjBiNTY4NjJfNS00LTEtMS0xMDc3MA_585aa184-03e7-45cc-bc7c-935a75b1e20e"
      unitRef="usd">40809000</us-gaap:OtherAssetsCurrent>
    <us-gaap:FurnitureAndFixturesGross
      contextRef="i68ecd84e8da440808154baac134e839e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y182MS9mcmFnOmU0Njg0NTE5ODc2ZjRiN2M5ZGYzNmRjOGVjZjA4ZTJmL3RhYmxlOjNhZTAyZjQ4MjgzYzQxMWQ5YzcwZmUyZGIwYjU2ODYyL3RhYmxlcmFuZ2U6M2FlMDJmNDgyODNjNDExZDljNzBmZTJkYjBiNTY4NjJfOC0yLTEtMS0xMDc3MA_17bddc7e-ac0e-4ae3-837e-a1c2f4d5ce36"
      unitRef="usd">54634000</us-gaap:FurnitureAndFixturesGross>
    <us-gaap:FurnitureAndFixturesGross
      contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y182MS9mcmFnOmU0Njg0NTE5ODc2ZjRiN2M5ZGYzNmRjOGVjZjA4ZTJmL3RhYmxlOjNhZTAyZjQ4MjgzYzQxMWQ5YzcwZmUyZGIwYjU2ODYyL3RhYmxlcmFuZ2U6M2FlMDJmNDgyODNjNDExZDljNzBmZTJkYjBiNTY4NjJfOC00LTEtMS0xMDc3MA_bbd5e666-9aea-4a89-bdfb-87d420e4a4b2"
      unitRef="usd">47355000</us-gaap:FurnitureAndFixturesGross>
    <us-gaap:CapitalizedComputerSoftwareGross
      contextRef="i68ecd84e8da440808154baac134e839e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y182MS9mcmFnOmU0Njg0NTE5ODc2ZjRiN2M5ZGYzNmRjOGVjZjA4ZTJmL3RhYmxlOjNhZTAyZjQ4MjgzYzQxMWQ5YzcwZmUyZGIwYjU2ODYyL3RhYmxlcmFuZ2U6M2FlMDJmNDgyODNjNDExZDljNzBmZTJkYjBiNTY4NjJfOS0yLTEtMS0xMDc3MA_60a54a1f-6584-42d1-8c11-655d6bc78416"
      unitRef="usd">254090000</us-gaap:CapitalizedComputerSoftwareGross>
    <us-gaap:CapitalizedComputerSoftwareGross
      contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y182MS9mcmFnOmU0Njg0NTE5ODc2ZjRiN2M5ZGYzNmRjOGVjZjA4ZTJmL3RhYmxlOjNhZTAyZjQ4MjgzYzQxMWQ5YzcwZmUyZGIwYjU2ODYyL3RhYmxlcmFuZ2U6M2FlMDJmNDgyODNjNDExZDljNzBmZTJkYjBiNTY4NjJfOS00LTEtMS0xMDc3MA_85e1dc03-6ce7-497e-bcdb-378dda1d36e2"
      unitRef="usd">220971000</us-gaap:CapitalizedComputerSoftwareGross>
    <us-gaap:LeaseholdImprovementsGross
      contextRef="i68ecd84e8da440808154baac134e839e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y182MS9mcmFnOmU0Njg0NTE5ODc2ZjRiN2M5ZGYzNmRjOGVjZjA4ZTJmL3RhYmxlOjNhZTAyZjQ4MjgzYzQxMWQ5YzcwZmUyZGIwYjU2ODYyL3RhYmxlcmFuZ2U6M2FlMDJmNDgyODNjNDExZDljNzBmZTJkYjBiNTY4NjJfMTAtMi0xLTEtMTA3NzA_db1c9882-ad65-49cb-9f96-7f07cc6d1f81"
      unitRef="usd">9616000</us-gaap:LeaseholdImprovementsGross>
    <us-gaap:LeaseholdImprovementsGross
      contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y182MS9mcmFnOmU0Njg0NTE5ODc2ZjRiN2M5ZGYzNmRjOGVjZjA4ZTJmL3RhYmxlOjNhZTAyZjQ4MjgzYzQxMWQ5YzcwZmUyZGIwYjU2ODYyL3RhYmxlcmFuZ2U6M2FlMDJmNDgyODNjNDExZDljNzBmZTJkYjBiNTY4NjJfMTAtNC0xLTEtMTA3NzA_aa86d2c2-01fb-4f91-ac75-d787ab731b95"
      unitRef="usd">9600000</us-gaap:LeaseholdImprovementsGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i68ecd84e8da440808154baac134e839e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y182MS9mcmFnOmU0Njg0NTE5ODc2ZjRiN2M5ZGYzNmRjOGVjZjA4ZTJmL3RhYmxlOjNhZTAyZjQ4MjgzYzQxMWQ5YzcwZmUyZGIwYjU2ODYyL3RhYmxlcmFuZ2U6M2FlMDJmNDgyODNjNDExZDljNzBmZTJkYjBiNTY4NjJfMTEtMi0xLTEtMTA3NzA_00511c60-0048-4352-92dc-539a0fdacce3"
      unitRef="usd">318340000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y182MS9mcmFnOmU0Njg0NTE5ODc2ZjRiN2M5ZGYzNmRjOGVjZjA4ZTJmL3RhYmxlOjNhZTAyZjQ4MjgzYzQxMWQ5YzcwZmUyZGIwYjU2ODYyL3RhYmxlcmFuZ2U6M2FlMDJmNDgyODNjNDExZDljNzBmZTJkYjBiNTY4NjJfMTEtNC0xLTEtMTA3NzA_77d21b11-a47f-4784-a5af-be3876aada58"
      unitRef="usd">277926000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i68ecd84e8da440808154baac134e839e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y182MS9mcmFnOmU0Njg0NTE5ODc2ZjRiN2M5ZGYzNmRjOGVjZjA4ZTJmL3RhYmxlOjNhZTAyZjQ4MjgzYzQxMWQ5YzcwZmUyZGIwYjU2ODYyL3RhYmxlcmFuZ2U6M2FlMDJmNDgyODNjNDExZDljNzBmZTJkYjBiNTY4NjJfMTItMi0xLTEtMTA3NzA_c4b8fe4d-fd99-4c05-a335-a3b3c32bab35"
      unitRef="usd">190578000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y182MS9mcmFnOmU0Njg0NTE5ODc2ZjRiN2M5ZGYzNmRjOGVjZjA4ZTJmL3RhYmxlOjNhZTAyZjQ4MjgzYzQxMWQ5YzcwZmUyZGIwYjU2ODYyL3RhYmxlcmFuZ2U6M2FlMDJmNDgyODNjNDExZDljNzBmZTJkYjBiNTY4NjJfMTItNC0xLTEtMTA3NzA_5d27f4c9-e373-43b6-8a92-3c52c42f011d"
      unitRef="usd">161752000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i68ecd84e8da440808154baac134e839e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y182MS9mcmFnOmU0Njg0NTE5ODc2ZjRiN2M5ZGYzNmRjOGVjZjA4ZTJmL3RhYmxlOjNhZTAyZjQ4MjgzYzQxMWQ5YzcwZmUyZGIwYjU2ODYyL3RhYmxlcmFuZ2U6M2FlMDJmNDgyODNjNDExZDljNzBmZTJkYjBiNTY4NjJfMTMtMi0xLTEtMTA3NzA_50500f17-1703-4941-8ff5-228fb83c7012"
      unitRef="usd">127762000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y182MS9mcmFnOmU0Njg0NTE5ODc2ZjRiN2M5ZGYzNmRjOGVjZjA4ZTJmL3RhYmxlOjNhZTAyZjQ4MjgzYzQxMWQ5YzcwZmUyZGIwYjU2ODYyL3RhYmxlcmFuZ2U6M2FlMDJmNDgyODNjNDExZDljNzBmZTJkYjBiNTY4NjJfMTMtNC0xLTEtMTA3NzA_ec0b2695-6bed-44df-b76a-a1ebb1580f41"
      unitRef="usd">116174000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:CashSurrenderValueOfLifeInsurance
      contextRef="i68ecd84e8da440808154baac134e839e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y182MS9mcmFnOmU0Njg0NTE5ODc2ZjRiN2M5ZGYzNmRjOGVjZjA4ZTJmL3RhYmxlOjNhZTAyZjQ4MjgzYzQxMWQ5YzcwZmUyZGIwYjU2ODYyL3RhYmxlcmFuZ2U6M2FlMDJmNDgyODNjNDExZDljNzBmZTJkYjBiNTY4NjJfMTYtMi0xLTEtMTA3NzA_ed5006a6-1f9a-47cb-8cc1-36bcc419221b"
      unitRef="usd">114037000</us-gaap:CashSurrenderValueOfLifeInsurance>
    <us-gaap:CashSurrenderValueOfLifeInsurance
      contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y182MS9mcmFnOmU0Njg0NTE5ODc2ZjRiN2M5ZGYzNmRjOGVjZjA4ZTJmL3RhYmxlOjNhZTAyZjQ4MjgzYzQxMWQ5YzcwZmUyZGIwYjU2ODYyL3RhYmxlcmFuZ2U6M2FlMDJmNDgyODNjNDExZDljNzBmZTJkYjBiNTY4NjJfMTYtNC0xLTEtMTA3NzA_67048910-a2e4-4a6b-95cb-ac41cf172833"
      unitRef="usd">98161000</us-gaap:CashSurrenderValueOfLifeInsurance>
    <us-gaap:OtherAssetsMiscellaneous
      contextRef="i68ecd84e8da440808154baac134e839e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y182MS9mcmFnOmU0Njg0NTE5ODc2ZjRiN2M5ZGYzNmRjOGVjZjA4ZTJmL3RhYmxlOjNhZTAyZjQ4MjgzYzQxMWQ5YzcwZmUyZGIwYjU2ODYyL3RhYmxlcmFuZ2U6M2FlMDJmNDgyODNjNDExZDljNzBmZTJkYjBiNTY4NjJfMTctMi0xLTEtMTA3NzA_7fcca5fc-a6a8-4d05-988d-6bc073cb40fe"
      unitRef="usd">43872000</us-gaap:OtherAssetsMiscellaneous>
    <us-gaap:OtherAssetsMiscellaneous
      contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y182MS9mcmFnOmU0Njg0NTE5ODc2ZjRiN2M5ZGYzNmRjOGVjZjA4ZTJmL3RhYmxlOjNhZTAyZjQ4MjgzYzQxMWQ5YzcwZmUyZGIwYjU2ODYyL3RhYmxlcmFuZ2U6M2FlMDJmNDgyODNjNDExZDljNzBmZTJkYjBiNTY4NjJfMTctNC0xLTEtMTA3NzA_e8373a79-1b79-4c1e-8ea6-45cad253d826"
      unitRef="usd">36959000</us-gaap:OtherAssetsMiscellaneous>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i68ecd84e8da440808154baac134e839e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y182MS9mcmFnOmU0Njg0NTE5ODc2ZjRiN2M5ZGYzNmRjOGVjZjA4ZTJmL3RhYmxlOjNhZTAyZjQ4MjgzYzQxMWQ5YzcwZmUyZGIwYjU2ODYyL3RhYmxlcmFuZ2U6M2FlMDJmNDgyODNjNDExZDljNzBmZTJkYjBiNTY4NjJfMTgtMi0xLTEtMTA3NzA_3e16c202-df06-447e-bc90-1ce05f614f87"
      unitRef="usd">157909000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y182MS9mcmFnOmU0Njg0NTE5ODc2ZjRiN2M5ZGYzNmRjOGVjZjA4ZTJmL3RhYmxlOjNhZTAyZjQ4MjgzYzQxMWQ5YzcwZmUyZGIwYjU2ODYyL3RhYmxlcmFuZ2U6M2FlMDJmNDgyODNjNDExZDljNzBmZTJkYjBiNTY4NjJfMTgtNC0xLTEtMTA3NzA_19f86d3b-df1b-4316-8154-537a33436d57"
      unitRef="usd">135120000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:AccountsPayableTradeCurrent
      contextRef="i68ecd84e8da440808154baac134e839e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y182MS9mcmFnOmU0Njg0NTE5ODc2ZjRiN2M5ZGYzNmRjOGVjZjA4ZTJmL3RhYmxlOjNhZTAyZjQ4MjgzYzQxMWQ5YzcwZmUyZGIwYjU2ODYyL3RhYmxlcmFuZ2U6M2FlMDJmNDgyODNjNDExZDljNzBmZTJkYjBiNTY4NjJfMjEtMi0xLTEtMTA3NzA_0569c4db-954b-4377-8b2e-bf6846c90ebb"
      unitRef="usd">48468000</us-gaap:AccountsPayableTradeCurrent>
    <us-gaap:AccountsPayableTradeCurrent
      contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y182MS9mcmFnOmU0Njg0NTE5ODc2ZjRiN2M5ZGYzNmRjOGVjZjA4ZTJmL3RhYmxlOjNhZTAyZjQ4MjgzYzQxMWQ5YzcwZmUyZGIwYjU2ODYyL3RhYmxlcmFuZ2U6M2FlMDJmNDgyODNjNDExZDljNzBmZTJkYjBiNTY4NjJfMjEtNC0xLTEtMTA3NzA_f643f88a-f043-45d4-8028-d9f1cf8907d1"
      unitRef="usd">28089000</us-gaap:AccountsPayableTradeCurrent>
    <amn:AccountsPayableToSubcontractor
      contextRef="i68ecd84e8da440808154baac134e839e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y182MS9mcmFnOmU0Njg0NTE5ODc2ZjRiN2M5ZGYzNmRjOGVjZjA4ZTJmL3RhYmxlOjNhZTAyZjQ4MjgzYzQxMWQ5YzcwZmUyZGIwYjU2ODYyL3RhYmxlcmFuZ2U6M2FlMDJmNDgyODNjNDExZDljNzBmZTJkYjBiNTY4NjJfMjItMi0xLTEtMTA3NzA_014e52ff-49ef-4ceb-96dc-c4226a59d540"
      unitRef="usd">147776000</amn:AccountsPayableToSubcontractor>
    <amn:AccountsPayableToSubcontractor
      contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y182MS9mcmFnOmU0Njg0NTE5ODc2ZjRiN2M5ZGYzNmRjOGVjZjA4ZTJmL3RhYmxlOjNhZTAyZjQ4MjgzYzQxMWQ5YzcwZmUyZGIwYjU2ODYyL3RhYmxlcmFuZ2U6M2FlMDJmNDgyODNjNDExZDljNzBmZTJkYjBiNTY4NjJfMjItNC0xLTEtMTA3NzA_4ebf53a7-86a0-4f52-8c69-189b7c8a2860"
      unitRef="usd">79364000</amn:AccountsPayableToSubcontractor>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i68ecd84e8da440808154baac134e839e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y182MS9mcmFnOmU0Njg0NTE5ODc2ZjRiN2M5ZGYzNmRjOGVjZjA4ZTJmL3RhYmxlOjNhZTAyZjQ4MjgzYzQxMWQ5YzcwZmUyZGIwYjU2ODYyL3RhYmxlcmFuZ2U6M2FlMDJmNDgyODNjNDExZDljNzBmZTJkYjBiNTY4NjJfMjMtMi0xLTEtMTA3NzA_aa30d075-cd62-4560-9ce6-48569f1a7a18"
      unitRef="usd">60414000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y182MS9mcmFnOmU0Njg0NTE5ODc2ZjRiN2M5ZGYzNmRjOGVjZjA4ZTJmL3RhYmxlOjNhZTAyZjQ4MjgzYzQxMWQ5YzcwZmUyZGIwYjU2ODYyL3RhYmxlcmFuZ2U6M2FlMDJmNDgyODNjNDExZDljNzBmZTJkYjBiNTY4NjJfMjMtNC0xLTEtMTA3NzA_7c1a7841-048f-452e-8b94-e59ca1f14192"
      unitRef="usd">37849000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:LossContingencyAccrualCarryingValueCurrent
      contextRef="i68ecd84e8da440808154baac134e839e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y182MS9mcmFnOmU0Njg0NTE5ODc2ZjRiN2M5ZGYzNmRjOGVjZjA4ZTJmL3RhYmxlOjNhZTAyZjQ4MjgzYzQxMWQ5YzcwZmUyZGIwYjU2ODYyL3RhYmxlcmFuZ2U6M2FlMDJmNDgyODNjNDExZDljNzBmZTJkYjBiNTY4NjJfMjQtMi0xLTEtMTA3NzA_6bbda510-4e98-461b-8082-defdf4eddb97"
      unitRef="usd">11627000</us-gaap:LossContingencyAccrualCarryingValueCurrent>
    <us-gaap:LossContingencyAccrualCarryingValueCurrent
      contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y182MS9mcmFnOmU0Njg0NTE5ODc2ZjRiN2M5ZGYzNmRjOGVjZjA4ZTJmL3RhYmxlOjNhZTAyZjQ4MjgzYzQxMWQ5YzcwZmUyZGIwYjU2ODYyL3RhYmxlcmFuZ2U6M2FlMDJmNDgyODNjNDExZDljNzBmZTJkYjBiNTY4NjJfMjQtNC0xLTEtMTA3NzA_d049fd6e-ec21-4557-a66e-5500e20ac385"
      unitRef="usd">7613000</us-gaap:LossContingencyAccrualCarryingValueCurrent>
    <us-gaap:SelfInsuranceReserveCurrent
      contextRef="i68ecd84e8da440808154baac134e839e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y182MS9mcmFnOmU0Njg0NTE5ODc2ZjRiN2M5ZGYzNmRjOGVjZjA4ZTJmL3RhYmxlOjNhZTAyZjQ4MjgzYzQxMWQ5YzcwZmUyZGIwYjU2ODYyL3RhYmxlcmFuZ2U6M2FlMDJmNDgyODNjNDExZDljNzBmZTJkYjBiNTY4NjJfMjUtMi0xLTEtMTA3NzA_7f331142-ba7d-4658-a96b-192c60cc78ce"
      unitRef="usd">6773000</us-gaap:SelfInsuranceReserveCurrent>
    <us-gaap:SelfInsuranceReserveCurrent
      contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y182MS9mcmFnOmU0Njg0NTE5ODc2ZjRiN2M5ZGYzNmRjOGVjZjA4ZTJmL3RhYmxlOjNhZTAyZjQ4MjgzYzQxMWQ5YzcwZmUyZGIwYjU2ODYyL3RhYmxlcmFuZ2U6M2FlMDJmNDgyODNjNDExZDljNzBmZTJkYjBiNTY4NjJfMjUtNC0xLTEtMTA3NzA_9a6bbb3b-c214-4801-a9bf-e6cd9f31c7e1"
      unitRef="usd">8897000</us-gaap:SelfInsuranceReserveCurrent>
    <us-gaap:OtherAccountsPayableAndAccruedLiabilities
      contextRef="i68ecd84e8da440808154baac134e839e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y182MS9mcmFnOmU0Njg0NTE5ODc2ZjRiN2M5ZGYzNmRjOGVjZjA4ZTJmL3RhYmxlOjNhZTAyZjQ4MjgzYzQxMWQ5YzcwZmUyZGIwYjU2ODYyL3RhYmxlcmFuZ2U6M2FlMDJmNDgyODNjNDExZDljNzBmZTJkYjBiNTY4NjJfMjYtMi0xLTEtMTA3NzA_47c5d144-b638-4ba4-8668-abc0c96aeffa"
      unitRef="usd">9036000</us-gaap:OtherAccountsPayableAndAccruedLiabilities>
    <us-gaap:OtherAccountsPayableAndAccruedLiabilities
      contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y182MS9mcmFnOmU0Njg0NTE5ODc2ZjRiN2M5ZGYzNmRjOGVjZjA4ZTJmL3RhYmxlOjNhZTAyZjQ4MjgzYzQxMWQ5YzcwZmUyZGIwYjU2ODYyL3RhYmxlcmFuZ2U6M2FlMDJmNDgyODNjNDExZDljNzBmZTJkYjBiNTY4NjJfMjYtNC0xLTEtMTA3NzA_0dc91088-40dd-4515-9cac-f813c1096116"
      unitRef="usd">6069000</us-gaap:OtherAccountsPayableAndAccruedLiabilities>
    <amn:AccountsPayableAndAccruedExpensesExcludingAccruedCompensationAndBenefitsCurrent
      contextRef="i68ecd84e8da440808154baac134e839e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y182MS9mcmFnOmU0Njg0NTE5ODc2ZjRiN2M5ZGYzNmRjOGVjZjA4ZTJmL3RhYmxlOjNhZTAyZjQ4MjgzYzQxMWQ5YzcwZmUyZGIwYjU2ODYyL3RhYmxlcmFuZ2U6M2FlMDJmNDgyODNjNDExZDljNzBmZTJkYjBiNTY4NjJfMjctMi0xLTEtMTA3NzA_6cd926c2-d56b-45cf-ad5e-4022baac3404"
      unitRef="usd">284094000</amn:AccountsPayableAndAccruedExpensesExcludingAccruedCompensationAndBenefitsCurrent>
    <amn:AccountsPayableAndAccruedExpensesExcludingAccruedCompensationAndBenefitsCurrent
      contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y182MS9mcmFnOmU0Njg0NTE5ODc2ZjRiN2M5ZGYzNmRjOGVjZjA4ZTJmL3RhYmxlOjNhZTAyZjQ4MjgzYzQxMWQ5YzcwZmUyZGIwYjU2ODYyL3RhYmxlcmFuZ2U6M2FlMDJmNDgyODNjNDExZDljNzBmZTJkYjBiNTY4NjJfMjctNC0xLTEtMTA3NzA_8b5a53c4-8e7c-4489-b21a-556c9520c154"
      unitRef="usd">167881000</amn:AccountsPayableAndAccruedExpensesExcludingAccruedCompensationAndBenefitsCurrent>
    <us-gaap:AccruedSalariesCurrent
      contextRef="i68ecd84e8da440808154baac134e839e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y182MS9mcmFnOmU0Njg0NTE5ODc2ZjRiN2M5ZGYzNmRjOGVjZjA4ZTJmL3RhYmxlOjNhZTAyZjQ4MjgzYzQxMWQ5YzcwZmUyZGIwYjU2ODYyL3RhYmxlcmFuZ2U6M2FlMDJmNDgyODNjNDExZDljNzBmZTJkYjBiNTY4NjJfMzAtMi0xLTEtMTA3NzA_89c262ba-2f1b-4351-8a22-22cb75893180"
      unitRef="usd">114299000</us-gaap:AccruedSalariesCurrent>
    <us-gaap:AccruedSalariesCurrent
      contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y182MS9mcmFnOmU0Njg0NTE5ODc2ZjRiN2M5ZGYzNmRjOGVjZjA4ZTJmL3RhYmxlOjNhZTAyZjQ4MjgzYzQxMWQ5YzcwZmUyZGIwYjU2ODYyL3RhYmxlcmFuZ2U6M2FlMDJmNDgyODNjNDExZDljNzBmZTJkYjBiNTY4NjJfMzAtNC0xLTEtMTA3NzA_3ee1d439-4caa-4e23-8947-077f3f850a73"
      unitRef="usd">59721000</us-gaap:AccruedSalariesCurrent>
    <amn:AccruedBonusesAndCommissions
      contextRef="i68ecd84e8da440808154baac134e839e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y182MS9mcmFnOmU0Njg0NTE5ODc2ZjRiN2M5ZGYzNmRjOGVjZjA4ZTJmL3RhYmxlOjNhZTAyZjQ4MjgzYzQxMWQ5YzcwZmUyZGIwYjU2ODYyL3RhYmxlcmFuZ2U6M2FlMDJmNDgyODNjNDExZDljNzBmZTJkYjBiNTY4NjJfMzEtMi0xLTEtMTA3NzA_2ace17cf-3367-4b90-b4df-ed22b85ef947"
      unitRef="usd">66215000</amn:AccruedBonusesAndCommissions>
    <amn:AccruedBonusesAndCommissions
      contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y182MS9mcmFnOmU0Njg0NTE5ODc2ZjRiN2M5ZGYzNmRjOGVjZjA4ZTJmL3RhYmxlOjNhZTAyZjQ4MjgzYzQxMWQ5YzcwZmUyZGIwYjU2ODYyL3RhYmxlcmFuZ2U6M2FlMDJmNDgyODNjNDExZDljNzBmZTJkYjBiNTY4NjJfMzEtNC0xLTEtMTA3NzA_3b1fe41e-79d0-4e50-bdba-22a4924f5db6"
      unitRef="usd">34514000</amn:AccruedBonusesAndCommissions>
    <amn:AccruedTravelExpense
      contextRef="i68ecd84e8da440808154baac134e839e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y182MS9mcmFnOmU0Njg0NTE5ODc2ZjRiN2M5ZGYzNmRjOGVjZjA4ZTJmL3RhYmxlOjNhZTAyZjQ4MjgzYzQxMWQ5YzcwZmUyZGIwYjU2ODYyL3RhYmxlcmFuZ2U6M2FlMDJmNDgyODNjNDExZDljNzBmZTJkYjBiNTY4NjJfMzItMi0xLTEtMTA3NzA_a6b144f6-d91c-4eef-a45a-b42330963a50"
      unitRef="usd">2673000</amn:AccruedTravelExpense>
    <amn:AccruedTravelExpense
      contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y182MS9mcmFnOmU0Njg0NTE5ODc2ZjRiN2M5ZGYzNmRjOGVjZjA4ZTJmL3RhYmxlOjNhZTAyZjQ4MjgzYzQxMWQ5YzcwZmUyZGIwYjU2ODYyL3RhYmxlcmFuZ2U6M2FlMDJmNDgyODNjNDExZDljNzBmZTJkYjBiNTY4NjJfMzItNC0xLTEtMTA3NzA_0a55824d-dd40-4345-a2f5-453806098c41"
      unitRef="usd">1998000</amn:AccruedTravelExpense>
    <us-gaap:AccruedInsuranceCurrent
      contextRef="i68ecd84e8da440808154baac134e839e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y182MS9mcmFnOmU0Njg0NTE5ODc2ZjRiN2M5ZGYzNmRjOGVjZjA4ZTJmL3RhYmxlOjNhZTAyZjQ4MjgzYzQxMWQ5YzcwZmUyZGIwYjU2ODYyL3RhYmxlcmFuZ2U6M2FlMDJmNDgyODNjNDExZDljNzBmZTJkYjBiNTY4NjJfMzMtMi0xLTEtMTA3NzA_76028924-16c1-4b66-9bdc-340e4698859c"
      unitRef="usd">6627000</us-gaap:AccruedInsuranceCurrent>
    <us-gaap:AccruedInsuranceCurrent
      contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y182MS9mcmFnOmU0Njg0NTE5ODc2ZjRiN2M5ZGYzNmRjOGVjZjA4ZTJmL3RhYmxlOjNhZTAyZjQ4MjgzYzQxMWQ5YzcwZmUyZGIwYjU2ODYyL3RhYmxlcmFuZ2U6M2FlMDJmNDgyODNjNDExZDljNzBmZTJkYjBiNTY4NjJfMzMtNC0xLTEtMTA3NzA_3502b434-a8f2-474d-89a9-683b877b29a3"
      unitRef="usd">5590000</us-gaap:AccruedInsuranceCurrent>
    <us-gaap:WorkersCompensationLiabilityCurrent
      contextRef="i68ecd84e8da440808154baac134e839e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y182MS9mcmFnOmU0Njg0NTE5ODc2ZjRiN2M5ZGYzNmRjOGVjZjA4ZTJmL3RhYmxlOjNhZTAyZjQ4MjgzYzQxMWQ5YzcwZmUyZGIwYjU2ODYyL3RhYmxlcmFuZ2U6M2FlMDJmNDgyODNjNDExZDljNzBmZTJkYjBiNTY4NjJfMzQtMi0xLTEtMTA3NzA_49f8deb8-8186-4ee3-be87-25dff38c733e"
      unitRef="usd">10297000</us-gaap:WorkersCompensationLiabilityCurrent>
    <us-gaap:WorkersCompensationLiabilityCurrent
      contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y182MS9mcmFnOmU0Njg0NTE5ODc2ZjRiN2M5ZGYzNmRjOGVjZjA4ZTJmL3RhYmxlOjNhZTAyZjQ4MjgzYzQxMWQ5YzcwZmUyZGIwYjU2ODYyL3RhYmxlcmFuZ2U6M2FlMDJmNDgyODNjNDExZDljNzBmZTJkYjBiNTY4NjJfMzQtNC0xLTEtMTA3NzA_cc244f96-7d82-4f22-a81a-69684c1e6db6"
      unitRef="usd">10244000</us-gaap:WorkersCompensationLiabilityCurrent>
    <us-gaap:DeferredCompensationLiabilityCurrent
      contextRef="i68ecd84e8da440808154baac134e839e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y182MS9mcmFnOmU0Njg0NTE5ODc2ZjRiN2M5ZGYzNmRjOGVjZjA4ZTJmL3RhYmxlOjNhZTAyZjQ4MjgzYzQxMWQ5YzcwZmUyZGIwYjU2ODYyL3RhYmxlcmFuZ2U6M2FlMDJmNDgyODNjNDExZDljNzBmZTJkYjBiNTY4NjJfMzUtMi0xLTEtMTA3NzA_8898a53b-25ad-4755-a8bb-369ca0b2e68c"
      unitRef="usd">117020000</us-gaap:DeferredCompensationLiabilityCurrent>
    <us-gaap:DeferredCompensationLiabilityCurrent
      contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y182MS9mcmFnOmU0Njg0NTE5ODc2ZjRiN2M5ZGYzNmRjOGVjZjA4ZTJmL3RhYmxlOjNhZTAyZjQ4MjgzYzQxMWQ5YzcwZmUyZGIwYjU2ODYyL3RhYmxlcmFuZ2U6M2FlMDJmNDgyODNjNDExZDljNzBmZTJkYjBiNTY4NjJfMzUtNC0xLTEtMTA3NzA_5dceb5e0-e4b1-49e8-b2a7-9d3a2cde2207"
      unitRef="usd">97184000</us-gaap:DeferredCompensationLiabilityCurrent>
    <us-gaap:OtherEmployeeRelatedLiabilitiesCurrent
      contextRef="i68ecd84e8da440808154baac134e839e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y182MS9mcmFnOmU0Njg0NTE5ODc2ZjRiN2M5ZGYzNmRjOGVjZjA4ZTJmL3RhYmxlOjNhZTAyZjQ4MjgzYzQxMWQ5YzcwZmUyZGIwYjU2ODYyL3RhYmxlcmFuZ2U6M2FlMDJmNDgyODNjNDExZDljNzBmZTJkYjBiNTY4NjJfMzYtMi0xLTEtMTA3NzA_7729182b-885c-44a8-8ec7-2ad7ff8d5e0b"
      unitRef="usd">4807000</us-gaap:OtherEmployeeRelatedLiabilitiesCurrent>
    <us-gaap:OtherEmployeeRelatedLiabilitiesCurrent
      contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y182MS9mcmFnOmU0Njg0NTE5ODc2ZjRiN2M5ZGYzNmRjOGVjZjA4ZTJmL3RhYmxlOjNhZTAyZjQ4MjgzYzQxMWQ5YzcwZmUyZGIwYjU2ODYyL3RhYmxlcmFuZ2U6M2FlMDJmNDgyODNjNDExZDljNzBmZTJkYjBiNTY4NjJfMzYtNC0xLTEtMTA3NzA_61d94abe-462f-4f83-b361-dad5833c6523"
      unitRef="usd">4163000</us-gaap:OtherEmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i68ecd84e8da440808154baac134e839e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y182MS9mcmFnOmU0Njg0NTE5ODc2ZjRiN2M5ZGYzNmRjOGVjZjA4ZTJmL3RhYmxlOjNhZTAyZjQ4MjgzYzQxMWQ5YzcwZmUyZGIwYjU2ODYyL3RhYmxlcmFuZ2U6M2FlMDJmNDgyODNjNDExZDljNzBmZTJkYjBiNTY4NjJfMzctMi0xLTEtMTA3NzA_388863a1-c81d-43e1-a9aa-8ce05c13ab85"
      unitRef="usd">321938000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y182MS9mcmFnOmU0Njg0NTE5ODc2ZjRiN2M5ZGYzNmRjOGVjZjA4ZTJmL3RhYmxlOjNhZTAyZjQ4MjgzYzQxMWQ5YzcwZmUyZGIwYjU2ODYyL3RhYmxlcmFuZ2U6M2FlMDJmNDgyODNjNDExZDljNzBmZTJkYjBiNTY4NjJfMzctNC0xLTEtMTA3NzA_389f04d9-73c0-4333-b2e9-7afedd9eb3e9"
      unitRef="usd">213414000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:WorkersCompensationLiabilityNoncurrent
      contextRef="i68ecd84e8da440808154baac134e839e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y182MS9mcmFnOmU0Njg0NTE5ODc2ZjRiN2M5ZGYzNmRjOGVjZjA4ZTJmL3RhYmxlOjNhZTAyZjQ4MjgzYzQxMWQ5YzcwZmUyZGIwYjU2ODYyL3RhYmxlcmFuZ2U6M2FlMDJmNDgyODNjNDExZDljNzBmZTJkYjBiNTY4NjJfNDYtMi0xLTEtMTA3NzA_2466217e-d802-4efd-87a1-af90465cc537"
      unitRef="usd">20716000</us-gaap:WorkersCompensationLiabilityNoncurrent>
    <us-gaap:WorkersCompensationLiabilityNoncurrent
      contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y182MS9mcmFnOmU0Njg0NTE5ODc2ZjRiN2M5ZGYzNmRjOGVjZjA4ZTJmL3RhYmxlOjNhZTAyZjQ4MjgzYzQxMWQ5YzcwZmUyZGIwYjU2ODYyL3RhYmxlcmFuZ2U6M2FlMDJmNDgyODNjNDExZDljNzBmZTJkYjBiNTY4NjJfNDYtNC0xLTEtMTA3NzA_3ae69ef5-8af0-4211-a94a-339b672ec3d4"
      unitRef="usd">20930000</us-gaap:WorkersCompensationLiabilityNoncurrent>
    <us-gaap:SelfInsuranceReserveNoncurrent
      contextRef="i68ecd84e8da440808154baac134e839e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y182MS9mcmFnOmU0Njg0NTE5ODc2ZjRiN2M5ZGYzNmRjOGVjZjA4ZTJmL3RhYmxlOjNhZTAyZjQ4MjgzYzQxMWQ5YzcwZmUyZGIwYjU2ODYyL3RhYmxlcmFuZ2U6M2FlMDJmNDgyODNjNDExZDljNzBmZTJkYjBiNTY4NjJfNDctMi0xLTEtMTA3NzA_c8a5fb23-a78e-420c-8971-eaf5abab760e"
      unitRef="usd">31768000</us-gaap:SelfInsuranceReserveNoncurrent>
    <us-gaap:SelfInsuranceReserveNoncurrent
      contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y182MS9mcmFnOmU0Njg0NTE5ODc2ZjRiN2M5ZGYzNmRjOGVjZjA4ZTJmL3RhYmxlOjNhZTAyZjQ4MjgzYzQxMWQ5YzcwZmUyZGIwYjU2ODYyL3RhYmxlcmFuZ2U6M2FlMDJmNDgyODNjNDExZDljNzBmZTJkYjBiNTY4NjJfNDctNC0xLTEtMTA3NzA_fdb76b90-4a6b-4038-837a-ba93017a4675"
      unitRef="usd">31997000</us-gaap:SelfInsuranceReserveNoncurrent>
    <us-gaap:LiabilityForUncertainTaxPositionsNoncurrent
      contextRef="i68ecd84e8da440808154baac134e839e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y182MS9mcmFnOmU0Njg0NTE5ODc2ZjRiN2M5ZGYzNmRjOGVjZjA4ZTJmL3RhYmxlOjNhZTAyZjQ4MjgzYzQxMWQ5YzcwZmUyZGIwYjU2ODYyL3RhYmxlcmFuZ2U6M2FlMDJmNDgyODNjNDExZDljNzBmZTJkYjBiNTY4NjJfNDgtMi0xLTEtMTA3NzA_3b293a2e-cb0d-4d1c-bb5f-fd0079b548b8"
      unitRef="usd">5403000</us-gaap:LiabilityForUncertainTaxPositionsNoncurrent>
    <us-gaap:LiabilityForUncertainTaxPositionsNoncurrent
      contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y182MS9mcmFnOmU0Njg0NTE5ODc2ZjRiN2M5ZGYzNmRjOGVjZjA4ZTJmL3RhYmxlOjNhZTAyZjQ4MjgzYzQxMWQ5YzcwZmUyZGIwYjU2ODYyL3RhYmxlcmFuZ2U6M2FlMDJmNDgyODNjNDExZDljNzBmZTJkYjBiNTY4NjJfNDgtNC0xLTEtMTA3NzA_846f87b3-ede2-41a4-9393-5754fea449de"
      unitRef="usd">5447000</us-gaap:LiabilityForUncertainTaxPositionsNoncurrent>
    <us-gaap:OtherSundryLiabilitiesNoncurrent
      contextRef="i68ecd84e8da440808154baac134e839e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y182MS9mcmFnOmU0Njg0NTE5ODc2ZjRiN2M5ZGYzNmRjOGVjZjA4ZTJmL3RhYmxlOjNhZTAyZjQ4MjgzYzQxMWQ5YzcwZmUyZGIwYjU2ODYyL3RhYmxlcmFuZ2U6M2FlMDJmNDgyODNjNDExZDljNzBmZTJkYjBiNTY4NjJfNTAtMi0xLTEtMTA3NzA_f8f68646-6cc9-43d8-a560-3bc2608c1efb"
      unitRef="usd">49228000</us-gaap:OtherSundryLiabilitiesNoncurrent>
    <us-gaap:OtherSundryLiabilitiesNoncurrent
      contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y182MS9mcmFnOmU0Njg0NTE5ODc2ZjRiN2M5ZGYzNmRjOGVjZjA4ZTJmL3RhYmxlOjNhZTAyZjQ4MjgzYzQxMWQ5YzcwZmUyZGIwYjU2ODYyL3RhYmxlcmFuZ2U6M2FlMDJmNDgyODNjNDExZDljNzBmZTJkYjBiNTY4NjJfNTAtNC0xLTEtMTA3NzA_aca8e36c-10b9-4678-bbbb-e14720caea92"
      unitRef="usd">49533000</us-gaap:OtherSundryLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i68ecd84e8da440808154baac134e839e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y182MS9mcmFnOmU0Njg0NTE5ODc2ZjRiN2M5ZGYzNmRjOGVjZjA4ZTJmL3RhYmxlOjNhZTAyZjQ4MjgzYzQxMWQ5YzcwZmUyZGIwYjU2ODYyL3RhYmxlcmFuZ2U6M2FlMDJmNDgyODNjNDExZDljNzBmZTJkYjBiNTY4NjJfNTEtMi0xLTEtMTA3NzA_b1566e8b-abe7-4026-bbb7-3de34e363c3a"
      unitRef="usd">107115000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i61f65cd0793e47078410af8ea7c03faa_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y182MS9mcmFnOmU0Njg0NTE5ODc2ZjRiN2M5ZGYzNmRjOGVjZjA4ZTJmL3RhYmxlOjNhZTAyZjQ4MjgzYzQxMWQ5YzcwZmUyZGIwYjU2ODYyL3RhYmxlcmFuZ2U6M2FlMDJmNDgyODNjNDExZDljNzBmZTJkYjBiNTY4NjJfNTEtNC0xLTEtMTA3NzA_8b8eb984-d471-4911-99e7-dd63ebfd8dae"
      unitRef="usd">107907000</us-gaap:OtherLiabilitiesNoncurrent>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139669123208664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page - shares<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Nov. 03, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Sep. 30,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-16753<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">AMN HEALTHCARE SERVICES, INC.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">06-1500476<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">8840 Cypress Waters Boulevard<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Dallas<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">TX<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">75019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">866<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">871-8519<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.01 par value<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">AMN<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding (excluding treasury shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">47,275,009<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001142750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139669122277704">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 137,041<span></span>
</td>
<td class="nump">$ 29,213<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net of allowances of $6,148 and $7,043 at September&#160;30, 2021 and December&#160;31, 2020, respectively</a></td>
<td class="nump">570,101<span></span>
</td>
<td class="nump">376,099<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_amn_Accountsreceivablesubcontractor', window );">Accounts receivable, subcontractor</a></td>
<td class="nump">141,626<span></span>
</td>
<td class="nump">73,985<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseCurrent', window );">Prepaid expenses</a></td>
<td class="nump">19,367<span></span>
</td>
<td class="nump">13,629<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other current assets</a></td>
<td class="nump">31,396<span></span>
</td>
<td class="nump">40,809<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">899,531<span></span>
</td>
<td class="nump">533,735<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashAndInvestmentsNoncurrent', window );">Restricted cash, cash equivalents and investments</a></td>
<td class="nump">63,603<span></span>
</td>
<td class="nump">61,347<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Fixed assets, net of accumulated depreciation of $190,578 and $161,752 at September&#160;30, 2021 and December&#160;31, 2020, respectively</a></td>
<td class="nump">127,762<span></span>
</td>
<td class="nump">116,174<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">36,487<span></span>
</td>
<td class="nump">77,735<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">157,909<span></span>
</td>
<td class="nump">135,120<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">893,283<span></span>
</td>
<td class="nump">864,485<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net of accumulated amortization of $262,253 and $215,234 at September&#160;30, 2021 and December&#160;31, 2020, respectively</a></td>
<td class="nump">530,422<span></span>
</td>
<td class="nump">564,911<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">2,708,997<span></span>
</td>
<td class="nump">2,353,507<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable and accrued expenses</a></td>
<td class="nump">284,094<span></span>
</td>
<td class="nump">167,881<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued compensation and benefits</a></td>
<td class="nump">321,938<span></span>
</td>
<td class="nump">213,414<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayableCurrent', window );">Current portion of notes payable</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">4,688<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current portion of operating lease liabilities</a></td>
<td class="nump">14,396<span></span>
</td>
<td class="nump">15,032<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Deferred revenue</a></td>
<td class="nump">17,904<span></span>
</td>
<td class="nump">11,004<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other current liabilities</a></td>
<td class="nump">2,854<span></span>
</td>
<td class="nump">10,938<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">641,186<span></span>
</td>
<td class="nump">422,957<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermNotesPayable', window );">Notes payable, net of unamortized fees and premium</a></td>
<td class="nump">842,027<span></span>
</td>
<td class="nump">857,961<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred income taxes, net</a></td>
<td class="nump">61,187<span></span>
</td>
<td class="nump">67,205<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities</a></td>
<td class="nump">15,004<span></span>
</td>
<td class="nump">77,800<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">107,115<span></span>
</td>
<td class="nump">107,907<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">1,666,519<span></span>
</td>
<td class="nump">1,533,830<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $0.01 par value; 10,000 shares authorized; none issued and outstanding at September&#160;30, 2021 and December&#160;31, 2020</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.01 par value; 200,000 shares authorized; 49,836 issued and 47,275 outstanding at September&#160;30, 2021 and 49,614 issued and 47,053 outstanding at December&#160;31, 2020</a></td>
<td class="nump">498<span></span>
</td>
<td class="nump">496<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">480,364<span></span>
</td>
<td class="nump">468,726<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury stock, at cost; 2,561 shares at September&#160;30, 2021 and December&#160;31, 2020</a></td>
<td class="num">(119,143)<span></span>
</td>
<td class="num">(119,143)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">680,729<span></span>
</td>
<td class="nump">469,558<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive income</a></td>
<td class="nump">30<span></span>
</td>
<td class="nump">40<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders&#8217; equity</a></td>
<td class="nump">1,042,478<span></span>
</td>
<td class="nump">819,677<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders&#8217; equity</a></td>
<td class="nump">$ 2,708,997<span></span>
</td>
<td class="nump">$ 2,353,507<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amn_Accountsreceivablesubcontractor">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accounts receivable, subcontractor</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amn_Accountsreceivablesubcontractor</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130532-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of notes payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6787-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6387103&amp;loc=d3e6435-108320<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123349782&amp;loc=d3e5879-108316<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndInvestmentsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The noncurrent cash, cash equivalents and investments that is restricted as to withdrawal or usage. Restrictions may include legally restricted deposits held as compensating balances against borrowing arrangements, contracts entered into with others, or entity statements of intention with regard to particular deposits classified as long-term; that is not expected to be released from such existing restrictions within one year of the balance sheet date or operating cycle, whichever is longer. Excludes compensating balance arrangements that are not agreements which legally restrict the use of cash amounts shown on the balance sheet. Includes noncurrent cash equivalents and investments that are similarly restricted as to withdrawal, usage or disposal.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=120413173&amp;loc=SL6242262-115580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120413209&amp;loc=SL6242269-115581<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndInvestmentsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139669122298712">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets (Parenthetical) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Accounts receivable, allowance</a></td>
<td class="nump">$ 6,148<span></span>
</td>
<td class="nump">$ 7,043<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Accumulated depreciation - fixed assets</a></td>
<td class="nump">190,578<span></span>
</td>
<td class="nump">161,752<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization</a></td>
<td class="nump">$ 262,253<span></span>
</td>
<td class="nump">$ 215,234<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized (in shares)</a></td>
<td class="nump">10,000,000<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">200,000,000<span></span>
</td>
<td class="nump">200,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">49,836,000<span></span>
</td>
<td class="nump">49,614,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding (in shares)</a></td>
<td class="nump">47,275,000<span></span>
</td>
<td class="nump">47,053,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury stock (in shares)</a></td>
<td class="nump">2,561,000<span></span>
</td>
<td class="nump">2,561,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139669121840712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Comprehensive Income - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">$ 877,800<span></span>
</td>
<td class="nump">$ 551,631<span></span>
</td>
<td class="nump">$ 2,621,190<span></span>
</td>
<td class="nump">$ 1,762,443<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of revenue</a></td>
<td class="nump">571,935<span></span>
</td>
<td class="nump">366,998<span></span>
</td>
<td class="nump">1,745,914<span></span>
</td>
<td class="nump">1,178,204<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">305,865<span></span>
</td>
<td class="nump">184,633<span></span>
</td>
<td class="nump">875,276<span></span>
</td>
<td class="nump">584,239<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative</a></td>
<td class="nump">173,932<span></span>
</td>
<td class="nump">111,235<span></span>
</td>
<td class="nump">491,773<span></span>
</td>
<td class="nump">394,537<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization (exclusive of depreciation included in cost of revenue)</a></td>
<td class="nump">26,104<span></span>
</td>
<td class="nump">26,936<span></span>
</td>
<td class="nump">74,098<span></span>
</td>
<td class="nump">69,096<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">200,036<span></span>
</td>
<td class="nump">138,171<span></span>
</td>
<td class="nump">565,871<span></span>
</td>
<td class="nump">463,633<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income from operations</a></td>
<td class="nump">105,829<span></span>
</td>
<td class="nump">46,462<span></span>
</td>
<td class="nump">309,405<span></span>
</td>
<td class="nump">120,606<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense, net, and other</a></td>
<td class="nump">5,223<span></span>
</td>
<td class="nump">12,564<span></span>
</td>
<td class="nump">24,278<span></span>
</td>
<td class="nump">35,061<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossAttributableToParent', window );">Income before income taxes</a></td>
<td class="nump">100,606<span></span>
</td>
<td class="nump">33,898<span></span>
</td>
<td class="nump">285,127<span></span>
</td>
<td class="nump">85,545<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="nump">26,583<span></span>
</td>
<td class="nump">7,831<span></span>
</td>
<td class="nump">73,956<span></span>
</td>
<td class="nump">24,188<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net income</a></td>
<td class="nump">74,023<span></span>
</td>
<td class="nump">26,067<span></span>
</td>
<td class="nump">211,171<span></span>
</td>
<td class="nump">61,357<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted', window );">Net income</a></td>
<td class="nump">74,023<span></span>
</td>
<td class="nump">26,067<span></span>
</td>
<td class="nump">211,171<span></span>
</td>
<td class="nump">61,357<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract', window );"><strong>Other comprehensive income (loss):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Foreign currency translation and other</a></td>
<td class="nump">11<span></span>
</td>
<td class="num">(14)<span></span>
</td>
<td class="num">(10)<span></span>
</td>
<td class="num">(119)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss)</a></td>
<td class="nump">11<span></span>
</td>
<td class="num">(14)<span></span>
</td>
<td class="num">(10)<span></span>
</td>
<td class="num">(119)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income</a></td>
<td class="nump">$ 74,034<span></span>
</td>
<td class="nump">$ 26,053<span></span>
</td>
<td class="nump">$ 211,161<span></span>
</td>
<td class="nump">$ 61,238<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Net income per common share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (in dollars per share)</a></td>
<td class="nump">$ 1.55<span></span>
</td>
<td class="nump">$ 0.55<span></span>
</td>
<td class="nump">$ 4.43<span></span>
</td>
<td class="nump">$ 1.29<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (in dollars per share)</a></td>
<td class="nump">$ 1.54<span></span>
</td>
<td class="nump">$ 0.55<span></span>
</td>
<td class="nump">$ 4.40<span></span>
</td>
<td class="nump">$ 1.29<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted average common shares outstanding:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">47,737<span></span>
</td>
<td class="nump">47,476<span></span>
</td>
<td class="nump">47,666<span></span>
</td>
<td class="nump">47,406<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">48,080<span></span>
</td>
<td class="nump">47,676<span></span>
</td>
<td class="nump">48,022<span></span>
</td>
<td class="nump">47,647<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 18: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of income (loss) attributable to parent. Includes, but is not limited to, income (loss) from continuing operations, discontinued operations and equity method investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1377-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1930-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1930-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1930-109256<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1930-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569643-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139669120443464">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Stockholders' Equity - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Cumulative Effect, Period of Adoption, Adjustment</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional Paid-in Capital</div></th>
<th class="th"><div>Treasury Stock</div></th>
<th class="th"><div>Retained Earnings</div></th>
<th class="th">
<div>Retained Earnings </div>
<div>Cumulative Effect, Period of Adoption, Adjustment</div>
</th>
<th class="th"><div>Accumulated Other Comprehensive Income</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Beginning balance (in shares) at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49,283<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,561<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2019</a></td>
<td class="nump">$ 736,742<span></span>
</td>
<td class="num">$ (1,154)<span></span>
</td>
<td class="nump">$ 493<span></span>
</td>
<td class="nump">$ 455,193<span></span>
</td>
<td class="num">$ (119,143)<span></span>
</td>
<td class="nump">$ 400,047<span></span>
</td>
<td class="num">$ (1,154)<span></span>
</td>
<td class="nump">$ 152<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Equity awards vested and exercised, net of shares withheld for payroll taxes (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">140<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Equity awards vested and exercised, net of shares withheld for payroll taxes</a></td>
<td class="num">(4,353)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="num">(4,354)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
<td class="nump">4,927<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,927<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income (loss)</a></td>
<td class="nump">12,918<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,965<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(47)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Ending balance (in shares) at Mar. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49,423<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,561<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Mar. 31, 2020</a></td>
<td class="nump">749,080<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 494<span></span>
</td>
<td class="nump">455,766<span></span>
</td>
<td class="num">$ (119,143)<span></span>
</td>
<td class="nump">411,858<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">105<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Beginning balance (in shares) at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49,283<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,561<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2019</a></td>
<td class="nump">736,742<span></span>
</td>
<td class="num">(1,154)<span></span>
</td>
<td class="nump">$ 493<span></span>
</td>
<td class="nump">455,193<span></span>
</td>
<td class="num">$ (119,143)<span></span>
</td>
<td class="nump">400,047<span></span>
</td>
<td class="num">(1,154)<span></span>
</td>
<td class="nump">152<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income (loss)</a></td>
<td class="nump">61,238<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Ending balance (in shares) at Sep. 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49,550<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,561<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Sep. 30, 2020</a></td>
<td class="nump">807,073<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 495<span></span>
</td>
<td class="nump">465,438<span></span>
</td>
<td class="num">$ (119,143)<span></span>
</td>
<td class="nump">460,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Beginning balance (in shares) at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49,283<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,561<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2019</a></td>
<td class="nump">$ 736,742<span></span>
</td>
<td class="num">$ (1,154)<span></span>
</td>
<td class="nump">$ 493<span></span>
</td>
<td class="nump">455,193<span></span>
</td>
<td class="num">$ (119,143)<span></span>
</td>
<td class="nump">400,047<span></span>
</td>
<td class="num">$ (1,154)<span></span>
</td>
<td class="nump">152<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingStandardsUpdateExtensibleList', window );">Accounting Standards Update [Extensible Enumeration]</a></td>
<td class="text">Accounting Standards Update 2016-13 [Member]<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Ending balance (in shares) at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49,614<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,561<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Dec. 31, 2020</a></td>
<td class="nump">$ 819,677<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 496<span></span>
</td>
<td class="nump">468,726<span></span>
</td>
<td class="num">$ (119,143)<span></span>
</td>
<td class="nump">469,558<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Beginning balance (in shares) at Mar. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49,423<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,561<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Mar. 31, 2020</a></td>
<td class="nump">749,080<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 494<span></span>
</td>
<td class="nump">455,766<span></span>
</td>
<td class="num">$ (119,143)<span></span>
</td>
<td class="nump">411,858<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">105<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Equity awards vested and exercised, net of shares withheld for payroll taxes (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">119<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Equity awards vested and exercised, net of shares withheld for payroll taxes</a></td>
<td class="num">(288)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="num">(289)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
<td class="nump">6,347<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,347<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income (loss)</a></td>
<td class="nump">22,267<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,325<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(58)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Ending balance (in shares) at Jun. 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49,542<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,561<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Jun. 30, 2020</a></td>
<td class="nump">777,406<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 495<span></span>
</td>
<td class="nump">461,824<span></span>
</td>
<td class="num">$ (119,143)<span></span>
</td>
<td class="nump">434,183<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">47<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Equity awards vested and exercised, net of shares withheld for payroll taxes (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Equity awards vested and exercised, net of shares withheld for payroll taxes</a></td>
<td class="num">(158)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(158)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
<td class="nump">3,772<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,772<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income (loss)</a></td>
<td class="nump">26,053<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26,067<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(14)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Ending balance (in shares) at Sep. 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49,550<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,561<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Sep. 30, 2020</a></td>
<td class="nump">807,073<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 495<span></span>
</td>
<td class="nump">465,438<span></span>
</td>
<td class="num">$ (119,143)<span></span>
</td>
<td class="nump">460,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Beginning balance (in shares) at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49,614<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,561<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2020</a></td>
<td class="nump">819,677<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 496<span></span>
</td>
<td class="nump">468,726<span></span>
</td>
<td class="num">$ (119,143)<span></span>
</td>
<td class="nump">469,558<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Equity awards vested and exercised, net of shares withheld for payroll taxes (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">132<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Equity awards vested and exercised, net of shares withheld for payroll taxes</a></td>
<td class="num">(5,258)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="num">(5,259)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
<td class="nump">9,287<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,287<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income (loss)</a></td>
<td class="nump">70,354<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70,378<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(24)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Ending balance (in shares) at Mar. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49,746<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,561<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Mar. 31, 2021</a></td>
<td class="nump">894,060<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 497<span></span>
</td>
<td class="nump">472,754<span></span>
</td>
<td class="num">$ (119,143)<span></span>
</td>
<td class="nump">539,936<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Beginning balance (in shares) at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49,614<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,561<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2020</a></td>
<td class="nump">819,677<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 496<span></span>
</td>
<td class="nump">468,726<span></span>
</td>
<td class="num">$ (119,143)<span></span>
</td>
<td class="nump">469,558<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income (loss)</a></td>
<td class="nump">211,161<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Ending balance (in shares) at Sep. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49,836<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,561<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Sep. 30, 2021</a></td>
<td class="nump">1,042,478<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 498<span></span>
</td>
<td class="nump">480,364<span></span>
</td>
<td class="num">$ (119,143)<span></span>
</td>
<td class="nump">680,729<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Beginning balance (in shares) at Mar. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49,746<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,561<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Mar. 31, 2021</a></td>
<td class="nump">894,060<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 497<span></span>
</td>
<td class="nump">472,754<span></span>
</td>
<td class="num">$ (119,143)<span></span>
</td>
<td class="nump">539,936<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Equity awards vested and exercised, net of shares withheld for payroll taxes (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">78<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Equity awards vested and exercised, net of shares withheld for payroll taxes</a></td>
<td class="num">(470)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="num">(471)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
<td class="nump">6,019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income (loss)</a></td>
<td class="nump">66,773<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">66,770<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Ending balance (in shares) at Jun. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49,824<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,561<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Jun. 30, 2021</a></td>
<td class="nump">966,382<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 498<span></span>
</td>
<td class="nump">478,302<span></span>
</td>
<td class="num">$ (119,143)<span></span>
</td>
<td class="nump">606,706<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Equity awards vested and exercised, net of shares withheld for payroll taxes (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Equity awards vested and exercised, net of shares withheld for payroll taxes</a></td>
<td class="num">(527)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(527)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
<td class="nump">2,589<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,589<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income (loss)</a></td>
<td class="nump">74,034<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">74,023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Ending balance (in shares) at Sep. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49,836<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,561<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Sep. 30, 2021</a></td>
<td class="nump">$ 1,042,478<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 498<span></span>
</td>
<td class="nump">$ 480,364<span></span>
</td>
<td class="num">$ (119,143)<span></span>
</td>
<td class="nump">$ 680,729<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingStandardsUpdateExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates amendment to accounting standards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL121967933-165497<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL121967933-165497<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL122642865-165497<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL121967933-165497<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL121967933-165497<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL120254526-165497<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 27: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=122150657&amp;loc=SL122150809-237846<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL122642865-165497<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S65<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124359872&amp;loc=SL124427846-239511<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124402435&amp;loc=SL124402458-218513<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124402435&amp;loc=SL124402458-218513<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL120254526-165497<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 45: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 49: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 50: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 51: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 52: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 53: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 54: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 55: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 56: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 57: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 58: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 59: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 60: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 61: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)<br><br>Reference 62: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(1)<br><br>Reference 63: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(2)<br><br>Reference 64: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(01)<br><br>Reference 65: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(03)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingStandardsUpdateExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=122142933&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=122142933&amp;loc=d3e11178-113907<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123468992&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139669119778904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Cash Flows - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 211,171<span></span>
</td>
<td class="nump">$ 61,357<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization (inclusive of depreciation included in cost of revenue)</a></td>
<td class="nump">75,871<span></span>
</td>
<td class="nump">70,077<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNoncashIncomeExpense', window );">Non-cash interest expense and other</a></td>
<td class="num">(4,541)<span></span>
</td>
<td class="nump">3,727<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WriteOffOfDeferredDebtIssuanceCost', window );">Write-off of fees on credit facilities and senior notes</a></td>
<td class="nump">158<span></span>
</td>
<td class="nump">1,773<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Change in fair value of contingent consideration</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(1,700)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_amn_AccountsReceivableAndSalesCreditsCreditLossExpenseReversal', window );">Increase in allowance for credit losses and sales credits</a></td>
<td class="nump">2,103<span></span>
</td>
<td class="nump">7,580<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Provision for deferred income taxes</a></td>
<td class="num">(4,328)<span></span>
</td>
<td class="num">(17,923)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="nump">17,895<span></span>
</td>
<td class="nump">15,046<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnDispositionOfAssets', window );">Loss on disposal or sale of fixed assets</a></td>
<td class="nump">386<span></span>
</td>
<td class="nump">3,664<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeAmortizationOfDiscount', window );">Amortization of discount on investments</a></td>
<td class="num">(41)<span></span>
</td>
<td class="num">(96)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_amn_GainLossOnDeferredCompensation', window );">Net loss on deferred compensation balances</a></td>
<td class="nump">96<span></span>
</td>
<td class="nump">798<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_amn_LesseeOperatingLeaseNoncashExpense', window );">Non-cash lease expense</a></td>
<td class="num">(257)<span></span>
</td>
<td class="nump">244<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in assets and liabilities, net of effects from acquisitions:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="num">(196,342)<span></span>
</td>
<td class="nump">15,151<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_amn_IncreaseDecreaseinAccountsReceivablessubcontractor', window );">Accounts receivable, subcontractor</a></td>
<td class="num">(67,641)<span></span>
</td>
<td class="nump">16,414<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable', window );">Income taxes receivable</a></td>
<td class="nump">5,472<span></span>
</td>
<td class="nump">6,157<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidExpense', window );">Prepaid expenses</a></td>
<td class="num">(5,695)<span></span>
</td>
<td class="num">(3,361)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherCurrentAssets', window );">Other current assets</a></td>
<td class="nump">3,411<span></span>
</td>
<td class="nump">2,977<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets', window );">Other assets</a></td>
<td class="nump">780<span></span>
</td>
<td class="nump">3,378<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable and accrued expenses</a></td>
<td class="nump">112,183<span></span>
</td>
<td class="num">(5,484)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities', window );">Accrued compensation and benefits</a></td>
<td class="nump">96,666<span></span>
</td>
<td class="nump">7,630<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities', window );">Other liabilities</a></td>
<td class="num">(26,268)<span></span>
</td>
<td class="nump">29,592<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability', window );">Deferred revenue</a></td>
<td class="nump">6,276<span></span>
</td>
<td class="num">(32)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInRestrictedCashAndInvestmentsForOperatingActivities', window );">Restricted investments balance</a></td>
<td class="nump">16<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">227,371<span></span>
</td>
<td class="nump">216,981<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchase and development of fixed assets</a></td>
<td class="num">(38,710)<span></span>
</td>
<td class="num">(27,357)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireShortTermInvestments', window );">Purchase of investments</a></td>
<td class="num">(32,437)<span></span>
</td>
<td class="num">(37,418)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments', window );">Proceeds from maturity of investments</a></td>
<td class="nump">40,000<span></span>
</td>
<td class="nump">21,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireEquitySecuritiesFvNi', window );">Purchase of equity investment</a></td>
<td class="num">(500)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireLifeInsurancePolicies', window );">Payments to fund deferred compensation plan</a></td>
<td class="num">(6,094)<span></span>
</td>
<td class="num">(7,171)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfTradingSecuritiesHeldforinvestment', window );">Proceeds from sale of equity investment</a></td>
<td class="nump">78<span></span>
</td>
<td class="nump">303<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireNotesReceivable', window );">Purchase of convertible promissory notes</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(490)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Cash paid for acquisitions, net of cash and restricted cash received</a></td>
<td class="num">(41,264)<span></span>
</td>
<td class="num">(476,491)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireIntangibleAssets', window );">Cash paid for other intangibles</a></td>
<td class="num">(90)<span></span>
</td>
<td class="num">(1,400)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromPreviousAcquisition', window );">Cash received for working capital adjustments for prior year acquisitions</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">66<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(79,017)<span></span>
</td>
<td class="num">(528,458)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfSecuredDebt', window );">Payments on term loans</a></td>
<td class="num">(21,875)<span></span>
</td>
<td class="num">(203,125)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSecuredDebt', window );">Proceeds from term loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">250,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLinesOfCredit', window );">Payments on revolving credit facility</a></td>
<td class="num">(70,000)<span></span>
</td>
<td class="num">(205,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromLinesOfCredit', window );">Proceeds from revolving credit facility</a></td>
<td class="nump">70,000<span></span>
</td>
<td class="nump">245,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt', window );">Proceeds from senior notes</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">202,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfFinancingCosts', window );">Payment of financing costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(6,898)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_amn_PaymentsForPreviousAcquisitionEarnOutPayment', window );">Earn-out payments to settle contingent consideration liabilities for prior acquisitions</a></td>
<td class="num">(3,100)<span></span>
</td>
<td class="num">(10,622)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Cash paid for shares withheld for taxes</a></td>
<td class="num">(6,255)<span></span>
</td>
<td class="num">(4,798)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by (used in) financing activities</a></td>
<td class="num">(31,230)<span></span>
</td>
<td class="nump">266,557<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect of exchange rate changes on cash</a></td>
<td class="num">(10)<span></span>
</td>
<td class="num">(119)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net increase (decrease) in cash, cash equivalents and restricted cash</a></td>
<td class="nump">117,114<span></span>
</td>
<td class="num">(45,039)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash at beginning of period</a></td>
<td class="nump">83,990<span></span>
</td>
<td class="nump">153,962<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash at end of period</a></td>
<td class="nump">201,104<span></span>
</td>
<td class="nump">108,923<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental disclosures of cash flow information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Cash paid for amounts included in the measurement of operating lease liabilities</a></td>
<td class="nump">35,066<span></span>
</td>
<td class="nump">15,079<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Cash paid for interest (net of $248 and $300 capitalized for the nine months ended September 30, 2021 and 2020, respectively)</a></td>
<td class="nump">19,301<span></span>
</td>
<td class="nump">13,848<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Cash paid for income taxes</a></td>
<td class="nump">72,863<span></span>
</td>
<td class="nump">30,727<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract', window );"><strong>Acquisitions:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOfAssetsAcquired', window );">Fair value of tangible assets acquired in acquisitions, net of cash and restricted cash received</a></td>
<td class="nump">1,906<span></span>
</td>
<td class="nump">35,704<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_amn_SupplementalDisclosuresOfNonCashInvestingAndFinancingActivitiesGoodwill', window );">Goodwill</a></td>
<td class="nump">28,135<span></span>
</td>
<td class="nump">274,427<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_amn_SupplementalDisclosuresOfNonCashInvestingAndFinancingActivitiesIntangibleAssets', window );">Intangible assets</a></td>
<td class="nump">12,440<span></span>
</td>
<td class="nump">228,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAssumed1', window );">Liabilities assumed</a></td>
<td class="num">(1,217)<span></span>
</td>
<td class="num">(61,640)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Net cash paid for acquisitions</a></td>
<td class="nump">41,264<span></span>
</td>
<td class="nump">476,491<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract', window );"><strong>Supplemental disclosures of non-cash investing and financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_amn_Purchaseoffixedassetsrecordedinaccountspayableandaccruedexpenses', window );">Purchase of fixed assets recorded in accounts payable and accrued expenses</a></td>
<td class="nump">$ 5,080<span></span>
</td>
<td class="nump">$ 1,007<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amn_AccountsReceivableAndSalesCreditsCreditLossExpenseReversal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accounts Receivable And Sales Credits, Credit Loss Expense (Reversal)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amn_AccountsReceivableAndSalesCreditsCreditLossExpenseReversal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amn_GainLossOnDeferredCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gain (Loss) On Deferred Compensation</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amn_GainLossOnDeferredCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amn_IncreaseDecreaseinAccountsReceivablessubcontractor">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase Decrease in Accounts Receivables, subcontractor</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amn_IncreaseDecreaseinAccountsReceivablessubcontractor</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amn_LesseeOperatingLeaseNoncashExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Noncash Expense</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amn_LesseeOperatingLeaseNoncashExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amn_PaymentsForPreviousAcquisitionEarnOutPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payments For Previous Acquisition, Earn-Out Payment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amn_PaymentsForPreviousAcquisitionEarnOutPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amn_Purchaseoffixedassetsrecordedinaccountspayableandaccruedexpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Purchase of fixed assets recorded in accounts payable and accrued expenses</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amn_Purchaseoffixedassetsrecordedinaccountspayableandaccruedexpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amn_SupplementalDisclosuresOfNonCashInvestingAndFinancingActivitiesGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Supplemental Disclosures Of Non Cash Investing And Financing Activities, Goodwill</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amn_SupplementalDisclosuresOfNonCashInvestingAndFinancingActivitiesGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amn_SupplementalDisclosuresOfNonCashInvestingAndFinancingActivitiesIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Supplemental Disclosures Of Non Cash Investing And Financing Activities, Intangible Assets</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amn_SupplementalDisclosuresOfNonCashInvestingAndFinancingActivitiesIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfAssetsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fair value of assets acquired in noncash investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4313-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4332-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfAssetsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnDispositionOfAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of property, plant and equipment assets, excluding oil and gas property and timber property.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2443-110228<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnDispositionOfAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 310<br> -Section 45<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123371682&amp;loc=d3e55415-109406<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in income taxes receivable, which represents the amount due from tax authorities for refunds of overpayments or recoveries of income taxes paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInIncomeTaxesReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherCurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherCurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInRestrictedCashAndInvestmentsForOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in marketable securities and investments pledged or subject to withdrawal restrictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInRestrictedCashAndInvestmentsForOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeAmortizationOfDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accretion of purchase discount on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeAmortizationOfDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAssumed1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fair value of liabilities assumed in noncash investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4304-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4332-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4313-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAssumed1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashInvestingAndFinancingItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for loan and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireEquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to acquire investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as investing activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123583714&amp;loc=SL75117360-209713<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3444-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireEquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireLifeInsurancePolicies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for payment of premium on corporate-owned life insurance policy, classified as investing activities. Includes, but is not limited to, bank-owned life insurance policy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21C<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=SL94080552-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireLifeInsurancePolicies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireNotesReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to acquire an agreement for an unconditional promise by the maker to pay the entity (holder) a definite sum of money at a future date. Such amount may include accrued interest receivable in accordance with the terms of the note. The note also may contain provisions including a discount or premium, payable on demand, secured, or unsecured, interest bearing or noninterest bearing, among myriad other features and characteristics.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireNotesReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for securities or other assets acquired, which qualify for treatment as an investing activity and are to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfSecuredDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from amounts received from issuance of long-term debt that is wholly or partially secured by collateral. Excludes proceeds from tax exempt secured debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfSecuredDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a borrowing with the highest claim on the assets of the entity in case of bankruptcy or liquidation (with maturities initially due after one year or beyond the operating cycle, if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromPreviousAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash inflow representing an adjustment to the purchase price of a previous acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromPreviousAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the sale, maturity and collection of all investments such as debt, security and so forth during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfTradingSecuritiesHeldforinvestment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the sale of securities classified as trading securities and held for investment purposes. Excludes proceeds from trading securities purchased and held principally for the purpose of selling them in the near term (thus held for only a short period of time).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfTradingSecuritiesHeldforinvestment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfSecuredDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to repay long-term debt that is wholly or partially secured by collateral. Excludes repayments of tax exempt secured debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfSecuredDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WriteOffOfDeferredDebtIssuanceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Write-off of amounts previously capitalized as debt issuance cost in an extinguishment of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WriteOffOfDeferredDebtIssuanceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139669118052792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Cash Flows (Parenthetical) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfCashFlowsAbstract', window );"><strong>Statement of Cash Flows [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaidCapitalized', window );">Interest capitalized</a></td>
<td class="nump">$ 248<span></span>
</td>
<td class="nump">$ 300<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidCapitalized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest capitalized, classified as investing activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidCapitalized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfCashFlowsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfCashFlowsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139669119568904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccounting', window );">Basis of Presentation</a></td>
<td class="text">BASIS OF PRESENTATION<div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The condensed consolidated balance sheets and related condensed consolidated statements of comprehensive income and cash flows contained in this Quarterly Report on Form&#160;10-Q (this &#8220;Quarterly Report&#8221;), which are unaudited, include the accounts of AMN&#160;Healthcare Services, Inc. and its wholly-owned subsidiaries (collectively, the &#8220;Company&#8221;). All significant intercompany balances and transactions have been eliminated in consolidation. In the opinion of management, all entries necessary for a fair presentation of such unaudited condensed consolidated financial statements have been included. These entries consisted of all normal recurring items. The results of operations for the interim period are not necessarily indicative of the results to be expected for any other interim period or for the entire fiscal year or for any future period.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited condensed consolidated financial statements do not include all information and notes necessary for a complete presentation of financial position, results of operations and cash flows in conformity with accounting principles generally accepted in the United States (&#8220;U.S. GAAP&#8221;). Please refer to the Company&#8217;s audited consolidated financial statements and the related notes for the fiscal year ended December&#160;31, 2020, contained in the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2020, filed with the Securities and Exchange Commission on February 26, 2021 (&#8220;2020 Annual Report&#8221;). </span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with U.S. GAAP requires management to make a number of estimates and assumptions relating to the reporting of assets and liabilities and the disclosure of contingent assets and liabilities at the dates of the financial statements and the reported amounts of revenue and expenses during the reporting periods. On an ongoing basis, the Company evaluates its estimates, including those related to intangible assets purchased in a business combination, asset impairments, accruals for self-insurance, compensation and related benefits, accounts receivable, contingencies and litigation, contingent consideration liabilities associated with acquisitions, and income taxes. Actual results could differ from those estimates under different assumptions or conditions. The impact of the novel coronavirus (COVID-19) pandemic did not have a material effect on the Company&#8217;s estimates as of September&#160;30, 2021.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Adopted Accounting Pronouncements</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standard Update (&#8220;ASU&#8221;) 2019-12, &#8220;Simplifying the Accounting for Income Taxes.&#8221; The standard is expected to reduce cost and complexity related to accounting for income taxes. The new guidance eliminates certain exceptions and clarifies and amends existing guidance to promote consistent application among reporting entities. Depending on the amended guidance within this standard, adoption is to be applied on a retrospective, modified retrospective or prospective basis. The Company adopted this standard effective January 1, 2021, and the adoption did not have a material effect on the Company&#8217;s consolidated financial statements.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2020, the FASB issued ASU 2020-01, &#8220;Clarifying the Interactions between Topic 321, Topic 323, and Topic 815.&#8221; The new guidance clarifies the interactions between accounting standards that apply to equity investments without readily determinable fair values. Specifically, it addresses the accounting for the transition into and out of the equity method. The Company adopted this standard effective January 1, 2021 on a prospective basis, and the adoption did not have a material effect on the Company&#8217;s consolidated financial statements.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash, Cash Equivalents and Restricted Cash</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents. Cash and cash equivalents include currency on hand, deposits with financial institutions, money market funds, commercial paper and other highly liquid investments. Restricted cash and cash equivalents primarily includes cash and commercial paper that serve as collateral for the Company&#8217;s captive insurance subsidiary claim payments. See Note (7), &#8220;Fair Value Measurement&#8221; for additional information.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the accompanying condensed consolidated balance sheets and related notes to the amounts presented in the accompanying condensed consolidated statements of cash flows.</span></div><div style="margin-top:14pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:66.590%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.544%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137,041&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,213&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash and cash equivalents (included in other current assets)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,118&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,626&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash, cash equivalents and investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,603&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,347&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents and restricted cash and investments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218,762&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109,186&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less restricted investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,658)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25,196)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents and restricted cash</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201,104&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,990&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:4pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounts Receivable</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records accounts receivable at the invoiced amount. Accounts receivable are non-interest bearing. The Company maintains an allowance for expected credit losses based on the Company&#8217;s historical write-off experience, an assessment of its customers&#8217; financial conditions and available information that is relevant to assessing the collectability of cash flows, which includes current conditions and forecasts about future economic conditions.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a reconciliation of activity in the allowance for credit losses for accounts receivable:</span></div><div style="margin-top:14pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:66.590%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.544%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1,</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,043&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,332&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zMS9mcmFnOmNlNDgxOGVmYTM1YjQ2NDI4NGUxN2Q2NWEwYThiNjc3L3RhYmxlOmU5MmY2N2EzMmZkYjRlZmY5MmRhZThhMjE3M2M0NzBmL3RhYmxlcmFuZ2U6ZTkyZjY3YTMyZmRiNGVmZjkyZGFlOGEyMTczYzQ3MGZfMi0wLTEtMS0xMDc3MA_2e5b46ce-627c-4ad2-9f91-f5ecc232b823"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zMS9mcmFnOmNlNDgxOGVmYTM1YjQ2NDI4NGUxN2Q2NWEwYThiNjc3L3RhYmxlOmU5MmY2N2EzMmZkYjRlZmY5MmRhZThhMjE3M2M0NzBmL3RhYmxlcmFuZ2U6ZTkyZjY3YTMyZmRiNGVmZjkyZGFlOGEyMTczYzQ3MGZfMi0wLTEtMS0xMDc3MA_5c495df8-c4dc-4a11-8dcb-5b212c885604">Adoption of the credit loss standard, cumulative-effect adjustment to retained earnings</span></span></span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,334&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for expected credit losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">325&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,178&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts written off charged against the allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,220)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,333)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of September 30,</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,148&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,511&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccounting">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccounting</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139669119392104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">Acquisitions</a></td>
<td class="text">ACQUISITIONS <div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As set forth below, the Company completed two acquisitions from January&#160;1, 2020 through September&#160;30, 2021, which were accounted for using the acquisition method of accounting. Accordingly, the Company recorded the tangible and intangible assets acquired and liabilities assumed at their estimated fair values as of the applicable date of acquisition. Since the applicable date of acquisition, the Company has revised the allocation of the purchase price to the tangible and intangible assets acquired and liabilities assumed based on analysis of information that has been made available through September&#160;30, 2021. The allocations will continue to be updated through the measurement period, if necessary. The Company recognizes acquisition-related costs in selling, general and administrative expenses in the consolidated statements of comprehensive income.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Synzi and SnapMD Acquisition</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 7, 2021, the Company completed its acquisition of Synzi Holdings, Inc. (&#8220;Synzi&#8221;) and its wholly-owned subsidiary, SnapMD, LLC (&#8220;SnapMD&#8221;). Synzi is a virtual care communication platform that enables organizations to conduct virtual visits and use secure messaging, text, and email for clinician-to-patient and clinician-to-clinician communications. SnapMD is a full-service virtual care management company, specializing in providing software to enable healthcare providers to better engage with their patients. The initial purchase price of $42,240 consisted entirely of cash consideration paid upon acquisition. The acquisition was funded primarily through borrowings under the Senior Credit Facility (as defined below). The results of Synzi and SnapMD have been included in the Company&#8217;s technology and workforce solutions segment since the date of acquisition. During the second quarter of 2021, $92 was returned to the Company in respect of the final working capital settlement.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preliminary allocation of the $42,148 purchase price, which was reduced by the final working capital settlement, consisted of (1) $2,790 of fair value of tangible assets acquired, which included $884 cash received, (2) $1,217 of liabilities assumed, (3) $12,440 of identified intangible assets, and (4) $28,135 of goodwill, of which $6,085 is deductible for tax purposes. The provisional items pending finalization are income tax related matters and the assessment of additional information related to determining the fair value of certain assets acquired and liabilities assumed. The fair value of intangible assets primarily includes $10,890 of developed technology and $1,220 of trademarks with a weighted average useful life of approximately seven years. </span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stratus Video Acquisition</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 14, 2020, the Company completed its acquisition of Stratus Video, a remote video interpreting company that provides healthcare interpretation via remote video, over the phone, and onsite in-person, all supported by proprietary technology platforms. The initial purchase price of $485,568 consisted entirely of cash consideration paid upon acquisition. The acquisition was funded primarily through (1) borrowings under the Company&#8217;s $400,000 secured revolving credit facility (the &#8220;Senior Credit Facility&#8221;), provided for under a credit agreement (the &#8220;New Credit Agreement&#8221;), and (2) the Second Amendment (as defined in Note (6) below) to the New Credit Agreement, which provided $250,000 of additional available borrowings to the Company. The Senior Credit Facility, New Credit Agreement and Second Amendment are more fully described in Note (6), &#8220;Notes Payable and Credit Agreement.&#8221; The results of Stratus Video have been included in the Company&#8217;s technology and workforce solutions segment since the date of acquisition. During the second quarter of 2020, an additional $99 of cash consideration was paid to the selling shareholders in respect of the final working capital settlement. The Company incurred $10,548 of acquisition-related costs during the nine months ended September 30, 2020 as a result of its acquisition of Stratus Video.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The allocation of the $485,667 purchase price, which included the additional cash consideration paid for the final working capital settlement and was finalized during the first quarter of 2021, consisted of (1) $44,092</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of fair value of tangible assets acquired, which included $9,176 cash received, (2) $56,059 of liabilities assumed, (3) $228,000 of identified intangible assets, and (4) $269,634 of goodwill, of which $10,182 is deductible for tax purposes. The intangible assets acquired have a weighted average useful life of approximately seventeen years. The following table summarizes the fair value and useful life of each intangible asset acquired as of the acquisition date:</span></div><div style="margin-top:14pt;text-align:center;text-indent:13.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:68.128%"><tr><td style="width:1.0%"/><td style="width:4.693%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:38.170%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.423%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.423%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:3.835%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.856%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Useful Life</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in years)</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Identifiable intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer Relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tradenames and Trademarks</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 - 10</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed Technology</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interpreter Database</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228,000&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><div style="margin-top:4pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the third quarter of 2020, the Company revised the estimated useful lives for the tradenames and trademarks intangible assets as a result of its plan to rebrand the language services business. Based on this change in circumstances since the date of acquisition, the Company determined that the remaining useful lives of the assets are 5 years and is amortizing the remaining value on a straight-line basis over the remaining useful life. The Company will continue to evaluate the remaining useful lives of other intangible assets impacted by its brand consolidation efforts.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Approximately $35,329 of revenue and $8,322 of income before income taxes of Stratus Video were included in the unaudited condensed consolidated statement of comprehensive income for the three months ended September 30, 2020. Approximately $78,080 of revenue and $13,787 of income before income taxes of Stratus Video were included in the unaudited condensed consolidated statement of comprehensive income for the nine months ended September 30, 2020.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Pro Forma Financial Information (Unaudited)</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summary presents unaudited pro forma consolidated results of operations of the Company as if the acquisition of Stratus Video had occurred on January 1, 2019, which gives effect to certain adjustments, including acquisition-related costs of $1,023 and $11,662, that were reclassified from the three and nine months ended September 30, 2020, respectively, to the three and nine months ended September 30, 2019, respectively. The unaudited pro forma financial information is not necessarily indicative of the operating results that would have occurred had the acquisition been consummated as of the date indicated, nor is it necessarily indicative of the Company&#8217;s future operating results. </span></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.584%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.215%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.317%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">551,631&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,776,315&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from operations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,465&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135,618&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,030&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,434&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI http://asc.fasb.org/topic&amp;trid=2303972<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139669120065624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">Revenue Recognition</a></td>
<td class="text">REVENUE RECOGNITION<div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue primarily consists of fees earned from the temporary staffing and permanent placement of healthcare professionals, executives, and leaders (clinical and operational). The Company also generates revenue from its software as a service (&#8220;SaaS&#8221;)-based technologies, including vendor management systems and scheduling software, and outsourced workforce services, including language interpretation and recruitment process outsourcing. The Company recognizes revenue when control of its services is transferred to its customers, in an amount that reflects the consideration the Company expects to be entitled to receive in exchange for those services. Revenue from temporary staffing services is recognized as the services are rendered by clinical and non-clinical healthcare professionals. Under the Company&#8217;s managed services program (&#8220;MSP&#8221;) arrangements, the Company manages all or a part of a customer&#8217;s supplemental workforce needs utilizing its own network of healthcare professionals along with those of third-party subcontractors. Revenue and the related direct costs under MSP arrangements are recorded in accordance with the accounting guidance on reporting revenue gross as a principal versus net as an agent. When the Company uses subcontractors and acts as an agent, revenue is recorded net of the related subcontractor&#8217;s expense. Revenue from permanent placement and outsourced workforce services is recognized as the services are rendered. Depending on the arrangement, the Company&#8217;s SaaS-based revenue is recognized either as the services are rendered or ratably over the applicable arrangement&#8217;s service period.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s customers are primarily billed as services are rendered. Any fees billed in advance of being earned are recorded as deferred revenue. While payment terms vary by the type of customer and the services rendered, the term between invoicing and when payment is due is not significant. During the nine months ended September 30, 2021 and 2020, previously deferred revenue recognized as revenue was $10,515 and $11,408, respectively.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has elected to apply the following practical expedients and optional exemptions related to contract costs and revenue recognition:</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Recognize incremental costs of obtaining a contract with amortization periods of one year or less as expense when incurred. These costs are recorded within selling, general and administrative expenses.</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Recognize revenue in the amount of consideration that the Company has a right to invoice the customer if that amount corresponds directly with the value to the customer of the Company&#8217;s services completed to date.</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Exemptions from disclosing the value of unsatisfied performance obligations for (i) contracts with an original expected length of one year or less, (ii) contracts for which revenue is recognized in the amount of consideration that the Company has a right to invoice for services performed and (iii) contracts for which variable consideration is allocated entirely to a wholly unsatisfied performance obligation or to a wholly unsatisfied promise to transfer a distinct service that forms part of a single performance obligation.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note (5), &#8220;Segment Information,&#8221; for additional information regarding the Company&#8217;s revenue disaggregated by service type.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130551-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130556-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130550-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130558-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139669117959848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income Per Common Share<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Net Income Per Common Share</a></td>
<td class="text">NET INCOME PER COMMON SHARE<div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net income per common share is calculated by dividing net income by the weighted average number of common shares outstanding during the reporting period. The following table sets forth the computation of basic and diluted net income per common share:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.724%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.429%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,023&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,067&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">211,171&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,357&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income per common share - basic </span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.55&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.55&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.43&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income per common share - diluted </span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.54&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.55&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.40&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.29&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding - basic</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,737&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,476&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,666&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,406&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plus dilutive effect of potential common shares</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">343&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">356&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding - diluted</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,080&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,676&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,022&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,647&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:4pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share-based awards to purchase 21 and 26 shares of common stock were not included in the above calculation of diluted net income per common share for the three and nine months ended September 30, 2021, respectively, because the effect of these instruments was anti-dilutive. Share-based awards to purchase 84 and 79 shares of common stock were not included in the above calculation of diluted net income per common share for the three and nine months ended September 30, 2020, respectively, because the effect of these instruments was anti-dilutive.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI http://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139669120026568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segment Information</a></td>
<td class="text">SEGMENT INFORMATION<div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s operating segments are identified in the same manner as they are reported internally and used by the Company&#8217;s chief operating decision maker for the purpose of evaluating performance and allocating resources. The Company has three reportable segments: (1) nurse and allied solutions, (2) physician and leadership solutions, and (3) technology and workforce solutions. The nurse and allied solutions segment includes the Company&#8217;s travel nurse staffing, rapid response nurse staffing and labor disruption, allied staffing, local staffing, and revenue cycle solutions businesses. The physician and leadership solutions segment includes the Company&#8217;s locum tenens staffing, healthcare interim leadership staffing, executive search, and physician permanent placement businesses. The technology and workforce solutions segment includes the Company&#8217;s language services, vendor management systems, workforce optimization, recruitment process outsourcing, telehealth, credentialing, and flex pool management and other outsourced solutions businesses.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s chief operating decision maker relies on internal management reporting processes that provide revenue and operating income by reportable segment for making financial decisions and allocating resources. Segment operating income represents income before income taxes plus depreciation, amortization of intangible assets, share-based compensation, interest expense, net, and other, and unallocated corporate overhead. The Company&#8217;s management does not evaluate, manage or measure performance of segments using asset information; accordingly, asset information by segment is not prepared or disclosed.</span></div><div><span><br/></span></div><div style="margin-bottom:3pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a reconciliation of revenue and operating income by reportable segment to consolidated results and was derived from each segment&#8217;s internal financial information as used for corporate management purposes:</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:40.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.227%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.227%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.227%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.184%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nurse and allied solutions</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">627,049&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">382,699&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,908,195&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,251,509&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Physician and leadership solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,663&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109,116&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">430,523&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">355,580&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology and workforce solutions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,088&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,816&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">282,472&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155,354&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">877,800&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">551,631&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,621,190&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,762,443&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment operating income</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nurse and allied solutions</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92,564&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,923&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">283,768&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173,706&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Physician and leadership solutions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,301&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,538&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,366&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,432&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology and workforce solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,210&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,680&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131,952&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,814&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159,075&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94,141&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">478,086&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">281,952&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unallocated corporate overhead</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,867&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,490&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,915&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,223&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,104&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,936&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,098&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,096&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation (included in cost of revenue)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">686&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">481&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,773&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">981&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,589&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,772&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,895&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,046&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net, and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,223&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,564&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,278&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,061&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before income taxes</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,606&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,898&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">285,127&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,545&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present the Company&#8217;s revenue disaggregated by service type:</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:37.350%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.524%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nurse&#160;and&#160;Allied Solutions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Physician and Leadership Solutions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Technology and Workforce Solutions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Temporary staffing</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">627,049&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132,848&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">759,897&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Permanent placement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,815&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,815&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outsourced workforce</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,802&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,802&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SaaS-based technologies</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,286&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,286&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">627,049&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,663&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,088&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">877,800&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:37.350%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.524%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nurse&#160;and&#160;Allied Solutions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Physician and Leadership Solutions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Technology and Workforce Solutions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Temporary staffing</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">382,699&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95,648&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">478,347&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Permanent placement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,468&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,468&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outsourced workforce</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,159&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,159&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SaaS-based technologies</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,657&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,657&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">382,699&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109,116&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,816&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">551,631&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:37.350%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.524%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nurse&#160;and&#160;Allied Solutions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Physician and Leadership Solutions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Technology and Workforce Solutions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Temporary staffing</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,908,195&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">379,814&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,288,009&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Permanent placement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,709&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,709&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outsourced workforce</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164,595&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164,595&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SaaS-based technologies</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117,877&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117,877&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,908,195&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">430,523&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">282,472&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,621,190&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:37.350%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.524%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nurse&#160;and&#160;Allied Solutions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Physician and Leadership Solutions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Technology and Workforce Solutions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Temporary staffing</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,251,509&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">310,945&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,562,454&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Permanent placement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,635&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,635&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outsourced workforce</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87,705&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87,705&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SaaS-based technologies</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,649&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,649&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,251,509&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">355,580&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155,354&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,762,443&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;padding-left:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the activity related to the carrying value of goodwill by reportable segment:</span></div><div style="margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:37.788%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.111%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nurse&#160;and&#160;Allied Solutions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Physician and Leadership Solutions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Technology and Workforce Solutions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, January 1, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">339,015&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152,800&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">372,670&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">864,485&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill adjustment for Stratus Video acquisition</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">663&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">663&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill from Synzi and SnapMD acquisition</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,135&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,135&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, September 30, 2021</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">339,015&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152,800&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">401,468&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">893,283&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated impairment loss as of December 31, 2020 and September 30, 2021</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154,444&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,495&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214,939&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI http://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139669121277080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Notes Payable and Credit Agreement<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Notes Payable and Credit Agreement</a></td>
<td class="text">NOTES PAYABLE AND CREDIT AGREEMENTOn February 9, 2018, the Company entered into the New Credit Agreement with several lenders to provide for the $400,000 Senior Credit Facility to replace its then-existing credit facilities. On June 14, 2019, the Company entered into the first amendment to the New Credit Agreement (the &#8220;First Amendment&#8221;) to provide for, among other things, a $150,000 secured term loan credit facility (the &#8220;Term Loan&#8221;). The Company fully repaid all amounts under the Term Loan in 2019. On February 14, 2020, the Company entered into the second amendment to the New Credit Agreement (the &#8220;Second Amendment&#8221;) to provide for, among other things, a $250,000 secured term loan credit facility (the &#8220;Additional Term Loan&#8221;). The Second Amendment (together with the New Credit Agreement and the First Amendment, collectively, the &#8220;Amended Credit Agreement&#8221;) extended the maturity date of the Senior Credit Facility to be coterminous with the Additional Term Loan. The Company used the proceeds from the Additional Term Loan, together with a drawdown of a portion of the Senior Credit Facility, to complete its acquisition of Stratus Video as more fully described in Note (2), &#8220;Acquisitions.&#8221; The Company repaid its outstanding indebtedness under the Additional Term Loan in the first quarter of 2021. The maturity date of the Senior Credit Facility is February 14, 2025.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139669119579272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurement<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Measurement</a></td>
<td class="text">FAIR VALUE MEASUREMENT<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s valuation techniques and inputs used to measure fair value and the definition of the three levels (Level 1, Level 2, and Level 3) of the fair value hierarchy are disclosed in Part II, Item 8, &#8220;Financial Statements and Supplementary Data&#8212;Notes to Consolidated Financial Statements&#8212;Note 3&#8212;Fair Value Measurement&#8221; of the 2020 Annual Report. The Company has not changed the valuation techniques or inputs it uses for its fair value measurement during the nine months ended September 30, 2021.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Assets and Liabilities Measured on a Recurring Basis</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning in the third quarter of 2021, the Company invests a portion of its cash and cash equivalents in non-federally insured money market funds that are measured at fair value based on quoted prices, which are Level 1 inputs.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a deferred compensation plan for certain executives and employees, which is composed of deferred compensation and all related income and losses attributable thereto. The Company&#8217;s obligation under its deferred compensation plan is measured at fair value based on quoted market prices of the participants&#8217; elected investments, which are Level 1 inputs.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s restricted cash equivalents and investments that serve as collateral for the Company&#8217;s captive insurance company primarily consist of commercial paper that is measured at observable market prices for identical securities that are traded in less active markets, which are Level 2 inputs. The Company&#8217;s cash equivalents also include commercial paper classified as Level 2 in the fair value hierarchy. Of the $126,584 commercial paper issued and outstanding as of September&#160;30, 2021, $17,658 had original maturities greater than three months, which were considered available-for-sale securities. As of December&#160;31, 2020, the Company had $58,345 commercial paper issued and outstanding, of which $25,196 had original maturities greater than three months and were considered available-for-sale securities.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s contingent consideration liabilities associated with acquisitions are measured at fair value using a probability-weighted discounted cash flow analysis or a simulation-based methodology for the acquired companies, which are Level 3 inputs. The Company recognizes changes to the fair value of its contingent consideration liabilities in selling, general and administrative expenses in the condensed consolidated statements of comprehensive income.</span></div><div style="margin-bottom:3pt;margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present information about the above-referenced assets and liabilities and indicate the fair value hierarchy of the valuation techniques utilized to determine such fair value: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.929%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.765%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.208%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurements as of September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted&#160;Prices&#160;in<br/>Active&#160;Markets<br/>for Identical<br/>Assets<br/>(Level 1)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant Other Observable Inputs<br/>(Level 2)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant Unobservable Inputs<br/>(Level 3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,569&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,569&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(117,020)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(117,020)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126,584&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126,584&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.929%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.765%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.208%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurements as of December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted&#160;Prices&#160;in<br/>Active&#160;Markets<br/>for Identical<br/>Assets<br/>(Level 1)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant Other Observable Inputs<br/>(Level 2)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant Unobservable Inputs<br/>(Level 3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,198&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,198&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(97,184)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(97,184)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,345&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,345&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition contingent consideration liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:4pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Level 3 Information</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables set forth a reconciliation of changes in the fair value of contingent consideration liabilities classified as Level 3 in the fair value hierarchy:</span></div><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.291%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.192%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.194%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of July 1,</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,100)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of contingent consideration liability from b4health acquisition </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,700&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of September 30,</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,400)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.291%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.192%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.194%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1,</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,000)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23,100)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlement of Advanced contingent consideration liability for year ended December 31, 2019</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlement of b4health contingent consideration liability for year ended December 31, 2020</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of contingent consideration liability from b4health acquisition </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,700&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of September 30,</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,400)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Assets Measured on a Non-Recurring Basis</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company applies fair value techniques on a non-recurring basis associated with valuing potential impairment losses related to its goodwill, indefinite-lived intangible assets, long-lived assets, and equity investments. </span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluates goodwill and indefinite-lived intangible assets annually for impairment and whenever events or changes in circumstances indicate that it is more likely than not that an impairment exists. The Company determines the fair value of its reporting units based on a combination of inputs, including the market capitalization of the Company, as well as Level 3 inputs such as discounted cash flows, which are not observable from the market, directly or indirectly. The Company determines the fair value of its indefinite-lived intangible assets using the income approach (relief-from-royalty method) based on Level 3 inputs.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s equity investment represents an investment in a non-controlled corporation without a readily determinable market value. The Company has elected to measure the investment at cost minus impairment, if any, plus or minus changes resulting from observable price changes. The fair value is determined by using quoted prices for identical or similar investments of the same issuer, which are Level 2 inputs, and other information available to the Company such as the rights and obligations of the securities. The Company recognizes changes to the fair value of its equity investment in interest expense, net, and other in the condensed consolidated statements of comprehensive income. The balance of the equity investment was $22,633 and $15,449 as of September&#160;30, 2021 and December&#160;31, 2020, respectively.</span></div><div style="margin-top:4pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no triggering events identified, no indication of impairment of the Company&#8217;s goodwill, indefinite-lived intangible assets, long-lived assets, or equity investments, and no impairment charges recorded during the nine months ended September 30, 2021 and 2020. </span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value of Financial Instruments</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is required to disclose the fair value of financial instruments for which it is practicable to estimate the value, even though these instruments are not recognized at fair value in the consolidated balance sheets. The fair value of the Company&#8217;s 4.625% senior notes due 2027 (the &#8220;2027 Notes&#8221;) and 4.000% senior notes due 2029 (the &#8220;2029 Notes&#8221;) was estimated using quoted market prices in active markets for identical liabilities, which are Level 1 inputs. The carrying amounts and estimated fair value of the 2027 Notes and the 2029 Notes are presented in the following table. See additional information regarding the 2027 Notes and the 2029 Notes in Part II, Item 8, &#8220;Financial Statements and Supplementary Data&#8212;Notes to Consolidated Financial Statements&#8212;Note (8), Notes Payable and Credit Agreement&#8221; of the 2020 Annual Report. </span></div><div style="margin-top:14pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:38.373%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.666%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.969%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.666%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.960%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027 Notes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">518,750&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">521,250&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2029 Notes</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">350,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">359,625&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">350,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">357,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>The fair value of the Company&#8217;s long-term self-insurance accruals cannot be estimated as the Company cannot reasonably determine the timing of future payments.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139669119346904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">LEASES</a></td>
<td class="text">LEASESDuring the three months ended September 30, 2021, the Company entered into an arrangement to terminate the lease agreement (as amended to date) for its office space in San Diego. The termination will occur in two phases: the first phase terminates the Company&#8217;s right to use certain floors effective February 28, 2022 and the second phase reduces the remaining lease term to December 31, 2024 from its original termination date of July 31, 2027. As a result of the arrangement, which was accounted for as a modification, the Company paid a termination fee of $17,000, remeasured the lease liability using its incremental borrowing rate as the discount rate, and recorded decreases to its operating lease liabilities and right-of-use assets of $27,340 during the three months ended September 30, 2021. Prior to the modification, the total remaining lease payments for this office lease were $62,487. Under the modified lease terms, the total remaining lease payments (excluding the termination fee paid during the three months ended September 30, 2021) are $9,564.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139669119408088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text">INCOME TAXES<div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company is subject to taxation in the U.S. and various states and foreign jurisdictions. With few exceptions, as of September&#160;30, 2021, the Company is no longer subject to state, local or foreign examinations by tax authorities for tax years before 2011, and the Company is no longer subject to U.S. federal income or payroll tax examinations for tax years before 2017. </span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notwithstanding the foregoing, the Company could adjust its provision for income taxes and contingent tax liability based on future developments.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">CARES Act</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 27, 2020, the Coronavirus Aid, Relief, and Economic Security Act (the &#8220;CARES Act&#8221;) was enacted and signed into law in response to the COVID-19 pandemic. Among other things, the CARES Act contains significant business tax provisions, including a deferral of payment of employer payroll taxes and an employer retention credit for employer payroll taxes.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has deferred payment of the employer&#8217;s share of payroll taxes of $48,452, which is included in accrued compensation and benefits and other long-term liabilities in the consolidated balance sheet as of September&#160;30, 2021, with half of such taxes to be paid by the end of 2021 and the other half to be paid by the end of 2022. The Company has claimed an employee retention employment tax credit of $1,756.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139669122297592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies: Legal Proceedings<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies: Legal Proceedings</a></td>
<td class="text">COMMITMENTS AND CONTINGENCIES: LEGAL PROCEEDINGSFrom time to time, the Company is involved in various lawsuits, claims, investigations, and proceedings that arise in the ordinary course of business. These matters typically relate to professional liability, tax, compensation, contract, competitor disputes and employee-related matters and include individual and class action lawsuits, as well as inquiries and investigations by governmental agencies regarding the Company&#8217;s employment and compensation practices. Additionally, some of the Company&#8217;s clients may also become subject to claims, governmental inquiries and investigations, and legal actions relating to services provided by the Company&#8217;s healthcare professionals. Depending upon the particular facts and circumstances, the <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Company may also be subject to indemnification obligations under its contracts with such clients relating to these matters. The Company accrues for contingencies and records a liability when management believes an adverse outcome from a loss contingency is both probable and the amount, or a range, can be reasonably estimated. Significant judgment is required to determine both probability of loss and the estimated amount. The Company reviews its loss contingencies at least quarterly and adjusts its accruals and/or disclosures to reflect the impact of negotiations, settlements, rulings, advice of legal counsel, or other new information, as deemed necessary. The most significant matters for which the Company has established loss contingencies are class actions related to wage and hour claims under California and Federal law. Specifically, among other claims in these lawsuits, it is alleged that certain expense reimbursements should be considered wages and included in the regular rate of pay for purposes of calculating overtime rates. </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On May 26, 2016, former travel nurse Verna Maxwell Clarke filed a complaint against AMN Services, LLC, in California Superior Court in Los Angeles County. The Company removed the case to the United States District Court for the Central District of California (Case No. 2:16-cv-04132-DSF-KS) (the &#8220;Clarke Matter&#8221;). The complaint asserts that, due to the Company&#8217;s per diem adjustment practices, traveling nurses&#8217; per diem benefits should be included in their regular rate of pay for the purposes of calculating their overtime compensation. On June 26, 2018, the district court denied the plaintiffs&#8217; Motion for Summary Judgment in its entirety, and granted the Company&#8217;s Motion for Summary Judgment with respect to the Plaintiffs&#8217; per diem and overtime claims. The plaintiffs filed an appeal of the judgment relating to the per diem claims with the Ninth Circuit Court of Appeals (the &#8220;Ninth Circuit&#8221;). On February 8, 2021, a three-judge panel of the Ninth Circuit issued an opinion that reversed the district court&#8217;s granting of the Company&#8217;s Motion for Summary Judgment and remanded the matter to the district court instructing the district to enter partial summary judgment in favor of the Plaintiffs. On May 7, 2021, the Ninth Circuit issued an order denying the Company&#8217;s petition for rehearing. On August 26, 2021, the Company filed a Petition for Writ of Certiorari in the United States Supreme Court seeking review of the Ninth Circuit&#8217;s decision. At this time, it is unknown whether the Supreme Court will consider the appeal.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On May 2, 2019, former travel nurse Sara Woehrle filed a complaint against AMN Services, LLC, and Providence Health System &#8211; Southern California in California Superior Court in Los Angeles County. The Company removed the case to the United States District Court for the Central District of California (Case No. 2:19-cv-05282 DSF-KS). The complaint asserts that, due to the Company&#8217;s per diem adjustment practices, traveling nurses&#8217; per diem benefits should be included in their regular rate of pay for the purposes of calculating their overtime compensation. The Complaint also alleges that the putative class members were denied required meal periods, denied proper overtime compensation, were not compensated for all time worked, including reporting time and training time, and received non-compliant wage statements. The Company has reached a preliminary agreement to settle this matter in its entirety. Final settlement is not expected until the fourth quarter of 2022.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company believes that its wage and hour practices, including those associated with the cases described above, conform with the applicable law in all material respects. However, because of the February 2021 ruling by the Ninth Circuit in the Clarke Matter and the inherent uncertainty of litigation, the Company is not able to reasonably predict if any matter will be resolved in a manner that is materially adverse to the Company. Accordingly, the Company recorded an increase to its accruals established in connection with the matters described above amounting to $20,000 during the fourth quarter of 2020, and the ultimate resolution could result in a loss of up to $15,000, excluding penalties, in excess of the amounts currently accrued. For all other matters, the Company is unable to currently estimate the possible loss or range of loss beyond the amounts already accrued. Loss contingencies accrued as of September&#160;30, 2021 are included in accounts payable and accrued expenses and other long-term liabilities in the consolidated balance sheets.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139669118011864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Balance Sheet Details<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract', window );"><strong>Balance Sheet Related Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock', window );">Balance Sheet Details</a></td>
<td class="text">BALANCE SHEET DETAILS<div style="margin-bottom:3pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated balance sheets detail is as follows:</span></div><div style="margin-bottom:3pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.946%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.771%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.931%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash and cash equivalents</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,118&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,626&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes receivable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,119&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,591&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,159&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,592&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,396&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,809&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,634&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,355&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">254,090&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">220,971&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,616&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,600&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">318,340&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">277,926&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(190,578)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(161,752)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed assets, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127,762&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116,174&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Life insurance cash surrender value</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114,037&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98,161&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,872&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,959&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157,909&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135,120&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade accounts payable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,468&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,089&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subcontractor payable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147,776&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,364&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,414&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,849&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss contingencies</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,627&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,613&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Professional liability reserve</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,773&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,897&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,036&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,069&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">284,094&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167,881&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued compensation and benefits:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued payroll</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114,299&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,721&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued bonuses and commissions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,215&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,514&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued travel expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,673&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,998&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health insurance reserve</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,627&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,590&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Workers compensation reserve</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,297&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,244&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117,020&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97,184&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,807&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,163&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued compensation and benefits</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">321,938&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213,414&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Workers compensation reserve</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,716&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,930&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Professional liability reserve</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,768&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,997&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized tax benefits</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,403&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,447&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,228&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,533&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107,115&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107,907&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetRelatedDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -URI http://asc.fasb.org/topic&amp;trid=2122208<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalBalanceSheetDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139669117892616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation (Policies)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text">The preparation of financial statements in conformity with U.S. GAAP requires management to make a number of estimates and assumptions relating to the reporting of assets and liabilities and the disclosure of contingent assets and liabilities at the dates of the financial statements and the reported amounts of revenue and expenses during the reporting periods. On an ongoing basis, the Company evaluates its estimates, including those related to intangible assets purchased in a business combination, asset impairments, accruals for self-insurance, compensation and related benefits, accounts receivable, contingencies and litigation, contingent consideration liabilities associated with acquisitions, and income taxes. Actual results could differ from those estimates under different assumptions or conditions. The impact of the novel coronavirus (COVID-19) pandemic did not have a material effect on the Company&#8217;s estimates as of September&#160;30, 2021.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recently Adopted Accounting Pronouncements</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Adopted Accounting Pronouncements</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standard Update (&#8220;ASU&#8221;) 2019-12, &#8220;Simplifying the Accounting for Income Taxes.&#8221; The standard is expected to reduce cost and complexity related to accounting for income taxes. The new guidance eliminates certain exceptions and clarifies and amends existing guidance to promote consistent application among reporting entities. Depending on the amended guidance within this standard, adoption is to be applied on a retrospective, modified retrospective or prospective basis. The Company adopted this standard effective January 1, 2021, and the adoption did not have a material effect on the Company&#8217;s consolidated financial statements.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2020, the FASB issued ASU 2020-01, &#8220;Clarifying the Interactions between Topic 321, Topic 323, and Topic 815.&#8221; The new guidance clarifies the interactions between accounting standards that apply to equity investments without readily determinable fair values. Specifically, it addresses the accounting for the transition into and out of the equity method. The Company adopted this standard effective January 1, 2021 on a prospective basis, and the adoption did not have a material effect on the Company&#8217;s consolidated financial statements.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy', window );">Cash, Cash Equivalents and Restricted Cash</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash, Cash Equivalents and Restricted Cash</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents. Cash and cash equivalents include currency on hand, deposits with financial institutions, money market funds, commercial paper and other highly liquid investments. Restricted cash and cash equivalents primarily includes cash and commercial paper that serve as collateral for the Company&#8217;s captive insurance subsidiary claim payments. See Note (7), &#8220;Fair Value Measurement&#8221; for additional information.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TradeAndOtherAccountsReceivablePolicy', window );">Accounts Receivable</a></td>
<td class="text"><div style="margin-top:4pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounts Receivable</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records accounts receivable at the invoiced amount. Accounts receivable are non-interest bearing. The Company maintains an allowance for expected credit losses based on the Company&#8217;s historical write-off experience, an assessment of its customers&#8217; financial conditions and available information that is relevant to assessing the collectability of cash flows, which includes current conditions and forecasts about future economic conditions.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue primarily consists of fees earned from the temporary staffing and permanent placement of healthcare professionals, executives, and leaders (clinical and operational). The Company also generates revenue from its software as a service (&#8220;SaaS&#8221;)-based technologies, including vendor management systems and scheduling software, and outsourced workforce services, including language interpretation and recruitment process outsourcing. The Company recognizes revenue when control of its services is transferred to its customers, in an amount that reflects the consideration the Company expects to be entitled to receive in exchange for those services. Revenue from temporary staffing services is recognized as the services are rendered by clinical and non-clinical healthcare professionals. Under the Company&#8217;s managed services program (&#8220;MSP&#8221;) arrangements, the Company manages all or a part of a customer&#8217;s supplemental workforce needs utilizing its own network of healthcare professionals along with those of third-party subcontractors. Revenue and the related direct costs under MSP arrangements are recorded in accordance with the accounting guidance on reporting revenue gross as a principal versus net as an agent. When the Company uses subcontractors and acts as an agent, revenue is recorded net of the related subcontractor&#8217;s expense. Revenue from permanent placement and outsourced workforce services is recognized as the services are rendered. Depending on the arrangement, the Company&#8217;s SaaS-based revenue is recognized either as the services are rendered or ratably over the applicable arrangement&#8217;s service period.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s customers are primarily billed as services are rendered. Any fees billed in advance of being earned are recorded as deferred revenue. While payment terms vary by the type of customer and the services rendered, the term between invoicing and when payment is due is not significant. During the nine months ended September 30, 2021 and 2020, previously deferred revenue recognized as revenue was $10,515 and $11,408, respectively.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has elected to apply the following practical expedients and optional exemptions related to contract costs and revenue recognition:</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Recognize incremental costs of obtaining a contract with amortization periods of one year or less as expense when incurred. These costs are recorded within selling, general and administrative expenses.</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Recognize revenue in the amount of consideration that the Company has a right to invoice the customer if that amount corresponds directly with the value to the customer of the Company&#8217;s services completed to date.</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Exemptions from disclosing the value of unsatisfied performance obligations for (i) contracts with an original expected length of one year or less, (ii) contracts for which revenue is recognized in the amount of consideration that the Company has a right to invoice for services performed and (iii) contracts for which variable consideration is allocated entirely to a wholly unsatisfied performance obligation or to a wholly unsatisfied promise to transfer a distinct service that forms part of a single performance obligation.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Net Income per Common Share</a></td>
<td class="text">Basic net income per common share is calculated by dividing net income by the weighted average number of common shares outstanding during the reporting period.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingPolicyPolicyTextBlock', window );">Segment Information</a></td>
<td class="text">The Company&#8217;s chief operating decision maker relies on internal management reporting processes that provide revenue and operating income by reportable segment for making financial decisions and allocating resources. Segment operating income represents income before income taxes plus depreciation, amortization of intangible assets, share-based compensation, interest expense, net, and other, and unallocated corporate overhead. The Company&#8217;s management does not evaluate, manage or measure performance of segments using asset information; accordingly, asset information by segment is not prepared or disclosed.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock', window );">Fair Value of Assets and Liabilities</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Assets and Liabilities Measured on a Recurring Basis</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning in the third quarter of 2021, the Company invests a portion of its cash and cash equivalents in non-federally insured money market funds that are measured at fair value based on quoted prices, which are Level 1 inputs.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a deferred compensation plan for certain executives and employees, which is composed of deferred compensation and all related income and losses attributable thereto. The Company&#8217;s obligation under its deferred compensation plan is measured at fair value based on quoted market prices of the participants&#8217; elected investments, which are Level 1 inputs.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s restricted cash equivalents and investments that serve as collateral for the Company&#8217;s captive insurance company primarily consist of commercial paper that is measured at observable market prices for identical securities that are traded in less active markets, which are Level 2 inputs. The Company&#8217;s cash equivalents also include commercial paper classified as Level 2 in the fair value hierarchy. Of the $126,584 commercial paper issued and outstanding as of September&#160;30, 2021, $17,658 had original maturities greater than three months, which were considered available-for-sale securities. As of December&#160;31, 2020, the Company had $58,345 commercial paper issued and outstanding, of which $25,196 had original maturities greater than three months and were considered available-for-sale securities.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s contingent consideration liabilities associated with acquisitions are measured at fair value using a probability-weighted discounted cash flow analysis or a simulation-based methodology for the acquired companies, which are Level 3 inputs. The Company recognizes changes to the fair value of its contingent consideration liabilities in selling, general and administrative expenses in the condensed consolidated statements of comprehensive income.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Assets Measured on a Non-Recurring Basis</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company applies fair value techniques on a non-recurring basis associated with valuing potential impairment losses related to its goodwill, indefinite-lived intangible assets, long-lived assets, and equity investments. </span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluates goodwill and indefinite-lived intangible assets annually for impairment and whenever events or changes in circumstances indicate that it is more likely than not that an impairment exists. The Company determines the fair value of its reporting units based on a combination of inputs, including the market capitalization of the Company, as well as Level 3 inputs such as discounted cash flows, which are not observable from the market, directly or indirectly. The Company determines the fair value of its indefinite-lived intangible assets using the income approach (relief-from-royalty method) based on Level 3 inputs.</span></div>The Company&#8217;s equity investment represents an investment in a non-controlled corporation without a readily determinable market value. The Company has elected to measure the investment at cost minus impairment, if any, plus or minus changes resulting from observable price changes. The fair value is determined by using quoted prices for identical or similar investments of the same issuer, which are Level 2 inputs, and other information available to the Company such as the rights and obligations of the securities. The Company recognizes changes to the fair value of its equity investment in interest expense, net, and other in the condensed consolidated statements of comprehensive income.<div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value of Financial Instruments</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is required to disclose the fair value of financial instruments for which it is practicable to estimate the value, even though these instruments are not recognized at fair value in the consolidated balance sheets. The fair value of the Company&#8217;s 4.625% senior notes due 2027 (the &#8220;2027 Notes&#8221;) and 4.000% senior notes due 2029 (the &#8220;2029 Notes&#8221;) was estimated using quoted market prices in active markets for identical liabilities, which are Level 1 inputs. The carrying amounts and estimated fair value of the 2027 Notes and the 2029 Notes are presented in the following table. See additional information regarding the 2027 Notes and the 2029 Notes in Part II, Item 8, &#8220;Financial Statements and Supplementary Data&#8212;Notes to Consolidated Financial Statements&#8212;Note (8), Notes Payable and Credit Agreement&#8221; of the 2020 Annual Report. </span></div><div style="margin-top:14pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:38.373%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.666%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.969%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.666%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.960%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027 Notes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">518,750&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">521,250&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2029 Notes</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">350,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">359,625&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">350,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">357,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>The fair value of the Company&#8217;s long-term self-insurance accruals cannot be estimated as the Company cannot reasonably determine the timing of future payments.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Entity's cash and cash equivalents accounting policy with respect to restricted balances.  Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4273-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130561-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130563-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130563-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130564-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for segment reporting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TradeAndOtherAccountsReceivablePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e4975-111524<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5212-111524<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=SL6953423-111524<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5093-111524<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5033-111524<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10133-111534<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TradeAndOtherAccountsReceivablePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139669120086472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock', window );">Reconciliation of Cash, Cash Equivalents and Restricted Cash</a></td>
<td class="text">The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the accompanying condensed consolidated balance sheets and related notes to the amounts presented in the accompanying condensed consolidated statements of cash flows.<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:66.590%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.544%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137,041&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,213&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash and cash equivalents (included in other current assets)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,118&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,626&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash, cash equivalents and investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,603&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,347&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents and restricted cash and investments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218,762&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109,186&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less restricted investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,658)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25,196)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents and restricted cash</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201,104&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,990&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock', window );">Reconciliation of Activity in Allowance for Credit Losses for Accounts Receivable</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a reconciliation of activity in the allowance for credit losses for accounts receivable:</span></div><div style="margin-top:14pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:66.590%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.544%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1,</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,043&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,332&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zMS9mcmFnOmNlNDgxOGVmYTM1YjQ2NDI4NGUxN2Q2NWEwYThiNjc3L3RhYmxlOmU5MmY2N2EzMmZkYjRlZmY5MmRhZThhMjE3M2M0NzBmL3RhYmxlcmFuZ2U6ZTkyZjY3YTMyZmRiNGVmZjkyZGFlOGEyMTczYzQ3MGZfMi0wLTEtMS0xMDc3MA_2e5b46ce-627c-4ad2-9f91-f5ecc232b823"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmEzODNjOGM3ODc4YTQ5OGQ5MWY5ZTg5MDFmMGNmZDljL3NlYzphMzgzYzhjNzg3OGE0OThkOTFmOWU4OTAxZjBjZmQ5Y18zMS9mcmFnOmNlNDgxOGVmYTM1YjQ2NDI4NGUxN2Q2NWEwYThiNjc3L3RhYmxlOmU5MmY2N2EzMmZkYjRlZmY5MmRhZThhMjE3M2M0NzBmL3RhYmxlcmFuZ2U6ZTkyZjY3YTMyZmRiNGVmZjkyZGFlOGEyMTczYzQ3MGZfMi0wLTEtMS0xMDc3MA_5c495df8-c4dc-4a11-8dcb-5b212c885604">Adoption of the credit loss standard, cumulative-effect adjustment to retained earnings</span></span></span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,334&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for expected credit losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">325&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,178&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts written off charged against the allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,220)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,333)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of September 30,</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,148&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,511&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of supplemental cash flow information for the periods presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139669119590424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock', window );">Schedule of Intangible Assets Acquired</a></td>
<td class="text">The following table summarizes the fair value and useful life of each intangible asset acquired as of the acquisition date:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:68.128%"><tr><td style="width:1.0%"/><td style="width:4.693%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:38.170%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.423%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.423%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:3.835%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.856%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Useful Life</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in years)</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Identifiable intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer Relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tradenames and Trademarks</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 - 10</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed Technology</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interpreter Database</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228,000&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionProFormaInformationTextBlock', window );">Schedule of Pro Forma Financial Information</a></td>
<td class="text">The unaudited pro forma financial information is not necessarily indicative of the operating results that would have occurred had the acquisition been consummated as of the date indicated, nor is it necessarily indicative of the Company&#8217;s future operating results. <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.584%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.215%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.317%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">551,631&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,776,315&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from operations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,465&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135,618&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,030&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,434&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionProFormaInformationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionProFormaInformationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of finite-lived intangible assets acquired as part of a business combination or through an asset purchase, by major class and in total, including the value of the asset acquired, any significant residual value (the expected value of the asset at the end of its useful life) and the weighted-average amortization period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139669119591544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income Per Common Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Computation of Basic and Diluted Net Income Per Common Share</a></td>
<td class="text">The following table sets forth the computation of basic and diluted net income per common share:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.724%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.429%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,023&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,067&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">211,171&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,357&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income per common share - basic </span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.55&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.55&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.43&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income per common share - diluted </span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.54&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.55&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.40&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.29&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding - basic</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,737&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,476&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,666&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,406&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plus dilutive effect of potential common shares</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">343&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">356&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding - diluted</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,080&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,676&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,022&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,647&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139669212554008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Reconciliation of Revenue and Segment Operating Income by Reportable Segment</a></td>
<td class="text"><div style="margin-bottom:3pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a reconciliation of revenue and operating income by reportable segment to consolidated results and was derived from each segment&#8217;s internal financial information as used for corporate management purposes:</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:40.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.227%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.227%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.227%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.184%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nurse and allied solutions</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">627,049&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">382,699&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,908,195&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,251,509&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Physician and leadership solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,663&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109,116&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">430,523&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">355,580&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology and workforce solutions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,088&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,816&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">282,472&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155,354&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">877,800&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">551,631&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,621,190&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,762,443&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment operating income</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nurse and allied solutions</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92,564&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,923&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">283,768&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173,706&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Physician and leadership solutions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,301&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,538&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,366&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,432&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology and workforce solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,210&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,680&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131,952&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,814&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159,075&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94,141&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">478,086&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">281,952&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unallocated corporate overhead</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,867&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,490&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,915&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,223&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,104&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,936&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,098&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,096&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation (included in cost of revenue)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">686&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">481&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,773&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">981&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,589&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,772&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,895&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,046&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net, and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,223&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,564&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,278&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,061&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before income taxes</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,606&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,898&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">285,127&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,545&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Disaggregation of Revenue</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present the Company&#8217;s revenue disaggregated by service type:</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:37.350%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.524%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nurse&#160;and&#160;Allied Solutions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Physician and Leadership Solutions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Technology and Workforce Solutions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Temporary staffing</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">627,049&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132,848&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">759,897&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Permanent placement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,815&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,815&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outsourced workforce</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,802&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,802&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SaaS-based technologies</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,286&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,286&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">627,049&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,663&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,088&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">877,800&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:37.350%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.524%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nurse&#160;and&#160;Allied Solutions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Physician and Leadership Solutions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Technology and Workforce Solutions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Temporary staffing</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">382,699&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95,648&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">478,347&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Permanent placement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,468&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,468&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outsourced workforce</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,159&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,159&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SaaS-based technologies</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,657&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,657&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">382,699&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109,116&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,816&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">551,631&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:37.350%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.524%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nurse&#160;and&#160;Allied Solutions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Physician and Leadership Solutions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Technology and Workforce Solutions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Temporary staffing</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,908,195&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">379,814&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,288,009&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Permanent placement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,709&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,709&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outsourced workforce</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164,595&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164,595&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SaaS-based technologies</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117,877&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117,877&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,908,195&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">430,523&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">282,472&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,621,190&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:37.350%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.524%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nurse&#160;and&#160;Allied Solutions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Physician and Leadership Solutions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Technology and Workforce Solutions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Temporary staffing</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,251,509&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">310,945&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,562,454&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Permanent placement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,635&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,635&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outsourced workforce</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87,705&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87,705&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SaaS-based technologies</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,649&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,649&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,251,509&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">355,580&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155,354&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,762,443&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Summary of Goodwill by Reportable Segment</a></td>
<td class="text"><div style="margin-top:9pt;padding-left:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the activity related to the carrying value of goodwill by reportable segment:</span></div><div style="margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:37.788%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.111%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nurse&#160;and&#160;Allied Solutions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Physician and Leadership Solutions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Technology and Workforce Solutions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, January 1, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">339,015&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152,800&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">372,670&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">864,485&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill adjustment for Stratus Video acquisition</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">663&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">663&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill from Synzi and SnapMD acquisition</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,135&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,135&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, September 30, 2021</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">339,015&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152,800&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">401,468&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">893,283&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated impairment loss as of December 31, 2020 and September 30, 2021</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154,444&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,495&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214,939&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139669120068680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurement (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Schedule of Financial Assets and Liabilities Measured at Fair Value on Recurring Basis</a></td>
<td class="text"><div style="margin-bottom:3pt;margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present information about the above-referenced assets and liabilities and indicate the fair value hierarchy of the valuation techniques utilized to determine such fair value: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.929%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.765%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.208%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurements as of September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted&#160;Prices&#160;in<br/>Active&#160;Markets<br/>for Identical<br/>Assets<br/>(Level 1)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant Other Observable Inputs<br/>(Level 2)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant Unobservable Inputs<br/>(Level 3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,569&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,569&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(117,020)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(117,020)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126,584&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126,584&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.929%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.765%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.208%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurements as of December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted&#160;Prices&#160;in<br/>Active&#160;Markets<br/>for Identical<br/>Assets<br/>(Level 1)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant Other Observable Inputs<br/>(Level 2)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant Unobservable Inputs<br/>(Level 3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,198&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,198&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(97,184)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(97,184)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,345&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,345&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition contingent consideration liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock', window );">Reconciliations of Changes in the Fair Value of Contingent Consideration Liabilities</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables set forth a reconciliation of changes in the fair value of contingent consideration liabilities classified as Level 3 in the fair value hierarchy:</span></div><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.291%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.192%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.194%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of July 1,</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,100)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of contingent consideration liability from b4health acquisition </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,700&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of September 30,</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,400)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.291%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.192%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.194%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1,</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,000)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23,100)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlement of Advanced contingent consideration liability for year ended December 31, 2019</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlement of b4health contingent consideration liability for year ended December 31, 2020</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of contingent consideration liability from b4health acquisition </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,700&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of September 30,</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,400)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTextBlock', window );">Schedule of Fair Value of Financial Instruments</a></td>
<td class="text">See additional information regarding the 2027 Notes and the 2029 Notes in Part II, Item 8, &#8220;Financial Statements and Supplementary Data&#8212;Notes to Consolidated Financial Statements&#8212;Note (8), Notes Payable and Credit Agreement&#8221; of the 2020 Annual Report. <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:38.373%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.666%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.969%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.666%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.960%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027 Notes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">518,750&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">521,250&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2029 Notes</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">350,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">359,625&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">350,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">357,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19279-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined) which are not recognized in the financial statements (off-balance sheet) because they fail to meet some other criterion for recognition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13467-108611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139669117753528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Balance Sheet Details (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract', window );"><strong>Balance Sheet Related Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_amn_ScheduleofSupplementalBalanceSheetDisclosuresTableTextBlock', window );">Schedule of Supplemental Balance Sheet Disclosures</a></td>
<td class="text"><div style="margin-bottom:3pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated balance sheets detail is as follows:</span></div><div style="margin-bottom:3pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.946%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.771%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.931%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash and cash equivalents</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,118&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,626&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes receivable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,119&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,591&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,159&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,592&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,396&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,809&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,634&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,355&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">254,090&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">220,971&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,616&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,600&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">318,340&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">277,926&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(190,578)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(161,752)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed assets, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127,762&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116,174&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Life insurance cash surrender value</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114,037&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98,161&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,872&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,959&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157,909&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135,120&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade accounts payable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,468&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,089&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subcontractor payable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147,776&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,364&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,414&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,849&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss contingencies</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,627&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,613&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Professional liability reserve</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,773&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,897&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,036&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,069&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">284,094&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167,881&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued compensation and benefits:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued payroll</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114,299&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,721&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued bonuses and commissions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,215&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,514&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued travel expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,673&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,998&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health insurance reserve</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,627&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,590&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Workers compensation reserve</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,297&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,244&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117,020&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97,184&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,807&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,163&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued compensation and benefits</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">321,938&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213,414&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Workers compensation reserve</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,716&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,930&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Professional liability reserve</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,768&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,997&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized tax benefits</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,403&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,447&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,228&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,533&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107,115&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107,907&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amn_ScheduleofSupplementalBalanceSheetDisclosuresTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of Supplemental Balance Sheet Disclosures [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amn_ScheduleofSupplementalBalanceSheetDisclosuresTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetRelatedDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139669209135400">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Basis of Presentation - Reconciliation of Cash, Cash Equivalents and Restricted Cash (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 137,041<span></span>
</td>
<td class="nump">$ 29,213<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalents', window );">Restricted cash and cash equivalents (included in other current assets)</a></td>
<td class="nump">18,118<span></span>
</td>
<td class="nump">18,626<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashAndInvestmentsNoncurrent', window );">Restricted cash, cash equivalents and investments</a></td>
<td class="nump">63,603<span></span>
</td>
<td class="nump">61,347<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_amn_TotalCashCashEquivalentsAndRestrictedCashCashEquivalentsandInvestments', window );">Total cash, cash equivalents and restricted cash and investments</a></td>
<td class="nump">218,762<span></span>
</td>
<td class="nump">109,186<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedInvestments', window );">Less restricted investments</a></td>
<td class="num">(17,658)<span></span>
</td>
<td class="num">(25,196)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Total cash, cash equivalents and restricted cash</a></td>
<td class="nump">$ 201,104<span></span>
</td>
<td class="nump">$ 83,990<span></span>
</td>
<td class="nump">$ 108,923<span></span>
</td>
<td class="nump">$ 153,962<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amn_TotalCashCashEquivalentsAndRestrictedCashCashEquivalentsandInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total Cash, Cash Equivalents, And Restricted Cash, Cash Equivalents, and Investments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amn_TotalCashCashEquivalentsAndRestrictedCashCashEquivalentsandInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndInvestmentsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The noncurrent cash, cash equivalents and investments that is restricted as to withdrawal or usage. Restrictions may include legally restricted deposits held as compensating balances against borrowing arrangements, contracts entered into with others, or entity statements of intention with regard to particular deposits classified as long-term; that is not expected to be released from such existing restrictions within one year of the balance sheet date or operating cycle, whichever is longer. Excludes compensating balance arrangements that are not agreements which legally restrict the use of cash amounts shown on the balance sheet. Includes noncurrent cash equivalents and investments that are similarly restricted as to withdrawal, usage or disposal.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=120413173&amp;loc=SL6242262-115580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120413209&amp;loc=SL6242269-115581<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndInvestmentsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Investments which are not defined as or included in marketable (debt, equity, or other) securities whose use is restricted in whole or in part, generally by contractual agreements or regulatory requirements. For use in an unclassified balance sheet.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=120413173&amp;loc=SL6242262-115580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120413209&amp;loc=SL6242269-115581<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139669122517656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation - Reconciliation of Activity in Allowance for Credit Losses for Accounts Receivable (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward', window );"><strong>Accounts Receivable, Allowance for Credit Loss [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Beginning balance</a></td>
<td class="nump">$ 7,043<span></span>
</td>
<td class="nump">$ 3,332<span></span>
</td>
<td class="nump">$ 3,332<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingStandardsUpdateExtensibleList', window );">Accounting Standards Update [Extensible Enumeration]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Accounting Standards Update 2016-13 [Member]<span></span>
</td>
<td class="text">Accounting Standards Update 2016-13 [Member]<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Provision for expected credit losses</a></td>
<td class="nump">325<span></span>
</td>
<td class="nump">5,178<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs', window );">Amounts written off charged against the allowance</a></td>
<td class="num">(1,220)<span></span>
</td>
<td class="num">(1,333)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Ending balance</a></td>
<td class="nump">6,148<span></span>
</td>
<td class="nump">8,511<span></span>
</td>
<td class="nump">$ 7,043<span></span>
</td>
<td class="nump">$ 3,332<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember', window );">Cumulative Effect, Period of Adoption, Adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward', window );"><strong>Accounts Receivable, Allowance for Credit Loss [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Beginning balance</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 1,334<span></span>
</td>
<td class="nump">1,334<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Ending balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 1,334<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingStandardsUpdateExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates amendment to accounting standards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL121967933-165497<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL121967933-165497<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL122642865-165497<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL121967933-165497<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL121967933-165497<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL120254526-165497<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 27: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=122150657&amp;loc=SL122150809-237846<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL122642865-165497<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S65<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124359872&amp;loc=SL124427846-239511<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124402435&amp;loc=SL124402458-218513<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124402435&amp;loc=SL124402458-218513<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL120254526-165497<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 45: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 49: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 50: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 51: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 52: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 53: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 54: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 55: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 56: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 57: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 58: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 59: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 60: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 61: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)<br><br>Reference 62: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(1)<br><br>Reference 63: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(2)<br><br>Reference 64: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(01)<br><br>Reference 65: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(03)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingStandardsUpdateExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of direct write-downs of accounts receivable charged against the allowance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139669120294472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="4">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 07, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Feb. 14, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($) </div>
<div>acquisition</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 14, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Feb. 09, 2018 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfBusinessesAcquired', window );">Number of acquisitions | acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 893,283,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 893,283,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 864,485,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(211,171,000)<span></span>
</td>
<td class="num">$ (61,357,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=amn_SynziMember', window );">Synzi</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 42,240,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAcquiredFromAcquisition', window );">Cash returned to the Company for final working capital settlement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 92,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_amn_BusinessCombinationConsiderationTransferredNetOfWorkingCapitalAdjustment', window );">Purchase price, net of working capital adjustment</a></td>
<td class="nump">42,148,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_amn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalentsAndPropertyPlantAndEquipment', window );">Fair value of tangible assets acquired</a></td>
<td class="nump">2,790,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,790,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents', window );">Cash received</a></td>
<td class="nump">884,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">884,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities', window );">Liabilities assumed</a></td>
<td class="nump">1,217,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,217,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Identifiable intangible assets</a></td>
<td class="nump">12,440,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,440,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">28,135,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28,135,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount', window );">Goodwill expected to be deductible for tax purposes</a></td>
<td class="nump">$ 6,085,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,085,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Intangible assets acquired, weighted average useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=amn_SynziMember', window );">Synzi | Developed Technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Identifiable intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,890,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=amn_SynziMember', window );">Synzi | Trademarks</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Identifiable intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,220,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=amn_StratusVideoMember', window );">Stratus Video</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 485,568,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 99,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_amn_BusinessCombinationConsiderationTransferredNetOfWorkingCapitalAdjustment', window );">Purchase price, net of working capital adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 485,667,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents', window );">Cash received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,176,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities', window );">Liabilities assumed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">56,059,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Identifiable intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 228,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">228,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">269,634,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount', window );">Goodwill expected to be deductible for tax purposes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,182,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Intangible assets acquired, weighted average useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">17 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts', window );">Acquisition-related costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,548,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_amn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets', window );">Fair value of tangible assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 44,092,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual', window );">Pro forma information, revenue of acquiree since acquisition date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 35,329,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">78,080,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual', window );">Pro forma information, income before income taxes of acquiree since acquisition date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,322,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,787,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=amn_StratusVideoMember', window );">Stratus Video | Acquisition-related Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,023,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,662,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=amn_StratusVideoMember', window );">Stratus Video | Developed Technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Identifiable intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Useful Life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=amn_StratusVideoMember', window );">Stratus Video | Tradenames and Trademarks</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Identifiable intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 40,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Useful Life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_SecuredDebtMember', window );">Term Loan | Term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Term loan credit facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 250,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 150,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amn_BusinessCombinationConsiderationTransferredNetOfWorkingCapitalAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Consideration Transferred, Net Of Working Capital Adjustment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amn_BusinessCombinationConsiderationTransferredNetOfWorkingCapitalAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalentsAndPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Cash And Equivalents And Property, Plant, And Equipment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalentsAndPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Tangible Assets</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of goodwill arising from a business combination that is expected to be deductible for tax purposes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 23<br> -URI http://asc.fasb.org/extlink&amp;oid=123586518&amp;loc=d3e1043-128460<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAcquisitionRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the amount of earnings or loss of the acquiree since the acquisition date included in the consolidated income statement for the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the amount of revenue of the acquiree since the acquisition date included in the consolidated income statement for the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable intangible assets recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAcquiredFromAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the acquisition of business during the period (for example, cash that was held by the acquired business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAcquiredFromAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfBusinessesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of businesses acquired by the entity during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfBusinessesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=amn_SynziMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=amn_SynziMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=amn_StratusVideoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=amn_StratusVideoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonrecurringAdjustmentAxis=us-gaap_AcquisitionRelatedCostsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonrecurringAdjustmentAxis=us-gaap_AcquisitionRelatedCostsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksAndTradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksAndTradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_SecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_SecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=amn_TermDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=amn_TermDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139669121516232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions - Schedule of Intangible Assets Acquired (Details) - Stratus Video - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Feb. 14, 2020</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Fair Value</a></td>
<td class="nump">$ 228,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 228,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=amn_StratusVideoMember', window );">Customer Relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Fair Value</a></td>
<td class="nump">$ 171,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Useful Life</a></td>
<td class="text">20 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=amn_StratusVideoMember', window );">Tradenames and Trademarks</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Fair Value</a></td>
<td class="nump">$ 40,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Useful Life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=amn_StratusVideoMember', window );">Developed Technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Fair Value</a></td>
<td class="nump">$ 16,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Useful Life</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=amn_StratusVideoMember', window );">Interpreter Database</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Fair Value</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Useful Life</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Tradenames and Trademarks</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Useful Life</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Tradenames and Trademarks</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Useful Life</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable intangible assets recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=amn_StratusVideoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=amn_StratusVideoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksAndTradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksAndTradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=amn_InterpreterDatabaseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=amn_InterpreterDatabaseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139669125917096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions - Schedule of Pro Forma Financial Information (Details) - Stratus Video - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaRevenue', window );">Revenue</a></td>
<td class="nump">$ 551,631<span></span>
</td>
<td class="nump">$ 1,776,315<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax', window );">Income from operations</a></td>
<td class="nump">50,465<span></span>
</td>
<td class="nump">135,618<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 29,030<span></span>
</td>
<td class="nump">$ 71,434<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of pro forma income from continuing operations as if the business combination had been completed at the beginning of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=amn_StratusVideoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=amn_StratusVideoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139669119675736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Previously deferred revenue recognized during period</a></td>
<td class="nump">$ 10,515<span></span>
</td>
<td class="nump">$ 11,408<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityRevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139669122323832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income Per Common Share (Details) - USD ($)<br> $ / shares in Units, shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net income</a></td>
<td class="nump">$ 74,023<span></span>
</td>
<td class="nump">$ 26,067<span></span>
</td>
<td class="nump">$ 211,171<span></span>
</td>
<td class="nump">$ 61,357<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted', window );">Net Income - diluted</a></td>
<td class="nump">$ 74,023<span></span>
</td>
<td class="nump">$ 26,067<span></span>
</td>
<td class="nump">$ 211,171<span></span>
</td>
<td class="nump">$ 61,357<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net income per common share - basic (in dollars per share)</a></td>
<td class="nump">$ 1.55<span></span>
</td>
<td class="nump">$ 0.55<span></span>
</td>
<td class="nump">$ 4.43<span></span>
</td>
<td class="nump">$ 1.29<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net income per common share - diluted (in dollars per share)</a></td>
<td class="nump">$ 1.54<span></span>
</td>
<td class="nump">$ 0.55<span></span>
</td>
<td class="nump">$ 4.40<span></span>
</td>
<td class="nump">$ 1.29<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average common shares outstanding - basic (in shares)</a></td>
<td class="nump">47,737<span></span>
</td>
<td class="nump">47,476<span></span>
</td>
<td class="nump">47,666<span></span>
</td>
<td class="nump">47,406<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment', window );">Plus dilutive effect of potential common shares (in shares)</a></td>
<td class="nump">343<span></span>
</td>
<td class="nump">200<span></span>
</td>
<td class="nump">356<span></span>
</td>
<td class="nump">241<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average common shares outstanding - diluted (in shares)</a></td>
<td class="nump">48,080<span></span>
</td>
<td class="nump">47,676<span></span>
</td>
<td class="nump">48,022<span></span>
</td>
<td class="nump">47,647<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Common stock excluded from calculation of EPS (in shares)</a></td>
<td class="nump">21<span></span>
</td>
<td class="nump">84<span></span>
</td>
<td class="nump">26<span></span>
</td>
<td class="nump">79<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1377-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1930-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1930-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1930-109256<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1930-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139669119463976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2021 </div>
<div>segment</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of reportable segments</a></td>
<td class="nump">3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139669206274488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information - Reconciliation of Revenue and Segment Operating Income by Reportable Segment (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems', window );"><strong>Segment Reporting, Revenue Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">$ 877,800<span></span>
</td>
<td class="nump">$ 551,631<span></span>
</td>
<td class="nump">$ 2,621,190<span></span>
</td>
<td class="nump">$ 1,762,443<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Segment operating income</a></td>
<td class="nump">105,829<span></span>
</td>
<td class="nump">46,462<span></span>
</td>
<td class="nump">309,405<span></span>
</td>
<td class="nump">120,606<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization (exclusive of depreciation included in cost of revenue)</a></td>
<td class="nump">26,104<span></span>
</td>
<td class="nump">26,936<span></span>
</td>
<td class="nump">74,098<span></span>
</td>
<td class="nump">69,096<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSoldDepreciation', window );">Depreciation (included in cost of revenue)</a></td>
<td class="nump">686<span></span>
</td>
<td class="nump">481<span></span>
</td>
<td class="nump">1,773<span></span>
</td>
<td class="nump">981<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="nump">2,589<span></span>
</td>
<td class="nump">3,772<span></span>
</td>
<td class="nump">17,895<span></span>
</td>
<td class="nump">15,046<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense, net, and other</a></td>
<td class="nump">5,223<span></span>
</td>
<td class="nump">12,564<span></span>
</td>
<td class="nump">24,278<span></span>
</td>
<td class="nump">35,061<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income before income taxes</a></td>
<td class="nump">100,606<span></span>
</td>
<td class="nump">33,898<span></span>
</td>
<td class="nump">285,127<span></span>
</td>
<td class="nump">85,545<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=amn_NurseAndAlliedHealthcareStaffingMember', window );">Nurse and allied solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems', window );"><strong>Segment Reporting, Revenue Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">627,049<span></span>
</td>
<td class="nump">382,699<span></span>
</td>
<td class="nump">1,908,195<span></span>
</td>
<td class="nump">1,251,509<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=amn_PhysicianAndLeadershipSolutionsMember', window );">Physician and leadership solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems', window );"><strong>Segment Reporting, Revenue Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">150,663<span></span>
</td>
<td class="nump">109,116<span></span>
</td>
<td class="nump">430,523<span></span>
</td>
<td class="nump">355,580<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=amn_TechnologyAndWorkforceSolutionsMember', window );">Technology and workforce solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems', window );"><strong>Segment Reporting, Revenue Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">100,088<span></span>
</td>
<td class="nump">59,816<span></span>
</td>
<td class="nump">282,472<span></span>
</td>
<td class="nump">155,354<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems', window );"><strong>Segment Reporting, Revenue Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">877,800<span></span>
</td>
<td class="nump">551,631<span></span>
</td>
<td class="nump">2,621,190<span></span>
</td>
<td class="nump">1,762,443<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Segment operating income</a></td>
<td class="nump">159,075<span></span>
</td>
<td class="nump">94,141<span></span>
</td>
<td class="nump">478,086<span></span>
</td>
<td class="nump">281,952<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating segments | Nurse and allied solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems', window );"><strong>Segment Reporting, Revenue Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">627,049<span></span>
</td>
<td class="nump">382,699<span></span>
</td>
<td class="nump">1,908,195<span></span>
</td>
<td class="nump">1,251,509<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Segment operating income</a></td>
<td class="nump">92,564<span></span>
</td>
<td class="nump">52,923<span></span>
</td>
<td class="nump">283,768<span></span>
</td>
<td class="nump">173,706<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating segments | Physician and leadership solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems', window );"><strong>Segment Reporting, Revenue Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">150,663<span></span>
</td>
<td class="nump">109,116<span></span>
</td>
<td class="nump">430,523<span></span>
</td>
<td class="nump">355,580<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Segment operating income</a></td>
<td class="nump">19,301<span></span>
</td>
<td class="nump">15,538<span></span>
</td>
<td class="nump">62,366<span></span>
</td>
<td class="nump">45,432<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating segments | Technology and workforce solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems', window );"><strong>Segment Reporting, Revenue Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">100,088<span></span>
</td>
<td class="nump">59,816<span></span>
</td>
<td class="nump">282,472<span></span>
</td>
<td class="nump">155,354<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Segment operating income</a></td>
<td class="nump">47,210<span></span>
</td>
<td class="nump">25,680<span></span>
</td>
<td class="nump">131,952<span></span>
</td>
<td class="nump">62,814<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Unallocated corporate overhead</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems', window );"><strong>Segment Reporting, Revenue Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_amn_UnallocatedCorporateOverhead', window );">Unallocated corporate overhead</a></td>
<td class="nump">$ 23,867<span></span>
</td>
<td class="nump">$ 16,490<span></span>
</td>
<td class="nump">$ 74,915<span></span>
</td>
<td class="nump">$ 76,223<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amn_UnallocatedCorporateOverhead">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Unallocated corporate overhead.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amn_UnallocatedCorporateOverhead</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSoldDepreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for allocation of cost of tangible asset over its useful life directly used in production of good and rendering of service.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSoldDepreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123384075&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingRevenueReconcilingItemLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=amn_NurseAndAlliedHealthcareStaffingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=amn_NurseAndAlliedHealthcareStaffingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=amn_PhysicianAndLeadershipSolutionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=amn_PhysicianAndLeadershipSolutionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=amn_TechnologyAndWorkforceSolutionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=amn_TechnologyAndWorkforceSolutionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139669122293320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information - Disaggregation of Revenue (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">$ 877,800<span></span>
</td>
<td class="nump">$ 551,631<span></span>
</td>
<td class="nump">$ 2,621,190<span></span>
</td>
<td class="nump">$ 1,762,443<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=amn_NurseAndAlliedHealthcareStaffingMember', window );">Nurse&#160;and&#160;Allied Solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">627,049<span></span>
</td>
<td class="nump">382,699<span></span>
</td>
<td class="nump">1,908,195<span></span>
</td>
<td class="nump">1,251,509<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=amn_PhysicianAndLeadershipSolutionsMember', window );">Physician and Leadership Solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">150,663<span></span>
</td>
<td class="nump">109,116<span></span>
</td>
<td class="nump">430,523<span></span>
</td>
<td class="nump">355,580<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=amn_TechnologyAndWorkforceSolutionsMember', window );">Technology and workforce solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">100,088<span></span>
</td>
<td class="nump">59,816<span></span>
</td>
<td class="nump">282,472<span></span>
</td>
<td class="nump">155,354<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=amn_TemporaryStaffingMember', window );">Temporary staffing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">759,897<span></span>
</td>
<td class="nump">478,347<span></span>
</td>
<td class="nump">2,288,009<span></span>
</td>
<td class="nump">1,562,454<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=amn_TemporaryStaffingMember', window );">Temporary staffing | Nurse&#160;and&#160;Allied Solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">627,049<span></span>
</td>
<td class="nump">382,699<span></span>
</td>
<td class="nump">1,908,195<span></span>
</td>
<td class="nump">1,251,509<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=amn_TemporaryStaffingMember', window );">Temporary staffing | Physician and Leadership Solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">132,848<span></span>
</td>
<td class="nump">95,648<span></span>
</td>
<td class="nump">379,814<span></span>
</td>
<td class="nump">310,945<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=amn_TemporaryStaffingMember', window );">Temporary staffing | Technology and workforce solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=amn_PermanentPlacementMember', window );">Permanent placement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">17,815<span></span>
</td>
<td class="nump">13,468<span></span>
</td>
<td class="nump">50,709<span></span>
</td>
<td class="nump">44,635<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=amn_PermanentPlacementMember', window );">Permanent placement | Nurse&#160;and&#160;Allied Solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=amn_PermanentPlacementMember', window );">Permanent placement | Physician and Leadership Solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">17,815<span></span>
</td>
<td class="nump">13,468<span></span>
</td>
<td class="nump">50,709<span></span>
</td>
<td class="nump">44,635<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=amn_PermanentPlacementMember', window );">Permanent placement | Technology and workforce solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=amn_OutsourcedWorkforceMember', window );">Outsourced workforce</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">58,802<span></span>
</td>
<td class="nump">38,159<span></span>
</td>
<td class="nump">164,595<span></span>
</td>
<td class="nump">87,705<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=amn_OutsourcedWorkforceMember', window );">Outsourced workforce | Nurse&#160;and&#160;Allied Solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=amn_OutsourcedWorkforceMember', window );">Outsourced workforce | Physician and Leadership Solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=amn_OutsourcedWorkforceMember', window );">Outsourced workforce | Technology and workforce solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">58,802<span></span>
</td>
<td class="nump">38,159<span></span>
</td>
<td class="nump">164,595<span></span>
</td>
<td class="nump">87,705<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=amn_SaaSBasedTechnologiesMember', window );">SaaS-based technologies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">41,286<span></span>
</td>
<td class="nump">21,657<span></span>
</td>
<td class="nump">117,877<span></span>
</td>
<td class="nump">67,649<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=amn_SaaSBasedTechnologiesMember', window );">SaaS-based technologies | Nurse&#160;and&#160;Allied Solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=amn_SaaSBasedTechnologiesMember', window );">SaaS-based technologies | Physician and Leadership Solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=amn_SaaSBasedTechnologiesMember', window );">SaaS-based technologies | Technology and workforce solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">$ 41,286<span></span>
</td>
<td class="nump">$ 21,657<span></span>
</td>
<td class="nump">$ 117,877<span></span>
</td>
<td class="nump">$ 67,649<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=amn_NurseAndAlliedHealthcareStaffingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=amn_NurseAndAlliedHealthcareStaffingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=amn_PhysicianAndLeadershipSolutionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=amn_PhysicianAndLeadershipSolutionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=amn_TechnologyAndWorkforceSolutionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=amn_TechnologyAndWorkforceSolutionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=amn_TemporaryStaffingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=amn_TemporaryStaffingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=amn_PermanentPlacementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=amn_PermanentPlacementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=amn_OutsourcedWorkforceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=amn_OutsourcedWorkforceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=amn_SaaSBasedTechnologiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=amn_SaaSBasedTechnologiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139669121604808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information - Summary of Goodwill by Reportable Segment (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, beginning balance</a></td>
<td class="nump">$ 864,485<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Goodwill adjustment for Stratus Video acquisition</a></td>
<td class="nump">663<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill from Synzi and SnapMD acquisition</a></td>
<td class="nump">28,135<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, ending balance</a></td>
<td class="nump">893,283<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss', window );">Accumulated impairment loss</a></td>
<td class="nump">214,939<span></span>
</td>
<td class="nump">$ 214,939<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=amn_NurseAndAlliedHealthcareStaffingMember', window );">Nurse&#160;and&#160;Allied Solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, beginning balance</a></td>
<td class="nump">339,015<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Goodwill adjustment for Stratus Video acquisition</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill from Synzi and SnapMD acquisition</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, ending balance</a></td>
<td class="nump">339,015<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss', window );">Accumulated impairment loss</a></td>
<td class="nump">154,444<span></span>
</td>
<td class="nump">154,444<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=amn_PhysicianAndLeadershipSolutionsMember', window );">Physician and Leadership Solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, beginning balance</a></td>
<td class="nump">152,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Goodwill adjustment for Stratus Video acquisition</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill from Synzi and SnapMD acquisition</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, ending balance</a></td>
<td class="nump">152,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss', window );">Accumulated impairment loss</a></td>
<td class="nump">60,495<span></span>
</td>
<td class="nump">60,495<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=amn_TechnologyAndWorkforceSolutionsMember', window );">Technology and workforce solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, beginning balance</a></td>
<td class="nump">372,670<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Goodwill adjustment for Stratus Video acquisition</a></td>
<td class="nump">663<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill from Synzi and SnapMD acquisition</a></td>
<td class="nump">28,135<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, ending balance</a></td>
<td class="nump">401,468<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss', window );">Accumulated impairment loss</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated impairment loss for an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairedAccumulatedImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillPurchaseAccountingAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123586518&amp;loc=d3e961-128460<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillPurchaseAccountingAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=amn_NurseAndAlliedHealthcareStaffingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=amn_NurseAndAlliedHealthcareStaffingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=amn_PhysicianAndLeadershipSolutionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=amn_PhysicianAndLeadershipSolutionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=amn_TechnologyAndWorkforceSolutionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=amn_TechnologyAndWorkforceSolutionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139669119398232">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Notes Payable and Credit Agreement (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Feb. 14, 2020</div></th>
<th class="th"><div>Jun. 14, 2019</div></th>
<th class="th"><div>Feb. 09, 2018</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Senior Credit Facility | Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_SecuredDebtMember', window );">Term Loan | Term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Term loan credit facility</a></td>
<td class="nump">$ 250,000,000<span></span>
</td>
<td class="nump">$ 150,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_SecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_SecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=amn_TermDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=amn_TermDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139669122075416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurement - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Oct. 20, 2020</div></th>
<th class="th"><div>Aug. 13, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Impairment charges</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=amn_A4.625SeniorNotesDue2027Member', window );">2027 Notes | Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.625%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=amn_A4000SeniorNotesDue2029Member', window );">2029 Notes | Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember', window );">Fair Value, Measurements, Nonrecurring | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity investment balance</a></td>
<td class="nump">22,633,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,449,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_CommercialPaperMember', window );">Commercial paper | Fair Value, Measurements, Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueNetAssetLiability', window );">Commercial paper</a></td>
<td class="nump">126,584,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">58,345,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_CommercialPaperMember', window );">Commercial paper | Fair Value, Measurements, Recurring | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueNetAssetLiability', window );">Commercial paper</a></td>
<td class="nump">126,584,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">58,345,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale securities</a></td>
<td class="nump">$ 17,658,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,196,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=123594786&amp;loc=SL75136599-209740<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueNetAssetLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of asset after deduction of liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueNetAssetLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=amn_A4.625SeniorNotesDue2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=amn_A4.625SeniorNotesDue2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=amn_A4000SeniorNotesDue2029Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=amn_A4000SeniorNotesDue2029Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139669126829224">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurement - Financial Assets and Liabilities (Details) - Fair Value, Measurements, Recurring - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByLiabilityClassAxis=amn_DeferredCompensationMember', window );">Deferred compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueNetAssetLiability', window );">Assets (liabilities) measured at fair value</a></td>
<td class="num">$ (117,020)<span></span>
</td>
<td class="num">$ (97,184)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByLiabilityClassAxis=amn_DeferredCompensationMember', window );">Deferred compensation | Quoted&#160;Prices&#160;in Active&#160;Markets for Identical Assets (Level 1)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueNetAssetLiability', window );">Assets (liabilities) measured at fair value</a></td>
<td class="num">(117,020)<span></span>
</td>
<td class="num">(97,184)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByLiabilityClassAxis=amn_DeferredCompensationMember', window );">Deferred compensation | Significant Other Observable Inputs (Level 2)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueNetAssetLiability', window );">Assets (liabilities) measured at fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByLiabilityClassAxis=amn_DeferredCompensationMember', window );">Deferred compensation | Significant Unobservable Inputs (Level 3)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueNetAssetLiability', window );">Assets (liabilities) measured at fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByLiabilityClassAxis=amn_ContingentConsiderationMember', window );">Acquisition contingent consideration liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueNetAssetLiability', window );">Assets (liabilities) measured at fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8,000)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByLiabilityClassAxis=amn_ContingentConsiderationMember', window );">Acquisition contingent consideration liabilities | Quoted&#160;Prices&#160;in Active&#160;Markets for Identical Assets (Level 1)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueNetAssetLiability', window );">Assets (liabilities) measured at fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByLiabilityClassAxis=amn_ContingentConsiderationMember', window );">Acquisition contingent consideration liabilities | Significant Other Observable Inputs (Level 2)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueNetAssetLiability', window );">Assets (liabilities) measured at fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByLiabilityClassAxis=amn_ContingentConsiderationMember', window );">Acquisition contingent consideration liabilities | Significant Unobservable Inputs (Level 3)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueNetAssetLiability', window );">Assets (liabilities) measured at fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8,000)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_MoneyMarketFundsMember', window );">Money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueNetAssetLiability', window );">Assets (liabilities) measured at fair value</a></td>
<td class="nump">31,569<span></span>
</td>
<td class="nump">2,198<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_MoneyMarketFundsMember', window );">Money market funds | Quoted&#160;Prices&#160;in Active&#160;Markets for Identical Assets (Level 1)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueNetAssetLiability', window );">Assets (liabilities) measured at fair value</a></td>
<td class="nump">31,569<span></span>
</td>
<td class="nump">2,198<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_MoneyMarketFundsMember', window );">Money market funds | Significant Other Observable Inputs (Level 2)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueNetAssetLiability', window );">Assets (liabilities) measured at fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_MoneyMarketFundsMember', window );">Money market funds | Significant Unobservable Inputs (Level 3)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueNetAssetLiability', window );">Assets (liabilities) measured at fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_CommercialPaperMember', window );">Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueNetAssetLiability', window );">Assets (liabilities) measured at fair value</a></td>
<td class="nump">126,584<span></span>
</td>
<td class="nump">58,345<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_CommercialPaperMember', window );">Commercial paper | Quoted&#160;Prices&#160;in Active&#160;Markets for Identical Assets (Level 1)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueNetAssetLiability', window );">Assets (liabilities) measured at fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_CommercialPaperMember', window );">Commercial paper | Significant Other Observable Inputs (Level 2)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueNetAssetLiability', window );">Assets (liabilities) measured at fair value</a></td>
<td class="nump">126,584<span></span>
</td>
<td class="nump">58,345<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_CommercialPaperMember', window );">Commercial paper | Significant Unobservable Inputs (Level 3)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueNetAssetLiability', window );">Assets (liabilities) measured at fair value</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueNetAssetLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of asset after deduction of liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueNetAssetLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=amn_DeferredCompensationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=amn_DeferredCompensationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=amn_ContingentConsiderationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=amn_ContingentConsiderationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_MoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_MoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139669121946728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurement - Reconciliation of Changes in Contingent Consideration Liabilities (Details) - Level 3 - Acquisition contingent consideration liabilities - Fair Value, Measurements, Recurring - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Beginning balance</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (8,100)<span></span>
</td>
<td class="num">$ (8,000)<span></span>
</td>
<td class="num">$ (23,100)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Ending balance</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(1,400)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(1,400)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Advanced</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements', window );">Settlement of contingent consideration liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">20,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">b4health</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements', window );">Settlement of contingent consideration liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Change in fair value of contingent consideration liability from acquisition</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 6,700<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 1,700<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of settlements of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=amn_ContingentConsiderationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=amn_ContingentConsiderationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=amn_AdvancedMedicalPersonnelServicesInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=amn_AdvancedMedicalPersonnelServicesInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=amn_B4healthLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=amn_B4healthLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139669121661752">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurement - Fair Value of Financial Instruments (Details) - Senior Notes - USD ($)<br></strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=amn_A4.625SeniorNotesDue2027Member', window );">2027 Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Carrying Amount</a></td>
<td class="nump">$ 500,000,000<span></span>
</td>
<td class="nump">$ 500,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Estimated Fair Value</a></td>
<td class="nump">518,750,000<span></span>
</td>
<td class="nump">521,250,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=amn_A4000SeniorNotesDue2029Member', window );">2029 Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Carrying Amount</a></td>
<td class="nump">350,000,000<span></span>
</td>
<td class="nump">350,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Estimated Fair Value</a></td>
<td class="nump">$ 359,625,000<span></span>
</td>
<td class="nump">$ 357,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=amn_A4.625SeniorNotesDue2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=amn_A4.625SeniorNotesDue2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=amn_A4000SeniorNotesDue2029Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=amn_A4000SeniorNotesDue2029Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139669117972120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($) </div>
<div>phase</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_amn_NumberOfPhasesOfLeaseTerminationAgreement', window );">Number of phases of lease termination agreement | phase</a></td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_amn_PaymentsOfLeaseTerminationFee', window );">Payments of lease termination fee</a></td>
<td class="nump">$ 17,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_amn_OperatingLeaseRightOfUseAssetIncreaseDecreaseFromModification', window );">Operating lease, right-of-use asset, decrease from modification</a></td>
<td class="nump">27,340<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_amn_OperatingLeaseLiabilityIncreaseDecreaseFromModification', window );">Operating lease, liability, decrease from modification</a></td>
<td class="nump">27,340<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_amn_LesseeOperatingLeaseLiabilityToBePaidPremodification', window );">Remaining lease payments, premodification</a></td>
<td class="nump">62,487<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_amn_LesseeOperatingLeaseLiabilityToBePaidPostmodification', window );">Remaining lease payments, postmodification</a></td>
<td class="nump">$ 9,564<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amn_LesseeOperatingLeaseLiabilityToBePaidPostmodification">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Liability, To Be Paid, Postmodification</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amn_LesseeOperatingLeaseLiabilityToBePaidPostmodification</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amn_LesseeOperatingLeaseLiabilityToBePaidPremodification">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Liability, To Be Paid, Premodification</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amn_LesseeOperatingLeaseLiabilityToBePaidPremodification</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amn_NumberOfPhasesOfLeaseTerminationAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number Of Phases Of Lease Termination Agreement</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amn_NumberOfPhasesOfLeaseTerminationAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amn_OperatingLeaseLiabilityIncreaseDecreaseFromModification">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Lease, Liability, Increase (Decrease) From Modification</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amn_OperatingLeaseLiabilityIncreaseDecreaseFromModification</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amn_OperatingLeaseRightOfUseAssetIncreaseDecreaseFromModification">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Lease, Right-Of-Use Asset, Increase (Decrease) From Modification</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amn_OperatingLeaseRightOfUseAssetIncreaseDecreaseFromModification</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amn_PaymentsOfLeaseTerminationFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payments Of Lease Termination Fee</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amn_PaymentsOfLeaseTerminationFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139669118125960">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Taxes (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_amn_DeferredPayrollTaxesCARESAct', window );">Deferred payroll taxes, CARES Act</a></td>
<td class="nump">$ 48,452<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_amn_EmployeeRetentionEmploymentTaxCreditCARESAct', window );">Employee retention employment tax credit, CARES Act</a></td>
<td class="nump">$ 1,756<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amn_DeferredPayrollTaxesCARESAct">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Payroll Taxes, CARES Act</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amn_DeferredPayrollTaxesCARESAct</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amn_EmployeeRetentionEmploymentTaxCreditCARESAct">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Employee Retention Employment Tax Credit, CARES Act</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amn_EmployeeRetentionEmploymentTaxCreditCARESAct</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139669117845944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies: Legal Proceedings (Details) - Wage and Hour claims - Pending Litigation - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease', window );">Increase to loss contingency accruals</a></td>
<td class="nump">$ 20,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=amn_WageAndHourClaimsMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyEstimateOfPossibleLoss', window );">Estimate of possible loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in loss contingency liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyEstimateOfPossibleLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reflects the estimated amount of loss from the specified contingency as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124440162&amp;loc=d3e12021-110248<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyEstimateOfPossibleLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=amn_WageAndHourClaimsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=amn_WageAndHourClaimsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139669120258200">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Details (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Other current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalents', window );">Restricted cash and cash equivalents</a></td>
<td class="nump">$ 18,118<span></span>
</td>
<td class="nump">$ 18,626<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesReceivable', window );">Income taxes receivable</a></td>
<td class="nump">1,119<span></span>
</td>
<td class="nump">6,591<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsMiscellaneousCurrent', window );">Other</a></td>
<td class="nump">12,159<span></span>
</td>
<td class="nump">15,592<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other current assets</a></td>
<td class="nump">31,396<span></span>
</td>
<td class="nump">40,809<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNetAbstract', window );"><strong>Fixed assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FurnitureAndFixturesGross', window );">Furniture and equipment</a></td>
<td class="nump">54,634<span></span>
</td>
<td class="nump">47,355<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalizedComputerSoftwareGross', window );">Software</a></td>
<td class="nump">254,090<span></span>
</td>
<td class="nump">220,971<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseholdImprovementsGross', window );">Leasehold improvements</a></td>
<td class="nump">9,616<span></span>
</td>
<td class="nump">9,600<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Fixed assets, gross</a></td>
<td class="nump">318,340<span></span>
</td>
<td class="nump">277,926<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Accumulated depreciation</a></td>
<td class="num">(190,578)<span></span>
</td>
<td class="num">(161,752)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Fixed assets, net</a></td>
<td class="nump">127,762<span></span>
</td>
<td class="nump">116,174<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsAbstract', window );"><strong>Other assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashSurrenderValueOfLifeInsurance', window );">Life insurance cash surrender value</a></td>
<td class="nump">114,037<span></span>
</td>
<td class="nump">98,161<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsMiscellaneous', window );">Other</a></td>
<td class="nump">43,872<span></span>
</td>
<td class="nump">36,959<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">157,909<span></span>
</td>
<td class="nump">135,120<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract', window );"><strong>Accounts payable and accrued expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableTradeCurrent', window );">Trade accounts payable</a></td>
<td class="nump">48,468<span></span>
</td>
<td class="nump">28,089<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_amn_AccountsPayableToSubcontractor', window );">Subcontractor payable</a></td>
<td class="nump">147,776<span></span>
</td>
<td class="nump">79,364<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">60,414<span></span>
</td>
<td class="nump">37,849<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualCarryingValueCurrent', window );">Loss contingencies</a></td>
<td class="nump">11,627<span></span>
</td>
<td class="nump">7,613<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SelfInsuranceReserveCurrent', window );">Professional liability reserve</a></td>
<td class="nump">6,773<span></span>
</td>
<td class="nump">8,897<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccountsPayableAndAccruedLiabilities', window );">Other</a></td>
<td class="nump">9,036<span></span>
</td>
<td class="nump">6,069<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_amn_AccountsPayableAndAccruedExpensesExcludingAccruedCompensationAndBenefitsCurrent', window );">Accounts payable and accrued expenses</a></td>
<td class="nump">284,094<span></span>
</td>
<td class="nump">167,881<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrentAbstract', window );"><strong>Accrued compensation and benefits:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedSalariesCurrent', window );">Accrued payroll</a></td>
<td class="nump">114,299<span></span>
</td>
<td class="nump">59,721<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_amn_AccruedBonusesAndCommissions', window );">Accrued bonuses and commissions</a></td>
<td class="nump">66,215<span></span>
</td>
<td class="nump">34,514<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_amn_AccruedTravelExpense', window );">Accrued travel expense</a></td>
<td class="nump">2,673<span></span>
</td>
<td class="nump">1,998<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedInsuranceCurrent', window );">Health insurance reserve</a></td>
<td class="nump">6,627<span></span>
</td>
<td class="nump">5,590<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WorkersCompensationLiabilityCurrent', window );">Workers compensation reserve</a></td>
<td class="nump">10,297<span></span>
</td>
<td class="nump">10,244<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationLiabilityCurrent', window );">Deferred compensation</a></td>
<td class="nump">117,020<span></span>
</td>
<td class="nump">97,184<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherEmployeeRelatedLiabilitiesCurrent', window );">Other</a></td>
<td class="nump">4,807<span></span>
</td>
<td class="nump">4,163<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued compensation and benefits</a></td>
<td class="nump">321,938<span></span>
</td>
<td class="nump">213,414<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrentAbstract', window );"><strong>Other long-term liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WorkersCompensationLiabilityNoncurrent', window );">Workers compensation reserve</a></td>
<td class="nump">20,716<span></span>
</td>
<td class="nump">20,930<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SelfInsuranceReserveNoncurrent', window );">Professional liability reserve</a></td>
<td class="nump">31,768<span></span>
</td>
<td class="nump">31,997<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent', window );">Unrecognized tax benefits</a></td>
<td class="nump">5,403<span></span>
</td>
<td class="nump">5,447<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherSundryLiabilitiesNoncurrent', window );">Other</a></td>
<td class="nump">49,228<span></span>
</td>
<td class="nump">49,533<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">$ 107,115<span></span>
</td>
<td class="nump">$ 107,907<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amn_AccountsPayableAndAccruedExpensesExcludingAccruedCompensationAndBenefitsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accounts Payable And Accrued Expenses, Excluding Accrued Compensation And Benefits, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amn_AccountsPayableAndAccruedExpensesExcludingAccruedCompensationAndBenefitsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amn_AccountsPayableToSubcontractor">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accounts payable to subcontractor.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amn_AccountsPayableToSubcontractor</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amn_AccruedBonusesAndCommissions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued Bonuses And Commissions</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amn_AccruedBonusesAndCommissions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_amn_AccruedTravelExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued Travel Expense</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">amn_AccruedTravelExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>amn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableTradeCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableTradeCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedInsuranceCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable to insurance entities to mitigate potential loss from various risks or to satisfy a promise to provide certain coverage's to employees. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedInsuranceCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedSalariesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of the obligations incurred through that date and payable for employees' services provided. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedSalariesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedComputerSoftwareGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated amortization of capitalized costs for computer software, including but not limited to, acquired and internally developed computer software.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedComputerSoftwareGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashSurrenderValueOfLifeInsurance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of amounts which could be received based on the terms of the insurance contract upon surrendering life policies owned by the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6812-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashSurrenderValueOfLifeInsurance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements payable within one year (or the operating cycle, if longer). Represents currently earned compensation under compensation arrangements that is not actually paid until a later date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 710<br> -SubTopic 10<br> -Section 25<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=6409733&amp;loc=d3e19512-108361<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 710<br> -SubTopic 10<br> -Section 30<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6409875&amp;loc=d3e20028-108363<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FurnitureAndFixturesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation of equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FurnitureAndFixturesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount due within one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.5(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.10)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.3(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseholdImprovementsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation of additions or improvements to assets held under a lease arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6812-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseholdImprovementsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount recognized for uncertainty in income taxes classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUncertainTaxPositionsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualCarryingValueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss contingency liability expected to be resolved within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualCarryingValueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred and payable to vendors for goods and services received classified as other, and expenses incurred but not yet paid, payable within one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsMiscellaneous">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other miscellaneous assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsMiscellaneous</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsMiscellaneousCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other miscellaneous assets expected to be realized or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsMiscellaneousCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherEmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligations incurred for employer-related costs classified as other, payable within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherEmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherSundryLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Obligations not otherwise itemized or categorized in the footnotes to the financial statements that are expected to be paid after one year (or the normal operating cycle, if longer), from the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherSundryLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SelfInsuranceReserveCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of accrued known and estimated losses incurred as of the balance sheet date for which no insurance coverage exists, and for which a claim has been made or is probable of being asserted, typically arising from workmen's compensation-type of incidents and personal injury to nonemployees from accidents on the entity's property that are expected to be paid within one year (or the normal operating cycle, if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SelfInsuranceReserveCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SelfInsuranceReserveNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of accrued known and estimated losses incurred as of the balance sheet date for which no insurance coverage exists, and for which a claim has been made or is probable of being asserted, typically arising from workmen's compensation-type of incidents and personal injury to nonemployees from accidents on the entity's property that are expected to be paid after one year (or the normal operating cycle, if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SelfInsuranceReserveNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WorkersCompensationLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations and payables pertaining to claims incurred of a workers compensation nature. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WorkersCompensationLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WorkersCompensationLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations and payables pertaining to claims incurred of a workers compensation nature. Used to reflect the noncurrent portion of the liabilities (due beyond one year; or beyond one operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WorkersCompensationLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>59
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
M6'!VULS2 Y9>*?IUE!K9';O=05SP6.XYB1'^QL4$UFG2&98T1G*=D 4. #?$
MT4Q0?*]!MHK@PI+27)#6SRFU4!H(FLB!]4>"(<7<K_WUE[O)I#-ZG7TZSFN4
M?VFK :?MNYO/D_QSZ.2?IY/734+.<+PL"?'[(UMAAR=N.Q-R.AQG0GS/]O:1
MI24RS^_Y"NM./&<?5I:P7<_/Y)Z,<B.[W?98??9/1VXCUZG LR+7E$8D19_(
M+;KD$3BU20TR$S\(G8:8:E < J0),9:AAOBTQJP1X!-]M[X(R-^-B/>K;YH]
M5Z%82=J$^!!&&N*<<^9ST6S[!Z5&T?95O-RCEU@5 9<8WS2J-2S%UGB5P/&M
MG#P=$Q+-E L&08:7)"82J3E^34@3_BNEVOZ<TT#PE"\D^DJ1CVFS(Z=T)LWH
M,QK!1J\;=8=HTCQZ_@7YG#4*')$;'0)G&[-&(81IN_ >KR2.FJW"$2M"/F(9
M-AIRM1:!MG&IA&!:$L;1>$[2M!'\6:PUDSY@R.S-D77.UI$.$9)>-T(^8LZ+
MD!&_'H8X2IKMHG%8!/V>7L-)P>B"RV;]N'Z&U3-L+([W1]072N0/)J<_Z3(T
M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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MB=#]1\_^QJA=]]WP5AFCJNYR*P7 MP;P^T:!D-_?V$^1PZ?GBW\ 4$L#!!0
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MB- "\'S#N7J=Z,MI\V=D_AM02P,$%     @ .X)E4VM%P?DL!@  Z1D  !@
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M<I6EBII;@/K\KBR;KV_:;Z_O_Z?#U?\!4$L#!!0    ( #N"95/7:PL8^0H
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M:'T _U\:0UO#)QA>R.(W4$L#!!0    ( #N"95,'$,GVWPH  %4<   8
M>&PO=V]R:W-H965T<R]S:&5E=#@N>&ULO5EM<]NX$?XK&#73L6=H693\FA?/
MR$YRY[9)?%&2?NCT T1"$AH2X &@%?77]]D%25&RG;O<S?2+39' [F+WV6=W
MR9=KZ[[ZE5)!?"L+XU\-5B%4SX^/?;92I?1#6RF#)POK2AGPTRV/?>64S'E3
M61R/1Z.SXU)J,[AZR??NW-5+6X="&W7GA*_+4KK-M2KL^M4@';0W/NKE*M"-
MXZN7E5RJF0J?JSN'7\>=E%R7RGAMC7!J\6HP39]?G]!Z7O!%J[7O70LZR=S:
MK_3C-G\U&)%!JE!9( D2_^[5C2H*$@0S?FUD#CJ5M+%_W4I_RV?'6>;2JQM;
M_%/G8?5J<#$0N5K(N@@?[?IGU9SGE.1EMO#\5ZR;M:.!R&H?;-ELA@6E-O&_
M_-;XX?=L&#<;QFQW5,16OI9!7KUT=BT<K88TNN"C\FX8IPT%918<GFKL"U?7
MTFLO[$+<.>65"9)\]?(X0#0M.,X:,==1S/@),9?BG35AY<4;DZM\=_\Q3.KL
M&K=V78^_*W"FJJ&8C!(Q'HW3[\B;=.><L+S)$_(^N*4T^K]\O$3<6.-MH7,9
MD6'RG>.3.]YJ(TVF92%FN*D P^#%OZ9S'QR ]._O6'32673"%IW\6<]_5PPE
M[7-?R4R]&E0DR-VKP=7U='8[$Q_>BKN/;V9OWG^:?KK]\%Y\6BF1603(>)73
M5>,#_)C+ L=5@H'DV2-.%?SHB1U^ZQ:<(;,EM*\H6>^5T :_%4O)I%^)!5+?
MT_8 EL!>;418X?"_U-(%Y8J-^*@JZX* [RG71#HZ^D4<\)J__N5B/!Z]V%_*
MM],7AXE8KW2V$M(I41M9YQK&)61!4><*:F!&EMFZL7/Z[KWX6<DBK#+:,8.[
M=*9\(FY--F2#-1:N5[8H-D=V3<;Z>NYUKJ73RHL#Y!L3RKTJ-@F+;PR\@0>D
MV;1V#<6T*(372Z,7.I,FP"38G\55K;^CIP$IXR6SE!<K"0?.E3)"%1H)S\Z&
MP[(^9(>PEY7;2IL&L:4T8%&*2"(D=.."338*>CP(5X#"A10+J9VH]N#N:_BP
M\]]3,5]T2=&+_M;@QNGYD)#F56<!R=">!$ 3F6:(3PL@+*N=TV8)IZO2\S;<
M]"!4#A8JCY/1*V0ZG9>=J$N!)]KF''5C0W=&#7QHD\/A%"&2$7HB@X6=0GVK
M$$ Z#;D#L;!8X_8EXUFK$\?0T+/0/H/1&R5=^Y1V+^I0XVG<%H_PQ_R86SY*
MBUSRDS:QZK8DA>>/!)0P5:B@'@1UJZ:R7D?F>]R]>YD:X4:Z==B@((55FT04
MK HARS14>K%4!C*0*_1<5:'-;24^&W8 DR?2IDF2S\/94/PTG=YMT^2N4"BJ
M5-\1!$2(-O=R*3U_ ?.V[OP-)W(Z<<@C>46/M9'LAU!1H1*OX<MR#LV3E$L-
M"LX>33VT9FI,#2D/*>OO/Z9HH0L\8._2GAEE Z+4D,*;;]E*FB6K+[7G)HAT
MJ;FK*?;CLU@;.]^2T%W;MDXF5 (=E72/@*/GOD<"WX4,/OVU1B+X'M-0P$KY
M%6@5IN;C0;+R09<<=CJ'].CWJ@@SC@I!J(FS8S/I!A&#]VWI*;2<ZV+K"UJ;
MPZ6%]91K7&\8BV3"4_M"W,:&-$3P&Y A8Q 167;EPJE[9>I8R8@WD,I(U)HY
M:_< ,?_!81\H51&II:7;<RKR21]&0MW+HF:KJ-1TSFIK5A1M_1;#<!;("5C0
M\T*UQZUJ!WSXB%(IYK4'9#UQ;3FGHL')SFN%AE[M^+ )Y2GP4\2<0'.\.-(&
M3J5BE#"3X(Q;PFE-F"//%[K9'[T#\E;Z7L*D9!N-K(T8!6'96-&+%5>"O*&=
MW7!Y;Q&9T&:$S "V2%JDE0IS;"J"_*;@YFD6:BXAD<Y@5)$#(PMBD86S9>/#
M+19KI*%K5C2PZ7 )5Q!31VTQ6\AI66B!8RSJ/=8X:^2]=C48[>;#E]O71^GE
MH4!4<U7J#,*9<&)%E(+T.@*;@LZ,F>(Q.NFE"V-N1CP:J:)I?X?(YPPV@V:G
MN666G6[I^ Y&X3IKX(S&H..:\2B]C.#;MK.]G2!GDTN7>W%M\:]CDK?3V77+
M'0+44^\J;+>)SQ5E5[=M.OO<[2+-1^DX:;NC&?Q9Z,6F39R>. +B;8SM)XYM
M(X3#X%M=Z 2[PHV$<"JO,^IF?8C%BVO@-V*M7MK(72V[""+Q!E/CLD9!H=ZW
MZ[< )^6H!D E5;5MB2S08BQ:C$LX/">ST-N0BDX0-%> ($I/U_H0X"IX(&MR
MJP1!]-B#6@Q*@R%BAPQD$FC@PEIPG$XZI4?;0+?N0880,$BT;OL<UD<]%_&#
M4\%97\7.-1&ES>D<^>Y]RH.J]Y/)*SJJ)2_9X&]'>P-PVO(W:;@ZQ2*7)AV[
M=O;]L23YS<K/'7&K/=97QCV@W$%X]IF?'(W2#I<W'-$.EK?4!+:=^%R%-;6U
MG]!D9V)"IVDO)_%@\>=%>KJ#V1U0;2'3M:_[\GLH]5U&AI6,D-E0.*GR!FIM
M[\$6,<\)!K8.@M[$4-N;HP-TA%\J$MSC4YTA2,T03QY""AI9-,3F.7C3-S;M
M)0G=XH%$1S@9RB.<E70U;-A84RI8D/\I?$1P/L#<_Q,V-VA[$_XKWN!<<%K7
M%7R$LYUFRN'G_8.VE<QSH[[2RQ5B4&A(R!^$B1L"IY?07Y#EU.9MHC.=4DA&
M?G,"WQ=4P6/V<C>NM@9%0[>->N]1-S+0-(4:O"%OH'<$*^2*.__&C*T#4/-!
M.'5376& 0CBE^XIN88%"Z;D5*#&N\O @T=Q$#/"D].1AAWV/94^:B_FA;$<U
M-MSW%N^KY3S@MQI4'FGZILCC<8O5!R&758CO()JV9CO ;R@;:<23F\;>&=S_
MGGCZX/RPXX2WE#Q?*'G$.\PFZ#AI=9OA/'/EL5>0.R-:S(0%3+1K)A1.18#[
M7M,9B82!F@P=3]>$9PR^!QZ*K=>N*[OVM./_F+I\>E+WXV]VXG#4].)MU]L,
MD=OQY_<HV7L9U$V2PT>ZF8>CT'>@_4RDD_-D=)+B:GR9C-/)[\/80?LN@DX1
M81NSHYT7#D5ZD:3I!?T[&Y_M2WTB*/W,/ILD9Z.).$N3R<DY2D$ &GX@GOOB
MQC#D_&R,.?(R22_.Q#^("WJ;^FL/TO/D[/3B4!R,3Y/T\NSPQ]4_HQ8M24<G
MN+J8))>7H[8G\]QMQM9^A_((OE2:'AD!VFD+1EJ==3/4<"NSOY9?VI@C+H8P
M"W0G::+:K23T08%Z,#*?.-:N&<:4?ETCF*$-1#W#6$C%;,[CT!.5 /4H@(-I
M*E^#?M6172Q8D-.*9Q_20F(\S[5 ,=%F? $/EF_D]"AT.S#$9O!>ZH*/UW]I
MP^RE>?#%V!?GY:BE[3B:]XEQ$-KL9D_[;G-+DPV$]W1#G\(NBO2<RG3S2HK8
MQM)<LC_;_!!%\6>3V'Q$.M@)Q6X$F!L?1OQYS'M.]>N&CN*LTVL'G@G*\PG^
M3Y+)9!PGG<8&=M164Z_MS>JR+OAEWU'3"<C\/W7,DS@G-.]R #&#$\?WR>GX
M!51.)B<T/-UK?K?R'6!-QJ<">79^(:8-21*$T-0+ A'&<+<DR"\)K6'/20=I
M@IIR2/\GD\GAWOEWV?&9.$O2DPO*R.0T3<5C'QF.>Y]Z ,PE?]#B^=>$^-6G
MN]M],YO&3T7;Y?&#VSO83?E5J 6VCH;GIP/AXD>L^"/8BC\<S6U %O#E"MVF
M<K0 SQ<6!:3Y00JZ+XE7_P-02P,$%     @ .X)E4X->S,XJ"P  GQ\  !@
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M^T5_F\G!<0;6CZ.I=WTJ5LC/DJ3K9A4Y<>"6H""FP%X<[CQ6<;1P=$0AP59
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MT+.T""$[H'@-@*,PZEZG31[9P "O#N"NO4,[<'N#OVRA.^1D ^3V@0+G'9@
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M:W/;N!7]*QC5TTEFT(COAV-[QGGL-IU-XK&\NQ\Z_0"3D,2&)+@ :%OY]7L
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MDL/H+. ,BQ9TPB9$8=0^@]>ID^YXO,X)O#$F%L;<I$*94B/\&R?&:BJ0_\Z
M=VOPK@?O_J^*OH#Y>3Z9P33^)QY^FD!\.X;1W63\<0[QA[O)Y&9R._\LX1H3
M75)CP943JGW9!+M"&*F\8'(#%!>)!W!IE5^XI8XY9D;%9U=@\ $U$R"0]D\;
M((="JP>>(= IX)U?=<.P&88AS%!RFML"7;.4"VXWSD5C(5B*P*UQ+O(W?.3&
M<KF$M#)>5,8<30N(_I^E1&AW/?>K%[@ON#86&%'./.US*;UV*[_^<AE%X?MK
M[Q?O_/QL^_V;HPR;A*R(IR)/ERYQ-C0'K]H75=(&T]+Q(58Y",7D44J;@Z!S
M9_6)K';A6C#?2VY1"K%Q:C&> 1/"!2\EB58Z]7U>-0(IX.7Q@M7[78D6A2^(
M1JP55>./JS:K'']:MNBG9(LS6J*#FPKQA(+'O,A=+=%']W5\,CG7E&[QJ!R:
M0*>IORX>4&PJ-7=DG U^W\JU%/AH*POG1)=%J5T^&;,(:N$G3W=*@A38B<*E
M*LT3]^<4.*R=TFPCTC:DB)F!A5;Y26=*Z4 @!IEFZTRMI2/)H%#:7Y5G&3L0
MXIL7 FW5W2R]+[GA.U<ZN"A_ U^H+A0P [FB,[8J\PQ-JGGBRQ+<20FOHS?-
M6N4G(-/:2GN0[[9+7%!Z8!A+&^D.%$[*)Q8SB6:_;9Z3P,5].D'NJ7](>,?:
M72V5N#^R>]Q\UX87K><ND6#OBLY1+_U#Q)".U.K5;5W/UF^=N+KBG\RKA](-
MTTLN#1W/"W(-6[_3TT)7CX]J8%7A+_Q$67H^^,\5O==0.P-:7RA7;=7 !:A?
M@(-O4$L#!!0    ( #N"95.T=^ZAU0H  /H@   9    >&PO=V]R:W-H965T
M<R]S:&5E=#$T+GAM;,U:6V_<NA'^*\36+6Q MO?J2Q(;L!T'QT5NC9/TH>@#
M5^+N$I%$A:2\V?/K^\U0M[W8<7K:HB]>D2*'<_UFAO*KI;'?W$(I+WYD:>XN
M>@OOBQ?'QRY>J$RZ(U.H'&]FQF;28VCGQZZP2B:\*4N/A_W^R7$F==Z[?,5S
M'^WE*U/Z5.?JHQ6NS#)I5]<J-<N+WJ!73WS2\X6GB>/+5X6<JWOEOQ0?+4;'
M#95$9RIWVN3"JME%[VKPXGI,ZWG!5ZV6KO,L2)*I,=]H<)=<]/K$D$I5[(F"
MQ,^#NE%I2H3 QO>*9J\YDC9VGVOJ;UAVR#*53MV8].\Z\8N+WEE/)&HFR]1_
M,LO?5"7/A.C%)G7\5RS#VM&X)^+2>9-5F\%!IO/P*W]4>NAL..L_LF%8;1@R
MW^$@YO*U]/+RE35+86DUJ-$#B\J[P9S.R2CWWN*MQCY_^49J*[[*M%3BG9*N
MM H:]Z^./6C3BN.XHG,=Z P?H7,NWIG<+YRXS1.5K.\_!D\-8\.:L>OADP3O
M57$D1OU(#/O#P1/T1HV@(Z8W^KF@K[6+4T.R.O&/JZGS%K[QSR?.&#=GC/F,
M\1]6YI-T*!!?N$+&ZJ*'2'/*/JC>Y9NKNT_BZ]7;+[?BW>W5_9=/M^]NWW\6
MGQ=*W)BLD/GJ+W\Z&PY.7SKQ !8D.[U7\2+7WTM(*O-$Z+PHO1.E4XGP1F2!
M23$COA^8;UKE01*.K7/--,R,9_S"*B52]:!2)_;?TJ\81"(\#"/>&0:C@WI/
MA_!"*RMMO%@)B1.38 )%+(F/TGIQ=Q>).Z\R<18)$F38?_E&YS*/M4S%O9>>
M=1G$N"^+(N4Q<$20W[/HPY?OC8>DD.S&Y,ZD.L&V1.RBT]D@1M5@M_F8F<'+
M6B2X8U]<Y7D)<I]48:P_ZMI +*03N?$B7LA\KH(R=]K#V-H<VI-%G)C1%,8=
MK64M'R(IK<[G3#"'PX@L!)RB@!,(%T@V5;:)F2-QY9RJ-/96RZE.84\<4\F6
M" )%R!"7E@E?2Z>=N%9SG><TAF6"W;5-Q/<21@)U:(&(1_RJEEGG#\K128+T
M4?D,21)+M^#S^4%]+S7$8C.">&[RPYE*X!9I2C0"4Y!*K8!P]ALRTJS,$]AS
M(3U[359SCG%'283*+,WWTI"]"ZMCY2*Q7.AXP1LK;ZT4OFTP2?ZN+)&.,8V<
M$\Q5I#)GL\3*>F0XH7Y 791'@EI55J1FI=K#H$ BP)X-'>RF2CLA,W):ROZI
M<[P.H8>8($^0WEL]+;V<IF0 994W1SM#W4Q3/0]DH2L5'.@)8<#@,[58F2 H
ML_;^ EZ@8PT6JA Z?2DXP[(8Y 4<7<_4?2,%0 X",Y4M3PFXU9 .WL"8*"1I
M.R4EPH?83GX'\5@69+'@80 "Q6HATT,V2*GA?3'P0CM/8N)EIBS#12$+9<.!
M&WHS4^* S;.N)X[A!(SJ& 0<!5>(NL:)D6V2@'NI<JXJ2RHJ.Q0W?%)QV]I*
MG2&'2LM$;8L2I](Y/=,DA.L<\"A8'XD/P?![@^%)-#D;;]/4SI5$#V9"T><\
M'@@])/O,-BQ%('4:G4S.$'C8837@!K107]6:FJ.X]$'O>95U M35REDB'H+%
MX/!T](/4*=GB$-H_=-!$1_$$@\3):Q57C R8D?XZA!$S>Y.S:#2>/%?$B,@&
MCO:&DVAP?O+K(C'-7Y1GIQ^ &EBB-%$3"D&?=H ?MC>0BJ)LJ3V<+(;C.$[R
M[BE\+1T;%"YNIH':ZG#)Y2Z64B8W9=Z$[@QE/J22Z8JR":)!"J>S,F5V#@/(
M9,HO3&)2,U\U4<O,U)@E<[T+P$<[ =RJV,QS_3LD#$F7*X -CZX3TG/TA'A
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MQM,;'88E?12AY0.T7QCC]Q-VT']F+?X!4$L#!!0    ( #N"95/2T6XD*@H
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MF'HZ>PY@ 99?1\XIR:?SEFX\^*6U#=<*&8A(P:*%_]1TWCW#)INV\4\!I>H
MZ^#. %JIFB.X.YV,(R:Y0P&48;>ZV\P(]+#,T.(9JB'F$_0,<<LC*QEXJJ9Q
M9MY*)J'HTHT=#YY>]90&F=2^1Q@P^(U:#"8094; 14754%L,&\;):43CO<'_
M-^H^2>%VC@GTSL%+_P#E+S@ *(+IG\PH8UE\>N*PHS<[)P[8/$,]\:%W20"(
M^@]/P251EYP8\"6,*@3BRR&<4!E1W,E>Q3W5%LTPT_G/KBA%A?0GQ]#07;>!
M-%"=+Z"(.N6*%7JO7\7P+V8GY_G9Y:NG-,-1;YPU1 RQ<_DC]8LY2%WDYV>7
M"+SRR2D8:6KI-%F4-%8/3L2B<AX1#PE^ZMZ$_@C:/_**JV]4/!IVYB3=T#B5
M@]!IO@.1T7V>7>:GK\Z^5<2<R I'+T[.\MG5^?>+))WY]\DSZ@?_[IVD??DU
M%%9"0?-PG'&4<"751VI#8NC2^0:D4M66;UHZQM]KPJK8)B +.<:FP?@V12TS
M$W.6JLU8 C\=3>"](;6,?WUL%WLRQ(+T+7KZSO8YQ@\=QM"#<G@&WKN:)]D%
M!7I%]WP?(F*;1!PPK,R_0%^[U7EP7,&W37Q?2CYP,%]:@;B*2ZQ+)/B@_XD7
MT$J&O);NS/!A<+I@%^M1_^H>^%Q:6SZ:JB)4B%H#I33ZJ() Y1BFI&%P^#4^
MXMKYY(+%T*S=O<*X72@%?[8C7JM;QA2<C#MAXA1,TQB1D'PC5^6"T]!E4>.*
M=DT!SL-1A#E!V5 !I @0T*[,9^YN*9H)+TINK_M[\16E'8GB?9%P"^2I=W;]
M1UO3]U225?\>I$!WBH/A'<M4BE#P3*.J'M+O93I"P,@XI$V_$U:9;RG<_&A,
M#\*1A.Z5P'22)PSDW1B'KX#%;]^IC6^P=)O&-A%#;9"D%+@\Y$YO<42L'3F[
M556Z/O.RT^MN6AFB\^X&WVV-J&\EB/LR\%@FY"T:-(5>842@X56+2*L;JXAW
MQ<DEPSZ;KE)V@ZF<_99.5=HES\>\'A",QNF/6P>YO,M578::JTKN1="U^N"S
M0^['8-6KR?G)V7\@4]8&4F!3+3-EU-:+[)!6A",K?D"7*GQW<H5(?#693J?C
MZZ]VUU_MK*>Y<51.&;Q@%+::>@=@[0"T7MK_,\Q:*.?XUEJ\3\U)+#'Q5&&=
MW&EJWXD23AVXC^\F>MT,FZ&_W$<9OUP"$R^52Z&_?S.0OZ-QV.UMGMVB&F67
MW>66L>O^1.*^.Q=TVXS^VH)-?_):2,(];_I.-$:GMR [O'R9!V[NU%:.;K#+
MC5STN 9"&MRJZ70XS:XYGZ-3I>P8\=S(2<0S0"^[B9;[D*PU\JBGP1?9V72:
MPSWIT^PROSB;#I\!QI[@64_#IV?RX^G958ZXZ'V_X/_'A@?'O;]C >!<\E_K
M\-WONI$_:4E/TU\$7<O?P72ORY\3_:S<DF[45'J!I=/)Q=F!S'OCE\9N^*]B
MYK9I[)H_KOAZ!+V WQ<68H0OM$'Z.ZEW_PM02P,$%     @ .X)E4RW+9NXA
M!   ! H  !D   !X;"]W;W)K<VAE971S+W-H965T,C N>&ULK5;;;N,V$/V5
M@1H4,:!&-UNV4]N G=W%MMA%@R1M'XH^T-+88E<BM205)_OU.Z1DQ7$3HP'Z
M(O$R,^?,C>1L)]4772 :>*A*H>=>84Q]&00Z*[!B^D+6*&AG(U7%#$W5-M"U
M0I8[I:H,XC!,@XIQX2UF;NU:+6:R,247>*U -U7%U.,*2[F;>Y&W7[CAV\+8
MA6 QJ]D6;]'\7E\KF@6]E9Q7*#27 A1NYMXRNER-K+P3^(/C3A^,P7JREO*+
MG?R2S[W0$L(2,V,M,/K=XQ66I35$-+YV-KT>TBH>CO?6/SC?R9<UTW@ERS]Y
M;HJY-_$@QPUK2G,C=Q^Q\\<1S&2IW1=VG6SH0=9H(ZM.F1A47+1_]M#%X;\H
MQ)U"['BW0([E.V;88J;D#I25)FMVX%QUVD2."YN46Z-HEY.>6:R8YAKD!JX5
M:A2&N5B=W[%UB7HP"PQA6,D@Z^RM6GOQ*_:F\%D*4VAX+W+,G^L'Q*TG&.\)
MKN*3!F^QOH D]"$.X^B$O:1W.''VDE?L_::V3/!OSD\?KJ30LN1YZS83^?,X
M4%P^<,%$QED)M[2(5(]&PU_+M3:**NKO$XR&/:.A8S1\A=$-9I(02MYC7C%=
M^.X+[[\V_)Z5#M72NT$"YIG!W.V_E*"3:+;)+W7-,IQ[M755W:.WN"L0-K*D
M#N5B"\8F'VHE[WF.!$O-=\PP<PSM%_"(H7IBZ/85UE+9V8Z;@@LPA,6R3%8U
M$X\6CFSGU.56OL\&3=:LI, CN-K>FR[=EI"&>!G9VJID8['K-G&T_080_933
MSBO84!3T!5#=T<X:55]\\ ZS;B5R*V&;(LOL7Y$X@R@9^^$PHE$\]>,H.4Q=
M]JK>.1=9V>2M%Y+<4'0**$5[P+2F0 P@FOA1-+&_-$Z/K;Z2%"[N2:YU-$W\
M-$P@C?QD.(8[::BVWY#/8W,Q$1FG,43AU(\F*7Q"K0^5#F7/H[&?CB8#.(]'
M?C1-!V^'IW"&D1^%0QI-$G\Z#>%$#X[Z'AR]L0>7]KK@YM'F86D[PQ4CW8)P
MI3#G!CY)RH=V*TNJ-%>#9 :)/;7/2XUYDL+_U)CL@+9K@F?4LY9Z^42=[:FK
MGOIE6^VNP%==$S+7'[\RT=#-#53^9V"K.Z%_XB=)#,M<UGL.%O< R3:9R)G*
M*<--U5 +TSW\$VXV=#$#R_]IVNJP_:S0T#N"4HU,"?)8PX\_3.(H_ID@DV1(
MAS.Y[MX#ECL^U-@6QC.WDG@$5%WC"2R[HV&GN#%HN5&/%TQM28=M"4F;HR"=
M1WX<AP/[3Y)D<.3_\S/A#%(_&DYL'?JC*'JQ#(.#F[E" K;O#PTNYNTEW:_V
M3YQE>[,_B;?OH\_$FQA#B1M2#2_&5$ZJ?7.T$R-K=\^OI:%7@QL6]$Q#905H
M?R/IV.PF%J!_^"V^ U!+ P04    "  [@F537=\LE[H#  !("   &0   'AL
M+W=O<FMS:&5E=',O<VAE970R,2YX;6R-5MMNVS@0_96!MEBT@#>ZV++=K&W
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M%.H-DY$#LEVEK:%%8]?72FA:AE8MZ.N#TCC0?2ZH,YUA$O3?L]E?4$L#!!0
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MJ]9Y:=E !&,G(?HM22!KG#''5!J1'+/%1FCYG:M33N(:M=OT)\)M<@*C.Q<
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M4U77@ZICY,J=?X_2P&GJF@7<J*BR )A?2&E>._9(;>YHDS]02P,$%     @
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M*<82^0#U_9QSN;G(WWO8OMET^3]02P,$%     @ .X)E4Q;\C[)N P  ,0\
M !D   !X;"]W;W)K<VAE971S+W-H965T,CDN>&ULO5==:^,X%/TKPLS##.S4
MEN)\=$@"G82RA19*TW8?EGU0XIM8U+8\DMRTL#]^KQ37SM!&+AO(2VS9.O=>
MG6.=7(VW4CWI%,"0ESPK]"1(C2E_A*%>I9!S?29+*/#-6JJ<&QRJ3:A+!3QQ
MH#P+610-PIR+(IB.W;-;-1W+RF2B@%M%=)7G7+W^A$QN)P$-WA[<B4UJ[(-P
M.B[Y!A9@'LI;A:.PB9*(' HM9$$4K"?!!?TQ9WT+<#,>!6SUWCVQ2UE*^60'
M5\DDB&Q%D,'*V! <+\\P@RRSD;".7W70H,EI@?OW;]$OW>)Q,4NN82:SOT1B
MTDDP"D@":UYEYDYN_X1Z0:[ E<RT^R7;>FX4D%6EC<QK,%:0BV)WY2\U$7L
M&A\ L!K /@OHU8#>9P%Q#8@=,[NE.![FW/#I6,DM478V1K,WCDR'QN6+PNJ^
M, K?"L29Z<7J5R6TL!IH\ITL\+M*J@R(7).KPO!B(Y8XNM :C"9NLH*$?)V#
MX2+3WRS$*&XJ31Y% A+'#XLY^?KE&_E"1$'N4UEI7B1Z'!JLUN8,5W5E/W>5
ML0.57<+RC-#X#\(B%GT G_GA"RC/2"\Z")_[X3=<(9PZ./T='B+%#<^LX9FY
M>#T?SY:Z2U$( ]^O\6M//J#X[VL$DBL#N?['D[;7I.VYM/$A$KE0Y)%G%7PD
MP X[<%AK$,]3QD91A'0][S/5.>VWTN*FM-A;VLQ]W*#('63<?7^I*+5GS?TF
M</^45 ^:M(,CJ!Z\XY .Z4$.ATW.H3?G@X9UE9%KL?XPJ1_,(O(*7/DH'S5U
MC+RA[A5/H. Y:(*;G;@A_HT\^6*?-['/3RDGC5IGC(X0M ;O*QI'!P6E>WY,
MCY!TUH'N=TI*6\>BS!MK#L_8%I1(]CVLTD)F<O/J"]QZ$NV=5-'6<:C?<CH4
MC=_OT<%A15L[HOUC-FD'^A.*M@Y%_1:%%(/"]A!_B>T6;,/D"]S:$!V>5-'6
M=ZC?>#H4';U7]+"@K2'1\Z,$]:/C3D%9:U',;U$W2'=>Y>1?\G\<F+6FQ.@I
M]65[79/?@SJH[D!W[QW6FA;S=U(W_.48JEN/8O%)J6YMBAUE4QUHZFDFPKWC
MB3U,8F^]$7C<R&"-L:*S(896N_/9;F!DZ4XL2VFP172W*9YI0=D)^'XMI7D;
MV$-0<TJ>_@=02P,$%     @ .X)E4Q%CRG&< @  H@8  !D   !X;"]W;W)K
M<VAE971S+W-H965T,S N>&ULG55=;YLP%/TK5V@/K;25KT#:*D%JTE6+M$Y1
MLW8/TQY<N 2K8%/;)-V_GVT(HTT:37L!7W//N>=>6X?)EHLG62 J>*E*)J=.
MH51]Z;HR+; B\HS7R/27G(N**!V*M2MK@22SH*IT \^+W8I0YB03N[<4R80W
MJJ0,EP)D4U5$_)YAR;=3QW=V&W=T72BSX2:3FJQQA>J^7@H=N3U+1BMDDG(&
M O.I<^5?SF.3;Q,>*&[E8 VFDT?.GTRPR*:.9P1AB:DR#$2_-CC'LC1$6L9S
MQ^GT)0UPN-ZQW]C>=2^/1.*<ES]HIHJI<^Y ACEI2G7'MU^PZR<R?"DOI7W"
MMLOU'$@;J7C5@;6"BK+V35ZZ.0P FN<P(.@ P;\"P@X0VD9;9;:M:Z)(,A%\
M"\)D:S:SL+.Q:-T-9>845TKHKU3C5'*5/C=44C-2"9]@I6])UI0(/(>EX&!'
M!3>4$9924L*"M1?'G,#)-2I"2WEJ<$H0U4AXH!ER'=^OKN'DPRE\ ,K@>\$;
M25@F)Z[2DDUA-^WDS5IYP3OR0KCE3!42/K,,LP/X^7'\Q1&\JT?5SRO8S6L6
M'"5<87T&H?<1 B_P#NGY;_@K.6%_?*'E"]_AFS52[T@)@W.$GU_U'BP45O+7
MD1JCOL;(UAB]4^,.-\@:/'1X+3"V0.,7FR2*_#CT)^YF.)/]-'\\UFE1G_=*
M6-0+BXX*6["45PBYX!5H6Q/V6AZ\9"U/--3IC>+HC<S]+#^,8O_\L,JX5QD?
M5?E-6S&U2@\IB_=&$UQXH?=&V7[6V!^%HS?"W($-5"C6UATEI+QAJG6$?K<W
MX"OK.^[?]-:];XE84^T()>8:ZIV-]51$ZXAMH'AM3>61*VU1=EGHGP@*DZ"_
MYYRK76 *]+^EY ]02P,$%     @ .X)E4U,JX.-2 @  .P4  !D   !X;"]W
M;W)K<VAE971S+W-H965T,S$N>&ULC51;;],P%/XK5K2'38+FTG:,*8W4"P@>
M)E4M@P?$@YN<)M8<.]A.N_'K.;;34*:V\)+8Q^?[OG/Q<;J7ZDE7 (8\UUSH
M25 9T]R'H<XKJ*D>R 8$GFREJJG!K2I#W2B@A0/5/$RBZ#:L*1-!ECK;4F6I
M; UG I:*Z+:NJ7J9 9?[21 '!\.*E96QAC!+&UK"&LQCLU2X"WN6@M4@-)."
M*-A.@FE\/Q]9?^?PE<%>'ZV)S60CY9/=?"XF060# @ZYL0P4?SN8 ^>6",/X
MV7$&O:0%'J\/[!]=[IC+AFJ82_Z-%:::!'<!*6!+6VY6<O\)NGS&EB^77+LO
MV7O?\3@@>:N-K#LP1E SX?_TN:O#$2 ^!T@Z0/(:,#H#&': H4O41^;26E!#
MLU3)/5'6&]GLPM7&H3$;)FP7UT;A*4.<R5:P ]$"64$N2\%<::\78"CC^H:\
M)8_K!;F^NB%7A GRI9*MIJ+0:6A0VS*$>:<S\SK)&9WWY$$*4VGR0110_(T/
M,>8^\.00^"RY2+B&9D"&T1N21$E\(I[Y_\.C"^$,^SH.'=_P'W7<*EF3.::J
M\()B+TU%YJZ+H,CWZ48[^X\+@J-><.0$1V<$EPIV#-O!7^RM!:6@P*GR02C?
MS%]H*EK%1$D:4$P6I]KF56Z=BAWY719'XWB<AKOC8I[PBD?17>_E4PB/[B$F
M7+KQU"27K3"^L[VU?P&F[N*_LL_P9?"#_(?&/RL/5)5,:,)ABY31X!W.E?*C
MZC=&-NZV;Z3!JKMEA:\;*.N YULIS6%C!?KW,OL-4$L#!!0    ( #N"95.Z
MM &SY ,  "$.   9    >&PO=V]R:W-H965T<R]S:&5E=#,R+GAM;*U736_C
M-A#]*X200P+L6M^2'=@&XH^B>]C"6#?=0]$#(]&V$$IT22K._ON.*$61*5IQ
MN[W8(OGFS<S3D!I.3XP_BP,A$KWFM! SZR#E\=ZV17(@.18C=B0%K.P8S[&$
M(=_;XL@)3I513FW/<2([QUEAS:=J;L/G4U9*FA5DPY$H\QSS'PM"V6EFN=;;
MQ+=L?Y#5A#V?'O&>;(E\/&XXC.R6)<UR4HB,%8B3W<QZ<._7KC)0B#\R<A*=
M9U2E\L38<S7XDLXLIXJ(4)+(B@+#WPM9$DHK)HCC[X;4:GU6AMWG-_9?5/*0
MS!,69,GH]RR5AYDUME!*=KBD\AL[_4J:A,**+V%4J%]T:K".A9)22)8WQA!!
MGA7U/WYMA.@8 (_9P&L,/-T@N&#@-P;^M1Z"QB"XUD/8&*C4[3IW)=P*2SR?
M<G9"O$(#6_6@U%?6H%=65(6RE1Q6,["3\]^@%K\4"<L)VA".EBS/X?5M#Y@3
M=+LB$F=4W*'/Z'&[0K<W=^@&V4A4JP)E!7HL,BD^=29^/[!2X"*%R9NS\=26
M$&WETTZ:R!9U9-Z%R'STE17R(-"Z2$EJL%\-VT\&[&U0J97*>Y-JX0T2;LEQ
MA'SG$_(<SS7$L[S>W#&E\W/>U__9^YD8?ELWON+S+_"M,2^R8B]4U=3E\N?#
MDY <=OY? _Q!RQ\H_F"@+C-5EZ;*J6TC95L=A2_S.' \?VJ_=-]''^5%3A2?
MHU8&E.NZL7L.6_=AD>N'[V1G689MEN&'63:[[S-*,UI*8Z4OPJOR[:-,^1I0
MIGS[L(%\HS;?Z,JWBHY0-TE]VJCC P2  S]+T"T<&RFC%'.A0&KUSJ1*[2ON
MA.B.PE 3I0]R>J!5'Q2, DW>M<F=-S$+$K>"Q#\A2%,1_T*2V"1)H$G2!QDD
MZ8- $DT1D[=+BHQ;1<:#BGQ7GW9(&K\0#JW*F28"0:\C)'Q0X.PYJYAZV:A)
M[2_L9A+'OK8MEB94$$>:*B94%&FHM9'+B<S"3%IA)H/";&@IZHJ S@J1W0Y:
M+<1VZ,@D*62&J:;4!ZI,>C'Z>L4O^QCH/S5%##RAKH>!)W#-:KC.>^/B_'^%
MTMU) Z(T+L_>W-@9:SDO3; XZA6+F<WS-'7,;,&%H];M=';NH$!-+P<M9/*,
MR&M"2^B#T(ZS'"68)B7%JE6'$EIOMA\JX_;?H:O+TL>, UT3 X]>+@9,K)\J
M=J?ES0G?J[N&@!HH"UEW,>UL>Y]Y4%V\-K]P[Y>N87Y5W7]4B_U.7U^>OF*^
MSPJ!*-F!*V<40Z"\OH_4 \F.JN%^8A+:=_5X@#L<X14 UG<,MFPSJ!RTM\+Y
M/U!+ P04    "  [@F53#-SPR D"  !:!   &0   'AL+W=O<FMS:&5E=',O
M<VAE970S,RYX;6R%E,ENVS 0AE^%T*D%6M.6G2Z!+,!.6C2'!(:-MH>B!TH:
M242XJ.3(2MZ^7&35!>KT8G&9_YN?PZ&S09M'VP(@>9)"V772(G;7E-JR!<GL
M3'>@W$ZMC63HIJ:AMC/ JB"2@J;S^3LJ&5=)GH6UG<DSW:/@"G:&V%Y*9IZW
M(/2P3A;):6'/FQ;] LVSCC5P /S:[8R;T8E2<0G*<JV(@7J=;!;7VY6/#P'?
M. SV;$S\20JM'_WDKEHG<V\(!)3H"<Q]CG #0GB0L_%K9"932B\\'Y_HG\/9
MW5D*9N%&B^^\PG:=?$A(!37K!>[U\ 7&\UQY7JF%#;]DB+&K-"%E;U'+4>P<
M2*[BESV-=3@3I(L+@G04I,%W3!1<WC)D>6;T0(R/=C0_"$<-:F>.*W\I!S1N
MESL=Y@=H7(F1W*EXP;Y2;\D#,X;Y<I%7MX","_LZH^C2>1$M1_0VHM,+Z(_D
M7BML+?FD*JC^UE-G<_*:GKQNTQ>!!^AF9#E_0])YNK#1^ O8Y52"9< N_U."
M/73:(%<-^;$I+!K7,#]?P*\F_"K@5Q?P#[TLP!!=NQ[V"5@A@(SN[;^J&G%7
M >??U#%?9O1X[H">W;<$TX2NMJ34O<)X]=/J]' VL5_^A,=7=\],PY4E FHG
MG<_>N[PF=G*<H.Y"]Q0:72^&8>L>/Q@?X/9KK?$T\0FFOY/\-U!+ P04
M"  [@F53[ Y8 V\&  ":'P  &0   'AL+W=O<FMS:&5E=',O<VAE970S-"YX
M;6R]65MOVS84_BN"T8<42&M>1%V"Q$!C>UB!=0N:=GL8]J#(C"54$CV)SF78
MCQ]UB6B3QVR2#GY))/D[)+]S#L]W*)W?B_I;DW$NO8>RJ)J+22;EYFPZ;=*,
METGS7FQXI7ZY%7692'5;KZ?-IN;)JC,JBRE!*)B625Y-9N?=LZMZ=BZVLL@K
M?E5[S;8LD_KQDA?B_F*")T\//N?K3+8/IK/S3;+FUUQ^W5S5ZFXZCK+*2UXU
MN:B\FM]>3#[@LR6-6H,.\7O.[YN=:Z^E<B/$M_;FX^IB@MH5\8*GLATB4?_N
M^)P713N26L??PZ"3<<[6</?Z:?2?.O**S$W2\+DH_LA7,KN81!-OQ6^3;2$_
MB_N?^4"(M>.EHFBZO][]@$43+]TV4I2#L5I!F5?]_^1A<,2.@1H'-B"# 3$-
M_ ,&=#"@SYW!'PS\Y\[ !H..^K3GWCEND<AD=EZ+>Z]NT6JT]J+S?F>M_)57
M;:)<RUK]FBL[.;OF:Q5VZ7VL^J1K@_?.^\Q34:5YD?</Q*UZ<L>K+?>2:N4]
MV?RVX;4"5&MEG8J2>S>/"K<1M4QN"C["3A9<)GG1O%4#?[U>>"=OWGIOO+SR
MOF1BVZ@!F_.I5%3:!4W38=F7_;+)@653[Y.H9-9XRVK%5X#]PFT?.^RGRH6C
M'\F3'R^)<\!KOGGO473J$40PL)[Y\\T11.?'9E^^>O8]9] QJ6@W'OU.4O7)
MH!+D=,R?,;/:K)&\]/[\11EWE\U?CJG]<6J_F]H_,/4P#Y11O6'0&;;U\VX6
MA6&$%.&[W4#9,,9P0/$^;&'#2$ PCHWAEC8.AP'Q?3KB]GBRD2=S\GQRL1CW
M8-[M08AX/Q+;70)B$8D-XC;,#_R &+QM%$6QCYA!&YB3H  %,.M@9!TX62^X
M4L-TJ$IM*4K*-L'^Z1^<\(>TV#9*>-J*M=K%*N<46[73V[*3BD:V@+I/E;>0
MRP)K^23 R#<\!J%B&A@>LU&AC^+(<)B-"F(4'_!7./HK?+Z_3E[JA-!>4F20
MF]L8/S*WBHW!84@-_C8HWAEHCWTTLH_<>R1+:OZN;2-6BF^I>JNF\P3$-;)#
MR2)SA]@@&H;F!K%!.(QB<W\ *(;\ ^&.1\*QD_#'2O*:J\#RAY8L/_4J+D^[
MC2)DQFN(>&PMA!%B!&=N@S!A@;$=%C:*^"0T$]U&48:" Z'&2/<QZ#O<^Q:$
MJSZ&#\70D\D#A[L+!-3$O?K4$P=PE$;FYET ,!(Q3$*#.X"+&//9 ?([31QV
MDO]U6S=];Y841:[2O1'%MDWUQB&IF.CAR;'U'.M> M/7*OI@N5>A2(A\<]\"
M.!JI4AV;8;1Q2M C;.U>"$B8VL'Q@4CJ]@6[^Y>K[+')5<7NY:U01S]>-UF^
M>5Y$=?> V=$CJD4<NU7<%5%;!I57@\ L2! .Q1B;V@O@?(J86>"6 (XRQB)T
M()Y:@+%;@;_P-*M$(=:/74#;4[,J4"E_7CRUTN'HZ/'4JH/=LN.*)Z <"*$H
M,N,)R)#2?RN<@,1$Q#<U> E-RQAE/AQ.HE6&N%5&'WF;WN.N\!%=OPD^=OB(
MKNZ$O#9\@^6>7D%G)@ ''IH ''QJ H#.8Q/1<D+<<O*2@Q,!RCR+4<A,^C8N
M]K%OL;=AOG*FV5,O 1QI18@<X*[%A;C%Q<Y>[U_O5;T#T4I#CJXT1"L->;72
M$.# !?4.  [L'0 <W#M 0%?O0+36$+?6O"BU@?.6W=+/ 1@CL2F?"P!&(AH&
M9N\/X'!(PT.O!8C6/^(^ZH&9_4.]%-'R1^)C9SC5@D3=@N3(< J<<:!>"L)!
MO12  WLI .?JI:A62>H^Y;PDOX>A]K<C1=CD#L!4HV">[P!80&A@%FX YC.?
M'JC;5"LT=2LTF-T_U%G2G5>Y1W^72[5@T5>_S1TLO]M9 CBHLP1@8&<)3>OH
M+*G62?K_O="EP*O:D&"S*P-@JL1'R*0.O*NE>^W&0-W&!:HO.<1<BS1UB_37
M2C4>(DUD]YJN5FFF+CUQQ^M,E6Q7'FEEI.'1DUAK$W5KTTOX#?&-[(\+- I"
M,[XV# >^V4LO %CHQ]CL2R!8L/LJL*<_W?G66/)ZW7WD;12Q;27[+T3CT_%#
M\H?N\ZGQ_!*?S3'P?('/EOUG8CU\_]7Z4U*O\ZI12GZKID+O0Y6*=?\AN+^1
M8M-]Z;P14HJRN\PZU6\!ZO=;(>3333O!^#E^]A]02P,$%     @ .X)E4_@Q
M].)P!@  4R@  !D   !X;"]W;W)K<VAE971S+W-H965T,S4N>&ULO5I=;]LV
M%/TKA%<,';#6XJ>D+ G01!I6H-V"N-T>ACVH-FT+U8<GT4D+[,>/DA71%BDJ
MD!&]))9\+JE[CWB.=,W+Q[SX6FXY%^!;FF3EU6PKQ.YB/B^76YY&Y=M\QS/Y
MS3HOTDC(PV(S+W<%CU9U4)K,D>.P>1K%V>SZLCYW5UQ?YGN1Q!F_*T"Y3].H
M^'[#D_SQ:@9G3R?NX\U65"?FUY>[:,,77'S>W17R:-Z.LHI3GI5QGH&"KZ]F
M[^!%R.J &O%GS!_+H\^@2N5+GG^M#MZOKF9.=44\X4M1#1')?P_\EB=)-9*\
MCG^;06?MG%7@\>>GT7^MDY?)?(E*?ILG?\4KL;V:>3.PXNMHGXC[_/$WWB1$
MJ_&6>5+6?\%C@W5F8+DO19XVP?(*TC@[_(^^-84X"I#CF -0$X"Z :0G #<!
M^+DSD": /'<&V@34J<\/N=>%"R(175\6^2,H*K0<K?I05[^.EO6*L^I&68A"
M?AO+.'&]X!M)NP#OL\--5Y'W!@1Q&6TV!=\<3N1K<,\?>+;GX'7 110GY4\2
M]7D1@->O?@*O0)R!3]M\7T;9JKR<"WE=U>CS97,--X=K0#W7@,''/!/;$H39
MBJ\,\8$]WK?$SV4]VJ*@IZ+<(.N "[Y["[#S,T .@H;KN7U^N&-*Y[S9P]&S
MGQ0#MW<(KL?# W?(/=_EA8BSS<F]\O<'"0?O!4_+?RR3D78R4D]&>B9K;C/3
M/70(9'5@)7\/UY[K>HY,\>&8&AU&*608GL("'888@M#O#!?J..@R1 AN<2=Y
MTC9/:LWS]WU1\A]_@,SY1:Z9PX=W21+S%5CDR;XJ;6DI)VNG82_/G=M.YH[E
M[A!(CZK(D.L0O\.=#L,>8GX'%N@PR9L'?=KASH!#%%+'-W/GM7EZUCSOMM_+
M>!E'TN6R%?@@W9D7Y3;>/8LYOYW$?WGFH*-<P!G+71-Y4D;J,(8[Y)EPC@\A
MZ[!GP!'L4-09+S3@,*74<\SLP2/'@]9</_'E-LN3?/.])K!ZD)&577)0/H,_
MB-0T: (&E4I#/)I!;&#&<3RORZ".H[ZG$ZC#D(>(B[H$&J:E%%/20Z#R"&@W
MB4\\E265C[6@%-%Z+4MKJZ"29$@G($Q),V2C"6-:Y5S)A.]V"=-QQ/4P<;N,
MZ3B$/.F=?I<R'0BIM+M>SI0W0+LYZ)R!_\"9+@B58D-O FJ5=D-_-+7^\ZS0
M@#-ZH0%G-D,3T.:&2'D'LGN'D=JS3!(I+4?PY8E%2M,1&DML$WE27XP\TA59
M \ZGK L+###L2C$F'5I-.&F[A/:PJOP$V?W$R.I9UHF4P",R :M*^)']8=S&
M*M7*VWWA&(8$PY#0"CG-2SD,LCO,'9<ERZI"[I)HR:N2VNJEM!RY$]"CQ!O9
MG[=M]'CZHG,]2+L4&6"8,&W-Z3#JN)I)&F"$,-RWXI1K(+MK&.@ZWR.QDG'L
MO#RK6"DWMC^%6UAM(FV+;A@2#$-"*^0T+V41V&X19A;/LD-\U*J9H%>#E4[C
MT=V:)G)H99I@AI5I@)E6I@%F69E8&02V&X29T[/,$"L5QQ/T<+ 2=SRZBX/U
MAHJV+@<AP3 DM$).\U(N@NTN\L=>E/E>TG/$E*U@2K;Q!)T:HF2:C.[4$+UC
M0N5;7N>]_-8 PW)E=M\L###("-5>+ PXSW6=GD5'E$$0NT&8"#O?#XD2<C)!
M_X8HZ2:C^S=$;Z1H7>]!2# ,":V0T[R.&OIVC^BA\2Q#)$JYR00]':*TFHSN
MZ1"]M:*1. @)AB&A%7*:ES(%8C>%'A+/<D"BI)M,T+TA2M#)Z.X-T9LH1H4U
M-6\,"FMHR1@55L=9%)8J*Z%V*UE$T>)-]2O["H@G)F-NXXPJ]:83-&:H$FLZ
MNC%#]0X)@<CK=+5O#3 $&>VV4@TP*!]LW0XN-."8RTA/LXTJFZ!VF^CA['QC
MI$K1Z03=&7KT2^GH[@P=[LX,0X)A2&B%G.:EO(+:O:*?R;.\D2I1IQ.T<:A2
M<3JZC4/UCHK&XR D&(:$5LAI7LHNJ-TN^GD\RQZ9DG$V0>.&*65GHQLW320;
MD%H#S"2U!IA1:@TXD]3.CS9)I;S8U+O32K#,]YDX[(9IS[8[X-[5^[XZYV_@
MQ2TTG _@17C8WZ:&/VRW^Q@5FS@K0<+7<BKGK2MOP.*P@^UP(/)=O47K2RY$
MGM8?M_6RKP#R^W6>BZ>#:H)V'^'U_U!+ P04    "  [@F53,]T V3X$  !/
M$@  &0   'AL+W=O<FMS:&5E=',O<VAE970S-BYX;6RU6%V3FS84_2L:-]-)
M9M(%"8PA]7IF/_J1F6QG9YVD#YT^R" ;-4(BDEAG^^LC! M>8S#;>OU@2Z![
M.-*]YUAHOA7RBTH)T>!;QK@ZGZ1:Y^\<1\4IR; Z$SGAYLY:R QKTY4;1^62
MX,0&9<Q!KALX&:9\LIC;:[=R,1>%9I236PE4D658/EP2)K;G$SAYO'!'-ZDN
M+SB+>8XW9$GTI_Q6FI[3H"0T(UQ1P8$DZ_/)!7QWA:(RP([X3,E6[;1!.965
M$%_*SOOD?.*6C @CL2XAL/FY)U>$L1+)\/A:@TZ:9Y:!N^U']%_MY,UD5EB1
M*\'^I(E.SR?A!"1DC0NF[\3V=U)/:%KBQ8(I^PVV]5AW N)":9'5P89!1GGU
MB[_5"[$38' .!Z Z .T'^#T!7AW@V8E6S.RTKK'&B[D46R#+T0:M;-BUL=%F
M-I27:5QJ:>Y2$Z<72[(Q2='@/:]*HES:G\"R2BH0:_";$,F6,@96#^".Y$)J
MO&($/,:]OB8:4Z;>F*A/RVOP^M4;\ I0#CZFHE"8)VKN:,.S?)H3UYPN*TZH
MAU,$;@37J0*_\(0D3^,=,[]FDNAQDI=H$'!)\C/@N6\!<A$\P.=J./R:Q"8<
MVG!W@([7K+EG\;P>O&9)_[H3YMN4XQ;+Y.\!9+]!]BVR?P3Y+5B1#>6<\HTI
M<H9Y3 ZEH0(++%BI]_M%&/A^.)T[]P=(3!L2TU$D $[^,05LR\04%S!CL"X4
M^$P3(HQ^OQ94T;+@#E&K'C'=H18$WF%>0<,K&,=K+44&E@_\7PI,@8(EQ_G-
M]3%"08<0"J'7LU2SAM)L9+X(3XXD:]8A$$8>"GL6)6P8A(,,+N*XR J&-4D
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MH=9:T;"U/E.JJ&NB@>M'TSVE'AWVE&WKMVC8;S^2..6"B<V#S5WYUF6**R9
MC1 J:DT4^2<6*FJ]$8W;<8X4*NIZGC=#P:PO\:WGH9$[S/\C5-3=:?9N?5'K
MDVC<3O,_2K6[^1S8_:+68=%8AQTAUZZ]^B[T@["'1&NO:-A>GRO7J+.Y=?>E
M.C2D8NGLO+)G1&[L288"L2BXKM[>FZO-:<F%/2-PVN'54<L-EJ;H%6!D;4+=
MLYE9(EF=7E0=+7)[ + 26HO,-E/[?UP.,/?70NC'3OF Y@QI\1U02P,$%
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M"8.50+*I*BR>ED#Y=N&,G=W +2E*90;<)*YQ 6M0=_5*Z)[;JV2D B8)9TA
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M;O>&Y^/OR\?)S@MUQ]G![['%+U!+ P04    "  [@F534]DK*;(!  !3&P
M$P   %M#;VYT96YT7U1Y<&5S72YX;6S-F<UNPC 0A%\%Y8J(L9W2'P&7MM>6
M0U_ 338D(HDMVU!X^SKA1VI%HR(J=2ZQ$N_.C+W2=\GT;6?(#;9UU;A95'AO
M'AAS:4&U<K$VU(2=7-M:^?!JE\RH=*66Q,1X/&&I;CPU?N1;C6@^?:)<K2L_
M>-Z&SZ[4S2RR5+EH\+@O;+UFD3*F*E/EPS[;--DWE]'!(0Z=78TK2N.&H2!B
M9QW:G9\-#GVO&[*VS&BP4-:_J#I4L6W%G-]5Y.)^B3,9=9Z7*64Z7=>A)7;&
MDLI<0>3K*MZ+#ON=?;AAVC_YU?Z=3)]AJ%Q8;5R8F*7+[8XC:;M')@B1]67_
M$4^.0?KJ\U$[[8RR7WJ'Z_W0=M7-P[%NN?Z.O\[XI']A#@&20X+D2$!RW(#D
MF(#DN 7)<0>2XQXD!Q^C!$$A*D=!*D=A*D>!*D>A*D?!*D?A*D<!*T<AJT A
MJT AJT AJT AJT AJT AJT AJT AJT AJT AJT0AJT0AJT0AJT0AJT0AJT0A
MJT0AJT0AJT0AJT0A:X)"U@2%K D*61,4LB8H9$W^DZSO6J_^^C=/N\:U*INC
M/^O^I<T_ 5!+ 0(4 Q0    ( #N"95,'04UB@0   +$    0
M  "  0    !D;V-0<F]P<R]A<' N>&UL4$L! A0#%     @ .X)E4VPN37_O
M    *P(  !$              ( !KP   &1O8U!R;W!S+V-O<F4N>&UL4$L!
M A0#%     @ .X)E4YE<G",0!@  G"<  !,              ( !S0$  'AL
M+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4    "  [@F5330_-@V0%   D%@
M&               @($."   >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L!
M A0#%     @ .X)E4TMCSDYA!P  AAX  !@              ("!J T  'AL
M+W=O<FMS:&5E=',O<VAE970R+GAM;%!+ 0(4 Q0    ( #N"95/Z.FO4D@,
M )@,   8              " @3\5  !X;"]W;W)K<VAE971S+W-H965T,RYX
M;6Q02P$"% ,4    "  [@F53:T7!^2P&  #I&0  &               @($'
M&0  >&PO=V]R:W-H965T<R]S:&5E=#0N>&UL4$L! A0#%     @ .X)E4\92
M8UA/"@  WT$  !@              ("!:1\  'AL+W=O<FMS:&5E=',O<VAE
M970U+GAM;%!+ 0(4 Q0    ( #N"95/7:PL8^0H  $@Q   8
M  " @>XI  !X;"]W;W)K<VAE971S+W-H965T-BYX;6Q02P$"% ,4    "  [
M@F5326_25D@"   M!0  &               @($=-0  >&PO=V]R:W-H965T
M<R]S:&5E=#<N>&UL4$L! A0#%     @ .X)E4P<0R?;?"@  51P  !@
M         ("!FS<  'AL+W=O<FMS:&5E=',O<VAE970X+GAM;%!+ 0(4 Q0
M   ( #N"95.#7LS.*@L  )\?   8              " @;!"  !X;"]W;W)K
M<VAE971S+W-H965T.2YX;6Q02P$"% ,4    "  [@F53;]8EVQH'  "K$0
M&0              @($03@  >&PO=V]R:W-H965T<R]S:&5E=#$P+GAM;%!+
M 0(4 Q0    ( #N"95/-D!UHJ ,  'T)   9              " @6%5  !X
M;"]W;W)K<VAE971S+W-H965T,3$N>&UL4$L! A0#%     @ .X)E4S4N=%2$
M"   Y1@  !D              ("!0%D  'AL+W=O<FMS:&5E=',O<VAE970Q
M,BYX;6Q02P$"% ,4    "  [@F53=)=2@/(#   -"@  &0
M@('[80  >&PO=V]R:W-H965T<R]S:&5E=#$S+GAM;%!+ 0(4 Q0    ( #N"
M95.T=^ZAU0H  /H@   9              " @21F  !X;"]W;W)K<VAE971S
M+W-H965T,30N>&UL4$L! A0#%     @ .X)E4YFK\"ZH P  40@  !D
M         ("!,'$  'AL+W=O<FMS:&5E=',O<VAE970Q-2YX;6Q02P$"% ,4
M    "  [@F53S)'& TD$  !R"0  &0              @($/=0  >&PO=V]R
M:W-H965T<R]S:&5E=#$V+GAM;%!+ 0(4 Q0    ( #N"95/2T6XD*@H  !P:
M   9              " @8]Y  !X;"]W;W)K<VAE971S+W-H965T,3<N>&UL
M4$L! A0#%     @ .X)E4VDIN#',!   / H  !D              ("!\(,
M 'AL+W=O<FMS:&5E=',O<VAE970Q."YX;6Q02P$"% ,4    "  [@F53V-Y'
M&?H1   S-0  &0              @('SB   >&PO=V]R:W-H965T<R]S:&5E
M=#$Y+GAM;%!+ 0(4 Q0    ( #N"95,MRV;N(00   0*   9
M  " @22;  !X;"]W;W)K<VAE971S+W-H965T,C N>&UL4$L! A0#%     @
M.X)E4UW?+)>Z P  2 @  !D              ("!?)\  'AL+W=O<FMS:&5E
M=',O<VAE970R,2YX;6Q02P$"% ,4    "  [@F532D7U,OH"  #;!@  &0
M            @(%MHP  >&PO=V]R:W-H965T<R]S:&5E=#(R+GAM;%!+ 0(4
M Q0    ( #N"95,T[Y5[U 8  +D3   9              " @9ZF  !X;"]W
M;W)K<VAE971S+W-H965T,C,N>&UL4$L! A0#%     @ .X)E4QD \^D?!0
M6PX  !D              ("!J:T  'AL+W=O<FMS:&5E=',O<VAE970R-"YX
M;6Q02P$"% ,4    "  [@F53,IWFW-,$  !,"@  &0              @('_
ML@  >&PO=V]R:W-H965T<R]S:&5E=#(U+GAM;%!+ 0(4 Q0    ( #N"95-;
MP71-& ,  *\)   9              " @0FX  !X;"]W;W)K<VAE971S+W-H
M965T,C8N>&UL4$L! A0#%     @ .X)E4[ VB!++ P  N0P  !D
M     ("!6+L  'AL+W=O<FMS:&5E=',O<VAE970R-RYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( #N"95.ZM &SY ,  "$.   9              "
M@>3/  !X;"]W;W)K<VAE971S+W-H965T,S(N>&UL4$L! A0#%     @ .X)E
M4PS<\,@) @  6@0  !D              ("!_],  'AL+W=O<FMS:&5E=',O
M<VAE970S,RYX;6Q02P$"% ,4    "  [@F53[ Y8 V\&  ":'P  &0
M        @($_U@  >&PO=V]R:W-H965T<R]S:&5E=#,T+GAM;%!+ 0(4 Q0
M   ( #N"95/X,?3B< 8  %,H   9              " @>7<  !X;"]W;W)K
M<VAE971S+W-H965T,S4N>&UL4$L! A0#%     @ .X)E4S/= -D^!   3Q(
M !D              ("!C.,  'AL+W=O<FMS:&5E=',O<VAE970S-BYX;6Q0
M2P$"% ,4    "  [@F53@ARXN7<"  "*!@  &0              @($!Z
M>&PO=V]R:W-H965T<R]S:&5E=#,W+GAM;%!+ 0(4 Q0    ( #N"95-JR]'R
MQP,  *P/   9              " @:_J  !X;"]W;W)K<VAE971S+W-H965T
M,S@N>&UL4$L! A0#%     @ .X)E4X/*>.'X!   6B$  !D
M ("!K>X  'AL+W=O<FMS:&5E=',O<VAE970S.2YX;6Q02P$"% ,4    "  [
M@F538 <78X\#   &#0  &0              @('<\P  >&PO=V]R:W-H965T
M<R]S:&5E=#0P+GAM;%!+ 0(4 Q0    ( #N"95.NWK02J@(   8(   9
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M970T-2YX;6Q02P$"% ,4    "  [@F53O;X)2O\"  ")#P  #0
M    @ $)"0$ >&PO<W1Y;&5S+GAM;%!+ 0(4 Q0    ( #N"95.7BKL<P
M !,"   +              "  3,, 0!?<F5L<R\N<F5L<U!+ 0(4 Q0    (
M #N"95/[.1TIU0,  "H>   /              "  1P- 0!X;"]W;W)K8F]O
M:RYX;6Q02P$"% ,4    "  [@F53N#;$W*D!   N&P  &@
M@ $>$0$ >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4    "  [
M@F534]DK*;(!  !3&P  $P              @ '_$@$ 6T-O;G1E;G1?5'EP
=97-=+GAM;%!+!08     -0 U &H.  #B% $    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.21.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>265</ContextCount>
  <ElementCount>335</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>45</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>7</UnitCount>
  <MyReports>
    <Report instance="amn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amnhealthcare.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="amn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>1001002 - Statement - Condensed Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amnhealthcare.com/role/CondensedConsolidatedBalanceSheets</Role>
      <ShortName>Condensed Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="amn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1002003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amnhealthcare.com/role/CondensedConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>Condensed Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="amn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1003004 - Statement - Condensed Consolidated Statements of Comprehensive Income</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofComprehensiveIncome</Role>
      <ShortName>Condensed Consolidated Statements of Comprehensive Income</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="amn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1004005 - Statement - Condensed Consolidated Statements of Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofStockholdersEquity</Role>
      <ShortName>Condensed Consolidated Statements of Stockholders' Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="amn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>1005006 - Statement - Condensed Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofCashFlows</Role>
      <ShortName>Condensed Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="amn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>1006007 - Statement - Condensed Consolidated Statements of Cash Flows (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofCashFlowsParenthetical</Role>
      <ShortName>Condensed Consolidated Statements of Cash Flows (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="amn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>2101101 - Disclosure - Basis of Presentation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amnhealthcare.com/role/BasisofPresentation</Role>
      <ShortName>Basis of Presentation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="amn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>2106102 - Disclosure - Acquisitions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amnhealthcare.com/role/Acquisitions</Role>
      <ShortName>Acquisitions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="amn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>2111103 - Disclosure - Revenue Recognition</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amnhealthcare.com/role/RevenueRecognition</Role>
      <ShortName>Revenue Recognition</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="amn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>2113104 - Disclosure - Net Income Per Common Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amnhealthcare.com/role/NetIncomePerCommonShare</Role>
      <ShortName>Net Income Per Common Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="amn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>2116105 - Disclosure - Segment Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amnhealthcare.com/role/SegmentInformation</Role>
      <ShortName>Segment Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="amn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>2122106 - Disclosure - Notes Payable and Credit Agreement</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.amnhealthcare.com/role/NotesPayableandCreditAgreement</Role>
      <ShortName>Notes Payable and Credit Agreement</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="amn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>2124107 - Disclosure - Fair Value Measurement</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amnhealthcare.com/role/FairValueMeasurement</Role>
      <ShortName>Fair Value Measurement</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="amn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>2130108 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amnhealthcare.com/role/Leases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="amn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>2132109 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amnhealthcare.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="amn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>2134110 - Disclosure - Commitments and Contingencies: Legal Proceedings</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amnhealthcare.com/role/CommitmentsandContingenciesLegalProceedings</Role>
      <ShortName>Commitments and Contingencies: Legal Proceedings</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="amn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>2136111 - Disclosure - Balance Sheet Details</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amnhealthcare.com/role/BalanceSheetDetails</Role>
      <ShortName>Balance Sheet Details</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="amn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>2202201 - Disclosure - Basis of Presentation (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amnhealthcare.com/role/BasisofPresentationPolicies</Role>
      <ShortName>Basis of Presentation (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="amn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>2303301 - Disclosure - Basis of Presentation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amnhealthcare.com/role/BasisofPresentationTables</Role>
      <ShortName>Basis of Presentation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.amnhealthcare.com/role/BasisofPresentation</ParentRole>
      <Position>20</Position>
    </Report>
    <Report instance="amn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>2307302 - Disclosure - Acquisitions (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amnhealthcare.com/role/AcquisitionsTables</Role>
      <ShortName>Acquisitions (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.amnhealthcare.com/role/Acquisitions</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="amn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>2314303 - Disclosure - Net Income Per Common Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amnhealthcare.com/role/NetIncomePerCommonShareTables</Role>
      <ShortName>Net Income Per Common Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.amnhealthcare.com/role/NetIncomePerCommonShare</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="amn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>2317304 - Disclosure - Segment Information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amnhealthcare.com/role/SegmentInformationTables</Role>
      <ShortName>Segment Information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.amnhealthcare.com/role/SegmentInformation</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="amn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>2325305 - Disclosure - Fair Value Measurement (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amnhealthcare.com/role/FairValueMeasurementTables</Role>
      <ShortName>Fair Value Measurement (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.amnhealthcare.com/role/FairValueMeasurement</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="amn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>2337306 - Disclosure - Balance Sheet Details (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amnhealthcare.com/role/BalanceSheetDetailsTables</Role>
      <ShortName>Balance Sheet Details (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.amnhealthcare.com/role/BalanceSheetDetails</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="amn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>2404401 - Disclosure - Basis of Presentation - Reconciliation of Cash, Cash Equivalents and Restricted Cash (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amnhealthcare.com/role/BasisofPresentationReconciliationofCashCashEquivalentsandRestrictedCashDetails</Role>
      <ShortName>Basis of Presentation - Reconciliation of Cash, Cash Equivalents and Restricted Cash (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="amn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>2405402 - Disclosure - Basis of Presentation - Reconciliation of Activity in Allowance for Credit Losses for Accounts Receivable (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amnhealthcare.com/role/BasisofPresentationReconciliationofActivityinAllowanceforCreditLossesforAccountsReceivableDetails</Role>
      <ShortName>Basis of Presentation - Reconciliation of Activity in Allowance for Credit Losses for Accounts Receivable (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="amn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>2408403 - Disclosure - Acquisitions - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amnhealthcare.com/role/AcquisitionsNarrativeDetails</Role>
      <ShortName>Acquisitions - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="amn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>2409404 - Disclosure - Acquisitions - Schedule of Intangible Assets Acquired (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amnhealthcare.com/role/AcquisitionsScheduleofIntangibleAssetsAcquiredDetails</Role>
      <ShortName>Acquisitions - Schedule of Intangible Assets Acquired (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report instance="amn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>2410405 - Disclosure - Acquisitions - Schedule of Pro Forma Financial Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amnhealthcare.com/role/AcquisitionsScheduleofProFormaFinancialInformationDetails</Role>
      <ShortName>Acquisitions - Schedule of Pro Forma Financial Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>30</Position>
    </Report>
    <Report instance="amn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>2412406 - Disclosure - Revenue Recognition (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amnhealthcare.com/role/RevenueRecognitionDetails</Role>
      <ShortName>Revenue Recognition (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.amnhealthcare.com/role/RevenueRecognition</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="amn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>2415407 - Disclosure - Net Income Per Common Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amnhealthcare.com/role/NetIncomePerCommonShareDetails</Role>
      <ShortName>Net Income Per Common Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.amnhealthcare.com/role/NetIncomePerCommonShareTables</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="amn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>2418408 - Disclosure - Segment Information - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amnhealthcare.com/role/SegmentInformationNarrativeDetails</Role>
      <ShortName>Segment Information - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>33</Position>
    </Report>
    <Report instance="amn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>2419409 - Disclosure - Segment Information - Reconciliation of Revenue and Segment Operating Income by Reportable Segment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amnhealthcare.com/role/SegmentInformationReconciliationofRevenueandSegmentOperatingIncomebyReportableSegmentDetails</Role>
      <ShortName>Segment Information - Reconciliation of Revenue and Segment Operating Income by Reportable Segment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="amn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>2420410 - Disclosure - Segment Information - Disaggregation of Revenue (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amnhealthcare.com/role/SegmentInformationDisaggregationofRevenueDetails</Role>
      <ShortName>Segment Information - Disaggregation of Revenue (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="amn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>2421411 - Disclosure - Segment Information - Summary of Goodwill by Reportable Segment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amnhealthcare.com/role/SegmentInformationSummaryofGoodwillbyReportableSegmentDetails</Role>
      <ShortName>Segment Information - Summary of Goodwill by Reportable Segment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="amn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>2423412 - Disclosure - Notes Payable and Credit Agreement (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.amnhealthcare.com/role/NotesPayableandCreditAgreementDetails</Role>
      <ShortName>Notes Payable and Credit Agreement (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.amnhealthcare.com/role/NotesPayableandCreditAgreement</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="amn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>2426413 - Disclosure - Fair Value Measurement - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amnhealthcare.com/role/FairValueMeasurementNarrativeDetails</Role>
      <ShortName>Fair Value Measurement - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="amn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>2427414 - Disclosure - Fair Value Measurement - Financial Assets and Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amnhealthcare.com/role/FairValueMeasurementFinancialAssetsandLiabilitiesDetails</Role>
      <ShortName>Fair Value Measurement - Financial Assets and Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="amn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>2428415 - Disclosure - Fair Value Measurement - Reconciliation of Changes in Contingent Consideration Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amnhealthcare.com/role/FairValueMeasurementReconciliationofChangesinContingentConsiderationLiabilitiesDetails</Role>
      <ShortName>Fair Value Measurement - Reconciliation of Changes in Contingent Consideration Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="amn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>2429416 - Disclosure - Fair Value Measurement - Fair Value of Financial Instruments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amnhealthcare.com/role/FairValueMeasurementFairValueofFinancialInstrumentsDetails</Role>
      <ShortName>Fair Value Measurement - Fair Value of Financial Instruments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="amn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>2431417 - Disclosure - Leases (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amnhealthcare.com/role/LeasesDetails</Role>
      <ShortName>Leases (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.amnhealthcare.com/role/Leases</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="amn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>2433418 - Disclosure - Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amnhealthcare.com/role/IncomeTaxesDetails</Role>
      <ShortName>Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.amnhealthcare.com/role/IncomeTaxes</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="amn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>2435419 - Disclosure - Commitments and Contingencies: Legal Proceedings (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amnhealthcare.com/role/CommitmentsandContingenciesLegalProceedingsDetails</Role>
      <ShortName>Commitments and Contingencies: Legal Proceedings (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.amnhealthcare.com/role/CommitmentsandContingenciesLegalProceedings</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="amn-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>2438420 - Disclosure - Balance Sheet Details (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amnhealthcare.com/role/BalanceSheetDetailsDetails</Role>
      <ShortName>Balance Sheet Details (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.amnhealthcare.com/role/BalanceSheetDetailsTables</ParentRole>
      <Position>45</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" original="amn-20210930.htm">amn-20210930.htm</File>
    <File>amn-20210930.xsd</File>
    <File>amn-20210930_cal.xml</File>
    <File>amn-20210930_def.xml</File>
    <File>amn-20210930_lab.xml</File>
    <File>amn-20210930_pre.xml</File>
    <File>amn-ex101x20210930x10q.htm</File>
    <File>amn-ex311x20210930x10q.htm</File>
    <File>amn-ex312x20210930x10q.htm</File>
    <File>amn-ex321x20210930x10q.htm</File>
    <File>amn-ex322x20210930x10q.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>amn-20210930_g1.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy>http://fasb.org/srt/2021-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/us-gaap/2021-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2021</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>64
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "amn-20210930.htm": {
   "axisCustom": 0,
   "axisStandard": 18,
   "contextCount": 265,
   "dts": {
    "calculationLink": {
     "local": [
      "amn-20210930_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "amn-20210930_def.xml"
     ]
    },
    "inline": {
     "local": [
      "amn-20210930.htm"
     ]
    },
    "labelLink": {
     "local": [
      "amn-20210930_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "amn-20210930_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "amn-20210930.xsd"
     ],
     "remote": [
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 410,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2021-01-31": 3,
    "http://xbrl.sec.gov/dei/2021": 5,
    "total": 8
   },
   "keyCustom": 27,
   "keyStandard": 308,
   "memberCustom": 18,
   "memberStandard": 27,
   "nsprefix": "amn",
   "nsuri": "http://www.amnhealthcare.com/20210930",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amn-20210930.htm",
      "contextRef": "i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover Page",
     "role": "http://www.amnhealthcare.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amn-20210930.htm",
      "contextRef": "i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amn-20210930.htm",
      "contextRef": "i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2111103 - Disclosure - Revenue Recognition",
     "role": "http://www.amnhealthcare.com/role/RevenueRecognition",
     "shortName": "Revenue Recognition",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amn-20210930.htm",
      "contextRef": "i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amn-20210930.htm",
      "contextRef": "i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2113104 - Disclosure - Net Income Per Common Share",
     "role": "http://www.amnhealthcare.com/role/NetIncomePerCommonShare",
     "shortName": "Net Income Per Common Share",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amn-20210930.htm",
      "contextRef": "i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amn-20210930.htm",
      "contextRef": "i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2116105 - Disclosure - Segment Information",
     "role": "http://www.amnhealthcare.com/role/SegmentInformation",
     "shortName": "Segment Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amn-20210930.htm",
      "contextRef": "i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amn-20210930.htm",
      "contextRef": "i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2122106 - Disclosure - Notes Payable and Credit Agreement",
     "role": "http://www.amnhealthcare.com/role/NotesPayableandCreditAgreement",
     "shortName": "Notes Payable and Credit Agreement",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amn-20210930.htm",
      "contextRef": "i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amn-20210930.htm",
      "contextRef": "i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2124107 - Disclosure - Fair Value Measurement",
     "role": "http://www.amnhealthcare.com/role/FairValueMeasurement",
     "shortName": "Fair Value Measurement",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amn-20210930.htm",
      "contextRef": "i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amn-20210930.htm",
      "contextRef": "i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2130108 - Disclosure - Leases",
     "role": "http://www.amnhealthcare.com/role/Leases",
     "shortName": "Leases",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amn-20210930.htm",
      "contextRef": "i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amn-20210930.htm",
      "contextRef": "i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2132109 - Disclosure - Income Taxes",
     "role": "http://www.amnhealthcare.com/role/IncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amn-20210930.htm",
      "contextRef": "i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amn-20210930.htm",
      "contextRef": "i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2134110 - Disclosure - Commitments and Contingencies: Legal Proceedings",
     "role": "http://www.amnhealthcare.com/role/CommitmentsandContingenciesLegalProceedings",
     "shortName": "Commitments and Contingencies: Legal Proceedings",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amn-20210930.htm",
      "contextRef": "i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amn-20210930.htm",
      "contextRef": "i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2136111 - Disclosure - Balance Sheet Details",
     "role": "http://www.amnhealthcare.com/role/BalanceSheetDetails",
     "shortName": "Balance Sheet Details",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amn-20210930.htm",
      "contextRef": "i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amn-20210930.htm",
      "contextRef": "i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UseOfEstimates",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2202201 - Disclosure - Basis of Presentation (Policies)",
     "role": "http://www.amnhealthcare.com/role/BasisofPresentationPolicies",
     "shortName": "Basis of Presentation (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amn-20210930.htm",
      "contextRef": "i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UseOfEstimates",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amn-20210930.htm",
      "contextRef": "i68ecd84e8da440808154baac134e839e_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1001002 - Statement - Condensed Consolidated Balance Sheets",
     "role": "http://www.amnhealthcare.com/role/CondensedConsolidatedBalanceSheets",
     "shortName": "Condensed Consolidated Balance Sheets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amn-20210930.htm",
      "contextRef": "i68ecd84e8da440808154baac134e839e_I20210930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:AccountsReceivableNetCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amn-20210930.htm",
      "contextRef": "i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2303301 - Disclosure - Basis of Presentation (Tables)",
     "role": "http://www.amnhealthcare.com/role/BasisofPresentationTables",
     "shortName": "Basis of Presentation (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amn-20210930.htm",
      "contextRef": "i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amn-20210930.htm",
      "contextRef": "i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2307302 - Disclosure - Acquisitions (Tables)",
     "role": "http://www.amnhealthcare.com/role/AcquisitionsTables",
     "shortName": "Acquisitions (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amn-20210930.htm",
      "contextRef": "i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amn-20210930.htm",
      "contextRef": "i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2314303 - Disclosure - Net Income Per Common Share (Tables)",
     "role": "http://www.amnhealthcare.com/role/NetIncomePerCommonShareTables",
     "shortName": "Net Income Per Common Share (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amn-20210930.htm",
      "contextRef": "i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amn-20210930.htm",
      "contextRef": "i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2317304 - Disclosure - Segment Information (Tables)",
     "role": "http://www.amnhealthcare.com/role/SegmentInformationTables",
     "shortName": "Segment Information (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amn-20210930.htm",
      "contextRef": "i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amn-20210930.htm",
      "contextRef": "i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2325305 - Disclosure - Fair Value Measurement (Tables)",
     "role": "http://www.amnhealthcare.com/role/FairValueMeasurementTables",
     "shortName": "Fair Value Measurement (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amn-20210930.htm",
      "contextRef": "i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amn-20210930.htm",
      "contextRef": "i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "amn:ScheduleofSupplementalBalanceSheetDisclosuresTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2337306 - Disclosure - Balance Sheet Details (Tables)",
     "role": "http://www.amnhealthcare.com/role/BalanceSheetDetailsTables",
     "shortName": "Balance Sheet Details (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amn-20210930.htm",
      "contextRef": "i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "amn:ScheduleofSupplementalBalanceSheetDisclosuresTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amn-20210930.htm",
      "contextRef": "i68ecd84e8da440808154baac134e839e_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2404401 - Disclosure - Basis of Presentation - Reconciliation of Cash, Cash Equivalents and Restricted Cash (Details)",
     "role": "http://www.amnhealthcare.com/role/BasisofPresentationReconciliationofCashCashEquivalentsandRestrictedCashDetails",
     "shortName": "Basis of Presentation - Reconciliation of Cash, Cash Equivalents and Restricted Cash (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amn-20210930.htm",
      "contextRef": "i68ecd84e8da440808154baac134e839e_I20210930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "amn:TotalCashCashEquivalentsAndRestrictedCashCashEquivalentsandInvestments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amn-20210930.htm",
      "contextRef": "i61f65cd0793e47078410af8ea7c03faa_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2405402 - Disclosure - Basis of Presentation - Reconciliation of Activity in Allowance for Credit Losses for Accounts Receivable (Details)",
     "role": "http://www.amnhealthcare.com/role/BasisofPresentationReconciliationofActivityinAllowanceforCreditLossesforAccountsReceivableDetails",
     "shortName": "Basis of Presentation - Reconciliation of Activity in Allowance for Credit Losses for Accounts Receivable (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amn-20210930.htm",
      "contextRef": "i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:ProvisionForDoubtfulAccounts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amn-20210930.htm",
      "contextRef": "i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfBusinessesAcquired",
      "reportCount": 1,
      "unique": true,
      "unitRef": "acquisition",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2408403 - Disclosure - Acquisitions - Narrative (Details)",
     "role": "http://www.amnhealthcare.com/role/AcquisitionsNarrativeDetails",
     "shortName": "Acquisitions - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amn-20210930.htm",
      "contextRef": "i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfBusinessesAcquired",
      "reportCount": 1,
      "unique": true,
      "unitRef": "acquisition",
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amn-20210930.htm",
      "contextRef": "i67759f1dfa1b4429aabe1215e03414dc_I20200214",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2409404 - Disclosure - Acquisitions - Schedule of Intangible Assets Acquired (Details)",
     "role": "http://www.amnhealthcare.com/role/AcquisitionsScheduleofIntangibleAssetsAcquiredDetails",
     "shortName": "Acquisitions - Schedule of Intangible Assets Acquired (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amn-20210930.htm",
      "contextRef": "i3d55955405794cb789f5432f8c06331e_I20200214",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amn-20210930.htm",
      "contextRef": "i68ecd84e8da440808154baac134e839e_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1002003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)",
     "role": "http://www.amnhealthcare.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
     "shortName": "Condensed Consolidated Balance Sheets (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amn-20210930.htm",
      "contextRef": "i68ecd84e8da440808154baac134e839e_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amn-20210930.htm",
      "contextRef": "ic430d291a7804180aa0b06c38d0c7c55_D20200701-20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessAcquisitionsProFormaRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2410405 - Disclosure - Acquisitions - Schedule of Pro Forma Financial Information (Details)",
     "role": "http://www.amnhealthcare.com/role/AcquisitionsScheduleofProFormaFinancialInformationDetails",
     "shortName": "Acquisitions - Schedule of Pro Forma Financial Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amn-20210930.htm",
      "contextRef": "ic430d291a7804180aa0b06c38d0c7c55_D20200701-20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessAcquisitionsProFormaRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:RevenueFromContractWithCustomerPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amn-20210930.htm",
      "contextRef": "i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerLiabilityRevenueRecognized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2412406 - Disclosure - Revenue Recognition (Details)",
     "role": "http://www.amnhealthcare.com/role/RevenueRecognitionDetails",
     "shortName": "Revenue Recognition (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:RevenueFromContractWithCustomerPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amn-20210930.htm",
      "contextRef": "i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerLiabilityRevenueRecognized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted",
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amn-20210930.htm",
      "contextRef": "i150492f298fa47a78ef2c10a285a64f8_D20210701-20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2415407 - Disclosure - Net Income Per Common Share (Details)",
     "role": "http://www.amnhealthcare.com/role/NetIncomePerCommonShareDetails",
     "shortName": "Net Income Per Common Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amn-20210930.htm",
      "contextRef": "i150492f298fa47a78ef2c10a285a64f8_D20210701-20210930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amn-20210930.htm",
      "contextRef": "i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfOperatingSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2418408 - Disclosure - Segment Information - Narrative (Details)",
     "role": "http://www.amnhealthcare.com/role/SegmentInformationNarrativeDetails",
     "shortName": "Segment Information - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amn-20210930.htm",
      "contextRef": "i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfOperatingSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amn-20210930.htm",
      "contextRef": "i150492f298fa47a78ef2c10a285a64f8_D20210701-20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2419409 - Disclosure - Segment Information - Reconciliation of Revenue and Segment Operating Income by Reportable Segment (Details)",
     "role": "http://www.amnhealthcare.com/role/SegmentInformationReconciliationofRevenueandSegmentOperatingIncomebyReportableSegmentDetails",
     "shortName": "Segment Information - Reconciliation of Revenue and Segment Operating Income by Reportable Segment (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amn-20210930.htm",
      "contextRef": "i150492f298fa47a78ef2c10a285a64f8_D20210701-20210930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:CostOfGoodsAndServicesSoldDepreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amn-20210930.htm",
      "contextRef": "i150492f298fa47a78ef2c10a285a64f8_D20210701-20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2420410 - Disclosure - Segment Information - Disaggregation of Revenue (Details)",
     "role": "http://www.amnhealthcare.com/role/SegmentInformationDisaggregationofRevenueDetails",
     "shortName": "Segment Information - Disaggregation of Revenue (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amn-20210930.htm",
      "contextRef": "i6aff1598e94c41a9a49290be61afbb6c_D20210701-20210930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amn-20210930.htm",
      "contextRef": "i61f65cd0793e47078410af8ea7c03faa_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2421411 - Disclosure - Segment Information - Summary of Goodwill by Reportable Segment (Details)",
     "role": "http://www.amnhealthcare.com/role/SegmentInformationSummaryofGoodwillbyReportableSegmentDetails",
     "shortName": "Segment Information - Summary of Goodwill by Reportable Segment (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amn-20210930.htm",
      "contextRef": "i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:GoodwillPurchaseAccountingAdjustments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amn-20210930.htm",
      "contextRef": "i1809609cdf714d66916ae3141253f6cd_I20180209",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2423412 - Disclosure - Notes Payable and Credit Agreement (Details)",
     "role": "http://www.amnhealthcare.com/role/NotesPayableandCreditAgreementDetails",
     "shortName": "Notes Payable and Credit Agreement (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amn-20210930.htm",
      "contextRef": "i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AssetImpairmentCharges",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2426413 - Disclosure - Fair Value Measurement - Narrative (Details)",
     "role": "http://www.amnhealthcare.com/role/FairValueMeasurementNarrativeDetails",
     "shortName": "Fair Value Measurement - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amn-20210930.htm",
      "contextRef": "i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AssetImpairmentCharges",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amn-20210930.htm",
      "contextRef": "i7406af186f1f431ba3a5cae4e80d7461_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueNetAssetLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2427414 - Disclosure - Fair Value Measurement - Financial Assets and Liabilities (Details)",
     "role": "http://www.amnhealthcare.com/role/FairValueMeasurementFinancialAssetsandLiabilitiesDetails",
     "shortName": "Fair Value Measurement - Financial Assets and Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amn-20210930.htm",
      "contextRef": "i7406af186f1f431ba3a5cae4e80d7461_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueNetAssetLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amn-20210930.htm",
      "contextRef": "i150492f298fa47a78ef2c10a285a64f8_D20210701-20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1003004 - Statement - Condensed Consolidated Statements of Comprehensive Income",
     "role": "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofComprehensiveIncome",
     "shortName": "Condensed Consolidated Statements of Comprehensive Income",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amn-20210930.htm",
      "contextRef": "i150492f298fa47a78ef2c10a285a64f8_D20210701-20210930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:CostOfGoodsAndServicesSold",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amn-20210930.htm",
      "contextRef": "id213a9f9047d4508aeef40c71a6fe7f3_I20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2428415 - Disclosure - Fair Value Measurement - Reconciliation of Changes in Contingent Consideration Liabilities (Details)",
     "role": "http://www.amnhealthcare.com/role/FairValueMeasurementReconciliationofChangesinContingentConsiderationLiabilitiesDetails",
     "shortName": "Fair Value Measurement - Reconciliation of Changes in Contingent Consideration Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amn-20210930.htm",
      "contextRef": "id213a9f9047d4508aeef40c71a6fe7f3_I20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amn-20210930.htm",
      "contextRef": "i74b3184e58994da0b7590f17370f09da_I20210930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentFaceAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2429416 - Disclosure - Fair Value Measurement - Fair Value of Financial Instruments (Details)",
     "role": "http://www.amnhealthcare.com/role/FairValueMeasurementFairValueofFinancialInstrumentsDetails",
     "shortName": "Fair Value Measurement - Fair Value of Financial Instruments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amn-20210930.htm",
      "contextRef": "i74b3184e58994da0b7590f17370f09da_I20210930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentFaceAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amn-20210930.htm",
      "contextRef": "i150492f298fa47a78ef2c10a285a64f8_D20210701-20210930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "amn:NumberOfPhasesOfLeaseTerminationAgreement",
      "reportCount": 1,
      "unique": true,
      "unitRef": "phase",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2431417 - Disclosure - Leases (Details)",
     "role": "http://www.amnhealthcare.com/role/LeasesDetails",
     "shortName": "Leases (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amn-20210930.htm",
      "contextRef": "i150492f298fa47a78ef2c10a285a64f8_D20210701-20210930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "amn:NumberOfPhasesOfLeaseTerminationAgreement",
      "reportCount": 1,
      "unique": true,
      "unitRef": "phase",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amn-20210930.htm",
      "contextRef": "i68ecd84e8da440808154baac134e839e_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "amn:DeferredPayrollTaxesCARESAct",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2433418 - Disclosure - Income Taxes (Details)",
     "role": "http://www.amnhealthcare.com/role/IncomeTaxesDetails",
     "shortName": "Income Taxes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amn-20210930.htm",
      "contextRef": "i68ecd84e8da440808154baac134e839e_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "amn:DeferredPayrollTaxesCARESAct",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amn-20210930.htm",
      "contextRef": "ibdd33d48b3ef404689d6e95d9989f154_D20201001-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyAccrualCarryingValuePeriodIncreaseDecrease",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2435419 - Disclosure - Commitments and Contingencies: Legal Proceedings (Details)",
     "role": "http://www.amnhealthcare.com/role/CommitmentsandContingenciesLegalProceedingsDetails",
     "shortName": "Commitments and Contingencies: Legal Proceedings (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amn-20210930.htm",
      "contextRef": "ibdd33d48b3ef404689d6e95d9989f154_D20201001-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyAccrualCarryingValuePeriodIncreaseDecrease",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amn-20210930.htm",
      "contextRef": "i68ecd84e8da440808154baac134e839e_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestrictedCashAndCashEquivalents",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2438420 - Disclosure - Balance Sheet Details (Details)",
     "role": "http://www.amnhealthcare.com/role/BalanceSheetDetailsDetails",
     "shortName": "Balance Sheet Details (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "amn:ScheduleofSupplementalBalanceSheetDisclosuresTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "amn-20210930.htm",
      "contextRef": "i68ecd84e8da440808154baac134e839e_I20210930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxesReceivable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amn-20210930.htm",
      "contextRef": "i2f727815e2874946b60bd2e1bb5e93be_I20191231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharesIssued",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1004005 - Statement - Condensed Consolidated Statements of Stockholders' Equity",
     "role": "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofStockholdersEquity",
     "shortName": "Condensed Consolidated Statements of Stockholders' Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amn-20210930.htm",
      "contextRef": "ib229d5f30fdf41e28a8c14b58ac7f71a_D20200101-20200331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amn-20210930.htm",
      "contextRef": "i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1005006 - Statement - Condensed Consolidated Statements of Cash Flows",
     "role": "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofCashFlows",
     "shortName": "Condensed Consolidated Statements of Cash Flows",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amn-20210930.htm",
      "contextRef": "i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amn-20210930.htm",
      "contextRef": "i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InterestPaidCapitalized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1006007 - Statement - Condensed Consolidated Statements of Cash Flows (Parenthetical)",
     "role": "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofCashFlowsParenthetical",
     "shortName": "Condensed Consolidated Statements of Cash Flows (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amn-20210930.htm",
      "contextRef": "i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InterestPaidCapitalized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amn-20210930.htm",
      "contextRef": "i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccounting",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2101101 - Disclosure - Basis of Presentation",
     "role": "http://www.amnhealthcare.com/role/BasisofPresentation",
     "shortName": "Basis of Presentation",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amn-20210930.htm",
      "contextRef": "i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccounting",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amn-20210930.htm",
      "contextRef": "i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2106102 - Disclosure - Acquisitions",
     "role": "http://www.amnhealthcare.com/role/Acquisitions",
     "shortName": "Acquisitions",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "amn-20210930.htm",
      "contextRef": "i4252e39cc9684462b05d84ebd7d340ee_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 45,
   "tag": {
    "amn_A4.625SeniorNotesDue2027Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "4.625% Senior Notes Due 2027 [Member]",
        "label": "4.625% Senior Notes Due 2027 [Member]",
        "verboseLabel": "2027 Notes"
       }
      }
     },
     "localname": "A4.625SeniorNotesDue2027Member",
     "nsuri": "http://www.amnhealthcare.com/20210930",
     "presentation": [
      "http://www.amnhealthcare.com/role/FairValueMeasurementFairValueofFinancialInstrumentsDetails",
      "http://www.amnhealthcare.com/role/FairValueMeasurementNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "amn_A4000SeniorNotesDue2029Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "4.000% Senior Notes Due 2029",
        "label": "4.000% Senior Notes Due 2029 [Member]",
        "terseLabel": "2029 Notes"
       }
      }
     },
     "localname": "A4000SeniorNotesDue2029Member",
     "nsuri": "http://www.amnhealthcare.com/20210930",
     "presentation": [
      "http://www.amnhealthcare.com/role/FairValueMeasurementFairValueofFinancialInstrumentsDetails",
      "http://www.amnhealthcare.com/role/FairValueMeasurementNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "amn_AccountsPayableAndAccruedExpensesExcludingAccruedCompensationAndBenefitsCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.amnhealthcare.com/role/BalanceSheetDetailsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounts Payable And Accrued Expenses, Excluding Accrued Compensation And Benefits, Current",
        "label": "Accounts Payable And Accrued Expenses, Excluding Accrued Compensation And Benefits, Current",
        "totalLabel": "Accounts payable and accrued expenses"
       }
      }
     },
     "localname": "AccountsPayableAndAccruedExpensesExcludingAccruedCompensationAndBenefitsCurrent",
     "nsuri": "http://www.amnhealthcare.com/20210930",
     "presentation": [
      "http://www.amnhealthcare.com/role/BalanceSheetDetailsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amn_AccountsPayableToSubcontractor": {
     "auth_ref": [],
     "calculation": {
      "http://www.amnhealthcare.com/role/BalanceSheetDetailsDetails": {
       "order": 2.0,
       "parentTag": "amn_AccountsPayableAndAccruedExpensesExcludingAccruedCompensationAndBenefitsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounts payable to subcontractor.",
        "label": "Accounts Payable to Subcontractor",
        "terseLabel": "Subcontractor payable"
       }
      }
     },
     "localname": "AccountsPayableToSubcontractor",
     "nsuri": "http://www.amnhealthcare.com/20210930",
     "presentation": [
      "http://www.amnhealthcare.com/role/BalanceSheetDetailsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amn_AccountsReceivableAndSalesCreditsCreditLossExpenseReversal": {
     "auth_ref": [],
     "calculation": {
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounts Receivable And Sales Credits, Credit Loss Expense (Reversal)",
        "label": "Accounts Receivable And Sales Credits, Credit Loss Expense (Reversal)",
        "terseLabel": "Increase in allowance for credit losses and sales credits"
       }
      }
     },
     "localname": "AccountsReceivableAndSalesCreditsCreditLossExpenseReversal",
     "nsuri": "http://www.amnhealthcare.com/20210930",
     "presentation": [
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amn_Accountsreceivablesubcontractor": {
     "auth_ref": [],
     "calculation": {
      "http://www.amnhealthcare.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounts receivable, subcontractor",
        "label": "Accounts receivable, subcontractor",
        "terseLabel": "Accounts receivable, subcontractor"
       }
      }
     },
     "localname": "Accountsreceivablesubcontractor",
     "nsuri": "http://www.amnhealthcare.com/20210930",
     "presentation": [
      "http://www.amnhealthcare.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amn_AccruedBonusesAndCommissions": {
     "auth_ref": [],
     "calculation": {
      "http://www.amnhealthcare.com/role/BalanceSheetDetailsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_EmployeeRelatedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued Bonuses And Commissions",
        "label": "Accrued Bonuses And Commissions",
        "terseLabel": "Accrued bonuses and commissions"
       }
      }
     },
     "localname": "AccruedBonusesAndCommissions",
     "nsuri": "http://www.amnhealthcare.com/20210930",
     "presentation": [
      "http://www.amnhealthcare.com/role/BalanceSheetDetailsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amn_AccruedTravelExpense": {
     "auth_ref": [],
     "calculation": {
      "http://www.amnhealthcare.com/role/BalanceSheetDetailsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_EmployeeRelatedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued Travel Expense",
        "label": "Accrued Travel Expense",
        "terseLabel": "Accrued travel expense"
       }
      }
     },
     "localname": "AccruedTravelExpense",
     "nsuri": "http://www.amnhealthcare.com/20210930",
     "presentation": [
      "http://www.amnhealthcare.com/role/BalanceSheetDetailsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amn_AdvancedMedicalPersonnelServicesInc.Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Advanced Medical Personnel Services, Inc. [Member]",
        "label": "Advanced Medical Personnel Services, Inc. [Member]",
        "terseLabel": "Advanced"
       }
      }
     },
     "localname": "AdvancedMedicalPersonnelServicesInc.Member",
     "nsuri": "http://www.amnhealthcare.com/20210930",
     "presentation": [
      "http://www.amnhealthcare.com/role/FairValueMeasurementReconciliationofChangesinContingentConsiderationLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "amn_B4healthLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "b4health, LLC [Member]",
        "label": "b4health, LLC [Member]",
        "terseLabel": "b4health"
       }
      }
     },
     "localname": "B4healthLLCMember",
     "nsuri": "http://www.amnhealthcare.com/20210930",
     "presentation": [
      "http://www.amnhealthcare.com/role/FairValueMeasurementReconciliationofChangesinContingentConsiderationLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "amn_BusinessCombinationConsiderationTransferredNetOfWorkingCapitalAdjustment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Consideration Transferred, Net Of Working Capital Adjustment",
        "label": "Business Combination, Consideration Transferred, Net Of Working Capital Adjustment",
        "terseLabel": "Purchase price, net of working capital adjustment"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferredNetOfWorkingCapitalAdjustment",
     "nsuri": "http://www.amnhealthcare.com/20210930",
     "presentation": [
      "http://www.amnhealthcare.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalentsAndPropertyPlantAndEquipment": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Cash And Equivalents And Property, Plant, And Equipment",
        "label": "Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Cash And Equivalents And Property, Plant, And Equipment",
        "terseLabel": "Fair value of tangible assets acquired"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalentsAndPropertyPlantAndEquipment",
     "nsuri": "http://www.amnhealthcare.com/20210930",
     "presentation": [
      "http://www.amnhealthcare.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Tangible Assets",
        "label": "Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Tangible Assets",
        "terseLabel": "Fair value of tangible assets acquired"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTangibleAssets",
     "nsuri": "http://www.amnhealthcare.com/20210930",
     "presentation": [
      "http://www.amnhealthcare.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amn_ContingentConsiderationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contingent Consideration [Member]",
        "label": "Contingent Consideration [Member]",
        "verboseLabel": "Acquisition contingent consideration liabilities"
       }
      }
     },
     "localname": "ContingentConsiderationMember",
     "nsuri": "http://www.amnhealthcare.com/20210930",
     "presentation": [
      "http://www.amnhealthcare.com/role/FairValueMeasurementFinancialAssetsandLiabilitiesDetails",
      "http://www.amnhealthcare.com/role/FairValueMeasurementReconciliationofChangesinContingentConsiderationLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "amn_DeferredCompensationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Compensation [Member]",
        "label": "Deferred Compensation [Member]",
        "terseLabel": "Deferred compensation"
       }
      }
     },
     "localname": "DeferredCompensationMember",
     "nsuri": "http://www.amnhealthcare.com/20210930",
     "presentation": [
      "http://www.amnhealthcare.com/role/FairValueMeasurementFinancialAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "amn_DeferredPayrollTaxesCARESAct": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Payroll Taxes, CARES Act",
        "label": "Deferred Payroll Taxes, CARES Act",
        "terseLabel": "Deferred payroll taxes, CARES Act"
       }
      }
     },
     "localname": "DeferredPayrollTaxesCARESAct",
     "nsuri": "http://www.amnhealthcare.com/20210930",
     "presentation": [
      "http://www.amnhealthcare.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amn_EmployeeRetentionEmploymentTaxCreditCARESAct": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employee Retention Employment Tax Credit, CARES Act",
        "label": "Employee Retention Employment Tax Credit, CARES Act",
        "terseLabel": "Employee retention employment tax credit, CARES Act"
       }
      }
     },
     "localname": "EmployeeRetentionEmploymentTaxCreditCARESAct",
     "nsuri": "http://www.amnhealthcare.com/20210930",
     "presentation": [
      "http://www.amnhealthcare.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amn_GainLossOnDeferredCompensation": {
     "auth_ref": [],
     "calculation": {
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 21.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gain (Loss) On Deferred Compensation",
        "label": "Gain (Loss) On Deferred Compensation",
        "negatedTerseLabel": "Net loss on deferred compensation balances"
       }
      }
     },
     "localname": "GainLossOnDeferredCompensation",
     "nsuri": "http://www.amnhealthcare.com/20210930",
     "presentation": [
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amn_IncreaseDecreaseinAccountsReceivablessubcontractor": {
     "auth_ref": [],
     "calculation": {
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase Decrease in Accounts Receivables, subcontractor",
        "label": "Increase Decrease in Accounts Receivables, subcontractor",
        "negatedTerseLabel": "Accounts receivable, subcontractor"
       }
      }
     },
     "localname": "IncreaseDecreaseinAccountsReceivablessubcontractor",
     "nsuri": "http://www.amnhealthcare.com/20210930",
     "presentation": [
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amn_InterpreterDatabaseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interpreter Database [Member]",
        "label": "Interpreter Database [Member]",
        "terseLabel": "Interpreter Database"
       }
      }
     },
     "localname": "InterpreterDatabaseMember",
     "nsuri": "http://www.amnhealthcare.com/20210930",
     "presentation": [
      "http://www.amnhealthcare.com/role/AcquisitionsScheduleofIntangibleAssetsAcquiredDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "amn_LesseeOperatingLeaseLiabilityToBePaidPostmodification": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Operating Lease, Liability, To Be Paid, Postmodification",
        "label": "Lessee, Operating Lease, Liability, To Be Paid, Postmodification",
        "terseLabel": "Remaining lease payments, postmodification"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityToBePaidPostmodification",
     "nsuri": "http://www.amnhealthcare.com/20210930",
     "presentation": [
      "http://www.amnhealthcare.com/role/LeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amn_LesseeOperatingLeaseLiabilityToBePaidPremodification": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Operating Lease, Liability, To Be Paid, Premodification",
        "label": "Lessee, Operating Lease, Liability, To Be Paid, Premodification",
        "terseLabel": "Remaining lease payments, premodification"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityToBePaidPremodification",
     "nsuri": "http://www.amnhealthcare.com/20210930",
     "presentation": [
      "http://www.amnhealthcare.com/role/LeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amn_LesseeOperatingLeaseNoncashExpense": {
     "auth_ref": [],
     "calculation": {
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 22.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Operating Lease, Noncash Expense",
        "label": "Lessee, Operating Lease, Noncash Expense",
        "terseLabel": "Non-cash lease expense"
       }
      }
     },
     "localname": "LesseeOperatingLeaseNoncashExpense",
     "nsuri": "http://www.amnhealthcare.com/20210930",
     "presentation": [
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amn_NumberOfPhasesOfLeaseTerminationAgreement": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Phases Of Lease Termination Agreement",
        "label": "Number Of Phases Of Lease Termination Agreement",
        "terseLabel": "Number of phases of lease termination agreement"
       }
      }
     },
     "localname": "NumberOfPhasesOfLeaseTerminationAgreement",
     "nsuri": "http://www.amnhealthcare.com/20210930",
     "presentation": [
      "http://www.amnhealthcare.com/role/LeasesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "amn_NurseAndAlliedHealthcareStaffingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nurse and allied healthcare staffing.",
        "label": "Nurse and Allied Healthcare Staffing [Member]",
        "terseLabel": "Nurse\u00a0and\u00a0Allied Solutions",
        "verboseLabel": "Nurse and allied solutions"
       }
      }
     },
     "localname": "NurseAndAlliedHealthcareStaffingMember",
     "nsuri": "http://www.amnhealthcare.com/20210930",
     "presentation": [
      "http://www.amnhealthcare.com/role/SegmentInformationDisaggregationofRevenueDetails",
      "http://www.amnhealthcare.com/role/SegmentInformationReconciliationofRevenueandSegmentOperatingIncomebyReportableSegmentDetails",
      "http://www.amnhealthcare.com/role/SegmentInformationSummaryofGoodwillbyReportableSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "amn_OperatingLeaseLiabilityIncreaseDecreaseFromModification": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Lease, Liability, Increase (Decrease) From Modification",
        "label": "Operating Lease, Liability, Increase (Decrease) From Modification",
        "negatedLabel": "Operating lease, liability, decrease from modification"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityIncreaseDecreaseFromModification",
     "nsuri": "http://www.amnhealthcare.com/20210930",
     "presentation": [
      "http://www.amnhealthcare.com/role/LeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amn_OperatingLeaseRightOfUseAssetIncreaseDecreaseFromModification": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Lease, Right-Of-Use Asset, Increase (Decrease) From Modification",
        "label": "Operating Lease, Right-Of-Use Asset, Increase (Decrease) From Modification",
        "negatedTerseLabel": "Operating lease, right-of-use asset, decrease from modification"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAssetIncreaseDecreaseFromModification",
     "nsuri": "http://www.amnhealthcare.com/20210930",
     "presentation": [
      "http://www.amnhealthcare.com/role/LeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amn_OutsourcedWorkforceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Outsourced Workforce [Member]",
        "label": "Outsourced Workforce [Member]",
        "terseLabel": "Outsourced workforce"
       }
      }
     },
     "localname": "OutsourcedWorkforceMember",
     "nsuri": "http://www.amnhealthcare.com/20210930",
     "presentation": [
      "http://www.amnhealthcare.com/role/SegmentInformationDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "amn_PaymentsForPreviousAcquisitionEarnOutPayment": {
     "auth_ref": [],
     "calculation": {
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments For Previous Acquisition, Earn-Out Payment",
        "label": "Payments For Previous Acquisition, Earn-Out Payment",
        "negatedLabel": "Earn-out payments to settle contingent consideration liabilities for prior acquisitions"
       }
      }
     },
     "localname": "PaymentsForPreviousAcquisitionEarnOutPayment",
     "nsuri": "http://www.amnhealthcare.com/20210930",
     "presentation": [
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amn_PaymentsOfLeaseTerminationFee": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments Of Lease Termination Fee",
        "label": "Payments Of Lease Termination Fee",
        "terseLabel": "Payments of lease termination fee"
       }
      }
     },
     "localname": "PaymentsOfLeaseTerminationFee",
     "nsuri": "http://www.amnhealthcare.com/20210930",
     "presentation": [
      "http://www.amnhealthcare.com/role/LeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amn_PermanentPlacementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Permanent Placement [Member]",
        "label": "Permanent Placement [Member]",
        "terseLabel": "Permanent placement"
       }
      }
     },
     "localname": "PermanentPlacementMember",
     "nsuri": "http://www.amnhealthcare.com/20210930",
     "presentation": [
      "http://www.amnhealthcare.com/role/SegmentInformationDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "amn_PhysicianAndLeadershipSolutionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Physician And Leadership Solutions [Member]",
        "label": "Physician And Leadership Solutions [Member]",
        "terseLabel": "Physician and leadership solutions",
        "verboseLabel": "Physician and Leadership Solutions"
       }
      }
     },
     "localname": "PhysicianAndLeadershipSolutionsMember",
     "nsuri": "http://www.amnhealthcare.com/20210930",
     "presentation": [
      "http://www.amnhealthcare.com/role/SegmentInformationDisaggregationofRevenueDetails",
      "http://www.amnhealthcare.com/role/SegmentInformationReconciliationofRevenueandSegmentOperatingIncomebyReportableSegmentDetails",
      "http://www.amnhealthcare.com/role/SegmentInformationSummaryofGoodwillbyReportableSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "amn_Purchaseoffixedassetsrecordedinaccountspayableandaccruedexpenses": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchase of fixed assets recorded in accounts payable and accrued expenses",
        "label": "Purchase of fixed assets recorded in accounts payable and accrued expenses",
        "terseLabel": "Purchase of fixed assets recorded in accounts payable and accrued expenses"
       }
      }
     },
     "localname": "Purchaseoffixedassetsrecordedinaccountspayableandaccruedexpenses",
     "nsuri": "http://www.amnhealthcare.com/20210930",
     "presentation": [
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amn_SaaSBasedTechnologiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "SaaS-Based Technologies [Member]",
        "label": "SaaS-Based Technologies [Member]",
        "terseLabel": "SaaS-based technologies"
       }
      }
     },
     "localname": "SaaSBasedTechnologiesMember",
     "nsuri": "http://www.amnhealthcare.com/20210930",
     "presentation": [
      "http://www.amnhealthcare.com/role/SegmentInformationDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "amn_ScheduleofSupplementalBalanceSheetDisclosuresTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Supplemental Balance Sheet Disclosures [Table Text Block]",
        "label": "Schedule of Supplemental Balance Sheet Disclosures [Table Text Block]",
        "terseLabel": "Schedule of Supplemental Balance Sheet Disclosures"
       }
      }
     },
     "localname": "ScheduleofSupplementalBalanceSheetDisclosuresTableTextBlock",
     "nsuri": "http://www.amnhealthcare.com/20210930",
     "presentation": [
      "http://www.amnhealthcare.com/role/BalanceSheetDetailsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "amn_StratusVideoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stratus Video [Member]",
        "label": "Stratus Video [Member]",
        "terseLabel": "Stratus Video"
       }
      }
     },
     "localname": "StratusVideoMember",
     "nsuri": "http://www.amnhealthcare.com/20210930",
     "presentation": [
      "http://www.amnhealthcare.com/role/AcquisitionsNarrativeDetails",
      "http://www.amnhealthcare.com/role/AcquisitionsScheduleofIntangibleAssetsAcquiredDetails",
      "http://www.amnhealthcare.com/role/AcquisitionsScheduleofProFormaFinancialInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "amn_SupplementalDisclosuresOfNonCashInvestingAndFinancingActivitiesGoodwill": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Supplemental Disclosures Of Non Cash Investing And Financing Activities, Goodwill",
        "label": "Supplemental Disclosures Of Non Cash Investing And Financing Activities, Goodwill",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "SupplementalDisclosuresOfNonCashInvestingAndFinancingActivitiesGoodwill",
     "nsuri": "http://www.amnhealthcare.com/20210930",
     "presentation": [
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amn_SupplementalDisclosuresOfNonCashInvestingAndFinancingActivitiesIntangibleAssets": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Supplemental Disclosures Of Non Cash Investing And Financing Activities, Intangible Assets",
        "label": "Supplemental Disclosures Of Non Cash Investing And Financing Activities, Intangible Assets",
        "terseLabel": "Intangible assets"
       }
      }
     },
     "localname": "SupplementalDisclosuresOfNonCashInvestingAndFinancingActivitiesIntangibleAssets",
     "nsuri": "http://www.amnhealthcare.com/20210930",
     "presentation": [
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amn_SynziMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Synzi",
        "label": "Synzi [Member]",
        "terseLabel": "Synzi"
       }
      }
     },
     "localname": "SynziMember",
     "nsuri": "http://www.amnhealthcare.com/20210930",
     "presentation": [
      "http://www.amnhealthcare.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "amn_TechnologyAndWorkforceSolutionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Technology And Workforce Solutions [Member]",
        "label": "Technology And Workforce Solutions [Member]",
        "terseLabel": "Technology and workforce solutions"
       }
      }
     },
     "localname": "TechnologyAndWorkforceSolutionsMember",
     "nsuri": "http://www.amnhealthcare.com/20210930",
     "presentation": [
      "http://www.amnhealthcare.com/role/SegmentInformationDisaggregationofRevenueDetails",
      "http://www.amnhealthcare.com/role/SegmentInformationReconciliationofRevenueandSegmentOperatingIncomebyReportableSegmentDetails",
      "http://www.amnhealthcare.com/role/SegmentInformationSummaryofGoodwillbyReportableSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "amn_TemporaryStaffingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary Staffing [Member]",
        "label": "Temporary Staffing [Member]",
        "terseLabel": "Temporary staffing"
       }
      }
     },
     "localname": "TemporaryStaffingMember",
     "nsuri": "http://www.amnhealthcare.com/20210930",
     "presentation": [
      "http://www.amnhealthcare.com/role/SegmentInformationDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "amn_TermDebtMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term Debt [Member]",
        "label": "Term Debt [Member]",
        "terseLabel": "Term Debt"
       }
      }
     },
     "localname": "TermDebtMember",
     "nsuri": "http://www.amnhealthcare.com/20210930",
     "presentation": [
      "http://www.amnhealthcare.com/role/AcquisitionsNarrativeDetails",
      "http://www.amnhealthcare.com/role/NotesPayableandCreditAgreementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "amn_TotalCashCashEquivalentsAndRestrictedCashCashEquivalentsandInvestments": {
     "auth_ref": [],
     "calculation": {
      "http://www.amnhealthcare.com/role/BasisofPresentationReconciliationofCashCashEquivalentsandRestrictedCashDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.amnhealthcare.com/role/BasisofPresentationReconciliationofCashCashEquivalentsandRestrictedCashDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total Cash, Cash Equivalents, And Restricted Cash, Cash Equivalents, and Investments",
        "label": "Total Cash, Cash Equivalents, And Restricted Cash, Cash Equivalents, and Investments",
        "totalLabel": "Total cash, cash equivalents and restricted cash and investments"
       }
      }
     },
     "localname": "TotalCashCashEquivalentsAndRestrictedCashCashEquivalentsandInvestments",
     "nsuri": "http://www.amnhealthcare.com/20210930",
     "presentation": [
      "http://www.amnhealthcare.com/role/BasisofPresentationReconciliationofCashCashEquivalentsandRestrictedCashDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amn_UnallocatedCorporateOverhead": {
     "auth_ref": [],
     "calculation": {
      "http://www.amnhealthcare.com/role/SegmentInformationReconciliationofRevenueandSegmentOperatingIncomebyReportableSegmentDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unallocated corporate overhead.",
        "label": "Unallocated Corporate Overhead",
        "verboseLabel": "Unallocated corporate overhead"
       }
      }
     },
     "localname": "UnallocatedCorporateOverhead",
     "nsuri": "http://www.amnhealthcare.com/20210930",
     "presentation": [
      "http://www.amnhealthcare.com/role/SegmentInformationReconciliationofRevenueandSegmentOperatingIncomebyReportableSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "amn_WageAndHourClaimsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Wage And Hour Claims [Member]",
        "label": "Wage And Hour Claims [Member]",
        "terseLabel": "Wage and Hour claims"
       }
      }
     },
     "localname": "WageAndHourClaimsMember",
     "nsuri": "http://www.amnhealthcare.com/20210930",
     "presentation": [
      "http://www.amnhealthcare.com/role/CommitmentsandContingenciesLegalProceedingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.amnhealthcare.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.amnhealthcare.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.amnhealthcare.com/role/CoverPage"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.amnhealthcare.com/role/CoverPage"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.amnhealthcare.com/role/CoverPage"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.amnhealthcare.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r570"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.amnhealthcare.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r571"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.amnhealthcare.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.amnhealthcare.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.amnhealthcare.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two",
        "terseLabel": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.amnhealthcare.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.amnhealthcare.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.amnhealthcare.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.amnhealthcare.com/role/CoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r572"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.amnhealthcare.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding (excluding treasury shares)"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.amnhealthcare.com/role/CoverPage"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.amnhealthcare.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r572"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.amnhealthcare.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.amnhealthcare.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r572"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.amnhealthcare.com/role/CoverPage"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.amnhealthcare.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r573"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.amnhealthcare.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r572"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.amnhealthcare.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r572"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.amnhealthcare.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r572"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.amnhealthcare.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r572"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.amnhealthcare.com/role/CoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.amnhealthcare.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r568"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.amnhealthcare.com/role/CoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r569"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.amnhealthcare.com/role/CoverPage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.amnhealthcare.com/role/CoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "srt_ConsolidationItemsAxis": {
     "auth_ref": [
      "r113",
      "r165",
      "r184",
      "r185",
      "r186",
      "r187",
      "r189",
      "r191",
      "r195",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r285",
      "r286",
      "r288",
      "r290",
      "r291"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Axis]",
        "terseLabel": "Consolidation Items [Axis]"
       }
      }
     },
     "localname": "ConsolidationItemsAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/SegmentInformationReconciliationofRevenueandSegmentOperatingIncomebyReportableSegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidationItemsDomain": {
     "auth_ref": [
      "r113",
      "r165",
      "r184",
      "r185",
      "r186",
      "r187",
      "r189",
      "r191",
      "r195",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r285",
      "r286",
      "r288",
      "r290",
      "r291"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Domain]",
        "terseLabel": "Consolidation Items [Domain]"
       }
      }
     },
     "localname": "ConsolidationItemsDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/SegmentInformationReconciliationofRevenueandSegmentOperatingIncomebyReportableSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember": {
     "auth_ref": [
      "r2",
      "r118",
      "r126",
      "r132",
      "r222",
      "r385",
      "r386",
      "r387",
      "r400",
      "r401",
      "r440",
      "r443",
      "r445",
      "r446",
      "r576"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption, Adjustment [Member]",
        "terseLabel": "Cumulative Effect, Period of Adoption, Adjustment"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAdjustmentMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/BasisofPresentationReconciliationofActivityinAllowanceforCreditLossesforAccountsReceivableDetails",
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAxis": {
     "auth_ref": [
      "r2",
      "r118",
      "r126",
      "r132",
      "r222",
      "r385",
      "r386",
      "r387",
      "r400",
      "r401",
      "r440",
      "r443",
      "r445",
      "r446",
      "r576"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption [Axis]",
        "terseLabel": "Cumulative Effect, Period Of Adoption [Axis]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/BasisofPresentationReconciliationofActivityinAllowanceforCreditLossesforAccountsReceivableDetails",
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionDomain": {
     "auth_ref": [
      "r2",
      "r118",
      "r126",
      "r132",
      "r222",
      "r385",
      "r386",
      "r387",
      "r400",
      "r401",
      "r440",
      "r443",
      "r445",
      "r446",
      "r576"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption [Domain]",
        "terseLabel": "Cumulative Effect, Period Of Adoption [Domain]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/BasisofPresentationReconciliationofActivityinAllowanceforCreditLossesforAccountsReceivableDetails",
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_LitigationCaseAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Litigation Case [Axis]",
        "terseLabel": "Litigation Case [Axis]"
       }
      }
     },
     "localname": "LitigationCaseAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/CommitmentsandContingenciesLegalProceedingsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_LitigationCaseTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Litigation Case [Domain]",
        "terseLabel": "Litigation Case [Domain]"
       }
      }
     },
     "localname": "LitigationCaseTypeDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/CommitmentsandContingenciesLegalProceedingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r296",
      "r328",
      "r374",
      "r376",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r547",
      "r549",
      "r565",
      "r566"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/AcquisitionsScheduleofIntangibleAssetsAcquiredDetails",
      "http://www.amnhealthcare.com/role/CommitmentsandContingenciesLegalProceedingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r296",
      "r328",
      "r374",
      "r376",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r547",
      "r549",
      "r565",
      "r566"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/AcquisitionsScheduleofIntangibleAssetsAcquiredDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r198",
      "r356",
      "r360",
      "r505",
      "r546",
      "r548"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/SegmentInformationDisaggregationofRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r198",
      "r356",
      "r360",
      "r505",
      "r546",
      "r548"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/SegmentInformationDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r296",
      "r328",
      "r364",
      "r374",
      "r376",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r547",
      "r549",
      "r565",
      "r566"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/AcquisitionsScheduleofIntangibleAssetsAcquiredDetails",
      "http://www.amnhealthcare.com/role/CommitmentsandContingenciesLegalProceedingsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r296",
      "r328",
      "r364",
      "r374",
      "r376",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r547",
      "r549",
      "r565",
      "r566"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/AcquisitionsScheduleofIntangibleAssetsAcquiredDetails",
      "http://www.amnhealthcare.com/role/CommitmentsandContingenciesLegalProceedingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingStandardsUpdateExtensibleList": {
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r119",
      "r120",
      "r121",
      "r122",
      "r213",
      "r214",
      "r219",
      "r220",
      "r221",
      "r222",
      "r223",
      "r224",
      "r277",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r400",
      "r401",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r490",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates amendment to accounting standards.",
        "label": "Accounting Standards Update [Extensible Enumeration]",
        "terseLabel": "Accounting Standards Update [Extensible Enumeration]"
       }
      }
     },
     "localname": "AccountingStandardsUpdateExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/BasisofPresentationReconciliationofActivityinAllowanceforCreditLossesforAccountsReceivableDetails",
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts Payable and Accrued Liabilities, Current [Abstract]",
        "terseLabel": "Accounts payable and accrued expenses:"
       }
      }
     },
     "localname": "AccountsPayableAndAccruedLiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/BalanceSheetDetailsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r39",
      "r493"
     ],
     "calculation": {
      "http://www.amnhealthcare.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable and accrued expenses"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsPayableTradeCurrent": {
     "auth_ref": [
      "r17",
      "r39"
     ],
     "calculation": {
      "http://www.amnhealthcare.com/role/BalanceSheetDetailsDetails": {
       "order": 1.0,
       "parentTag": "amn_AccountsPayableAndAccruedExpensesExcludingAccruedCompensationAndBenefitsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Trade, Current",
        "terseLabel": "Trade accounts payable"
       }
      }
     },
     "localname": "AccountsPayableTradeCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/BalanceSheetDetailsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock": {
     "auth_ref": [
      "r230"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of allowance for credit loss on accounts receivable.",
        "label": "Accounts Receivable, Allowance for Credit Loss [Table Text Block]",
        "terseLabel": "Reconciliation of Activity in Allowance for Credit Losses for Accounts Receivable"
       }
      }
     },
     "localname": "AccountsReceivableAllowanceForCreditLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/BasisofPresentationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r8",
      "r27",
      "r203",
      "r204"
     ],
     "calculation": {
      "http://www.amnhealthcare.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "verboseLabel": "Accounts receivable, net of allowances of $6,148 and $7,043 at September\u00a030, 2021 and December\u00a031, 2020, respectively"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedInsuranceCurrent": {
     "auth_ref": [
      "r16",
      "r17",
      "r43"
     ],
     "calculation": {
      "http://www.amnhealthcare.com/role/BalanceSheetDetailsDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_EmployeeRelatedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable to insurance entities to mitigate potential loss from various risks or to satisfy a promise to provide certain coverage's to employees. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Insurance, Current",
        "terseLabel": "Health insurance reserve"
       }
      }
     },
     "localname": "AccruedInsuranceCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/BalanceSheetDetailsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r43"
     ],
     "calculation": {
      "http://www.amnhealthcare.com/role/BalanceSheetDetailsDetails": {
       "order": 5.0,
       "parentTag": "amn_AccountsPayableAndAccruedExpensesExcludingAccruedCompensationAndBenefitsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "terseLabel": "Accrued expenses"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/BalanceSheetDetailsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedSalariesCurrent": {
     "auth_ref": [
      "r16",
      "r17",
      "r43"
     ],
     "calculation": {
      "http://www.amnhealthcare.com/role/BalanceSheetDetailsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_EmployeeRelatedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of the obligations incurred through that date and payable for employees' services provided. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Salaries, Current",
        "terseLabel": "Accrued payroll"
       }
      }
     },
     "localname": "AccruedSalariesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/BalanceSheetDetailsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r37",
      "r254"
     ],
     "calculation": {
      "http://www.amnhealthcare.com/role/BalanceSheetDetailsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "negatedTerseLabel": "Accumulated depreciation",
        "terseLabel": "Accumulated depreciation - fixed assets"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/BalanceSheetDetailsDetails",
      "http://www.amnhealthcare.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r30",
      "r56",
      "r57",
      "r58",
      "r535",
      "r557",
      "r561"
     ],
     "calculation": {
      "http://www.amnhealthcare.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "verboseLabel": "Accumulated other comprehensive income"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r55",
      "r58",
      "r65",
      "r66",
      "r67",
      "r115",
      "r116",
      "r117",
      "r434",
      "r552",
      "r553",
      "r578"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Income"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Acquired Finite-Lived Intangible Assets [Line Items]",
        "terseLabel": "Acquired Finite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "AcquiredFiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/AcquisitionsScheduleofIntangibleAssetsAcquiredDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": {
     "auth_ref": [
      "r244"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Acquired Finite-lived Intangible Assets, Weighted Average Useful Life",
        "terseLabel": "Intangible assets acquired, weighted average useful life"
       }
      }
     },
     "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_AcquisitionRelatedCostsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Category of acquisition-related costs allocated to (included in) reported pro forma earnings (supplemental pro forma information).",
        "label": "Acquisition-related Costs [Member]",
        "terseLabel": "Acquisition-related Costs"
       }
      }
     },
     "localname": "AcquisitionRelatedCostsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r28",
      "r388",
      "r493"
     ],
     "calculation": {
      "http://www.amnhealthcare.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.",
        "label": "Additional Paid in Capital",
        "verboseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r115",
      "r116",
      "r117",
      "r385",
      "r386",
      "r387",
      "r445"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-in Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r377",
      "r378",
      "r389",
      "r390"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Share-based compensation"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "verboseLabel": "Adjustments to reconcile net income to net cash provided by operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivable": {
     "auth_ref": [
      "r209",
      "r225",
      "r226",
      "r229"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable.",
        "label": "Accounts Receivable, Allowance for Credit Loss",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/BasisofPresentationReconciliationofActivityinAllowanceforCreditLossesforAccountsReceivableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": {
     "auth_ref": [
      "r34",
      "r209",
      "r225"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.",
        "label": "Accounts Receivable, Allowance for Credit Loss, Current",
        "verboseLabel": "Accounts receivable, allowance"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Accounts Receivable, Allowance for Credit Loss [Roll Forward]",
        "terseLabel": "Accounts Receivable, Allowance for Credit Loss [Roll Forward]"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableRollforward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/BasisofPresentationReconciliationofActivityinAllowanceforCreditLossesforAccountsReceivableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs": {
     "auth_ref": [
      "r228"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of direct write-downs of accounts receivable charged against the allowance.",
        "label": "Accounts Receivable, Allowance for Credit Loss, Writeoff",
        "negatedTerseLabel": "Amounts written off charged against the allowance"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableWriteOffs",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/BasisofPresentationReconciliationofActivityinAllowanceforCreditLossesforAccountsReceivableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r146"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "verboseLabel": "Common stock excluded from calculation of EPS (in shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/NetIncomePerCommonShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AssetImpairmentCharges": {
     "auth_ref": [
      "r97",
      "r250"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.",
        "label": "Asset Impairment Charges",
        "terseLabel": "Impairment charges"
       }
      }
     },
     "localname": "AssetImpairmentCharges",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/FairValueMeasurementNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r109",
      "r173",
      "r186",
      "r193",
      "r218",
      "r278",
      "r279",
      "r280",
      "r282",
      "r283",
      "r284",
      "r285",
      "r287",
      "r289",
      "r291",
      "r292",
      "r431",
      "r435",
      "r463",
      "r491",
      "r493",
      "r514",
      "r531"
     ],
     "calculation": {
      "http://www.amnhealthcare.com/role/CondensedConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "verboseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r10",
      "r12",
      "r53",
      "r109",
      "r218",
      "r278",
      "r279",
      "r280",
      "r282",
      "r283",
      "r284",
      "r285",
      "r287",
      "r289",
      "r291",
      "r292",
      "r431",
      "r435",
      "r463",
      "r491",
      "r493"
     ],
     "calculation": {
      "http://www.amnhealthcare.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Other current assets:",
        "verboseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/BalanceSheetDetailsDetails",
      "http://www.amnhealthcare.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecurities": {
     "auth_ref": [
      "r215",
      "r216",
      "r231",
      "r519"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale",
        "terseLabel": "Available-for-sale securities"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/FairValueMeasurementNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BalanceSheetRelatedDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Balance Sheet Related Disclosures [Abstract]",
        "terseLabel": "Balance Sheet Related Disclosures [Abstract]"
       }
      }
     },
     "localname": "BalanceSheetRelatedDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_BasisOfAccounting": {
     "auth_ref": [
      "r114"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting [Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "BasisOfAccounting",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/BasisofPresentation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r373",
      "r375"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/AcquisitionsNarrativeDetails",
      "http://www.amnhealthcare.com/role/AcquisitionsScheduleofIntangibleAssetsAcquiredDetails",
      "http://www.amnhealthcare.com/role/AcquisitionsScheduleofProFormaFinancialInformationDetails",
      "http://www.amnhealthcare.com/role/FairValueMeasurementReconciliationofChangesinContingentConsiderationLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r373",
      "r375",
      "r418",
      "r419"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/AcquisitionsNarrativeDetails",
      "http://www.amnhealthcare.com/role/AcquisitionsScheduleofIntangibleAssetsAcquiredDetails",
      "http://www.amnhealthcare.com/role/AcquisitionsScheduleofProFormaFinancialInformationDetails",
      "http://www.amnhealthcare.com/role/FairValueMeasurementReconciliationofChangesinContingentConsiderationLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition [Line Items]",
        "terseLabel": "Business Acquisition [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/AcquisitionsNarrativeDetails",
      "http://www.amnhealthcare.com/role/AcquisitionsScheduleofProFormaFinancialInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionProFormaInformationTextBlock": {
     "auth_ref": [
      "r415",
      "r416"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate.",
        "label": "Business Acquisition, Pro Forma Information [Table Text Block]",
        "terseLabel": "Schedule of Pro Forma Financial Information"
       }
      }
     },
     "localname": "BusinessAcquisitionProFormaInformationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/AcquisitionsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount": {
     "auth_ref": [
      "r426"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of goodwill arising from a business combination that is expected to be deductible for tax purposes.",
        "label": "Business Acquisition, Goodwill, Expected Tax Deductible Amount",
        "terseLabel": "Goodwill expected to be deductible for tax purposes"
       }
      }
     },
     "localname": "BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax": {
     "auth_ref": [
      "r415",
      "r416"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of pro forma income from continuing operations as if the business combination had been completed at the beginning of a period.",
        "label": "Business Acquisition, Pro Forma Income (Loss) from Continuing Operations, Net of Tax",
        "terseLabel": "Income from operations"
       }
      }
     },
     "localname": "BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/AcquisitionsScheduleofProFormaFinancialInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss": {
     "auth_ref": [
      "r415",
      "r416"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period.",
        "label": "Business Acquisition, Pro Forma Net Income (Loss)",
        "terseLabel": "Net income"
       }
      }
     },
     "localname": "BusinessAcquisitionsProFormaNetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/AcquisitionsScheduleofProFormaFinancialInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessAcquisitionsProFormaRevenue": {
     "auth_ref": [
      "r415",
      "r416"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.",
        "label": "Business Acquisition, Pro Forma Revenue",
        "terseLabel": "Revenue"
       }
      }
     },
     "localname": "BusinessAcquisitionsProFormaRevenue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/AcquisitionsScheduleofProFormaFinancialInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationAcquisitionRelatedCosts": {
     "auth_ref": [
      "r413"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.",
        "label": "Business Combination, Acquisition Related Costs",
        "terseLabel": "Acquisition-related costs"
       }
      }
     },
     "localname": "BusinessCombinationAcquisitionRelatedCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination and Asset Acquisition [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationAndAssetAcquisitionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1": {
     "auth_ref": [
      "r96",
      "r427"
     ],
     "calculation": {
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.",
        "label": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability",
        "terseLabel": "Change in fair value of contingent consideration"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationDisclosureTextBlock": {
     "auth_ref": [
      "r428"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).",
        "label": "Business Combination Disclosure [Text Block]",
        "verboseLabel": "Acquisitions"
       }
      }
     },
     "localname": "BusinessCombinationDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/Acquisitions"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual": {
     "auth_ref": [
      "r414"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the amount of earnings or loss of the acquiree since the acquisition date included in the consolidated income statement for the reporting period.",
        "label": "Business Combination, Pro Forma Information, Earnings or Loss of Acquiree since Acquisition Date, Actual",
        "terseLabel": "Pro forma information, income before income taxes of acquiree since acquisition date"
       }
      }
     },
     "localname": "BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual": {
     "auth_ref": [
      "r414"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the amount of revenue of the acquiree since the acquisition date included in the consolidated income statement for the reporting period.",
        "label": "Business Combination, Pro Forma Information, Revenue of Acquiree since Acquisition Date, Actual",
        "terseLabel": "Pro forma information, revenue of acquiree since acquisition date"
       }
      }
     },
     "localname": "BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents": {
     "auth_ref": [
      "r421"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents",
        "terseLabel": "Cash received"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles": {
     "auth_ref": [
      "r420",
      "r421"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of identifiable intangible assets recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles",
        "terseLabel": "Fair Value",
        "verboseLabel": "Identifiable intangible assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/AcquisitionsNarrativeDetails",
      "http://www.amnhealthcare.com/role/AcquisitionsScheduleofIntangibleAssetsAcquiredDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities": {
     "auth_ref": [
      "r421"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities",
        "terseLabel": "Liabilities assumed"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CapitalizedComputerSoftwareGross": {
     "auth_ref": [
      "r567"
     ],
     "calculation": {
      "http://www.amnhealthcare.com/role/BalanceSheetDetailsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated amortization of capitalized costs for computer software, including but not limited to, acquired and internally developed computer software.",
        "label": "Capitalized Computer Software, Gross",
        "terseLabel": "Software"
       }
      }
     },
     "localname": "CapitalizedComputerSoftwareGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/BalanceSheetDetailsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAcquiredFromAcquisition": {
     "auth_ref": [
      "r80"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the acquisition of business during the period (for example, cash that was held by the acquired business).",
        "label": "Cash Acquired from Acquisition",
        "verboseLabel": "Cash returned to the Company for final working capital settlement"
       }
      }
     },
     "localname": "CashAcquiredFromAcquisition",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r7",
      "r35",
      "r99"
     ],
     "calculation": {
      "http://www.amnhealthcare.com/role/BasisofPresentationReconciliationofCashCashEquivalentsandRestrictedCashDetails": {
       "order": 1.0,
       "parentTag": "amn_TotalCashCashEquivalentsAndRestrictedCashCashEquivalentsandInvestments",
       "weight": 1.0
      },
      "http://www.amnhealthcare.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents",
        "verboseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/BasisofPresentationReconciliationofCashCashEquivalentsandRestrictedCashDetails",
      "http://www.amnhealthcare.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy": {
     "auth_ref": [
      "r18",
      "r100",
      "r512"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Entity's cash and cash equivalents accounting policy with respect to restricted balances.  Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.",
        "label": "Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Cash, Cash Equivalents and Restricted Cash"
       }
      }
     },
     "localname": "CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/BasisofPresentationPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r93",
      "r99",
      "r105"
     ],
     "calculation": {
      "http://www.amnhealthcare.com/role/BasisofPresentationReconciliationofCashCashEquivalentsandRestrictedCashDetails_1": {
       "order": 1.0,
       "parentTag": "amn_TotalCashCashEquivalentsAndRestrictedCashCashEquivalentsandInvestments",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "periodEndLabel": "Cash, cash equivalents and restricted cash at end of period",
        "periodStartLabel": "Cash, cash equivalents and restricted cash at beginning of period",
        "verboseLabel": "Total cash, cash equivalents and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/BasisofPresentationReconciliationofCashCashEquivalentsandRestrictedCashDetails",
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r93",
      "r472"
     ],
     "calculation": {
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net increase (decrease) in cash, cash equivalents and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]",
        "verboseLabel": "Supplemental disclosures of non-cash investing and financing activities:"
       }
      }
     },
     "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashSurrenderValueOfLifeInsurance": {
     "auth_ref": [
      "r13",
      "r38"
     ],
     "calculation": {
      "http://www.amnhealthcare.com/role/BalanceSheetDetailsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of amounts which could be received based on the terms of the insurance contract upon surrendering life policies owned by the entity.",
        "label": "Cash Surrender Value of Life Insurance",
        "terseLabel": "Life insurance cash surrender value"
       }
      }
     },
     "localname": "CashSurrenderValueOfLifeInsurance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/BalanceSheetDetailsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommercialPaperMember": {
     "auth_ref": [
      "r275"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds.",
        "label": "Commercial Paper [Member]",
        "terseLabel": "Commercial paper"
       }
      }
     },
     "localname": "CommercialPaperMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/FairValueMeasurementFinancialAssetsandLiabilitiesDetails",
      "http://www.amnhealthcare.com/role/FairValueMeasurementNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r48",
      "r263",
      "r521",
      "r539"
     ],
     "calculation": {
      "http://www.amnhealthcare.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r260",
      "r261",
      "r262",
      "r272",
      "r564"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "Commitments and Contingencies: Legal Proceedings"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/CommitmentsandContingenciesLegalProceedings"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r115",
      "r116",
      "r445"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r26"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "verboseLabel": "Common stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r26"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "verboseLabel": "Common stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r26"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "verboseLabel": "Common stock, shares issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r26",
      "r329"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "verboseLabel": "Common stock, shares outstanding (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r26",
      "r493"
     ],
     "calculation": {
      "http://www.amnhealthcare.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "verboseLabel": "Common stock, $0.01 par value; 200,000 shares authorized; 49,836 issued and 47,275 outstanding at September\u00a030, 2021 and 49,614 issued and 47,053 outstanding at December\u00a031, 2020"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r61",
      "r63",
      "r64",
      "r71",
      "r524",
      "r542"
     ],
     "calculation": {
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofComprehensiveIncome": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "terseLabel": "Comprehensive income (loss)",
        "totalLabel": "Comprehensive income"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofComprehensiveIncome",
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityCurrent": {
     "auth_ref": [
      "r337",
      "r338",
      "r357"
     ],
     "calculation": {
      "http://www.amnhealthcare.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "Contract with Customer, Liability, Current",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": {
     "auth_ref": [
      "r358"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.",
        "label": "Contract with Customer, Liability, Revenue Recognized",
        "terseLabel": "Previously deferred revenue recognized during period"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityRevenueRecognized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/RevenueRecognitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CorporateNonSegmentMember": {
     "auth_ref": [
      "r184",
      "r185",
      "r186",
      "r187",
      "r189",
      "r195",
      "r197"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Corporate headquarters or functional department that may not earn revenues or may earn revenues that are only incidental to the activities of the entity and is not considered an operating segment.",
        "label": "Corporate, Non-Segment [Member]",
        "terseLabel": "Unallocated corporate overhead"
       }
      }
     },
     "localname": "CorporateNonSegmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/SegmentInformationReconciliationofRevenueandSegmentOperatingIncomebyReportableSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r76",
      "r505"
     ],
     "calculation": {
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "verboseLabel": "Cost of revenue"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSoldDepreciation": {
     "auth_ref": [
      "r74",
      "r252"
     ],
     "calculation": {
      "http://www.amnhealthcare.com/role/SegmentInformationReconciliationofRevenueandSegmentOperatingIncomebyReportableSegmentDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for allocation of cost of tangible asset over its useful life directly used in production of good and rendering of service.",
        "label": "Cost, Depreciation",
        "terseLabel": "Depreciation (included in cost of revenue)"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSoldDepreciation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/SegmentInformationReconciliationofRevenueandSegmentOperatingIncomebyReportableSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/AcquisitionsNarrativeDetails",
      "http://www.amnhealthcare.com/role/NotesPayableandCreditAgreementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/AcquisitionsNarrativeDetails",
      "http://www.amnhealthcare.com/role/NotesPayableandCreditAgreementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CustomerRelationshipsMember": {
     "auth_ref": [
      "r423"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.",
        "label": "Customer Relationships [Member]",
        "terseLabel": "Customer Relationships"
       }
      }
     },
     "localname": "CustomerRelationshipsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/AcquisitionsScheduleofIntangibleAssetsAcquiredDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r107",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r310",
      "r317",
      "r318",
      "r320",
      "r326"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "terseLabel": "Notes Payable and Credit Agreement"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/NotesPayableandCreditAgreement"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r21",
      "r22",
      "r23",
      "r108",
      "r113",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r298",
      "r300",
      "r306",
      "r307",
      "r308",
      "r309",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r322",
      "r323",
      "r324",
      "r325",
      "r483",
      "r515",
      "r517",
      "r530"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/FairValueMeasurementFairValueofFinancialInstrumentsDetails",
      "http://www.amnhealthcare.com/role/FairValueMeasurementNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r293",
      "r322",
      "r323",
      "r481",
      "r483",
      "r484"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "terseLabel": "Carrying Amount"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/FairValueMeasurementFairValueofFinancialInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFairValue": {
     "auth_ref": [
      "r308",
      "r322",
      "r323",
      "r461"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.",
        "label": "Debt Instrument, Fair Value Disclosure",
        "terseLabel": "Estimated Fair Value"
       }
      }
     },
     "localname": "DebtInstrumentFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/FairValueMeasurementFairValueofFinancialInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r45",
      "r294"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Interest rate"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/FairValueMeasurementNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/NotesPayableandCreditAgreementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r46",
      "r108",
      "r113",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r298",
      "r300",
      "r306",
      "r307",
      "r308",
      "r309",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r322",
      "r323",
      "r324",
      "r325",
      "r483"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/FairValueMeasurementFairValueofFinancialInstrumentsDetails",
      "http://www.amnhealthcare.com/role/FairValueMeasurementNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r46",
      "r108",
      "r113",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r298",
      "r300",
      "r306",
      "r307",
      "r308",
      "r309",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r319",
      "r322",
      "r323",
      "r324",
      "r325",
      "r330",
      "r331",
      "r332",
      "r333",
      "r480",
      "r481",
      "r483",
      "r484",
      "r529"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/NotesPayableandCreditAgreementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredCompensationLiabilityCurrent": {
     "auth_ref": [
      "r362",
      "r363"
     ],
     "calculation": {
      "http://www.amnhealthcare.com/role/BalanceSheetDetailsDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_EmployeeRelatedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements payable within one year (or the operating cycle, if longer). Represents currently earned compensation under compensation arrangements that is not actually paid until a later date.",
        "label": "Deferred Compensation Liability, Current",
        "terseLabel": "Deferred compensation"
       }
      }
     },
     "localname": "DeferredCompensationLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/BalanceSheetDetailsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r97",
      "r110",
      "r397",
      "r404",
      "r405",
      "r406"
     ],
     "calculation": {
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "verboseLabel": "Provision for deferred income taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r391",
      "r392"
     ],
     "calculation": {
      "http://www.amnhealthcare.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred Income Tax Liabilities, Net",
        "terseLabel": "Deferred income taxes, net"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationAndAmortization": {
     "auth_ref": [
      "r97",
      "r252"
     ],
     "calculation": {
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      },
      "http://www.amnhealthcare.com/role/SegmentInformationReconciliationofRevenueandSegmentOperatingIncomebyReportableSegmentDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.",
        "label": "Depreciation, Depletion and Amortization, Nonproduction",
        "terseLabel": "Depreciation and amortization (exclusive of depreciation included in cost of revenue)"
       }
      }
     },
     "localname": "DepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofComprehensiveIncome",
      "http://www.amnhealthcare.com/role/SegmentInformationReconciliationofRevenueandSegmentOperatingIncomebyReportableSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r97",
      "r168"
     ],
     "calculation": {
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and amortization (inclusive of depreciation included in cost of revenue)"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DevelopedTechnologyRightsMember": {
     "auth_ref": [
      "r424"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights to developed technology, which can include the right to develop, use, market, sell, or offer for sale products, compounds, or intellectual property.",
        "label": "Developed Technology Rights [Member]",
        "terseLabel": "Developed Technology"
       }
      }
     },
     "localname": "DevelopedTechnologyRightsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/AcquisitionsNarrativeDetails",
      "http://www.amnhealthcare.com/role/AcquisitionsScheduleofIntangibleAssetsAcquiredDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r356"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "terseLabel": "Disaggregation of Revenue"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/SegmentInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Earnings Per Share [Abstract]",
        "verboseLabel": "Net income per common share:"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r72",
      "r124",
      "r125",
      "r126",
      "r127",
      "r128",
      "r133",
      "r136",
      "r143",
      "r144",
      "r145",
      "r149",
      "r150",
      "r446",
      "r447",
      "r525",
      "r543"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Basic (in dollars per share)",
        "verboseLabel": "Net income per common share - basic (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofComprehensiveIncome",
      "http://www.amnhealthcare.com/role/NetIncomePerCommonShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r72",
      "r124",
      "r125",
      "r126",
      "r127",
      "r128",
      "r136",
      "r143",
      "r144",
      "r145",
      "r149",
      "r150",
      "r446",
      "r447",
      "r525",
      "r543"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Diluted (in dollars per share)",
        "verboseLabel": "Net income per common share - diluted (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofComprehensiveIncome",
      "http://www.amnhealthcare.com/role/NetIncomePerCommonShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "auth_ref": [
      "r146",
      "r147"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "terseLabel": "Net Income per Common Share"
       }
      }
     },
     "localname": "EarningsPerSharePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/BasisofPresentationPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r146",
      "r147",
      "r148",
      "r151"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "verboseLabel": "Net Income Per Common Share"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/NetIncomePerCommonShare"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r472"
     ],
     "calculation": {
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "verboseLabel": "Effect of exchange rate changes on cash"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r43"
     ],
     "calculation": {
      "http://www.amnhealthcare.com/role/BalanceSheetDetailsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.amnhealthcare.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee-related Liabilities, Current",
        "totalLabel": "Accrued compensation and benefits",
        "verboseLabel": "Accrued compensation and benefits"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/BalanceSheetDetailsDetails",
      "http://www.amnhealthcare.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Employee-related Liabilities [Abstract]",
        "terseLabel": "Accrued compensation and benefits:"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrentAndNoncurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/BalanceSheetDetailsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r2",
      "r65",
      "r66",
      "r67",
      "r115",
      "r116",
      "r117",
      "r120",
      "r129",
      "r131",
      "r152",
      "r222",
      "r329",
      "r334",
      "r385",
      "r386",
      "r387",
      "r400",
      "r401",
      "r445",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r552",
      "r553",
      "r554",
      "r578"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquitySecuritiesFvNi": {
     "auth_ref": [
      "r460"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.",
        "label": "Equity Securities, FV-NI, Current",
        "terseLabel": "Equity investment balance"
       }
      }
     },
     "localname": "EquitySecuritiesFvNi",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/FairValueMeasurementNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/FairValueMeasurementFairValueofFinancialInstrumentsDetails",
      "http://www.amnhealthcare.com/role/FairValueMeasurementFinancialAssetsandLiabilitiesDetails",
      "http://www.amnhealthcare.com/role/FairValueMeasurementNarrativeDetails",
      "http://www.amnhealthcare.com/role/FairValueMeasurementReconciliationofChangesinContingentConsiderationLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r448",
      "r449",
      "r450",
      "r458"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]",
        "verboseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/FairValueMeasurementFairValueofFinancialInstrumentsDetails",
      "http://www.amnhealthcare.com/role/FairValueMeasurementFinancialAssetsandLiabilitiesDetails",
      "http://www.amnhealthcare.com/role/FairValueMeasurementNarrativeDetails",
      "http://www.amnhealthcare.com/role/FairValueMeasurementReconciliationofChangesinContingentConsiderationLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain": {
     "auth_ref": [
      "r453"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Class of asset.",
        "label": "Asset Class [Domain]",
        "terseLabel": "Asset Class [Domain]"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/FairValueMeasurementFinancialAssetsandLiabilitiesDetails",
      "http://www.amnhealthcare.com/role/FairValueMeasurementNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueByAssetClassAxis": {
     "auth_ref": [
      "r448",
      "r458"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by class of asset.",
        "label": "Asset Class [Axis]",
        "terseLabel": "Asset Class [Axis]"
       }
      }
     },
     "localname": "FairValueByAssetClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/FairValueMeasurementFinancialAssetsandLiabilitiesDetails",
      "http://www.amnhealthcare.com/role/FairValueMeasurementNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r308",
      "r322",
      "r323",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r449",
      "r494",
      "r495",
      "r496"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/FairValueMeasurementFinancialAssetsandLiabilitiesDetails",
      "http://www.amnhealthcare.com/role/FairValueMeasurementNarrativeDetails",
      "http://www.amnhealthcare.com/role/FairValueMeasurementReconciliationofChangesinContingentConsiderationLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByLiabilityClassAxis": {
     "auth_ref": [
      "r457",
      "r458"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by class of liability.",
        "label": "Liability Class [Axis]",
        "terseLabel": "Liability Class [Axis]"
       }
      }
     },
     "localname": "FairValueByLiabilityClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/FairValueMeasurementFinancialAssetsandLiabilitiesDetails",
      "http://www.amnhealthcare.com/role/FairValueMeasurementReconciliationofChangesinContingentConsiderationLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r448",
      "r449",
      "r451",
      "r452",
      "r459"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Measurement Frequency [Axis]",
        "terseLabel": "Measurement Frequency [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/FairValueMeasurementFinancialAssetsandLiabilitiesDetails",
      "http://www.amnhealthcare.com/role/FairValueMeasurementNarrativeDetails",
      "http://www.amnhealthcare.com/role/FairValueMeasurementReconciliationofChangesinContingentConsiderationLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r457"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "verboseLabel": "Fair Value Measurement"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/FairValueMeasurement"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r308",
      "r365",
      "r366",
      "r371",
      "r372",
      "r449",
      "r494"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "verboseLabel": "Quoted\u00a0Prices\u00a0in Active\u00a0Markets for Identical Assets (Level 1)"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/FairValueMeasurementFinancialAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r308",
      "r322",
      "r323",
      "r365",
      "r366",
      "r371",
      "r372",
      "r449",
      "r495"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Significant Other Observable Inputs (Level 2)",
        "verboseLabel": "Level 2"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/FairValueMeasurementFinancialAssetsandLiabilitiesDetails",
      "http://www.amnhealthcare.com/role/FairValueMeasurementNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r308",
      "r322",
      "r323",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r449",
      "r496"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Level 3",
        "verboseLabel": "Significant Unobservable Inputs (Level 3)"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/FairValueMeasurementFinancialAssetsandLiabilitiesDetails",
      "http://www.amnhealthcare.com/role/FairValueMeasurementReconciliationofChangesinContingentConsiderationLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain": {
     "auth_ref": [
      "r453"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents classes of liabilities measured and disclosed at fair value.",
        "label": "Fair Value by Liability Class [Domain]",
        "terseLabel": "Fair Value by Liability Class [Domain]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/FairValueMeasurementFinancialAssetsandLiabilitiesDetails",
      "http://www.amnhealthcare.com/role/FairValueMeasurementReconciliationofChangesinContingentConsiderationLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]",
        "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/FairValueMeasurementReconciliationofChangesinContingentConsiderationLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": {
     "auth_ref": [
      "r453",
      "r458"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]",
        "terseLabel": "Reconciliations of Changes in the Fair Value of Contingent Consideration Liabilities"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/FairValueMeasurementTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement frequency.",
        "label": "Measurement Frequency [Domain]",
        "terseLabel": "Measurement Frequency [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/FairValueMeasurementFinancialAssetsandLiabilitiesDetails",
      "http://www.amnhealthcare.com/role/FairValueMeasurementNarrativeDetails",
      "http://www.amnhealthcare.com/role/FairValueMeasurementReconciliationofChangesinContingentConsiderationLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.",
        "label": "Fair Value Measurement, Policy [Policy Text Block]",
        "terseLabel": "Fair Value of Assets and Liabilities"
       }
      }
     },
     "localname": "FairValueMeasurementPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/BasisofPresentationPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings": {
     "auth_ref": [
      "r454"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings",
        "verboseLabel": "Change in fair value of contingent consideration liability from acquisition"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/FairValueMeasurementReconciliationofChangesinContingentConsiderationLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements": {
     "auth_ref": [
      "r455"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of settlements of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements",
        "verboseLabel": "Settlement of contingent consideration liability"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/FairValueMeasurementReconciliationofChangesinContingentConsiderationLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": {
     "auth_ref": [
      "r453"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value",
        "negatedPeriodEndLabel": "Ending balance",
        "negatedPeriodStartLabel": "Beginning balance"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/FairValueMeasurementReconciliationofChangesinContingentConsiderationLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r308",
      "r322",
      "r323",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r494",
      "r495",
      "r496"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/FairValueMeasurementFinancialAssetsandLiabilitiesDetails",
      "http://www.amnhealthcare.com/role/FairValueMeasurementNarrativeDetails",
      "http://www.amnhealthcare.com/role/FairValueMeasurementReconciliationofChangesinContingentConsiderationLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsNonrecurringMember": {
     "auth_ref": [
      "r448",
      "r449",
      "r451",
      "r452",
      "r456",
      "r459"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Infrequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, not frequently measured at fair value.",
        "label": "Fair Value, Nonrecurring [Member]",
        "terseLabel": "Fair Value, Measurements, Nonrecurring"
       }
      }
     },
     "localname": "FairValueMeasurementsNonrecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/FairValueMeasurementNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "auth_ref": [
      "r457",
      "r459"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.",
        "label": "Fair Value, Recurring [Member]",
        "terseLabel": "Fair Value, Measurements, Recurring"
       }
      }
     },
     "localname": "FairValueMeasurementsRecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/FairValueMeasurementFinancialAssetsandLiabilitiesDetails",
      "http://www.amnhealthcare.com/role/FairValueMeasurementNarrativeDetails",
      "http://www.amnhealthcare.com/role/FairValueMeasurementReconciliationofChangesinContingentConsiderationLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueNetAssetLiability": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of asset after deduction of liability.",
        "label": "Fair Value, Net Asset (Liability)",
        "terseLabel": "Assets (liabilities) measured at fair value",
        "verboseLabel": "Commercial paper"
       }
      }
     },
     "localname": "FairValueNetAssetLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/FairValueMeasurementFinancialAssetsandLiabilitiesDetails",
      "http://www.amnhealthcare.com/role/FairValueMeasurementNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueOfAssetsAcquired": {
     "auth_ref": [
      "r102",
      "r103",
      "r104"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fair value of assets acquired in noncash investing or financing activities.",
        "label": "Fair Value of Assets Acquired",
        "terseLabel": "Fair value of tangible assets acquired in acquisitions, net of cash and restricted cash received"
       }
      }
     },
     "localname": "FairValueOfAssetsAcquired",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Finite-Lived Intangible Asset, Useful Life",
        "terseLabel": "Useful Life"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/AcquisitionsNarrativeDetails",
      "http://www.amnhealthcare.com/role/AcquisitionsScheduleofIntangibleAssetsAcquiredDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r248"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "terseLabel": "Accumulated amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable": {
     "auth_ref": [
      "r243"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table containing detailed characteristics of finite-lived intangible assets acquired during a business combination. Finite-lived intangible assets are assets that have no physical form, but have expected future economic benefit, and are expected to be used over a defined period. Acquired finite-lived intangible assets are disclosed by major class (assets that can be grouped together because they are similar, either by their nature or by their use in operations of the Entity) and in total. Additionally, any significant residual value (the expected value of the asset at the end of its useful life) and the weighted-average amortization period are also disclosed.",
        "label": "Finite-Lived Intangible Assets Acquired as Part of Business Combination [Table]",
        "terseLabel": "Finite-Lived Intangible Assets Acquired as Part of Business Combination [Table]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/AcquisitionsScheduleofIntangibleAssetsAcquiredDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r243",
      "r245",
      "r248",
      "r249",
      "r506",
      "r510"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/AcquisitionsNarrativeDetails",
      "http://www.amnhealthcare.com/role/AcquisitionsScheduleofIntangibleAssetsAcquiredDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r243",
      "r247"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/AcquisitionsNarrativeDetails",
      "http://www.amnhealthcare.com/role/AcquisitionsScheduleofIntangibleAssetsAcquiredDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FurnitureAndFixturesGross": {
     "auth_ref": [
      "r253"
     ],
     "calculation": {
      "http://www.amnhealthcare.com/role/BalanceSheetDetailsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation of equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.",
        "label": "Furniture and Fixtures, Gross",
        "terseLabel": "Furniture and equipment"
       }
      }
     },
     "localname": "FurnitureAndFixturesGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/BalanceSheetDetailsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnDispositionOfAssets": {
     "auth_ref": [
      "r97",
      "r251",
      "r256"
     ],
     "calculation": {
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, excluding oil and gas property and timber property.",
        "label": "Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property",
        "negatedLabel": "Loss on disposal or sale of fixed assets"
       }
      }
     },
     "localname": "GainLossOnDispositionOfAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r234",
      "r235",
      "r493",
      "r513"
     ],
     "calculation": {
      "http://www.amnhealthcare.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "periodEndLabel": "Goodwill, ending balance",
        "periodStartLabel": "Goodwill, beginning balance",
        "terseLabel": "Goodwill",
        "verboseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/AcquisitionsNarrativeDetails",
      "http://www.amnhealthcare.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.amnhealthcare.com/role/SegmentInformationSummaryofGoodwillbyReportableSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAcquiredDuringPeriod": {
     "auth_ref": [
      "r237"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.",
        "label": "Goodwill, Acquired During Period",
        "terseLabel": "Goodwill from Synzi and SnapMD acquisition"
       }
      }
     },
     "localname": "GoodwillAcquiredDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/SegmentInformationSummaryofGoodwillbyReportableSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillImpairedAccumulatedImpairmentLoss": {
     "auth_ref": [
      "r236",
      "r239"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated impairment loss for an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Impaired, Accumulated Impairment Loss",
        "terseLabel": "Accumulated impairment loss"
       }
      }
     },
     "localname": "GoodwillImpairedAccumulatedImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/SegmentInformationSummaryofGoodwillbyReportableSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillPurchaseAccountingAdjustments": {
     "auth_ref": [
      "r238",
      "r412"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Purchase Accounting Adjustments",
        "terseLabel": "Goodwill adjustment for Stratus Video acquisition"
       }
      }
     },
     "localname": "GoodwillPurchaseAccountingAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/SegmentInformationSummaryofGoodwillbyReportableSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Goodwill [Roll Forward]",
        "terseLabel": "Goodwill [Roll Forward]"
       }
      }
     },
     "localname": "GoodwillRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/SegmentInformationSummaryofGoodwillbyReportableSegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r75",
      "r109",
      "r173",
      "r185",
      "r189",
      "r192",
      "r195",
      "r218",
      "r278",
      "r279",
      "r280",
      "r283",
      "r284",
      "r285",
      "r287",
      "r289",
      "r291",
      "r292",
      "r463"
     ],
     "calculation": {
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "totalLabel": "Gross profit"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossAttributableToParent": {
     "auth_ref": [
      "r67",
      "r77"
     ],
     "calculation": {
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of income (loss) attributable to parent. Includes, but is not limited to, income (loss) from continuing operations, discontinued operations and equity method investments.",
        "label": "Income (Loss) Attributable to Parent, before Tax",
        "totalLabel": "Income before income taxes"
       }
      }
     },
     "localname": "IncomeLossAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r69",
      "r173",
      "r185",
      "r189",
      "r192",
      "r195",
      "r511",
      "r522",
      "r527",
      "r544"
     ],
     "calculation": {
      "http://www.amnhealthcare.com/role/SegmentInformationReconciliationofRevenueandSegmentOperatingIncomebyReportableSegmentDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "totalLabel": "Income before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/SegmentInformationReconciliationofRevenueandSegmentOperatingIncomebyReportableSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r111",
      "r394",
      "r395",
      "r396",
      "r402",
      "r407",
      "r409",
      "r410",
      "r411"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "verboseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r112",
      "r130",
      "r131",
      "r171",
      "r393",
      "r403",
      "r408",
      "r545"
     ],
     "calculation": {
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "verboseLabel": "Income tax expense"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesPaidNet": {
     "auth_ref": [
      "r101"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.",
        "label": "Income Taxes Paid, Net",
        "verboseLabel": "Cash paid for income taxes"
       }
      }
     },
     "localname": "IncomeTaxesPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesReceivable": {
     "auth_ref": [
      "r51",
      "r520",
      "r540"
     ],
     "calculation": {
      "http://www.amnhealthcare.com/role/BalanceSheetDetailsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount due within one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes.",
        "label": "Income Taxes Receivable, Current",
        "terseLabel": "Income taxes receivable"
       }
      }
     },
     "localname": "IncomeTaxesReceivable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/BalanceSheetDetailsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
     "auth_ref": [
      "r96"
     ],
     "calculation": {
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.",
        "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities",
        "terseLabel": "Accounts payable and accrued expenses"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r96"
     ],
     "calculation": {
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedLabel": "Accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": {
     "auth_ref": [
      "r96",
      "r504"
     ],
     "calculation": {
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 18.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.",
        "label": "Increase (Decrease) in Contract with Customer, Liability",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "IncreaseDecreaseInContractWithCustomerLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities": {
     "auth_ref": [
      "r96"
     ],
     "calculation": {
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 16.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.",
        "label": "Increase (Decrease) in Employee Related Liabilities",
        "terseLabel": "Accrued compensation and benefits"
       }
      }
     },
     "localname": "IncreaseDecreaseInEmployeeRelatedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInIncomeTaxesReceivable": {
     "auth_ref": [
      "r96"
     ],
     "calculation": {
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in income taxes receivable, which represents the amount due from tax authorities for refunds of overpayments or recoveries of income taxes paid.",
        "label": "Increase (Decrease) in Income Taxes Receivable",
        "negatedTerseLabel": "Income taxes receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInIncomeTaxesReceivable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in assets and liabilities, net of effects from acquisitions:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherCurrentAssets": {
     "auth_ref": [
      "r96"
     ],
     "calculation": {
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in current assets classified as other.",
        "label": "Increase (Decrease) in Other Current Assets",
        "negatedTerseLabel": "Other current assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherCurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherNoncurrentAssets": {
     "auth_ref": [
      "r96"
     ],
     "calculation": {
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in noncurrent assets classified as other.",
        "label": "Increase (Decrease) in Other Noncurrent Assets",
        "negatedLabel": "Other assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherNoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingLiabilities": {
     "auth_ref": [
      "r96"
     ],
     "calculation": {
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 17.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating liabilities classified as other.",
        "label": "Increase (Decrease) in Other Operating Liabilities",
        "terseLabel": "Other liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidExpense": {
     "auth_ref": [
      "r96"
     ],
     "calculation": {
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.",
        "label": "Increase (Decrease) in Prepaid Expense",
        "negatedLabel": "Prepaid expenses"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInRestrictedCashAndInvestmentsForOperatingActivities": {
     "auth_ref": [
      "r96"
     ],
     "calculation": {
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 19.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in marketable securities and investments pledged or subject to withdrawal restrictions.",
        "label": "Increase (Decrease) in Restricted Investments for Operating Activities",
        "negatedTerseLabel": "Restricted investments balance"
       }
      }
     },
     "localname": "IncreaseDecreaseInRestrictedCashAndInvestmentsForOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r242",
      "r246"
     ],
     "calculation": {
      "http://www.amnhealthcare.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "verboseLabel": "Intangible assets, net of accumulated amortization of $262,253 and $215,234 at September\u00a030, 2021 and December\u00a031, 2020, respectively"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r68",
      "r167",
      "r479",
      "r482",
      "r526"
     ],
     "calculation": {
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossAttributableToParent",
       "weight": -1.0
      },
      "http://www.amnhealthcare.com/role/SegmentInformationReconciliationofRevenueandSegmentOperatingIncomebyReportableSegmentDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "terseLabel": "Interest expense, net, and other"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofComprehensiveIncome",
      "http://www.amnhealthcare.com/role/SegmentInformationReconciliationofRevenueandSegmentOperatingIncomebyReportableSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidCapitalized": {
     "auth_ref": [
      "r84",
      "r101"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest capitalized, classified as investing activity.",
        "label": "Interest Paid, Capitalized, Investing Activities",
        "verboseLabel": "Interest capitalized"
       }
      }
     },
     "localname": "InterestPaidCapitalized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofCashFlowsParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r90",
      "r94",
      "r101"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "verboseLabel": "Cash paid for interest (net of $248 and $300 capitalized for the nine months ended September 30, 2021 and 2020, respectively)"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentIncomeAmortizationOfDiscount": {
     "auth_ref": [
      "r79"
     ],
     "calculation": {
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 20.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accretion of purchase discount on nonoperating securities.",
        "label": "Investment Income, Amortization of Discount",
        "negatedTerseLabel": "Amortization of discount on investments"
       }
      }
     },
     "localname": "InvestmentIncomeAmortizationOfDiscount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseholdImprovementsGross": {
     "auth_ref": [
      "r14",
      "r253"
     ],
     "calculation": {
      "http://www.amnhealthcare.com/role/BalanceSheetDetailsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation of additions or improvements to assets held under a lease arrangement.",
        "label": "Leasehold Improvements, Gross",
        "terseLabel": "Leasehold improvements"
       }
      }
     },
     "localname": "LeaseholdImprovementsGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/BalanceSheetDetailsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]",
        "terseLabel": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "auth_ref": [
      "r489"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
        "label": "Lessee, Operating Leases [Text Block]",
        "terseLabel": "LEASES"
       }
      }
     },
     "localname": "LesseeOperatingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r42",
      "r109",
      "r187",
      "r218",
      "r278",
      "r279",
      "r280",
      "r283",
      "r284",
      "r285",
      "r287",
      "r289",
      "r291",
      "r292",
      "r432",
      "r435",
      "r436",
      "r463",
      "r491",
      "r492"
     ],
     "calculation": {
      "http://www.amnhealthcare.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r33",
      "r109",
      "r218",
      "r463",
      "r493",
      "r518",
      "r537"
     ],
     "calculation": {
      "http://www.amnhealthcare.com/role/CondensedConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and stockholders\u2019 equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "verboseLabel": "LIABILITIES AND STOCKHOLDERS\u2019 EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesAssumed1": {
     "auth_ref": [
      "r102",
      "r103",
      "r104"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fair value of liabilities assumed in noncash investing or financing activities.",
        "label": "Liabilities Assumed",
        "negatedTerseLabel": "Liabilities assumed"
       }
      }
     },
     "localname": "LiabilitiesAssumed1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r44",
      "r109",
      "r218",
      "r278",
      "r279",
      "r280",
      "r283",
      "r284",
      "r285",
      "r287",
      "r289",
      "r291",
      "r292",
      "r432",
      "r435",
      "r436",
      "r463",
      "r491",
      "r492",
      "r493"
     ],
     "calculation": {
      "http://www.amnhealthcare.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "verboseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilityForUncertainTaxPositionsNoncurrent": {
     "auth_ref": [
      "r47"
     ],
     "calculation": {
      "http://www.amnhealthcare.com/role/BalanceSheetDetailsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherLiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount recognized for uncertainty in income taxes classified as noncurrent.",
        "label": "Liability for Uncertainty in Income Taxes, Noncurrent",
        "terseLabel": "Unrecognized tax benefits"
       }
      }
     },
     "localname": "LiabilityForUncertainTaxPositionsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/BalanceSheetDetailsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r40"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Maximum borrowing capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/AcquisitionsNarrativeDetails",
      "http://www.amnhealthcare.com/role/NotesPayableandCreditAgreementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars.",
        "label": "Line of Credit [Member]",
        "terseLabel": "Line of Credit"
       }
      }
     },
     "localname": "LineOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/AcquisitionsNarrativeDetails",
      "http://www.amnhealthcare.com/role/NotesPayableandCreditAgreementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LitigationStatusAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by status of pending, threatened, or settled litigation.",
        "label": "Litigation Status [Axis]",
        "terseLabel": "Litigation Status [Axis]"
       }
      }
     },
     "localname": "LitigationStatusAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/CommitmentsandContingenciesLegalProceedingsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LitigationStatusDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Status of pending, threatened, or settled litigation.",
        "label": "Litigation Status [Domain]",
        "terseLabel": "Litigation Status [Domain]"
       }
      }
     },
     "localname": "LitigationStatusDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/CommitmentsandContingenciesLegalProceedingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r23",
      "r307",
      "r321",
      "r322",
      "r323",
      "r517",
      "r533"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt",
        "verboseLabel": "Term loan credit facility"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/AcquisitionsNarrativeDetails",
      "http://www.amnhealthcare.com/role/NotesPayableandCreditAgreementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermNotesPayable": {
     "auth_ref": [
      "r46"
     ],
     "calculation": {
      "http://www.amnhealthcare.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of notes payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.",
        "label": "Notes Payable, Noncurrent",
        "verboseLabel": "Notes payable, net of unamortized fees and premium"
       }
      }
     },
     "localname": "LongTermNotesPayable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r46"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/AcquisitionsNarrativeDetails",
      "http://www.amnhealthcare.com/role/FairValueMeasurementFairValueofFinancialInstrumentsDetails",
      "http://www.amnhealthcare.com/role/FairValueMeasurementNarrativeDetails",
      "http://www.amnhealthcare.com/role/NotesPayableandCreditAgreementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r46",
      "r276"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/AcquisitionsNarrativeDetails",
      "http://www.amnhealthcare.com/role/FairValueMeasurementFairValueofFinancialInstrumentsDetails",
      "http://www.amnhealthcare.com/role/FairValueMeasurementNarrativeDetails",
      "http://www.amnhealthcare.com/role/NotesPayableandCreditAgreementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LossContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Loss Contingencies [Line Items]",
        "terseLabel": "Loss Contingencies [Line Items]"
       }
      }
     },
     "localname": "LossContingenciesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/CommitmentsandContingenciesLegalProceedingsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesTable": {
     "auth_ref": [
      "r263",
      "r264",
      "r265",
      "r267",
      "r268",
      "r269",
      "r271",
      "r273",
      "r274"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.",
        "label": "Loss Contingencies [Table]",
        "terseLabel": "Loss Contingencies [Table]"
       }
      }
     },
     "localname": "LossContingenciesTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/CommitmentsandContingenciesLegalProceedingsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingencyAccrualCarryingValueCurrent": {
     "auth_ref": [
      "r263"
     ],
     "calculation": {
      "http://www.amnhealthcare.com/role/BalanceSheetDetailsDetails": {
       "order": 6.0,
       "parentTag": "amn_AccountsPayableAndAccruedExpensesExcludingAccruedCompensationAndBenefitsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss contingency liability expected to be resolved within one year or the normal operating cycle, if longer.",
        "label": "Loss Contingency, Accrual, Current",
        "terseLabel": "Loss contingencies"
       }
      }
     },
     "localname": "LossContingencyAccrualCarryingValueCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/BalanceSheetDetailsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease": {
     "auth_ref": [
      "r263"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in loss contingency liability.",
        "label": "Loss Contingency Accrual, Period Increase (Decrease)",
        "terseLabel": "Increase to loss contingency accruals"
       }
      }
     },
     "localname": "LossContingencyAccrualCarryingValuePeriodIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/CommitmentsandContingenciesLegalProceedingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyEstimateOfPossibleLoss": {
     "auth_ref": [
      "r266",
      "r270",
      "r273"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the estimated amount of loss from the specified contingency as of the balance sheet date.",
        "label": "Loss Contingency, Estimate of Possible Loss",
        "terseLabel": "Estimate of possible loss"
       }
      }
     },
     "localname": "LossContingencyEstimateOfPossibleLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/CommitmentsandContingenciesLegalProceedingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MoneyMarketFundsMember": {
     "auth_ref": [
      "r365"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities.",
        "label": "Money Market Funds [Member]",
        "terseLabel": "Money market funds"
       }
      }
     },
     "localname": "MoneyMarketFundsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/FairValueMeasurementFinancialAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r93"
     ],
     "calculation": {
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by (used in) financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Cash flows from financing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r93"
     ],
     "calculation": {
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Cash flows from investing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r93",
      "r95",
      "r98"
     ],
     "calculation": {
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Cash flows from operating activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r6",
      "r59",
      "r62",
      "r67",
      "r70",
      "r98",
      "r109",
      "r119",
      "r124",
      "r125",
      "r126",
      "r127",
      "r130",
      "r131",
      "r141",
      "r173",
      "r185",
      "r189",
      "r192",
      "r195",
      "r218",
      "r278",
      "r279",
      "r280",
      "r283",
      "r284",
      "r285",
      "r287",
      "r289",
      "r291",
      "r292",
      "r447",
      "r463",
      "r523",
      "r541"
     ],
     "calculation": {
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "negatedLabel": "Net loss",
        "verboseLabel": "Net income"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/AcquisitionsNarrativeDetails",
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": {
     "auth_ref": [
      "r124",
      "r125",
      "r126",
      "r127",
      "r133",
      "r134",
      "r142",
      "r145",
      "r173",
      "r185",
      "r189",
      "r192",
      "r195"
     ],
     "calculation": {
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.",
        "label": "Net Income (Loss) Available to Common Stockholders, Basic",
        "terseLabel": "Net income",
        "totalLabel": "Net income"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofComprehensiveIncome",
      "http://www.amnhealthcare.com/role/NetIncomePerCommonShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted": {
     "auth_ref": [
      "r135",
      "r137",
      "r138",
      "r139",
      "r140",
      "r142",
      "r145"
     ],
     "calculation": {
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofComprehensiveIncome": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.",
        "label": "Net Income (Loss) Available to Common Stockholders, Diluted",
        "terseLabel": "Net Income - diluted",
        "totalLabel": "Net income"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofComprehensiveIncome",
      "http://www.amnhealthcare.com/role/NetIncomePerCommonShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]",
        "terseLabel": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/BasisofPresentationReconciliationofActivityinAllowanceforCreditLossesforAccountsReceivableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable": {
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r118",
      "r119",
      "r120",
      "r121",
      "r122",
      "r123",
      "r126",
      "r132",
      "r149",
      "r213",
      "r214",
      "r219",
      "r220",
      "r221",
      "r222",
      "r223",
      "r224",
      "r277",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r398",
      "r399",
      "r400",
      "r401",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r490",
      "r507",
      "r508",
      "r509",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summarization of the changes in an accounting principle or a new accounting pronouncement, including the line items affected by the change and the financial effects of the change on those particular line items.",
        "label": "Accounting Standards Update and Change in Accounting Principle [Table]",
        "terseLabel": "New Accounting Pronouncements or Change in Accounting Principle [Table]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/BasisofPresentationReconciliationofActivityinAllowanceforCreditLossesforAccountsReceivableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Recently Adopted Accounting Pronouncements"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/BasisofPresentationPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncashInvestingAndFinancingItemsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Noncash Investing and Financing Items [Abstract]",
        "terseLabel": "Acquisitions:"
       }
      }
     },
     "localname": "NoncashInvestingAndFinancingItemsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NonrecurringAdjustmentAxis": {
     "auth_ref": [
      "r417"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information about material and nonrecurring adjustment directly attributable to the business combination(s) included in the reported pro forma revenue and earnings (supplemental pro forma information).",
        "label": "Nonrecurring Adjustment [Axis]",
        "terseLabel": "Nonrecurring Adjustment [Axis]"
       }
      }
     },
     "localname": "NonrecurringAdjustmentAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NonrecurringAdjustmentDomain": {
     "auth_ref": [
      "r417"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Material, nonrecurring adjustment(s) allocated (included) to (in) reported pro forma revenue and earnings (supplemental pro forma information).",
        "label": "Nonrecurring Adjustment [Domain]",
        "terseLabel": "Nonrecurring Adjustment [Domain]"
       }
      }
     },
     "localname": "NonrecurringAdjustmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NotesPayableCurrent": {
     "auth_ref": [
      "r41"
     ],
     "calculation": {
      "http://www.amnhealthcare.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer.",
        "label": "Notes Payable, Current",
        "terseLabel": "Current portion of notes payable"
       }
      }
     },
     "localname": "NotesPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NumberOfBusinessesAcquired": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of businesses acquired by the entity during the period.",
        "label": "Number of Businesses Acquired",
        "terseLabel": "Number of acquisitions"
       }
      }
     },
     "localname": "NumberOfBusinessesAcquired",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_NumberOfOperatingSegments": {
     "auth_ref": [
      "r161"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.",
        "label": "Number of Operating Segments",
        "terseLabel": "Number of reportable segments"
       }
      }
     },
     "localname": "NumberOfOperatingSegments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "totalLabel": "Total operating expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "verboseLabel": "Operating expenses:"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r173",
      "r185",
      "r189",
      "r192",
      "r195"
     ],
     "calculation": {
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossAttributableToParent",
       "weight": 1.0
      },
      "http://www.amnhealthcare.com/role/SegmentInformationReconciliationofRevenueandSegmentOperatingIncomebyReportableSegmentDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Income from operations",
        "verboseLabel": "Segment operating income"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofComprehensiveIncome",
      "http://www.amnhealthcare.com/role/SegmentInformationReconciliationofRevenueandSegmentOperatingIncomebyReportableSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r486"
     ],
     "calculation": {
      "http://www.amnhealthcare.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Current portion of operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r486"
     ],
     "calculation": {
      "http://www.amnhealthcare.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasePayments": {
     "auth_ref": [
      "r487",
      "r488"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.",
        "label": "Operating Lease, Payments",
        "verboseLabel": "Cash paid for amounts included in the measurement of operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeasePayments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r485"
     ],
     "calculation": {
      "http://www.amnhealthcare.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 7.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingSegmentsMember": {
     "auth_ref": [
      "r184",
      "r185",
      "r186",
      "r187",
      "r189",
      "r195"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Operating Segments [Member]",
        "terseLabel": "Operating segments"
       }
      }
     },
     "localname": "OperatingSegmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/SegmentInformationReconciliationofRevenueandSegmentOperatingIncomebyReportableSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherAccountsPayableAndAccruedLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://www.amnhealthcare.com/role/BalanceSheetDetailsDetails": {
       "order": 4.0,
       "parentTag": "amn_AccountsPayableAndAccruedExpensesExcludingAccruedCompensationAndBenefitsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities incurred and payable to vendors for goods and services received classified as other, and expenses incurred but not yet paid, payable within one year or the operating cycle, if longer.",
        "label": "Other Accounts Payable and Accrued Liabilities",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherAccountsPayableAndAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/BalanceSheetDetailsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Assets [Abstract]",
        "verboseLabel": "Other assets:"
       }
      }
     },
     "localname": "OtherAssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/BalanceSheetDetailsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherAssetsCurrent": {
     "auth_ref": [
      "r52",
      "r493"
     ],
     "calculation": {
      "http://www.amnhealthcare.com/role/BalanceSheetDetailsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.amnhealthcare.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current assets classified as other.",
        "label": "Other Assets, Current",
        "terseLabel": "Other current assets",
        "totalLabel": "Other current assets"
       }
      }
     },
     "localname": "OtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/BalanceSheetDetailsDetails",
      "http://www.amnhealthcare.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsMiscellaneous": {
     "auth_ref": [],
     "calculation": {
      "http://www.amnhealthcare.com/role/BalanceSheetDetailsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other miscellaneous assets.",
        "label": "Other Assets, Miscellaneous",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherAssetsMiscellaneous",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/BalanceSheetDetailsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsMiscellaneousCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.amnhealthcare.com/role/BalanceSheetDetailsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other miscellaneous assets expected to be realized or consumed within one year or operating cycle, if longer.",
        "label": "Other Assets, Miscellaneous, Current",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherAssetsMiscellaneousCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/BalanceSheetDetailsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r38"
     ],
     "calculation": {
      "http://www.amnhealthcare.com/role/BalanceSheetDetailsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.amnhealthcare.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other assets",
        "totalLabel": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/BalanceSheetDetailsDetails",
      "http://www.amnhealthcare.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r429",
      "r430",
      "r433"
     ],
     "calculation": {
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent",
        "terseLabel": "Foreign currency translation and other"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r60",
      "r63",
      "r429",
      "r430",
      "r433"
     ],
     "calculation": {
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent",
        "totalLabel": "Other comprehensive income (loss)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]",
        "terseLabel": "Other comprehensive income (loss):"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherEmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r43"
     ],
     "calculation": {
      "http://www.amnhealthcare.com/role/BalanceSheetDetailsDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_EmployeeRelatedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligations incurred for employer-related costs classified as other, payable within one year or the normal operating cycle, if longer.",
        "label": "Other Employee-related Liabilities, Current",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherEmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/BalanceSheetDetailsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesCurrent": {
     "auth_ref": [
      "r15",
      "r16",
      "r43",
      "r493"
     ],
     "calculation": {
      "http://www.amnhealthcare.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Current",
        "verboseLabel": "Other current liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r47"
     ],
     "calculation": {
      "http://www.amnhealthcare.com/role/BalanceSheetDetailsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.amnhealthcare.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "totalLabel": "Other long-term liabilities",
        "verboseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/BalanceSheetDetailsDetails",
      "http://www.amnhealthcare.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Liabilities, Noncurrent [Abstract]",
        "terseLabel": "Other long-term liabilities:"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/BalanceSheetDetailsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherNoncashIncomeExpense": {
     "auth_ref": [
      "r98"
     ],
     "calculation": {
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.",
        "label": "Other Noncash Income (Expense)",
        "negatedLabel": "Non-cash interest expense and other"
       }
      }
     },
     "localname": "OtherNoncashIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherSundryLiabilitiesNoncurrent": {
     "auth_ref": [
      "r24",
      "r516",
      "r532"
     ],
     "calculation": {
      "http://www.amnhealthcare.com/role/BalanceSheetDetailsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherLiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Obligations not otherwise itemized or categorized in the footnotes to the financial statements that are expected to be paid after one year (or the normal operating cycle, if longer), from the balance sheet date.",
        "label": "Other Sundry Liabilities, Noncurrent",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherSundryLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/BalanceSheetDetailsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfFinancingCosts": {
     "auth_ref": [
      "r89"
     ],
     "calculation": {
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for loan and debt issuance costs.",
        "label": "Payments of Financing Costs",
        "negatedTerseLabel": "Payment of financing costs"
       }
      }
     },
     "localname": "PaymentsOfFinancingCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [
      "r87"
     ],
     "calculation": {
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Payment, Tax Withholding, Share-based Payment Arrangement",
        "negatedLabel": "Cash paid for shares withheld for taxes"
       }
      }
     },
     "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesGross": {
     "auth_ref": [
      "r83",
      "r425"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.",
        "label": "Payments to Acquire Businesses, Gross",
        "terseLabel": "Cash consideration"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": {
     "auth_ref": [
      "r83"
     ],
     "calculation": {
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.",
        "label": "Payments to Acquire Businesses, Net of Cash Acquired",
        "negatedLabel": "Cash paid for acquisitions, net of cash and restricted cash received",
        "terseLabel": "Net cash paid for acquisitions"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireEquitySecuritiesFvNi": {
     "auth_ref": [
      "r91",
      "r217"
     ],
     "calculation": {
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to acquire investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as investing activity.",
        "label": "Payments to Acquire Equity Securities, FV-NI",
        "negatedLabel": "Purchase of equity investment"
       }
      }
     },
     "localname": "PaymentsToAcquireEquitySecuritiesFvNi",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireIntangibleAssets": {
     "auth_ref": [
      "r84"
     ],
     "calculation": {
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.",
        "label": "Payments to Acquire Intangible Assets",
        "negatedTerseLabel": "Cash paid for other intangibles"
       }
      }
     },
     "localname": "PaymentsToAcquireIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireLifeInsurancePolicies": {
     "auth_ref": [
      "r85",
      "r92"
     ],
     "calculation": {
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for payment of premium on corporate-owned life insurance policy, classified as investing activities. Includes, but is not limited to, bank-owned life insurance policy.",
        "label": "Payment to Acquire Life Insurance Policy, Investing Activities",
        "negatedTerseLabel": "Payments to fund deferred compensation plan"
       }
      }
     },
     "localname": "PaymentsToAcquireLifeInsurancePolicies",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireNotesReceivable": {
     "auth_ref": [
      "r82"
     ],
     "calculation": {
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to acquire an agreement for an unconditional promise by the maker to pay the entity (holder) a definite sum of money at a future date. Such amount may include accrued interest receivable in accordance with the terms of the note. The note also may contain provisions including a discount or premium, payable on demand, secured, or unsecured, interest bearing or noninterest bearing, among myriad other features and characteristics.",
        "label": "Payments to Acquire Notes Receivable",
        "negatedTerseLabel": "Purchase of convertible promissory notes"
       }
      }
     },
     "localname": "PaymentsToAcquireNotesReceivable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r84"
     ],
     "calculation": {
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Purchase and development of fixed assets"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireShortTermInvestments": {
     "auth_ref": [
      "r85"
     ],
     "calculation": {
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for securities or other assets acquired, which qualify for treatment as an investing activity and are to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.",
        "label": "Payments to Acquire Short-term Investments",
        "negatedTerseLabel": "Purchase of investments"
       }
      }
     },
     "localname": "PaymentsToAcquireShortTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PendingLitigationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Risk of loss associated with the outcome of pending litigation against the entity, for example, but not limited to, litigation in arbitration or within the trial process.",
        "label": "Pending Litigation [Member]",
        "terseLabel": "Pending Litigation"
       }
      }
     },
     "localname": "PendingLitigationMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/CommitmentsandContingenciesLegalProceedingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r25",
      "r327"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "verboseLabel": "Preferred stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r25"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "verboseLabel": "Preferred stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r25",
      "r327"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred stock, shares issued (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r25"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "verboseLabel": "Preferred stock, shares outstanding (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r25",
      "r493"
     ],
     "calculation": {
      "http://www.amnhealthcare.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "verboseLabel": "Preferred stock, $0.01 par value; 10,000 shares authorized; none issued and outstanding at September\u00a030, 2021 and December\u00a031, 2020"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseCurrent": {
     "auth_ref": [
      "r9",
      "r11",
      "r232",
      "r233"
     ],
     "calculation": {
      "http://www.amnhealthcare.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense, Current",
        "verboseLabel": "Prepaid expenses"
       }
      }
     },
     "localname": "PrepaidExpenseCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfSecuredDebt": {
     "auth_ref": [
      "r86"
     ],
     "calculation": {
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from amounts received from issuance of long-term debt that is wholly or partially secured by collateral. Excludes proceeds from tax exempt secured debt.",
        "label": "Proceeds from Issuance of Secured Debt",
        "terseLabel": "Proceeds from term loans"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfSecuredDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt": {
     "auth_ref": [
      "r86"
     ],
     "calculation": {
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a borrowing with the highest claim on the assets of the entity in case of bankruptcy or liquidation (with maturities initially due after one year or beyond the operating cycle, if longer).",
        "label": "Proceeds from Issuance of Senior Long-term Debt",
        "terseLabel": "Proceeds from senior notes"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfSeniorLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromLinesOfCredit": {
     "auth_ref": [
      "r86",
      "r108"
     ],
     "calculation": {
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.",
        "label": "Proceeds from Lines of Credit",
        "verboseLabel": "Proceeds from revolving credit facility"
       }
      }
     },
     "localname": "ProceedsFromLinesOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromPreviousAcquisition": {
     "auth_ref": [
      "r81"
     ],
     "calculation": {
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash inflow representing an adjustment to the purchase price of a previous acquisition.",
        "label": "Proceeds from Previous Acquisition",
        "terseLabel": "Cash received for working capital adjustments for prior year acquisitions"
       }
      }
     },
     "localname": "ProceedsFromPreviousAcquisition",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments": {
     "auth_ref": [
      "r81"
     ],
     "calculation": {
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the sale, maturity and collection of all investments such as debt, security and so forth during the period.",
        "label": "Proceeds from Sale, Maturity and Collection of Investments",
        "terseLabel": "Proceeds from maturity of investments"
       }
      }
     },
     "localname": "ProceedsFromSaleMaturityAndCollectionsOfInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfTradingSecuritiesHeldforinvestment": {
     "auth_ref": [],
     "calculation": {
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the sale of securities classified as trading securities and held for investment purposes. Excludes proceeds from trading securities purchased and held principally for the purpose of selling them in the near term (thus held for only a short period of time).",
        "label": "Proceeds from Sale of Debt and Equity Securities, FV-NI, Held-for-investment",
        "terseLabel": "Proceeds from sale of equity investment"
       }
      }
     },
     "localname": "ProceedsFromSaleOfTradingSecuritiesHeldforinvestment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r36",
      "r253"
     ],
     "calculation": {
      "http://www.amnhealthcare.com/role/BalanceSheetDetailsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "totalLabel": "Fixed assets, gross"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/BalanceSheetDetailsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r19",
      "r20",
      "r255",
      "r493",
      "r528",
      "r538"
     ],
     "calculation": {
      "http://www.amnhealthcare.com/role/BalanceSheetDetailsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.amnhealthcare.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "totalLabel": "Fixed assets, net",
        "verboseLabel": "Fixed assets, net of accumulated depreciation of $190,578 and $161,752 at September\u00a030, 2021 and December\u00a031, 2020, respectively"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/BalanceSheetDetailsDetails",
      "http://www.amnhealthcare.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment, Net [Abstract]",
        "terseLabel": "Fixed assets:"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/BalanceSheetDetailsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ProvisionForDoubtfulAccounts": {
     "auth_ref": [
      "r73",
      "r227"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable.",
        "label": "Accounts Receivable, Credit Loss Expense (Reversal)",
        "terseLabel": "Provision for expected credit losses"
       }
      }
     },
     "localname": "ProvisionForDoubtfulAccounts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/BasisofPresentationReconciliationofActivityinAllowanceforCreditLossesforAccountsReceivableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable": {
     "auth_ref": [
      "r184",
      "r189"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification, description, and amounts of all significant reconciling items in the reconciliation of total revenues from reportable segments to the entity's consolidated revenues.",
        "label": "Reconciliation of Revenue from Segments to Consolidated [Table]",
        "terseLabel": "Reconciliation Of Revenue From Segments To Consolidated [Table]"
       }
      }
     },
     "localname": "ReconciliationOfRevenueFromSegmentsToConsolidatedTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/SegmentInformationReconciliationofRevenueandSegmentOperatingIncomebyReportableSegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RepaymentsOfLinesOfCredit": {
     "auth_ref": [
      "r88",
      "r108"
     ],
     "calculation": {
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.",
        "label": "Repayments of Lines of Credit",
        "negatedTerseLabel": "Payments on revolving credit facility"
       }
      }
     },
     "localname": "RepaymentsOfLinesOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfSecuredDebt": {
     "auth_ref": [
      "r88"
     ],
     "calculation": {
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to repay long-term debt that is wholly or partially secured by collateral. Excludes repayments of tax exempt secured debt.",
        "label": "Repayments of Secured Debt",
        "negatedLabel": "Payments on term loans"
       }
      }
     },
     "localname": "RepaymentsOfSecuredDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedCashAndCashEquivalents": {
     "auth_ref": [
      "r18",
      "r99",
      "r105",
      "r512",
      "r534"
     ],
     "calculation": {
      "http://www.amnhealthcare.com/role/BalanceSheetDetailsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherAssetsCurrent",
       "weight": 1.0
      },
      "http://www.amnhealthcare.com/role/BasisofPresentationReconciliationofCashCashEquivalentsandRestrictedCashDetails": {
       "order": 2.0,
       "parentTag": "amn_TotalCashCashEquivalentsAndRestrictedCashCashEquivalentsandInvestments",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Restricted Cash and Cash Equivalents",
        "terseLabel": "Restricted cash and cash equivalents",
        "verboseLabel": "Restricted cash and cash equivalents (included in other current assets)"
       }
      }
     },
     "localname": "RestrictedCashAndCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/BalanceSheetDetailsDetails",
      "http://www.amnhealthcare.com/role/BasisofPresentationReconciliationofCashCashEquivalentsandRestrictedCashDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedCashAndInvestmentsNoncurrent": {
     "auth_ref": [
      "r562",
      "r563"
     ],
     "calculation": {
      "http://www.amnhealthcare.com/role/BasisofPresentationReconciliationofCashCashEquivalentsandRestrictedCashDetails": {
       "order": 3.0,
       "parentTag": "amn_TotalCashCashEquivalentsAndRestrictedCashCashEquivalentsandInvestments",
       "weight": 1.0
      },
      "http://www.amnhealthcare.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The noncurrent cash, cash equivalents and investments that is restricted as to withdrawal or usage. Restrictions may include legally restricted deposits held as compensating balances against borrowing arrangements, contracts entered into with others, or entity statements of intention with regard to particular deposits classified as long-term; that is not expected to be released from such existing restrictions within one year of the balance sheet date or operating cycle, whichever is longer. Excludes compensating balance arrangements that are not agreements which legally restrict the use of cash amounts shown on the balance sheet. Includes noncurrent cash equivalents and investments that are similarly restricted as to withdrawal, usage or disposal.",
        "label": "Restricted Cash and Investments, Noncurrent",
        "terseLabel": "Restricted cash, cash equivalents and investments",
        "verboseLabel": "Restricted cash, cash equivalents and investments"
       }
      }
     },
     "localname": "RestrictedCashAndInvestmentsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/BasisofPresentationReconciliationofCashCashEquivalentsandRestrictedCashDetails",
      "http://www.amnhealthcare.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedInvestments": {
     "auth_ref": [
      "r562",
      "r563"
     ],
     "calculation": {
      "http://www.amnhealthcare.com/role/BasisofPresentationReconciliationofCashCashEquivalentsandRestrictedCashDetails_1": {
       "order": 2.0,
       "parentTag": "amn_TotalCashCashEquivalentsAndRestrictedCashCashEquivalentsandInvestments",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investments which are not defined as or included in marketable (debt, equity, or other) securities whose use is restricted in whole or in part, generally by contractual agreements or regulatory requirements. For use in an unclassified balance sheet.",
        "label": "Restricted Investments",
        "negatedTerseLabel": "Less restricted investments"
       }
      }
     },
     "localname": "RestrictedInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/BasisofPresentationReconciliationofCashCashEquivalentsandRestrictedCashDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r29",
      "r334",
      "r388",
      "r493",
      "r536",
      "r556",
      "r561"
     ],
     "calculation": {
      "http://www.amnhealthcare.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "verboseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r2",
      "r115",
      "r116",
      "r117",
      "r120",
      "r129",
      "r131",
      "r222",
      "r385",
      "r386",
      "r387",
      "r400",
      "r401",
      "r445",
      "r552",
      "r554"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained Earnings"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Contract with Customer [Abstract]",
        "terseLabel": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r164",
      "r165",
      "r184",
      "r190",
      "r191",
      "r198",
      "r199",
      "r201",
      "r355",
      "r356",
      "r505"
     ],
     "calculation": {
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Revenue",
        "verboseLabel": "Revenue"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofComprehensiveIncome",
      "http://www.amnhealthcare.com/role/SegmentInformationDisaggregationofRevenueDetails",
      "http://www.amnhealthcare.com/role/SegmentInformationReconciliationofRevenueandSegmentOperatingIncomebyReportableSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
     "auth_ref": [
      "r106",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r361"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue from contract with customer.",
        "label": "Revenue from Contract with Customer [Policy Text Block]",
        "terseLabel": "Revenue Recognition"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/BasisofPresentationPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "auth_ref": [
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r359",
      "r361"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.",
        "label": "Revenue from Contract with Customer [Text Block]",
        "terseLabel": "Revenue Recognition"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/RevenueRecognition"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.",
        "label": "Revolving Credit Facility [Member]",
        "terseLabel": "Senior Credit Facility",
        "verboseLabel": "Revolving Credit Facility"
       }
      }
     },
     "localname": "RevolvingCreditFacilityMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/AcquisitionsNarrativeDetails",
      "http://www.amnhealthcare.com/role/NotesPayableandCreditAgreementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "auth_ref": [
      "r418",
      "r419"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/AcquisitionsNarrativeDetails",
      "http://www.amnhealthcare.com/role/AcquisitionsScheduleofProFormaFinancialInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of supplemental cash flow information for the periods presented.",
        "label": "Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]",
        "terseLabel": "Reconciliation of Cash, Cash Equivalents and Restricted Cash"
       }
      }
     },
     "localname": "ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/BasisofPresentationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r145"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "verboseLabel": "Computation of Basic and Diluted Net Income Per Common Share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/NetIncomePerCommonShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": {
     "auth_ref": [
      "r448",
      "r449"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]",
        "verboseLabel": "Schedule of Financial Assets and Liabilities Measured at Fair Value on Recurring Basis"
       }
      }
     },
     "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/FairValueMeasurementTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTextBlock": {
     "auth_ref": [
      "r461",
      "r462"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined) which are not recognized in the financial statements (off-balance sheet) because they fail to meet some other criterion for recognition.",
        "label": "Schedule of Fair Value, Off-balance Sheet Risks [Table Text Block]",
        "terseLabel": "Schedule of Fair Value of Financial Instruments"
       }
      }
     },
     "localname": "ScheduleOfFairValueOffBalanceSheetRisksTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/FairValueMeasurementTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock": {
     "auth_ref": [
      "r243"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of finite-lived intangible assets acquired as part of a business combination or through an asset purchase, by major class and in total, including the value of the asset acquired, any significant residual value (the expected value of the asset at the end of its useful life) and the weighted-average amortization period.",
        "label": "Schedule of Finite-Lived Intangible Assets Acquired as Part of Business Combination [Table Text Block]",
        "terseLabel": "Schedule of Intangible Assets Acquired"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/AcquisitionsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "auth_ref": [
      "r240",
      "r241"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.",
        "label": "Schedule of Goodwill [Table Text Block]",
        "terseLabel": "Summary of Goodwill by Reportable Segment"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/SegmentInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r173",
      "r176",
      "r188",
      "r240"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/SegmentInformationDisaggregationofRevenueDetails",
      "http://www.amnhealthcare.com/role/SegmentInformationSummaryofGoodwillbyReportableSegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "auth_ref": [
      "r173",
      "r176",
      "r188",
      "r240"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "verboseLabel": "Reconciliation of Revenue and Segment Operating Income by Reportable Segment"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/SegmentInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SecuredDebtMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collateralized debt obligation backed by, for example, but not limited to, pledge, mortgage or other lien on the entity's assets.",
        "label": "Secured Debt [Member]",
        "verboseLabel": "Term Loan"
       }
      }
     },
     "localname": "SecuredDebtMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/AcquisitionsNarrativeDetails",
      "http://www.amnhealthcare.com/role/NotesPayableandCreditAgreementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r160",
      "r164",
      "r165",
      "r166",
      "r167",
      "r168",
      "r169",
      "r170",
      "r171",
      "r172",
      "r173",
      "r174",
      "r175",
      "r184",
      "r185",
      "r186",
      "r187",
      "r189",
      "r190",
      "r191",
      "r192",
      "r193",
      "r195",
      "r201",
      "r258",
      "r259",
      "r546"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segments [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/SegmentInformationDisaggregationofRevenueDetails",
      "http://www.amnhealthcare.com/role/SegmentInformationReconciliationofRevenueandSegmentOperatingIncomebyReportableSegmentDetails",
      "http://www.amnhealthcare.com/role/SegmentInformationSummaryofGoodwillbyReportableSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]",
        "terseLabel": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r160",
      "r162",
      "r163",
      "r173",
      "r177",
      "r189",
      "r193",
      "r194",
      "r195",
      "r196",
      "r198",
      "r200",
      "r201",
      "r202"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "verboseLabel": "Segment Information"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/SegmentInformation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Segment Reporting Information [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/SegmentInformationDisaggregationofRevenueDetails",
      "http://www.amnhealthcare.com/role/SegmentInformationSummaryofGoodwillbyReportableSegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingPolicyPolicyTextBlock": {
     "auth_ref": [
      "r178",
      "r179",
      "r180",
      "r181",
      "r182",
      "r183",
      "r199"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for segment reporting.",
        "label": "Segment Reporting, Policy [Policy Text Block]",
        "terseLabel": "Segment Information"
       }
      }
     },
     "localname": "SegmentReportingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/BasisofPresentationPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingRevenueReconcilingItemLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting, Revenue Reconciling Item [Line Items]",
        "terseLabel": "Segment Reporting, Revenue Reconciling Item [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingRevenueReconcilingItemLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/SegmentInformationReconciliationofRevenueandSegmentOperatingIncomebyReportableSegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SelfInsuranceReserveCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.amnhealthcare.com/role/BalanceSheetDetailsDetails": {
       "order": 3.0,
       "parentTag": "amn_AccountsPayableAndAccruedExpensesExcludingAccruedCompensationAndBenefitsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount of accrued known and estimated losses incurred as of the balance sheet date for which no insurance coverage exists, and for which a claim has been made or is probable of being asserted, typically arising from workmen's compensation-type of incidents and personal injury to nonemployees from accidents on the entity's property that are expected to be paid within one year (or the normal operating cycle, if longer).",
        "label": "Self Insurance Reserve, Current",
        "terseLabel": "Professional liability reserve"
       }
      }
     },
     "localname": "SelfInsuranceReserveCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/BalanceSheetDetailsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SelfInsuranceReserveNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.amnhealthcare.com/role/BalanceSheetDetailsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherLiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount of accrued known and estimated losses incurred as of the balance sheet date for which no insurance coverage exists, and for which a claim has been made or is probable of being asserted, typically arising from workmen's compensation-type of incidents and personal injury to nonemployees from accidents on the entity's property that are expected to be paid after one year (or the normal operating cycle, if longer).",
        "label": "Self Insurance Reserve, Noncurrent",
        "terseLabel": "Professional liability reserve"
       }
      }
     },
     "localname": "SelfInsuranceReserveNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/BalanceSheetDetailsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r78"
     ],
     "calculation": {
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "verboseLabel": "Selling, general and administrative"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bond that takes priority over other debt securities sold by the issuer. In the event the issuer goes bankrupt, senior debt holders receive priority for (must receive) repayment prior to (relative to) junior and unsecured (general) creditors.",
        "label": "Senior Notes [Member]",
        "terseLabel": "Senior Notes"
       }
      }
     },
     "localname": "SeniorNotesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/FairValueMeasurementFairValueofFinancialInstrumentsDetails",
      "http://www.amnhealthcare.com/role/FairValueMeasurementNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r96"
     ],
     "calculation": {
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.amnhealthcare.com/role/SegmentInformationReconciliationofRevenueandSegmentOperatingIncomebyReportableSegmentDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Noncash Expense",
        "netLabel": "Share-based compensation",
        "verboseLabel": "Share-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.amnhealthcare.com/role/SegmentInformationReconciliationofRevenueandSegmentOperatingIncomebyReportableSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharesIssued": {
     "auth_ref": [
      "r329"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.",
        "label": "Shares, Issued",
        "periodEndLabel": "Ending balance (in shares)",
        "periodStartLabel": "Beginning balance (in shares)"
       }
      }
     },
     "localname": "SharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r5",
      "r160",
      "r164",
      "r165",
      "r166",
      "r167",
      "r168",
      "r169",
      "r170",
      "r171",
      "r172",
      "r173",
      "r174",
      "r175",
      "r184",
      "r185",
      "r186",
      "r187",
      "r189",
      "r190",
      "r191",
      "r192",
      "r193",
      "r195",
      "r201",
      "r240",
      "r257",
      "r258",
      "r259",
      "r546"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments [Axis]"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/SegmentInformationDisaggregationofRevenueDetails",
      "http://www.amnhealthcare.com/role/SegmentInformationReconciliationofRevenueandSegmentOperatingIncomebyReportableSegmentDetails",
      "http://www.amnhealthcare.com/role/SegmentInformationSummaryofGoodwillbyReportableSegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r2",
      "r50",
      "r65",
      "r66",
      "r67",
      "r115",
      "r116",
      "r117",
      "r120",
      "r129",
      "r131",
      "r152",
      "r222",
      "r329",
      "r334",
      "r385",
      "r386",
      "r387",
      "r400",
      "r401",
      "r445",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r552",
      "r553",
      "r554",
      "r578"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r115",
      "r116",
      "r117",
      "r152",
      "r505"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": {
     "auth_ref": [
      "r25",
      "r26",
      "r329",
      "r334"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture",
        "terseLabel": "Equity awards vested and exercised, net of shares withheld for payroll taxes (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
     "auth_ref": [
      "r25",
      "r26",
      "r334",
      "r379",
      "r380"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture",
        "terseLabel": "Equity awards vested and exercised, net of shares withheld for payroll taxes"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r26",
      "r31",
      "r32",
      "r109",
      "r211",
      "r218",
      "r463",
      "r493"
     ],
     "calculation": {
      "http://www.amnhealthcare.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "totalLabel": "Total stockholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "verboseLabel": "Stockholders\u2019 equity:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SupplementalBalanceSheetDisclosuresTextBlock": {
     "auth_ref": [
      "r54"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity.",
        "label": "Supplemental Balance Sheet Disclosures [Text Block]",
        "terseLabel": "Balance Sheet Details"
       }
      }
     },
     "localname": "SupplementalBalanceSheetDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/BalanceSheetDetails"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "verboseLabel": "Supplemental disclosures of cash flow information:"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TradeAndOtherAccountsReceivablePolicy": {
     "auth_ref": [
      "r205",
      "r206",
      "r207",
      "r208",
      "r210",
      "r212"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for accounts receivable.",
        "label": "Accounts Receivable [Policy Text Block]",
        "terseLabel": "Accounts Receivable"
       }
      }
     },
     "localname": "TradeAndOtherAccountsReceivablePolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/BasisofPresentationPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_TrademarksAndTradeNamesMember": {
     "auth_ref": [
      "r422"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style, or rights either acquired through registration of a business name to gain or protect exclusive use thereof.",
        "label": "Trademarks and Trade Names [Member]",
        "terseLabel": "Tradenames and Trademarks"
       }
      }
     },
     "localname": "TrademarksAndTradeNamesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/AcquisitionsNarrativeDetails",
      "http://www.amnhealthcare.com/role/AcquisitionsScheduleofIntangibleAssetsAcquiredDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TrademarksMember": {
     "auth_ref": [
      "r422"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style.",
        "label": "Trademarks [Member]",
        "terseLabel": "Trademarks"
       }
      }
     },
     "localname": "TrademarksMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockMember": {
     "auth_ref": [
      "r49",
      "r335"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Treasury Stock [Member]",
        "terseLabel": "Treasury Stock"
       }
      }
     },
     "localname": "TreasuryStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockShares": {
     "auth_ref": [
      "r49",
      "r335"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.",
        "label": "Treasury Stock, Shares",
        "terseLabel": "Treasury stock (in shares)"
       }
      }
     },
     "localname": "TreasuryStockShares",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockValue": {
     "auth_ref": [
      "r49",
      "r335",
      "r336"
     ],
     "calculation": {
      "http://www.amnhealthcare.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.",
        "label": "Treasury Stock, Value",
        "negatedTerseLabel": "Treasury stock, at cost; 2,561 shares at September\u00a030, 2021 and December\u00a031, 2020"
       }
      }
     },
     "localname": "TreasuryStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r153",
      "r154",
      "r155",
      "r156",
      "r157",
      "r158",
      "r159"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/BasisofPresentationPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment": {
     "auth_ref": [
      "r145"
     ],
     "calculation": {
      "http://www.amnhealthcare.com/role/NetIncomePerCommonShareDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.",
        "label": "Weighted Average Number Diluted Shares Outstanding Adjustment",
        "verboseLabel": "Plus dilutive effect of potential common shares (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/NetIncomePerCommonShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r135",
      "r145"
     ],
     "calculation": {
      "http://www.amnhealthcare.com/role/NetIncomePerCommonShareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "totalLabel": "Weighted average common shares outstanding - diluted (in shares)",
        "verboseLabel": "Diluted (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofComprehensiveIncome",
      "http://www.amnhealthcare.com/role/NetIncomePerCommonShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]",
        "verboseLabel": "Weighted average common shares outstanding:"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r133",
      "r145"
     ],
     "calculation": {
      "http://www.amnhealthcare.com/role/NetIncomePerCommonShareDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Weighted average common shares outstanding - basic (in shares)",
        "verboseLabel": "Basic (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofComprehensiveIncome",
      "http://www.amnhealthcare.com/role/NetIncomePerCommonShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WorkersCompensationLiabilityCurrent": {
     "auth_ref": [
      "r43"
     ],
     "calculation": {
      "http://www.amnhealthcare.com/role/BalanceSheetDetailsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_EmployeeRelatedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations and payables pertaining to claims incurred of a workers compensation nature. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Workers' Compensation Liability, Current",
        "terseLabel": "Workers compensation reserve"
       }
      }
     },
     "localname": "WorkersCompensationLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/BalanceSheetDetailsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_WorkersCompensationLiabilityNoncurrent": {
     "auth_ref": [
      "r47"
     ],
     "calculation": {
      "http://www.amnhealthcare.com/role/BalanceSheetDetailsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherLiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations and payables pertaining to claims incurred of a workers compensation nature. Used to reflect the noncurrent portion of the liabilities (due beyond one year; or beyond one operating cycle if longer).",
        "label": "Workers' Compensation Liability, Noncurrent",
        "terseLabel": "Workers compensation reserve"
       }
      }
     },
     "localname": "WorkersCompensationLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/BalanceSheetDetailsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_WriteOffOfDeferredDebtIssuanceCost": {
     "auth_ref": [
      "r79"
     ],
     "calculation": {
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 23.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Write-off of amounts previously capitalized as debt issuance cost in an extinguishment of debt.",
        "label": "Write off of Deferred Debt Issuance Cost",
        "terseLabel": "Write-off of fees on credit facilities and senior notes"
       }
      }
     },
     "localname": "WriteOffOfDeferredDebtIssuanceCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.amnhealthcare.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    }
   },
   "unitCount": 7
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4273-108586"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4297-108586"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4304-108586"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4313-108586"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4332-108586"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=SL98516268-108586"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(c))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6787-107765"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21728-107793"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6812-107765"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1448-109256"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1377-109256"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1505-109256"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1930-109256"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1930-109256"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1930-109256"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6812-107765"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1930-109256"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e3842-109258"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e4984-109258"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "http://asc.fasb.org/topic&trid=2144383"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6911-107765"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8657-108599"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8672-108599"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8844-108599"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8981-108599"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8475-108599"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "http://asc.fasb.org/topic&trid=2134510"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e4975-111524"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=SL6953423-111524"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5212-111524"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5033-111524"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5093-111524"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10133-111534"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124402435&loc=SL124402458-218513"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124402435&loc=SL124402458-218513"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=124260329&loc=d3e26610-111562"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aa)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583714&loc=SL75117360-209713"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124258926&loc=SL82898722-210454"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=123349782&loc=d3e5879-108316"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(24))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=123351718&loc=d3e2420-110228"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=123351718&loc=d3e2443-110228"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14394-108349"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14453-108349"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14472-108349"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=124440162&loc=d3e12021-110248"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=124440162&loc=d3e12053-110248"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=99376301&loc=SL5988623-112600"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S65",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359872&loc=SL124427846-239511"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "http://asc.fasb.org/topic&trid=2208564"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21521-112644"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21538-112644"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130531-203044"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130532-203044"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130551-203045"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130556-203045"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130558-203045"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130561-203045"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130563-203045"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130563-203045"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130564-203045"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130543-203045"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130549-203045"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130549-203045"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130550-203045"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "http://asc.fasb.org/topic&trid=49130388"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "710",
   "URI": "http://asc.fasb.org/extlink&oid=6409733&loc=d3e19512-108361"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "10",
   "Topic": "710",
   "URI": "http://asc.fasb.org/extlink&oid=6409875&loc=d3e20028-108363"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.14)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=123468992&loc=d3e4534-113899"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11149-113907"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11178-113907"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "http://asc.fasb.org/topic&trid=2144680"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123586518&loc=d3e961-128460"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123586518&loc=d3e1043-128460"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(3)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(4)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "37",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123455525&loc=d3e2207-128464"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123413009&loc=d3e4845-128472"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5333-128473"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "38",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5504-128473"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e7008-128479"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "http://asc.fasb.org/topic&trid=2303972"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569616-111683"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569643-111683"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19279-110258"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=SL6742756-110258"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594786&loc=SL75136599-209740"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13467-108611"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL120254526-165497"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL120254526-165497"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL122642865-165497"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL122642865-165497"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/subtopic&trid=77888251"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29,30)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848",
   "URI": "http://asc.fasb.org/extlink&oid=122150657&loc=SL122150809-237846"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=123353855&loc=SL119991595-234733"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "912",
   "URI": "http://asc.fasb.org/extlink&oid=123371682&loc=d3e55415-109406"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.3(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "http://asc.fasb.org/extlink&oid=123384075&loc=d3e41242-110953"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(6))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.8)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.10)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(15))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "210",
   "URI": "http://asc.fasb.org/topic&trid=2122208"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.5(c))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117819544-158441"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e637-108580"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=120413173&loc=SL6242262-115580"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "210",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=120413209&loc=SL6242269-115581"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "http://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "http://asc.fasb.org/extlink&oid=123360121&loc=d3e27327-108691"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r568": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r569": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e681-108580"
  },
  "r570": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r571": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r572": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r573": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "848"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "848"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Topic": "848"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669686-108580"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e557-108580"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(5))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(b)(2))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.20)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.8)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3367-108585"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3444-108585"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21C",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=SL94080552-108585"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>65
<FILENAME>0001142750-21-000046-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001142750-21-000046-xbrl.zip
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MV,PBRG(^LU[H[>"(C)&  Z.MDREH 2(9$K1TI@0<8A%E.1?+K0A/7@-E7&E
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MYOJPOD<^O6YN?6Q<^(__B !!J$"+&(,OP A?6$MT@:YS9,H3QB+Z.__]+Z-
M_G93!5XID\EXN /J#T0TJI]'5Y9WH_G-V_7=YM;NZX/:[M;?.[O-VM]O=_?>
MKC>:M>9.#4E;$YE9C?+:SFZ-BE_"K[6=E[7FGUNU+_C<%9=;WVCFP]1PN-9%
M([7P?*01YV(V;H[KKU".7K\V/(ZU_UR.KMK8S:FA QG#],G(%\/^14#GO>C@
M+8_S:"^"/2_.H^T7L7O7^/][U*ZML<]?RM'_X^RE<?+V'P@@@N2I2 12 83A
MX(U$%DI2GCS07%$!/8YX.APYP__]+RK);YP\J^7.OS^?62YJ0!E[#&H@E?YQ
M:B#OHR_'G?VS'. '5<7=2G-G][9^^SKMJ=C-@]A-LX_-'^6NEI[>'.[7D9)L
MHW([0CIR\+&Q^>ZXGNG*_KO.83,?PVO9NY/#YL%->H/M;+3J)_5SI#*B<;).
M&OM;>.P=TJ1#I$R-%BK'B\/]1KO1QC;>I#>.4"^,A")X0PM@FA36.5HHA@(S
M+&DOY83>P SHS2,-UOLQG.;N>F-O>\1C*HHSICC#JR%VR7%2O]>YLH0S5JG8
MM#& 0O2]<7KX"_01D8+A61FEV7S/Z^_Y]<G*VHP$<C=6AKT*#]_ P\*.\5PQ
MOC7(LT>UERTDIXW>ZHO'C*1NC6:4\J,:X]S:,IKKGXFF'HE_H@A*,I\*XG(T
M05M5.))MKD],><]$XC;/?M*"2B7XSX=4?V".JM4YJ@WZ_M\KMM.]$N0_1W3U
MY/1HI6;;PZ\<F=QR@C&)%O^'7!>#%ZX\G\>X87"O<?/H0V0W'K4&V?(.&WCD
MR0V3]Q__ 460.+E0,,9B 1 5CA"+GQS31H:\S%ROK*W7&[4_M]9?-__<6-_-
M+&SWW?;&UMZSVG9C8W619B.N]/'HCB]:0WR:OX=9_V7KD_7#6D9!K9=JGW%1
MLX/:WFGT.1\BU%K=VO9P4-LX'H6C?GW0BY8F+@%BE8JO'_[1P(1>941,_:[
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M[^G0O&:<%Z(")>H@[JA2S2WR(*4EHTD+$\+6MA2\[^1T0[:6L;Y!@%Z&UFB
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MG/6^H-GT!9M[D-;JY:2LL,#8;]4UJZHPKDC(;R. ;\A*TUU.M-=,&>]!<ZD
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M=:87K@51?9@*[05/W 3+P"=6$Y6C T+B$+UR&**AC-65-;SOY/1$S-:/9&,
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M<-Q&QL>CP?'@=#0<][G:E-&(ZQ[Y.S?5SQ-#[1S'G:_,]'C"C$T@S"(0INL
MB245A;5@ O> 2D<@X10H1L5K4"%Z35O;W,B^DV*%9JK=\RF)ZQ[::^"^#7!W
MHWZ%GD/45@-#RP%##N )%>C$@S7:42'N.I29%_6_J(A_ _<*@GNYL;L&[ML
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M"*0% V]DCB*S:&31 $JKOFT,T!C@[B,8C0'F9(!NW")'Z<@E5;P 3U HO&@
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MVQ@EH/6R#FDI6ZHIWWNN(];D.J'[3$\GT[3=M.VF]WLW7>X!0"/'VR7'[L%
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M0_2",VZR",2S##I%6SZ-N0)&QTPFKZQ'&6^><=/@NTCX=LKRO17)!)Z M!>
M2CL@80*0SZ@8Y[4N>6N;3[=^;/G;JXK:E8U/-B O$LB=T*)R-N:<$9C4&="1
M 2>5@[('.Y*>L6!PL@^KN=L#M5RYV6=^/$MO1NF(TG"1@S\FS_('61Y^/#FC
MP]2[N*$K6P1,==!8;TZ[O* W<4SD@I/)8);"Z:3)ZLR%%S8[/&^F,1^;M::T
M-Z:OEU/5NTSZ;+628- HP&*IXD4$!HQ+)[.S.F0S&0ZBV&*;:"P 0NO11>BV
MN&)3.@TMXOFL)X=>H@MO3*"MX="BF;+3OMLF)@P+$B0Q!VB%!TI6 N6L4*'+
M1OA;&$32:++19*/)#DTZ+K)/1EI1G"LEF)>:G-918728E%J,SFP<.B^'=I/&
ME55.%<<8DA0UZ"58\95%@B2RSI)9H:6N0T]4'^7<'6,VC4>;FWJ3@/FE?BH7
MK*@K3E9QB4%;$IIE<E$6E47>BN:GWCES=-27P,BY-45XR=J%FT4+EF4%-F@>
M=0VT";'HX2GK3QE->C7IM>CSQIMS9QO4<B=4VAW4DJE(9),=:!DB(-<9O&<"
M7 K>"9&=='+Q@UH:F38RO1]D.@.7>F](J!R23XBN^+'<!JM]<8E(&BM-\V-7
M@T*GDJ^\=2D+7MQ7[A'0UJ$P$344.^KL31&E1-6197W1SDT:D38BO64BS<)9
M7D@SHHU(FCM69$T@E3$&3S&T<Y,E<F4GTRU+8=#G!,PF6;C2Q7K$K($S:Q&U
M4I&*ZRX7/#NKT62CR4:3'9IDR ,/-B=3D(?96LT+"DU AEXEYYK>7!4.[209
M1I]$,98 CI$#2EV'W2B"2,8$Y9,S6#C4,M-G9G.(=)RC^*^1+W^T_#<.WF[_
MW_$_D_N@X;^V/]W3-5\<?]:G.Y]<?[GK0__F-/UP\<6/%S-/!L=CM(U_Z<<C
M/WPY.+YX'.K-=*ICO;?)RS^^&\31JXK/!VR"T?-,R_._?/[R@_%+'7M,7A/L
M@3/ZRI?9 W[E:]_Z6/- 2'FC3_WV:TI>_3?OP[7:!X5(U^1:U0-N;[:RVAKX
MUK6Z!\J(-;E6SLLB6)<%:Q\(;:[UJ>=)[1=O.)=)0HYU]>6R?,9\]ML1>O::
MU;B7;>.?[LE=YYY"*G)P>#=W9:YJ G)45.M8-5YY;]/VNC([HKQU>/*NFRFQ
M5H_D<PNAL8ZI?81@<#S^^KR;T+<>U#?N_LJ'MJ9KYV"8_.G9\$-;/5\\E*=I
MY,L/8^^Q'QZ7J[YZ!-T-%\L&/*.=$,Z.S@Y]'>RW/WJ5AKVO>Q%-BN3:@YM&
MW$F7?2[?<SF_%WON%^&]&9SAU3;Q)&]M4;?\+3!LW*/;.3HY.QXM:!_:N*?3
M%M8=+:Q-[R/XJ=;W40KGI;Y\CE+?\[O?L!3IV3*DI5;:&QFY)8>DF4LZ<^>8
M%3(XLN<G!5Q(WC*DOSPCV'VW__/O'YZ+OP9__?GT<._1;VKO]=_J^>N=#WM'
MOZMZ77NO?W_W_.,?AU-G!!]W\*^#_Y;K^._A7S__SO8>_2WV#PX'NX^>B+\.
M_G[W7#P7>P?_?KWWYQ]Y=W">TO>,O=]]%.3NS@OFK4//(D1I$5#F"%;H^D\R
MFGO-HU+C0EY]24^1F[4A6)F#U.]T';E=H*_O.>G,M[^>_#9]#'IS<KLG)YU+
M8[&/'1;3*-!:Q2"7YP_H*8%'3A"XCUD+(N]K@9C3C<(:A=UG"K-H7+GYG+R2
M2"+Z:'+A,BMS<M9EMAA]UOAM3G[C'7[C3"JEI0.5D(I*HPA4%!JHR'B4";7G
MJ>8-V[X1]XWC[K%O-F/YJD])".^]JV4#Q*7C@9%5WEE$EK-HSMD=PUYV8$]9
M:0PF@//&%EG#!)!/!!18($:":6/GKUY=,[PW37,?-,TLI:4WY[566GH7-*<Z
M-.=TU$6*!C"$L;;W<.!,#*!U,#PH1ZCC(BI+&]$UHELYHILI#5]S9-PI:1 Q
M&6)*<&8UH;0D:4'!]49O\X;8N\TR%2<F4 IP&!V@DPB6>0%"DI#%GCE&6;VW
MVBUS[O9%C>0:R:TSR1F?C=.9*:,3BA2\D((QGJUASDM2+<B^/![[T&W#IE-B
M+$-FQ0G%&"QX4@9$BBQS*IN0<87'YBY<;Q36*&R=*4SSK%6(S#B9T#!CD3.?
M;?(F,)F];SIM-?BMVV8R\++=<*]K2R,$9%:"*UL1<,.-]-;ZX'%KVQ8_5)M%
MS49:3C'DU4E<%S6+Y4[2MWFQO;.]\S;?N>F3128DW?/O_#">]MZFTUI$X(]C
M+[U/PS X3;'?.TZCWDGN34YO>N\&HU>OTF&LVT+OC?\P/#D\[(W\^V\DP]ZO
M >Z7GG(QD2V/9=.-(2$)])HSPW)PZ'3,0HYG)''&)S.2.)/7\B0F!UJ/SH;E
MT4VFK4\.NL;__KL[G[UMQ3-LQ7L/I[(2;0@R<&5!ZV@!=53@D2+P8L*R00LI
M0_$TN%REJ>L+:M]R3Z%\2;1S23C^PQ^>I0;C1<"XFY:71!'+V1)0T@J0M  K
M@@#)/1,I*I%9A7$#\7J!>):SV:0\<T(6S J&"9V+27'I;) ^4@KJ&BB^\2%M
MP_HM8KV;HN8R3UP20M3* 7HCH$8$017.3AY5*-2]M:WZ0KGYFP,WJ"\)ZC>;
MY-ZLU*S4K-2LU*S4K'3W$I2$-RQH[2P%S.4[D9+VQ@1I$S?)- FZIA)TZ@!'
M&:%U%@DB<0V8M067#2ONI\/(;)3>I8D&G4ZSN1,-V@YGVCO7XIV;W@IB3,A
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MH-!*I! +:IE#IJ(UR<V2-=;0>VOH[;0H06UMENB @N& AA7T&A9 4>;.)UY
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M/E4F6Z/&&E*WZM*=WA4J0F,5DTH#C;/!DD&5'=!P@]2L/+VX3)O*Z:/\;J.
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MSVB[;3#OJ]3KZ__4(A\3DSP3''NI8H+)GCLM#2-&FQ2PX!'#1'\[YR85WV-
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M,I4Z*W]T0K-1I$8;F%NO!^/PN@))'@C';0"_WG@#HVYLE1?VG:RX40#$QA8
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M'5[0'G=CE=4W?L4\ZPPNMSG\PM7URA L_7V0 E4F#FW"-T)UF;'DIZ+=V,_
M_IO\?9 (-<PXF76#X9+DZ''G2L0P@0N5]]Z&E-' 6:V"H]H3[AU18K#U[WY
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M@[#DC2HO@DU@DIK9H_:2RN"#MT=OD)V;U/:;U]2_7&@#3$3MB12E8-$*6=/
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M(FQLVD6U@!4G0;X\$CPWP3O+==&B[?X\_4@<_VOS\L>KH=O-JJ"<2BY99UT
M[[*G%0:=IX6&IY)]>@UJX\*7OGS%RU(((!]9LI-_/AI-!K5)/XVQ]O#?^//[
M03[>/_-++WQQYA[P3U\)D3P!&HK/?N6"$Y"HHW#\@\QR/S<<%W[NGVM$')%S
MR^(8PSL6"K7UIS!\'TXG&_^Z['F0VS'7A?-/__EAF!NIV^L&>V4WZ$=GY$M.
M/%TB+<'>O$RN?^*;BHB7>#0B;^_PS9/!) U'DY,Q[M!M?AD2V'\T89[."/.
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MK<9.-RPTL/.X8Z:.H78>J^V/CU\KST/6QK B:[J]((LCZJ!8M^ME@O?@R,X
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MEH'@3,:V##Z'&%-0RA.<35^NE)#2O=>G?8)'8X)"Z&#8:6@>C*AI'[L_-"&
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M<?JO0 $1G0F*?) &\O4!^7Q<(5D;14+.D+Q'1A:G85Y(8.BEU$*H(, WD#\
MD+MLE'3T\"Y&2#KYF&2J1X.]+ ZD;#['FB%]/KI0I$H!:#DWO&0&25D6N1(,
MLX(L>?(AUJ('KN_XC<NC-:"O+M!3()\3@_"<:RC*.J>,Y,4*#UPJ[QO0UPSH
M\\&%4BR"#8$Y*Q,C; ,+DM!N<R&/K&HMF+""0+^C4PL_%*9_AO#GK,;R\5D2
MX&!1C+E%0L_/HD9TW ;!%4^00XA<RPA9)*&<T<HVUV-=>.K/A?B"SBG;&"W3
MU@(9)%HSAUDP SKR".!5P+;=\0! KK+5*'(798#"?;#122V]YL79:&(#^?J
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MK#(JBWHHN"_TLLX$-Z"O(-!5ME&'&#-'A)*"#SHJ+-&)S&W6;:M@W8"^(.&
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ME01 :HJ1A;0(XE<\.R#L?L&J>.+OG3'H,OX*.L76:!0KKOZ[8UWE3)WR7V@
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MI#2QQKJUPKK%0_/($B-.&12X5(C#UB'-E4*"61!@+CG'?8UU-=;56 ?8$K7
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M\[H._2/QY79,$:C]8G1[[4YY\@K+=%]K@+LS@%LNFJ:UT58P!RJ*#6"7"0$
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M#3R)#WV0+_DH7W*]_)*_!.C0+F[^)^*($8Y!HC(. )JD<\0L/LF5"\H ]=\
M=A!M_D)"MPE_3@!K D>LO@D_(W=Q\>FSP3/['("$J9:(7Y=W8&6''2RR2_+G
M.U'^)<UA"D"7/P+.JE\C7!A^NOA-@&ETZ\%R3>,J<)J,[+##NRG0Z,(([P+
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MHHRXZ<M>7AFP<V7V<J%!>SN!PG4$2J*M*FF#M76+Y'9CJY*VG)?GE5W%I'T
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M_G"0Q;:W*X8[8M7: 8+.1RQ9.V;QRF,7K1WMY.J*M>=3>'6$BC4IHI9?]:0
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M;&K+>^ G#/VD++2  >!\)ER;++^3C0I9/&! 4OL4I[<K@TU[M?00DOC"EMK
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MTRC*A1?4^1W'!9!3=XR-XM-@W2RX43X+[A)4$2_)IP1?4AXM&*\.*%AOC"7
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M :S-:EF_T''7&G5:\(__:4Z3&:82H*_MNXAF:FK1Q4TD9/(>1[I*29/&2#D
MQR*YPQCE?WE^%*)SUO;1A?:Q^;7)8PT^?3;^D34J,\&4<9K_\9^_VV6ULR;F
M1R+FCE43\],@YHY51<R7".VL-?MX85RGL!3C6Q-#GS_M0MP.,[TYT;O[RMXZ
MM;LFW^.2;[LFWZ=!ONUMR/=R&GDQX!OZ :^!B)WIG1TE_ZKI^,SIN%V+X2="
MQ^V'BF%K:/QH7C<OFTBR=+_5Z;6XT,4-YZA_Z[>KFT:M?D;J=C2V Q$WOOSR
MQ4)1>;O5:M=4?F0JKZ7U$Z'RO4GKFMR?*KE;+:MY]?GZ-"C^& #X/W]\^VA<
M!9C>Z CC7>A0AP5$RMIG^_BH>'WYCV>.BM_M7]P9[#UV]Z)"?6#)8F;7N'ED
MW+R\^%CC9ADW+VW?D?/NC(]>\!.3UVM,/3*FOGO_H<;4,J:^X[:<-:*>$*)^
MO/BC1M0RHGZTQ\*O<?14</3KM_<UCI9Q]"OWM]Y![O].>7*%C,#'3;>S1LUN
MMWN?=+O1L#EJ[93"M@-5RGU3,[<Y->KW7$,=[&KB.CHX[Y^]V&MV>O?+4%SW
MUG:SU^_M/WMQV!P,NP?.7J1)GJ?#]/[CJ.SN>/O^X/FR;0:V]FB>G;0M+:[=
M/>75G1+HEGAI::V/4M9156&PG/OZ^*3!M1[#U;4>.]16=/*FTL>=<78JS;"N
MK_[^^>+[CV_OK\^B8&)U ?GA$')%%S$MVL2=!JA9(G=0VBZ9Q)0/JM)J*LEW
M4VSE@M-87&[HQ+WS9,-,[ '/G0NPQF4LIK8_P1 :OHB"<'R#J2J\X2EZ8=Y[
M84/=]"[%^4<JM[<3\29KW,#XTN/,VK- X6+-SY(6]N*QU>C>L-GAJIM=U6@,
MU!^@7N>0KWV (CTZ97VRNLB'\LC?7WS\_H_+BV_OC>OWW_Z\NGQ_;1I7GR^W
MT2ZMWI*.M R%S6Z74=G4E.BYVMH\JP*K:EW^]X/416[D0/3MZX-\>]N-,_];
M_N]A5K4=1'Y<7WP^)E HA^V(^[_X^%\7JQ-<-I#K>L_0D:ODRONOYH3%1$)2
M9]"!2',.N=]E=8-MNO-5WEE[Z8;71=5HG7?L=%216G';'5J/HP/7&N8#_=X'
M2 &M-8M3URPNCPB1?WR[NO[^Y2LV$C\F;*Z;1X3!<7=^Q(U?_N.OBV_?_Z^Q
MK6JU8]#M+%2K%=G;)"[E?"-?*5);C"IYO84N=0SO^ EP?W:$CU8[PG\?A^X"
M_I@F,_]O_Q]02P,$%     @ .X)E4RZNO:J)#0  IH<  !    !A;6XM,C R
M,3 Y,S N>'-D[5U;<Z,X%G[O7\'Z96>KQC'8)'%2G=YRTIV95*435^R>F;<I
M&82M;2QY),AE?OT>";"Q 1EL9Y8=/-73;4#GHO,='1U=$!___3KWC6?,!6'T
MJF6=F"T#4X>YA$ZO6M_&M^U^Z]^?/GSX^(]V^[?KIWOC,W/".::!<<,Q"K!K
MO)!@9OSJ8O'=\#B;&[\R_IT\HW;[DR*Z88LW3J:SP.B:76OS*;_L(],[M;K=
M]N3,==MVKS=I]\VNV;90U^WWNSVS-YG\.+UT^G ]Z9ZUO5/[M&V?GY^UD>>9
M;1.9IUZ_?PY%^XKIJ[@4S@S/D0$5H^+R55RU9D&PN.QT7EY>3EYZ)XQ/.UW3
MM#J_?;T?J:*MN*Q/Z/>UTJ\3[B?E>QWY>(($3HJC.5TK#=<SC/Q@YB".3QPV
M[\@JFQ<],Z&0_(A& J$B0-192G #W@[>%ECDT\#CCGPLY8 IK';7:ADH"#B9
MA &^97S^&7LH](.K5DC_")%//()= -C'$L*U JG' >)3'#R@.18+Y."R=?ST
MP3"D^<E\P7A@T R]A\1$Z2UXH,BDRCU0.0+LGCDH4%XHRPL@4!7-4'6P'PAY
MU5[Q.'D5;JM37H-0M*<(+7;0(DT9:1+?J:Y-RA^MBXN+SJMTL'P]<KU%E6_+
MGVVK6TULD=N5EPU7[83N$#JL&E<U'1*Z/77(;4I%'K&-4EV+DFHH1@([)U/V
MW'$Q49ZUQ1LWB\L?RO_692)*6:#HY9WXWF)!J,>B&W!+VN\R,>(3]I)(E8F%
M.9ZJ_KE$W.',W^+6G05G"\P#@D4ZCBH&,XZ]JQ9$EG822W[WT>0$%$E*9/BO
M.X)\W $2[-^O*I+02BRN6@+L[^/(-#6N]P*":L5Z XF 8*Y@_G^OOH/\JM4'
M$B?T_Q:U=[%7M?9 0BC9H?*2>@S/#>)>M6X8)(!#- 7EY/UO3W=;^GPE>T65
ML$Z8K[3Z9$*B!7^,]BIQ;!N*TI"D'SN;!!NL0H'=1_I)_=[T])@X+J(AW/"1
MTG3KULTEBV\FYM0:F;J8 C'\$,PGKLR>KY$O.]#1#.- 5+3^5G8:6"P%2Q>P
M&($]\1*7F*>19FK$7(V([1&RE(V'@ D-9C@@H/"!\5OGK0=31H1=P#1^6)/R
MKZ:#NS2@8-X-FT,-9U"&/.,[&!//J\;''03H8>Z9IET.YI4<@WG&FB0C$G6$
M>H7$*&#.]QGS7<S%ES]"$KP=%ND<_GJ@;=,\W07HM*!_&I&H(]"I)H?$[-9G
M+P?H:_/9ZF$]-<VSG=HO\#>4@".8.58_<"]<0H8>YC/3/-\/Y@;WR]=($##\
M,%6)2I#FT6O@@K&7944#%"(<GXF08[A07"0F:3[-1F$(7NO 4'9?-)9\=*C
MH+A;$A5H*S''AC>3,9KX^\,3<]&!TS-[O=+@1/P:#LT3=AAUB$_45=2MR/]E
MAO:,?-D!(.H^81%PXD#'()]]Q@$B_MYX[B-:YP2V:=MEG:!MK&N1='8_1EU>
M2A4#=#%6RD3/?XCU.3K1KDC^;OT/W0B$'QVISHXT< +R#"-%0@<^9)]R?LAC
M_(9CEP3W3 @LX'+@."P$PP(Q!B-#4'^G +6G-GI7.[75K.>.KI:H9A!J+)4S
M0!TC4L^(]%-W$@V-E8J-]+^! XU2*&[57&6-4)_!GUE95-/D#37W#@EA#KD^
M$SSOZ4W?Q 0P7?\'Q#FH\[Q3M-0RT@>ZOJU6!(IQ:1M+CHV/2W(;F!OZF'EW
M4!\Z)>"Q XCD@5"E(+;OBUYY"7I8+VRU J"#-1$E.ZR5,".29B3BCI@O$1ER
M)K?"H5M"H3\GR+^CGKR6Q0Z'>QDI6NPMTU:+ F6Q!X&&DF@L11HIF8UT@"?\
MC&F(968WC9A60C:'7)N8P'_9*!PS,5)<&HW +DVLF(N^"4$$/2N!1R/;Q@,.
MHI7A(>8W;#YG=#0#HU?"I8B'OI7TK&RG!ISBA6H#>!D1,T-Q.V*R0V*OYZ3-
M\2V[EXUB&GR:F/(7F'>7V+:%E3[ G=IJZ;$\5 T,=",\E4NNJ5RH$CXYY/KP
M=F9E\[:823HA:S0".T2T0B;Z8';>RW8V.6@T,8AE+;K7[$4)=OI@UK?-?AFH
MFCZ5D37TYIQZG.,BZL9E'Q=8&HQ.HXYA\O:$Y?LITN7C$H=!_("*Z'WEPC8O
MROE*=EH_&0'():.$9JE7TG5.WHR5:LMB1W=3@R\BT'3*\70=Y<.XT!;F6K?H
MFK9EEG.+=3%IMSAB+)F.POD<\3?F_<28^T)\_]UB1A5)>O0MV\HL+.>C'\N4
ML"=2CRU^-;IA 19#]"8- 4$R6NP<0&-1>Q>KC6[TK+29=%<N]65&-Y*A$7-4
M(3Q>BUTR/0(5&V*GT6@ICOIFV+.MS!KA=M@:V=)N$>&_(#_$7S&2EJK<OG(9
MZ%L5=)&9.0/)QE!\C!2CA@.QPR!5PT8[3.V>]K*3!OF@-'&DFF?6O<:JI1CJ
MH]R9;65F20L0:_J -<_:RT7*:*$:>H1[@B8P3).O3Q\*TE)"]#"?VU9F_J@0
MYM7*:[S\+CNZE,@C^K&M,MM+9XA.L2#TAE$Y"H<B\L49XJI1N53CX+YQ !7T
MGM.WK;(A/7>?:Z2/W'NXTLA84^GH6GEM/KG'O-3>"Q%P=1S!X4)+.3%Z%[FP
MK<P ISBXK!Z >Z0W>2RE-M()[L%*%=.TF$2;)_=,*SL='1$VSKB[-)IU2FT[
MZ%FVE1F21/2-].AH"GJ,7BNZ=9I.[]OR")I-@\<3WXJ\F<;>Q<USR/6^WK.M
M3%A)F[Z1'B\W*9!@'K]6M,QWY%N>]WB*_"%G#L;RE,JJK_*7YZMO,;:575E(
M<8^FM-+\+PTEP4B). *:9_A=6MT.[/6M\M2V,@&Q*KR-;+GI,XQV>T,L2Z]O
MB6=6=I5G[9@C(^;3;!1V>CV\B(MV\K)WWLNNT^0BTL2YRQRC'JB=E(ML?;N;
MZ;@*P/E[AZ^/G?7S4*/KM3-3Y8FI\6G)"CO XO=1N%A$MY"_,J)X]!X8E6\9
MW]%G+&2_,*!N/"B'W]&;H]!/),O++0--8)R.G."JY2%?G@PI#X>]:AV,/X6_
M9>NZ:@4\E =/RM.G+Q>8$^:.U=F0;LCC_8_1LTGD!O  3TC0,D0(*I(@E&5^
MXBQ<7+6B@B3 \Y81'3 9W9DS"L["W^[@B62^.H5VTWZ?L8<YET?NS!>8"J7
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M04'*<J"&4H%?;;N N//BJ\ZKTE)8(5T]4Y[',! LY# 6E0LW'H-?>H?6$-3
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MAZ![!!&PUKQI+K2V!:RUP3_MPI;:Y[F^QGLPRC!>C*YWV>0V<U("+I.U:T.
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M_9,/"GWR)T*;!Q!.QP/IW![#B^RVPF?E>6&B<$>GI17,Q]ID,T2M14K%:O5
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M!(.268LU[4FJ&N#3S!DL"86&$/J8HK<A>PP-J;HSZ1AI]>/0+_,5S-]/:X[
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MR=A,M%B1&,%3S$03!&KK28_TT<C78AJ3/=>1*HV$THPDUX][.XLA&:W(#['
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M%0'7C_BEJ/.7-%G,-S]9*1@(7>_I_W8[EG--'KZZ%]. 9_\\/4OG_WTQO2G
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MNQ_P\%/HJS+EK,XDN#IF_YVP3H$(_<F]PB[POOB]R]G7JSQUEGC)F8'L"7J
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MDQ+>:L/JF MWH3IUXO2FD1H)@5:2^&,V7J37.<]'*5$3R[%N#4$Y!.K!.\^
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M(B6ML][;,0T?<>F-$3>\N7X$7R'O],9]W<PM.$=T"?'OLV8^'RE&*.Z&9?2
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MBD6D,Y$!8M#H%6?"P7G!0043HU3>QTI]O;OQG#93>M!!A='!JWJS-%_\]J5
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M0@]1);$1\=MF,GG>S/YTLS@*3CB9N (E#6["(28PU#@TVY@+QL>H0IWY+CO
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M0B+D7"[;I4X[)EU.=8J)'WR99P=&U5;4L<L\VT7:K0LQ6,* R-)<G+T"IT(
M-#F)%X9)I>MTZY],LG(O3NR5K-Q'-]5S56W ?-_)RKW4=6?2ZA!95R= 5EPC
MGRGDI!P(%=#"(U:"Y#)H(2*WI,XMB/<]6=F?WO<1\9':LX6FDA!<)L=35UBC
MP?$H@)HD*/,D"M&F8_=A)"OW4L<![=E[R/(HR4K)>$ ;VD!B'*TK+B@@FQUX
M;8-R5'DA3B99>:BN^Y?D49*5HLR2HC% ,J34MD>%RV<>J K4.>T-:W5YUX-(
M5AZJZOXE.6"R\E6S2/,W[FLQ6=TT/D47>KQX_&&64K>D9+O/[2OY>, JMF_*
MLM+XG(20#/=?%TPB>&)[CHKRDF0^:O>(KM=L^,6+Z1R]OU74XO+.6QUMT,2!
MBF@&(<0,UB0#EOB@1 @\L3J5H[< ZFI E@]ZG<]%^-R5R5>+K[^[+^.SY=F3
M9C9K_L3#\*G[A'^S^#IBZ"]9;RTH2G'Q7.&+HW,"GZ-3B1C\29W[1?9!.?S>
MU0=7MJW.:GJID'!\V4P_O$^SLR*'$?=H&X7 RIV\!$2R>(Y:!.1HTKA]9\)]
MG1%15U&<" <.E6L%1_/Z^L[#*H[33"@+0$/((!PZ5(;B85HJ0XV(R49;Z[JA
M&V"&BGG6T'-7V=Z7,.;UW6KE>"?%'5-9@A4:E^$]LA;7!5XFXJT64K ZY=,W
ML1PK8-E9N]MS1KM)N<+><!W1VH1O@ZEJ,'(7JN/$)+MJ[$X"=!#W4%10UF:9
M# ?IT>D22F5DN[(0"-561V&=KC-B=C@*?",Z.00#]I%R!<V_39^;R>=BE5ZW
M6<]=;LM4"@@#-SS%0#!N :U2#R9YRAAU4K<;4K W!>Z$-;R9V%US-Z<L]23V
M&O.44EB6:A@\ 3=UXI9:*SP#(IP'@;# JU1N9C=<<Z\]-;7:J;:@G(#NNXFW
MPAY0');%VF%YC_]FM=&A=2,0#?HLQJ!E;-%-]9X[2((9SYEP--:IQ=F%YE2,
MP,Z2KE!XN(UIS? VJ*H:@KMQ'<<4[*ZW;Q"A@] 'V!#6Z%A.VML0@1@6<=,3
M HP/OFQ3$5\&&PVKTX0Q)!6^81(.Q81]9%V# 5?BF.M#*DCB4Z82B,^T5.,0
M\ XMD](3Z!Q*P-$Z]\;>Q#*\$="'ENX(%1\@XI[SUIN Y08)RTX3/-HH$VB!
M>HL>CD&+1 CF<'&&"KUE\-V2M;SZJ0]:;1V%=.L[VG]"\KD;S_[+39;I]^3F
M:&D6T^65FY6[CCYWF!'=ZF/[2D?NOX;MED=%.1>)D>B\D%D;J3-'0]HJHI//
M<M3J"=TVT8M'E%FYJP$^+\?.%S=B-6]G]=CX>OJV^ .E\0!_X54SG6V^?>+F
MX_EEJ%HXSB13 101I2*79'!EFU!2<RL3-]+7,<A[74;7@^D"S*NT6.'98/DZ
M<MD1*BR^QMJL)O5S<*MFYD"LR3+B6UJGUOMV3,/O>,?CW/;YUI.F*L0W'G_&
ME[OX<L^;V3M7VIEQ]2L!E<W]\KL1YSG8' UDRQP(D@D8;A5H:2S-R2G/ZS3A
MMD7X/?.KBA8KF-*__6N)G+_$\_SSJ_'(!2Z#1\J;P$J%(@_@B<D0.,G*",*D
MK<.L76B^9Q9UUDZ%B,Q**)>]5T\_NMD'Y#'CFI! ,UB1<)F:*7!EYE_FPDM%
M,J6VC@.V&\_WS)H>-%2A9?1ZM/+%%#V?-%^\=8NT*K./;](LX%^X#VEDF<93
MEPC$ERPBS1$Q4P92(\=9,B(37H5+[3%^S_RJI,F;G!.]V>,=9'8>5P\D:RW*
MG4NZ!-%H1O-0&0,\!N6\X=14FH+0VQ*&*F:Z/SP]CO;O2^'4Q>J??%VM_^G$
MS<\;ER)1E)F0P'OI2P)7@'%:0<[6:L8BTY7RI;=".E8&[4@,N8VGG315P3G8
M$L\.@:PD\(]IX^=I]KD(XL7TTW)Q_<+CJZO:S(9NL:ZJZ;M:*SM. K G MV]
M?1Y7^P^)W3X[;HS+H'R9A**U1/,G6.">.AY5ML37,5\?%JN_D<M\8*3>1^DU
M:B2;LS,\]\9N\L;A ;C. 44BI,Z20/01S6\\A<!X+4"DH$(P1!I;)^B\$\[1
M?:8C:7N[T+*SJBI$G:^\;5=23L]GZ5_+- WGU:7:1VUL+!E?+D&88NTDJ\%H
M)E-"D>!_:]N-MX'[84'VJ;T*8<-=&<T+@.NWJ@W$8<S"VT$>W<+K1\&W$:AG
M[=0TV^Z FB*5VK $3.-K)&S S31SW%ME8#XP*J*OD\ X&H':&U-'X\\^2AF(
M-_.+?7E3VYX$Y\0*\*Y<Z&8M&IE6$S#1EO.>.%9IG&$;=$>TG_I2:PO:=-))
M3<OH*L:K9_@:)F-<,Z?\>:NTD/B55R:!M-819:4.7@]'G9L OQ/V=-1,S8WG
MR=>++_]SG&;XD(]?7Z;/:;+:?@TR6W.'.Z\M?W 9P1J'VLZ1^FB2$[). K4=
MOA\&=L\ZK)!BW?E"W,2[?O7:@!W<VKX5[M'M[M[TWF87ZU5I0QE3MX+..7N6
M-"\1.MR B<0-V'(-Y5JFJ'AI2*N<<#H>P]H;YO>#8/OHJB:Q5G&X^4H";'/+
ME[0F$2_ 14M 1,+ )9*!^FQ#-M)063FN?A/4_;"J>E+G;<3IJ(L*1OGU$I35
M*\*\8<$E-.M*<Y,H%\'9K"50)0WS7ALIAQ@<\\-6ZJB;"F5 UQ&]<F<7K38M
M<%4U@6Y#=AQKIZOF[B1"1[%7'S]U!5^.W!%K(QC/<\GN.#!!)\#]SE*9*'Y=
MQQ4;E@[?,$V&8L,^TNYY2.IC\;-B\EV:CIO9:@#DLV5"U>C-(4<$42P84+I<
M1ZL#!SSW)#!J/9=<:TJVBOYV]AG>_91CCY4[5!--%3'VW#CZ6!!";@"SF\D6
M,6F2B :THI'.-#EP(4G(U'%NHI VM=/O'0\Y"?7V)<2AQH,DKY@O=<9!H6$J
MI([@?<"O B-6AT"3J#13]!Z-![D?UF!G_=SDC*PT0:(-JN][J,A>>FLW2N(0
MH0\W5$1*B@B"!9'Q_!+4X#M M0+&M ^VU*3G.B/&[OM0D0I,V$?656X]N3C@
M+BYJD,EX)8"F4I)EC023<8U)$F4M-U;F.E.';T"Y-[,I]M+1C<EB701\JV$X
MS(B*Y^.IFY::O?/#U%T[3/L=6]'J435'6>R_UJWQ%IYP14RRE$<FT"WTAJ+G
MJ#W:F2DE%W9GAML\]?CM8"\O6I-P5=D:PL$PID"X<GNO0ILZ>*URTCSC+GAO
M6\)>#C#RPFK.I417@Y>+3X0H X-44F"H]D+3R%!&=05T<B,O]N'<'B,O]M%4
MS1*;SIX*%2QIB4X*'DBRS*H4X(P*X 11Q.,JC*PS!.X[;]/LA9>#:O_^MVE*
MHIDILUMM+B^E-25<HS1PZ32:35FG4&?"]0FW:>[%D-9MFOMHZB$ULK59UX\V
MS1[:-/<BT% =;8=H_R&QVSM<G(P9DC8,A D:C!,.) D4E^XX=96;!!X$JP]N
MT[R7I-Y'Z17(_'LS35]_=[-_IL7SY31N B&9!R:D4Z#*#8*BS)U#NUN"#XDF
MY9TUO$Z!W&X\1_>2CJ3OIG=E57"6;FD?%40$[APNL=S6%J(%HVP 1F5./&E'
M*G4?G'RG;P<"=5=5W7:$BP# Y::=64 8/@")S((@5(%-2@#1.O-HF0NB<A?+
M+E@_'(]^-%:SK_=NR;1[^ZXO;U.VT&*!PW@AM99X='>D*ZUN(^R]XD3-O;3:
M0J,7*HOHP<4RNSU'#L92#@%M:$Y9T"'6R4$^4-*W]U8>'.?WH4+/=9+/4DXS
M7 @:-)]0TBN4%_>>4TH"6D4VRW*P>09H$P4(UECOLZ=4;'G1.VOH;G_"$6W)
M^Z'*IG<]]%QD^;29+E >9=1L@Z\A?N U8)(RQG&%+J'1(Z2UX*2FD*P)D6?!
M/ TM"'+G0WYPI(8VZCH?M\ZAX#F6,>B^&,AEY&<R8!B-$%BB.B?\J:H<ESOE
M,4,].2*]:&^@%NCMF0-M(/X8,]2+@@\8$W.(=HXU9L@$&J+#,Y=)L8YP(T9(
MC"AN"'>&#3?RXZ&,&:K-GWV4<JPQ0\03)B/*@,50NF=- ./0T8C1:C37G%5#
M-L0_C#%#^ZCUD#%#^^BD[@#&NP8!<,ES8%&"SR&"T)R"U8*!\M38H+,VO/(U
M4B<^):8G^Z@O'=:\%*'5 ($V8'],B>E?[YV&>!RBM*-/B2G^OI0R@:79X0XO
M&6[ "!_=59:IDLKDRK6;#WU*S' $VT=7 TV)H9L(AT)#T@4/D11HP2%(1W #
M5Y1H0G*RVY?#5IP20^^32=63.EM,B3E$%S5MJET#; S+GGH-/&0.PC .EFB+
MAWW.R?B@'(V#T>2!#!/JFR:'Z&*@W82OH6F1LV2* K5<@1#HJ'K.-+!DK.(\
MT\PJ][#<!/6]T>007=Q:Z3!,N^#U"'^3GWYTTP]I/I[>$IVOUDS8 Y":K89]
MRVFK$3'JF!UG(J<L!0O)2^V"YCXZEH34?">Q>\!T_':HEQ>M.5FJS#F^@T2'
M5":UE0EP^#;RK((1> #K4*>%_7ZV*7;/USUUD["<K+Y\VTPFSYO9GVX61\:@
MF*DF0(@S:.MD"GB094@R)6FL$))6/BEJ+>WHU9P#O@$5RSIZX,U X\W_&"\^
MWEC,_/IJYF^WI+U.8:\^:V23$82B)TI#&13&<YG>KC40;[U(.C#'*O=&][F<
M!UU>T ?M6L0*AN7,0,&J-HNZ94WOTF)QWBHZ'SGF3%+H!H<RXD*$4&2M!5AF
MN=-,,,\JCW;O?4T_7HE[R9Z!+F[JL+*_HZY?-O/YBVF8+-%2?S']S<VF^&OS
MD8B:$*/04;3X[@LG.%@;&4BC@_*>1L&'2Z=76>*/M^8A<&N@LJ3N)Z;09<(B
M'I$Y2UWF\@DPVG*0(67G-3$Q5!Z(7L_*.H[;?)X#-C2['%D&X3T'H? /ZTJE
MI(DY.D$5%97/Z^]SBD@OCMJ@VK^'4T3N3!!&28T/' (Q:&([%L&$:,"B<4VE
MX$[IRC&*$Z\>V8L[!U:/[*'#H^?TVX#]43W2O]Z[58\<H+2C,\U)Y9GQ'H11
MHJ2:#?B<"5 62<Q94YGMJ3*LI^J1P0BVCZX&SO=*SY*SW)0+"-&D3E&!-2:!
M-YIX'TB4L7+@\N'E>_=2YQ[YWGUT4;<B=T>O:%34QTP29"?05DW<E;D0"4+(
MQGJ6I:75"W%/<5!"3Q941XT]R$$);1;X8U!"WX,2]J+5\$WC!W#B00Y*H"'P
M%"@%)U0$M%9B"? YB(XH5G8./"U^D+ZG00GWF_/[4*'G00EW-U]+%X0PS$.@
M+I3>D@ F<H7VC:8J>(8_V2K%^=$*O[="6[?"[Z.-"N;ED^5\/$WX0H5_+<?S
M<QV5=ZN$/1.A&J0N!I#,'KP.$IA3SA8+NU;IQ"V OF^3L@\M5<@G[8)5OIRE
MS4T=;0!6-0:_"?$XQEPO"FU!DN[:J&"&?1NH5HIH97"K]:78@%H%GN-6&Q0>
M^;A%9EDI]74DNGS###H.6_910M\W8L;/;AI2_#W%<7"3-VDV;Z;3-'F'A_8X
MI)):_WDS!U4D3Z0.Y4YR<S[,TFH\3D50P3JI=/:^A373_HG#FS8]JZJI+N>>
M)SL]$>>%_"]?/EV#L4E&GC(![AU"B C+,^6!>1=)U!(!M9GF=..#3TFWW:1V
MI*E+Q)NH><S 1)D?%I@$1Y.!F$5$^$8X77G0X"E/7>HIJMF+]@8:*; ]P*,-
MQ!]3EWI1\ %3<P[1SI&F+D67T3UW#HR4#H1('(SR 50@V=@HC;;#55,_E*E+
MM?FSCU*.-75)$&$Y#18BBQ%/84G 4N$@&9NYR\98.^" B0<Q=6DOM1XR=6D?
MG1S["M#-SYI\<5?EY3WK?5\"VNYA5:\!/6"]6_VW5MC(G979$"&XS=9*&E)P
MS$6:>:*[.=CNN<<O%GYY4;BJB<E6RP3&4&0Q808,51F\YC+XX)7-@UPE=-P>
MVW)7\*6BGKN0'I\UR^EBE&+B5&L/,B4T@?4J?I\#!!=R-H[;:.O42MR&Z*%W
MM.[#M^UMN1<M5<B';.-:RVMDG#5&10M:)8)'D(_@;-1@"4^:$.6"&(8\:T _
MN---1_6OB.O@IXM@RHR_!-P3-).UI6#0Z0$>C63,4<?=_;W3^0%W?G0AY7&T
M?U\Z/ZZ_DBM?+R0TVSV^?M'S<D$9FN_>209H<.$6SX)PMLX$M)M8'G[D;B].
MW+E=[JV;"COE=42OW-DFUMT&5]7HW&W(CA.2ZZJY.XG04>Q#TD*%K%,V ABZ
M<""2LF \,6!-IL%3BG;A$%M);3I\(\ V%!OVD7;?>5_QLV+R79J.F]FK9I'F
MSY8)5:,WM5*1QTB+;4=D.9^# :>L "-YECIR(6FK7.^=3QG>LNY'$TT5,?:<
MRGTL""$W@-DU,,69%HYY,%DB.B,S6!DCZ#)<(C$GJ)&M]'O'0TY"O7T)L<(F
M_K*9?EBDV5E9]7O\-ZM]RD@3%6,6G$X"A$H!O&<,F'&X=FI]M'7:XG:A^;ZM
MP<[ZJ="4LHUI_7ZT0575&MR-ZSBV8'>]?8,('80^P#:R1B<]#<+B6>6TXR"$
M4V"IL>5V,IZ-DL8-M)$<T0X<B@G[R+H" ZX<<.N3C>98>CP%<.[+E=64@#-.
M \TD4RHR25Q44?X-*,,;$7WHJ.E3P .F0<L%YN/%*NWFIO&BG2+@L?DR?7"3
M-[,FI!3+A*7#TY\'/*2OM&?7]=U(=V;/N/.4D"R288ZK;%F,-AJCO"&C Y[7
M=3.?SZ\_YB+D*JTD43!5;& T99@(X#)W0*QSN'<E5%&=4/?MF+H?75<_^>OC
M$&9+-WGJ9K.O^*.5!?@FS<9-?#$-,S3[TK-T_M^10[N=9"^!\#*!/D@%7L<,
M6F?TR@@:?4H.((P](!]C(^R%2S?/P"&45B%AN07\M_EB?.86Z75^@W\Q1F^A
M_,*(&6XI12\P6706!$>XQA@/C HO7+E[M=)0PU;P3I5%/2BCBFF]M?9SIS*S
ML+I:#+)5!H2W!&P(# P3CFOT-*.I4]"X&\]0&<1!F'"0D(^=VYO/%J.7*/,/
MZ[F;\W-/(^*J@Z0"5,@H%5MF6"I.P%!<@V)6!=FJ$@(__@I'\+MM?NQ^_K&B
M-WTHM.E-L#UN"S?17/$OVF#:)P1S@-*/%7CI0TNW*KRCB(=2O\7]ST@B(;N,
M)Y5Q$CQ/$BCA+)% -0NM:I7OH=IO";(,I?5])-MSDNT/]R$]GL;_;):SIQ,W
M/MMX_]PEEY0U$*B)(%29\!V)A3+&EPJ2M"1;RMZ9?;GEXX>S\?J3>].OT&I8
M_Q?K?+=PB^7Y7!1"2622>(@A%K(2#=[CM]1&;A7EB9@Z0VAVH3F!\[HW8==(
MG6QAVC12M4!5-W6R$]>14B>=]?8-(G00>@W_;C<Z*I/-3!O@00OT.J4!$V2&
MZ*2,*1+C5)TQ[4-2X5NIDX&8L(^L*S#@39J6Z.TEN,WE\ESJF&V)4N72!)PC
M6(.'5>(I:VJ5S;1.?/$60$>(^_2@KZ9_8?=H&13KYVVY*O"\0(P2:3R>=-(K
M H(Z#VBN9,B2I9 L,;3=W0RM#/B+QY[ F7^X&'N<LW0!8DVI-C!Z]\:O !C>
M 3]0!=M*[""_GEWMJW 4<\8)I8$SHDK.OMPD*RSX%++S'AV*[=$U]UF-=SC4
M_6IQ'['UK+W?W9?QV?)L<V$T%2ZARXB^Y'FK&@6;209IDBW]I;+E/1:M]'?M
MT<,ZTP<+O^E#<OL6&JQ_7/[PZ/O_[2__!U!+ P04    "  [@F53=*L/>KPE
M  !P*   $P   &%M;BTR,#(Q,#DS,%]G,2YJ<&>M=V58'=N6;6W<'0+!"1[<
M78(3W-W=@P;7X,&"2W ('MPEV,:#!'=W$H+K?H1S^MS;K_M]W3_>J*]6K3EG
MK5ECKK*Q('.0-0!#5E)&$@!!@0"CIPV '*.R*%DYNCJZ6#DZD;$SL0 \;V3D
MH8^!/\#X<P8  D#_<?P3@T%]CL$\[23/-L%_MJ'/GFU$X&^ GC/"(/UM/%LT
M&,\6TA_[&5#/(R^>^]( LX7%4\3NJ87[>]1?GMRT]'\\;,^MSE/['Q[.YY;Q
M7Y[GG-?/?:>G2O];0._]"?__CSW7C/#W+#[7#27RU_YWC.2?6?O+?OELV__#
M_B_\J2GGV6<)\ +<@/%3W5Q_Y?LO^'=?SM]C_P<\7QGSK]%_WR><?W@]WQ,8
ME#\F4N+?^9_F$:!ZZBH! $O<D_\]@ ^ (/_YN9)^V@#("8 F:N9H8@Z8!?P9
M"UD$0@ 4! 0$1 041$043&0D9$Q<=!04=%Q\;&Q<;&Q\3)1G_'WX[P%"149&
M14/%0$/#P$%#0\/YTZ#A_#4$\W^3 -(%8"(\%> $#:( H#!!T)@@R/)3L?"0
M7I#P$TM8T#/^GAWHIW)@8.'@$1"1D$'_=Q $0$'_1Q # ,& H*%@H&#AX1!@
MH5'8GX*8T##D6*RPHLK&V!3O MG@<.)SJ]^\HL15^6;"SN$<-"$&3Y6@^FO]
MU-2%$R^O)IA:_).:F41WOBO7BTGU#?/?M2$]4VZ;9Y(TB04?ZI)Z?VR=%];W
M36]?:%BXAR87-?3/[%QR2VE:>H2E%#>"9W>O, $HJ">V,,^<X.%@.9\ID+-B
MP3PQ>$>!#<L6&(_SA\$WE8E?[)0FZ\Y!"6*JN*8N'*=4<'\(P%-S=D\^D<A_
M82:ASN5JOO$/A?\W YI_48 L "C0S]?$!(2!"XD17[M#V.)+-Z8 N*,:_KK8
M/0BPZ'A6YECJ]K+%CZZYJ_V$WZ:B )YW=7#Y^+)QJ1DM+6F"^>#'0X$Y?,=H
MWPW:E^J9[U_UZ$T-3VH?TV4][>Z9JB[>EFZ:*W/P]=]>%RE,#I(TX$E="):W
M=&[/6DX95$VT-#!K[=>YH:C>\F>4H4^:@AL6#.];LH^T20VU)PS']4Y*[0@9
MK/LX\*+:[8T3O;Y->Q]>"!HJ9PB2*A_&W*9<M.:[QN1? B-#K+5'J-4W&N.W
M98TW+<?17J4N@HKF7-KWJV?>DZH'@]32J5BNQ$.RGJL5J_I.CV69DLMO:PP3
M-_3Z>3AJDNU?F!$O-OH*3Z@_$KCBZNI/URQDDNI_1#==,,-K<K#->##?ODXZ
M7ZWT]:^X4"B)5^=!+5ASS;?M,<U69"MJ'_%XFJ<"_SW#^Y<K$ "/V&+Q5G\9
MG;-KYUSSE@]C[<!\I&3D/=,%@>IA3=;%G2"SV .%K-V&?S0*<D>MX84W?7#X
M[8F[( '3>Q>&ZF+9RV/'O$/_KL<[""!UO['_FXT6G#<2=62O-CEYQ_ NM+Z"
M,/.*_TJGK1;[8(5Y1K%\5=>)^8%XM$X[*GZE56SU9.H>-_O-CO_><C+=A.$L
M:84F^T&8ADMU=8MNV'%TT0._#MJ]9 N8VSRV^N.JXJWA?HH_]WY!<5X7!"#
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MQ3-* Y1A[7#S#*(0<\@(0C!-!.8QCM.((;?\5"NY(WRJB2?J!_V@SR9(JU!
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MU.=XIF5*+MYNVEW[%24LD D)H P"S3AIB"&CB,!(828$R:(X46X'<"<D+>\
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M:!J49WK->$3;Z37B#MK B\+A8;.]"MP-[)/]B+M'9\J97=O#GM,KKL*4A'$
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M?1O^.VBL +\9.T!KB.,AE>LPV9'4A.!/S%H3X.[A0-T*O8G/UX=U>.;C=BN
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M&*;I%17R+@FP. .-IQ@6%9AG F-QGQR>XGAK'Z#*@ML%_SY+,J$S8BA,25Y
M3*2$@A("$4<T,YG(,N(5MSQZ\M1\\+UQP%GGG^3X'*[NK]!5( S\,?&<?U":
MX\FY]LIS?/ZDT1(=3TZ@G>EX^H(K!7)N-QOM<AA*/0QU]Z*#Y%&_R>?-87Y[
M*F]_N^";37W(KA5F&%,)N3 <8FHR*(3U=C')4IRA(E4B2,IY*$,G1PG./E :
M>*T 3^PE]=O%3V&AAJ:MD#7J+_ S$(##J +%-O9UI(0&@ORL_M!0XUWY,6A%
M87O:=FC2A3/#:>%T')705;T<IS*#*<T12[4BF0S2/QC"R*E]!)Z;N2G[?OVP
M%^B-J^K?_M#@T+.\_.&A[_S;9WWG?2K)QOM5"/R O-("#_SQ:'>;;\VPZ3RO
M@%VVHX;RQUWH7S2A'[3GVY K,LS7**:AK_,E&@#JLU^A(<;J6WGUR)_*8(+3
M 5UJ^Y^WUIKY=B:0D32E&"8:V?T$3^Q^HC (<EXDA+)$%!K/EOJ[.T3\ZO\U
M.3N@%V.PBC&.AATP-[*VUK'$6O]<+7XZEI"ER<!P6:9*AE9AG</<CZ^O@W"L
MFJO'/7!."]A:67XW2SMC5EI=@")R@=6YT4:NJ[HPZ>-RJDLW]'1?Y\OYUI+9
M3ZT^+K=V^>>N&+OTL'][^IW_UVI=NLJWO^:;F9.QT4IQ6#!.(&8YA30A!50%
MSYF0BK,L*#4R8.RI.9N5Z;"T'1R,!Y7U0#R!TOYFO^NF$!J1"%@83Q]Q&+B'
M=OUB(AWNQ85C%M<Y"QA_7)\K')@C5ZK'(WIK#ZX>]%?^JY8R_*U2SINE.J?&
MZ0K2C J(4^T$1:6! N$T)1*G@M"P@O0S(X6\3^-4H5>&@BW_U<B+!LL(GH34
MCXHBP#0P[=3X6!,;@5'PIK8R8I7Y!1QB"_Z='&ML;;^N"9^0\>N\O!\=--(S
M=CNFY^7N[ ^];3)_"X1HACB#N28)Q$F60$:X@$81C! S&6(ZC!.ZAIL>,>Q%
MEM9[<TOA8>?Z\\5B]:>KRRDW G\I;E),RWR&OY";!&> ;\$7^TM0UO3^CW]+
MB^0_LN0&N-_'\JIW]HFM'Z7EC^P%UOQ'+;?V0[ (W(9UKJ0?%<5:G:&/3YIE
M^=Q:%FZV3A:K615@G!]4;6L_K39#Y'+[H!65M3H'')6Z?*;^DK^\[KFRFJTJ
M/WF[>GA<+<O\$[<C4"176A0$%C*C$%-FG9I<99;*)$D*E2FC5*\JME.C36US
M5A=3'8SLM0'K!MB/7*+!-C"[!"/6OPJM"XEAJL].CO@Z56==DS];;=9YTY6'
MEN_F&[E8N>CUH<6U9"C/12HA=NED.,N(W159ARC%4B7V_V0F#:HMZQIL:M31
M.B)L6=N[VK43Y\"3O2O1&^V$+A2X_B=K'8@,<T)V:L#7.>GJF/K9$ZNN>WIN
MI,I@3>-O,RQ2DV(!I=0(8HP3* 21,-$9EZ)0"DOA4ZMQ\NE!1#%>V45E'."E
MJ8%[EV?@>6Y6^D(R].ZDM&N(_<:I"<?=8#P;8=P=Q:G)'6TA3EYT7>"C2W.W
M'FG_E6*(8RRD@BC%[JV6[M"'ND!IJG7!-3(T"_$&>M@P-2=AOQ=_;.E0\UJ'
MNHZF;OY7OTA&R-*$!3@& GRLN,<%S>\]]PSB<ER!X2#1D! [7B5(T@.H<[&3
M/H_J&5*1/[3:+?2=J>4)/^O'U=HE"7Y<FM7ZH4X@K7]X2-$3>9)0EUR3I=CI
M&A,#.9,:ID87A%-&:2'#0L8]+9E>-/E%PMW*@,_ZIU[NJO>XMA\<M#GK8Q?Q
M!*H9EZ]\?5E@^*;G8GH&=H9?H(&)M9E!J454K\-^$J UBQNW&LT50V9,7HEI
MW.!13UO&#2M=!]A1P.G*QX57,+Y?;N?;IP_SA?YC5VDW2VP,%I8ZF;3.)LLT
M%%F60LU-@E!>$%UX"3B>>OC4O,C*/N ,!)6%_K6,1\!UL]:U< P=??9'(JBJ
M\=R4>Q4V'CULM-K&<]-HES>>O29*A:/UO;K3G>T%?ZR6ZV?9SY_V2C8Y2BC!
M%$,M:.&:X>60NW-U2A.1R\1DI A29(]JW=1HH5WJ4.>X.5?I<M6#NZH]S:H,
MX@IUHKB_!('1[K&7=K3P^(BK>FT591STARR=O-+"UZR7C /NA2+)2(-<K;?[
M8;[D=AO(%_>K2F*J);<KC' BNRFEU.Z=<P$ID4[2,N,\27A!B)=,?\B@4Z/\
M9[JP>ZM!8W8,K=WS"Q"8R! )UJ$WM]<C>HW.[D6(AI+9/3_P:ZGL7H2B0V3W
M\KU7>K<U(;K1[E>+N7RJ_O<0#,H2QG$F4F@T,A!KY,3 L8$$:X)8GC"9]JO#
MOC3RU"CJ>>GT:0^FIW=Y<1$"/<>8T(Z7--&R^@94%H-O]7^'K4_VQ6L8/^[B
MZ*_CH_F"<M;_\GY >,NC^_5*[>3V;OU%KW_.I2[S$9."&907.914<,M4VC*5
M-@*:)!<))D8GW"OA\]P 4R.DVL;Z&*$T,RC+\RR0W6P3 YZ!2:4',D%MCKJF
M?W6+HY,/'ZV]4=?4VJV-.J_K&P9W1U_KQU4E0E)Z06_=^>?ZJ>S**X3 1&.[
M.Y+$[I,X(U D"8(BDRC+C$$:>TF#>8XWM=>]#A$_L_D&E%8#5_1061[8]M@'
M=]_ >C0TQXFU7P5DCR"\%SQ7Q.6[GS]RJ-YKLL?1>[_;>F9^-35"'U;K=ZN=
MV)K=XK@XY?-JL3"K]9]\K68*)5*)W,",(6()1QO(N"I@AHV0J<OIY#HH[RO4
M@JE1T,D*K+.U5^";FPKX4,TE,' 3OEI^>Z1!UV!@XAH&_O!,L+X0QLT#"[9B
MW"RPOB =Y8#U?E!?+^S+ U\LFIX(LX*IK'!9"(RR#&*2&NMUB11RH@W&,I=,
M>\5_SCQ_:A17.P>EC: Q,M2?>HZ@K__4&Y=Q_"5/2'IX1B<G?H4G]/QY(WL^
M)R=S[.F<OJQGKR)W9'5G:E:8+[_/6(%2H:V_DJ6N@I_*''*=$$@2C1G7/.5A
M#>"/1IC::UL=":\,N'?M7NLN"(&=B(Y0]/,HKL)FX%=W#\O!.O!MD%CJ613B
M]ADZ&F7<YD+G)GG44>CLA?W></M;;?3:^G9ET\5[OKY;E[LC509:[_7ZRP^^
MUC-%$;9OOH$&<?O:&UQ BA6'G F4"82%,458%K;?P"&_\>,D7>_M!AMG^ UX
MY&OPLSQF>#-? F7=);[>@$>]!ALW@_."-M>LAQ^!Q,=X\/!J ^Z7"EQKLXN<
M5%;7ISG6;E :'H]CPH"*2CR>0X_*1F%PO*2HP+O[\=:+NOVFQT-!4U=$#W-J
M7)\6C2#3F,,T13@CV!")@]HGGAQE:A[*2WV)GET:3B/J1S17XS3T1B,8HF *
MZ80@*F.<'FE4@NB<[$L^Z+ZX;_J;I9:/F\U.JW<[EUQG:66^4B6S;,K_M8Z2
M5FY0O=Q47=4,3:EF,H6<)]R2 ^)09,+N7Q#"1KG$.!68#1=LPT2I@[OHS@:X
MOEGV*^O.-O4OO99S:_U>GJQT9C;@S_GVQP^]4&5,\)$_K5TD<,M_V1\Y]Z>Z
M*M#GZ;.8?KPT\!(-S%J5F:"R_Z;R>3;U?Z%PAH-:?1O<KM>N&T.5X5(IEWU8
MK8V>;W<Q_:0K\(R<E1=NQ\A)>KV!.L[9Z_^H*W.+/^T+#*S_A%.2*YAF3$&,
M)(.B( IJ*5+-19HE)BA7[WB(J5'C(<NU?Y''"2!]>>L:>(:FI3!D^N?Z'DU^
MF,S>3Z]3LG!^FF>S=H^O#$]P^S3?SK^7+/'6TD:9E54DE!<\P1#E.8)8Y87=
M-3$)70?H3!E,<IW[IK<=/WYJ+_;!0M<_-CRQ[02 W2_U]; ,_$('(A*4T'9^
MXE>GLYUX]&C);.>GU4YEZ[BJM];Z6MM'O=/5?S\N7:,ME[7_#^N7O]UMMJL'
MO6[2QI]F1FHM-$+0F,1^MHUK3Y-)#A.1YBPK2"YQ4%.)P/&G]NJ_:Z*+ZTHG
M(UB5/0A\OT_]@) .3!N-Y>!-8_M?73.XQOQRJPB:"1Q:BYU7H>ZC\-X'N]C*
M[T$VC*T(WP>@$TKQO1[3C^3^QN=+EV9TMWPWWSS6U4EWIJJ+F164,)&K'!I9
M8(BUHJZCA(%)D5F2RPQ*J&G:;OF16N=X7N_;\ZY;0_LO+@/+?JI5:2Q?N/,1
M^Y^R=LC,?[D 3@_!Q&[0_:CL>B#'(2YG)WCC+/VK [)E;'7.OWK4Z^T3N+<W
M;8$+D3U6<97WO^1BI]Q)]]U\48;)_L8WA^O=/WR=.X&(_;_%HSHO;*,26_>(
MH]*8U^1?DI;?35'#S^4!UYF I9*IP2FWE(5S"7&.&10BX9#)@@FB!$]DC.AS
MAPE3\\9B!I^C!)R[EN^J>'.D11DWW%P+:DPOVNR!YAC!YBXSIA!K]H#),]3L
M\Z2>E1,_^7SALHSMK\\7Z\-\<5H99;WS.RVVA[_-""N$(BF"&C$#L2HTY()E
MT%@>18HEPEX05##A.?#4.'-O-[04"$NW;[,W-K .PA=[/^H; M&!"<\9!@Z6
MW8!C="/6-@3B$[>DP7?P<2L9 B$Y*F (O3^,I/C#\J5.[M?5EYV0]=YWM9XI
ME_5LN(1);A)+2TD&:2;MY[*@W A#DJSP*@R_/-34B.B9<8U6MQ\!>>#:33EQ
MT1J89(XTMK<K\,S6:*"IE=P]-!GJ(X'W;,P10'P\@+AIV_SOUQ.U/S 5-=OK
M2[I-6):49.OQ@%'HU7\B#:$&W-$WRWPEM5:;#]9(Q]2_\ZWCYJ?;I?4F%PO7
MGW"UW-R9CTNW#2P[<<\43@J9R0SR/"$0Z]1 RBF'N+#_G@IN_\>K*/\*&Z9&
MNLT4@%ML\%!/P&V0YP>C0_/-PU?&SR$<&.^!:?LYU,[^&]#,H Q2'.;@\/_H
M@7^/K/3>"$9.40^W8^1\]=Y '2>O]W]4/VYTONJA>]1!NS&EA@B!H*((04PP
MA8QJ#EF>H#Q1,N-9T([W]#!38[AR2W8PL[<ZXQE0_9CK>JC&V+B&H11,/MT@
M1.67,T.-2B'=TWW)$A>N[JF<.%_.M_K3_*=6'ZU'O?P^=YU9*JE9^:_=?*W5
MK77/UML[TY3WOET]B/FR=+[+WA$S080N,F2@,,AN2%'.(#=$V;^F6 AN4BZ#
M6M-&L&EJ%%--"99S H=)-;J+S;2 .]JS$W-?]V9JH#6WNEM'J.QWA#7V([&1
M5VY@QAMKT<*5'N/!'%<#,H)=XZI#Q@/R2#<RXJ/[2I_<*F7?ATV9RGNWME[F
MS[F%9<:49(D6EJ")+B!FJ83<.G?0R"P3&J5Y&MJ3Y?1 4R/A6OFC-K:ED=88
M'"J,<@;?;JZ,B=K !-@?L!ZR*=UH7*&?<N;!(PNI=$_O6%'EPO7AIPJ?[-.T
MWC=F^^1RZOZPUO/-C_=5A\L9,RI+"YQ"@1,&77-PR A24&6Y-@AKD1GF>[)P
M>;BIT8.U#CKSP*),,*W;?OI'RCT OGS$$!>V@?FA,O:FU>VOM/<&U!:#]P-@
MZ'_B$!?+D4X=KL8TZ.S!'Z*.\P>/AXQV!N$_H?8Y1,!=O6LH5@_:90:Z&)]+
M9)XO=W:D>LC5<O.;-JNUKJ[[ZK++WO^R^WL[AO4(UT]E 9:SR!V.K!:+LH6?
M)46]V<Y2H5BN$;>>G*00&TZ@R+B 2&24(52D+$M#NK0/:&L0Y8_0\[UI3EK.
M!\RKO_7([1MR>?UVWA-9M($_./5ZU6G4Y2G)8:K@,-=F1>OKR^E6#'J8'FCF
M%[4T9.A%B%U&,IB]8Y><# W\B?*4P8>\LAG.Q^7C;KOYI'_J!?I=EUU%\S0W
MC$D.!7=;?U?(0B66$%%A4L0,(RH/DU3K&"V$.,;142NM ZAG7YL3>'+,"ZK3
M%&*2V&\OEAI297=,.-&FD$BS7)I>[82N0W.49*SY]^7<S*6K5[G;_M!K<"<V
M>EWJ]X+*?$O4%>"!VBQ=B'L&HN/@.'2 N=5#LC+T!M2(@6^5M4/T!SJ/R3 =
M@4Z,]SH]@,Y/_&S7GXY;>E;QZ(7YN-SLUDX$^[-V;TRYU=BMUW9S.4,&&R:4
M@*G.C:41J2!EEJ#M7W-A^201:9!(?_=P4^.4^_7*V*V8_7KR!5@TI9U@7=D=
M6&_3#;0?C\2#;V J<8:"O:6@-K7R>2MC(Y;(>($2MQRF>\AQ2U^\IG]4YN)W
M5X]L<9PDR1>]G*_6?ZRV>O-NIRV(K/Y<)AE+4YY)J%TC5NP*66BA4R@,US+-
MA=TH>24T7AQI:E3B+ .EF0&YSIU07@[>1@-H8++ _V[M_#] 96D%$K"V@A*S
MBXY'(&P!&>*QX!LI5-L%8Z34<!]$NC+#.^\?+S'<9QK/\L*];@CGRB^[Q\=%
M64+*%X=4JLV=^:-4R_E1)5A67;3K7K7VSW([_UG6]/QMM5)_SA>6! J"2)HC
M2+'$KI52!AEG$DI-.:,"4Z:(+ZM&LFEJ_-O8Y4\CL1;G,D^_ N1#NW^M&;62
M-#?@SC@7T$EL_0#[:0$[+["?&#C,[ :\WK+Y?R=>8?E&^J*,MXQ!GZ'(@'=\
ML&*---JG+3(T[8]@[$?WBU>\K3L8NLW*%_W=F5,[=EE62%50 1'+$,1%ED,A
M!8$F33*C2%X@XI4M<G&DJ7W:_K[DB_*%T0HT#1XU6/W4ZQ^:J[ HQ7EX_0(4
M44 ;^..TM[$,1\#:S $BG!?!B!J3.#_:J.&(BY-^&8FX?$/?R&;YK,_:/KVD
MI7U5$2IP)BU'Y"1W"0K$0,'R''(N>"JS1!KCY2U?&FAJ/-'\HN\-[5U9=!9:
MWRCF]8 -'K_L@56/R&4W$)%CEF<&&SE:V3WEXSCEA>M[[+KM [:[S7_.E5[5
M'S>:I2+7.(5%V18#)0KR'%.[G]9*"^LZ<./5,^?TXR='!)6%H#0Q8&=UC)O'
MWO8J-(9^R]M ](@TGD D8-MX%3)C[0##$ K;QIT%H&M'=GS3>)NKLP8_VR>=
MORJ<JW[#UH=?;']\^O2V2?%(36YXGL <%1KBG!:0I<9 3G*ND<*Y()DO51T]
M?6I,)6H#_5_)8\ N<]15, Q,40T"-\!:UX.BCO'P9ZBK<!F)H +Q"2*HL_/O
MX*?C>T:CI[/FMMGI_$6Q"[;_OM%FM_@T-WI&#4V0H@*FW.DX\(RZ+!)D_VJ=
MK,+^O<B\*OQ"!IT:E566 6=:K'+I%L)^&Z_8N W,?9T%SS? !]&(M<S'$(U4
MK-P:>"+5R,=0^)<;G[BWIYY6)<2[^;JJ"YB__+!;Q*]Z_=#6:<IED15&"JB0
MS.S.+A-0J%3"C#/"L% 29ZR1RO\:(*3E,[C7J_1<-__K&%EM]D$_7$GA59I9
M7NC[T5(\,$?2Q:KM=0I\M<6@-!G:#\G#0#I8(1C%5;[R&GE<K:L0,([4K8)N
M[L=-EN3NS/O-=OY@7VI+0DH@FK(<:J8PM(R#H*"&0Z0R^P.)1,:#LFB?/WZ"
MGHZCEKU]8<3R CH_!ND/R,!4\1*+&W"_6LSE$_A6__>K_K4%O]E?[G]&C"N?
MAB,J*[P88M37__3T7K[G9Z[J>9@D?VBU6[@G\O5ROOR^:7JX_\8W<WF[5._F
MBYW[@)?"H791RS6=980764XTE-2)(\M,0L9D[OZ4%A3I(F-%6(%33TM"WHEQ
MBI^<A/ZN"@^44D7.^E)5LK8?_*&W3<6DG:*3,'JPEY93#3RNZKEXGJ=9PR_(
MT&'P>@8E4]5S*"$O9W%S8FDJ":EAR.M*/..>F?6T9=PCM>L .SIQN_)Q?=6A
MOOS0BX4C!;Y\FF'!2,*X8TMCMVT9EI!JH2%-,4I(S@757LJ?IQ\_-8^I%C8J
M302UC:'B3\_@ZV:NZT$9F)""\.BA[71JVE<H.CU[W,@Z3J>F<JS>=/*J:SVA
M1B>NW$95K<4VOSVU_E9)-2:I43JU+A!-F("8)1H*DAFHC50X36EF\C0HW2;0
M@*F][.VO[5Z?L3V%&R">VO_03V4S>)U"O9WXZ(_HYL0!_@K?)@R]@9P:3R->
MR9L)@^B\&Q/XG"M5+NR379C[[8+;$5UC=&,9+R&I$[!S/1P8D5 4N8*)2F2F
M,XYTCGMI,KP<:6I$5UH'2O."&LQ?AM3SM"L&4 -S4@!&_046SLU_&'F%H]%>
M1USAW*3/2BN<O2%\0_/)KLWB_L=JJ?_854D[*$,%$J6F;0(Q2:TW)$D.B4!,
MFIR;A'IO9UX^?&JO?6D?* T$E87^6YDCX"YO9*Z!8^"7.P")H$W,N2GWVL(<
M/6RT#<RY:;2W+V>OZ?>5+H6!W#YHK7_HY6;^4Q]TL_[0VSOSE?^Z=XG&J^7M
M=KN>B]VV:@1USTN5#J.0*K 1T&1V!X.Q"^<FFD&$D$8J+X1*BA!MPROM"7KU
M1] OK'279'L^C8KAFX73R MS *Y=+3\W8<0U&)AO*OB?304\DRB\*6/J=OMC
MI^1.HLI)@?:LW)%V-:]X?D@D@*-Z*]?:-*I/$PG EYY/K,?V;'M<]AZ8I90D
M@A($B22NKQT2D#.#89I9/N6,9X8%,>KSUO93(<:O;@S 2]L".Q17,/E16?CD
MQ]C>1,R">3[!N.V!JT>/V_SWV72.6OL^_VG?>FEW:EHV-:]ZV]_NMC]6Z_E_
M:S5C&I'4& 9S)9PWDR>0IXF 3"54")2J1,BPP^F.T29Y .T.E#?.VANP*>T%
M?&\P>#-?UO\:Z+=T8>[W(D?"<>"WNSF1KP"L# 4'2V,64E^$(W(I]?GQ1BZF
MOCCQXW+JR[?THY+/>F.] +G5RLD]W"Y5*U^NI628"\H2+NW.B"(-L2E2*!#.
M(,M2FHA<)@FA8:SB-_#T".9@-W#2_3?E_P+]K]W\)U^4":0NIZ)W"J[G>B0F
M,<;U$,:<,]=#F$.["BFD1**,$)1G*$@3./YJC!&5FL9:^+%_?(0'_A"TP"TE
M@1R4+9N'D?T,0RGJ]\%SZ%$_%6%PO/QJ!-[=M^M()2A_S^?*;C!G!*4)*:B%
MER3V2Y%F&MKOAH0:8<-2A$6&TK OQ8L1IO=)*%^/1VL=,*NUI9O*7/!F6<5E
M_H(P+=^>OV1)8BGJ<6[WC:4SZBZW^W6PG"\UL!_X[8\-T$ME?_+%_G*4E7P@
M2VZ<V&-:/L'^P?[5/OW1]6O^J1=/@5[LR]7RXZXK5F!@DFHL \ZT&_#^EUSL
ME%/V>-N"N;FHW?#HH&$5LS7'29@BM]-X/L;(+3!.3O"X;<7IR_H1C'W"(81U
M^Y//%U7 JN43_U@M[/,V=0KCC'*D4R4I3(RT%(2TL6YKHJ#4199*I) =)R3\
M%&S!U")5+D!<A>S#V*('])G4%)$<(F:H*XJ1D'.E88J(9D8*26F07MNPT(_1
M\.^0[PZ!JFP<>A'\2'U0: >F_1:J=9^F_03<84<[AE'/X:9)<X]'][T!C/I!
M"+=BU$]&;Y!>?E3Z/ZAO8.2QKBF\,U^T]96U>J?%=L9Y08T2 DKKISFQ>P&I
M]6VA2+G.*6,:9:*I/?;=>Y\<R>MU>UYH/#"7[4MD[;M5%L4N5GP9O*<^#:OO
M)KH_5&/MFA_W*!E0VPB<D3$WR9TH1-X5GQYKY&UPYX2/][W=EX<K-K746/?*
MEG>U%NM,J90:GB60:+O9Q5@:Z_-H"?.<(L,*ZQ+Y]CN[--3TMKXQ9&HO MS-
M#3%!&Y@<VFCM[01W<='REX**A=I(JE#=OVO_'D<>R@>3#J6HSMM'$XWRF41;
M/\KK^J%W[V4AXDPQ1?.$YI!KG4(L4VS_A N8*^MI846T0 /MW<OQ__^W<Z]@
M-XA)G1 ,"3?$[MLU@R+/)12)T48SI:3.A]FWA\,^TJY]#-AC[]2#P9S@/KV<
MPVOLTI^!]TI[],J&B>[0GP'4?W_^_#%AGY7->CN[7Z_43FXWMTOU1:]_SJ7>
MO%L]\/ER1B5*,EIPF M+8#@K".0Y9S E.<HY9DFNO$[%.T>9&E?5AI;G0[6E
MX%MEJF=M5C>HW1P5#:J!F:@72MYDXX5"%Z78![3HQ/[M)95TCS *87A-LJ$%
MOXM[5JNWFM;\QA>NV>67'UIO6PUL#GHO:4'L!MUNQY' !F+E&JHYV1Z4<9UK
M:42&PAI#! P^-:JH[06EP>"=WEJ6#HS?!6'OY]X,A>C C/*LC]8+9%M=M;X-
MHZ?3 [.X]>8A!HQ;:]X#FJ,Z\S[/" \K?M*;C=;[I(1/FEL*:#I2?UW]IMT)
M^OU:/ZS4W,QE%=%15$O-.((9=M(;F&20*ZZA2$F*<4%REGCI#O8U8&JD]EF[
M3XK+Z5@X\T$3^[T!C\\-]X^O]5J7RU'*H=$>F/ J\]M)-.4,;L!^#C?@ZPK\
MINMDG/M1X?</>PZ]#".%0X=:CJ!PZ358=H11>SUVM/#J-9-NAUVO>DX_U_F=
MMJ0HY^6CK%M^^^!* ?^[>F<H8R2A-(.:$ IQ@A$4>9'#(D=:"2VI_<"$>,H=
M8TWM&](VM=PB\I:QX(UV:85EY>W* -6^=KYT"8?:)9D#N=J4^9YK_5,O=SHP
M,[-K9?S\Z$AX#_P5:5MY8_<@UL_:H]XVN<PO?ZQVD%'H*@"FJ)YRUWBC.L8>
M$W_I!_O<TI>(Q/;C<K-=EY_*)F/T,]_J+UMW#G6O[>^;_89^US,E<:Z-=7-E
MXO09*,*0YIF&F2RX81DO9%@/6/^AIT93^VQG=T 72B_>>/NRS1 H#DX^PAU(
M-%;?[%/#P>>R=6QE.CC8'I-V0O&*S$+>PX],2J&P''-4\!.N+95L=\-0(N5I
M:E)(M<X@%BB!C"@$<T,595E&C2 ]>I&<',SK31J_]XCS8UU12E,N%J'@+KS?
M2'_ 1B^G&Z272.?\!RJ4>[5>(9V3/5\&%Z\7B#OD?+M:NFV;7LJG6RG7.[YX
MR]?K)_M/I?3<VZ9T6A,F"<4PI9Q 3!!W4I$4\J00UGG)!"V"ME7^0T_-?7&6
MVUU28WI7[=6UH/MQQC!0#AV&<RBVK+X!M=TWX&WL<MQP@*(R3<#PH])/."PO
M.:G'$_HZ+3]7BY_VF6_76LVW'[@LHTMUVU"A"56)W4LQ5,H(%):;B%0P%XGB
MG"*4Z"Q4UJ%CO)"W:"PUA]I<4-D+&H-#'9<NE$U24%50NW=E6$.<&0*%U!AF
M1/&LD)PRY-7=-SK&HRBCZ^5\M1X27E__,!)H@_N)9WXC(_;!#<(DLN_8->+(
M/J3'Y(]]29^;PG/:WNX>=@ON2OK?&Z/EUFY:YRMU9V[5ZM%%V^I<+(610)D+
MS*O"N#1=#3G-."P$SQ4N>)X0KV06_R&G1B<'JT%E]@VH# =W!C2F]\A_\UR
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M'YKSL.7U@W3^@'F%ZP(>UX]8J[9P7_DOO7&"]G_H[2RA0HL");#($@IQZG:
MBEGB=+)C>5%HR5D89QX/,CTZ+(N)'ZUUP*S6371IZTP.8[L3@/H1V74@#<Q1
M=9_(TKJZ984U,![YG)]\5%XY,<RHE'%^FB_9H./*?B_ZK92K7:EI^,5Q"%^K
MS=\?E=UPO?]EO_>;N5CH3_/-=F:=I50QZS%E&4N<H+M[^S&#=@O$,U-@EB*O
M#D:!XTYMDW0P&^SM!I7AX-O!=/!^N7LH3_M7H?LHWP7Q8X\!8!Z84J(B'$PX
M@7A%92'?L4>EID! 7O)5Z.W]2.SMZN%QK7^X!_[4%45:9KPSEB=G:4XR)2B%
MVI2B5XQ FA$&<Y0SBH23GRE"A&<ZQ@HBJQ&49IZ9VJLW=A>P!3&I,3B!>8XD
MQ$4FH4!)!AD3$J=,2D."3@1B 3N&H.$)8,&;A6N6'0]?/X*/A-K I/X<L&?=
MQ4N/T048K,4WX':[7<_%;MMT&[_G<9/H/>"*RNE=XXW*XQX3?\G=/K?TW5W:
MC\%W1_Y57KY]['O7KLMM8?^V6JD_YXO%+,LE-2KGD)#<)</I!%(E,"0I3HE2
M.BV2P$0&GV&GMP,]6 UX76JRK-X8+F4E+:E?-#^S/_L+*M -RK/R-/(O*,UO
M4(8!WX(O]I>E5+[]'_]F$?R/++D![G>WO.Z=ENT?I>6/[ 5V.H_::2SI1: *
MM-=*^VZ$XZ[>X%OC_;(U%4*.Z-[L;0:-T>>_&3WVR_X81=Y!>PP\\I[:'XKC
M77; O?TH\+?=9K[4F\VM_-=NOIF[U_;>_NK]X!M]OYY+?;LH5]O^<S/@^U_N
M'=3*TN\[77;8<_8]./=Z1I.$J%PDKHJ96E],"$@E1Q#G1*+<I(C@/,07BVK=
MU+RWQF2@:YN=HR$T4'N[RUC?EO\"C[OUHV7XP%A?W+7U8\=76[&!:;29%VA-
M[&9/G3>@F459FWV8!Z@F$H]9!\$W*@7'M7!4KAX$W)>D/LP@485S/\R7?"E?
M".<61.M49C!!KG6\*#BD),NAX9*K/,UI+DD$X=P30T\MG'%2./?-KM%V-<T,
M8DOHGEH5/U(>!NN!&?>"A.[>^#$E=#L0&T-"]]3P4Y#0[8#%4T*WZPG]J.WK
MNA3]>OJR7<E_ELI@,Y47!&>Y@DX%TPGH8LA$+B$GR'!NG=/$B![M-H]'\GJ+
MQN^UV1@*-L[2&[<+=WW'_P.@F[Q(FT2:7GOS,(([L39^1-83ZG$(:P_OEPK>
MTKYXE'1^[E&IY\0PHU+,^6F^I)*.*X<M4=[GN\M4<*:H]8D*8C>YB"60FI3#
M1 F)LX+S0J-AJI3[9,6/$R;T+Y<-K$D(7AT_2AD2\8$))[!"MDG8&Z)"H2^*
MKU(Q^SI5"7TAZELW&ZD2X9TV>KUV/EJ=\=,J@'#98XH;G!0<09(D3IR:6PY,
M6085M[^TA&=9FK(P<=/.\:86Q&O,?9:25YZ,A(J:=L/L1V81P1N8N_:X'5+W
MVF54D?/W/'&)+'?:/>;(TJ=> !S+H/K=%E?Y<$8PX7E*-4PPM9R2JPPRG O[
M/SHALD I9C*&Y.'4R"2BUN&5(H<38HH.=</A10T'88:S@TU"QO <%UR\/MH!
M9/G'M=9U#1]76A/7_@(IU[+-53^*G%"8)MPH27*<HB /X^*(4Z.%TV=/C<T]
MZR0OX][[P*\_FJ]RB.</9(S3NM/@#'T"]V+4USY5.PV"QTG9F1O#-5,/5=UE
M.>%J6?U#I?;^J^K0_?;V\_LOMW([R[%.$4\TS'(I(699 46:(^N>I*;01<XS
MDOHP4.C 4R.BQG:P;HP'>F]]F:@@2_MO0#D#=S+CK\<9M"+=W#0DS@-3U![B
MO=W@8'BY2WH[$L3^.J=#03V2N&E,R(/D3/O@UJ%A&O2XT81+^TRRK5;:Z_Z>
M\?_5^I^61=^V1'3VZJ@'A8\9SI*,JSR!*;&?7YR@''*2IY GJ68ISE2J@OIP
M^@T[M6]!;?5SR2$[@%[_#"SN\(3=,YP?'<RA@_B5P?\G:)O<UE<^6!TQ7!^$
M4MP@O=_0XX;F@^ X"LB'W7UE<]!W=N^]6+EV9INO^M?V-SN/?\XX)QDSQL!<
MI1IBG!C(L5%0,"H3B25"-%!'I'.\Z9TZ'IH%@E:/^9Y-&T]"[$<_T6 ;F'5:
M>+4L!=^<K: T=HB.BEV@#-,E\>2(K]/YL&OR9[L9=MYTC:2&JWEK%[E]754E
M;C/&4YYG#$&4*PXQ21*[UZ7$M1M2!&<H52[V[I_GV3U<D%<S0FYG?1HEM%FM
M]=4R&V=!]B.3>- -S";/"BG/U$[>-*!:KSVV,,<EB 80Z3@[Y"L(=ER:_FGQ
MCHMW727DL;GG3^ZI3<\M++DJ"!(0X41!G-$"<D8,3#!"64:T+$30D=[I8::V
M26JL!(^5F64&):_%6EW9SS*XJ.<,OGZ,<CUJ S/)'K#:P@'ZEW5C,(22QLNA
M7D,XX\QTS^ADG+NZ;PK1XUK+>;DSLG]>Z#*2OU2WK5KA69XFQK!$0Y;0#.($
M8\@3AJ%,\SP12!89*\+RB"X/.C6Z:-M<446[FOJ-=4<6NU*Y8&6 :E];_D25
M64AE2K>[8*U_ZN4N5%'>:ZW\R";V"@Q,/6US;\#>X'(=VB;'S$KR!RAR:I+'
MP"/G)_E#<9RD%'!O;Z?&?;*_\ 5?'X2?9S+34F=Y"AF6KB9."\M>9;<+C!0J
MJ$Q94"3X]#!38ZE&;-[Z-';,1;#[<@I);_?E2GR&=U]*:!H+AW%?.C"([;Z<
M&FIL]Z5CNB?<EZZK>VJQRQ]:[1;ZSNS#,E4:E.685CYD'7=4=\O/VL5\Z]9%
MF[)Y_"&.B"ES 5GM<I@2RQ1.U3VE%+(B$UK)G.:A\J51[9M>:+>9GO-IZC)!
MOJCS <N/<[O[0C-)5\76BG':S_A^TF6GL,!-5]Q? 3^R>[5E'9@CGZWG?HEN
M+J[H\1J";^4DP2!!ZT'@CRNP']7"<07ZAP#W2.!_D$%Z.Y"-1%:91WM"T^SW
MLJQVEJ0)-D6!(-'N*$]K!KDT".:H8)@CB8D.V@=[CSQ!-W.O*E;E@)]2[POV
M/CV7P=LAC0_NT#[JW=N/9V+TX%ME;5PAVS"$8GNPGJ./[=2&@7+"SPU\0&]!
MVX?5LBRP/JHOG"5)KCC#&#J)5<M4*G/"B*FK?A;8B=HJDX1YLEW#3<\Q?5L7
M-E?5_B?: ?=N2=()NQ\SQ8)R8#*J,:P5$RI+;]IERU$E5R\B$EMS]?R 8XNN
M7ISZ"=75R_?T8Y66\V4=LMV#5NDL9U*)#&4P-79OC 434* L@T5J<D0908KS
M'MHL)X;R^NT?7YREO>?AE:EAI'$*53^NZ O2.!31!N;V C#!I- Q]:A<<&J<
M42F@8Z(OW_RN2_NZ$9OMG7%R=F[O]46O?\ZEWGQ9+=1,:L18(C.(96&=")H@
MR$U20)1J+44A49Z)4"?BW&!3="&>G=6%>@EG4?7U$6(@-;B'4$%4FEE&AQI#
M@;,TIG]P"8W(WL'9X4;V#2Y-^]@SN'C'%7H 7W9+M7YJZPP<2@"X)!DBK("%
MT G$69) EKA0.DJH99$DEV&M'BX-.+602%]]@"Y,_:@B)E(#$T85*ZIL?2$I
M,D EA2\P\04$N@8=7TC  X*3@@(^]_5CDWM>%HEMOJ[JHN&7:NJSE*4IR2EQ
MS@:"F# #*5$:&B2S!+D2+X%Z[#DN#CS1'<CS%H.K\C6:[TT//#&[C+X?\<0!
M<QSF:6QU =7:6G#4?B$>]7A#$Y5[+H\Z*OEX@_"2??QO[%UFX?0I]3M=_??C
M\K/>;-=S)^3MWC3K.GU<_M15E]3-A]7Z[K%L(_=,WEECZ^@HY$*LFD%L= &I
MT!(6!3>8\)3C/.O!4#%LFRB)'29BN6L_!2"XO4H&;K"B+*$?S8VV(J,5A)33
M &^:"?W5I::V%J<UF_)SLY_/('+>,>&-74QRO6%CEYQ$@_)$84J\9\<.5;73
M3&=&*FK)F<%"&:<!H#FDV/6]<7_4>28S&=ATT&?8J>U'G^6KOXF7A.ZY"-=&
MN?I".T+$JTQ WQLW1I#K%!@C!;R>#3V1X-<I./P#82?O#A>I:C*85N;+[O%Q
M4=:T\\5OE2_SY8?6VW9]\/,D0R)D+GFBH-W;"HA1H2"EB$*%#3,Z(RI1F:]F
MU15V3(VRVMF'[<F >C:@G$Z[*-Y?7NF:Y>KFLA$786!R"\<_),LSZI+X"V"-
MM#0CZ6$-NT1!"ED1@.T0S+KFZ:/I9T6 H"VG%>-Q/>.QZY746FT^V.E]X2XM
M]^N:NVR2+R[MMO3=_[=>*+L9/&S<9P7/$_NYXE +;2!6AD!J<@%%AA-JC!*2
M!364[&/$U#YAS1R ^T4!&UZ]J?I?N_GVJ17T"(S7]ED=SQ#NP)@/'=5]!O>7
M&NYW6FS+T^CW%>Z'N=R #_\)__AX ]RDH)T5]%B3\.#O%:#&C0?W,63<$/$5
M4!U%C:]Y5L^(!-_\^+!8_>D.QNP?JP"("WDLU8FN:0?V;G<I0KED&/*48(AE
MBJ! FD#,THPSC=P^(3#%YDJ3II>(\\S/42W/QK[JR]42EOT>Y\T\RQ?_5)_'
MP)9&5R^M9P1DQ.4:.C;BUL'-I3K-=W_[^&Q53K6%;+FJ@S0_BH5OW'#+M4:-
M&XB)!.%1B";6<WMR]VZS73WH]6>]*#=MFQ_SQTU=8:040ISP F*-+"T+*2!/
M%(-4,F,HS6F:!8D'=(PU-0^V,14\LS60.SN@]:3%.( -S7@GL1J@4LL#CK@$
MU3'>N-QS>>)'M.)Q2T^=U]UZ.=\Z!G(,]<O]:?.W]6KC&G S)5*=0D.(W0JG
MA-A=L*90"<)-FG-J6-"1T]F1IL86>T/+#[S;YS[V$'<]BZL?641!:V"J> Y4
M8^4-*.V,*.=Z"8JX4JYG1QM7QO72I(\D7"_>T+-XRC[B[6KIG!AMW1>]^31?
MZH];_;"9%80CD2(#*6(28D,H9-IN]%),\S3+!<^8"&&(\T--C2*<I>"9J>";
M,Q:4U@9V1NI V(\KXN V,%GTA2R\Q.HB&G$KK<X/-V[!U<5I']5=7;ZC=^3]
M4:^W3_?V%V!KZ>A]\PEUC46%H5F>8I?U+ 3$2BEHB4)!DMD-2,&U2"@-BPYU
M#3>]R(_E9B<75+<77.HR;86WM">>"2W:G_TE9<E-3FCYD?U+6J0W)$=.;^B+
M_:TH7<#_\6]ID?Q'EMP ]SM:7O=.R_:/TO)']@([DT?M]I]Z\10<L#^_J$4F
M:,IT :5VF>V%LKZB%ADDJL@PSW-N! D1\8ZUI&-(>!\M:$1<O0\\HJ U_,%&
M:>8-* W=GV:4ID9NP.L#2>QCB?,#CGW\<''J)XX9+M_3L\BN29E\7\M/SQ*9
MT*R0#!9()1"CQ)*%8L1^"RCB!ILLY2:$+(Y&F!I#?'5C@-4^X[B?$/<QD'[L
M<!4\ U/"(0O[_25,PBOESLT[;FG<T2CCUL*=F^11\=O9"Z^HG3U=X:D2*F1A
MO_[2Y'9;2-VVT"AI]X:2"U/@PF2!YW_G!YN>?U>5@RY6R^_0[D0?P.)@=H]*
MVM,(TX)24W $BT(8B[!)("<9@GF>)DH)3(CD00P:!=\QJ'0,=#UI-0IF0_-K
M"=<X1<DCER-/I1 YO 1YB.+CM_QQ;M^^^7]KY;39=O;E^+(RVS_Y6E=19YJF
M)A6NE;DKZL,%S2!7J;#;[I3(--<JR<,*2"X,.+6(76-<:,+$!5@]3_XB@C7T
M\=_!5-#8"AICHX?V?8&)G*EP8="1,Q'\(#C.-/"\KV\/%;']N-QLUV4&^"$B
MG1.&L4(<JL*="B9809JG!#*B+)$03!%"86U33HXS-?HHTR\/=EX1[3\'K!^3
M1(!K8 +IA52/5B:=.$3N7G)ZK)$;EG1.^+A'2??E_4CA/5\O[19R<V^YQFDT
M[O,"-<$FX3J#6A=VRT=P AGB#DF&<L60-C)0FO7<4-/;\/VAMTWC1KO'=OVI
M2Y569W1@>N99>(6R &:9ALIDUGD37$"1(PT1E<K^B.0DIR&D&P/<,5BWL1/<
M.R?$6>J33QF&K1_OQD!L8.+M!U8P\UY"(BKUGAUL5.Z]-.67Y'OQ^G[L^]MN
M8WE\LRGU8S;S,@_L?KWZL%H_\,]5W?N,$NN785- @J6+O3F=@(12R+,L*Z@1
MNN!!3.$QYM1(XW,?;4L?;/V8(C)B Y-&8RUHF7L#K+V@-!A< C.8/@+@B<HD
M/N..2BH!0+SDEY!;(V=P5%$/HS.1.T_/(.GRR7$!*5449IID.$\S0_.@GMW=
MPTTM!OW\P/][9T2D#[I^/!,/LX$IYL*Q?^2(DA\LXQS]OT(TR6_ZWL?_,2))
MMXO%ZD]7[6WYZ=UJ)[9FMVC:_G[64L]_NJKO&188LT0+F..<VBTDL7L<K#1D
MA<9(,8HSD<ZLE?.5^K+EZZT?L_@-'O*VO#1AP&^S_CY?.D>RGYJ<)^["<,X0
M1I 7PGJ,"<TM[I1#65""24J2E/$:]_=+];JH-P8,N(FJ.JD,";@?O<>'<&":
MWW=2/UAW _:S*#7WWJZUFF_!IZB$'P94W&Y/?D./V^HI"(ZC/D]A=U^1.G*B
M@Y0=4\^_+ZLFJO+IZYHO-Z[4N6RN7/ZM*GZZ5?^UJRK=_]#;._.5_[IWC9?M
M#UI-QKZNJA9CLRQ-29JJ F;(?5<RI"&760:3/%$YS7*4*1FLX3Z6]5/;6]>3
M!+*>)=@>)E8Z=JN>BO&C_3KXL>]D%WE@$C_?]Q"\<;3]UQO0_ HT&( 6".6O
M0 L&<,"AS.]UZ>P6"[L3J- XTQ8P<F+*V.L8/]=EM!F,GSXS]N*<S,@9W8BP
M#Z?2\]F[6HOM_][9C8=>+YX^ZT<[T*R0!6*:,LBQYG;;5%!(47DH+R1BJ:($
M,9_/6\<84_L(-6:"O9V@,M3ON].%9O?7(1)&0Q_ !\/C3:L> )P@OXV6__Y]
M]?-_VKLKWK-_*.FN)+JN9XY"1QZ3:DC#Y])^/K%3==(/?/W/1E*")0DB1#@1
MU5Q#C%()*>;6@35)@70J"A*FUO%R@*F]U ?[PKS'(^#\'+QKX!CX_3V8-H#H
MQKEY1_59C@89U:TX-\677_ZSUT5J__-I;JPOL=FMW7[Z?K68NQ+;6292R6E.
MH-2N^ GS!(J4&HAYBA E4J,\2@^@DZ-[_9:/WT.CW<?&[):N!-9HZW<IETSC
MJE6JS<2CO>G*ID"GU\3SP"4>Q*.V!VIW!W(F@[W-H#3ZZ:8E:39$,XPPX(9M
M'G1ZZ-?M(-0)Q\4V0MUWAV\TWB^W\^U39T=P1F6.L24MGC+LLOT(Y#K+[2)(
MR9%,D6!>4N]^PTW-4ZDL!J<ZB;<;B8,W^I?K3^'^N'7=17;KI[#N[)ZK<7G/
M$A?C@5G+$]XXFQE_9'KM:SP>/]H6QW^J[=U.P%WA[29NI5SOM(NF_-2+NBYU
MECIU$$HI%)A(B$7J]$$,@IS3@N4JE<QX!33.#3 U.JEM=)%T:V13&^[?<> D
MB-V<$ .:X4\32U0J^YKJ\"M1\6^P<"TZ(W5."$0IJ!5"%P0=/0Y.WC9:\X(N
MH]M="3JOZQ^<_3#?2+ZX+W,5/MA_V\Q80:7,"@Z9R7.[R2M2*$1!8"((S202
MA=/"#@S/'HTR-4K;1R K2T%E*BAM#8_1'H/J'Z6]"JJQXK0A*/4*U9Y%X:I@
M[?%31P_7GIW8J8#M^8MC"",^O;<;Z >^U7?FWO[ M75U%\QRPTVFE(8%DP+B
M C/($Z=]4V1Y)CC*)<']-1+/C#HU0FBL=.>_C[6=8!&<-^N'N%\T)SJ. [/%
M"_G$IQO0!K4Q.G)N51!( ZHJGAOY%046+X#1K;5XZ>;PK=17+7\L5XO5]Z?;
MI?K':OU/L[*_>%]6BUU9'5"?C4A&$%4XA4@XF3[-4LC<GPA1N$!$Y(I[>2/>
M(TZ-B Y&EZDJ?S9F@TUCM_\6PP_RRSNQZ$ .?3YUP- :#/86@[W)E\^M>H+I
MOX&+#NI(.[H8X 9M\X* ZMCW^3UGM(U@T+3:.\.P&Z\KY'R[>A#S9?D;]5G+
MU?>E$_/XJ.QOV=S,7=[0;5EC5 ?ZE36H)1UD?V9_(=O_,I-%FJ68*I@4VFXV
M,^SZUDD.<XH2*51.>1&DS3&0G5/[*+1,<U5=SMI^Q:.QU]//DYW *@W\Q=D7
MJ;:F> ,.DP3M68)JFLV1IRH_].TEKJ=ZT_['^/6M ZW&(#6QL6U]E3K:@0 _
M5WL[U'#]>_:Y_^\*]W[RA2[+-3;;]5QNM7(_L.,__X?6E3.=R31#4D"5N1(P
M17)($\QA@3)!B$YP5LCPTKNK; IAG_$J\IR1-Z#L J</MI8,L][/I/HYWP*Q
MK]]S88_2R/!V??U7515Y(J7(89HEQ)W2IU @DD(CL,DYPA0)$5K8-_*:#E_O
M%[:BVE6XO,9:2H$ED=:IHT(IB$U!71&3ACDV"4%:$,9$>$O-459R'!&F2F);
M>J_FF(OGY\:-MB #.VO5&U7VS6P9Z-RU_0*4/W2+\O+?6C?$[99Y-;#16V7V
MMVCT/IE7@W>J2>;U#^WG*57Y*Q^M Z;5+,N)-H9C6&0Y@IAR2[#<Y% ADR2I
M,8H3$>[XM(>8IA]SI"P WLR78<EI)_%4!2I4DF:0%-CU<T <BIPDKGF@R MB
M71!6A+H<UZ$YMF) )"#]/AE]H1GX"U"9=0,JP^(1^:GI1N7E9P.,2K.GIO:2
M-4]>TW.[>,CGN^?KN[7E'$NT_\D7.]UHULT*39'D%B2"E'V7L<X@SYG3G"PT
M*S*=2!/:Q?WRJ--S+.L\U$V5A_K(U^"G,[A\S]5JL>#K32G[6;[S@:^\SS)X
M.H]QH1W:17R6VVL-MK^\H#(9E#8?)"PCNH'^$,5U]CS&'=>E\P?BR'$+N+6G
M>^:>Z,[9[DQ5AVU=P1/5V7OU5F0(D<(DD!#.[<:895 03B%16.9)IG"1!NE=
M!HX_M:.,O?DN3'%2QJ&O?F[HPGAZ,,/!/;23$P/I<!>H'UYQO:1 &\9UI/H!
M=.1K]7Q,3X6\\JB@DIK8[M^@PF"J3)8[M\MNH3BFD"JIH>**&8(20Y,BS $[
M.<X$7:[*P%IA,U!#_3262M),480AHWEJG5G)(,M%!C/$,U50Z\ZF:<AGXFHD
MQ_@85&(^,CZ:?MQ^-48#,_AM+>#:_+H-P=>=&,35HCLYTKC2<UV3/5*:Z[RX
M9T:VYAN].?B&'.-,:@.IG0S$4DE([;L..>*&)]9?3)17F>KIQT_M;:^LZ^W?
MO<#.[Q7OC\C [[8_&.$YT2?G'#?Y^?D0XV8YGYS>43KSZ:MZ5YM;#ECSQ<>E
MTK_^+_TT*U22<(DH- EA]G.-[3N,E(+VWRG+.<Z+Q$O\YNP(4WMYFZ+GRDI0
MF@FLG<&%XB^ ['Z-H\ S\)L<C$R?^N_3L[^FY/O%$\>N\CX]H1.%W6<N#'^1
MOVCK:-HGOO\E?]CUTW_8-9T56MI-#%(0T=3UJ<TPY 9S2'*-A!%&$B)\W^-3
M TSM-6YL!(V1P%GI_Q*?!/'R.WPM-$.'2L)0"7J!NZ;>Z_T]^<#17M^NZ;3?
MWL[K^CG/=>.0#]8>5ZCDONO_F&]_O-UMMJL'O:ZD@K[J7]O?K+'_G#&#=8&0
M@ 4C".)$Y) Q@:!$J:2NQVS&@F25PX:?VHM?6]_D)+NLT##W.Q!]/_=\.$P'
M9HP&3O=R@,9T\*>U'33&@V^5^<#9#\H)1'3R^R$7=1,0:,*HFX1^\+S<1/1\
M2C]Z^X>>?_^QU>KVIUYS2Y@[5\=S9][-%SO[K\>J2H@0)=.T@%K9Y<$IHU!D
MB,.48*$0DPH)%!9]#;1@>G'9VM+^*2ZA:R!HD>2($4BPRWH5J?W&R+R 0IN"
MF)2B)*S-U( K,$;?J<9\P"O[G[4:W8!52WL, C7V8OE]D@9<@H&_27OT:]-!
M9;L[_CM6)[L!]8SB?9)Z(A?UFQ1JPZ@?I9X O?PJ]7U,O\_2!SY?E_D3OY<*
M@>69H^NTLENO[</KLF>=XS1GFD AG1:T4 6D>99"D1)%M$P+%I;DX#/HU#QL
M9W.5''0#VF:7=8"5X6'\YH6\'ZG%QG-@)FM#N;=R *WI$%BBTI37P*-R4P@4
M+PDIZ-YPY9 ON\?'1?E0OG@WW\C%R@VRN3-_K)8N]7ZO#7R[5!_F2[Z4[L][
MF>"/]K[E]_F^X-$Z;8KFA!20&%% G+@.Q*X +9'8B 011IE7['X VZ;&:0?[
MZM-Y?[V,V*O6372OO!9#QR=;,P.MJ8$[ ^SDJM*DED3V4H']!%N"V4Y&>[^>
MMZ^\GOY**:^XKB-IJKS"^@9)L RT AUB+;%''$W692"HV@(P0PW1;W]0Y1E^
MY;\.IARBP%HY =$,09Q* W&.#.0F03!G:<%S1KAD25B,JFNXZ06DZD1;:VZ'
M@D<XK'Y.?RRH!OZX'3!J41_X-DC4W >2J(Y^YX"C.O@^4W_IV'O=TU>;=/G=
M>K /[[38?K6/N/TUW\PT1231*8<\R82E"T$AYPF%J4 YR])4*!,D#W5JD*FY
MV,Y&Z(P$SLH;X.P$WYREH?EQIQ#U8XIK<1J8(?I U$-)]#P&D85#3PPTLD[H
M^:D>RX)V7!N>A%.GTU9*Q_^/YNOW2_6.;[4K=*>4$@RQ8@QBI FDPG +8H&P
M8!FSM.";B'-ND*F]^DU>=RVO[2P%UE3@;/5/R3D+:?>['PNH@=_]7A@%)>A<
M J%7DL[9AXZ6J'-I6NUDG8O7]DW8<7;.%_-R^WQG6L?I7_3WNDG4V]5RLUK,
M5=G*S<F2S8J$R(P0":GA=M- 1 :%EAQ**3/K#AC&51Z6N-/'C*F1Q?-9N,A
MDX/B)@*:F8"O*]">BW6DW6P"?8F>*^?G;0R_'@-STHNE6!V6PCQ;BFW@4O1(
M KH&R<C)0+U,&3DIZ!JXCI.#KGI:ST+,Q6+UIY-Q^;!:OUOMQ-;L%K=2KG;5
MB8N>_W2#_&,]=\KM9C,3.1;4R6,4NN"N3H%!X2044UGDF1"&T9SV:.89:(;7
MNSM^5\_;A])@\*>U<ZO=BVR _,'7WUT&RW<^7VZV8/M# ][,-K T,7"M_-AS
M".A'ZYA5X7TP\P;LIP/,:@W>KK6:;\L>$3>@G(-=DXC%COVPBUL&&6C#N 62
M_0 Z*IWL^9A^G%A6$;>4:O^P<WU1#YQ3*A5))$1(V-TESS3DV(G(9BI!0J:2
MI4&YX)>'G)K[6)5:+_:1E,7!^,"*:P^X_9@L+H@#DU>%7\O:&W"P=Y R3G]X
MHO*3Q["C4I(_#"]9*.#.JZ6 W+G;!TMZA_IDI9%1>2I<6@F&6&82LC0S4&,E
MB1:8%C*HK5;78%,CF^?2,^[PNC0WAK3/,=!^9!,+OH%IY@KDKI'J.0O)4+H\
MQP.^E@C/V:EW*.Z<OZ=GCNU\:5VA3_.?6KT\G?^=_]=J_7;!-QM70?=N]6"W
M);.$IAG2.8-9HIT<?JJA,(A JI!.<D&D46'IMF'C3XUN*O-A:?]Q"LP-*.<
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M;^Q:H$L3/U'><_&6?I3Q^VJI+1VM_ZFW'W9+U;CXJ$BXI(Q Q4A97IE BHV
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M;'F&3H:ODIL,G03[P&)THP/ "K1<7("&=+ CNR%4;X !" 9L'^!#S0MV&!@
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M[^YB;%>*.FG6=7BHWT3TG4-INP0E2L^<I#@B.XHH6)80K420,0G#..-YM[8
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M^ME(<)I1C%^L4$'*R'F;CD*[4-=;=X(3 >](-?5L\J[J^FYQYZ4/RJ  EUT
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M)9TBZ^(@\G+%)9G)'&+M.52',)=Z(9>[#!KI%SSEF$O;0J-'2>LC"7T4 '8
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MHF#'LI=]5-(ILFZ?V/-,.ZHPC#A(F=9ELK5H3 /+24@4!:-L,W/L!RU[V0L
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MZ>AS@%XIQMBCI?CK%B8I6Y:9!;(D:?/PC( Q:[B<;9N4]GD[=&QX24^U:8.
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MDKDPD &)Y$3+",($$ $32U;3 K:I(GSTX'&=VW:X.(R#'9Q3VY0%L>"2E:F
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MO>+W@,C8=7)#2/5)@.S)XI'#$O_ KYD4[7_/EO,W9S@YOR[:DI@Q&^\@<I=
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M5<-CZ'">=P"<CQ??\OR2-W^0RLYGI,GS;'G-J%/!/!JN%'"R)TEG*U.[5&I
M[44L#G4.;;J4/D/8N-D"PX-I2#GT!:OK%:3(>8[2U8M0XHX+$=#1@J3!F$4Q
M6>HV)1F/:1GW K$I>/;A]OYXF9'3.$SBVGSV/<\O?GXBV%_0<5R/XN^KX5#Y
MED6H:H:?]V!B;61A/<&?D^]K/0KM-8^6MRD"W8:Z<4^W(UC@@XNH S7U;CF?
M3BYJ]=,TO9O\53\M_FM>[Y>2+DIKP< :DVM-IH: ID"RF7Q^*[1HY-,^2=*X
M)OCPTG\X"F00472 J3?X?4)J<?*_Y%O,SK\OZ<DGLW+Q+V+SY7JRL8Z%J(&5
M5/N):7(M'%=@,[D6,<94;)N,FN<H&U>%-4?8H(+I &BKAG+?9F?I]_/O\]F/
M50SW:LM( H IB;P.P^GT%[X RAB =+]PW*B4;*,BDR=I&M=@;PZN@831 :R>
M9-7E:F@7&!]$K"T1:#75TZVV*7CB3O*,Z;)=?NAP1MCV\&IFTC>'UX!"Z<#:
M?Q7C\GQY::5F(B).5I*BSV=Y);)I>G4^FU],_G?U_9.+/Y79>1V*!B]-#;8H
M#H[E EI$)WQ"A0]'Y0X5A!]H!>/VSVT.VU$$/7ZG\&WX>RI+\E&1C6%\BJ",
MR^!Y4B"""F1HL*1XF^X]FZ@:M_'N>&IT5X%TH$3O!'UN>W=@3(JL5Q H12U>
MD-6"9>"LD-(+H[5IX[6N(69<@^\( 9%#!3!@K]5#O-7%MY-5S)#DL4KO_EC>
M3TK^?4J,JAP\+84I8[#.C%JUC^5DR-JB0&K.L0067*,Y9<^2-FY$Y&#Q/W)/
MAY1$!X[$4U<:IT)(;S(=YB9'#\HQ!A@D[3S!@["F9.7:I+P]1=&X@8^A@30(
MW_O"SX?9-%Y?A&7KZBZ@193:N30C."DM9&=SL%&R5GDW:\D9]Y!KB)P].=Z!
M740^1YW)N_B$/^N%?'4Q:A%3OCN]]>'E6]8\>,\D&)O(?\[: &)4X R+=9Z'
M2JZ-W;0'L>-&.HZ1ZM58@!VHM@=+_#+'E*]O;G-467I-&[@H6HH2M(&M9A"%
MS-9*%2)K<SIN(&KD]*_6@-@,P+VE,W(;LH?+F)TL0YQ-5_R9S4]1DU.KG(5D
M!:GU&E<)OL95C O:A"SC5C/P-K]EY)RO(P%G8&[WH:#6\^D4LPX\U/&03(3Z
M0P(6<D=LT2&J5+A3S8[*]22-G IV?.4T@&0Z@-@6E>;7*S,EI&3(T^5D;X(J
MV@)&C5#(G%7<>I:W:T:S^W7FUC2.G%)V9! VDET'J#S)9^4FXO*9I#C_<;.4
M&- H$1&2#M6U$A9<\A*8+['F!Z"Q;5S/#42->X%T;-P-)9T.@';I:V_!O[J#
MT"D9(5A+OA0Z#4Y$1[Z482%)- 5;)LYN0>*XMT;'!F$;R?7E+-RNY^U?W_-T
MD1=O_XIGR]KC\.K[FD)%_X!7U[BO\S27R6W^L? 8I%<6;/ )%-<> B>C%X4R
M#B,6X>/NWL6A9&T%5/O2@3JV/#L( M[.J5J%J-8P>)IN0YRWP=-LR=>G#5N<
M8*"<1*C-'X QSISUUHA&<<#]Z!WW\#]"*/ (8NS %+C:@2?$S_D=?TYR)XLA
MN$0M.6U]%L%S&T BRSYXCJZT*09=3\^X,<!C(&&]IWV(6,8_U.L*7L^FRSK0
MNLY^.3^?+!8DL\4I,8"324+NF!&>]J71X&T6(#AJCR49I]-V)_23[Q@W^G=$
MR S*[#Y \V6./_+9E;5P*JW0RD8#W&E9QWG$.LJ10?2&6VM%$E%O#Y9[SQXW
M?#<.2/9G;C_'U8T??J,80RS>IJH80VT 2<9B(#;5SKED/?K,<FB6C+N.H'%#
M<N,=6 <)I@-\_6,V_R<][*Y#<LV]G]=+XH8'ESB"4S6J:,@=08\,K"\VHBB&
MLS8%+EL0-ZY5/@+NAA98!QB\GI"]<4TBE)#HX :FZEUPG141LBN@-1:O2ZWA
M;I/!O0UUX\;D1D#AX"+K (:K4..SO#SUB3F5,8-V=? -DG7IN*P=V7Q*B>?B
M'S;+&S)"_"Q]XT;=1H!B [%U ,;G%Z1=YLI8!R'5*IV:91IJ#PI3=YOVUD;?
MIAGM,!!TOQ $AQ56!Q'=U9ZZLXPU_+(942=O0:?+84L%7# 1R*M2V8MD$!NF
M!F^D;=S3^%C%,,.)IP-UM\FJO9,=;;7W43(/B=6J,=H\=1MY8"*8$KE0'MMX
MO=O1UT&-S("HV,'QV%-$'0!O79+#G=5(S"P27R 71ZO1D:P&4P(8QV-"KI4U
MJ@G@-M/500U-.Z -*)(. ':S1][-YG^G!<TO<#+]@G]]FBTF56!WBS^RM#)B
MDE"L\:"4">"M%\"RB"R(3"Y4FYY;.Q#901%..^BU$E8'.%QQ[F0Y3?.?:_EW
MZH6/HJ0 (M1]%2,''^M -LMYD(89+]K<@#Y'V;BAY<:(&U0LO<!L_4J*]M)X
M4T"8.HK#,B2+ERM FZWA&;4J;5IQ/4W3N-'C8T#K<%$,YHX^.57@ZA_JCX"+
M_'__S_\'4$L#!!0    ( #N"95,(U^OE0R   % * 0 :    86UN+65X,3 Q
M>#(P,C$P.3,P>#$P<2YH=&WM/6MSVDBVW^^OZ/7L3G"5+".>QLFFBMADXAT;
MIS SV7RZU:#&:",D5A(F[*_?<TYW2T((&_P(<I;4KL?6H]5]^KQ?_>XOY]=G
M_:^?.VP<35SV^8\/EQ=G[.#H^/A+]>SX^+Q_SC[UKRY9S2Q;K!]P+W0BQ_>X
M>WS<Z1ZP@W$434^/C^?SN3FOFGYP>]SO'>-0M6/7]T-AVI%]\/X=7H&?@MOO
M_^_=7XZ.V+D_G$V$%[%A('@D;#8+'>^6?;%%^(T=':FGSOSI(G!NQQ&KE"L6
M^^('WYP[+N]'3N2*]WJ<=\?R[W?'])%W ]]>O']G.W?,L?]^X%1'3<OFMM5J
MU$2M-JCR9KE2&=DMSOE);=!H_;\%DSR&Q^4[8;1PQ=\/)HYW-!;X_=-&<QJ]
MG3MV-#ZURN6_'2P]%XGOT1%WG5OOE&8+=T<^K$W='OJN'YS^4J9_;_'.T8A/
M''=Q^J;O3$3(NF+.>OZ$>V^,$"!\%(K &<D'0^<_ KX('Z<_YW(V31C'=3RA
M9W>",^K\\]/%AXL^L\JF]>X8']=+BA<FYP70"=XO/Y%>- ]N8=V1/SVMF77X
M\)3;-NS-D2M&T:G5K)F5U$5:;WPU!8@A;(H(GAT2E0<@85GUO\EIV&+H!QR1
M]73FV2+ IP[>7W;:-QW6[_2N+KKM_L5UE[5_ZW4Z5YUN?Q.(E,T:@.1@2SB6
MS?(*("O5%2@V+?.DO@S%?\W"R!DMY"4'EN%%I]6ZV4HF\7*@K>6 ]N!]?^R$
M[%+P4+"^"(!"",2L?1L(001=BO")7W^IUMYJV/QX%#AX'T_HQTPB'U@$A4,&
M\"!J #;G>)'/>,C\$8O&@K6B,;/Y O^\$=-(3 8B,"2S*^']7W\YJ53*.P5D
M9S02P\BY$^P<&/5NH0G L-X>&FRP8-RSV4!$<R$\]OO%9>_Z*^MUVI?]KP:[
M-#^;!N/L7+A\S@/!7&?BH(R9\B#R1!".G2DK%0"TE[ (^))=#* B1-M77?8)
MP?CIK-WK&.RB>T:@[(H[;G,&''6JF&HA -@7'M\UA4OPF2MR8$L9T<J1$2A6
MK7JNM+7J.Q&W>4"X3]SV6(>=L0O69VUVR6YVN5/ 2^LG;Y^Z3:  ;"C_-Y#V
MS:(+^[:YNQW+D()9;2$8-,LD;B7)?UFV1F,.1H4((NYX['HT<H9"JBL&"%H4
M NUIX+BL@E*V7"F,E$W/M C\S$ EA8/^9 /(0-PN@?6C$X01:^-=4OD [.GY
M*T!++><*M)NJ53!H9Q90>(#? '-%Z;P1Q/\Q\P2KE@GDC<* /+N$@L#<L^^#
M.Q@[P2/ ;M4* _;,"HH =0F;9=:<(4AC%>.)WV>V W1[ W12UY4&BKLP6$'
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M+@9+BI1L;.9J*!1[<28383LR-5ZF+^A0\#H=VUAO4&J28J[OW:JTC,B), +
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MD U=#L]YMXPH)FZDDMZ\![$(@<X&@>]/CN!#W$MRV\R5I"_50U2HUJ,$#OR
M/@$$.25UT?4]%=55Q1_9?#1@C"!8="&$K*.%'< $.\P:ML5(Y^T6/!F[:KY,
ME^\GU#H<+M-=>W8+$B@.UAE:-X9O>YBT+/X]<P)JGV$K=*%13-@D0D%,N]Z"
MD%^6JBJ/H*KMB.K-EE2UAO6MIRI#IX*B("3 ;4)E&0(*@8!*(>TT+F#B>S-9
M7ZZN8]9DG)$;^/_")$A'YEO(PR5U6FT^86ZSX9NBT](JT_G#@9AR)T!4P=(
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M?4XKSHI/W0,+I8_J)@-X2_=:*('RB.6OVP**%.:$$1\^#^!4H7W&,G F@UD
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MF$J#,@+-"JR.2 08-AK(=,!L11^S^B- F@4GU(%<6H5Z@Z3+2+H!=M"6D'J
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M'&NE3>==T_\=4DJMSU.IQIV?NS(%RS[!B%WKE&<_5RU.0\V"D?V0T<JOT#E
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M0C2DON0]J:0;DP58URPM.\])3[>P8A:RSME:'T/NR@[EA<F1[M9;ECC61G@
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MJ-=/I\5>AU777M]Z">%^_<VN@220]-)34)(H0K9G9^:9U]W9SIO^J!=^/Q_
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M              "  28M @!A;6XM,C R,3 Y,S!?9S$N:G!G4$L! A0#%
M  @ .X)E4Z84*7^CP   Z<<' !0              ( !$U," &%M;BTR,#(Q
M,#DS,%]L86(N>&UL4$L! A0#%     @ .X)E4^M9&S;8=   )D$% !0
M         ( !Z!,# &%M;BTR,#(Q,#DS,%]P<F4N>&UL4$L! A0#%     @
M.X)E4PC7Z^5#(   4 H! !H              ( !\H@# &%M;BUE>#$P,7@R
M,#(Q,#DS,'@Q,'$N:'1M4$L! A0#%     @ .X)E4U)EB]$E"   4"H  !H
M             ( !;:D# &%M;BUE>#,Q,7@R,#(Q,#DS,'@Q,'$N:'1M4$L!
M A0#%     @ .X)E4V;&^$LH"   ,RH  !H              ( !RK$# &%M
M;BUE>#,Q,G@R,#(Q,#DS,'@Q,'$N:'1M4$L! A0#%     @ .X)E4QEAZ4L=
M!0  5!<  !H              ( !*KH# &%M;BUE>#,R,7@R,#(Q,#DS,'@Q
M,'$N:'1M4$L! A0#%     @ .X)E4P)AH.X7!0  >18  !H
M ( !?[\# &%M;BUE>#,R,G@R,#(Q,#DS,'@Q,'$N:'1M4$L%!@     ,  P
*+0,  ,[$ P    $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
